PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Jung, SK; Jeong, DG; Chung, SJ; Kim, JH; Park, BC; Tonks, NK; Ryu, SE; Kim, SJ				Jung, Suk-Kyeong; Jeong, Dae Gwin; Chung, Sang J.; Kim, Jae Hoon; Park, Byoung Chul; Tonks, Nicholas K.; Ryu, Seong Eon; Kim, Seung Jun			Crystal structure of ED-Eya2: insight into dual roles as a protein tyrosine phosphatase and a transcription factor	FASEB JOURNAL			English	Article						branchio-oto-renal syndrome; eyes absent phosphatase; halo-acid dehalogenase	EYES-ABSENT GENE; BRANCHIOOTORENAL SYNDROME; PHOSPHOSERINE PHOSPHATASE; HUMAN HOMOLOG; DROSOPHILA; MUTATIONS; EYA; COMPLEX; BOR; DEPHOSPHORYLATION	Eya proteins are transcription factors that play pivotal roles in organ formation during development by mediating interactions between Sine Oculis (SO) and Dachshund (DAC). Remarkably, the transcriptional activity of Eya proteins is regulated by a dephosphorylating activity within its Eya domain (ED). However, the molecular basis for the link between catalytic and transcriptional activities remains unclear. Here we report the first description of the crystal structure of the ED of human Eya2 (ED-Eya2), determined at 2.4-angstrom resolution. In stark contrast to other members of the haloacid dehalogenase (HAD) family to which ED-Eya2 belongs, the helix-bundle motif (HBM) is elongated along the back of the catalytic site. This not only results in a structure that accommodates large protein substrates but also positions the catalytic and the SO-interacting sites on opposite faces, which suggests that SO binding is not directly affected by catalytic function. Based on the observation that the DAC-binding site is located between the catalytic core and SO binding sites within ED-Eya2, we propose that catalytic activity can be translated to SO binding through DAC, which acts as a transcriptional switch. We also captured at two stages of reaction cycles-acyl-phosphate intermediate and transition state of hydrolysis step, which provided a detailed view of reaction mechanism. The ED-Eya2 structure defined here serves as a model for other members of the Eya family and provides a framework for understanding the role of Eya phosphatase mutations in disease.-Jung, S.-K., Jeong, D. G., Chung, S. J., Kim, J. H., Park, B. C., Tonks, N. K., Ryu, S. E., Kim, S. J.. Crystal structure of ED-Eya2: insight into dual roles as a protein tyrosine phosphatase and a transcription factor. FASEB J. 24, 560-569 (2010). www.fasebj.org	[Jung, Suk-Kyeong; Jeong, Dae Gwin; Park, Byoung Chul; Kim, Seung Jun] Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Taejon 305600, South Korea; [Chung, Sang J.] Korea Res Inst Biosci & Biotechnol, BioNanotechnol Res Ctr, Taejon 305600, South Korea; [Kim, Jae Hoon; Ryu, Seong Eon] Korea Res Inst Biosci & Biotechnol, System Prote Res Ctr, Taejon 305600, South Korea; [Kim, Jae Hoon] Jeju Natl Univ, Coll Appl Life Sci, Fac Biotechnol, Cheju, South Korea; [Tonks, Nicholas K.; Kim, Seung Jun] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Ryu, Seong Eon] Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Jeju National University; Cold Spring Harbor Laboratory; Hanyang University	Kim, SJ (corresponding author), Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, 52 Eoeun Dong, Taejon 305600, South Korea.	ryuse@hanyang.ac.kr; ksj@kribb.re.kr	Kim, Seung Jun/N-5248-2019	Kim, Seung Jun/0000-0002-6913-6358	Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	Korea Research Institute of Bioscience and Biotechnology Research Initiative Program	The authors thank the staff of Pohang Accelerator Laboratory 4A Macromolecular Crystallography Wiggler Beamline (Pohang, Korea) and SPring8 BL38B1 (Hyogo, Japan) for their help with data collection. This research was supported by a grant from the Korea Research Institute of Bioscience and Biotechnology Research Initiative Program.	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Azuma N, 2000, HUM MOL GENET, V9, P363, DOI 10.1093/hmg/9.3.363; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bui QT, 2000, GENETICS, V155, P709; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Epstein JA, 2003, NATURE, V426, P238, DOI 10.1038/426238a; Ghosh A, 2008, MOL CELL, V32, P478, DOI 10.1016/j.molcel.2008.09.021; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; JEMC J, 2007, ANN REV BIOCH, V76; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krishnan N, 2009, J BIOL CHEM, V284, P16066, DOI 10.1074/jbc.C900032200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Lu ZB, 2005, BIOCHEMISTRY-US, V44, P8684, DOI 10.1021/bi050009j; Migliosi V, 2004, CLIN GENET, V66, P478, DOI 10.1111/j.1399-0004.2004.00318.x; Mutsuddi M, 2005, GENETICS, V170, P687, DOI 10.1534/genetics.104.039156; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozaki H, 2002, J HUM GENET, V47, P107, DOI 10.1007/s100380200011; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2006, FEBS LETT, V580, P3853, DOI 10.1016/j.febslet.2006.06.009; Rayapureddi JP, 2005, BIOCHEMISTRY-US, V44, P751, DOI 10.1021/bi0481794; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Rebay I, 2005, TRENDS GENET, V21, P163, DOI 10.1016/j.tig.2005.01.005; Ridder IS, 1999, J BIOL CHEM, V274, P30672, DOI 10.1074/jbc.274.43.30672; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Vincent C, 1997, EUR J HUM GENET, V5, P242, DOI 10.1159/000484770; Wang H, 2005, J MOL BIOL, V348, P917, DOI 10.1016/j.jmb.2005.01.072; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Zhang ZY, 2002, ANNU REV PHARMACOL, V42, P209, DOI 10.1146/annurev.pharmtox.42.083001.144616	43	34	39	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					560	569		10.1096/fj.09-143891	http://dx.doi.org/10.1096/fj.09-143891			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19858093	Green Accepted, Green Published			2022-12-25	WOS:000274045000023
J	Hao, L; Rizzo, P; Osipo, C; Pannuti, A; Wyatt, D; Cheung, LWK; Sonenshein, G; Osborne, BA; Miele, L				Hao, L.; Rizzo, P.; Osipo, C.; Pannuti, A.; Wyatt, D.; Cheung, L. W-K; Sonenshein, G.; Osborne, B. A.; Miele, L.			Notch-1 activates estrogen receptor-alpha-dependent transcription via IKK alpha in breast cancer cells	ONCOGENE			English	Article						breast cancer; estrogen; ER alpha; IKK alpha; Notch-1	NF-KAPPA-B; EPIDERMAL-GROWTH-FACTOR; CYCLIN D1; INDEPENDENT ACTIVATION; KINASE PATHWAY; C-MYC; GENE; TARGET; BINDING; EXPRESSION	Approximately 80% of breast cancers express the estrogen receptor-alpha (ER alpha) and are treated with anti-estrogens. Resistance to these agents is a major cause of mortality. We have shown that estrogen inhibits Notch, whereas anti-estrogens or estrogen withdrawal activate Notch signaling. Combined inhibition of Notch and estrogen signaling has synergistic effects in ER alpha-positive breast cancer models. However, the mechanisms whereby Notch-1 promotes the growth of ER alpha-positive breast cancer cells are unknown. Here, we demonstrate that Notch-1 increases the transcription of ER alpha-responsive genes in the presence or absence of estrogen via a novel chromatin crosstalk mechanism. Our data support a model in which Notch-1 can activate the transcription of ER alpha-target genes via IKK alpha-dependent cooperative chromatin recruitment of Notch-CSL-MAML1 transcriptional complexes (NTC) and ER alpha, which promotes the recruitment of p300. CSL binding elements frequently occur in close proximity to estrogen-responsive elements (EREs) in the human and mouse genomes. Our observations suggest that a hitherto unknown Notch-1/ER alpha chromatin crosstalk mediates Notch signaling effects in ER alpha-positive breast cancer cells and contributes to regulate the transcriptional functions of ER alpha itself. Oncogene (2010) 29, 201-213; doi:10.1038/onc.2009.323; published online 19 October 2009	[Pannuti, A.; Miele, L.] Univ Mississippi, Med Ctr, Inst Canc, Jackson, MS 39216 USA; [Hao, L.; Rizzo, P.; Osipo, C.; Wyatt, D.; Cheung, L. W-K] Loyola Univ Chicago, Cardinal Bernardin Canc Ctr, Breast Canc Program, Maywood, IL USA; [Cheung, L. W-K] Loyola Univ Chicago, Dept Prevent Med & Bioinformat Core, Maywood, IL USA; [Sonenshein, G.] Boston Univ, Dept Biochem, Boston, MA 02215 USA; [Osborne, B. A.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Mississippi; University of Mississippi Medical Center; Loyola University Chicago; Loyola University Chicago; Boston University; University of Massachusetts System; University of Massachusetts Amherst	Miele, L (corresponding author), Univ Mississippi, Med Ctr, Inst Canc, 2500 N State St,Guyton 2 Bldg,Suite G751-05, Jackson, MS 39216 USA.	lmiele@ci.umsmed.edu		Miele, Lucio/0000-0002-5853-7287; rizzo, paola/0000-0001-7174-9674	Schmitt Fellowship Foundation;  [P01AG025531]; NATIONAL INSTITUTE ON AGING [P01AG025531] Funding Source: NIH RePORTER	Schmitt Fellowship Foundation; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Grant P01AG025531 (LM, BAO) and the Schmitt Fellowship Foundation (LH). We are grateful to Geraldine Weinmaster, Peter Strack and Rafi Kopan for the gift of reagents and cell lines, and to Sarah Bray for helpful discussions.	Aguilera C, 2004, P NATL ACAD SCI USA, V101, P16537, DOI 10.1073/pnas.0404429101; Albanese C, 2003, MOL BIOL CELL, V14, P585, DOI 10.1091/mbc.02-06-0101; Arsura M, 2003, ONCOGENE, V22, P412, DOI 10.1038/sj.onc.1206132; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baonza A, 2005, DEV CELL, V8, P529, DOI 10.1016/j.devcel.2005.01.019; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Bunone G, 1996, EMBO J, V15, P2174, DOI 10.1002/j.1460-2075.1996.tb00571.x; Callahan R, 2004, J MAMMARY GLAND BIOL, V9, P145, DOI 10.1023/B:JOMG.0000037159.63644.81; Callahan R, 2001, J MAMMARY GLAND BIOL, V6, P23, DOI 10.1023/A:1009512414430; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cenni B, 1999, TRENDS ENDOCRIN MET, V10, P41, DOI 10.1016/S1043-2760(98)00121-0; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; Dickson BC, 2007, MODERN PATHOL, V20, P685, DOI 10.1038/modpathol.3800785; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; DUBIK D, 1992, ONCOGENE, V7, P1587; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; ElShamy WM, 2004, NAT CELL BIOL, V6, P954, DOI 10.1038/ncb1171; Fernandez-Majada V, 2007, P NATL ACAD SCI USA, V104, P276, DOI 10.1073/pnas.0606476104; Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035; Gallahan D, 1996, CANCER RES, V56, P1775; Gillesby BE, 1997, BIOCHEMISTRY-US, V36, P6080, DOI 10.1021/bi962131b; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hayward P, 2005, DEVELOPMENT, V132, P1819, DOI 10.1242/dev.01724; Iso T, 2001, MOL CELL BIOL, V21, P6080, DOI 10.1128/MCB.21.17.6080-6089.2001; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Jehn BM, 1999, J IMMUNOL, V162, P635; JELTSCH JM, 1987, NUCLEIC ACIDS RES, V15, P1401, DOI 10.1093/nar/15.4.1401; Ribeiro MSJ, 2007, BIOCHEM J, V404, P289, DOI 10.1042/BJ20061900; KATO S, 1995, SCIENCE, V270, P1491, DOI 10.1126/science.270.5241.1491; Kiaris H, 2004, AM J PATHOL, V165, P695, DOI 10.1016/S0002-9440(10)63333-0; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Likhite VS, 2006, MOL ENDOCRINOL, V20, P3120, DOI 10.1210/me.2006-0068; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Maier MM, 2000, BIOCHEM BIOPH RES CO, V275, P652, DOI 10.1006/bbrc.2000.3354; Martin MB, 2000, ENDOCRINOLOGY, V141, P4503, DOI 10.1210/en.141.12.4503; Miele L, 2006, CLIN CANCER RES, V12, P1074, DOI 10.1158/1078-0432.CCR-05-2570; Miele L, 2008, EXPERT REV ANTICANC, V8, P1197, DOI 10.1586/14737140.8.8.1197; Nam YS, 2007, P NATL ACAD SCI USA, V104, P2103, DOI 10.1073/pnas.0611092104; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; NUNEZ AM, 1989, EMBO J, V8, P823, DOI 10.1002/j.1460-2075.1989.tb03443.x; Park KJ, 2005, MOL CELL, V18, P71, DOI 10.1016/j.molcel.2005.03.006; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Reedijk M, 2008, BREAST CANCER RES TR, V111, P439, DOI 10.1007/s10549-007-9805-3; Rizzo P, 2008, CANCER RES, V68, P5226, DOI 10.1158/0008-5472.CAN-07-5744; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Song LL, 2008, ONCOGENE, V27, P5833, DOI 10.1038/onc.2008.190; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Vooijs M, 2004, J BIOL CHEM, V279, P50864, DOI 10.1074/jbc.M409430200; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Wu J, 2005, MOL CELL BIOL, V25, P1458, DOI 10.1128/MCB.25.4.1458-1474.2005; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	61	94	98	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2010	29	2					201	213		10.1038/onc.2009.323	http://dx.doi.org/10.1038/onc.2009.323			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	544IU	19838210	Green Accepted			2022-12-25	WOS:000273650000004
J	Thobe, MN; Gurusamy, D; Pathrose, P; Waltz, SE				Thobe, M. N.; Gurusamy, D.; Pathrose, P.; Waltz, S. E.			The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells	ONCOGENE			English	Article						Ron receptor; prostate cancer; chemokines; receptor tyrosine kinase; Met receptor; angiogenesis	HEPATOCYTE GROWTH-FACTOR; FACTOR-LIKE PROTEIN; CXC-CHEMOKINES; TUMOR-GROWTH; C-MET; ALTERED EXPRESSION; ENHANCES GROWTH; BREAST-CANCER; KAPPA-B; PROGRESSION	Overexpression of the Ron receptor tyrosine kinase has recently been shown in a wide variety of human cancers. However, no studies have examined Ron receptor expression or function during prostate tumorigenesis. In this study we report that Ron is highly expressed in human prostate adenocarcinoma and metastatic lymph nodes when compared with normal prostate or benign prostate hyperplasia. Furthermore, we show that Ron is over-expressed in PC-3 and DU145 prostate cancer cell lines, and that the levels of angiogenic chemokines produced by prostate cancer cells positively correlate with Ron expression. The knockdown of Ron in PC-3 or DU145 cells results in a significant decrease in angiogenic chemokine production and is associated with a decreased activation of the transcription factor nuclear factor-kappa B (NF-kappa B). Moreover, exogenous overexpression of Ron in LNCaP cells is sufficient to induce a significant increase in angiogenic chemokines that can be abrogated by inhibition of NF-kappa B signaling. Given that the function of angiogenic chemokines is important in the development of new blood vessels, we also examined the ability of Ron to modulate endothelial cell migration. Our data show that knockdown of Ron in prostate cancer cells results in significantly less endothelial cell chemotaxis when compared with Ron-expressing cells in vitro as well as in reduced tumor growth and decreased microvessel density after orthotopic transplantation into the prostate in vivo. In total, our data suggest that the Ron receptor is important in modulating prostate tumor growth by modulating angiogenic chemokine production and subsequent endothelial cell recruitment. Oncogene (2010) 29, 214-226; doi:10.1038/onc.2009.331; published online 19 October 2009	[Thobe, M. N.; Gurusamy, D.; Pathrose, P.; Waltz, S. E.] Univ Cincinnati, Dept Canc & Cell Biol, Coll Med, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Waltz, SE (corresponding author), Univ Cincinnati, Dept Canc & Cell Biol, Coll Med, Vontz Bldg Mol Studies,3125 Eden Ave, Cincinnati, OH 45267 USA.	susan.waltz@uc.edu	Gurusamy, Devikala/T-3410-2019	Waltz, Susan/0000-0003-3572-4642; Gurusamy, Devikala/0000-0002-1727-8653	National Institutes of Health [CA-125370]; Department of Defense Congressionally Directed Medical Research Programs [PC060821]; NATIONAL CANCER INSTITUTE [R21CA125370, R01CA125379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Congressionally Directed Medical Research Programs(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Sandy Schwemberger for her assistance with the flow cytometry experiments as well as Sarah Kader for her technical contributions. This work was supported by Public Health Services Grants CA-125370 (SEW) from the National Institutes of Health, and by grant project no. PC060821 (MNT) from the Department of Defense Congressionally Directed Medical Research Programs.	Addison CL, 2000, J IMMUNOL, V165, P5269, DOI 10.4049/jimmunol.165.9.5269; Balbay MD, 1999, CLIN CANCER RES, V5, P783; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; Bezerra JA, 1998, J CLIN INVEST, V101, P1175, DOI 10.1172/JCI1744; BEZERRA JA, 1993, HEPATOLOGY, V18, P394, DOI 10.1016/0270-9139(93)90024-H; Chen YQ, 2000, EXP CELL RES, V261, P229, DOI 10.1006/excr.2000.5012; Collado B, 2007, PEPTIDES, V28, P1896, DOI 10.1016/j.peptides.2007.04.015; CRAFT PS, 1994, ANN ONCOL, V5, P305, DOI 10.1093/oxfordjournals.annonc.a058829; Dhanasekaran SM, 2004, FASEB J, V18, P243, DOI 10.1096/fj.04-2415fje; Greene GF, 1997, AM J PATHOL, V150, P1571; Hepburn PJ, 1997, PROSTATE, V33, P123; Jimenez JA, 2006, UROL ONCOL-SEMIN ORI, V24, P260, DOI 10.1016/j.urolonc.2005.11.022; Keeley EC, 2008, ARTERIOSCL THROM VAS, V28, P1928, DOI 10.1161/ATVBAHA.108.162925; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Leonis Mike A, 2007, Future Oncol, V3, P441, DOI 10.2217/14796694.3.4.441; Li YH, 2003, CANCER BIOTHER RADIO, V18, P829, DOI 10.1089/108497803770418373; Lissbrant IF, 1997, PROSTATE, V33, P38; Loh SA, 2009, PLAST RECONSTR SURG, V123, p65S, DOI 10.1097/PRS.0b013e318191bdf4; Maggiora P, 1998, ONCOGENE, V16, P2927, DOI 10.1038/sj.onc.1201812; Moore BB, 1999, AM J PATHOL, V154, P1503, DOI 10.1016/S0002-9440(10)65404-1; NIKOLAIDIS NM, 2009, SHOCK IN PRESS; O'Toole JM, 2006, CANCER RES, V66, P9162, DOI 10.1158/0008-5472.CAN-06-0283; Peace BE, 2005, CANCER RES, V65, P1285, DOI 10.1158/0008-5472.CAN-03-3580; Peace BE, 2001, ONCOGENE, V20, P6142, DOI 10.1038/sj.onc.1204836; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Puri N, 2007, CANCER RES, V67, P3529, DOI 10.1158/0008-5472.CAN-06-4416; Ren Y, 2005, CLIN CANCER RES, V11, P6190, DOI 10.1158/1078-0432.CCR-04-2553; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Salcedo R, 2000, FASEB J, V14, P2055, DOI 10.1096/fj.99-0963com; Sawa Y, 2008, CELL TISSUE RES, V333, P237, DOI 10.1007/s00441-008-0625-5; Shen H, 2006, FASEB J, V20, P59, DOI 10.1096/fj.05-4764com; Shen H, 2004, AM J PHYSIOL-CELL PH, V286, pC840, DOI 10.1152/ajpcell.00335.2003; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Thomas RM, 2007, CANCER RES, V67, P6075, DOI 10.1158/0008-5472.CAN-06-4128; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Verras M, 2007, CANCER RES, V67, P967, DOI 10.1158/0008-5472.CAN-06-3552; Wagh PK, 2008, ADV CANCER RES, V100, P1, DOI 10.1016/S0065-230X(08)00001-8; Wang MH, 2007, J PATHOL, V213, P402, DOI 10.1002/path.2245; Waugh DJJ, 2008, FRONT BIOSCI, V13, P4595, DOI 10.2741/3025; Welm AL, 2007, P NATL ACAD SCI USA, V104, P7570, DOI 10.1073/pnas.0702095104; Wilson C, 2008, J PHARMACOL EXP THER, V327, P746, DOI 10.1124/jpet.108.143826; Yoshida S, 2002, J CLIN ENDOCR METAB, V87, P2376, DOI 10.1210/jc.87.5.2376; Zhou YQ, 2003, ONCOGENE, V22, P186, DOI 10.1038/sj.onc.1206075; Zinser GM, 2006, CANCER RES, V66, P11967, DOI 10.1158/0008-5472.CAN-06-2473	46	47	49	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2010	29	2					214	226		10.1038/onc.2009.331	http://dx.doi.org/10.1038/onc.2009.331			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	544IU	19838218	Green Accepted			2022-12-25	WOS:000273650000005
J	Renko, M; Sabotic, J; Mihelic, M; Brzin, J; Kos, J; Turk, D				Renko, Miha; Sabotic, Jerica; Mihelic, Marko; Brzin, Joze; Kos, Janko; Turk, Dusan			Versatile Loops in Mycocypins Inhibit Three Protease Families	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CYSTEINE PROTEASE; PROTEINASE-INHIBITOR; MACROMOLECULAR STRUCTURES; ANGSTROM RESOLUTION; MAMMALIAN LEGUMAIN; TRYPSIN-INHIBITOR; TRANSGENIC PLANTS; ERYTHRINA-CAFFRA; STRUCTURAL BASIS	Mycocypins, clitocypins and macrocypins, are cysteine protease inhibitors isolated from the mushrooms Clitocybe nebularis and Macrolepiota procera. Lack of sequence homology to other families of protease inhibitors suggested that mycocypins inhibit their target cysteine protease by a unique mechanism and that a novel fold may be found. The crystal structures of the complex of clitocypin with the papain-like cysteine protease cathepsin V and of macrocypin and clitocypin alone have revealed yet another motif of binding to papain like-cysteine proteases, which in a yet unrevealed way occludes the catalytic residue. The binding is associated with a peptide-bond flip of glycine that occurs before or concurrently with the inhibitor docking. Mycocypins possess a beta-trefoil fold, the hallmark of Kunitz-type inhibitors. It is a tree-like structure with two loops in the root region, a stem comprising a six-stranded beta-barrel, and two layers of loops (6 + 3) in the crown region. The two loops that bind to cysteine cathepsins belong to the lower layer of the crown loops, whereas a single loop from the crown region can inhibit trypsin or asparaginyl endopeptidase, as demonstrated by site-directed mutagenesis. These loops present a versatile surface with the potential to bind to additional classes of proteases. When appropriately engineered, they could provide the basis for possible exploitation in crop protection.	[Renko, Miha; Mihelic, Marko; Turk, Dusan] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Ljubljana 1000, Slovenia; [Sabotic, Jerica; Brzin, Joze; Kos, Janko] Jozef Stefan Inst, Dept Biotechnol, Ljubljana 1000, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute	Turk, D (corresponding author), Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Jamova 39, Ljubljana 1000, Slovenia.	dusan.turk@ijs.si	Sabotič, Jerica/AAJ-5050-2021	Sabotič, Jerica/0000-0002-2404-0192; Turk, Dusan/0000-0003-0205-6609	Slovenian Research Agency [P1-0048, P4-0127]; Young Researcher fellowship; European Commission [LSHG-2006-018830]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Young Researcher fellowship; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Slovenian Research Agency Grants P1-0048 (to D.T.) and P4-0127 (to J.K.), by a Young Researcher fellowship (to M.R.), and by the European Commission Framework VI Program (CAMP project, LSHG-2006-018830).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; AGO H, 1991, J BIOCHEM-TOKYO, V110, P360, DOI 10.1093/oxfordjournals.jbchem.a123586; Alvarez-Fernandez M, 1999, J BIOL CHEM, V274, P19195, DOI 10.1074/jbc.274.27.19195; Andrejasic M, 2008, ACTA CRYSTALLOGR D, V64, P1093, DOI 10.1107/S0907444908027388; Araujo APU, 2005, BIOL CHEM, V386, P561, DOI 10.1515/BC.2005.066; Benchabane M, 2008, PLANT PHYSIOL BIOCH, V46, P701, DOI 10.1016/j.plaphy.2008.04.005; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Brzin J, 2000, J BIOL CHEM, V275, P20104, DOI 10.1074/jbc.M001392200; Chen JM, 1997, J BIOL CHEM, V272, P8090, DOI 10.1074/jbc.272.12.8090; Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001; Cloutier C, 2000, ARCH INSECT BIOCHEM, V44, P69, DOI 10.1002/1520-6327(200006)44:2&lt;69::AID-ARCH2&gt;3.0.CO;2-6; De Leo F, 1998, PLANT PHYSIOL, V118, P997, DOI 10.1104/pp.118.3.997; Fitzgerald CE, 2003, NAT STRUCT BIOL, V10, P764, DOI 10.1038/nsb949; Frost CJ, 2008, PLANT PHYSIOL, V146, P818, DOI 10.1104/pp.107.113027; Galesa K, 2006, ACTA CRYSTALLOGR F, V62, P10, DOI 10.1107/S1744309105038534; GRAVES BJ, 1990, BIOCHEMISTRY-US, V29, P2679, DOI 10.1021/bi00463a009; GREEN TR, 1972, SCIENCE, V175, P776, DOI 10.1126/science.175.4023.776; Guncar G, 1999, EMBO J, V18, P793, DOI 10.1093/emboj/18.4.793; Hansen D, 2007, BIOCHEM BIOPH RES CO, V360, P735, DOI 10.1016/j.bbrc.2007.06.144; Jenko S, 2003, J MOL BIOL, V326, P875, DOI 10.1016/S0022-2836(02)01432-8; JONGSMA MA, 1995, P NATL ACAD SCI USA, V92, P8041, DOI 10.1073/pnas.92.17.8041; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lenarcic B, 1999, J BIOL CHEM, V274, P563, DOI 10.1074/jbc.274.2.563; Ljunggren A, 2007, J MOL BIOL, V371, P137, DOI 10.1016/j.jmb.2007.05.005; Micheelsen PO, 2008, J MOL BIOL, V380, P681, DOI 10.1016/j.jmb.2008.05.034; Mihelic M, 2007, BIOL CHEM, V388, P1123, DOI 10.1515/BC.2007.155; Mihelic M, 2006, FEBS LETT, V580, P4195, DOI 10.1016/j.febslet.2006.06.076; MORRISON JF, 1982, TRENDS BIOCHEM SCI, V7, P102, DOI 10.1016/0968-0004(82)90157-8; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; ONESTI S, 1991, J MOL BIOL, V217, P153, DOI 10.1016/0022-2836(91)90618-G; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ravichandran S, 1999, ACTA CRYSTALLOGR D, V55, P1814, DOI 10.1107/S0907444999009877; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; Sabotic J, 2007, PROTEIN EXPRES PURIF, V53, P104, DOI 10.1016/j.pep.2006.11.015; Sabotic J, 2006, BIOL CHEM, V387, P1559, DOI 10.1515/BC.2006.194; Sabotic J, 2009, FEBS J, V276, P4334, DOI 10.1111/j.1742-4658.2009.07138.x; Somoza JR, 2000, BIOCHEMISTRY-US, V39, P12543, DOI 10.1021/bi000951p; Song HK, 1998, J MOL BIOL, V275, P347, DOI 10.1006/jmbi.1997.1469; STUBBS MT, 1990, EMBO J, V9, P1939, DOI 10.1002/j.1460-2075.1990.tb08321.x; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Turk B, 1997, BIOL CHEM, V378, P141; Turk D, 1998, BIOL CHEM, V379, P137, DOI 10.1515/bchm.1998.379.2.137; TURK D, 1992, THESIS TU MUENCHEN G; Ussuf KK, 2001, CURR SCI INDIA, V80, P847; Vallee F, 1998, STRUCTURE, V6, P649, DOI 10.1016/S0969-2126(98)00066-5; WEINER MP, 1994, PCR METH APPL, V4, pS131	49	49	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					308	316		10.1074/jbc.M109.043331	http://dx.doi.org/10.1074/jbc.M109.043331			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19846555	Green Published, hybrid			2022-12-25	WOS:000273070100032
J	Demory, ML; Boerner, JL; Davidson, R; Faust, W; Miyake, T; Lee, I; Huttemann, M; Douglas, R; Haddad, G; Parsons, SJ				Demory, Michelle L.; Boerner, Julie L.; Davidson, Robert; Faust, William; Miyake, Tsuyoshi; Lee, Icksoo; Huettemann, Maik; Douglas, Robert; Haddad, Gabriel; Parsons, Sarah J.			Epidermal Growth Factor Receptor Translocation to the Mitochondria REGULATION AND EFFECT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; CLATHRIN-MEDIATED ENDOCYTOSIS; EGF RECEPTOR; OXIDATIVE-PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; OUTER-MEMBRANE; BREAST-CANCER; CELLULAR SRC; SUBUNIT-II; KINASE	Co-overexpression of the epidermal growth factor (EGF) receptor (EGFR) and c-Src frequently occurs in human tumors and is linked to enhanced tumor growth. In experimental systems this synergistic growth requires EGF-dependent association of c-Src with the EGFR and phosphorylation of Tyr-845 of the receptor by c-Src. A search for signaling mediators of Tyr(P)-845 revealed that mitochondrial cytochrome c oxidase subunit II (CoxII) binds EGFR in a Tyr(P)-845- and EGF-dependent manner. In cells this association involves translocation of EGFR to the mitochondria, but regulation of this process is ill-defined. The current study demonstrates that c-Src translocates to the mitochondria with similar kinetics as EGFR and that the catalytic activity of EGFR and c-Src as well as endocytosis and a mitochondrial localization signal are required for these events. CoxII can be phosphorylated by EGFR and c-Src, and EGF stimulation reduces Cox activity and cellular ATP, an event that is dependent in large part on EGFR localized to the mitochondria. These findings suggest EGFR plays a novel role in modulating mitochondrial function via its association with, and modification of CoxII.	[Demory, Michelle L.; Boerner, Julie L.; Davidson, Robert; Faust, William; Miyake, Tsuyoshi; Parsons, Sarah J.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Demory, Michelle L.; Boerner, Julie L.; Davidson, Robert; Faust, William; Miyake, Tsuyoshi; Parsons, Sarah J.] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA; [Boerner, Julie L.; Lee, Icksoo; Huettemann, Maik] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Boerner, Julie L.] Wayne State Univ, Dept Pharmacol, Detroit, MI 48201 USA; [Lee, Icksoo; Huettemann, Maik] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Douglas, Robert; Haddad, Gabriel] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Haddad, Gabriel] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of Virginia; University of Virginia; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; Wayne State University; University of California System; University of California San Diego; University of California System; University of California San Diego	Parsons, SJ (corresponding author), Univ Virginia, Dept Microbiol, POB 800734, Charlottesville, VA 22908 USA.	sap@virginia.edu		Huttemann, Maik/0000-0001-6310-7081	National Institutes of Health [PO1 HD 32473, CA71449, CA123037]; Susan G. Komen Breast Cancer Foundation [DISS 0402970]; The Sharp Foundation of the University of Virginia Cancer Center [119867]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032473] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA123037, R01CA071449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); The Sharp Foundation of the University of Virginia Cancer Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HD 32473 (to R. D. and G. H.), CA71449 (to S. J. P.), and CA123037 ( to S. J. P.). This study was also supported by Susan G. Komen Breast Cancer Foundation Grant DISS 0402970 (to M. L. D.) and The Sharp Foundation of the University of Virginia Cancer Center Project 119867 (to S. J. P.).	Biscardi JS, 1998, MOL CARCINOGEN, V21, P261, DOI 10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N; Biscardi JS, 1999, ADV CANCER RES, V76, P61; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; CABRAL F, 1978, J BIOL CHEM, V253, P297; CLARK AJL, 1985, P NATL ACAD SCI USA, V82, P8374, DOI 10.1073/pnas.82.24.8374; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; Douglas RM, 2006, NEUROSCIENCE, V139, P1249, DOI 10.1016/j.neuroscience.2006.01.061; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; GLENNEY JR, 1988, CELL, V52, P675, DOI 10.1016/0092-8674(88)90405-9; HERTEL C, 1985, J BIOL CHEM, V260, P2547; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Huttemann M, 2007, BBA-MOL CELL RES, V1773, P1701, DOI 10.1016/j.bbamcr.2007.10.001; Itoh S, 2005, J BIOL CHEM, V280, P26383, DOI 10.1074/jbc.M410262200; Jaramillo ML, 2006, EXP CELL RES, V312, P2778, DOI 10.1016/j.yexcr.2006.05.008; Jo M, 2003, J BIOL CHEM, V278, P1642, DOI 10.1074/jbc.M210877200; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kloth MT, 2003, J BIOL CHEM, V278, P1671, DOI 10.1074/jbc.M207289200; LARKIN JM, 1986, J CELL BIOL, V103, P2619, DOI 10.1083/jcb.103.6.2619; Lee I, 2005, J BIOL CHEM, V280, P6094, DOI 10.1074/jbc.M411335200; Liao HJ, 2007, MOL BIOL CELL, V18, P1064, DOI 10.1091/mbc.E06-09-0802; Lu Y, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-63; Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161; Lunn JA, 2000, AM J PHYSIOL-CELL PH, V279, pC2019, DOI 10.1152/ajpcell.2000.279.6.C2019; MAA MC, 1995, P NATL ACAD SCI USA, V92, P6981, DOI 10.1073/pnas.92.15.6981; MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253; Miyazaki T, 2003, J CELL BIOL, V160, P709, DOI 10.1083/jcb.200209098; OTTENHOFFKALFF AE, 1992, CANCER RES, V52, P4773; PARSONS SJ, 1984, J VIROL, V51, P272, DOI 10.1128/JVI.51.2.272-282.1984; Reichert AS, 2002, BBA-MOL CELL RES, V1592, P41, DOI 10.1016/S0167-4889(02)00263-X; SAINSBURY JRC, 1987, LANCET, V1, P1398; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; Tice DA, 1999, P NATL ACAD SCI USA, V96, P1415, DOI 10.1073/pnas.96.4.1415; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Ware MF, 1997, J BIOL CHEM, V272, P30185, DOI 10.1074/jbc.272.48.30185; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4; Yang WL, 1998, BIOCHEMISTRY-US, V37, P14175, DOI 10.1021/bi981402a	41	118	120	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36592	36604		10.1074/jbc.M109.000760	http://dx.doi.org/10.1074/jbc.M109.000760			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19840943	hybrid, Green Published			2022-12-25	WOS:000272970500060
J	Feng, Q; He, B; Jung, SY; Song, YC; Qin, J; Tsai, SY; Tsai, MJ; O'Malley, BW				Feng, Qin; He, Bin; Jung, Sung-Yun; Song, Yongcheng; Qin, Jun; Tsai, Sophia Y.; Tsai, Ming-Jer; O'Malley, Bert W.			Biochemical Control of CARM1 Enzymatic Activity by Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE METHYLTRANSFERASE CARM1; HORMONE RECEPTOR SUPERFAMILY; COACTIVATOR COMPLEX; HISTONE H3; METHYLATION; PROTEIN; GENE; COACTIVATOR-ASSOCIATED-ARGININE-METHYLTRANSFERASE-1; TRANSCRIPTION; ACTIVATION	Coactivator-associated arginine methyltransferase 1 (CARM1) is a dual functional coregulator that facilitates transcription initiation by methylation of Arg(17) and Arg(26) of histone H3 and also dictates the subsequent coactivator complex disassembly by methylation of the steroid receptor coactivator family coactivators and p300/cAMP-response element-binding protein-binding protein. However, the regulation of CARM1 enzymatic activity and substrate specificity remains largely unknown. In this study, we report that CARM1 function is regulated by phosphorylation at Ser(217), a residue completely conserved in the type I protein arginine methyltransferase (PRMT) family of enzymes. Comparative analysis of the published CARM1 crystal structures reveals that the hydroxyl group of Ser(217) forms a strong hydrogen bond with the carbonyl oxygen atom of Tyr(154) to lock the cofactor S-adenosylmethionine inside the binding cavity. Phosphorylation of Ser(217) disrupts this hydrogen bond and subsequently abolishes S-adenosylmethionine binding and its methyltransferase activity. Importantly, Tyr(154) is also conserved in the type I PRMT family of enzymes, suggesting a general role of this hydrogen bond in maintaining the holo structure of the type I PRMT catalytic domain. Moreover, we found that phosphorylation at Ser(217) also promoted CARM1 cytoplasmic localization and that this translocation occurred mainly during mitosis. We propose that phosphorylation at Ser(217) serves as a molecular switch for controlling CARM1 enzymatic activity during the cell cycle.	[Feng, Qin; He, Bin; Jung, Sung-Yun; Qin, Jun; Tsai, Sophia Y.; Tsai, Ming-Jer; O'Malley, Bert W.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Jung, Sung-Yun; Qin, Jun] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Song, Yongcheng] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	O'Malley, BW (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	berto@bcm.edu		Jung, Sung Yun/0000-0003-1521-7977	National Institutes of Health [5F32DK078473]; NIDDK [1K01DK081446, 5P01 DK059820]; NCI Baylor College of Medicine Cancer Center [P30CA125123]; NIDDK-NURSA (Nuclear Receptor Signaling Atlas) [U19 DK062434]; Baylor College of Medicine; Welch Foundation [Q-1521]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK078473, P01DK059820, K01DK081446, U19DK062434] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI Baylor College of Medicine Cancer Center; NIDDK-NURSA (Nuclear Receptor Signaling Atlas); Baylor College of Medicine; Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK National Research Service Award Individual Postdoctoral Fellowship 5F32DK078473 (to Q. F.), NIDDK Mentored Research Scientist Development Award 1K01DK081446 (to B. H.), NIDDK Grant 5P01 DK059820 and NCI Baylor College of Medicine Cancer Center Cores Grant P30CA125123 (to B. W. O.), and NIDDK-NURSA (Nuclear Receptor Signaling Atlas) Grant U19 DK062434 (to B. W. O., M.-J. T., and S. Y. T.). This work was also supported by a Baylor College of Medicine start-up fund (to Y. S.) and Welch Foundation Grant Q-1521 (to B. W. O.).	Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Chen DG, 2000, J BIOL CHEM, V275, P40810, DOI 10.1074/jbc.M005459200; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Chevillard-Briet M, 2002, EMBO J, V21, P5457, DOI 10.1093/emboj/cdf548; El Messaoudi S, 2006, P NATL ACAD SCI USA, V103, P13351, DOI 10.1073/pnas.0605692103; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Feng Q, 2002, MOL CELL BIOL, V22, P536, DOI 10.1128/MCB.22.2.536-546.2002; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Feng Q, 2006, MOL CELL BIOL, V26, P7846, DOI 10.1128/MCB.00568-06; Frietze S, 2008, CANCER RES, V68, P301, DOI 10.1158/0008-5472.CAN-07-1983; Fujiwara T, 2006, MOL CELL BIOL, V26, P2273, DOI 10.1128/MCB.26.6.2273-2285.2006; Han SJ, 2009, TRENDS ENDOCRIN MET, V20, P8, DOI 10.1016/j.tem.2008.10.001; Higashimoto K, 2007, P NATL ACAD SCI USA, V104, P12318, DOI 10.1073/pnas.0610792104; Jung SY, 2008, ANAL CHEM, V80, P1721, DOI 10.1021/ac7021025; Kim J, 2004, J BIOL CHEM, V279, P25339, DOI 10.1074/jbc.M402544200; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lee YH, 2005, P NATL ACAD SCI USA, V102, P3611, DOI 10.1073/pnas.0407159102; Li HW, 2002, J BIOL CHEM, V277, P44623, DOI 10.1074/jbc.M206187200; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Majumder S, 2006, PROSTATE, V66, P1292, DOI 10.1002/pros.20438; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Oh AS, 2008, MOL CELL BIOL, V28, P6580, DOI 10.1128/MCB.00118-08; ONATE SA, 1995, SCIENCE, V270, P1354; Stallcup MR, 2000, BIOCHEM SOC T, V28, P415, DOI 10.1042/0300-5127:0280415; Teyssier C, 2002, J BIOL CHEM, V277, P46066, DOI 10.1074/jbc.M207623200; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Urwyler O, 2007, DIFFERENTIATION, V75, P757, DOI 10.1111/j.1432-0436.2007.00175.x; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018; Xu Jianming, 2002, Rev Endocr Metab Disord, V3, P185, DOI 10.1023/A:1020016208071; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Yadav N, 2003, P NATL ACAD SCI USA, V100, P6464, DOI 10.1073/pnas.1232272100; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; ZENG ZM, 1994, ENDOCRINOLOGY, V135, P248, DOI 10.1210/en.135.1.248; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509	39	50	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36167	36174		10.1074/jbc.M109.065524	http://dx.doi.org/10.1074/jbc.M109.065524			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19843527	Green Published, hybrid			2022-12-25	WOS:000272970500018
J	Ge, X; Qiu, Y; Loh, HH; Law, PY				Ge, Xin; Qiu, Yu; Loh, Horace H.; Law, Ping-Yee			GRIN1 Regulates mu-Opioid Receptor Activities by Tethering the Receptor and G Protein in the Lipid Raft	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTORS; CELL-ADHESION MOLECULE; RICH MEMBRANE DOMAINS; NEURITE OUTGROWTH; SIGNAL-TRANSDUCTION; SPINAL-CORD; ADENYLATE-CYCLASE; COUPLED RECEPTOR; BINDING-SITE; PC12 CELLS	The lipid raft location of mu-opioid receptor (MOR) determines the receptor activities. However, the manner in which MOR is anchored within the lipid rafts is undetermined. Using the targeted proteomic approach and mass spectrometry analyses, we have identified GRIN1 (G protein-regulated inducer of neurite outgrowth 1) can tether MOR with the G protein alpha-subunit and subsequently regulate the receptor distribution within the lipid rafts. Glutathione S-transferase fusion pulldown and receptor mutational analyses indicate that GRIN1-MOR interaction involves a receptor sequence (267)GSKEK(271) within the MOR third intracellular loop that is not involved in G alpha interaction. The GRIN1 domains involved in MOR interaction are also distinct from those involved in G alpha interaction. Pertussis toxin pretreatment reduced the amount of GRIN1 co-immunoprecipitated with MOR but not the amount with G alpha. Furthermore, overexpression of GRIN1 significantly enhanced the amount of MOR in lipid raft and the receptor signaling magnitude as measured by Src kinase activation. Such increase in MOR signaling was demonstrated further by determining the GRIN1-dependent pertussis toxin-sensitive neurite outgrowth. In contrast to minimal neurite outgrowth induced by etorphine in control neuroblastoma N2A cells, overexpression of GRIN1 resulted in the increase in etorphine- and non-morphine-induced neurite outgrowth in these cells. Knocking down endogenous GRIN1 by small interfering RNA attenuated the agonist-induced neurite outgrowth. Disrupting lipid raft by methyl-beta-cyclodextrin also blocked neurite outgrowth. Hence, by tethering G alpha with MOR, GRIN1 stabilizes the receptor within the lipid rafts and potentiates the receptor signaling in the neurite outgrowth processes.	[Ge, Xin; Qiu, Yu; Loh, Horace H.; Law, Ping-Yee] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Ge, X (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA.	gexx0019@umn.edu		Law, Ping-Yee/0000-0002-5364-1093	National Institutes of Health [DA007339, DA016674, DA000564, DA011806]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA000564, R01DA007339, R56DA000564, P50DA011806, K05DA000513, R01DA016674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA007339, DA016674, DA000564, and DA011806.	Anafi M, 1996, J BIOL CHEM, V271, P21365, DOI 10.1074/jbc.271.35.21365; ARVIDSSON U, 1995, J NEUROSCI, V15, P3328; Balbis A, 2007, ENDOCRINOLOGY, V148, P2944, DOI 10.1210/en.2006-1674; Barnett-Norris J, 2005, LIFE SCI, V77, P1625, DOI 10.1016/j.lfs.2005.05.040; Besson JM, 1999, LANCET, V353, P1610, DOI 10.1016/S0140-6736(99)01313-6; Brailoiu E, 2004, NEUROSCI LETT, V365, P10, DOI 10.1016/j.neulet.2004.03.092; CARTER BD, 1992, J NEUROCHEM, V58, P1611, DOI 10.1111/j.1471-4159.1992.tb10032.x; Chaipatikul V, 2003, J PHARMACOL EXP THER, V305, P909, DOI 10.1124/jpet.102.046219; Chen CG, 2006, J BIOL CHEM, V281, P7983, DOI 10.1074/jbc.M509805200; Chen LT, 1999, J BIOL CHEM, V274, P26931, DOI 10.1074/jbc.274.38.26931; CHUN MY, 1994, P NATL ACAD SCI USA, V91, P11728, DOI 10.1073/pnas.91.24.11728; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; CONNAUGHTON JF, 1975, ADDICT DIS, V2, P21; Di Vizio D, 2008, CELL CYCLE, V7, P2257, DOI 10.4161/cc.7.14.6475; Encinas M, 2001, J NEUROSCI, V21, P1464, DOI 10.1523/JNEUROSCI.21-05-01464.2001; Evan BJ, 2008, BIOCHEM BIOPH RES CO, V377, P1067, DOI 10.1016/j.bbrc.2008.10.108; Ge X, 2009, MOL PHARMACOL, V75, P1307, DOI 10.1124/mol.108.054064; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Head BP, 2007, TRENDS CELL BIOL, V17, P51, DOI 10.1016/j.tcb.2006.11.008; Head BP, 2006, J BIOL CHEM, V281, P26391, DOI 10.1074/jbc.M602577200; IGNELZI MA, 1994, NEURON, V12, P873, DOI 10.1016/0896-6273(94)90339-5; Jia CYH, 2005, MOL CELL PROTEOMICS, V4, P1155, DOI 10.1074/mcp.M500108-MCP200; Kabbani N, 2007, P NATL ACAD SCI USA, V104, P20570, DOI 10.1073/pnas.0710314104; Kahn L, 2005, EUR J NEUROSCI, V21, P493, DOI 10.1111/j.1460-9568.2005.03883.x; Lisanti Michael P., 1994, Trends in Cell Biology, V4, P231, DOI 10.1016/0962-8924(94)90114-7; LISANTI MP, 1994, J CELL BIOL, V126, P111, DOI 10.1083/jcb.126.1.111; Macdonald JL, 2005, J LIPID RES, V46, P1061, DOI 10.1194/jlr.D400041-JLR200; MCKENZIE FR, 1990, BIOCHEM J, V267, P391, DOI 10.1042/bj2670391; Miller JH, 1999, DEV BRAIN RES, V114, P69, DOI 10.1016/S0165-3806(99)00021-8; Monastyrskaya K, 2005, J BIOL CHEM, V280, P7135, DOI 10.1074/jbc.M405806200; Moron JA, 2007, MOL CELL PROTEOMICS, V6, P29, DOI 10.1074/mcp.M600184-MCP200; Mukherjee A, 2003, J BIOL CHEM, V278, P40806, DOI 10.1074/jbc.M306440200; Nakata H, 2005, MOL PHARMACOL, V67, P695, DOI 10.1124/mol.104.003913; Nassogne MC, 1998, DEV BRAIN RES, V110, P61, DOI 10.1016/S0165-3806(98)00094-7; Navratil AM, 2003, J BIOL CHEM, V278, P31593, DOI 10.1074/jbc.M304273200; Oh DY, 2007, J CELL BIOCHEM, V101, P221, DOI 10.1002/jcb.21166; Ohkubo S, 2007, YAKUGAKU ZASSHI, V127, P27, DOI 10.1248/yakushi.127.27; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Philip F, 2004, BIOCHEMISTRY-US, V43, P11691, DOI 10.1021/bi049381+; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; RAMOSMORALES F, 1995, ONCOGENE, V11, P1665; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; Reversi A, 2006, AM J PHYSIOL-REG I, V291, pR861, DOI 10.1152/ajpregu.00333.2006; ROERIG SC, 1992, MOL PHARMACOL, V41, P822; ROSS EM, 1995, CURR BIOL, V5, P107, DOI 10.1016/S0960-9822(95)00026-1; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Schmid RS, 2000, J NEUROSCI, V20, P4177; Smith KE, 2006, J NEUROSCI, V26, P2391, DOI 10.1523/JNEUROSCI.3092-05.2006; Sugawara Y, 2007, CELL SIGNAL, V19, P1301, DOI 10.1016/j.cellsig.2007.01.012; Trujillo KA, 2002, NEUROTOX RES, V4, P373, DOI 10.1080/10298420290023954; VANOOYEN A, 1995, J THEOR BIOL, V172, P63, DOI 10.1006/jtbi.1995.0005; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Xu W, 2006, J PHARMACOL EXP THER, V317, P1295, DOI 10.1124/jpet.105.099507; Yeh GC, 1998, NEUROSCI LETT, V252, P25, DOI 10.1016/S0304-3940(98)00528-X; Yin DL, 1997, NEUROSCI RES, V29, P121, DOI 10.1016/S0168-0102(97)00080-1; Zhang L, 2006, MOL PHARMACOL, V69, P1810, DOI 10.1124/mol.105.021352; Zhang L, 2009, J BIOL CHEM, V284, P1990, DOI 10.1074/jbc.M807971200; Zhang WD, 2002, J NEUROSCI RES, V69, P427, DOI 10.1002/jnr.10313; Zhang WS, 2007, J NEUROCHEM, V103, P1157, DOI 10.1111/j.1471-4159.2007.04813.x; Zhao H, 2006, MOL PHARMACOL, V69, P1421, DOI 10.1124/mol.105.020024; Zheng H, 2008, P NATL ACAD SCI USA, V105, P9421, DOI 10.1073/pnas.0802253105	64	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36521	36534		10.1074/jbc.M109.024109	http://dx.doi.org/10.1074/jbc.M109.024109			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19861419	Green Published, hybrid			2022-12-25	WOS:000272970500054
J	Wu, ZZ; Li, DP; Chen, SR; Pan, HL				Wu, Zi-Zhen; Li, De-Pei; Chen, Shao-Rui; Pan, Hui-Lin			Aminopyridines Potentiate Synaptic and Neuromuscular Transmission by Targeting the Voltage-activated Calcium Channel beta Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EATON MYASTHENIC SYNDROME; GATED POTASSIUM CHANNELS; PRIMARY SENSORY NEURONS; MULTIPLE-SCLEROSIS; DOUBLE-BLIND; K+ CURRENTS; N-TYPE; GANGLION NEURONS; 4-AMINOPYRIDINE; EXPRESSION	Aminopyridines such as 4-aminopyridine (4-AP) are widely used as voltage-activated K+ (Kv) channel blockers and can improve neuromuscular function in patients with spinal cord injury, myasthenia gravis, or multiple sclerosis. Here, we present novel evidence that 4-AP and several of its analogs directly stimulate high voltage-activated Ca2+ channels (HVACCs) in acutely dissociated neurons. 4-AP, 4-(aminomethyl) pyridine, 4-(methylamino) pyridine, and 4-di(methylamino) pyridine profoundly increased HVACC, but not T-type, currents in dissociated neurons from the rat dorsal root ganglion, superior cervical ganglion, and hippocampus. The widely used Kv channel blockers, including tetraethylammonium, alpha-dendrotoxin, phrixotoxin-2, and BDS-I, did not mimic or alter the effect of 4-AP on HVACCs. In HEK293 cells expressing various combinations of N-type (Cav2.2) channel subunits, 4-AP potentiated Ca2+ currents primarily through the intracellular beta(3) subunit. In contrast, 4-AP had no effect on Cav3.2 channels expressed in HEK293 cells. Furthermore, blocking Kv channels did not mimic or change the potentiating effects of 4-AP on neurotransmitter release from sensory and motor nerve terminals. Thus, our findings challenge the conventional view that 4-AP facilitates synaptic and neuromuscular transmission by blocking Kv channels. Aminopyridines can directly target presynaptic HVACCs to potentiate neurotransmitter release independent of Kv channels.	[Pan, Hui-Lin] Univ Texas MD Anderson Canc Ctr, Div Anesthesiol & Crit Care, Unit 110, Houston, TX 77030 USA; [Pan, Hui-Lin] Univ Texas Houston, Grad Sch Biomed Sci, Program Neurosci, Houston, TX 77225 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Pan, HL (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Anesthesiol & Crit Care, Unit 110, 1515 Holcombe Blvd, Houston, TX 77030 USA.	huilinpan@mdanderson.org		Pan, Hui-Lin/0000-0001-8444-3770	National Institutes of Health [GM64830, NS45602]; American Heart Association; Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Hawkins Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM64830 and NS45602 and by the American Heart Association. This work was also supported by the Hawkins Endowment (to H.-L. P.).	BALDWIN TJ, 1992, COLD SPRING HARB SYM, V57, P491, DOI 10.1101/SQB.1992.057.01.054; BEVER CT, 1994, NEUROLOGY, V44, P1054, DOI 10.1212/WNL.44.6.1054; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Catacuzzeno L, 2008, J PHYSIOL-LONDON, V586, P5101, DOI 10.1113/jphysiol.2008.159384; Chien LY, 2007, J NEUROSCI, V27, P9855, DOI 10.1523/JNEUROSCI.0604-07.2007; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; DAVIS FA, 1990, ANN NEUROL, V27, P186, DOI 10.1002/ana.410270215; Diochot S, 1998, J BIOL CHEM, V273, P6744, DOI 10.1074/jbc.273.12.6744; Diochot S, 1999, BRIT J PHARMACOL, V126, P251, DOI 10.1038/sj.bjp.0702283; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; ELLINOR PT, 1994, NATURE, V372, P272, DOI 10.1038/372272a0; FICKER E, 1992, J PHYSIOL-LONDON, V445, P431, DOI 10.1113/jphysiol.1992.sp018932; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Guan D, 2006, J PHYSIOL-LONDON, V571, P371, DOI 10.1113/jphysiol.2005.097006; HANSEBOUT RR, 1993, J NEUROTRAUM, V10, P1, DOI 10.1089/neu.1993.10.1; Harvey AL, 2001, TOXICON, V39, P15, DOI 10.1016/S0041-0101(00)00162-8; HAYDON PG, 1994, NEURON, V13, P1275, DOI 10.1016/0896-6273(94)90414-6; HOFER CA, 1993, AM J MED, V95, P431, DOI 10.1016/0002-9343(93)90314-F; HOFMANN F, 1994, ANNU REV NEUROSCI, V17, P399, DOI 10.1146/annurev.neuro.17.1.399; Judge SI, 2006, PHARMACOL THERAPEUT, V111, P224, DOI 10.1016/j.pharmthera.2005.10.006; KIM YI, 1988, SCIENCE, V239, P405, DOI 10.1126/science.2447652; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Li DP, 2002, J PHYSIOL-LONDON, V543, P807, DOI 10.1113/jphysiol.2002.020644; Ludwig A, 1997, J NEUROSCI, V17, P1339; LUNDH H, 1979, J NEUROL NEUROSUR PS, V42, P171, DOI 10.1136/jnnp.42.2.171; Mathie A, 1998, GEN PHARMACOL-VASC S, V30, P13, DOI 10.1016/S0306-3623(97)00034-7; Moyer M, 1999, J NEUROPHYSIOL, V82, P3030, DOI 10.1152/jn.1999.82.6.3030; Murakami M, 2002, J BIOL CHEM, V277, P40342, DOI 10.1074/jbc.M203425200; POLMAN CH, 1994, ARCH NEUROL-CHICAGO, V51, P1136, DOI 10.1001/archneur.1994.00540230074016; POLMAN CH, 1994, ARCH NEUROL-CHICAGO, V51, P292, DOI 10.1001/archneur.1994.00540150090022; RANDALL A, 1995, J NEUROSCI, V15, P2995; Rezazadeh S, 2006, J PHARMACOL EXP THER, V317, P292, DOI 10.1124/jpet.105.097618; ROBERTSON BE, 1994, AM J PHYSIOL-CELL PH, V267, pC1589, DOI 10.1152/ajpcell.1994.267.6.C1589; Sanders DB, 2000, NEUROLOGY, V54, P603, DOI 10.1212/WNL.54.3.603; SHERRATT RM, 1980, NATURE, V283, P570, DOI 10.1038/283570a0; Strupp M, 2004, NEUROLOGY, V62, P1623, DOI 10.1212/01.WNL.0000125691.74109.53; THOMSEN RH, 1983, J PHARMACOL EXP THER, V227, P260; Vydyanathan A, 2005, J NEUROPHYSIOL, V93, P3401, DOI 10.1152/jn.01267.2004; Wang YG, 2006, J CARDIOVASC ELECTR, V17, P298, DOI 10.1111/j.1540-8167.2006.00362.x; WILLIAMS ME, 1992, SCIENCE, V257, P389, DOI 10.1126/science.1321501; Wirtz PW, 2009, CLIN PHARMACOL THER, V86, P44, DOI 10.1038/clpt.2009.35; Wu ZZ, 2005, J BIOL CHEM, V280, P18142, DOI 10.1074/jbc.M501229200; Wu ZZ, 2004, J PHARMACOL EXP THER, V311, P939, DOI 10.1124/jpet.104.073429; Zhou HY, 2009, J NEUROCHEM, V108, P305, DOI 10.1111/j.1471-4159.2008.05772.x	44	83	85	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36453	36461		10.1074/jbc.M109.075523	http://dx.doi.org/10.1074/jbc.M109.075523			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19850918	hybrid, Green Published			2022-12-25	WOS:000272970500047
J	Ikonomov, OC; Sbrissa, D; Fenner, H; Shisheva, A				Ikonomov, Ognian C.; Sbrissa, Diego; Fenner, Homer; Shisheva, Assia			PIKfyve-ArPIKfyve-Sac3 Core Complex CONTACT SITES AND THEIR CONSEQUENCE FOR Sac3 PHOSPHATASE ACTIVITY AND ENDOCYTIC MEMBRANE HOMEOSTASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL 3,5-BISPHOSPHATE; LIPID KINASE; ENDOCYTOSED RECEPTORS; MULTIVESICULAR BODY; MAMMALIAN ORTHOLOG; PROTEIN-KINASE; PIKFYVE; VAC14; INSULIN; PHOSPHATASE	The phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P-2) metabolizing enzymes, the kinase PIKfyve and the phosphatase Sac3, constitute a single multiprotein complex organized by the PIKfyve regulator ArPIKfyve and its ability to homodimerize. We previously established that PIKfyve is activated within the triple PIKfyve-ArPIKfyve-Sac3 (PAS) core. These data assign an atypical function for the phosphatase in PtdIns(3,5)P-2 biosynthesis, thus raising the question of whether Sac3 retains its PtdIns(3,5)P-2 hydrolyzing activity within the PAS complex. Herein, we address the issue of Sac3 functionality by a combination of biochemical and morphological assays in triple-transfected COS cells using a battery of truncated or point mutants of the three proteins. We identified the Cpn60_TCP1 domain of PIKfyve as a major determinant for associating the ArPIKfyve-Sac3 subcomplex. Neither Sac3 nor PIKfyve enzymatic activities affected the PAS complex formation or stability. Using the well established formation of aberrant cell vacuoles as a sensitive functional measure of localized PtdIns(3,5)P-2 reduction, we observed a mitigated vacuolar phenotype by kinase-deficient PIKfyve(K1831E) if its ArPIKfyve- Sac3 binding region was deleted, suggesting reduced Sac3 access to, and turnover of PtdIns(3,5)P-2. In contrast, PIKfyve(K1831E), which displays intact ArPIKfyve-Sac3 binding, triggered a more severe vacuolar phenotype if coexpressed with ArPIKfyve(WT)-Sac3(WT) but minimal defects when coexpressed with ArPIKfyve(WT) and phosphatase-deficient Sac3(D488A). These data indicate that Sac3 assembled in the PAS regulatory core complex is an active PtdIns(3,5)P-2 phosphatase. Based on these and other data, presented herein, we propose a model of domain interactions within the PAS core and their role in regulating the enzymatic activities.	[Ikonomov, Ognian C.; Sbrissa, Diego; Fenner, Homer; Shisheva, Assia] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA	Wayne State University	Shisheva, A (corresponding author), Wayne State Univ, Sch Med, Dept Physiol, 540 E Canfield, Detroit, MI 48201 USA.	ashishev@med.wayne.edu			National Institutes of Health [DK58058]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058058] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK58058 (to A.S.). This work was also supported by American Diabetes Association Research grants (to A.S.).	Balla T, 2006, J ENDOCRINOL, V188, P135, DOI 10.1677/joe.1.06595; Bonangelino CJ, 2002, J CELL BIOL, V156, P1015, DOI 10.1083/jcb.200201002; Botelho RJ, 2008, MOL BIOL CELL, V19, P4273, DOI 10.1091/mbc.E08-04-0405; Chow CY, 2007, NATURE, V448, P68, DOI 10.1038/nature05876; Clague MJ, 2009, EXP CELL RES, V315, P1627, DOI 10.1016/j.yexcr.2008.10.005; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Dove SK, 2002, CURR BIOL, V12, P885, DOI 10.1016/S0960-9822(02)00891-6; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Ikonomov NC, 2007, EXP CELL RES, V313, P2404, DOI 10.1016/j.yexcr.2007.03.024; Ikonomov OC, 2003, MOL BIOL CELL, V14, P4581, DOI 10.1091/mbc.E03-04-0222; Ikonomov OC, 2002, J BIOL CHEM, V277, P9206, DOI 10.1074/jbc.M108750200; Ikonomov OC, 2001, J BIOL CHEM, V276, P26141, DOI 10.1074/jbc.M101722200; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Ikonomov OC, 2009, J BIOL CHEM, V284, P23961, DOI 10.1074/jbc.M109.025361; Ikonomov OC, 2009, J BIOL CHEM, V284, P3750, DOI 10.1074/jbc.M806539200; Jefferies HBJ, 2008, EMBO REP, V9, P164, DOI 10.1038/sj.embor.7401155; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Lemaire JF, 2006, FEBS LETT, V580, P6948, DOI 10.1016/j.febslet.2006.11.061; Nicot AS, 2006, MOL BIOL CELL, V17, P3062, DOI 10.1091/mbc.e05-12-1120; Poccia D, 2009, BIOCHEM J, V418, P233, DOI 10.1042/BJ20082105; Rudge SA, 2004, MOL BIOL CELL, V15, P24, DOI 10.1091/mbc.E03-05-0297; Rusten TE, 2006, MOL BIOL CELL, V17, P3989, DOI 10.1091/mbc.E06-03-0239; Rutherford AC, 2006, J CELL SCI, V119, P3944, DOI 10.1242/jcs.03153; Sbrissa D, 1999, J BIOL CHEM, V274, P21589, DOI 10.1074/jbc.274.31.21589; Sbrissa D, 2004, MOL CELL BIOL, V24, P10437, DOI 10.1128/MCB.24.23.10437-10447.2004; Sbrissa D, 2002, J BIOL CHEM, V277, P6073, DOI 10.1074/jbc.M110194200; Sbrissa D, 2000, BIOCHEMISTRY-US, V39, P15980, DOI 10.1021/bi001897f; Sbrissa D, 2007, J BIOL CHEM, V282, P23878, DOI 10.1074/jbc.M611678200; Sbrissa D, 2008, J MOL BIOL, V384, P766, DOI 10.1016/j.jmb.2008.10.009; Shisheva A, 1999, MOL CELL BIOL, V19, P623; Shisheva A, 2001, METHOD ENZYMOL, V329, P39; Shisheva A, 2008, CELL BIOL INT, V32, P591, DOI 10.1016/j.cellbi.2008.01.006; Shisheva A, 2008, AM J PHYSIOL-ENDOC M, V295, pE536, DOI 10.1152/ajpendo.90353.2008; Strauss H. M., 2008, V186, P461, DOI 10.1007/978-3-540-72843-6_19; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P17518, DOI 10.1073/pnas.0702275104	37	51	51	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35794	35806		10.1074/jbc.M109.037515	http://dx.doi.org/10.1074/jbc.M109.037515			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19840946	Green Published, hybrid			2022-12-25	WOS:000272645600056
J	Tong, YF; Hota, PK; Penachioni, JY; Hamaneh, MB; Kim, S; Alviani, RS; Shen, LM; He, H; Tempel, W; Tamagnone, L; Park, HW; Buck, M				Tong, Yufeng; Hota, Prasanta K.; Penachioni, Junia Y.; Hamaneh, Mehdi B.; Kim, SoonJeung; Alviani, Rebecca S.; Shen, Limin; He, Hao; Tempel, Wolfram; Tamagnone, Luca; Park, Hee-Won; Buck, Matthias			Structure and Function of the Intracellular Region of the Plexin-B1 Transmembrane Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; R-RAS; CRYSTAL-STRUCTURE; BINDING; DOMAIN; GAP; SEMAPHORINS; AUTOINHIBITION; REFINEMENT; MODEL	Members of the plexin family are unique transmembrane receptors in that they interact directly with Rho family small GTPases; moreover, they contain a GTPase-activating protein (GAP) domain for R-Ras, which is crucial for plexin-mediated regulation of cell motility. However, the functional role and structural basis of the interactions between the different intracellular domains of plexins remained unclear. Here we present the 2.4 angstrom crystal structure of the complete intracellular region of human plexin-B1. The structure is monomeric and reveals that the GAP domain is folded into one structure from two segments, separated by the Rho GTPase binding domain (RBD). The RBD is not dimerized, as observed previously. Instead, binding of a conserved loop region appears to compete with dimerization and anchors the RBD to the GAP domain. Cell-based assays on mutant proteins confirm the functional importance of this coupling loop. Molecular modeling based on structural homology to p120(GAP).H-Ras suggests that Ras GTPases can bind to the plexin GAP region. Experimentally, we show that the monomeric intracellular plexin-B1 binds R-Ras but not H-Ras. These findings suggest that the monomeric form of the intracellular region is primed for GAP activity and extend a model for plexin activation.	[Hota, Prasanta K.; Hamaneh, Mehdi B.; Kim, SoonJeung; Alviani, Rebecca S.; Buck, Matthias] Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Dept Neurosci, Sch Med, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Shen, Limin; He, Hao; Tempel, Wolfram; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON M5G 1L7, Canada; [Penachioni, Junia Y.; Tamagnone, Luca] Univ Turin, Inst Canc Res & Treatment, I-10060 Turin, Italy	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Toronto; Structural Genomics Consortium; University of Toronto; University of Turin	Tamagnone, L (corresponding author), Univ Turin, IRCC, Str Prov 142, I-10060 Candiolo, Italy.	luca.tamagnone@ircc.it; heewon.park@utoronto.ca; matthias.buck@case.edu	Tong, Yufeng/D-2785-2011; Buck, Matthias/B-2106-2017; Hota, Prasanta Kumar/J-4319-2019; Tamagnone, Luca/J-8948-2018	Tong, Yufeng/0000-0001-7740-1812; Buck, Matthias/0000-0002-2958-0403; Hota, Prasanta Kumar/0000-0002-4057-1831; Tamagnone, Luca/0000-0002-2884-7946	National Institutes of Health [R01GM73071, K02HL084384, Y1-GM-1104]; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Italian Association for Cancer Research and Regione Piemonte; NCI [Y1-CO-1020]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL084384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Italian Association for Cancer Research and Regione Piemonte(Fondazione AIRC per la ricerca sul cancro); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants R01GM73071 and K02HL084384 (to M. B.) and in part by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust. Supported by grants from the Italian Association for Cancer Research and Regione Piemonte. Drs. Christina Kiel and Luis Serrano (EMBLCRG, Barcelona) helped us early in this project with a homology model of plexin-B1 based on p120<SUP>GAP</SUP>. Crystallographic data shown in this report were derived from work performed at Argonne National Laboratory, Structural Biology Center, beam line 19ID, at the Advanced Photon Source. Data collection at GM/CA CAT, beam line 23ID-B, has been funded by NCI Grant Y1-CO-1020 and NIGM Grant Y1-GM-1104 from the National Institutes of Health. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. Calculations were carried out at the Case Western Reserve University High Performance Cluster, at the Ohio Supercomputer Center (Columbus, OH), and at LoneStar (Austin, TX) via a TeraGrid Award (to M. B.).	Ahmadian MR, 2003, J MOL BIOL, V329, P699, DOI 10.1016/S0022-2836(03)00514-X; Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; Barberis D, 2004, FASEB J, V18, P592, DOI 10.1096/fj.03-0957fje; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bouguet-Bonnet S, 2008, J MOL BIOL, V377, P1474, DOI 10.1016/j.jmb.2008.01.081; Buck M, 2004, J MOL BIOL, V338, P271, DOI 10.1016/j.jmb.2004.02.036; Canagarajah B, 2004, CELL, V119, P407, DOI 10.1016/j.cell.2004.10.012; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Drugan JK, 2000, J BIOL CHEM, V275, P35021, DOI 10.1074/jbc.M004386200; Ehrhardt A, 2002, EXP HEMATOL, V30, P1089, DOI 10.1016/S0301-472X(02)00904-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; He HW, 2009, P NATL ACAD SCI USA, V106, P15610, DOI 10.1073/pnas.0906923106; Hota PK, 2009, PROTEIN SCI, V18, P1060, DOI 10.1002/pro.116; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neufeld G, 2005, FRONT BIOSCI-LANDMRK, V10, P751, DOI 10.2741/1569; Ohba Y, 2000, J BIOL CHEM, V275, P20020, DOI 10.1074/jbc.M000981200; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pasterkamp RJ, 2005, TRENDS CELL BIOL, V15, P61, DOI 10.1016/j.tcb.2004.12.005; Pasterkamp RJ, 2001, BRAIN RES REV, V35, P36, DOI 10.1016/S0165-0173(00)00050-3; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Puschel AW, 2007, ADV EXP MED BIOL, V600, P12; Radley TL, 2003, J MOL BIOL, V332, P529, DOI 10.1016/S0022-2836(03)00925-2; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tong YF, 2005, STRUCTURE, V13, P7, DOI 10.1016/j.str.2004.10.018; Tong Y, 2008, STRUCTURE, V16, P246, DOI 10.1016/j.str.2007.12.012; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Turner LJ, 2004, J BIOL CHEM, V279, P33199, DOI 10.1074/jbc.M402943200; Uesugi K, 2009, J BIOL CHEM, V284, P6743, DOI 10.1074/jbc.M805213200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Venkateswarlu K, 2004, J BIOL CHEM, V279, P6205, DOI 10.1074/jbc.C300482200; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020	48	63	66	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35962	35972		10.1074/jbc.M109.056275	http://dx.doi.org/10.1074/jbc.M109.056275			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19843518	hybrid, Green Published			2022-12-25	WOS:000272645600071
J	Rha, GB; Wu, G; Shoelson, SE; Chi, YI				Rha, Geun Bae; Wu, Guangteng; Shoelson, Steven E.; Chi, Young-In			Multiple Binding Modes between HNF4 alpha and the LXXLL Motifs of PGC-1 alpha Lead to Full Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-GAMMA COACTIVATOR-1-ALPHA; NUCLEAR FACTOR 4-ALPHA; ALPHA ERR-ALPHA; TRANSCRIPTIONAL COACTIVATOR; ESTROGEN-RECEPTOR; GENE-EXPRESSION; LIGAND-BINDING; STRUCTURAL BASIS; INSULIN-SECRETION; ANDROGEN RECEPTOR	Hepatocyte nuclear factor 4 alpha (HNF4 alpha) is a novel nuclear receptor that participates in a hierarchical network of transcription factors regulating the development and physiology of such vital organs as the liver, pancreas, and kidney. Among the various transcriptional coregulators with which HNF4 alpha interacts, peroxisome proliferation-activated receptor gamma(PPAR gamma) coactivator 1 alpha(PGC-1 alpha) represents a novel coactivator whose activation is unusually robust and whose binding mode appears to be distinct from that of canonical coactivators such as NCoA/SRC/p160 family members. To elucidate the potentially unique molecular mechanism of PGC-1 alpha recruitment, we have determined the crystal structure of HNF4 alpha in complex with a fragment of PGC-1 alpha containing all three of its LXXLL motifs. Despite the presence of all three LXXLL motifs available for interactions, only one is bound at the canonical binding site, with no additional contacts observed between the two proteins. However, a close inspection of the electron density map indicates that the bound LXXLL motif is not a selected one but an averaged structure of more than one LXXLL motif. Further biochemical and functional studies show that the individual LXXLL motifs can bind but drive only minimal transactivation. Only when more than one LXXLL motif is involved can significant transcriptional activity be measured, and full activation requires all three LXXLL motifs. These findings led us to propose a model wherein each LXXLL motif has an additive effect, and the multiple binding modes by HNF4 alpha toward the LXXLL motifs of PGC-1 alpha could account for the apparent robust activation by providing a flexible mechanism for combinatorial recruitment of additional coactivators and mediators.	[Rha, Geun Bae; Wu, Guangteng; Chi, Young-In] Univ Kentucky, Dept Mol & Cellular Biochem, Struct Biol Ctr, Lexington, KY 40536 USA; [Shoelson, Steven E.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; [Shoelson, Steven E.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA	University of Kentucky; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Chi, YI (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Struct Biol Ctr, 741 S Limestone Ave, Lexington, KY 40536 USA.	ychi@uky.edu			National Institutes of Health [P20RR20171]; American Diabetes Association [7-08-CD-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR20171 from the COBRE Program of the NCRR. This work was also supported by American Diabetes Association Grant 7-08-CD-03 (to Y.I.C.).	Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Bogan AA, 2000, J MOL BIOL, V302, P831, DOI 10.1006/jmbi.2000.4099; Bourdoncle A, 2005, J MOL BIOL, V347, P921, DOI 10.1016/j.jmb.2005.01.048; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Delerive P, 2002, J BIOL CHEM, V277, P3913, DOI 10.1074/jbc.M109409200; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Dubbink HJ, 2006, MOL ENDOCRINOL, V20, P1742, DOI 10.1210/me.2005-0348; Dubbink HJ, 2004, MOL ENDOCRINOL, V18, P2132, DOI 10.1210/me.2003-0375; Duda K, 2004, J BIOL CHEM, V279, P23311, DOI 10.1074/jbc.M400864200; Gee AC, 1999, MOL ENDOCRINOL, V13, P1912, DOI 10.1210/me.13.11.1912; Greschik H, 2008, J BIOL CHEM, V283, P20220, DOI 10.1074/jbc.M801920200; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI22365; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hentschke M, 2002, BIOCHEM BIOPH RES CO, V299, P872, DOI 10.1016/S0006-291X(02)02753-5; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Iordanidou P, 2005, J BIOL CHEM, V280, P21810, DOI 10.1074/jbc.M501221200; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Knutti D, 2001, TRENDS ENDOCRIN MET, V12, P360, DOI 10.1016/S1043-2760(01)00457-X; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Krylova IN, 2005, CELL, V120, P343, DOI 10.1016/j.cell.2005.01.024; Li Y, 2003, STRUCTURE, V11, P741, DOI 10.1016/S0969-2126(03)00133-3; Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu D, 2005, J MOL ENDOCRINOL, V34, P473, DOI 10.1677/jme.1.01586; Lu P, 2008, J BIOL CHEM, V283, P33685, DOI 10.1074/jbc.M806213200; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Miura A, 2006, J BIOL CHEM, V281, P5246, DOI 10.1074/jbc.M507496200; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Needham M, 2000, J STEROID BIOCHEM, V72, P35, DOI 10.1016/S0960-0760(00)00027-3; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Parviz F, 2003, NAT GENET, V34, P292, DOI 10.1038/ng1175; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rochette-Egly C, 2005, J BIOL CHEM, V280, P32565, DOI 10.1074/jbc.R500008200; Ruse MD, 2002, MOL CELL BIOL, V22, P1626, DOI 10.1128/MCB.22.6.1626-1638.2002; Savkur RS, 2005, MOL PHARMACOL, V68, P511, DOI 10.1124/mol.105.012708.; Savkur RS, 2005, J PHARMACOL EXP THER, V312, P170, DOI 10.1124/jpet.104.072124; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shiraki T, 2005, PROTEINS, V58, P418, DOI 10.1002/prot.20266; Sladek FM, 1999, MOL CELL BIOL, V19, P6509; Sladek FM, 2001, NUCL RECEPTORS GENET; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; Stallcup MR, 2000, BIOCHEM SOC T, V28, P415, DOI 10.1042/0300-5127:0280415; Tcherepanova I, 2000, J BIOL CHEM, V275, P16302, DOI 10.1074/jbc.M001364200; VAGIN A, 1997, J APPL CRYSTALLOGR, V30, P1002; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Wang HY, 2000, J BIOL CHEM, V275, P35953, DOI 10.1074/jbc.M006612200; Wang W, 2005, P NATL ACAD SCI USA, V102, P7505, DOI 10.1073/pnas.0409482102; Warnmark A, 2002, J BIOL CHEM, V277, P21862, DOI 10.1074/jbc.M200764200; Westin S, 1998, NATURE, V395, P199, DOI 10.1038/26040; Wu YF, 2003, J BIOL CHEM, V278, P8637, DOI 10.1074/jbc.M210910200; Wu YF, 2002, J BIOL CHEM, V277, P8898, DOI 10.1074/jbc.M110761200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yoon JC, 2003, DEV CELL, V5, P73, DOI 10.1016/S1534-5807(03)00170-9; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	75	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35165	35176		10.1074/jbc.M109.052506	http://dx.doi.org/10.1074/jbc.M109.052506			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19846556	hybrid, Green Published			2022-12-25	WOS:000272439600070
J	Emerson, GL; Li, Y; Frace, MA; Olsen-Rasmussen, MA; Khristova, ML; Govil, D; Sammons, SA; Regnery, RL; Karem, KL; Damon, IK; Carroll, DS				Emerson, Ginny L.; Li, Yu; Frace, Michael A.; Olsen-Rasmussen, Melissa A.; Khristova, Marina L.; Govil, Dhwani; Sammons, Scott A.; Regnery, Russell L.; Karem, Kevin L.; Damon, Inger K.; Carroll, Darin S.			The Phylogenetics and Ecology of the Orthopoxviruses Endemic to North America	PLOS ONE			English	Article							MONKEYPOX VIRUS; POXVIRUS GENOME; AVIAN POX; SEQUENCE; COWPOX; INFECTION; TRANSMISSION; EVOLUTION; INFERENCE; ALIGNMENT	The data presented herein support the North American orthopoxviruses (NA OPXV) in a sister relationship to all other currently described Orthopoxvirus (OPXV) species. This phylogenetic analysis reaffirms the identification of the NA OPXV as close relatives of "Old World'' (Eurasian and African) OPXV and presents high support for deeper nodes within the Chordopoxvirinae family. The natural reservoir host(s) for many of the described OPXV species remains unknown although a clear virus-host association exists between the genus OPXV and several mammalian taxa. The hypothesized host associations and the deep divergence of the OPXV/NA OPXV clades depicted in this study may reflect the divergence patterns of the mammalian faunas of the Old and New World and reflect a more ancient presence of OPXV on what are now the American continents. Genes from the central region of the poxvirus genome are generally more conserved than genes from either end of the linear genome due to functional constraints imposed on viral replication abilities. The relatively slower evolution of these genes may more accurately reflect the deeper history among the poxvirus group, allowing for robust placement of the NA OPXV within Chordopoxvirinae. Sequence data for nine genes were compiled from three NA OPXV strains plus an additional 50 genomes collected from Genbank. The current, gene sequence based phylogenetic analysis reaffirms the identification of the NA OPXV as the nearest relatives of "Old World'' OPXV and presents high support for deeper nodes within the Chordopoxvirinae family. Additionally, the substantial genetic distances that separate the currently described NA OPXV species indicate that it is likely that many more undescribed OPXV/NA OPXV species may be circulating among wild animals in North America.			Emerson, GL (corresponding author), Ctr Dis Control & Prevent, Coordinating Ctr Infect Dis, CCID, CDC, Atlanta, GA 30333 USA.	DCarroll@cdc.gov						Afonso CL, 2006, J VIROL, V80, P4978, DOI 10.1128/JVI.80.10.4978-4991.2006; Afonso CL, 2005, J VIROL, V79, P966, DOI 10.1128/JVI.79.2.966-977.2005; Alexander A.D., 1972, Journal Wildl Dis, V8, P119; Babkin IV, 2006, MOL BIOL+, V40, P20; Baxby D., 1981, TRENDS IMMUNOL, V3, P26; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Bratke KA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-67; Cameron C, 1999, VIROLOGY, V264, P298, DOI 10.1006/viro.1999.0001; Chantrey J, 1999, EPIDEMIOL INFECT, V122, P455, DOI 10.1017/S0950268899002423; Delhon G, 2004, J VIROL, V78, P168, DOI 10.1128/JVI.78.1.168-177.2004; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Hazel SM, 2000, EPIDEMIOL INFECT, V124, P551, DOI 10.1017/S0950268899003799; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 2005, MOL PHYLOGENET EVOL, V35, P186, DOI 10.1016/j.ympev.2004.12.008; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P56; KHODAKEVICH L, 1986, LANCET, V1, P98; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P115; KNIGHT JC, 1992, VIROLOGY, V190, P423, DOI 10.1016/0042-6822(92)91228-M; LADNYJ ID, 1972, B WORLD HEALTH ORGAN, V46, P593; Lefkowitz EJ, 2006, VIRUS RES, V117, P105, DOI 10.1016/j.virusres.2006.01.016; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; LOURIE B, 1975, J INFECT DIS, V132, P677, DOI 10.1093/infdis/132.6.677; Marchal J, 1930, J PATHOL BACTERIOL, V33, P713, DOI 10.1002/path.1700330317; McInnes CJ, 2006, J GEN VIROL, V87, P2115, DOI 10.1099/vir.0.81966-0; NITSCHE A, 2007, EUROSURVEILLANCE, V12, P3178; OSTERHAUS ADME, 1981, LAB ANIM SCI, V31, P704; REGNERY DC, 1987, ARCH VIROL, V94, P159, DOI 10.1007/BF01313734; Rocke TE, 2004, VACCINE, V22, P2757, DOI 10.1016/j.vaccine.2004.01.030; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Senkevich TG, 1997, VIROLOGY, V233, P19, DOI 10.1006/viro.1997.8607; Shchelkunov SN, 1998, VIROLOGY, V243, P432, DOI 10.1006/viro.1998.9039; Smits JE, 2005, VET PATHOL, V42, P59, DOI 10.1354/vp.42-1-59; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; Thiel T, 2005, J WILDLIFE DIS, V41, P342, DOI 10.7589/0090-3558-41.2.342; Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404; Upton C, 2003, J VIROL, V77, P7590, DOI 10.1128/JVI.77.13.7590-7600.2003; Van Riper C, 2002, AUK, V119, P929, DOI 10.1642/0004-8038(2002)119[0929:EAEOAP]2.0.CO;2; von Magnus P., 1959, Acta Pathologica et Microbiologica Scandinavica, V46, P156; Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Willer DO, 1999, VIROLOGY, V264, P319, DOI 10.1006/viro.1999.0002; Woodall J., 1967, ATAS SIMP SIO BIOTA, V6, P31; Yager JA, 2006, VET DERMATOL, V17, P443, DOI 10.1111/j.1365-3164.2006.00553.x	45	43	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7666	10.1371/journal.pone.0007666	http://dx.doi.org/10.1371/journal.pone.0007666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19865479	Green Submitted, Green Published, gold			2022-12-25	WOS:000271232000017
J	Bullock, AN; Russo, S; Amos, A; Pagano, N; Bregman, H; Debreczeni, JE; Lee, WH; von Delft, F; Meggers, E; Knapp, S				Bullock, Alex N.; Russo, Santina; Amos, Ann; Pagano, Nicholas; Bregman, Howard; Debreczeni, Judit E.; Lee, Wen Hwa; von Delft, Frank; Meggers, Eric; Knapp, Stefan			Crystal Structure of the PIM2 Kinase in Complex with an Organoruthenium Inhibitor	PLOS ONE			English	Article							HALF-SANDWICH COMPLEXES; PROVIRAL INSERTION SITE; MYC; PHOSPHORYLATION; TRANSFORMATION; SPECIFICITY; ACTIVATION; EXPRESSION; LEUKEMIA; GROWTH	Background: The serine/threonine kinase PIM2 is highly expressed in human leukemia and lymphomas and has been shown to positively regulate survival and proliferation of tumor cells. Its diverse ATP site makes PIM2 a promising target for the development of anticancer agents. To date our knowledge of catalytic domain structures of the PIM kinase family is limited to PIM1 which has been extensively studied and which shares about 50% sequence identity with PIM2. Principal Findings: Here we determined the crystal structure of PIM2 in complex with an organoruthenium complex (inhibition in sub-nanomolar level). Due to its extraordinary shape complementarity this stable organometallic compound is a highly potent inhibitor of PIM kinases. Significance: The structure of PIM2 revealed several differences to PIM1 which may be explored further to generate isoform selective inhibitors. It has also demonstrated how an organometallic inhibitor can be adapted to the binding site of protein kinases to generate highly potent inhibitors.			Bullock, AN (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford, England.	stefan.knapp@sgc.ox.ac.uk	Lee, Wen Hwa/GZA-8183-2022; Knapp, Stefan/AAG-2347-2019; Lee, Wen Hwa/G-1250-2013; Meggers, Eric/B-8541-2014	Lee, Wen Hwa/0000-0002-4098-5225; Knapp, Stefan/0000-0001-5995-6494; Lee, Wen Hwa/0000-0002-4098-5225; Meggers, Eric/0000-0002-8851-7623; von Delft, Frank/0000-0003-0378-0017	CIHR Funding Source: Medline; Wellcome Trust Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Adam M, 2006, CANCER RES, V66, P3828, DOI 10.1158/0008-5472.CAN-05-2309; Agrawal S, 2008, LEUKEMIA, V22, P78, DOI 10.1038/sj.leu.2404988; Allen JD, 1997, ONCOGENE, V15, P1133, DOI 10.1038/sj.onc.1201288; Atilla-Gokcumen GE, 2006, CHEMBIOCHEM, V7, P1443, DOI 10.1002/cbic.200600117; Bregman H, 2004, J AM CHEM SOC, V126, P13594, DOI 10.1021/ja046049c; BREUER ML, 1989, EMBO J, V8, P743, DOI 10.1002/j.1460-2075.1989.tb03434.x; Bullock AN, 2005, J MED CHEM, V48, P7604, DOI 10.1021/jm0504858; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen JL, 2008, BLOOD, V111, P1677, DOI 10.1182/blood-2007-04-083808; Cohen AM, 2004, LEUKEMIA LYMPHOMA, V45, P951, DOI 10.1080/10428190310001641251; Debreczeni JE, 2006, ANGEW CHEM INT EDIT, V45, P1580, DOI 10.1002/anie.200503468; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Giles F, 2005, BLOOD, V105, P4158, DOI 10.1182/blood-2005-03-1150; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Jacobs MD, 2005, J BIOL CHEM, V280, P13728, DOI 10.1074/jbc.M413155200; Kumar A, 2005, J MOL BIOL, V348, P183, DOI 10.1016/j.jmb.2005.02.039; Meggers E, 2007, CURR OPIN CHEM BIOL, V11, P287, DOI 10.1016/j.cbpa.2007.05.013; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Pagano N, 2007, ORG BIOMOL CHEM, V5, P1218, DOI 10.1039/b700433h; Pogacic V, 2007, CANCER RES, V67, P6916, DOI 10.1158/0008-5472.CAN-07-0320; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; Williams DS, 2005, ANGEW CHEM INT EDIT, V44, P1984, DOI 10.1002/anie.200462501; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Zhang YD, 2007, MOL CANCER RES, V5, P909, DOI 10.1158/1541-7786.MCR-06-0388; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	30	70	74	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7112	10.1371/journal.pone.0007112	http://dx.doi.org/10.1371/journal.pone.0007112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841674	Green Published, gold			2022-12-25	WOS:000271012900002
J	Foster, KG; Acosta-Jaquez, HA; Romeo, Y; Ekim, B; Soliman, GA; Carriere, A; Roux, PP; Ballif, BA; Fingar, DC				Foster, Kathryn G.; Acosta-Jaquez, Hugo A.; Romeo, Yves; Ekim, Bilgen; Soliman, Ghada A.; Carriere, Audrey; Roux, Philippe P.; Ballif, Bryan A.; Fingar, Diane C.			Regulation of mTOR Complex 1 (mTORC1) by Raptor Ser(863) and Multisite Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX-1; RICH AKT SUBSTRATE; 40 KDA PRAS40; MAMMALIAN TARGET; CELL-GROWTH; RAG GTPASES; PHOSPHOPROTEOME ANALYSIS; PROTEIN-PHOSPHORYLATION; BINDING PARTNER; RAPAMYCIN TOR	The rapamycin-sensitive mTOR complex 1 (mTORC1) promotes protein synthesis, cell growth, and cell proliferation in response to growth factors and nutritional cues. To elucidate the poorly defined mechanisms underlying mTORC1 regulation, we have studied the phosphorylation of raptor, an mTOR-interacting partner. We have identified six raptor phosphorylation sites that lie in two centrally localized clusters (cluster 1, Ser(696)/Thr(706) and cluster 2, Ser(855)/Ser(859)/Ser(863)/Ser(877)) using tandem mass spectrometry and generated phosphospecific antibodies for each of these sites. Here we focus primarily although not exclusively on raptor Ser(863) phosphorylation. We report that insulin promotes mTORC1-associated phosphorylation of raptor Ser(863) via the canonical PI3K/TSC/Rheb pathway in a rapamycin-sensitive manner. mTORC1 activation by other stimuli (e. g. amino acids, epidermal growth factor/MAPK signaling, and cellular energy) also promote raptor Ser(863) phosphorylation. Rheb overexpression increases phosphorylation on raptor Ser(863) as well as on the five other identified sites (e. g. Ser(859), Ser(855), Ser(877), Ser(696), and Thr(706)). Strikingly, raptor Ser(863) phosphorylation is absolutely required for raptor Ser(859) and Ser(855) phosphorylation. These data suggest that mTORC1 activation leads to raptor multisite phosphorylation and that raptor Ser(863) phosphorylation functions as a master biochemical switch that modulates hierarchical raptor phosphorylation (e. g. on Ser(859) and Ser(855)). Importantly, mTORC1 containing phosphorylation site-defective raptor exhibits reduced in vitro kinase activity toward the substrate 4EBP1, with a multisite raptor 6A mutant more strongly defective that single-site raptor S863A. Taken together, these data suggest that complex raptor phosphorylation functions as a biochemical rheostat that modulates mTORC1 signaling in accordance with environmental cues.	[Foster, Kathryn G.; Acosta-Jaquez, Hugo A.; Ekim, Bilgen; Soliman, Ghada A.; Fingar, Diane C.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Soliman, Ghada A.; Fingar, Diane C.] Univ Michigan, Sch Med, Dept Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Romeo, Yves; Carriere, Audrey; Roux, Philippe P.] Univ Montreal, Dept Pathol & Cell Biol, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Ballif, Bryan A.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA; [Ballif, Bryan A.] Univ Vermont, Vermont Genet Network, Prote Facil, Burlington, VT 05405 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universite de Montreal; University of Vermont; University of Vermont	Fingar, DC (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	dfingar@umich.edu	Roux, Philippe P./J-3996-2012; Soliman, Ghada A/U-6472-2017; Romeo, Yves/AAC-1669-2021	Roux, Philippe P./0000-0002-5962-0250; Soliman, Ghada A/0000-0002-8629-6062; Carriere, Audrey/0000-0002-4277-7905	National Institutes of Health [R01 DK078135]; NIDDK [P20 RR16462]; National Center for Research Resources; American Diabetes Association; American Heart Association; Cole Foundation; Terry Fox Foundation; Canadian Cancer Society Research Institute [018311]; Human Frontier Science Program; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572, R01DK078135] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Cole Foundation; Terry Fox Foundation; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Human Frontier Science Program(Human Frontier Science Program); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK078135 from the NIDDK (to D. C. F.) and P20 RR16462 to the Vermont Genetics Network. This work was also supported by the Institutional Development Award Networks of the Biomedical Research Excellence (INBRE) Program of the National Center for Research Resources (to B. A. B.), a Jr. Faculty Award from the American Diabetes Association (to D. C. F.), the American Heart Association (to G. A. S. and B. E.), the Cole Foundation (to A. C.), Terry Fox Foundation through the Canadian Cancer Society Research Institute Grant 018311, and a Career Development Award from the Human Frontier Science Program (to P. P. R.).	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Avruch J, 2009, BIOCHEM SOC T, V37, P223, DOI 10.1042/BST0370223; Ballif BA, 2004, MOL CELL PROTEOMICS, V3, P1093, DOI 10.1074/mcp.M400085-MCP200; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Choi KM, 2003, J BIOL CHEM, V278, P19667, DOI 10.1074/jbc.M301142200; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gingras AC, 2001, GENE DEV, V15, P2852; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Imami K, 2008, ANAL SCI, V24, P161, DOI 10.2116/analsci.24.161; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MACDOUGALD OA, 1995, J BIOL CHEM, V270, P647, DOI 10.1074/jbc.270.2.647; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Munton RP, 2007, MOL CELL PROTEOMICS, V6, P283, DOI 10.1074/mcp.M600046-MCP200; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Shaw RJ, 2008, TRENDS BIOCHEM SCI, V33, P565, DOI 10.1016/j.tibs.2008.09.005; STUDENT AK, 1980, J BIOL CHEM, V255, P4745; Sui SH, 2008, PROTEOMICS, V8, P2024, DOI 10.1002/pmic.200700896; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Trinidad JC, 2008, MOL CELL PROTEOMICS, V7, P684, DOI 10.1074/mcp.M700170-MCP200; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907; Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zinzalla V, 2008, NATURE, V454, P287, DOI 10.1038/454287a	73	130	135	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					80	94		10.1074/jbc.M109.029637	http://dx.doi.org/10.1074/jbc.M109.029637			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864431	hybrid, Green Published			2022-12-25	WOS:000273070100009
J	Mapingire, OS; Henderson, NS; Duret, G; Thanassi, DG; Delcour, AH				Mapingire, Owen S.; Henderson, Nadine S.; Duret, Guillaume; Thanassi, David G.; Delcour, Anne H.			Modulating Effects of the Plug, Helix, and N- and C-terminal Domains on Channel Properties of the PapC Usher	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL OUTER-MEMBRANE; ESCHERICHIA-COLI; PILUS BIOGENESIS; STRUCTURAL BASIS; SECRETION; FORMS; RECOGNITION; ADHESIN; COMPLEX; SITE	The chaperone/usher system is one of the best characterized pathways for protein secretion and assembly of cell surface appendages in Gram-negative bacteria. In particular, this pathway is used for biogenesis of the P pilus, a key virulence factor used by uropathogenic Escherichia coli to adhere to the host urinary tract. The P pilus individual subunits bound to the periplasmic chaperone PapD are delivered to the outer membrane PapC usher, which serves as an assembly platform for subunit incorporation into the pilus and secretion of the pilus fiber to the cell surface. PapC forms a dimeric, twin pore complex, with each monomer composed of a 24-stranded transmembrane beta-barrel channel, an internal plug domain that occludes the channel, and globular N- and C-terminal domains that are located in the periplasm. Here we have used planar lipid bilayer electrophysiology to characterize the pore properties of wild type PapC and domain deletion mutants for the first time. The wild type pore is closed most of the time but displays frequent short-lived transitions to various open states. In comparison, PapC mutants containing deletions of the plug domain, an alpha-helix that caps the plug domain, or the N- and C-terminal domains form channels with higher open probability but still exhibiting dynamic behavior. Removal of the plug domain results in a channel with extremely large conductance. These observations suggest that the plug gates the usher channel closed and that the periplasmic domains and alpha-helix function to modulate the gating activity of the PapC twin pore.	[Henderson, Nadine S.; Thanassi, David G.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Ctr Infect Dis, Stony Brook, NY 11794 USA; [Mapingire, Owen S.; Duret, Guillaume; Delcour, Anne H.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Houston System; University of Houston	Thanassi, DG (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Ctr Infect Dis, Stony Brook, NY 11794 USA.	david.thanassi@stonybrook.edu; adelcour@uh.edu			National Institutes of Health [GM062987]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062987] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM062987 ( to D. G. T.).	BAGA M, 1987, CELL, V49, P241, DOI 10.1016/0092-8674(87)90565-4; Basle A, 2004, BBA-BIOMEMBRANES, V1664, P100, DOI 10.1016/j.bbamem.2004.04.009; Brok R, 1999, J MOL BIOL, V294, P1169, DOI 10.1006/jmbi.1999.3340; Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004; Capitani G, 2006, PROTEINS, V65, P816, DOI 10.1002/prot.21147; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; Delcour AH, 2003, FRONT BIOSCI-LANDMRK, V8, pD1055, DOI 10.2741/1132; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; DODSON KW, 1993, P NATL ACAD SCI USA, V90, P3670, DOI 10.1073/pnas.90.8.3670; Duret G, 2008, J BIOL CHEM, V283, P15771, DOI 10.1074/jbc.M708970200; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Jacob-Dubuisson F, 1999, J BIOL CHEM, V274, P37731, DOI 10.1074/jbc.274.53.37731; Kostakioti M, 2005, J BACTERIOL, V187, P4306, DOI 10.1128/JB.187.13.4306-4314.2005; Li HL, 2004, J MOL BIOL, V344, P1397, DOI 10.1016/j.jmb.2004.10.008; Ng TW, 2004, J BACTERIOL, V186, P5321, DOI 10.1128/JB.186.16.5321-5331.2004; Nishiyama M, 2005, EMBO J, V24, P2075, DOI 10.1038/sj.emboj.7600693; Nishiyama M, 2008, SCIENCE, V320, P376, DOI 10.1126/science.1154994; NORGREN M, 1987, MOL MICROBIOL, V1, P169, DOI 10.1111/j.1365-2958.1987.tb00509.x; Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173; Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1111/j.1574-6968.1998.tb13027.x; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; ROBERTS JA, 1994, P NATL ACAD SCI USA, V91, P11889, DOI 10.1073/pnas.91.25.11889; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 1998, EMBO J, V17, P2177, DOI 10.1093/emboj/17.8.2177; SHARON N, 1987, FEBS LETT, V217, P145, DOI 10.1016/0014-5793(87)80654-3; So SSK, 2006, MOL MICROBIOL, V60, P364, DOI 10.1111/j.1365-2958.2006.052111.x; Stathopoulos C, 2000, MICROBES INFECT, V2, P1061, DOI 10.1016/S1286-4579(00)01260-0; Sugawara E, 1996, J BACTERIOL, V178, P6067, DOI 10.1128/jb.178.20.6067-6069.1996; Thanassi DG, 2002, J BACTERIOL, V184, P6260, DOI 10.1128/JB.184.22.6260-6269.2002; Wright KJ, 2007, CELL MICROBIOL, V9, P2230, DOI 10.1111/j.1462-5822.2007.00952.x; Yu X, 2009, BIOCHEM J, V418, P541, DOI 10.1042/BJ20080992; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9	35	38	38	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36324	36333		10.1074/jbc.M109.055798	http://dx.doi.org/10.1074/jbc.M109.055798			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19850919	Green Published, hybrid			2022-12-25	WOS:000272970500034
J	Jordanova, R; Groves, MR; Kostova, E; Woltersdorf, C; Liebau, E; Tucker, PA				Jordanova, Rositsa; Groves, Matthew R.; Kostova, Elena; Woltersdorf, Christian; Liebau, Eva; Tucker, Paul A.			Fatty Acid- and Retinoid-binding Proteins Have Distinct Binding Pockets for the Two Types of Cargo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; FAR PROTEINS; ASCARIS-SUUM; NEMATODES; RECEPTOR; PHOSPHORYLATION; POLYPROTEIN; SECRETION; SYSTEM; DOMAIN	Parasitic nematodes cause serious diseases in humans, animals, and plants. They have limited lipid metabolism and are reliant on lipid-binding proteins to acquire these metabolites from their hosts. Several structurally novel families of lipid-binding proteins in nematodes have been described, including the fatty acid- and retinoid-binding protein family (FAR). In Caenorhabditis elegans, used as a model for studying parasitic nematodes, eight C. elegans FAR proteins have been described. The crystal structure of C. elegans FAR-7 is the first structure of a FAR protein, and it exhibits a novel fold. It differs radically from the mammalian fatty acid- binding proteins and has two ligand binding pockets joined by a surface groove. The first can accommodate the aliphatic chain of fatty acids, whereas the second can accommodate the bulkier retinoids. In addition to demonstrating lipid binding by fluorescence spectroscopy, we present evidence that retinol binding is positively regulated by casein kinase II phosphorylation at a conserved site near the bottom of the second pocket. far-7::GFP (green fluorescent protein) expression shows that it is localized in the head hypodermal syncytia and the excretory cell but that this localization changes under starvation conditions. In conclusion, our study provides the basic structural and functional information for investigation of inhibitors of lipid binding by FAR proteins.	European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; [Woltersdorf, Christian; Liebau, Eva] Univ Munster, Inst Anim Physiol, D-48143 Munster, Germany	European Molecular Biology Laboratory (EMBL); University of Munster		tucker@embl-hamburg.de		Kostova, Elena/0000-0002-8116-727X; Groves, Matthew/0000-0001-9859-5177	Marie Curie Intra-European [MEIF-CT-2006-025860]	Marie Curie Intra-European(European Commission)	This work was supported by Marie Curie Intra-European Fellowship Contract MEIF-CT-2006-025860 (to R. J.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrett J, 2001, PERSPECTIVES ON HELMINTHOLOGY, P309; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; BOURGUET W, 1995, NATURE, V375, P377, DOI 10.1038/375377a0; BRENNER S, 1974, GENETICS, V77, P71; Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4; BUELT MK, 1991, J BIOL CHEM, V266, P12266; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Garofalo A, 2003, MED MICROBIOL IMMUN, V192, P47, DOI 10.1007/s00430-002-0158-6; Garofalo A, 2003, J BIOL CHEM, V278, P8065, DOI 10.1074/jbc.M206278200; Garofalo A, 2002, MOL BIOCHEM PARASIT, V122, P161, DOI 10.1016/S0166-6851(02)00097-X; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GRANATO M, 1994, NUCLEIC ACIDS RES, V22, P1762, DOI 10.1093/nar/22.9.1762; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jordanova R, 2005, J BIOL CHEM, V280, P41429, DOI 10.1074/jbc.M504474200; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kennedy MW, 1997, J BIOL CHEM, V272, P29442, DOI 10.1074/jbc.272.47.29442; KENNEDY MW, 1995, BIOCHEMISTRY-US, V34, P6700, DOI 10.1021/bi00020a015; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; McDermott L, 1999, MOL CELL BIOCHEM, V192, P69, DOI 10.1023/A:1006822321081; MEENAN N, 2004, THESIS U GLASGOW GLA; Meenan NAG, 2005, J BIOMOL NMR, V32, P176, DOI 10.1007/s10858-005-6070-9; Mueller-Dieckmann J, 2006, ACTA CRYSTALLOGR D, V62, P1446, DOI 10.1107/S0907444906038121; NIELSEN SU, 1993, J LIPID RES, V34, P1355; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Plenefisch J, 2000, MOL BIOCHEM PARASIT, V105, P223, DOI 10.1016/S0166-6851(99)00179-6; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; PRINSEN CFM, 1994, BBA-LIPID LIPID MET, V1215, P103, DOI 10.1016/0005-2760(94)90097-3; Prior A, 2001, BIOCHEM J, V356, P387, DOI 10.1042/0264-6021:3560387; SAMBROOK J, 1989, MOL CLONING LAB MANU, pB20; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Solovyova AS, 2003, EUR BIOPHYS J BIOPHY, V32, P465, DOI 10.1007/s00249-003-0297-8; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Tendler M, 1996, P NATL ACAD SCI USA, V93, P269, DOI 10.1073/pnas.93.1.269; Tendler M, 2008, ACTA TROP, V108, P263, DOI 10.1016/j.actatropica.2008.09.002; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WILKINSON TCI, 1986, BIOCHEM J, V238, P419, DOI 10.1042/bj2380419; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	51	30	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35818	35826		10.1074/jbc.M109.022731	http://dx.doi.org/10.1074/jbc.M109.022731			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19828452	Green Published, hybrid			2022-12-25	WOS:000272645600058
J	Thompson, SM; Fernig, DG; Jesudason, EC; Losty, PD; van de Westerlo, EMA; van Kuppevelt, TH; Turnbull, JE				Thompson, Sophie M.; Fernig, David G.; Jesudason, Edwin C.; Losty, Paul D.; van de Westerlo, Els M. A.; van Kuppevelt, Toin H.; Turnbull, Jeremy E.			Heparan Sulfate Phage Display Antibodies Identify Distinct Epitopes with Complex Binding Characteristics INSIGHTS INTO PROTEIN BINDING SPECIFICITIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; IDURONATE 2-SULFATE RESIDUES; MONOCLONAL-ANTIBODY; KERATAN SULFATE; SUBSTITUTION PATTERN; SEQUENCE-ANALYSIS; ANTITHROMBIN-III; SKELETAL-MUSCLE; IDENTIFICATION; DOMAINS	Heparan sulfate (HS) binds and modulates the transport and activity of a large repertoire of regulatory proteins. The HS phage display antibodies are powerful tools for the analysis of native HS structure in situ; however, their epitopes are not well defined. Analysis of the binding specificities of a set of HS antibodies by competitive binding assays with well defined chemically modified heparins demonstrates that O-sulfates are essential for binding; however, increasing sulfation does not necessarily correlate with increased antibody reactivity. IC50 values for competition with double modified heparins were not predictable from IC50 values with corresponding singly modified heparins. Binding assays and immunohistochemistry revealed that individual antibodies recognize distinct epitopes and that these are not single linear sequences but families of structurally similar motifs in which subtle variations in sulfation and conformation modify the affinity of interaction. Modeling of the antibodies demonstrates that they possess highly basic CDR3 and surrounding surfaces, presenting a number of possible orientations for HS binding. Unexpectedly, there are significant differences between the existence of epitopes in tissue sections and observed in vitro in dot blotted tissue extracts, demonstrating that in vitro specificity does not necessarily correlate with specificity in situ/vivo. The epitopes are therefore more complex than previously considered. Overall, these data have significance for structure-activity relationships of HS, because the model of one antibody recognizing multiple HS structures and the influence of other in situ HS-binding proteins on epitope availability are likely to reflect the selectivity of many HS-protein interactions in vivo.	[Thompson, Sophie M.; Fernig, David G.; Turnbull, Jeremy E.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Jesudason, Edwin C.; Losty, Paul D.] Royal Liverpool Childrens Hosp, Div Child Hlth, Sch Reprod & Dev Med, Liverpool L12 2AP, Merseyside, England; [van de Westerlo, Els M. A.; van Kuppevelt, Toin H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Matrix Biochem, NL-6500 HB Nijmegen, Netherlands	University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool; Radboud University Nijmegen	Turnbull, JE (corresponding author), Univ Liverpool, Sch Biol Sci, Crown St, Liverpool L69 7ZB, Merseyside, England.	turnbull@liverpool.ac.uk	Fernig, David G/A-3590-2008; van Kuppevelt, A.H.M.S.M./L-4463-2015	Fernig, David G/0000-0003-4875-4293; 	Human Frontiers Science Program; Birth Defects Foundation; Biotechnology and Biological Sciences Research Council (United Kingdom); North West Cancer Research Fund	Human Frontiers Science Program(Human Frontier Science Program); Birth Defects Foundation; Biotechnology and Biological Sciences Research Council (United Kingdom)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); North West Cancer Research Fund	This work was supported by the Human Frontiers Science Program, the Birth Defects Foundation, the Biotechnology and Biological Sciences Research Council (United Kingdom), and the North West Cancer Research Fund.	Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; ATHA DH, 1984, P NATL ACAD SCI-BIOL, V81, P1030, DOI 10.1073/pnas.81.4.1030; Bernsen MR, 2003, CANCER IMMUNOL IMMUN, V52, P780, DOI 10.1007/s00262-003-0421-8; CATERSON B, 1983, J BIOL CHEM, V258, P8848; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Couchman J R, 1984, Prog Clin Biol Res, V151, P31; COUCHMAN JR, 1984, NATURE, V307, P650, DOI 10.1038/307650a0; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Drummond KJ, 2001, PROTEOMICS, V1, P304, DOI 10.1002/1615-9861(200102)1:2<304::AID-PROT304>3.0.CO;2-B; FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P; Gallagher JT, 2006, BIOCHEM SOC T, V34, P438, DOI 10.1042/BST0340438; Guerrini M, 2008, J BIOL CHEM, V283, P26662, DOI 10.1074/jbc.M801102200; Guerrini M, 2006, BIOCHEM J, V399, P191, DOI 10.1042/BJ20060656; Guimond SE, 1999, CURR BIOL, V9, P1343, DOI 10.1016/S0960-9822(00)80060-3; Hjelm R, 2007, BIOCHEMISTRY-US, V46, P3378, DOI 10.1021/bi6024929; HOVINGH P, 1986, BIOCHEM J, V237, P573, DOI 10.1042/bj2370573; Hricovini M, 2001, BIOCHEM J, V359, P265, DOI 10.1042/0264-6021:3590265; Jenniskens GJ, 2006, J CELL PHYSIOL, V206, P283, DOI 10.1002/jcp.20450; Jenniskens GJ, 2000, J NEUROSCI, V20, P4099; Jenniskens GJ, 2002, DEV DYNAM, V225, P70, DOI 10.1002/dvdy.10138; KOZACK RE, 1995, BIOPHYS J, V68, P807, DOI 10.1016/S0006-3495(95)80257-2; Kreuger J, 2001, J BIOL CHEM, V276, P30744, DOI 10.1074/jbc.M102628200; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; KURE S, 1986, J IMMUNOL, V137, P3900; Kurup S, 2007, J BIOL CHEM, V282, P21032, DOI 10.1074/jbc.M702073200; Lensen JFM, 2005, J AM SOC NEPHROL, V16, P1279, DOI 10.1681/ASN.2004050413; LINDAHL U, 1979, P NATL ACAD SCI USA, V76, P3198, DOI 10.1073/pnas.76.7.3198; LINDBLOM A, 1990, GLYCOCONJUGATE J, V7, P545, DOI 10.1007/BF01189076; Lookene A, 1996, BIOCHEMISTRY-US, V35, P12155, DOI 10.1021/bi960008e; LYON M, 1987, BIOCHEM J, V242, P493, DOI 10.1042/bj2420493; LYON M, 1994, J BIOL CHEM, V269, P11208; MEHMET H, 1986, EUR J BIOCHEM, V157, P385, DOI 10.1111/j.1432-1033.1986.tb09680.x; Merry CLR, 1999, J BIOL CHEM, V274, P18455, DOI 10.1074/jbc.274.26.18455; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Mulloy B, 2000, GLYCOBIOLOGY, V10, P1147, DOI 10.1093/glycob/10.11.1147; Murphy KJ, 2004, J BIOL CHEM, V279, P27239, DOI 10.1074/jbc.M401774200; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Ori A, 2008, FRONT BIOSCI-LANDMRK, V13, P4309, DOI 10.2741/3007; PETITOU M, 1988, EUR J BIOCHEM, V176, P637, DOI 10.1111/j.1432-1033.1988.tb14324.x; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; Powell Andrew K., 2009, V534, P313, DOI 10.1007/978-1-59745-022-5_22; Rahmoune H, 1998, J BIOL CHEM, V273, P7303, DOI 10.1074/jbc.273.13.7303; Rudd TR, 2007, GLYCOBIOLOGY, V17, P983, DOI 10.1093/glycob/cwm062; RUDLAND PS, 1993, J HISTOCHEM CYTOCHEM, V41, P887, DOI 10.1177/41.6.7686196; Shriver Z, 2000, P NATL ACAD SCI USA, V97, P10359, DOI 10.1073/pnas.97.19.10359; SMITS NC, 2004, AM J PHYSIOL-LUNG C, V30, pL166; SORRELL JM, 1990, J HISTOCHEM CYTOCHEM, V38, P393, DOI 10.1177/38.3.1689338; SORRELL JM, 1988, CELL TISSUE RES, V252, P523, DOI 10.1007/BF00216639; SORRELL JM, 1988, J IMMUNOL, V140, P4263; ten Dam GB, 2006, J BIOL CHEM, V281, P4654, DOI 10.1074/jbc.M506357200; ten Dam GB, 2003, J HISTOCHEM CYTOCHEM, V51, P727; THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006; Thompson SM, 2007, PEDIATR SURG INT, V23, P411, DOI 10.1007/s00383-006-1864-8; Toida T, 1997, BIOCHEM J, V322, P499, DOI 10.1042/bj3220499; TURNBULL JE, 1990, BIOCHEM J, V265, P715, DOI 10.1042/bj2650715; TURNBULL JE, 1991, BIOCHEM J, V277, P297, DOI 10.1042/bj2770297; Turnbull JE, 1999, P NATL ACAD SCI USA, V96, P2698, DOI 10.1073/pnas.96.6.2698; TURNBULL JE, 1991, BIOCHEM J, V273, P553, DOI 10.1042/bj2730553; van de Westerlo EMA, 2002, BLOOD, V99, P2427, DOI 10.1182/blood.V99.7.2427; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; VANDENBORN J, 1992, KIDNEY INT, V41, P115, DOI 10.1038/ki.1992.15; VANDENBORN J, 1991, LAB INVEST, V65, P287; Venkataraman G, 1999, SCIENCE, V286, P537, DOI 10.1126/science.286.5439.537; Yates EA, 2000, CARBOHYD RES, V329, P239, DOI 10.1016/S0008-6215(00)00144-0; Yates EA, 1996, CARBOHYD RES, V294, P15; Yates EA, 2004, J MED CHEM, V47, P277, DOI 10.1021/jm0309755	67	32	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35621	35631		10.1074/jbc.M109.009712	http://dx.doi.org/10.1074/jbc.M109.009712			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19837661	Green Published, hybrid			2022-12-25	WOS:000272645600040
J	Yan, BX; Yates, Z; Balland, A; Kleemann, GR				Yan, Boxu; Yates, Zac; Balland, Alain; Kleemann, Gerd R.			Human IgG1 Hinge Fragmentation as the Result of H2O2-mediated Radical Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT MONOCLONAL-ANTIBODY; PROTEIN-SULFENIC ACIDS; FREE AMINO-ACIDS; HYDROGEN-PEROXIDE; POSTTRANSLATIONAL MODIFICATIONS; HEART-MITOCHONDRIA; SINGLET DIOXYGEN; OXIDATIVE STRESS; REDOX REGULATION; HUMAN MYOGLOBIN	Hinge cleavage of a recombinant human IgG1 antibody, generated during production in a Chinese hamster ovary cell culture, was observed in the purified material. The cleavage products could be reproduced by incubation of the antibody with H2O2 and featured complementary ladders of the C-and N-terminal residues (Asp(226)-Lys(227)-Thr(228)-His(229)-Thr(230)) in the heavy chain of the Fab domain and the upper hinge of one of the Fc domains, respectively. Two adducts of +45 and +71 Da were also observed at the N-terminal residues of some Fc fragments and were identified as isocyanate and alpha-ketoacyl derivatives generated by radical cleavage at the alpha-carbon position through the diamide and alpha-amidation pathways. We determined that the hinge cleavage was initiated by radical-induced breakage of the disulfide bond between the two hinge cysteines at position 231 (Cys(231)-Pro-Pro-Cys-Pro), followed by the formation of a thiyl radical (Cys(231)-S-center dot) on one cysteine and sulfenic acid (Cys(231)-SOH) on the other. The location of the initial radical attack and the critical role of Cys(231) were demonstrated by the observation that 5,5-dimethyl-1-pyrroline N-oxide only reacted with the Cys(231) radical and completely blocked hinge cleavage, suggesting the necessity of an electron/radical transfer from the Cys(231) radical to the hinge residues where cleavage was observed. As a precursor of hydroxyl radicals, H2O2 is widely produced in healthy cells and tissues and therefore could be the source for the radical-induced fragmentation of human IgG1 antibodies in vivo.	[Yan, Boxu; Yates, Zac; Balland, Alain; Kleemann, Gerd R.] Amgen Inc, Dept Analyt & Formulat Sci, Seattle, WA 98119 USA	Amgen	Yan, BX (corresponding author), 1201 Amgen Ct W, Seattle, WA 98119 USA.	byan@amgen.com						Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; BERLETT BS, 1990, P NATL ACAD SCI USA, V87, P389, DOI 10.1073/pnas.87.1.389; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Claiborne A, 2001, ADV PROTEIN CHEM, V58, P215; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Cohen SL, 2007, J AM CHEM SOC, V129, P6976, DOI 10.1021/ja0705994; Cordoba AJ, 2005, J CHROMATOGR B, V818, P115, DOI 10.1016/j.jchromb.2004.12.033; Datta D, 2002, P NATL ACAD SCI USA, V99, P2636, DOI 10.1073/pnas.052709399; DAVIES KJA, 1987, J BIOL CHEM, V262, P9908; Davies M. J., 1997, RADICAL MEDIATED PRO, P50; DEAN RT, 1989, FREE RADICAL RES COM, V7, P97, DOI 10.3109/10715768909087929; Deterding LJ, 2004, J BIOL CHEM, V279, P11600, DOI 10.1074/jbc.M310704200; DeYulia GJ, 2005, P NATL ACAD SCI USA, V102, P5044, DOI 10.1073/pnas.0501154102; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Frokjaer S, 2005, NAT REV DRUG DISCOV, V4, P298, DOI 10.1038/nrd1695; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; Gaza-Bulseco G, 2008, PHARM RES-DORDR, V25, P1881, DOI 10.1007/s11095-008-9606-3; HORNE C, 1982, J IMMUNOL, V129, P660; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; KATO Y, 1992, J BIOL CHEM, V267, P23646; KICE JL, 1980, ADV PHYS ORG CHEM, V17, P65; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Martinez T, 2008, BIOCHEMISTRY-US, V47, P7496, DOI 10.1021/bi800576c; Nathan C, 2003, J CLIN INVEST, V111, P769, DOI 10.1172/JCI200318174; Paget MSB, 2003, ANNU REV GENET, V37, P91, DOI 10.1146/annurev.genet.37.110801.142538; POOLE LB, 1989, J BIOL CHEM, V264, P12330; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; PURDIE JW, 1967, J AM CHEM SOC, V89, P226, DOI 10.1021/ja00978a007; Reichert JM, 2006, NAT REV DRUG DISCOV, V5, P191, DOI 10.1038/nrd1987; Reth M, 2002, NAT IMMUNOL, V3, P1129, DOI 10.1038/ni1202-1129; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rhee SG, 2003, J AM SOC NEPHROL, V14, pS211, DOI 10.1097/01.ASN.0000077404.45564.7E; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Schrama D, 2006, NAT REV DRUG DISCOV, V5, P147, DOI 10.1038/nrd1957; Shen HM, 2006, FASEB J, V20, P1589, DOI 10.1096/fj.05-5603rev; Shukla AA, 2007, J CHROMATOGR B, V848, P28, DOI 10.1016/j.jchromb.2006.09.026; STADTMAN ER, 1993, ANNU REV BIOCHEM, V62, P797, DOI 10.1146/annurev.bi.62.070193.004053; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; STADTMAN ER, 1991, J BIOL CHEM, V266, P17201; Stamler JS, 1998, NAT STRUCT BIOL, V5, P247, DOI 10.1038/nsb0498-247; STANFIELD RL, 1990, SCIENCE, V248, P712, DOI 10.1126/science.2333521; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; van der Wijk T, 2004, J BIOL CHEM, V279, P44355, DOI 10.1074/jbc.M407483200; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang PX, 2007, J AM SOC NEPHROL, V18, P1239, DOI 10.1681/ASN.2006111299; Wentworth AD, 2000, P NATL ACAD SCI USA, V97, P10930, DOI 10.1073/pnas.97.20.10930; Wentworth P, 2003, P NATL ACAD SCI USA, V100, P1490, DOI 10.1073/pnas.0437831100; Witting PK, 2000, J BIOL CHEM, V275, P20391, DOI 10.1074/jbc.M000373200; Witting PK, 2001, J BIOL CHEM, V276, P16540, DOI 10.1074/jbc.M011707200; WOLFF SP, 1987, BIOCHEM J, V245, P243, DOI 10.1042/bj2450243; Xu X, 2002, P NATL ACAD SCI USA, V99, P3376, DOI 10.1073/pnas.052710099; Yan BX, 2007, J CHROMATOGR A, V1164, P153, DOI 10.1016/j.chroma.2007.06.063; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200; Zhu XY, 2004, P NATL ACAD SCI USA, V101, P2247, DOI 10.1073/pnas.0307311101	59	31	33	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35390	35402		10.1074/jbc.M109.064147	http://dx.doi.org/10.1074/jbc.M109.064147			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850927	hybrid, Green Published			2022-12-25	WOS:000272645600015
J	Zhang, HD; Beckman, JW; Guengerich, FP				Zhang, Huidong; Beckman, Jeff W.; Guengerich, F. Peter			Frameshift Deletion by Sulfolobus solfataricus P2 DNA Polymerase Dpo4 T239W Is Selective for Purines and Involves Normal Conformational Change Followed by Slow Phosphodiester Bond Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-BASE DELETIONS; NUCLEOTIDE MISINCORPORATION; TRANSLESION SYNTHESIS; CRYSTAL-STRUCTURE; ABASIC LESION; ERROR-PRONE; FIDELITY; BYPASS; MISALIGNMENT; REPLICATION	The human DNA polymerase kappa homolog Sulfolobus solfataricus DNA polymerase IV (Dpo4) produces " -1" frameshift deletions while copying unmodified DNA and, more frequently, when bypassing DNA adducts. As judged by steady-state kinetics and mass spectrometry, bypass of purine template bases to produce these deletions occurred rarely but with 10-fold higher frequency than with pyrimidines. The DNA adduct 1, N-2-etheno-2'-deoxyguanosine, with a larger stacking surface than canonical purines, showed the highest frequency of formation of -1 frameshift deletions. Dpo4 T239W, a mutant we had previously shown to produce fluorescence changes attributed to conformational change following dNTP binding opposite cognate bases (Beckman, J. W., Wang, Q., and Guengerich, F. P. (2008) J. Biol. Chem. 283, 36711-36723), reported similar conformational changes when the incoming dNTP complemented the base following a templating purine base or bulky adduct (i.e. the "+1" base). However, in all mispairing cases, phosphodiester bond formation was inefficient. The frequency of -1 frameshift events and the associated conformational changes were not dependent on the context of the remainder of the sequence. Collectively, our results support a mechanism for -1 frameshift deletions by Dpo4 that involves formation of active complexes via a favorable conformational change that skips the templating base, without causing slippage or flipping out of the base, to incorporate a complementary residue opposite the +1 base, in a mechanism previously termed " dNTP-stabilized incorporation." The driving force is attributed to be the stacking potential between the templating base and the incoming dNTP base.	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu	zhang, huidong/B-5667-2011	Zhang, Huidong/0000-0001-7845-3331	USPHS [R01 ES010375, P30 ES000267]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267, R01ES010375] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES010375 and P30 ES000267 (to F.P.G.) from the USPHS.	Bauer J, 2007, P NATL ACAD SCI USA, V104, P14905, DOI 10.1073/pnas.0700717104; BEBENEK K, 1990, P NATL ACAD SCI USA, V87, P4946, DOI 10.1073/pnas.87.13.4946; Beckman JW, 2008, J BIOL CHEM, V283, P36711, DOI 10.1074/jbc.M806785200; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; BOND JA, 1981, J TOXICOL ENV HEALTH, V7, P327, DOI 10.1080/15287398109529983; BORER PN, 1975, HDB BIOCH MOL BIOL, P589; Choi JY, 2006, J BIOL CHEM, V281, P38244, DOI 10.1074/jbc.M608369200; Efrati E, 1997, J BIOL CHEM, V272, P2559; Eoff RL, 2009, BIOCHEMISTRY-US, V48, P7079, DOI 10.1021/bi9003588; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Irimia A, 2007, J BIOL CHEM, V282, P36421, DOI 10.1074/jbc.M707267200; Kokoska RJ, 2002, J BIOL CHEM, V277, P19633, DOI 10.1074/jbc.M202021200; KUNKEL TA, 1986, J BIOL CHEM, V261, P3581; KUNKEL TA, 1988, J BIOL CHEM, V263, P14784; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2004, P NATL ACAD SCI USA, V101, P2265, DOI 10.1073/pnas.0308332100; Loeb LA, 1996, MUTAT RES-FUND MOL M, V350, P279, DOI 10.1016/0027-5107(95)00117-4; MCCANN J, 1975, P NATL ACAD SCI USA, V72, P979, DOI 10.1073/pnas.72.3.979; Ohashi E, 2000, J BIOL CHEM, V275, P39678, DOI 10.1074/jbc.M005309200; Potapova O, 2002, J BIOL CHEM, V277, P28157, DOI 10.1074/jbc.M202607200; Rechkoblit O, 2006, PLOS BIOL, V4, P25, DOI 10.1371/journal.pbio.0040011; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Wang Y, 2008, BIOCHEMISTRY-US, V47, P7322, DOI 10.1021/bi800152j; Wilson RC, 2008, MOL CELL, V29, P767, DOI 10.1016/j.molcel.2008.01.014; Wolfle WT, 2003, GENE DEV, V17, P2191, DOI 10.1101/gad.1108603; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200; Zhang HD, 2009, J MOL BIOL, V392, P251, DOI 10.1016/j.jmb.2009.07.019; Zhang H, 2009, J BIOL CHEM, V284, P17687, DOI 10.1074/jbc.M109014274; Zhang HD, 2009, J BIOL CHEM, V284, P3563, DOI 10.1074/jbc.M807778200	36	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35144	35153		10.1074/jbc.M109.067397	http://dx.doi.org/10.1074/jbc.M109.067397			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19837980	hybrid, Green Published			2022-12-25	WOS:000272439600068
J	Kurokawa, K; Mizumura, H; Takaki, T; Ishii, Y; Ichihashi, N; Lee, BL; Sekimizu, K				Kurokawa, Kenji; Mizumura, Hikaru; Takaki, Tohru; Ishii, Yumiko; Ichihashi, Norikazu; Lee, Bok Luel; Sekimizu, Kazuhisa			Rapid Exchange of Bound ADP on the Staphylococcus aureus Replication Initiation Protein DnaA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI CHROMOSOME; BACILLUS-SUBTILIS; ATP-HYDROLYSIS; IN-VITRO; E. COLI; ORIGIN; GENE; HDA; MECHANISM; CYCLE	In Escherichia coli, regulatory inactivation of the replication initiator DnaA occurs after initiation as a result of hydrolysis of bound ATP to ADP, but it has been unknown how DnaA is controlled to coordinate cell growth and chromosomal replication in Gram-positive bacteria such as Staphylococcus aureus. This study examined the roles of ATP binding and its hydrolysis in the regulation of the S. aureus DnaA activity. In vitro, S. aureus DnaA melted S. aureus oriC in the presence of ATP but not ADP by a mechanism independent of ATP hydrolysis. Unlike E. coli DnaA, binding of ADP to S. aureus DnaA was unstable. As a result, at physiological concentrations of ATP, ADP bound to S. aureus DnaA was rapidly exchanged for ATP, thereby regenerating the ability of DnaA to form the open complex in vitro. Therefore, we examined whether formation of ADP-DnaA participates in suppression of replication initiation in vivo. Induction of the R318H mutant of the AAA+ sensor 2 protein, which has decreased intrinsic ATPase activity, caused over-initiation of chromosome replication in S. aureus, suggesting that formation of ADP-DnaA suppresses the initiation step in S. aureus. Together with the biochemical features of S. aureus DnaA, the weak ability to convert ATP-DnaA into ADP-DnaA and the instability of ADP-DnaA, these results suggest that there may be unidentified system(s) for reducing the cellular ratio of ATP-DnaA to ADP-DnaA in S. aureus and thereby delaying the reinitiation of DNA replication.	[Sekimizu, Kazuhisa] Univ Tokyo, Microbiol Lab, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Kurokawa, Kenji; Lee, Bok Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea	University of Tokyo; Pusan National University	Kurokawa, K (corresponding author), Univ Tokyo, Microbiol Lab, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kurokawa@mol.f.u-tokyo.ac.jp	Ichihashi, Norikazu/AAY-6897-2020		Japan Society for the Promotion of Science; NEDO of Japan; Kyorin Pharmaceutical Co., Ltd.; Genome Pharmaceuticals Co., Ltd.	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NEDO of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Kyorin Pharmaceutical Co., Ltd.; Genome Pharmaceuticals Co., Ltd.	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, by the Industrial Technology Research Grant Program of the NEDO of Japan (2004), and by grants from Kyorin Pharmaceutical Co., Ltd. and Genome Pharmaceuticals Co., Ltd.	BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; BRAMHILL D, 1988, CELL, V52, P743, DOI 10.1016/0092-8674(88)90412-6; BRAUN RE, 1985, CELL, V40, P159, DOI 10.1016/0092-8674(85)90319-8; BRENDLER T, 1995, EMBO J, V14, P4083, DOI 10.1002/j.1460-2075.1995.tb00080.x; BROYLES SS, 1986, J MOL BIOL, V187, P47, DOI 10.1016/0022-2836(86)90405-5; Camara JE, 2005, EMBO REP, V6, P736, DOI 10.1038/sj.embor.7400467; Dervyn E, 2001, SCIENCE, V294, P1716, DOI 10.1126/science.1066351; Donachie WD, 2003, CURR OPIN MICROBIOL, V6, P146, DOI 10.1016/S1369-5274(03)00026-2; Erzberger JP, 2006, NAT STRUCT MOL BIOL, V13, P676, DOI 10.1038/nsmb1115; Fujimitsu K, 2009, GENE DEV, V23, P1221, DOI 10.1101/gad.1775809; FUKUOKA T, 1990, J BIOCHEM-TOKYO, V107, P732, DOI 10.1093/oxfordjournals.jbchem.a123117; GEISSENDORFER M, 1990, APPL MICROBIOL BIOT, V33, P657, DOI 10.1007/BF00604933; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gon S, 2006, EMBO J, V25, P1137, DOI 10.1038/sj.emboj.7600990; Goranov AI, 2005, P NATL ACAD SCI USA, V102, P12932, DOI 10.1073/pnas.0506174102; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Ichihashi N, 2003, J BIOL CHEM, V278, P28778, DOI 10.1074/jbc.M212202200; Inoue R, 2001, MOL GENET GENOMICS, V266, P564, DOI 10.1007/s004380100564; Ishikawa S, 2007, DNA RES, V14, P155, DOI 10.1093/dnares/dsm017; Kaguni JM, 2006, ANNU REV MICROBIOL, V60, P351, DOI 10.1146/annurev.micro.60.080805.142111; Katayama T, 1998, CELL, V94, P61, DOI 10.1016/S0092-8674(00)81222-2; Katayama T, 2001, MOL MICROBIOL, V41, P9, DOI 10.1046/j.1365-2958.2001.02483.x; Kato J, 2001, EMBO J, V20, P4253, DOI 10.1093/emboj/20.15.4253; Keyamura K, 2007, GENE DEV, V21, P2083, DOI 10.1101/gad.1561207; Kornberg A., 1992, DNA REPLICATION; Krause M, 1997, J MOL BIOL, V274, P365, DOI 10.1006/jmbi.1997.1404; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Li Y, 2004, MOL GENET GENOMICS, V271, P447, DOI 10.1007/s00438-004-0996-6; Li Y, 2007, MICROBIOL-SGM, V153, P3370, DOI 10.1099/mic.0.2007/009001-0; LOBNEROLESEN A, 1989, CELL, V57, P881, DOI 10.1016/0092-8674(89)90802-7; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; MAHAFFY JM, 1989, J THEOR BIOL, V140, P453, DOI 10.1016/S0022-5193(89)80109-2; Marsin S, 2001, J BIOL CHEM, V276, P45818, DOI 10.1074/jbc.M101996200; Messer W, 2002, FEMS MICROBIOL REV, V26, P355, DOI 10.1016/S0168-6445(02)00127-4; Mizushima T, 1996, J BIOL CHEM, V271, P3633; MORIYA S, 1994, MOL MICROBIOL, V12, P469, DOI 10.1111/j.1365-2958.1994.tb01035.x; Moriya S, 1999, PLASMID, V41, P17, DOI 10.1006/plas.1998.1381; Mott ML, 2008, CELL, V135, P623, DOI 10.1016/j.cell.2008.09.058; Murai N, 2006, FEMS MICROBIOL LETT, V254, P19, DOI 10.1111/j.1574-6968.2005.00012.x; Nishida S, 2002, J BIOL CHEM, V277, P14986, DOI 10.1074/jbc.M108303200; Noirot-Gros MF, 2002, P NATL ACAD SCI USA, V99, P8342, DOI 10.1073/pnas.122040799; Noirot-Gros MF, 2006, P NATL ACAD SCI USA, V103, P2368, DOI 10.1073/pnas.0506914103; Ogata Y, 1997, BBA-GENE STRUCT EXPR, V1353, P298, DOI 10.1016/S0167-4781(97)00105-X; Ogura Y, 2001, J BACTERIOL, V183, P3833, DOI 10.1128/JB.183.13.3833-3841.2001; Ozaki S, 2008, J BIOL CHEM, V283, P8351, DOI 10.1074/jbc.M708684200; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; Riber L, 2006, GENE DEV, V20, P2121, DOI 10.1101/gad.379506; Rokop ME, 2004, MOL MICROBIOL, V52, P1757, DOI 10.1111/j.1365-2958.2004.04091.x; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7131; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7124; Simmons LA, 2004, MOL MICROBIOL, V51, P349, DOI 10.1046/j.1365-2958.2003.03842.x; Skarstad K, 1995, METHOD ENZYMOL, V262, P604; SKARSTAD K, 1994, BBA-GENE STRUCT EXPR, V1217, P111, DOI 10.1016/0167-4781(94)90025-6; SLATER S, 1995, CELL, V82, P927, DOI 10.1016/0092-8674(95)90272-4; Soufo CD, 2008, DEV CELL, V15, P935, DOI 10.1016/j.devcel.2008.09.010; Speck C, 1999, EMBO J, V18, P6169, DOI 10.1093/emboj/18.21.6169; Su'etsugu M, 2005, J BIOL CHEM, V280, P6528, DOI 10.1074/jbc.M412060200; Su'etsugu M, 2001, MOL MICROBIOL, V40, P376, DOI 10.1046/j.1365-2958.2001.02378.x; Su'etsugu M, 2008, J BIOL CHEM, V283, P36118, DOI 10.1074/jbc.M803158200; Takenaka H, 2004, J MOL BIOL, V340, P29, DOI 10.1016/j.jmb.2004.04.045; Velten M, 2003, MOL CELL, V11, P1009, DOI 10.1016/S1097-2765(03)00130-8; Yamagishi JI, 1996, ANTIMICROB AGENTS CH, V40, P1157, DOI 10.1128/AAC.40.5.1157; Zheng WD, 2001, EMBO J, V20, P1164, DOI 10.1093/emboj/20.5.1164	65	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34201	34210		10.1074/jbc.M109.060681	http://dx.doi.org/10.1074/jbc.M109.060681			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19841480	Green Published, hybrid			2022-12-25	WOS:000272165200052
J	Hardy, RD; Coalson, JJ; Peters, J; Chaparro, A; Techasaensiri, C; Cantwell, AM; Kannan, TR; Baseman, JB; Dube, PH				Hardy, R. Doug; Coalson, Jacqueline J.; Peters, Jay; Chaparro, Adriana; Techasaensiri, Chonnamet; Cantwell, Angelene M.; Kannan, T. R.; Baseman, Joel B.; Dube, Peter H.			Analysis of Pulmonary Inflammation and Function in the Mouse and Baboon after Exposure to Mycoplasma pneumoniae CARDS Toxin	PLOS ONE			English	Article							AIRWAY HYPERRESPONSIVENESS; BRONCHIAL-ASTHMA; ALLERGIC MICE; INFECTION; MODEL; ADULTS; HYPERREACTIVITY; EXACERBATION; LIPOPEPTIDE; OBSTRUCTION	Mycoplasma pneumoniae produces an ADP-ribosylating and vacuolating toxin known as the CARDS (Community Acquired Respiratory Distress Syndrome) toxin that has been shown to be cytotoxic to mammalian cells in tissue and organ culture. In this study we tested the ability of recombinant CARDS (rCARDS) toxin to elicit changes within the pulmonary compartment in both mice and baboons. Animals responded to a respiratory exposure to rCARDS toxin in a dose and activity-dependent manner by increasing the expression of the pro-inflammatory cytokines IL-1 alpha, 1 beta, 6, 12, 17, TNF-alpha and IFN-gamma. There was also a dose-dependent increase in several growth factors and chemokines following toxin exposure including KC, IL-8, RANTES, and G-CSF. Increased expression of IFN-gamma was observed only in the baboon; otherwise, mice and baboons responded to CARDS toxin in a very similar manner. Introduction of rCARDS toxin to the airways of mice or baboons resulted in a cellular inflammatory response characterized by a dose-dependent early vacuolization and cytotoxicity of the bronchiolar epithelium followed by a robust peribronchial and perivascular lymphocytic infiltration. In mice, rCARDS toxin caused airway hyper-reactivity two days after toxin exposure as well as prolonged airway obstruction. The changes in airway function, cytokine expression, and cellular inflammation correlate temporally and are consistent with what has been reported for M. pneumoniae infection. Altogether, these data suggest that the CARDS toxin interacts extensively with the pulmonary compartment and that the CARDS toxin is sufficient to cause prolonged inflammatory responses and airway dysfunction.			Hardy, RD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Internal Med & Pediat Infect Dis, San Antonio, TX 78229 USA.	Dube@UTHSCSA.EDU		Hardy, MD, Robert Doug/0000-0003-0632-6610	NIAID NIH HHS [U19 AI070412, AI 070412] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070412] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Baseman J B, 1993, Subcell Biochem, V20, P243; Baseman JB, 1997, EMERG INFECT DIS, V3, P21, DOI 10.3201/eid0301.970103; Baseman JB, 1996, AM J RESP CRIT CARE, V154, pS137, DOI 10.1164/ajrccm/154.4_Pt_2.S137; Bubeck SS, 2007, INFECT IMMUN, V75, P697, DOI 10.1128/IAI.00403-06; Chu HW, 2005, J IMMUNOL, V174, P5713, DOI 10.4049/jimmunol.174.9.5713; Chu HW, 2003, CHEST, V123, p390S, DOI 10.1378/chest.123.3_suppl.390S; CHU HW, 2005, AM J PHYSL LUNG CELL; CIMOLAI N, 1992, MICROBIOL IMMUNOL, V36, P465, DOI 10.1111/j.1348-0421.1992.tb02045.x; COUCH RB, 1964, JAMA-J AM MED ASSOC, V187, P442; Dube PH, 2004, INFECT IMMUN, V72, P3561, DOI 10.1128/IAI.72.6.3561-3570.2004; FEIZI T, 1967, IMMUNOLOGY, V13, P405; Fonseca-Aten M, 2005, AM J RESP CELL MOL, V32, P201, DOI 10.1165/rcmb.2004-0197OC; Galanos C, 2000, J ENDOTOXIN RES, V6, P471, DOI 10.1179/096805100101532441; Giavedoni LD, 2005, J IMMUNOL METHODS, V301, P89, DOI 10.1016/j.jim.2005.03.015; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hardy RD, 2002, INFECT IMMUN, V70, P649, DOI 10.1128/IAI.70.2.649-654.2002; Hardy RD, 2001, INFECT IMMUN, V69, P3869, DOI 10.1128/IAI.69.6.3869-3876.2001; Into T, 2002, MICROBIOL IMMUNOL, V46, P265, DOI 10.1111/j.1348-0421.2002.tb02695.x; Johnston SL, 2005, AM J RESP CRIT CARE; Kannan TR, 2006, P NATL ACAD SCI USA, V103, P6724, DOI 10.1073/pnas.0510644103; Kannan TR, 2005, INFECT IMMUN, V73, P2828, DOI 10.1128/IAI.73.5.2828-2834.2005; Kraft M, 2008, EUR RESPIR J, V31, P43, DOI 10.1183/09031936.00103307; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; Kraft M, 2002, CHEST, V121, P1782, DOI 10.1378/chest.121.6.1782; KRUEGER KM, 1995, CLIN MICROBIOL REV, V8, P34, DOI 10.1128/CMR.8.1.34; Lieberman D, 2003, AM J RESP CRIT CARE, V167, P406, DOI 10.1164/rccm.200209-996OC; Liu J, 1998, J Tongji Med Univ, V18, P216; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; McCurnin D, 2008, PEDIATRICS, V122, pE1262, DOI 10.1542/peds.2008-2045; SABATO AR, 1984, ARCH DIS CHILD, V59, P1034, DOI 10.1136/adc.59.11.1034; Salvatore CM, 2008, INFECT IMMUN, V76, P732, DOI 10.1128/IAI.00878-07; Salvatore CM, 2007, INFECT IMMUN, V75, P236, DOI 10.1128/IAI.01249-06; Schwarze J, 1997, J CLIN INVEST, V100, P226, DOI 10.1172/JCI119516; SEGGEV JS, 1986, ANN ALLERGY, V57, P263; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Talkington DF, 2004, CLIN DIAGN LAB IMMUN, V11, P862, DOI 10.1128/CDLI.11.5.862-867.2004; Thomson MA, 2006, PEDIATRICS, V118, P2038, DOI 10.1542/peds.2006-0622; van Schaik SM, 1998, J INFECT DIS, V177, P269, DOI 10.1086/514208; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Waites KB, 2003, PEDIATR PULM, V36, P267, DOI 10.1002/ppul.10346; Woolard MD, 2004, J ALLERGY CLIN IMMUN, V114, P645, DOI 10.1016/j.jaci.2004.06.019; Wu Q, 2007, AM J PHYSIOL-LUNG C, V292, pL1064, DOI 10.1152/ajplung.00301.2006	44	72	85	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7562	10.1371/journal.pone.0007562	http://dx.doi.org/10.1371/journal.pone.0007562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859545	Green Submitted, Green Published, gold			2022-12-25	WOS:000271147400001
J	Qureshi, AH; Chaoji, V; Maiguel, D; Faridi, MH; Barth, CJ; Salem, SM; Singhal, M; Stoub, D; Krastins, B; Ogihara, M; Zaki, MJ; Gupta, V				Qureshi, Amir H.; Chaoji, Vineet; Maiguel, Dony; Faridi, Mohd Hafeez; Barth, Constantinos J.; Salem, Saeed M.; Singhal, Mudita; Stoub, Darren; Krastins, Bryan; Ogihara, Mitsunori; Zaki, Mohammed J.; Gupta, Vineet			Proteomic and Phospho-Proteomic Profile of Human Platelets in Basal, Resting State: Insights into Integrin Signaling	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; FLOW-CYTOMETRIC ANALYSIS; ACTIVATED PLATELETS; MASS-SPECTROMETRY; THREONINE PHOSPHORYLATION; AFFINITY-CHROMATOGRAPHY; PROTEIN INTERACTIONS; INTERACTION NETWORKS; IDENTIFICATION; INTERACTOME	During atherogenesis and vascular inflammation quiescent platelets are activated to increase the surface expression and ligand affinity of the integrin alpha IIb beta 3 via inside-out signaling. Diverse signals such as thrombin, ADP and epinephrine transduce signals through their respective GPCRs to activate protein kinases that ultimately lead to the phosphorylation of the cytoplasmic tail of the integrin alpha IIb beta 3 and augment its function. The signaling pathways that transmit signals from the GPCR to the cytosolic domain of the integrin are not well defined. In an effort to better understand these pathways, we employed a combination of proteomic profiling and computational analyses of isolated human platelets. We analyzed ten independent human samples and identified a total of 1507 unique proteins in platelets. This is the most comprehensive platelet proteome assembled to date and includes 190 membrane-associated and 262 phosphorylated proteins, which were identified via independent proteomic and phospho-proteomic profiling. We used this proteomic dataset to create a platelet protein-protein interaction (PPI) network and applied novel contextual information about the phosphorylation step to introduce limited directionality in the PPI graph. This newly developed contextual PPI network computationally recapitulated an integrin signaling pathway. Most importantly, our approach not only provided insights into the mechanism of integrin alpha IIb beta 3 activation in resting platelets but also provides an improved model for analysis and discovery of PPI dynamics and signaling pathways in the future.			Qureshi, AH (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Nephrol, Boston, MA 02115 USA.	vgupta2@med.miami.edu	Ogihara, Mitsunori/AAB-8275-2020	Ogihara, Mitsunori/0000-0002-5690-7854; Zaki, Mohammed/0000-0003-4711-0234; Gupta, Vineet/0000-0001-6987-2550	Direct For Computer & Info Scie & Enginr [0958490] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK068253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS053659] Funding Source: NIH RePORTER; NIBIB NIH HHS [1R01EB0080161] Funding Source: Medline; NIDDK NIH HHS [K01DK068253, K01 DK068253] Funding Source: Medline; NINDS NIH HHS [R03NS053659, R03 NS053659] Funding Source: Medline	Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; ANAGLI J, 1991, BIOCHEM J, V274, P497, DOI 10.1042/bj2740497; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bagamery K, 2005, CLIN LAB HAEMATOL, V27, P75, DOI 10.1111/j.1365-2257.2004.00662.x; BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Cagney G, 2008, ARTERIOSCL THROM VAS, V28, P1214, DOI 10.1161/ATVBAHA.108.167452; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cardigan R, 2005, VOX SANG, V88, P153, DOI 10.1111/j.1423-0410.2005.00618.x; CARRELL NA, 1985, J BIOL CHEM, V260, P1743; Claeys D, 2005, ELECTROPHORESIS, V26, P1189, DOI 10.1002/elps.200406196; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Cowan KJ, 2000, J BIOL CHEM, V275, P36423, DOI 10.1074/jbc.M004068200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Curvers J, 2008, TRANSFUSION, V48, P1439, DOI 10.1111/j.1537-2995.2008.01738.x; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Dittrich M, 2008, ARTERIOSCL THROM VAS, V28, P1326, DOI 10.1161/ATVBAHA.107.161000; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Garcia A, 2004, PROTEOMICS, V4, P656, DOI 10.1002/pmic.200300665; Garcia A, 2004, BLOOD, V103, P2088, DOI 10.1182/blood-2003-07-2392; Garcia A, 2006, PROTEOMICS, V6, P5332, DOI 10.1002/pmic.200600299; Garcia BA, 2005, J PROTEOME RES, V4, P1516, DOI 10.1021/pr0500760; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gnatenko DV, 2006, BLOOD, V108, P3983, DOI 10.1182/blood-2006-06-026518; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Greening DW, 2008, PROTEOM CLIN APPL, V2, P63, DOI 10.1002/prca.200780067; Greening David W., 2009, V528, P245, DOI 10.1007/978-1-60327-310-7_17; Hayashi M, 1999, ARCH BIOCHEM BIOPHYS, V371, P133, DOI 10.1006/abbi.1999.1427; Immler D, 1998, ELECTROPHORESIS, V19, P1015, DOI 10.1002/elps.1150190617; Kirk RI, 2000, J BIOL CHEM, V275, P30901, DOI 10.1074/jbc.M001908200; Lerea KM, 2007, BBA-MOL CELL RES, V1773, P185, DOI 10.1016/j.bbamcr.2006.08.053; Lerea KM, 1999, J BIOL CHEM, V274, P1914, DOI 10.1074/jbc.274.4.1914; MacDonald JA, 2002, MOL CELL PROTEOMICS, V1, P314, DOI 10.1074/mcp.M200002-MCP200; Maguire PB, 2002, PROTEOMICS, V2, P642, DOI 10.1002/1615-9861(200206)2:6<642::AID-PROT642>3.0.CO;2-I; Marcus K, 2003, ANAL BIOANAL CHEM, V376, P973, DOI 10.1007/s00216-003-2021-z; Marcus K, 2000, ELECTROPHORESIS, V21, P2622, DOI 10.1002/1522-2683(20000701)21:13<2622::AID-ELPS2622>3.0.CO;2-3; Martens L, 2005, PROTEOMICS, V5, P3193, DOI 10.1002/pmic.200401142; Moebius J, 2005, MOL CELL PROTEOMICS, V4, P1754, DOI 10.1074/mcp.M500209-MCP200; Moore RE, 2002, J AM SOC MASS SPECTR, V13, P378, DOI 10.1016/S1044-0305(02)00352-5; Murakami T, 1996, EUR J CLIN INVEST, V26, P996, DOI 10.1046/j.1365-2362.1996.2360585.x; MUSZYNSKA G, 1992, J CHROMATOGR, V604, P19, DOI 10.1016/0021-9673(92)85524-W; O'Neill EE, 2002, PROTEOMICS, V2, P288, DOI 10.1002/1615-9861(200203)2:3<288::AID-PROT288>3.0.CO;2-0; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Palmer-Toy DE, 2005, J PROTEOME RES, V4, P2404, DOI 10.1021/pr050208p; Phipps RP, 2001, LANCET, V357, P2023, DOI 10.1016/S0140-6736(00)05108-4; Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sato K, 2002, J BIOL CHEM, V277, P29568, DOI 10.1074/jbc.M203179200; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Senis YA, 2007, MOL CELL PROTEOMICS, V6, P548, DOI 10.1074/mcp.D600007-MCP200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; VERHALLEN PFJ, 1987, BIOCHIM BIOPHYS ACTA, V903, P206, DOI 10.1016/0005-2736(87)90170-2; Vijayan KV, 2004, J BIOL CHEM, V279, P33039, DOI 10.1074/jbc.C400239200; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wagner CL, 1996, BLOOD, V88, P907; Winkler W, 2008, MOL CELL PROTEOMICS, V7, P193, DOI 10.1074/mcp.M700137-MCP200; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zahedi RP, 2008, J PROTEOME RES, V7, P526, DOI 10.1021/pr0704130; Zahedi RP, 2006, BBA-PROTEINS PROTEOM, V1764, P1963, DOI 10.1016/j.bbapap.2006.08.017; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	67	102	106	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7627	10.1371/journal.pone.0007627	http://dx.doi.org/10.1371/journal.pone.0007627			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859549	Green Submitted, Green Published, gold			2022-12-25	WOS:000271147400019
J	Ben Arous, J; Laffont, S; Chatenay, D				Ben Arous, Juliette; Laffont, Sophie; Chatenay, Didier			Molecular and Sensory Basis of a Food Related Two-State Behavior in C. elegans	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; CGMP; MODULATION; MECHANISMS; EXPERIENCE; FAT	Most animals display multiple behavioral states and control the time allocation to each of their activity phases depending on their environment. Here we develop a new quantitative method to analyze Caenorhabditis elegans behavioral states. We show that the dwelling and roaming two-state behavior of C. elegans is tightly controlled by the concentration of food in the environment of the animal. Sensory perception through the amphid neurons is necessary to extend roaming phases while internal metabolic perception of food nutritional value is needed to induce dwelling. Our analysis also shows that the proportion of time spent in each state is modulated by past nutritional experiences of the animal. This two-state behavior is regulated through serotonin as well as insulin and TGF-beta signaling pathways. We propose a model where food nutritional value is assessed through internal metabolic signaling. Biogenic amines signaling could allow the worm to adapt to fast changes in the environment when peptide transcriptional pathways may mediate slower adaptive changes.			Ben Arous, J (corresponding author), Univ Paris 06, CNRS, Ecole Normale Super, Lab Phys Stat, Paris, France.	juliette.benarous@lps.ens.fr						BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gems D, 1998, GENETICS, V150, P129; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Gruninger TR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000117; Hapiak VM, 2009, GENETICS, V181, P153, DOI 10.1534/genetics.108.096891; HERBERS JM, 1981, OECOLOGIA, V49, P252, DOI 10.1007/BF00349198; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Kang CH, 2009, GENE DEV, V23, P12, DOI 10.1101/gad.1723409; Kaun KR, 2007, J EXP BIOL, V210, P3547, DOI 10.1242/jeb.006924; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Riddle DL, 1997, C ELEGANS, P739; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schafer WR, 2005, CURR BIOL, V15, pR723, DOI 10.1016/j.cub.2005.08.020; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005	24	73	86	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7584	10.1371/journal.pone.0007584	http://dx.doi.org/10.1371/journal.pone.0007584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851507	Green Published, gold, Green Submitted			2022-12-25	WOS:000271022300015
J	Terrien, J; Zahariev, A; Blanc, S; Aujard, F				Terrien, Jeremy; Zahariev, Alexandre; Blanc, Stephane; Aujard, Fabienne			Impaired Control of Body Cooling during Heterothermia Represents the Major Energetic Constraint in an Aging Non-Human Primate Exposed to Cold	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; LESSER MOUSE LEMUR; DOUBLY LABELED WATER; DAILY TORPOR; AMBIENT-TEMPERATURE; MICROCEBUS-MURINUS; THERMOREGULATORY RESPONSES; REPRODUCTIVE FUNCTION; PROSIMIAN PRIMATE; GENE-EXPRESSION	Daily heterothermia is used by small mammals for energy and water savings, and seems to be preferentially exhibited during winter rather than during summer. This feature induces a trade-off between the energy saved during daily heterothermia and the energy cost of arousal, which can impact energy balance and survival under harsh environmental conditions. Especially, aging may significantly affect such trade off during cold-induced energy stress, but direct evidences are still lacking. We hypothesized that aging could alter the energetics of daily heterothermia, and that the effects could differ according to season. In the gray mouse lemur (Microcebus murinus), a non-human primate species which exhibits daily heterothermia, we investigated the effects of exposures to 25 and 12 degrees C on body composition, energy balance, patterns of heterothermia and water turnover in adult (N = 8) and aged animals (N = 7) acclimated to winter-like or summer-like photoperiods. Acclimation to summer prevented animals from deep heterothermia, even during aging. During winter, adult animals at 12 degrees C and aged animals at 25 degrees C exhibited low levels of energy expenditure with minor modulations of heterothermia. The major effects of cold were observed during winter, and were particularly pronounced in aged mouse lemurs which exhibited deep heterothermia phases. Body composition was not significantly affected by age and could not explain the age-related differences in heterothermia patterns. However, aging was associated with increased levels of energy expenditure during cold exposure, in concomitance with impaired energy balance. Interestingly, increased energy expenditure and depth of heterothermia phases were strongly correlated. In conclusion, it appeared that the exhibition of shallow heterothermia allowed energy savings during winter in adult animals only. Aged animals exhibited deep heterothermia and increased levels of energy expenditure, impairing energy balance. Thus, an impaired control of the heterothermic process induced high energy costs in the aging mouse lemur exposed to cold.			Terrien, J (corresponding author), MNHN, CNRS, UMR 7179, Brunoy, France.	jeremy.terrien@hotmail.fr	Jeremy, TERRIEN/J-7359-2013; TERRIEN, Jeremy/F-6538-2010	Terrien, Jeremy/0000-0001-8530-4481				Anderson GS, 1999, INT J BIOMETEOROL, V43, P99, DOI 10.1007/s004840050123; Aujard F, 2001, NEUROSCIENCE, V105, P403, DOI 10.1016/S0306-4522(01)00202-0; Aujard F, 1998, J COMP PHYSIOL B, V168, P540, DOI 10.1007/s003600050175; Aujard F, 1998, PHYSIOL BEHAV, V64, P513, DOI 10.1016/S0031-9384(98)00087-0; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; DeGroot DW, 2007, AM J PHYSIOL-REG I, V292, pR103, DOI 10.1152/ajpregu.00074.2006; DIEM K, 1963, VITAMINES LIPOSOLUBL, P459; Duchamp C, 1997, AM J PHYSIOL-ENDOC M, V272, pE453, DOI 10.1152/ajpendo.1997.272.3.E453; ELLISON GTH, 1992, J THERM BIOL, V17, P25, DOI 10.1016/0306-4565(92)90016-9; Frank SM, 2000, AM J PHYSIOL-REG I, V279, pR349, DOI 10.1152/ajpregu.2000.279.1.R349; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 2003, J COMP PHYSIOL B, V173, P55, DOI 10.1007/s00360-002-0311-y; Genin F, 2000, PHYSIOL BEHAV, V71, P315, DOI 10.1016/S0031-9384(00)00335-8; Genin F, 2003, AM J PHYSIOL-REG I, V284, pR811, DOI 10.1152/ajpregu.00525.2002; Giroud S, 2008, AM J PHYSIOL-REG I, V294, pR1958, DOI 10.1152/ajpregu.00794.2007; Giroud S, 2009, J COMP PHYSIOL B, V179, P99, DOI 10.1007/s00360-008-0294-4; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; Hampl R, 2006, PHYSIOL RES, V55, P123, DOI 10.33549/physiolres.930758; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; HELDMAIER G, 1992, J COMP PHYSIOL B, V162, P696, DOI 10.1007/BF00301619; Kenney WL, 1996, J APPL PHYSIOL, V80, P512, DOI 10.1152/jappl.1996.80.2.512; Lovegrove BG, 1999, J COMP PHYSIOL B, V169, P11, DOI 10.1007/s003600050188; Perret M, 2006, M S-MED SCI, V22, P279, DOI 10.1051/medsci/2006223279; Perret M, 2005, EXP GERONTOL, V40, P582, DOI 10.1016/j.exger.2005.05.002; Perret M, 1997, J BIOL RHYTHM, V12, P136, DOI 10.1177/074873049701200205; Perret M, 2001, AM J PHYSIOL-REG I, V281, pR1925, DOI 10.1152/ajpregu.2001.281.6.R1925; Perret M, 2001, INT J PRIMATOL, V22, P5, DOI 10.1023/A:1026457813626; PERRET M, 1992, FOLIA PRIMATOL, V59, P1; Perret M, 1998, J MAMMAL, V79, P1093, DOI 10.2307/1383001; Pinheiro J. C., 2005, NLME LINEAR NONLINEA; PROTHERO J, 1986, J THEOR BIOL, V121, P403, DOI 10.1016/S0022-5193(86)80099-6; *R DEV COR T, 2004, R LANG ENV STAT COMP; Ricquier D, 2006, CR BIOL, V329, P578, DOI 10.1016/j.crvi.2005.10.010; Schmid J, 2009, NATURWISSENSCHAFTEN, V96, P737, DOI 10.1007/s00114-009-0523-z; Schmid J, 2009, NATURWISSENSCHAFTEN, V96, P609, DOI 10.1007/s00114-009-0515-z; Schmid J, 2000, J COMP PHYSIOL B, V170, P633, DOI 10.1007/s003600000146; SCHOELLER DA, 1986, AM J PHYSIOL, V250, pR823, DOI 10.1152/ajpregu.1986.250.5.R823; SCHOELLER DA, 1982, J APPL PHYSIOL, V53, P955, DOI 10.1152/jappl.1982.53.4.955; Seguy M, 2005, J COMP PHYSIOL B, V175, P107, DOI 10.1007/s00360-004-0467-8; Sell H, 2004, INT J BIOCHEM CELL B, V36, P2098, DOI 10.1016/j.biocel.2004.04.003; Shefer VI, 1997, EXP GERONTOL, V32, P325, DOI 10.1016/S0531-5565(96)00131-3; Speakman J.R., 1997, DOUBLY LABELLED WATE; Terrien J, 2008, AM J PHYSIOL-REG I, V295, pR696, DOI 10.1152/ajpregu.00629.2007; Terrien J, 2009, CHRONOBIOL INT, V26, P838, DOI 10.1080/07420520903044281; Tiraby C, 2003, TRENDS ENDOCRIN MET, V14, P439, DOI 10.1016/j.tem.2003.10.001; TUCKER VA, 1965, J CELL COMPAR PHYSL, V65, P393, DOI 10.1002/jcp.1030650313; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; WONG WW, 1987, AM J CLIN NUTR, V45, P905, DOI 10.1093/ajcn/45.5.905; YAMASHITA H, 1994, LIFE SCI, V55, P141, DOI 10.1016/0024-3205(94)90105-8	50	11	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7587	10.1371/journal.pone.0007587	http://dx.doi.org/10.1371/journal.pone.0007587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851464	Green Published, gold, Green Submitted			2022-12-25	WOS:000271022300018
J	Galli, S; Jahn, O; Hitt, R; Hesse, D; Opitz, L; Plessmann, U; Urlaub, H; Poderoso, JJ; Jares-Erijman, EA; Jovin, TM				Galli, Soledad; Jahn, Olaf; Hitt, Reiner; Hesse, Doerte; Opitz, Lennart; Plessmann, Uwe; Urlaub, Henning; Poderoso, Juan Jose; Jares-Erijman, Elizabeth A.; Jovin, Thomas M.			A New Paradigm for MAPK: Structural Interactions of hERK1 with Mitochondria in HeLa Cells	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; ACTIVATED PROTEIN-KINASES; SIGNAL-REGULATED KINASE; FACTOR-A TFAM; HISTONE H1.2; PKC-EPSILON; ERK; PHOSPHORYLATION; IDENTIFICATION; VDAC	Extracellular signal-regulated protein kinase 1 and 2 (ERK1/2) are members of the MAPK family and participate in the transduction of stimuli in cellular responses. Their long-term actions are accomplished by promoting the expression of specific genes whereas faster responses are achieved by direct phosphorylation of downstream effectors located throughout the cell. In this study we determined that hERK1 translocates to the mitochondria of HeLa cells upon a proliferative stimulus. In the mitochondrial environment, hERK1 physically associates with (i) at least 5 mitochondrial proteins with functions related to transport (i.e. VDAC1), signalling, and metabolism; (ii) histones H2A and H4; and (iii) other cytosolic proteins. This work indicates for the first time the presence of diverse ERK-complexes in mitochondria and thus provides a new perspective for assessing the functions of ERK1 in the regulation of cellular signalling and trafficking in HeLa cells.			Galli, S (corresponding author), Max Planck Inst Biophys Chem, Lab Cellular Dynam, Gottingen, Germany.	sgalli@qo.fcen.uba.ar; tjovin@gwdg.de	Jahn, Olaf/AAD-8212-2020	Jahn, Olaf/0000-0002-3397-8924				Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bretz F, 2005, METHOD INFORM MED, V44, P431; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Carreras MC, 2004, HEPATOLOGY, V40, P157, DOI 10.1002/hep.20255; Casar B, 2008, MOL CELL, V31, P708, DOI 10.1016/j.molcel.2008.07.024; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cobb MH, 2000, TRENDS BIOCHEM SCI, V25, P7, DOI 10.1016/S0968-0004(99)01508-X; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; CREWS CM, 1991, P NATL ACAD SCI USA, V88, P8845, DOI 10.1073/pnas.88.19.8845; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Enriquez JA, 1996, EUR J BIOCHEM, V237, P601, DOI 10.1111/j.1432-1033.1996.0601p.x; Fink M, 2007, MOL CELL BIOL, V27, P3589, DOI 10.1128/MCB.02077-06; Furuno T, 2001, J IMMUNOL, V166, P4416, DOI 10.4049/jimmunol.166.7.4416; Galli S, 2003, CANCER RES, V63, P6370; Galli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002379; Garstka HL, 2003, NUCLEIC ACIDS RES, V31, P5039, DOI 10.1093/nar/gkg717; Jahn O, 2006, ANAL BIOANAL CHEM, V386, P92, DOI 10.1007/s00216-006-0592-1; Jimenez C, 2007, J EXP BOT, V58, P1001, DOI 10.1093/jxb/erl260; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Karlsson M, 2006, BIOCHEM SOC T, V34, P842, DOI 10.1042/BST0340842; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Komiya T, 1996, J BIOL CHEM, V271, P22105, DOI 10.1074/jbc.271.36.22105; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Landgrebe J, 2006, COMPUT STAT DATA AN, V50, P499, DOI 10.1016/j.csda.2004.08.014; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Levin-Salomon V, 2009, BIOCHEM J, V417, P331, DOI 10.1042/BJ20081335; LINDEN M, 1983, BIOCHIM BIOPHYS ACTA, V736, P125, DOI 10.1016/0005-2736(83)90177-3; Lloyd Alison C, 2006, J Biol, V5, P13, DOI 10.1186/jbiol46; Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Okamura H, 2008, J CELL BIOCHEM, V103, P1488, DOI 10.1002/jcb.21537; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Philipova R, 2005, J CELL SCI, V118, P5767, DOI 10.1242/jcs.02683; Ping PP, 2002, J CLIN INVEST, V109, P499, DOI 10.1172/JCI200213200; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Ray D, 2005, GENE, V346, P41, DOI 10.1016/j.gene.2004.10.026; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rostovtseva TK, 2000, P NATL ACAD SCI USA, V97, P7819, DOI 10.1073/pnas.140115397; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schwertz H, 2007, PROTEOMICS, V7, P4579, DOI 10.1002/pmic.200700734; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shaul YD, 2006, J CELL BIOL, V172, P885, DOI 10.1083/jcb.200509063; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi Y, 2003, BIOCHEM BIOPH RES CO, V303, P475, DOI 10.1016/S0006-291X(03)00359-0; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; Song CX, 2002, AM J PHYSIOL-HEART C, V282, pH1166, DOI 10.1152/ajpheart.00830.2001; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	68	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7541	10.1371/journal.pone.0007541	http://dx.doi.org/10.1371/journal.pone.0007541			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847302	Green Published, gold, Green Submitted			2022-12-25	WOS:000271022000012
J	Ramachandran, V; Arumugam, T; Langley, R; Hwang, RF; Vivas-Mejia, P; Sood, AK; Lopez-Berestein, G; Logsdon, CD				Ramachandran, Vijaya; Arumugam, Thiruvengadam; Langley, Robert; Hwang, Rosa F.; Vivas-Mejia, Pablo; Sood, Anil K.; Lopez-Berestein, Gabriel; Logsdon, Craig D.			The ADMR Receptor Mediates the Effects of Adrenomedullin on Pancreatic Cancer Cells and on Cells of the Tumor Microenvironment	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-RELATED PEPTIDE; HYDROPS-FETALIS; MICE LACKING; EXPRESSION; PROLIFERATION; ANGIOGENESIS; INVOLVEMENT; SURVIVAL; LINES	Background: Adrenomedullin (AM) is highly expressed in pancreatic cancer and stimulates pancreatic cancer cells leading to increased tumor growth and metastasis. The current study examines the role of specific AM receptors on tumor and cells resembling the tumor microenvironment (human pancreatic stellate - HPSC, human umbilical vein - HUVEC and mouse lung endothelial cells - MLEC). Methods and Findings: AM receptors ADMR and CRLR were present in HPSC, HUVEC and MLECs while PDAC cells possessed only ADMR receptors as assessed by RT-PCR and western blotting. All cell lines expressed and secreted AM as indicated by ELISA. The growth of each of the cell lines was stimulated by exogenous AM and inhibited by the antagonist AMA. AM also stimulated in vitro angiogenesis assessed by polygon formation of endothelial cell lines. SiRNA-mediated silencing of ADMR, but not CRLR, reduced basal growth of all cells examined and reduced polygon formation of endothelial cells in vitro. Orthotopic tumors developed with shADMR bearing cancer cells had dramatically reduced primary tumor volume (>90%) and lung and liver metastasis compared to shControl bearing cells. To validate ADMR as a potential therapeutic target, in vivo studies were conducted using neutral nanoliposomes to systemically deliver human siRNA to ADMR to silence human cancer cells and mouse siRNA to ADMR to silence mouse tumor stromal cells. Systemic silencing of both human and mouse ADMR had no obvious adverse effects but strongly reduced tumor development. Conclusion: ADMR mediates the stimulatory effects of AM on cancer cells and on endothelial and stellate cells within the tumor microenvironment. These data support the further development of ADMR as a useful target treatment of pancreatic cancer.			Ramachandran, V (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	clogsdon@mdanderson.org			NCI NIH HHS [P30 CA016672, P20 CA101936, CA16672] Funding Source: Medline; NIDDK NIH HHS [R01 DK052067, DK052067] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, P20CA101936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052067] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albertin G, 2001, INT J MOL MED, V8, P423; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Caron KM, 2001, P NATL ACAD SCI USA, V98, P615, DOI 10.1073/pnas.021548898; Cormier-Regard S, 1998, J BIOL CHEM, V273, P17787, DOI 10.1074/jbc.273.28.17787; Dackor RT, 2006, MOL CELL BIOL, V26, P2511, DOI 10.1128/MCB.26.7.2511-2518.2006; Fernandez-Sauze S, 2004, INT J CANCER, V108, P797, DOI 10.1002/ijc.11663; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Gorbig MN, 2001, J HEPATOL, V34, P222; Guidolin D, 2008, PEPTIDES, V29, P2013, DOI 10.1016/j.peptides.2008.07.009; Hayakawa H, 1999, HYPERTENSION, V33, P689, DOI 10.1161/01.HYP.33.2.689; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kato H, 1997, ENDOCRINOLOGY, V138, P2615, DOI 10.1210/en.138.6.2615; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Langley RR, 2003, CANCER RES, V63, P2971; Martinez A, 1996, ENDOCRINOLOGY, V137, P2626, DOI 10.1210/en.137.6.2626; Martinez A, 2000, ENDOCRINOLOGY, V141, P406, DOI 10.1210/en.141.1.406; Miller MJ, 1996, J BIOL CHEM, V271, P23345; Miyashita K, 2003, HYPERTENS RES, V26, pS93, DOI 10.1291/hypres.26.S93; Nakayama M, 1998, BIOCHEM BIOPH RES CO, V243, P514, DOI 10.1006/bbrc.1998.8131; NUKI C, 1993, BIOCHEM BIOPH RES CO, V196, P245, DOI 10.1006/bbrc.1993.2241; Oehler MK, 2001, ONCOGENE, V20, P2937, DOI 10.1038/sj.onc.1204422; Peiper M, 1997, INT J CANCER, V71, P993, DOI 10.1002/(SICI)1097-0215(19970611)71:6<993::AID-IJC15>3.0.CO;2-7; Pio R, 2001, J BIOL CHEM, V276, P12292, DOI 10.1074/jbc.M007822200; PLIARCHOPOULOU K, 2009, CANC TREAT IN PRESS; Ramachandran V, 2007, CANCER RES, V67, P2666, DOI 10.1158/0008-5472.CAN-06-3362; Rocchi P, 2001, CANCER RES, V61, P1196; Shibata Y, 2006, UROLOGY, V68, P1127, DOI 10.1016/j.urology.2006.06.025; Sumanas S, 2005, BLOOD, V106, P534, DOI 10.1182/blood-2004-12-4653; ZHAO L, 1996, AM J PHYSIOL, V271, P622	32	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7502	10.1371/journal.pone.0007502	http://dx.doi.org/10.1371/journal.pone.0007502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847298	Green Published, Green Submitted, gold			2022-12-25	WOS:000271022000010
J	Karlberg, T; van den Berg, S; Hammarstrom, M; Sagemark, J; Johansson, I; Holmberg-Schiavone, L; Schuler, H				Karlberg, Tobias; van den Berg, Susanne; Hammarstrom, Martin; Sagemark, Johanna; Johansson, Ida; Holmberg-Schiavone, Lovisa; Schuler, Herwig			Crystal Structure of the ATPase Domain of the Human AAA plus Protein Paraplegin/SPG7	PLOS ONE			English	Article							SPASTIC PARAPLEGIA; SPG7 MUTATIONS; MITOCHONDRIA; RESIDUES; BINDING; FAMILY; REGION; FTSH	Paraplegin is an m-AAA protease of the mitochondrial inner membrane that is linked to hereditary spastic paraplegias. The gene encodes an FtsH-homology protease domain in tandem with an AAA+ homology ATPase domain. The protein is believed to form a hexamer that uses ATPase-driven conformational changes in its AAA-domain to deliver substrate peptides to its protease domain. We present the crystal structure of the AAA-domain of human paraplegin bound to ADP at 2.2 angstrom. This enables assignment of the roles of specific side chains within the catalytic cycle, and provides the structural basis for understanding the mechanism of disease mutations.			Karlberg, T (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden.	herwig.schuler@ki.se	Schuler, Herwig/E-5751-2011	Schuler, Herwig/0000-0003-4059-3501	CIHR Funding Source: Medline; Wellcome Trust Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Arnoldi A, 2008, HUM MUTAT, V29, P522, DOI 10.1002/humu.20682; Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Brugman F, 2008, NEUROLOGY, V71, P1500, DOI 10.1212/01.wnl.0000319700.11606.21; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Elleuch N, 2006, NEUROLOGY, V66, P654, DOI 10.1212/01.wnl.0000201185.91110.15; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Ferreirinha F, 2001, AM J HUM GENET, V69, P196; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Juhola MK, 2000, FEBS LETT, V481, P91, DOI 10.1016/S0014-5793(00)01989-X; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niwa H, 2002, STRUCTURE, V10, P1415, DOI 10.1016/S0969-2126(02)00855-9; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rugarli EI, 2006, TRENDS MOL MED, V12, P262, DOI 10.1016/j.molmed.2006.04.002; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Wilkinson PA, 2004, BRAIN, V127, P973, DOI 10.1093/brain/awh125; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200; Zhang XD, 2008, NAT STRUCT MOL BIOL, V15, P1223, DOI 10.1038/nsmb.1501	34	30	31	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e6975	10.1371/journal.pone.0006975	http://dx.doi.org/10.1371/journal.pone.0006975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841671	Green Published, Green Submitted, gold			2022-12-25	WOS:000271012900001
J	Pilling, D; Fan, T; Huang, D; Kaul, B; Gomer, RH				Pilling, Darrell; Fan, Ted; Huang, Donna; Kaul, Bhavika; Gomer, Richard H.			Identification of Markers that Distinguish Monocyte-Derived Fibrocytes from Monocytes, Macrophages, and Fibroblasts	PLOS ONE			English	Article							PERIPHERAL-BLOOD FIBROCYTES; COLONY-STIMULATING FACTOR; T-CELL APOPTOSIS; CIRCULATING FIBROCYTES; MONOCLONAL-ANTIBODY; GENE-EXPRESSION; LUNG FIBROBLASTS; DENDRITIC CELLS; STROMAL CELLS; BURN PATIENTS	Background: The processes that drive fibrotic diseases are complex and include an influx of peripheral blood monocytes that can differentiate into fibroblast-like cells called fibrocytes. Monocytes can also differentiate into other cell types, such as tissue macrophages. The ability to discriminate between monocytes, macrophages, fibrocytes, and fibroblasts in fibrotic lesions could be beneficial in identifying therapies that target either stromal fibroblasts or fibrocytes. Methodology/Principal Findings: We have identified markers that discriminate between human peripheral blood monocytes, tissue macrophages, fibrocytes, and fibroblasts. Amongst these four cell types, only peripheral blood monocytes express the combination of CD45RO, CD93, and S100A8/A9; only macrophages express the combination of CD45RO, 25F9, S100A8/A9, and PM-2K; only fibrocytes express the combination of CD45RO, 25F9, and S100A8/A9, but not PM-2K; and only fibroblasts express the combination of CD90, cellular fibronectin, hyaluronan, and TE-7. These markers are effective both in vitro and in sections from human lung. We found that markers such as CD34, CD68, and collagen do not effectively discriminate between the four cell types. In addition, IL-4, IL-12, IL-13, IFN-gamma, and SAP differentially regulate the expression of CD32, CD163, CD172a, and CD206 on both macrophages and fibrocytes. Finally, CD49c (alpha 3 integrin) expression identifies a subset of fibrocytes, and this subset increases with time in culture. Conclusions/Significance: These results suggest that discrimination of monocytes, macrophages, fibrocytes, and fibroblasts in fibrotic lesions is possible, and this may allow for an assessment of fibrocytes in fibrotic diseases.			Pilling, D (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	dpilling@rice.edu		Gomer, Richard/0000-0003-2361-4307; Huang, Donna/0000-0001-8620-639X; Pilling, Darrell/0000-0002-7413-2773	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083029] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL083029, R01 HL083029] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; BECKER S, 1987, J IMMUNOL, V139, P3703; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Bohlson SS, 2005, J IMMUNOL, V175, P1239, DOI 10.4049/jimmunol.175.2.1239; BRUGGER W, 1991, J LEUKOCYTE BIOL, V49, P483, DOI 10.1002/jlb.49.5.483; Bucala, 2007, FIBROCYTES NEW INSIG, P37, DOI DOI 10.1142/9789812706690_0003; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Cabezon T, 2007, INT J CANCER, V121, P1433, DOI 10.1002/ijc.22850; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Dewald O, 2004, AM J PATHOL, V164, P665, DOI 10.1016/S0002-9440(10)63154-9; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; EPSTEIN AL, 1987, BLOOD, V70, P1124; Erdag G, 2008, J CUTAN PATHOL, V35, P752, DOI 10.1111/j.1600-0560.2007.00895.x; Faint JM, 1999, J IMMUNOL METHODS, V225, P53, DOI 10.1016/S0022-1759(99)00027-7; Faust J, 1999, J CELL BIOCHEM, V72, P67, DOI 10.1002/(SICI)1097-4644(19990101)72:1<67::AID-JCB8>3.0.CO;2-A; FIRESTEIN GS, 1987, CELL IMMUNOL, V104, P343, DOI 10.1016/0008-8749(87)90036-0; FLAVELL DJ, 1987, J HISTOCHEM CYTOCHEM, V35, P1217, DOI 10.1177/35.11.3309045; Fonseca JE, 2002, ARTHRITIS RHEUM-US, V46, P1210, DOI 10.1002/art.10207; Garcia-Vicuna R, 2004, ARTHRITIS RHEUM-US, V50, P3866, DOI 10.1002/art.20615; Gomperts BN, 2007, J LEUKOCYTE BIOL, V82, P449, DOI 10.1189/jlb.0906587; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gottfried E, 2008, SCAND J IMMUNOL, V67, P453, DOI 10.1111/j.1365-3083.2008.02091.x; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Gratchev A, 2001, SCAND J IMMUNOL, V53, P386, DOI 10.1046/j.1365-3083.2001.00885.x; Halder S, 2005, CELL RES, V15, P739, DOI 10.1038/sj.cr.7290344; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Haudek SB, 2008, P NATL ACAD SCI USA, V105, P10179, DOI 10.1073/pnas.0804910105; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Hosokawa Y, 2005, CLIN EXP IMMUNOL, V141, P467, DOI 10.1111/j.1365-2249.2005.02852.x; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; Inoue T, 2005, KIDNEY INT, V67, P2488, DOI 10.1111/j.1523-1755.2005.00358.x; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; KO SD, 1977, P NATL ACAD SCI USA, V74, P3429, DOI 10.1073/pnas.74.8.3429; Kunisch E, 2004, ANN RHEUM DIS, V63, P774, DOI 10.1136/ard.2003.013029; Lax S, 2007, FEBS LETT, V581, P3550, DOI 10.1016/j.febslet.2007.06.063; LIPTAY MJ, 1993, J CLIN INVEST, V91, P588, DOI 10.1172/JCI116238; Lucattelli M, 2003, EUR RESPIR J, V22, P728, DOI 10.1183/09031936.03.00047603; MacFadyen JR, 2005, FEBS LETT, V579, P2569, DOI 10.1016/j.febslet.2005.03.071; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Naik-Mathuria B, 2008, WOUND REPAIR REGEN, V16, P266, DOI 10.1111/j.1524-475X.2008.00366.x; NICKOLOFF BJ, 1991, ARCH DERMATOL, V127, P523, DOI 10.1001/archderm.127.4.523; Olert J, 2001, PATHOL RES PRACT, V197, P823, DOI 10.1078/0344-0338-00166; Olson MC, 1995, IMMUNITY, V3, P703, DOI 10.1016/1074-7613(95)90060-8; Parsonage G, 2003, THROMB HAEMOSTASIS, V90, P688, DOI 10.1160/TH03-04-0208; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Peduto L, 2009, J IMMUNOL, V182, P5789, DOI 10.4049/jimmunol.0803974; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; PHIPPS RP, 1989, AM J RESP CELL MOL, V1, P65, DOI 10.1165/ajrcmb/1.1.65; Pilling D, 1999, EUR J IMMUNOL, V29, P1041, DOI 10.1002/(SICI)1521-4141(199903)29:03<1041::AID-IMMU1041>3.0.CO;2-#; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Pilling D, 2006, J LEUKOCYTE BIOL, V79, P1242, DOI 10.1189/jlb.0805456; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rosseau S, 2000, AM J PHYSIOL-LUNG C, V279, pL25, DOI 10.1152/ajplung.2000.279.1.L25; Salmon M, 1997, J CLIN INVEST, V99, P439, DOI 10.1172/JCI119178; SALMON M, 1994, EUR J IMMUNOL, V24, P892, DOI 10.1002/eji.1830240417; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; SIMMONS DL, 1992, J IMMUNOL, V148, P267; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Su YP, 2005, J BIOL CHEM, V280, P32811, DOI 10.1074/jbc.M503457200; TAKEYA M, 1991, J PATHOL, V163, P315, DOI 10.1002/path.1711630408; TERSTAPPEN LWMM, 1990, J LEUKOCYTE BIOL, V48, P138, DOI 10.1002/jlb.48.2.138; VAAGE J, 1990, J LEUKOCYTE BIOL, V48, P274, DOI 10.1002/jlb.48.3.274; Wang JF, 2007, WOUND REPAIR REGEN, V15, P113, DOI 10.1111/j.1524-475X.2006.00192.x; Wang JF, 2007, J LEUKOCYTE BIOL, V82, P1554, DOI 10.1189/0507306; Way KJ, 2009, J LEUKOCYTE BIOL, V85, P766, DOI 10.1189/jlb.1108689; Yang LJ, 2005, WOUND REPAIR REGEN, V13, P398, DOI 10.1111/j.1067-1927.2005.130407.x; Yang LJ, 2002, LAB INVEST, V82, P1183, DOI 10.1097/01.LAB.0000027841.50269.61; Zeng L, 1996, J HISTOCHEM CYTOCHEM, V44, P845, DOI 10.1177/44.8.8756757; Zhao HJ, 2009, PROSTATE, V69, P991, DOI 10.1002/pros.20946; Zola H., 2007, LEUKOCYTE STROMAL CE; ZWADLO G, 1985, J IMMUNOL, V134, P1487	87	368	381	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7475	10.1371/journal.pone.0007475	http://dx.doi.org/10.1371/journal.pone.0007475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834619	Green Submitted, Green Published, gold			2022-12-25	WOS:000270880700006
J	Venkatachari, NJ; Alber, S; Watkins, SC; Ayyavoo, V				Venkatachari, Narasimhan J.; Alber, Sean; Watkins, Simon C.; Ayyavoo, Velpandi			HIV-1 Infection of DC: Evidence for the Acquisition of Virus Particles from Infected T Cells by Antigen Uptake Mechanism	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MONOCYTE-DERIVED MACROPHAGES; PLASMACYTOID DENDRITIC CELLS; TYPE-1 INFECTION; IN-VIVO; IMMUNOLOGICAL SYNAPSE; VIROLOGICAL SYNAPSE; TRANSMISSION; MUCOSA; TROGOCYTOSIS	Dendritic cells (DC) play a pivotal role in transmission and dissemination of HIV-1. Earlier studies reported that DC present at the site of infection trap virus particles via DC-SIGN and transfer the virus to the interacting naive T cells. This prompted us to ask the question whether DC could acquire virus from infected T cells during DC-T cell interaction. To address this, we investigated the likely transfer of virus from HIV-1 infected T cells to DC and the underlying mechanisms involved. Results indicate that DC acquire virus from infected T cells via antigen uptake mechanism and this results in infection of DC with expression of proteins directed by viral DNA. Further studies with HIV-1 lacking the Env protein also resulted in infection of DC. The use of antibodies against DC-SIGN and DC-SIGN-R ruled out a role for receptor in the infection of DC. Additional data show that DC infection is directly correlated with the ability of DC to take up antigen from infected T cells. Overall, these studies provide evidence to suggest that HIV-1, besides infecting immune cells, also utilizes immunological mechanism(s) to acquire and disseminate virus.			Venkatachari, NJ (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.	velpandi@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552; Ayyavoo, Velpandi/0000-0002-9043-0885	NIAID NIH HHS [R56 AI050463, R01 AI050463, R56 AI-50463] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI050463, R01AI050463] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aziz S, 2005, JAIDS-J ACQ IMM DEF, V38, P23, DOI 10.1097/00126334-200501010-00005; Bhoopat L, 2001, MODERN PATHOL, V14, P1263, DOI 10.1038/modpathol.3880472; Bounou S, 2004, FASEB J, V18, P1294, DOI 10.1096/fj.04-1755fje; Bromley SK, 2002, IMMUNOLOGY, V106, P289, DOI 10.1046/j.1365-2567.2002.01441.x; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; Caumartin J, 2006, TRANSPL IMMUNOL, V17, P20, DOI 10.1016/j.trim.2006.09.032; Choi YK, 2003, J PATHOL, V201, P616, DOI 10.1002/path.1482; Chow YH, 2002, J ACQ IMMUN DEF SYND, V30, P1, DOI 10.1097/00126334-200205010-00001; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Dustin ML, 2002, ARTHRITIS RES THER, V4, pS119, DOI 10.1186/ar559; Fackler OT, 2007, NAT REV IMMUNOL, V7, P310, DOI 10.1038/nri2041; Frankel SS, 1996, SCIENCE, V272, P115, DOI 10.1126/science.272.5258.115; Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31; Groot F, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-75; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Gummuluru S, 2002, J VIROL, V76, P10692, DOI 10.1128/JVI.76.21.10692-10701.2002; GUPTA P, 1989, J VIROL, V63, P2361, DOI 10.1128/JVI.63.5.2361-2365.1989; Gurney KB, 2005, J VIROL, V79, P5762, DOI 10.1128/JVI.79.9.5762-5773.2005; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Hioe CE, 2001, J VIROL, V75, P1077, DOI 10.1128/JVI.75.2.1077-1082.2001; Hu JJ, 1999, AIDS RES HUM RETROV, V15, P1305, DOI 10.1089/088922299310205; Ignatius R, 2002, J VIROL, V76, P9787, DOI 10.1128/JVI.76.19.9787-9797.2002; Ji X, 2005, MOL IMMUNOL, V42, P145, DOI 10.1016/j.molimm.2004.06.015; Ji X, 2006, CURR PROTEIN PEPT SC, V7, P317, DOI 10.2174/138920306778017990; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Lekkerkerker AN, 2006, CURR HIV RES, V4, P169, DOI 10.2174/157016206776055020; Levine BL, 1998, J HEMATOTHER, V7, P437, DOI 10.1089/scd.1.1998.7.437; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Majumder B, 2005, J VIROL, V79, P7990, DOI 10.1128/JVI.79.13.7990-8003.2005; MASSO M, 2003, MEDGENMED, V2, P1; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Morrow Gavin, 2007, Curr HIV/AIDS Rep, V4, P29, DOI 10.1007/s11904-007-0005-x; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; Piguet V, 2004, J CLIN INVEST, V114, P605, DOI 10.1172/JCI200422812; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Riond J, 2007, SCAND J IMMUNOL, V66, P441, DOI 10.1111/j.1365-3083.2007.01996.x; Russo V, 2000, BLOOD, V95, P3473, DOI 10.1182/blood.V95.11.3473.011k06_3473_3477; Sabado RL, 2007, EUR J IMMUNOL, V37, P1752, DOI 10.1002/eji.200636981; Salter RD, 2006, IMMUNOL RES, V36, P211, DOI 10.1385/IR:36:1:211; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Steinman RM, 1999, HUM IMMUNOL, V60, P562, DOI 10.1016/S0198-8859(99)00030-0; STLUCE S, 1993, J MED VIROL, V41, P71, DOI 10.1002/jmv.1890410115; Trapp S, 2006, J LEUKOCYTE BIOL, V80, P1076, DOI 10.1189/jlb.0206121; Turville SG, 2008, NAT METHODS, V5, P75, DOI 10.1038/NMETH1137; Venkatachari NJ, 2007, VIROLOGY, V358, P347, DOI 10.1016/j.virol.2006.08.030; WANG JH, 2007, J VIROL; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101; Zheng JY, 2006, JAIDS-J ACQ IMM DEF, V43, P127, DOI 10.1097/01.qai.0000228149.17669.08	55	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7470	10.1371/journal.pone.0007470	http://dx.doi.org/10.1371/journal.pone.0007470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829715	Green Accepted, gold, Green Published			2022-12-25	WOS:000270847800009
J	Craven, RR; Gao, X; Allen, IC; Gris, D; Wardenburg, JB; McElvania-TeKippe, E; Ting, JP; Duncan, JA				Craven, Robin R.; Gao, Xi; Allen, Irving C.; Gris, Denis; Wardenburg, Juliane Bubeck; McElvania-TeKippe, Erin; Ting, Jenny P.; Duncan, Joseph A.			Staphylococcus aureus alpha-Hemolysin Activates the NLRP3-Inflammasome in Human and Mouse Monocytic Cells	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; COMMUNITY-ASSOCIATED MRSA; CASPASE ACTIVATION; ENDOTHELIAL-CELLS; CIAS1 MUTATIONS; WALL COMPONENTS; DEATH PATHWAY; CUTTING EDGE; RECEPTOR 2; TOXIN	Community Acquired Methicillin Resistant Staphylococcus aureus (CA-MRSA) causes severe necrotizing infections of the skin, soft tissues, and lungs. Staphylococcal alpha-hemolysin is an essential virulence factor in mouse models of CA-MRSA necrotizing pneumonia. S. aureus alpha-hemolysin has long been known to induce inflammatory signaling and cell death in host organisms, however the mechanism underlying these signaling events were not well understood. Using highly purified recombinant alpha-hemolysin, we now demonstrate that alpha-hemolysin activates the Nucleotide-binding domain and leucine-rich repeat containing gene family, pyrin domain containing 3 protein (NLRP3) inflammasome, a host inflammatory signaling complex involved in responses to pathogens and endogenous danger signals. Non-cytolytic mutant alpha-hemolysin molecules fail to elicit NLRP3-inflammasome signaling, demonstrating that the responses are not due to non-specific activation of this innate immune signaling system by bacterially derived proteins. In monocyte-derived cells from humans and mice, inflammasome assembly in response to alpha-hemolysin results in activation of the cysteine proteinase, caspase-1. We also show that inflammasome activation by alpha-hemolysin works in conjunction with signaling by other CA-MRSA-derived Pathogen Associated Molecular Patterns (PAMPs) to induce secretion of pro-inflammatory cytokines IL-1 beta and IL-18. Additionally, alpha-hemolysin induces cell death in these cells through an NLRP3-dependent program of cellular necrosis, resulting in the release of endogenous pro-inflammatory molecules, like the chromatin-associated protein, High-mobility group box 1 (HMGB1). These studies link the activity of a major S. aureus virulence factor to a specific host signaling pathway. The cellular events linked to inflammasome activity have clear relevance to the disease processes associated with CA-MRSA including tissue necrosis and inflammation.			Craven, RR (corresponding author), Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27515 USA.	jaduncan@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; Gris, Denis/ABE-5229-2021; Gris, Denis/AGA-1192-2022	Gris, Denis/0000-0003-1215-2434; Gris, Denis/0000-0003-1215-2434	NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, U54AI057157, U19AI067798] Funding Source: NIH RePORTER; NCRR NIH HHS [RR025746, KL2 RR025746] Funding Source: Medline; NIAID NIH HHS [U54 AI057157, U19-AI067798, AI057157, U19 AI067798, U54 AI057153, AI057153] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; BHAKDI S, 1989, INFECT IMMUN, V57, P3512, DOI 10.1128/IAI.57.11.3512-3519.1989; BRAMLEY AJ, 1989, INFECT IMMUN, V57, P2489, DOI 10.1128/IAI.57.8.2489-2494.1989; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Ellis MW, 2004, CLIN INFECT DIS, V39, P971, DOI 10.1086/423965; Essmann F, 2003, CELL DEATH DIFFER, V10, P1260, DOI 10.1038/sj.cdd.4401301; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; FUJISAWA A, 2006, BLOOD; Grimminger F, 1997, J IMMUNOL, V159, P1909; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132715; McElroy MC, 1999, INFECT IMMUN, V67, P5541, DOI 10.1128/IAI.67.10.5541-5544.1999; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Onogawa T, 2002, FEMS IMMUNOL MED MIC, V33, P15, DOI 10.1111/j.1574-695X.2002.tb00566.x; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Rose F, 2002, AM J PHYSIOL-LUNG C, V282, pL207, DOI 10.1152/ajplung.00156.2001; Saito M, 2008, BLOOD, V111, P2132, DOI 10.1182/blood-2007-06-094201; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; SEEGER W, 1990, LAB INVEST, V63, P341; Siqueira JA, 1997, J MED MICROBIOL, V46, P486, DOI 10.1099/00222615-46-6-486; Srivastava SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006293; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; SUTTORP N, 1992, THROMB RES, V67, P243, DOI 10.1016/0049-3848(92)90143-X; SUTTORP N, 1993, J EXP MED, V178, P337, DOI 10.1084/jem.178.1.337; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tao M, 1999, FEMS IMMUNOL MED MIC, V23, P135; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Yoshimura A, 1999, J IMMUNOL, V163, P1	52	299	310	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7446	10.1371/journal.pone.0007446	http://dx.doi.org/10.1371/journal.pone.0007446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826485	Green Submitted, Green Published, gold			2022-12-25	WOS:000270808700009
J	Sallustio, F; De Benedictis, L; Castellano, G; Zaza, G; Loverre, A; Costantino, V; Grandaliano, G; Schena, FP				Sallustio, Fabio; De Benedictis, Luca; Castellano, Giuseppe; Zaza, Gianluigi; Loverre, Antonia; Costantino, Vincenzo; Grandaliano, Giuseppe; Schena, Francesco P.			TLR2 plays a role in the activation of human resident renal stem/progenitor cells	FASEB JOURNAL			English	Article						renal stem cell; chemokine receptor; complement; MCP-1	MESENCHYMAL STEM-CELLS; TOLL-LIKE RECEPTORS; PROGENITOR CELLS; KIDNEY REPAIR; REGENERATION; MOBILIZATION; COMPLEMENT; DANGER; ANGIOGENESIS; CONTRIBUTE	In the past few years, adult renal progenitor/stem cells (ARPCs) have been identified in human kidneys, and particularly in Bowman's capsule and proximal tubules. They may play an important role in the kidney regenerative processes and might prospectively be the ideal cell type for the treatment of both acute and chronic renal injury. In this study, microarray analysis identified 6 gene clusters that discriminated normal human glomerular and tubular ARPCs from renal proximal tubular epithelial cells and mesenchymal stem cells. The top-scored pathway in the ARPC gene expression profile contained growth factor receptors and immune system-related genes, including toll-like receptor 2 (TLR2). Stimulation of TLR2 by ligands that mime inflammatory mediators or damage associated molecular pattern molecules induced secretion of elevated amounts of monocyte chemoattractant protein-1 (MCP-1), IL-6, IL-8, and C3 via NF-kappa B activation. TLR2 stimulation also increased the ARPC proliferation rate, suggesting a role for TLR2 in ARPC activation via autocrine signaling. Moreover, TLR2 stimulation improved ARPC differentiation into renal epithelial cells and was responsible of ARPC branching morphogenesis and tubule-like structures formation. For the first time, this study provides a genomic characterization of renal multipotent progenitor cells and shows that TLR2 found on ARPCs might be responsible for their activation in the kidney, orchestrating the activation of crucial signaling networks necessary for renal repair.-Sallustio, F., De Benedictis, L., Castellano, G., Zaza, G., Loverre, A., Costantino, V., Grandaliano, G., Schena, F. P. TLR2 plays a role in the activation of human resident renal stem/progenitor cells. FASEB J. 24, 514-525 (2010). www.fasebj.org	[Sallustio, Fabio; De Benedictis, Luca; Castellano, Giuseppe; Zaza, Gianluigi; Loverre, Antonia; Costantino, Vincenzo; Grandaliano, Giuseppe; Schena, Francesco P.] Univ Bari, Nephrol Dialysis & Transplantat Unit, Dept Emergency & Organ Transplantat, I-70124 Bari, Italy	Universita degli Studi di Bari Aldo Moro	Schena, FP (corresponding author), Univ Bari, Nephrol Dialysis & Transplantat Unit, Dept Emergency & Organ Transplantat, Piazza G Cesare 11, I-70124 Bari, Italy.	fp.schena@nephro.uniba.it	Sallustio, Fabio/AFP-7212-2022; Grandaliano, Giuseppe/J-7822-2016; Castellano, Giuseppe/H-1626-2012; Sallustio, Fabio/D-2326-2011; Grandaliano, Giuseppe/G-2963-2012; Schena, Francesco P/K-6982-2016; Zaza, Gianluigi/K-3827-2018	Sallustio, Fabio/0000-0002-5132-6532; Grandaliano, Giuseppe/0000-0003-1213-2177; Castellano, Giuseppe/0000-0002-0153-3795; Sallustio, Fabio/0000-0002-5132-6532; Schena, Francesco P/0000-0001-7927-5207; Zaza, Gianluigi/0000-0002-6004-6196	Regione Puglia (Progetto strategico 2006) [PS 144/06]; Ministry of University and Research (MIUR) [PRIN 2005 069117]	Regione Puglia (Progetto strategico 2006); Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	We thank Michele Battaglia (University of Bari) for harvesting the renal tissue, and Antonio Traficante (Di Venere Hospital, Bari, Italy). We thank Paola Romagnani (University of Florence, Florence, Italy) and Giovanni Camussi (University of Turin, Turin, Italy) for help in laboratory procedures. This study was supported by grants from Regione Puglia (Progetto strategico 2006 PS 144/06) and from the Ministry of University and Research (MIUR; PRIN 2005 069117).	Aliprantis AO, 2000, EMBO J, V19, P3325, DOI 10.1093/emboj/19.13.3325; Aliprantis AO, 1999, SCIENCE, V285, P736, DOI 10.1126/science.285.5428.736; Anders HJ, 2007, CURR OPIN NEPHROL HY, V16, P177, DOI 10.1097/MNH.0b013e32803fb767; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Bonventre JV, 2003, J AM SOC NEPHROL, V14, pS55, DOI 10.1097/01.ASN.0000067652.51441.21; Bussolati B, 2005, AM J PATHOL, V166, P545, DOI 10.1016/S0002-9440(10)62276-6; Bussolati B, 2008, AM J NEPHROL, V28, P813, DOI 10.1159/000137681; Castellano G, 2005, J AM SOC NEPHROL, V16, P2003, DOI 10.1681/ASN.2002120972; Chen J, 2008, KIDNEY INT, V74, P879, DOI 10.1038/ki.2008.304; Cho HH, 2006, STEM CELLS, V24, P2744, DOI 10.1634/stemcells.2006-0189; Duffield JS, 2005, KIDNEY INT, V68, P1956, DOI 10.1111/j.1523-1755.2005.00629.x; Duffield JS, 2005, J CLIN INVEST, V115, P1743, DOI 10.1172/JCI22593; Fibbe WE, 2000, SEMIN HEMATOL, V37, P19, DOI 10.1016/S0037-1963(00)90085-4; Gupta S, 2002, KIDNEY INT, V62, P1285, DOI 10.1111/j.1523-1755.2002.kid569.x; HUMES HD, 1989, J CLIN INVEST, V84, P1757, DOI 10.1172/JCI114359; Humphreys B D, 2006, Minerva Urol Nefrol, V58, P329; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Kale S, 2003, J CLIN INVEST, V112, P42, DOI 10.1172/JCI200317856; Lang A, 2005, J AM SOC NEPHROL, V16, P383, DOI 10.1681/ASN.2004040276; LATERVEER L, 1995, BLOOD, V85, P2269, DOI 10.1182/blood.V85.8.2269.bloodjournal8582269; Leemans JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005704; Li M, 2008, NEPHROL DIAL TRANSPL, V23, P860, DOI 10.1093/ndt/gfm670; Little MH, 2006, J AM SOC NEPHROL, V17, P2390, DOI 10.1681/ASN.2006030218; Loverre A, 2008, TRANSPLANTATION, V85, P1112, DOI 10.1097/TP.0b013e31816a8891; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; Nam NH, 2006, MINI-REV MED CHEM, V6, P945, DOI 10.2174/138955706777934937; Nishida M, 2003, AM J KIDNEY DIS, V42, DOI 10.1053/S0272-6386(03)01021-7; Plotkin MD, 2006, AM J PHYSIOL-RENAL, V291, pF902, DOI 10.1152/ajprenal.00396.2005; Ratajczak J, 2004, BLOOD, V103, P2071, DOI 10.1182/blood-2003-06-2099; Reca R, 2007, STEM CELLS, V25, P3093, DOI 10.1634/stemcells.2007-0525; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Sagrinati C, 2008, TRENDS MOL MED, V14, P277, DOI 10.1016/j.molmed.2008.05.005; Sagrinati C, 2006, J AM SOC NEPHROL, V17, P2443, DOI 10.1681/ASN.2006010089; SCHENA FP, 1998, KIDNEY INT S, V66, P11; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; Stich S, 2008, EUR J CELL BIOL, V87, P365, DOI 10.1016/j.ejcb.2008.03.009; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; Widera D, 2004, EUR J CELL BIOL, V83, P381, DOI 10.1078/0171-9335-00403; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yokoo T, 2008, KIDNEY INT, V74, P847, DOI 10.1038/ki.2008.327	42	93	96	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					514	525		10.1096/fj.09-136481	http://dx.doi.org/10.1096/fj.09-136481			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19843711				2022-12-25	WOS:000274045000019
J	Jang, GY; Jeon, JH; Cho, SY; Shin, DM; Kim, CW; Jeong, EM; Bae, HC; Kim, TW; Lee, SH; Choi, Y; Lee, DS; Park, SC; Kim, IG				Jang, G-Y; Jeon, J-H; Cho, S-Y; Shin, D-M; Kim, C-W; Jeong, E. M.; Bae, H. C.; Kim, T. W.; Lee, S-H; Choi, Y.; Lee, D-S; Park, S-C; Kim, I-G			Transglutaminase 2 suppresses apoptosis by modulating caspase 3 and NF-kappa B activity in hypoxic tumor cells	ONCOGENE			English	Article						apoptosis; caspase 3; hypoxia-inducible factor-1; NF-kappa B; transglutaminase 2	TISSUE TRANSGLUTAMINASE; OXIDATIVE STRESS; CANCER-THERAPY; BREAST-CANCER; GENE-EXPRESSION; DRUG-RESISTANT; IDENTIFICATION; ACTIVATION; PROTEIN; ALPHA	The expression of hypoxia-inducible factor-1 (HIF-1) correlates with poor clinical outcomes and confers resistance to the apoptosis of the tumor cells that are exposed to hypoxia. Presently, the mechanism underlying this phenomenon is poorly understood. In this study we provide evidence that transglutaminase 2 (TG2), an enzyme that catalyses protein crosslinking reactions, is a transcriptional target of HIF-1 to enhance the survival of hypoxic cells. We found that hypoxia induces TG2 expression through an HIF-1 dependent pathway and concurrently activates intracellular TG2. The hypoxic cells overexpressing TG2 showed resistance to apoptosis. Conversely, the hypoxic cells treated with either TG2 inhibitor or small interfering RNA (siRNA) became sensitive to apoptosis. Activation of TG2 in response to hypoxic stress inhibited caspase-3 activity by forming crosslinked multimer, resulting in insoluble aggregates. TG2 also activates nuclear factor (NF)-kappa B pathway after hypoxic stress, and thereby induces the expression of cellular inhibitor of apoptosis 2. The anti-apoptotic role of TG2 was further confirmed in vivo using xenografts in athymic mice. Our results indicate that TG2 is an antiapoptotic mediator of HIF-1 through modulating both apoptosis and survival pathways and may confer a selective growth advantage to tumor cells. These findings suggest that the inhibition of TG2 may offer a novel strategy for anticancer therapy. Oncogene (2010) 29, 356-367; doi:10.1038/onc.2009.342; published online 19 October 2009	[Jang, G-Y; Cho, S-Y; Shin, D-M; Kim, C-W; Jeong, E. M.; Lee, S-H; Choi, Y.; Park, S-C; Kim, I-G] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, AARC, Seoul 110799, South Korea; [Jeon, J-H] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul 110799, South Korea; [Bae, H. C.; Kim, T. W.] Korea Univ, Grad Sch Med, Lab Infect & Immunol, Seoul, South Korea; [Lee, D-S] Seoul Natl Univ, Coll Med, Inst Canc Res, Seoul 110799, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Kim, IG (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, AARC, 28 Yongon Dong, Seoul 110799, South Korea.	igkim@plaza.snu.ac.kr	Jeon, Ju-Hong/D-5740-2012; Lee, Dong-Sup/J-2777-2012	Kim, Chai-Wan/0000-0001-5105-2829; Jeong, Eui Man/0000-0003-0692-2033; /0000-0001-8564-2392; Jeon, Ju-Hong/0000-0002-5603-2955	Korea Science and Engineering Foundation [R11-2002-097-09005-0, R01-2005000-10364-0]; Research Program for New Drug Target Discovery [M10748000296-07N4800-29610]; Korea Ministry of Education, Science and Technology	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Research Program for New Drug Target Discovery(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	We thank Dr YD Kim for critical comments on this paper. We also thank Dr Shigetaka Kitajima (Tokyo Medical and Dental University, Japan) for providing cIAP2 reporter construct. This work was supported by the grants from Korea Science and Engineering Foundation (R11-2002-097-09005-0 and R01-2005000-10364-0) and also by the Research Program for New Drug Target Discovery (M10748000296-07N4800-29610). GYJ, SYC, EMJ, SHL and YC were supported by the graduate program of BK21, Korea Ministry of Education, Science and Technology.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Antonyak MA, 2004, J BIOL CHEM, V279, P41461, DOI 10.1074/jbc.M404976200; Antonyak MA, 2006, P NATL ACAD SCI USA, V103, P18609, DOI 10.1073/pnas.0604844103; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Baylin SB, 1997, SCIENCE, V277, P1948, DOI 10.1126/science.277.5334.1948; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Brunelle JK, 2002, APOPTOSIS, V7, P475, DOI 10.1023/A:1020668923852; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Choi K, 2005, CHEM BIOL, V12, P469, DOI 10.1016/j.chembiol.2005.02.007; Dachs GU, 1997, NAT MED, V3, P515, DOI 10.1038/nm0597-515; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; Dirmeier R, 2004, METHOD ENZYMOL, V381, P589; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Filiano AJ, 2008, FASEB J, V22, P2662, DOI 10.1096/fj.07-097709; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Hasegawa G, 2003, BIOCHEM J, V373, P793, DOI 10.1042/BJ20021084; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Hui AS, 2006, FASEB J, V20, P466, DOI 10.1096/fj.05-5086com; Jeon JH, 2004, EXP MOL MED, V36, P576, DOI 10.1038/emm.2004.74; Jeon JH, 2003, EMBO J, V22, P5273, DOI 10.1093/emboj/cdg495; Jeon JH, 2003, FEBS LETT, V534, P180, DOI 10.1016/S0014-5793(02)03836-X; Kaidi A, 2006, CANCER RES, V66, P6683, DOI 10.1158/0008-5472.CAN-06-0425; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; LEE KN, 1989, BIOCHEM BIOPH RES CO, V162, P1370, DOI 10.1016/0006-291X(89)90825-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Mishra S, 2004, J BIOL CHEM, V279, P23863, DOI 10.1074/jbc.M311919200; Park SS, 2006, J BIOL CHEM, V281, P34965, DOI 10.1074/jbc.M604150200; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Piret JP, 2002, BIOCHEM PHARMACOL, V64, P889, DOI 10.1016/S0006-2952(02)01155-3; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Reed JC, 2006, NAT CLIN PRACT ONCOL, V3, P388, DOI 10.1038/ncponc0538; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shin DM, 2004, J BIOL CHEM, V279, P15032, DOI 10.1074/jbc.M308734200; Shin DM, 2008, FASEB J, V22, P2498, DOI 10.1096/fj.07-095455; Sohn J, 2003, J CLIN INVEST, V111, P121, DOI 10.1172/JCI200315937; Verma A, 2007, DRUG RESIST UPDATE, V10, P144, DOI 10.1016/j.drup.2007.06.002; Wykoff CC, 2000, ONCOGENE, V19, P6297, DOI 10.1038/sj.onc.1204012; Yamaguchi H, 2006, MOL CELL BIOL, V26, P569, DOI 10.1128/MCB.26.2.569-579.2006; Yuan L, 2005, MOL CANCER THER, V4, P1293, DOI 10.1158/1535-7163.MCT-04-0328; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zhang RL, 2003, GLIA, V42, P194, DOI 10.1002/glia.10222; Zhang ZB, 2003, CIRC RES, V92, P1153, DOI 10.1161/01.RES.0000071749.22027.45	45	102	104	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2010	29	3					356	367		10.1038/onc.2009.342	http://dx.doi.org/10.1038/onc.2009.342			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	546EO	19838207				2022-12-25	WOS:000273793200005
J	Menon, BRK; Davison, PA; Hunter, CN; Scrutton, NS; Heyes, DJ				Menon, Binuraj R. K.; Davison, Paul A.; Hunter, C. Neil; Scrutton, Nigel S.; Heyes, Derren J.			Mutagenesis Alters the Catalytic Mechanism of the Light-driven Enzyme Protochlorophyllide Oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRODUCT RELEASE STEPS; DYNAMICS; KINETICS; PROTON; NADPH; STATE; CYCLE; TEMPERATURE; VISCOSITY	The light-activated enzyme protochlorophyllide oxidoreductase (POR) catalyzes an essential step in the synthesis of the most abundant pigment on Earth, chlorophyll. This unique reaction involves the sequential addition of a hydride and proton across the C17=C18 double bond of protochlorophyllide (Pchlide) by dynamically coupled quantum tunneling and is an important model system for studying the mechanism of hydrogen transfer reactions. In the present work, we have combined site-directed mutagenesis studies with a variety of sensitive spectroscopic and kinetic measurements to provide new insights into the mechanistic role of three universally conserved Cys residues in POR. We show that mutation of Cys-226 dramatically alters the catalytic mechanism of the enzyme. In contrast to wild-type POR, the characteristic charge-transfer intermediate, formed upon hydride transfer from NADPH to the C17 position of Pchlide, is absent in C226S variant enzymes. This suggests a concerted hydrogen transfer mechanism where proton transfer only is rate-limiting. Moreover, Pchlide reduction does not require the network of solvent-coupled conformational changes that play a key role in the proton transfer step of wild-type POR. We conclude that this globally important enzyme is finely tuned to facilitate efficient photochemistry, and the removal of a key interaction with Pchlide in the C226S variants significantly affects the local active site structure in POR, resulting in a shorter donor-acceptor distance for proton transfer.	[Menon, Binuraj R. K.; Scrutton, Nigel S.; Heyes, Derren J.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Davison, Paul A.; Hunter, C. Neil] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England	University of Manchester; University of Sheffield	Scrutton, NS (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England.	nigel.scrutton@manchester.ac.uk; derren.heyes@manchester.ac.uk	Menon, Binuraj/AAO-7752-2021; menon, binuraj/D-6731-2015	Menon, Binuraj/0000-0001-6852-8053; Heyes, Derren/0000-0002-7453-1571	Biotechnology and Biological Sciences Research Council (BBSRC), UK; BBSRC [BB/D01963X/1, BB/G021546/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G021546/1, BB/D01963X/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC), UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC), UK.	ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Aronsson H, 2003, PLANT MOL BIOL, V51, P1, DOI 10.1023/A:1020795415631; Birve SJ, 1996, BIOCHEM J, V317, P549, DOI 10.1042/bj3170549; Buhr F, 2008, P NATL ACAD SCI USA, V105, P12629, DOI 10.1073/pnas.0803950105; Dietzek B, 2006, J PHYS CHEM B, V110, P4399, DOI 10.1021/jp0556456; Durin G, 2009, BIOPHYS J, V96, P1902, DOI [10.1016/j.bpj.2008.10.065, 10.1016/j.bpj.200X.10.065]; Hay S, 2008, ANGEW CHEM INT EDIT, V47, P537, DOI 10.1002/anie.200704484; Heyes DJ, 2008, BIOCHEMISTRY-US, V47, P10991, DOI 10.1021/bi801521c; Heyes DJ, 2007, J BIOL CHEM, V282, P32015, DOI 10.1074/jbc.M706098200; Heyes DJ, 2006, J BIOL CHEM, V281, P26847, DOI 10.1074/jbc.M602943200; Heyes DJ, 2009, ANGEW CHEM INT EDIT, V48, P3850, DOI 10.1002/anie.200900086; Heyes DJ, 2009, J BIOL CHEM, V284, P3762, DOI 10.1074/jbc.M808548200; Heyes DJ, 2000, FEBS LETT, V483, P47, DOI 10.1016/S0014-5793(00)02081-0; Heyes DJ, 2005, TRENDS BIOCHEM SCI, V30, P642, DOI 10.1016/j.tibs.2005.09.001; Heyes DJ, 2004, BIOCHEMISTRY-US, V43, P8265, DOI 10.1021/bi049576h; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2003, BIOCHEMISTRY-US, V42, P523, DOI 10.1021/bi0268448; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; IvkovicJensen MM, 1997, BIOCHEMISTRY-US, V36, P8135, DOI 10.1021/bi970327l; Knapp MJ, 2002, J AM CHEM SOC, V124, P3865, DOI 10.1021/ja012205t; Kuznetsov AM, 1999, CAN J CHEM, V77, P1085, DOI 10.1139/cjc-77-5-6-1085; Lebedev N, 1998, PHOTOSYNTH RES, V58, P5, DOI 10.1023/A:1006082119102; Masgrau L, 2006, SCIENCE, V312, P237, DOI 10.1126/science.1126002; OLIVER RP, 1981, BIOCHEM J, V195, P93, DOI 10.1042/bj1950093; Pudney CR, 2006, J AM CHEM SOC, V128, P14053, DOI 10.1021/ja0614619; Sytina OA, 2008, NATURE, V456, P1001, DOI 10.1038/nature07354; Townley HE, 2001, PROTEINS, V44, P329, DOI 10.1002/prot.1098; Zhao GJ, 2008, BIOPHYS J, V94, P38, DOI 10.1529/biophysj.107.113738	30	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2113	2119		10.1074/jbc.M109.071522	http://dx.doi.org/10.1074/jbc.M109.071522			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19850924	Green Published, hybrid			2022-12-25	WOS:000273429100055
J	Okemefuna, AI; Nan, R; Miller, A; Gor, J; Perkins, SJ				Okemefuna, Azubuike I.; Nan, Ruodan; Miller, Ami; Gor, Jayesh; Perkins, Stephen J.			Complement Factor H Binds at Two Independent Sites to C-reactive Protein in Acute Phase Concentrations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATOR FACTOR-H; SEDIMENTATION-VELOCITY; X-RAY; SCATTERING DATA; FACTOR-I; POLYMORPHISM; ACTIVATION; NEUTRON; ULTRACENTRIFUGATION; DISTRIBUTIONS	Factor H (FH) regulates the activation of C3b in the alternative complement pathway, both in serum and at host cell surfaces. It is composed of 20 short complement regulator (SCR) domains. The Y402H polymorphism in FH is a risk factor for age-related macular degeneration. C-reactive protein (CRP) is an acute phase protein that binds Ca2+. We established the FH-CRP interaction using improved analytical ultracentrifugation (AUC), surface plasmon resonance (SPR), and synchrotron x-ray scattering methods. Physiological FH and CRP concentrations were used in 137 mM NaCl and 2 mM Ca2+, in which the occurrence of denatured CRP was avoided. In solution, AUC revealed FH-CRP binding. The FH-CRP interaction inhibited the formation of higher FH oligomers, indicating that CRP blocked FH dimerization sites at both SCR-6/8 and SCR-16/20. SPR confirmed the FH-CRP interaction and its NaCl concentration dependence upon using either immobilized FH or CRP. The SCR-1/5 fragment of FH did not bind to CRP. In order of increasing affinity, SCR-16/20, SCR-6/8 (His-402), and SCR-6/8 (Tyr-402) fragments bound to CRP. X-ray scattering showed that FH became more compact when binding to CRP, which is consistent with CRP binding at two different FH sites. We concluded that FH and CRP bind at elevated acute phase concentrations of CRP in physiological buffer. The SCR-16/20 site is novel and indicates the importance of the FH-CRP interaction for both age-related macular degeneration and atypical hemolytic uremic syndrome.	[Okemefuna, Azubuike I.; Nan, Ruodan; Miller, Ami; Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Biol Mol & Struct, London WC1E 6BT, England	University of London; University College London	Perkins, SJ (corresponding author), UCL, Dept Biol Mol & Struct, Darwin Bldg,Gower St, London WC1E 6BT, England.	s.perkins@medsch.ucl.ac.uk			BBSRC [BB/E013104/1] Funding Source: UKRI; MRC [G0801724] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E013104/1] Funding Source: Medline; Medical Research Council [G0801724] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Biro A, 2007, IMMUNOLOGY, V121, P40, DOI 10.1111/j.1365-2567.2007.02535.x; Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Blizniukov OP, 2003, MOL BIOL+, V37, P912, DOI 10.1023/B:MBIL.0000008361.22136.c8; Bonner A, 2007, J BIOL CHEM, V282, P16969, DOI 10.1074/jbc.M701281200; Bonner A, 2009, J BIOL CHEM, V284, P5077, DOI 10.1074/jbc.M807529200; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Christopeit T, 2009, ANAL BIOCHEM, V391, P39, DOI 10.1016/j.ab.2009.04.037; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; DEBEER FC, 1982, J IMMUNOL METHODS, V50, P17, DOI 10.1016/0022-1759(82)90300-3; FARRIES TC, 1990, COMPLEMENT INFLAMMAT, V7, P30, DOI 10.1159/000463124; Fenaille F, 2007, GLYCOBIOLOGY, V17, P932, DOI 10.1093/glycob/cwm060; Fernando AN, 2007, J MOL BIOL, V368, P564, DOI 10.1016/j.jmb.2007.02.038; Ferreira VP, 2006, J IMMUNOL, V177, P6308, DOI 10.4049/jimmunol.177.9.6308; Gaboriaud C, 2004, TRENDS IMMUNOL, V25, P368, DOI 10.1016/j.it.2004.04.008; Gilbert HE, 2005, J MOL BIOL, V346, P859, DOI 10.1016/j.jmb.2004.12.006; Glatter O., 1982, SMALL ANGLE X RAY SC; Hakobyan S, 2008, J BIOL CHEM, V283, P30451, DOI 10.1074/jbc.M803648200; Herbert AP, 2007, J BIOL CHEM, V282, P18960, DOI 10.1074/jbc.M609636200; Hurwitz S, 1996, CRIT REV BIOCHEM MOL, V31, P41, DOI 10.3109/10409239609110575; Jarva H, 1999, J IMMUNOL, V163, P3957; Johnson PT, 2006, P NATL ACAD SCI USA, V103, P17456, DOI 10.1073/pnas.0606234103; KAPLAN MH, 1974, J IMMUNOL, V112, P2135; KINOSHITA CM, 1989, BIOCHEMISTRY-US, V28, P9840, DOI 10.1021/bi00451a044; Laine M, 2007, J IMMUNOL, V178, P3831, DOI 10.4049/jimmunol.178.6.3831; Li KY, 2008, J MOL BIOL, V384, P137, DOI 10.1016/j.jmb.2008.08.084; Mold C, 1999, IMMUNOPHARMACOLOGY, V42, P23, DOI 10.1016/S0162-3109(99)00007-7; Nan RD, 2008, J MOL BIOL, V375, P891, DOI 10.1016/j.jmb.2007.11.015; Nan R, 2008, J MOL BIOL, V384, P1341, DOI 10.1016/j.jmb.2008.10.030; Narayanan T, 2001, NUCL INSTRUM METH A, V467, P1005, DOI 10.1016/S0168-9002(01)00553-8; NELSON SR, 1991, CLIN CHIM ACTA, V200, P191, DOI 10.1016/0009-8981(91)90090-Y; Okemefuna AI, 2008, J MOL BIOL, V375, P80, DOI 10.1016/j.jmb.2007.09.026; Okemefuna AI, 2010, J BIOL CHEM, V285, P1041, DOI 10.1074/jbc.M109.044495; Okemefuna AI, 2009, J MOL BIOL, V391, P119, DOI 10.1016/j.jmb.2009.06.013; Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Ormsby RJ, 2008, INVEST OPHTH VIS SCI, V49, P1763, DOI 10.1167/iovs.07-1297; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; PERKINS SJ, 1985, EUR J BIOCHEM, V147, P525; PERKINS SJ, 1991, BIOCHEMISTRY-US, V30, P2847, DOI 10.1021/bi00225a017; PERKINS SJ, 1986, PROTIDES BIOL FLUIDS, V34, P323; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Saunders RE, 2007, HUM MUTAT, V28, P222, DOI 10.1002/humu.20435; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shrive AK, 1996, NAT STRUCT BIOL, V3, P346, DOI 10.1038/nsb0496-346; SIM RB, 1993, METHOD ENZYMOL, V223, P13; Sjoberg AP, 2007, J BIOL CHEM, V282, P10894, DOI 10.1074/jbc.M610256200; Skerka C, 2007, MOL IMMUNOL, V44, P3398, DOI 10.1016/j.molimm.2007.02.012; Tanious FA, 2008, METHOD CELL BIOL, V84, P53, DOI 10.1016/S009911-679X(07)84003-9; Thompson D, 1999, STRUCTURE, V7, P169, DOI 10.1016/S0969-2126(99)80023-9; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147; Yu JM, 2007, BIOCHEMISTRY-US, V46, P8451, DOI 10.1021/bi700459a	57	96	97	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1053	1065		10.1074/jbc.M109.044529	http://dx.doi.org/10.1074/jbc.M109.044529			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19850925	hybrid, Green Published			2022-12-25	WOS:000273258200026
J	Sullivan, CP; Seidl, SE; Rich, CB; Raymondjean, M; Schreiber, BM				Sullivan, Christopher P.; Seidl, Stephanie E.; Rich, Celeste B.; Raymondjean, Michel; Schreiber, Barbara M.			Secretory Phospholipase A(2), Group IIA Is a Novel Serum Amyloid A Target Gene ACTIVATION OF SMOOTH MUSCLE CELL EXPRESSION BY AN INTERLEUKIN-1 RECEPTOR-INDEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACUTE-PHASE RESPONSE; C-REACTIVE PROTEIN; LOW-DENSITY LIPOPROTEINS; APOLIPOPROTEIN-A-I; C/EBP-BETA; TRANSCRIPTIONAL REGULATION; ATHEROSCLEROTIC LESIONS; CARDIOVASCULAR-DISEASE; MACROPHAGE CHOLESTEROL	Atherosclerosis is a multifactorial vascular disease characterized by formation of inflammatory lesions. Elevated circulating acute phase proteins indicate disease risk. Serum amyloid A (SAA) is one such marker but its function remains unclear. To determine the role of SAA on aortic smooth muscle cell gene expression, a preliminary screen of a number of genes was performed and a strong up-regulation of expression of secretory phospholipase A(2), group IIA (sPLA(2)) was identified. The SAA-induced increase in sPLA(2) was validated by real time PCR, Western blot analysis, and enzyme activity assays. Demonstrating that SAA increased expression of sPLA(2) heteronuclear RNA and that inhibiting transcription eliminated the effect of SAA on sPLA(2) mRNA suggested that the increase was transcriptional. Transient transfections and electrophoretic mobility shift assays identified CAAT enhancer-binding protein (C/EBP) and nuclear factor kappa B (NF kappa B) as key regulatory sites mediating the induction of sPLA2. Moreover, SAA activated the inhibitor of NF-kappa B kinase (IKK) in cultured smooth muscle cells. Previous reports showed that interleukin (IL)-1 beta up-regulates Pla2g2a gene transcription via C/EBP beta and NF kappa B. Interestingly, SAA activated smooth muscle cell IL-1 beta mRNA expression, however, blocking IL-1 receptors had no effect on SAA-mediated activation of sPLA(2) expression. Thus, the observed changes in sPLA(2) expression were not secondary to SAA-induced IL-1 receptor activation. The association of SAA with high density lipoprotein abrogated the SAA-induced increase in sPLA(2) expression. These data suggest that during atherogenesis, SAA can amplify the involvement of smooth muscle cells in vascular inflammation and that this can lead to deposition of sPLA(2) and subsequent local changes in lipid homeostasis.	[Sullivan, Christopher P.; Seidl, Stephanie E.; Rich, Celeste B.; Schreiber, Barbara M.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Raymondjean, Michel] Univ Paris 06, Physiol Physiopathol & Vieillissement UR4, F-75252 Paris, France	Boston University; UDICE-French Research Universities; Sorbonne Universite	Schreiber, BM (corresponding author), 72 E Concord St, Boston, MA 02118 USA.	schreibe@biochem.bumc.bu.edu		Schreiber, Barbara/0000-0001-8560-4249	National Institutes of Health [HL079201]; American Heart Association [0256215T, 0455846T]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL079201 and American Heart Association Grants 0256215T and 0455846T.	Andreani M, 2000, BBA-MOL CELL BIOL L, V1488, P149, DOI 10.1016/S1388-1981(00)00117-7; Anthonsen MW, 2000, ARTERIOSCL THROM VAS, V20, P1276, DOI 10.1161/01.ATV.20.5.1276; Antonio V, 2002, BIOCHEM J, V368, P415, DOI 10.1042/BJ20020658; Balsinde J, 2002, BIOCHEM J, V364, P695, DOI 10.1042/BJ20020142; BAMBERGER M, 1985, BIOCHEMISTRY-US, V24, P3693, DOI 10.1021/bi00335a044; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Begbie M, 2000, THROMB HAEMOSTASIS, V84, P216; BENDITT EP, 1989, J EXP MED, V169, P1841, DOI 10.1084/jem.169.5.1841; Cai L, 2005, J BIOL CHEM, V280, P2954, DOI 10.1074/jbc.M411555200; Cai ZH, 2007, J VIROL, V81, P6128, DOI 10.1128/JVI.02627-06; Chait A, 2005, J LIPID RES, V46, P389, DOI 10.1194/jlr.R400017-JLR200; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; COLLET X, 1990, BIOCHIM BIOPHYS ACTA, V1043, P301, DOI 10.1016/0005-2760(90)90031-R; Couturier C, 1999, J BIOL CHEM, V274, P23085, DOI 10.1074/jbc.274.33.23085; Couturier C, 2000, ARTERIOSCL THROM VAS, V20, P2559, DOI 10.1161/01.ATV.20.12.2559; de Beer FC, 2000, J LIPID RES, V41, P1849; de Winther MPJ, 2005, ARTERIOSCL THROM VAS, V25, P904, DOI 10.1161/01.ATV.0000160340.72641.87; Dorsam G, 2000, J PHARMACOL EXP THER, V292, P271; Elinder LS, 1997, ARTERIOSCL THROM VAS, V17, P2257, DOI 10.1161/01.ATV.17.10.2257; Ghesquiere SAI, 2005, J LIPID RES, V46, P201, DOI 10.1194/jlr.M400253-JLR200; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Han CY, 2006, ARTERIOSCL THROM VAS, V26, P1806, DOI 10.1161/01.ATV.0000227472.70734.ad; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Houliston RA, 2001, BIOCHEM BIOPH RES CO, V287, P881, DOI 10.1006/bbrc.2001.5681; Hurt-Camejo E, 2001, ARTHRITIS RHEUM, V44, P2761, DOI 10.1002/1529-0131(200112)44:12<2761::AID-ART463>3.0.CO;2-5; HurtCamejo E, 1997, ARTERIOSCL THROM VAS, V17, P300, DOI 10.1161/01.ATV.17.2.300; Ivandic B, 1999, ARTERIOSCL THROM VAS, V19, P1284, DOI 10.1161/01.ATV.19.5.1284; Jaulmes A, 2006, FASEB J, V20, P1727, DOI 10.1096/fj.05-5514fje; Jensen LE, 1998, BIOCHEM J, V334, P489, DOI 10.1042/bj3340489; KENNEDY BP, 1995, J BIOL CHEM, V270, P22378, DOI 10.1074/jbc.270.38.22378; Kisilevsky R, 2003, J LIPID RES, V44, P2257, DOI 10.1194/jlr.M300133-JLR200; Kitaoka Y, 2007, BRAIN RES, V1142, P247, DOI 10.1016/j.brainres.2007.01.097; Kramer F, 2008, MOL IMMUNOL, V45, P2678, DOI 10.1016/j.molimm.2007.12.017; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Kugiyama K, 1999, CIRCULATION, V100, P1280, DOI 10.1161/01.CIR.100.12.1280; Kumon Y, 1997, SCAND J IMMUNOL, V46, P284, DOI 10.1046/j.1365-3083.1997.d01-128.x; LABEQUE R, 1993, P NATL ACAD SCI USA, V90, P3476, DOI 10.1073/pnas.90.8.3476; Larson MA, 2003, BIOCHEM BIOPH RES CO, V301, P1030, DOI 10.1016/S0006-291X(03)00045-7; Lee YM, 1996, MOL CELL BIOL, V16, P4257; LEMAHIEU RA, 1993, J MED CHEM, V36, P3029, DOI 10.1021/jm00072a025; Libby P, 2004, AM J MED, V116, P9, DOI 10.1016/j.amjmed.2004.02.006; Mahmoudi M, 2007, HISTOPATHOLOGY, V50, P535, DOI 10.1111/j.1365-2559.2006.02503.x; Mallat Z, 2007, ARTERIOSCL THROM VAS, V27, P1177, DOI 10.1161/ATVBAHA.107.139352; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; Menschikowski M, 2006, PROSTAG OTH LIPID M, V79, P1, DOI 10.1016/j.prostaglandins.2005.10.005; Menschikowski M, 2004, FEBS LETT, V577, P81, DOI 10.1016/j.febslet.2004.09.067; Menschikowski M, 1995, ATHEROSCLEROSIS, V118, P173, DOI 10.1016/0021-9150(95)05604-1; MITCHELL TI, 1991, J CLIN INVEST, V87, P1177, DOI 10.1172/JCI115116; Mounier CM, 1998, J BIOL CHEM, V273, P23764, DOI 10.1074/jbc.273.37.23764; NAKANO T, 1990, FEBS LETT, V261, P171, DOI 10.1016/0014-5793(90)80663-4; O'Brien Kevin D, 2006, Curr Atheroscler Rep, V8, P62, DOI 10.1007/s11883-006-0066-0; Oestvang J, 2006, BBA-MOL CELL BIOL L, V1761, P1309, DOI 10.1016/j.bbalip.2006.06.003; OHARA O, 1990, NUCLEIC ACIDS RES, V18, P6997, DOI 10.1093/nar/18.23.6997; Okamoto H, 2008, J RHEUMATOL, V35, P752; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Peilot H, 2000, J BIOL CHEM, V275, P22895, DOI 10.1074/jbc.M002783200; Plevy SE, 1997, MOL CELL BIOL, V17, P4572, DOI 10.1128/MCB.17.8.4572; PRUZANSKI W, 1995, BIOCHEM J, V309, P461, DOI 10.1042/bj3090461; Pruzanski W, 1998, J LIPID RES, V39, P2150; Pruzanski W, 2001, LAB INVEST, V81, P757, DOI 10.1038/labinvest.3780284; QIAO JH, 1994, ARTERIOSCLER THROMB, V14, P1480, DOI 10.1161/01.ATV.14.9.1480; Rawadi G, 1999, J IMMUNOL, V162, P2193; RAY A, 1995, J BIOL CHEM, V270, P7365, DOI 10.1074/jbc.270.13.7365; RAYMONDJEAN M, 1988, P NATL ACAD SCI USA, V85, P757, DOI 10.1073/pnas.85.3.757; Rich CB, 1999, J BIOL CHEM, V274, P33433, DOI 10.1074/jbc.274.47.33433; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; ROKITA H, 1994, J RHEUMATOL, V21, P400; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Schiering A, 1999, ATHEROSCLEROSIS, V144, P73, DOI 10.1016/S0021-9150(99)00045-3; Schreiber BM, 1999, BIOCHEM J, V344, P7, DOI 10.1042/0264-6021:3440007; Schreiber BM, 2002, AMYLOID, V9, P276, DOI 10.3109/13506120209114107; SCHREIBER BM, 1988, ATHEROSCLEROSIS, V69, P69, DOI 10.1016/0021-9150(88)90290-0; SCHREIBER BM, 1992, ATHEROSCLEROSIS, V95, P201, DOI 10.1016/0021-9150(92)90023-A; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Tam SP, 2005, J LIPID RES, V46, P2091, DOI 10.1194/jlr.M500191-JLR200; Tam SP, 2002, J LIPID RES, V43, P1410, DOI 10.1194/jlr.M100388-JLR200; Tietge UJF, 2000, J BIOL CHEM, V275, P10077, DOI 10.1074/jbc.275.14.10077; Tietge UJF, 2005, J LIPID RES, V46, P1604, DOI 10.1194/jlr.M400469-JLR200; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Urieli-Shoval S, 2002, BLOOD, V99, P1224, DOI 10.1182/blood.V99.4.1224; URIELISHOVAL S, 1994, AM J PATHOL, V145, P650; van der Westhuyzen DR, 2007, CURR OPIN LIPIDOL, V18, P147, DOI 10.1097/MOL.0b013e328051b4fe; van der Westhuyzen DR, 2005, J BIOL CHEM, V280, P35890, DOI 10.1074/jbc.M505685200; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Walder K, 2002, DIABETES, V51, P1859, DOI 10.2337/diabetes.51.6.1859; Walker G, 1997, BRIT J PHARMACOL, V121, P787, DOI 10.1038/sj.bjp.0701170; Webb NR, 2003, ARTERIOSCL THROM VAS, V23, P263, DOI 10.1161/01.ATV.0000051701.90972.E5; Xanthoulea S, 2005, CURR OPIN LIPIDOL, V16, P536, DOI 10.1097/01.mol.0000180167.15820.ae; Yamada T, 1996, PATHOL INT, V46, P797, DOI 10.1111/j.1440-1827.1996.tb03552.x	93	20	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					565	575		10.1074/jbc.M109.070565	http://dx.doi.org/10.1074/jbc.M109.070565			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19850938	Green Published, hybrid			2022-12-25	WOS:000273070100058
J	Valadon, P; Darsow, B; Buss, TN; Czarny, M; Griffin, NM; Nguyen, HN; Oh, P; Borgstrom, P; Chrastina, A; Schnitzer, JE				Valadon, Philippe; Darsow, Bryan; Buss, Tim N.; Czarny, Malgorzata; Griffin, Noelle M.; Nguyen, Han N.; Oh, Phil; Borgstrom, Per; Chrastina, Adrian; Schnitzer, Jan E.			Designed Auto-assembly of Nanostreptabodies for Rapid Tissue-specific Targeting in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT PROTEIN-PRODUCTION; TRANSIENT GENE-EXPRESSION; ENZYMATIC BIOTINYLATION; MAMMALIAN-CELLS; ANTIBODY; FRAGMENTS; STREPTAVIDIN; MULTIVALENT; LIBRARIES; CAVEOLAE	Molecular medicine can benefit greatly from antibodies that deliver therapeutic and imaging agents to select organs and diseased tissues. Yet the development of complex and defined composite nanostructures remains a challenge that requires both designed stoichiometric assembly and superior in vivo testing ability. Here, we generate nanostructures called nanostreptabodies by controlled sequential assembly of biotin-engineered antibody fragments on a streptavidin scaffold with a defined capacity for additional biotinylated payloads such as other antibodies to create bispecific antibodies as well as organic and non-organic moieties. When injected intravenously, these novel and stable nanostructures exhibit exquisite targeting with tissue-specific imaging and delivery, including rapid transendothelial transport that enhances tissue penetration. This "tinkertoy construction" strategy provides a very flexible and efficient way to link targeting vectors with reporter and/or effector agents, thereby providing virtually endless combinations potentially useful for multipurpose molecular and functional imaging in vivo as well as therapies.	[Valadon, Philippe; Czarny, Malgorzata; Griffin, Noelle M.; Nguyen, Han N.; Oh, Phil; Chrastina, Adrian; Schnitzer, Jan E.] Proteogenom Res Inst Syst Med, San Diego, CA 92121 USA; [Valadon, Philippe; Darsow, Bryan; Buss, Tim N.; Czarny, Malgorzata; Griffin, Noelle M.; Nguyen, Han N.; Oh, Phil; Borgstrom, Per; Chrastina, Adrian; Schnitzer, Jan E.] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA		Schnitzer, JE (corresponding author), Proteogenom Res Inst Syst Med, 11107 Roselle St, San Diego, CA 92121 USA.	jschnitzer@prism-sd.org	Chrastina, Adrian/AHE-3296-2022	Chrastina, Adrian/0000-0002-4097-9773	National Institutes of Health, NCI [R01CA119378, PO1CA104898, R24CA95893]; National Institutes of Health, NHLBI [R01HL58216, RO1HL074063]; NATIONAL CANCER INSTITUTE [R24CA095893, R01CA119378, P01CA104898] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074063, R01HL058216] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA119378, PO1CA104898, and R24CA95893 from the NCI and Grants R01HL58216 and RO1HL074063 from the NHLBI.	Asai T, 2005, J IMMUNOL METHODS, V299, P63, DOI 10.1016/j.jim.2005.01.020; Backer MV, 2006, BIOCONJUGATE CHEM, V17, P912, DOI 10.1021/bc060037u; Baldi L, 2005, BIOTECHNOL PROGR, V21, P148, DOI 10.1021/bp049830x; Baldi L, 2007, BIOTECHNOL LETT, V29, P677, DOI 10.1007/s10529-006-9297-y; Barat B, 2007, BIOMOL ENG, V24, P283, DOI 10.1016/j.bioeng.2007.02.003; Batchelor RH, 2007, BIOTECHNIQUES, V43, P503, DOI 10.2144/000112564; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bergner A, 2002, J GEN PHYSIOL, V119, P187, DOI 10.1085/jgp.119.2.187; Carver LA, 2003, NAT REV CANCER, V3, P571, DOI 10.1038/nrc1146; Chang CH, 2007, CLIN CANCER RES, V13, p5586S, DOI 10.1158/1078-0432.CCR-07-1217; Chinol M, 2000, RADIOIMMUNOTHERAPY OF CANCER, P169; Chinol M, 1998, BRIT J CANCER, V78, P189, DOI 10.1038/bjc.1998.463; Cloutier SM, 2000, MOL IMMUNOL, V37, P1067, DOI 10.1016/S0161-5890(01)00023-2; Coloma MJ, 1997, NAT BIOTECHNOL, V15, P159, DOI 10.1038/nbt0297-159; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; CULL MG, 1992, P NATL ACAD SCI USA, V89, P1865, DOI 10.1073/pnas.89.5.1865; Deyev SM, 2003, NAT BIOTECHNOL, V21, P1486, DOI 10.1038/nbt916; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Gaidamakova EK, 2001, J CONTROL RELEASE, V74, P341, DOI 10.1016/S0168-3659(01)00345-5; Goldenberg DM, 2006, J CLIN ONCOL, V24, P823, DOI 10.1200/JCO.2005.03.8471; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; Guo F, 2006, P NATL ACAD SCI USA, V103, P11009, DOI 10.1073/pnas.0603822103; Hodneland CD, 2002, P NATL ACAD SCI USA, V99, P5048, DOI 10.1073/pnas.072685299; Howarth M, 2006, NAT METHODS, V3, P267, DOI 10.1038/NMETH861; Hust M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-14; JONES TD, 2009, METHOD MOL BIOL, V525, pR14; Jones Tim D., 2009, V525, P405, DOI 10.1007/978-1-59745-554-1_21; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Kulman JD, 2007, PROTEIN EXPRES PURIF, V52, P320, DOI 10.1016/j.pep.2006.09.011; Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; Lee HS, 1999, MOL IMMUNOL, V36, P61, DOI 10.1016/S0161-5890(98)00109-6; Li JD, 2007, PROTEIN ENG DES SEL, V20, P491, DOI 10.1093/protein/gzm038; Marshall D, 1996, BRIT J CANCER, V73, P565, DOI 10.1038/bjc.1996.99; Marvin JS, 2005, ACTA PHARMACOL SIN, V26, P649, DOI 10.1111/j.1745-7254.2005.00119.x; McIntosh DP, 2002, P NATL ACAD SCI USA, V99, P1996, DOI 10.1073/pnas.251662398; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; Oh P, 2007, NAT BIOTECHNOL, V25, P327, DOI 10.1038/nbt1292; Pearce LA, 1997, BIOCHEM MOL BIOL INT, V42, P1179; Persic L, 1997, GENE, V187, P9, DOI 10.1016/S0378-1119(96)00628-2; Pham PL, 2006, MOL BIOTECHNOL, V34, P225, DOI 10.1385/MB:34:2:225; Pluckthun A, 1997, IMMUNOTECHNOLOGY, V3, P83, DOI 10.1016/S1380-2933(97)00067-5; Saviranta P, 1998, BIOCONJUGATE CHEM, V9, P725, DOI 10.1021/bc9800217; Schnitzer JE, 1998, NEW ENGL J MED, V339, P472, DOI 10.1056/NEJM199808133390711; Scholler N, 2006, J IMMUNOL METHODS, V317, P132, DOI 10.1016/j.jim.2006.10.003; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Valadon P, 2006, P NATL ACAD SCI USA, V103, P407, DOI 10.1073/pnas.0506938103; Weiden PL, 2000, CANCER BIOTHER RADIO, V15, P15, DOI 10.1089/cbr.2000.15.15; Wu CB, 2007, NAT BIOTECHNOL, V25, P1290, DOI 10.1038/nbt1345	49	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					713	722		10.1074/jbc.M109.061838	http://dx.doi.org/10.1074/jbc.M109.061838			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19850928	hybrid, Green Published			2022-12-25	WOS:000273070100072
J	Cheng, XW; Kao, HY				Cheng, Xiwen; Kao, Hung-Ying			G Protein Pathway Suppressor 2 (GPS2) Is a Transcriptional Corepressor Important for Estrogen Receptor alpha-mediated Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT BREAST-CANCER; N-COR; HISTONE DEACETYLASE; SILENCING MEDIATOR; SMRT COREPRESSOR; RETINOIC ACID; COMPLEX; ACTIVATION; RECRUITMENT; REPRESSION	We have identified G protein suppressor 2 (GPS2) as a stable component of the SMRT corepressor complexes. GPS2 potently represses basal transcription, with the repression domain mapped to the N-terminal silencing mediator of retinoic acid and thyroid hormone receptor (SMRT)-interacting domain. Knockdown of GPS2 abrogates, whereas overexpression potentiates, SMRT-mediated repression activity. The SMRT complexes are involved in 4-hydroxyl-tamoxifen (4OHT)-mediated gene repression by estrogen receptor alpha (ER alpha). We show that 4OHT recruits SMRT and GPS2 to the promoter of pS2, an ER alpha target gene, in a dynamic manner. Unexpectedly, we also found that estradiol (E2) promotes promoter recruitment of the SMRT complexes. While knockdown of GPS2 compromised 4OHT-mediated repression, it enhanced E2-induced expression of a reporter gene and several endogenous ER alpha target genes, including pS2, cyclin D1 (CCND1), progesterone receptor (PR), and c-MYC. Finally, we show that depletion of GPS2 or SMRT by siRNA promotes cell proliferation in MCF-7 breast cancer cells. Thus, we concluded that GPS2 is an integral component of the SMRT complexes, important for ligand-dependent gene regulations by ER alpha and a suppressor for MCF-7 cell proliferation.	Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Dept Biochem, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland	Kao, HY (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk43@cwru.edu	Cheng, Xiwen/B-8385-2014	Cheng, Xiwen/0000-0001-7398-1522	National Institutes of Health [R01 DK078965]; American Cancer Society; Ohio Cancer Research Associate [5302]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Ohio Cancer Research Associate; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK078965. This work was also supported by grants from the Pardee Foundation, American Cancer Society, and Ohio Cancer Research Associate (5302).	Alland L, 1997, NATURE, V387, P49, DOI 10.1038/387049a0; Baniahmad A, 1998, MOL ENDOCRINOL, V12, P504, DOI 10.1210/me.12.4.504; Breiding DE, 1997, MOL CELL BIOL, V17, P7208, DOI 10.1128/MCB.17.12.7208; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Chun ACS, 2000, AIDS RES HUM RETROV, V16, P1689, DOI 10.1089/08892220050193155; De Amicis F, 2009, MOL ENDOCRINOL, V23, P454, DOI 10.1210/me.2008-0267; Diederichs S, 2004, J BIOL CHEM, V279, P33727, DOI 10.1074/jbc.M401708200; Eriksson M, 2007, PHYSIOL BEHAV, V92, P54, DOI 10.1016/j.physbeh.2007.05.026; Fleming FJ, 2004, J CLIN ENDOCR METAB, V89, P375, DOI 10.1210/jc.2003-031048; Fujita T, 2003, J BIOL CHEM, V278, P26704, DOI 10.1074/jbc.M301031200; Graham JD, 2000, STEROIDS, V65, P579, DOI 10.1016/S0039-128X(00)00116-1; Graham JD, 2000, J STEROID BIOCHEM, V74, P255, DOI 10.1016/S0960-0760(00)00101-1; Guenther MG, 2000, GENE DEV, V14, P1048; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bi602636m; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Huang EY, 2000, GENE DEV, V14, P45; Huang HJ, 2002, MOL ENDOCRINOL, V16, P1778, DOI 10.1210/me.2002-0089; Jakobsson T, 2009, MOL CELL, V34, P510, DOI 10.1016/j.molcel.2009.05.006; Jin DY, 1997, J BIOL CHEM, V272, P25816, DOI 10.1074/jbc.272.41.25816; Jonas BA, 2004, J BIOL CHEM, V279, P54676, DOI 10.1074/jbc.M410128200; Kao HY, 2000, GENE DEV, V14, P55; Keeton EK, 2005, MOL ENDOCRINOL, V19, P1543, DOI 10.1210/me.2004-0395; Lavinsky RM, 1998, P NATL ACAD SCI USA, V95, P2920, DOI 10.1073/pnas.95.6.2920; Lee TH, 2006, DNA REPAIR, V5, P32, DOI 10.1016/j.dnarep.2005.07.004; Li H, 1997, MOL ENDOCRINOL, V11, P2025, DOI 10.1210/me.11.13.2025; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li Y, 2006, GENE DEV, V20, P2566, DOI 10.1101/gad.1455006; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Oberley MJ, 2003, METHOD ENZYMOL, V371, P577; Ordentlich P, 1999, P NATL ACAD SCI USA, V96, P2639, DOI 10.1073/pnas.96.6.2639; Park DJ, 1999, J CLIN INVEST, V103, P1399, DOI 10.1172/JCI2887; Peng YC, 2000, J VIROL, V74, P5872, DOI 10.1128/JVI.74.13.5872-5879.2000; Peng YC, 2001, MOL CELL BIOL, V21, P5913, DOI 10.1128/MCB.21.17.5913-5924.2001; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Peterson TJ, 2007, MOL CELL BIOL, V27, P5933, DOI 10.1128/MCB.00237-07; Sande S, 1996, MOL ENDOCRINOL, V10, P813, DOI 10.1210/me.10.7.813; Sanyal S, 2007, P NATL ACAD SCI USA, V104, P15665, DOI 10.1073/pnas.0706736104; Schiff R, 2003, CLIN CANCER RES, V9, p447S; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Shou J, 2004, JNCI-J NATL CANCER I, V96, P926, DOI 10.1093/jnci/djh166; Smith CL, 1997, MOL ENDOCRINOL, V11, P657, DOI 10.1210/me.11.6.657; Spain BH, 1996, MOL CELL BIOL, V16, P6698; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Stanya KJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-7; Takimoto GS, 1999, J STEROID BIOCHEM, V69, P45, DOI 10.1016/S0960-0760(98)00148-4; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Xie W, 1999, MOL ENDOCRINOL, V13, P2151, DOI 10.1210/me.13.12.2151; Yamamoto Y, 2001, J BIOL CHEM, V276, P42684, DOI 10.1074/jbc.M107844200; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang DH, 2008, J BIOL CHEM, V283, P8580, DOI 10.1074/jbc.M708209200; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9	53	28	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36395	36404		10.1074/jbc.M109.062109	http://dx.doi.org/10.1074/jbc.M109.062109			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858209	Green Published, hybrid			2022-12-25	WOS:000272970500041
J	Chebel, A; Rouault, JP; Urbanowicz, I; Baseggio, L; Chien, WW; Salles, G; Ffrench, M				Chebel, Amel; Rouault, Jean-Pierre; Urbanowicz, Iwona; Baseggio, Lucile; Chien, Wei-Wen; Salles, Gilles; Ffrench, Martine			Transcriptional Activation of hTERT, the Human Telomerase Reverse Transcriptase, by Nuclear Factor of Activated T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC SUBUNIT HTERT; GENE PROMOTER; CANCER-CELLS; FACTOR NFAT1; C-MYC; REPRESSES TRANSCRIPTION; HUMAN-LYMPHOCYTES; EPITHELIAL-CELLS; TUMOR-CELLS; EXPRESSION	Telomerase is essential for telomere maintenance, and its activation is thought to be a critical step in cellular immortalization and tumorigenesis. Human telomerase reverse transcriptase (hTERT) is a major component of telomerase activity. We show here that hTERT is expressed soon after lymphocyte activation and that its expression is inhibited by rapamycin, wortmannin, and FK506, which was the most potent inhibitor. These results suggest a potential role for the transcription factor nuclear factor of activated T cells (NFAT) in the regulation of hTERT expression. Five putative NFAT-binding sites were identified in the hTERT promoter. In luciferase assays, the hTERT promoter was activated by overexpressed NFAT1. Moreover, serial deletions revealed that the promoter activation was mainly due to a -40 NFAT1-binding site flanked by two SP1-binding sites. Mutation of the -40 NFAT-binding site caused a 53% reduction in the transcriptional activity of hTERT promoter. Simultaneous mutations of the -40 NFAT-responsive element together with one or both SP1-binding sites led to a more dramatic decrease in luciferase activity than single mutations, suggesting a functional synergy between NFAT1 and SP1 in hTERT transcriptional regulation. NFAT1 overexpression in MCF7 and Jurkat cell lines induced an increase in endogenous hTERT mRNA expression. Inversely, its down-regulation was induced by NFAT1 silencing. Furthermore, chromatin immunoprecipitation assay demonstrated that NFAT1 directly binds to two sites (-40 and -775) in the endogenous hTERT promoter. Thus, we show for the first time the direct involvement of NFAT1 in the transcriptional regulation of hTERT.	[Baseggio, Lucile; Ffrench, Martine] Hosp Civils Lyon, CHLS, Hematol Lab, F-69310 Pierre Benite, France; [Ffrench, Martine] Univ Lyon 1, CNRS, ENS, Hosp Civils Lyon,UMR 5239,Fac Lyon Sud, F-69921 Oullins, France; [Rouault, Jean-Pierre] Univ Lyon 1, CNRS, INRA, ENS,Inst Genom Fonct Lyon,UMR 5242, F-69007 Lyon, France; [Salles, Gilles] Hosp Civils Lyon, CHLS, Serv Hematol, F-69310 Pierre Benite, France	CHU Lyon; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); CHU Lyon	Ffrench, M (corresponding author), Hosp Civils Lyon, CHLS, Hematol Lab, Chemin Grand Revoyet, F-69310 Pierre Benite, France.	martine.ffrench@chu-lyon.fr	Salles, Gilles/Z-2336-2019	Salles, Gilles/0000-0002-9541-8666	Ligues Contre le Cancer du Rhone, et de Saone et Loire; Region Rhones Alpes [00 81 60 45]; Canceropole Lyon Auvergne Rhone-Alpes	Ligues Contre le Cancer du Rhone, et de Saone et Loire; Region Rhones Alpes(Region Auvergne-Rhone-Alpes); Canceropole Lyon Auvergne Rhone-Alpes	This work was supported by the Ligues Contre le Cancer du Rhone, et de Saone et Loire, by the Region Rhones Alpes (Contract 00 81 60 45), and by the Canceropole Lyon Auvergne Rhone-Alpes.	ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bodnar AG, 1996, EXP CELL RES, V228, P58, DOI 10.1006/excr.1996.0299; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Buchkovich KJ, 1996, MOL BIOL CELL, V7, P1443, DOI 10.1091/mbc.7.9.1443; Chebel A, 2007, LEUKEMIA RES, V31, P1649, DOI 10.1016/j.leukres.2007.03.021; Cong YS, 2000, J BIOL CHEM, V275, P35665, DOI 10.1074/jbc.C000637200; COUNTER CM, 1995, BLOOD, V85, P2315, DOI 10.1182/blood.V85.9.2315.bloodjournal8592315; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Dong JJ, 2005, CANCER RES, V65, P1961, DOI 10.1158/0008-5472.CAN-04-2501; FRANTZ B, 1994, EMBO J, V13, P861, DOI 10.1002/j.1460-2075.1994.tb06329.x; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Fujimoto K, 2000, NUCLEIC ACIDS RES, V28, P2557, DOI 10.1093/nar/28.13.2557; Fujimoto R, 2003, ORAL ONCOL, V39, P445, DOI 10.1016/S1368-8375(03)00003-4; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Guilleret I, 2004, BIOCHEM BIOPH RES CO, V325, P1037, DOI 10.1016/j.bbrc.2004.10.137; Guilleret I, 2003, EXP CELL RES, V289, P326, DOI 10.1016/S0014-4827(03)00281-7; Gunes C, 2000, CANCER RES, V60, P2116; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; Horikawa I, 1999, CANCER RES, V59, P826; Hsiao RS, 1997, ANTICANCER RES, V17, P827; Kanaya T, 2000, CLIN CANCER RES, V6, P1239; Kang SS, 1999, J BIOL CHEM, V274, P13085, DOI 10.1074/jbc.274.19.13085; Kawauchi K, 2005, J IMMUNOL, V174, P5261, DOI 10.4049/jimmunol.174.9.5261; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kyo S, 2000, NUCLEIC ACIDS RES, V28, P669, DOI 10.1093/nar/28.3.669; Kyo S, 1999, CANCER RES, V59, P5917; Liu KB, 1999, P NATL ACAD SCI USA, V96, P5147, DOI 10.1073/pnas.96.9.5147; Liu KB, 2001, J IMMUNOL, V166, P4826, DOI 10.4049/jimmunol.166.8.4826; Loh C, 1996, J BIOL CHEM, V271, P10884, DOI 10.1074/jbc.271.18.10884; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; MCKEON F, 1991, CELL, V66, P823, DOI 10.1016/0092-8674(91)90426-Y; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Monticelli S, 2002, EUR J IMMUNOL, V32, P2971, DOI 10.1002/1521-4141(2002010)32:10<2971::AID-IMMU2971>3.0.CO;2-G; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Oh S, 1999, J BIOL CHEM, V274, P37473, DOI 10.1074/jbc.274.52.37473; Poncet D, 2008, BLOOD, V111, P2388, DOI 10.1182/blood-2007-09-111245; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; Santini MP, 2001, P NATL ACAD SCI USA, V98, P9575, DOI 10.1073/pnas.161299698; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SHAW KTY, 1995, P NATL ACAD SCI USA, V92, P11205, DOI 10.1073/pnas.92.24.11205; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Sheridan CM, 2002, J BIOL CHEM, V277, P48664, DOI 10.1074/jbc.M207029200; Stewart SA, 2002, P NATL ACAD SCI USA, V99, P12606, DOI 10.1073/pnas.182407599; Takakura M, 1999, CANCER RES, V59, P551; Takakura M, 2001, NUCLEIC ACIDS RES, V29, P3006, DOI 10.1093/nar/29.14.3006; Trama J, 2002, J IMMUNOL, V169, P5477, DOI 10.4049/jimmunol.169.10.5477; Ulaner GA, 1998, CANCER RES, V58, P4168; Urbanowicz-Kachnowicz I, 1999, INT J CANCER, V82, P98, DOI 10.1002/(SICI)1097-0215(19990702)82:1<98::AID-IJC17>3.0.CO;2-A; WELSHONS WV, 1988, MOL CELL ENDOCRINOL, V57, P169, DOI 10.1016/0303-7207(88)90072-X; Won JJ, 2002, FASEB J, V16, P1943, DOI 10.1096/fj.02-0311fje; Xiao S, 1999, EUR J IMMUNOL, V29, P3456, DOI 10.1002/(SICI)1521-4141(199911)29:11<3456::AID-IMMU3456>3.3.CO;2-2; Xiao XD, 2003, EXP MOL PATHOL, V75, P238, DOI 10.1016/S0014-4800(03)00092-3; Yasumoto S, 1996, ONCOGENE, V13, P433; Zhou CX, 2003, MOL CANCER THER, V2, P789	63	35	36	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35725	35734		10.1074/jbc.M109.009183	http://dx.doi.org/10.1074/jbc.M109.009183			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19843528	hybrid, Green Published			2022-12-25	WOS:000272645600050
J	Reed, CA; Mayhew, CN; McClendon, AK; Yang, X; Witkiewicz, A; Knudsen, ES				Reed, C. A.; Mayhew, C. N.; McClendon, A. K.; Yang, X.; Witkiewicz, A.; Knudsen, E. S.			RB has a critical role in mediating the in vivo checkpoint response, mitigating secondary DNA damage and suppressing liver tumorigenesis initiated by aflatoxin B1	ONCOGENE			English	Article						retinoblastoma tumor suppressor; aflatoxin B1; carbon tetrachloride; DNA damage; cell cycle; hepatocellular carcinoma	RETINOBLASTOMA TUMOR-SUPPRESSOR; CELL-CYCLE CONTROL; HEPATITIS-C; HEPATOCELLULAR CARCINOMAS; PROLIFERATION; GENES; PATHOGENESIS; PROTEINS; CANCER; 13Q	Hepatocellular carcinoma (HCC) is a significant worldwide health concern that is associated with discrete etiological events, encompassing viral infection, metabolic stress and genotoxic compounds. In particular, exposure to the genotoxic hepatocarcinogen aflatoxin B1 (AFB1) is a significant factor in the genesis of human liver cancer. Presumably, genetic events associated with HCC could influence the effect of environmental insults, yielding a predilection for tumor development. The retinoblastoma (RB) tumor suppressor pathway is functionally inactivated in HCC through discrete mechanisms; however, the role of RB in suppressing tumorigenesis in this disease is poorly understood. Therefore, we analysed how RB status affects the response to AFB1 in reference to acute exposures and tumor development reflective of chronic exposure. Liver-specific Rb deletion resulted in an aberrant proliferative response to AFB1. This cell-cycle induction was associated with increased levels of secondary genetic damage and failure in appropriate cell-cycle coupling. This effect of RB loss was unique to AFB1 and involved the induction of a non-canonical proliferative pathway, and was not merely reflective of the overall cell-cycle deregulation or aberrant regenerative responses. The acute responses to AFB1 exposure presaged aberrations in hepatocyte nuclear morphology and ploidy with RB loss. Correspondingly, RB-deficient livers showed significantly enhanced susceptibility to liver tumorigenesis initiated by AFB1. Combined, these studies show that RB has a critical role in mediating checkpoint responses in liver tissue to maintain genome integrity and in suppressing tumorigenesis. Oncogene (2009) 28, 4434-4443; doi:10.1038/onc.2009.303; published online 19 October 2009	[Knudsen, E. S.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Mayhew, C. N.] Cincinnati Childrens Hosp, Res Fdn, Div Dev Biol, Cincinnati, OH USA; [Witkiewicz, A.] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Jefferson University	Knudsen, ES (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, 233 S 10th St, Philadelphia, PA 19107 USA.	eknudsen@kimmelcancercenter.org	Mayhew, Christopher N/AGB-4929-2022		NCI NIH HHS [R01 CA127387-05, R01 CA127387] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA127387] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Azechi H, 2001, ONCOLOGY-BASEL, V60, P346, DOI 10.1159/000058531; Bioulac-Sage P, 2003, HEPATOLOGY, V37, P480, DOI 10.1053/jhep.2003.50058; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; DeGregori J, 2006, CURR MOL MED, V6, P739; Donehower LA, 1997, CANCER SURV, V29, P329; Edamoto Y, 2003, INT J CANCER, V106, P334, DOI 10.1002/ijc.11254; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; FUJIMOTO Y, 1994, CANCER RES, V54, P281; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Knudsen ES, 2008, NAT REV CANCER, V8, P714, DOI 10.1038/nrc2401; Knudsen ES, 2006, CURR MOL MED, V6, P749; Knudsen ES, 2006, EXP BIOL MED, V231, P1271; Knudsen KE, 2000, MOL CELL BIOL, V20, P7751, DOI 10.1128/MCB.20.20.7751-7763.2000; Laurent-Puig P, 2006, ONCOGENE, V25, P3778, DOI 10.1038/sj.onc.1209547; LAZAREVA MN, 1981, ONCODEV BIOL MED, V2, P89; Markey MP, 2007, ONCOGENE, V26, P6307, DOI 10.1038/sj.onc.1210450; Mayhew CN, 2007, GASTROENTEROLOGY, V133, P976, DOI 10.1053/j.gastro.2007.06.025; Mayhew CN, 2005, CANCER RES, V65, P4568, DOI 10.1158/0008-5472.CAN-04-4221; McGivern DR, 2009, ANNU REV PATHOL-MECH, V4, P399, DOI 10.1146/annurev.pathol.4.110807.092202; Munakata T, 2005, P NATL ACAD SCI USA, V102, P18159, DOI 10.1073/pnas.0505605102; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Skawran B, 2008, MODERN PATHOL, V21, P1479, DOI 10.1038/modpathol.2008.147; Stevens C, 2003, CELL CYCLE, V2, P435, DOI 10.4161/cc.2.5.462; Thorgeirsson SS, 2002, NAT GENET, V31, P339, DOI 10.1038/ng0802-339; Wikenheiser-Brokamp KA, 2006, CELL MOL LIFE SCI, V63, P767, DOI 10.1007/s00018-005-5487-3; Yang XP, 2003, CANCER RES, V63, P7753; Yu MC, 2004, GASTROENTEROLOGY, V127, pS72, DOI 10.1016/j.gastro.2004.09.018; ZHANG X, 1994, CANCER RES, V54, P4177; ZHANG YJ, 1993, BIOCHEM BIOPH RES CO, V196, P1010, DOI 10.1006/bbrc.1993.2350	30	20	23	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 17	2009	28	50					4434	4443		10.1038/onc.2009.303	http://dx.doi.org/10.1038/onc.2009.303			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DU	19838213	Green Accepted			2022-12-25	WOS:000272876500003
J	Glauser, G; Dubugnon, L; Mousavi, SAR; Rudaz, S; Wolfender, JL; Farmer, EE				Glauser, Gaetan; Dubugnon, Lucie; Mousavi, Seyed A. R.; Rudaz, Serge; Wolfender, Jean-Luc; Farmer, Edward E.			Velocity Estimates for Signal Propagation Leading to Systemic Jasmonic Acid Accumulation in Wounded Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTAINING GALACTOLIPIDS; GENE-EXPRESSION; LIPOXYGENASE; IDENTIFICATION; BIOSYNTHESIS; TRANSDUCTION; RESOLUTION; MOVEMENT; EXTRACTS; MUTATION	The wound response prohormone jasmonic acid (JA) accumulates rapidly in tissues both proximal and distal to injury sites in plants. Using quantitative liquid chromatography-mass spectrometry after flash freezing of tissues, we found that JA accumulated within 30 s of injury in wounded Arabidopsis leaves (p = 3.5 e(-7)). JA augmentation distal to wounds was strongest in unwounded leaves with direct vascular connections to wounded leaves wherein JA levels increased significantly within 120 s of wounding (p = 0.00027). This gave conservative and statistically robust temporal boundaries for the average velocity of the long distance signal leading to distal JA accumulation in unwounded leaves of 3.4-4.5 cm min(-1). Like JA, transcripts of the JA synthesis gene LIPOXYGENASE2 (LOX2) and the jasmonate response gene JAZ10.3 also accumulated to higher levels in directly interconnected leaves than in indirectly connected leaves. JA accumulation in a lox2-1 mutant plant was initiated rapidly after wounding then slowed progressively compared with the wild type (WT). Despite this, JAZ10.3 expression in the two genotypes was similar. Free cyclopentenone jasmonate levels were similar in both resting WT and lox2-1. In contrast, bound cyclopentenone jasmonates (arabidopsides) were far lower in lox2-1 than in the WT. The major roles of LOX2 are to generate arabidopsides and the large levels of JA that accumulate proximal to the wound. LOX2is not essential for some of the most rapid events elicited by wounding.	[Dubugnon, Lucie; Mousavi, Seyed A. R.; Farmer, Edward E.] Univ Lausanne, CH-1015 Lausanne, Switzerland; [Glauser, Gaetan; Rudaz, Serge; Wolfender, Jean-Luc] Univ Lausanne, Sch Pharmaceut Sci, Univ Geneva, CH-1211 Geneva 4, Switzerland	University of Lausanne; University of Geneva; University of Lausanne	Farmer, EE (corresponding author), Univ Lausanne, CH-1015 Lausanne, Switzerland.	edward.farmer@unil.ch	Farmer, Edward E/H-1635-2011; Rudaz, Serge/AAB-2861-2021; Mousavi, Seyed/H-9532-2012; Jean-Luc, Wolfender JLW/O-2163-2018; Glauser, Gaetan/K-7574-2017; Jean-Luc, Wolfender JLW/EWV-1043-2022	Rudaz, Serge/0000-0002-4180-5417; Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Glauser, Gaetan/0000-0002-0983-8614; Jean-Luc, Wolfender JLW/0000-0002-0125-952X; Mousavi, Seyed Ali Reza/0000-0002-2948-1771	Swiss National Science Foundation [205320-124667/1, 3100A0-122441]; SystemsX.ch	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch	This work was supported in part by Swiss National Science Foundation Grants 205320-124667/1 ( to J.-L.W., S. R., and E. E. F.), 3100A0-122441 ( to E. E. F.) and SystemsX.ch ( to E. E. F.).	Andreu V, 2007, PLANT PHYSIOL, V145, P1336, DOI 10.1104/pp.107.109637; Bannenberg G, 2009, LIPIDS, V44, P85, DOI 10.1007/s11745-008-3245-7; BELL E, 1995, P NATL ACAD SCI USA, V92, P8675, DOI 10.1073/pnas.92.19.8675; Beyhl D, 2009, PLANT J, V58, P715, DOI 10.1111/j.1365-313X.2009.03820.x; Bottcher C, 2007, PLANTA, V226, P629, DOI 10.1007/s00425-007-0511-5; Bonaventure G, 2007, PLANT J, V49, P889, DOI 10.1111/j.1365-313X.2006.03002.x; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Buseman CM, 2006, PLANT PHYSIOL, V142, P28, DOI 10.1104/pp.106.082115; Chico JM, 2008, CURR OPIN PLANT BIOL, V11, P486, DOI 10.1016/j.pbi.2008.06.003; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; DAVIS JM, 1991, P NATL ACAD SCI USA, V88, P2393, DOI 10.1073/pnas.88.6.2393; Dengler NG, 2006, CAN J BOT, V84, P1660, DOI 10.1139/B06-126; Farmer EE, 2007, NATURE, V448, P659, DOI 10.1038/448659a; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Fisahn J, 2004, PLANT CELL PHYSIOL, V45, P456, DOI 10.1093/pcp/pch054; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Glauser G, 2008, RAPID COMMUN MASS SP, V22, P3154, DOI 10.1002/rcm.3716; Glauser G, 2008, J BIOL CHEM, V283, P16400, DOI 10.1074/jbc.M801760200; Glauser G, 2008, J CHROMATOGR A, V1180, P90, DOI 10.1016/j.chroma.2007.12.021; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Howe G.A., 2008, INDUCED PLANT RESIST, P349; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Howe Gregg A., 2008, P7, DOI 10.1007/978-1-4020-8182-8_1; Koo AJK, 2009, PLANT J, V59, P974, DOI 10.1111/j.1365-313X.2009.03924.x; KOO AJ, 2009, PHYTOCHEMIS IN PRESS; Kourtchenko O, 2007, PLANT PHYSIOL, V145, P1658, DOI 10.1104/pp.107.104752; Maffei ME, 2007, TRENDS PLANT SCI, V12, P310, DOI 10.1016/j.tplants.2007.06.001; Mene-Saffrane L, 2007, J BIOL CHEM, V282, P35749, DOI 10.1074/jbc.M706838200; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Mueller MJ, 2006, PLANT J, V45, P472, DOI 10.1111/j.1365-313X.2005.02614.x; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Reymond P, 2004, PLANT CELL, V16, P3132, DOI 10.1105/tpc.104.026120; Roberts K, 2007, NEW PHYTOL, V175, P707, DOI 10.1111/j.1469-8137.2007.02136.x; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Schommer C, 2008, PLOS BIOL, V6, P1991, DOI 10.1371/journal.pbio.0060230; Staswick PE, 2009, PLANT PHYSIOL, V150, P1310, DOI 10.1104/pp.109.138529; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stork W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004697; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708	41	170	181	4	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34506	34513		10.1074/jbc.M109.061432	http://dx.doi.org/10.1074/jbc.M109.061432			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19846562	Green Published, hybrid			2022-12-25	WOS:000272439600004
J	Oesterholm, C; Barczyk, MM; Busse, M; Gronning, M; Reed, RK; Kusche-Gullberg, M				Oesterholm, Cecilia; Barczyk, Malgorzata M.; Busse, Marta; Gronning, Mona; Reed, Rolf K.; Kusche-Gullberg, Marion			Mutation in the Heparan Sulfate Biosynthesis Enzyme EXT1 Influences Growth Factor Signaling and Fibroblast Interactions with the Extracellular Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC FIBROBLASTS; TUMOR SUPPRESSORS; MOUSE DEVELOPMENT; LIGAND-BINDING; IN-VIVO; COLLAGEN; ADHESION; COMPLEX; DIFFERENTIATION; PROTEOGLYCANS	Heparan sulfate (HS) chains bind and modulate the signaling efficiency of many ligands, including members of the fibroblast growth factor (FGF) and platelet-derived growth factor families. We previously reported the structure of HS synthesized by embryonic fibroblasts from mice with a gene trap mutation of Ext1 that encodes a glycosyltransferase involved in HS chain elongation. The gene trap mutation results in low expression of Ext1, and, as a consequence, HS chain length is substantially reduced. In the present study, Ext1 mutant and wild-type mouse embryonic fibroblasts were analyzed for the functional consequences of the Ext1 mutation for growth factor signaling and interaction with the extracellular matrix. Here, we show that the phosphorylation of ERK1/2 in response to FGF2 stimulation was markedly decreased in the Ext1 mutant fibroblasts, whereas neither PDGF-BB nor FGF10 signaling was significantly affected. Furthermore, Ext1 mutants displayed reduced ability to attach to collagen I and to contract collagen lattices, even though no differences in the expression of collagen-binding integrins were observed. Reintroduction of Ext1in the Ext1 mutant fibroblasts rescued HS chain length, FGF2 signaling, and the ability of the fibroblasts to contract collagen. These data suggest that the length of the HS chains is a critical determinant of HS-protein interactions and emphasize the essential role of EXT1 in providing specific binding sites for growth factors and extracellular matrix proteins.	[Oesterholm, Cecilia; Barczyk, Malgorzata M.; Gronning, Mona; Reed, Rolf K.; Kusche-Gullberg, Marion] Univ Bergen, Dept Biomed, NO-5009 Bergen, Norway; [Busse, Marta] Lincolns Inn Fields Labs, Canc Res UK, Vasc Biol Lab, London WC2A 3PX, England	University of Bergen; Cancer Research UK	Kusche-Gullberg, M (corresponding author), Univ Bergen, Dept Biomed, Jonas Lies Vei 91, NO-5009 Bergen, Norway.	Marion.Kusche@biomed.uib.no	Reed, Rolf K./B-9422-2017; Corbascio, Cecilia Österholm/ABF-2213-2020; Kusche-Gullberg, Marion/P-4466-2016	Reed, Rolf K./0000-0002-2633-6595; Corbascio, Cecilia Österholm/0000-0001-7506-084X; Kusche-Gullberg, Marion/0000-0002-5636-1695	University of Bergen; Research Council of Norway; Norwegian Cancer Society [PK01-20080052]; Meltzer Foundation	University of Bergen; Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Meltzer Foundation	This work was supported by grants from the University of Bergen, the Research Council of Norway, the Norwegian Cancer Society (PK01-20080052), and the Meltzer Foundation.	Abe M, 2007, J CELL BIOCHEM, V102, P1290, DOI 10.1002/jcb.21359; Allen BL, 2003, J CELL BIOL, V163, P637, DOI 10.1083/jcb.200307053; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Busse M, 2003, J BIOL CHEM, V278, P41333, DOI 10.1074/jbc.M308314200; Busse M, 2007, J BIOL CHEM, V282, P32802, DOI 10.1074/jbc.M703560200; Chen YL, 2008, ARTHRITIS RHEUM-US, V58, P577, DOI 10.1002/art.23146; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Gotte M, 2008, HUM MOL GENET, V17, P996, DOI 10.1093/hmg/ddm372; GOODGER SJ, 2008, J BIOL CHEM; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T; Hecht JT, 2005, DIFFERENTIATION, V73, P212, DOI 10.1111/j.1432-0436.2005.00025.x; Hecht JT, 2002, BONE, V31, P199, DOI 10.1016/S8756-3282(02)00796-2; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; KATO M, 1994, J BIOL CHEM, V269, P18881; KODA JE, 1984, J BIOL CHEM, V259, P1763; Koziel L, 2004, DEV CELL, V6, P801, DOI 10.1016/j.devcel.2004.05.009; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; MACCARANA M, 1993, J BIOL CHEM, V268, P23898; Mahalingam Y, 2007, J BIOL CHEM, V282, P3221, DOI 10.1074/jbc.M604938200; McCormick C, 2000, P NATL ACAD SCI USA, V97, P668, DOI 10.1073/pnas.97.2.668; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Patel VN, 2008, J BIOL CHEM, V283, P9308, DOI 10.1074/jbc.M709995200; Popova SN, 2004, DEV BIOL, V270, P427, DOI 10.1016/j.ydbio.2004.03.006; Popova SN, 2007, MOL CELL BIOL, V27, P4306, DOI 10.1128/MCB.00041-07; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; SANANTONIO JD, 1994, J CELL BIOL, V125, P1179, DOI 10.1083/jcb.125.5.1179; Senay C, 2000, EMBO REP, V1, P282, DOI 10.1093/embo-reports/kvd045; SOLOMON L, 1964, AM J HUM GENET, V16, P351; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928; Sweeney SM, 1998, P NATL ACAD SCI USA, V95, P7275, DOI 10.1073/pnas.95.13.7275; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; van Horssen J, 2003, LANCET NEUROL, V2, P482, DOI 10.1016/S1474-4422(03)00484-8; Vuoriluoto K, 2008, EXP CELL RES, V314, P3369, DOI 10.1016/j.yexcr.2008.07.005; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Yamada S, 2004, J BIOL CHEM, V279, P32134, DOI 10.1074/jbc.M312624200; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Zhang WQ, 2006, J BIOL CHEM, V281, P37302, DOI 10.1074/jbc.M604905200	49	28	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34935	34943		10.1074/jbc.M109.005264	http://dx.doi.org/10.1074/jbc.M109.005264			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19850926	Green Published, hybrid			2022-12-25	WOS:000272439600049
J	Grover, D; Ford, D; Brown, C; Hoe, N; Erdem, A; Tavare, S; Tower, J				Grover, Dhruv; Ford, Daniel; Brown, Christopher; Hoe, Nicholas; Erdem, Aysen; Tavare, Simon; Tower, John			Hydrogen Peroxide Stimulates Activity and Alters Behavior in Drosophila melanogaster	PLOS ONE			English	Article							GENE-EXPRESSION; LIFE-SPAN; SUPEROXIDE-DISMUTASE; CIRCADIAN REGULATION; OXIDATIVE STRESS; METABOLISM; FLY; MITOCHONDRIA; RESISTANCE; TRANSGENES	Circadian rhythms in animals are regulated at the level of individual cells and by systemic signaling to coordinate the activities of multiple tissues. The circadian pacemakers have several physiological outputs, including daily locomotor rhythms. Several redox-active compounds have been found to function in regulation of circadian rhythms in cells, however, how particular compounds might be involved in regulating specific animal behaviors remains largely unknown. Here the effects of hydrogen peroxide on Drosophila movement were analyzed using a recently developed three-dimensional real-time multiple fly tracking assay. Both hydrogen peroxide feeding and direct injection of hydrogen peroxide caused increased adult fly locomotor activity. Continuous treatment with hydrogen peroxide also suppressed daily locomotor rhythms. Conditional over-expression of the hydrogen peroxide-producing enzyme superoxide dismutase ( SOD) also increased fly activity and altered the patterns of locomotor activity across days and weeks. The real-time fly tracking system allowed for detailed analysis of the effects of these manipulations on behavior. For example, both hydrogen peroxide feeding and SOD over-expression increased all fly motion parameters, however, hydrogen peroxide feeding caused relatively more erratic movement, whereas SOD over-expression produced relatively faster-moving flies. Taken together, the data demonstrate that hydrogen peroxide has dramatic effects on fly movement and daily locomotor rhythms, and implicate hydrogen peroxide in the normal control of these processes.			Grover, D (corresponding author), Howard Hughes Med Inst, Ashburn, VA USA.	jtower@usc.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011833] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG002790] Funding Source: Medline; NIA NIH HHS [AG011833, R01 AG011833] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allegra M, 2003, J PINEAL RES, V34, P1, DOI 10.1034/j.1600-079X.2003.02112.x; Allikian MJ, 2002, GENOME BIOL, V3; [Anonymous], 2007, TSERIES TIME SERIES; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Besson M, 2005, J NEUROBIOL, V62, P386, DOI 10.1002/neu.20111; Bieschke ET, 1998, MOL GEN GENET, V258, P571, DOI 10.1007/s004380050770; Bjornberg O, 2006, ANTIOXID REDOX SIGN, V8, P354, DOI 10.1089/ars.2006.8.354; Boothroyd CE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030054; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Brockwell P, 1993, TIME SERIES THEORY M; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Cleveland RB., 1990, J OFF STAT, V6, P3; Curtis C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r262; Davis RA, 2006, J AM STAT ASSOC, V101, P223, DOI 10.1198/016214505000000745; DEGOOIJER JG, 1985, INT STAT REV, V53, P301, DOI 10.2307/1402894; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Driver C, 2004, BIOGERONTOLOGY, V5, P185, DOI 10.1023/B:BGEN.0000031156.75376.e3; Feldman A, 2004, ADAPT BEHAV, V12, P241, DOI 10.1177/105971230401200309; Ford D, 2007, EXP GERONTOL, V42, P483, DOI 10.1016/j.exger.2007.01.004; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fridovich I, 2004, AGING CELL, V3, P13, DOI 10.1046/j.1474-9728.2003.00075.x; Gems D, 2005, MECH AGEING DEV, V126, P381, DOI 10.1016/j.mad.2004.09.001; Goncharova ND, 2006, EXP GERONTOL, V41, P778, DOI 10.1016/j.exger.2006.04.006; Green CB, 2006, CELL METAB, V4, P3, DOI 10.1016/j.cmet.2006.06.002; Grover D, 2008, J R SOC INTERFACE, V5, P1181, DOI 10.1098/rsif.2007.1333; Grover Dhruv, 2009, BMC Res Notes, V2, P58, DOI 10.1186/1756-0500-2-58; Grover D, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-93; Grzelak A, 2004, FREE RADICAL RES, V38, P1155, DOI 10.1080/10715760412331272486; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Howlader G, 2006, J INSECT PHYSIOL, V52, P779, DOI 10.1016/j.jinsphys.2006.05.001; Kadener S, 2006, P NATL ACAD SCI USA, V103, P13537, DOI 10.1073/pnas.0605962103; Kaneuchi T, 2003, BIOGERONTOLOGY, V4, P157, DOI 10.1023/A:1024145822785; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Kondratov RV, 2007, AGEING RES REV, V6, P12, DOI 10.1016/j.arr.2007.02.003; Krishnan N, 2008, BIOCHEM BIOPH RES CO, V374, P299, DOI 10.1016/j.bbrc.2008.07.011; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; Lee CC, 2006, CANCER CAUSE CONTROL, V17, P525, DOI 10.1007/s10552-005-9003-8; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; MARGOLIASH E, 1958, BIOCHEM J, V68, P468, DOI 10.1042/bj0680468; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nishinokubi Izumi, 2006, J Circadian Rhythms, V4, P4, DOI 10.1186/1740-3391-4-4; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; R Development Core Team, 2006, R LANG ENV STAT COMP; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Sun JT, 2002, GENETICS, V161, P661; SZEBENYI AL, 1969, ANIM BEHAV, V17, P641, DOI 10.1016/S0003-3472(69)80006-0; Tammero LF, 2002, J EXP BIOL, V205, P327; Tan Dun-Xian, 2002, Current Topics in Medicinal Chemistry, V2, P181, DOI 10.2174/1568026023394443; Thomson SL, 2002, HEREDITY, V88, P52, DOI 10.1038/sj.hdy.6800008; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Williams AE, 2004, PHYSIOL BIOCHEM ZOOL, V77, P10, DOI 10.1086/381467; Yang JS, 2009, J GERONTOL A-BIOL, V64, P828, DOI 10.1093/gerona/glp054	67	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7580	10.1371/journal.pone.0007580	http://dx.doi.org/10.1371/journal.pone.0007580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862323	Green Published, gold, Green Submitted			2022-12-25	WOS:000271194600006
J	Tan, M; Jones, G; Zhu, GJ; Ye, JP; Hong, TY; Zhou, SY; Zhang, SY; Zhang, LB				Tan, Min; Jones, Gareth; Zhu, Guangjian; Ye, Jianping; Hong, Tiyu; Zhou, Shanyi; Zhang, Shuyi; Zhang, Libiao			Fellatio by Fruit Bats Prolongs Copulation Time	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; CYNOPTERUS-SPHINX; MATING-BEHAVIOR; CHIROPTERA; SYSTEM	Oral sex is widely used in human foreplay, but rarely documented in other animals. Fellatio has been recorded in bonobos Pan paniscus, but even then functions largely as play behaviour among juvenile males. The short-nosed fruit bat Cynopterus sphinx exhibits resource defence polygyny and one sexually active male often roosts with groups of females in tents made from leaves. Female bats often lick their mate's penis during dorsoventral copulation. The female lowers her head to lick the shaft or the base of the male's penis but does not lick the glans penis which has already penetrated the vagina. Males never withdrew their penis when it was licked by the mating partner. A positive relationship exists between the length of time that the female licked the male's penis during copulation and the duration of copulation. Furthermore, mating pairs spent significantly more time in copulation if the female licked her mate's penis than if fellatio was absent. Males also show postcopulatory genital grooming after intromission. At present, we do not know why genital licking occurs, and we present four non-mutually exclusive hypotheses that may explain the function of fellatio in C. sphinx.			Tan, M (corresponding author), Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China.	zhanglb@gdei.gd.cn	Zhang, Shuyi/B-5117-2011	Jones, Gareth/0000-0002-1904-3735	CSRD VA [I01 CX002007] Funding Source: Medline	CSRD VA		Bagemihl B., 1999, BIOL EXUBERANCE ANIM; BALASINGH J, 1995, ETHOLOGY, V100, P210; Baron S, 2000, ANTIVIR RES, V48, P71, DOI 10.1016/S0166-3542(00)00126-1; Bates PJJ, 1997, BATS INDIAN SUBCONTI; BRADBURY JW, 1977, Z TIERPSYCHOL, V45, P225; CANFIELD PJ, 1991, AUST VET J, V68, P167, DOI 10.1111/j.1751-0813.1991.tb03171.x; CHAN CSM, 2006, HK BIODIVERS, V11, P8; Corlett Richard T., 2005, Urban Ecosystems, V8, P275, DOI 10.1007/s11252-005-3260-x; DEWAAL FBM, 1995, SCI AM, V272, P82, DOI 10.1038/scientificamerican0395-82; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; French B, 1998, SOUTHWEST NAT, V43, P484; Gopukumar N, 2005, J MAMMAL, V86, P281, DOI 10.1644/BFW-031.1; GOPUKUMAR N, 2002, J SCI ED, V6, P63; HART BL, 1987, PHYSIOL BEHAV, V41, P321, DOI 10.1016/0031-9384(87)90395-7; Jia Zhiyun, 2000, Acta Theriologica Sinica, V20, P108; Karuppudurai T, 2008, MAMM BIOL, V73, P138, DOI 10.1016/j.mambio.2007.02.006; Keeley ATH, 2004, J MAMMAL, V85, P113, DOI 10.1644/BME-004; Koilraj BJ, 2001, CURR SCI INDIA, V80, P15; KOYAMA N, 1988, PRIMATES, V29, P163, DOI 10.1007/BF02381120; Lockhart AB, 1996, BIOL REV, V71, P415, DOI 10.1111/j.1469-185X.1996.tb01281.x; MANDEL ID, 1993, CRIT REV ORAL BIOL M, V4, P599, DOI 10.1177/10454411930040034701; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Mayer F, 2007, HEREDITY, V99, P257, DOI 10.1038/sj.hdy.6800989; McCracken Gary F., 2000, P321, DOI 10.1016/B978-012195670-7/50009-6; Morga Francisco J., 2001, Veterinaria Mexico, V32, P301; Nathan PT, 2005, CURR SCI INDIA, V88, P1679; Neuweiler G., 2000, BIOL BATS; NIE YG, 2006, J CHINA W NOR U, V27, P86; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; REEDER DM, 2003, SEXUAL SELECTION REP, P255; Schurmann C, 1982, ORANGUTAN ITS BIOL C, P269; Simmons NB, 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Smith Stephanie J., 2006, Mammalian Species, P1; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Thrall PH, 2000, P ROY SOC B-BIOL SCI, V267, P1555, DOI 10.1098/rspb.2000.1178; WANG S, 2004, CHINA SPECIES RES LI, V1; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P123; Zhang Wei, 2008, Shengtaixue Zazhi, V27, P286	39	18	20	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7595	10.1371/journal.pone.0007595	http://dx.doi.org/10.1371/journal.pone.0007595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862320	Green Submitted, Green Published, gold			2022-12-25	WOS:000271194600007
J	Arciuch, VGA; Galli, S; Franco, MC; Lam, PY; Cadenas, E; Carreras, MC; Poderoso, JJ				Antico Arciuch, Valeria Gabriela; Galli, Soledad; Franco, Maria Clara; Lam, Philip Y.; Cadenas, Enrique; Cecilia Carreras, Maria; Jose Poderoso, Juan			Akt1 Intramitochondrial Cycling Is a Crucial Step in the Redox Modulation of Cell Cycle Progression	PLOS ONE			English	Article							MITOCHONDRIAL NITRIC-OXIDE; KINASE; ACTIVATION; PHOSPHORYLATION; PHENOTYPE; APOPTOSIS; OXIDATION; ONCOGENE; PROTEINS; AKT/PKB	Akt is a serine/threonine kinase involved in cell proliferation, apoptosis, and glucose metabolism. Akt is differentially activated by growth factors and oxidative stress by sequential phosphorylation of Ser(473) by mTORC2 and Thr(308) by PDK1. On these bases, we investigated the mechanistic connection of H2O2 yield, mitochondrial activation of Akt1 and cell cycle progression in NIH/3T3 cell line with confocal microscopy, in vivo imaging, and directed mutagenesis. We demonstrate that modulation by H2O2 entails the entrance of cytosolic P-Akt1 Ser(473) to mitochondria, where it is further phosphorylated at Thr(308) by constitutive PDK1. Phosphorylation of Thr(308) in mitochondria determines Akt1 passage to nuclei and triggers genomic post-translational mechanisms for cell proliferation. At high H2O2, Akt1-PDK1 association is disrupted and P-Akt1 Ser(473) accumulates in mitochondria in detriment to nuclear translocation; accordingly, Akt1 T308A is retained in mitochondria. Low Akt1 activity increases cytochrome c release to cytosol leading to apoptosis. As assessed by mass spectra, differential H2O2 effects on Akt1-PDK interaction depend on the selective oxidation of Cys(310) to sulfenic or cysteic acids. These results indicate that Akt1 intramitochondrial-cycling is central for redox modulation of cell fate.			Arciuch, VGA (corresponding author), Univ Buenos Aires, Univ Hosp, Lab Oxygen Metab, Buenos Aires, DF, Argentina.	vantico@hospitaldeclinicas.uba.ar; jpoderos@fmed.uba.ar	Franco, Maria/O-7862-2015		NIA NIH HHS [AG016718, R01 AG016718] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Aran M, 2008, FEBS J, V275, P1450, DOI 10.1111/j.1742-4658.2008.06299.x; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; BELLACOSA A, 1993, ONCOGENE, V8, P745; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Carreras Maria C., 2004, Molecular Aspects of Medicine, V25, P125, DOI 10.1016/j.mam.2004.02.014; Carreras MC, 2007, AM J PHYSIOL-CELL PH, V292, pC1569, DOI 10.1152/ajpcell.00248.2006; Cefaratti C, 2000, J BIOL CHEM, V275, P3772, DOI 10.1074/jbc.275.6.3772; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Connor KM, 2005, J BIOL CHEM, V280, P16916, DOI 10.1074/jbc.M410690200; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Finocchietto P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001749; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Galli S, 2003, CANCER RES, V63, P6370; Galli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002379; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Liu XS, 2004, ANTICANCER RES, V24, P2697; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Ohori K, 2008, AM J PHYSIOL-HEART C, V295, pH2079, DOI 10.1152/ajpheart.00092.2008; ROBEY RB, 2005, SEMINARS CANC BIOL, V19, P25; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Toral-Barza L, 2007, MOL CANCER THER, V6, P3028, DOI 10.1158/1535-7163.MCT-07-0211; Wang Y, 2008, J CELL PHYSIOL, V215, P676, DOI 10.1002/jcp.21350	39	59	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7523	10.1371/journal.pone.0007523	http://dx.doi.org/10.1371/journal.pone.0007523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844585	Green Published, gold, Green Submitted			2022-12-25	WOS:000271013000009
J	Doeschl-Wilson, AB; Brindle, W; Emmans, G; Kyriazakis, I				Doeschl-Wilson, Andrea B.; Brindle, Will; Emmans, Gerry; Kyriazakis, Ilias			Unravelling the Relationship between Animal Growth and Immune Response during Micro-Parasitic Infections	PLOS ONE			English	Article							DISEASE RESISTANCE; HOST NUTRITION; TRADE-OFFS; GASTROINTESTINAL PARASITISM; GROWING PIG; FEED-INTAKE; SELECTION; MODEL; CONSEQUENCES; ENERGY	Background: Both host genetic potentials for growth and disease resistance, as well as nutrition are known to affect responses of individuals challenged with micro-parasites, but their interactive effects are difficult to predict from experimental studies alone. Methodology/Principal Findings: Here, a mathematical model is proposed to explore the hypothesis that a host's response to pathogen challenge largely depends on the interaction between a host's genetic capacities for growth or disease resistance and the nutritional environment. As might be expected, the model predicts that if nutritional availability is high, hosts with higher growth capacities will also grow faster under micro-parasitic challenge, and more resistant animals will exhibit a more effective immune response. Growth capacity has little effect on immune response and resistance capacity has little effect on achieved growth. However, the influence of host genetics on phenotypic performance changes drastically if nutrient availability is scarce. In this case achieved growth and immune response depend simultaneously on both capacities for growth and disease resistance. A higher growth capacity (achieved e. g. through genetic selection) would be detrimental for the animal's ability to cope with pathogens and greater resistance may reduce growth in the short-term. Significance: Our model can thus explain contradicting outcomes of genetic selection observed in experimental studies and provides the necessary biological background for understanding the influence of selection and/or changes in the nutritional environment on phenotypic growth and immune response.			Doeschl-Wilson, AB (corresponding author), Scottish Agr Coll, Edinburgh, Midlothian, Scotland.	andrea.wilson@sac.ac.uk		Wilson, Andrea/0000-0002-2658-6973				ANDERSON R M, 1991; Antia R, 1996, P ROY SOC B-BIOL SCI, V263, P257, DOI 10.1098/rspb.1996.0040; BEILHARZ RG, 1993, J ANIM BREED GENET, V110, P161, DOI 10.1111/j.1439-0388.1993.tb00728.x; BHARGAVA K K, 1970, Journal of Nutrition, V100, P241; Bishop SC, 2007, SMALL RUMINANT RES, V70, P48, DOI 10.1016/j.smallrumres.2007.01.006; Bishop SC, 1999, ANIM SCI, V69, P515, DOI 10.1017/S1357729800051365; BLACK JL, 1986, RES DEV AGRIC, V3, P121; Bryant JR, 2007, ANIMAL, V1, P175, DOI 10.1017/S1751731107657747; Coop RL, 2001, TRENDS PARASITOL, V17, P325, DOI 10.1016/S1471-4922(01)01900-6; Datta FU, 1998, INT J PARASITOL, V28, P1269, DOI 10.1016/S0020-7519(98)00104-0; DEJONG G, 1992, AM NAT, V139, P749, DOI 10.1086/285356; Doeschl-Wilson AB, 2008, GENET SEL EVOL, V40, P241, DOI 10.1051/gse:2008001; Exton MS, 1997, APPETITE, V29, P369, DOI 10.1006/appe.1997.0116; FERGUSON NS, 2007, MECH MODELING PIG PO, P22; Frank JW, 2005, VET IMMUNOL IMMUNOP, V107, P179, DOI 10.1016/j.vetimm.2005.04.014; Friggens NC, 2007, ANIMAL, V1, P87, DOI 10.1017/S1751731107657772; Green DM, 2003, ANIM SCI, V77, P113, DOI 10.1017/S1357729800053716; Greiner LL, 2000, J ANIM SCI, V78, P2690; Gross WB, 2002, AVIAN DIS, V46, P1007, DOI 10.1637/0005-2086(2002)046[1007:EOGSFH]2.0.CO;2; Houdijk JGM, 2006, P NUTR SOC, V65, p68A; Houston AI, 2007, P ROY SOC B-BIOL SCI, V274, P2835, DOI 10.1098/rspb.2007.0934; Hutchings MR, 2001, ECOLOGY, V82, P1138, DOI 10.1890/0012-9658(2001)082[1138:HPSAFT]2.0.CO;2; Imsland AK, 2002, AQUACULTURE, V204, P167, DOI 10.1016/S0044-8486(01)00656-1; Knap PW, 2000, ANIM SCI, V70, P39, DOI 10.1017/S1357729800051584; Kyriazakis I, 1998, ANIM BEHAV, V56, P265, DOI 10.1006/anbe.1998.0761; Kyriazakis I, 1996, VET PARASITOL, V61, P297, DOI 10.1016/0304-4017(95)00824-1; Kyriazakis I, 2009, VOLUNTARY FEED INTAKE IN PIGS, P307; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Mallard B. A., 1998, Proceedings of the 6th World Congress on Genetics Applied to Livestock Production, Armidale, Australia, January 11-16, 1998. Volume 27: Reproduction; fish breeding; genetics and the environment; genetics in agricultural systems; disease resistance; animal welfare; computing and information technology; tree breeding., P257; Mangel M, 2001, EVOL ECOL RES, V3, P583; McNamara JP, 2000, J DAIRY SCI, V83, P128, DOI 10.3168/jds.S0022-0302(00)74864-8; Medley GF, 2002, PARASITOLOGY, V125, pS61, DOI 10.1017/S0031182002002354; Morris CA, 2000, ANIM SCI, V70, P17, DOI 10.1017/S1357729800051560; Rauw WM, 2003, J ANIM SCI, V81, P939; Rauw WM, 1998, LIVEST PROD SCI, V56, P15, DOI 10.1016/S0301-6226(98)00147-X; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Ritz BW, 2006, J NUTR, V136, P1141, DOI 10.1093/jn/136.5.1141; Roff Derek A., 1992; Sandberg FB, 2006, J ANIM SCI, V84, P1552, DOI 10.2527/2006.8461552x; Sandberg FB, 2005, BRIT J NUTR, V93, P213, DOI 10.1079/BJN20041322; SCRIMSHAW NS, 1968, WHO MONOGRAPH SERIES, V57; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shudo E, 2001, J THEOR BIOL, V209, P233, DOI 10.1006/jtbi.2000.2259; Soler JJ, 2003, P ROY SOC B-BIOL SCI, V270, P241, DOI 10.1098/rspb.2002.2217; Stearns S.C., 1992, pi; TSIAGBE VK, 1987, POULTRY SCI, V66, P1147, DOI 10.3382/ps.0661147; Vagenas D, 2007, PARASITOLOGY, V134, P1263, DOI 10.1017/S0031182007002570; Vagenas D, 2007, PARASITOLOGY, V134, P1279, DOI 10.1017/S0031182007002624; van der Waaij EH, 2000, J ANIM SCI, V78, P2809; van der Waaij EH, 2004, J ANIM SCI, V82, P973; Wellock IJ, 2003, ANIM SCI, V77, P255, DOI 10.1017/S1357729800058999	51	21	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7508	10.1371/journal.pone.0007508	http://dx.doi.org/10.1371/journal.pone.0007508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838306	Green Published, Green Submitted, gold			2022-12-25	WOS:000270880900011
J	Ernst, J; Ghanem, L; Bar-Joseph, Z; McNamara, M; Brown, J; Steinman, RA				Ernst, Jason; Ghanem, Louis; Bar-Joseph, Ziv; McNamara, Michael; Brown, Jason; Steinman, Richard A.			IL-3 and Oncogenic Abl Regulate the Myeloblast Transcriptome by Altering mRNA Stability	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; AU-RICH ELEMENTS; CELL-PROLIFERATION; C-MYB; GRANULOCYTIC DIFFERENTIATION; MYELOID DIFFERENTIATION; GENE-TRANSCRIPTION; P110-DELTA ISOFORM; UP-REGULATION; G-CSF	The growth factor interleukin-3 (IL-3) promotes the survival and growth of multipotent hematopoietic progenitors and stimulates myelopoiesis. It has also been reported to oppose terminal granulopoiesis and to support leukemic cell growth through autocrine or paracrine mechanisms. The degree to which IL-3 acts at the posttranscriptional level is largely unknown. We have conducted global mRNA decay profiling and bioinformatic analyses in 32Dcl3 myeloblasts indicating that IL-3 caused immediate early stabilization of hundreds of transcripts in pathways relevant to myeloblast function. Stabilized transcripts were enriched for AU-Response elements (AREs), and an ARE-containing domain from the interleukin-6 (IL-6) 39-UTR rendered a heterologous gene responsive to IL-3-mediated transcript stabilization. Many IL-3-stabilized transcripts had been associated with leukemic transformation. Deregulated Abl kinase shared with IL-3 the ability to delay turnover of transcripts involved in proliferation or differentiation blockade, relying, in part, on signaling through the Mek/Erk pathway. These findings support a model of IL-3 action through mRNA stability control and suggest that aberrant stabilization of an mRNA network linked to IL-3 contributes to leukemic cell growth.			Ernst, J (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, Boston, MA USA.	steinman@pitt.edu	Ghanem, Louis/R-3733-2016; Bar-Joseph, Ziv/GWN-2754-2022	Ghanem, Louis/0000-0002-7723-5241; Bar-Joseph, Ziv/0000-0003-3430-6051				Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; BIES J, 1995, CELL GROWTH DIFFER, V6, P59; Billottet C, 2006, ONCOGENE, V25, P6648, DOI 10.1038/sj.onc.1209670; CALABRETTA B, 1993, CANCER INVEST, V11, P191, DOI 10.3109/07357909309024839; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen Y, 2007, BLOOD, V110, P2889, DOI 10.1182/blood-2007-01-066316; Corradini F, 2007, BLOOD CELL MOL DIS, V39, P292, DOI 10.1016/j.bcmd.2007.06.002; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Esnault S, 2002, BLOOD, V99, P4048, DOI 10.1182/blood.V99.11.4048; Figueroa A, 2003, MOL CELL BIOL, V23, P4991, DOI 10.1128/MCB.23.14.4991-5004.2003; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Gaines Peter, 2005, Curr Protoc Immunol, VChapter 22, DOI 10.1002/0471142735.im22f05s67; Ghanem L, 2005, LEUKEMIA RES, V29, P1315, DOI 10.1016/j.leukres.2005.03.018; Ghanem L, 2006, LEUKEMIA RES, V30, P1285, DOI 10.1016/j.leukres.2005.12.023; Guchhait P, 2003, J IMMUNOL METHODS, V283, P195, DOI 10.1016/j.jim.2003.09.013; Hevehan DL, 2000, EXP HEMATOL, V28, P1016, DOI 10.1016/S0301-472X(00)00505-1; Hevehan DL, 2002, BLOOD, V99, P1627, DOI 10.1182/blood.V99.5.1627; Huang TS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-31; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; *ING SYST INC, 2005, IPA NETW GEN ALG; Ino T, 1995, ONCOGENE, V11, P2705; Jaramillo M, 2002, J IMMUNOL, V169, P7026, DOI 10.4049/jimmunol.169.12.7026; Jijon HB, 2002, AM J PHYSIOL-CELL PH, V283, pC31, DOI 10.1152/ajpcell.00113.2001; Khanna-Gupta A, 2001, P NATL ACAD SCI USA, V98, P8000, DOI 10.1073/pnas.141229598; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Lam LT, 2001, GENOME BIOL, V2; Li SG, 2001, BLOOD, V97, P1442, DOI 10.1182/blood.V97.5.1442; Liu J, 2008, LEUKEMIA, V22, P791, DOI 10.1038/leu.2008.3; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; Matsui H, 2007, MOL CELL, V25, P99, DOI 10.1016/j.molcel.2006.12.007; MATULONIS U, 1993, EXP HEMATOL, V21, P1460; Mondal K, 2000, J LEUKOCYTE BIOL, V67, P216, DOI 10.1002/jlb.67.2.216; Munoz L, 2001, HAEMATOLOGICA, V86, P1261; Nowak R, 1999, CYTOKINE, V11, P435, DOI 10.1006/cyto.1998.0445; Numata A, 2005, J BIOL CHEM, V280, P12621, DOI 10.1074/jbc.M408442200; Raghavan A, 2004, GENOMICS, V84, P1002, DOI 10.1016/j.ygeno.2004.08.007; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Shimada H, 2000, BLOOD, V96, P655; Steinman RA, 2007, LEUKEMIA, V21, P1158, DOI 10.1038/sj.leu.2404656; Steinman RA, 1999, LEUKEMIA, V13, P54, DOI 10.1038/sj.leu.2401253; STEINMAN RA, 1994, BLOOD, V83, P119; Stoecklin G, 2003, ONCOGENE, V22, P3554, DOI 10.1038/sj.onc.1206418; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Sugiura R, 2004, CELL CYCLE, V3, P286; Sugiyama H, 1996, LEUKEMIA LYMPHOMA, V21, P49, DOI 10.3109/10428199609067579; Sujobert P, 2005, BLOOD, V106, P1063, DOI 10.1182/blood-2004-08-3225; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Tamura M, 2002, J CLIN ENDOCR METAB, V87, P3263, DOI 10.1210/jc.87.7.3263; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Testa U, 2002, BLOOD, V100, P2980, DOI 10.1182/blood-2002-03-0852; VALTIERI M, 1987, J IMMUNOL, V138, P3829; VELLENGA E, 1987, LEUKEMIA, V1, P584; Wang P, 1998, J IMMUNOL, V160, P4427; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yang XL, 2004, J BIOL CHEM, V279, P49298, DOI 10.1074/jbc.M407535200; Yen JJY, 2006, VITAM HORM, V74, P147, DOI 10.1016/S0083-6729(06)74006-7; Zhang W, 1995, CLIN CANCER RES, V1, P1051; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	63	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7469	10.1371/journal.pone.0007469	http://dx.doi.org/10.1371/journal.pone.0007469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829692	Green Published, gold, Green Accepted			2022-12-25	WOS:000270847800008
J	Shin, DH; Chun, YS; Lee, KH; Shin, HW; Park, JW				Shin, Dong Hoon; Chun, Yang-Sook; Lee, Kyoung-Hwa; Shin, Hyun-Woo; Park, Jong-Wan			Arrest Defective-1 Controls Tumor Cell Behavior by Acetylating Myosin Light Chain Kinase	PLOS ONE			English	Article							SMOOTH-MUSCLE; ARD1 GENE; PHOSPHORYLATION; PHOSPHATASE; PROTEIN; DESTABILIZATION; IDENTIFICATION; HIF-1-ALPHA; METASTASIS; INHIBITORS	Background: The enhancement of cell motility is a critical event during tumor cell spreading. Since myosin light chain kinase (MLCK) regulates cell behavior, it is regarded as a promising target in terms of preventing tumor invasion and metastasis. Since MLCK was identified to be associated with human arrest defective-1 (hARD1) through yeast two-hybrid screening, we here tested the possibility that hARD1 acts as a regulator of MLCK and by so doing controls tumor cell motility. Methodology/ Principal Findings: The physical interaction between MLCK and hARD1 was confirmed both in vivo and in vitro by immunoprecipitation assay and affinity chromatography. hARD1, which is known to have the activity of protein lysine epsilon-acetylation, bound to and acetylated MLCK activated by Ca2+ signaling, and by so doing deactivated MLCK, which led to a reduction in the phosphorylation of MLC. Furthermore, hARD1 inhibited tumor cell migration and invasion MLCK-dependently. Our mutation study revealed that hARD1 associated with an IgG motif of MLCK and acetylated the Lys608 residue in this motif. The K608A-mutated MLCK was neither acetylated nor inactivated by hARD1, and its stimulatory effect on cell motility was not inhibited by hARD1. Conclusion/Significance: These results indicate that hARD1 is a bona fide regulator of MLCK, and that hARD1 plays a crucial role in the balance between tumor cell migration and stasis. Thus, hARD1 could be a therapeutic target in the context of preventing tumor invasion and metastasis.			Shin, DH (corresponding author), Seoul Natl Univ, Coll Med, Dept Pharmacol, Ischem Hypox Dis Inst, Seoul, South Korea.	parkjw@snu.ac.kr	Park, Jong-Wan/J-2758-2012; Shin, Dong Hoon/J-5520-2012; Chun, Yang Sook/J-2789-2012; Song, Young Goo/AGV-5104-2022	Song, Young Goo/0000-0002-0733-4156				ADELSTEIN RS, 1980, ANNU REV BIOCHEM, V921, P956; ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Arnesen T, 2005, FEBS LETT, V579, P6428, DOI 10.1016/j.febslet.2005.10.036; Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Chun YS, 2003, CANCER RES, V63, P8700; Dulyaninova NG, 2004, EXP CELL RES, V299, P303, DOI 10.1016/j.yexcr.2004.06.015; EINHEBER S, 1990, P NATL ACAD SCI USA, V87, P2157, DOI 10.1073/pnas.87.6.2157; Fajmut A, 2005, FEBS LETT, V579, P4361, DOI 10.1016/j.febslet.2005.06.076; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23936; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; Gillespie GY, 1999, CANCER RES, V59, P2076; Herring BP, 2000, AM J PHYSIOL-CELL PH, V279, pC1656, DOI 10.1152/ajpcell.2000.279.5.C1656; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kaneko K, 2002, PANCREAS, V24, P34, DOI 10.1097/00006676-200201000-00005; Kim SH, 2006, BIOCHEM BIOPH RES CO, V340, P422, DOI 10.1016/j.bbrc.2005.12.018; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lazar V, 1999, GENOMICS, V57, P256, DOI 10.1006/geno.1999.5774; LEE FJS, 1989, J BACTERIOL, V171, P5795, DOI 10.1128/jb.171.11.5795-5802.1989; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Lim JH, 2006, CANCER RES, V66, P10677, DOI 10.1158/0008-5472.CAN-06-3171; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; Minamiya Y, 2005, TUMOR BIOL, V26, P153, DOI 10.1159/000086487; PARK EC, 1992, EMBO J, V11, P2087, DOI 10.1002/j.1460-2075.1992.tb05267.x; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Smith L, 1999, J BIOL CHEM, V274, P29433, DOI 10.1074/jbc.274.41.29433; Smith L, 2000, FEBS LETT, V480, P298, DOI 10.1016/S0014-5793(00)01931-1; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tohtong R, 2003, PROSTATE CANCER P D, V6, P212, DOI 10.1038/sj.pcan.4500663; WHITEWAY M, 1987, MOL CELL BIOL, V7, P3713, DOI 10.1128/MCB.7.10.3713; WHITEWAY M, 1985, CELL, V43, P483, DOI 10.1016/0092-8674(85)90178-3; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x	38	60	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7451	10.1371/journal.pone.0007451	http://dx.doi.org/10.1371/journal.pone.0007451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826488	Green Published, gold, Green Submitted			2022-12-25	WOS:000270808700012
J	Nabavi, S; Nazar, RN				Nabavi, Sadeq; Nazar, Ross N.			Fail-safe termination elements: a common feature of the eukaryotic genome?	FASEB JOURNAL			English	Article							RNA-POLYMERASE-II; TRANSCRIPTIONAL TERMINATION; MESSENGER-RNAS; POLYADENYLATION; INITIATION; POLY(A); GENES; SURVEILLANCE; DOWNSTREAM; EFFICIENCY	A recent scan of the human genome (1) identified similar to 11 million hairpins. Some have been linked to known sequences, such as viruses, transposable elements, and, more recently, regulating or microRNAs, but the significance, if any, of most sequences that can be predicted to form hairpins remains unknown. Here we show that hairpins that are cleaved by RNase III-like nucleases can induce termination, even with normally polyadenylated transcripts, and that a cleaved hairpin downstream of a normal termination signal can induce fail-safe termination. Because such cleavage sites appear common to intergenic regions, the results raise the possibility that similar fail-safe termination elements are widely distributed in the eukaryotic genome to prevent read-through transcription from disrupting downstream promoter elements or opposing transcription.-Nabavi, S., Nazar, R. N. Fail-safe termination elements: a common feature of the eukaryotic genome? FASEB J. 24, 684-688 (2010). www.fasebj.org	[Nabavi, Sadeq; Nazar, Ross N.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Nazar, RN (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rnnazar@uoguelph.ca		Nabavi, Sadegh/0000-0002-3940-1210	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We are very grateful to Dr. D. Frendeway (Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA) for providing the Pac1 endonuclease used in this study. This study was supported by the Natural Sciences and Engineering Research Council of Canada.	Aranda A, 2001, MOL CELL, V7, P1003, DOI 10.1016/S1097-2765(01)00235-0; ASHFIELD R, 1991, EMBO J, V10, P4197, DOI 10.1002/j.1460-2075.1991.tb04998.x; BAKKEN A, 1982, P NATL ACAD SCI-BIOL, V79, P56, DOI 10.1073/pnas.79.1.56; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; BERNSTEIN P, 1989, TRENDS BIOCHEM SCI, V14, P373, DOI 10.1016/0968-0004(89)90011-X; Danin-Kreiselman M, 2003, MOL CELL, V11, P1279, DOI 10.1016/S1097-2765(03)00137-0; Dye MJ, 1999, MOL CELL, V3, P371, DOI 10.1016/S1097-2765(00)80464-5; El Hage A, 2008, GENE DEV, V22, P1069, DOI 10.1101/gad.463708; ELION EA, 1984, CELL, V39, P663, DOI 10.1016/0092-8674(84)90473-2; Ge DL, 2005, CURR BIOL, V15, P140, DOI 10.1016/j.cub.2004.12.001; Greger IH, 1998, EMBO J, V17, P4771, DOI 10.1093/emboj/17.16.4771; GRUMMT I, 1985, CELL, V43, P801, DOI 10.1016/0092-8674(85)90253-3; Hitchen J, 1997, J MOL BIOL, V274, P481, DOI 10.1006/jmbi.1997.1376; Huang YQ, 1996, MOL CELL BIOL, V16, P1534; HYMAN LE, 1993, MOL CELL BIOL, V13, P5159, DOI 10.1128/MCB.13.9.5159; Kawauchi J, 2008, GENE DEV, V22, P1082, DOI 10.1101/gad.463408; KUHN A, 1990, NATURE, V344, P559, DOI 10.1038/344559a0; Lee A, 2005, MOL CELL, V19, P39, DOI 10.1016/j.molcel.2005.05.021; LOSSON R, 1983, CELL, V32, P371, DOI 10.1016/0092-8674(83)90456-7; MATHEWS DH, 2007, CURR PROTOC NUCL ACI, V11; Nabavi S, 2008, J BIOL CHEM, V283, P13601, DOI 10.1074/jbc.M710125200; Nazar RN, 2007, FASEB J, V21, pA1028; Rotondo G, 1996, NUCLEIC ACIDS RES, V24, P2377, DOI 10.1093/nar/24.12.2377; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; Shwed PS, 1999, NUCLEIC ACIDS RES, V27, P2883, DOI 10.1093/nar/27.14.2883; SOLLNERWEBB B, 1979, CELL, V18, P485, DOI 10.1016/0092-8674(79)90066-7; West S, 2006, RNA, V12, P655, DOI 10.1261/rna.2232406; Zer C, 2005, J BIOL CHEM, V280, P28997, DOI 10.1074/jbc.M505913200	28	2	2	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2010	24	3					684	688		10.1096/fj.09-142745	http://dx.doi.org/10.1096/fj.09-142745			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	561KE	19841037				2022-12-25	WOS:000274974600004
J	Oda, T; Hashimoto, H; Kuwabara, N; Akashi, S; Hayashi, K; Kojima, C; Wong, HL; Kawasaki, T; Shimamoto, K; Sato, M; Shimizu, T				Oda, Takashi; Hashimoto, Hiroshi; Kuwabara, Naoyuki; Akashi, Satoko; Hayashi, Kokoro; Kojima, Chojiro; Wong, Hann Ling; Kawasaki, Tsutomu; Shimamoto, Ko; Sato, Mamoru; Shimizu, Toshiyuki			Structure of the N-terminal Regulatory Domain of a Plant NADPH Oxidase and Its Functional Implications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY BURST OXIDASE; GTPASE-BINDING DOMAIN; PROTEIN; RAC; HOMOLOGS; REVEALS; CALCIUM; COMPLEX; CA2+; ACTIVATION	Plant NADPH oxidases (Rboh, for respiratory burst oxidase homolog) produce reactive oxygen species that are key regulators of various cellular events including plant innate immunity. Rbohs possess a highly conserved cytoplasmic N-terminal region containing two EF-hand motifs that regulate Rboh activity. Rice (Oryza sativa) RbohB (OsRbohB) is regulated by the direct binding of a small GTPase (Rac1) to this regulatory region as well as by Ca2+ binding to the EF-hands. Here, we present the atomic structure of the N-terminal region of OsRbohB. The structure reveals that OsRbohB forms a unique dimer stabilized by swapping the EF-hand motifs. We identified two additional EF-hand-like motifs that were not predicted from sequence data so far. These EF-hand-like motifs together with the swapped EF-hands form a structure similar to that found in calcineurin B. We observed conformational changes mediated by Ca2+ binding to only one EF-hand. Structure-based in vitro pulldown assays and NMR titration experiments defined the OsRac1 binding interface within the coiled-coil region created by swapping the EF-hands. In addition, we demonstrate a direct intramolecular interaction between the N and C terminus, and that the complete N-terminal cytoplasmic region is required for this interaction. The structural features and intramolecular interactions characterized here might be common elements shared by Rbohs that contribute to the regulation of reactive oxygen species production.	[Sato, Mamoru; Shimizu, Toshiyuki] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Kanagawa 2300045, Japan; [Hayashi, Kokoro; Kojima, Chojiro] Nara Inst Sci & Technol, Biophys Lab, Nara 6300192, Japan; [Wong, Hann Ling; Kawasaki, Tsutomu; Shimamoto, Ko] Nara Inst Sci & Technol, Plant Mol Genet Lab, Nara 6300192, Japan	Yokohama City University; Nara Institute of Science & Technology; Nara Institute of Science & Technology	Shimizu, T (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, 1-7-29 Suehiro Cho, Kanagawa 2300045, Japan.	shimizu@tsurumi.yokohama-cu.ac.jp	Wong, Hann Ling/S-8148-2017; Kojima, Chojiro/AFV-4592-2022	Wong, Hann Ling/0000-0001-8903-1812; Kojima, Chojiro/0000-0003-2723-8249; Kuwabara, Naoyuki/0000-0002-1659-323X; Hashimoto, Hiroshi/0000-0003-1503-6789; Akashi, Satoko/0000-0002-8978-6358	Targeted Proteins Research Program (TPRP); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Targeted Proteins Research Program (TPRP)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Targeted Proteins Research Program (TPRP) and grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DOKE N, 1983, PHYSIOL PLANT PATHOL, V23, P345, DOI 10.1016/0048-4059(83)90019-X; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Groom QJ, 1996, PLANT J, V10, P515, DOI 10.1046/j.1365-313X.1996.10030515.x; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kawasaki T, 2006, P NATL ACAD SCI USA, V103, P230, DOI 10.1073/pnas.0509875103; Kawasaki T, 1999, P NATL ACAD SCI USA, V96, P10922, DOI 10.1073/pnas.96.19.10922; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin GD, 1997, NAT STRUCT BIOL, V4, P539, DOI 10.1038/nsb0797-539; Mongrand S, 2004, J BIOL CHEM, V279, P36277, DOI 10.1074/jbc.M403440200; Mott HR, 1999, NATURE, V399, P384, DOI 10.1038/20732; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakashima A, 2008, PLANT CELL, V20, P2265, DOI 10.1105/tpc.107.054395; Oda T, 2008, ACTA CRYSTALLOGR F, V64, P867, DOI 10.1107/S1744309108026535; Ogasawara Y, 2008, J BIOL CHEM, V283, P8885, DOI 10.1074/jbc.M708106200; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; POTTS BCM, 1995, NAT STRUCT BIOL, V2, P790, DOI 10.1038/nsb0995-790; Reynolds C, 2009, BIOINFORMATICS, V25, P413, DOI 10.1093/bioinformatics/btn584; Sagi M, 2001, PLANT PHYSIOL, V126, P1281, DOI 10.1104/pp.126.3.1281; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Sendamarai AK, 2008, P NATL ACAD SCI USA, V105, P7410, DOI 10.1073/pnas.0801318105; Takeda S, 2008, SCIENCE, V319, P1241, DOI 10.1126/science.1152505; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thao NP, 2007, PLANT CELL, V19, P4035, DOI 10.1105/tpc.107.055517; Torres MA, 1998, PLANT J, V14, P365, DOI 10.1046/j.1365-313X.1998.00136.x; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Verdino P, 2002, EMBO J, V21, P5007, DOI 10.1093/emboj/cdf526; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Yoshioka H, 2001, MOL PLANT MICROBE IN, V14, P725, DOI 10.1094/MPMI.2001.14.6.725	46	111	117	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1435	1445		10.1074/jbc.M109.058909	http://dx.doi.org/10.1074/jbc.M109.058909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19864426	hybrid, Green Published			2022-12-25	WOS:000273258200063
J	Jarman, KE; Moretti, PAB; Zebol, JR; Pitson, SM				Jarman, Kate E.; Moretti, Paul A. B.; Zebol, Julia R.; Pitson, Stuart M.			Translocation of Sphingosine Kinase 1 to the Plasma Membrane Is Mediated by Calcium- and Integrin-binding Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT TRANSLOCATION; CYTOPLASMIC DOMAIN; ACTIVATION; CIB1; CELL; SPHINGOSINE-1-PHOSPHATE; CALMODULIN; INTERACTS; SENSOR; CA2+	SK1 (sphingosine kinase 1) plays an important role in many aspects of cellular regulation. Most notably, elevated cellular SK1 activity leads to increased cell proliferation, protection from apoptosis, and induction of neoplastic transformation. We have previously shown that translocation of SK1 from the cytoplasm to the plasma membrane is integral for oncogenesis mediated by this enzyme. The molecular mechanism mediating this translocation of SK1 has remained undefined. Here, we demonstrate a direct role for CIB1 (calcium and integrin-binding protein 1) in this process. We show that CIB1 interacts with SK1 in a Ca2+-dependent manner at the previously identified "calmodulin-binding site" of SK1. We also demonstrate that CIB1 functions as a Ca2+-myristoyl switch, providing a mechanism whereby it translocates SK1 to the plasma membrane. Both small interfering RNA knockdown of CIB1 and the use of a dominant-negative CIB1 we have generated prevent the agonist-dependent translocation of SK1. Furthermore, we demonstrate the requirement of CIB1-mediated translocation of SK1 in controlling cellular sphingosine 1-phosphate generation and associated anti-apoptotic signaling.	[Jarman, Kate E.; Moretti, Paul A. B.; Zebol, Julia R.; Pitson, Stuart M.] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Jarman, Kate E.; Pitson, Stuart M.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia	Centre for Cancer Biology; SA Pathology; University of Adelaide	Pitson, SM (corresponding author), SA Pathol, Ctr Canc Biol, Frome Rd, Adelaide, SA 5000, Australia.	stuart.pitson@health.sa.gov.au	Pitson, Stuart/B-9342-2009	Pitson, Stuart/0000-0002-9527-2740	Fay Fuller Foundation; Australian postgraduate award; Dawes postgraduate scholarship [453512]; National Health and Medical Research Council of Australia	Fay Fuller Foundation; Australian postgraduate award(Australian Government); Dawes postgraduate scholarship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Fay Fuller Foundation, an Australian postgraduate award, and Dawes postgraduate scholarship (to K. E. J.), Project Grant 453512, and a senior research fellowship from the National Health and Medical Research Council of Australia (to S. M. P.).	Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; BarPeled M, 1996, ANAL BIOCHEM, V241, P140, DOI 10.1006/abio.1996.0390; Barry WT, 2002, J BIOL CHEM, V277, P28877, DOI 10.1074/jbc.M202983200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Blazejczyk M, 2006, BBA-MOL BASIS DIS, V1762, P66, DOI 10.1016/j.bbadis.2005.09.006; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; French KJ, 2003, CANCER RES, V63, P5962; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Himes SR, 1996, IMMUNITY, V5, P479, DOI 10.1016/S1074-7613(00)80503-8; Hollenbach AD, 2002, BBA-GENE STRUCT EXPR, V1574, P321, DOI 10.1016/S0167-4781(02)00230-0; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Leclercq TM, 2008, J BIOL CHEM, V283, P9606, DOI 10.1074/jbc.M708782200; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Naik MU, 2003, BLOOD, V102, P3629, DOI 10.1182/blood-2003-05-1703; Naik UP, 2003, BLOOD, V102, P1355, DOI 10.1182/blood-2003-02-0591; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pitson SM, 2002, J BIOL CHEM, V277, P49545, DOI 10.1074/jbc.M206687200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stabler SM, 1999, J CELL BIOL, V145, P1277, DOI 10.1083/jcb.145.6.1277; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Sutherland CM, 2006, J BIOL CHEM, V281, P11693, DOI 10.1074/jbc.M601042200; Thorogate R, 2007, BIOCHEM J, V402, P71, DOI 10.1042/BJ20061111; Wattenberg BW, 2006, J LIPID RES, V47, P1128, DOI 10.1194/jlr.R600003-JLR200; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Yamniuk AP, 2009, PROTEIN SCI, V18, P1128, DOI 10.1002/pro.104; Yamniuk AP, 2005, PROTEIN SCI, V14, P1429, DOI 10.1110/ps.041312805; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b; Young KW, 2003, CELL CALCIUM, V33, P119, DOI 10.1016/S0143-4160(02)00205-1; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06; Zayed MA, 2007, CIRC RES, V101, P1185, DOI 10.1161/CIRCRESAHA.107.157586; Zebol JR, 2009, INT J BIOCHEM CELL B, V41, P822, DOI 10.1016/j.biocel.2008.08.012	40	106	112	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					483	492		10.1074/jbc.M109.068395	http://dx.doi.org/10.1074/jbc.M109.068395			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19854831	hybrid, Green Published			2022-12-25	WOS:000273070100050
J	Matsumura, T; Suzuki, T; Aizawa, K; Sawaki, D; Munemasa, Y; Ishida, J; Nagai, R				Matsumura, Takayoshi; Suzuki, Toru; Aizawa, Kenichi; Sawaki, Daigo; Munemasa, Yoshiko; Ishida, Junichi; Nagai, Ryozo			Regulation of Transforming Growth Factor-beta-dependent Cyclooxygenase-2 Expression in Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; METASTASIS SUPPRESSOR; HUMAN-DISEASE; PROTEIN; FIBROSIS; GENE; TRANSCRIPTION; MECHANISMS; NM23-H1; BINDING	Abnormal transforming growth factor-beta (TGF-beta) signaling is a critical contributor to the pathogenesis of various human diseases ranging from tissue fibrosis to tumor formation. Excessive TGF-beta signaling stimulates fibrotic responses. Recent research has focused in the main on the antiproliferative effects of TGF-beta in fibroblasts, and it is presently understood that TGF-beta-stimulated cyclooxygenase-2 (COX-2) induction in fibroblasts is essential for antifibroproliferative effects of TGF-beta. Both TGF-beta and COX-2 have been implicated in tumor growth, invasion, and metastasis, and therefore tumor-associated fibroblasts are a recent topic of interest. Here we report the identification of positive and negative regulatory factors of COX-2 expression induced by TGF-beta as determined using proteomic approaches. We show that TGF-beta coordinately up-regulates three factors, heterogeneous nuclear ribonucleoprotein A/B (HNRPAB), nucleotide diphosphate kinase A (NDPK A), and nucleotide diphosphate kinase A (NDPK B). Functional pathway analysis showed that HNRPAB augments mRNA and protein levels of COX-2 and subsequent prostaglandin E-2 (PGE(2)) production by suppressing degradation of COX-2 mRNA. In contrast, NDPK A and NDPK B attenuated mRNA and protein levels of COX-2 by affecting TGF-beta-Smad2/3/4 signaling at the receptor level. Collectively, we report on a new regulatory pathway of TGF-beta in controlling expression of COX-2 in fibroblasts, which advances our understanding of pathophysiological mechanisms of TGF-beta	[Suzuki, Toru; Aizawa, Kenichi] Univ Tokyo, Dept Ubiquitous Prevent Med, Bunkyo Ku, Tokyo 1138655, Japan; [Nagai, Ryozo] Univ Tokyo, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo	Suzuki, T (corresponding author), Univ Tokyo, Dept Ubiquitous Prevent Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	torusuzu-tky@umin.ac.jp; nagai-tky@umin.ac.jp	SAWAKI, Daigo/T-6871-2018	SAWAKI, Daigo/0000-0003-1417-2033; Suzuki, Toru/0000-0002-8371-664X; , Junichi/0000-0001-9703-9419	Ministry of Education, Culture, Sports, Science, and Technology; New Energy and Industrial Technology Development Organization; Ministry of Health, Labor, and Welfare	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology; the New Energy and Industrial Technology Development Organization; and the Ministry of Health, Labor, and Welfare.	Adegboyega PA, 2004, CLIN CANCER RES, V10, P5870, DOI 10.1158/1078-0432.CCR-0431-03; Benson JR, 2004, LANCET ONCOL, V5, P229, DOI 10.1016/S1470-2045(04)01426-3; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Boissan M, 2006, J BIOENERG BIOMEMBR, V38, P169, DOI 10.1007/s10863-006-9031-4; Bonner JC, 2002, AM J PATHOL, V161, P459, DOI 10.1016/S0002-9440(10)64202-2; Crawford Y, 2009, CANCER CELL, V15, P21, DOI 10.1016/j.ccr.2008.12.004; Dean JLE, 2002, BIOCHEM J, V366, P709, DOI 10.1042/BJ20020402; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; FLETCHER BS, 1992, J BIOL CHEM, V267, P4338; Gao CJ, 2004, J BIOL CHEM, V279, P11236, DOI 10.1074/jbc.M313385200; Gasparini G, 2003, LANCET ONCOL, V4, P605, DOI 10.1016/S1470-2045(03)01220-8; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; KAMADA S, 1992, GENE, V119, P229, DOI 10.1016/0378-1119(92)90276-U; Kapoun AM, 2004, CIRC RES, V94, P453, DOI 10.1161/01.RES.0000117070.86556.9F; Kaul R, 2006, J VIROL, V80, P1321, DOI 10.1128/JVI.80.3.1321-1331.2006; Keerthisingam CB, 2001, AM J PATHOL, V158, P1411, DOI 10.1016/S0002-9440(10)64092-8; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Lombardi D, 2006, J BIOENERG BIOMEMBR, V38, P177, DOI 10.1007/s10863-006-9032-3; Luo J, 1998, J NEUROCHEM, V71, P526; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Matsumura T, 2005, J BIOL CHEM, V280, P12123, DOI 10.1074/jbc.M410578200; Matsumura T, 2006, BIOCHEM BIOPH RES CO, V351, P965, DOI 10.1016/j.bbrc.2006.10.137; MORITA I, 1995, J BIOL CHEM, V270, P10902, DOI 10.1074/jbc.270.18.10902; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Rouzer CA, 2008, J BIOL CHEM, V283, P8065, DOI 10.1074/jbc.R800005200; Roymans D, 2002, CLIN EXP METASTAS, V19, P465, DOI 10.1023/A:1020396722860; Seong HA, 2007, J BIOL CHEM, V282, P12075, DOI 10.1074/jbc.M609832200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sonoshita M, 2002, CANCER RES, V62, P6846; Steeg PS, 2008, CLIN CANCER RES, V14, P5006, DOI 10.1158/1078-0432.CCR-08-0238; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Suzuki T, 2009, J BIOL CHEM, V284, P9549, DOI 10.1074/jbc.M806230200; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Vancheri C, 2004, TRENDS IMMUNOL, V25, P40, DOI 10.1016/j.it.2003.11.001; Venkov CD, 2007, J CLIN INVEST, V117, P482, DOI 10.1172/JCI29544; Verrecchia F, 2006, AUTOIMMUN REV, V5, P563, DOI 10.1016/j.autrev.2006.06.001; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487	47	24	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35861	35871		10.1074/jbc.M109.014639	http://dx.doi.org/10.1074/jbc.M109.014639			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19837676	Green Published, hybrid			2022-12-25	WOS:000272645600062
J	Suzuki, Y; Minami, M; Suzuki, M; Abe, K; Zenno, SH; Tsujimoto, M; Matsumoto, K; Minami, Y				Suzuki, Yukari; Minami, Michiko; Suzuki, Miho; Abe, Keiko; Zenno, Shuhei; Tsujimoto, Masafumi; Matsumoto, Ken; Minami, Yasufumi			The Hsp90 Inhibitor Geldanamycin Abrogates Colocalization of eIF4E and eIF4E-Transporter into Stress Granules and Association of eIF4E with eIF4G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAP-DEPENDENT TRANSLATION; MESSENGER-RNA TRANSLATION; P-BODIES; BINDING PROTEIN; CHAPERONE; MECHANISMS; INITIATION; RICH; REPRESSION; HEAT-SHOCK-PROTEIN-90	The eukaryotic translation initiation factor eIF4E plays a critical role in the control of translation initiation through binding to the mRNA 5' cap structure. eIF4E is also a component of processing bodies and stress granules, which are two types of cytoplasmic RNA granule in which translationally inactivated mRNAs accumulate. We found that treatment with the Hsp90 inhibitor geldanamycin leads to a substantial reduction in the number of HeLa cells that contain processing bodies. In contrast, stress granules are not disrupted but seem to be only partially affected by the inhibition of Hsp90. However, it is striking that eIF4E as well as its binding partner eIF4E transporter (4E-T), which mediates the import of eIF4E into the nucleus, are obviously lost from stress granules. Furthermore, the amount of eIF4G that is associated with the cap via eIF4E is reduced by geldanamycin treatment. Thus, the chaperone activity of Hsp90 probably contributes to the correct localization of eIF4E and 4E-T to stress granules and also to the interaction between eIF4E and eIF4G, both of which may be needed for eIF4E to acquire the physiological functionality that underlies the mechanism of translation initiation.	[Tsujimoto, Masafumi; Matsumoto, Ken] RIKEN, Lab Cellular Biochem, Wako, Saitama 3510198, Japan; [Suzuki, Yukari; Abe, Keiko] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Minami, Michiko; Suzuki, Miho] Tokyo Gakugei Univ, Fac Educ, Dept Nat & Environm Sci, Tokyo 1848501, Japan; [Zenno, Shuhei; Minami, Yasufumi] Maebashi Inst Technol, Dept Biotechnol, Maebashi, Gunma 3710816, Japan; [Matsumoto, Ken] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	RIKEN; University of Tokyo; Tokyo Gakugei University; Japan Science & Technology Agency (JST)	Matsumoto, K (corresponding author), RIKEN, Lab Cellular Biochem, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	matsumok@riken.jp; yminami@maebashi-it.ac.jp	Matsumoto, Ken/F-9083-2013	Matsumoto, Ken/0000-0002-7864-3394	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Aoki K, 2002, NUCLEIC ACIDS RES, V30, P5182, DOI 10.1093/nar/gkf638; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Citri A, 2006, J BIOL CHEM, V281, P14361, DOI 10.1074/jbc.M512613200; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Deuerling E, 2004, CRIT REV BIOCHEM MOL, V39, P261, DOI 10.1080/10409230490892496; Dostie J, 2000, EMBO J, V19, P3142, DOI 10.1093/emboj/19.12.3142; Dostie J, 2000, J CELL BIOL, V148, P239, DOI 10.1083/jcb.148.2.239; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Lian S, 2007, MOL BIOL CELL, V18, P3375, DOI 10.1091/mbc.E07-01-0070; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Matsumoto K, 1998, TRENDS CELL BIOL, V8, P318, DOI 10.1016/S0962-8924(98)01300-2; Minshall N, 2004, NUCLEIC ACIDS RES, V32, P1325, DOI 10.1093/nar/gkh303; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Pare JM, 2009, MOL BIOL CELL, V20, P3273, DOI 10.1091/mbc.E09-01-0082; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Shinozaki F, 2006, J BIOL CHEM, V281, P16361, DOI 10.1074/jbc.M600891200; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Standart N, 2008, BIOCHEM SOC T, V36, P671, DOI 10.1042/BST0360671; Tahbaz N, 2004, EMBO REP, V5, P189, DOI 10.1038/sj.embor.7400070; Tanaka KJ, 2006, J BIOL CHEM, V281, P40096, DOI 10.1074/jbc.M609059200; Tay WL, 2009, MODERN PATHOL, V22, P282, DOI 10.1038/modpathol.2008.181; Terasawa K, 2006, MOL CELL BIOL, V26, P3378, DOI 10.1128/MCB.26.9.3378-3389.2006; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	63	34	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35597	35604		10.1074/jbc.M109.036285	http://dx.doi.org/10.1074/jbc.M109.036285			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850929	hybrid, Green Published			2022-12-25	WOS:000272645600037
J	Ishii, N; Matsumura, T; Kinoshita, H; Motoshima, H; Kojima, K; Tsutsumi, A; Kawasaki, S; Yano, M; Senokuchi, T; Asano, T; Nishikawa, T; Araki, E				Ishii, Norio; Matsumura, Takeshi; Kinoshita, Hiroyuki; Motoshima, Hiroyuki; Kojima, Kanou; Tsutsumi, Atsuyuki; Kawasaki, Shuji; Yano, Miyuki; Senokuchi, Takafumi; Asano, Tomoichiro; Nishikawa, Takeshi; Araki, Eiichi			Activation of AMP-activated Protein Kinase Suppresses Oxidized Low-density Lipoprotein-induced Macrophage Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; MUSCLE-CELL-PROLIFERATION; PHOSPHATIDYLINOSITOL 3-KINASE; MURINE MACROPHAGES; SKELETAL-MUSCLE; DNA-SYNTHESIS; GROWTH; INHIBITION; CANCER; P53	Macrophage-derived foam cells play important roles in the progression of atherosclerosis. We reported previously that ERK1/2-dependent granulocyte/macrophage colony-stimulating factor (GM-CSF) expression, leading to p38 MAPK/Akt signaling, is important for oxidized low density lipoprotein (Ox-LDL)-induced macrophage proliferation. Here, we investigated whether activation of AMP-activated protein kinase (AMPK) could suppress macrophage proliferation. Ox-LDL-induced proliferation of mouse peritoneal macrophages was assessed by [H-3] thymidine incorporation and cell counting assays. The proliferation was significantly inhibited by the AMPK activator 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) and restored by dominant-negative AMPK alpha 1, suggesting that AMPK activation suppressed macrophage proliferation. AICAR partially suppressed Ox-LDL-induced ERK1/2 phosphorylation and GM-CSF expression, suggesting that another mechanism is also involved in the AICAR-mediated suppression of macrophage proliferation. AICAR suppressed GM-CSF-induced macrophage proliferation without suppressing p38 MAPK/Akt signaling. GM-CSF suppressed p53 phosphorylation and expression and induced Rb phosphorylation. Overexpression of p53 or p27(kip) suppressed GM-CSF-induced macrophage proliferation. AICAR induced cell cycle arrest, increased p53 phosphorylation and expression, and suppressed GM-CSF-induced Rb phosphorylation via AMPK activation. Moreover, AICAR induced p21(cip) and p27kip expression via AMPK activation, and small interfering RNA (siRNA) of p21cip and p27kip restored AICAR-mediated suppression of macrophage proliferation. In conclusion, AMPK activation suppressed Ox-LDL-induced macrophage proliferation by suppressing GM-CSF expression and inducing cell cycle arrest. These effects of AMPK activation may represent therapeutic targets for atherosclerosis.	[Ishii, Norio; Matsumura, Takeshi; Kinoshita, Hiroyuki; Motoshima, Hiroyuki; Kojima, Kanou; Tsutsumi, Atsuyuki; Kawasaki, Shuji; Yano, Miyuki; Senokuchi, Takafumi; Nishikawa, Takeshi; Araki, Eiichi] Kumamoto Univ, Dept Metab Med, Grad Sch Med Sci, Kumamoto 8608556, Japan; [Asano, Tomoichiro] Hiroshima Univ, Dept Med Chem, Div Mol Med Sci, Grad Sch Biomed Sci, Hiroshima 7348551, Japan	Kumamoto University; Hiroshima University	Matsumura, T (corresponding author), Kumamoto Univ, Dept Metab Med, Grad Sch Med Sci, 1-1-1 Honjo, Kumamoto 8608556, Japan.	takeshim@gpo.kumamoto-u.ac.jp			Japan Society for the Promotion of Science, Japan [21591144, 20390259]; Takeda Science Foundation; Advanced Education Program for Integrated Clinical, Basic and Social Medicine; Graduate School of Medical Sciences, Kumamoto University	Japan Society for the Promotion of Science, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Advanced Education Program for Integrated Clinical, Basic and Social Medicine; Graduate School of Medical Sciences, Kumamoto University	This work was supported by grants-in-aid for scientific research from the Japan Society for the Promotion of Science, Japan ( 21591144, to T. M. and 20390259, to E. A.), a grant from the Takeda Science Foundation ( to T. M.), and the Advanced Education Program for Integrated Clinical, Basic and Social Medicine, Graduate School of Medical Sciences, Kumamoto University ( Support Program for Improving Graduate School Education, MEXT, Japan).	Biwa T, 2000, J BIOL CHEM, V275, P5810, DOI 10.1074/jbc.275.8.5810; Biwa T, 1998, J BIOL CHEM, V273, P28305, DOI 10.1074/jbc.273.43.28305; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Campas C, 2003, BLOOD, V101, P3674, DOI 10.1182/blood-2002-07-2339; CHODAKEWITZ JA, 1988, J IMMUNOL, V140, P832; Garcia-Gil M, 2003, NEUROSCIENCE, V117, P811, DOI 10.1016/S0306-4522(02)00836-9; GORDON D, 1990, P NATL ACAD SCI USA, V87, P4600, DOI 10.1073/pnas.87.12.4600; GRANA X, 1995, ONCOGENE, V11, P211; Hamilton JA, 1999, ARTERIOSCL THROM VAS, V19, P98, DOI 10.1161/01.ATV.19.1.98; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Igata M, 2005, CIRC RES, V97, P837, DOI 10.1161/01.RES.0000185823.73556.06; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kemp BE, 1999, TRENDS BIOCHEM SCI, V24, P22, DOI 10.1016/S0968-0004(98)01340-1; Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044; Martens JS, 1998, J BIOL CHEM, V273, P4915, DOI 10.1074/jbc.273.9.4915; Matsumura T, 1997, ARTERIOSCL THROM VAS, V17, P3013, DOI 10.1161/01.ATV.17.11.3013; Matsumura T, 1999, J BIOL CHEM, V274, P37665, DOI 10.1074/jbc.274.53.37665; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107, DOI 10.1152/ajpendo.1997.273.6.E1107; MUNKER R, 1986, NATURE, V323, P79, DOI 10.1038/323079a0; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; ROSENFELD ME, 1990, ARTERIOSCLEROSIS, V10, P680, DOI 10.1161/01.ATV.10.5.680; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SAKAI M, 1994, J BIOL CHEM, V269, P31430; Sakoda H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1239, DOI 10.1152/ajpendo.00455.2001; Sanders MJ, 2007, BIOCHEM J, V403, P139, DOI 10.1042/BJ20061520; Senokuchi T, 2005, J BIOL CHEM, V280, P6627, DOI 10.1074/jbc.M412531200; Senokuchi T, 2004, ATHEROSCLEROSIS, V176, P233, DOI 10.1016/j.atherosclerosis.2004.05.019; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; SPAGNOLI LG, 1991, ATHEROSCLEROSIS, V88, P87, DOI 10.1016/0021-9150(91)90260-A; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Taketa K, 2008, J BIOL CHEM, V283, P9852, DOI 10.1074/jbc.M703318200; Young ME, 1996, FEBS LETT, V382, P43, DOI 10.1016/0014-5793(96)00129-9	39	37	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34561	34569		10.1074/jbc.M109.028043	http://dx.doi.org/10.1074/jbc.M109.028043			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19843515	Green Published, hybrid			2022-12-25	WOS:000272439600011
J	Oddoux, S; Brocard, J; Schweitzer, A; Szentesi, P; Giannesini, B; Brocard, J; Faure, J; Pernet-Gallay, K; Bendahan, D; Lunardi, J; Csernoch, L; Marty, I				Oddoux, Sarah; Brocard, Julie; Schweitzer, Annie; Szentesi, Peter; Giannesini, Benoit; Brocard, Jacques; Faure, Julien; Pernet-Gallay, Karine; Bendahan, David; Lunardi, Joel; Csernoch, Laszlo; Marty, Isabelle			Triadin Deletion Induces Impaired Skeletal Muscle Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOPLASMIC-RETICULUM MEMBRANE; JUNCTIONAL FOOT PROTEIN; RYANODINE-RECEPTOR; DIHYDROPYRIDINE RECEPTOR; GLYCOPROTEIN TRIADIN; CARDIAC-MUSCLE; CALSEQUESTRIN; MICE; MYOTUBES; CA2+	Triadin is a multiple proteins family, some isoforms being involved in muscle excitation-contraction coupling, and some having still unknown functions. To obtain clues on triadin functions, we engineered a triadin knock-out mouse line and characterized the physiological effect of triadin ablation on skeletal muscle function. These mice presented a reduced muscle strength, which seemed not to alter their survival and has been characterized in the present work. We first checked in these mice the expression level of the different proteins involved in calcium homeostasis and observed in fast muscles an increase in expression of dihydropyridine receptor, with a large reduction in calsequestrin expression. Electron microscopy analysis of KO muscles morphology demonstrated the presence of triads in abnormal orientation and a reduction in the sarcoplasmic reticulum terminal cisternae volume. Using calcium imaging on cultured myotubes, we observed a reduction in the total amount of calcium stored in the sarcoplasmic reticulum. Physiological studies have been performed to evaluate the influence of triadin deletion on skeletal muscle function. Muscle strength has been measured both on the whole animal model, using hang test or electrical stimulation combined with NMR analysis and strength measurement, or on isolated muscle using electrical stimulation. All the results obtained demonstrate an important reduction in muscle strength, indicating that triadin plays an essential role in skeletal muscle function and in skeletal muscle structure. These results indicate that triadin alteration leads to the development of a myopathy, which could be studied using this new animal model.	[Oddoux, Sarah; Brocard, Julie; Faure, Julien; Lunardi, Joel; Marty, Isabelle] Equipe Muscle & Pathol, Grenoble Inst Neurosci, INSERM, U836, F-38000 Grenoble, France; [Oddoux, Sarah; Brocard, Julie; Faure, Julien; Lunardi, Joel; Marty, Isabelle] Univ Grenoble 1, F-38000 Grenoble, France; [Schweitzer, Annie; Brocard, Jacques; Pernet-Gallay, Karine] Equipe Physiopathol Cytosquelette, Grenoble Inst Neurosci, INSERM, U836, F-38000 Grenoble, France; [Szentesi, Peter; Csernoch, Laszlo] Univ Debrecen, Dept Physiol, Sch Med, H-4012 Debrecen, Hungary; [Szentesi, Peter; Csernoch, Laszlo] Univ Debrecen, Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Giannesini, Benoit; Bendahan, David] Fac Med Timone, CNRS, UMR 6612, Ctr Resonance Magnet Biol & Med, F-13000 Marseille, France; [Faure, Julien; Lunardi, Joel] Hop Michallon Biochim & Genet Mol, Ctr Hosp Reg Univ Grenoble, F-38000 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Debrecen; University of Debrecen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Marty, I (corresponding author), UJF, INSERM, U836, Grenoble Inst Neurosci,Eq Muscle & Pathol, Site Sante,BP 170, F-38042 Grenoble 9, France.	isabelle.marty@ujf-grenoble.fr	Marty, Isabelle/ABF-5362-2020; Fauré, julien/AAJ-1845-2020; Marty, Isabelle/N-7114-2017; Brocard, Jacques/I-3135-2017	Marty, Isabelle/0000-0003-3625-913X; Fauré, julien/0000-0002-3660-9809; Brocard, Jacques/0000-0002-0752-5737; Oddoux, Sarah/0000-0002-2888-8430; Szentesi, Peter/0000-0003-2621-2282; Brocard, Julie/0000-0001-9345-5191; Csernoch, Laszlo/0000-0002-2446-1456	Association Francaise contre les Myopathies; Agence Nationale de la Recherche-Maladies Rares; Hungarian Research Found [OTKA K75604]	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Agence Nationale de la Recherche-Maladies Rares(French National Research Agency (ANR)); Hungarian Research Found(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by grants from Association Francaise contre les Myopathies, the Agence Nationale de la Recherche-Maladies Rares, and the Hungarian Research Found (Grant OTKA K75604).	Ahern C A, 2001, BMC Physiol, V1, P8, DOI 10.1186/1472-6793-1-8; ARNOLD DL, 1984, MAGNET RESON MED, V1, P307, DOI 10.1002/mrm.1910010303; BRANDT NR, 1990, J MEMBRANE BIOL, V113, P237, DOI 10.1007/BF01870075; Caswell AH, 1999, BIOCHEMISTRY-US, V38, P90, DOI 10.1021/bi981306+; CASWELL AH, 1991, BIOCHEMISTRY-US, V30, P7507, DOI 10.1021/bi00244a020; Ducreux S, 2004, J BIOL CHEM, V279, P43838, DOI 10.1074/jbc.M403612200; Dupe V, 1997, DEVELOPMENT, V124, P399; FLUCHER BE, 1992, DEV BIOL, V154, P245, DOI 10.1016/0012-1606(92)90065-O; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; Fodor J, 2008, J PHYSIOL-LONDON, V586, P5803, DOI 10.1113/jphysiol.2008.160457; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Gregg RG, 1996, P NATL ACAD SCI USA, V93, P13961, DOI 10.1073/pnas.93.24.13961; Groh S, 1999, J BIOL CHEM, V274, P12278, DOI 10.1074/jbc.274.18.12278; GUO W, 1995, J BIOL CHEM, V270, P9027, DOI 10.1074/jbc.270.16.9027; KIM KC, 1990, BIOCHEMISTRY-US, V29, P9281, DOI 10.1021/bi00491a025; KNUDSON CM, 1989, J BIOL CHEM, V264, P1345; KNUDSON CM, 1993, J BIOL CHEM, V268, P12646; Kobayashi YM, 2000, J BIOL CHEM, V275, P17639, DOI 10.1074/jbc.M002091200; Kobayashi YM, 1999, J BIOL CHEM, V274, P28660, DOI 10.1074/jbc.274.40.28660; Lee EH, 2006, J BIOL CHEM, V281, P10042, DOI 10.1074/jbc.M600981200; LIU GH, 1994, J BIOL CHEM, V269, P33028; LUNARDI J, 1989, FEBS LETT, V245, P223, DOI 10.1016/0014-5793(89)80226-1; MARTY I, 1994, P NATL ACAD SCI USA, V91, P2270, DOI 10.1073/pnas.91.6.2270; MARTY I, 1995, BIOCHEM J, V307, P769, DOI 10.1042/bj3070769; Marty I, 2000, J BIOL CHEM, V275, P8206, DOI 10.1074/jbc.275.11.8206; Marty I, 2009, J PHYSIOL-LONDON, V587, P3117, DOI 10.1113/jphysiol.2009.171892; MOUTIN MJ, 1994, J BIOL CHEM, V269, P11147; Ohkura M, 1998, BIOCHEMISTRY-US, V37, P12987, DOI 10.1021/bi972803d; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Pouvreau S, 2007, P NATL ACAD SCI USA, V104, P5235, DOI 10.1073/pnas.0700748104; Rezgui SS, 2005, J BIOL CHEM, V280, P39302, DOI 10.1074/jbc.M506566200; Shen XH, 2007, J BIOL CHEM, V282, P37864, DOI 10.1074/jbc.M705702200; Shin DW, 2000, FEBS LETT, V486, P178, DOI 10.1016/S0014-5793(00)02246-8; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Thevenon D, 2003, BIOCHEM BIOPH RES CO, V303, P669, DOI 10.1016/S0006-291X(03)00406-6; Tijskens P, 2003, J MOL CELL CARDIOL, V35, P961, DOI 10.1016/S0022-2828(03)00181-0; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Vassilopoulos S, 2005, J BIOL CHEM, V280, P28601, DOI 10.1074/jbc.M501484200; Vassilopoulos S, 2007, CELL CALCIUM, V41, P179, DOI 10.1016/j.ceca.2006.06.003; Wang Y, 2009, CELL CALCIUM, V45, P29, DOI 10.1016/j.ceca.2008.05.006; Westerblad H, 1998, J PHYSIOL-LONDON, V510, P269, DOI 10.1111/j.1469-7793.1998.269bz.x; Zhang L, 1997, J BIOL CHEM, V272, P23389, DOI 10.1074/jbc.272.37.23389; Zhao XL, 2005, PHYSIOL GENOMICS, V23, P72, DOI 10.1152/physiolgenomics.00020.2005	44	56	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34918	34929		10.1074/jbc.M109.022442	http://dx.doi.org/10.1074/jbc.M109.022442			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19843516	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000272439600047
J	Enomoto, M; Goto, H; Tomono, Y; Kasahara, K; Tsujimura, K; Kiyono, T; Inagaki, M				Enomoto, Masato; Goto, Hidemasa; Tomono, Yasuko; Kasahara, Kousuke; Tsujimura, Kunio; Kiyono, Tohru; Inagaki, Masaki			Novel Positive Feedback Loop between Cdk1 and Chk1 in the Nucleus during G2/M Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; CHECKPOINT PATHWAYS; PHOSPHORYLATION; KINASE; REPLICATION; ACTIVATION; BINDING; MITOSIS; SITE	Chk1, one of the critical transducers in DNA damage/replication checkpoints, prevents entry into mitosis through inhibition of Cdk1 activity. However, it has remained unclear how this inhibition is cancelled at the G(2)/M transition. We reported recently that Chk1 is phosphorylated at Ser(286) and Ser(301) by Cdk1 during mitosis. Here, we show that mitotic Chk1 phosphorylation is accompanied by Chk1 translocation from the nucleus to the cytoplasm in prophase. This translocation advanced in accordance with prophase progression and was regulated by Crm-1-dependent nuclear export. Exogenous Chk1 mutated at Ser(286) and Ser(301) to Ala (S286A/S301A) was observed mainly in the nuclei of prophase cells, although such nuclear accumulation was hardly observed in wild-type Chk1. Induction of S286A/S301A resulted in the delay of mitotic entry. Biochemical analyses using immunoprecipitated cyclin B-1-Cdk1 complexes revealed S286A/S301A expression to block the adequate activation of Cdk1. In support of this, S286A/S301A expression retained Wee1 at higher levels and Cdk1-induced phosphorylation of cyclin B-1 and vimentin at lower levels. A kinase-dead version of S286A/S301A also localized predominantly in the nucleus but lost the ability to delay mitotic entry. These results indicate that Chk1 phosphorylation by Cdk1 participates in cytoplasmic sequestration of Chk1 activity, which releases Cdk1 inhibition in the nucleus and promotes mitotic entry.	[Goto, Hidemasa; Inagaki, Masaki] Aichi Canc Ctr, Div Biochem, Res Inst, Chikusa Ku, Aichi 4648681, Japan; [Enomoto, Masato; Goto, Hidemasa; Inagaki, Masaki] Nagoya Univ, Grad Sch Med, Dept Cellular Oncol, Aichi 4668550, Japan; [Tomono, Yasuko] Shigei Med Res Inst, Div Mol & Cell Biol, Okayama 7010202, Japan; [Tsujimura, Kunio] Hamamatsu Univ Sch Med, Dept Infect Dis, Hamamatsu, Shizuoka 4313192, Japan; [Kiyono, Tohru] Natl Canc Ctr, Res Inst, Div Virol, Chuo Ku, Tokyo 1040045, Japan	Aichi Cancer Center; Nagoya University; Hamamatsu University School of Medicine; National Cancer Center - Japan	Goto, H (corresponding author), Aichi Canc Ctr, Div Biochem, Res Inst, Chikusa Ku, 1-1 Kanokoden, Aichi 4648681, Japan.	hgoto@aichi-cc.jp; minagaki@aichi-cc.jp	Inagaki, Masaki/B-9920-2016; Kiyono, Tohru/H-5834-2011	Goto, Hidemasa/0000-0002-6796-4467	Japan Society for the Promotion of Science; Ministry of Education, Science, Technology, Sports, and Culture of Japan; Ministry of Health and Welfare of Japan; Uehara Memorial Foundation; Naito Foundation; Takeda Science Foundation; Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research [19057010] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Technology, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Princess Takamatsu Cancer Research Fund; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science and from the Ministry of Education, Science, Technology, Sports, and Culture of Japan, a grant-in-aid for the Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health and Welfare of Japan, the Uehara Memorial Foundation, the Naito Foundation, the Takeda Science Foundation, and a research grant from the Princess Takamatsu Cancer Research Fund.	Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Goto H, 2007, NAT PROTOC, V2, P2574, DOI 10.1038/nprot.2007.374; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Ikegami Y, 2008, BIOCHEM BIOPH RES CO, V377, P1227, DOI 10.1016/j.bbrc.2008.10.119; Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; Rhind N, 2000, J CELL SCI, V113, P3889; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Shiromizu T, 2006, GENES CELLS, V11, P477, DOI 10.1111/j.1365-2443.2006.00955.x; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Tibelius A, 2009, J CELL BIOL, V185, P1149, DOI 10.1083/jcb.200810159; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	23	55	55	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34223	34230		10.1074/jbc.C109.051540	http://dx.doi.org/10.1074/jbc.C109.051540			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19837665	Green Published, hybrid			2022-12-25	WOS:000272165200054
J	Hausberger, M; Gautier, E; Biquand, V; Lunel, C; Jego, P				Hausberger, Martine; Gautier, Emmanuel; Biquand, Veronique; Lunel, Christophe; Jego, Patrick			Could Work Be a Source of Behavioural Disorders? A Study in Horses	PLOS ONE			English	Article							STRESS; STEREOTYPIES; AFFECTIVITY; PREVALENCE; MANAGEMENT	Stress at work, as shown by a number of human studies, may lead to a variety of negative and durable effects, such as impaired psychological functioning ( anxiety, depression.). Horses share with humans this characteristic of working on a daily basis and are submitted then to work stressors related to physical constraints and/or more "psychological'' conflicts, such as potential controversial orders from the riders or the requirement to suppress emotions. On another hand, horses may perform abnormal repetitive behaviour ("stereotypies'') in response to adverse life conditions. In the present study, we investigated whether the type of work the horses are used for may have an impact on their tendency to show stereotypic behaviour ( and its type) outside work. Observations in their box of 76 horses all living in the same conditions, belonging to one breed and one sex, revealed that the prevalence and types of stereotypies performed strongly depended upon the type of work they were used for. The stereotypies observed involved mostly mouth movements and head tossing/nodding. Work constraints probably added to unfavourable living conditions, favouring the emergence of chronic abnormal behaviours. This is especially remarkable as the 23 hours spent in the box were influenced by the one hour work performed every day. To our knowledge, this is the first evidence of potential effects of work stressors on the emergence of abnormal behaviours in an animal species. It raises an important line of thought on the chronic impact of the work situation on the daily life of individuals.			Hausberger, M (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Campus Beaulieu, Rennes, France.	martine.hausberger@univ-rennes1.fr						ALTMAN J, 1974, BEHAVIOUR, V19, P227; [Anonymous], 2004, ANIM WELFARE; Benhajali H, 2008, APPL ANIM BEHAV SCI, V112, P196, DOI 10.1016/j.applanim.2007.08.007; BOLGER N, 1989, J PERS SOC PSYCHOL, V57, P808, DOI 10.1037/0022-3514.57.5.808; Broom D. M., 1993, Equine Veterinary Education, V5, P151, DOI 10.1111/j.2042-3292.1993.tb01026.x; Christie JL, 2006, CAN VET J, V47, P136; Cook WR, 2002, J EQUINE VET SCI, V22, P7, DOI 10.1016/S0737-0806(02)70207-4; Cook WR, 2003, PFERDEHEILKUNDE, V19, P75, DOI 10.21836/PEM20030111; Cook WR, 1999, J EQUINE VET SCI, V19, P196, DOI 10.1016/S0737-0806(99)80067-7; Cooper J, 1998, EQUINE VET J S, V27, P5; Cooper JJ, 2000, APPL ANIM BEHAV SCI, V69, P67, DOI 10.1016/S0168-1591(00)00115-5; FRASER AF, 1992, ABNORMAL ANOMALOUS B; Goodwin D, 2002, EQUINE VET J, V34, P686, DOI 10.2746/042516402776250450; Hall C, 2008, J APPL ANIM WELF SCI, V11, P249, DOI 10.1080/10888700802101130; Hausberger M, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P33; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; Hausberger M, 2007, APPL ANIM BEHAV SCI, V107, P299, DOI 10.1016/j.applanim.2006.10.003; Hausberger M, 2008, APPL ANIM BEHAV SCI, V109, P1, DOI 10.1016/j.applanim.2007.04.015; Heleski CR, 2002, APPL ANIM BEHAV SCI, V78, P291, DOI 10.1016/S0168-1591(02)00108-9; HOUTMAN ILD, 1994, SCAND J WORK ENV HEA, V20, P139, DOI 10.5271/sjweh.1419; Hutri M, 2002, J CAREER DEV, V29, P19, DOI 10.1023/A:1016547718122; Iverson RD, 1998, J VOCAT BEHAV, V52, P1, DOI 10.1006/jvbe.1996.1556; MADIGAN JE, 1998, EQUINE VET J S, V27, P28; Mann S, 2004, BRIT J GUID COUNS, V32, P205, DOI 10.1080/0369880410001692247; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Mason G., 2007, STEREOTYPIC BEHAV CA; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; McGreevy P, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P196; MCGREEVY PD, 1995, VET REC, V137, P36, DOI 10.1136/vr.137.2.36; Mills DS, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P212; Mills DS, 2002, IPPOLOGIA, V13, P33; Mills DS, 2002, APPL ANIM BEHAV SCI, V78, P115, DOI 10.1016/S0168-1591(02)00096-5; Newton SA, 2000, EQUINE VET J, V32, P208, DOI 10.2746/042516400776563617; Nicol CJ, 2002, VET REC, V151, P658, DOI 10.1136/vr.151.22.658; O'Brien A, 2008, ANXIETY STRESS COPIN, V21, P55, DOI 10.1080/10615800701529504; Odberg F O, 1999, Equine Vet J Suppl, P26; Odberg F.O., 1978, P 1 WORLD C ETH APPL, V1, P475; ODBERG FO, 1987, EQUINE VET J, V19, P268, DOI 10.1111/j.2042-3306.1987.tb01402.x; SANKEY C, 2008, ANIM COGN IN PRESS; Schaubroeck J, 2000, J ORGAN BEHAV, V21, P163, DOI 10.1002/(SICI)1099-1379(200003)21:2<163::AID-JOB37>3.0.CO;2-L; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; Waters AJ, 2002, EQUINE VET J, V34, P572, DOI 10.2746/042516402776180241	42	41	41	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7625	10.1371/journal.pone.0007625	http://dx.doi.org/10.1371/journal.pone.0007625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	511UJ	19862328	Green Published, gold, Green Submitted			2022-12-25	WOS:000271194600014
J	Liu, JL; Li, M; Dang, XR; Wang, ZH; Rao, ZR; Wu, SX; Li, YQ; Wang, W				Liu, Jun-Li; Li, Min; Dang, Xiao-Rong; Wang, Zheng-Hong; Rao, Zhi-Ren; Wu, Sheng-Xi; Li, Yun-Qing; Wang, Wen			A NMDA Receptor Antagonist, MK-801 Impairs Consolidating Extinction of Auditory Conditioned Fear Responses in a Pavlovian Model	PLOS ONE			English	Article							IMMEDIATE EXTINCTION; PROTEIN-SYNTHESIS; ACQUISITION; RECONSOLIDATION; EXPRESSION; STIMULUS; RAT; AMYGDALA; MEMORY; INHIBITION	Background: In auditory fear conditioning, repeated presentation of the tone in the absence of shock leads to extinction of the acquired fear responses. The glutamate N-methyl-D-aspartate receptor (NMDAR) is thought to be involved in the extinction of the conditioned fear responses, but its detailed role in initiating and consolidating or maintaining the fear extinction memory is unclear. Here we investigated this issue by using a NMDAR antagonist, MK-801. Methods/Main Findings: The effects of immediate (beginning at 10 min after the conditioning) and delayed (beginning at 24 h after conditioning) extinctions were first compared with the finding that delayed extinction caused a better and long-lasting (still significant on the 20(th) day after extinction) depression on the conditioned fear responses. In a second experiment, MK-801 was intraperitoneally (i.p.) injected at 40 min before, 4 h or 12 h after the delayed extinction, corresponding to critical time points for initiating, consolidating or maintaining the fear extinction memory. i.p. injection of MK-801 at either 40 min before or 4 h after delayed extinction resulted in an impairment of initiating and consolidating fear extinction memory, which caused a long lasting increased freezing score that was still significant on the 7th day after extinction, compared with extinction group. However, MK-801 administered at 12 h after the delayed extinction, when robust consolidation has been occurred and stabilized, did not affect the established extinction memory. Furthermore, the changed freezing behaviors was not due to an alteration in general anxiety levels, since MK-801 treatment had no effect on the percentage of open-arm time or open-arm entries in an Elevated Plus Maze (EPM) task. Conclusions/Significance: Our data suggested that the activation of NMDARs plays important role in initiation and consolidation but not maintenance of fear extinction memory. Together with the fact that NMDA receptor is very important for memory, our data added experimental evidence to the concept that the extinction of conditioned fear responses is a procedure of initiating and consolidating new memory other than simply "erasing'' the fear memory.			Liu, JL (corresponding author), Fourth Mil Med Univ, Dept Teaching & Training, Xian 710032, Peoples R China.	xllm113@hotmail.com; wangwen@fmmu.edu.cn						Alberini CM, 2006, CELL MOL LIFE SCI, V63, P999, DOI 10.1007/s00018-006-6025-7; Amaral Olavo B, 2008, Recent Pat CNS Drug Discov, V3, P166, DOI 10.2174/157488908786242470; Baker JD, 1996, BEHAV NEUROSCI, V110, P618, DOI 10.1037/0735-7044.110.3.618; Cammarota M, 2007, REV BRAS PSIQUIATR, V29, P80, DOI 10.1590/S1516-44462007000100019; CAMPEAU S, 1992, BEHAV NEUROSCI, V106, P569, DOI 10.1037/0735-7044.106.3.569; CRUZ APM, 1993, BRAZ J MED BIOL RES, V26, P615; Davis Michael, 2006, NeuroRx, V3, P82, DOI 10.1016/j.nurx.2005.12.008; Eisenberg M, 2004, EUR J NEUROSCI, V20, P3397, DOI 10.1111/j.1460-9568.2004.03818.x; Filipkowski RK, 2001, NEUROSCIENCE, V106, P679, DOI 10.1016/S0306-4522(01)00310-4; Garakani A, 2006, MT SINAI J MED, V73, P941; Goosens KA, 2004, EUR J NEUROSCI, V20, P537, DOI 10.1111/j.1460-9568.2004.03513.x; Johnson DM, 2000, BRAIN RES, V857, P66, DOI 10.1016/S0006-8993(99)02388-4; Langton JM, 2007, LEARN MEMORY, V14, P665, DOI 10.1101/lm.692407; Larkin AE, 2008, BRAIN RES, V1199, P126, DOI 10.1016/j.brainres.2008.01.019; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; Myers KM, 2006, LEARN MEMORY, V13, P216, DOI 10.1101/lm.119806; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; Sacchetti B, 1999, J NEUROSCI, V19, P9570; Schiller D, 2008, LEARN MEMORY, V15, P394, DOI 10.1101/lm.909208; Sullivan GM, 2004, NEUROSCIENCE, V128, P7, DOI 10.1016/j.neuroscience.2004.06.015; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; van der Meulen JAJ, 2003, NEUROREPORT, V14, P2225, DOI 10.1097/00001756-200312020-00018; Wang W, 2008, NEUROSCI LETT, V441, P237, DOI 10.1016/j.neulet.2008.06.031; Woods AM, 2008, LEARN MEMORY, V15, P909, DOI 10.1101/lm.1078508; Zellner MR, 2009, BEHAV BRAIN RES, V197, P442, DOI 10.1016/j.bbr.2008.10.013; Zhang WN, 2004, BEHAV BRAIN RES, V154, P199, DOI 10.1016/j.bbr.2004.02.016	30	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7548	10.1371/journal.pone.0007548	http://dx.doi.org/10.1371/journal.pone.0007548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	511ER	19855841	Green Published, Green Submitted, gold			2022-12-25	WOS:000271147200003
J	Alvarez-Rueda, N; Biron, M; Le Pape, P				Alvarez-Rueda, Nidia; Biron, Marlene; Le Pape, Patrice			Infectivity of Leishmania mexicana Is Associated with Differential Expression of Protein Kinase C-Like Triggered during a Cell-Cell Contact	PLOS ONE			English	Article							PROTOZOAN PARASITE LEISHMANIA; EXTRACELLULAR PHOSPHORYLATION; TRYPANOSOMA-BRUCEI; FLAGELLAR-LENGTH; DRUG TARGETS; DONOVANI; SURFACE; IDENTIFICATION; RESISTANCE; VIRULENCE	Mammalian host cell invasion by Leishmania is a complex process in which various parasite and host cell components interact, triggering the activation of signaling cascades in both cells. Little is known regarding PKC biological functions in Leishmania sp. during parasite-macrophage interaction. PKC-like enzyme was first identified in homogenates and membrane fraction of L. mexicana stationary promastigotes by immunoblot. PKC-like enzyme activity was then detected in cell homogenates but also on intact promastigotes showing for the first time the presence of an ecto-PKC dependent on Ca(2+)/phosphatidylserine for activation. This ecto-PKC was activated with phorbol myristate acetate (PMA) and inhibited by RO-32-0432, a selective PKC alpha beta(I)epsilon bisindolylmaleimide inhibitor. Interestingly, the Leishmania PKC-activity was higher in the infective stationary than in non-infective logarithmic stage. Then, promastigotes at different stages of time proliferation curve were used in order to identify the role of PKC-like during macrophage invasion. After attachment to macrophages, PKC-like is over-expressed in promastigotes at the 6(th) culture day but also at the 4(th) day of culture corresponding to the maximal infection capacity. An antibody microarray for MAPK and PKC corroborate the Leishmania PKC-like over-expression during contact with macrophages. Pretreatment with RO-32-0432 inhibitor reduced the number of infected macrophages and the parasite burden. These data suggest for the first time a direct link between PKC expression level and infectivity, and provide evidence that PKC-like plays a critical role in attachment and in the internalization steps involved in the invasion process.			Alvarez-Rueda, N (corresponding author), Univ Nantes, Nantes Atlantique Univ, EA IICiMed 1155, Dept Parasitol & Mycol Med,Fac Pharm, Nantes, France.	patrice.le-pape@univ-nantes.fr	Le Pape, Patrice/AAY-3632-2021; Le Pape, Patrice/W-1472-2019	Le Pape, Patrice/0000-0001-5059-6402; ALVAREZ RUEDA, Nidia/0000-0002-5629-1930				Alexander J, 1999, J CELL SCI, V112, P2993; Alvarez N, 2002, J ENZYM INHIB MED CH, V17, P443, DOI 10.1080/1475636021000005749; Babinska A, 2000, AM J PHYSIOL-HEART C, V278, pH2008, DOI 10.1152/ajpheart.2000.278.6.H2008; BANERJEE C, 1990, J GEN MICROBIOL, V136, P1051, DOI 10.1099/00221287-136-6-1051; BANERJEE C, 1992, MOL BIOCHEM PARASIT, V52, P195, DOI 10.1016/0166-6851(92)90052-L; Barreto-De-Souza V, 2006, J INFECT DIS, V194, P846, DOI 10.1086/506618; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Beverley SM, 1995, ANN TROP MED PARASIT, V89, P11, DOI 10.1080/00034983.1995.11813009; BIRCHALL AM, 1994, J PHARMACOL EXP THER, V268, P922; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRITTINGHAM A, 1995, J IMMUNOL, V155, P3102; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Croft SL, 2005, TRENDS PARASITOL, V21, P508, DOI 10.1016/j.pt.2005.08.026; de Almeida-Amaral EE, 2008, EXP PARASITOL, V118, P165, DOI 10.1016/j.exppara.2007.07.001; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DOYLE PS, 1991, EXP PARASITOL, V73, P326, DOI 10.1016/0014-4894(91)90104-5; EPAND RM, 1990, TRENDS PHARMACOL SCI, V11, P317, DOI 10.1016/0165-6147(90)90234-Y; Erdmann M, 2006, MOL BIOL CELL, V17, P2035, DOI 10.1091/mbc.E05-10-0976; Gallagher SR., 2007, CURR PROTOC CELL BIO; Gomez ML, 1999, INT J PARASITOL, V29, P981, DOI 10.1016/S0020-7519(99)00041-7; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HERMOSO T, 1994, ACTA TROP, V56, P1, DOI 10.1016/0001-706X(94)90034-5; Hermoso Tomas, 1993, Biological Research, V26, P267; Herrling PL, 2005, PROG DRUG RES, V62, P1; Hsieh YH, 2007, CANCER RES, V67, P4320, DOI 10.1158/0008-5472.CAN-06-2486; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; KEITH K, 1990, MOL BIOCHEM PARASIT, V43, P107, DOI 10.1016/0166-6851(90)90135-9; Knockaert M, 2000, CHEM BIOL, V7, P411, DOI 10.1016/S1074-5521(00)00124-1; Korzeniewski Krzysztof, 2004, Int Marit Health, V55, P155; Kuhn D, 2005, MOL MICROBIOL, V56, P1169, DOI 10.1111/j.1365-2958.2005.04614.x; Kultz D, 1998, J MOL EVOL, V46, P571, DOI 10.1007/PL00006338; Lam JSY, 2008, NEUROSCI LETT, V434, P150, DOI 10.1016/j.neulet.2008.01.064; Le Pape P, 2008, J ENZYM INHIB MED CH, V23, P708, DOI [10.1080/14756360802208137, 10.1080/14756360802208137 ]; LESTER DS, 1990, BIOCHIM BIOPHYS ACTA, V1052, P293, DOI 10.1016/0167-4889(90)90224-2; Makioka A, 2000, EXP PARASITOL, V95, P288, DOI 10.1006/expr.2000.4538; McGwire BS, 2002, J BIOL CHEM, V277, P8802, DOI 10.1074/jbc.M109072200; Merritt JE, 1999, CANCER CHEMOTH PHARM, V43, P371, DOI 10.1007/s002800050909; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Myler PJ, 2008, ADV EXP MED BIOL, V625, P133, DOI 10.1007/978-0-387-77570-8_11; Naula C, 2005, BBA-PROTEINS PROTEOM, V1754, P151, DOI 10.1016/j.bbapap.2005.08.018; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; OUELLETTE M, 1991, RES MICROBIOL, V142, P737, DOI 10.1016/0923-2508(91)90089-S; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Reithinger R, 2003, EMERG INFECT DIS, V9, P727; Robert-Gangneux F, 2000, PARASITE, V7, P95, DOI 10.1051/parasite/2000072095; Roffey J, 2009, CURR OPIN CELL BIOL, V21, P268, DOI 10.1016/j.ceb.2009.01.019; Sacerdoti-Sierra N, 1997, J BIOL CHEM, V272, P30760, DOI 10.1074/jbc.272.49.30760; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Seaman J, 1996, INT J EPIDEMIOL, V25, P862, DOI 10.1093/ije/25.4.862; Vannier-Santos MA, 2002, CURR PHARM DESIGN, V8, P297, DOI 10.2174/1381612023396230; VANNIERSANTOS MA, 1995, EUR J CELL BIOL, V67, P112; Vieira LL, 1997, MOL BIOCHEM PARASIT, V90, P449, DOI 10.1016/S0166-6851(97)00180-1; Wiese M, 2003, EUKARYOT CELL, V2, P769, DOI 10.1128/EC.2.4.769-777.2003; Wiese M, 2007, INT J PARASITOL, V37, P1053, DOI 10.1016/j.ijpara.2007.04.008; Yao CQ, 2002, MOL BIOCHEM PARASIT, V121, P119, DOI 10.1016/S0166-6851(02)00030-0	56	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7581	10.1371/journal.pone.0007581	http://dx.doi.org/10.1371/journal.pone.0007581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851504	gold, Green Published, Green Submitted			2022-12-25	WOS:000271022300013
J	Pardo, J; Galvez, EM; Koskinen, A; Simon, MM; Lobigs, M; Regner, M; Mullbacher, A				Pardo, Julian; Ma Galvez, Eva; Koskinen, Aulikki; Simon, Markus M.; Lobigs, Mario; Regner, Matthias; Muellbacher, Arno			Caspase-Dependent Inhibition of Mousepox Replication by gzmB	PLOS ONE			English	Article							GRANZYME-B; ECTROMELIA VIRUS; CELL-DEATH; MEDIATED APOPTOSIS; VIRAL PROTEIN; IN-VITRO; T-CELLS; PERFORIN; VIVO; FAS	Background: Ectromelia virus is a natural mouse pathogen, causing mousepox. The cytotoxic T (Tc) cell granule serine-protease, granzyme B, is important for its control, but the underlying mechanism is unknown. Using ex vivo virus immune Tc cells, we have previously shown that granzyme B is able to activate several independent pro-apoptotic pathways, including those mediated by Bid/Bak/Bax and caspases-3/-7, in target cells pulsed with Tc cell determinants. Methods and Findings: Here we analysed the physiological relevance of those pro-apoptotic pathways in ectromelia infection, by incubating ectromelia-immune ex vivo Tc cells from granzyme A deficient (GzmB(+) Tc cells) or granzyme A and granzyme B deficient (GzmAxB(-/-) Tc cell) mice with ectromelia-infected target cells. We found that gzmB-induced apoptosis was totally blocked in ectromelia infected or peptide pulsed cells lacking caspases-3/-7. However ectromelia inhibited only partially apoptosis in cells deficient for Bid/Bak/Bax and not at all when both pathways were operative suggesting that the virus is able to interfere with apoptosis induced by gzmB in case not all pathways are activated. Importantly, inhibition of viral replication in vitro, as seen with wild type cells, was not affected by the lack of Bid/Bak/Bax but was significantly reduced in caspase-3/-7- deficient cells. Both caspase dependent processes were strictly dependent on gzmB, since Tc cells, lacking both gzms, neither induced apoptosis nor reduced viral titers. Significance: Out findings present the first evidence on the biological importance of the independent gzmB-inducible proapoptotic pathways in a physiological relevant virus infection model.	[Pardo, Julian] Fdn Aragon I D ARAID, Gobierno De Aragon, Spain; [Ma Galvez, Eva] CSIC, Inst Carboquim, Zaragoza, Spain; [Koskinen, Aulikki; Regner, Matthias; Muellbacher, Arno] Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Viral Immunol Grp, Canberra, ACT, Australia; [Lobigs, Mario] Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Mol Virol Grp, Canberra, ACT, Australia; [Simon, Markus M.] Max Planck Inst Immunobiol, Metschnikoff Lab, Freiburg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Carboquimica (ICB); Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research; Max Planck Society	Pardo, J (corresponding author), Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain.	pardojim@unizar.es; Matthias.Regner@anu.edu.au; arno.mullbacher@anu.edu.au	Pardo, Julián/K-6764-2014; Galvez, Eva M./K-6751-2014; lobigs, mario/ABC-5711-2020	Pardo, Julián/0000-0003-0154-0730; Galvez, Eva M./0000-0001-6928-5516; 				Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Aoyagi M, 2007, PROTEIN SCI, V16, P118, DOI 10.1110/ps.062454707; Ashton-Rickardt PG, 2005, CRIT REV IMMUNOL, V25, P161, DOI 10.1615/CritRevImmunol.v25.i3.10; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; BLANDEN RV, 1974, TRANSPLANT REV, V19, P56; Bossi G, 2005, SEMIN IMMUNOL, V17, P87, DOI 10.1016/j.smim.2004.09.007; Boya P, 2003, BIOCHEM BIOPH RES CO, V304, P575, DOI 10.1016/S0006-291X(03)00630-2; Brick DJ, 2000, J GEN VIROL, V81, P1087, DOI 10.1099/0022-1317-81-4-1087; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Chen NH, 2003, VIROLOGY, V317, P165, DOI 10.1016/S0042-6822(03)00520-8; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Dobbelstein M, 1996, J VIROL, V70, P6479, DOI 10.1128/JVI.70.9.6479-6485.1996; FENNER F, 1949, J IMMUNOL, V63, P341; Fischer SF, 2006, CELL DEATH DIFFER, V13, P109, DOI 10.1038/sj.cdd.4401718; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Krzyowska M, 2002, MICROBES INFECT, V4, P599, DOI 10.1016/S1286-4579(02)01578-2; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lieberman J, 2003, CURR OPIN IMMUNOL, V15, P553, DOI 10.1016/S0952-7915(03)00108-0; Macen JL, 1996, P NATL ACAD SCI USA, V93, P9108, DOI 10.1073/pnas.93.17.9108; Martin P, 2005, BLOOD, V106, P2871, DOI 10.1182/blood-2005-04-1522; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Mullbacher A, 1999, P NATL ACAD SCI USA, V96, P13950, DOI 10.1073/pnas.96.24.13950; Mullbacher A, 1996, P NATL ACAD SCI USA, V93, P5783, DOI 10.1073/pnas.93.12.5783; Mullbacher A, 1999, J VIROL, V73, P1665; Mullbacher A, 2004, PROG MOL SUBCELL BIO, V36, P39; Mullbacher A, 1999, J IMMUNOL, V162, P7315; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; Pardo J, 2007, CELL DEATH DIFFER, V14, P1768, DOI 10.1038/sj.cdd.4402183; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; Pardo J, 2002, EUR J IMMUNOL, V32, P1980, DOI 10.1002/1521-4141(200207)32:7<1980::AID-IMMU1980>3.0.CO;2-Z; Pardo J, 2002, EUR J IMMUNOL, V32, P2881, DOI 10.1002/1521-4141(2002010)32:10<2881::AID-IMMU2881>3.0.CO;2-K; PEITSCH MC, 1994, METHOD ENZYMOL, V244, P80; Pereira RA, 2000, J VIROL, V74, P1029, DOI 10.1128/JVI.74.2.1029-1032.2000; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; PICKUP DJ, 1986, P NATL ACAD SCI USA, V83, P7698, DOI 10.1073/pnas.83.20.7698; POSTIGO A, 2006, CELL DEATH DIFFER; Regner M, 2009, J IMMUNOL, V183, P37, DOI 10.4049/jimmunol.0900466; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; Riera L, 2000, EUR J IMMUNOL, V30, P1350, DOI 10.1002/(SICI)1521-4141(200005)30:5<1350::AID-IMMU1350>3.0.CO;2-J; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; SIMON MM, 1994, METHOD ENZYMOL, V244, P68; Simon MM, 1997, J EXP MED, V186, P1781, DOI 10.1084/jem.186.10.1781; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; TEWARI M, 1995, J BIOL CHEM, V270, P22705, DOI 10.1074/jbc.270.39.22705; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Turk B, 2007, FEBS LETT, V581, P2761, DOI 10.1016/j.febslet.2007.05.038; Turner SJ, 2000, J GEN VIROL, V81, P2425, DOI 10.1099/0022-1317-81-10-2425; vandenBroek HF, 1995, EUR J IMMUNOL, V25, P3514, DOI 10.1002/eji.1830251246; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wallich R, 2001, VIRAL IMMUNOL, V14, P71, DOI 10.1089/08828240151061428; Wang Y, 2004, IMMUNOL CELL BIOL, V82, P170, DOI 10.1046/j.0818-9641.2004.01227.x; Wasilenko ST, 2005, J VIROL, V79, P14031, DOI 10.1128/JVI.79.22.14031-14043.2005; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	61	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7512	10.1371/journal.pone.0007512	http://dx.doi.org/10.1371/journal.pone.0007512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838298	gold, Green Published, Green Submitted			2022-12-25	WOS:000270880900013
J	Sacristan, S; Vigouroux, M; Pedersen, C; Skamnioti, P; Thordal-Christensen, H; Micali, C; Brown, JKM; Ridout, CJ				Sacristan, Soledad; Vigouroux, Marielle; Pedersen, Carsten; Skamnioti, Pari; Thordal-Christensen, Hans; Micali, Cristina; Brown, James K. M.; Ridout, Christopher J.			Coevolution between a Family of Parasite Virulence Effectors and a Class of LINE-1 Retrotransposons	PLOS ONE			English	Article							POWDERY MILDEW RESISTANCE; TRANSPOSABLE ELEMENTS; PHYLOGENETIC ANALYSIS; ADAPTIVE EVOLUTION; BLUMERIA-GRAMINIS; RXLR EFFECTORS; GENE FAMILY; DISEASE; PROTEIN; FUNGI	Parasites are able to evolve rapidly and overcome host defense mechanisms, but the molecular basis of this adaptation is poorly understood. Powdery mildew fungi (Erysiphales, Ascomycota) are obligate biotrophic parasites infecting nearly 10,000 plant genera. They obtain their nutrients from host plants through specialized feeding structures known as haustoria. We previously identified the AVRk1 powdery mildew-specific gene family encoding effectors that contribute to the successful establishment of haustoria. Here, we report the extensive proliferation of the AVRk1 gene family throughout the genome of B. graminis, with sequences diverging in formae speciales adapted to infect different hosts. Also, importantly, we have discovered that the effectors have coevolved with a particular family of LINE-1 retrotransposons, named TE1a. The coevolution of these two entities indicates a mutual benefit to the association, which could ultimately contribute to parasite adaptation and success. We propose that the association would benefit 1) the powdery mildew fungus, by providing a mechanism for amplifying and diversifying effectors and 2) the associated retrotransposons, by providing a basis for their maintenance through selection in the fungal genome.			Sacristan, S (corresponding author), John Innes Ctr, Dept Dis & Stress Biol, Norwich, Norfolk, England.	soledad.sacristan@upm.es	Pedersen, Carsten/F-6797-2014; Thordal-Christensen, Hans/F-6281-2014; Pedersen, Carsten/L-7266-2013; SACRISTAN, SOLEDAD/H-1062-2015	Pedersen, Carsten/0000-0002-9520-2232; Thordal-Christensen, Hans/0000-0001-8813-0157; Pedersen, Carsten/0000-0002-9520-2232; SACRISTAN, SOLEDAD/0000-0002-5753-2644; Ridout, Christopher/0000-0001-9287-938X	BBSRC [BB/E000983/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E000983/1, BB/C506299/1, BBS/E/J/0000A252] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Birch PRJ, 2008, CURR OPIN PLANT BIOL, V11, P373, DOI 10.1016/j.pbi.2008.04.005; Brown JKM, 2002, POWDERY MILDEWS: A COMPREHENSIVE TREATISE, P56; Brown JKM, 1995, PLANT PATHOL, V44, P1039, DOI 10.1111/j.1365-3059.1995.tb02663.x; Catanzariti AM, 2007, FEMS MICROBIOL LETT, V269, P181, DOI 10.1111/j.1574-6968.2007.00684.x; Charleston MA, 1998, MATH BIOSCI, V149, P191, DOI 10.1016/S0025-5564(97)10012-8; Charleston MA, 2002, SYST BIOL, V51, P528, DOI 10.1080/10635150290069940; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Grell MN, 2003, GENE, V311, P181, DOI 10.1016/S0378-1119(03)00610-3; HAFNER MS, 1988, NATURE, V332, P258, DOI 10.1038/332258a0; HIURA U., 1955, Berichte des Ohara Instituts fur Landwirtschaftliche Biologie, Okayama Universitat, V10, P135; Hughes J, 2007, SYST BIOL, V56, P232, DOI 10.1080/10635150701311370; Inuma T, 2007, MOL PHYLOGENET EVOL, V44, P741, DOI 10.1016/j.ympev.2007.01.007; JENSEN J, 1995, HEREDITAS, V122, P197, DOI 10.1111/j.1601-5223.1995.00197.x; Jiang RHY, 2006, GENOME RES, V16, P827, DOI 10.1101/gr.5193806; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; JORGENSEN JH, 1994, CRIT REV PLANT SCI, V13, P97, DOI 10.1080/713608055; KEARNEY B, 1988, NATURE, V332, P541, DOI 10.1038/332541a0; Khang CH, 2008, MOL PLANT MICROBE IN, V21, P658, DOI 10.1094/MPMI-21-5-0658; Kidwell MG, 2000, TRENDS ECOL EVOL, V15, P95, DOI 10.1016/S0169-5347(99)01817-0; Kulikova T, 2007, NUCLEIC ACIDS RES, V35, pD16, DOI 10.1093/nar/gkl913; Kvitko BH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000388; LENK A, 2009, ADV BOT RES IN PRESS; Ma WB, 2008, CURR OPIN PLANT BIOL, V11, P412, DOI 10.1016/j.pbi.2008.05.001; Marchal E, 1902, CR HEBD ACAD SCI, V135, P210; Munroe SH, 2004, J CELL BIOCHEM, V93, P664, DOI 10.1002/jcb.20252; OKU T, 1985, Annals of the Phytopathological Society of Japan, V51, P613, DOI 10.3186/jjphytopath.51.613; Page RDM, 1998, TRENDS ECOL EVOL, V13, P356, DOI 10.1016/S0169-5347(98)01438-4; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; Ronquist F, 1995, CLADISTICS, V11, P73, DOI 10.1111/j.1096-0031.1995.tb00005.x; Sacristan S, 2008, MOL PLANT PATHOL, V9, P369, DOI 10.1111/J.1364-3703.2007.00460.X; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shen QH, 2003, PLANT CELL, V15, P732, DOI 10.1105/tpc.009258; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Skamnioti P, 2005, MOL PLANT PATHOL, V6, P551, DOI [10.1111/j.1364-3703.2005.00302.x, 10.1111/J.1364-3703.2005.00302.X]; Skamnioti P, 2008, FUNGAL GENET BIOL, V45, P243, DOI 10.1016/j.fgb.2007.09.011; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smartt JS, 1995, EVOLUTION CROP PLANT, VSecond edn., P133; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Soanes DM, 2006, MOL PLANT PATHOL, V7, P61, DOI 10.1111/J.1364-3703.2005.00317.X; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stevens C, 1998, MOL MICROBIOL, V29, P165, DOI 10.1046/j.1365-2958.1998.00918.x; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Takamatsu Susumu, 2004, Mycoscience, V45, P340, DOI 10.1007/s10267-004-0187-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TOSA Y, 1995, JPN J GENET, V70, P127, DOI 10.1266/jjg.70.127; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yahiaoui N, 2006, PLANT J, V47, P85, DOI 10.1111/j.1365-313X.2006.02772.x; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhou EX, 2007, FUNGAL GENET BIOL, V44, P1024, DOI 10.1016/j.fgb.2007.02.003; Zohary D., 1988, DOMESTICATION PLANTS	63	50	50	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7463	10.1371/journal.pone.0007463	http://dx.doi.org/10.1371/journal.pone.0007463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829700	Green Submitted, Green Published, gold			2022-12-25	WOS:000270847800006
J	Szymanski, J; Jozefczuk, S; Nikoloski, Z; Selbig, J; Nikiforova, V; Catchpole, G; Willmitzer, L				Szymanski, Jedrzej; Jozefczuk, Szymon; Nikoloski, Zoran; Selbig, Joachim; Nikiforova, Victoria; Catchpole, Gareth; Willmitzer, Lothar			Stability of Metabolic Correlations under Changing Environmental Conditions in Escherichia coli - A Systems Approach	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SMALL-WORLD; TREHALOSE SYNTHESIS; GENE-EXPRESSION; TEMPERATURE; STRESS; NETWORKS; YEAST; STABILIZATION; TRANSCRIPTOME	Background: Biological systems adapt to changing environments by reorganizing their cellular and physiological program with metabolites representing one important response level. Different stresses lead to both conserved and specific responses on the metabolite level which should be reflected in the underlying metabolic network. Methodology/Principal Findings: Starting from experimental data obtained by a GC-MS based high-throughput metabolic profiling technology we here develop an approach that: (1) extracts network representations from metabolic condition-dependent data by using pairwise correlations, (2) determines the sets of stable and condition-dependent correlations based on a combination of statistical significance and homogeneity tests, and (3) can identify metabolites related to the stress response, which goes beyond simple observations about the changes of metabolic concentrations. The approach was tested with Escherichia coli as a model organism observed under four different environmental stress conditions (cold stress, heat stress, oxidative stress, lactose diauxie) and control unperturbed conditions. By constructing the stable network component, which displays a scale free topology and small-world characteristics, we demonstrated that: (1) metabolite hubs in this reconstructed correlation networks are significantly enriched for those contained in biochemical networks such as EcoCyc, (2) particular components of the stable network are enriched for functionally related biochemical pathways, and (3) independently of the response scale, based on their importance in the reorganization of the correlation network a set of metabolites can be identified which represent hypothetical candidates for adjusting to a stress-specific response. Conclusions/Significance: Network-based tools allowed the identification of stress-dependent and general metabolic correlation networks. This correlation-network-based approach does not rely on major changes in concentration to identify metabolites important for stress adaptation, but rather on the changes in network properties with respect to metabolites. This should represent a useful complementary technique in addition to more classical approaches.			Szymanski, J (corresponding author), Max Planck Inst Mol Plant Physiol, Potsdam, Germany.	willmitzer@mpimp-golm.mpg.de	Willmitzer, Lothar/F-7377-2011	Nikoloski, Zoran/0000-0003-2671-6763; Szymanski, Jedrzej/0000-0003-1086-0920				Akaike H, 1983, INT STAT I, V44, P277, DOI DOI 10.1086/PHOS.50.4.187553; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Arita M, 2005, J BIOCHEM, V138, P1, DOI 10.1093/jb/mvi094; ATTFIELD PV, 1987, FEBS LETT, V225, P259, DOI 10.1016/0014-5793(87)81170-5; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Becerra M, 2003, COMP FUNCT GENOM, V4, P366, DOI 10.1002/cfg.301; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Bijlsma R., 1997, ENV STRESS ADAPTATIO; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P459, DOI 10.1016/0011-2240(88)90054-5; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; CSARDI G, IGRAPH LIB, P29; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; Evans RI, 1998, INT J FOOD MICROBIOL, V40, P159, DOI 10.1016/S0168-1605(98)00029-4; FELL D, 1992, BIOCH J         0901, P313; Fell DA, 2000, NAT BIOTECHNOL, V18, P1121, DOI 10.1038/81025; Gadgil M, 2005, BIOTECHNOL PROGR, V21, P689, DOI 10.1021/bp049630l; Hirt H., 2004, PLANT RESPONSES ABIO; HOTTIGER T, 1994, EUR J BIOCHEM, V219, P187, DOI 10.1111/j.1432-1033.1994.tb19929.x; Hounsa CG, 1998, MICROBIOL-UK, V144, P671, DOI 10.1099/00221287-144-3-671; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kandror O, 2002, P NATL ACAD SCI USA, V99, P9727, DOI 10.1073/pnas.142314099; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Koerkamp MG, 2002, MOL BIOL CELL, V13, P2783, DOI 10.1091/mbc.E02-02-0075; Kopka J, 2006, J BIOTECHNOL, V124, P312, DOI 10.1016/j.jbiotec.2005.12.012; Kose F, 2001, BIOINFORMATICS, V17, P1198, DOI 10.1093/bioinformatics/17.12.1198; Kusano M, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-53; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Ma HW, 2003, BIOINFORMATICS, V19, P1423, DOI 10.1093/bioinformatics/btg177; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; MARCOTTE EM, 2001, NAT BIOTECHNOL, P626; MARR AG, 1962, J BACTERIOL, V84, P1260, DOI 10.1128/JB.84.6.1260-1267.1962; Muller-Linow M, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-44; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nikiforova VJ, 2005, J EXP BOT, V56, P1887, DOI 10.1093/jxb/eri179; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Phadtare S, 2004, J BACTERIOL, V186, P7007, DOI 10.1128/JB.186.20.7007-7014.2004; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; ROTTEM S, 1978, EUR J BIOCHEM, V85, P445, DOI 10.1111/j.1432-1033.1978.tb12258.x; RUDOLPH AS, 1985, CRYOBIOLOGY, V22, P367, DOI 10.1016/0011-2240(85)90184-1; Sahara T, 2002, J BIOL CHEM, V277, P50015, DOI 10.1074/jbc.M209258200; Sakamoto T, 1986, AKAIKE INFORM CRITER; Schade B, 2004, MOL BIOL CELL, V15, P5492, DOI 10.1091/mbc.E04-03-0167; Schauer N, 2006, TRENDS PLANT SCI, V11, P508, DOI 10.1016/j.tplants.2006.08.007; Schuster S, 2001, TRENDS BIOTECHNOL, V19, P85, DOI 10.1016/S0167-7799(01)01573-6; Shahjee HM, 2002, J BIOSCIENCES, V27, P515, DOI 10.1007/BF02705049; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smart AG, 2008, P NATL ACAD SCI USA, V105, P13223, DOI 10.1073/pnas.0803571105; Southam AD, 2008, J PROTEOME RES, V7, P5277, DOI 10.1021/pr800353t; STEFAN H, 2003, YEAST STRESS RESPONS; Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120; Steuer R, 2007, BIOINFORMATICS, V23, P1378, DOI 10.1093/bioinformatics/btm065; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Szymanski J, 2007, PHYTOCHEMISTRY, V68, P2163, DOI 10.1016/j.phytochem.2007.04.017; Tai SL, 2007, MOL BIOL CELL, V18, P5100, DOI 10.1091/mbc.E07-02-0131; Taymaz-Nikerel H, 2009, ANAL BIOCHEM, V386, P9, DOI 10.1016/j.ab.2008.11.018; Traxler MF, 2006, P NATL ACAD SCI USA, V103, P2374, DOI 10.1073/pnas.0510995103; Virgilio C. de, 1994, European Journal of Biochemistry, V219, P179, DOI 10.1111/j.1432-1033.1994.tb19928.x; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weckwerth W, 2002, CURR OPIN BIOTECH, V13, P156, DOI 10.1016/S0958-1669(02)00299-9; Winder CL, 2008, ANAL CHEM, V80, P2939, DOI 10.1021/ac7023409; Wittmann C, 2007, J BIOTECHNOL, V132, P375, DOI 10.1016/j.jbiotec.2007.07.495; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	71	28	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7441	10.1371/journal.pone.0007441	http://dx.doi.org/10.1371/journal.pone.0007441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829699	Green Published, Green Submitted, gold			2022-12-25	WOS:000270847800003
J	Pich, OQ; Burgos, R; Querol, E; Pinol, J				Pich, Oscar Q.; Burgos, Raul; Querol, Enrique; Pinol, Jaume			P110 and P140 Cytadherence-Related Proteins Are Negative Effectors of Terminal Organelle Duplication in Mycoplasma genitalium	PLOS ONE			English	Article							MINIMAL GENE COMPLEMENT; GLIDING MOTILITY; ATTACHMENT ORGANELLE; CELL-ADHESION; PNEUMONIAE; ULTRASTRUCTURE; TRANSCRIPTION; REVEALS; MOBILE; P41	Background: The terminal organelle is a complex structure involved in many aspects of the biology of mycoplasmas such as cell adherence, motility or cell division. Mycoplasma genitalium cells display a single terminal organelle and duplicate this structure prior to cytokinesis in a coordinated manner with the cell division process. Despite the significance of the terminal organelle in mycoplasma virulence, little is known about the mechanisms governing its duplication. Methodology/Principal Findings: In this study we describe the isolation of a mutant, named T192, with a transposon insertion close to the 39 end of the mg192 gene encoding for P110 adhesin. This mutant shows a truncated P110, low levels of P140 and P110 adhesins, a large number of non-motile cells and a high frequency of new terminal organelle formation. Further analyses revealed that the high rates of new terminal organelle formation in T192 cells are a direct consequence of the reduced levels of P110 and P140 rather than to the expression of a truncated P110. Consistently, the phenotype of the T192 mutant was successfully complemented by the reintroduction of the mg192 WT allele which restored the levels of P110 and P140 to those of the WT strain. Quantification of DAPI-stained DNA also showed that the increase in the number of terminal organelles in T192 cells is not accompanied by a higher DNA content, indicating that terminal organelle duplication does not trigger DNA replication in mycoplasmas. Conclusions/Significance: Our results demonstrate the existence of a mechanism regulating terminal organelle duplication in M. genitalium and strongly suggest the implication of P110 and P140 adhesins in this mechanism.			Pich, OQ (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.	jaume.pinyol@uab.es	Pich, Oscar Quijada/F-7795-2016; Burgos, Raul/AAL-3612-2021	Pich, Oscar Quijada/0000-0003-3561-630X; Pinol, Jaume/0000-0002-9055-8934; Burgos, Raul/0000-0002-4452-9235				BOATMAN ES, 1979, MYCOPLASMAS, V1, P63; BREDT W, 1977, J BACTERIOL, V130, P937, DOI 10.1128/JB.130.2.937-938.1977; BREDT W, 1968, PATHOL MICROBIOL, V32, P321, DOI 10.1159/000162074; Burgos R, 2008, MOL MICROBIOL, V69, P1029, DOI 10.1111/j.1365-2958.2008.06343.x; Burgos R, 2007, J BACTERIOL, V189, P7014, DOI 10.1128/JB.00975-07; Burgos R, 2006, J BACTERIOL, V188, P8627, DOI 10.1128/JB.00978-06; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; GOBEL U, 1981, J CELL BIOL, V91, P537, DOI 10.1083/jcb.91.2.537; Hasselbring BA, 2006, J BACTERIOL, V188, P6335, DOI 10.1128/JB.00698-06; Hasselbring BM, 2007, J BACTERIOL, V189, P7442, DOI 10.1128/JB.00867-07; Hasselbring BM, 2007, MOL MICROBIOL, V63, P44, DOI 10.1111/j.1365-2958.2006.05507.x; Hasselbring BM, 2006, P NATL ACAD SCI USA, V103, P16478, DOI 10.1073/pnas.0608051103; Hatchel JM, 2008, MICROBIOL-SGM, V154, P286, DOI 10.1099/mic.0.2007/012765-0; Hatchel JM, 2006, MICROBIOL-SGM, V152, P2181, DOI 10.1099/mic.0.28905-0; Hegermann J, 2002, NATURWISSENSCHAFTEN, V89, P453, DOI 10.1007/s00114-002-0359-2; Herrmann R, 1998, CURR OPIN MICROBIOL, V1, P572, DOI 10.1016/S1369-5274(98)80091-X; Hottes AK, 2005, MOL MICROBIOL, V58, P1340, DOI 10.1111/j.1365-2958.2005.04912.x; HU PC, 1987, INFECT IMMUN, V55, P1126, DOI 10.1128/IAI.55.5.1126-1131.1987; Lluch-Senar M, 2007, MICROBIOL-SGM, V153, P2743, DOI 10.1099/mic.0.2006/007559-0; MENG KE, 1980, J BACTERIOL, V144, P390, DOI 10.1128/JB.144.1.390-399.1980; MERNAUGH GR, 1993, CLIN INFECT DIS, V17, pS69, DOI 10.1093/clinids/17.Supplement_1.S69; Miyata M, 2000, MICROBIOL-UK, V146, P1311, DOI 10.1099/00221287-146-6-1311; Nakane D, 2007, P NATL ACAD SCI USA, V104, P19518, DOI 10.1073/pnas.0704280104; Pich OQ, 2006, MICROBIOL-SGM, V152, P519, DOI 10.1099/mic.0.28287-0; Pich OQ, 2008, MICROBIOL-SGM, V154, P3188, DOI 10.1099/mic.0.2008/020636-0; Pich OQ, 2006, MOL MICROBIOL, V60, P1509, DOI 10.1111/j.1365-2958.2006.05187.x; QUINLAN DC, 1972, J BACTERIOL, V112, P1375, DOI 10.1128/JB.112.3.1375-1379.1972; RADESTOCK U, 1977, J BACTERIOL, V129, P1495, DOI 10.1128/JB.129.3.1495-1501.1977; Regula JT, 2001, MICROBIOL-UK, V147, P1045, DOI 10.1099/00221287-147-4-1045; ROSENGARTEN R, 1987, J BACTERIOL, V169, P1891, DOI 10.1128/jb.169.5.1891-1898.1987; Seto S, 2001, J BACTERIOL, V183, P1621, DOI 10.1128/JB.183.5.1621-1630.2001; TAYLORROBINSON D, 1983, YALE J BIOL MED, V56, P910; TULLY JG, 1979, J INFECT DIS, V139, P478, DOI 10.1093/infdis/139.4.478	33	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7452	10.1371/journal.pone.0007452	http://dx.doi.org/10.1371/journal.pone.0007452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19829712	Green Published, gold, Green Submitted			2022-12-25	WOS:000270808700013
J	Wen, JM; Jiang, XZ; Dai, YB; Zhang, YJ; Tang, YX; Sun, H; Mi, TJ; Phatarpekar, PV; Kellems, RE; Blackburn, MR; Xia, Y				Wen, Jiaming; Jiang, Xianzhen; Dai, Yingbo; Zhang, Yujin; Tang, Yuxin; Sun, Hong; Mi, Tiejuan; Phatarpekar, Prasad V.; Kellems, Rodney E.; Blackburn, Michael R.; Xia, Yang			Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A(2B) adenosine receptor signaling	FASEB JOURNAL			English	Article						adenosine deaminase-deficient mice; sickle cell disease; TGF-beta; signaling pathway	DEAMINASE-DEFICIENT MICE; CAVERNOSAL NERVE RESECTION; SICKLE-CELL-DISEASE; VENOOCCLUSIVE DYSFUNCTION; FIBROBLAST PROLIFERATION; PULMONARY-FIBROSIS; LUNG FIBROBLASTS; FIBROTIC PLAQUE; NITRIC-OXIDE; MOUSE MODEL	Priapism is a condition of persistent penile erection in the absence of sexual excitation. Of men with sickle cell disease (SCD), 40% display priapism. The disorder is a dangerous and urgent condition, given its association with penile fibrosis and eventual erectile dysfunction. Current strategies to prevent its progression are poor because of a lack of fundamental understanding of the molecular mechanisms for penile fibrosis in priapism. Here we demonstrate that increased adenosine is a novel causative factor contributing to penile fibrosis in two independent animal models of priapism, adenosine deaminase (ADA)-deficient mice and SCD transgenic mice. An important finding is that chronic reduction of adenosine by ADA enzyme therapy successfully attenuated penile fibrosis in both mouse models, indicating an essential role of increased adenosine in penile fibrosis and a novel therapeutic possibility for this serious complication. Subsequently, we identified that both mice models share a similar fibrotic gene expression profile in penile tissue (including procollagen I, TGF-beta(1) 1, and plasminogen activator inhibitor-1 mRNA), suggesting that they share similar signaling pathways for progression to penile fibrosis. Thus, in an effort to decipher specific cell types and underlying mechanism responsible for adenosine-mediated penile fibrosis, we purified corpus cavernosal fibroblast cells (CCFCs), the major cell type involved in this process, from wild-type mice. Quantitative RT-PCR showed that the major receptor expressed in these cells is the adenosine receptor A(2B)R. Based on this fact, we further purified CCFCs from A(2B)R-deficient mice and demonstrated that A(2B)R is essential for excess adenosine-mediated penile fibrosis. Finally, we revealed that TGF-beta functions downstream of the A(2B)R to increase CCFC collagen secretion and proliferation. Overall, our studies identify an essential role of increased adenosine in the pathogenesis of penile fibrosis via A(2B)R signaling and offer a potential target for prevention and treatment of penile fibrosis, a dangerous complication seen in priapism.-Wen, J., Jiang, X., Dai, Y., Zhang, Y., Tang, Y., Sun, H., Mi, T., Phatarpekar, P. V., Kellems, R. E., Blackburn, M. R., Xia, Y. Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A(2B) adenosine receptor signaling. FASEB J. 24, 740-749 (2010). www.fasebj.org	[Wen, Jiaming; Dai, Yingbo; Zhang, Yujin; Mi, Tiejuan; Phatarpekar, Prasad V.; Kellems, Rodney E.; Blackburn, Michael R.; Xia, Yang] Univ Texas Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Wen, Jiaming; Jiang, Xianzhen; Dai, Yingbo; Tang, Yuxin] Cent S Univ, Xiangya Hosp 3, Dept Urol, Changsha, Hunan, Peoples R China; [Sun, Hong] Cent S Univ, Xiangya Hosp 3, Dept Otorhinolaryngol, Changsha, Hunan, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; Central South University; Central South University	Xia, Y (corresponding author), Univ Texas Houston Med Sch, Dept Biochem & Mol Biol, 6431 Fannin St,MSB 6-200, Houston, TX 77030 USA.	yang.xia@uth.tmc.edu	tang, yuxin/GZN-2336-2022	Blackburn, Michael/0000-0002-1394-9966	U.S. National Institute of Health [DK077748, DK083559, HL070952]; China Scholarship Council [2008637068]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077748, R01DK083559] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institute of Health grants DK077748 (to Y.X.), DK083559 (to Y. X), and HL070952 (to M. R. B.) and by China Scholarship Council 2008637068 (to J.W.).	Bivalacqua TJ, 2009, J SEX MED, V6, P2494, DOI 10.1111/j.1743-6109.2009.01359.x; Blackburn MR, 2000, J BIOL CHEM, V275, P32114, DOI 10.1074/jbc.M005153200; Blackburn MR, 2005, ADV IMMUNOL, V86, P1, DOI 10.1016/S0065-2776(04)86001-2; Blackburn MR, 1996, J BIOL CHEM, V271, P15203, DOI 10.1074/jbc.271.25.15203; Blackburn MR, 1998, J BIOL CHEM, V273, P5093, DOI 10.1074/jbc.273.9.5093; Booth C, 2007, CLIN IMMUNOL, V123, P139, DOI 10.1016/j.clim.2006.12.009; Bruno D, 2001, J UROLOGY, V166, P803, DOI 10.1016/S0022-5347(05)65841-7; Burnett AL, 2006, J UROLOGY, V175, pS25, DOI 10.1016/S0022-5347(05)00309-5; Burnett AL, 2003, INT J IMPOT RES, V15, pS80, DOI 10.1038/sj.ijir.3901077; Burnett AL, 2003, J UROLOGY, V170, P26, DOI 10.1097/01.ju.0000046303.22757.f2; Chan ESL, 2006, BRIT J PHARMACOL, V148, P1144, DOI 10.1038/sj.bjp.0706812; Chandrasekharan BP, 2009, FASEB J, V23, P2727, DOI 10.1096/fj.09-129544; Che J, 2007, MOL PHARMACOL, V72, P1626, DOI 10.1124/mol.107.038760; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chunn JL, 2006, AM J PHYSIOL-LUNG C, V290, pL579, DOI 10.1152/ajplung.00258.2005; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; Chunn JL, 2001, J IMMUNOL, V167, P4676, DOI 10.4049/jimmunol.167.8.4676; Claudino MA, 2009, J SEX MED, V6, P2187, DOI 10.1111/j.1743-6109.2009.01337.x; Cronstein Bruce N, 2004, ScientificWorldJournal, V4, P1; Dai YB, 2009, J SEX MED, V6, P292, DOI 10.1111/j.1743-6109.2008.01187.x; Davila HH, 2004, BIOL REPROD, V71, P1568, DOI 10.1095/biolreprod.104.030833; de Andrade CR, 2001, J PERIODONTOL, V72, P1726, DOI 10.1902/jop.2001.72.12.1726; Diggs LW, 1934, SOUTH MED J, V27, P839; Eickelberg O, 2001, FASEB J, V15, P797, DOI 10.1096/fj.00-0233com; Ferrini MG, 2006, UROLOGY, V68, P429, DOI 10.1016/j.urology.2006.05.011; Fredholm BB, 2007, CELL DEATH DIFFER, V14, P1315, DOI 10.1038/sj.cdd.4402132; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Hershfield MS, 2005, EUR J IMMUNOL, V35, P25, DOI 10.1002/eji.200425738; Konigshoff M, 2007, AM J RESP CELL MOL, V37, P640, DOI 10.1165/rcmb.2006-0379TR; Kovanecz I, 2008, INT J IMPOT RES, V20, P202, DOI 10.1038/sj.ijir.3901612; Kovanecz I, 2008, BJU INT, V101, P203, DOI 10.1111/j.1464-410X.2007.07223.x; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Paszty C, 1997, Curr Opin Hematol, V4, P88; Rachid D, 2009, UROLOGY, V74, P1054, DOI 10.1016/j.urology.2009.04.071; Ramirez A, 2007, AM J PHYSIOL-LUNG C, V293, pL972, DOI 10.1152/ajplung.00010.2007; Ryan TM, 1997, SCIENCE, V278, P873, DOI 10.1126/science.278.5339.873; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Van Der Horst C., 2003, Int. braz j urol., V29, P391, DOI 10.1590/S1677-55382003000500002; Vernet D, 2002, NITRIC OXIDE-BIOL CH, V7, P262, DOI 10.1016/S1089-8603(02)00124-6; Zhong HY, 2005, AM J RESP CELL MOL, V32, P2, DOI 10.1165/rcmb.2004-0103OC	41	60	62	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2010	24	3					740	749		10.1096/fj.09-144147	http://dx.doi.org/10.1096/fj.09-144147			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	561KE	19858092	Green Published			2022-12-25	WOS:000274974600010
J	Zhu, T; Tsuji, T; Chen, C				Zhu, T.; Tsuji, T.; Chen, C.			Roles of PKC isoforms in the induction of apoptosis elicited by aberrant Ras	ONCOGENE			English	Article						PKC isoforms; oncogenic Ras; p73; apoptosis	PROTEIN-KINASE-C; PROTEOLYTIC ACTIVATION; TYROSINE PHOSPHORYLATION; DELTA ACTIVATION; P73; CELLS; GROWTH; ALPHA; TRANSLOCATION; PATHWAY	Emerging evidence indicates that suppression of protein kinase C (PKC) renders the susceptibility of cells expressing mutated ras to apoptosis. Although the effort has been made, the underlying molecular mechanisms are not fully understood. In this study, using small hairpin RNAs (shRNAs) or PKC inhibitor, we show that the concurrent suppression of PKC-alpha and beta induces cells ectopically expressing nu-ras to undergo apoptosis. In this apoptotic process, PKC-delta is upregulated and translocated from the cytosol to the nucleus. The activated PKC-delta associates with and phosphorylates p73 to initiate apoptosis. In this apoptotic process, Akt seems to be downstream of oncogenic Ras. Moreover, overexpression of PKC-delta, without co-suppression of PKC-alpha and beta, is not apoptotic to the cells, suggesting that PKC-delta and PKC-alpha/beta function oppositely to facilitate cells harboring nu-ras to survive. Thus, our study shows that PKC-alpha and beta are necessary for sustaining the homeostasis in cells containing a hyperactive Ras. The abrogation of these two isoforms switches on the p73-regulated apoptotic machinery through the activation of PKC-delta. Oncogene (2010) 29, 1050-1061; doi:10.1038/onc.2009.344; published online 19 October 2009	[Zhu, T.; Tsuji, T.; Chen, C.] Harvard Univ, Sch Med, Dept Radiat Oncol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Chen, C (corresponding author), Harvard Univ, Sch Med, Dept Radiat Oncol, Beth Israel Deaconess Med Ctr, 99 Brookline Ave,RN-325F, Boston, MA 02215 USA.	cchen6@bidmc.harvard.edu			National Institutes of Health [RO1CA100498]; Department of Defense [W81XWH-04-1-0246]; NATIONAL CANCER INSTITUTE [R01CA100498] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs Z Luo and Q Yu (Boston University School of Medicine, Boston, MA, USA) for providing various reagents and useful suggestions. This study is supported by the National Institutes of Health (RO1CA100498) and the Department of Defense (W81XWH-04-1-0246).	Aaltonen V, 2007, CANCER LETT, V253, P97, DOI 10.1016/j.canlet.2007.01.011; Agami R, 1999, NATURE, V399, P809; Atten MJ, 2005, INVEST NEW DRUG, V23, P111, DOI 10.1007/s10637-005-5855-8; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Braun MU, 2003, J MOL CELL CARDIOL, V35, P895, DOI 10.1016/S0022-2828(03)00142-1; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Chau BN, 2004, MOL CELL BIOL, V24, P4438, DOI 10.1128/MCB.24.10.4438-4447.2004; Chen CY, 1998, CELL DEATH DIFFER, V5, P984, DOI 10.1038/sj.cdd.4400448; Chen CY, 1998, J BIOL CHEM, V273, P16700, DOI 10.1074/jbc.273.27.16700; Chen EB, 2001, J IRON STEEL RES INT, V8, P12; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; Deng X, 2001, J Natl Cancer Inst Monogr, P30; Denning MF, 1996, J BIOL CHEM, V271, P5325, DOI 10.1074/jbc.271.10.5325; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; DeVries-Seimon TA, 2007, J BIOL CHEM, V282, P22307, DOI 10.1074/jbc.M703661200; Eitel K, 2003, DIABETES, V52, P991, DOI 10.2337/diabetes.52.4.991; Emoto Y, 1996, BLOOD, V87, P1990; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; FUKASAWA K, 1995, ONCOGENE, V10, P1; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Gong JG, 1999, NATURE, V399, P806; Gonzalez S, 2003, MOL CELL BIOL, V23, P8161, DOI 10.1128/MCB.23.22.8161-8171.2003; Guo JJ, 2009, J CELL BIOCHEM, V107, P76, DOI 10.1002/jcb.22102; Gutcher I, 2003, CELL MOL LIFE SCI, V60, P1061, DOI 10.1007/s00018-003-2281-y; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Jackson DN, 2004, FASEB J, V18, P627, DOI 10.1096/fj.03-0979rev; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kajimoto T, 2004, J BIOL CHEM, V279, P12668, DOI 10.1074/jbc.M312350200; Kampfer S, 2001, J BIOL CHEM, V276, P42834, DOI 10.1074/jbc.M102047200; Kaul S, 2005, J BIOL CHEM, V280, P28721, DOI 10.1074/jbc.M501092200; Kawakami Y, 2003, P NATL ACAD SCI USA, V100, P9470, DOI 10.1073/pnas.1633695100; Kheifets V, 2006, J BIOL CHEM, V281, P23218, DOI 10.1074/jbc.M602075200; Kiley SC, 1999, ONCOGENE, V18, P6748, DOI 10.1038/sj.onc.1203101; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li WQ, 1998, MOL CELL BIOL, V18, P5888, DOI 10.1128/MCB.18.10.5888; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Mandil R, 2001, CANCER RES, V61, P4612; Matassa AA, 2001, J BIOL CHEM, V276, P29719, DOI 10.1074/jbc.M100273200; MCCORMICK F, 1993, NATURE, V363, P15, DOI 10.1038/363015a0; McNeill H, 1999, CURR BIOL, V9, pR176, DOI 10.1016/S0960-9822(99)80107-9; Min BW, 2008, EXP MOL MED, V40, P699, DOI 10.3858/emm.2008.40.6.699; Mizuno K, 1997, EUR J BIOCHEM, V250, P7, DOI 10.1111/j.1432-1033.1997.00007.x; Murriel CL, 2004, J BIOL CHEM, V279, P47985, DOI 10.1074/jbc.M405071200; Ni HY, 2003, BRIT J HAEMATOL, V121, P849, DOI 10.1046/j.1365-2141.2003.04368.x; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Ren J, 2002, J BIOL CHEM, V277, P33758, DOI 10.1074/jbc.M110667200; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Rusanescu G, 2001, MOL CELL BIOL, V21, P2650, DOI 10.1128/MCB.21.8.2650-2658.2001; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Sitailo LA, 2004, J INVEST DERMATOL, V123, P434, DOI 10.1111/j.0022-202X.2004.23403.x; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Wang HG, 1998, BIOFACTORS, V8, P13, DOI 10.1002/biof.5520080103; Whelan RDH, 1998, ONCOGENE, V16, P1939, DOI 10.1038/sj.onc.1201725; Xia SH, 2007, J BIOL CHEM, V282, P13199, DOI 10.1074/jbc.M610225200; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Zhang XM, 2005, CANCER CHEMOTH PHARM, V55, P251, DOI 10.1007/s00280-004-0863-5	60	18	18	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 18	2010	29	7					1050	1061		10.1038/onc.2009.344	http://dx.doi.org/10.1038/onc.2009.344			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	556PV	19838205	Green Accepted			2022-12-25	WOS:000274604400011
J	Su, F; Pascal, LE; Xiao, W; Wang, Z				Su, F.; Pascal, L. E.; Xiao, W.; Wang, Z.			Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53	ONCOGENE			English	Article						U19/EAF2; prostate cancer; tumor suppressor; TSP-1; p53	HIPPEL-LINDAU PROTEIN; ELONGATION-FACTOR ELL; PROSTATE-CANCER; GENE; ANGIOGENESIS; GROWTH; CELLS; CARCINOMA; APOPTOSIS; TRANSACTIVATION	Inactivation of U19/EAF2 has been shown previously to lead to tumorigenesis in multiple organs; however, the mechanism of U19/EAF2 tumor suppression remains unclear. In this paper, we report that the expression of an anti-angiogenic protein, thrombospondin-1 (TSP-1) is down-regulated in the prostate and liver of U19/EAF2 knockout mouse. The U19/EAF2 knockout liver displayed increased CD31-positive blood vessels, suggesting that the TSP-1 down-regulation can contribute to increased angiogenesis. TSP-1 is reported to be a p53-target gene and p53 is a known binding partner of ELL, which binds to U19/EAF2. Here, we show that U19/EAF2 can co-localize and co-immunoprecipitate with p53 in transfected cells. In a TSP-1 promoter-driven luciferase reporter assay, p53 transfection suppressed the TSP-1 promoter activity and U19/EAF2 co-transfection blocked the p53 suppression of TSP-1 promoter. However, U19/EAF2 transfection alone had little or no effect on the TSP-1 promoter. The above observations together suggest that U19/EAF2 regulates the expression of TSP-1 via blocking p53 repression of the TSP-1 promoter. Oncogene (2010) 29, 421-431; doi:10.1038/onc.2009.326; published online 12 October 2009	[Su, F.; Pascal, L. E.; Wang, Z.] Univ Pittsburgh, Sch Med, Inst Canc, Dept Urol, Pittsburgh, PA 15232 USA; [Xiao, W.] Chinese Acad Sci, Inst Hydrobiol, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan, Peoples R China; [Wang, Z.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, Z (corresponding author), Univ Pittsburgh, Sch Med, Inst Canc, Dept Urol, 5200 Ctr Ave,Suite G40, Pittsburgh, PA 15232 USA.	wangz2@upmc.edu	Pascal, Laura E./AAH-5743-2019; Xiao, Wuhan/GLU-7352-2022	Pascal, Laura E./0000-0003-3840-1662; SU, FEI/0000-0001-5834-4074	NIH [R01 CA 120386, R37 DK51993]; Prostate Cancer Specialized Program of Research Excellence (SPORE) [P50 CA90386]; NATIONAL CANCER INSTITUTE [P50CA090386, R01CA120386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK051193] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Specialized Program of Research Excellence (SPORE); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by NIH Grant Number R01 CA 120386, R37 DK51993, and Prostate Cancer Specialized Program of Research Excellence (SPORE), P50 CA90386.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez AA, 2001, GYNECOL ONCOL, V82, P273, DOI 10.1006/gyno.2001.6287; Azam N, 2001, J BIOL CHEM, V276, P2766, DOI 10.1074/jbc.M005626200; Cinatl J, 1999, AM J PATHOL, V155, P285, DOI 10.1016/S0002-9440(10)65122-X; DONOVIEL DB, 1988, J BIOL CHEM, V263, P18590; Duan X, 2008, INT J RADIAT BIOL, V84, P211, DOI 10.1080/09553000801902117; FRAMSON P, 1993, J BIOL CHEM, V268, P4989; Freitas TMC, 2005, EXP MOL PATHOL, V79, P79, DOI 10.1016/j.yexmp.2005.02.006; Harada H, 2003, CANCER LETT, V191, P109, DOI 10.1016/S0304-3835(02)00592-X; Jiang C, 2004, MOL CANCER THER, V3, P877; Kwak C, 2002, BJU INT, V89, P303, DOI 10.1046/j.1464-4096.2001.01417.x; MAEDA K, 1995, BRIT J CANCER, V72, P319, DOI 10.1038/bjc.1995.331; Mitani K, 2000, BIOCHEM BIOPH RES CO, V279, P563, DOI 10.1006/bbrc.2000.3970; Nelius T, 2007, INT J CANCER, V121, P999, DOI 10.1002/ijc.22802; Reiher FK, 2001, J UROLOGY, V165, P2075, DOI 10.1016/S0022-5347(05)66297-0; Ren B, 2006, BBA-REV CANCER, V1765, P178, DOI 10.1016/j.bbcan.2005.11.002; Roe JS, 2006, MOL CELL, V22, P395, DOI 10.1016/j.molcel.2006.04.006; SELFRIDGE J, 1992, SOMAT CELL MOLEC GEN, V18, P325, DOI 10.1007/BF01235756; Shinobu N, 1999, J BIOL CHEM, V274, P17003, DOI 10.1074/jbc.274.24.17003; Simone F, 2003, BLOOD, V101, P2355, DOI 10.1182/blood-2002-06-1664; Tokunaga T, 1998, VIRCHOWS ARCH, V433, P415, DOI 10.1007/s004280050268; Wang Z, 1997, P NATL ACAD SCI USA, V94, P12999, DOI 10.1073/pnas.94.24.12999; Wiederschain D, 2003, MOL CELL BIOL, V23, P4230, DOI 10.1128/MCB.23.12.4230-4246.2003; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Xiao WH, 2006, PROSTATE, V66, P1, DOI 10.1002/pros.20309; Xiao WH, 2003, CANCER RES, V63, P4698; Xiao WH, 2009, CANCER RES, V69, P2599, DOI 10.1158/0008-5472.CAN-08-2595; Zhou JG, 2009, J BIOL CHEM, V284, P19142, DOI 10.1074/jbc.M109.010439	28	32	34	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2010	29	3					421	431		10.1038/onc.2009.326	http://dx.doi.org/10.1038/onc.2009.326			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	546EO	19826414	Green Accepted			2022-12-25	WOS:000273793200011
J	Glekas, GD; Foster, RM; Cates, JR; Estrella, JA; Wawrzyniak, MJ; Rao, CV; Ordal, GW				Glekas, George D.; Foster, Richard M.; Cates, Joseph R.; Estrella, Jeffrey A.; Wawrzyniak, Michael J.; Rao, Christopher V.; Ordal, George W.			A PAS Domain Binds Asparagine in the Chemotaxis Receptor McpB in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; LIGAND-BINDING; ASPARTATE RECEPTOR; BACTERIAL CHEMOTAXIS; CRYSTAL-STRUCTURES; I-TASSER; KINASE; ADAPTATION; SERVER; PHOSPHORYLATION	During chemotaxis toward asparagine by Bacillus subtilis, the ligand is thought to bind to the chemoreceptor McpB on the exterior of the cell and induce a conformational change. This change affects the degree of phosphorylation of the CheA kinase bound to the cytoplasmic region of the receptor. Until recently, the sensing domains of the B. subtilis receptors were thought to be structurally similar to the well studied Escherichia coli four-helical bundle. However, sequence analysis has shown the sensing domains of receptors from these two organisms to be vastly different. Homology modeling of the sensing domain of the B. subtilis asparagine receptor McpB revealed two tandem PAS domains. McpB mutants having alanine substitutions in key arginine and tyrosine residues of the upper PAS domain but not in any residues of the lower PAS domain exhibited a chemotactic defect in both swarm plates and capillary assays. Thus, binding does not appear to occur across any dimeric surface but within a monomer. A modified capillary assay designed to determine the concentration of attractant where chemotaxis is most sensitive showed that when Arg-111, Tyr-121, or Tyr-133 is mutated to an alanine, much more asparagine is required to obtain an active chemoreceptor. Isothermal titration calorimetry experiments on the purified sensing domain showed a K-D to asparagine of 14 mu M, with the three mutations leading to less efficient binding. Taken together, these results reveal not only a novel chemoreceptor sensing domain architecture but also, possibly, a different mechanism for chemoreceptor activation.	[Rao, Christopher V.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Ordal, George W.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rao, CV (corresponding author), Univ Illinois, 600 S Mathews,211 RAL, Urbana, IL 61801 USA.	chris@scs.uiuc.edu; ordal@uiuc.edu			National Institutes of Health [R01GM54365]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM54365.	Acher FC, 2005, BIOPOLYMERS, V80, P357, DOI 10.1002/bip.20229; ADLER J, 1973, J GEN MICROBIOL, V74, P77, DOI 10.1099/00221287-74-1-77; Aizawa S., 2001, BACILLUS SUBTILIS IT, P437; Anantharaman V, 2000, TRENDS BIOCHEM SCI, V25, P535, DOI 10.1016/S0968-0004(00)01672-8; Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1016/S0378-1097(99)00197-4; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bjorkman AM, 2001, J BIOL CHEM, V276, P2808, DOI 10.1074/jbc.M009593200; BOURRET RB, 1989, J BIOL CHEM, V264, P7085; Chervitz SA, 1996, P NATL ACAD SCI USA, V93, P2545, DOI 10.1073/pnas.93.6.2545; Cheung J, 2008, J BIOL CHEM, V283, P30256, DOI 10.1074/jbc.M805253200; Falke JJ, 2001, TRENDS BIOCHEM SCI, V26, P257, DOI 10.1016/S0968-0004(00)01770-9; GOLDMAN DJ, 1982, BIOCHEMISTRY-US, V21, P915, DOI 10.1021/bi00534a016; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Jensen AA, 2000, EUR J PHARMACOL, V397, P247, DOI 10.1016/S0014-2999(00)00283-1; Kim KK, 1999, NATURE, V400, P787, DOI 10.1038/23512; Kristich CJ, 2002, J BIOL CHEM, V277, P25356, DOI 10.1074/jbc.M201334200; LIN LN, 1994, BIOCHEMISTRY-US, V33, P6564, DOI 10.1021/bi00187a025; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; MACNAB RM, 1978, CRC CR REV BIOCH MOL, V5, P291, DOI 10.3109/10409237809177145; MANSON MD, 1992, ADV MICROB PHYSIOL, V33, P277, DOI 10.1016/S0065-2911(08)60219-2; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; MILBURN MV, 1991, SCIENCE, V254, P1342, DOI 10.1126/science.1660187; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Neiditch MB, 2005, MOL CELL, V18, P507, DOI 10.1016/j.molcel.2005.04.020; ORDAL GW, 1977, J BACTERIOL, V129, P156, DOI 10.1128/JB.129.1.156-165.1977; ORDAL GW, 1975, SCIENCE, V189, P802, DOI 10.1126/science.808854; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Paas Y, 2000, TRENDS PHARMACOL SCI, V21, P87, DOI 10.1016/S0165-6147(99)01443-1; Paas Y, 1996, NEURON, V17, P979, DOI 10.1016/S0896-6273(00)80228-7; Pappalardo L, 2003, J BIOL CHEM, V278, P39185, DOI 10.1074/jbc.C300344200; Park SY, 2006, NAT STRUCT MOL BIOL, V13, P400, DOI 10.1038/nsmb1085; Rao CV, 2008, TRENDS MICROBIOL, V16, P480, DOI 10.1016/j.tim.2008.07.003; Reinelt S, 2003, J BIOL CHEM, V278, P39189, DOI 10.1074/jbc.M305864200; Stock AM, 2006, NAT STRUCT MOL BIOL, V13, P862, DOI 10.1038/nsmb1006-862; Surette MG, 1996, J BIOL CHEM, V271, P17966, DOI 10.1074/jbc.271.30.17966; Szurmant H, 2004, J MOL BIOL, V344, P919, DOI 10.1016/j.jmb.2004.09.093; Szurmant H, 2004, J BIOL CHEM, V279, P21787, DOI 10.1074/jbc.M311497200; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; ULLAH AHJ, 1981, J BACTERIOL, V145, P958, DOI 10.1128/JB.145.2.958-965.1981; Ulrich LE, 2005, BIOINFORMATICS, V21, P45, DOI 10.1093/bioinformatics/bti1204; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WOLFF C, 1988, J BACTERIOL, V170, P4509, DOI 10.1128/jb.170.10.4509-4515.1988; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Yeh JI, 1996, J MOL BIOL, V262, P186, DOI 10.1006/jmbi.1996.0507; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhou YF, 2008, J MOL BIOL, V383, P49, DOI 10.1016/j.jmb.2008.08.010; Zimmer MA, 2002, MOL MICROBIOL, V45, P555, DOI 10.1046/j.1365-2958.2002.03035.x	50	53	54	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1870	1878		10.1074/jbc.M109.072108	http://dx.doi.org/10.1074/jbc.M109.072108			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19864420	hybrid, Green Published			2022-12-25	WOS:000273429100033
J	Jedrychowski, MP; Gartner, CA; Gygi, SP; Zhou, L; Herz, J; Kandror, KV; Pilch, PF				Jedrychowski, Mark P.; Gartner, Carlos A.; Gygi, Steven P.; Zhou, Li; Herz, Joachim; Kandror, Konstantin V.; Pilch, Paul F.			Proteomic Analysis of GLUT4 Storage Vesicles Reveals LRP1 to Be an Important Vesicle Component and Target of Insulin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT ADIPOSE-CELLS; RECEPTOR-RELATED PROTEIN-1; 3T3-L1 ADIPOCYTES; GLUCOSE-TRANSPORT; GLUT4-CONTAINING VESICLES; SUBCELLULAR-LOCALIZATION; MEMBRANE-PROTEINS; KINETIC-ANALYSIS; PLASMA-MEMBRANE; AKT SUBSTRATE	Insulin stimulates the translocation of intracellular GLUT4 to the plasma membrane where it functions in adipose and muscle tissue to clear glucose from circulation. The pathway and regulation of GLUT4 trafficking are complicated and incompletely understood and are likely to be contingent upon the various proteins other than GLUT4 that comprise and interact with GLUT4-containing vesicles. Moreover, not all GLUT4 intracellular pools are insulin-responsive as some represent precursor compartments, thus posing a biochemical challenge to the purification and characterization of their content. To address these issues, we immunodepleted precursor GLUT4-rich vesicles and then immunopurified GLUT4 storage vesicle (GSVs) from primary rat adipocytes and subjected them to semi-quantitative and quantitative proteomic analysis. The purified vesicles translocate to the cell surface almost completely in response to insulin, the expected behavior for bona fide GSVs. In total, over 100 proteins were identified, about 50 of which are novel in this experimental context. LRP1 (low density lipoprotein receptor-related protein 1) was identified as a major constituent of GSVs, and we show it interacts with the lumenal domains of GLUT4 and other GSV constituents. Its cytoplasmic tail interacts with the insulin-signaling pathway target, AS160 (Akt substrate of 160 kDa). Depletion of LRP1 from 3T3-L1 adipocytes reduces GLUT4 expression and correspondingly results in decreased insulin-stimulated 2-[H-3] deoxyglucose uptake. Furthermore, adipose-specific LRP1 knock-out mice also exhibit decreased GLUT4 expression. These findings suggest LRP1 is an important component of GSVs, and its expression is needed for the formation of fully functional GSVs.	[Jedrychowski, Mark P.; Kandror, Konstantin V.; Pilch, Paul F.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Gartner, Carlos A.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Zhou, Li; Herz, Joachim] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	Boston University; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas	Pilch, PF (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	ppilch@.edu		Pilch, Paul/0000-0003-1997-0499; Kandror, Konstantin/0000-0002-8601-9313	National Institutes of Health [DK30435]; American Diabetes Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Foundation(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant DK30435. This work was also supported by a grant from the American Diabetes Foundation (to P. F. P.).	APPELL KC, 1988, J BIOL CHEM, V263, P10824; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; Bakalarski CE, 2008, J PROTEOME RES, V7, P4756, DOI 10.1021/pr800333e; Barile M, 2005, MOL CELL PROTEOMICS, V4, P1095, DOI 10.1074/mcp.M500049-MCP200; Belfort GM, 2005, J BIOL CHEM, V280, P7262, DOI 10.1074/jbc.M404851200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Bose A, 2005, J BIOL CHEM, V280, P36946, DOI 10.1074/jbc.M508317200; Brooks CC, 2000, J BIOL CHEM, V275, P2029, DOI 10.1074/jbc.275.3.2029; Carvalho E, 2004, J BIOL CHEM, V279, P21598, DOI 10.1074/jbc.M312269200; CORVERA S, 1989, J BIOL CHEM, V264, P10133; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; DEHERREROS AG, 1989, J BIOL CHEM, V264, P19994; DESCAMPS O, 1993, J BIOL CHEM, V268, P974; El-Jack AK, 1999, MOL BIOL CELL, V10, P1581, DOI 10.1091/mbc.10.5.1581; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Guilherme A, 2000, J BIOL CHEM, V275, P38151, DOI 10.1074/jbc.M003432200; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; HOLMAN GD, 1990, J BIOL CHEM, V265, P18172; Hosaka T, 2005, MOL BIOL CELL, V16, P2882, DOI 10.1091/mbc.E05-01-0072; Huang SH, 2007, MOL CELL BIOL, V27, P3456, DOI 10.1128/MCB.01719-06; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Hubner K, 2002, INT REV CYTOL, V214, P103; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Janz R, 1998, J BIOL CHEM, V273, P2851, DOI 10.1074/jbc.273.5.2851; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; KAHN BB, 1988, J CLIN INVEST, V82, P691, DOI 10.1172/JCI113649; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Kandror KV, 1998, BIOCHEM J, V331, P829, DOI 10.1042/bj3310829; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Kupriyanova TA, 2000, J BIOL CHEM, V275, P36263, DOI 10.1074/jbc.M002797200; Kupriyanova TA, 2002, J BIOL CHEM, V277, P9133, DOI 10.1074/jbc.M106999200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lee W, 2000, BIOCHEMISTRY-US, V39, P9358, DOI 10.1021/bi0007021; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Livingstone C, 1996, BIOCHEM J, V315, P487, DOI 10.1042/bj3150487; Mastick CC, 1997, ENDOCRINOLOGY, V138, P2391, DOI 10.1210/en.138.6.2391; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; Pilch PF, 2008, ACTA PHYSIOL, V192, P89, DOI 10.1111/j.1748-1716.2007.01788.x; PILCH PF, 1979, J BIOL CHEM, V254, P3375; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Ramus C, 2006, MOL CELL PROTEOMICS, V5, P68, DOI 10.1074/mcp.M500205-MCP200; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Rea S, 1997, DIABETES, V46, P1667, DOI 10.2337/diabetes.46.11.1667; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; Shi J, 2008, J BIOL CHEM, V283, P30311, DOI 10.1074/jbc.M805182200; SIMPSON IA, 1983, BIOCHIM BIOPHYS ACTA, V763, P393, DOI 10.1016/0167-4889(83)90101-5; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; TANNER LI, 1987, J BIOL CHEM, V262, P8975; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; THOIDIS G, 1993, J BIOL CHEM, V268, P11691; Thurmond DC, 2001, MOL MEMBR BIOL, V18, P237; Wang B, 2004, MOL CELL BIOL, V24, P2767, DOI 10.1128/MCB.24.7.2767-2778.2004; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; YANG J, 1993, J BIOL CHEM, V268, P4600; YEH JI, 1995, BIOCHEMISTRY-US, V34, P15523, DOI 10.1021/bi00047a018; Zhang HY, 2004, J BIOL CHEM, V279, P2221, DOI 10.1074/jbc.M310679200; ZORZANO A, 1989, J BIOL CHEM, V264, P12358	70	102	103	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					104	114		10.1074/jbc.M109.040428	http://dx.doi.org/10.1074/jbc.M109.040428			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864425	Green Published, hybrid			2022-12-25	WOS:000273070100011
J	Kobayashi, E; Shimizu, R; Kikuchi, Y; Takahashi, S; Yamamoto, M				Kobayashi, Eri; Shimizu, Ritsuko; Kikuchi, Yuko; Takahashi, Satoru; Yamamoto, Masayuki			Loss of the Gata1 Gene IE Exon Leads to Variant Transcript Expression and the Production of a GATA1 Protein Lacking the N-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSIENT MYELOPROLIFERATIVE DISORDER; DOWN-SYNDROME; IN-VIVO; MEGAKARYOBLASTIC LEUKEMIA; ALTERNATIVE PROMOTERS; FUNCTIONAL-ANALYSIS; MOUSE; DIFFERENTIATION; MICE; ERYTHROPOIESIS	GATA1 is essential for the differentiation of erythroid cells and megakaryocytes. The Gata1 gene is composed of multiple untranslated first exons and five common coding exons. The erythroid first exon (IE exon) is important for Gata1 gene expression in hematopoietic lineages. Because previous IE exon knockdown analyses resulted in embryonic lethality, less is understood about the contribution of the IE exon to adult hematopoiesis. Here, we achieved specific deletion of the floxed IE exon in adulthood using an inducible Cre expression system. In this conditional knock-out mouse line, the Gata1 mRNA level was significantly down-regulated in the megakaryocyte lineage, resulting in thrombocytopenia with a marked proliferation of megakaryocytes. By contrast, in the erythroid lineage, Gata1 mRNA was expressed abundantly utilizing alternative first exons. Especially, the IEb/c and newly identified IEd exons were transcribed at a level comparable with that of the IE exon in control mice. Surprisingly, in the IE-null mouse, these transcripts failed to produce full-length GATA1 protein, but instead yielded GATA1 lacking the N-terminal domain inefficiently. With low level expression of the short form of GATA1, IE-null mice showed severe anemia with skewed erythroid maturation. Notably, the hematological phenotypes of adult IE-null mice substantially differ from those observed in mice harboring conditional ablation of the entire Gata1 gene. The present study demonstrates that the IE exon is instrumental to adult erythropoiesis by regulating the proper level of transcription and selecting the correct transcription start site of the Gata1 gene.	[Shimizu, Ritsuko] Tohoku Univ, Grad Sch Med, Dept Expt Hematol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kobayashi, Eri; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Dept Med Biochem, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kikuchi, Yuko; Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, ERATO Environm Response Project, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Takahashi, Satoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan	Tohoku University; Tohoku University; Japan Science & Technology Agency (JST); Tohoku University; University of Tsukuba	Shimizu, R (corresponding author), Tohoku Univ, Grad Sch Med, Dept Expt Hematol, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan.	rshimizu@m.tains.tohoku.ac.jp; masiyamamoto@m.tains.tohoku.ac.jp	Shimizu, Ritsuko/A-4877-2010; Yamamoto, Masayuki/A-4873-2010	Shimizu, Ritsuko/0000-0001-6672-7606; Yamamoto, Masayuki/0000-0002-9073-9436	Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for Promotion of Science; JST-ERATO; Naito Foundation; Tohoku University Global COE	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST-ERATO(Japan Science & Technology Agency (JST)); Naito Foundation(Naito Memorial Foundation); Tohoku University Global COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research from Ministry of Education, Culture, Sports, Science, and Technology and Japan Society for Promotion of Science (to R. S. and M. Y.), Scientific Research on Priority Areas (to R. S. and M. Y.) and Specially Promoted Research (to M. Y.), grants from the JST-ERATO project (to M. Y.), Naito Foundation (to M. Y.), and Tohoku University Global COE program for the Conquest of Diseases with Network Medicine (to M. Y.).	Aizencang GI, 2000, J BIOL CHEM, V275, P2295, DOI 10.1074/jbc.275.4.2295; Bishop TR, 1996, NUCLEIC ACIDS RES, V24, P2511, DOI 10.1093/nar/24.13.2511; Bose F, 2006, MOL CELL BIOL, V26, P3942, DOI 10.1128/MCB.26.10.3942-3954.2006; CALLIGARIS R, 1995, P NATL ACAD SCI USA, V92, P11598, DOI 10.1073/pnas.92.25.11598; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Chen D, 2009, CANCER LETT, V273, P15, DOI 10.1016/j.canlet.2008.05.038; CHRETIEN S, 1988, P NATL ACAD SCI USA, V85, P6, DOI 10.1073/pnas.85.1.6; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; Dyer KD, 2007, J IMMUNOL, V179, P1693, DOI 10.4049/jimmunol.179.3.1693; Ferreira R, 2005, MOL CELL BIOL, V25, P1215, DOI 10.1128/MCB.25.4.1215-1227.2005; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Greene ME, 2003, BLOOD CELL MOL DIS, V31, P351, DOI 10.1016/j.bcmd.2003.08.001; Gutierrez L, 2008, BLOOD, V111, P4375, DOI 10.1182/blood-2007-09-115121; ITO E, 1993, NATURE, V362, P466, DOI 10.1038/362466a0; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lowry JA, 2006, INT J BIOCHEM CELL B, V38, P6, DOI 10.1016/j.biocel.2005.06.017; Minegishi N, 1998, J BIOL CHEM, V273, P3625, DOI 10.1074/jbc.273.6.3625; Moroni E, 2000, J BIOL CHEM, V275, P10567, DOI 10.1074/jbc.275.14.10567; Muntean AG, 2005, BLOOD, V106, P1223, DOI 10.1182/blood-2005-02-0551; NICOLIS S, 1991, NUCLEIC ACIDS RES, V19, P5285, DOI 10.1093/nar/19.19.5285; NIWA H, 1993, J BIOCHEM-TOKYO, V113, P343, DOI 10.1093/oxfordjournals.jbchem.a124049; Ohneda K, 2002, GENES CELLS, V7, P1243, DOI 10.1046/j.1365-2443.2002.00595.x; Onodera K, 1997, J BIOCHEM, V121, P251; Pan XQ, 2005, J BIOL CHEM, V280, P22385, DOI 10.1074/jbc.M500081200; Pan XQ, 2000, J BIOCHEM, V127, P105, DOI 10.1093/oxfordjournals.jbchem.a022570; PISCHEDDA C, 1995, P NATL ACAD SCI USA, V92, P3511, DOI 10.1073/pnas.92.8.3511; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; SAHR KE, 1994, GENOMICS, V24, P491, DOI 10.1006/geno.1994.1658; Shimizu R, 2004, MOL CELL BIOL, V24, P10814, DOI 10.1128/MCB.24.24.10814-10825.2004; Shimizu R, 2004, BLOOD, V103, P2560, DOI 10.1182/blood-2003-07-2514; Shimizu R, 2001, EMBO J, V20, P5250, DOI 10.1093/emboj/20.18.5250; Shimizu R, 2008, NAT REV CANCER, V8, P279, DOI 10.1038/nrc2348; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Takahashi S, 2000, BLOOD, V96, P910, DOI 10.1182/blood.V96.3.910.015k29_910_916; Takahashi S, 1998, BLOOD, V92, P434, DOI 10.1182/blood.V92.2.434.414k24_434_442; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; Vannucchi AM, 2005, AM J PATHOL, V167, P849, DOI 10.1016/S0002-9440(10)62056-1; Vannucchi AM, 2001, BLOOD, V97, P3040, DOI 10.1182/blood.V97.10.3040; Wakabayashi J, 2003, GENES CELLS, V8, P619, DOI 10.1046/j.1365-2443.2003.00658.x; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Xu G, 2003, BLOOD, V102, P2960, DOI 10.1182/blood-2003-02-0390; Zaika AI, 2002, J EXP MED, V196, P765, DOI 10.1084/jem.20020179; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	47	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					773	783		10.1074/jbc.M109.030726	http://dx.doi.org/10.1074/jbc.M109.030726			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19854837	Green Published, hybrid			2022-12-25	WOS:000273070100078
J	Solassol, J; Rouanet, P; Lamy, PJ; Allal, C; Favre, G; Maudelonde, T; Mange, A				Solassol, J.; Rouanet, P.; Lamy, P. J.; Allal, C.; Favre, G.; Maudelonde, T.; Mange, A.			Serum protein signature may improve detection of ductal carcinoma in situ of the breast	ONCOGENE			English	Article						breast; diagnosis; serum; profiling	PLATELET FACTOR-IV; SELDI-TOF-MS; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; OVARIAN-CANCER; ENDOTHELIAL-CELL; TUMOR-MARKERS; BIOMARKERS; IDENTIFICATION; GROWTH	Ductal carcinoma in situ (DCIS) of the breast is part of a spectrum of preinvasive lesions that originate within normal breast tissue and progress to invasive breast cancer. The detection of DCIS is important for the reduction of mortality from breast cancer, but the diagnosis of preinvasive breast tumors is hampered by the lack of an adequate detection method. To identify the changes in protein expression during the initial stage of tumorigenesis and to identify the presence of new DCIS markers, we analysed serum from 60 patients with breast cancer and 60 normal controls using mass spectrometry. A 23-protein index was generated that correctly distinguishes the DCIS and control groups with sensitivities and specificities in excess of 80% in two independent cohorts. Two candidate peptides were purified and identified as platelet factor 4 (PF-4) and complement C3a(desArg) anaphylatoxin (C3a(desArg)) using liquid chromatography-tandem mass spectrometry (LC-MS/MS). In an independent serum set of 165 patients, PF-4 and C3a(desArg) were significantly upregulated in DCIS compared with non-cancerous controls, as validated using western blot and enzyme-linked immunosorbent assay. We conclude that our serum protein-based test, used in conjunction with image-based screening practices, could improve the sensitivity and specificity of breast cancer detection. Oncogene (2010) 29, 550-560; doi: 10.1038/onc.2009.341; published online 26 October 2009	[Solassol, J.; Maudelonde, T.; Mange, A.] Univ Montpellier I, Montpellier, France; [Solassol, J.; Maudelonde, T.; Mange, A.] CHU Montpellier, Univ Hosp Montpellier, Dept Cellular Biol, Montpellier, France; [Solassol, J.; Maudelonde, T.; Mange, A.] CRLC, Dept Clin Oncoprote, Montpellier, France; [Rouanet, P.] CRLC, Dept Surg Oncol, Montpellier, France; [Lamy, P. J.] CRLC, Dept Biol, Montpellier, France; [Allal, C.; Favre, G.] CPTP, U563, INSERM, Toulouse, France	Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Mange, A (corresponding author), Batiment Rech CRLC Val Aurelle,Parc Euromed,208, F-34298 Montpellier 5, France.	alain.mange@univ-montp1.fr	Solassol, Jerome/G-2320-2018; FAVRE, Gilles/K-9189-2014; ALLAL, Ben C/I-8146-2014; Mange, Alain/U-1157-2017; Lamy, Pierre-Jean/I-6077-2015; Lamy, Pierre-Jean/AAZ-1696-2020	Solassol, Jerome/0000-0002-0293-6158; FAVRE, Gilles/0000-0002-2344-1883; ALLAL, Ben C/0000-0002-4207-2219; Mange, Alain/0000-0002-1566-9407; Lamy, Pierre-Jean/0000-0002-5750-159X; Lamy, Pierre-Jean/0000-0002-5750-159X	Comite de l'Herault de la Ligue Contre le Cancer; INSERM [RBM 03-63]	Comite de l'Herault de la Ligue Contre le Cancer; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported in part by grants from the Comite de l'Herault de la Ligue Contre le Cancer. Serum collection was supported by INSERM (RBM 03-63).	Albrethsen J, 2007, CLIN CHEM, V53, P852, DOI 10.1373/clinchem.2006.082644; Alexander H, 2004, CLIN CANCER RES, V10, P7500, DOI 10.1158/1078-0432.CCR-04-1002; Becker S, 2004, ANN SURG ONCOL, V11, P907, DOI 10.1245/ASO.2004.03.557; Belluco C, 2007, ANN SURG ONCOL, V14, P2470, DOI 10.1245/s10434-007-9354-3; Bijker N, 2006, J CLIN ONCOL, V24, P3381, DOI 10.1200/JCO.2006.06.1366; Bjorge L, 2005, BRIT J CANCER, V92, P895, DOI 10.1038/sj.bjc.6602334; Brozkova K, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2101; Carlevaro MF, 1997, J CELL BIOL, V136, P1375, DOI 10.1083/jcb.136.6.1375; Cavanaugh PG, 1998, J CELL PHYSIOL, V174, P48, DOI 10.1002/(SICI)1097-4652(199801)174:1<48::AID-JCP6>3.0.CO;2-G; Cavanaugh PG, 1999, BREAST CANCER RES TR, V56, P203; Cervi D, 2008, BLOOD, V111, P1201, DOI 10.1182/blood-2007-04-084798; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-25; Elmore JG, 2005, JAMA-J AM MED ASSOC, V293, P1245, DOI 10.1001/jama.293.10.1245; Esserman LJ, 2007, EXPERT REV MOL DIAGN, V7, P533, DOI 10.1586/14737159.7.5.533; Gast M. C. W., 2006, Cancer Biomarkers, V2, P235; Gast MCW, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-389; GENGRINOVITCH S, 1995, J BIOL CHEM, V270, P15059, DOI 10.1074/jbc.270.25.15059; Goncalves A, 2006, ONCOGENE, V25, P981, DOI 10.1038/sj.onc.1209131; Greene FL, 2002, CANC STAGING MANUAL; GUPTA SK, 1994, J CELL BIOL, V127, P1121, DOI 10.1083/jcb.127.4.1121; GUPTA SK, 1995, P NATL ACAD SCI USA, V92, P7799, DOI 10.1073/pnas.92.17.7799; Hagedorn M, 2001, FASEB J, V15, P550; Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hu Y, 2005, BREAST, V14, P250, DOI 10.1016/j.breast.2005.01.008; Jacot W, 2008, J THORAC ONCOL, V3, P840, DOI 10.1097/JTO.0b013e31817e464a; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kang XX, 2005, CLIN CHEM, V51, P56, DOI 10.1373/clinchem.2004.032458; Kopczynski Z, 1998, BRIT J CANCER, V78, P466, DOI 10.1038/bjc.1998.516; Kozak KR, 2005, PROTEOMICS, V5, P4589, DOI 10.1002/pmic.200500093; Kramar A, 2001, COMPUT METH PROG BIO, V66, P199, DOI 10.1016/S0169-2607(00)00129-2; Kuerer HM, 2009, J CLIN ONCOL, V27, P279, DOI 10.1200/JCO.2008.18.3103; Lee IN, 2006, PROTEOMICS, V6, P2865, DOI 10.1002/pmic.200500488; Levenson VV, 2007, BBA-GEN SUBJECTS, V1770, P847, DOI 10.1016/j.bbagen.2007.01.017; Li JN, 2005, CLIN CHEM, V51, P2229, DOI 10.1373/clinchem.2005.052878; Li JN, 2002, CLIN CHEM, V48, P1296; MAIONE TE, 1990, SCIENCE, V247, P77, DOI 10.1126/science.1688470; Mange A, 2008, J CHROMATOGR B, V876, P252, DOI 10.1016/j.jchromb.2008.11.003; Mathelin C, 2006, BREAST CANCER RES TR, V96, P83, DOI 10.1007/s10549-005-9046-2; Miguet L, 2006, J PROTEOME RES, V5, P2258, DOI 10.1021/pr060058y; NICOLSON GL, 1992, J NATL CANCER I MONO, V13, P153; Orel SG, 1999, RADIOLOGY, V211, P845, DOI 10.1148/radiology.211.3.r99jn31845; Pavlakis K, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-88; Perollet C, 1998, BLOOD, V91, P3289, DOI 10.1182/blood.V91.9.3289.3289_3289_3299; Petricoin EF, 2004, CURR OPIN BIOTECH, V15, P24, DOI 10.1016/j.copbio.2004.01.005; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Rai AJ, 2002, ARCH PATHOL LAB MED, V126, P1518; Roesch-Ely M, 2007, ONCOGENE, V26, P54, DOI 10.1038/sj.onc.1209770; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Semmes OJ, 2005, CLIN CHEM, V51, P102, DOI 10.1373/clinchem.2004.038950; SHARPE RJ, 1990, JNCI-J NATL CANCER I, V82, P848, DOI 10.1093/jnci/82.10.848; Solassol J, 2006, EXPERT REV PROTEOMIC, V3, P311, DOI 10.1586/14789450.3.3.311; Solassol K, 2005, ANAL BIOCHEM, V338, P26, DOI 10.1016/j.ab.2004.11.031; Song J, 2006, CLIN CHEM, V52, P1045, DOI 10.1373/clinchem.2005.065722; Timms JF, 2007, CLIN CHEM, V53, P645, DOI 10.1373/clinchem.2006.080101; van der Merwe DE, 2007, ADV CANCER RES, V96, P23, DOI 10.1016/S0065-230X(06)96002-3; Vlahou Antonia, 2003, Clin Breast Cancer, V4, P203, DOI 10.3816/CBC.2003.n.026; Ward DG, 2006, BRIT J CANCER, V94, P1898, DOI 10.1038/sj.bjc.6603188	61	23	25	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2010	29	4					550	560		10.1038/onc.2009.341	http://dx.doi.org/10.1038/onc.2009.341			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	549WH	19855429				2022-12-25	WOS:000274084600008
J	Chernov, KG; Barbet, A; Hamon, L; Ovchinnikov, LP; Curmi, PA; Pastre, D				Chernov, Konstantin G.; Barbet, Aurelie; Hamon, Loic; Ovchinnikov, Lev P.; Curmi, Patrick A.; Pastre, David			Role of Microtubules in Stress Granule Assembly MICROTUBULE DYNAMICAL INSTABILITY FAVORS THE FORMATION OF MICROMETRIC STRESS GRANULES IN CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DNA MOBILITY; MESSENGER-RNA; FORCE GENERATION; ACTIN POLYMERIZATION; MOTILITY DRIVEN; CYTOPLASM; CELLS; DIFFUSION; TIA-1; PHOSPHORYLATION	Following exposure to various stresses (arsenite, UV, hyperthermia, and hypoxia), mRNAs are assembled into large cytoplasmic bodies known as "stress granules," in which mRNAs and associated proteins may be processed by specific enzymes for different purposes like transient storing, sorting, silencing, or other still unknown processes. To limit mRNA damage during stress, the assembly of micrometric granules has to be rapid, and, indeed, it takes only similar to 10-20 min in living cells. However, such a rapid assembly breaks the rules of hindered diffusion in the cytoplasm, which states that large cytoplasmic bodies are almost immobile. In the present work, using HeLa cells and YB-1 protein as a stress granule marker, we studied three hypotheses to understand how cells overcome the limitation of hindered diffusion: shuttling of small messenger ribonucleoprotein particles from small to large stress granules, sliding of messenger ribonucleoprotein particles along microtubules, microtubule-mediated stirring of large stress granules. Our data favor the two last hypotheses and underline that microtubule dynamic instability favors the formation of micrometric stress granules.	[Chernov, Konstantin G.; Barbet, Aurelie; Hamon, Loic; Curmi, Patrick A.; Pastre, David] Univ Evry Val Essonne, Lab Struct Act Biomol Normales & Pathol, EA3637, INSERM,U829, F-91025 Evry, France; [Chernov, Konstantin G.; Ovchinnikov, Lev P.] Russian Acad Sci, Inst Prot Res, Pushchino 142290, Moscow Region, Russia	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Russian Academy of Sciences	Curmi, PA (corresponding author), Univ Evry Val Essonne, Lab Struct Act Biomol Normales & Pathol, EA3637, INSERM,U829, F-91025 Evry, France.	pcurmi@univ-evry.fr; david.pastre@univ-evry.fr	CURMI, Patrick/G-4036-2013; Pastre, David/B-2958-2014; Ovchinnikov, Lev/L-2397-2015	Pastre, David/0000-0002-3348-9514; CURMI, Patrick A./0000-0001-5045-8501; hamon, loic/0000-0003-2032-7994	INSERM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by INSERM.	Aizer A, 2008, MOL BIOL CELL, V19, P4154, DOI 10.1091/mbc.E08-05-0513; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; ArrioDupont M, 1996, BIOPHYS J, V70, P2327, DOI 10.1016/S0006-3495(96)79798-9; BERSHADSKY AD, 1981, P NATL ACAD SCI-BIOL, V78, P3610, DOI 10.1073/pnas.78.6.3610; BOUCHARD P, 1981, P NATL ACAD SCI-BIOL, V78, P1033, DOI 10.1073/pnas.78.2.1033; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Chernov KG, 2008, FEBS LETT, V582, P2875, DOI 10.1016/j.febslet.2008.07.019; CLARK TG, 1982, P NATL ACAD SCI-BIOL, V79, P4655, DOI 10.1073/pnas.79.15.4655; Dauty E, 2005, J BIOL CHEM, V280, P7823, DOI 10.1074/jbc.M412374200; Davydova EK, 1997, NUCLEIC ACIDS RES, V25, P2911, DOI 10.1093/nar/25.14.2911; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Finsy R, 2004, LANGMUIR, V20, P2975, DOI 10.1021/la035966d; Footer MJ, 2007, P NATL ACAD SCI USA, V104, P2181, DOI 10.1073/pnas.0607052104; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; GUNDERSEN GG, 1987, J CELL BIOL, V105, P251, DOI 10.1083/jcb.105.1.251; Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; INOUE S, 1995, MOL BIOL CELL, V6, P1619, DOI 10.1091/mbc.6.12.1619; Ivanov PA, 2003, EXP CELL RES, V290, P227, DOI 10.1016/S0014-4827(03)00290-8; JORDAN MA, 1992, J CELL SCI, V102, P401; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kim WJ, 2005, MOL CELL BIOL, V25, P2450, DOI 10.1128/MCB.25.6.2450-2462.2005; Kolobova E, 2009, EXP CELL RES, V315, P542, DOI 10.1016/j.yexcr.2008.11.011; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lalli G, 2003, J CELL SCI, V116, P4639, DOI 10.1242/jcs.00727; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; LUBYPHELPS K, 1987, P NATL ACAD SCI USA, V84, P4910, DOI 10.1073/pnas.84.14.4910; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Mogilner A, 2003, BIOPHYS J, V84, P1591, DOI 10.1016/S0006-3495(03)74969-8; Mogilner A, 1996, BIOPHYS J, V71, P3030, DOI 10.1016/S0006-3495(96)79496-1; Mollet S, 2008, MOL BIOL CELL, V19, P4469, DOI 10.1091/mbc.E08-05-0499; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nguyen TT, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031409; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pourroy B, 2004, MOL PHARMACOL, V66, P580; Shah JV, 2000, MOL BIOL CELL, V11, P3495, DOI 10.1091/mbc.11.10.3495; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tsai NP, 2009, NEUROSCIENCE, V159, P647, DOI 10.1016/j.neuroscience.2008.12.053; Tsai NP, 2008, EMBO J, V27, P715, DOI 10.1038/emboj.2008.19; Vorobjev IA, 1999, J CELL SCI, V112, P2277; WEITZ DA, 1986, PHYS REV LETT, V57, P2037, DOI 10.1103/PhysRevLett.57.2037; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Yang WH, 2007, RNA, V13, P704, DOI 10.1261/rna.411907; YAO JH, 1993, PHYS REV B, V47, P14110, DOI 10.1103/PhysRevB.47.14110	55	80	82	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36569	36580		10.1074/jbc.M109.042879	http://dx.doi.org/10.1074/jbc.M109.042879			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19843517	Green Published, hybrid			2022-12-25	WOS:000272970500058
J	Liu, XQ; Martin, CT				Liu, Xiaoqing; Martin, Craig T.			Transcription Elongation Complex Stability THE TOPOLOGICAL LOCK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; VESICULAR STOMATITIS-VIRUS; ESCHERICHIA-COLI; THERMODYNAMIC ANALYSIS; HYBRID DUPLEXES; II ELONGATION; NASCENT RNA; DNA; TERMINATION; MECHANISM	Transcription machinery from a variety of organisms shows striking mechanistic similarity. Both multi- and single subunit RNA polymerases have evolved an 8 - 10-base pair RNA-DNA hybrid as a part of a stably transcribing elongation complex. Through characterization of halted complexes that can readily carry out homopolymeric slippage synthesis, this study reveals that T7 RNA polymerase elongation complexes containing only a 4-base pair hybrid can nevertheless be more stable than those with the normal 8-base pair hybrid. We propose that a key feature of this stability is the topological threading of RNA through the complex and/or around the DNA template strand. The data are consistent with forward translocation as a mechanism to allow unthreading of the topological lock, as can occur during programmed termination of transcription.	[Liu, Xiaoqing; Martin, Craig T.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Martin, CT (corresponding author), Univ Massachusetts, Dept Chem, 710 N Pleasant St,Lederle Grad Res Tower 104, Amherst, MA 01003 USA.	CMartin@chem.umass.edu	Martin, Craig T/L-3596-2013	Martin, Craig T/0000-0003-1029-5239	National Institutes of Health [GM55002]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055002] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM55002.	AHN BY, 1989, J VIROL, V63, P226, DOI 10.1128/JVI.63.1.226-232.1989; CHAMBERLIN M, 1964, J MOL BIOL, V8, P708, DOI 10.1016/S0022-2836(64)80120-0; CUNNINGHAM PR, 1991, NUCLEIC ACIDS RES, V19, P4669, DOI 10.1093/nar/19.17.4669; GILL SC, 1990, BIOPHYS CHEM, V37, P239; Gong P, 2004, J BIOL CHEM, V279, P44277, DOI 10.1074/jbc.M409118200; Gong P, 2006, J BIOL CHEM, V281, P23533, DOI 10.1074/jbc.M604023200; Huang JB, 2000, J MOL BIOL, V303, P347, DOI 10.1006/jmbi.2000.4150; Kireeva ML, 2000, J BIOL CHEM, V275, P6530, DOI 10.1074/jbc.275.9.6530; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Korzheva N, 1998, COLD SPRING HARB SYM, V63, P337, DOI 10.1101/sqb.1998.63.337; Kuzmine I, 2001, NUCLEIC ACIDS RES, V29, P2601, DOI 10.1093/nar/29.12.2601; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; Martin CT, 2003, METHOD ENZYMOL, V371, P13; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; MARTIN FH, 1980, NUCLEIC ACIDS RES, V8, P2295, DOI 10.1093/nar/8.10.2295; MCGEOCH DJ, 1979, CELL, V17, P673, DOI 10.1016/0092-8674(79)90274-5; Pal M, 2003, P NATL ACAD SCI USA, V100, P5700, DOI 10.1073/pnas.1037057100; Park JS, 2006, P NATL ACAD SCI USA, V103, P4870, DOI 10.1073/pnas.0600145103; Qi FX, 1996, METHOD ENZYMOL, V273, P71; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; ROSE JK, 1980, CELL, V19, P415, DOI 10.1016/0092-8674(80)90515-2; Santangelo TJ, 2004, MOL CELL, V14, P117, DOI 10.1016/S1097-2765(04)00154-6; SCHUBERT M, 1980, J VIROL, V34, P550, DOI 10.1128/JVI.34.2.550-559.1980; SCHWER B, 1988, EMBO J, V7, P1183, DOI 10.1002/j.1460-2075.1988.tb02929.x; SCHWER B, 1987, CELL, V50, P163, DOI 10.1016/0092-8674(87)90212-1; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2000, P NATL ACAD SCI USA, V97, P14109, DOI 10.1073/pnas.250473197; WAGNER LA, 1990, NUCLEIC ACIDS RES, V18, P3529, DOI 10.1093/nar/18.12.3529; Wilson KS, 1999, J MOL BIOL, V289, P1179, DOI 10.1006/jmbi.1999.2814; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; Zhou Y, 2007, P NATL ACAD SCI USA, V104, P10352, DOI 10.1073/pnas.0606306104; Zhou Y, 2006, J BIOL CHEM, V281, P24441, DOI 10.1074/jbc.M604369200	36	8	9	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36262	36270		10.1074/jbc.M109.056820	http://dx.doi.org/10.1074/jbc.M109.056820			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19846559	hybrid, Green Published			2022-12-25	WOS:000272970500028
J	Passero, CJ; Okumura, S; Carattino, MD				Passero, Christopher J.; Okumura, Sora; Carattino, Marcelo D.			Conformational Changes Associated with Proton-dependent Gating of ASIC1a	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSING ION CHANNELS; EPITHELIAL SODIUM-CHANNELS; GATED CATION CHANNEL; SHAKER K+ CHANNEL; MOLECULAR-CLONING; NA+ CHANNELS; FUNCTIONAL EXPRESSION; EXTRACELLULAR DOMAIN; SURFACE EXPRESSION; VOLTAGE-CLAMP	Acid-sensing ion channels are proton-gated Na+ channels expressed predominantly in neurons. How channel structure translates an environmental stimulus into changes in pore permeability remains largely undefined. The pore of ASIC1 is defined by residues in the second transmembrane domain (TM2), although a segment of the outer vestibule is formed by residues of TM1. We used the voltage clamp fluorometry technique to define the role of the region preceding TM2 (pre-TM2) in activation and desensitization of mouse ASIC1a. Oocytes expressing E425C channels labeled with Alexa Fluor 488 C5-maleimide showed a change in the emission of the fluorescent probe in response to extracellular acidification. The time course of the change in fluorescence correlated with activation but not desensitization of E425C channels. The fluorescence emission did not change following extracellular acidification in oocytes carrying an inactivating mutation (W287G/E425C), although these channels were labeled and expressed at the plasma membrane. Our data indicate that pore opening occurs in conjunction with a conformational rearrangement of the pre-TM2. We observed a change in the emission of the fluorescent probe when labeled E425C channels transition from the desensitized to the resting state. The substituted-cysteine-accessibility method was used to determine whether the pre-TM2 has different conformations in the resting and desensitized states. State-dependent changes in accessibility to 2-[(trimethylammonium) ethyl] methanethiosulfonate bromide modification were observed in oocytes expressing K421C, K422C, Y424C, and E425C channels. Our results suggest that the pre-TM2 of ASIC1a undergoes dynamic conformational rearrangements during proton-dependent gating.	[Passero, Christopher J.; Okumura, Sora; Carattino, Marcelo D.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Carattino, MD (corresponding author), Univ Pittsburgh, Dept Med, Renal Electrolyte Div, S834 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	mdc4@pitt.edu			National Institutes of Health [DK051391, F32 DK080574]; American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051391, R37DK051391, F32DK080574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK051391. Supported by National Institutes of Health Postdoctoral Fellowship Award F32 DK080574. Supported by a Carl W. Gottschalk award from the American Society of Nephrology.	Akopian AN, 2000, NEUROREPORT, V11, P2217, DOI 10.1097/00001756-200007140-00031; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Bannister JPA, 2005, P NATL ACAD SCI USA, V102, P18718, DOI 10.1073/pnas.0505766102; Bassler EL, 2001, J BIOL CHEM, V276, P33782, DOI 10.1074/jbc.M104030200; Benson CJ, 2001, ANN NY ACAD SCI, V940, P96; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Bubien JK, 2004, AM J PHYSIOL-CELL PH, V287, pC1282, DOI 10.1152/ajpcell.00077.2004; Carattino MD, 2003, J BIOL CHEM, V278, P36202, DOI 10.1074/jbc.M300312200; Cha A, 1998, J GEN PHYSIOL, V112, P391, DOI 10.1085/jgp.112.4.391; Cha A, 1998, METHOD ENZYMOL, V296, P566; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Coric T, 2003, J BIOL CHEM, V278, P45240, DOI 10.1074/jbc.M304441200; Cushman KA, 2007, J GEN PHYSIOL, V129, P345, DOI 10.1085/jgp.200709757; de Weille JR, 1998, FEBS LETT, V433, P257, DOI 10.1016/S0014-5793(98)00916-8; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Grunder S, 2000, NEUROREPORT, V11, P1607; Immke D C, 2001, ScientificWorldJournal, V1, P510; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V245, P589, DOI 10.1006/bbrc.1998.8483; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; JAVITCH JA, 1995, NEURON, V14, P825, DOI 10.1016/0896-6273(95)90226-0; Kapoor N, 2009, J BIOL CHEM, V284, P24526, DOI 10.1074/jbc.M109.037390; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; Li M, 2000, J GEN PHYSIOL, V115, P491, DOI 10.1085/jgp.115.4.491; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Mamet J, 2002, J NEUROSCI, V22, P10662; Mannuzzu LM, 1996, SCIENCE, V271, P213, DOI 10.1126/science.271.5246.213; Meinild AK, 2002, BIOCHEMISTRY-US, V41, P1250, DOI 10.1021/bi011661r; Passero CJ, 2008, J BIOL CHEM, V283, P36586, DOI 10.1074/jbc.M805676200; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Ugawa S, 2001, NEUROREPORT, V12, P2865, DOI 10.1097/00001756-200109170-00022; Vila-Carriles WH, 2006, J BIOL CHEM, V281, P19220, DOI 10.1074/jbc.M603100200; Virkki LV, 2006, J BIOL CHEM, V281, P28837, DOI 10.1074/jbc.M603861200; Voilley N, 2001, J NEUROSCI, V21, P8026, DOI 10.1523/JNEUROSCI.21-20-08026.2001; Voilley Nicolas, 2004, Current Drug Targets - Inflammation and Allergy, V3, P71, DOI 10.2174/1568010043483980; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Yiangou YG, 2001, EUR J GASTROEN HEPAT, V13, P891, DOI 10.1097/00042737-200108000-00003; Zhang P, 2006, J GEN PHYSIOL, V127, P109, DOI 10.1085/jgp.200509396; ZHENG J, 2003, SCI STKE, pPL7	55	32	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36473	36481		10.1074/jbc.M109.055418	http://dx.doi.org/10.1074/jbc.M109.055418			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858190	hybrid, Green Published			2022-12-25	WOS:000272970500049
J	Malik, S; Shukla, A; Sen, P; Bhaumik, SR				Malik, Shivani; Shukla, Abhijit; Sen, Payel; Bhaumik, Sukesh R.			The 19 S Proteasome Subcomplex Establishes a Specific Protein Interaction Network at the Promoter for Stimulated Transcriptional Initiation in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; REGULATORY PARTICLE; 26S PROTEASOME; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ORGANIZATION; NUCLEOSOME ACETYLATION; MULTIUBIQUITIN CHAIN; UBIQUITINATED GCN4P; ATPASE COMPLEX	The 26 S proteasome complex that comprises the 20 S core and 19 S regulatory (with six ATPases) particles is engaged in an ATP-dependent degradation of a variety of key regulatory proteins and, thus, controls important cellular processes. Interestingly, several recent studies have implicated the 19 S regulatory particle in controlling eukaryotic transcriptional initiation or activation independently of the 20 S core particle. However, the mechanism of action of the 19 S proteasome subcomplex in regulation of eukaryotic transcriptional activation is not clearly understood in vivo. Here, using a chromatin immunoprecipitation assay in conjunction with mutational and transcriptional analyses in Saccharomyces cerevisiae, we show that the 19 S proteasomal subcomplex establishes a specific protein interaction network at the upstream activating sequence of the promoter. Such an interaction network is essential for formation of the preinitiation complex at the core promoter to initiate transcription. Furthermore, we demonstrate that the formation of the transcription complex assembly at the promoter is dependent on 19 S ATPase activity. Intriguingly, 19 S ATPases appear to cross-talk for stimulation of the assembly of transcription factors at the promoter. Together, these results provide significant insights as to how the 19 S proteasome subcomplex regulates the formation of the active transcription complex assembly and, hence, transcriptional initiation) at the promoter in vivo.	[Malik, Shivani; Shukla, Abhijit; Sen, Payel; Bhaumik, Sukesh R.] So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA	Southern Illinois University System; Southern Illinois University	Bhaumik, SR (corresponding author), So Illinois Univ, Sch Med, Dept Biochem & Mol Biol, Carbondale, IL 62901 USA.	sbhaumik@siumed.edu	Sen, Payel/D-2835-2016	Sen, Payel/0000-0003-2809-0901	National Institutes of Health [1R15GM088798-01]; American Heart Association [0635008N]; American Cancer Society Research Scholar [06-52]; Mallinckrodt Foundation; Southern Illinois University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM088798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Cancer Society Research Scholar(American Cancer Society); Mallinckrodt Foundation; Southern Illinois University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R15GM088798-01. This work was also supported by American Heart Association National Scientist Development Grant 0635008N, American Cancer Society Research Scholar Grant 06-52, a Mallinckrodt Foundation award, and several internal grants from Southern Illinois University.	Auld KL, 2006, CELL CYCLE, V5, P1503, DOI 10.4161/cc.5.14.2979; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Bhaumik SR, 2003, METHOD ENZYMOL, V370, P445; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Bhaumik SR, 2008, CRIT REV BIOCHEM MOL, V43, P419, DOI 10.1080/10409230802605914 ; Brachmann CB, 1998, YEAST, V14, P115; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; Coux Olivier, 2002, Prog Mol Subcell Biol, V29, P85; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Dembla-Rajpal N, 2004, BBA-GENE STRUCT EXPR, V1680, P34, DOI 10.1016/j.bbaexp.2004.08.008; Dick TP, 1998, J BIOL CHEM, V273, P25637, DOI 10.1074/jbc.273.40.25637; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; FINLEY D, 1994, MOL CELL BIOL, V14, P5501, DOI 10.1128/MCB.14.8.5501; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Green MR, 2000, TRENDS BIOCHEM SCI, V25, P59, DOI 10.1016/S0968-0004(99)01527-3; Groll M, 2003, CURR OPIN STRUC BIOL, V13, P665, DOI 10.1016/j.sbi.2003.10.005; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; He HL, 1998, J BIOL CHEM, V273, P25015, DOI 10.1074/jbc.273.39.25015; Hilt W, 1996, TRENDS BIOCHEM SCI, V21, P96, DOI 10.1016/S0968-0004(96)10012-8; Horwitz AA, 2007, J BIOL CHEM, V282, P22921, DOI 10.1074/jbc.M702846200; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Kang JS, 2001, J BIOL CHEM, V276, P42003, DOI 10.1074/jbc.M105961200; Kinyamu HK, 2007, MOL CELL BIOL, V27, P4891, DOI 10.1128/MCB.02162-06; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Koh SS, 1998, MOL CELL, V1, P895, DOI 10.1016/S1097-2765(00)80088-X; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Larsen CN, 1997, CELL, V91, P431, DOI 10.1016/S0092-8674(00)80427-4; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lee DY, 2005, CELL, V123, P423, DOI 10.1016/j.cell.2005.08.015; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Makino Y, 1999, GENES CELLS, V4, P529, DOI 10.1046/j.1365-2443.1999.00277.x; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Rasti M, 2006, EMBO J, V25, P2710, DOI 10.1038/sj.emboj.7601169; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Roberts SM, 1996, MOL CELL BIOL, V16, P3206; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Rubin DM, 1998, EMBO J, V17, P4909, DOI 10.1093/emboj/17.17.4909; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Seong KM, 2007, MOL CELLS, V24, P194; Seong KM, 2007, FEBS LETT, V581, P2567, DOI 10.1016/j.febslet.2007.04.064; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; Sikder D, 2006, J BIOL CHEM, V281, P27346, DOI 10.1074/jbc.M604706200; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Soond SM, 2008, J BIOL CHEM, V283, P16077, DOI 10.1074/jbc.M800384200; Sterner DE, 1999, MOL CELL BIOL, V19, P86; Sulahian R, 2006, NUCLEIC ACIDS RES, V34, P1351, DOI 10.1093/nar/gkl012; Sun LP, 2002, BIOCHEM BIOPH RES CO, V296, P991, DOI 10.1016/S0006-291X(02)02026-0; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; Valley CC, 2005, MOL CELL BIOL, V25, P5417, DOI 10.1128/MCB.25.13.5417-5428.2005; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Weeda G, 1997, NUCLEIC ACIDS RES, V25, P2274, DOI 10.1093/nar/25.12.2274; Yanagi S, 2000, BIOCHEM BIOPH RES CO, V279, P568, DOI 10.1006/bbrc.2000.3969; Yi P, 2008, MOL CELL, V29, P465, DOI 10.1016/j.molcel.2007.12.030; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang XD, 2000, MOL CELL, V6, P1473, DOI 10.1016/S1097-2765(00)00143-X; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191; Zhu QZ, 2004, FEBS LETT, V556, P19, DOI 10.1016/S0014-5793(03)01347-4	81	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35714	35724		10.1074/jbc.M109.035709	http://dx.doi.org/10.1074/jbc.M109.035709			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19843524	Green Published, hybrid			2022-12-25	WOS:000272645600049
J	Peng, HZ; Ivanov, AV; Oh, HJ; Lau, YFC; Rauscher, FJ				Peng, Hongzhuang; Ivanov, Alexey V.; Oh, Hyun J.; Lau, Yun-Fai C.; Rauscher, Frank J., III			Epigenetic Gene Silencing by the SRY Protein Is Mediated by a KRAB-O Protein That Recruits the KAP1 Co-repressor Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; DNA-BINDING SITE; TRANSCRIPTIONAL REPRESSION; SEX DETERMINATION; DOMAIN PROTEIN; A DOMAIN; BOX; COREPRESSOR; INTERACTS; COMPLEX	The sex determination transcription factor SRY is a cell fate-determining transcription factor that mediates testis differentiation during embryogenesis. It may function by repressing the ovarian determinant gene, RSPO1, action in the ovarian developmental pathway and activates genes, such as SOX9, important for testis differentiation at the onset of gonadogenesis. Further, altered expression of SRY and related SOX genes contribute to oncogenesis in many human cancers. Little is known of the mechanisms by which SRY regulates its target genes. Recently a KRAB domain protein (KRAB-O) that lacks a zinc finger motif has been demonstrated to interact with SRY and hypothesized to function as an adaptor molecule for SRY by tethering the KAP1-NuRD-SETDB1-HP1 silencing machinery to repress SRY targets. We have critically examined this hypothesis by reconstituting and characterizing SRY-KRAB-O-KAP1 interactions. These recombinant molecules can form a ternary complex by direct and high affinity interactions. The KRAB-O protein can simultaneously bind KAP1 and SRY in a noncompetitive but also noncooperative manner. An extensive mutagenesis analysis suggests that different surfaces on KRAB-O are utilized for these independent interactions. Transcriptional repression by SRY requires binding to KRAB-O, thus bridging to the KAP1 repression machinery. This repression machinery is recruited to SRY target promoters in chromatin templates via SRY. These results suggest that SRY has co-opted the KRAB-O protein to recruit the KAP1 repression machinery to sex determination target genes. Other KRAB domain proteins, which lack a zinc finger DNA-binding motif, may function in similar roles as adaptor proteins for epigenetic gene silencing.	[Peng, Hongzhuang; Rauscher, Frank J., III] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Ivanov, Alexey V.] W Virginia Univ, Sch Med, Dept Biochem, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Oh, Hyun J.; Lau, Yun-Fai C.] Univ Calif San Francisco, Vet Affairs Med Ctr, Dept Med, Div Cell & Dev Genet, San Francisco, CA 94121 USA	The Wistar Institute; West Virginia University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Rauscher, FJ (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	Rauscher@wistar.org	Lau, Yun-Fai C/E-4465-2014; Ivanov, Alexey/I-9445-2012	Lau, Yun-Fai C/0000-0002-9119-7050; Oh, Kelly/0000-0001-8203-5247; Ivanov, Alexey/0000-0002-8617-4604	National Institutes of Health [CA 095561, CA 092088, DAMD 17-02-1-0631, HD38117]; Pardee Foundation; Samuel Waxman Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038117] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA095561, R01CA092088] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pardee Foundation; Samuel Waxman Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 095561, CA 092088, and DAMD 17-02-1-0631 ( to F.J.R.) and HD38117 ( to Y.-F.C.L.). This work was also supported by the Pardee Foundation and the Samuel Waxman Foundation ( to F.J.R.).	Abrink M, 2001, P NATL ACAD SCI USA, V98, P1422, DOI 10.1073/pnas.041616998; Bernard P, 2008, INT J BIOCHEM CELL B, V40, P2889, DOI 10.1016/j.biocel.2008.06.006; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Jin VX, 2007, GENOME RES, V17, P807, DOI 10.1101/gr.6006107; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Klenova E, 2002, METHODS, V26, P254, DOI 10.1016/S1046-2023(02)00029-4; Lechner MS, 2000, MOL CELL BIOL, V20, P6449, DOI 10.1128/MCB.20.17.6449-6465.2000; Li YM, 2006, MOL CELL ENDOCRINOL, V257-8, P35, DOI 10.1016/j.mce.2006.06.008; Li ZB, 2003, EMBO J, V22, P1857, DOI 10.1093/emboj/cdg173; MARGOLIN JF, 1994, P NATL ACAD SCI USA, V91, P4509, DOI 10.1073/pnas.91.10.4509; Mitchell CL, 2002, MOL GENET METAB, V77, P217, DOI 10.1016/S1096-7192(02)00165-8; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Nikulina K, 2006, BIOCHEM BIOPH RES CO, V348, P839, DOI 10.1016/j.bbrc.2006.07.150; Oh H, 2005, BIOL REPROD, V72, P407, DOI 10.1095/biolreprod.104.034447; Oh HJ, 2006, MOL CELL ENDOCRINOL, V247, P47, DOI 10.1016/j.mce.2005.12.011; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Peng HZ, 2007, J MOL BIOL, V370, P269, DOI 10.1016/j.jmb.2007.03.047; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Peng HZ, 2000, J MOL BIOL, V295, P1139, DOI 10.1006/jmbi.1999.3402; Peng HZ, 2002, CANCER RES, V62, P3773; PENGUE G, 1994, NUCLEIC ACIDS RES, V22, P2908, DOI 10.1093/nar/22.15.2908; Phillips NB, 2004, BIOCHEMISTRY-US, V43, P7066, DOI 10.1021/bi049920a; Polanco JC, 2009, BIOL CELL, V101, P55, DOI 10.1042/BC20080061; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Tamashiro DAA, 2008, BBA-GEN SUBJECTS, V1780, P1395, DOI 10.1016/j.bbagen.2008.07.001; WITZGALL R, 1994, P NATL ACAD SCI USA, V91, P4514, DOI 10.1073/pnas.91.10.4514; Zhang W, 2008, CANCER RES, V68, P2764, DOI 10.1158/0008-5472.CAN-07-6349	36	52	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35670	35680		10.1074/jbc.M109.032086	http://dx.doi.org/10.1074/jbc.M109.032086			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850934	Green Published, hybrid			2022-12-25	WOS:000272645600045
J	Douzi, B; Durand, E; Bernard, C; Alphonse, S; Cambillau, C; Filloux, A; Tegoni, M; Voulhoux, R				Douzi, Badreddine; Durand, Eric; Bernard, Cedric; Alphonse, Sebastien; Cambillau, Christian; Filloux, Alain; Tegoni, Mariella; Voulhoux, Rome			The XcpV/GspI Pseudopilin Has a Central Role in the Assembly of a Quaternary Complex within the T2SS Pseudopilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-2 SECRETION SYSTEM; CAMPESTRIS PV. CAMPESTRIS; GRAM-NEGATIVE BACTERIA; II PROTEIN SECRETION; PSEUDOMONAS-AERUGINOSA; COMPONENTS; PATHWAY; LOCALIZATION; APPARATUS; XPSG	Gram-negative bacteria use the sophisticated type II secretion system (T2SS) to secrete a large number of exoproteins into the extracellular environment. Five proteins of the T2SS, the pseudopilins GspG-H-I-J-K, are proposed to assemble into a pseudopilus involved in the extrusion of the substrate through the outer membrane channel. Recent structural data have suggested that the three pseudopilins GspI-J-K are organized in a trimeric complex located at the tip of the GspG-containing pseudopilus. In the present work we combined two biochemical techniques to investigate the protein-protein interaction network between the five Pseudomonas aeruginosa Xcp pseudopilins. The soluble domains of XcpT-U-V-W-X (respectively homologous to GspG-H-I-J-K) were purified, and the interactions were tested by surface plasmon resonance and affinity co-purification in all possible combinations. We found an XcpV(I)-W-J-X-K complex, which demonstrates that the crystallized trimeric complex also exists in the P. aeruginosa T2SS. Interestingly, our systematic approach revealed an additional and yet uncharacterized interaction between XcpU(H) and XcpW(J). This observation suggested the existence of a quaternary, rather than ternary, complex (XcpU(H)-V-I-W-J-X-K) at the tip of the pseudopilus. The assembly of this quaternary complex was further demonstrated by co-purification using affinity chromatography. Moreover, by testing various combinations of pseudopilins by surface plasmon resonance and affinity chromatography, we were able to dissect the different possible successive steps occurring during the formation of the quaternary complex. We propose a model in which XcpV(I) is the nucleator that first binds XcpX(K) and XcpW(J) at different sites. Then the ternary complex recruits XcpU(H) through a direct interaction with XcpW(J).	[Durand, Eric; Filloux, Alain; Voulhoux, Rome] Univ Aix Marseille 2, LISM UPR 9027, IMM, CNRS, F-13402 Marseille 20, France; [Douzi, Badreddine; Bernard, Cedric; Alphonse, Sebastien; Cambillau, Christian; Tegoni, Mariella] CNRS, UMR6098, F-13288 Marseille 9, France; [Douzi, Badreddine; Bernard, Cedric; Alphonse, Sebastien; Cambillau, Christian; Tegoni, Mariella] Univ Aix Marseille 1, F-13288 Marseille 9, France; [Douzi, Badreddine; Bernard, Cedric; Alphonse, Sebastien; Cambillau, Christian; Tegoni, Mariella] Univ Aix Marseille 2, F-13288 Marseille 9, France; [Douzi, Badreddine] Fac Pharm, Lab Malad Transmissibles & Subst Biologiquement A, LR99ES27, TU-5000 Monastir, Tunisia; [Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Div Cell & Mol Biol, London SW7 2AZ, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Universite de Monastir; Imperial College London	Voulhoux, R (corresponding author), Univ Aix Marseille 2, LISM UPR 9027, IMM, CNRS, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	voulhoux@ifr88.cnrs-mrs.fr	Voulhoux, Rome/AAT-5333-2021; douzi, Badreddine/Z-5707-2019; Douzi, Badreddine/ABA-4540-2021; Durand, Eric/E-6739-2017	Douzi, Badreddine/0000-0003-3140-4713; Durand, Eric/0000-0002-0577-8220; Alphonse, Sebastien/0000-0002-2054-2005	Agence Nationale de la Recherche Program [ANR-JC07-183230]; Royal Society	Agence Nationale de la Recherche Program(French National Research Agency (ANR)); Royal Society(Royal Society of London)	This work was supported by Agence Nationale de la Recherche Program "Jeune Chercheur" Grant ANR-JC07-183230 and by funds from the Royal Society ( to A. F.).	ABRAMOFF MD, 2004, BIOPHOTONICS INT, V11, P39; BALLY M, 1992, MOL MICROBIOL, V6, P1121, DOI 10.1111/j.1365-2958.1992.tb01550.x; Bleves S, 1998, MOL MICROBIOL, V27, P31, DOI 10.1046/j.1365-2958.1998.00653.x; Bogomolovas J, 2009, PROTEIN EXPRES PURIF, V64, P16, DOI 10.1016/j.pep.2008.10.003; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Douet V, 2004, RES MICROBIOL, V155, P71, DOI 10.1016/j.resmic.2003.10.001; Durand E, 2005, J BIOL CHEM, V280, P31378, DOI 10.1074/jbc.M505812200; Durand E, 2003, J BACTERIOL, V185, P2749, DOI 10.1128/JB.185.9.2749-2758.2003; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Filloux A, 1998, FEMS MICROBIOL REV, V22, P177, DOI 10.1016/S0168-6445(98)00013-8; Hansen JK, 2006, J MOL MICROB BIOTECH, V11, P192, DOI 10.1159/000094054; Hu NT, 2002, BIOCHEM J, V365, P205, DOI 10.1042/BJ20020194; Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Kuo WW, 2005, J BIOMED SCI, V12, P587, DOI 10.1007/s11373-005-7372-3; Lam AY, 2009, J STRUCT BIOL, V166, P8, DOI 10.1016/j.jsb.2008.11.008; Lu HM, 1997, MOL MICROBIOL, V25, P247, DOI 10.1046/j.1365-2958.1997.4561818.x; NUNN DN, 1993, J BACTERIOL, V175, P4375, DOI 10.1128/JB.175.14.4375-4382.1993; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Veesler D, 2009, ANAL BIOCHEM, V388, P115, DOI 10.1016/j.ab.2009.02.018; Vignon G, 2003, J BACTERIOL, V185, P3416, DOI 10.1128/JB.185.11.3416-3428.2003; Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735; Yanez ME, 2008, J MOL BIOL, V377, P91, DOI 10.1016/j.jmb.2007.08.041; Yanez ME, 2008, J MOL BIOL, V375, P471, DOI 10.1016/j.jmb.2007.10.035	25	47	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34580	34589		10.1074/jbc.M109.042366	http://dx.doi.org/10.1074/jbc.M109.042366			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19828448	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000272439600013
J	Zhang, J; Li, SH; Musa, S; Zhou, H; Xiang, X				Zhang, Jun; Li, Shihe; Musa, Shamsideen; Zhou, Henry; Xiang, Xin			Dynein Light Intermediate Chain in Aspergillus nidulans Is Essential for the Interaction between Heavy and Intermediate Chains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOPLASMIC DYNEIN; NUCLEAR MIGRATION; DYNACTIN INTERACTION; INTRACELLULAR-TRANSPORT; NEURITE OUTGROWTH; FILAMENTOUS FUNGI; MITOTIC SPINDLE; MOTOR; PROTEIN; TCTEX-1	Cytoplasmic dynein is a complex containing heavy chains (HCs), intermediate chains (ICs), light intermediate chains (LICs), and light chains (LCs). The HCs are responsible for motor activity. The ICs at the tail region of the motor interact with dynactin, which is essential for dynein function. However, functions of other subunits and how they contribute to the assembly of the core complex are not clearly defined. Here, we analyzed in the filamentous fungus Aspergillus nidulans functions of the only LIC and two LCs, RobA (Roadblock/LC7) and TctexA (Tctex1) in dynein-mediated nuclear distribution (nud). Whereas the deletion mutant of tctexA did not exhibit an apparent nud mutant phenotype, the deletion mutant of robA exhibited a nud phenotype at an elevated temperature, which is similar to the previously characterized nudG (LC8) deletion mutant. Remarkably, in contrast to the single mutants, the robA and nudG double deletion mutant exhibits a severe nud phenotype at various temperatures. Thus, functions of these two LC classes overlap to some extent, but the presence of both becomes important under specific conditions. The single LIC, however, is essential for dynein function in nuclear distribution. This is evidenced by the identification of the nudN gene as the LIC coding gene, and by the nud phenotype exhibited by the LIC down-regulating mutant, alcA-LIC. Without a functional LIC, the HC-IC association is significantly weakened, and the HCs could no longer accumulate at the microtubule plus end. Thus, the LIC is essential for the assembly of the core complex of dynein in Aspergillus.	[Zhang, Jun; Li, Shihe; Musa, Shamsideen; Zhou, Henry; Xiang, Xin] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	Xiang, X (corresponding author), Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Dept Biochem & Mol Biol, Bethesda, MD 20814 USA.	xxiang@usuhs.mil			National Institutes of Health [GM069527]; USUHS; CNP; USU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069527] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USUHS; CNP; USU; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM069527 (to X. X.). This work was also supported by a USUHS intramural grant (to X. X.), a grant from CNP (Comprehensive Neuroscience Program)DOD (to X. X.), and the USU Center for Health Disparities (to S. M.).	Abenza JF, 2009, TRAFFIC, V10, P57, DOI 10.1111/j.1600-0854.2008.00848.x; Barbar E, 2008, BIOCHEMISTRY-US, V47, P503, DOI 10.1021/bi701995m; Beckwith SM, 1998, J CELL BIOL, V143, P1239, DOI 10.1083/jcb.143.5.1239; Burgess SA, 2003, NATURE, V421, P715, DOI 10.1038/nature01377; Caviston JP, 2007, P NATL ACAD SCI USA, V104, P10045, DOI 10.1073/pnas.0610628104; Chuang JZ, 2005, DEV CELL, V9, P75, DOI 10.1016/j.devcel.2005.04.003; Davis L, 2005, GENETICS, V170, P581, DOI 10.1534/genetics.104.040253; Dick T, 1996, MOL GEN GENET, V251, P38; Han GS, 2001, CURR BIOL, V11, P719, DOI 10.1016/S0960-9822(01)00200-7; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; King SJ, 2002, PROTEIN SCI, V11, P1239, DOI 10.1110/ps.2520102; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; Lee WL, 2005, J CELL BIOL, V168, P201, DOI 10.1083/jcb.200407036; Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Levy JR, 2008, J CELL SCI, V121, P3187, DOI 10.1242/jcs.033878; Li MG, 2004, MOL BIOL CELL, V15, P3005, DOI 10.1091/mbc.E04-01-0013; Liu B, 2000, MOL GEN GENET, V263, P375, DOI 10.1007/s004380051181; Liu B, 2003, MOL MICROBIOL, V47, P291, DOI 10.1046/j.1365-2958.2003.03285.x; Lo KWH, 2006, J BIOL CHEM, V281, P9552, DOI 10.1074/jbc.M511721200; Ma S, 1999, J CELL BIOL, V147, P1261, DOI 10.1083/jcb.147.6.1261; Miki F, 2002, MOL BIOL CELL, V13, P930, DOI 10.1091/mbc.01-11-0543; Miller RK, 2006, CURR TOP DEV BIOL, V76, P49, DOI 10.1016/S0070-2153(06)76002-1; Mische S, 2008, MOL BIOL CELL, V19, P4918, DOI 10.1091/mbc.E08-05-0483; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Palmer KJ, 2009, MOL BIOL CELL, V20, P2885, DOI 10.1091/mbc.E08-12-1160; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Roberts AJ, 2009, CELL, V136, P485, DOI 10.1016/j.cell.2008.11.049; Sachdev P, 2007, EMBO J, V26, P2621, DOI 10.1038/sj.emboj.7601716; Samso M, 1998, J MOL BIOL, V276, P927, DOI 10.1006/jmbi.1997.1584; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7; Sivaram MVS, 2009, EMBO J, V28, P902, DOI 10.1038/emboj.2009.38; Song J, 2005, J MOL BIOL, V354, P1043, DOI 10.1016/j.jmb.2005.10.017; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tang Q, 2002, MOL BIOL CELL, V13, P4484, DOI 10.1091/mbc.e02-05-0245; Tynan SH, 2000, J BIOL CHEM, V275, P32769, DOI 10.1074/jbc.M001537200; Tynan SH, 2000, J BIOL CHEM, V275, P32763, DOI 10.1074/jbc.M001536200; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Xiang X, 1999, CURR GENET, V35, P626, DOI 10.1007/s002940050461; Xiang X, 2004, FUNGAL GENET BIOL, V41, P411, DOI 10.1016/j.fgb.2003.11.010; Xiang X, 2003, CURR OPIN MICROBIOL, V6, P628, DOI 10.1016/j.mib.2003.10.009; XIANG X, 1995, P NATL ACAD SCI USA, V92, P9890, DOI 10.1073/pnas.92.21.9890; Yeh TY, 2006, TRAFFIC, V7, P1495, DOI 10.1111/j.1600-0854.2006.00482.x; Yoder JH, 2001, MOL BIOL CELL, V12, P2921, DOI 10.1091/mbc.12.10.2921; Zekert N, 2009, MOL BIOL CELL, V20, P673, DOI 10.1091/mbc.E08-07-0685; Zhang J, 2002, MOL MICROBIOL, V44, P381, DOI 10.1046/j.1365-2958.2002.02900.x; Zhang J, 2008, TRAFFIC, V9, P1073, DOI 10.1111/j.1600-0854.2008.00748.x; Zhuang L, 2007, GENETICS, V175, P1185, DOI 10.1534/genetics.106.069013	56	13	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34760	34768		10.1074/jbc.M109.026872	http://dx.doi.org/10.1074/jbc.M109.026872			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19837669	Green Published, hybrid			2022-12-25	WOS:000272439600031
J	Provenzano, PP; Inman, DR; Eliceiri, KW; Keely, PJ				Provenzano, P. P.; Inman, D. R.; Eliceiri, K. W.; Keely, P. J.			Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage	ONCOGENE			English	Article						epithelial morphogenesis; breast cancer; breast tissue density; cell-extracellular matrix interaction; mechanotransduction; 3D matrix/focal adhesion	FOCAL ADHESION KINASE; ACTIVATED PROTEIN-KINASE; EPITHELIAL-SPECIFIC DISRUPTION; CARCINOMA IN-SITU; MAMMOGRAPHIC DENSITY; EXTRACELLULAR-MATRIX; CANCER RISK; MALIGNANT PHENOTYPE; GROWTH-FACTORS; STRESS FIBERS	Mammographically dense breast tissue is one of the greatest risk factors for developing breast carcinoma, yet the associated molecular mechanisms remain largely unknown. Importantly, regions of high breast density are associated with increased stromal collagen and epithelial cell content. We set out to determine whether increased collagen-matrix density, in the absence of stromal cells, was sufficient to promote proliferation and invasion characteristic of a malignant phenotype in non-transformed mammary epithelial cells. We demonstrate that increased collagen-matrix density increases matrix stiffness to promote an invasive phenotype. High matrix stiffness resulted in increased formation of activated three-dimensional (3D)-matrix adhesions and a chronically elevated outside-in/inside-out focal adhesion (FA) kinase (FAK)-Rho signaling loop, which was necessary to generate and maintain the invasive phenotype. Moreover, this signaling network resulted in hyperactivation of the Ras-mitogen-activated protein kinase (MAPK) pathway, which promoted growth of mammary epithelial cells in vitro and in vivo and activated a clinically relevant proliferation signature that predicts patient outcome. Hence, the current data provide compelling evidence for the importance of the mechanical features of the microenvironment, and suggest that mechanotransduction in these cells occurs through a FAK-Rho-ERK signaling network with extracellular signal-regulated kinase (ERK) as a bottleneck through which much of the response to mechanical stimuli is regulated. As such, we propose that increased matrix stiffness explains part of the mechanism behind increased epithelial proliferation and cancer risk in human patients with high breast tissue density. Oncogene (2009) 28, 4326-4343; doi: 10.1038/onc.2009.299; published online 12 October 2009	[Provenzano, P. P.; Inman, D. R.; Keely, P. J.] Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA; [Provenzano, P. P.; Eliceiri, K. W.; Keely, P. J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Provenzano, P. P.; Eliceiri, K. W.; Keely, P. J.] Univ Wisconsin, Lab Opt & Computat Instrumentat, Madison, WI USA; [Provenzano, P. P.; Inman, D. R.; Keely, P. J.] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Provenzano, PP (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, M5-C119, Seattle, WA 98109 USA.	ppproven@fhcrc.org; pjkeely@wisc.edu	Eliceiri, Kevin/ABD-4516-2020; Peng, Chunwei/F-6788-2010	Eliceiri, Kevin/0000-0001-8678-670X; Provenzano, Paolo/0000-0002-9313-1370	NIH [T32CA009681, CA076537, EB000184]; DOD [W81XWH-04-1-042]; Cancer Soc [RSG-00339CSM]; NATIONAL CANCER INSTITUTE [R29CA076537, R01CA142833, T32CA009681, R01CA114462, R01CA076537] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000184] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Cancer Soc; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank Drs Caroline Alexander and Andreas Friedl for helpful discussions regarding mice and xenograft experiments; Drs Ray Vanderby, Ashish Oza and Wilmot Valhmu for helpful discussions and equipment access for mechanical testing, and Dr John G White for helpful discussions regarding microscopy. This work was supported by an NIH postdoctoral training grant (T32CA009681) to PPP, and grants from the DOD (W81XWH-04-1-042 (PPP)), Am. Cancer Soc. (RSG-00339CSM(PJK)) and NIH (CA076537 (PJK) and EB000184 (KWE)).	Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622; Boyd N F, 2001, Curr Oncol Rep, V3, P314, DOI 10.1007/s11912-001-0083-7; Boyd NF, 1998, CANCER EPIDEM BIOMAR, V7, P1133; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gill JK, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1507; Guo YP, 2001, CANCER EPIDEM BIOMAR, V10, P243; Habel LA, 2004, JNCI-J NATL CANCER I, V96, P1467, DOI 10.1093/jnci/djh260; KEELY PJ, 1995, J CELL SCI, V108, P595; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Krouskop TA, 1998, ULTRASONIC IMAGING, V20, P260, DOI 10.1177/016173469802000403; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Li T, 2005, CANCER EPIDEM BIOMAR, V14, P343, DOI 10.1158/1055-9965.EPI-04-0490; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Martin LJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1831; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Plewes DB, 2000, PHYS MED BIOL, V45, P1591, DOI 10.1088/0031-9155/45/6/314; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Provenzano PP, 2008, AM J PATHOL, V173, P1551, DOI 10.2353/ajpath.2008.080308; Provenzano PP, 2006, MATRIX BIOL, V25, P71, DOI 10.1016/j.matbio.2005.09.005; Provenzano PP, 2003, J APPL PHYSIOL, V94, P314, DOI 10.1152/japplphysiol.00340.2002; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Samani A, 2001, IEEE T MED IMAGING, V20, P271, DOI 10.1109/42.921476; Sarvazyan A. P., 1995, ACOUST IMAGING, P223, DOI [10.1007/978-1-4615-1943-0_23, DOI 10.1007/978-1-4615-1943-0_23]; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1998, MOL CELL BIOL, V18, P2571, DOI 10.1128/MCB.18.5.2571; Schlaepfer DD, 1996, MOL CELL BIOL, V16, P5623; Sniadecki NJ, 2007, P NATL ACAD SCI USA, V104, P14553, DOI 10.1073/pnas.0611613104; Sumi C, 2000, PHYS MED BIOL, V45, P1511, DOI 10.1088/0031-9155/45/6/308; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Ursin G, 2005, BREAST CANCER RES, V7, pR605, DOI 10.1186/bcr1260; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang HB, 2001, P NATL ACAD SCI USA, V98, P11295, DOI 10.1073/pnas.201201198; Wang JG, 2005, LIFE SCI, V76, P2817, DOI 10.1016/j.lfs.2004.10.050; Wang JG, 2001, BIOCHEM BIOPH RES CO, V288, P356, DOI 10.1006/bbrc.2001.5775; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	57	451	460	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2009	28	49					4326	4343		10.1038/onc.2009.299	http://dx.doi.org/10.1038/onc.2009.299			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DT	19826415	Green Accepted			2022-12-25	WOS:000272876400002
J	Courtin, D; Oesterholt, M; Huismans, H; Kusi, K; Milet, J; Badaut, C; Gaye, O; Roeffen, W; Remarque, EJ; Sauerwein, R; Garcia, A; Luty, AJF				Courtin, David; Oesterholt, Mayke; Huismans, Harm; Kusi, Kwadwo; Milet, Jacqueline; Badaut, Cyril; Gaye, Oumar; Roeffen, Will; Remarque, Edmond J.; Sauerwein, Robert; Garcia, Andre; Luty, Adrian J. F.			The Quantity and Quality of African Children's IgG Responses to Merozoite Surface Antigens Reflect Protection against Plasmodium falciparum Malaria	PLOS ONE			English	Article							GLUTAMATE-RICH PROTEIN; BLOOD-STAGE ANTIGENS; SICKLE-CELL TRAIT; APICAL MEMBRANE ANTIGEN-1; GROWTH IN-VITRO; CLINICAL MALARIA; ANTIBODY-RESPONSES; IMMUNOGLOBULIN-G; SERUM ANTIBODIES; PARASITE GROWTH	Background Antibodies, particularly cytophilic IgG subclasses, with specificity for asexual blood stage antigens of Plasmodium falciparum, are thought to play an important role in acquired immunity to malaria. Evaluating such responses in longitudinal sero-epidemiological field studies, allied to increasing knowledge of the immunological mechanisms associated with anti-malarial protection, will help in the development of malaria vaccines. Methods and Findings: We conducted a 1-year follow-up study of 305 Senegalese children and identified those resistant or susceptible to malaria. In retrospective analyses we then compared post-follow-up IgG responses to six asexual-stage candidate malaria vaccine antigens in groups of individuals with clearly defined clinical and parasitological histories of infection with P. falciparum. In age-adjusted analyses, children resistant to malaria as well as to high-density parasitemia, had significantly higher IgG1 responses to GLURP and IgG3 responses to MSP2 than their susceptible counterparts. Among those resistant to malaria, high anti-MSP1 IgG1 levels were associated with protection against high-density parasitemia. To assess functional attributes, we used an in vitro parasite growth inhibition assay with purified IgG. Samples from individuals with high levels of IgG directed to MSP1, MSP2 and AMA1 gave the strongest parasite growth inhibition, but a marked age-related decline was observed in these effects. Conclusion: Our data are consistent with the idea that protection against P. falciparum malaria in children depends on acquisition of a constellation of appropriate, functionally active IgG subclass responses directed to multiple asexual stage antigens. Our results suggest at least two distinct mechanisms via which antibodies may exert protective effects. Although declining with age, the growth inhibitory effects of purified IgG measurable in vitro reflected levels of anti-AMA1, -MSP1 and -MSP2, but not of anti-GLURP IgG. The latter could act on parasite growth via indirect parasiticidal pathways.			Courtin, D (corresponding author), Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	A.Luty@mmb.umcn.nl	Sauerwein, Robert/C-8519-2013; Garcia, Andre/ABA-1820-2020; Luty, Adrian/CAH-2547-2022; Garcia, Andre/S-2959-2016; Remarque, Ed/AAE-8643-2020; Kusi, Kwadwo Asamoah/J-5941-2019; Roeffen, W.F.G./L-4607-2015; Remarque, Edmond J/B-2217-2010; courtin, david/A-1584-2017	Garcia, Andre/0000-0002-1808-472X; Garcia, Andre/0000-0002-1808-472X; Kusi, Kwadwo Asamoah/0000-0001-5483-9985; courtin, david/0000-0002-5263-4430; MILET, Jacqueline/0000-0003-2710-1517; Badaut, Cyril/0000-0002-0064-6384; Luty, Adrian John Frederick/0000-0001-8830-3425				Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; ALYAMAN F, 1994, AM J TROP MED HYG, V51, P593, DOI 10.4269/ajtmh.1994.51.593; Aribot G, 1996, AM J TROP MED HYG, V54, P449, DOI 10.4269/ajtmh.1996.54.449; Arnot DE, 2008, CLIN VACCINE IMMUNOL, V15, P1345, DOI 10.1128/CVI.00172-08; Bonnet S, 2006, VACCINE, V24, P5997, DOI 10.1016/j.vaccine.2006.04.069; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Braga TM, 2002, AM J TROP MED HYG, V66, P461, DOI 10.4269/ajtmh.2002.66.461; Branch OH, 1998, AM J TROP MED HYG, V58, P211, DOI 10.4269/ajtmh.1998.58.211; BROWN GV, 1983, AM J TROP MED HYG, V32, P1221, DOI 10.4269/ajtmh.1983.32.1221; Cabrera G, 2005, J INFECT DIS, V191, P1631, DOI 10.1086/429832; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Corran PH, 2004, INFECT IMMUN, V72, P6185, DOI 10.1128/IAI.72.10.6185-6189.2004; Dent AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003557; Dodoo D, 2000, J INFECT DIS, V181, P1202, DOI 10.1086/315341; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Garcia A, 2004, MICROBES INFECT, V6, P68, DOI 10.1016/j.micinf.2003.09.021; Gray JC, 2007, CLIN CHEM, V53, P1244, DOI 10.1373/clinchem.2006.081695; Hermsen CC, 2007, VACCINE, V25, P2930, DOI 10.1016/j.vaccine.2006.06.081; Iriemenam NC, 2009, VACCINE, V27, P62, DOI 10.1016/j.vaccine.2008.10.025; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Lusingu JPA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-48; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; Meraldi V, 2004, PARASITE IMMUNOL, V26, P265, DOI 10.1111/j.0141-9838.2004.00705.x; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Migot-Nabias F, 2006, MICROBES INFECT, V8, P2352, DOI 10.1016/j.micinf.2006.03.021; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Ntoumi F, 2002, IMMUNOL LETT, V84, P9, DOI 10.1016/S0165-2478(02)00131-1; Oeuvray C, 2000, INFECT IMMUN, V68, P2617, DOI 10.1128/IAI.68.5.2617-2620.2000; Okech BA, 2004, INFECT IMMUN, V72, P1557, DOI 10.1128/IAI.72.3.1557-1567.2004; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; RASHEED FN, 1995, PARASITE IMMUNOL, V17, P1, DOI 10.1111/j.1365-3024.1995.tb00960.x; Robert V, 1998, TROP MED INT HEALTH, V3, P667, DOI 10.1046/j.1365-3156.1998.00288.x; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sarr JB, 2006, MICROBES INFECT, V8, P1260, DOI 10.1016/j.micinf.2005.12.005; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; Tebo AE, 2001, EXP PARASITOL, V98, P20, DOI 10.1006/expr.2001.4619; Theisen M, 1998, INFECT IMMUN, V66, P11, DOI 10.1128/IAI.66.1.11-17.1998; THEISEN M, 1995, CLIN DIAGN LAB IMMUN, V2, P30, DOI 10.1128/CDLI.2.1.30-34.1995; Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006; VERNES A, 1984, AM J TROP MED HYG, V33, P197, DOI 10.4269/ajtmh.1984.33.197; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744	52	79	79	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7590	10.1371/journal.pone.0007590	http://dx.doi.org/10.1371/journal.pone.0007590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859562	Green Published, Green Submitted, gold			2022-12-25	WOS:000271147400008
J	Pothlichet, J; Burtey, A; Kubarenko, AV; Caignard, G; Solhonne, B; Tangy, F; Ben-Ali, M; Quintana-Murci, L; Heinzmann, A; Chiche, JD; Vidalain, PO; Weber, ANR; Chignard, M; Si-Tahar, M				Pothlichet, Julien; Burtey, Anne; Kubarenko, Andriy V.; Caignard, Gregory; Solhonne, Brigitte; Tangy, Frederic; Ben-Ali, Meriem; Quintana-Murci, Lluis; Heinzmann, Andrea; Chiche, Jean-Daniel; Vidalain, Pierre-Olivier; Weber, Alexander N. R.; Chignard, Michel; Si-Tahar, Mustapha			Study of Human RIG-I Polymorphisms Identifies Two Variants with an Opposite Impact on the Antiviral Immune Response	PLOS ONE			English	Article							INFLUENZA-A-VIRUS; SIGNALING PATHWAYS; RECRUITMENT DOMAIN; EPITHELIAL-CELLS; CARD; RECOGNITION; COMMON; MDA5; LGP2; ELECTROSTATICS	Background RIG-I is a pivotal receptor that detects numerous RNA and DNA viruses. Thus, its defectiveness may strongly impair the host antiviral immunity. Remarkably, very little information is available on RIG-I single-nucleotide polymorphisms (SNPs) presenting a functional impact on the host response. Methodology/Principal Findings: Here, we studied all non-synonymous SNPs of RIG-I using biochemical and structural modeling approaches. We identified two important variants: (i) a frameshift mutation (P(229)fs) that generates a truncated, constitutively active receptor and (ii) a serine to isoleucine mutation (S183I), which drastically inhibits antiviral signaling and exerts a down-regulatory effect, due to unintended stable complexes of RIG-I with itself and with MAVS, a key downstream adapter protein. Conclusions/Significance: Hence, this study characterized P(229)fs and S(183)ISNPs as major functional RIG-I variants and potential genetic determinants of viral susceptibility. This work also demonstrated that serine 183 is a residue that critically regulates RIG-I-induced antiviral signaling.			Pothlichet, J (corresponding author), Inst Pasteur, Unite Def Innee & Inflammat, Paris, France.	sitahar@pasteur.fr	Si-Tahar, Mustapha/W-8034-2019; Vidalain, Pierre-Olivier/F-9778-2019; Chignard, Michel/B-4351-2008; SI-TAHAR, Mustapha/L-4149-2014; Quintana-Murci, Lluis/AAB-7468-2022; Chiche, Jean-Daniel/P-5220-2017	Si-Tahar, Mustapha/0000-0002-5792-7742; Vidalain, Pierre-Olivier/0000-0003-3082-7407; Chignard, Michel/0000-0003-3810-6575; SI-TAHAR, Mustapha/0000-0002-5792-7742; Chiche, Jean-Daniel/0000-0002-6433-6254; Caignard, Gregory/0000-0001-7021-0749; Quintana-Murci, Lluis/0000-0003-2429-6320; Burtey, Anne/0000-0003-4548-8807; Weber, Alexander/0000-0002-8627-7056				Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Caignard G, 2007, VIROLOGY, V368, P351, DOI 10.1016/j.virol.2007.06.037; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Chi HB, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-211; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Day CL, 1999, CELL DEATH DIFFER, V6, P1125, DOI 10.1038/sj.cdd.4400584; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dyson HJ, 2006, P NATL ACAD SCI USA, V103, P13057, DOI 10.1073/pnas.0605504103; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gregersen N, 2006, J INHERIT METAB DIS, V29, P456, DOI 10.1007/s10545-006-0301-4; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hausmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003965; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kubarenko A, 2007, BIOCHEM SOC T, V35, P1515, DOI 10.1042/BST0351515; Lad SP, 2008, MOL IMMUNOL, V45, P2277, DOI 10.1016/j.molimm.2007.11.018; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lloyd AR, 2007, IMMUNOL CELL BIOL, V85, P24, DOI 10.1038/sj.icb.7100010; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Moore CB, 2008, IMMUNITY, V28, P735, DOI 10.1016/j.immuni.2008.05.005; Palsson-McDermott EM, 2007, BIOCHEM SOC T, V35, P1437, DOI 10.1042/BST0351437; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pettit FK, 2007, J MOL BIOL, V369, P863, DOI 10.1016/j.jmb.2007.03.036; Picard C, 2007, IMMUNOL RES, V38, P347, DOI 10.1007/s12026-007-0006-2; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reiche EMV, 2007, CURR MED CHEM, V14, P1325; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Sanchez R, 2000, METH MOL B, V143, P97; Sanders CR, 2001, BIOCHEMISTRY-US, V40, P9453, DOI 10.1021/bi010894f; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Schroder M, 2007, BIOCHEM SOC T, V35, P1512, DOI 10.1042/BST0351512; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tebbutt SJ, 2007, CHEST, V131, P1216, DOI 10.1378/chest.06-2252; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Werts C, 2006, CELL DEATH DIFFER, V13, P798, DOI 10.1038/sj.cdd.4401890; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265	51	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7582	10.1371/journal.pone.0007582	http://dx.doi.org/10.1371/journal.pone.0007582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859543	Green Published, Green Submitted, gold			2022-12-25	WOS:000271147400006
J	Liu, D; Fan, J; Mei, MX; Ingvarsson, S; Chen, HP				Liu, Dong; Fan, Jing; Mei, Manxue; Ingvarsson, Sigurdur; Chen, Huiping			Identification of miRNAs in a Liver of a Human Fetus by a Modified Method	PLOS ONE			English	Article							CELL-DEATH; MICRORNAS; EXPRESSION; SYSTEM; DIFFERENTIATION; DROSOPHILA; ELEGANS; GENES	Background: miRNAs are 17-25 nucleotides long RNA molecules that have been found to regulate gene expression in human cells. There are studies showing that different groups of miRNAs are involved in development of different tissues. In hepatocytes there are reported particular types of miRNAs that regulate gene expression. Methods: We established a human fetal liver cDNA library by a modified cloning protocol. Then plasmid isolation from the colonies was performed. After sequencing and database searching, the miRNAs were recognized. RT-PCR and sequencing were carried out to validate the miRNAs detected. Real-time PCR was used to analyze the expression of each miRNA. Results: One novel miRNA was discovered, together with another 35 previously-known miRNAs in the fetal liver. Some of them existed in variants. The miRNAs identified were validated by RT-PCR and sequencing. Quantitative analysis showed that they have variable expression. Conclusion: Our results indicate that a special group of miRNAs may play an important role in fetal liver development in a synergistic manner.	[Liu, Dong; Fan, Jing; Chen, Huiping] Huazhong Univ Sci & Technol, Dept Med Genet, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Mei, Manxue] Wuhan Polytech Univ, Hubei Key Lab Anim Nutr & Feed Sci, Dept Feed Sci, Wuhan, Hubei, Peoples R China; [Ingvarsson, Sigurdur] Univ Iceland, Inst Expt Pathol, Reykjavik, Iceland; [Ingvarsson, Sigurdur] Univ Iceland, Fac Med, Reykjavik, Iceland	Huazhong University of Science & Technology; Wuhan Polytechnic University; University of Iceland; University of Iceland	Liu, D (corresponding author), Huazhong Univ Sci & Technol, Dept Med Genet, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	huiping@mail.hust.edu.cn	Ingvarsson, Sigurdur/E-7448-2011	Ingvarsson, Sigurdur/0000-0003-4125-1714				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; FU H, 2003, FEBS LETT, V579, P3849; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Liao YC, 2008, INT J BIOCHEM CELL B, V40, P843, DOI 10.1016/j.biocel.2007.04.008; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang B, 2009, CANCER RES, V69, P75, DOI 10.1158/0008-5472.CAN-08-1393	23	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7594	10.1371/journal.pone.0007594	http://dx.doi.org/10.1371/journal.pone.0007594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855840	Green Published, Green Submitted, gold			2022-12-25	WOS:000271147200014
J	Smith, TK; Vasileva, N; Gluenz, E; Terry, S; Portman, N; Kramer, S; Carrington, M; Michaeli, S; Gull, K; Rudenko, G				Smith, Terry K.; Vasileva, Nadina; Gluenz, Eva; Terry, Stephen; Portman, Neil; Kramer, Susanne; Carrington, Mark; Michaeli, Shulamit; Gull, Keith; Rudenko, Gloria			Blocking Variant Surface Glycoprotein Synthesis in Trypanosoma brucei Triggers a General Arrest in Translation Initiation	PLOS ONE			English	Article							BLOOD-STREAM-FORM; UNFOLDED-PROTEIN RESPONSE; VSG EXPRESSION SITES; CELL-CYCLE ARREST; AFRICAN TRYPANOSOMES; ANTIGENIC VARIATION; PATHWAY; IDENTIFICATION; MEMBRANE; TRANSCRIPTION	Background: The African trypanosome Trypanosoma brucei is covered with a dense layer of Variant Surface Glycoprotein (VSG), which protects it from lysis by host complement via the alternative pathway in the mammalian bloodstream. Blocking VSG synthesis by the induction of VSG RNAi triggers an unusually precise precytokinesis cell-cycle arrest. Methodology/Principal Findings: Here, we characterise the cells arrested after the induction of VSG RNAi. We were able to rescue the VSG221 RNAi induced cell-cycle arrest through expression of a second different VSG (VSG117 which is not recognised by the VSG221 RNAi) from the VSG221 expression site. Metabolic labeling of the arrested cells showed that blocking VSG synthesis triggered a global translation arrest, with total protein synthesis reduced to less than 1-4% normal levels within 24 hours of induction of VSG RNAi. Analysis by electron microscopy showed that the translation arrest was coupled with rapid disassociation of ribosomes from the endoplasmic reticulum. Polysome analysis showed a drastic decrease in polysomes in the arrested cells. No major changes were found in levels of transcription, total RNA transcript levels or global amino acid concentrations in the arrested cells. Conclusions: The cell-cycle arrest phenotype triggered by the induction of VSG221 RNAi is not caused by siRNA toxicity, as this arrest can be alleviated if a second different VSG is inserted downstream of the active VSG221 expression site promoter. Analysis of polysomes in the stalled cells showed that the translation arrest is mediated at the level of translation initiation rather than elongation. The cell-cycle arrest induced in the presence of a VSG synthesis block is reversible, suggesting that VSG synthesis and/or trafficking to the cell surface could be monitored during the cell-cycle as part of a specific cell-cycle checkpoint.			Smith, TK (corresponding author), Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9AJ, Fife, Scotland.	gloria.rudenko@medawar.ox.ac.uk	Michaeli, Shulamit/AAC-8255-2022; Carrington, Mark/N-3653-2019; Carrington, Mark/N-4892-2018; Kramer, Susanne/M-5026-2017; Terry, Stephen/AAC-8511-2019	Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Terry, Stephen/0000-0001-8195-898X; Portman, Neil/0000-0003-0248-0258; Rudenko, Gloria/0000-0003-1884-4933; Gluenz, Eva/0000-0003-4346-8896	Wellcome Trust [095161] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Amiguet-Vercher A, 2004, MOL MICROBIOL, V51, P1577, DOI 10.1111/j.1365-2958.2003.03937.x; Ariyanayagam MR, 2005, BIOCHEM J, V391, P425, DOI 10.1042/BJ20050911; Bangs JD, 1997, EMBO J, V16, P4285, DOI 10.1093/emboj/16.14.4285; Barry JD, 2005, BIOCHEM SOC T, V33, P986, DOI 10.1042/BST20050986; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Benz C, 2007, MOL BIOCHEM PARASIT, V156, P217, DOI 10.1016/j.molbiopara.2007.08.005; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BLUM ML, 1993, NATURE, V362, P603, DOI 10.1038/362603a0; Brecht M, 1998, MOL BIOCHEM PARASIT, V97, P189, DOI 10.1016/S0166-6851(98)00151-0; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Dhalia R, 2006, NUCLEIC ACIDS RES, V34, P2495, DOI 10.1093/nar/gkl290; Djikeng A, 2003, RNA, V9, P802, DOI 10.1261/rna.5270203; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; ERONDU NE, 1992, MOL BIOCHEM PARASIT, V51, P111, DOI 10.1016/0166-6851(92)90206-Y; Figueiredo LM, 2008, PLOS BIOL, V6, P1539, DOI 10.1371/journal.pbio.0060161; FREYMANN D, 1990, J MOL BIOL, V216, P141, DOI 10.1016/S0022-2836(05)80066-X; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gibellini F, 2009, MOL MICROBIOL, V73, P826, DOI 10.1111/j.1365-2958.2009.06764.x; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Hughes K, 2007, EMBO J, V26, P2400, DOI 10.1038/sj.emboj.7601678; Jetton N, 2009, MOL MICROBIOL, V72, P442, DOI 10.1111/j.1365-2958.2009.06657.x; Koumandou VL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-298; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Li ZY, 2008, EUKARYOT CELL, V7, P1941, DOI 10.1128/EC.00249-08; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003814; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Lustig Y, 2007, EMBO REP, V8, P408, DOI 10.1038/sj.embor.7400930; Magez S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000122; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; Martin KL, 2006, MOL MICROBIOL, V61, P89, DOI 10.1111/j.1365-2958.2006.05216.x; Martin KL, 2006, BIOCHEM J, V396, P287, DOI 10.1042/BJ20051825; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; Moraes MCS, 2007, EUKARYOT CELL, V6, P1979, DOI 10.1128/EC.00249-07; MunozJordan JL, 1996, SCIENCE, V272, P1795, DOI 10.1126/science.272.5269.1795; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Nolan DP, 2008, MOL BIOCHEM PARASIT, V157, P233, DOI 10.1016/j.molbiopara.2007.10.006; Pays E, 2004, CURR OPIN MICROBIOL, V7, P369, DOI 10.1016/j.mib.2004.05.001; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Potter MD, 2001, TRENDS CELL BIOL, V11, P112, DOI 10.1016/S0962-8924(00)01905-X; Rout MP, 2001, J BIOL CHEM, V276, P38261; Rudenko G, 1998, MOL BIOCHEM PARASIT, V95, P97, DOI 10.1016/S0166-6851(98)00099-1; RUDENKO G, 1989, EMBO J, V8, P4259, DOI 10.1002/j.1460-2075.1989.tb08611.x; Seiser RM, 2000, J BIOL CHEM, V275, P33820, DOI 10.1074/jbc.M004462200; Sheader K, 2005, P NATL ACAD SCI USA, V102, P8716, DOI 10.1073/pnas.0501886102; Sheader K, 2004, J BIOL CHEM, V279, P13363, DOI 10.1074/jbc.M312307200; Sivan G, 2007, MOL CELL BIOL, V27, P6639, DOI 10.1128/MCB.00798-07; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; Tkacz ID, 2007, RNA, V13, P30, DOI 10.1261/rna.174307; Valdes J, 1996, NUCLEIC ACIDS RES, V24, P1809, DOI 10.1093/nar/24.10.1809; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Westermeier Reiner, 2008, V424, P73, DOI 10.1007/978-1-60327-064-9_7; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	59	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7532	10.1371/journal.pone.0007532	http://dx.doi.org/10.1371/journal.pone.0007532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855834	Green Published, Green Accepted, gold			2022-12-25	WOS:000271147200001
J	Gilliland, WD; Vietti, DL; Schweppe, NM; Guo, FL; Johnson, TJ; Hawley, RS				Gilliland, William D.; Vietti, Dana L.; Schweppe, Nicole M.; Guo, Fengli; Johnson, Teri J.; Hawley, R. Scott			Hypoxia Transiently Sequesters Mps1 and Polo to Collagenase-Sensitive Filaments in Drosophila Prometaphase Oocytes	PLOS ONE			English	Article							EARLY EMBRYOGENESIS; SPINDLE CHECKPOINT; MEIOTIC SPINDLE; CYCLIN-B; PROTEIN; KINASE; MELANOGASTER; OOGENESIS; CHROMOSOMES; SEGREGATION	Background: The protein kinases Mps1 and Polo, which are required for proper cell cycle regulation in meiosis and mitosis, localize to numerous ooplasmic filaments during prometaphase in Drosophila oocytes. These filaments first appear throughout the oocyte at the end of prophase and are disassembled after egg activation. Methodology/Principal Findings: We showed here that Mps1 and Polo proteins undergo dynamic and reversible localization to static ooplasmic filaments as part of an oocyte-specific response to hypoxia. The observation that Mps1- and Polo-associated filaments reappear in the same locations through multiple cycles of oxygen deprivation demonstrates that underlying structural components of the filaments must still be present during normoxic conditions. Using immuno-electron microscopy, we observed triple-helical binding of Mps1 to numerous electron-dense filaments, with the gold label wrapped around the outside of the filaments like a garland. In addition, we showed that in live oocytes the relocalization of Mps1 and Polo to filaments is sensitive to injection of collagenase, suggesting that the structural components of the filaments are composed of collagen-like fibrils. However, the collagen-like genes we have been able to test so far (vkg and CG42453) did not appear to be associated with the filaments, demonstrating that the collagenase-sensitive component of the filaments is one of a number of other Drosophila proteins bearing a collagenase cleavage site. Finally, as hypoxia is known to cause Mps1 protein to accumulate at kinetochores in syncytial embryos, we also show that GFP-Polo accumulates at both kinetochores and centrosomes in hypoxic syncytial embryos. Conclusions/Significance: These findings identify both a novel cellular structure (the ooplasmic filaments) as well as a new localization pattern for Mps1 and Polo and demonstrate that hypoxia affects Polo localization in Drosophila.			Gilliland, WD (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	wgillila@depaul.edu		Hawley, R. Scott/0000-0002-6478-0494				Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; BLUMBERG B, 1988, J BIOL CHEM, V263, P18328; Bonde P, 2007, J THORAC CARDIOV SUR, V133, P763, DOI 10.1016/j.jtcvs.2006.07.044; BRAND AH, 1994, GENE DEV, V8, P629, DOI 10.1101/gad.8.5.629; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Castillo AR, 2002, J CELL BIOL, V156, P453, DOI 10.1083/jcb.200111025; Duman JG, 2002, J CELL SCI, V115, P1251; Fischer MG, 2004, CURR BIOL, V14, P2019, DOI 10.1016/j.cub.2004.11.008; FOE VE, 1985, J CELL BIOL, V100, P1623, DOI 10.1083/jcb.100.5.1623; Gilliland WD, 2005, CURR BIOL, V15, P672; Gilliland WD, 2007, PLOS GENET, V3, P1178, DOI 10.1371/journal.pgen.0030113; Gilliland WD, 2009, DEV BIOL, V325, P122, DOI 10.1016/j.ydbio.2008.10.003; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; HINTON HE, 1969, ANNU REV ENTOMOL, V14, P343, DOI 10.1146/annurev.en.14.010169.002015; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Hughes SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000348; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Jacobs HW, 1998, GENE DEV, V12, P3741, DOI 10.1101/gad.12.23.3741; King R. C., 1970, OVARIAN DEV DROSOPHI; KNIBIEHLER B, 1990, CELL DIFFER DEV, V30, P147, DOI 10.1016/0922-3371(90)90082-8; Kramer J, 2003, NAT CELL BIOL, V5, P261, DOI 10.1038/ncb944; LEPARCO Y, 1986, BIOL CELL, V56, P217; MAHAJANMIKLOS S, 1994, DEV BIOL, V165, P336, DOI 10.1006/dbio.1994.1257; MAHOWALD AP, 1980, GENET BIOL DROSOPHIL, P141; Monen J, 2005, NAT CELL BIOL, V7, P1248, DOI 10.1038/ncb1331; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Moutinho-Santos T, 1999, BIOL CELL, V91, P585, DOI 10.1016/S0248-4900(00)88523-8; OTOUSA J, 1982, GENETICS, V102, P503; Pandey R, 2007, J CELL SCI, V120, P2807, DOI 10.1242/jcs.007690; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; SPRADLING AC, 1994, DEV DROSOPHILA MELAN, P1; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sullivan W., 2000, DROSOPHILA PROTOCOLS; THEURKAUF WE, 1992, J CELL BIOL, V116, P1167, DOI 10.1083/jcb.116.5.1167; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tran DH, 2003, DEVELOPMENT, V130, P6273, DOI 10.1242/dev.00854; VARDY L, 2009, P NATL ACAD SCI US; Vardy L, 2007, DEV CELL, V12, P157, DOI 10.1016/j.devcel.2006.10.017; Winey M, 2002, ONCOGENE, V21, P6161, DOI 10.1038/sj.onc.1205712; Worthington C., 1993, WORTHINGTON ENZYME M; Xiang Y, 2007, PLOS BIOL, V5, P2831, DOI 10.1371/journal.pbio.0050323; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182	44	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7544	10.1371/journal.pone.0007544	http://dx.doi.org/10.1371/journal.pone.0007544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847308	Green Published, gold, Green Submitted			2022-12-25	WOS:000271022000013
J	Julia, A; Erra, A; Palacio, C; Tomas, C; Sans, X; Barcelo, P; Marsal, S				Julia, Antonio; Erra, Alba; Palacio, Carles; Tomas, Carlos; Sans, Xavier; Barcelo, Pere; Marsal, Sara			An Eight-Gene Blood Expression Profile Predicts the Response to Infliximab in Rheumatoid Arthritis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; REGULATORY T-CELLS; TNF-ALPHA THERAPY; MONOCLONAL-ANTIBODY; MICROARRAY DATA; DISEASE; CANCER; POPULATION; VALIDATION; SIGNATURE	Background: TNF alpha blockade agents like infliximab are actually the treatment of choice for those rheumatoid arthritis (RA) patients who fail standard therapy. However, a considerable percentage of anti-TNF alpha treated patients do not show a significant clinical response. Given that new therapies for treatment of RA have been recently approved, there is a pressing need to find a system that reliably predicts treatment response. We hypothesized that the analysis of whole blood gene expression profiles of RA patients could be used to build a robust predictor to infliximab therapy. Methods and Findings: We performed microarray gene expression analysis on whole blood RNA samples from RA patients starting infliximab therapy (n = 44). The clinical response to infliximab was determined at week 14 using the EULAR criteria. Blood cell populations were determined using flow cytometry at baseline, week 2 and week 14 of treatment. Using complete cross-validation and repeated random sampling we identified a robust 8-gene predictor model (96.6% Leave One Out prediction accuracy, P = 0.0001). Applying this model to an independent validation set of RA patients, we estimated an 85.7% prediction accuracy (75-100%, 95% CI). In parallel, we also observed a significantly higher number of CD4+CD25+ cells (i.e. regulatory T cells) in the responder group compared to the non responder group at baseline (P = 0.0009). Conclusions: The present 8-gene model obtained from whole blood expression efficiently predicts response to infliximab in RA patients. The application of the present system in the clinical setting could assist the clinician in the selection of the optimal treatment strategy in RA.			Julia, A (corresponding author), Hosp Univ Vall Hebron, Inst Recerca, Grp Recerca Reumatol, Barcelona, Spain.	smarsal@ir.vhebron.net		marsal, sara/0000-0001-5515-3854; Palacio-Garcia, Carles/0000-0002-9085-3327; Julia Cano, Antonio/0000-0001-6064-3620				Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; ARNETT FC, 1989, B RHEUM DIS, V38, P1; Bach JF, 2003, NAT REV IMMUNOL, V3, P189, DOI 10.1038/nri1026; BATLIWALLA FM, 2006, MOL MED; Bolstad B, 2005, BIOINFORMATICS COMPU; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bryl E, 2001, J IMMUNOL, V167, P3231, DOI 10.4049/jimmunol.167.6.3231; Ebert BL, 2008, PLOS MED, V5, P312, DOI 10.1371/journal.pmed.0050035; EFRON B, 1998, INTRO BOOTSTRAP CHAP; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Fessler MB, 2002, J BIOL CHEM, V277, P31291, DOI 10.1074/jbc.M200755200; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hyrich KL, 2006, RHEUMATOLOGY, V45, P1558, DOI 10.1093/rheumatology/kel149; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lequerre T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1990; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Marotte H, 2006, ANN RHEUM DIS, V65, P342, DOI 10.1136/ard.2005.037150; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Mugnier B, 2003, ARTHRITIS RHEUM, V48, P1849, DOI 10.1002/art.11168; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Olsen NJ, 2004, ANN RHEUM DIS, V63, P1387, DOI 10.1136/ard.2003.017194; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; SALEEM B, 2006, DRUG DISCOV TODAY, V3, P11; Sekiguchi N, 2008, RHEUMATOLOGY, V47, P780, DOI 10.1093/rheumatology/ken083; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Smolkin M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-36; Strand V, 2007, NAT REV DRUG DISCOV, V6, P75, DOI 10.1038/nrd2196; Tydell CC, 2007, J IMMUNOL, V179, P421, DOI 10.4049/jimmunol.179.1.421; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499	39	76	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7556	10.1371/journal.pone.0007556	http://dx.doi.org/10.1371/journal.pone.0007556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847310	Green Published, gold, Green Submitted			2022-12-25	WOS:000271022000018
J	Selinummi, J; Ruusuvuori, P; Podolsky, I; Ozinsky, A; Gold, E; Yli-Harja, O; Aderem, A; Shmulevich, I				Selinummi, Jyrki; Ruusuvuori, Pekka; Podolsky, Irina; Ozinsky, Adrian; Gold, Elizabeth; Yli-Harja, Olli; Aderem, Alan; Shmulevich, Ilya			Bright Field Microscopy as an Alternative to Whole Cell Fluorescence in Automated Analysis of Macrophage Images	PLOS ONE			English	Article							SEGMENTATION	Background: Fluorescence microscopy is the standard tool for detection and analysis of cellular phenomena. This technique, however, has a number of drawbacks such as the limited number of available fluorescent channels in microscopes, overlapping excitation and emission spectra of the stains, and phototoxicity. Methodology: We here present and validate a method to automatically detect cell population outlines directly from bright field images. By imaging samples with several focus levels forming a bright field z -stack, and by measuring the intensity variations of this stack over the z -dimension, we construct a new two dimensional projection image of increased contrast. With additional information for locations of each cell, such as stained nuclei, this bright field projection image can be used instead of whole cell fluorescence to locate borders of individual cells, separating touching cells, and enabling single cell analysis. Using the popular CellProfiler freeware cell image analysis software mainly targeted for fluorescence microscopy, we validate our method by automatically segmenting low contrast and rather complex shaped murine macrophage cells. Significance: The proposed approach frees up a fluorescence channel, which can be used for subcellular studies. It also facilitates cell shape measurement in experiments where whole cell fluorescent staining is either not available, or is dependent on a particular experimental condition. We show that whole cell area detection results using our projected bright field images match closely to the standard approach where cell areas are localized using fluorescence, and conclude that the high contrast bright field projection image can directly replace one fluorescent channel in whole cell quantification. Matlab code for calculating the projections can be downloaded from the supplementary site: http://sites.google.com/site/brightfieldorstaining			Selinummi, J (corresponding author), Inst Syst Biol, Seattle, WA USA.	ishmulevich@systemsbiology.org	Ruusuvuori, Pekka/AAC-2617-2022; Ruusuvuori, Pekka/C-9229-2016	Ruusuvuori, Pekka/0000-0001-9086-9591; Yli-Harja, Olli/0000-0001-8581-4414	NIGMS NIH HHS [P50 GM076547] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali R, 2008, I S BIOMED IMAGING, P181, DOI 10.1109/ISBI.2008.4540962; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen TB, 2008, J BIOMED INFORM, V41, P1021, DOI 10.1016/j.jbi.2008.02.007; Curl CL, 2005, CYTOM PART A, V65A, P88, DOI 10.1002/cyto.a.20134; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Jones TR, 2005, LECT NOTES COMPUT SC, V3765, P535; Korzynska A, 2007, PATTERN ANAL APPL, V10, P301, DOI 10.1007/s10044-007-0069-7; Kvarnstrom M, 2008, OPT EXPRESS, V16, P12943, DOI 10.1364/OE.16.012943; Long X, 2008, IMAGE VISION COMPUT, V26, P578, DOI 10.1016/j.imavis.2007.07.004; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Molder A, 2008, J MICROSC-OXFORD, V232, P240, DOI 10.1111/j.1365-2818.2008.02095.x; Niemistoe A, 2007, P ANN INT IEEE EMBS, P5559, DOI 10.1109/IEMBS.2007.4353606; Pacheco P, 2007, J IMMUNOL, V179, P8500, DOI 10.4049/jimmunol.179.12.8500; Schlumberger MC, 2007, MOL MICROBIOL, V65, P741, DOI 10.1111/j.1365-2958.2007.05823.x; Zimmer C, 2006, IEEE SIGNAL PROC MAG, V23, P54, DOI 10.1109/MSP.2006.1628878	18	71	76	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7497	10.1371/journal.pone.0007497	http://dx.doi.org/10.1371/journal.pone.0007497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847301	Green Published, Green Submitted, gold			2022-12-25	WOS:000271022000009
J	Watson, CL; Lockwood, DNJ				Watson, Claire L.; Lockwood, Diana N. J.			Single Nucleotide Polymorphism Analysis of European Archaeological M. leprae DNA	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; LEPROSY; REMAINS; GENOME	Background: Leprosy was common in Europe eight to twelve centuries ago but molecular confirmation of this has been lacking. We have extracted M. leprae ancient DNA (aDNA) from medieval bones and single nucleotide polymorphism (SNP) typed the DNA, this provides insight into the pattern of leprosy transmission in Europe and may assist in the understanding of M. leprae evolution. Methods and Findings: Skeletons have been exhumed from 3 European countries (the United Kingdom, Denmark and Croatia) and are dated around the medieval period (476 to 1350 A. D.). we tested for the presence of 3 previously identified single nucleotide polymorphisms (SNPs) in 10 aDNA extractions. M. leprae aDNA was extracted from 6 of the 10 bone samples. SNP analysis of these 6 extractions were compared to previously analysed European SNP data using the same PCR assays and were found to be the same. Testing for the presence of SNPs in M. leprae DNA extracted from ancient bone samples is a novel approach to analysing European M. leprae DNA and the findings concur with the previously published data that European M. leprae strains fall in to one group (SNP group 3). Conclusions: These findings support the suggestion that the M. leprae genome is extremely stable and show that archaeological M. leprae DNA can be analysed to gain detailed information about the genotypic make-up of European leprosy, which may assist in the understanding of leprosy transmission worldwide.			Watson, CL (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis, London WC1, England.	claire.watson@lshtm.ac.uk						ARRIAZA BT, 1995, AM J PHYS ANTHROPOL, V98, P37, DOI 10.1002/ajpa.1330980104; Barnes I, 2006, P ROY SOC B-BIOL SCI, V273, P645, DOI 10.1098/rspb.2005.3339; Boldsen JL, 2006, AM J PHYS ANTHROPOL, V130, P344, DOI 10.1002/ajpa.20363; Bouwman AS, 2005, J ARCHAEOL SCI, V32, P703, DOI 10.1016/j.jas.2004.11.014; BROTHWELL D R, 1958, Med Hist, V2, P287; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cooper A, 2000, SCIENCE, V289, P1139; Donoghue HD, 1998, LETT APPL MICROBIOL, V27, P265; Donoghue HD, 2005, P ROY SOC B-BIOL SCI, V272, P389, DOI 10.1098/rspb.2004.2966; Donoghue HD, 2004, LANCET INFECT DIS, V4, P584, DOI 10.1016/S1473-3099(04)01133-8; Eiglmeier K, 2001, LEPROSY REV, V72, P387; Gill AL, 2005, QJM-INT J MED, V98, P505, DOI 10.1093/qjmed/hci079; Haas CJ, 2000, AM J CLIN PATHOL, V114, P428, DOI 10.1093/ajcp/114.3.428; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Nerlich AG, 1997, LANCET, V350, P1404, DOI 10.1016/S0140-6736(05)65185-9; Ortner D. J., 1985, IDENTIFICATION PATHO, V28; RAFI A, 1994, LANCET, V343, P1360, DOI 10.1016/S0140-6736(94)92494-5; REES JW, 1964, BRIT J EXP PATHOL, V45, P207; RICHARDS P, 1960, Centaurus, V7, P101, DOI 10.1111/j.1600-0498.1960.tb00260.x; Rojas-Espinosa O, 2005, CLIN EXP IMMUNOL, V140, P436, DOI 10.1111/j.1365-2249.2005.02776.x; SKINSNES OK, 1976, INT J LEPROSY, V44, P376; Spigelman M, 1993, INT J OSTEOARCHAEOL, V3, P137, DOI DOI 10.1002/0A.1390030211; STORRS EE, 1974, SCIENCE, V183, P851, DOI 10.1126/science.183.4127.851; Taylor GM, 2006, J ARCHAEOL SCI, V33, P1569, DOI 10.1016/j.jas.2006.02.008; Taylor GM, 1999, MICROBIOL-UK, V145, P899, DOI 10.1099/13500872-145-4-899; VOGELSANG T M, 1965, Med Hist, V9, P29; WOODS SA, 1990, MOL MICROBIOL, V4, P1745, DOI 10.1111/j.1365-2958.1990.tb00552.x; Zink AR, 2002, FEMS MICROBIOL LETT, V213, P141, DOI 10.1111/j.1574-6968.2002.tb11298.x	29	24	24	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7547	10.1371/journal.pone.0007547	http://dx.doi.org/10.1371/journal.pone.0007547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509MN	19847306	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000271022000014
J	Noll, C; Planque, C; Ripoll, C; Guedj, F; Diez, A; Ducros, V; Belin, N; Duchon, A; Paul, JL; Badel, A; de Freminville, B; Grattau, Y; Blehaut, H; Herault, Y; Janel, N; Delabar, JM				Noll, Christophe; Planque, Chris; Ripoll, Clementine; Guedj, Faycal; Diez, Anna; Ducros, Veronique; Belin, Nicole; Duchon, Arnaud; Paul, Jean-Louis; Badel, Anne; de Freminville, Benedicte; Grattau, Yann; Blehaut, Henri; Herault, Yann; Janel, Nathalie; Delabar, Jean-Maurice			DYRK1A, a Novel Determinant of the Methionine-Homocysteine Cycle in Different Mouse Models Overexpressing this Down-Syndrome-Associated Kinase	PLOS ONE			English	Article							S-ADENOSYLHOMOCYSTEINE HYDROLASE; MENTAL-RETARDATION; METABOLISM; LIVER; MICE; PREVALENCE; EXPRESSION; PATHWAYS; DISEASE; CELLS	Background: Hyperhomocysteinemia, characterized by increased plasma homocysteine level, is associated with an increased risk of atherosclerosis. On the contrary, patients with Down syndrome appear to be protected from the development of atherosclerosis. We previously found a deleterious effect of hyperhomocysteinemia on expression of DYRK1A, a Down-syndrome-associated kinase. As increased expression of DYRK1A and low plasma homocysteine level have been associated with Down syndrome, we aimed to analyze the effect of its over-expression on homocysteine metabolism in mice. Methodology/Principal Findings: Effects of DYRK1A over-expression were examined by biochemical analysis of methionine metabolites, real-time quantitative reverse-transcription polymerase chain reaction, and enzyme activities. We found that over-expression of Dyrk1a increased the hepatic NAD(P) H: quinone oxidoreductase and S-adenosylhomocysteine hydrolase activities, concomitant with decreased level of plasma homocysteine in three mice models overexpressing Dyrk1a. Moreover, these effects were abolished by treatment with harmine, the most potent and specific inhibitor of Dyrk1a. The increased NAD(P) H: quinone oxidoreductase and S-adenosylhomocysteine hydrolase activities were also found in lymphoblastoid cell lines from patients with Down syndrome. Conclusions/Significance: Our results might give clues to understand the protective effect of Down syndrome against vascular defect through a decrease of homocysteine level by DYRK1A over-expression. They reveal a link between the Dyrk1a signaling pathway and the homocysteine cycle.			Noll, C (corresponding author), Univ Paris Diderot, CNRS, EAC 4413, Unit Funct & Adapt Biol BFA, Paris, France.	nathalie.janel@univ-paris-diderot.fr	paul, jean-louis/D-8071-2017; duchon, arnaud/D-2764-2013; Herault, Yann/B-5500-2012	duchon, arnaud/0000-0003-3043-702X; Herault, Yann/0000-0001-7049-6900; Diez-Betriu, Anna/0000-0002-4318-2348; Janel, Nathalie/0000-0002-4746-8941				Aleksunes LM, 2006, CELL STRESS CHAPERON, V11, P356, DOI 10.1379/CSC-217.1; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Davisson Muriel T., 1993, V384, P117; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Draheim CC, 2006, MENT RETARD DEV D R, V12, P3, DOI 10.1002/mrdd.20095; Draheim CC, 2002, MENT RETARD, V40, P436, DOI 10.1352/0047-6765(2002)040<0436:POPIAR>2.0.CO;2; Ducros V, 2002, J CHROMATOGR B, V781, P207, DOI 10.1016/S1570-0232(02)00497-X; ERNSTER L, 1967, METHOD ENZYMOL, V10, P309, DOI DOI 10.1016/0076-6879(67)10059-1; Finkelstein JD, 1998, EUR J PEDIATR, V157, pS40, DOI 10.1007/PL00014300; FORTIN LJ, 1995, CLIN BIOCHEM, V28, P155, DOI 10.1016/0009-9120(94)00073-5; Galletti P, 2007, FEBS J, V274, P5263, DOI 10.1111/j.1742-4658.2007.06048.x; Gellekink H, 2005, CLIN CHEM, V51, P1487, DOI 10.1373/clinchem.2004.046995; Hamelet J, 2009, BIOCHEM BIOPH RES CO, V378, P673, DOI 10.1016/j.bbrc.2008.11.126; Han JM, 2007, J PHARMACOL EXP THER, V321, P249, DOI 10.1124/jpet.106.110866; HERSHFIELD MS, 1985, BIOCHEM J, V230, P43, DOI 10.1042/bj2300043; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Joung EJ, 2007, ANTIOXID REDOX SIGN, V9, P2087, DOI 10.1089/ars.2007.1827; Kloor D, 1998, BIOCHEM PHARMACOL, V56, P1493, DOI 10.1016/S0006-2952(98)00250-0; Kuhn C, 2009, J BIOL CHEM, V284, P17320, DOI 10.1074/jbc.M109.006759; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Licastro F, 2006, ARCH GERONTOL GERIAT, V43, P381, DOI 10.1016/j.archger.2006.01.003; MILLER JW, 1994, BIOCHEM J, V298, P415, DOI 10.1042/bj2980415; MURDOCH JC, 1977, BRIT MED J, V2, P226, DOI 10.1136/bmj.2.6081.226; Pogribna M, 2001, AM J HUM GENET, V69, P88, DOI 10.1086/321262; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Siarey RJ, 2006, J NEUROCHEM, V98, P1266, DOI 10.1111/j.1471-4159.2006.03971.x; SMITH DJ, 1995, GENOMICS, V27, P425, DOI 10.1006/geno.1995.1073; Smith MD, 1997, J MICROBIOL METH, V28, P21, DOI 10.1016/S0167-7012(96)00958-X; Stead LM, 2000, BIOCHEM J, V350, P685, DOI 10.1042/0264-6021:3500685; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Villanueva JA, 2004, HEPATOLOGY, V39, P1303, DOI 10.1002/hep.20168; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; YLAHERTTUALA S, 1989, ATHEROSCLEROSIS, V76, P269, DOI 10.1016/0021-9150(89)90110-X	39	40	42	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7540	10.1371/journal.pone.0007540	http://dx.doi.org/10.1371/journal.pone.0007540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844572	gold, Green Submitted, Green Published			2022-12-25	WOS:000271013000016
J	Siso-Nadal, F; Fox, JJ; Laporte, SA; Hebert, TE; Swain, PS				Siso-Nadal, Fernando; Fox, Jeffrey J.; Laporte, Stephane A.; Hebert, Terence E.; Swain, Peter S.			Cross-Talk between Signaling Pathways Can Generate Robust Oscillations in Calcium and cAMP	PLOS ONE			English	Article							PROTEIN-KINASE-A; INTRACELLULAR CA2+ OSCILLATIONS; CYCLIC-AMP; PHOSPHOLIPASE-C; INOSITOL 1,4,5-TRISPHOSPHATE; ADENYLYL-CYCLASE; PHOSPHORYLATION; CELLS; BETA; STIMULATION	Background: To control and manipulate cellular signaling, we need to understand cellular strategies for information transfer, integration, and decision-making. A key feature of signal transduction is the generation of only a few intracellular messengers by many extracellular stimuli. Methodology/Principal Findings: Here we model molecular cross-talk between two classic second messengers, cyclic AMP (cAMP) and calcium, and show that the dynamical complexity of the response of both messengers increases substantially through their interaction. In our model of a non-excitable cell, both cAMP and calcium concentrations can oscillate. If mutually inhibitory, cross-talk between the two second messengers can increase the range of agonist concentrations for which oscillations occur. If mutually activating, cross-talk decreases the oscillation range, but can generate 'bursting' oscillations of calcium and may enable better filtering of noise. Conclusion: We postulate that this increased dynamical complexity allows the cell to encode more information, particularly if both second messengers encode signals. In their native environments, it is unlikely that cells are exposed to one stimulus at a time, and cross-talk may help generate sufficiently complex responses to allow the cell to discriminate between different combinations and concentrations of extracellular agonists.			Siso-Nadal, F (corresponding author), Gene Network Sci, Cambridge, MA USA.	peter.swain@ed.ac.uk	Laporte, Stephane/ABC-4228-2021; Fox, Jeff/L-4683-2019; Swain, Peter S/AAW-3265-2020; Laporte, Stephane A/F-3282-2012	Laporte, Stephane/0000-0002-0633-543X; Fox, Jeff/0000-0002-3780-4956; Swain, Peter/0000-0001-7489-8587				Ali H, 1998, J BIOL CHEM, V273, P11012, DOI 10.1074/jbc.273.18.11012; Borghans JAM, 1997, BIOPHYS CHEM, V66, P25, DOI 10.1016/S0301-4622(97)00010-0; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Dupont G, 2003, LECT NOTES PHYS, V623, P131; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Flaherty P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000185; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; GREEN AK, 1994, BIOCHEM J, V302, P949, DOI 10.1042/bj3020949; Guimond J, 2005, CELL SIGNAL, V17, P49, DOI 10.1016/j.cellsig.2004.05.012; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Houart G, 1999, B MATH BIOL, V61, P507, DOI 10.1006/bulm.1999.0095; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; KAWABE J, 1994, J BIOL CHEM, V269, P16554; KEIZER J, 1992, BIOPHYS J, V61, P649, DOI 10.1016/S0006-3495(92)81870-2; KENNEDY CRJ, 1995, BBA-LIPID LIPID MET, V1258, P206, DOI 10.1016/0005-2760(95)00049-I; Kummer U, 2000, BIOPHYS J, V79, P1188, DOI 10.1016/S0006-3495(00)76373-9; Laglia G, 1996, ENDOCRINOLOGY, V137, P3170, DOI 10.1210/en.137.8.3170; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Larsen AZ, 2003, LECT NOTES PHYS, V623, P153; Lawler OA, 2001, J BIOL CHEM, V276, P33596, DOI 10.1074/jbc.M104434200; Liu MY, 1996, NATURE, V382, P83, DOI 10.1038/382083a0; Marhl M, 2000, BIOSYSTEMS, V57, P75, DOI 10.1016/S0303-2647(00)00090-3; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; MEYER T, 1988, SCIENCE, V240, P653, DOI 10.1126/science.2452482; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; RAPP PE, 1981, J THEOR BIOL, V90, P531, DOI 10.1016/0022-5193(81)90304-0; RAPP PE, 1977, J THEOR BIOL, V66, P497, DOI 10.1016/0022-5193(77)90299-5; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Shannon C.E., 1999, MATH THEORY COMMUNIC; SHEN P, 1995, CELL CALCIUM, V17, P225, DOI 10.1016/0143-4160(95)90037-3; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; VOLPE P, 1990, AM J PHYSIOL, V258, pC1086, DOI 10.1152/ajpcell.1990.258.6.C1086; Werry TD, 2003, BIOCHEM J, V374, P281, DOI 10.1042/BJ20030312; Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; Wu BQ, 2006, J CELL BIOL, V173, P327, DOI 10.1083/jcb.200602089; Yu XT, 2004, J NEUROPHYSIOL, V91, P2297, DOI 10.1152/jn.00787.2003; Yue CP, 1998, J BIOL CHEM, V273, P18023, DOI 10.1074/jbc.273.29.18023	46	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7189	10.1371/journal.pone.0007189	http://dx.doi.org/10.1371/journal.pone.0007189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844582	Green Submitted, Green Published, gold			2022-12-25	WOS:000271013000001
J	Davis, R; Rizwani, W; Banerjee, S; Kovacs, M; Haura, E; Coppola, D; Chellappan, S				Davis, Rebecca; Rizwani, Wasia; Banerjee, Sarmistha; Kovacs, Michelle; Haura, Eric; Coppola, Domenico; Chellappan, Srikumar			Nicotine Promotes Tumor Growth and Metastasis in Mouse Models of Lung Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR SUBUNIT GENES; ACETYLCHOLINE-RECEPTOR; CIGARETTE-SMOKING; ESTROGEN-RECEPTOR; CELL-PROLIFERATION; SUSCEPTIBILITY LOCUS; COTININE LEVELS; TOBACCO-SMOKE; A/J MICE	Background: Nicotine is the major addictive component of tobacco smoke. Although nicotine is generally thought to have limited ability to initiate cancer, it can induce cell proliferation and angiogenesis in a variety of systems. These properties might enable nicotine to facilitate the growth of tumors already initiated. Here we show that nicotine significantly promotes the progression and metastasis of tumors in mouse models of lung cancer. This effect was observed when nicotine was administered through intraperitoneal injections, or through over-the-counter transdermal patches. Methods and Findings: In the present study, Line1 mouse adenocarcinoma cells were implanted subcutaneously into syngenic BALB/c mice. Nicotine administration either by intraperitoneal (i.p.) injection or transdermal patches caused a remarkable increase in the size of implanted Line1 tumors. Once the tumors were surgically removed, nicotine treated mice had a markedly higher tumor recurrence (59.7%) as compared to the vehicle treated mice (19.5%). Nicotine also increased metastasis of dorsally implanted Line1 tumors to the lungs by 9 folds. These studies on transplanted tumors were extended to a mouse model where the tumors were induced by the tobacco carcinogen, NNK. Lung tumors were initiated in A/J mice by i.p. injection of NNK; administration of 1 mg/kg nicotine three times a week led to an increase in the size and the number of tumors formed in the lungs. In addition, nicotine significantly reduced the expression of epithelial markers, E-Cadherin and beta-Catenin as well as the tight junction protein ZO-1; these tumors also showed an increased expression of the alpha(7) nAChR subunit. We believe that exposure to nicotine either by tobacco smoke or nicotine supplements might facilitate increased tumor growth and metastasis. Conclusions: Our earlier results indicated that nicotine could induce invasion and epithelial-mesenchymal transition (EMT) in cultured lung, breast and pancreatic cancer cells. This study demonstrates for the first time that administration of nicotine either by i.p. injection or through over-the-counter dermal patches can promote tumor growth and metastasis in immunocompetent mice. These results suggest that while nicotine has only limited capacity to initiate tumor formation, it can facilitate the progression and metastasis of tumors pre-initiated by tobacco carcinogens.			Davis, R (corresponding author), Mayo Clin Jacksonville, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	Srikumar.Chellappan@moffitt.org			NATIONAL CANCER INSTITUTE [R01CA063136, R01CA127725] Funding Source: NIH RePORTER; NCI NIH HHS [CA63136, CA127725, R01 CA063136, R01 CA127725] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Berger F, 1998, J NEUROSCI, V18, P6871; BRUNNEMANN KD, 1991, CRIT REV TOXICOL, V21, P235, DOI 10.3109/10408449109017910; Carlisle DL, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-27; CASTONGUAY A, 1983, CANCER RES, V43, P1223; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen DN, 1997, J BIOL CHEM, V272, P24024, DOI 10.1074/jbc.272.38.24024; Clementi F, 2000, EUR J PHARMACOL, V393, P3, DOI 10.1016/S0014-2999(00)00066-2; Copeland RL, 2007, NEUROTOX RES, V12, P61, DOI 10.1007/BF03033901; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Dasgupta P, 2006, J CLIN INVEST, V116, P2208, DOI 10.1172/JCI28164; Etard C, 2005, DEV DYNAM, V234, P1016, DOI 10.1002/dvdy.20592; Garces YI, 2004, CHEST, V126, P1733, DOI 10.1378/chest.126.6.1733; Carracedo DG, 2007, ANTICANCER RES, V27, P835; Gautam A, 2003, ONCOGENE, V22, P2135, DOI 10.1038/sj.onc.1206232; GERZANICH V, 1994, MOL PHARMACOL, V45, P212; Gorrod J.W., 1999, ANAL DETERMINATION N; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Grozio A, 2007, ANTI-CANCER AGENT ME, V7, P461; Guo JJ, 2008, CANCER RES, V68, P8473, DOI 10.1158/0008-5472.CAN-08-0131; Hecht SS, 2002, LANCET ONCOL, V3, P461, DOI 10.1016/S1470-2045(02)00815-X; HECHT SS, 1988, CANCER LETT, V42, P141, DOI 10.1016/0304-3835(88)90251-0; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Hershberger PA, 2005, CANCER RES, V65, P1598, DOI 10.1158/0008-5472.CAN-04-2694; HILL P, 1983, J CHRON DIS, V36, P439, DOI 10.1016/0021-9681(83)90136-4; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Itier V, 2001, FEBS LETT, V504, P118, DOI 10.1016/S0014-5793(01)02702-8; Jarzynka MJ, 2006, INT J ONCOL, V28, P337; JOHNSTONEARLY A, 1980, JAMA-J AM MED ASSOC, V244, P2175, DOI 10.1001/jama.244.19.2175; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Lindstrom J, 1996, Ion Channels, V4, P377; MANACKJEE R, 1990, P NATL ACAD SCI USA, V87, P3294; MATHAI M, 1990, AUST NZ J OBSTET GYN, V30, P33, DOI 10.1111/j.1479-828X.1990.tb03192.x; MATSUKURA S, 1984, NEW ENGL J MED, V311, P828, DOI 10.1056/NEJM198409273111305; Mukhin AG, 2008, J NUCL MED, V49, P1628, DOI 10.2967/jnumed.108.050716; Omoto Y, 2001, BIOCHEM BIOPH RES CO, V285, P340, DOI 10.1006/bbrc.2001.5158; Oshikawa J, 2003, AM J PHYSIOL-CELL PH, V285, pC567, DOI 10.1152/ajpcell.00422.2002; Paleari L, 2009, AM J RESP CRIT CARE, V179, P1141, DOI 10.1164/rccm.200806-908OC; Razani-Boroujerdi S, 2007, AM J RESP CELL MOL, V36, P13, DOI 10.1165/rcmb.2005-0330OC; RICHARDSON GE, 1993, ANN INTERN MED, V119, P383, DOI 10.7326/0003-4819-119-5-199309010-00006; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Schuller HM, 2003, ANAT REC PART A, V270A, P51, DOI 10.1002/ar.a.10019; SCHULLER HM, 1995, LAB INVEST, V73, P448; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; Sharma G, 2002, J NEUROBIOL, V53, P524, DOI 10.1002/neu.10114; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; Shin VY, 2004, CARCINOGENESIS, V25, P2487, DOI 10.1093/carcin/bgh266; Stabile LP, 2002, CANCER RES, V62, P2141; Stabile LP, 2005, CANCER RES, V65, P1459, DOI 10.1158/0008-5472.CAN-04-1872; THOMPSON SG, 1990, THORAX, V45, P356, DOI 10.1136/thx.45.5.356; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; VIJAYARAGHAVAN S, 1995, J NEUROSCI, V15, P3679; WAGENKNECHT LE, 1990, AM J PUBLIC HEALTH, V80, P1053, DOI 10.2105/AJPH.80.9.1053; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850; YUHAS JM, 1974, CANCER RES, V34, P2005; YUHAS JM, 1975, CANCER RES, V35, P242; YUHAS JM, 1975, CANCER RES, V35, P237; YUHAS JM, 1974, CANCER RES, V34, P722	65	143	150	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7524	10.1371/journal.pone.0007524	http://dx.doi.org/10.1371/journal.pone.0007524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841737	gold, Green Published, Green Submitted			2022-12-25	WOS:000271012900016
J	Pilka, ES; Niesen, FH; Lee, WH; El-Hawari, Y; Dunford, JE; Kochan, G; Wsol, V; Martin, HJ; Maser, E; Oppermann, U				Pilka, Ewa S.; Niesen, Frank H.; Lee, Wen Hwa; El-Hawari, Yasser; Dunford, James E.; Kochan, Grazyna; Wsol, Vladimir; Martin, Hans-Joerg; Maser, Edmund; Oppermann, Udo			Structural Basis for Substrate Specificity in Human Monomeric Carbonyl Reductases	PLOS ONE			English	Article							SHORT-CHAIN DEHYDROGENASES/REDUCTASES; REDUCTION; DEHYDROGENASE/REDUCTASE; PURIFICATION; ENZYMES; CYTOSOL; LIVER; NNK; SDR	Carbonyl reduction constitutes a phase I reaction for many xenobiotics and is carried out in mammals mainly by members of two protein families, namely aldo-keto reductases and short-chain dehydrogenases/reductases. In addition to their capacity to reduce xenobiotics, several of the enzymes act on endogenous compounds such as steroids or eicosanoids. One of the major carbonyl reducing enzymes found in humans is carbonyl reductase 1 (CBR1) with a very broad substrate spectrum. A paralog, carbonyl reductase 3 (CBR3) has about 70% sequence identity and has not been sufficiently characterized to date. Screening of a focused xenobiotic compound library revealed that CBR3 has narrower substrate specificity and acts on several orthoquinones, as well as isatin or the anticancer drug oracin. To further investigate structure-activity relationships between these enzymes we crystallized CBR3, performed substrate docking, site-directed mutagenesis and compared its kinetic features to CBR1. Despite high sequence similarities, the active sites differ in shape and surface properties. The data reveal that the differences in substrate specificity are largely due to a short segment of a substrate binding loop comprising critical residues Trp229/Pro230, Ala235/Asp236 as well as part of the active site formed by Met141/Gln142 in CBR1 and CBR3, respectively. The data suggest a minor role in xenobiotic metabolism for CBR3.			Pilka, ES (corresponding author), Univ Oxford, Struct Genom Consortium, Headington, England.	udo.oppermann@sgc.ox.ac.uk	Wsol, Vladimir/K-3476-2016; Lee, Wen Hwa/GZA-8183-2022; Maser, Edmund/B-1728-2010; Kochan, Grazyna/A-1094-2009; Lee, Wen Hwa/G-1250-2013	Wsol, Vladimir/0000-0003-3745-7648; Lee, Wen Hwa/0000-0002-4098-5225; Lee, Wen Hwa/0000-0002-4098-5225; Dunford, James/0000-0002-9932-4042; Kochan, Grazyna/0000-0002-0534-9661	CIHR Funding Source: Medline; Wellcome Trust Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Atalla A, 1999, TOXICOLOGY, V139, P155, DOI 10.1016/S0300-483X(99)00114-6; Atalla A, 2000, XENOBIOTICA, V30, P755, DOI 10.1080/00498250050119826; Botella JA, 2004, CURR BIOL, V14, P782, DOI 10.1016/j.cub.2004.04.036; Bray JE, 2009, CHEM-BIOL INTERACT, V178, P99, DOI 10.1016/j.cbi.2008.10.058; Carbone DL, 2004, FREE RADICAL BIO MED, V37, P1430, DOI 10.1016/j.freeradbiomed.2004.07.016; Doorn JA, 2004, BIOCHEMISTRY-US, V43, P13106, DOI 10.1021/bi049136q; Doorn JA, 2003, CHEM-BIOL INTERACT, V143, P93, DOI 10.1016/S0009-2797(02)00178-3; Doorn JA, 2002, CHEM RES TOXICOL, V15, P1445, DOI 10.1021/tx025590o; El-Hawari Y, 2009, CHEM-BIOL INTERACT, V178, P234, DOI 10.1016/j.cbi.2008.11.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Ghosh D, 2001, J BIOL CHEM, V276, P18457, DOI 10.1074/jbc.M100538200; Hoffmann F, 2007, DRUG METAB REV, V39, P87, DOI 10.1080/03602530600969440; Ismail E, 2000, CANCER RES, V60, P1173; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; Lakhman SS, 2005, DRUG METAB DISPOS, V33, P254, DOI 10.1124/dmd.104.002006; Matsunaga T, 2006, DRUG METAB PHARMACOK, V21, P1, DOI 10.2133/dmpk.21.1; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miura T, 2008, MOL CELL BIOCHEM, V315, P113, DOI 10.1007/s11010-008-9794-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Oppermann U, 2007, ANNU REV PHARMACOL, V47, P293, DOI 10.1146/annurev.pharmtox.47.120505.105316; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Porte S, 2009, CHEM-BIOL INTERACT, V178, P288, DOI 10.1016/j.cbi.2008.10.018; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P11003, DOI 10.1021/bi980475r; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; WERMUTH B, 1986, BIOCHEM PHARMACOL, V35, P1277, DOI 10.1016/0006-2952(86)90271-6; WERMUTH B, 1981, J BIOL CHEM, V256, P1206	29	46	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7113	10.1371/journal.pone.0007113	http://dx.doi.org/10.1371/journal.pone.0007113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841672	Green Published, gold			2022-12-25	WOS:000271012900003
J	Mendoza-Vargas, A; Olvera, L; Olvera, M; Grande, R; Vega-Alvarado, L; Taboada, B; Jimenez-Jacinto, V; Salgado, H; Juarez, K; Contreras-Moreira, B; Huerta, AM; Collado-Vides, J; Morett, E				Mendoza-Vargas, Alfredo; Olvera, Leticia; Olvera, Maricela; Grande, Ricardo; Vega-Alvarado, Leticia; Taboada, Blanca; Jimenez-Jacinto, Veronica; Salgado, Heladia; Juarez, Katy; Contreras-Moreira, Bruno; Huerta, Araceli M.; Collado-Vides, Julio; Morett, Enrique			Genome-Wide Identification of Transcription Start Sites, Promoters and Transcription Factor Binding Sites in E. coli	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PROTEIN H-NS; ESCHERICHIA-COLI; RNA-POLYMERASE; MESSENGER-RNA; GENE-EXPRESSION; DNA-SEQUENCES; SIGMA-FACTOR; GROWTH; K-12	Despite almost 40 years of molecular genetics research in Escherichia coli a major fraction of its Transcription Start Sites (TSSs) are still unknown, limiting therefore our understanding of the regulatory circuits that control gene expression in this model organism. RegulonDB (http://regulondb.ccg.unam.mx/) is aimed at integrating the genetic regulatory network of E. coli K12 as an entirely bioinformatic project up till now. In this work, we extended its aims by generating experimental data at a genome scale on TSSs, promoters and regulatory regions. We implemented a modified 59 RACE protocol and an unbiased High Throughput Pyrosequencing Strategy (HTPS) that allowed us to map more than 1700 TSSs with high precision. From this collection, about 230 corresponded to previously reported TSSs, which helped us to benchmark both our methodologies and the accuracy of the previous mapping experiments. The other ca 1500 TSSs mapped belong to about 1000 different genes, many of them with no assigned function. We identified promoter sequences and type of sigma factors that control the expression of about 80% of these genes. As expected, the housekeeping sigma(70) was the most common type of promoter, followed by sigma(38). The majority of the putative TSSs were located between 20 to 40 nucleotides from the translational start site. Putative regulatory binding sites for transcription factors were detected upstream of many TSSs. For a few transcripts, riboswitches and small RNAs were found. Several genes also had additional TSSs within the coding region. Unexpectedly, the HTPS experiments revealed extensive antisense transcription, probably for regulatory functions. The new information in RegulonDB, now with more than 2400 experimentally determined TSSs, strengthens the accuracy of promoter prediction, operon structure, and regulatory networks and provides valuable new information that will facilitate the understanding from a global perspective the complex and intricate regulatory network that operates in E. coli.			Mendoza-Vargas, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico.	emorett@ibt.unam.mx	Taboada, Blanca/A-3974-2019; Morett, Enrique/G-3401-2013; Contreras-Moreira, Bruno/G-4334-2011	JUAREZ, KATY/0000-0002-4400-4674; Morett, Enrique/0000-0001-5723-0032; Taboada, Blanca/0000-0003-1896-5962; Collado-Vides, Julio/0000-0001-8780-7664; Jimenez-Jacinto, Veronica/0000-0001-6742-1537; Contreras Moreira, Bruno/0000-0002-5462-907X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071962] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM071962, GM071962-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abreu-Goodger C, 2004, TRENDS GENET, V20, P475, DOI 10.1016/j.tig.2004.08.003; BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Burr T, 2000, NUCLEIC ACIDS RES, V28, P1864, DOI 10.1093/nar/28.9.1864; BYRNE CR, 1988, J BACTERIOL, V170, P3150, DOI 10.1128/jb.170.7.3150-3157.1988; BYSTROM AS, 1989, J MOL BIOL, V208, P575, DOI 10.1016/0022-2836(89)90149-6; COLE ST, 1982, MOL GEN GENET, V188, P472, DOI 10.1007/BF00330051; DERSCH P, 1993, MOL MICROBIOL, V8, P875, DOI 10.1111/j.1365-2958.1993.tb01634.x; Fickett JW, 1997, GENOME RES, V7, P861, DOI 10.1101/gr.7.9.861; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GALAS DJ, 1985, J MOL BIOL, V186, P117, DOI 10.1016/0022-2836(85)90262-1; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Herring CD, 2005, J BACTERIOL, V187, P6166, DOI 10.1128/JB.187.17.6166-6174.2005; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; Huerta AM, 1998, NUCLEIC ACIDS RES, V26, P55, DOI 10.1093/nar/26.1.55; Huerta AM, 2006, PLOS GENET, V2, P1740, DOI 10.1371/journal.pgen.0020185; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Kanhere A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-1; Ko JH, 2006, FEBS LETT, V580, P539, DOI 10.1016/j.febslet.2005.12.066; LATEANA A, 1989, FEBS LETT, V244, P34, DOI 10.1016/0014-5793(89)81156-1; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; Liu MY, 1997, J BIOL CHEM, V272, P17502, DOI 10.1074/jbc.272.28.17502; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Merino E, 2005, TRENDS GENET, V21, P260, DOI 10.1016/j.tig.2005.03.002; Mitchell JE, 2003, NUCLEIC ACIDS RES, V31, P4689, DOI 10.1093/nar/gkg694; NAKAO T, 1987, MOL GEN GENET, V210, P364, DOI 10.1007/BF00325707; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Ozoline ON, 1997, NUCLEIC ACIDS RES, V25, P4703, DOI 10.1093/nar/25.23.4703; Pedersen AG, 1999, COMPUT CHEM, V23, P191, DOI 10.1016/S0097-8485(99)00015-7; Richard DJ, 1999, MICROBIOL-SGM, V145, P2903, DOI 10.1099/00221287-145-10-2903; Roth ME, 2004, NAT BIOTECHNOL, V22, P418, DOI 10.1038/nbt948; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; SEEBURG PH, 1977, EUR J BIOCHEM, V74, P107, DOI 10.1111/j.1432-1033.1977.tb11372.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; THOMPSON JA, 1979, J VIROL, V31, P437, DOI 10.1128/JVI.31.2.437-446.1979; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; TRAVERS AA, 1969, NATURE, V222, P537, DOI 10.1038/222537a0; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484	53	187	190	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7526	10.1371/journal.pone.0007526	http://dx.doi.org/10.1371/journal.pone.0007526			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838305	Green Published, gold, Green Submitted			2022-12-25	WOS:000270880900016
J	Owens, TW; Foster, FM; Valentijn, A; Gilmore, AP; Streuli, CH				Owens, Thomas W.; Foster, Fiona M.; Valentijn, Anthony; Gilmore, Andrew P.; Streuli, Charles H.			Role for X-linked Inhibitor of Apoptosis Protein Upstream of Mitochondrial Permeabilization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; SUBCELLULAR-LOCALIZATION; CASPASE ACTIVATION; EFFECTOR CASPASES; SERINE-PROTEASE; XIAP; BAX; ANOIKIS; IAPS; MICE	Apoptosis is controlled by a signaling equilibrium between prosurvival and proapoptotic pathways, such that unwanted apoptosis is avoided, but when required it occurs rapidly and efficiently. Many apoptosis regulators display dual roles, depending upon whether a cell has received an apoptotic stimulus or not. Here, we identify a novel and unexpected function for X-linked inhibitor of apoptosis (XIAP) that occurs when apoptosis is triggered under physiological conditions. We show that in response to loss of survival signals provided by cell adhesion, endogenous XIAP translocates from the cytosol into a mitochondrial 400-kDa complex and that this occurs very early in the apoptosis process. Membrane-associated XIAP induces mitochondrial outer membrane permeabilization leading to cytochrome c and Smac release, which is dependent on Bax and Bak. Thus, although XIAP suppresses apoptosis in healthy cells, our data indicate that XIAP may contribute to it in response to a proapoptotic signal such as loss of extracellular matrix-dependent survival signaling. We suggest that, as with Bcl-2 family proteins, more diverse functions for XIAP exist than previously identified. Moreover, switching the function of proteins from anti-to proapoptotic forms may be a common theme in the efficient execution of cell death.	[Owens, Thomas W.; Foster, Fiona M.; Valentijn, Anthony; Gilmore, Andrew P.; Streuli, Charles H.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England	University of Manchester	Streuli, CH (corresponding author), Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England.	charles.streuli@manchester.ac.uk			Wellcome Trust; Cancer Research United Kingdom	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research United Kingdom(Cancer Research UK)	This work was funded by the Wellcome Trust and Cancer Research United Kingdom.	Brookes PS, 2002, PROTEOMICS, V2, P969, DOI 10.1002/1615-9861(200208)2:8<969::AID-PROT969>3.0.CO;2-3; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Conte D, 2001, P NATL ACAD SCI USA, V98, P5049, DOI 10.1073/pnas.081547998; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Ditzel M, 2008, MOL CELL, V32, P540, DOI 10.1016/j.molcel.2008.09.025; Dogan T, 2008, NAT CELL BIOL, V10, P1447, DOI 10.1038/ncb1804; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Gilmore AP, 2009, CURR OPIN CELL BIOL, V21, P654, DOI 10.1016/j.ceb.2009.05.009; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Gilmore AP, 2000, J CELL BIOL, V149, P431, DOI 10.1083/jcb.149.2.431; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kamer I, 2005, CELL, V122, P593, DOI 10.1016/j.cell.2005.06.014; Karbowski M, 2006, NATURE, V443, P658, DOI 10.1038/nature05111; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Manara A, 2009, BBA-MOL CELL BIOL L, V1791, P997, DOI 10.1016/j.bbalip.2009.05.003; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Owens TW, 2009, CELL DEATH DIFFER, V16, P1551, DOI 10.1038/cdd.2009.102; Park HJ, 2006, J BIOL CHEM, V281, P34277, DOI 10.1074/jbc.M603443200; Pullan S, 1996, J CELL SCI, V109, P631; Sauerwald TM, 2002, BIOTECHNOL BIOENG, V77, P704, DOI 10.1002/bit.10154; Silke J, 2004, J BIOL CHEM, V279, P4313, DOI 10.1074/jbc.M305661200; Streuli CH, 2009, J CELL SCI, V122, P171, DOI 10.1242/jcs.018945; Tenev T, 2005, NAT CELL BIOL, V7, P70, DOI 10.1038/ncb1204; Trapp T, 2003, MOL CELL NEUROSCI, V23, P302, DOI 10.1016/S1044-7431(03)00013-7; Upton JP, 2007, CELL DEATH DIFFER, V14, P932, DOI 10.1038/sj.cdd.4402092; Valentijn AJ, 2004, J BIOL CHEM, V279, P32848, DOI 10.1074/jbc.M313375200; Valentijn AJ, 2003, J CELL BIOL, V162, P599, DOI 10.1083/jcb.200302154; Valentijn AJ, 2008, BIOCHEM J, V412, P347, DOI 10.1042/BJ20071548; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang PB, 2003, J BIOL CHEM, V278, P19917, DOI 10.1074/jbc.M210337200; Wang XY, 2004, NEUROBIOL DIS, V16, P179, DOI 10.1016/j.nbd.2004.01.014; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	39	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1081	1088		10.1074/jbc.M109.072322	http://dx.doi.org/10.1074/jbc.M109.072322			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19875445	Green Published, hybrid			2022-12-25	WOS:000273258200029
J	Reilly, MC; Levery, SB; Castle, SA; Klutts, JS; Doering, TL				Reilly, Morgann C.; Levery, Steven B.; Castle, Sherry A.; Klutts, J. Stacey; Doering, Tamara L.			A Novel Xylosylphosphotransferase Activity Discovered in Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURE MUTANT STRAINS; CAPSULE-ASSOCIATED GENE; GLUCURONIC ACID; VIRULENCE; GLYCOSYLTRANSFERASES; XYLOSE; BETA-1,2-XYLOSYLTRANSFERASE; GALACTOXYLOMANNAN; IDENTIFICATION; MECHANISMS	Cryptococcus neoformans is a fungal pathogen that causes serious disease in immunocompromised individuals. The organism produces a distinctive polysaccharide capsule that is necessary for its virulence, a predominantly polysaccharide cell wall, and a variety of protein- and lipid-linked glycans. The glycan synthetic pathways of this pathogen are of great interest. Here we report the detection of a novel glycosylphosphotransferase activity in C. neoformans, identification of the corresponding gene, and characterization of the encoded protein. The observed activity is specific for UDP-xylose as a donor and for mannose acceptors and forms a xylose-alpha-1-phosphate-6-mannose linkage. This is the first report of a xylosylphosphotransferase activity in any system.	[Reilly, Morgann C.; Klutts, J. Stacey; Doering, Tamara L.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Levery, Steven B.] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen N, Denmark; [Castle, Sherry A.] Univ New Hampshire, Dept Chem, Durham, NH 03824 USA; [Klutts, J. Stacey] Univ Iowa, Dept Pathol, Carver Coll Med & Pathol & Lab Med, Iowa City, IA 52246 USA	Washington University (WUSTL); University of Copenhagen; University System Of New Hampshire; University of New Hampshire; University of Iowa	Doering, TL (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, 660 S Euclid Ave,Campus Box 8230, St Louis, MO 63110 USA.	doering@wustl.edu		Reilly, Morgann/0000-0002-5526-8245; Klutts, James/0000-0003-3788-1940	National Institutes of Health [RO1 GM071007]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM071007 (in support of the studies of cryptococcal glycan synthesis in the Doering laboratory).	Bao M, 1996, J BIOL CHEM, V271, P31446, DOI 10.1074/jbc.271.49.31446; Bar-Peled M, 2001, P NATL ACAD SCI USA, V98, P12003, DOI 10.1073/pnas.211229198; BRAULKE T, 2008, J INHERIT METAB DIS; Brown T., 2004, CURR PROTOCOLS MOL B, V67, p4.9.1; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Castle SA, 2008, EUKARYOT CELL, V7, P1611, DOI 10.1128/EC.00458-07; Chang YC, 1999, J BACTERIOL, V181, P5636, DOI 10.1128/JB.181.18.5636-5643.1999; Chang YC, 1996, INFECT IMMUN, V64, P1977, DOI 10.1128/IAI.64.6.1977-1983.1996; Chang YC, 1998, INFECT IMMUN, V66, P2230, DOI 10.1128/IAI.66.5.2230-2236.1998; Cherniak R, 1998, INFECT IMMUN, V66, P2996, DOI 10.1128/IAI.66.6.2996-2998.1998; Davidson RC, 2002, MICROBIOL-SGM, V148, P2607, DOI 10.1099/00221287-148-8-2607; Doering TL, 2009, ANNU REV MICROBIOL, V63, P223, DOI 10.1146/annurev.micro.62.081307.162753; EDMAN JC, 1990, MOL CELL BIOL, V10, P4538, DOI 10.1128/MCB.10.9.4538; FROMTLING RA, 1982, MYCOPATHOLOGIA, V79, P23, DOI 10.1007/BF00636177; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Griffith CL, 2004, J BIOL CHEM, V279, P51669, DOI 10.1074/jbc.M408889200; Gutierrez ALS, 2007, GLYCOBIOLOGY, V17, p1C, DOI 10.1093/glycob/cwm030; Heise N, 2002, GLYCOBIOLOGY, V12, P409, DOI 10.1093/glycob/cwf053; Heiss C, 2009, CARBOHYD RES, V344, P915, DOI 10.1016/j.carres.2009.03.003; JACOBSON ES, 1982, J BACTERIOL, V150, P1292, DOI 10.1128/JB.150.3.1292-1296.1982; Jigami Y, 1999, BBA-GEN SUBJECTS, V1426, P335, DOI 10.1016/S0304-4165(98)00134-2; Klutts JS, 2008, J BIOL CHEM, V283, P14327, DOI 10.1074/jbc.M708927200; Klutts JS, 2007, J BIOL CHEM, V282, P17890, DOI 10.1074/jbc.M701941200; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Kwon-Chung KJ, 1998, MED MYCOL, V36, P38; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P1869, DOI 10.1128/IAI.60.5.1869-1874.1992; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; LI YT, 1967, J BIOL CHEM, V242, P5474; Liu X, 2006, MOL MICROBIOL, V61, P1132, DOI 10.1111/j.1365-2958.2006.05299.x; Moyrand F, 2002, MOL MICROBIOL, V45, P837, DOI 10.1046/j.1365-2958.2002.03059.x; Nelson RT, 2001, GENETICS, V157, P935; Nielsen K, 2003, INFECT IMMUN, V71, P4831, DOI 10.1128/IAI.71.9.4831-4841.2003; Pohl S, 2009, BBA-MOL BASIS DIS, V1792, P221, DOI 10.1016/j.bbadis.2009.01.009; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Schutzbach J, 2007, CARBOHYD RES, V342, P881, DOI 10.1016/j.carres.2007.01.002; Sperisen P, 2005, PLOS COMPUT BIOL, V1, P492, DOI 10.1371/journal.pcbi.0010063; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; WICKES BL, 1994, MICROBIOL-SGM, V140, P543, DOI 10.1099/00221287-140-3-543; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Wopereis S, 2006, CLIN CHEM, V52, P574, DOI 10.1373/clinchem.2005.063040; Yan Z, 2002, J CLIN MICROBIOL, V40, P965, DOI 10.1128/JCM.40.3.965-972.2002	44	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36118	36127		10.1074/jbc.M109.056226	http://dx.doi.org/10.1074/jbc.M109.056226			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19864415	hybrid, Green Published			2022-12-25	WOS:000272970500013
J	Crane, JM; Bennett, JL; Verkman, AS				Crane, Jonathan M.; Bennett, Jeffrey L.; Verkman, A. S.			Live Cell Analysis of Aquaporin-4 M1/M23 Interactions and Regulated Orthogonal Array Assembly in Glial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSENSITIVE WATER CHANNEL; NEUROMYELITIS-OPTICA; PLASMA-MEMBRANE; SQUARE ARRAYS; M23 ISOFORMS; BRAIN EDEMA; SPINAL-CORD; RAT-BRAIN; MICE; PARTICLES	Aquaporin-4 (AQP4) can assemble into supramolecular aggregates called orthogonal arrays of particles (OAPs). In cells expressing single AQP4 isoforms, we found previously that OAP formation by AQP4-M23 requires N terminus interactions just downstream of Met-23 and that the inability of AQP4-M1 to form OAPs involves blocking by residues upstream of Met-23. Here, we studied M1/M23 interactions and regulated OAP assembly by nanometer-resolution tracking of quantum dot-labeled AQP4 in live cells expressing differentially tagged AQP4 isoforms and in primary glial cell cultures in which native AQP4 was labeled with a monoclonal recombinant neuromyelitis optica autoantibody. OAP assembly was assessed independently by Blue Native gel electrophoresis. We found that OAPs in native glial cells could be reproduced in transfected cells expressing equal amounts of AQP4-M1 and -M23. Mutants of M23 that do not themselves form OAPs, including M23-F26Q and M23-G28P, were able to fully co-associate with native M23 to form large immobile OAPs. Analysis of a palmitoylation-null M1 mutant (C13A/C17A) indicated palmitoylation-dependent OAP assembly only in the presence of M23, with increased M1 palmitoylation causing progressive OAP disruption. Differential regulation of OAP assembly by palmitoylation, calcium elevation, and protein kinase C activation was found in primary glial cell cultures. Weconclude that M1 and M23 co-assemble in AQP4OAPs and that specific signaling events can regulateOAP assembly in glial cells.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Neurol, Aurora, CO 80045 USA; [Bennett, Jeffrey L.] Univ Colorado Denver, Dept Ophthalmol, Aurora, CO 80045 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus		Alan.Verkman@ucsf.edu			National Institutes of Health [EB00415, HL73856, DK35124, EY13574, DK72517]; Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society [NMSSRG4320]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, R01DK035124, P30DK072517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Charitable Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EB00415, HL73856, DK35124, EY13574, and DK72517 and by a grant from the Guthy-Jackson Charitable Foundation (to A. S. V.). This work was also supported by Grant NMSSRG4320 from the National Multiple Sclerosis Society (to J. L. B.).	Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Auguste KI, 2007, FASEB J, V21, P108, DOI 10.1096/fj.06-6848com; BENNETT JL, 2009, ANN NEUROL IN PRESS; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Bloch O, 2006, J CEREBR BLOOD F MET, V26, P1527, DOI 10.1038/sj.jcbfm.9600306; Carmosino M, 2001, J CELL BIOL, V154, P1235, DOI 10.1083/jcb.200103010; CRANE JM, 2009, BIOPHYS J IN PRESS; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; Crane JM, 2008, BIOPHYS J, V94, P702, DOI 10.1529/biophysj.107.115121; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; Dietrich LEP, 2004, EMBO REP, V5, P1053, DOI 10.1038/sj.embor.7400277; FRIGERI A, 1995, J CELL SCI, V108, P2993; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Han ZQ, 1998, J BIOL CHEM, V273, P6001, DOI 10.1074/jbc.273.11.6001; HASEGAWA H, 1994, J BIOL CHEM, V269, P5497; HATTON JD, 1984, EPILEPSIA, V25, P145, DOI 10.1111/j.1528-1157.1984.tb04170.x; Hinson SR, 2007, NEUROLOGY, V69, P2221, DOI 10.1212/01.WNL.0000289761.64862.ce; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052; LANDIS DMD, 1974, J CELL BIOL, V60, P316, DOI 10.1083/jcb.60.1.316; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lu MQ, 1996, P NATL ACAD SCI USA, V93, P10908, DOI 10.1073/pnas.93.20.10908; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Moe SE, 2008, GENOMICS, V91, P367, DOI 10.1016/j.ygeno.2007.12.003; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Nielsen S, 1997, J NEUROSCI, V17, P171; Padmawar P, 2005, NAT METHODS, V2, P825, DOI 10.1038/NMETH801; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; SCHOTLAND DL, 1981, ACTA NEUROPATHOL, V54, P189, DOI 10.1007/BF00687741; Silberstein C, 2004, AM J PHYSIOL-RENAL, V287, pF501, DOI 10.1152/ajprenal.00439.2003; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Sonnleitner A, 1999, BIOPHYS J, V77, P2638, DOI 10.1016/S0006-3495(99)77097-9; Sorbo JG, 2008, BIOCHEMISTRY-US, V47, P2631, DOI 10.1021/bi702146k; Suzuki H, 2008, BBA-BIOMEMBRANES, V1778, P1181, DOI 10.1016/j.bbamem.2007.12.007; Van Hoek AN, 2000, AM J PHYSIOL-RENAL, V278, pF310, DOI 10.1152/ajprenal.2000.278.2.F310; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; WOLBURG H, 1995, J BRAIN RES, V36, P239; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Yang BX, 1997, BIOCHEMISTRY-US, V36, P7625, DOI 10.1021/bi970231r; Yang BX, 1996, J BIOL CHEM, V271, P4577; YANG BX, 1995, J BIOL CHEM, V270, P22907, DOI 10.1074/jbc.270.39.22907	48	65	70	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35850	35860		10.1074/jbc.M109.071670	http://dx.doi.org/10.1074/jbc.M109.071670			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19843522	hybrid, Green Published			2022-12-25	WOS:000272645600061
J	McLean, KJ; Lafite, P; Levy, C; Cheesman, MR; Mast, N; Pikuleva, IA; Leys, D; Munro, AW				McLean, Kirsty J.; Lafite, Pierre; Levy, Colin; Cheesman, Myles R.; Mast, Natalia; Pikuleva, Irina A.; Leys, David; Munro, Andrew W.			The Structure of Mycobacterium tuberculosis CYP125 MOLECULAR BASIS FOR CHOLESTEROL BINDING IN A P450 NEEDED FOR HOST INFECTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOPHYSICAL CHARACTERIZATION; CYTOCHROME-P450 46A1; AZOLE ANTIFUNGALS; CRYSTAL-STRUCTURE; GROWTH; IDENTIFICATION; PURIFICATION; HYDROXYLASE; DEGRADATION; FLAVODOXIN	We report characterization and the crystal structure of the Mycobacterium tuberculosis cytochrome P450 CYP125, a P450 implicated in metabolism of host cholesterol and essential for establishing infection in mice. CYP125 is purified in a high spin form and undergoes both type I and II spectral shifts with various azole drugs. The 1.4-angstrom structure of ligand-free CYP125 reveals a "letterbox" active site cavity of dimensions appropriate for entry of a polycyclic sterol. A mixture of hexa-coordinate and penta-coordinate states could be discerned, with water binding as the 6th heme-ligand linked to conformation of the I-helix Val(267) residue. Structures in complex with androstenedione and the antitubercular drug econazole reveal that binding of hydrophobic ligands occurs within the active site cavity. Due to the funnel shape of the active site near the heme, neither approaches the heme iron. A model of the cholesterol CYP125 complex shows that the alkyl side chain extends toward the heme iron, predicting hydroxylation of cholesterol C27. The alkyl chain is in close contact to Val(267), suggesting a substrate binding-induced low-to high-spin transition coupled to reorientation of the latter residue. Reconstitution of CYP125 activity with a redox partner system revealed exclusively cholesterol 27-hydroxylation, consistent with structure and modeling. This activity may enable catabolism of host cholesterol or generation of immunomodulatory compounds that enable persistence in the host. This study reveals structural and catalytic properties of a potential M. tuberculosis drug target enzyme, and the likely mode by which the host-derived substrate is bound and hydroxylated.	[McLean, Kirsty J.; Lafite, Pierre; Levy, Colin; Leys, David; Munro, Andrew W.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Cheesman, Myles R.] Univ E Anglia, Sch Chem Sci & Pharm, Norwich NR4 7TJ, Norfolk, England; [Mast, Natalia; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	University of Manchester; University of East Anglia; Case Western Reserve University	Munro, AW (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.	Andrew.Munro@Manchester.ac.uk	Lafite, Pierre/F-6806-2011; Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022	Lafite, Pierre/0000-0003-1637-4966; Munro, Andrew/0000-0002-4642-180X; Pikuleva, Irina/0000-0001-9742-6232; Levy, Colin/0000-0002-9724-310X; McLean, Kirsty/0000-0002-7193-5044	United Kingdom Biotechnology and Biological Sciences Research Council [C19757]; European Union [NM4TB]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by United Kingdom Biotechnology and Biological Sciences Research Council Grant C19757 and European Union Framework Programme VI project NM4TB.	Ahmad Z, 2006, INT J ANTIMICROB AG, V28, P543, DOI 10.1016/j.ijantimicag.2006.07.028; Ahmad Z, 2006, FEMS MICROBIOL LETT, V261, P181, DOI 10.1111/j.1574-6968.2006.00350.x; Belin P, 2009, P NATL ACAD SCI USA, V106, P7426, DOI 10.1073/pnas.0812191106; Bellamine A, 1999, P NATL ACAD SCI USA, V96, P8937, DOI 10.1073/pnas.96.16.8937; Brennan PJ, 2007, CURR TOP MED CHEM, V7, P475, DOI 10.2174/156802607780059763; Brzostek A, 2007, FEMS MICROBIOL LETT, V275, P106, DOI 10.1111/j.1574-6968.2007.00865.x; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Dutton P L, 1978, Methods Enzymol, V54, P411; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; HASEMANN CA, 1994, J MOL BIOL, V236, P1169, DOI 10.1016/0022-2836(94)90019-1; Hotsclaw CM, 2008, ACS CHEM BIOL, V3, P619, DOI 10.1021/cb800145r; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; JENKINS CM, 1994, J BIOL CHEM, V269, P27401; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2004, TRENDS MICROBIOL, V12, P537, DOI 10.1016/j.tim.2004.10.005; Lafite P, 2007, BIOCHEMISTRY-US, V46, P10237, DOI 10.1021/bi700876a; Lawson RJ, 2004, BIOCHEMISTRY-US, V43, P12410, DOI 10.1021/bi049132l; Leys D, 2003, J BIOL CHEM, V278, P5141, DOI 10.1074/jbc.M209928200; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; McIver L, 1998, EUR J BIOCHEM, V257, P577, DOI 10.1046/j.1432-1327.1998.2570577.x; McLean KJ, 2008, DRUG METAB REV, V40, P427, DOI 10.1080/03602530802186389 ; McLean KJ, 2007, ARCH BIOCHEM BIOPHYS, V464, P228, DOI 10.1016/j.abb.2007.03.026; McLean KJ, 2006, BIOCHEMISTRY-US, V45, P8427, DOI 10.1021/bi0601609; McLean KJ, 2008, J BIOL CHEM, V283, P33406, DOI 10.1074/jbc.M802115200; McLean KJ, 2006, TRENDS MICROBIOL, V14, P220, DOI 10.1016/j.tim.2006.03.002; McLean KJ, 2002, MICROBIOL-SGM, V148, P2937, DOI 10.1099/00221287-148-10-2937; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; MILES JS, 1992, BIOCHEM J, V288, P503, DOI 10.1042/bj2880503; Mohn WW, 2008, J BIOL CHEM, V283, P35368, DOI 10.1074/jbc.M805496200; Ouellet H, 2008, J BIOL CHEM, V283, P5069, DOI 10.1074/jbc.M708734200; Ouellet H, 2009, BIOCHEMISTRY-US, V48, P863, DOI 10.1021/bi801595t; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pieters J, 2001, MICROBES INFECT, V3, P249, DOI 10.1016/S1286-4579(01)01376-4; Quaroni LG, 2004, BIOCHEMISTRY-US, V43, P16416, DOI 10.1021/bi049163g; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SLIGAR SG, 1976, P NATL ACAD SCI USA, V73, P1078, DOI 10.1073/pnas.73.4.1078; Strushkevich N, 2008, J MOL BIOL, V380, P95, DOI 10.1016/j.jmb.2008.03.065; Umetani M, 2007, NAT MED, V13, P1185, DOI 10.1038/nm1641; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005	46	88	98	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35524	35533		10.1074/jbc.M109.032706	http://dx.doi.org/10.1074/jbc.M109.032706			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19846552	Green Published, hybrid			2022-12-25	WOS:000272645600029
J	Reisenauer, MR; Anderson, M; Huang, L; Zhang, ZJ; Zhou, QL; Kone, BC; Morris, AP; LeSage, GD; Dryer, SE; Zhang, WZ				Reisenauer, Mary Rose; Anderson, Marc; Huang, Le; Zhang, Zhijing; Zhou, Qiaoling; Kone, Bruce C.; Morris, Andrew P.; LeSage, Gene D.; Dryer, Stuart E.; Zhang, Wenzheng			AF17 Competes with AF9 for Binding to Dot1a to Up-regulate Transcription of Epithelial Na+ Channel alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-ZIPPER PROTEIN; SODIUM-CHANNEL; SURFACE EXPRESSION; CELL-SURFACE; UBIQUITIN LIGASE; ACUTE-LEUKEMIA; ENAC-ALPHA; ALDOSTERONE; NEDD4-2; GENE	We previously reported that Dot1a center dot AF9 complex represses transcription of the epithelial Na+ channel subunit alpha (alpha-ENaC) gene in mouse inner medullary collecting duct mIMCD3 cells and mouse kidney. Aldosterone relieves this repression by down-regulating the complex through various mechanisms. Whether these mechanisms are sufficient and conserved in human cells or can be applied to other aldosterone-regulated genes remains largely unknown. Here we demonstrate that human embryonic kidney 293T cells express the three ENaC subunits and all of the ENaC transcriptional regulators examined. These cells respond to aldosterone and display benzamil-sensitive Na+ currents, as measured by whole-cell patch clamping. We also show that AF17 and AF9 competitively bind to the same domain of Dot1a in multiple assays and have antagonistic effects on expression of an alpha-ENaC promoter-luciferase construct. Overexpression of Dot1a or AF9 decreased mRNA expression of the ENaC subunits and their transcriptional regulators and reduced benzamil-sensitive Na+ currents. AF17 overexpression caused the opposite effects, accompanied by redirection of Dot1a from the nucleus to the cytoplasm and reduction in histone H3 K79 methylation. The nuclear export inhibitor leptomycin B blocked the effect of AF17 overexpression on H3 K79 hypomethylation. RNAi-mediated knockdown of AF17 yielded nuclear enrichment of Dot1a and histone H3 K79 hypermethylation. As with AF9, AF17 displays nuclear and cytoplasmic co-localization with Sgk1. Therefore, AF17 competes with AF9 to bind Dot1a, decreases Dot1a nuclear expression by possibly facilitating its nuclear export, and relieves Dot1a center dot AF9-mediated repression of alpha-ENaC and other target genes.	[Morris, Andrew P.; LeSage, Gene D.; Zhang, Wenzheng] Univ Texas Hlth Sci Ctr, Dept Internal Med, Houston, TX 77030 USA; [Huang, Le; Zhang, Wenzheng] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Anderson, Marc; Dryer, Stuart E.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Zhou, Qiaoling] Cent S Univ, Xiangya Hosp, Dept Internal Med, Changsha 410008, Hunan, Peoples R China	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston; Central South University	Zhang, WZ (corresponding author), Univ Texas Med Sch Houston, Dept Internal Med, 6431 Fannin,MSB 1-150, Houston, TX 77030 USA.	wenzheng.zhang@uth.tmc.edu			National Institutes of Health [R01 DK080236, R01 DK082529, R01 DK075065]; American Heart Association [0865271F]; American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK070834, R01DK080236, R01DK075065, R01DK082529] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Society of Nephrology; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK080236 ( to W.Z.), R01 DK082529 ( to S. E. D.), and R01 DK075065 ( to B. K.). This work was also supported by American Heart Association Beginning Grant-in-aid 0865271F ( to W.Z.) and an American Society of Nephrology Carl W. Gottschalk Research Scholar Grant ( to W.Z.).	Bangel N, 2008, J CYST FIBROS, V7, P197, DOI 10.1016/j.jcf.2007.07.012; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Boulkroun S, 2008, AM J PHYSIOL-RENAL, V295, pF889, DOI 10.1152/ajprenal.00001.2008; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Chang SS, 1996, NAT GENET, V12, P248, DOI 10.1038/ng0396-248; CHAPLIN T, 1995, BLOOD, V85, P1435, DOI 10.1182/blood.V85.6.1435.bloodjournal8561435; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Eaton DC, 2001, J MEMBRANE BIOL, V184, P313, DOI 10.1007/s00232-001-0098-x; Ecelbarger CA, 2001, EXP NEUROL, V171, P227, DOI 10.1006/exnr.2001.7775; Eguchi M, 2003, INT J HEMATOL, V78, P390, DOI 10.1007/BF02983811; Fejes-Toth G, 1998, P NATL ACAD SCI USA, V95, P2973, DOI 10.1073/pnas.95.6.2973; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gilmore ES, 2001, J BIOL CHEM, V276, P42610, DOI 10.1074/jbc.M106919200; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kim EY, 2007, NEUROSCIENCE, V146, P1652, DOI 10.1016/j.neuroscience.2007.03.038; Kim EY, 2007, MOL PHARMACOL, V72, P622, DOI 10.1124/mol.107.038026; Kim EY, 2007, J NEUROPHYSIOL, V97, P3508, DOI 10.1152/jn.00009.2007; Lin YM, 2001, CANCER RES, V61, P6345; Loffing J, 2006, ANNU REV PHYSIOL, V68, P461, DOI 10.1146/annurev.physiol.68.040104.131654; MARUNAKA Y, 1992, AM J PHYSIOL, V263, pF392, DOI 10.1152/ajprenal.1992.263.3.F392; Mastroberardino L, 1998, MOL BIOL CELL, V9, P3417, DOI 10.1091/mbc.9.12.3417; Nishiyama K, 2007, J BIOL CHEM, V282, P17200, DOI 10.1074/jbc.M611609200; Okada Y, 2005, CELL, V121, P167, DOI 10.1016/j.cell.2005.02.020; PRASAD R, 1994, P NATL ACAD SCI USA, V91, P8107, DOI 10.1073/pnas.91.17.8107; Rao US, 2004, CELL CALCIUM, V35, P21, DOI 10.1016/S0143-4160(03)00157-X; Ridgway LD, 2009, AM J PHYSIOL-CELL PH, V297, pC55, DOI 10.1152/ajpcell.00073.2009; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; RUBNITZ JE, 1994, BLOOD, V84, P1747; Shigaev A, 2000, AM J PHYSIOL-RENAL, V278, pF613, DOI 10.1152/ajprenal.2000.278.4.F613; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200; Suzukawa K, 2005, INT J HEMATOL, V82, P38, DOI 10.1532/IJH97.05025; Thomas CP, 2004, CURR OPIN NEPHROL HY, V13, P541, DOI 10.1097/00041552-200409000-00010; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Verrey F, 2008, KIDNEY INT, V73, P691, DOI 10.1038/sj.ki.5002737; ZEIDEL ML, 1988, J CLIN INVEST, V82, P1067, DOI 10.1172/JCI113663; Zhang WZ, 2007, J CLIN INVEST, V117, P773, DOI 10.1172/JCI29850; Zhang WZ, 2006, J BIOL CHEM, V281, P18059, DOI 10.1074/jbc.M601903200; Zhang WZ, 2004, AM J PHYSIOL-RENAL, V286, pF1171, DOI 10.1152/ajprenal.00043.2003; Zhang WZ, 2006, AM J PHYSIOL-CELL PH, V290, pC936, DOI 10.1152/ajpcell.00431.2005; Zhang WZ, 2004, BIOCHEM J, V377, P641, DOI 10.1042/BJ20030839; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	49	37	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35659	35669		10.1074/jbc.M109.038448	http://dx.doi.org/10.1074/jbc.M109.038448			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19864429	Green Published, hybrid			2022-12-25	WOS:000272645600044
J	Yamazaki, M; Fukushima, H; Shin, M; Katagiri, T; Doi, T; Takahashi, T; Jimi, E				Yamazaki, Masato; Fukushima, Hidefumi; Shin, Masashi; Katagiri, Takenobu; Doi, Takahiro; Takahashi, Tetsu; Jimi, Eijiro			Tumor Necrosis Factor alpha Represses Bone Morphogenetic Protein (BMP) Signaling by Interfering with the DNA Binding of Smads through the Activation of NF-kappa B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD MONONUCLEAR-CELLS; OSTEOBLAST DIFFERENTIATION; TNF-ALPHA; RHEUMATOID-ARTHRITIS; ESTROGEN DEFICIENCY; RESPONSIVE ELEMENT; C2C12 MYOBLASTS; INHIBITION; RECEPTOR; INFLAMMATION	Bone morphogenetic proteins (BMPs) induce not only bone formation in vivo but also osteoblast differentiation of mesenchymal cells in vitro. Tumor necrosis factor alpha (TNF alpha) inhibits both osteoblast differentiation and bone formation induced by BMPs. However, the molecular mechanisms of these inhibitions remain unknown. In this study, we found that TNF alpha inhibited the alkaline phosphatase activity and markedly reduced BMP2- and Smad-induced reporter activity in MC3T3-E1 cells. TNF alpha had no effect on the phosphorylation of Smad1, Smad5, and Smad8 or on the nuclear translocation of the Smad1-Smad4 complex. In p65-deficient mouse embryonic fibroblasts, overexpression of p65, a subunit of NF-kappa B, inhibited BMP2- and Smad-induced reporter activity in a dose-dependent manner. Furthermore, this p65-mediated inhibition of BMP2- and Smad-responsive promoter activity was restored after inhibition of NF-kappa B by the overexpression of the dominant negative I kappa B alpha. Although TNF alpha failed to affect receptor-dependent formation of the Smad1-Smad4 complex, p65 associated with the complex. Chromatin immunoprecipitation and electrophoresis mobility shift assays revealed that TNF alpha suppressed the DNA binding of Smad proteins to the target gene. Importantly, the specific NF-kappa B inhibitor, BAY11-7082, abolished these phenomena. These results suggest that TNF alpha inhibits BMP signaling by interfering with the DNA binding of Smads through the activation of NF-kappa B.	[Jimi, Eijiro] Kyushu Dent Coll, Div Mol Signaling & Biochem, Dept Biosci, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; [Yamazaki, Masato; Takahashi, Tetsu] Kyushu Dent Coll, Dept Oral & Maxillofacial Surg, Kitakyushu, Fukuoka 8038580, Japan; [Jimi, Eijiro] Kyushu Dent Coll, Oral Biol Res Ctr, Kitakyushu, Fukuoka 8038580, Japan; [Katagiri, Takenobu] Saitama Med Univ, Res Ctr Genom Med, Div Pathophysiol & Translat Res, Hidaka, Saitama 3501241, Japan; [Doi, Takahiro] RIKEN BioResource Ctr, Technol & Dev Team, BioSignal Program, Subteam BioSignal Integrat, Tsukuba, Ibaraki 3050074, Japan	Kyushu Dental University; Kyushu Dental University; Kyushu Dental University; Saitama Medical University; RIKEN	Jimi, E (corresponding author), Kyushu Dent Coll, Div Mol Signaling & Biochem, Dept Biosci, Kokurakita Ku, 2-6-1 Manazuru, Kitakyushu, Fukuoka 8038580, Japan.	ejimi@kyu-dent.ac.jp			Kyushu Dental College; Ministry of Education, Culture, Sports, Science and Technology of Japan [20390473]; Astellas Foundation for Research on Metabolic Disorders	Kyushu Dental College(Kyushu Dental College); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Astellas Foundation for Research on Metabolic Disorders	This work was supported in part by a grant-in-aid from Kyushu Dental College Internal Grants (to H. F. and E. J.), a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to E. J.: 20390473), and by the Astellas Foundation for Research on Metabolic Disorders (to E. J.).	Ammann P, 1997, J CLIN INVEST, V99, P1699, DOI 10.1172/JCI119333; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Buma P, 2008, J BIOMED MATER RES B, V84B, P231, DOI 10.1002/jbm.b.30865; CANALIS E, 1987, ENDOCRINOLOGY, V121, P1596, DOI 10.1210/endo-121-5-1596; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doi TS, 1997, J EXP MED, V185, P953, DOI 10.1084/jem.185.5.953; Eliseev RA, 2006, EXP CELL RES, V312, P40, DOI 10.1016/j.yexcr.2005.09.016; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilbert L, 2000, ENDOCRINOLOGY, V141, P3956, DOI 10.1210/en.141.11.3956; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Gilbert LC, 2005, AM J PHYSIOL-ENDOC M, V288, pE1011, DOI 10.1152/ajpendo.00534.2004; Hay E, 2004, J BIOL CHEM, V279, P1650, DOI 10.1074/jbc.M300969200; Hay E, 2001, J BIOL CHEM, V276, P29028, DOI 10.1074/jbc.M011265200; Ishida W, 2000, J BIOL CHEM, V275, P6075, DOI 10.1074/jbc.275.9.6075; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Karin M, 2008, CELL RES, V18, P334, DOI 10.1038/cr.2008.30; KATAGIRI T, 1994, J CELL BIOL, V127, P1755, DOI 10.1083/jcb.127.6.1755; Katagiri T, 2002, GENES CELLS, V7, P949, DOI 10.1046/j.1365-2443.2002.00573.x; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kusumoto K, 2002, J INT MED RES, V30, P251, DOI 10.1177/147323000203000305; Li Y, 2007, J BONE MINER RES, V22, P646, DOI 10.1359/JBMR.070121; Lu XH, 2006, J BIOL CHEM, V281, P6297, DOI 10.1074/jbc.M507804200; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Mukai T, 2007, BIOCHEM BIOPH RES CO, V356, P1004, DOI 10.1016/j.bbrc.2007.03.099; Nakase T, 1997, BONE, V21, P17, DOI 10.1016/S8756-3282(97)00038-0; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nanes MS, 2003, GENE, V321, P1, DOI 10.1016/S0378-1119(03)00841-2; Nishimura R, 2002, BONE, V31, P303, DOI 10.1016/S8756-3282(02)00826-8; PACIFICI R, 1991, P NATL ACAD SCI USA, V88, P5134, DOI 10.1073/pnas.88.12.5134; RALSTON SH, 1990, J BONE MINER RES, V5, P983; Ranganathan P, 2008, CURR OPIN MOL THER, V10, P562; Sapkota G, 2007, MOL CELL, V25, P441, DOI 10.1016/j.molcel.2007.01.006; ten Dijke P, 2006, CURR MED RES OPIN, V22, pS7, DOI 10.1185/030079906X80576; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Vaidya R, 2008, J SPINAL DISORD TECH, V21, P557, DOI 10.1097/BSD.0b013e31815ea897; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yamamoto N, 1997, BIOCHEM BIOPH RES CO, V238, P574, DOI 10.1006/bbrc.1997.7325	41	95	102	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35987	35995		10.1074/jbc.M109.070540	http://dx.doi.org/10.1074/jbc.M109.070540			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19854828	hybrid, Green Published			2022-12-25	WOS:000272645600073
J	Ma, JJ; Ren, ZJ; Ma, Y; Xu, L; Zhao, Y; Zheng, CG; Fang, YH; Xue, T; Sun, BL; Xiao, WH				Ma, Jiajia; Ren, Zijia; Ma, Yang; Xu, Lu; Zhao, Ying; Zheng, Chaogu; Fang, Yinghui; Xue, Ting; Sun, Baolin; Xiao, Weihua			Targeted Knockdown of EGR-1 Inhibits IL-8 Production and IL-8-mediated Invasion of Prostate Cancer Cells through Suppressing EGR-1/NF-kappa B Synergy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSE PROTEIN EGR-1; ACTIVATED T-CELLS; NF-KAPPA-B; METHYLATION STATES; CXC-CHEMOKINES; EXPRESSION; GROWTH; INTERLEUKIN-8; GENE; TRANSCRIPTION	IL-8 produced by prostate cancer cells may be responsible for the androgen-independent growth of advanced prostate cancers. Accumulating evidence from microarray analyses and animal genetic models highlights the central involvement of the transcription factor early growth response-1 (EGR-1) in prostate carcinoma progression. It is unknown, however, whether knockdown of EGR-1 inhibits IL-8 production and IL-8-mediated tumor metastasis. Here we show that EGR-1 knockdown by a specific shRNA-Egr1 inhibited gene transcription and production of IL-8 by the human prostate cancer cell line DU145. Conversely, enforced expression of EGR-1 in EGR-1-lacking PC3 prostate cancer cells markedly enhanced IL-8 transcription and secretion. By using wild type and a series of mutant IL-8 promoter luciferase constructs, we found that the NF-kappa B binding site is important for EGR-1 regulation of IL-8. Furthermore, silencing EGR-1 suppressed a synergistically functional interaction between EGR-1 and NF-kappa B. Consequently, knockdown of EGR-1 inhibited IL-8-mediated tumor colony formation and invasion. Thus, targeted knockdown of EGR-1 could be an effective therapeutic approach against prostate cancer.	[Xiao, Weihua] Univ Sci & Technol China, Inst Immunol, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Xiao, WH (corresponding author), Univ Sci & Technol China, Inst Immunol, Sch Life Sci, 443 Huangshan Rd, Hefei 230027, Anhui, Peoples R China.	xiaow@ustc.edu.cn	薛, 挺/D-4799-2011; Xiao, Weihua/N-2775-2013; Sun, Baolin/C-8354-2014	薛, 挺/0000-0002-5644-6613; Xiao, Weihua/0000-0001-9102-6326; Sun, Baolin/0000-0002-2896-3015	National Natural Science Foundation of China [30771973, 30721002]; National Basic Research Program of China (973 Program) [2007CB914503]; Ministry of Science and Technology of China [KSCX1-YW-R-58, KJCX2-YW-N38]; China Ministry of Education [20060358019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); China Ministry of Education(Ministry of Education, China)	This work was supported in part by grants from the National Natural Science Foundation of China (30771973, 30721002), National Basic Research Program of China (973 Program) (2007CB914503), Ministry of Science and Technology of China (KSCX1-YW-R-58 and KJCX2-YW-N38), and China Ministry of Education (20060358019).	Ahmed MM, 2001, AM J CLIN ONCOL-CANC, V24, P500, DOI 10.1097/00000421-200110000-00017; Araki S, 2007, CANCER RES, V67, P6854, DOI 10.1158/0008-5472.CAN-07-1162; Baron V, 2003, ANN NY ACAD SCI, V1002, P197, DOI 10.1196/annals.1281.024; Chapman NR, 2000, J BIOL CHEM, V275, P4719, DOI 10.1074/jbc.275.7.4719; Cogswell PC, 1997, J EXP MED, V185, P491, DOI 10.1084/jem.185.3.491; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Decker EL, 1998, J BIOL CHEM, V273, P26923, DOI 10.1074/jbc.273.41.26923; Eid MA, 1998, CANCER RES, V58, P2461; Ferrer FA, 1998, UROLOGY, V51, P161, DOI 10.1016/S0090-4295(97)00491-3; Huang JT, 2005, AM J PATHOL, V166, P1807, DOI 10.1016/S0002-9440(10)62490-X; Inoue K, 2000, CLIN CANCER RES, V6, P2104; Lehrer S, 2004, TECHNOL CANCER RES T, V3, P411, DOI 10.1177/153303460400300501; Lentsch Alex B, 2006, Future Oncol, V2, P651, DOI 10.2217/14796694.2.5.651; Liu CT, 1998, CANCER GENE THER, V5, P3; MacManus CF, 2007, MOL CANCER RES, V5, P737, DOI 10.1158/1541-7786.MCR-07-0032; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Moon Y, 2007, BIOCHEM BIOPH RES CO, V362, P256, DOI 10.1016/j.bbrc.2007.07.168; Moore BB, 1999, AM J PATHOL, V154, P1503, DOI 10.1016/S0002-9440(10)65404-1; Mora GR, 2005, PROSTATE, V63, P198, DOI 10.1002/pros.20153; Murphy C, 2005, CLIN CANCER RES, V11, P4117, DOI 10.1158/1078-0432.CCR-04-1518; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Salah Z, 2007, CANCER RES, V67, P9835, DOI 10.1158/0008-5472.CAN-07-1886; Seaton A, 2008, CARCINOGENESIS, V29, P1148, DOI 10.1093/carcin/bgn109; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thigpen AE, 1996, J UROLOGY, V155, P975, DOI 10.1016/S0022-5347(01)66361-4; Uehara H, 2005, PROSTATE, V64, P40, DOI 10.1002/pros.20223; Uzzo RG, 2006, CARCINOGENESIS, V27, P1980, DOI 10.1093/carcin/bgl034; Veltri RW, 1999, UROLOGY, V53, P139, DOI 10.1016/S0090-4295(98)00455-5; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Waugh DJJ, 2008, FRONT BIOSCI, V13, P4595, DOI 10.2741/3025; Xiao DM, 2005, CANCER RES, V65, P9934, DOI 10.1158/0008-5472.CAN-05-1830; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8	33	57	62	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34600	34606		10.1074/jbc.M109.016246	http://dx.doi.org/10.1074/jbc.M109.016246			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19837667	Green Published, hybrid			2022-12-25	WOS:000272439600015
J	Tanner, DR; Cariello, DA; Woolstenhulme, CJ; Broadbent, MA; Buskirk, AR				Tanner, Douglas R.; Cariello, Daniel A.; Woolstenhulme, Christopher J.; Broadbent, Mark A.; Buskirk, Allen R.			Genetic Identification of Nascent Peptides That Induce Ribosome Stalling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-MESSENGER-RNA; PROLYL-TRANSFER-RNA; ESCHERICHIA-COLI; TRANSLATION ARREST; TRANSFERASE CENTER; TRYPTOPHAN INDUCTION; RARE CODONS; AMINO-ACID; A-SITE; SECM	Several nascent peptides stall ribosomes during their own translation in both prokaryotes and eukaryotes. Leader peptides that induce stalling can regulate downstream gene expression. Interestingly, stalling peptides show little sequence similarity and interact with the ribosome through distinct mechanisms. To explore the scope of regulation by stalling peptides and to better understand the mechanism of stalling, we identified and characterized new examples from random libraries. We created a genetic selection that ties the life of Escherichia coli cells to stalling at a specific site. This selection relies on the natural bacterial system that rescues arrested ribosomes. We altered transfer-messenger RNA, a key component of this rescue system, to direct the completion of a necessary protein if and only if stalling occurs. We identified three classes of stalling peptides: C-terminal Pro residues, SecM-like peptides, and the novel stalling sequence FXXYXIWPP. Like the leader peptides SecM and TnaC, the FXXYXIWPP peptide induces stalling efficiently by inhibiting peptidyl transfer. The nascent peptide exit tunnel and peptidyltransferase center are implicated in this stalling event, although mutations in the ribosome affect stalling on SecM and FXXYXIWPP differently. We conclude that ribosome stalling can be caused by numerous sequences and is more common than previously believed.	[Tanner, Douglas R.; Cariello, Daniel A.; Woolstenhulme, Christopher J.; Broadbent, Mark A.; Buskirk, Allen R.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Brigham Young University	Buskirk, AR (corresponding author), Brigham Young Univ, Dept Chem & Biochem, C203 BNSN, Provo, UT 84602 USA.	buskirk@chem.byu.edu			National Institutes of Health [GM77633]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077633] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM77633 (to A. B.).	Beringer M, 2008, RNA, V14, P795, DOI 10.1261/rna.980308; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; Butkus ME, 2003, J BACTERIOL, V185, P6719, DOI 10.1128/JB.185.22.6719-6722.2003; Collier J, 2004, J BIOL CHEM, V279, P54193, DOI 10.1074/jbc.M314012200; CRAIGEN WJ, 1986, NATURE, V322, P273, DOI 10.1038/322273a0; Cruz-Vera LR, 2006, P NATL ACAD SCI USA, V103, P3598, DOI 10.1073/pnas.0600082103; Cruz-Vera LR, 2005, MOL CELL, V19, P333, DOI 10.1016/j.molcel.2005.06.013; Cruz-Vera LR, 2007, J BACTERIOL, V189, P3140, DOI 10.1128/JB.01869-06; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; Gabashvili IS, 2001, MOL CELL, V8, P181, DOI 10.1016/S1097-2765(01)00293-3; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Gong F, 2001, J BIOL CHEM, V276, P1974, DOI 10.1074/jbc.M008892200; Gurvich OL, 2003, EMBO J, V22, P5941, DOI 10.1093/emboj/cdg561; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; HENTZEN D, 1972, BIOCHIM BIOPHYS ACTA, V281, P228, DOI 10.1016/0005-2787(72)90174-8; Janzen DM, 2002, MOL CELL BIOL, V22, P8562, DOI 10.1128/MCB.22.24.8562-8570.2002; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Li X, 2006, RNA, V12, P248, DOI 10.1261/rna.2212606; Lovett PS, 1996, MICROBIOL REV, V60, P366, DOI 10.1128/MMBR.60.2.366-385.1996; Miller J.H., 1972, EXPT MOL GENETICS; Mitra K, 2006, MOL CELL, V22, P533, DOI 10.1016/j.molcel.2006.05.003; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; MOTTAGUITABAR S, 1994, EMBO J, V13, P249, DOI 10.1002/j.1460-2075.1994.tb06255.x; Muto H, 2008, BIOCHEM BIOPH RES CO, V366, P1043, DOI 10.1016/j.bbrc.2007.12.072; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Oliver D, 1998, J BACTERIOL, V180, P5240, DOI 10.1128/JB.180.19.5240-5242.1998; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; POOLE ES, 1995, EMBO J, V14, P151, DOI 10.1002/j.1460-2075.1995.tb06985.x; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Sunohara T, 2004, J BIOL CHEM, V279, P15368, DOI 10.1074/jbc.M312805200; Tanner DR, 2006, J BIOL CHEM, V281, P10561, DOI 10.1074/jbc.M600167200; Tenson T, 2002, CELL, V108, P591, DOI 10.1016/S0092-8674(02)00669-4; Thanaraj TA, 1996, PROTEIN SCI, V5, P1594, DOI 10.1002/pro.5560050814; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Vazquez-Laslop N, 2008, MOL CELL, V30, P190, DOI 10.1016/j.molcel.2008.02.026; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Woolhead CA, 2006, MOL CELL, V22, P587, DOI 10.1016/j.molcel.2006.05.021; Yap MN, 2009, MOL CELL, V34, P201, DOI 10.1016/j.molcel.2009.04.002	47	76	78	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34809	34818		10.1074/jbc.M109.039040	http://dx.doi.org/10.1074/jbc.M109.039040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840930	Green Published, hybrid			2022-12-25	WOS:000272439600036
J	Tariq, M; Memon, M; Jafferani, A; Shoukat, S; Gowani, SA; Nusrat, R; Riaz, M; Patel, J; Jamil, B; Smego, RA				Tariq, Muhammad; Memon, Murtaza; Jafferani, Asif; Shoukat, Sana; Gowani, Saqib Ali; Nusrat, Rabeeya; Riaz, Mehmood; Patel, Junaid; Jamil, Bushra; Smego, Raymond A., Jr.			Massive Fluid Requirements and an Unusual BUN/Creatinine Ratio for Pre-Renal Failure in Patients with Cholera	PLOS ONE			English	Article							VIBRIO-CHOLERAE; DIAGNOSIS; DIARRHEA; THERAPY	Background: Cholera is an important infectious cause of secretory diarrhea. The primary symptom of infection is the sudden onset of watery diarrhea with subsequent volume depletion causing renal insufficiency. The objective of this research is to study the level of dehydration at presentation and subsequent fluid management in patients with cholera. Methods: This study was conducted on 191 patients of Cholera admitted at a tertiary care hospital in Karachi, Pakistan during the period of 5 years. Medical charts were evaluated retrospectively for initial hydration status, baseline lab investigations on admission and discharge and fluid therapy given to all the patients while their stay in the hospital and the data was analyzed on SPSS 15.0. Results: Out of the 191 patients, 83(43%) were males and 108 (57%) were females with mean age of 42.3 years (SD +/- 18.34). The average duration of symptoms was 3.75 days (SD +/- 2.04). Of 191 patients, 175 (92.1%) presented with dehydration, 80 (42.3%) were given Ringer's Lactate (R/L) + Normal Saline (N/S), 45 (24%) patients were given R/L + N/S + Oral Rehydration Therapy (ORS), 27 (14.3%) of the patients were kept on R/L only and remaining were given various combinations of R/L, N/S, ORS and Dextrose Saline (D/S). On admission mean Blood Urea Nitrogen (BUN) was 24.54 (SD +/- 16.6), mean creatinine was 2.47 (SD +/- 2.35) and mean BUN/Creatinine ratio was 11.63 (SD +/- 5.7). Conclusion: Aggressive fluid rehydration remains the cornerstone of management of cholera. Instead of presenting with a classical BUN/Creatinine ratio of. 20: 1, patients with pre-renal failure in cholera may present with a BUN/Creatinine ratio of, <5:1.			Tariq, M (corresponding author), Aga Khan Univ, Dept Med, Karachi, Pakistan.	asifahsan_ali@yahoo.co.uk						Albert J, 1999, HUNTERS TROPICAL MED, V8th, P323; [Anonymous], MAN PAT CHOL; Baumann P., 1984, BERGEYS MANUAL SYSTE, P518; Carvounis CP, 2002, KIDNEY INT, V62, P2223, DOI 10.1046/j.1523-1755.2002.00683.x; CASH RA, 1974, J INFECT DIS, V129, P45, DOI 10.1093/infdis/129.1.45; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; GOH KT, 1987, T ROY SOC TROP MED H, V81, P230, DOI 10.1016/0035-9203(87)90223-9; Guerrant RL, 2003, CLIN INFECT DIS, V37, P398, DOI 10.1086/376619; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Le vine MM, 1981, ACUTE ENTERIC INFECT, P443; LENCER WI, 1992, J CELL BIOL, V117, P1197, DOI 10.1083/jcb.117.6.1197; Morris JG, 2003, CLIN INFECT DIS, V37, P272, DOI 10.1086/375600; RAMAMURTHY T, 1993, J CLIN MICROBIOL, V31, P3068, DOI 10.1128/JCM.31.11.3068-3070.1993; SAFRIN S, 1988, REV INFECT DIS, V10, P1012; STEFFEN R, 1986, REV INFECT DIS, V8, pS122	16	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7552	10.1371/journal.pone.0007552	http://dx.doi.org/10.1371/journal.pone.0007552			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855842	gold, Green Published			2022-12-25	WOS:000271147200005
J	Doucet, S; Soussignan, R; Sagot, P; Schaal, B				Doucet, Sebastien; Soussignan, Robert; Sagot, Paul; Schaal, Benoist			The Secretion of Areolar (Montgomery's) Glands from Lactating Women Elicits Selective, Unconditional Responses in Neonates	PLOS ONE			English	Article							BREAST-FEEDING BEHAVIOR; AUTONOMIC RESPONSES; MAMMARY PHEROMONE; RISK-FACTORS; HUMAN-MILK; HEART-RATE; ODOR; NEWBORNS; PERCEPTION; FEMALES	Background: The communicative meaning of human areolae for newborn infants was examined here in directly exposing 3-day old neonates to the secretion from the areolar glands of Montgomery donated by non related, non familiar lactating women. Methodology/Principal Findings: The effect of the areolar stimulus on the infants' behavior and autonomic nervous system was compared to that of seven reference stimuli originating either from human or non human mammalian sources, or from an arbitrarily-chosen artificial odorant. The odor of the native areolar secretion intensified more than all other stimuli the infants' inspiratory activity and appetitive oral responses. These responses appeared to develop independently from direct experience with the breast or milk. Conclusion/Significance: Areolar secretions from lactating women are especially salient to human newborns. Volatile compounds carried in these substrates are thus in a position to play a key role in establishing behavioral and physiological processes pertaining to milk transfer and production, and, hence, to survival and to the early engagement of attachment and bonding.			Doucet, S (corresponding author), Univ Bourgogne, Dev Ethol & Cognit Psychol Grp, Ctr Europeen Sci Gout, CNRS,UMR 5170, Dijon, France.	schaal@cesg.cnrs.fr						ALBONE ES, 1984, MAMMALIAN SEMIOCHEMI, P360; Allam MDE, 2006, INFANT BEHAV DEV, V29, P308, DOI 10.1016/j.infbeh.2005.12.008; Bengtsson S, 2001, NEUROREPORT, V12, P2027, DOI 10.1097/00001756-200107030-00048; Bingham PM, 2003, ARCH PEDIAT ADOL MED, V157, P72, DOI 10.1001/archpedi.157.10.1031; Carskadon MA, 2004, SLEEP, V27, P402; CLARKSON MG, 1983, CHILD DEV, V54, P162, DOI 10.1111/j.1467-8624.1983.tb00345.x; COOPER WO, 1995, PEDIATRICS, V96, P957; DECHATEAU P, 1977, DEV MED CHILD NEUROL, V19, P575; Dewey KG, 2003, PEDIATRICS, V112, P607, DOI 10.1542/peds.112.3.607; DOUCET S, AREOLAR GLANDS UNPUB; Doucet S, 2007, DEV PSYCHOBIOL, V49, P129, DOI 10.1002/dev.20210; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; ENGEN T, 1963, J COMP PHYSIOL PSYCH, V56, P73, DOI 10.1037/h0043633; GRAF MV, 1984, J CLIN ENDOCR METAB, V59, P127, DOI 10.1210/jcem-59-1-127; GRAHAM FK, 1966, PSYCHOL BULL, V65, P305, DOI 10.1037/h0023258; INSEL TR, 1990, MAMMALIAN PARENTING, P260, DOI DOI 10.1111/J.1749-6632.1992.TB34350.X; Kevern EB, 1990, MAMMALIAN PARENTING, P281; Kruzel ML, 2001, J MOL NEUROSCI, V17, P379, DOI 10.1385/JMN:17:3:379; Macfarlane A, 1975, Ciba Found Symp, P103; MAKIN JW, 1989, CHILD DEV, V60, P803, DOI 10.2307/1131020; Marlier L, 2005, CHILD DEV, V76, P155, DOI 10.1111/j.1467-8624.2005.00836.x; Michel MP, 2007, ARCH PEDIATRIE, V14, P454, DOI 10.1016/j.arcped.2007.01.005; Mizuno K, 2004, EARLY HUM DEV, V76, P83, DOI 10.1016/j.earlhumdev.2003.10.003; MODNEY BK, 1990, MAMMALIAN PARENTING, P305; Moncomble AS, 2005, ANIM BEHAV, V69, P29, DOI 10.1016/j.anbehav.2004.05.006; MONTGOMERY WF, 1837, EXPOSITION SIGNS SYM, P344; MORRONGIELLO BA, 1984, CHILD DEV, V55, P461; MORRONGIELLO BA, 1982, INFANT BEHAV DEV, V5, P249, DOI 10.1016/S0163-6383(82)80035-0; Muller-Schwarze D., 2006, CHEM ECOLOGY VERTEBR, P563; NASR AN, 1965, J HISTOCHEM CYTOCHEM, V13, P498, DOI 10.1177/13.6.498; POMERLEAUMALCUIT A, 1975, PSYCHOPHYSIOLOGY, V12, P527, DOI 10.1111/j.1469-8986.1975.tb00041.x; PORGES SW, 1992, BIOL PSYCHOL, V34, P93, DOI 10.1016/0301-0511(92)90012-J; PRECHTL HFR, 1974, BRAIN RES, V76, P185, DOI 10.1016/0006-8993(74)90454-5; Raimbault C, 2007, ACTA PAEDIATR, V96, P368, DOI 10.1111/j.1651-2227.2007.00114.x; RIGHARD L, 1990, LANCET, V336, P1105, DOI 10.1016/0140-6736(90)92579-7; Robson KS, 1973, EARLY HUM DEV, P224; ROVEE CK, 1969, J EXP CHILD PSYCHOL, V7, P245, DOI 10.1016/0022-0965(69)90047-2; RUSSELL MJ, 1976, NATURE, V260, P520, DOI 10.1038/260520a0; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; SCHAAL B, 1988, CHEM SENSES, V13, P145, DOI 10.1093/chemse/13.2.145; Schaal B, 2006, DEV PSYCHOBIOL, V48, P100, DOI 10.1002/dev.20122; Schaal B, 2003, NATURE, V424, P68, DOI 10.1038/nature01739; SCHAAL B, 1980, REPROD NUTR DEV, V20, P843, DOI 10.1051/rnd:19800510; Schaal B, 2000, CHEM SENSES, V25, P729, DOI 10.1093/chemse/25.6.729; Schaal B, 2009, BEHAV BRAIN RES, V200, P346, DOI 10.1016/j.bbr.2009.02.008; Sheu HM, 1999, BRIT J DERMATOL, V140, P385, DOI 10.1046/j.1365-2133.1999.02697.x; SMITH DM, 1982, ARCH PATHOL LAB MED, V106, P60; Soussignan R, 1997, PHYSIOL BEHAV, V62, P745, DOI 10.1016/S0031-9384(97)00187-X; Soussignan R, 1999, DEV PSYCHOBIOL, V35, P3, DOI 10.1002/(SICI)1098-2302(199907)35:1&lt;3::AID-DEV2&gt;3.0.CO;2-F; Stuck BA, 2007, SLEEP, V30, P506, DOI 10.1093/sleep/30.4.506; Sullivan RM, 1998, BIOL NEONATE, V74, P402, DOI 10.1159/000014061; Teschemacher H, 1997, BIOPOLYMERS, V43, P99, DOI [10.1002/(SICI)1097-0282(1997)43:2&lt;99::AID-BIP3&gt;3.0.CO;2-V, 10.1002/(SICI)1097-0282(1997)43:2<99::AID-BIP3>3.3.CO;2-8]; UVNASMOBERG K, 1989, ACTA PHYSIOL SCAND, V136, P41; UvnasMoberg K, 1996, ACTA PAEDIATR, V85, P525, DOI 10.1111/j.1651-2227.1996.tb14078.x; Varendi H, 2001, ACTA PAEDIATR, V90, P372, DOI 10.1080/080352501750126131; Zanardo V, 2001, J PEDIATR GASTR NUTR, V33, P160, DOI 10.1097/00005176-200108000-00012	56	78	81	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7579	10.1371/journal.pone.0007579	http://dx.doi.org/10.1371/journal.pone.0007579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509MQ	19851461	gold, Green Published, Green Submitted			2022-12-25	WOS:000271022300012
J	Lippert, E; Karrasch, T; Sun, XL; Allard, B; Herfarth, HH; Threadgill, D; Jobin, C				Lippert, Elisabeth; Karrasch, Thomas; Sun, Xiaolun; Allard, Brigitte; Herfarth, Hans H.; Threadgill, Deborah; Jobin, Christian			Gnotobiotic IL-10(-/-); NF-kappa B-EGFP Mice Develop Rapid and Severe Colitis Following Campylobacter jejuni Infection	PLOS ONE			English	Article							INTERLEUKIN-10-DEFICIENT MICE; COMMENSAL BACTERIA; ENTERIC BACTERIA; HOST-RESISTANCE; MODEL REVEALS; COLONIZATION; ACTIVATION; INNATE; NOD2; GASTROENTERITIS	Limited information is available on the molecular mechanisms associated with Campylobacter jejuni (C. jejuni) induced food-borne diarrheal illnesses. In this study, we investigated the function of TLR/NF-kappa B signaling in C. jejuni induced pathogenesis using gnotobiotic IL-10(-/-); NF-kappa B EGFP mice. In vitro analysis showed that C. jejuni induced I kappa B phosphorylation, followed by enhanced NF-kappa B transcriptional activity and increased IL-6, MIP-2 alpha and NOD2 mRNA accumulation in infected-mouse colonic epithelial cells CMT93. Importantly, these events were blocked by molecular delivery of an IkB inhibitor (Ad5I kappa BAA). NF-kappa B signalling was also important for C. jejuni-induced cytokine gene expression in bone marrow-derived dendritic cells. Importantly, C. jejuni associated IL-10(-/-); NF-kappa B EGFP mice developed mild (day 5) and severe (day 14) ulcerating colonic inflammation and bloody diarrhea as assessed by colonoscopy and histological analysis. Macroscopic analysis showed elevated EGFP expression indicating NF-kappa B activation throughout the colon of C. jejuni associated IL-10(-/-); NF-kappa B EGFP mice, while fluorescence microscopy revealed EGFP positive cells to be exclusively located in lamina propria mononuclear cells. Pharmacological NF-kappa B inhibition using Bay 11-7085 did not ameliorate C. jejuni induced colonic inflammation. Our findings indicate that C. jejuni induces rapid and severe intestinal inflammation in a susceptible host that correlates with enhanced NF-kappa B activity from lamina propria immune cells.			Lippert, E (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA.	Job@med.unc.edu	Schnoy, Elisabeth/AGS-8375-2022; Herfarth, Hans/K-7547-2019	Sun, Xiaolun/0000-0001-5601-0812	NCRR NIH HHS [P40RR018603, P40 RR018603] Funding Source: Medline; NIDDK NIH HHS [R0I DK 47700, R01 DK 73338, R01 DK073338, P30 DK34987, P30 DK034987, R01 DK047700] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047700, P30DK034987, R01DK073338] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Champion OL, 2008, MICROBES INFECT, V10, P922, DOI 10.1016/j.micinf.2008.05.001; Chang C, 2006, INFECT IMMUN, V74, P5261, DOI 10.1128/IAI.01094-05; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; Dave SH, 2007, J IMMUNOL, V179, P7852, DOI 10.4049/jimmunol.179.11.7852; Dieleman LA, 2000, INFECT IMMUN, V68, P5107, DOI 10.1128/IAI.68.9.5107-5113.2000; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; Feng CG, 2003, J IMMUNOL, V171, P4758, DOI 10.4049/jimmunol.171.9.4758; Fox JG, 2004, INFECT IMMUN, V72, P1116, DOI 10.1128/IAI.72.2.1116-1125.2004; FRIEDMAN CR, 2001, EPIDEMIOLOGY CAMPYLO, P121; Galanis E, 2007, CAN MED ASSOC J, V177, P570, DOI 10.1503/cmaj.070660; GIBSON DL, 2007, CELL MICROBIOL; Haller D, 2002, J BIOL CHEM, V277, P38168, DOI 10.1074/jbc.M205737200; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hofreuter D, 2008, CELL HOST MICROBE, V4, P425, DOI 10.1016/j.chom.2008.10.002; Karrasch T, 2007, J IMMUNOL, V178, P6522, DOI 10.4049/jimmunol.178.10.6522; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Mansfield LS, 2007, INFECT IMMUN, V75, P1099, DOI 10.1128/IAI.00833-06; Mansfield LS, 2008, MICROB PATHOGENESIS, V45, P241, DOI 10.1016/j.micpath.2008.05.010; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Muhlbauer M, 2008, IMMUNOLOGY, V124, P256, DOI 10.1111/j.1365-2567.2007.02763.x; Murphy C, 2006, J APPL MICROBIOL, V100, P623, DOI 10.1111/j.1365-2672.2006.02903.x; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Rath HC, 1999, INFECT IMMUN, V67, P2969, DOI 10.1128/IAI.67.6.2969-2974.1999; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shreeve JE, 2000, AVIAN DIS, V44, P983, DOI 10.2307/1593076; Snelling WJ, 2005, LETT APPL MICROBIOL, V41, P297, DOI 10.1111/j.1472-765X.2005.01788.x; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026; Watson RO, 2007, INFECT IMMUN, V75, P1994, DOI 10.1128/IAI.01216-06; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718	36	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7413	10.1371/journal.pone.0007413	http://dx.doi.org/10.1371/journal.pone.0007413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841748	gold, Green Published, Green Submitted			2022-12-25	WOS:000271012900008
J	Fischer, MD; Huber, G; Beck, SC; Tanimoto, N; Muehlfriedel, R; Fahl, E; Grimm, C; Wenzel, A; Reme, CE; van de Pavert, SA; Wijnholds, J; Pacal, M; Bremner, R; Seeliger, MW				Fischer, M. Dominik; Huber, Gesine; Beck, Susanne C.; Tanimoto, Naoyuki; Muehlfriedel, Regine; Fahl, Edda; Grimm, Christian; Wenzel, Andreas; Reme, Charlotte E.; van de Pavert, Serge A.; Wijnholds, Jan; Pacal, Marek; Bremner, Rod; Seeliger, Mathias W.			Noninvasive, In Vivo Assessment of Mouse Retinal Structure Using Optical Coherence Tomography	PLOS ONE			English	Article							MICE; NRL; DEFICIENT; ORIGIN; RPE65; GENE	Background: Optical coherence tomography (OCT) is a novel method of retinal in vivo imaging. In this study, we assessed the potential of OCT to yield histology-analogue sections in mouse models of retinal degeneration. Methodology/Principal Findings: We achieved to adapt a commercial 3(rd) generation OCT system to obtain and quantify high-resolution morphological sections of the mouse retina which so far required in vitro histology. OCT and histology were compared in models with developmental defects, light damage, and inherited retinal degenerations. In conditional knockout mice deficient in retinal retinoblastoma protein Rb, the gradient of Cre expression from center to periphery, leading to a gradual reduction of retinal thickness, was clearly visible and well topographically quantifiable. In Nrl knockout mice, the layer involvement in the formation of rosette-like structures was similarly clear as in histology. OCT examination of focal light damage, well demarcated by the autofluorescence pattern, revealed a practically complete loss of photoreceptors with preservation of inner retinal layers, but also more subtle changes like edema formation. In Crb1 knockout mice (a model for Leber's congenital amaurosis), retinal vessels slipping through the outer nuclear layer towards the retinal pigment epithelium (RPE) due to the lack of adhesion in the subapical region of the photoreceptor inner segments could be well identified. Conclusions/Significance: We found that with the OCT we were able to detect and analyze a wide range of mouse retinal pathology, and the results compared well to histological sections. In addition, the technique allows to follow individual animals over time, thereby reducing the numbers of study animals needed, and to assess dynamic processes like edema formation. The results clearly indicate that OCT has the potential to revolutionize the future design of respective short- and long-term studies, as well as the preclinical assessment of therapeutic strategies.			Fischer, MD (corresponding author), Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Div Ocular Neurodegenerat, Tubingen, Germany.	see@uni-tuebingen.de	Bremner, Rod/I-6490-2012; van de Pavert, Serge A./A-7307-2008; Wijnholds, Jan/V-3896-2018	Bremner, Rod/0000-0001-9184-7212; van de Pavert, Serge A./0000-0002-7147-4380; Wijnholds, Jan/0000-0003-0099-460X; Grimm, Christian/0000-0001-9318-4352				Barthelmes D, 2008, INVEST OPHTH VIS SCI, V49, P3529, DOI 10.1167/iovs.07-1320; Baumer N, 2002, DEVELOPMENT, V129, P4535; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Chen D, 2007, PLOS BIOL, V5, P1504, DOI 10.1371/journal.pbio.0050179; Edelhauser HF, 2008, INVEST OPHTH VIS SCI, V49, P4712, DOI 10.1167/iovs.08-1904; Feathers KL, 2008, INVEST OPHTH VIS SCI, V49, P1126, DOI 10.1167/iovs.07-1234; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; Kim JT, 2008, PLANT PATHOLOGY J, V24, P17, DOI 10.5423/PPJ.2008.24.1.017; KIM KH, 2008, J VIS, V24, P1; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Samardzija M, 2006, FASEB J, V20, P2411, DOI 10.1096/fj.06-5895fje; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; van de Pavert SA, 2007, GLIA, V55, P1486, DOI 10.1002/glia.20561; Wang NK, 2009, BRIT J OPHTHALMOL, V93, P1234, DOI 10.1136/bjo.2008.153577; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wenzel A, 2007, INVEST OPHTH VIS SCI, V48, P534, DOI 10.1167/iovs.06-0652; Wolf-Schnurrbusch UEK, 2008, INVEST OPHTH VIS SCI, V49, P3095, DOI 10.1167/iovs.07-1460; Xu J, 2009, INVEST OPHTH VIS SCI, V50, P2989, DOI 10.1167/iovs.08-2542	21	162	170	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7507	10.1371/journal.pone.0007507	http://dx.doi.org/10.1371/journal.pone.0007507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838301	Green Published, Green Submitted, gold			2022-12-25	WOS:000270880900010
J	Klimczak, RR; Koerber, JT; Dalkara, D; Flannery, JG; Schaffer, DV				Klimczak, Ryan R.; Koerber, James T.; Dalkara, Deniz; Flannery, John G.; Schaffer, David V.			A Novel Adeno-Associated Viral Variant for Efficient and Selective Intravitreal Transduction of Rat Muller Cells	PLOS ONE			English	Article							RETINAL-DETACHMENT; VISUAL FUNCTION; GENE-TRANSFER; VIRUS; VECTOR; THERAPY; ASTROCYTES; TROPISM; BINDING; VISION	Background: The pathologies of numerous retinal degenerative diseases can be attributed to a multitude of genetic factors, and individualized treatment options for afflicted patients are limited and cost-inefficient. In light of the shared neurodegenerative phenotype among these disorders, a safe and broad-based neuroprotective approach would be desirable to overcome these obstacles. As a result, gene delivery of secretable-neuroprotective factors to Muller cells, a type of retinal glia that contacts all classes of retinal neurons, represents an ideal approach to mediate protection of the entire retina through a simple and innocuous intraocular, or intravitreal, injection of an efficient vehicle such as an adeno-associated viral vector (AAV). Although several naturally occurring AAV variants have been isolated with a variety of tropisms, or cellular specificities, these vectors inefficiently infect Muller cells via intravitreal injection. Methodology/Principal Findings: We have previously applied directed evolution to create several novel AAV variants capable of efficient infection of both rat and human astrocytes through iterative selection of a panel of highly diverse AAV libraries. Here, in vivo and in vitro characterization of these isolated variants identifies a previously unreported AAV variant ShH10, closely related to AAV serotype 6 (AAV6), capable of efficient, selective Muller cell infection through intravitreal injection. Importantly, this new variant shows significantly improved transduction relative to AAV2 (>60%) and AAV6. Conclusions/Significance: Our findings demonstrate that AAV is a highly versatile vector capable of powerful shifts in tropism from minor sequence changes. This isolated variant represents a new therapeutic vector to treat retinal degenerative diseases through secretion of neuroprotective factors from Muller cells as well as provides new opportunities to study their biological functions in the retina.			Klimczak, RR (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	flannery@berkeley.edu; schaffer@berkeley.edu	Dalkara, Deniz/D-5057-2017	Dalkara, Deniz/0000-0003-4112-9321; Flannery, John/0000-0002-0720-8897	NEI NIH HHS [PN2 EY018241] Funding Source: Medline; NHLBI NIH HHS [R01HL081527, R01 HL081527] Funding Source: Medline; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081527] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBOTT NJ, 2006, BLOOD BRAIN BARRIERS, P189; Aleman TS, 2008, INVEST OPHTH VIS SCI, V49, P1580, DOI 10.1167/iovs.07-1110; Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Balazs E.A., 1982, AGING HUMAN VISUAL F, P45; BAME KJ, 1991, J BIOL CHEM, V266, P10287; Bartlett JS, 1998, HUM GENE THER, V9, P1181, DOI 10.1089/hum.1998.9.8-1181; Bartlett JS, 2000, J VIROL, V74, P2777, DOI 10.1128/JVI.74.6.2777-2785.2000; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CHIORINI J, 2009, MOL THER, V17; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Ciulla TA, 2009, CURR OPIN OPHTHALMOL, V20, P158, DOI 10.1097/ICU.0b013e32832d25b3; DALKARA D, 2009, MOL THER        0811; Ding W, 2005, GENE THER, V12, P873, DOI 10.1038/sj.gt.3302527; DORRELL MI, 2009, J CLIN INVEST   0202; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; Goodyear MJ, 2009, VISUAL NEUROSCI, V26, P159, DOI 10.1017/S0952523809090038; Halbert CL, 2000, J VIROL, V74, P1524, DOI 10.1128/JVI.74.3.1524-1532.2000; Hauck SM, 2003, GLIA, V44, P251, DOI 10.1002/glia.10292; Hellstrom M, 2009, GENE THER, V16, P521, DOI 10.1038/gt.2008.178; Jacobson SG, 2009, INVEST OPHTH VIS SCI, V50, P2368, DOI 10.1167/iovs.08-2696; Jacobson SG, 2009, INVEST OPHTH VIS SCI, V50, P1886, DOI 10.1167/iovs.08-3122; Koerber JT, 2008, MOL THER, V16, P1703, DOI 10.1038/mt.2008.167; KOERBER JT, 2009, MOL THER        0811; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Li QH, 2008, MOL VIS, V14, P1760; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Lupien CB, 2007, MOL VIS, V13, P1828; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; MERIGAN WH, 2008, ARVO ABSTR E, V4514; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Nakazawa T, 2006, MOL VIS, V12, P867; Park TK, 2009, GENE THER, V16, P916, DOI 10.1038/gt.2009.61; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Sakurai E, 2001, OPHTHALMIC RES, V33, P31, DOI 10.1159/000055638; Salmina AB, 2009, J ALZHEIMERS DIS, V16, P485, DOI 10.3233/JAD-2009-0988; Thomas CE, 2004, J VIROL, V78, P3110, DOI 10.1128/JVI.78.6.3110-3122.2004; Trivino A, 1996, VISION RES, V36, P2015, DOI 10.1016/0042-6989(95)00317-7; Wolf G, 2004, NUTR REV, V62, P283; Wu Z, 2006, J VIROL, V80, P11393, DOI 10.1128/JVI.01288-06; Wu ZJ, 2006, J VIROL, V80, P9093, DOI 10.1128/JVI.00895-06; Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899	46	122	145	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7467	10.1371/journal.pone.0007467	http://dx.doi.org/10.1371/journal.pone.0007467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826483	Green Published, gold, Green Submitted			2022-12-25	WOS:000270808700023
J	Moretti, A; Bellin, M; Jung, CB; Thies, TM; Takashima, Y; Bernshausen, A; Schiemann, M; Fischer, S; Moosmang, S; Smith, AG; Lam, JT; Laugwitz, KL				Moretti, Alessandra; Bellin, Milena; Jung, Christian B.; Thies, Tu-Mai; Takashima, Yasuhiro; Bernshausen, Alexandra; Schiemann, Matthias; Fischer, Stefanie; Moosmang, Sven; Smith, Austin G.; Lam, Jason T.; Laugwitz, Karl-Ludwig			Mouse and human induced pluripotent stem cells as a source for multipotent Isl1(+) cardiovascular progenitors	FASEB JOURNAL			English	Article						iPS cells; reprogramming; cardiac development; regenerative medicine	SMOOTH-MUSCLE; FIBROBLASTS; GENERATION; DIFFERENTIATION; EXPRESSION; INDUCTION; CARDIOMYOCYTE; LESSONS; MURINE	Ectopic expression of defined sets of genetic factors can reprogram somatic cells to create induced pluripotent stem (iPS) cells. The capacity to direct human iPS cells to specific differentiated lineages and to their progenitor populations can be used for disease modeling, drug discovery, and eventually autologous cell replacement therapies. During mouse cardiogenesis, the major lineages of the mature heart, cardiomyocytes, smooth muscle cells, and endothelial cells arise from a common, multipotent cardiovascular progenitor expressing the transcription factors Isl1 and Nkx2.5. Here we show, using genetic fate-mapping, that Isl1(+) multipotent cardiovascular progenitors can be generated from mouse iPS cells and spontaneously differentiate in all 3 cardiovascular lineages in vivo without teratoma. Moreover, we report the identification of human iPS-derived ISL1(+) progenitors with similar developmental potential. These results support the possibility to use patient-specific iPS-generated cardiovascular progenitors as a model to elucidate the pathogenesis of congenital and acquired forms of heart diseases.-Moretti, A., Bellin, M., Jung, C. B., Thies, T.-M., Takashima, Y., Bernshausen, A., Schiemann, M., Fischer, S., Moosmang, S., Smith, A. G., Lam, J. T., Laugwitz, K.-L. Mouse and human induced pluripotent stem cells as a source for multipotent Isl1(+) cardiovascular progenitors. FASEB J. 24, 700-711 (2010). www.fasebj.org	[Moretti, Alessandra; Bellin, Milena; Jung, Christian B.; Thies, Tu-Mai; Bernshausen, Alexandra; Lam, Jason T.; Laugwitz, Karl-Ludwig] Tech Univ Munich, Klinikum Rechts Isar, Dept Med, D-81675 Munich, Germany; [Moretti, Alessandra; Bellin, Milena; Jung, Christian B.; Thies, Tu-Mai; Bernshausen, Alexandra; Lam, Jason T.; Laugwitz, Karl-Ludwig] Tech Univ Munich, Deutsch Herzzentrum, Dept Med, D-81675 Munich, Germany; [Schiemann, Matthias] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Fischer, Stefanie; Moosmang, Sven] Tech Univ Munich, Inst Pharmacol, D-81675 Munich, Germany; [Takashima, Yasuhiro; Smith, Austin G.] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge, England	Technical University of Munich; German Heart Center Berlin; German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Cambridge	Lam, JT (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Dept Med, Ismaninger Str 22, D-81675 Munich, Germany.	jtlam@med1.med.tum.de; klaugwitz@med1.med.tum.de	Moretti, Alessandra/O-9271-2015; Bellin, Milena/M-2311-2014	Moretti, Alessandra/0000-0001-5782-7832; Bellin, Milena/0000-0001-5380-6743; Smith, Austin/0000-0002-3029-4682	European Research Council [MEXT-23208]; German Research Foundation [La 1238 3-1/4-1]; German Ministry for Education and Research [01 GN 0826]; MRC [G0800784, G1001028, G9806702] Funding Source: UKRI; Medical Research Council [G0800784, G1001028, G9806702, G0800784B] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); German Research Foundation(German Research Foundation (DFG)); German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Toshio Kitamura (University of Tokyo, Tokyo, Japan), Shinya Yamanaka (Kyoto University, Kyoto, Japan), and George Daley (Harvard Medical School, Boston, MA, USA) for providing viral vectors through Addgene. Some of the monoclonal antibodies were obtained from the Developmental Studies Hybridoma Bank, which was developed under the auspices of the National Institute Human Development and is maintained by the University of Iowa. The authors especially acknowledge K. Goetsch for her expertise in the FACS sorting analysis and M. Rudelius and D. Grewe for assistance in histology. This work was supported by a Marie Curie Excellence Team Grant from the European Research Council (MEXT-23208), the German Research Foundation (La 1238 3-1/4-1), and the German Ministry for Education and Research (01 GN 0826).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Laugwitz KL, 2008, DEVELOPMENT, V135, P193, DOI 10.1242/dev.001883; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Leschik J, 2008, NAT PROTOC, V3, P1381, DOI 10.1038/nprot.2008.116; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Moretti A, 2007, CELL MOL LIFE SCI, V64, P674, DOI 10.1007/s00018-007-6520-5; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; ORKIN SH, 1992, BLOOD, V80, P575; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Rubart M, 2006, ANNU REV PHYSIOL, V68, P29, DOI 10.1146/annurev.physiol.68.040104.124530; SASAKI H, 1993, DEVELOPMENT, V118, P47; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Schwahn DJ, 2005, PIGM CELL RES, V18, P203, DOI 10.1111/j.1600-0749.2005.00229.x; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S., 2001, BMC DEV BIOL, V1; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Sun YF, 2007, DEV BIOL, V304, P286, DOI 10.1016/j.ydbio.2006.12.048; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu SM, 2008, CELL, V132, P537, DOI 10.1016/j.cell.2008.02.002; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	53	88	98	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2010	24	3					700	711		10.1096/fj.09-139477	http://dx.doi.org/10.1096/fj.09-139477			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	561KE	19850773				2022-12-25	WOS:000274974600006
J	Forrester, MT; Seth, D; Hausladen, A; Eyler, CE; Foster, MW; Matsumoto, A; Benhar, M; Marshall, HE; Stamler, JS				Forrester, Michael T.; Seth, Divya; Hausladen, Alfred; Eyler, Christine E.; Foster, Matthew W.; Matsumoto, Akio; Benhar, Moran; Marshall, Harvey E.; Stamler, Jonathan S.			Thioredoxin-interacting Protein (Txnip) Is a Feedback Regulator of S-Nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; RED-BLOOD-CELLS; NITROSATIVE STRESS; OXIDATIVE STRESS; MOLECULAR-WEIGHT; DENITROSYLATION; NITROSOTHIOLS; BINDING; EXPRESSION; NITROSOGLUTATHIONE	Nitric oxide exerts a plethora of biological effects via protein S-nitrosylation, a redox-based reaction that converts a protein Cys thiol to a S-nitrosothiol. However, although the regulation of protein S-nitrosylation has been the subject of extensive study, much less is known about the systems governing protein denitrosylation. Most recently, thioredoxin/thioredoxin reductases were shown to mediate both basal and stimulus-coupled protein denitrosylation. We now demonstrate that protein denitrosylation by thioredoxin is regulated dynamically by thioredoxin-interacting protein (Txnip), a thioredoxin inhibitor. Endogenously synthesized nitric oxide represses Txnip, thereby facilitating thioredoxin-mediated denitrosylation. Autoregulation of denitrosylation thus allows cells to survive nitrosative stress. Our findings reveal that denitrosylation of proteins is dynamically regulated, establish a physiological role for thioredoxin in protection from nitrosative stress, and suggest new approaches to manipulate cellular S-nitrosylation.	[Forrester, Michael T.; Stamler, Jonathan S.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Seth, Divya; Hausladen, Alfred; Foster, Matthew W.; Matsumoto, Akio; Benhar, Moran; Marshall, Harvey E.; Stamler, Jonathan S.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Eyler, Christine E.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Forrester, Michael T.; Eyler, Christine E.] Duke Univ, Med Ctr, Med Scientist Training Program, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Stamler, JS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Box 2612, Durham, NC 27710 USA.	staml001@mc.duke.edu	Benhar, Moran/AAV-5764-2020; Eyler, Christine E/A-2921-2010	Benhar, Moran/0000-0002-7094-3456; Matsumoto, Akio/0000-0002-3402-6992; Stamler, Jonathan/0000-0002-6866-1572	NHLBI NIH HHS [R01 HL092994, R01 HL092994-03] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092994] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Atkuri KR, 2005, P NATL ACAD SCI USA, V102, P3756, DOI 10.1073/pnas.0409910102; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; CHEN KS, 1994, BBA-GENE STRUCT EXPR, V1219, P26, DOI 10.1016/0167-4781(94)90242-9; Chen PF, 1997, J BIOL CHEM, V272, P6114, DOI 10.1074/jbc.272.10.6114; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Diesen DL, 2008, CIRC RES, V103, P545, DOI 10.1161/CIRCRESAHA.108.176867; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Eu JP, 2000, BIOCHEMISTRY-US, V39, P1040, DOI 10.1021/bi992046e; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Forrester MT, 2009, NAT BIOTECHNOL, V27, P557, DOI 10.1038/nbt.1545; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; FOSTER MW, 2009, BIOCHEMISTRY; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hoffmann J, 2001, J BIOL CHEM, V276, P41383, DOI 10.1074/jbc.M107566200; Hwang CY, 2004, ONCOGENE, V23, P8868, DOI 10.1038/sj.onc.1208116; Inoue K, 1999, J BIOL CHEM, V274, P27069, DOI 10.1074/jbc.274.38.27069; Intaglietta M, 1996, CARDIOVASC RES, V32, P632; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Jensen DE, 1998, BIOCHEM J, V331, P659, DOI 10.1042/bj3310659; Junn E, 2000, J IMMUNOL, V164, P6287, DOI 10.4049/jimmunol.164.12.6287; Kim JE, 2004, J BIOL CHEM, V279, P9758, DOI 10.1074/jbc.M312722200; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; Kokkola T, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-21; Kurtz S, 2006, INFECT IMMUN, V74, P6855, DOI 10.1128/IAI.01022-06; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; LYONS CR, 1992, J BIOL CHEM, V267, P6370; Mani K, 2004, J BIOL CHEM, V279, P12918, DOI 10.1074/jbc.M313678200; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; McMahon TJ, 2005, P NATL ACAD SCI USA, V102, P14801, DOI 10.1073/pnas.0506957102; Morrell CN, 2005, P NATL ACAD SCI USA, V102, P3782, DOI 10.1073/pnas.0408310102; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Nozik-Grayck E, 2006, AM J PHYSIOL-LUNG C, V290, pL136, DOI 10.1152/ajplung.00230.2005; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Ozawa K, 2008, MOL CELL, V31, P395, DOI 10.1016/j.molcel.2008.05.024; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Schulze PC, 2006, ARTERIOSCL THROM VAS, V26, P2666, DOI 10.1161/01.ATV.0000248914.21018.f1; Schulze PC, 2002, CIRC RES, V91, P689, DOI 10.1161/01.RES.0000037982.55074.F6; Sengupta R, 2007, BIOCHEMISTRY-US, V46, P8472, DOI 10.1021/bi700449x; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P7674, DOI 10.1073/pnas.89.16.7674; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Stoyanovsky DA, 2005, J AM CHEM SOC, V127, P15815, DOI 10.1021/ja0529135; Tian J, 2008, P NATL ACAD SCI USA, V105, P10537, DOI 10.1073/pnas.0804852105; Tsai AG, 1998, P NATL ACAD SCI USA, V95, P6590, DOI 10.1073/pnas.95.12.6590; Tsikas D, 1999, ANAL BIOCHEM, V270, P231, DOI 10.1006/abio.1999.4084; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Wang GF, 2006, P NATL ACAD SCI USA, V103, P1295, DOI 10.1073/pnas.0508354103; Wang YL, 2002, J BIOL CHEM, V277, P26496, DOI 10.1074/jbc.M202133200; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Xu L, 2008, J BIOL CHEM, V283, P3077, DOI 10.1074/jbc.M705709200; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101	58	65	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36160	36166		10.1074/jbc.M109.057729	http://dx.doi.org/10.1074/jbc.M109.057729			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19847012	Green Published, hybrid			2022-12-25	WOS:000272970500017
J	Suenaga, Y; Ozaki, T; Tanaka, Y; Bu, YQ; Kamijo, T; Tokuhisa, T; Nakagawara, A; Tamura, T				Suenaga, Yusuke; Ozaki, Toshinori; Tanaka, Yuji; Bu, Youquan; Kamijo, Takehiko; Tokuhisa, Takeshi; Nakagawara, Akira; Tamura, Taka-aki			TATA-binding Protein (TBP)-like Protein Is Engaged in Etoposide-induced Apoptosis through Transcriptional Activation of Human TAp63 Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TBP-LIKE PROTEIN; P53 FAMILY; DIFFERENT MECHANISMS; MUTATIONAL ANALYSIS; P63; P73; EXPRESSION; CANCER; TLP/TRF2/TLF; FACTOR-2	Accumulating evidence indicates that TBP (TATA-binding protein)-like protein (TLP) contributes to the regulation of stress-mediated cell cycle checkpoint and apoptotic pathways, although its physiological target genes have remained elusive. In the present study, we have demonstrated that human TAp63 is one of the direct transcriptional target genes of TLP. Enforced expression of TLP results in the transcriptional induction of the endogenous TAp63, but not of the other p53 family members such as TAp73 and p53. Consistent with these results, small interference RNA-mediated knockdown led to a significant down-regulation of the endogenous TAp63. Luciferase reporter assay and chromatin immunoprecipitation analysis revealed that the genomic region located at positions -487 to -29, where +1 represents the transcriptional initiation site of TAp63, is required for TLP-dependent transcriptional activation of TAp63 and also TLP is efficiently recruited onto this region. Additionally, cells treated with anti-cancer drug etoposide underwent apoptosis in association with the transcriptional enhancement of TAp63 in a p53-independent manner, and the knockdown of the endogenous TLP reduced etoposide-induced apoptosis through repression of TAp63 expression. Taken together, our present study identifies a TLP-TAp63 pathway that is further implicated in stress-induced apoptosis.	[Suenaga, Yusuke; Ozaki, Toshinori; Bu, Youquan; Kamijo, Takehiko; Nakagawara, Akira] Chiba Canc Ctr, Res Inst, Div Biochem, Chuoh Ku, Chiba 2608717, Japan; [Suenaga, Yusuke; Tanaka, Yuji; Tamura, Taka-aki] Chiba Univ, Grad Sch Sci, Inage Ku, Chiba 2638522, Japan; [Tokuhisa, Takeshi] Chiba Univ, Grad Sch Med, Dept Dev Genet, Chiba 2608670, Japan	Chiba Cancer Center; Chiba University; Chiba University	Nakagawara, A (corresponding author), Chiba Canc Ctr, Res Inst, Div Biochem, Chuo Ku, 666-2 Nitona, Chiba 2608717, Japan.	akiranak@chiba-cc.jp; ttamura@faculty.chiba-u.jp		Suenaga, Yusuke/0000-0001-6902-5386; Tanaka, Yuji/0000-0003-4494-759X	Ministry of Health, Labor and Welfare for Third Term Comprehensive Control Research for Cancer; Ministry of Education, Culture, Sports, Science and Technology, Japan; Japan Society for the Promotion of Science; Uehara Memorial Foundation and Futaba Corporation; Grants-in-Aid for Scientific Research [20570123, 21390317] Funding Source: KAKEN	Ministry of Health, Labor and Welfare for Third Term Comprehensive Control Research for Cancer; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation and Futaba Corporation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid from the Ministry of Health, Labor and Welfare for Third Term Comprehensive Control Research for Cancer (to A.N.), a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to T.T. and A.N.), a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science (to A.N.), and grants from Uehara Memorial Foundation and Futaba Corporation (to T.T. and A.N.).	Bush SD, 2008, MOL CELL BIOL, V28, P83, DOI 10.1128/MCB.00809-07; Candi E, 2007, CELL CYCLE, V6, P274, DOI 10.4161/cc.6.3.3797; Chong JA, 2005, MOL CELL BIOL, V25, P2632, DOI 10.1128/MCB.25.7.2632-2643.2005; Davidson I, 2003, TRENDS BIOCHEM SCI, V28, P391, DOI 10.1016/S0968-0004(03)00117-8; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gressner O, 2005, EMBO J, V24, P2458, DOI 10.1038/sj.emboj.7600708; Hagiwara K, 1999, CANCER RES, V59, P4165; Ichikawa T, 2008, ONCOGENE, V27, P409, DOI 10.1038/sj.onc.1210658; Koster MI, 2006, CANCER RES, V66, P3981, DOI 10.1158/0008-5472.CAN-06-0027; Lantner F, 2007, BLOOD, V110, P4303, DOI 10.1182/blood-2007-04-087486; Levrero M, 2000, J CELL SCI, V113, P1661; MARTIN DW, 1993, J BIOL CHEM, V268, P13062; Moore PA, 1999, MOL CELL BIOL, V19, P7610; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Nakadai T, 2004, J BIOL CHEM, V279, P7447, DOI 10.1074/jbc.M305412200; Ohbayashi T, 1999, BIOCHEM BIOPH RES CO, V255, P137, DOI 10.1006/bbrc.1999.0159; Ohbayashi T, 2003, NUCLEIC ACIDS RES, V31, P2127, DOI 10.1093/nar/gkg315; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; Osada M, 1998, NAT MED, V4, P839, DOI 10.1038/nm0798-839; Ozaki T, 2005, CANCER SCI, V96, P729, DOI 10.1111/j.1349-7006.2005.00116.x; Park BJ, 2000, CANCER RES, V60, P3370; Park KA, 2006, MOL CELLS, V22, P203; Perletti L, 1999, J BIOL CHEM, V274, P15301, DOI 10.1074/jbc.274.22.15301; Petitjean A, 2005, ONCOGENE, V24, P512, DOI 10.1038/sj.onc.1208215; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Reina JH, 2007, GENE DEV, V21, P2855, DOI 10.1101/gad.1623207; Rocco JW, 2006, CELL CYCLE, V5, P936, DOI 10.4161/cc.5.9.2716; Shimada M, 2003, MOL CELL BIOL, V23, P4107, DOI 10.1128/MCB.23.12.4107-4120.2003; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Sunahara M, 1999, ONCOGENE, V18, P3761, DOI 10.1038/sj.onc.1202972; Teichmann M, 1999, P NATL ACAD SCI USA, V96, P13720, DOI 10.1073/pnas.96.24.13720; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	33	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35433	35440		10.1074/jbc.M109.050047	http://dx.doi.org/10.1074/jbc.M109.050047			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858204	hybrid, Green Published			2022-12-25	WOS:000272645600019
J	Ludlow, MJ; Durai, L; Ennion, SJ				Ludlow, Melanie J.; Durai, Latha; Ennion, Steven J.			Functional Characterization of Intracellular Dictyostelium discoideum P2X Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTRACTILE VACUOLE; ATP SYNTHESIS; CA2+ INFLUX; CHANNELS; CELLS; EXPRESSION; DYNAMICS; SUBUNITS; KINETICS; CURRENTS	Indicative of cell surface P2X ion channel activation, extracellular ATP evokes a rapid and transient calcium influx in the model eukaryote Dictyostelium discoideum. Five P2X-like proteins (dP2XA-E) are present in this organism. However, their roles in purinergic signaling are unclear, because dP2XA proved to have an intracellular localization on the contractile vacuole where it is thought to be required for osmoregulation. To determine functional properties of the remaining four dP2X-like proteins and to assess their cellular roles, we recorded membrane currents from expressed cloned receptors and generated a quintuple knock-out Dictyostelium strain devoid of dP2X receptors. ATP evoked inward currents at dP2XB and dP2XE receptors but not at dP2XC or dP2XD. beta,gamma-Imido-ATP was more potent than ATP at dP2XB but a weak partial agonist at dP2XE. Currents in dP2XB and dP2XE were strongly inhibited by Na+ but insensitive to copper and the P2 receptor antagonists pyridoxal phosphate-6-azophenyl-2', 4'-disulfonic acid and suramin. Unusual for P2X channels, dP2XA and dP2XB were also Cl--permeable. The extracellular purinergic response to ATP persisted in p2xA/B/C/D/E quintuple knock-out Dictyostelium demonstrating that dP2X channels are not responsible. dP2XB, -C, -D, and -E were found to be intracellularly localized to the contractile vacuole with the ligand binding domain facing the lumen. However, quintuple p2xA/B/C/D/E null cells were still capable of regulating cell volume in water demonstrating that, contrary to previous findings, dP2X receptors are not required for osmoregulation. Responses to the calmodulin antagonist calmidazolium, however, were reduced in p2xA/B/C/D/E null cells suggesting that dP2X receptors play a role in intracellular calcium signaling.	[Ludlow, Melanie J.; Durai, Latha; Ennion, Steven J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	University of Leicester	Ennion, SJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Med Sci Bldg,Univ Rd, Leicester LE1 9HN, Leics, England.	se15@le.ac.uk		Ludlow, Melanie/0000-0002-0720-5581	Wellcome Trust [WT081601MA]; Biotechnology and Biological Sciences Research Council [C19146] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust (Project Grant WT081601MA).	Agboh KC, 2004, J BIOL CHEM, V279, P41650, DOI 10.1074/jbc.M408203200; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; Bavan S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-17; Bo XN, 2003, MOL PHARMACOL, V63, P1407, DOI 10.1124/mol.63.6.1407; Burnstock G, 2009, ACTA PHYSIOL, V195, P415, DOI 10.1111/j.1748-1716.2009.01957.x; Clarke M, 2002, J CELL SCI, V115, P2893; COHEN SM, 1986, EMBO J, V5, P3361, DOI 10.1002/j.1460-2075.1986.tb04651.x; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Fischer M, 2004, FEBS LETT, V577, P227, DOI 10.1016/j.febslet.2004.09.084; Fountain SJ, 2008, J BIOL CHEM, V283, P15122, DOI 10.1074/jbc.M801512200; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Kirsten JH, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-71; Kreppel L, 2004, NUCLEIC ACIDS RES, V32, pD332, DOI 10.1093/nar/gkh138; Kuehnel MP, 2009, J CELL SCI, V122, P505, DOI 10.1242/jcs.034207; Kuehnel MP, 2009, J CELL SCI, V122, P499, DOI 10.1242/jcs.034199; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Ludlow MJ, 2008, CELL CALCIUM, V44, P567, DOI 10.1016/j.ceca.2008.04.001; Malchow D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-31; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; MONIAKIS J, 1995, J BIOL CHEM, V270, P28276; Nebl T, 1997, J CELL SCI, V110, P2845; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; Riedel T, 2007, BIOPHYS J, V93, P846, DOI 10.1529/biophysj.106.103614; Roberts JA, 2008, J BIOL CHEM, V283, P20126, DOI 10.1074/jbc.M800294200; Ruppelt A, 2001, J NEUROCHEM, V77, P1256, DOI 10.1046/j.1471-4159.2001.00348.x; Schlatterer C, 1996, BIOCHEM J, V313, P661, DOI 10.1042/bj3130661; Striedinger K, 2007, GLIA, V55, P652, DOI 10.1002/glia.20494; Torres GE, 1999, J BIOL CHEM, V274, P6653, DOI 10.1074/jbc.274.10.6653; Vervoort EB, 2000, NUCLEIC ACIDS RES, V28, P2069, DOI 10.1093/nar/28.10.2069; Wen YJ, 2009, MOL BIOL CELL, V20, P4278, DOI 10.1091/mbc.E09-03-0243	39	24	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35227	35239		10.1074/jbc.M109.045674	http://dx.doi.org/10.1074/jbc.M109.045674			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19833731	hybrid, Green Published			2022-12-25	WOS:000272439600075
J	Samuel, LJ; Latinkic, BV				Samuel, Lee J.; Latinkic, Branko V.			Early Activation of FGF and Nodal Pathways Mediates Cardiac Specification Independently of Wnt/beta-Catenin Signaling	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; MESODERM-INDUCING SIGNALS; EMBRYONIC STEM-CELLS; GROWTH-FACTOR-BETA; XENOPUS-EMBRYOS; HEART DEVELOPMENT; TGF-BETA; TERMINAL DIFFERENTIATION; ANTERIOR ENDODERM; ZEBRAFISH HEART	Background: Cardiac induction, the first step in heart development in vertebrate embryos, is thought to be initiated by anterior endoderm during gastrulation, but what the signals are and how they act is unknown. Several signaling pathways, including FGF, Nodal, BMP and Wnt have been implicated in cardiac specification, in both gain- and loss-of-function experiments. However, as these pathways regulate germ layer formation and patterning, their specific roles in cardiac induction have been difficult to define. Methodology/Principal Findings: To investigate the mechanisms of cardiac induction directly we devised an assay based on conjugates of anterior endoderm from early gastrula stage Xenopus embryos as the inducing tissue and pluripotent ectodermal explants as the responding tissue. We show that the anterior endoderm produces a specific signal, as skeletal muscle is not induced. Cardiac inducing signal needs up to two hours of interaction with the responding tissue to produce an effect. While we found that the BMP pathway was not necessary, our results demonstrate that the FGF and Nodal pathways are essential for cardiogenesis. They were required only during the first hour of cardiogenesis, while sustained activation of ERK was required for at least four hours. Our results also show that transient early activation of the Wnt/beta-catenin pathway has no effect on cardiogenesis, while later activation of the pathway antagonizes cardiac differentiation. Conclusions/Significance: We have described an assay for investigating the mechanisms of cardiac induction by anterior endoderm. The assay was used to provide evidence for a direct, early and transient requirement of FGF and Nodal pathways. In addition, we demonstrate that Wnt/beta-catenin pathway plays no direct role in vertebrate cardiac specification, but needs to be suppressed just prior to differentiation.			Samuel, LJ (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	latinkicb@cf.ac.uk		Latinkic, Branko/0000-0003-4952-123X				Agius E, 2000, DEVELOPMENT, V127, P1173; Alsan BH, 2002, DEVELOPMENT, V129, P1935; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Arai A, 1997, DEV DYNAM, V210, P344, DOI 10.1002/(SICI)1097-0177(199711)210:3<344::AID-AJA13>3.0.CO;2-A; Armes NA, 1997, DEVELOPMENT, V124, P3797; Asashima M, 2009, DEV DYNAM, V238, P1309, DOI 10.1002/dvdy.21979; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; CHAMBERS AE, 1994, GENE DEV, V8, P1324, DOI 10.1101/gad.8.11.1324; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; CORNELL RA, 1995, DEVELOPMENT, V121, P2429; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Dorey K, 2006, DEV BIOL, V292, P303, DOI 10.1016/j.ydbio.2006.01.006; DRYSDALE TA, 1994, DEV BIOL, V165, P432, DOI 10.1006/dbio.1994.1265; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; GURDON JB, 1985, CELL, V41, P913, DOI 10.1016/S0092-8674(85)80072-6; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jones CM, 1999, CURR BIOL, V9, P946, DOI 10.1016/S0960-9822(99)80421-7; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Korol O, 2008, DEV BIOL, V324, P131, DOI 10.1016/j.ydbio.2008.09.012; LABONNE C, 1995, DEVELOPMENT, V121, P1475; LaBonne C, 1997, DEV BIOL, V183, P9, DOI 10.1006/dbio.1996.8497; Ladd AN, 1998, DEV BIOL, V204, P407, DOI 10.1006/dbio.1998.9094; Latinkic BV, 2003, DEVELOPMENT, V130, P3865, DOI 10.1242/dev.00599; LOGAN M, 1993, DEVELOPMENT, V118, P865; Lough J, 2000, DEV DYNAM, V217, P327, DOI 10.1002/(SICI)1097-0177(200004)217:4<327::AID-DVDY1>3.3.CO;2-B; Lough J, 1996, DEV BIOL, V178, P198, DOI 10.1006/dbio.1996.0211; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Marques SR, 2008, DEV BIOL, V321, P397, DOI 10.1016/j.ydbio.2008.06.033; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Movassagh M, 2008, CARDIOVASC RES, V79, P436, DOI 10.1093/cvr/cvn105; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; NASCONE N, 1995, DEVELOPMENT, V121, P515; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Reifers F, 2000, DEVELOPMENT, V127, P225; Reiter JF, 2001, DEV BIOL, V234, P330, DOI 10.1006/dbio.2001.0259; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Schlange T, 2000, MECH DEVELOP, V91, P259, DOI 10.1016/S0925-4773(99)00311-1; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; SCHULTEMERKER S, 1995, CURR BIOL, V5, P62, DOI 10.1016/S0960-9822(95)00017-0; Schultheiss TM, 1997, COLD SPRING HARB SYM, V62, P413; Schultheiss TM, 1995, DEVELOPMENT, V121, P4203; Shi YQ, 2000, DEV BIOL, V224, P226, DOI 10.1006/dbio.2000.9802; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SUDARWAT.S, 1971, ROUX ARCH DEV BIOL, V166, P189, DOI 10.1007/BF00650029; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Walters MJ, 2001, MECH DEVELOP, V100, P263, DOI 10.1016/S0925-4773(00)00535-9; Yatskievych TA, 1997, DEVELOPMENT, V124, P2561; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	62	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7650	10.1371/journal.pone.0007650	http://dx.doi.org/10.1371/journal.pone.0007650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862329	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000271194600021
J	Fan, LJ; Bao, JD; Wang, Y; Yao, JQ; Gui, YJ; Hu, WM; Zhu, JQ; Zeng, MQ; Li, Y; Xu, YB				Fan, Longjiang; Bao, Jiandong; Wang, Yu; Yao, Jianqiang; Gui, Yijie; Hu, Weiming; Zhu, Jinqing; Zeng, Mengqian; Li, Yu; Xu, Yunbi			Post-Domestication Selection in the Maize Starch Pathway	PLOS ONE			English	Article							POPULATION-GENETICS; POSITIVE SELECTION; MOLECULAR EVIDENCE; EVOLUTION; GENES; POLYMORPHISM; MUTATIONS; DIVERSITY; BOTTLENECK; INSIGHTS	Modern crops have usually experienced domestication selection and subsequent genetic improvement (post-domestication selection). Chinese waxy maize, which originated from non-glutinous domesticated maize (Zea mays ssp. mays), provides a unique model for investigating the post-domestication selection of maize. In this study, the genetic diversity of six key genes in the starch pathway was investigated in a glutinous population that included 55 Chinese waxy accessions, and a selective bottleneck that resulted in apparent reductions in diversity in Chinese waxy maize was observed. Significant positive selection in waxy (wx) but not amylose extender1 (ae1) was detected in the glutinous population, in complete contrast to the findings in non-glutinous maize, which indicated a shift in the selection target from ae1 to wx during the improvement of Chinese waxy maize. Our results suggest that an agronomic trait can be quickly improved into a target trait with changes in the selection target among genes in a crop pathway.			Fan, LJ (corresponding author), Zhejiang Univ, Inst Crop Sci, Dept Agron, Hangzhou 310027, Peoples R China.	fanlj@zju.edu.cn	gui, yijiegui@zju.edu.cn/C-9375-2013; Bao, Jiandong/AAG-7303-2020	gui, yijiegui@zju.edu.cn/0000-0002-9201-5212; Bao, Jiandong/0000-0003-3423-5118; Xu, Yunbi/0000-0003-3361-4650; Wang, Zonghua/0000-0002-0869-9683; Wang, Yu/0000-0002-2819-4551; Fan, Longjiang/0000-0003-4846-0500				Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Burger JC, 2008, AM J BOT, V95, P113, DOI 10.3732/ajb.95.2.113; COLLINS GN, 1909, USDA BUR PLANT IND B, V161, P1; Dinges JR, 2001, PLANT PHYSIOL, V125, P1406, DOI 10.1104/pp.125.3.1406; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Fan LJ, 2008, MOL BREEDING, V22, P329, DOI 10.1007/s11032-008-9178-2; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; HUDSON RR, 1987, GENETICS, V116, P153; James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Manicacci D, 2007, J EVOLUTION BIOL, V20, P503, DOI 10.1111/j.1420-9101.2006.01264.x; Nei M., 1987, MOL EVOLUTIONARY GEN; OKAGAKI RJ, 1991, GENETICS, V128, P425; Olsen KM, 2002, GENETICS, V162, P941; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Sang T, 2009, PLANT PHYSIOL, V149, P63, DOI 10.1104/pp.108.128827; Shin JH, 2006, GENOME, V49, P1287, DOI 10.1139/G06-116; TAJIMA F, 1989, GENETICS, V123, P585; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian ML, 2009, GENET RESOUR CROP EV, V56, P247, DOI 10.1007/s10722-008-9360-8; Tian MengLiang, 2008, Acta Agronomica Sinica, V34, P729, DOI 10.3724/SP.J.1006.2008.00729; Tiffin P, 2001, GENETICS, V158, P401; TRACY WF, 2006, CROP SCI, V54, P46; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wright SI, 2005, MOL BIOL EVOL, V22, P506, DOI 10.1093/molbev/msi035; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Yu YC, 2008, PLANT CELL, V20, P2946, DOI 10.1105/tpc.108.060426; Zhang LQ, 2002, GENETICS, V162, P851; Zhao Q, 2008, GENETICS, V178, P2133, DOI 10.1534/genetics.107.085506; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	36	28	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7612	10.1371/journal.pone.0007612	http://dx.doi.org/10.1371/journal.pone.0007612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859548	Green Submitted, Green Published, gold			2022-12-25	WOS:000271147400014
J	Kuchenreuther, JM; Stapleton, JA; Swartz, JR				Kuchenreuther, Jon M.; Stapleton, James A.; Swartz, James R.			Tyrosine, Cysteine, and S-Adenosyl Methionine Stimulate In Vitro [FeFe] Hydrogenase Activation	PLOS ONE			English	Article							IRON-MOLYBDENUM COFACTOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BIOTIN SYNTHASE; ACTIVE-SITE; THERMOTOGA-MARITIMA; THIAZOLE SYNTHASE; PURIFIED PROTEINS; SULFUR CLUSTER; MATURATION	Background: [FeFe] hydrogenases are metalloenzymes involved in the anaerobic metabolism of H(2). These proteins are distinguished by an active site cofactor known as the H-cluster. This unique [6Fe-6S] complex contains multiple non-protein moieties and requires several maturation enzymes for its assembly. The pathways and biochemical precursors for H-cluster biosynthesis have yet to be elucidated. Principal Findings: We report an in vitro maturation system in which, for the first time, chemical additives enhance [FeFe] hydrogenase activation, thus signifying in situ H-cluster biosynthesis. The maturation system is comprised of purified hydrogenase apoprotein; a dialyzed Escherichia coli cell lysate containing heterologous HydE, HydF, and HydG maturases; and exogenous small molecules. Following anaerobic incubation of the Chlamydomonas reinhardtii HydA1 apohydrogenase with S-adenosyl methionine (SAM), cysteine, tyrosine, iron, sulfide, and the non-purified maturases, hydrogenase activity increased 5-fold relative to incubations without the exogenous substrates. No conditions were identified in which addition of guanosine triphosphate (GTP) improved hydrogenase maturation. Significance: The in vitro system allows for direct investigation of [FeFe] hydrogenase activation. This work also provides a foundation for studying the biosynthetic mechanisms of H-cluster biosynthesis using solely purified enzymes and chemical additives.			Kuchenreuther, JM (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	jswartz@stanford.edu		Stapleton, James/0000-0003-1133-4180				ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Boyer ME, 2008, BIOTECHNOL BIOENG, V99, P59, DOI 10.1002/bit.21511; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Bui BTS, 2006, BIOCHEMISTRY-US, V45, P3824, DOI 10.1021/bi052388m; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; Escalettes F, 1999, J AM CHEM SOC, V121, P3571, DOI 10.1021/ja9811748; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Guianvarc'h D, 1997, BIOCHEM BIOPH RES CO, V236, P402, DOI 10.1006/bbrc.1997.6952; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Kim DM, 1996, EUR J BIOCHEM, V239, P881, DOI 10.1111/j.1432-1033.1996.0881u.x; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Layer G, 2004, CURR OPIN CHEM BIOL, V8, P468, DOI 10.1016/j.cbpa.2004.08.001; Leonardi R, 2004, J BIOL CHEM, V279, P17054, DOI 10.1074/jbc.M312714200; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; McGlynn SE, 2007, J BIOL INORG CHEM, V12, P443, DOI 10.1007/s00775-007-0224-z; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; MULDER DW, 2009, BIOCHEMISTRY; Nicolet Y, 2002, J INORG BIOCHEM, V91, P1, DOI 10.1016/S0162-0134(02)00392-6; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pilak O, 2006, J MOL BIOL, V358, P798, DOI 10.1016/j.jmb.2006.02.035; PILET E, 2009, FEBS LETT; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Shima S, 2008, SCIENCE, V321, P572, DOI 10.1126/science.1158978; Sybirna K, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-73; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Wolf I, 1998, ARCH MICROBIOL, V170, P451, DOI 10.1007/s002030050666	35	52	54	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7565	10.1371/journal.pone.0007565	http://dx.doi.org/10.1371/journal.pone.0007565			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855833	Green Published, gold, Green Submitted			2022-12-25	WOS:000271147200008
J	Hancock, R; Hadj-Sahraoui, Y				Hancock, Ronald; Hadj-Sahraoui, Yasmina			Isolation of Cell Nuclei Using Inert Macromolecules to Mimic the Crowded Cytoplasm	PLOS ONE			English	Article							RNA-POLYMERASE-II; CHROMATIN FIBER; OSMOTIC-PRESSURE; PHYSICAL STATE; PROTEIN; TRANSCRIPTION; ORGANIZATION; COMPACTION; DIFFUSION; POTASSIUM	Cell nuclei are commonly isolated and studied in media which include millimolar concentrations of cations, which conserve the nuclear volume by screening the negative charges on chromatin and maintaining its compaction. However, two factors question if these ionic conditions correctly reproduce the environment of nuclei in vivo: the small-scale motion and conformation of chromatin in vivo are not reproduced in isolated nuclei, and experiments and theory suggest that small ions in the cytoplasm are not free in the soluble phase but are predominantly bound to macromolecules. We studied the possible role in maintaining the structure and functions of nuclei in vivo of a further but frequently overlooked property of the cytoplasm, the crowding or osmotic effects caused by diffusible macromolecules whose concentration, measured in several studies, is in the range of 130 mg/ml. Nuclei which conserved their volume in the cell and their ultrastructure seen by electron microscopy were released from K562 cells in media containing the inert polymer 70 kDa Ficoll (50% w/v) or 70 kDa dextran (35% w/v) to replace the diffusible cytoplasmic molecules which were dispersed on cell lysis with digitonin, with 100 mu M K-Hepes buffer as the only source of ions. Immunofluorescence labelling and experiments using cells expressing GFP-fusion proteins showed that internal compartments (nucleoli, PML and coiled bodies, foci of RNA polymerase II) were conserved in these nuclei, and nascent RNA transcripts could be elongated. Our observations are consistent with the hypothesis that crowding by diffusible cytoplasmic macromolecules is a crucial but overlooked factor which supports the nucleus in vivo by equilibrating the opposing osmotic pressure cause by the high concentration of macromolecules in the nucleus, and suggest that crowded media provide more physiological conditions to study nuclear structure and functions. They may also help to resolve the long-standing paradox that the small-scale motion and irregular conformation of chromatin seen in vivo are not reproduced in nuclei isolated in conventional ionic media.			Hancock, R (corresponding author), Univ Laval, Canc Res Ctr, Hop Hotel Dieu, Quebec City, PQ, Canada.	ronald.hancock@crhdq.ulaval.ca	Hancock, Ronald/F-8009-2016					AARONSON RP, 1981, J CELL BIOL, V90, P181, DOI 10.1083/jcb.90.1.181; AARONSON RP, 1974, J CELL BIOL, V62, P746, DOI 10.1083/jcb.62.3.746; ALLFREY VG, 1964, J CELL BIOL, V21, P213, DOI 10.1083/jcb.21.2.213; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; ANDERSON NG, 1952, J GEN PHYSIOL, V35, P781, DOI 10.1085/jgp.35.5.781; Antonenkov VD, 2004, AM J PHYSIOL-CELL PH, V287, pC1623, DOI 10.1152/ajpcell.00142.2004; ArrioDupont M, 1996, BIOPHYS J, V70, P2327, DOI 10.1016/S0006-3495(96)79798-9; BATTIN WT, 1959, EXP CELL RES, V17, P59, DOI 10.1016/0014-4827(59)90152-1; BEDNAR J, 1995, J CELL BIOL, V131, P1365, DOI 10.1083/jcb.131.6.1365; BIRBECK MSC, 1956, J BIOPHYS BIOCHEM CY, V2, P609, DOI 10.1083/jcb.2.5.609; BOHRER MP, 1979, J GEN PHYSIOL, V74, P583, DOI 10.1085/jgp.74.5.583; Busch H, 1977, Methods Cell Biol, V16, P1; CALLAN HG, 1949, EXP CELL RES S, V1, P48; Carter DRF, 2008, BIOCHEM SOC T, V36, P585, DOI 10.1042/BST0360585; Cassany Aurelia, 2008, V464, P181; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; CUNEO P, 1992, BIOCHEM J, V281, P507, DOI 10.1042/bj2810507; Cunha S, 2001, J STRUCT BIOL, V136, P53, DOI 10.1006/jsbi.2001.4420; Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554; Davis SK, 2004, BIOPHYS J, V86, P555, DOI 10.1016/S0006-3495(04)74134-X; Dekker J, 2008, J BIOL CHEM, V283, P34532, DOI 10.1074/jbc.M806479200; del Alamo M, 2005, J VIROL, V79, P14271, DOI 10.1128/JVI.79.22.14271-14281.2005; Dellaire G, 2006, J CELL SCI, V119, P1026, DOI 10.1242/jcs.02816; EDELMANN L, 1989, SCANNING MICROSCOPY, V3, P1219; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Engelhardt M, 2004, BIOCHEM BIOPH RES CO, V324, P1210, DOI 10.1016/j.bbrc.2004.09.175; Eskiw CH, 2008, J CELL SCI, V121, P1999, DOI 10.1242/jcs.027250; Faro-Trindade I, 2006, MOL BIOL CELL, V17, P2910, DOI 10.1091/mbc.E05-11-1024; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Galan A, 2001, J BIOL CHEM, V276, P957, DOI 10.1074/jbc.M006861200; GAMBLE J, 1983, J PHYSIOL-LONDON, V339, P505, DOI 10.1113/jphysiol.1983.sp014730; Granath KA., 1958, J COLLOID SCI, V13, P308; Gunther T, 2006, MAGNESIUM RES, V19, P225; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Hancock R, 2004, J STRUCT BIOL, V146, P281, DOI 10.1016/j.jsb.2003.12.008; Hancock R, 2007, SEMIN CELL DEV BIOL, V18, P668, DOI 10.1016/j.semcdb.2007.08.006; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; HARDING CV, 1959, J GEN PHYSIOL, V42, P1155, DOI 10.1085/jgp.42.6.1155; Herzfeld J, 2004, J MOL RECOGNIT, V17, P376, DOI 10.1002/JMR.703; Hicks GR, 1995, ANNU REV CELL DEV BI, V11, P155, DOI 10.1146/annurev.cb.11.110195.001103; HOGEBOOM GH, 1948, J BIOL CHEM, V172, P619; HOU L, 1990, BIOPHYS J, V58, P31, DOI 10.1016/S0006-3495(90)82351-1; Hudder A, 2003, MOL CELL BIOL, V23, P9318, DOI 10.1128/MCB.23.24.9318-9326.2003; JACKSON DA, 1988, J CELL SCI, V90, P365; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; KELLERMAYER M, 1986, P NATL ACAD SCI USA, V83, P1011, DOI 10.1073/pnas.83.4.1011; Kornberg A, 2000, J BACTERIOL, V182, P3613, DOI 10.1128/JB.182.13.3613-3618.2000; Lam YW, 2002, MOL BIOL CELL, V13, P2461, DOI 10.1091/mbc.02-03-0034; LATERVEER FD, 1995, EUR J BIOCHEM, V232, P569; Lenart P, 2006, METHODS, V38, P17, DOI 10.1016/j.ymeth.2005.07.010; LING GN, 1990, SCANNING MICROSCOPY, V4, P737; LUBYPHELPS K, 1986, J CELL BIOL, V102, P2015, DOI 10.1083/jcb.102.6.2015; LUE NF, 1987, P NATL ACAD SCI USA, V84, P8839, DOI 10.1073/pnas.84.24.8839; Luthi D, 1999, EXP PHYSIOL, V84, P231, DOI 10.1111/j.1469-445X.1999.01799.x; MACGREGOR HC, 1962, EXP CELL RES, V26, P520, DOI 10.1016/0014-4827(62)90156-8; Maughan DW, 2001, BIOPHYS J, V80, P435, DOI 10.1016/S0006-3495(01)76026-2; MAUGHAN DW, 2005, CONCENTRATIONS GLYCO; MURAMATSU M, 1963, CANCER RES, V25, P693; NAORA H, 1961, J GEN PHYSIOL, V44, P713, DOI 10.1085/jgp.44.4.713; Negendank M, 2005, J CELL PHYSL, V104, P443; OLINS DE, 1972, J CELL BIOL, V53, P715, DOI 10.1083/jcb.53.3.715; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; Pielak GJ, 2005, P NATL ACAD SCI USA, V102, P5901, DOI 10.1073/pnas.0501812102; Platani M, 2000, J CELL BIOL, V151, P1561, DOI 10.1083/jcb.151.7.1561; RIVAS G, 2004, MOL CELL PROTEOMICS, V4, P1541; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; ROSANIA GR, 1995, EXP CELL RES, V218, P114, DOI 10.1006/excr.1995.1137; Sear RP, 2005, J PHYS-CONDENS MAT, V17, pS3587, DOI 10.1088/0953-8984/17/45/052; Singh-Zocchi M, 1999, P NATL ACAD SCI USA, V96, P6711, DOI 10.1073/pnas.96.12.6711; Spitzer JJ, 2005, TRENDS BIOCHEM SCI, V30, P536, DOI 10.1016/j.tibs.2005.08.002; TAKAHASHI Y, 1974, DEV GROWTH DIFFER, V16, P281; van Holde K, 2007, SEMIN CELL DEV BIOL, V18, P651, DOI 10.1016/j.semcdb.2007.08.005; Vandelaer M, 1996, EXP CELL RES, V228, P125, DOI 10.1006/excr.1996.0307; VILKER VL, 1981, J COLLOID INTERF SCI, V79, P548, DOI 10.1016/0021-9797(81)90106-5; WALMSLEY ME, 1975, J CELL SCI, V17, P113; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; WICKER U, 1993, BIOCHIM BIOPHYS ACTA, V1142, P228, DOI 10.1016/0005-2728(93)90151-5; WIJMANS JG, 1985, J MEMBRANE SCI, V22, P117, DOI 10.1016/S0376-7388(00)80534-7; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; ZIMMERMAN SB, 1988, NUCLEIC ACIDS RES, V16, P6309, DOI 10.1093/nar/16.14.6309; Zimmerman SB, 2001, J BACTERIOL, V183, P5041, DOI 10.1128/JB.183.17.5041-5049.2001	82	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7560	10.1371/journal.pone.0007560	http://dx.doi.org/10.1371/journal.pone.0007560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851505	gold, Green Published, Green Submitted			2022-12-25	WOS:000271022300007
J	Shirinifard, A; Gens, JS; Zaitlen, BL; Poplawski, NJ; Swat, M; Glazier, JA				Shirinifard, Abbas; Gens, J. Scott; Zaitlen, Benjamin L.; Poplawski, Nikodem J.; Swat, Maciej; Glazier, James A.			3D Multi-Cell Simulation of Tumor Growth and Angiogenesis	PLOS ONE			English	Article							CELLULAR POTTS-MODEL; BLOOD-FLOW; NONLINEAR SIMULATION; MATHEMATICAL-MODEL; VASCULAR NETWORKS; FACTOR VEGF; INVASION; ADHESION; DISEASE; CELLS	We present a 3D multi-cell simulation of a generic simplification of vascular tumor growth which can be easily extended and adapted to describe more specific vascular tumor types and host tissues. Initially, tumor cells proliferate as they take up the oxygen which the pre-existing vasculature supplies. The tumor grows exponentially. When the oxygen level drops below a threshold, the tumor cells become hypoxic and start secreting pro-angiogenic factors. At this stage, the tumor reaches a maximum diameter characteristic of an avascular tumor spheroid. The endothelial cells in the pre-existing vasculature respond to the pro-angiogenic factors both by chemotaxing towards higher concentrations of pro-angiogenic factors and by forming new blood vessels via angiogenesis. The tumor-induced vasculature increases the growth rate of the resulting vascularized solid tumor compared to an avascular tumor, allowing the tumor to grow beyond the spheroid in these linear-growth phases. First, in the linear-spherical phase of growth, the tumor remains spherical while its volume increases. Second, in the linear-cylindrical phase of growth the tumor elongates into a cylinder. Finally, in the linear-sheet phase of growth, tumor growth accelerates as the tumor changes from cylindrical to paddle-shaped. Substantial periods during which the tumor grows slowly or not at all separate the exponential from the linear-spherical and the linear-spherical from the linear-cylindrical growth phases. In contrast to other simulations in which avascular tumors remain spherical, our simulated avascular tumors form cylinders following the blood vessels, leading to a different distribution of hypoxic cells within the tumor. Our simulations cover time periods which are long enough to produce a range of biologically reasonable complex morphologies, allowing us to study how tumor-induced angiogenesis affects the growth rate, size and morphology of simulated tumors.			Shirinifard, A (corresponding author), Indiana Univ, Biocomplex Inst, Bloomington, IN USA.	ashirini@indiana.edu		Glazier, James Alexander/0000-0003-3634-190X	NIGMS NIH HHS [R01 GM076692, R01 GM077138, 5R01 GM076692-01, 1R01 GM077138-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077138, R01GM076692] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alarcon T, 2005, MULTISCALE MODEL SIM, V3, P440, DOI 10.1137/040603760; Alarcon T, 2004, PROG BIOPHYS MOL BIO, V85, P451, DOI 10.1016/j.pbiomolbio.2004.02.004; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Balter A, 2007, SINGLE CELL BASED MO, P151, DOI [DOI 10.1007/978-3-7643-8123-3_7, 10.1007/978-3-7643-8123-3_7]; Bartha K, 2006, J THEOR BIOL, V241, P903, DOI 10.1016/j.jtbi.2006.01.022; Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445; Bray D., 1992, CELL MOVEMENTS; Burgess PK, 1997, J NEUROPATH EXP NEUR, V56, P704; Carmeliet P, 2001, NATURE, V412, P868, DOI 10.1038/35091178; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Chen N, 2007, COMPUT PHYS COMMUN, V176, P670, DOI 10.1016/j.cpc.2007.03.007; Cristini V, 2009, J MATH BIOL, V58, P723, DOI 10.1007/s00285-008-0215-x; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; DEWAAL RMW, 2005, MECH ANGIOGENESIS, P65; Dor Y, 2003, TRENDS CELL BIOL, V13, P131, DOI 10.1016/S0962-8924(03)00022-9; Fischer I, 2005, BRAIN PATHOL, V15, P297; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Fotos JS, 2006, CYTOTECHNOLOGY, V51, P7, DOI 10.1007/s10616-006-9006-7; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gerhardt H., 2008, ORGANOGENESIS, V4, P241, DOI [DOI 10.4161/0RG.4.4.7414, DOI 10.4161/org.4.4.7414]; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Glazier JA, 2007, SINGLE CELL BASED MO, P79, DOI [10.1007/978-3-7643-8123-3_4, DOI 10.1007/978-3-7643-8123-3_4]; Glazier JA, 2008, CURR TOP DEV BIOL, V81, P205, DOI 10.1016/S0070-2153(07)81007-6; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Jurasz P, 2003, BLOOD, V102, P3217, DOI 10.1182/blood-2003-02-0378; Kusters B, 2003, CANCER RES, V63, P5408; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Mantzaris NV, 2004, J MATH BIOL, V49, P111, DOI 10.1007/s00285-003-0262-2; Marti H.H., 2005, MECH ANGIOGENESIS, P163; McDougall SR, 2006, J THEOR BIOL, V241, P564, DOI 10.1016/j.jtbi.2005.12.022; Merks RMH, 2006, NONLINEARITY, V19, pC1, DOI 10.1088/0951-7715/19/1/000; Merks RMH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000163; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; PERRYN ED, 2003, DEV BIOL, P545; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Plank MJ, 2004, B MATH BIOL, V66, P1785, DOI 10.1016/j.bulm.2004.04.001; Popawski NJ, 2009, B MATH BIOL, V71, P1189, DOI 10.1007/s11538-009-9399-5; POPEL AS, 1989, CRIT REV BIOMED ENG, V17, P257; Poplawski NJ, 2008, MATH BIOSCI ENG, V5, P355; Poplawski NJ, 2007, PHYSICA A, V373, P521, DOI 10.1016/j.physa.2006.05.028; Pries AR, 2005, AM J PHYSIOL-HEART C, V288, pH1010, DOI 10.1152/ajpheart.00752.2004; Pries AR, 1996, CARDIOVASC RES, V32, P654, DOI 10.1016/S0008-6363(96)00065-X; Pries A, 2008, MICROCIRCULATION, V15, P753, DOI 10.1080/10739680802229076; Pries AR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000394; Ramis-Conde I, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016008; Robinson CJ, 2001, J CELL SCI, V114, P853; Rubenstein BM, 2008, BIOPHYS J, V95, P5661, DOI 10.1529/biophysj.108.140624; Sander LM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051901; Sanga S, 2007, NEUROIMAGE, V37, pS120, DOI 10.1016/j.neuroimage.2007.05.043; Serini G, 2003, EMBO J, V22, P1771, DOI 10.1093/emboj/cdg176; SHIMA DT, 1995, MOL MED, V1, P182, DOI 10.1007/BF03401566; Stephanou A, 2006, MATH COMPUT MODEL, V44, P96, DOI 10.1016/j.mcm.2004.07.021; Stephanou A, 2005, MATH COMPUT MODEL, V41, P1137, DOI 10.1016/j.mcm.2005.05.008; Swat Maciej H., 2009, V500, P361, DOI 10.1007/978-1-59745-525-1_13; VAUPEL P, 1989, CANCER RES, V49, P6449; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Welter M, 2008, J THEOR BIOL, V250, P257, DOI 10.1016/j.jtbi.2007.09.031; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Xu ZL, 2009, SOFT MATTER, V5, P769, DOI 10.1039/b812429a; Zheng X, 2005, B MATH BIOL, V67, P211, DOI 10.1016/j.bulm.2004.08.001	70	183	185	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7190	10.1371/journal.pone.0007190	http://dx.doi.org/10.1371/journal.pone.0007190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834621	Green Published, gold, Green Submitted			2022-12-25	WOS:000270880700001
J	Godbold, JA; Rosenberg, R; Solan, M				Godbold, Jasmin A.; Rosenberg, Rutger; Solan, Martin			Species-Specific Traits Rather Than Resource Partitioning Mediate Diversity Effects on Resource Use	PLOS ONE			English	Article							SEA SEASTARS ECHINODERMATA; BRISSOPSIS-LYRIFERA FORBES; SHALLOW REEF LAGOON; FEEDING ECOLOGY; ECHINOIDS ECHINODERMATA; PLANT DIVERSITY; DISCOVERY BAY; BIODIVERSITY; SELECTIVITY; HOLOTHURIANS	Background: The link between biodiversity and ecosystem processes has firmly been established, but the mechanisms underpinning this relationship are poorly documented. Most studies have focused on terrestrial plant systems where resource use can be difficult to quantify as species rely on a limited number of common resources. Investigating resource use at the bulk level may not always be of sufficient resolution to detect subtle differences in resource use, as species-specific nutritional niches at the biochemical level may also moderate diversity effects on resource use. Methodology/Principal Findings: Here we use three co-occurring marine benthic echinoderms (Brissopsis lyrifera, Mesothuria intestinalis, Parastichopus tremulus) that feed on the same phytodetrital food source, to determine whether resource partitioning is the principal mechanism underpinning diversity effects on resource use. Specifically we investigate the use of phytodetrital pigments ( chlorophylls and carotenoids) because many of these are essential for biological functions, including reproduction. Pigments were identified and quantified using reverse-phase high performance liquid Chromatography ( HPLC) and data were analysed using a combination of extended linear regression with generalised least squares (GLS) estimation and standard multivariate techniques. Our analyses reveal no species-specific selectivity for particular algal pigments, confirming that these three species do not partition food resources at the biochemical level. Nevertheless, we demonstrate increased total resource use in diverse treatments as a result of selection effects and the dominance of one species (B. lyrifera). Conclusion: Overall, we found no evidence for resource partitioning at the biochemical level, as pigment composition was similar between individuals, which is likely due to plentiful food availability. Reduced intra-specific competition in the species mixture combined with greater adsorption efficiency and differences in feeding behaviour likely explain the dominant use of resources by B. lyrifera.			Godbold, JA (corresponding author), Univ Aberdeen, Oceanlab, Newburgh, Aberdeen, Scotland.	j.a.godbold@abdn.ac.uk	Godbold, Jasmin/AAB-2522-2022; Solan, Martin/E-9338-2012; Godbold, Jasmin A/F-1577-2012	Godbold, Jasmin/0000-0001-5558-8188; Solan, Martin/0000-0001-9924-5574; Godbold, Jasmin A/0000-0001-5558-8188				Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; AMON RMW, 1991, PSZNI MAR ECOL, V12, P163; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; BARLOW RG, 1993, DEEP-SEA RES PT II, V40, P459, DOI 10.1016/0967-0645(93)90027-K; Barlow RG, 1997, MAR ECOL PROG SER, V161, P303, DOI 10.3354/meps161303; Behmer ST, 2008, P NATL ACAD SCI USA, V105, P1977, DOI 10.1073/pnas.0711870105; BILLETT DSM, 1991, OCEANOGR MAR BIOL, V29, P259; Bock MJ, 1999, LIMNOL OCEANOGR, V44, P1132, DOI 10.4319/lo.1999.44.4.1132; Boon AR, 1996, J SEA RES, V35, P279, DOI 10.1016/S1385-1101(96)90755-8; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Casazza G, 2002, B MAR SCI, V71, P1171; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARKE KR, 1994, MAR BIOL, V118, P167, DOI 10.1007/BF00699231; Dauwe B, 1998, MAR ECOL PROG SER, V173, P67, DOI 10.3354/meps173067; Duffy JE, 2003, ECOL LETT, V6, P637; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Fox JW, 2005, ECOL LETT, V8, P846, DOI 10.1111/j.1461-0248.2005.00795.x; George SB, 2001, AQUACULTURE, V199, P353, DOI 10.1016/S0044-8486(01)00578-6; Ginger ML, 2000, J MAR BIOL ASSOC UK, V80, P139, DOI 10.1017/S0025315499001654; Godbold JA, 2009, OIKOS, V118, P77, DOI 10.1111/j.1600-0706.2008.17072.x; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Griffin JN, 2008, ECOLOGY, V89, P298, DOI 10.1890/07-1220.1; HAMMOND LS, 1982, MAR ECOL PROG SER, V8, P25, DOI 10.3354/meps008025; HAMMOND LS, 1983, MAR ECOL PROG SER, V10, P297, DOI 10.3354/meps010297; HAUKSSON E, 1979, SARSIA, V64, P155, DOI 10.1080/00364827.1979.10411376; Hector Andy, 2009, P94; Hiratsuka Y, 2007, COMP BIOCHEM PHYS A, V148, P223, DOI 10.1016/j.cbpa.2007.04.009; Hollertz K, 1998, HYDROBIOLOGIA, V375-76, P287, DOI 10.1023/A:1017013123372; Hollertz K, 2001, MAR BIOL, V139, P951; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Howell KL, 2004, MAR ECOL PROG SER, V266, P103, DOI 10.3354/meps266103; Howell KL, 2003, MAR ECOL PROG SER, V255, P193, DOI 10.3354/meps255193; Hudson IR, 2005, J MARINE SYST, V57, P201, DOI 10.1016/j.jmarsys.2005.02.004; Hudson IR, 2003, PROG OCEANOGR, V59, P381, DOI 10.1016/j.pocean.2003.11.002; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Jeffrey S.W., 1997, UNESCO MONOGRAPHS OC, V10; JEFFREY SW, 1997, UNESCO MONOGRAPHS OC, V10, P447; Jonsson M, 2000, OIKOS, V89, P519, DOI 10.1034/j.1600-0706.2000.890311.x; Kawakami T, 1998, J EXP MAR BIOL ECOL, V226, P165, DOI 10.1016/S0022-0981(97)00236-0; Kirwan L, 2007, J ECOL, V95, P530, DOI 10.1111/j.1365-2745.2007.01225.x; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Levinton J, 2004, J EXP MAR BIOL ECOL, V300, P65, DOI 10.1016/j.jembe.2003.12.008; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Maechler M, 2008, CLUSTER CLUSTER ANAL; MANTOURA RFC, 1983, ANAL CHIM ACTA, V151, P297, DOI 10.1016/S0003-2670(00)80092-6; McKie BG, 2008, J ANIM ECOL, V77, P495, DOI 10.1111/j.1365-2656.2008.01357.x; Miller RJ, 2000, J MAR RES, V58, P653, DOI 10.1357/002224000321511061; Neto RR, 2006, DEEP-SEA RES PT I, V53, P516, DOI 10.1016/j.dsr.2005.12.001; Norberg J, 2000, OECOLOGIA, V122, P264, DOI 10.1007/PL00008855; Oksanen J., 2008, VEGAN COMMUNITY ECOL; PENRY DL, 1987, AM NAT, V129, P69, DOI 10.1086/284623; PETERSON CH, 1980, ECOLOGY, V61, P129, DOI 10.2307/1937163; Pinheiro J., 2006, NLME R PACKAGE FITTI; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plank LR, 2002, J WORLD AQUACULT SOC, V33, P127, DOI 10.1111/j.1749-7345.2002.tb00487.x; Quinn Q. P., 2002, EXPT DESIGN DATA ANA; *R DEV COR TEAM, 2007, A LANG ENV STAT COMP; Roberts D, 2000, OCEANOGR MAR BIOL, V38, P257; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Uthicke S, 1999, B MAR SCI, V64, P129; Uthicke S, 1999, J EXP MAR BIOL ECOL, V236, P69, DOI 10.1016/S0022-0981(98)00190-7; Wigham BD, 2008, DEEP-SEA RES PT II, V55, P2478, DOI 10.1016/j.dsr2.2008.06.007; Wigham BD, 2003, PROG OCEANOGR, V59, P409, DOI 10.1016/j.pocean.2003.11.003; Witte U, 2003, MAR ECOL PROG SER, V251, P27, DOI 10.3354/meps251027; Wojdak JM, 2007, ECOLOGY, V88, P2072, DOI 10.1890/06-0651.1; WRIGHT SW, 1997, MONOGR ON OCEAN METH, V10, P327	73	21	21	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7423	10.1371/journal.pone.0007423	http://dx.doi.org/10.1371/journal.pone.0007423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19829703	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000270808700006
J	Cohen, SB; Ma, W; Valova, VA; Algie, M; Harfoot, R; Woolley, AG; Robinson, PJ; Braithwaite, AW				Cohen, S. B.; Ma, W.; Valova, V. A.; Algie, M.; Harfoot, R.; Woolley, A. G.; Robinson, P. J.; Braithwaite, A. W.			Genotoxic stress-induced nuclear localization of oncoprotein YB-1 in the absence of proteolytic processing	ONCOGENE			English	Article						YB-1; oncoprotein; proteolysis; nuclear; translocation	BOX-BINDING-PROTEIN; MDR1 GENE-EXPRESSION; COLD SHOCK DOMAIN; P-GLYCOPROTEIN; DISEASE; CELLS; BINDING-PROTEIN-1; PROGRESSION; RESISTANCE; CISPLATIN	Y-box-binding protein 1 (YB-1) is an oncogenic transcription factor whose overexpression and nuclear localization is associated with tumor progression and drug resistance. Transcriptional activation of YB-1 in response to genotoxic stress is believed to occur in the cytoplasm through sequence-specific endoproteolytic cleavage by the 20S Proteasome, followed by nuclear translocation of cleaved YB-1. To study the proteolysis model, we developed a two-step affinity purification of endogenous YB-1 protein species and characterized the products using mass spectrometry. Whereas full-length YB-1 was readily identified, the smaller protein band thought to be activated YB-1 was identified as hnRNP A1. An antibody specific for YB-1 was generated, which revealed only one YB-1 species, even after genotoxic stress-induced nuclear YB-1 translocation. These findings warrant re-evaluation of the mechanism of YB-1 nuclear translocation and transcriptional activation. The relationship between nuclear YB-1 and tumor progression may also have to re-evaluated in some cases. Oncogene (2010) 29, 403-410; doi:10.1038/onc.2009.321; published online 19 October 2009	[Cohen, S. B.; Ma, W.; Braithwaite, A. W.] Childrens Med Res Inst, Cell Transformat Unit, Westmead, NSW 2145, Australia; [Cohen, S. B.; Robinson, P. J.; Braithwaite, A. W.] Univ Sydney, Fac Med, Sydney, NSW 2006, Australia; [Valova, V. A.; Robinson, P. J.] Childrens Med Res Inst, Cell Signalling Unit, Westmead, NSW 2145, Australia; [Algie, M.; Harfoot, R.; Woolley, A. G.; Braithwaite, A. W.] Univ Otago, Dunedin Sch Med, Dept Pathol, Cell Transformat Grp, Dunedin, New Zealand	Children's Medical Research Institute - Australia; University of Sydney; Children's Medical Research Institute - Australia; University of Otago	Braithwaite, AW (corresponding author), Childrens Med Res Inst, Cell Transformat Unit, 214 Hawkesbury Rd, Westmead, NSW 2145, Australia.	abraithwaite@cmri.org.au	Robinson, Phillip J/G-4008-2011	Robinson, Phillip J/0000-0002-7878-0313; Algie, Michael/0000-0002-0568-331X	National Health & Medical Research Council of Australia [423405, 477100]; Cancer Institute NSW [05/RLP/1-01]; Health Research Council of New Zealand [07/284A]; Children's Medical Research Institute Jeans-for-Genes Campaign	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute NSW; Health Research Council of New Zealand(Health Research Council of New Zealand); Children's Medical Research Institute Jeans-for-Genes Campaign	We thank Professor H-D Royer (CASEAR, Bonn, Germany) for a generous gift of the C-terminal YB-1 antibody. This research was supported by the National Health & Medical Research Council of Australia (SBC, 423405; PJP, 477100), the Cancer Institute NSW (AWB, WM, 05/RLP/1-01), the Health Research Council of New Zealand (AWB, AMW, RH, MA 07/284A) and the Children's Medical Research Institute Jeans-for-Genes Campaign (VAV).	ASAKUNO K, 1994, BIOCHEM BIOPH RES CO, V199, P1428, DOI 10.1006/bbrc.1994.1390; Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Berquin IM, 2005, ONCOGENE, V24, P3177, DOI 10.1038/sj.onc.1208504; Chatterjee M, 2008, BLOOD, V111, P3714, DOI 10.1182/blood-2007-05-089151; Fujita T, 2005, CLIN CANCER RES, V11, P8837, DOI 10.1158/1078-0432.CCR-05-0945; Gimenez-Bonafe P, 2004, PROSTATE, V59, P337, DOI 10.1002/pros.20023; Guay D, 2008, INT J BIOCHEM CELL B, V40, P2492, DOI 10.1016/j.biocel.2008.04.011; HORWITZ EM, 1994, J BIOL CHEM, V269, P14130; Ito Y, 2003, PATHOL INT, V53, P429, DOI 10.1046/j.1440-1827.2003.01494.x; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Lee SM, 2006, NEUROSCI LETT, V401, P188, DOI 10.1016/j.neulet.2006.03.016; Oda Y, 1998, CLIN CANCER RES, V4, P2273; Oda Y, 2003, J PATHOL, V199, P251, DOI 10.1002/path.1282; Ohga T, 1996, CANCER RES, V56, P4224; Raffetseder U, 2003, J BIOL CHEM, V278, P18241, DOI 10.1074/jbc.M212518200; Shibahara K, 2001, CLIN CANCER RES, V7, P3151; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; Stenina OI, 2000, J CLIN INVEST, V106, P579, DOI 10.1172/JCI9075; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407	20	45	47	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2010	29	3					403	410		10.1038/onc.2009.321	http://dx.doi.org/10.1038/onc.2009.321			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	546EO	19838214				2022-12-25	WOS:000273793200009
J	Nikandrova, YA; Jiao, YX; Baucum, AJ; Tavalin, SJ; Colbran, RJ				Nikandrova, Yelyzaveta A.; Jiao, Yuxia; Baucum, Anthony J.; Tavalin, Steven J.; Colbran, Roger J.			Ca2+/Calmodulin-dependent Protein Kinase II Binds to and Phosphorylates a Specific SAP97 Splice Variant to Disrupt Association with AKAP79/150 and Modulate alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid-type Glutamate Receptor (AMPAR) Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-ASPARTATE RECEPTOR; SYNAPSE-ASSOCIATED PROTEIN-97; POSTSYNAPTIC DENSITY PROTEIN; HUMAN DISCS LARGE; NR2B SUBUNIT; REGULATED INTERACTIONS; INHIBITOR PROTEIN; ALPHA-SUBUNIT; CAMKII; TRAFFICKING	Ca2+/calmodulin-dependent protein kinase II (CaMKII) promotes trafficking and activation of the GluR1 subunit of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors (AMPARs) during synaptic plasticity. GluR1 is also modulated in parallel by multiprotein complexes coordinated by synapse-associated protein 97 (SAP97) that contain A-kinase anchoring protein 79/150 (AKAP79/150), protein kinase A, and protein phosphatase 2B. Here we show that SAP97 is present in CaMKII immune complexes isolated from rodent brain as well as from HEK293 cells co-expressing CaMKII alpha and SAP97. CaMKII alpha phosphorylated recombinant SAP97 within immune complexes in vitro and in intact cells. Four alternative mRNA splice variants of SAP97 expressing combinations of four inserts (I2, I3, I4, I5) in the U5 region between Src homology 3 (SH3) and guanylyl kinase-like (GK) domains were identified in rat brain at postnatal day 21. CaMKII alpha preferentially phosphorylated a full-length SAP97 and a glutathione S-transferase (GST) fusion protein containing the I3 and I5 inserts (SAP97-I3I5 and GST-SH3-I3I5-GK, respectively) and also specifically interacted with GST-SH3-I3I5-GK compared with GST proteins containing other naturally occurring insert combinations. AKAP79/150 also directly and specifically bound only to GST-SH3-I3I5-GK, but CaMKII phosphorylation of GST-SH3-I3I5-GK prevented this interaction. AKAP79-dependent down-regulation of GluR1 AMPAR currents was ablated by overexpression of SAP97-I2I5 (which does not bind AKAP79) or by infusion of active CaMKII alpha. Collectively, the data suggest that CaMKII alpha targets a specific SAP97 splice variant to disengage AKAP79/150 from regulating GluR1 AMPARs, providing new insight into protein-protein interactions and phosphorylation events that are required for normal regulation of glutamatergic synaptic transmission, learning, and memory.	[Colbran, Roger J.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Baucum, Anthony J.; Colbran, Roger J.] Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; [Colbran, Roger J.] Vanderbilt Univ, Vanderbilt Kennedy Ctr Res Human Dev, Nashville, TN 37232 USA; [Tavalin, Steven J.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmacol, Memphis, TN 38163 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center	Colbran, RJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Rm 702,Light Hall, Nashville, TN 37232 USA.	roger.colbran@vanderbilt.edu	Jiao, Yuxia/H-3300-2019; Colbran, Roger/AAU-7708-2021; Baucum, Anthony/I-5109-2013	Jiao, Yuxia/0000-0002-8633-7047; Colbran, Roger/0000-0001-7401-8244; Baucum, Anthony/0000-0002-4756-9865	National Institutes of Health [RO1-MH63232, PO1-NS044282, R01-NS046661, T32-MH65215]; UNCF-Merck foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063232, T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044282, R01NS046661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNCF-Merck foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-MH63232 and PO1-NS044282 (to R.J.C.) and R01-NS046661 (to S.J.T.).; Supported by a Neurogenomics training grant funded by National Institutes of Health Grant T32-MH65215 and by a fellowship from the UNCF-Merck foundation.	Asrican B, 2007, J NEUROSCI, V27, P14007, DOI 10.1523/JNEUROSCI.3587-07.2007; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Boehm J, 2006, LEARN MEMORY, V13, P562, DOI 10.1101/lm.253506; BRICKEY DA, 1990, BIOCHEM BIOPH RES CO, V173, P578, DOI 10.1016/S0006-291X(05)80074-9; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang BH, 2001, NEUROSCIENCE, V102, P767, DOI 10.1016/S0306-4522(00)00520-0; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Gardoni F, 2003, J BIOL CHEM, V278, P44745, DOI 10.1074/jbc.M303576200; Gardoni F, 2007, J BIOL CHEM, V282, P28691, DOI 10.1074/jbc.M701899200; Godreau D, 2003, J BIOL CHEM, V278, P47046, DOI 10.1074/jbc.M308463200; Gomez LL, 2002, J NEUROSCI, V22, P7027; Griffith Leslie C, 2003, Mol Interv, V3, P386, DOI 10.1124/mi.3.7.386; Grueter CE, 2008, BIOCHEMISTRY-US, V47, P1760, DOI 10.1021/bi701755q; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Hanada T, 2003, J BIOL CHEM, V278, P34445, DOI 10.1074/jbc.M305209200; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hoshi N, 2005, NAT CELL BIOL, V7, P1066, DOI 10.1038/ncb1315; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jiao YX, 2008, J NEUROCHEM, V105, P1746, DOI 10.1111/j.1471-4159.2008.05280.x; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lu Y, 2007, EMBO J, V26, P4879, DOI 10.1038/sj.emboj.7601884; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Mauceri D, 2007, J NEUROCHEM, V100, P1032, DOI 10.1111/j.1471-4159.2006.04267.x; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; MCNEILL RB, 1995, J BIOL CHEM, V270, P10043, DOI 10.1074/jbc.270.17.10043; Mori K, 1998, J HUM GENET, V43, P123, DOI 10.1007/s100380050052; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Roberts S, 2007, EXP CELL RES, V313, P2521, DOI 10.1016/j.yexcr.2007.05.017; Robison AJ, 2005, J BIOL CHEM, V280, P39316, DOI 10.1074/jbc.M508189200; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Sessoms-Sikes S, 2005, MOL CELL NEUROSCI, V29, P139, DOI 10.1016/j.mcn.2005.01.006; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Snyder EM, 2005, J BIOL CHEM, V280, P16962, DOI 10.1074/jbc.M409693200; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; Tsui J, 2005, J BIOL CHEM, V280, P9210, DOI 10.1074/jbc.M407653200; Tunquist BJ, 2008, P NATL ACAD SCI USA, V105, P12557, DOI [10.1073/pnas.0805922105, 10.1073/pnas.0B05922105]; Waites CL, 2009, J NEUROSCI, V29, P4332, DOI 10.1523/JNEUROSCI.4431-08.2009; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Wu HJ, 1998, J CELL SCI, V111, P2365	63	37	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					923	934		10.1074/jbc.M109.033985	http://dx.doi.org/10.1074/jbc.M109.033985			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19858198	Green Published, hybrid			2022-12-25	WOS:000273258200012
J	Yalcin, A; Clem, B; Makoni, S; Clem, A; Nelson, K; Thornburg, J; Siow, D; Lane, AN; Brock, SE; Goswami, U; Eaton, JW; Telang, S; Chesney, J				Yalcin, A.; Clem, B.; Makoni, S.; Clem, A.; Nelson, K.; Thornburg, J.; Siow, D.; Lane, A. N.; Brock, S. E.; Goswami, U.; Eaton, J. W.; Telang, S.; Chesney, J.			Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling	ONCOGENE			English	Article						ras; phosphatidic acid; phosphocholine	PHOSPHATIDIC-ACID; HUMAN CANCER; PHOSPHOLIPASE-D; BREAST-CANCER; LUNG-CANCER; TUMOR PROGRESSION; DRUG-RESISTANCE; RAS ACTIVATION; EGF RECEPTOR; CELL-LINES	Choline is an essential anabolic substrate for the synthesis of phospholipids. Choline kinase phosphorylates choline to phosphocholine that serves as a precursor for the production of phosphatidylcholine, the major phospholipid constituent of membranes and substrate for the synthesis of lipid signaling molecules. Nuclear magnetic resonance (NMR)-based metabolomic studies of human tumors have identified a marked increase in the intracellular concentration of phosphocholine relative to normal tissues. We postulated that the observed intracellular pooling of phosphocholine may be required to sustain the production of the pleiotropic lipid second messenger, phosphatidic acid. Phosphatidic acid is generated from the cleavage of phosphatidylcholine by phospholipase D2 and is a key activator of the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K)/AKT survival signaling pathways. In this study we show that the steady-state concentration of phosphocholine is increased by the ectopic expression of oncogenic H-Ras(V12) in immortalized human bronchial epithelial cells. We then find that small interfering RNA (siRNA) silencing of choline kinase expression in transformed HeLa cells completely abrogates the high concentration of phosphocholine, which in turn decreases phosphatidylcholine, phosphatidic acid and signaling through the MAPK and PI3K/AKT pathways. This simultaneous reduction in survival signaling markedly decreases the anchorage-independent survival of HeLa cells in soft agar and in athymic mice. Last, we confirm the relative importance of phosphatidic acid for this pro-survival effect as phosphatidic acid supplementation fully restores MAPK signaling and partially rescues HeLa cells from choline kinase inhibition. Taken together, these data indicate that the pooling of phosphocholine in cancer cells may be required to provide a ready supply of phosphatidic acid necessary for the feed-forward amplification of cancer survival signaling pathways.	[Yalcin, A.; Clem, B.; Makoni, S.; Clem, A.; Nelson, K.; Thornburg, J.; Siow, D.; Lane, A. N.; Brock, S. E.; Goswami, U.; Eaton, J. W.; Telang, S.; Chesney, J.] Univ Louisville, Dept Biochem & Mol Biol, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40202 USA; [Yalcin, A.] Uludag Univ, Dept Biochem, Sch Vet Med, Bursa, Turkey	University of Louisville; Uludag University	Chesney, J (corresponding author), Univ Louisville, Dept Biochem & Mol Biol, James Graham Brown Canc Ctr, Mol Targets Program, 580 S Preston St,204E, Louisville, KY 40202 USA.	jaches03@louisville.edu	Yalcin, Abdullah/ABI-4164-2020; Yalcin, Abdullah/AAA-6938-2022	Yalcin, Abdullah/0000-0001-8519-8375; 	James Graham Brown Cancer Center; NIH [1 R01 CA11642801]; Kentucky Lung Cancer Research Program	James Graham Brown Cancer Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Lung Cancer Research Program	We gratefully acknowledge helpful discussions with Drs Binks Wattenberg, Mary Roth and Otto Grubraw. This work was supported by the James Graham Brown Cancer Center and by the following grants: NIH 1 R01 CA11642801 (JC) and the Kentucky Lung Cancer Research Program (JC).	Ackerstaff E, 2003, J CELL BIOCHEM, V90, P525, DOI 10.1002/jcb.10659; Al-Saffar NMS, 2006, CANCER RES, V66, P427, DOI 10.1158/0008-5472.CAN-05-1338; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 2002, BIOCHEM J, V363, P777, DOI 10.1042/0264-6021:3630777; Avruch J, 2001, RECENT PROG HORM RES, V56, P127, DOI 10.1210/rp.56.1.127; Banez-Coronel M, 2008, CURR CANCER DRUG TAR, V8, P709, DOI 10.2174/156800908786733432; BOS JL, 1989, CANCER RES, V49, P4682; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; de Molina AR, 2004, CANCER LETT, V206, P137, DOI 10.1016/j.canlet.2003.08.031; DEGANI H, 1986, RADIOLOGY, V161, P53, DOI 10.1148/radiology.161.1.3020609; Eliyahu G, 2007, INT J CANCER, V120, P1721, DOI 10.1002/ijc.22293; EXTON JH, 1990, J BIOL CHEM, V265, P1; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Foster DA, 2003, MOL CANCER RES, V1, P789; Glunde K, 2005, CANCER RES, V65, P11034, DOI 10.1158/0008-5472.CAN-05-1807; Glunde K, 2007, LANCET ONCOL, V8, P855, DOI 10.1016/S1470-2045(07)70289-9; Glunde K, 2006, EXPERT REV MOL DIAGN, V6, P821, DOI 10.1586/14737159.6.6.821; Grant S, 2008, J CLIN INVEST, V118, P3003, DOI 10.1172/JCI36898; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hancock JF, 2007, NAT CELL BIOL, V9, P615, DOI 10.1038/ncb0607-615; Hernandez-Alcoceba R, 1999, CANCER RES, V59, P3112; HernandezAlcoceba R, 1997, ONCOGENE, V15, P2289, DOI 10.1038/sj.onc.1201414; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Ihle NT, 2009, MOL CANCER THER, V8, P1, DOI 10.1158/1535-7163.MCT-08-0801; Iorio E, 2005, CANCER RES, V65, P9369, DOI 10.1158/0008-5472.CAN-05-1146; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Li GP, 1997, J BIOL CHEM, V272, P10337; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; Martinelli Giovanni, 2008, Clin Adv Hematol Oncol, V6, P303; Mazie AR, 2006, J CELL SCI, V119, P1645, DOI 10.1242/jcs.02858; McCubrey JA, 2007, ADV ENZYME REGUL, V47, P64, DOI 10.1016/j.advenzreg.2006.12.013; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Nozawa S, 2005, J BIOL CHEM, V280, P27544, DOI 10.1074/jbc.M411626200; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; ONODERA K, 1986, JPN J CANCER RES, V77, P1201; Pal SK, 2008, CLIN LUNG CANCER, V9, P340, DOI 10.3816/CLC.2008.n.049; Ramirez de Molina A, 2005, CANCER RES, V65, P5647, DOI 10.1158/0008-5472.CAN-04-4416; Ramirez de Molina A, 2002, BIOCHEM BIOPH RES CO, V296, P580, DOI 10.1016/S0006-291X(02)00920-8; Ramirez de Molina A, 2004, CANCER RES, V64, P6732, DOI 10.1158/0008-5472.CAN-04-0489; Ramirez de Molina A, 2002, ONCOGENE, V21, P937, DOI 10.1038/sj.onc.1205144; Ramirez de Molina A, 2007, LANCET ONCOL, V8, P889, DOI 10.1016/S1470-2045(07)70279-6; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Rizzo MA, 2002, PHARMACOL THERAPEUT, V94, P35, DOI 10.1016/S0163-7258(02)00170-5; Rizzo MA, 1999, J BIOL CHEM, V274, P1131, DOI 10.1074/jbc.274.2.1131; Rodriguez-Gonzalez A, 2003, ONCOGENE, V22, P8803, DOI 10.1038/sj.onc.1207062; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Soejima K, 2003, ONCOGENE, V22, P4723, DOI 10.1038/sj.onc.1206510; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; Telang S, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-77; Thornburg JM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2154; Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	57	78	86	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 7	2010	29	1					139	149		10.1038/onc.2009.317	http://dx.doi.org/10.1038/onc.2009.317			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	540XE	19855431				2022-12-25	WOS:000273373500013
J	Cho, J; Rameshwar, P; Sadoshima, J				Cho, Jaeyeaon; Rameshwar, Pranela; Sadoshima, Junichi			Distinct Roles of Glycogen Synthase Kinase (GSK)-3 alpha and GSK-3 beta in Mediating Cardiomyocyte Differentiation in Murine Bone Marrow-derived Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; PROGENITOR CELLS; TOPCARE-AMI; HEART; REGULATOR; PATHWAY; CARDIOGENESIS; KINASE-3-BETA	The signaling mechanisms facilitating cardiomyocyte (CM) differentiation from bone marrow (BM)-derived mesenchymal stem cells (MSCs) are not well understood. 5-Azacytidine (5-Aza), a DNA demethylating agent, induces expression of cardiac-specific genes, such as Nkx2.5 and alpha-MHC, in mouse BM-derived MSCs. 5-Aza treatment caused significant up-regulation of glycogen synthase kinase (GSK)-3 beta and down-regulation of beta-catenin, whereas it stimulated GSK-3 alpha expression only modestly. The promoter region of GSK-3 beta was heavily methylated in control MSCs, but was demethylated by 5-Aza. Although overexpression of GSK-3 beta potently induced CM differentiation, that of GSK-3 alpha induced markers of neuronal and chondrocyte differentiation. GSK-3 inhibitors, including LiCl, SB 216743, and BIO, abolished 5-Aza-induced up-regulation of CM-specific genes, suggesting that GSK-3 is necessary and sufficient for CM differentiation in MSCs. Although specific knockdown of endogenous GSK-3 alpha abolished 5-Aza-induced expression of cardiac specific genes, surprisingly, that of GSK-3 alpha facilitated CM differentiation in MSCs. Although GSK-3 alpha is found in both the cytosol and nucleus in MSCs, GSK-3 alpha is localized primarily in the nucleus. Nuclear-specific overexpression of GSK-3 beta failed to stimulate CM differentiation. Down-regulation of beta-catenin mediates GSK-3 beta-induced CM differentiation in MSCs, whereas up-regulation of c-Jun plays an important role in mediating CM differentiation induced by GSK-3 alpha knockdown. These results suggest that GSK-3 alpha and GSK-3 beta have distinct roles in regulating CM differentiation in BM-derived MSCs. GSK-3 beta in the cytosol induces CM differentiation of MSCs through down-regulation of beta-catenin. In contrast, GSK-3 alpha in the nucleus inhibits CM differentiation through down-regulation of c-Jun.	[Cho, Jaeyeaon; Sadoshima, Junichi] Univ Med & Dent New Jersey, Dept Cell Biol & Mol Med, Inst Cardiovasc Res, Newark, NJ 07103 USA; [Rameshwar, Pranela] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Sadoshima, J (corresponding author), 185 S Orange Ave,MSB G609, Newark, NJ 07103 USA.	sadoshju@umdnj.edu		Sadoshima, Junichi/0000-0003-3724-4132	National Institutes of Health [HL 059139, HL067724, HL069020, AG023039, AG027211, HL91469]; United States Public Health Service; New Jersey Commission of Science and Technology Stem Cell Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067724, P01HL059139, P01HL069020, R01HL091469] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG027211, R01AG023039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); New Jersey Commission of Science and Technology Stem Cell Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 059139, HL067724, HL069020, AG023039, AG027211, and HL91469 from the United States Public Health Service and grants from the New Jersey Commission of Science and Technology Stem Cell Research Grant Program.	Britten MB, 2003, CIRCULATION, V108, P2212, DOI 10.1161/01.CIR.0000095788.78169.AF; Cohen ED, 2008, DEVELOPMENT, V135, P789, DOI 10.1242/dev.016865; Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Flaherty MP, 2008, CIRCULATION, V117, P2241, DOI 10.1161/CIRCULATIONAHA.107.741066; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Force T, 2009, J BIOL CHEM, V284, P9643, DOI 10.1074/jbc.R800077200; Hanstein B, 1996, P NATL ACAD SCI USA, V93, P11540, DOI 10.1073/pnas.93.21.11540; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Hare JM, 2008, CURR OPIN ORGAN TRAN, V13, P536, DOI 10.1097/MOT.0b013e32830fdfc4; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hirotani S, 2007, CIRC RES, V101, P1164, DOI 10.1161/CIRCRESAHA.107.160614; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Koyanagi M, 2005, J BIOL CHEM, V280, P16838, DOI 10.1074/jbc.M500323200; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Kwon C, 2007, P NATL ACAD SCI USA, V104, P10894, DOI 10.1073/pnas.0704044104; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Matsuda T, 2008, P NATL ACAD SCI USA, V105, P20900, DOI 10.1073/pnas.0808315106; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; PFEFFER MA, 1995, ANNU REV MED, V46, P455, DOI 10.1146/annurev.med.46.1.455; Planat-Benard V, 2004, CIRC RES, V94, P223, DOI 10.1161/01.RES.0000109792.43271.47; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Sun LD, 2007, CELL SIGNAL, V19, P2255, DOI 10.1016/j.cellsig.2007.06.014; Tzahor E, 2007, DEV CELL, V13, P10, DOI 10.1016/j.devcel.2007.06.006; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Zhai PY, 2007, J BIOL CHEM, V282, P33181, DOI 10.1074/jbc.M705133200; Zhu WD, 2008, NATURE, V454, P345, DOI 10.1038/nature07027	35	59	64	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36647	36658		10.1074/jbc.M109.019109	http://dx.doi.org/10.1074/jbc.M109.019109			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858210	Green Published, hybrid			2022-12-25	WOS:000272970500065
J	Ellis, J; Gutierrez, A; Barsukov, IL; Huang, WC; Grossmann, JG; Roberts, GCK				Ellis, Jacqueline; Gutierrez, Aldo; Barsukov, Igor L.; Huang, Wei-Cheng; Grossmann, J. Guenter; Roberts, Gordon C. K.			Domain Motion in Cytochrome P450 Reductase CONFORMATIONAL EQUILIBRIA REVEALED BY NMR AND SMALL-ANGLE X-RAY SCATTERING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; FMN-BINDING DOMAIN; ELECTRON-TRANSFER; COENZYME BINDING; METHIONINE SYNTHASE; P450 OXIDOREDUCTASE; STRUCTURAL BASIS; NADPH; CLONING; PROTEIN	NADPH-cytochrome P450 reductase (CPR), a diflavin reductase, plays a key role in the mammalian P450 mono-oxygenase system. In its crystal structure, the two flavins are close together, positioned for interflavin electron transfer but not for electron transfer to cytochrome P450. A number of lines of evidence suggest that domain motion is important in the action of the enzyme. We report NMR and small-angle x-ray scattering experiments addressing directly the question of domain organization in human CPR. Comparison of the H-1-N-15 heteronuclear single quantum correlation spectrum of CPR with that of the isolated FMN domain permitted identification of residues in the FMN domain whose environment differs in the two situations. These include several residues that are solvent-exposed in the CPR crystal structure, indicating the existence of a second conformation in which the FMN domain is involved in a different interdomain interface. Small-angle x-ray scattering experiments showed that oxidized and NADPH-reduced CPRs have different overall shapes. The scattering curve of the reduced enzyme can be adequately explained by the crystal structure, whereas analysis of the data for the oxidized enzyme indicates that it exists as a mixture of approximately equal amounts of two conformations, one consistent with the crystal structure and one a more extended structure consistent with that inferred from the NMR data. The correlation between the effects of adenosine 2', 5'-bisphosphate and NADPH on the scattering curve and their effects on the rate of interflavin electron transfer suggests that this conformational equilibrium is physiologically relevant.	[Ellis, Jacqueline; Gutierrez, Aldo; Barsukov, Igor L.; Huang, Wei-Cheng; Roberts, Gordon C. K.] Univ Leicester, Dept Biochem, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England; [Grossmann, J. Guenter] Sci & Technol Facil Council, Daresbury Lab, Mol Biophys Grp, Warrington WA4 4AD, Cheshire, England	University of Leicester; STFC Daresbury Laboratory; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC)	Roberts, GCK (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Labs Struct Biol, Henry Wellcome Bldg,POB 138,Lancaster Rd, Leicester LE1 9HN, Leics, England.	gcr@le.ac.uk		Roberts, Gordon/0000-0001-6200-1373; Huang, Wei-Cheng/0000-0003-4437-3530	Biotechnology and Biological Sciences Research Council; Wellcome Trust	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the Biotechnology and Biological Sciences Research Council and the Wellcome Trust.	Aigrain L, 2009, EMBO REP, V10, P742, DOI 10.1038/embor.2009.82; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Bailey SM, 2001, BIOCHEM PHARMACOL, V62, P461, DOI 10.1016/S0006-2952(01)00674-8; Barsukov I, 1997, J BIOMOL NMR, V10, P63, DOI 10.1023/A:1018313830207; Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; ENOCH HG, 1979, J BIOL CHEM, V254, P8976; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Grossmann JG, 1998, J MOL BIOL, V279, P461, DOI 10.1006/jmbi.1998.1787; Gruez A, 2000, J MOL BIOL, V299, P199, DOI 10.1006/jmbi.2000.3748; Grunau A, 2006, BIOCHEMISTRY-US, V45, P1421, DOI 10.1021/bi052115r; Grunau A, 2007, BIOCHEMISTRY-US, V46, P8244, DOI 10.1021/bi700596s; Gutierrez A, 2003, EUR J BIOCHEM, V270, P2612, DOI 10.1046/j.1432-1033.2003.03633.x; Gutierrez A, 2002, BIOCHEMISTRY-US, V41, P4626, DOI 10.1021/bi0159433; Gutierrez A, 2001, BIOCHEMISTRY-US, V40, P1964, DOI 10.1021/bi001719m; Hall DA, 2001, P NATL ACAD SCI USA, V98, P9521, DOI 10.1073/pnas.171168898; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hubbard PA, 2001, J BIOL CHEM, V276, P29163, DOI 10.1074/jbc.M101731200; Ilagan RP, 2008, J BIOL CHEM, V283, P19603, DOI 10.1074/jbc.M802914200; ILAN Z, 1981, J BIOL CHEM, V256, P66; Iyanagi T, 2005, BIOCHEM BIOPH RES CO, V338, P520, DOI 10.1016/j.bbrc.2005.08.043; Jaffar M, 2001, ADV DRUG DELIVER REV, V53, P217, DOI 10.1016/S0169-409X(01)00228-9; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Leclerc D, 1998, P NATL ACAD SCI USA, V95, P3059, DOI 10.1073/pnas.95.6.3059; Mujacic M, 1999, GENE, V238, P325, DOI 10.1016/S0378-1119(99)00328-5; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Paine M.J.I., 2005, CYTOCHROME P450 STRU, P115, DOI DOI 10.1007/0-387-27447-2_4; Paine MJI, 2000, J BIOL CHEM, V275, P1471, DOI 10.1074/jbc.275.2.1471; Petoukhov MV, 2003, J APPL CRYSTALLOGR, V36, P540, DOI 10.1107/S0021889803000591; PORTER TD, 1986, BIOCHEMISTRY-US, V25, P1682, DOI 10.1021/bi00355a036; Rooseboom M, 2004, PHARMACOL REV, V56, P53, DOI 10.1124/pr.56.1.3; Saunders MP, 2000, BIOCHEM PHARMACOL, V59, P993, DOI 10.1016/S0006-2952(99)00405-0; SCHACTER BA, 1972, J BIOL CHEM, V247, P3601; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; SEM DS, 1993, BIOCHEMISTRY-US, V32, P11548, DOI 10.1021/bi00094a011; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; SMITH GCM, 1994, P NATL ACAD SCI USA, V91, P8710, DOI 10.1073/pnas.91.18.8710; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Welland A, 2008, BIOCHEMISTRY-US, V47, P9771, DOI 10.1021/bi800787m; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Zhao Q, 1999, PROTEIN SCI, V8, P298	48	110	112	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36628	36637		10.1074/jbc.M109.054304	http://dx.doi.org/10.1074/jbc.M109.054304			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858215	Green Published, hybrid			2022-12-25	WOS:000272970500063
J	Schmidt, A; Harada, SI; Kimmel, DB; Bai, C; Chen, F; Rutledge, SJ; Vogel, RL; Scafonas, A; Gentile, MA; Nantermet, PV; McElwee-Witmer, S; Pennypacker, B; Masarachia, P; Sahoo, SP; Kim, Y; Meissner, RS; Hartman, GD; Duggan, ME; Rodan, GA; Towler, DA; Ray, WJ				Schmidt, Azriel; Harada, Shun-Ichi; Kimmel, Donald B.; Bai, Chang; Chen, Fang; Rutledge, Su Jane; Vogel, Robert L.; Scafonas, Angela; Gentile, Michael A.; Nantermet, Pascale V.; McElwee-Witmer, Sheila; Pennypacker, Brenda; Masarachia, Patricia; Sahoo, Soumya P.; Kim, Yuntae; Meissner, Robert S.; Hartman, George D.; Duggan, Mark E.; Rodan, Gideon A.; Towler, Dwight A.; Ray, William J.			Identification of Anabolic Selective Androgen Receptor Modulators with Reduced Activities in Reproductive Tissues and Sebaceous Glands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; TERMINAL INTERACTIONS; PROTEIN-INTERACTION; PROMOTER ACTIVITY; GENETIC PATHWAYS; ER-ALPHA; INSENSITIVITY; TESTOSTERONE; MUTATIONS; EXPRESSION	Androgen replacement therapy is a promising strategy for the treatment of frailty; however, androgens pose risks for unwanted effects including virilization and hypertrophy of reproductive organs. Selective Androgen Receptor Modulators (SARMs) retain the anabolic properties of androgens in bone and muscle while having reduced effects in other tissues. We describe two structurally similar 4-aza-steroidal androgen receptor (AR) ligands, Cl-4AS-1, a full agonist, and TFM-4AS-1, which is a SARM. TFM-4AS-1 is a potent AR ligand (IC50, 38 nM) that partially activates an AR-dependent MMTV promoter (55% of maximal response) while antagonizing the N-terminal/C-terminal interaction within AR that is required for full receptor activation. Microarray analyses of MDA-MB-453 cells show that whereas Cl-4AS-1 behaves like 5 alpha-dihydrotestosterone (DHT), TFM-4AS-1 acts as a gene-selective agonist, inducing some genes as effectively as DHT and others to a lesser extent or not at all. This gene-selective agonism manifests as tissue-selectivity: in ovariectomized rats, Cl-4AS-1 mimics DHT while TFM-4AS-1 promotes the accrual of bone and muscle mass while having reduced effects on reproductive organs and sebaceous glands. Moreover, TFM-4AS-1 does not promote prostate growth and antagonizes DHT in seminal vesicles. To confirm that the biochemical properties of TFM-4AS-1 confer tissue selectivity, we identified a structurally unrelated compound, FTBU-1, with partial agonist activity coupled with antagonism of the N-terminal/C-terminal interaction and found that it also behaves as a SARM. TFM-4AS-1 and FTBU-1 represent two new classes of SARMs and will allow for comparative studies aimed at understanding the biophysical and physiological basis of tissue-selective effects of nuclear receptor ligands.	[Schmidt, Azriel; Harada, Shun-Ichi; Kimmel, Donald B.; Bai, Chang; Chen, Fang; Rutledge, Su Jane; Vogel, Robert L.; Scafonas, Angela; Gentile, Michael A.; Nantermet, Pascale V.; McElwee-Witmer, Sheila; Pennypacker, Brenda; Masarachia, Patricia; Rodan, Gideon A.; Towler, Dwight A.; Ray, William J.] Merck Res Labs, Dept Mol Endocrinol Bone Biol, West Point, PA 19486 USA; [Kim, Yuntae; Meissner, Robert S.; Hartman, George D.; Duggan, Mark E.] Merck Res Labs, Dept Med Chem, West Point, PA 19486 USA; [Sahoo, Soumya P.] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA	Merck & Company; Merck & Company; Merck & Company	Schmidt, A (corresponding author), Merck Res Labs, Dept Mol Endocrinol, POB 4, West Point, PA 19486 USA.	azriel_schmidt@merck.com	Ray, William J/E-9834-2016	Towler, Dwight/0000-0003-2107-7923; Ray, William/0000-0002-4491-167X				Bachmann GA, 1999, AM J OBSTET GYNECOL, V180, pS308, DOI 10.1016/S0002-9378(99)70724-6; Bain J, 2007, CLIN INTERV AGING, V2, P567; Beauchet O, 2006, EUR J ENDOCRINOL, V155, P773, DOI 10.1530/eje.1.02306; Bettoun DJ, 2005, J BIOL CHEM, V280, P38898, DOI 10.1074/jbc.C500324200; Bhasin S, 2003, J GERONTOL A-BIOL, V58, P1002; Bidder M, 2000, BIOCHEMISTRY-US, V39, P8917, DOI 10.1021/bi000343+; Carnahan RM, 2004, DRUG AGING, V21, P361, DOI 10.2165/00002512-200421060-00002; Chen F, 2004, J STEROID BIOCHEM, V91, P247, DOI 10.1016/j.jsbmb.2004.04.009; Chen TS, 2008, CURR OPIN CHEM BIOL, V12, P418, DOI 10.1016/j.cbpa.2008.07.001; Deeb A, 2008, J CLIN ENDOCR METAB, V93, P3691, DOI 10.1210/jc.2008-0737; Elhaji YA, 2004, MOL ENDOCRINOL, V18, P1876, DOI 10.1210/me.2004-0023; Gao WQ, 2007, DRUG DISCOV TODAY, V12, P241, DOI 10.1016/j.drudis.2007.01.003; Gao WQ, 2006, PHARM RES-DORDR, V23, P1641, DOI 10.1007/s11095-006-9024-3; Ghali SA, 2003, J CLIN ENDOCR METAB, V88, P2185, DOI 10.1210/jc.2002-021324; Gustafsson JA, 1998, CURR OPIN CHEM BIOL, V2, P508, DOI 10.1016/S1367-5931(98)80127-0; HALL RE, 1994, EUR J CANCER, V30A, P484, DOI 10.1016/0959-8049(94)90424-3; HALL RE, 1992, INT J CANCER, V52, P778, DOI 10.1002/ijc.2910520518; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Holterhus PM, 2005, EXP CLIN ENDOCR DIAB, V113, P457, DOI 10.1055/s-2005-865770; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Isidori A M, 2005, J Endocrinol Invest, V28, P73; Jaaskelainen J, 2006, J MOL ENDOCRINOL, V36, P361, DOI 10.1677/jme.1.01885; KALLIO PJ, 1995, MOL ENDOCRINOL, V9, P1017, DOI 10.1210/me.9.8.1017; Katzenellenbogen BS, 2002, SCIENCE, V295, P2380, DOI 10.1126/science.1070442; Kaufman J M, 2003, Aging Male, V6, P166, DOI 10.1080/713604787; Kilbourne EJ, 2007, CURR OPIN INVEST DR, V8, P821; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; Marks LS, 2008, UROLOGY, V72, P247, DOI 10.1016/j.urology.2008.03.033; Matsumoto T, 2008, J STEROID BIOCHEM, V109, P236, DOI 10.1016/j.jsbmb.2008.03.023; MCDONNELL DP, 1995, MOL ENDOCRINOL, V9, P659, DOI 10.1210/me.9.6.659; MEISSNER RS, 2009, ACS NAT M, V32; Nantermet PV, 2005, ENDOCRINOLOGY, V146, P564, DOI 10.1210/en.2004-1132; Nantermet PV, 2004, J BIOL CHEM, V279, P1310, DOI 10.1074/jbc.M310206200; Nettleship JE, 2009, FRONT HORM RES, V37, P91, DOI 10.1159/000176047; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; PFAHL M, 1993, ENDOCR REV, V14, P651, DOI 10.1210/er.14.5.651; Quigley CA, 2004, MECH AGEING DEV, V125, P683, DOI 10.1016/j.mad.2004.08.007; Scafonas A, 2008, J STEROID BIOCHEM, V110, P197, DOI 10.1016/j.jsbmb.2007.10.013; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; Schneikert J, 1996, J BIOL CHEM, V271, P23907, DOI 10.1074/jbc.271.39.23907; Stanworth RD, 2009, FRONT HORM RES, V37, P74, DOI 10.1159/000176046; Thompson J, 2001, MOL ENDOCRINOL, V15, P923, DOI 10.1210/me.15.6.923; Tolman RL, 1997, J STEROID BIOCHEM, V60, P303, DOI 10.1016/S0960-0760(96)00199-9; Valenti G, 2007, Minerva Ginecol, V59, P43; Vermeulen A, 2003, ANN ENDOCRINOL-PARIS, V64, P109; YAMAMOTO M, 1993, CALCIFIED TISSUE INT, V53, P278, DOI 10.1007/BF01320914; Yamamoto M, 1998, ENDOCRINOLOGY, V139, P1411, DOI 10.1210/en.139.3.1411; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V	48	30	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36367	36376		10.1074/jbc.M109.049734	http://dx.doi.org/10.1074/jbc.M109.049734			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19846549	Green Published, hybrid			2022-12-25	WOS:000272970500038
J	Vergarajauregui, S; Martina, JA; Puertollano, R				Vergarajauregui, Silvia; Martina, Jose A.; Puertollano, Rosa			Identification of the Penta-EF-hand Protein ALG-2 as a Ca2+-dependent Interactor of Mucolipin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR POTENTIAL CHANNEL; CALCIUM-BINDING PROTEIN; APOPTOSIS-LINKED GENE-2; GROWTH-FACTOR RECEPTOR; RETICULUM EXIT SITES; CATION CHANNEL; CA2+-BINDING PROTEINS; MEMBRANE TRAFFICKING; LYSOSOMAL PATHWAY; EPITHELIAL-CELLS	Loss of function mutations in mucolipin-1 (MCOLN1) have been linked to mucolipidosis type IV (MLIV), a recessive lysosomal storage disease characterized by severe neurological and ophthalmological abnormalities. MCOLN1 is an ion channel that regulates membrane transport along the endolysosomal pathway. It has been suggested that MCOLN1 participates in several Ca2+-dependent processes, including fusion of lysosomes with the plasma membrane, fusion of late endosomes and autophagosomes with lysosomes, and lysosomal biogenesis. Here, we searched for proteins that interact with MCOLN1 in a Ca2+-dependent manner. We found that the penta-EF-hand protein ALG-2 binds to the NH-terminal cytosolic tail of MCOLN1. The interaction is direct, strictly dependent on Ca2+, and mediated by a patch of charged and hydrophobic residues located between MCOLN1 residues 37 and 49. We further show that MCOLN1 and ALG-2 co-localize to enlarged endosomes induced by overexpression of an ATPase-defective dominant-negative form of Vps4B (Vps4B(E235Q)). In agreement with the proposed role of MCOLN1 in the regulation of fusion/fission events, we found that overexpression of MCOLN1 caused accumulation of enlarged, aberrant endosomes that contain both early and late endosome markers. Interestingly, aggregation of abnormal endosomes was greatly reduced when the ALG-2-binding domain in MCOLN1 was mutated, suggesting that ALG-2 regulates MCOLN1 function. Overall, our data provide new insight into the molecular mechanisms that regulate MCOLN1 activity. We propose that ALG-2 acts as a Ca2+ sensor that modulates the function of MCOLN1 along the late endosomal-lysosomal pathway.	[Vergarajauregui, Silvia; Martina, Jose A.; Puertollano, Rosa] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Puertollano, R (corresponding author), NHLBI, Cell Biol Lab, NIH, 9000 Rockville Pike,Bldg 50-3537, Bethesda, MD 20892 USA.	puertolr@mail.nih.gov	Vergarajauregui, Silvia/ABG-8402-2020; Martina, Jose A/C-2772-2013	Vergarajauregui, Silvia/0000-0002-9247-6123; Martina, Jose/0000-0001-5814-8807	NHLBI Intramural Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005903, ZIAHL000140] Funding Source: NIH RePORTER	NHLBI Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by a National Institutes of Health grant from NHLBI Intramural Research.	Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306; AMIR N, 1987, PEDIATRICS, V79, P953; Aukunuru JV, 2001, PHARM RES-DORDR, V18, P565, DOI 10.1023/A:1011060705599; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; BACH G, 1977, AM J HUM GENET, V29, P610; BACH G, 1975, BIOCHEM BIOPH RES CO, V66, P1483, DOI 10.1016/0006-291X(75)90526-4; Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Bach G, 2005, PFLUG ARCH EUR J PHY, V451, P313, DOI 10.1007/s00424-004-1361-7; Bargal R, 2000, NAT GENET, V26, P118, DOI 10.1038/79095; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Cantiello HF, 2005, PFLUG ARCH EUR J PHY, V451, P304, DOI 10.1007/s00424-005-1448-9; Chen CM, 2005, BIOCHEM BIOPH RES CO, V333, P51, DOI 10.1016/j.bbrc.2005.05.074; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Christensen KA, 2002, J CELL SCI, V115, P599; CRANDALL BF, 1982, AM J MED GENET, V12, P301, DOI 10.1002/ajmg.1320120308; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Draeby I, 2007, ARCH BIOCHEM BIOPHYS, V467, P87, DOI 10.1016/j.abb.2007.07.028; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/ng0501-64; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; FOLKERTH RD, 1995, J NEUROPATH EXP NEUR, V54, P154, DOI 10.1097/00005072-199503000-00002; Fujita H, 2003, J CELL SCI, V116, P401, DOI 10.1242/jcs.00213; GORDON PB, 1993, J BIOL CHEM, V268, P26107; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Hoffert JD, 2007, J PROTEOME RES, V6, P3501, DOI 10.1021/pr0701153; Holroyd C, 1999, MOL BIOL CELL, V10, P3035, DOI 10.1091/mbc.10.9.3035; Hwang IS, 2002, FEBS LETT, V529, P183, DOI 10.1016/S0014-5793(02)03329-X; Katoh K, 2005, BIOCHEM J, V391, P677, DOI 10.1042/BJ20050398; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; la Cour JM, 2003, AM J PATHOL, V163, P81, DOI 10.1016/S0002-9440(10)63632-2; la Cour JM, 2007, BIOCHEM BIOPH RES CO, V353, P1063, DOI 10.1016/j.bbrc.2006.12.143; LaPlante JM, 2006, MOL GENET METAB, V89, P339, DOI 10.1016/j.ymgme.2006.05.016; LaPlante JM, 2002, FEBS LETT, V532, P183, DOI 10.1016/S0014-5793(02)03670-0; LaPlante JM, 2004, BIOCHEM BIOPH RES CO, V322, P1384, DOI 10.1016/j.bbrc.2004.08.045; Lo KWH, 1999, BIOCHEMISTRY-US, V38, P7498, DOI 10.1021/bi990034n; Luzio JP, 2007, BIOCHEM SOC T, V35, P1088, DOI 10.1042/BST0351088; Mahul-Mellier AL, 2006, J NEUROSCI, V26, P542, DOI 10.1523/JNEUROSCI.3069-05.2006; Maki M, 2002, BBA-PROTEINS PROTEOM, V1600, P51, DOI 10.1016/S1570-9639(02)00444-2; Manzoni M, 2004, FEBS LETT, V567, P219, DOI 10.1016/j.febslet.2004.04.080; Martin-Nieto J, 1998, BIOCHEMISTRY-US, V37, P227, DOI 10.1021/bi971765v; Miedel MT, 2008, J EXP MED, V205, P1477, DOI 10.1084/jem.20072194; Miedel MT, 2006, J BIOL CHEM, V281, P12751, DOI 10.1074/jbc.M511104200; Missotten M, 1999, CELL DEATH DIFFER, V6, P124, DOI 10.1038/sj.cdd.4400456; Okumura M, 2009, BIOCHEM BIOPH RES CO, V386, P237, DOI 10.1016/j.bbrc.2009.06.015; Piper RC, 2004, TRENDS CELL BIOL, V14, P471, DOI 10.1016/j.tcb.2004.07.010; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Puertollano R, 2009, AM J PHYSIOL-RENAL, V296, pF1245, DOI 10.1152/ajprenal.90522.2008; Rao RV, 2004, J BIOL CHEM, V279, P177, DOI 10.1074/jbc.M304490200; Raychowdhury MK, 2004, HUM MOL GENET, V13, P617, DOI 10.1093/hmg/ddh067; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Satoh H, 2002, BBA-PROTEINS PROTEOM, V1600, P61, DOI 10.1016/S1570-9639(02)00445-4; Satoh H, 2002, BIOCHEM BIOPH RES CO, V291, P1166, DOI 10.1006/bbrc.2002.6600; Shibata H, 2004, J BIOCHEM, V135, P117, DOI 10.1093/jb/mvh014; Shibata H, 2008, J BIOL CHEM, V283, P9623, DOI 10.1074/jbc.M800717200; Shibata H, 2007, BIOCHEM BIOPH RES CO, V353, P756, DOI 10.1016/j.bbrc.2006.12.101; Slaugenhaupt SA, 1999, AM J HUM GENET, V65, P773, DOI 10.1086/302549; Soyombo AA, 2006, J BIOL CHEM, V281, P7294, DOI 10.1074/jbc.M508211200; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Suzuki H, 2008, STRUCTURE, V16, P1562, DOI 10.1016/j.str.2008.07.012; Suzuki H, 2009, BIOCHEM SOC T, V37, P190, DOI 10.1042/BST0370190; Tarabykina S, 2004, FRONT BIOSCI-LANDMRK, V9, P1817, DOI 10.2741/1358; Tarabykina S, 2000, J BIOL CHEM, V275, P10514, DOI 10.1074/jbc.275.14.10514; Tebar F, 2002, MOL BIOL CELL, V13, P2057, DOI 10.1091/mbc.01-12-0571; TELLEZNAGEL I, 1976, ARCH NEUROL-CHICAGO, V33, P828, DOI 10.1001/archneur.1976.00500120032005; Thompson EG, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-54; Treusch S, 2004, P NATL ACAD SCI USA, V101, P4483, DOI 10.1073/pnas.0400709101; Trioulier Y, 2004, J BIOL CHEM, V279, P2046, DOI 10.1074/jbc.M309243200; Venkatachalam K, 2008, CELL, V135, P838, DOI 10.1016/j.cell.2008.09.041; Venugopal B, 2009, J CELL PHYSIOL, V219, P344, DOI 10.1002/jcp.21676; Vergarajauregui S, 2006, TRAFFIC, V7, P337, DOI 10.1111/j.1600-0854.2006.00387.x; Vergarajauregui S, 2008, HUM MOL GENET, V17, P2723, DOI 10.1093/hmg/ddn174; Vergarajauregui S, 2008, AUTOPHAGY, V4, P832, DOI 10.4161/auto.6567; Vergarajauregui S, 2008, BIOCHEM J, V410, P417, DOI 10.1042/BJ20070713; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Wang GH, 2006, J PROTEOME RES, V5, P1214, DOI 10.1021/pr050406g; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yamasaki A, 2006, MOL BIOL CELL, V17, P4876, DOI 10.1091/mbc.E06-05-0444; Yan Q, 2004, J BIOL CHEM, V279, P18270, DOI 10.1074/jbc.M400093200; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914	80	64	65	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36357	36366		10.1074/jbc.M109.047241	http://dx.doi.org/10.1074/jbc.M109.047241			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19864416	hybrid, Green Published			2022-12-25	WOS:000272970500037
J	Chen, JH; Cai, ZW; Sheppard, DN				Chen, Jeng-Haur; Cai, Zhiwei; Sheppard, David N.			Direct Sensing of Intracellular pH by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Cl- Channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; DEPENDENT HCO3-TRANSPORT; MURINE CELL-LINE; CHLORIDE CHANNEL; R-DOMAIN; ATP-HYDROLYSIS; MECHANISM; MUTATIONS; PORE; INHIBITION	In cystic fibrosis (CF), dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel disrupts epithelial ion transport and perturbs the regulation of intracellular pH (pH(i)). CFTR modulates pH(i) through its role as an ion channel and by regulating transport proteins. However, it is unknown how CFTR senses pH(i). Here, we investigate the direct effects of pH(i) on recombinant CFTR using excised membrane patches. By altering channel gating, acidic pH(i) increased the open probability (P-o) of wild-type CFTR, whereas alkaline pH(i) decreased P-o and inhibited Cl- flow through the channel. Acidic pH(i) potentiated the MgATP dependence of wild-type CFTR by increasing MgATP affinity and enhancing channel activity, whereas alkaline pH(i) inhibited the MgATP dependence of wildtype CFTR by decreasing channel activity. Because these data suggest that pH(i) modulates the interaction of MgATP with the nucleotide-binding domains (NBDs) of CFTR, we examined the pH(i) dependence of site-directed mutations in the two ATP-binding sites of CFTR that are located at the NBD1:NBD2 dimer interface (site 1: K464A-, D572N-, and G1349D-CFTR; site 2: G551D-, K1250M-, and D1370N-CFTR). Site 2 mutants, but not site 1 mutants, perturbed both potentiation by acidic pH(i) and inhibition by alkaline pH(i), suggesting that site 2 is a critical determinant of the pH(i) sensitivity of CFTR. The effects of pH(i) also suggest that site 2 might employ substrate-assisted catalysis to ensure that ATP hydrolysis follows NBD dimerization. We conclude that the CFTR Cl- channel senses directly pH(i). The direct regulation of CFTR by pH(i) has important implications for the regulation of epithelial ion transport.	[Chen, Jeng-Haur; Cai, Zhiwei; Sheppard, David N.] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	University of Bristol	Chen, JH (corresponding author), Univ Iowa, Howard Hughes Med Inst, Dept Internal Med, Roy J & Lucille A Carver Coll Med, 500 EMRB, Iowa City, IA 52242 USA.	jeng-haur-chen@uiowa.edu; D.N.Sheppard@bristol.ac.uk	Sheppard, David N/AAV-4187-2021; Chen, Jeng-Haur/E-1483-2011	Sheppard, David N/0000-0001-5533-9130; Chen, Jeng-Haur/0000-0001-6756-6939	Cystic Fibrosis Trust; University of Bristol; Overseas Research Student award	Cystic Fibrosis Trust; University of Bristol; Overseas Research Student award	This work was supported by the Cystic Fibrosis Trust.; Supported by the University of Bristol and an Overseas Research Student award. Current address and to whom correspondence may be addressed: Howard Hughes Medical Institute, Dept. of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, 500 EMRB, Iowa City, IA 52242. Tel.: 319-335-6540; Fax: 319-335-7623; E-mail: jeng-haur-chen@uiowa.edu.	Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; ANDERSON MP, 1991, SCIENCE, V251, P679, DOI 10.1126/science.1704151; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Barriere H, 2001, AM J PHYSIOL-CELL PH, V281, pC810, DOI 10.1152/ajpcell.2001.281.3.C810; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Cai Z, 1999, BRIT J PHARMACOL, V128, P108, DOI 10.1038/sj.bjp.0702748; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; CARSON MR, 1995, J BIOL CHEM, V270, P1711, DOI 10.1074/jbc.270.4.1711; Choi JY, 2001, NATURE, V410, P94, DOI 10.1038/35065099; Cotten JF, 1997, J BIOL CHEM, V272, P25617, DOI 10.1074/jbc.272.41.25617; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dousmanis AG, 2002, J GEN PHYSIOL, V119, P545, DOI 10.1085/jgp.20028594; ELGAVISH A, 1991, BIOCHEM BIOPH RES CO, V180, P342, DOI 10.1016/S0006-291X(05)81298-7; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; Ernst R, 2006, J BIOL CHEM, V281, P27471, DOI 10.1074/jbc.M601131200; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Hanekop N, 2006, FEBS LETT, V580, P1036, DOI 10.1016/j.febslet.2005.11.012; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Howell LD, 2000, BIOCHEM BIOPH RES CO, V271, P518, DOI 10.1006/bbrc.2000.2659; Ikuma M, 2000, P NATL ACAD SCI USA, V97, P8675, DOI 10.1073/pnas.140220597; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Ko SBH, 2002, EMBO J, V21, P5662, DOI 10.1093/emboj/cdf580; Lansdell KA, 2000, J PHYSIOL-LONDON, V524, P317, DOI 10.1111/j.1469-7793.2000.t01-1-00317.x; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Li HY, 2009, BIODRUGS, V23, P203, DOI 10.2165/11313570-000000000-00000; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; MCCARTY NA, 1993, J GEN PHYSIOL, V102, P1, DOI 10.1085/jgp.102.1.1; Ostedgaard LS, 2000, P NATL ACAD SCI USA, V97, P5657, DOI 10.1073/pnas.100588797; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Ramjeesingh M, 1999, BIOCHEMISTRY-US, V38, P1463, DOI 10.1021/bi982243y; Reddy MM, 1998, AM J PHYSIOL-CELL PH, V275, pC1040, DOI 10.1152/ajpcell.1998.275.4.C1040; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RICH DP, 1993, J BIOL CHEM, V268, P20259; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Schulte U, 1999, P NATL ACAD SCI USA, V96, P15298, DOI 10.1073/pnas.96.26.15298; Scott-Ward TS, 2007, P NATL ACAD SCI USA, V104, P16365, DOI 10.1073/pnas.0701562104; Sheppard David N., 1999, Physiological Reviews, V79, pS23; SHEPPARD DN, 1995, EMBO J, V14, P876, DOI 10.1002/j.1460-2075.1995.tb07069.x; Sheppard DN, 1997, J PHYSIOL-LONDON, V503, P333, DOI 10.1111/j.1469-7793.1997.333bh.x; Sigel H, 2005, CHEM SOC REV, V34, P875, DOI 10.1039/b505986k; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; TABCHARANI JA, 1993, NATURE, V366, P79, DOI 10.1038/366079a0; Vergani P, 2005, BIOCHEM SOC T, V33, P1003, DOI 10.1042/BST0331003; Vergani P, 2003, J GEN PHYSIOL, V121, P17, DOI 10.1085/jgp.20028673; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; WINTER MC, 1994, BIOPHYS J, V66, P1398, DOI 10.1016/S0006-3495(94)80930-0; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Zegarra-Moran O, 2002, BRIT J PHARMACOL, V137, P504, DOI 10.1038/sj.bjp.0704882; Zhang ZR, 2004, J MEMBRANE BIOL, V199, P15, DOI 10.1007/s00232-004-0672-0; Zhou Z, 2002, J GEN PHYSIOL, V120, P647, DOI 10.1085/jgp.20028685; Zifarelli G, 2008, J GEN PHYSIOL, V132, P185, DOI 10.1085/jgp.200809999	55	33	33	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35495	35506		10.1074/jbc.M109.072678	http://dx.doi.org/10.1074/jbc.M109.072678			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19837660	hybrid, Green Published			2022-12-25	WOS:000272645600026
J	D'Angelo, G; Prencipe, L; Iodice, L; Beznoussenko, G; Savarese, M; Marra, P; Di Tullio, G; Martire, G; De Matteis, MA; Bonatti, S				D'Angelo, Giovanni; Prencipe, Libera; Iodice, Luisa; Beznoussenko, Galina; Savarese, Marco; Marra, PierFrancesco; Di Tullio, Giuseppe; Martire, Gianluca; De Matteis, Maria Antonietta; Bonatti, Stefano			GRASP65 and GRASP55 Sequentially Promote the Transport of C-terminal Valine-bearing Cargos to and through the Golgi Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM EXPORT; CELL-SURFACE; INTERMEDIATE COMPARTMENT; STRUCTURAL INTEGRITY; MEMBRANE-PROTEINS; SELECTIVE EXPORT; MAMMALIAN-CELLS; REGULATES GOLGI; PROTGF-ALPHA; ER EXPORT	The Golgi matrix proteins GRASP65 and GRASP55 have recognized roles in maintaining the architecture of the Golgi complex, in mitotic progression and in unconventional protein secretion whereas, surprisingly, they have been shown to be dispensable for the transport of commonly used reporter cargo proteins along the secretory pathway. However, it is becoming increasingly clear that many trafficking machineries operate in a cargo-specific manner, thus we have investigated whether GRASPs may control the trafficking of selected classes of cargo. We have taken into consideration the C-terminal valine-bearing receptors CD8 alpha and Frizzled4 that we show bind directly to the PSD95-DlgA-zo-1 (PDZ) domains of GRASP65 and GRASP55. We demonstrate that both GRASPs are needed sequentially for the efficient transport to and through the Golgi complex of these receptors, thus highlighting a novel role for the GRASPs in membrane trafficking. Our results open new perspectives for our understanding of the regulation of surface expression of a class of membrane proteins, and suggests the causal mechanisms of a dominant form of autosomal human familial exudative vitreoretinopathy that arises from the Frizzled4 mutation involving its C-terminal valine.	[D'Angelo, Giovanni; Prencipe, Libera; Iodice, Luisa; Savarese, Marco; Martire, Gianluca; Bonatti, Stefano] Univ Naples Federico II, Dept Biochem & Med Biotechnol, I-80131 Naples, Italy; [D'Angelo, Giovanni; Beznoussenko, Galina; Marra, PierFrancesco; Di Tullio, Giuseppe; De Matteis, Maria Antonietta] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy; [Iodice, Luisa; Martire, Gianluca] Univ Molise, Dept Environm Sci & Technol, I-86090 Isernia, Italy; [Marra, PierFrancesco] Inst Canc Res, Chester Beatty Labs, Sect Cell & Mol Biol, London SW3 6JB, England	University of Naples Federico II; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Molise; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Bonatti, S (corresponding author), Via S Pansini 5, I-80131 Naples, Italy.	bonatti@unina.it	De Matteis, Maria Antonietta/AHE-5161-2022; Savarese, Marco/J-8307-2016	De Matteis, Maria Antonietta/0000-0003-0053-3061; Savarese, Marco/0000-0002-2591-244X; D'Angelo, Giovanni/0000-0002-0734-4127; DANGELO, GIOVANNI/0000-0001-5466-8709	Ministero Universita Ricerca Scientifica e Tecnologica; Italian Association for Cancer Research and Telethon Italia; Fondazione Italiana Ricerca sul Cancro	Ministero Universita Ricerca Scientifica e Tecnologica; Italian Association for Cancer Research and Telethon Italia(Fondazione AIRC per la ricerca sul cancroFondazione Telethon); Fondazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from the Ministero Universita Ricerca Scientifica e Tecnologica (to S. B.), the Italian Association for Cancer Research and Telethon Italia (to A. D. M.), and the Telethon Electron Microscopy Core Facility and by a fellowship from the Fondazione Italiana Ricerca sul Cancro (to G. D. A.).	Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102; Behnia R, 2007, J CELL BIOL, V176, P255, DOI 10.1083/jcb.200607151; Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; BONATTI S, 1989, J BIOL CHEM, V264, P12590; Boyle LH, 2006, J IMMUNOL, V176, P6464, DOI 10.4049/jimmunol.176.11.6464; Crambert G, 2004, J BIOL CHEM, V279, P30888, DOI 10.1074/jbc.M313494200; DELONGH RU, 2006, FRONT BIOSCI, V11, P2442; Devine L, 2000, J IMMUNOL, V164, P833, DOI 10.4049/jimmunol.164.2.833; DIALYNAS DP, 1981, J EXP MED, V153, P595, DOI 10.1084/jem.153.3.595; DISANTO JP, 1988, EMBO J, V7, P3465, DOI 10.1002/j.1460-2075.1988.tb03221.x; Duran JM, 2008, MOL BIOL CELL, V19, P2579, DOI 10.1091/mbc.E07-10-0998; Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; GALLIONE CJ, 1985, J VIROL, V54, P374, DOI 10.1128/JVI.54.2.374-382.1985; HENNECKE S, 1993, J BIOL CHEM, V268, P26607; HOBBIE L, 1994, J BIOL CHEM, V269, P20958; Iodice L, 2001, J BIOL CHEM, V276, P28920, DOI 10.1074/jbc.M103558200; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Kinseth MA, 2007, CELL, V130, P524, DOI 10.1016/j.cell.2007.06.029; Kondylis V, 2005, MOL BIOL CELL, V16, P4061, DOI 10.1091/mbc.E04-10-0938; Kuehn MJ, 1997, CURR OPIN CELL BIOL, V9, P477, DOI 10.1016/S0955-0674(97)80022-1; Kuo A, 2000, EMBO J, V19, P6427, DOI 10.1093/emboj/19.23.6427; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Lotti LV, 1996, EXP CELL RES, V227, P323, DOI 10.1006/excr.1996.0281; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Martire G, 1996, J BIOL CHEM, V271, P3541; Mezzacasa A, 2002, TRAFFIC, V3, P833, DOI 10.1034/j.1600-0854.2002.31108.x; Mottola G, 2000, J BIOL CHEM, V275, P24070, DOI 10.1074/jbc.M910400199; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; NORMENT AM, 1988, EMBO J, V7, P3433, DOI 10.1002/j.1460-2075.1988.tb03217.x; Nufer O, 2002, J CELL SCI, V115, P619; PARNES JR, 1989, ADV IMMUNOL, V44, P265; PASCALE MC, 1992, J BIOL CHEM, V267, P9940; Paulhe F, 2004, J BIOL CHEM, V279, P55545, DOI 10.1074/jbc.M407813200; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Ronchi P, 2008, J CELL BIOL, V181, P105, DOI 10.1083/jcb.200710093; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; SCHMIDTULLRICH R, 1990, INT IMMUNOL, V2, P247, DOI 10.1093/intimm/2.3.247; Schotman H, 2008, DEV CELL, V14, P171, DOI 10.1016/j.devcel.2007.12.006; Sengupta D, 2009, J CELL BIOL, V186, P41, DOI 10.1083/jcb.200902110; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Spatuzza C, 2004, J BIOL CHEM, V279, P42535, DOI 10.1074/jbc.M401860200; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065; Urena JM, 1999, J CELL SCI, V112, P773; Vasile E, 2003, TRAFFIC, V4, P254, DOI 10.1034/j.1600-0854.2003.00080.x; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yao RJ, 2001, BIOCHEM BIOPH RES CO, V286, P771, DOI 10.1006/bbrc.2001.5430	58	52	52	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34849	34860		10.1074/jbc.M109.068403	http://dx.doi.org/10.1074/jbc.M109.068403			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840934	Green Published, hybrid			2022-12-25	WOS:000272439600040
J	Juge, N; Muroyama, A; Hiasa, M; Omote, H; Moriyama, Y				Juge, Narinobu; Muroyama, Akiko; Hiasa, Miki; Omote, Hiroshi; Moriyama, Yoshinori			Vesicular Inhibitory Amino Acid Transporter Is a Cl-/gamma-Aminobutyrate Co-transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLES; FUNCTIONAL RECONSTITUTION; GABA TRANSPORTER; RAT-BRAIN; IDENTIFICATION; GLYCINE; NEUROTRANSMITTER; NEURONS; PROTEIN; CARRIER	The vesicular inhibitory amino acid transporter (VIAAT) is a synaptic vesicle protein responsible for the vesicular storage of gamma-aminobutyrate (GABA) and glycine which plays an essential role in GABAergic and glycinergic neurotransmission. The transport mechanism of VIAAT remains largely unknown. Here, we show that proteoliposomes containing purified VIAAT actively took up GABA upon formation of membrane potential (Delta psi) (positive inside) but not Delta pH. VIAAT-mediated GABA uptake had an absolute requirement for Cl- and actually accompanied Cl- movement. Kinetic analysis indicated that one GABA molecule and two Cl- equivalents were transported during one transport cycle. VIAAT in which Glu(213) was specifically mutated to alanine completely lost the ability to take up both GABA and Cl-. Essentially the same results were obtained with glycine, another substrate of VIAAT. These results demonstrated that VIAAT is a vesicular Cl- transporter that co-transports Cl- with GABA or glycine in a Delta psi dependent manner. It is concluded that Cl- plays an essential role in vesicular storage of GABA and glycine.	[Juge, Narinobu; Muroyama, Akiko; Hiasa, Miki; Omote, Hiroshi; Moriyama, Yoshinori] Okayama Univ, Dept Membrane Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	Okayama University	Moriyama, Y (corresponding author), Okayama Univ, Dept Membrane Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan.	moriyama@pharm.okayama-u.ac.jp	OMOTE, Hiroshi/B-1635-2011; Juge, Narinobu/M-1125-2018	Juge, Narinobu/0000-0002-5825-6717	Ministry of Education, Science, Sports, and Culture of Japan; Ajinomoto 3A	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ajinomoto 3A	This work was supported in part by grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan and the Ajinomoto 3A Research grant (to Y.M.).	Bedet C, 2000, J NEUROCHEM, V75, P1654, DOI 10.1046/j.1471-4159.2000.0751654.x; BURGER PM, 1991, NEURON, V7, P287, DOI 10.1016/0896-6273(91)90267-4; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Dumoulin A, 1999, J CELL SCI, V112, P811; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; FYKSE EM, 1989, J NEUROCHEM, V52, P946, DOI 10.1111/j.1471-4159.1989.tb02546.x; Gasnier B, 2004, PFLUG ARCH EUR J PHY, V447, P756, DOI 10.1007/s00424-003-1091-2; HELL JW, 1991, BIOCHEMISTRY-US, V30, P11795, DOI 10.1021/bi00115a009; HELL JW, 1990, J BIOL CHEM, V265, P2111; HELL JW, 1988, EMBO J, V7, P3023, DOI 10.1002/j.1460-2075.1988.tb03166.x; Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200; KISH PE, 1989, P NATL ACAD SCI USA, V86, P3877, DOI 10.1073/pnas.86.10.3877; Martens H, 2008, J NEUROSCI, V28, P13125, DOI 10.1523/JNEUROSCI.3887-08.2008; MAYCOX PR, 1990, TRENDS NEUROSCI, V13, P83, DOI 10.1016/0166-2236(90)90178-D; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MCINTIRE SL, 1993, NATURE, V364, P334, DOI 10.1038/364334a0; Miyaji T, 2008, P NATL ACAD SCI USA, V105, P11720, DOI 10.1073/pnas.0804015105; MORIYAMA Y, 1991, J BIOL CHEM, V266, P22141; PATEL AJ, 1985, J NEUROCHEM, V44, P1816, DOI 10.1111/j.1471-4159.1985.tb07173.x; Sagne C, 1997, FEBS LETT, V417, P177, DOI 10.1016/S0014-5793(97)01279-9; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SIEGHART W, 1992, TRENDS PHARMACOL SCI, V13, P446, DOI 10.1016/0165-6147(92)90142-S; Takamori S, 2000, J NEUROSCI, V20, P4904; Wojcik SM, 2006, NEURON, V50, P575, DOI 10.1016/j.neuron.2006.04.016; Zomot E, 2007, NATURE, V449, P726, DOI 10.1038/nature06133	26	38	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35073	35078		10.1074/jbc.M109.062414	http://dx.doi.org/10.1074/jbc.M109.062414			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19843525	Green Published, hybrid			2022-12-25	WOS:000272439600061
J	Guo, YB; Zhang, XQ; Huang, J; Zeng, Y; Liu, W; Geng, C; Li, KW; Yang, D; Wu, SF; Wei, HD; Han, ZG; Qian, XH; Jiang, Y; He, FC				Guo, Yuanbiao; Zhang, Xuequn; Huang, Jian; Zeng, Yan; Liu, Wei; Geng, Chao; Li, Ka Wan; Yang, Dong; Wu, Songfeng; Wei, Handong; Han, Zeguang; Qian, Xiaohong; Jiang, Ying; He, Fuchu			Relationships between Hematopoiesis and Hepatogenesis in the Midtrimester Fetal Liver Characterized by Dynamic Transcriptomic and Proteomic Profiles	PLOS ONE			English	Article							STEM-CELL PROPERTIES; BONE-MARROW; SELF-RENEWAL; GENE-EXPRESSION; PROTEIN; MOUSE; SYSTEM; GROWTH; DIFFERENTIATION; IDENTIFICATION	In fetal hematopoietic organs, the switch from hematopoiesis is hypothesized to be a critical time point for organogenesis, but it is not yet evidenced. The transient coexistence of hematopoiesis will be useful to understand the development of fetal liver (FL) around this time and its relationship to hematopoiesis. Here, the temporal and the comparative transcriptomic and proteomic profiles were observed during the critical time points corresponding to the initiation (E11.5), peak (E14.5), recession (E15.5), and disappearance (3 ddp) of mouse FL hematopoiesis. We found that E11.5-E14.5 corresponds to a FL hematopoietic expansion phase with distinct molecular features, including the expression of new transcription factors, many of which are novel KRAB (Kruppel-associated box)-containing zinc finger proteins. This time period is also characterized by extensive depression of some liver functions, especially catabolism/utilization, immune and defense, classical complement cascades, and intrinsic blood coagulation. Instead, the other liver functions increased, such as xenobiotic and sterol metabolism, synthesis of carbohydrate and glycan, the alternate and lectin complement cascades and extrinsic blood coagulation, and etc. Strikingly, all of the liver functions were significantly increased at E14.5-E15.5 and thereafter, and the depression of the key pathways attributes to build the hematopoietic microenvironment. These findings signal hematopoiesis emigration is the key to open the door of liver maturation.			Guo, YB (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China.	jiangy@hupo.org.cn; hefc@nic.bmi.ac.cn		Guo, Yuanbiao/0000-0002-7571-8864; Han, Ze-Guang/0000-0002-1018-1752; li, ka wan/0000-0001-6983-5055				Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Byrd N, 2002, DEVELOPMENT, V129, P361; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chagraoui J, 2003, BLOOD, V101, P2973, DOI 10.1182/blood-2002-05-1341; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dong Z, 2004, J BIOL CHEM, V279, P9215, DOI 10.1074/jbc.M312225200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Ho AD, 2007, CURR OPIN HEMATOL, V14, P330, DOI 10.1097/MOH.0b013e3281900f12; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Kinoshita T, 1999, P NATL ACAD SCI USA, V96, P7265, DOI 10.1073/pnas.96.13.7265; Kinoshita T, 2002, BBA-MOL CELL RES, V1592, P303, DOI 10.1016/S0167-4889(02)00323-3; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; LANSDORP PM, 1993, J EXP MED, V178, P787, DOI 10.1084/jem.178.3.787; Li J, 2006, J BIOL CHEM, V281, P16536, DOI 10.1074/jbc.M601386200; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nogueira MM, 2000, BIOCHEM BIOPH RES CO, V276, P803, DOI 10.1006/bbrc.2000.3543; Nomura S, 1997, EXP HEMATOL, V25, P565; Ohno N, 2001, STEM CELLS, V19, P71, DOI 10.1634/stemcells.19-1-71; Peault B, 1996, J Hematother, V5, P369, DOI 10.1089/scd.1.1996.5.369; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Rasanen TL, 2002, J BIOL CHEM, V277, P39867, DOI 10.1074/jbc.M205967200; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Rudnick DA, 2001, P NATL ACAD SCI USA, V98, P8885, DOI 10.1073/pnas.151217998; Sandhu JS, 2001, AM J PATHOL, V159, P1323, DOI 10.1016/S0002-9440(10)62519-9; Sato EF, 2004, BIOCHEMISTRY-MOSCOW+, V69, P18, DOI 10.1023/B:BIRY.0000016346.61403.24; Sattler M, 1999, BLOOD, V93, P2928; Sitnicka E, 1996, BLOOD, V88, P82; SKORIN C, 1992, BIOCHEM J, V281, P561, DOI 10.1042/bj2810561; SLAPERCORTENBACH I, 1987, BLOOD, V69, P135; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takeuchi M, 2002, BLOOD, V99, P1190, DOI 10.1182/blood.V99.4.1190; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Wolber FM, 2002, EXP HEMATOL, V30, P1010, DOI 10.1016/S0301-472X(02)00881-0; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Ying WT, 2006, MOL CELL PROTEOMICS, V5, P1703, DOI 10.1074/mcp.M500344-MCP200; Zhang XQ, 2006, PROTEOMICS, V6, P5260, DOI 10.1002/pmic.200600006; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691	49	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7641	10.1371/journal.pone.0007641	http://dx.doi.org/10.1371/journal.pone.0007641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19865483	Green Published, gold, Green Submitted			2022-12-25	WOS:000271194600019
J	Legoffic, A; Calvo, E; Cano, C; Folch-Puy, E; Barthet, M; Delpero, JR; Ferres-Maso, M; Dagorn, JC; Closa, D; Iovanna, J				Legoffic, Aude; Calvo, Ezequiel; Cano, Carla; Folch-Puy, Emma; Barthet, Marc; Delpero, Jean Robert; Ferres-Maso, Montse; Dagorn, Jean Charles; Closa, Daniel; Iovanna, Juan			The reg4 Gene, Amplified in the Early Stages of Pancreatic Cancer Development, Is a Promising Therapeutic Target	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; GASTRIC-CANCER; IV; IDENTIFICATION; MARKER; FAMILY; OVEREXPRESSION; ADENOCARCINOMA; METASTASIS; EXPRESSION	Background: The aim of our work was to identify the genes specifically altered in pancreatic adenocarcinoma and especially those that are altered early in cancer development. Methodology/Principal Findings: Gene copy number was systematically assessed with an ultra-high resolution CGH oligonucleotide microarray in DNA from samples of pancreatic cancer. Several new cancer-associated variations were observed. In this work we focused on one of them, involving the reg4 gene. Gene copy number gain of the reg4 gene was confirmed by qPCR in 14 cancer samples. It was also found with increased copy number in most PanIN3 samples. The relationship betweena gain in reg4 gene copy number and cancer development was investigated on the human pancreatic cancer cell line Mia-PaCa2 xenografted under the skin of nude mice. When cells were transfected with a vector allowing reg4 expression, they generated tumors almost twice larger in size. In addition, these tumors were more resistant to gemcitabine treatment than control tumors. Interestingly, weekly intraperitoneal administration of a monoclonal antibody to reg4 halved the size of tumors generated by Mia-PaCa2 cells, suggesting that the antibody interfered with a paracrine/autocrine mechanism involving reg4 and stimulating cancer progression. The addition of gemcitabine resulted in further reduction, tumors becoming 5 times smaller than control. Exposure to reg4 antibody resulted in a significant decrease in intra-tumor levels of pAkt, Bcl-xL, Bcl-2, survivin and cyclin D1. Conclusions/Significance: It was concluded that adjuvant therapies targeting reg4 could improve the standard treatment of pancreatic cancer with gemcitabine.	[Legoffic, Aude; Cano, Carla; Barthet, Marc; Dagorn, Jean Charles; Iovanna, Juan] INSERM, U624, Parc Sci & Technol Luminy, F-13258 Marseille, France; [Calvo, Ezequiel] CHUL Res Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ, Canada; [Folch-Puy, Emma; Ferres-Maso, Montse; Closa, Daniel] IIBB CSIC IDIBAPS, Expt Pathol Dept, CIBERehd, Barcelona, Spain; [Delpero, Jean Robert] Inst Paoli Calmettes, Dept Chirurg Oncol, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Laval University; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; UNICANCER; Institut Paoli-Calmette (IPC)	Legoffic, A (corresponding author), INSERM, U624, Parc Sci & Technol Luminy, F-13258 Marseille, France.	juan.iovanna@inserm.fr	Puy, Emma Folch/AAX-5558-2020; Closa, Daniel/Y-3848-2019; Folch Puy, Emma/Q-3157-2017; Iovanna, Juan/M-9805-2017	Puy, Emma Folch/0000-0002-6277-9027; Folch Puy, Emma/0000-0002-6277-9027; Iovanna, Juan/0000-0003-1822-2237; Closa Autet, Daniel/0000-0003-3797-3095; DELPERO, JEAN ROBERT/0000-0002-0000-1332				Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bishnupuri KS, 2006, GASTROENTEROLOGY, V130, P137, DOI 10.1053/j.gastro.2005.10.001; Chappuis PO, 2001, CANCER INVEST, V19, P65, DOI 10.1081/CNV-100000076; EGUCHI H, 2009, PANCREAS        0620; Furukawa T, 2006, CANCER SCI, V97, P1, DOI 10.1111/j.1349-7006.2005.00134.x; Gu ZN, 2005, CLIN CANCER RES, V11, P2237, DOI 10.1158/1078-0432.CCR-04-0356; Harada T, 2007, BRIT J CANCER, V96, P373, DOI 10.1038/sj.bjc.6603563; Harada T, 2002, CANCER RES, V62, P835; Hartupee JC, 2001, BBA-GENE STRUCT EXPR, V1518, P287, DOI 10.1016/S0167-4781(00)00284-0; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Iovanna JL, 2005, BBA-GEN SUBJECTS, V1723, P8, DOI 10.1016/j.bbagen.2005.01.002; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kitoh H, 2005, J GASTROENTEROL, V40, P511, DOI 10.1007/s00535-005-1577-0; Kuniyasu H, 2009, CELL PROLIFERAT, V42, P110, DOI 10.1111/j.1365-2184.2008.00577.x; Mahlamaki EH, 1997, GENE CHROMOSOME CANC, V20, P383, DOI 10.1002/(SICI)1098-2264(199712)20:4<383::AID-GCC10>3.0.CO;2-O; Mitani Y, 2007, ONCOGENE, V26, P4383, DOI 10.1038/sj.onc.1210215; Miyagawa K, 2008, ANTICANCER RES, V28, P1169; Nanakin A, 2007, LAB INVEST, V87, P304, DOI 10.1038/labinvest.3700507; Ohara S, 2008, CANCER SCI, V99, P1570, DOI 10.1111/j.1349-7006.2008.00846.x; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Saif MW, 2007, WORLD J GASTROENTERO, V13, P4423; Schleger C, 2000, J PATHOL, V191, P27, DOI 10.1002/(SICI)1096-9896(200005)191:1<27::AID-PATH582>3.0.CO;2-J; Singh M, 2007, PANCREATOLOGY, V7, P9, DOI 10.1159/000101873; SolinasToldo S, 1996, CANCER RES, V56, P3803; Takehara A, 2006, CANCER SCI, V97, P1191, DOI 10.1111/j.1349-7006.2006.00297.x; Violette S, 2003, INT J CANCER, V103, P185, DOI 10.1002/ijc.10788; WAN J, 2009, J MED CHEM      0126; Zhang YW, 2003, CANCER LETT, V200, P69, DOI 10.1016/S0304-3835(03)00460-9	30	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7495	10.1371/journal.pone.0007495	http://dx.doi.org/10.1371/journal.pone.0007495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834624	Green Published, Green Submitted, gold			2022-12-25	WOS:000270880700017
J	Beaule, C; Swanstrom, A; Leone, MJ; Herzog, ED				Beaule, Christian; Swanstrom, Adrienne; Leone, Maria Juliana; Herzog, Erik D.			Circadian Modulation of Gene Expression, but not Glutamate Uptake, in Mouse and Rat Cortical Astrocytes	PLOS ONE			English	Article							CLOCK GENE; OSCILLATORS; TRANSPORTERS; RHYTHMS; ANALOGS; PROTEIN; GLIA	Background: Circadian clocks control daily rhythms including sleep-wake, hormone secretion, and metabolism. These clocks are based on intracellular transcription-translation feedback loops that sustain daily oscillations of gene expression in many cell types. Mammalian astrocytes display circadian rhythms in the expression of the clock genes Period1 (Per1) and Period2 (Per2). However, a functional role for circadian oscillations in astrocytes is unknown. Because uptake of extrasynaptic glutamate depends on the presence of Per2 in astrocytes, we asked whether glutamate uptake by glia is circadian. Methodology/Principal Findings: We measured glutamate uptake, transcript and protein levels of the astrocyte-specific glutamate transporter, Glast, and the expression of Per1 and Per2 from cultured cortical astrocytes and from explants of somatosensory cortex. We found that glutamate uptake and Glast mRNA and protein expression were significantly reduced in Clock/Clock, Per2- or NPAS2-deficient glia. Uptake was augmented when the medium was supplemented with dibutyryl-cAMP or B27. Critically, glutamate uptake was not circadian in cortical astrocytes cultured from rats or mice or in cortical slices from mice. Conclusion/Significance: We conclude that glutamate uptake levels are modulated by CLOCK, PER2, NPAS2, and the composition of the culture medium, and that uptake does not show circadian variations.			Beaule, C (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	Herzog@wustl.edu		Herzog, Erik/0000-0001-7209-5174	Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [MH 63104, R01 MH063104] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063104] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Barnard AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000040; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BRIDGES RJ, 1991, J MED CHEM, V34, P717, DOI 10.1021/jm00106a037; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; DEBRUYNE JP, 2007, NAT NEUROSCI; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Furuta A, 1997, J NEUROSCI, V17, P8363; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Hertz L, 1990, Adv Exp Med Biol, V265, P227; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; King DP, 1997, GENETICS, V146, P1049; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; MARPEGAN L, 2009, J BIOL RHYTHMS; Maywood ES, 2006, PROG BRAIN RES, V153, P253, DOI 10.1016/S0079-6123(06)53015-8; MCCLUNG CA, 2005, P NATL ACAD SCI US; NOBLE M, 1991, CULTURING NERVE CELL, P499; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Oishi K, 2006, J THROMB HAEMOST, V4, P1774, DOI 10.1111/j.1538-7836.2006.02032.x; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; ROYBAL K, 2007, P NATL ACAD SCI US; Schlag BD, 1998, MOL PHARMACOL, V53, P355, DOI 10.1124/mol.53.3.355; Spanagel R, 2005, NAT MED, V11, P35, DOI 10.1038/nm1163; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; TUREK FW, 2005, SCIENCE; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Waagepetersen HS, 2001, NEUROCHEM RES, V26, P661, DOI 10.1023/A:1010939304104; Womac AD, 2009, EUR J NEUROSCI, V30, P869, DOI 10.1111/j.1460-9568.2009.06874.x; Won CK, 2000, BRAIN RES, V887, P250, DOI 10.1016/S0006-8993(00)02922-X; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V12, P1	39	53	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7476	10.1371/journal.pone.0007476	http://dx.doi.org/10.1371/journal.pone.0007476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829696	Green Submitted, gold, Green Published			2022-12-25	WOS:000270847800013
J	Krauss, S; So, J; Hambrock, M; Kohler, A; Kunath, M; Scharff, C; Wessling, M; Grzeschik, KH; Schneider, R; Schweiger, S				Krauss, Sybille; So, Joyce; Hambrock, Melanie; Koehler, Andrea; Kunath, Melanie; Scharff, Constance; Wessling, Martina; Grzeschik, Karl-Heinz; Schneider, Rainer; Schweiger, Susann			Point Mutations in GLI3 Lead to Misregulation of its Subcellular Localization	PLOS ONE			English	Article							GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; HEDGEHOG SIGNAL-TRANSDUCTION; PROTEIN PHOSPHATASE 2A; SYNDROME GENE MID1; OPITZ-SYNDROME; SPINAL-CORD; ACTIVATOR FUNCTION; SYNDROME FAMILIES; UBIQUITIN LIGASE; VERTEBRATE LIMB	Background: Mutations in the transcription factor GLI3, a downstream target of Sonic Hedgehog (SHH) signaling, are responsible for the development of malformation syndromes such as Greig-cephalopolysyndactyly-syndrome (GCPS), or Pallister-Hall-syndrome (PHS). Mutations that lead to loss of function of the protein and to haploinsufficiency cause GCPS, while truncating mutations that result in constitutive repressor function of GLI3 lead to PHS. As an exception, some point mutations in the C-terminal part of GLI3 observed in GCPS patients have so far not been linked to loss of function. We have shown recently that protein phosphatase 2A (PP2A) regulates the nuclear localization and transcriptional activity a of GLI3 function. Principal Findings: We have shown recently that protein phosphatase 2A (PP2A) and the ubiquitin ligase MID1 regulate the nuclear localization and transcriptional activity of GLI3. Here we show mapping of the functional interaction between the MID1-a4-PP2A complex and GLI3 to a region between amino acid 568-1100 of GLI3. Furthermore we demonstrate that GCPS-associated point mutations, that are located in that region, lead to misregulation of the nuclear GLI3-localization and transcriptional activity. GLI3 phosphorylation itself however appears independent of its localization and remains untouched by either of the point mutations and by PP2A-activity, which suggests involvement of an as yet unknown GLI3 interaction partner, the phosphorylation status of which is regulated by PP2A activity, in the control of GLI3 subcellular localization and activity. Conclusions: The present findings provide an explanation for the pathogenesis of GCPS in patients carrying C-terminal point mutations, and close the gap in our understanding of how GLI3-genotypes give rise to particular phenotypes. Furthermore, they provide a molecular explanation for the phenotypic overlap between Opitz syndrome patients with dysregulated PP2A-activity and syndromes caused by GLI3-mutations.			Krauss, S (corresponding author), Charite, Dept Dermatol, Berlin, Germany.	rainer.schneider@uibk.ac.at	Krauss, Sybille/L-5328-2016; Scharff, Constance/HHN-0673-2022	Krauss, Sybille/0000-0002-5653-9289				Aranda-Orgilles B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003507; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Biesecker LG, 1997, NAT GENET, V17, P259, DOI 10.1038/ng1197-259; Bok J, 2007, DEVELOPMENT, V134, P1713, DOI 10.1242/dev.000760; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Buchner G, 1999, HUM MOL GENET, V8, P1397, DOI 10.1093/hmg/8.8.1397; Buttitta L, 2003, DEVELOPMENT, V130, P6233, DOI 10.1242/dev.00851; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Elson E, 2002, J MED GENET, V39, P804, DOI 10.1136/jmg.39.11.804; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Johnston JJ, 2005, AM J HUM GENET, V76, P609, DOI 10.1086/429346; Kalff-Suske M, 1999, HUM MOL GENET, V8, P1769, DOI 10.1093/hmg/8.9.1769; KAMACHI Y, 1993, MOL CELL BIOL, V13, P5206, DOI 10.1128/MCB.13.9.5206; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Kim JH, 2005, DEV DYNAM, V234, P984, DOI 10.1002/dvdy.20542; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; Krauss S, 2008, CANCER RES, V68, P4658, DOI 10.1158/0008-5472.CAN-07-6174; Lei QB, 2004, DEVELOPMENT, V131, P3593, DOI 10.1242/dev.01230; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Murone M, 1999, EXP CELL RES, V253, P25, DOI 10.1006/excr.1999.4676; Nybakken K, 2002, CURR OPIN GENET DEV, V12, P503, DOI 10.1016/S0959-437X(02)00333-7; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Perry J, 1999, GENOMICS, V62, P385, DOI 10.1006/geno.1999.6043; Persson M, 2002, GENE DEV, V16, P2865, DOI 10.1101/gad.243402; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Tyurina OV, 2005, DEV BIOL, V277, P537, DOI 10.1016/j.ydbio.2004.10.003; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2007, DEV BIOL, V305, P460, DOI 10.1016/j.ydbio.2007.02.029; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Wild A, 1997, HUM MOL GENET, V6, P1979, DOI 10.1093/hmg/6.11.1979; Winter J, 2004, HUM GENET, V114, P541, DOI 10.1007/s00439-004-1114-x; Winter J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-105; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; ZHOU H, 2006, MOL CELL BIOL MCB	45	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7471	10.1371/journal.pone.0007471	http://dx.doi.org/10.1371/journal.pone.0007471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829694	gold, Green Published			2022-12-25	WOS:000270847800010
J	Bhuiya, MW; Liu, CJ				Bhuiya, Mohammad-Wadud; Liu, Chang-Jun			Engineering Monolignol 4-O-Methyltransferases to Modulate Lignin Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAFFEIC ACID 3-O-METHYLTRANSFERASE; ADENOSYL-L-METHIONINE; O-METHYLTRANSFERASES; SUBSTRATE PREFERENCES; METHYLATION; ALFALFA; EVOLUTION; ALDEHYDE; ENZYME; POLYMERIZATION	Lignin is a complex polymer derived from the oxidative coupling of three classical monolignols. Lignin precursors are methylated exclusively at the meta-positions (i.e. 3/5-OH) of their phenyl rings by native O-methyltransferases, and are precluded from substitution of the para-hydroxyl (4-OH) position. Ostensibly, the para-hydroxyls of phenolics are critically important for oxidative coupling of phenoxy radicals to form polymers. Therefore, creating a 4-O-methyltransferase to substitute the para-hydroxyl of monolignols might well interfere with the synthesis of lignin. The phylogeny of plant phenolic O-methyltransferases points to the existence of a batch of evolutionarily "plastic" amino acid residues. Following one amino acid at a time path of directed evolution, and using the strategy of structure-based iterative site-saturation mutagenesis, we created a novel monolignol 4-O-methyltransferase from the enzyme responsible for methylating phenylpropenes. We show that two plastic residues in the active site of the parental enzyme are vital in dominating substrate discrimination. Mutations at either one of these separate the evolutionarily tightly linked properties of substrate specificity and regioselective methylation of native O-methyltransferase, thereby conferring the ability for para-methylation of the lignin monomeric precursors, primarily monolignols. Beneficial mutations at both sites have an additive effect. By further optimizing enzyme activity, we generated a triple mutant variant that may structurally constitute a novel phenolic substrate binding pocket, leading to its high binding affinity and catalytic efficiency on monolignols. The 4-O-methoxylation of monolignol efficiently impairs oxidative radical coupling in vitro, highlighting the potential for applying this novel enzyme in managing lignin polymerization in planta.	[Bhuiya, Mohammad-Wadud; Liu, Chang-Jun] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	United States Department of Energy (DOE); Brookhaven National Laboratory	Liu, CJ (corresponding author), 50 Bell Ave, Upton, NY 11973 USA.	cliu@bnl.gov			Office of Basic Energy Science, Department of Energy [DEAC0298CH10886]	Office of Basic Energy Science, Department of Energy(United States Department of Energy (DOE))	This work was supported by the Office of Basic Energy Science, Department of Energy Grant DEAC0298CH10886 (to C.J.L.).	Baerson SR, 2008, J BIOL CHEM, V283, P3231, DOI 10.1074/jbc.M706587200; Bhuiya MW, 2009, ANAL BIOCHEM, V384, P151, DOI 10.1016/j.ab.2008.09.031; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; BUGOS RC, 1991, PLANT MOL BIOL, V17, P1203, DOI 10.1007/BF00028736; Coiner H, 2006, PLANT J, V46, P193, DOI 10.1111/J.1365-313X.2006.02680.x; Davin LB, 2005, CURR OPIN BIOTECH, V16, P398, DOI 10.1016/j.copbio.2005.06.010; Dixon Richard A., 2003, Phytochemistry Reviews, V2, P289, DOI 10.1023/B:PHYT.0000045486.50637.37; EDWARDS R, 1991, ARCH BIOCHEM BIOPHYS, V287, P372, DOI 10.1016/0003-9861(91)90492-2; Fournand D, 2003, PHYTOCHEMISTRY, V62, P139, DOI 10.1016/S0031-9422(02)00573-3; Freudenberg K., 1968, CONSTITUTION BIOSYNT, P45; Gang DR, 2002, PLANT CELL, V14, P505, DOI 10.1105/tpc.010327; GOWRI G, 1991, PLANT PHYSIOL, V97, P7, DOI 10.1104/pp.97.1.7; Guo DJ, 2001, PLANT CELL, V13, P73, DOI 10.1105/tpc.13.1.73; Ibrahim RK, 1998, PLANT MOL BIOL, V36, P1, DOI 10.1023/A:1005939803300; Inoue K, 2000, ARCH BIOCHEM BIOPHYS, V375, P175, DOI 10.1006/abbi.1999.1674; Khersonsky O, 2006, CURR OPIN CHEM BIOL, V10, P498, DOI 10.1016/j.cbpa.2006.08.011; Li HM, 2006, PLANT MOL BIOL, V61, P537, DOI 10.1007/s11103-006-0029-4; Li LG, 2000, J BIOL CHEM, V275, P6537, DOI 10.1074/jbc.275.9.6537; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Morreel K, 2004, PLANT PHYSIOL, V136, P3537, DOI 10.1104/pp.104.049304; Osakabe K, 1999, P NATL ACAD SCI USA, V96, P8955, DOI 10.1073/pnas.96.16.8955; PAKUSCH AE, 1989, ARCH BIOCHEM BIOPHYS, V271, P488, DOI 10.1016/0003-9861(89)90299-3; Parvathi K, 2001, PLANT J, V25, P193, DOI 10.1046/j.1365-313x.2001.00956.x; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Rothman SC, 2003, J MOL BIOL, V327, P593, DOI 10.1016/S0022-2836(03)00095-0; Sasaki S, 2004, FEBS LETT, V562, P197, DOI 10.1016/S0014-5793(04)00224-8; Schmidt DMZ, 2003, BIOCHEMISTRY-US, V42, P8387, DOI 10.1021/bi034769a; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Wang JH, 1999, ARCH BIOCHEM BIOPHYS, V368, P172, DOI 10.1006/abbi.1999.1304; Wang JH, 1998, ARCH BIOCHEM BIOPHYS, V349, P153, DOI 10.1006/abbi.1997.0452; Weng JK, 2008, CURR OPIN BIOTECH, V19, P166, DOI 10.1016/j.copbio.2008.02.014; YE ZH, 1994, PLANT CELL, V6, P1427, DOI 10.1105/tpc.6.10.1427; Yuan L, 2005, MICROBIOL MOL BIOL R, V69, P373, DOI 10.1128/MMBR.69.3.373-392.2005; Zubieta C, 2002, PLANT CELL, V14, P1265, DOI 10.1105/tpc.001412	35	47	50	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					277	285		10.1074/jbc.M109.036673	http://dx.doi.org/10.1074/jbc.M109.036673			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19875443	Green Published, hybrid			2022-12-25	WOS:000273070100029
J	Edington, AR; McKinzie, AA; Reynolds, AJ; Kassiou, M; Ryan, RM; Vandenberg, RJ				Edington, Amelia R.; McKinzie, Audra A.; Reynolds, Aaron J.; Kassiou, Michael; Ryan, Renae M.; Vandenberg, Robert J.			Extracellular Loops 2 and 4 of GLYT2 Are Required for N-Arachidonylglycine Inhibition of Glycine Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROTRANSMITTER TRANSPORTERS; GLUTAMATE TRANSPORTER; BACTERIAL HOMOLOG; PAIN; EXPRESSION; MOLECULES; CLONING; ACIDS; LEUT	Concentrations of extracellular glycine in the central nervous system are regulated by Na+/Cl--dependent glycine transporters, GLYT1 and GLYT2. N-Arachidonylglycine (NAGly) is an endogenous inhibitor of GLYT2 with little or no effect on GLYT1 and is analgesic in rat models of neuropathic and inflammatory pain. Understanding the molecular basis of NAGly interactions with GLYT2 may allow for the development of novel therapeutics. In this study, chimeric transporters were used to determine the structural basis for differences in NAGly sensitivity between GLYT1 and GLYT2 and also the actions of a series of related N-arachidonyl amino acids. Extracellular loops 2 and 4 of GLYT2 are important in the selective inhibition of GLYT2 by NAGly and by the related compounds N-arachidonyl-gamma-aminobutyric acid and N-arachidonyl-D-alanine, whereas only the extracellular loop 4 of GLYT2 is required for N-arachidonyl-L-alanine inhibition of transport. These observations suggest that the structure of the head group of these compounds is important in determining how they interact with extracellular loops 2 and 4 of GLYT2. Site-directed mutagenesis of GLYT2 EL4 residues was used to identify the key residues Arg(531), Lys(532), and Ile(545) that contribute to the differences in NAGly sensitivity.	[Edington, Amelia R.; McKinzie, Audra A.; Ryan, Renae M.; Vandenberg, Robert J.] Univ Sydney, Sch Med Sci, Bosch Inst, Discipline Pharmacol,Transporter Biol Grp, Sydney, NSW 2006, Australia; [Kassiou, Michael] Univ Sydney, Discipline Med Radiat Sci, Sydney, NSW 2006, Australia; [Reynolds, Aaron J.; Kassiou, Michael] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Reynolds, Aaron J.; Kassiou, Michael] Brain & Mind Res Inst, Camperdown, NSW 2050, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney	Vandenberg, RJ (corresponding author), Univ Sydney, Sch Med Sci, Bosch Inst, Discipline Pharmacol,Transporter Biol Grp, Sydney, NSW 2006, Australia.	rvan9242@mail.usyd.edu.au	Vandenberg, Robert John/E-6018-2016; Ryan, Renae/AAC-3540-2021	Vandenberg, Robert John/0000-0003-1523-4814; Ryan, Renae/0000-0002-8680-4610; Kassiou, Michael/0000-0002-6655-0529	Australian National Health and Medical Research Council (NHMRC)	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by an Australian National Health and Medical Research Council (NHMRC) Project Grant.	APRISON M. H., 1965, LIFE SCI, V4, P2075, DOI 10.1016/0024-3205(65)90325-5; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Betz H, 2006, BIOCHEM SOC T, V34, P55, DOI 10.1042/BST0340055; Bezuglov V, 2001, BIOORG MED CHEM LETT, V11, P447, DOI 10.1016/S0960-894X(00)00689-2; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; GUASTELLA J, 1992, P NATL ACAD SCI USA, V89, P7189, DOI 10.1073/pnas.89.15.7189; Huang SM, 2001, J BIOL CHEM, V276, P42639, DOI 10.1074/jbc.M107351200; Ju PC, 2004, J BIOL CHEM, V279, P22983, DOI 10.1074/jbc.M312484200; LIU QR, 1993, J BIOL CHEM, V268, P22802; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Morita K, 2008, J PHARMACOL EXP THER, V326, P633, DOI 10.1124/jpet.108.136267; Nelson N, 1998, J NEUROCHEM, V71, P1785; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Succar R, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-24; Vandenberg RJ, 1998, BRIT J PHARMACOL, V123, P1593, DOI 10.1038/sj.bjp.0701776; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Wiles AL, 2006, J NEUROCHEM, V99, P781, DOI 10.1111/j.1471-4159.2006.04107.x; Wong LAQ, 2008, NEUROPHARMACOLOGY, V54, P189, DOI 10.1016/j.neuropharm.2007.05.004; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	23	24	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36424	36430		10.1074/jbc.M109.017509	http://dx.doi.org/10.1074/jbc.M109.017509			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19875446	Green Published, hybrid			2022-12-25	WOS:000272970500044
J	Journo, D; Mor, A; Abeliovich, H				Journo, Dikla; Mor, Angelika; Abeliovich, Hagai			Aup1-mediated Regulation of Rtg3 during Mitophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; AUTOPHAGIC DEGRADATION; SELECTIVE AUTOPHAGY; AMINOPEPTIDASE-I; YEAST; MITOCHONDRIA; VACUOLE; TARGET; BIOGENESIS; RAPAMYCIN	Mitophagy is an autophagic process that degrades mitochondria by an intracellular engulfment that leads to their delivery into the lumen of the cell's hydrolytic compartment, such as the lysosome in animal cells or the vacuole in yeast. It is hypothesized that such processes serve a quality control function to prevent or slow the accumulation of malfunctioning mitochondria, which are thought in turn to underlie central aspects of the aging process in eukaryotic organisms. We recently identified a conserved mitochondrial protein phosphatase homolog, Aup1, which is required for efficient stationary phase mitophagy in yeast. In the present report, we demonstrate that the retrograde signaling pathway (RTG) is defective in aup1 Delta mutants. In agreement with a role for Aup1 in the regulation of the RTG pathway, we find that deletion of RTG3, a transcription factor that mediates the RTG response, causes a defect in stationary phase mitophagy and that deletion of AUP1 leads to changes in Rtg3 phosphorylation patterns under these conditions. In addition, we find that mitophagic conditions lead to induction of RTG pathway target genes in an Aup1-dependent fashion. Thus, our results suggest that the function of Aup1 in mitophagy could be explained through its regulation of Rtg3-dependent transcription.	[Journo, Dikla; Mor, Angelika; Abeliovich, Hagai] Hebrew Univ Jerusalem, Dept Biochem & Food Sci, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem	Abeliovich, H (corresponding author), Hebrew Univ Jerusalem, Dept Biochem & Food Sci, Fac Agr Food & Environm Qual Sci, IL-76100 Rehovot, Israel.	ahagai@agri.huji.ac.il			Israel Science Foundation [1016/07]	Israel Science Foundation(Israel Science Foundation)	This work was supported by Israel Science Foundation Grant 1016/07 (to H.A.).	Abeliovich H, 1999, EMBO J, V18, P6005, DOI 10.1093/emboj/18.21.6005; Abeliovich H, 2003, MOL BIOL CELL, V14, P477, DOI 10.1091/mbc.E02-07-0413; Abeliovich H, 2001, MICROBIOL MOL BIOL R, V65, P463, DOI 10.1128/MMBR.65.3.463-479.2001; Abeliovich H, 1998, J BIOL CHEM, V273, P11719, DOI 10.1074/jbc.273.19.11719; Abeliovich H, 2000, J CELL BIOL, V151, P1025, DOI 10.1083/jcb.151.5.1025; Abeliovich H, 2007, AUTOPHAGY, V3, P275, DOI 10.4161/auto.3915; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bernales S, 2007, AUTOPHAGY, V3, P285, DOI 10.4161/auto.3930; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; Cohen R, 2007, FEMS MICROBIOL LETT, V273, P239, DOI 10.1111/j.1574-6968.2007.00798.x; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; Deffieu M, 2009, J BIOL CHEM, V284, P14828, DOI 10.1074/jbc.M109.005181; Dilova I, 2006, FEMS YEAST RES, V6, P112, DOI 10.1111/j.1567-1364.2005.00008.x; Dunn WA, 2005, AUTOPHAGY, V1, P75; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Farre JC, 2004, TRENDS CELL BIOL, V14, P515, DOI 10.1016/j.tcb.2004.07.014; Gerhardt B, 1998, J BIOL CHEM, V273, P15818, DOI 10.1074/jbc.273.25.15818; Giannattasio S, 2005, J BIOL CHEM, V280, P42528, DOI 10.1074/jbc.M509187200; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Klionsky DJ, 2005, CURR BIOL, V15, pR282, DOI 10.1016/j.cub.2005.04.013; Klionsky DJ, 2005, J CELL SCI, V118, P7, DOI 10.1242/jcs.01620; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; Kvam E, 2007, AUTOPHAGY, V3, P85, DOI 10.4161/auto.3586; Labbe S, 1999, METHOD ENZYMOL, V306, P145; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; LIAO XS, 1993, CELL, V72, P61, DOI 10.1016/0092-8674(93)90050-Z; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; Onodera J, 2004, J BIOL CHEM, V279, P16071, DOI 10.1074/jbc.M312706200; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Ruan HH, 2007, FEMS YEAST RES, V7, P209, DOI 10.1111/j.1567-1364.2006.00160.x; Sakai Y, 2006, BBA-MOL CELL RES, V1763, P1767, DOI 10.1016/j.bbamcr.2006.08.023; Sakumoto NM, 1999, YEAST, V15, P1669, DOI 10.1002/(SICI)1097-0061(199911)15:15<1669::AID-YEA480>3.0.CO;2-6; Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Van Helden J, 2000, YEAST, V16, P177, DOI 10.1002/(SICI)1097-0061(20000130)16:2<177::AID-YEA516>3.0.CO;2-9; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang CW, 2003, MOL MED, V9, P65, DOI 10.1007/BF03402040; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Winter G, 2008, AUTOPHAGY, V4, P28, DOI 10.4161/auto.5127; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102	60	62	66	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35885	35895		10.1074/jbc.M109.048140	http://dx.doi.org/10.1074/jbc.M109.048140			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19840933	Green Published, hybrid			2022-12-25	WOS:000272645600064
J	Postow, L; Woo, EM; Chait, BT; Funabiki, H				Postow, Lisa; Woo, Eileen M.; Chait, Brian T.; Funabiki, Hironori			Identification of SMARCAL1 as a Component of the DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNO-OSSEOUS DYSPLASIA; BLOOMS-SYNDROME HELICASE; WERNER-SYNDROME PROTEIN; CHECKPOINT RESPONSE; REPLICATION FORKS; BINDING-PROTEIN; RECQ HELICASES; ATR; RECOMBINATION; REGRESSION	SMARCAL1 (also known as HARP) is a SWI/SNF family protein with an ATPase activity stimulated by DNA containing both single-stranded and double-stranded regions. Mutations in SMARCAL1 are associated with the disease Schimke immuno-osseous dysplasia, a multisystem autosomal recessive disorder characterized by Tcell immunodeficiency, growth inhibition, and renal dysfunction. The cellular function of SMARCAL1, however, is unknown. Here, using Xenopus egg extracts and mass spectrometry, we identify SMARCAL1 as a protein recruited to double-stranded DNA breaks. SMARCAL1 binds to double-stranded breaks and stalled replication forks in both egg extract and human cells, specifically colocalizing with the single-stranded DNA binding factor RPA. In addition, SMARCAL1 interacts physically with RPA independently of DNA. SMARCAL1 is phosphorylated in a caffeine-sensitive manner in response to double-stranded breaks and stalled replication forks. It has been suggested that stalled forks can be stabilized by a mechanism involving caffeine-sensitive kinases, or they collapse and subsequently recruit Rad51 to promote homologous recombination repair. We show that depletion of SMARCAL1 from U2OS cells leads to increased frequency of RAD51 foci upon generation of stalled replication forks, indicating that fork breakdown is more prevalent in the absence of SMARCAL1. We propose that SMARCAL1 is a novel DNA damage-binding protein involved in replication fork stabilization.	Rockefeller Univ, Lab Chromosome & Cell Biol, New York, NY 10065 USA; [Woo, Eileen M.; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Postow, L (corresponding author), 1230 York Ave, New York, NY 10065 USA.	PostowL@rockefeller.edu		Funabiki, Hironori/0000-0003-4831-4087	National Institutes of Health [T32 CA09673, RR00862]; Leukemia and Lymphoma Society of America; Howard Hughes Medical Institute; Rockefeller University; Irma T. Hirschl/Monique Weill-Caulier Trust; NATIONAL CANCER INSTITUTE [T32CA009673] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K02HL084384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Rockefeller University; Irma T. Hirschl/Monique Weill-Caulier Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 CA09673 (to L. P.) and RR00862 (to B. T. C.).; Supported by a fellowship from the Leukemia and Lymphoma Society of America.; Supported by a Howard Hughes Medical Institute predoctoral award.; Supported by the Rockefeller University and the Irma T. Hirschl/Monique Weill-Caulier Trust.	Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Boerkoel CF, 2002, NAT GENET, V30, P215, DOI 10.1038/ng821; Boerkoel CF, 2000, EUR J PEDIATR, V159, P1, DOI 10.1007/s004310050001; Bohr VA, 2008, TRENDS BIOCHEM SCI, V33, P609, DOI 10.1016/j.tibs.2008.09.003; Branzei D, 2009, DNA REPAIR, V8, P1038, DOI 10.1016/j.dnarep.2009.04.014; Brosh RM, 1999, J BIOL CHEM, V274, P18341, DOI 10.1074/jbc.274.26.18341; Burgess RC, 2009, J CELL BIOL, V185, P969, DOI 10.1083/jcb.200810055; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Clewing JM, 2007, J MED GENET, V44, P122, DOI 10.1136/jmg.2006.044313; Coleman MA, 2000, GENOMICS, V65, P274, DOI 10.1006/geno.2000.6174; Doherty KM, 2005, J BIOL CHEM, V280, P29494, DOI 10.1074/jbc.M500653200; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Garcia PL, 2004, EMBO J, V23, P2882, DOI 10.1038/sj.emboj.7600301; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; HOCKENSMITH JW, 1986, BIOCHEMISTRY-US, V25, P7812, DOI 10.1021/bi00372a005; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Leach CA, 2005, J CELL BIOL, V171, P947, DOI 10.1083/jcb.200508100; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Machwe A, 2007, NUCLEIC ACIDS RES, V35, P5729, DOI 10.1093/nar/gkm561; Machwe A, 2006, BIOCHEMISTRY-US, V45, P13939, DOI 10.1021/bi0615487; Matsumoto K, 2000, NUCLEIC ACIDS RES, V28, P4689, DOI 10.1093/nar/28.23.4689; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meister P, 2005, J CELL BIOL, V168, P537, DOI 10.1083/jcb.200410006; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Morrison AJ, 2004, CELL, V119, P767, DOI 10.1016/j.cell.2004.11.037; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Muthuswami R, 2000, J BIOL CHEM, V275, P7648, DOI 10.1074/jbc.275.11.7648; O'Neill T, 2000, J BIOL CHEM, V275, P22719, DOI 10.1074/jbc.M001002200; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Postow L, 2008, J CELL BIOL, V182, P467, DOI 10.1083/jcb.200802146; Ralf C, 2006, J BIOL CHEM, V281, P22839, DOI 10.1074/jbc.M604268200; Rivera T, 2009, CHROMOSOMA, V118, P223, DOI 10.1007/s00412-008-0190-4; Shaw G, 2008, STRUCTURE, V16, P1417, DOI 10.1016/j.str.2008.06.012; Shen JC, 2003, MECH AGEING DEV, V124, P921, DOI 10.1016/S0047-6374(03)00164-7; Smith E, 2009, NAT CELL BIOL, V11, P278, DOI 10.1038/ncb1835; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; SPRANGER J, 1991, J PEDIATR-US, V119, P64, DOI 10.1016/S0022-3476(05)81040-6; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	52	87	88	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35951	35961		10.1074/jbc.M109.048330	http://dx.doi.org/10.1074/jbc.M109.048330			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19841479	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000272645600070
J	Bohnsack, RN; Song, XZ; Olson, LJ; Kudo, M; Gotschall, RR; Canfield, WM; Cummings, RD; Smith, DF; Dahms, NM				Bohnsack, Richard N.; Song, Xuezheng; Olson, Linda J.; Kudo, Mariko; Gotschall, Russell R.; Canfield, William M.; Cummings, Richard D.; Smith, David F.; Dahms, Nancy M.			Cation-independent Mannose 6-Phosphate Receptor A COMPOSITE OF DISTINCT PHOSPHOMANNOSYL BINDING SITES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-II; ALPHA-N-ACETYLGLUCOSAMINIDASE; LYSOSOMAL-ENZYMES; CARBOHYDRATE-RECOGNITION; LIGAND-BINDING; PHOSPHORYLATED OLIGOSACCHARIDES; EXTRACYTOPLASMIC REGION; UNCOVERING ENZYME; IDENTIFICATION; LOCALIZATION	The 300-kDa cation-independent mannose 6-phosphate receptor (CI-MPR), which contains multiple mannose 6-phosphate (Man-6-P) binding sites that map to domains 3, 5, and 9 within its 15-domain extracytoplasmic region, functions as an efficient carrier of Man-6-P-containing lysosomal enzymes. To determine the types of phosphorylated N-glycans recognized by each of the three carbohydrate binding sites of the CI-MPR, a phosphorylated glycan microarray was probed with truncated forms of the CI-MPR. Surface plasmon resonance analyses using lysosomal enzymes with defined N-glycans were performed to evaluate whether multiple domains are needed to form a stable, high affinity carbohydrate binding pocket. Like domain 3, adjacent domains increase the affinity of domain 5 for phosphomannosyl residues, with domain 5 exhibiting similar to 60-fold higher affinity for lysosomal enzymes containing the phosphodiester Man-P-GlcNAc when in the context of a construct encoding domains 5-9. In contrast, domain 9 does not require additional domains for high affinity binding. The three sites differ in their glycan specificity, with only domain 5 being capable of recognizing Man-P-GlcNAc. In addition, domain 9, unlike domains 1-3, interacts with Man(8)GlcNAc(2) and Man(9)GlcNAc(2) oligosaccharides containing a single phosphomonoester. Together, these data indicate that the assembly of three unique carbohydrate binding sites allows the CI-MPR to interact with the structurally diverse phosphorylated N-glycans it encounters on newly synthesized lysosomal enzymes.	[Bohnsack, Richard N.; Olson, Linda J.; Dahms, Nancy M.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Song, Xuezheng; Cummings, Richard D.; Smith, David F.] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Kudo, Mariko; Gotschall, Russell R.; Canfield, William M.] Genzyme Corp, Oklahoma City, OK 73104 USA	Medical College of Wisconsin; Emory University; Sanofi-Aventis; Genzyme Corporation	Smith, DF (corresponding author), O Wayne Rollins Res Ctr, 1510 Clifton Rd NE,Rm 4035, Atlanta, GA 30322 USA.	dfsmith@emory.edu; ndahms@mcw.edu		Gotschall, Robert Russell/0000-0002-5050-1386	National Institutes of Health [R01DK42667, GM085448]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK42667 (to N.M.D.) and GM085448 (to D.F.S.).	Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; BOBEK G, 1991, ENDOCRINOLOGY, V128, P2204, DOI 10.1210/endo-128-4-2204; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Brown J, 2008, EMBO J, V27, P265, DOI 10.1038/sj.emboj.7601938; Byrd JC, 2000, J BIOL CHEM, V275, P18647, DOI 10.1074/jbc.M001273200; Chavez CA, 2007, BIOCHEMISTRY-US, V46, P12604, DOI 10.1021/bi7011806; CLAIRMONT KB, 1991, J BIOL CHEM, V266, P12131; DAHMS NM, 1993, J BIOL CHEM, V268, P5457; DAHMS NM, 1994, J BIOL CHEM, V269, P3802; Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3; Dell'Angelica EC, 2001, CELL, V106, P395, DOI 10.1016/S0092-8674(01)00470-6; Devi GR, 1998, MOL ENDOCRINOL, V12, P1661, DOI 10.1210/me.12.11.1661; DISTLER JJ, 1991, J BIOL CHEM, V266, P21687; Do H, 2002, J BIOL CHEM, V277, P29737, DOI 10.1074/jbc.M202369200; Gary-Bobo M, 2007, CURR MED CHEM, V14, P2945, DOI 10.2174/092986707782794005; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Hancock MK, 2002, J BIOL CHEM, V277, P47205, DOI 10.1074/jbc.M208534200; Hancock MK, 2002, J BIOL CHEM, V277, P11255, DOI 10.1074/jbc.M109855200; HASILIK A, 1980, P NATL ACAD SCI-BIOL, V77, P7074, DOI 10.1073/pnas.77.12.7074; HEFLER SK, 1987, BIOCHEM BIOPH RES CO, V146, P1173, DOI 10.1016/0006-291X(87)90771-6; HOFLACK B, 1987, J BIOL CHEM, V262, P123; Kasper D, 1996, J CELL BIOL, V134, P615, DOI 10.1083/jcb.134.3.615; Kornfeld R, 1999, J BIOL CHEM, V274, P32778, DOI 10.1074/jbc.274.46.32778; Kornfeld S., 2001, METABOLIC MOL BASES, P3469; Kreiling JL, 2005, J BIOL CHEM, V280, P21067, DOI 10.1074/jbc.M412971200; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Kudo M, 2005, J BIOL CHEM, V280, P36141, DOI 10.1074/jbc.m509008200; Leksa V, 2002, J BIOL CHEM, V277, P40575, DOI 10.1074/jbc.M207979200; Linnell J, 2001, J BIOL CHEM, V276, P23986, DOI 10.1074/jbc.M100700200; LUDWIG T, 1994, EMBO J, V13, P3430, DOI 10.1002/j.1460-2075.1994.tb06648.x; Marron-Terada PG, 2000, BIOCHEMISTRY-US, V39, P2243, DOI 10.1021/bi992226o; Marron-Terada PG, 1998, J BIOL CHEM, V273, P22358, DOI 10.1074/jbc.273.35.22358; Moreland RJ, 2005, J BIOL CHEM, V280, P6780, DOI 10.1074/jbc.M404008200; Mullins C, 2001, BIOESSAYS, V23, P333, DOI 10.1002/bies.1048; MULLIS KG, 1992, ANAL BIOCHEM, V205, P200, DOI 10.1016/0003-2697(92)90424-6; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; NATOWICZ M, 1982, J BIOL CHEM, V257, P4412; Olson LJ, 1999, J BIOL CHEM, V274, P29889, DOI 10.1074/jbc.274.42.29889; Olson LJ, 1999, J BIOL CHEM, V274, P36905, DOI 10.1074/jbc.274.52.36905; Olson LJ, 2004, J BIOL CHEM, V279, P34000, DOI 10.1074/jbc.M404588200; Olson LJ, 2004, EMBO J, V23, P2019, DOI 10.1038/sj.emboj.7600215; POHLMANN R, 1995, J BIOL CHEM, V270, P27311, DOI 10.1074/jbc.270.45.27311; Reddy ST, 2004, J BIOL CHEM, V279, P38658, DOI 10.1074/jbc.M407474200; Reddy ST, 2002, PROTEIN EXPRES PURIF, V26, P290, DOI 10.1016/S1046-5928(02)00542-9; Roberts DL, 1998, CELL, V93, P639, DOI 10.1016/S0092-8674(00)81192-7; Rohrer J, 2001, MOL BIOL CELL, V12, P1623, DOI 10.1091/mbc.12.6.1623; SCHMIDT B, 1995, J BIOL CHEM, V270, P14975, DOI 10.1074/jbc.270.25.14975; Sleat DE, 1997, J BIOL CHEM, V272, P731, DOI 10.1074/jbc.272.2.731; Sohar I, 1998, BIOCHEM J, V330, P903, DOI 10.1042/bj3300903; Song XZ, 2009, J BIOL CHEM, V284, P35201, DOI 10.1074/jbc.M109.056119; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; Sun GJ, 2005, GLYCOBIOLOGY, V15, P1136, DOI 10.1093/glycob/cwi098; TOMODA H, 1991, CARBOHYD RES, V213, P37, DOI 10.1016/S0008-6215(00)90596-2; TONG PY, 1989, J BIOL CHEM, V264, P7970; Uson I, 2003, ACTA CRYSTALLOGR D, V59, P57, DOI 10.1107/S090744490201884X; VALENZANO KJ, 1995, J BIOL CHEM, V270, P16441, DOI 10.1074/jbc.270.27.16441; VARKI A, 1983, J BIOL CHEM, V258, P2808; VARKI A, 1983, ARCH BIOCHEM BIOPHYS, V222, P145, DOI 10.1016/0003-9861(83)90511-8; VARKI A, 1980, J BIOL CHEM, V255, P847; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; WAHEED A, 1981, J BIOL CHEM, V256, P5717; WESTLUND B, 1991, J BIOL CHEM, V266, P23233; York SJ, 1999, J BIOL CHEM, V274, P1164, DOI 10.1074/jbc.274.2.1164	64	49	50	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35215	35226		10.1074/jbc.M109.056184	http://dx.doi.org/10.1074/jbc.M109.056184			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840944	Green Published, hybrid			2022-12-25	WOS:000272439600074
J	Sen, B; Styner, M; Xie, ZH; Case, N; Rubin, CT; Rubin, J				Sen, Buer; Styner, Maya; Xie, Zhihui; Case, Natasha; Rubin, Clinton T.; Rubin, Janet			Mechanical Loading Regulates NFATc1 and beta-Catenin Signaling through a GSK3 beta Control Node	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; GLYCOGEN-SYNTHASE KINASE-3; MESENCHYMAL STEM-CELLS; BINDING-PROTEIN-ALPHA; GENE-EXPRESSION; CYCLOOXYGENASE-2 EXPRESSION; ESTROGEN-RECEPTOR; NUCLEAR FACTOR; INHIBITS ADIPOGENESIS; CALCIUM OSCILLATIONS	Mechanical stimulation can prevent adipogenic and improve osteogenic lineage allocation of mesenchymal stem cells (MSC), an effect associated with the preservation of beta-catenin levels. We asked whether mechanical up-regulation of beta-catenin was critical to reduction in adipogenesis as well as other mechanical events inducing alternate MSC lineage selection. In MSC cultured under strong adipogenic conditions, mechanical load (3600 cycles/day, 2% strain) inactivated GSK3 beta in a Wnt-independent fashion. Small interfering RNA targeting GSK3 beta prevented both strain-induced induction of beta-catenin and an increase in COX2, a factor associated with increased osteoprogenitor phenotype. Small interfering RNA knockdown of beta-catenin blocked mechanical reduction of peroxisome proliferator-activated receptor gamma and adiponectin, implicating beta-catenin in strain inhibition of adipogenesis. In contrast, the effect of both mechanical and pharmacologic inhibition of GSK3 beta on the putative beta-catenin target, COX2, was unaffected by beta-catenin knockdown. GSK3 beta inhibition caused accumulation of nuclear NFATc1; mechanical strain increased nuclear NFATc1, independent of beta-catenin. NFATc1 knockdown prevented mechanical stimulation of COX2, implicating NFATc1 signaling. Finally, inhibition of GSK3 beta caused association of RNA polymerase II with the COX2 gene, suggesting transcription initiation. These results demonstrate that mechanical inhibition of GSK3 beta induces activation of both beta-catenin and NFATc1 signaling, limiting adipogenesis via the former and promoting osteoblastic differentiation via NFATc1/COX2. Our novel findings suggest that mechanical loading regulates mesenchymal stem cell differentiation through inhibition of GSK3 beta, which in turn regulates multiple downstream effectors.	[Sen, Buer; Styner, Maya; Xie, Zhihui; Case, Natasha; Rubin, Janet] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Rubin, Clinton T.] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	University of North Carolina; University of North Carolina Chapel Hill; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sen, B (corresponding author), Univ N Carolina, Dept Med, 5030 Burnett Womack,CB 7170, Chapel Hill, NC 27599 USA.	buer_sen@med.unc.edu	Styner, Maya/I-2044-2019	Styner, Maya/0000-0001-9790-8645	National Institutes of Health [AR42360, AR52014]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052014, R56AR042360, R01AR042360, R01AR056655] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR42360 and AR52014 (to J.R.).	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Araki Y, 2003, CANCER RES, V63, P728; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Aydemir ABC, 2007, ANN NY ACAD SCI, V1117, P138, DOI 10.1196/annals.1402.004; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Canellada A, 2008, GLIA, V56, P709, DOI 10.1002/glia.20647; Case N, 2008, J BIOL CHEM, V283, P29196, DOI 10.1074/jbc.M801907200; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Clines GA, 2007, MOL ENDOCRINOL, V21, P486, DOI 10.1210/me.2006-0346; Cok SJ, 2001, J BIOL CHEM, V276, P23179, DOI 10.1074/jbc.M008461200; Cowin SC, 1998, AM J MED SCI, V316, P184, DOI 10.1097/00000441-199809000-00006; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Eisinger AL, 2006, J BIOL CHEM, V281, P20474, DOI 10.1074/jbc.M602859200; Fajas L, 2003, J LIPID RES, V44, P1652, DOI 10.1194/jlr.M300248-JLR200; Fan X, 2004, J CELL BIOCHEM, V93, P807, DOI 10.1002/jcb.20217; Flockhart RJ, 2008, FASEB J, V22, P4218, DOI 10.1096/fj.08-113076; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Glass DA, 2006, CURR TOP DEV BIOL, V73, P43, DOI 10.1016/S0070-2153(05)73002-7; Glass DA, 2007, ENDOCRINOLOGY, V148, P2630, DOI 10.1210/en.2006-1372; Godin LM, 2007, BIOMECH MODEL MECHAN, V6, P391, DOI 10.1007/s10237-006-0059-5; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; HUNG CT, 1995, CLIN ORTHOP RELAT R, P256; Iniguez MA, 2000, J BIOL CHEM, V275, P23627, DOI 10.1074/jbc.M001381200; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kawano S, 2006, CELL CALCIUM, V39, P313, DOI 10.1016/j.ceca.2005.11.008; Kawasaki T, 2007, NEOPLASIA, V9, P569, DOI 10.1593/neo.07334; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Lee HK, 2006, NUCLEIC ACIDS RES, V34, P5705, DOI 10.1093/nar/gkl698; Li HX, 2008, MOL CELL ENDOCRINOL, V291, P116, DOI 10.1016/j.mce.2008.05.005; Lin TH, 2007, BONE, V41, P562, DOI 10.1016/j.bone.2007.06.017; Liu JJ, 2006, MOL CELL BIOL, V26, P5827, DOI 10.1128/MCB.00441-06; Liu JJ, 2004, J BIOL CHEM, V279, P45020, DOI 10.1074/jbc.M407050200; MacAulay K, 2003, EUR J BIOCHEM, V270, P3829, DOI 10.1046/j.1432-1033.2003.03777.x; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; MINAIRE P, 1984, CALCIFIED TISSUE INT, V36, P338, DOI 10.1007/BF02405340; Park BH, 2004, MOL CELL BIOL, V24, P8671, DOI 10.1128/MCB.24.19.8671-8680.2004; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; RAISZ LG, 1995, J NUTR, V125, pS2024, DOI 10.1093/jn/125.suppl_7.2024S; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Rubin CT, 2007, P NATL ACAD SCI USA, V104, P17879, DOI 10.1073/pnas.0708467104; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; Sauer H, 1998, EXP CELL RES, V238, P13, DOI 10.1006/excr.1997.3809; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; SCHAFFER JL, 1994, J ORTHOP RES, V12, P709, DOI 10.1002/jor.1100120514; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shih TTF, 2004, SPINE, V29, P2844, DOI 10.1097/01.brs.0000147803.01224.5b; Tang QQ, 1997, P NATL ACAD SCI USA, V94, P13571, DOI 10.1073/pnas.94.25.13571; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Thiel A, 2006, J BIOL CHEM, V281, P4564, DOI 10.1074/jbc.M512722200; Wadleigh DJ, 1999, BIOCHEM BIOPH RES CO, V264, P865, DOI 10.1006/bbrc.1999.1606; Wang H, 2008, J BIOL CHEM, V283, P809, DOI 10.1074/jbc.M703021200; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Winslow MM, 2006, DEV CELL, V10, P771, DOI 10.1016/j.devcel.2006.04.006; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Yan HY, 2003, J LIPID RES, V44, P424, DOI 10.1194/jlr.M200357-JLR200; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P270, DOI 10.1016/j.bbrc.2007.09.129; Zhang XP, 2002, J CLIN INVEST, V109, P1405, DOI 10.1172/JCI200215681; Zmijewski JW, 2004, AGING CELL, V3, P309, DOI 10.1111/j.1474-9728.2004.00117.x	68	97	102	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34607	34617		10.1074/jbc.M109.039453	http://dx.doi.org/10.1074/jbc.M109.039453			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840939	Green Published, hybrid			2022-12-25	WOS:000272439600016
J	Clape, C; Fritz, V; Henriquet, C; Apparailly, F; Fernandez, PL; Iborra, F; Avances, C; Villalba, M; Culine, S; Fajas, L				Clape, Cyrielle; Fritz, Vanessa; Henriquet, Corinne; Apparailly, Florence; Fernandez, Pedro Luis; Iborra, Francois; Avances, Christophe; Villalba, Martin; Culine, Stephane; Fajas, Lluis			miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; MICRORNA EXPRESSION; PROMOTES ADIPOGENESIS; RADICAL PROSTATECTOMY; INVASION; PATHWAY; AND-145; GROWTH; TUMORS; RISK	Background: Micro RNAs are small, non-coding, single-stranded RNAs that negatively regulate gene expression at the post-transcriptional level. Since miR-143 was found to be down-regulated in prostate cancer cells, we wanted to analyze its expression in human prostate cancer, and test the ability of miR-43 to arrest prostate cancer cell growth in vitro and in vivo. Results: Expression of miR-143 was analyzed in human prostate cancers by quantitative PCR, and by in situ hybridization. miR-143 was introduced in cancer cells in vivo by electroporation. Bioinformatics analysis and luciferase-based assays were used to determine miR-143 targets. We show in this study that miR-143 levels are inversely correlated with advanced stages of prostate cancer. Rescue of miR-143 expression in cancer cells results in the arrest of cell proliferation and the abrogation of tumor growth in mice. Furthermore, we show that the effects of miR-143 are mediated, at least in part by the inhibition of extracellular signal-regulated kinase-5 (ERK5) activity. We show here that ERK5 is a miR-143 target in prostate cancer. Conclusions: miR-143 is as a new target for prostate cancer treatment.			Clape, C (corresponding author), IRCM, Montpellier, France.	lluis.fajas@inserm.fr	Fernandez, Pedro L/H-2594-2017; APPARAILLY, Florence/AAU-5489-2020; APPARAILLY, Florence/D-8635-2016; villalba, martin/N-7123-2017; villalba, martin/AAG-2604-2020; Coll, Lluis Fajas/C-8567-2014	APPARAILLY, Florence/0000-0003-1762-084X; villalba, martin/0000-0002-4385-4888; villalba, martin/0000-0002-4385-4888; Fajas, Lluis/0000-0002-1283-9503				Abella A, 2005, CELL METAB, V2, P239, DOI 10.1016/j.cmet.2005.09.003; Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Akao Y, 2007, DNA CELL BIOL, V26, P311, DOI 10.1089/dna.2006.0550; Amaral FC, 2009, J CLIN ENDOCR METAB, V94, P320, DOI 10.1210/jc.2008-1451; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Annicotte JS, 2006, MOL CELL BIOL, V26, P7561, DOI 10.1128/MCB.00605-06; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; Epstein JI, 2006, ADV ANAT PATHOL, V13, P57, DOI 10.1097/01.pap.0000202017.78917.18; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heidenreich A, 2008, EUR UROL, V53, P68, DOI 10.1016/j.eururo.2007.09.002; HUGGINS C, 1967, SCIENCE, V156, P1050, DOI 10.1126/science.156.3778.1050; Joniau S, 2008, BJU INT, V101, P5, DOI 10.1111/j.1464-410X.2007.07488.x; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kattan MW, 1999, J CLIN ONCOL, V17, P1499, DOI 10.1200/JCO.1999.17.5.1499; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mehta PB, 2003, ONCOGENE, V22, P1381, DOI 10.1038/sj.onc.1206154; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Pearson G, 2001, J BIOL CHEM, V276, P7927, DOI 10.1074/jbc.M009764200; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Sweat SD, 2002, J UROLOGY, V168, P525, DOI 10.1016/S0022-5347(05)64672-1; Terasawa K, 2003, GENES CELLS, V8, P263, DOI 10.1046/j.1365-2443.2003.00631.x; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; TONG AW, 2008, CANC GENE THER; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	38	163	181	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7542	10.1371/journal.pone.0007542	http://dx.doi.org/10.1371/journal.pone.0007542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855844	Green Published, gold, Green Submitted			2022-12-25	WOS:000271147200002
J	Kuntner, M; Coddington, JA				Kuntner, Matjaz; Coddington, Jonathan A.			Discovery of the Largest Orbweaving Spider Species: The Evolution of Gigantism in Nephila	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; ORB-WEAVING SPIDER; DWARF MALES; BODY-SIZE; ARANEAE; SELECTION; COEVOLUTION; CANNIBALISM; SYSTEMATICS; POPULATION	Background: More than 41,000 spider species are known with about 400-500 added each year, but for some well-known groups, such as the giant golden orbweavers, Nephila, the last valid described species dates from the 19(th) century. Nephila are renowned for being the largest web-spinning spiders, making the largest orb webs, and are model organisms for the study of extreme sexual size dimorphism (SSD) and sexual biology. Here, we report on the discovery of a new, giant Nephila species from Africa and Madagascar, and review size evolution and SSD in Nephilidae. Methodology: We formally describe N. komaci sp. nov., the largest web spinning species known, and place the species in phylogenetic context to reconstruct the evolution of mean size (via squared change parsimony). We then test female and male mean size correlation using phylogenetically independent contrasts, and simulate nephilid body size evolution using Monte Carlo statistics. Conclusions: Nephila females increased in size almost monotonically to establish a mostly African clade of true giants. In contrast, Nephila male size is effectively decoupled and hovers around values roughly one fifth of female size. Although N. komaci females are the largest Nephila yet discovered, the males are also large and thus their SSD is not exceptional.			Kuntner, M (corresponding author), Slovenian Acad Sci & Arts, Ctr Sci Res, Inst Biol, Ljubljana, Slovenia.	kuntner@gmail.com	Kuntner, Matjaz/AAE-2195-2020	Coddington, Jonathan A./0000-0001-6004-7730				Agnarsson I, 2005, SYST ENTOMOL, V30, P575, DOI 10.1111/j.1365-3113.2005.00289.x; CODDINGTON JA, 1997, GIANT FEMALE DWARF M, P687; Elgar MA, 2008, BIOL J LINN SOC, V94, P355, DOI 10.1111/j.1095-8312.2008.00986.x; Fairbairn DJ, 1996, EVOLUTION, V50, P1549, DOI 10.1111/j.1558-5646.1996.tb03927.x; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Foellmer MW, 2005, J EVOLUTION BIOL, V18, P629, DOI 10.1111/j.1420-9101.2005.00868.x; Fromhage L, 2006, BEHAV ECOL, V17, P353, DOI 10.1093/beheco/arj037; Fromhage L, 2007, ETHOLOGY, V113, P813, DOI 10.1111/j.1439-0310.2007.01383.x; Harvey MS, 2007, INVERTEBR SYST, V21, P407, DOI 10.1071/IS05016; Higgins L, 2002, OIKOS, V99, P377, DOI 10.1034/j.1600-0706.2002.990220.x; Hormiga G, 2000, SYST BIOL, V49, P435, DOI 10.1080/10635159950127330; Kasumovic MM, 2007, BEHAV ECOL, V18, P189, DOI 10.1093/beheco/arl072; Kuntner M, 2006, ZOOL SCR, V35, P19, DOI 10.1111/j.1463-6409.2006.00220.x; Kuntner M, 2005, INVERTEBR SYST, V19, P391, DOI 10.1071/IS05024; Kuntner M, 2009, J ZOOL, V277, P257, DOI 10.1111/j.1469-7998.2008.00533.x; Kuntner M, 2005, THESIS G WASHINGTON, P896; Kuntner M, 2008, J ARACHNOL, V36, P583, DOI 10.1636/T07-54.1; Kuntner M, 2008, CLADISTICS, V24, P147, DOI 10.1111/j.1096-0031.2007.00176.x; Kuntner M, 2007, SYST ENTOMOL, V32, P95, DOI 10.1111/j.1365-3113.2006.00348.x; Kuntner M, 2009, INVERTEBR SYST, V23, P193, DOI 10.1071/IS09002; Kuntner M, 2009, EVOLUTION, V63, P1451, DOI 10.1111/j.1558-5646.2009.00634.x; Maddison, 2019, MESQUITE MODULAR SYS; Midford P. E., 2008, PDAP PDTREE PACKAGE; MIYASHITA T, 1992, RES POPUL ECOL, V34, P143, DOI 10.1007/BF02513527; Moya-Larano J, 2009, J EVOLUTION BIOL, V22, P954, DOI 10.1111/j.1420-9101.2009.01707.x; Pekar S, 2006, J NAT HIST, V40, P1343, DOI 10.1080/00222930600901417; Prenter J, 1998, P ROY SOC B-BIOL SCI, V265, P57, DOI 10.1098/rspb.1998.0264; Schneider JM, 2005, EVOL ECOL, V19, P419, DOI 10.1007/s10682-005-8310-6; Schneider JM, 2008, AUST J ZOOL, V56, P233, DOI 10.1071/ZO08041; VOLLRATH F, 1992, NATURE, V360, P156, DOI 10.1038/360156a0; Vollrath F, 1998, TRENDS ECOL EVOL, V13, P159, DOI 10.1016/S0169-5347(97)01283-4; Wilder SM, 2008, AM NAT, V172, P431, DOI 10.1086/589518	34	62	63	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7516	10.1371/journal.pone.0007516	http://dx.doi.org/10.1371/journal.pone.0007516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844575	gold, Green Submitted, Green Published			2022-12-25	WOS:000271013000005
J	Sapriel, G; Quinet, M; Heijde, M; Jourdren, L; Tanty, V; Luo, GZ; Le Crom, S; Lopez, PJ				Sapriel, Guillaume; Quinet, Michelle; Heijde, Marc; Jourdren, Laurent; Tanty, Veronique; Luo, Guangzuo; Le Crom, Stephane; Lopez, Pascal Jean			Genome-Wide Transcriptome Analyses of Silicon Metabolism in Phaeodactylum tricornutum Reveal the Multilevel Regulation of Silicic Acid Transporters	PLOS ONE			English	Article							DIATOM THALASSIOSIRA-PSEUDONANA; PATTERN-FORMATION; SI REQUIREMENT; MARINE; MODEL; BACILLARIOPHYCEAE; PRECIPITATION; SELECTION; PEPTIDES; KINETICS	Background: Diatoms are largely responsible for production of biogenic silica in the global ocean. However, in surface seawater, Si(OH)(4) can be a major limiting factor for diatom productivity. Analyzing at the global scale the genes networks involved in Si transport and metabolism is critical in order to elucidate Si biomineralization, and to understand diatoms contribution to biogeochemical cycles. Methodology/Principal Findings: Using whole genome expression analyses we evaluated the transcriptional response to Si availability for the model species Phaeodactylum tricornutum. Among the differentially regulated genes we found genes involved in glutamine-nitrogen pathways, encoding putative extracellular matrix components, or involved in iron regulation. Some of these compounds may be good candidates for intracellular intermediates involved in silicic acid storage and/ or intracellular transport, which are very important processes that remain mysterious in diatoms. Expression analyses and localization studies gave the first picture of the spatial distribution of a silicic acid transporter in a diatom model species, and support the existence of transcriptional and post-transcriptional regulations. Conclusions/Significance: Our global analyses revealed that about one fourth of the differentially expressed genes are organized in clusters, underlying a possible evolution of P. tricornutum genome, and perhaps other pennate diatoms, toward a better optimization of its response to variable environmental stimuli. High fitness and adaptation of diatoms to various Si levels in marine environments might arise in part by global regulations from gene ( expression level) to genomic (organization in clusters, dosage compensation by gene duplication), and by post-transcriptional regulation and spatial distribution of SIT proteins.			Sapriel, G (corresponding author), Ecole Normale Super, CNRS, UMR 8186, Biomineralizat & Morphogenesis Grp, Paris, France.	pjlopez@biologie.ens.fr	Heijde, Marc/O-8958-2014; Le Crom, Stéphane/P-4176-2016; Lopez, Pascal Jean/A-7427-2011; Lopez, Pascal Jean/P-5813-2019	Le Crom, Stéphane/0000-0002-0534-7797; Lopez, Pascal Jean/0000-0002-9914-4252; Jourdren, Laurent/0000-0003-4253-1048; Luo, Guangzuo/0000-0002-8518-5766; heijde, marc/0000-0002-8109-8999				ALINE RF, 1984, PLANT PHYSIOL, V76, P674, DOI 10.1104/pp.76.3.674; Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Allen JT, 2005, NATURE, V437, P728, DOI 10.1038/nature03948; Alverson AJ, 2007, LIMNOL OCEANOGR, V52, P1420, DOI 10.4319/lo.2007.52.4.1420; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; BOROWITZKA LJ, 1977, ARCH MICROBIOL, V112, P147, DOI 10.1007/BF00429327; BOROWITZKA MA, 1978, J PHYCOL, V14, P10; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; BRZEZINSKI MA, 1990, MAR ECOL PROG SER, V67, P83, DOI 10.3354/meps067083; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CORADIN T, 2006, FLORICULTURE ORNAMEN, P101; De Martino A, 2007, J PHYCOL, V43, P992, DOI 10.1111/j.1529-8817.2007.00384.x; Del Amo Y, 1999, J PHYCOL, V35, P1162; Descles J, 2008, NEW PHYTOL, V177, P822, DOI 10.1111/j.1469-8137.2007.02303.x; Falciatore A, 2000, SCIENCE, V288, P2363, DOI 10.1126/science.288.5475.2363; Francius G, 2008, ENVIRON MICROBIOL, V10, P1344, DOI 10.1111/j.1462-2920.2007.01551.x; Frigeri LG, 2006, MOL CELL PROTEOMICS, V5, P182, DOI 10.1074/mcp.M500174-MCP200; FUHRMAN JA, 1978, NATURE, V272, P244, DOI 10.1038/272244a0; Grachev MA, 2008, BIOESSAYS, V30, P328, DOI 10.1002/bies.20731; GUILLARD RR, 1973, J PHYCOL, V9, P233; GUTENBRUNNER SA, 1994, J PHYCOL, V30, P129, DOI 10.1111/j.0022-3646.1994.00129.x; Harada H, 2006, PLANT PHYSIOL, V142, P1318, DOI 10.1104/pp.106.086561; Hildebrand M, 1997, NATURE, V385, P688, DOI 10.1038/385688b0; Iler, 1979, CHEM SILICA SOLUBILI; Kakinuma M, 2008, CELL BIOL TOXICOL, V24, P629, DOI 10.1007/s10565-007-9053-7; KLAVENESS D, 1975, J PHYCOL, V11, P349, DOI 10.1111/j.0022-3646.1975.00349.x; Kojima S, 2007, PLANT J, V52, P30, DOI 10.1111/j.1365-313X.2007.03223.x; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kroger N, 2007, CURR OPIN CHEM BIOL, V11, P662, DOI 10.1016/j.cbpa.2007.10.009; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2001, J BIOL CHEM, V276, P26066, DOI 10.1074/jbc.M102093200; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; LEWIN JC, 1958, J GEN MICROBIOL, V18, P418, DOI 10.1099/00221287-18-2-418; Likhoshway Ye V, 2006, Dokl Biol Sci, V408, P256, DOI 10.1134/S001249660603015X; Lopez PJ, 2005, CURR OPIN BIOTECH, V16, P180, DOI 10.1016/j.copbio.2005.02.002; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; Lutz K, 2005, PHYS CHEM CHEM PHYS, V7, P2812, DOI 10.1039/b505945c; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Martin-Jezequal V, 2003, PROG MOLEC, V33, P99; Martin-Jezequel V, 2000, J PHYCOL, V36, P821, DOI 10.1046/j.1529-8817.2000.00019.x; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Montsant A, 2005, J NANOSCI NANOTECHNO, V5, P5, DOI 10.1166/jnn.2005.003; NELSON DM, 1984, J PHYCOL, V20, P141, DOI 10.1111/j.0022-3646.1984.00141.x; PAASCHE E, 1973, MAR BIOL, V19, P117, DOI 10.1007/BF00353582; Petrova DP, 2007, DOKL BIOCHEM BIOPHYS, V417, P295, DOI 10.1134/S1607672907060014; PREISIG HR, 1994, PROTOPLASMA, V181, P29, DOI 10.1007/BF01666387; RIEDEL GF, 1985, J PHYCOL, V21, P168; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Sumper M, 2004, J MATER CHEM, V14, P2059, DOI 10.1039/b401028k; Sumper M, 2008, CHEMBIOCHEM, V9, P1187, DOI 10.1002/cbic.200700764; Sumper M, 2006, CHEMBIOCHEM, V7, P1419, DOI 10.1002/cbic.200600184; Thamatrakoln K, 2005, J NANOSCI NANOTECHNO, V5, P158, DOI 10.1166/jnn.2005.014; Thamatrakoln K, 2008, PLANT PHYSIOL, V146, P1397, DOI 10.1104/pp.107.107094; Thamatrakoln K, 2007, EUKARYOT CELL, V6, P271, DOI 10.1128/EC.00235-06; Thamatrakoln K, 2006, J PHYCOL, V42, P822, DOI 10.1111/j.1529-8817.2006.00233.x; THOMAS W H, 1975, Deep-Sea Research and Oceanographic Abstracts, V22, P671, DOI 10.1016/0011-7471(75)90005-4; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; Vartanian M, 2009, NEW PHYTOL, V182, P429, DOI 10.1111/j.1469-8137.2009.02769.x; Volcani B. E., 1981, SILICON SILICEOUS ST; Wenzl S, 2008, ANGEW CHEM INT EDIT, V47, P1729, DOI 10.1002/anie.200704994; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yool A, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002018; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	66	76	80	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7458	10.1371/journal.pone.0007458	http://dx.doi.org/10.1371/journal.pone.0007458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19829693	Green Published, Green Submitted, gold			2022-12-25	WOS:000270808700017
J	Capyk, JK; Kalscheuer, R; Stewart, GR; Liu, J; Kwon, H; Zhao, R; Okamoto, S; Jacobs, WR; Eltis, LD; Mohn, WW				Capyk, Jenna K.; Kalscheuer, Rainer; Stewart, Gordon R.; Liu, Jie; Kwon, Hyukin; Zhao, Rafael; Okamoto, Sachi; Jacobs, William R., Jr.; Eltis, Lindsay D.; Mohn, William W.			Mycobacterial Cytochrome P450 125 (Cyp125) Catalyzes the Terminal Hydroxylation of C27 Steroids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-KETOSTEROID 9-ALPHA-HYDROXYLASE; BETA-CYCLODEXTRIN; TUBERCULOSIS; CHOLESTEROL; MACROPHAGES; SURVIVAL; 27-HYDROXYLASE; IDENTIFICATION; REQUIREMENTS; ADAPTATION	Cyp125 (Rv3545c), a cytochrome P450, is encoded as part of the cholesterol degradation gene cluster conserved among members of the Mycobacterium tuberculosis complex. This enzyme has been implicated in mycobacterial pathogenesis, and a homologue initiates cholesterol catabolism in the soil actinomycete Rhodococcus jostii RHA1. In Mycobacterium bovis BCG, cyp125 was up-regulated 7.1-fold with growth on cholesterol. A cyp125 deletion mutant of BCG did not grow on cholesterol and accumulated 4-cholesten-3-one when incubated in the presence of cholesterol. Wild-type BCG grew on this metabolite. By contrast, a parallel cyp125 deletion mutation of M. tuberculosis H37Rv did not affect growth on cholesterol. Purified Cyp125 from M. tuberculosis, heterologously produced in R. jostii RHA1, bound cholesterol and 4-cholesten-3-one with apparent dissociation constants of 0.20 +/- 0.02 mu M and 0.27 +/- 0.05 mu M, respectively. When reconstituted with KshB, the cognate reductase of the ketosteroid 9 alpha-hydroxylase, Cyp125 catalyzed the hydroxylation of these steroids. MS and NMR analyses revealed that hydroxylation occurred at carbon 26 of the steroid side chain, allowing unambiguous classification of Cyp125 as a steroid C26-hydroxylase. This study establishes the catalytic function of Cyp125 and, in identifying an important difference in the catabolic potential of M. bovis and M. tuberculosis, suggests that Cyp125 may have an additional function in pathogenesis.	[Eltis, Lindsay D.] Univ British Columbia, Inst Life Sci, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Stewart, Gordon R.; Liu, Jie; Kwon, Hyukin; Okamoto, Sachi; Eltis, Lindsay D.; Mohn, William W.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Kalscheuer, Rainer; Jacobs, William R., Jr.] Yeshiva Univ Albert Einstein Coll Med, Howard Hughes Med Inst, Bronx, NY 10461 USA	University of British Columbia; University of British Columbia; Howard Hughes Medical Institute; Yeshiva University; Albert Einstein College of Medicine	Eltis, LD (corresponding author), 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	leltis@interchange.ubc.ca; wmohn@interchange.ubc.ca	Kalscheuer, Rainer/A-2852-2015; Kalscheuer, Rainer/AAF-1381-2020; Eltis, Lindsay D/J-8272-2015	Kalscheuer, Rainer/0000-0002-3378-2067; Eltis, Lindsay D/0000-0002-6774-8158; Jacobs, William/0000-0003-3321-3080	Canadian Institute for Health Research; British Columbia Lung Association; Michael Smith Foundation for Health Research (MSFHR)	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Lung Association; Michael Smith Foundation for Health Research (MSFHR)(Michael Smith Foundation for Health Research)	This work was supported in part by grants from the Canadian Institute for Health Research ( to L. D. E.), the British Columbia Lung Association ( to W. W. M.), and the Michael Smith Foundation for Health Research (MSFHR) Emerging Team programs.	Alcalde MA, 2009, J INCL PHENOM MACRO, V63, P309, DOI 10.1007/s10847-008-9524-3; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; BETSHOLTZ IH, 1995, J STEROID BIOCHEM, V55, P115, DOI 10.1016/0960-0760(95)00147-R; CALI JJ, 1991, J BIOL CHEM, V266, P7774; Capyk JK, 2009, J BIOL CHEM, V284, P9937, DOI 10.1074/jbc.M900719200; Chang JC, 2007, J INFECT DIS, V196, P788, DOI 10.1086/520089; Chang JC, 2009, J BACTERIOL, V191, P5232, DOI 10.1128/JB.00452-09; Chen WL, 2007, CELL METAB, V5, P73, DOI 10.1016/j.cmet.2006.11.012; DuSell CD, 2008, MOL ENDOCRINOL, V22, P65, DOI 10.1210/me.2007-0383; ELTIS LD, 1993, EUR J BIOCHEM, V213, P211, DOI 10.1111/j.1432-1033.1993.tb17750.x; Goncalves ER, 2006, APPL ENVIRON MICROB, V72, P6183, DOI 10.1128/AEM.00947-06; Gunsalus I C, 1978, Methods Enzymol, V52, P166; Hansson M, 2003, BBA-MOL CELL RES, V1593, P283, DOI 10.1016/S0167-4889(02)00398-1; Javitt NB, 2002, J LIPID RES, V43, P665; LACK NA, 2009, J BIOL CHEM IN PRESS; Mohn WW, 2008, J BIOL CHEM, V283, P35368, DOI 10.1074/jbc.M805496200; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Munro AW, 2003, BIOCHEM SOC T, V31, P625, DOI 10.1042/BST0310625; NESBITT NM, 2009, INFECT IMMU IN PRESS; Ouellet H, 2009, BIOCHEMISTRY-US, V48, P863, DOI 10.1021/bi801595t; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; R Core Team, 2022, R LANG ENV STAT COMP; Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102; ROSLONIEC K, 2009, MOL MICROBI IN PRESS; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Souidi M, 1998, CLIN CHIM ACTA, V269, P201, DOI 10.1016/S0009-8981(97)00201-5; van der Geize R, 2002, MOL MICROBIOL, V45, P1007, DOI 10.1046/j.1365-2958.2002.03069.x; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; *WHO, 2008, 4 WHO, P14; YAM K, 2010, BIOL RHODOC IN PRESS; Yam KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000344; Yang XX, 2007, BIOCHEMISTRY-US, V46, P9058, DOI 10.1021/bi700688x	35	122	130	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35534	35542		10.1074/jbc.M109.072132	http://dx.doi.org/10.1074/jbc.M109.072132			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19846551	Green Published, hybrid			2022-12-25	WOS:000272645600030
J	Stoltz, DA; Ozer, EA; Recker, TJ; Estin, M; Yang, X; Shih, DM; Lusis, AJ; Zabner, J				Stoltz, David A.; Ozer, Egon A.; Recker, Thomas J.; Estin, Miriam; Yang, Xia; Shih, Diana M.; Lusis, Aldons J.; Zabner, Joseph			A Common Mutation in Paraoxonase-2 Results in Impaired Lactonase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUORUM-SENSING SIGNAL; GENE POLYMORPHISMS; OXIDATIVE STRESS; PON1 STATUS; DISEASE; ASSOCIATION; EXPRESSION; RISK; INACTIVATION; PURIFICATION	Paraoxonases (PONs) are a family of lactonases with promiscuous enzyme activity that has been implicated in multiple diseases. PON2 is intracellularly located, is the most ubiquitously expressed PON, and has the highest lactonase activity of the PON family members. Whereas some single-nucleotide poly-morphisms (SNPs) in PON1 have resulted in altered enzymatic activity in serum, to date the functional consequences of SNPs on PON2 function remain unknown. We hypothesized that a common PON2 SNP would result in impaired lactonase activity. Substitution of cysteine for serine at codon 311 in recombinant PON2 resulted in normal protein production and localization but altered glycosylation and decreased lactonase activity. Moreover, we screened 200 human lung samples for the PON2 Cys(311) variant and found that in vivo this mutation impaired lactonase activity. These data suggest that impaired lactonase activity may play a role in innate immunity, atherosclerosis, and other diseases associated with the PON2 311 SNP.	[Zabner, Joseph] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Ozer, Egon A.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Yang, Xia] Rosetta Inpharmat Inc, Seattle, WA 98109 USA; [Shih, Diana M.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of Iowa; Northwestern University; Feinberg School of Medicine; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Zabner, J (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, 440 EMRB, Iowa City, IA 52242 USA.	joseph-zabner@uiowa.edu	Ozer, Egon/HHN-7954-2022; Ozer, Egon/W-9662-2019	Ozer, Egon/0000-0002-7131-3691; Zabner, Joseph/0000-0002-9606-1339; Stoltz, David/0000-0003-0893-9015	National Institutes of Health [DK54759, AI076671, HL61234-09]; Cystic Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL061234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI076671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54759, AI076671, HL61234-09. This work was also supported by the Cystic Fibrosis Foundation.	Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Bhattacharyya T, 2008, JAMA-J AM MED ASSOC, V299, P1265, DOI 10.1001/jama.299.11.1265; Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Brushia RJ, 2001, J LIPID RES, V42, P951; Camps J, 2009, CRIT REV CL LAB SCI, V46, P83, DOI 10.1080/10408360802610878; Chen Q, 2003, AM J HUM GENET, V72, P13, DOI 10.1086/345312; Chun CK, 2004, P NATL ACAD SCI USA, V101, P3587, DOI 10.1073/pnas.0308750101; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Draganov DI, 2004, N-S ARCH PHARMACOL, V369, P78, DOI 10.1007/s00210-003-0833-1; Durrington PN, 2001, ARTERIOSCL THROM VAS, V21, P473, DOI 10.1161/01.ATV.21.4.473; Erlich PM, 2006, HUM MOL GENET, V15, P77, DOI 10.1093/hmg/ddi428; Furlong CE, 2005, NEUROTOXICOLOGY, V26, P651, DOI 10.1016/j.neuro.2004.08.002; Furlong CE, 2007, J BIOCHEM MOL TOXIC, V21, P197, DOI 10.1002/jbt.20181; GAN KN, 1991, DRUG METAB DISPOS, V19, P100; Harel M, 2004, NAT STRUCT MOL BIOL, V11, P412, DOI 10.1038/nsmb767; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; HUMBERT R, 1993, NAT GENET, V3, P73, DOI 10.1038/ng0193-73; Jarvik GP, 2000, ARTERIOSCL THROM VAS, V20, P2441, DOI 10.1161/01.ATV.20.11.2441; Josse D, 1999, BIOCHEMISTRY-US, V38, P2816, DOI 10.1021/bi982281h; Josse D, 2002, J BIOL CHEM, V277, P33386, DOI 10.1074/jbc.M200108200; Karp Philip H, 2002, Methods Mol Biol, V188, P115; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; KUO CL, 1995, DRUG METAB DISPOS, V23, P935; Leus FR, 2001, ATHEROSCLEROSIS, V154, P641, DOI 10.1016/S0021-9150(00)00440-8; Martinelli N, 2004, EUR J CLIN INVEST, V34, P14, DOI 10.1111/j.1365-2362.2004.01292.x; Mochizuki H, 1998, GENE, V213, P149, DOI 10.1016/S0378-1119(98)00193-0; Ozer EA, 2005, FEMS MICROBIOL LETT, V253, P29, DOI 10.1016/j.femsle.2005.09.023; Parsek MR, 2000, P NATL ACAD SCI USA, V97, P8789, DOI 10.1073/pnas.97.16.8789; PEARSON JP, 1994, P NATL ACAD SCI USA, V91, P197, DOI 10.1073/pnas.91.1.197; PrimoParmo SL, 1996, GENOMICS, V33, P498, DOI 10.1006/geno.1996.0225; Richter RJ, 1999, PHARMACOGENETICS, V9, P745, DOI 10.1097/01213011-199912000-00009; Shi JJ, 2004, MOL BRAIN RES, V120, P201, DOI 10.1016/j.molbrainres.2003.10.018; Slowik A, 2007, CEREBROVASC DIS, V23, P395, DOI 10.1159/000101462; Stoltz DA, 2008, J CLIN INVEST, V118, P3123, DOI 10.1172/JCI35147; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Teiber JF, 2003, BIOCHEM PHARMACOL, V66, P887, DOI 10.1016/S0006-2952(03)00401-5; Teiber JF, 2008, INFECT IMMUN, V76, P2512, DOI 10.1128/IAI.01606-07; Wills AM, 2008, NEUROLOGY, V70, P929, DOI 10.1212/01.wnl.0000305956.37931.dd; Zintzaras E, 2004, J HUM GENET, V49, P474, DOI 10.1007/s10038-004-0176-x	40	47	48	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35564	35571		10.1074/jbc.M109.051706	http://dx.doi.org/10.1074/jbc.M109.051706			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19840942	Green Published, hybrid			2022-12-25	WOS:000272645600033
J	Watt, B; van Niel, G; Fowler, DM; Hurbain, I; Luk, KC; Stayrook, SE; Lemmon, MA; Raposo, G; Shorter, J; Kelly, JW; Marks, MS				Watt, Brenda; van Niel, Guillaume; Fowler, Douglas M.; Hurbain, Ilse; Luk, Kelvin C.; Stayrook, Steven E.; Lemmon, Mark A.; Raposo, Graca; Shorter, James; Kelly, Jeffery W.; Marks, Michael S.			N-terminal Domains Elicit Formation of Functional Pmel17 Amyloid Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SILVER COAT COLOR; MELANOMA-CELLS; EARLY MELANOSOMES; ALPHA-SYNUCLEIN; REPEAT DOMAIN; PROTEIN; YEAST; BIOGENESIS; GENE; MELANOCYTES	Pmel17 is a transmembrane protein that mediates the early steps in the formation of melanosomes, the subcellular organelles of melanocytes in which melanin pigments are synthesized and stored. In melanosome precursor organelles, proteolytic fragments of Pmel17 form insoluble, amyloid-like fibrils upon which melanins are deposited during melanosome maturation. The mechanism(s) by which Pmel17 becomes competent to form amyloid are not fully understood. To better understand how amyloid formation is regulated, we have defined the domains within Pmel17 that promote fibril formation in vitro. Using purified recombinant fragments of Pmel17, we show that two regions, an N-terminal domain of unknown structure and a downstream domain with homology to a polycystic kidney disease-1 repeat, efficiently form amyloid in vitro. Analyses of fibrils formed in melanocytes confirm that the polycystic kidney disease-1 domain forms at least part of the physiological amyloid core. Interestingly, this same domain is also required for the intracellular trafficking of Pmel17 to multivesicular compartments within which fibrils begin to form. Although a domain of imperfect repeats (RPT) is required for fibril formation in vivo and is a component of fibrils in melanosomes, RPT is not necessary for fibril formation in vitro and in isolation is unable to adopt an amyloid fold in a physiologically relevant time frame. These data define the structural core of Pmel17 amyloid, imply that the RPT domain plays a regulatory role in timing amyloid conversion, and suggest that fibril formation might be physically linked with multivesicular body sorting.	[Marks, Michael S.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Stayrook, Steven E.; Lemmon, Mark A.; Shorter, James] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [van Niel, Guillaume; Hurbain, Ilse; Raposo, Graca] Inst Curie, F-75005 Paris, France; [van Niel, Guillaume; Hurbain, Ilse; Raposo, Graca] CNRS, UMR144, F-75005 Paris, France; [Fowler, Douglas M.; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Chem, La Jolla, CA 92037 USA; [Fowler, Douglas M.; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, Dept Mol & Expt Med, La Jolla, CA 92037 USA	University of Pennsylvania; University of Pennsylvania; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Scripps Research Institute; Scripps Research Institute	Marks, MS (corresponding author), Univ Penn, Dept Pathol & Lab Med, 513 Stellar Chance Labs 6100,422 Curie Blvd, Philadelphia, PA 19104 USA.	marksm@mail.med.upenn.edu	van Niel, Guillaume/A-6585-2011; Luk, Kelvin/AAZ-4202-2020; Marks, Michael S/Q-7223-2019; van Niel, Guillaume/HCI-8445-2022; Shorter, James/E-8207-2011; Shorter, James/ABE-7307-2020	van Niel, Guillaume/0000-0002-8651-9705; Luk, Kelvin/0000-0002-6591-6269; Marks, Michael S/0000-0001-7435-7262; Shorter, James/0000-0001-5269-8533; Raposo, graca/0000-0001-9590-1298; Lemmon, Mark/0000-0002-3379-5319; Stayrook, Steven/0000-0002-1677-8293	National Institutes of Health [R01 AR048155]; NIAMS [R01 AG018917]; NIA; Director's New Innovator Award [1DP2OD002177-01]; CNRS; Institut Curie; Fondation pour la Recherche Medicale; Association pour la Recherche sur le Cancer; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018917] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Director's New Innovator Award; CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AR048155 from the NIAMS ( to M. S. M.), Grant R01 AG018917 from the NIA ( to J.W.K.), and Director's New Innovator Award 1DP2OD002177-01 ( to J.S.). This work was also supported by CNRS, Institut Curie, Fondation pour la Recherche Medicale, and Association pour la Recherche sur le Cancer ( to G. R.).	Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; BIRBECK MSC, 1963, ANN NY ACAD SCI, V100, P540, DOI 10.1111/j.1749-6632.1963.tb42871.x; Brunberg E, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-46; Bycroft M, 1999, EMBO J, V18, P297, DOI 10.1093/emboj/18.2.297; Chakraborty AK, 1996, EUR J BIOCHEM, V236, P180, DOI 10.1111/j.1432-1033.1996.t01-1-00180.x; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Chiamenti AM, 1996, MELANOMA RES, V6, P291, DOI 10.1097/00008390-199608000-00003; Clark LA, 2006, P NATL ACAD SCI USA, V103, P1376, DOI 10.1073/pnas.0506940103; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; DIMENT S, 1995, J BIOL CHEM, V270, P4213, DOI 10.1074/jbc.270.9.4213; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Falcon-Perez JM, 2002, J BIOL CHEM, V277, P28191, DOI 10.1074/jbc.M204011200; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Hamilton HL, 1940, ANAT REC, V78, P525, DOI 10.1002/ar.1090780407; Harper DC, 2008, J BIOL CHEM, V283, P2307, DOI 10.1074/jbc.M708007200; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Hurbain I, 2008, P NATL ACAD SCI USA, V105, P19726, DOI 10.1073/pnas.0803488105; Kerje S, 2004, GENETICS, V168, P1507, DOI 10.1534/genetics.104.027995; Kheterpal I, 2001, BIOCHEMISTRY-US, V40, P11757, DOI 10.1021/bi010805z; KLUNK WE, 1989, J HISTOCHEM CYTOCHEM, V37, P1273, DOI 10.1177/37.8.2666510; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kochneva-Pervukhova NV, 1998, EMBO J, V17, P5805, DOI 10.1093/emboj/17.19.5805; Koo HJ, 2008, BIOCHEM BIOPH RES CO, V368, P772, DOI 10.1016/j.bbrc.2008.01.140; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kummer MP, 2009, J BIOL CHEM, V284, P2296, DOI 10.1074/jbc.M808904200; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; KWON BS, 1991, P NATL ACAD SCI USA, V88, P9228, DOI 10.1073/pnas.88.20.9228; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; MAUL GG, 1969, J ULTRA MOL STRUCT R, V26, P163, DOI 10.1016/S0022-5320(69)90042-2; McGlinchey RP, 2009, P NATL ACAD SCI USA, V106, P13731, DOI 10.1073/pnas.0906509106; Mobius W, 2003, TRAFFIC, V4, P222; Mobius W, 2002, J HISTOCHEM CYTOCHEM, V50, P43; Moriyama K, 2002, TRAFFIC, V3, P666, DOI 10.1034/j.1600-0854.2002.30908.x; MOYER FH, 1966, AM ZOOL, V6, P43; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; Nichols SE, 2003, J INVEST DERMATOL, V121, P821, DOI 10.1046/j.1523-1747.2003.12474.x; PALMER I, 2000, CURRENT PROTOCOLS PR; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Qin Z, 2007, BIOCHEMISTRY-US, V46, P13322, DOI 10.1021/bi7014053; QUEVEDO WC, 1981, PIGMENT CELL 1981 PH, P177; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Robila V, 2008, J IMMUNOL, V181, P7843, DOI 10.4049/jimmunol.181.11.7843; SAEKI H, 1978, J CELL PHYSIOL, V94, P139, DOI 10.1002/jcp.1040940203; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; SILVERS WK (ED), 1979, COAT COLORS MICE MOD; SPANAKIS E, 1992, DEVELOPMENT, V114, P675; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; Toyama BH, 2007, NATURE, V449, P233, DOI 10.1038/nature06108; Valencia JC, 2007, J BIOL CHEM, V282, P11266, DOI 10.1074/jbc.M608449200; Vitrenko YA, 2007, J BIOL CHEM, V282, P1779, DOI 10.1074/jbc.M609269200; Wang Q, 2008, PLOS BIOL, V6, P1508, DOI 10.1371/journal.pbio.0060170; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Zou L, 2007, CELL RES, V17, P389, DOI 10.1038/cr.2007.5	60	78	82	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35543	35555		10.1074/jbc.M109.047449	http://dx.doi.org/10.1074/jbc.M109.047449			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19840945	Green Published, hybrid			2022-12-25	WOS:000272645600031
J	Askew, EB; Bai, SX; Hnat, AT; Minges, JT; Wilson, EM				Askew, Emily B.; Bai, Suxia; Hnat, Andrew T.; Minges, John T.; Wilson, Elizabeth M.			Melanoma Antigen Gene Protein-A11 (MAGE-11) F-box Links the Androgen Receptor NH2-terminal Transactivation Domain to p160 Coactivators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECURRENT PROSTATE-CANCER; EPIDERMAL-GROWTH-FACTOR; MESSENGER-RIBONUCLEIC-ACID; COOH-TERMINAL INTERACTION; LIGAND-BINDING DOMAIN; ACTIVATION FUNCTION 2; SCF UBIQUITIN LIGASE; NUCLEAR RECEPTOR; STEROID-RECEPTOR; PHOSPHORYLATION SITES	Androgen-dependent transcriptional activity by the androgen receptor (AR) and its coregulators is required for male reproductive development and function. In humans and other primates, melanoma antigen gene protein-A11 (MAGE-11) is an AR selective coregulator that increases AR transcriptional activity. Here we show that the interaction between AR and MAGE-11 is mediated by AR NH2-terminal FXXLF motif binding to a highly conserved MAGE-11 F-box in the MAGE homology domain, and is modulated by serum stimulation of mitogen-activated protein kinase phosphorylation of MAGE-11 Ser-174. The MAGE-11-dependent increase in AR transcriptional activity is mediated by a direct interaction between MAGE-11 and transcriptional intermediary factor 2 (TIF2) through the NH2-terminal region of TIF2, and by a MAGE-11 FXXIF motif interaction with an F-box-like region in activation domain 1 of TIF2. The results suggest that MAGE-11 functions as a bridging factor to recruit AR coactivators through a novel FXX(L/I) F motif-F-box interaction paradigm.	[Askew, Emily B.; Bai, Suxia; Hnat, Andrew T.; Minges, John T.; Wilson, Elizabeth M.] Univ N Carolina, Labs Reprod Biol, Chapel Hill, NC 27599 USA; [Askew, Emily B.; Wilson, Elizabeth M.] Univ N Carolina, Curriculum Toxicol, Chapel Hill, NC 27599 USA; [Askew, Emily B.; Bai, Suxia; Hnat, Andrew T.; Minges, John T.; Wilson, Elizabeth M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Bai, Suxia; Hnat, Andrew T.; Minges, John T.; Wilson, Elizabeth M.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Wilson, Elizabeth M.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wilson, EM (corresponding author), Univ N Carolina, Labs Reprod Biol, CB7500, Chapel Hill, NC 27599 USA.	emw@med.unc.edu	Askew, Eldon W/F-5347-2014		National Institutes of Health United States Public Health Service [HD16910]; NICHD [P01-CA77739]; NCI, a United States Department of Defense [PC073586]; National Institutes of Health Eunice Kennedy Shriver [U54-HD35041]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016910, R37HD016910, U54HD035041] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077739] Funding Source: NIH RePORTER	National Institutes of Health United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCI, a United States Department of Defense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health Eunice Kennedy Shriver(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health United States Public Health Service Grants HD16910 from the NICHD and P01-CA77739 from the NCI, a United States Department of Defense PC073586 Fellowship Award, National Institutes of Health Eunice Kennedy Shriver cooperative Agreement U54-HD35041 as part of the Specialized Cooperative Centers Program in Reproduction, and Infertility Research from the NICHD.	Agoulnik IU, 2008, MOL ENDOCRINOL, V22, P2420, DOI 10.1210/me.2007-0481; Agoulnik IU, 2006, CANCER RES, V66, P10594, DOI 10.1158/0008-5472.CAN-06-1023; Archer CT, 2008, J BIOL CHEM, V283, P21789, DOI 10.1074/jbc.M803075200; Askew EB, 2007, J BIOL CHEM, V282, P25801, DOI 10.1074/jbc.M703268200; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bai S, 2008, MOL HUM REPROD, V14, P107, DOI 10.1093/molehr/gam080; Bai S, 2008, MOL CELL BIOL, V28, P1947, DOI 10.1128/MCB.01672-07; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Chandra S, 2008, J BIOL CHEM, V283, P23950, DOI 10.1074/jbc.M800467200; Chen SY, 2006, MOL CELL BIOL, V26, P929, DOI 10.1128/MCB.26.3.929-939.2006; Chomez P, 2001, CANCER RES, V61, P5544; Craft N, 1999, NAT MED, V5, P280, DOI 10.1038/6495; Craig KL, 1999, PROG BIOPHYS MOL BIO, V72, P299, DOI 10.1016/S0079-6107(99)00010-3; CULIG Z, 1994, CANCER RES, V54, P5474; Dennis AP, 2001, FRONT BIOSCI, V6, pD954, DOI 10.2741/Dennis; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Giffin W, 1996, NATURE, V380, P265, DOI 10.1038/380265a0; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; Gregory CW, 1998, CANCER RES, V58, P5718; Gregory CW, 2001, CANCER RES, V61, P2892; Gregory CW, 2001, CANCER RES, V61, P4315; Han SJ, 2009, TRENDS ENDOCRIN MET, V20, P8, DOI 10.1016/j.tem.2008.10.001; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2006, J BIOL CHEM, V281, P6648, DOI 10.1074/jbc.M511738200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; He B, 2002, J BIOL CHEM, V277, P10226, DOI 10.1074/jbc.M111975200; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Hermand D, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-30; Hoang T, 2004, J BIOL CHEM, V279, P49120, DOI 10.1074/jbc.M409746200; Huang WB, 1999, J BIOL CHEM, V274, P25756, DOI 10.1074/jbc.274.36.25756; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Karpf AR, 2009, MOL CANCER RES, V7, P523, DOI 10.1158/1541-7786.MCR-08-0400; Langley E, 1998, J BIOL CHEM, V273, P92, DOI 10.1074/jbc.273.1.92; LANGLEY E, 1995, J BIOL CHEM, V270, P29983; Lavery DN, 2008, BIOCHEMISTRY-US, V47, P3360, DOI 10.1021/bi702221e; Lavery DN, 2008, BIOCHEMISTRY-US, V47, P3352, DOI 10.1021/bi702220p; Lopez GN, 2001, J BIOL CHEM, V276, P22177, DOI 10.1074/jbc.M010718200; LUBAHN DB, 1988, MOL ENDOCRINOL, V2, P1265, DOI 10.1210/mend-2-12-1265; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; NEWMARK JR, 1992, P NATL ACAD SCI USA, V89, P6319, DOI 10.1073/pnas.89.14.6319; Nie L, 2008, J BIOL CHEM, V283, P684, DOI 10.1074/jbc.M704981200; Onate SA, 1998, J BIOL CHEM, V273, P12101, DOI 10.1074/jbc.273.20.12101; Onoyama I, 2008, CELL CYCLE, V7, P3307, DOI 10.4161/cc.7.21.6931; Ponguta LA, 2008, J BIOL CHEM, V283, P20989, DOI 10.1074/jbc.M802392200; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P22, DOI 10.1210/mend-4-1-22; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; ROGNER UC, 1995, GENOMICS, V29, P725, DOI 10.1006/geno.1995.9945; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Rowan BG, 2000, J BIOL CHEM, V275, P4475, DOI 10.1074/jbc.275.6.4475; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; SIMENTAL JA, 1991, J BIOL CHEM, V266, P510; Smaldone S, 2004, MOL CELL BIOL, V24, P1058, DOI 10.1128/MCB.24.3.1058-1069.2004; Sonnberg S, 2008, P NATL ACAD SCI USA, V105, P10955, DOI 10.1073/pnas.0802042105; TAN JA, 1988, MOL ENDOCRINOL, V2, P1276, DOI 10.1210/mend-2-12-1276; VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2; Verma S, 2004, MOL CELL BIOL, V24, P8716, DOI 10.1128/MCB.24.19.8716-8726.2004; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Westbrook TF, 2008, NATURE, V452, P370, DOI 10.1038/nature06780; WONG CI, 1993, J BIOL CHEM, V268, P19004; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Yi P, 2005, MOL CELL BIOL, V25, P9687, DOI 10.1128/MCB.25.21.9687-9699.2005; Yuan X, 2009, UROL ONCOL-SEMIN ORI, V27, P36, DOI 10.1016/j.urolonc.2008.03.021; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P605, DOI 10.1210/me.9.5.605; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208; ZHOU ZX, 1994, J BIOL CHEM, V269, P13115	82	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34793	34808		10.1074/jbc.M109.065979	http://dx.doi.org/10.1074/jbc.M109.065979			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19828458	hybrid, Green Published			2022-12-25	WOS:000272439600035
J	Fan, XJ; Zhang, JY; Theves, M; Strauch, C; Nemet, I; Liu, XQ; Qian, J; Giblin, FJ; Monnier, VM				Fan, Xingjun; Zhang, Jianye; Theves, Mathilde; Strauch, Christopher; Nemet, Ina; Liu, Xiaoqin; Qian, Juan; Giblin, Frank J.; Monnier, Vincent M.			Mechanism of Lysine Oxidation in Human Lens Crystallins during Aging and in Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-CATALYZED OXIDATION; METHIONINE SULFOXIDE; PROTEIN OXIDATION; MAILLARD REACTION; EYE LENS; GLYCATION; CATARACT; SPECTROMETRY; ASCORBATE; PRODUCTS	Oxidative mechanisms during nuclear sclerosis of the lens are poorly understood, in particular metal-catalyzed oxidation. The lysyl oxidation product adipic semialdehyde (allysine, ALL) and its oxidized end-product 2-aminoadipic acid (2-AAA) were determined as a function of age and presence of diabetes. Surprisingly, whereas both ALL and 2-AAA increased with age and strongly correlated with cataract grade and protein absorbance at 350 nm, only ALL formation but not 2-AAA was increased by diabetes. To clarify the mechanism of oxidation, rabbit lenses were treated with hyperbaric oxygen (HBO) for 48 h, and proteins were analyzed by gas and liquid chromatography mass spectrometry for ALL, 2-AAA, and multiple glycation products. Upon exposure to HBO, rabbit lenses were swollen, and nuclei were yellow. Protein-bound ALL increased 8-fold in the nuclear protein fractions versus controls. A dramatic increase in methylglyoxal hydroimidazolone and carboxyethyl-lysine but no increase of 2-AAA occurred, suggesting more drastic conditions are needed to oxidize ALL into 2-AAA. Indeed the latter formed only upon depletion of glutathione and was catalyzed by H2O2. Neither carboxymethyl-lysine nor glyoxal hydroimidazolone, two markers of glyco-/lipoxidation, nor markers of lenticular glycemia (fructose-lysine, glucospane) were elevated by HBO, excluding significant lipid peroxidation and glucose involvement. The findings strongly implicate dicarbonyl/metal catalyzed oxidation of lysine to allysine, whereby low GSH combined with ascorbate-derived H2O2 likely contributes toward 2-AAA formation, since virtually no 2-AAA formed in the presence of methylglyoxal instead of ascorbate. An important translational conclusion is that chelating agents might help delay nuclear sclerosis.	[Fan, Xingjun; Zhang, Jianye; Theves, Mathilde; Strauch, Christopher; Nemet, Ina; Liu, Xiaoqin; Qian, Juan; Monnier, Vincent M.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Zhang, Jianye] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA; [Monnier, Vincent M.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Giblin, Frank J.] Oakland Univ, Eye Res Inst, Rochester, MI 48309 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Oakland University	Monnier, VM (corresponding author), Case Western Reserve Univ, Dept Pathol, Wolstein Bldg,2103 Cornell Rd, Cleveland, OH 44106 USA.	vmm3@case.edu	Nemet, Ina/ABG-2855-2021	Nemet, Ina/0000-0002-0657-7121	National Institutes of Health [EY07099, EY 02027, EY 014803]; NATIONAL EYE INSTITUTE [R01EY002027, R01EY007099, R24EY014803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY07099 (to V.M.M.), EY 02027 (to F.J.G.), and EY 014803 (to F.J.G.).	Ahmed N, 2002, BIOCHEM J, V364, P15, DOI 10.1042/bj3640015; Akagawa M, 2002, EUR J BIOCHEM, V269, P5451, DOI 10.1046/j.1432-1033.2002.03243.x; AMICI A, 1989, J BIOL CHEM, V264, P3341; Biemel KM, 2003, BIOCONJUGATE CHEM, V14, P619, DOI 10.1021/bc025653e; Boscia F, 2000, INVEST OPHTH VIS SCI, V41, P2461; Brennan LA, 2009, MOL VIS, V15, P985; BROT N, 1983, ARCH BIOCHEM BIOPHYS, V223, P271, DOI 10.1016/0003-9861(83)90592-1; DEVAMANOHARAN PS, 1995, OPHTHALMIC RES, V27, P39, DOI 10.1159/000267837; Ellis EA, 2000, FREE RADICAL BIO MED, V28, P91, DOI 10.1016/S0891-5849(99)00216-6; Fan XJ, 2006, P NATL ACAD SCI USA, V103, P16912, DOI 10.1073/pnas.0605101103; Fu SL, 1998, J BIOL CHEM, V273, P28603, DOI 10.1074/jbc.273.44.28603; GARLAND D, 1988, OXYGEN RADICALS BIOL, V49, P347; GARNER MH, 1980, P NATL ACAD SCI-BIOL, V77, P1274, DOI 10.1073/pnas.77.3.1274; Hazell Linda J, 2002, Clin Exp Optom, V85, P97; KAGAN HM, 1984, J BIOL CHEM, V259, P1203; Kyselova Z, 2005, PHYSIOL RES, V54, P49, DOI 10.33549/physiolres.930613; Lacy F, 2000, HYPERTENSION, V36, P878, DOI 10.1161/01.HYP.36.5.878; LOU MF, 1990, EXP EYE RES, V50, P819, DOI 10.1016/0014-4835(90)90133-F; MARTENSSON J, 1989, P NATL ACAD SCI USA, V86, P8727, DOI 10.1073/pnas.86.22.8727; NAGARAJ RH, 1991, P NATL ACAD SCI USA, V88, P10257, DOI 10.1073/pnas.88.22.10257; Padgaonkar VA, 2000, EXP EYE RES, V71, P371, DOI 10.1006/exer.2000.0887; PAOLISSO G, 1992, AM J PHYSIOL, V263, pE435, DOI 10.1152/ajpendo.1992.263.3.E435; Peng DQ, 2005, J BIOL CHEM, V280, P33775, DOI 10.1074/jbc.M504092200; PIRIE A, 1968, INVEST OPHTH VISUAL, V7, P634; Reddy VN, 2001, INVEST OPHTH VIS SCI, V42, P3247; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; Requena JR, 2003, AMINO ACIDS, V25, P221, DOI 10.1007/s00726-003-0012-1; Saxena P, 2000, INVEST OPHTH VIS SCI, V41, P1473; Sell DR, 2007, BIOCHEM J, V404, P269, DOI 10.1042/BJ20061645; SELLIN S, 1983, J BIOL CHEM, V258, P8872; Sochaski MA, 2001, ANAL CHEM, V73, P4662, DOI 10.1021/ac010228k; Thiagarajan G, 2004, INVEST OPHTH VIS SCI, V45, P2115, DOI 10.1167/iovs.03-0929; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; YU NT, 1985, P NATL ACAD SCI USA, V82, P7965, DOI 10.1073/pnas.82.23.7965	36	44	47	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34618	34627		10.1074/jbc.M109.032094	http://dx.doi.org/10.1074/jbc.M109.032094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19854833	hybrid, Green Published			2022-12-25	WOS:000272439600017
J	Lu, HK; Rentero, C; Raftery, MJ; Borges, L; Bryant, K; Tedla, N				Lu, Hao Kim; Rentero, Carles; Raftery, Mark J.; Borges, Luis; Bryant, Katherine; Tedla, Nicodemus			Leukocyte Ig-like Receptor B4 (LILRB4) Is a Potent Inhibitor of Fc gamma RI-mediated Monocyte Activation via Dephosphorylation of Multiple Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR NECROSIS FACTOR; RHEUMATOID-ARTHRITIS; CROSS-LINKING; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; MOUSE MACROPHAGES; DENDRITIC CELLS; BINDING DOMAIN; MYELOID CELLS; SH3 DOMAIN	The leukocyte immunoglobulin-like receptor (LILR) B4 belongs to a family of cell surface receptors that possesses cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). LILRB4 is believed to down-regulate activation signals mediated by non-receptor tyrosine kinase cascades through the recruitment of SHP-1. However, the exact mechanisms of LILRB4-mediated inhibition are not fully elucidated. In this study, we demonstrate high level surface expression of LILRB4 on THP-1 cells and primary peripheral blood monocytes, which profoundly inhibited production of a key pro-inflammatory cytokine (TNF alpha) induced by Fc gamma RI (CD64). We also report that LILRB4 aggregated to sites of activation upon co-ligation with CD64 and that this may enhance its inhibitory effects. Crosslinking of CD64 on THP-1 cells markedly increased phosphorylation of multiple proteins including tyrosine kinases and signaling molecules (Lck, Syk, LAT, and Erk), an adaptor protein that targets protein-tyrosine kinases for degradation (c-Cbl) and a protein involved in the formation of actin cytoskeletal rearrangement (alpha-actinin-4). Co-ligation of LILRB4 considerably reduced CD64-mediated phosphorylation of Lck, Syk, LAT, Erk, and c-Cbl but not alpha-actinin-4, suggesting selective inhibition of signaling molecules. Treatment of cells with a broad-spectrum phosphatase inhibitor, sodium pervanadate (SP), significantly reversed LILRB4-mediated inhibition of TNF alpha production and protein tyrosine phosphorylation. In comparison, treatment with an SHP-1 specific inhibitor, sodium stibogluconate (SS) has no effects indicating involvement of phosphatase(s) other than SHP-1 in LILRB4 signaling. Collectively, our data show LILRB4 is a potent inhibitor of monocytes activation. This may provide a new potential therapeutic strategy for inflammatory conditions characterized by excessive TNF alpha production.	[Lu, Hao Kim; Bryant, Katherine; Tedla, Nicodemus] Univ New S Wales, Ctr Infect & Inflammat Res, Sydney, NSW 2052, Australia; [Rentero, Carles] Univ New S Wales, Ctr Vasc Res, Sydney, NSW 2052, Australia; [Raftery, Mark J.] Univ New S Wales, Bioanalyt Mass Spectrometry Facil, Sydney, NSW 2052, Australia; [Bryant, Katherine] Univ New S Wales, Sch Med Sci, S Western Sydney Clin Sch, Sydney, NSW 2052, Australia; [Borges, Luis] Amgen Inc, Seattle, WA 98119 USA	University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of New South Wales Sydney; Amgen	Tedla, N (corresponding author), Univ New S Wales, Ctr Infect & Inflammat Res, Sydney, NSW 2052, Australia.	n.tedla@unsw.edu.au	Rentero Alfonso, Carles/L-4430-2017; Bryant, Katherine/E-8574-2010	Rentero Alfonso, Carles/0000-0003-4684-0278; Bryant, Katherine/0000-0002-8686-623X; Lu, Hao/0000-0002-3940-3283				AKERLEY WL, 1991, BLOOD, V77, P607; Akin O, 2008, CELL, V133, P841, DOI 10.1016/j.cell.2008.04.011; Araki N, 2000, J CELL SCI, V113, P3329; Bezman NA, 2008, J EXP MED, V205, P1775, DOI 10.1084/jem.20080240; Billadeau DD, 2002, J CLIN INVEST, V109, P161, DOI 10.1172/JCI14843; Borges L, 1997, J IMMUNOL, V159, P5192; BU JY, 1995, P NATL ACAD SCI USA, V92, P5106, DOI 10.1073/pnas.92.11.5106; Burshtyn DN, 1997, J BIOL CHEM, V272, P13066, DOI 10.1074/jbc.272.20.13066; CAMBIER JC, 1995, IMMUNOL TODAY, V16, P110, DOI 10.1016/0167-5699(95)80105-7; Cella M, 1997, J EXP MED, V185, P1743, DOI 10.1084/jem.185.10.1743; Chacko GW, 1996, J BIOL CHEM, V271, P10775, DOI 10.1074/jbc.271.18.10775; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; Cortesini R, 2007, J PANCREAS, V8, P697; Couttas TA, 2008, J PROTEOME RES, V7, P2632, DOI 10.1021/pr700644t; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; DEBETS JMH, 1988, J IMMUNOL, V141, P1197; DEBETS JMH, 1990, J IMMUNOL, V144, P1304; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; Dixson JD, 2003, J MOL EVOL, V56, P1, DOI 10.1007/s00239-002-2374-5; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; FUKAMACHI H, 1994, J IMMUNOL, V152, P642; Goodchild A, 2005, J PROTEOME RES, V4, P473, DOI 10.1021/pr049760p; GRAZIANO RF, 1987, J IMMUNOL, V139, P3536; HAMERMAN JA, 2006, SCI STKE, V320, pRE1; Hartgroves LC, 2003, J BIOL CHEM, V278, P20389, DOI 10.1074/jbc.M301212200; Huynh OA, 2007, RHEUMATOLOGY, V46, P742, DOI 10.1093/rheumatology/kel405; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Katz HR, 2007, IMMUNOL REV, V217, P222, DOI 10.1111/j.1600-065X.2007.00522.x; Kemp SF, 2002, J ALLERGY CLIN IMMUN, V110, P341, DOI 10.1067/mai.2002.126811; Kockx M, 2009, J BIOL CHEM, V284, P24144, DOI 10.1074/jbc.M109.032615; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Lupher ML, 1997, J BIOL CHEM, V272, P33140, DOI 10.1074/jbc.272.52.33140; Mitchell A, 2008, EUR J IMMUNOL, V38, P3459, DOI 10.1002/eji.200838415; Miyake S, 1999, J BIOL CHEM, V274, P16619, DOI 10.1074/jbc.274.23.16619; Ota Y, 1996, J EXP MED, V184, P1713, DOI 10.1084/jem.184.5.1713; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; PAN L, 1990, J IMMUNOL, V145, P267; Park RK, 1998, J IMMUNOL, V160, P5018; Pathak MK, 2001, J IMMUNOL, V167, P3391, DOI 10.4049/jimmunol.167.6.3391; PELTZ G, 1988, MOL IMMUNOL, V25, P243, DOI 10.1016/0161-5890(88)90015-6; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Takeshita T, 1996, BIOCHEM BIOPH RES CO, V225, P1035, DOI 10.1006/bbrc.1996.1290; Tamai K, 2007, BIOCHEM BIOPH RES CO, V360, P721, DOI 10.1016/j.bbrc.2007.06.105; Tedla N, 2003, P NATL ACAD SCI USA, V100, P1174, DOI 10.1073/pnas.0337567100; Tridandapani S, 2000, J BIOL CHEM, V275, P20480, DOI 10.1074/jbc.M909462199; UNKELESS JC, 1975, J EXP MED, V142, P1520, DOI 10.1084/jem.142.6.1520; Vivier E, 1997, IMMUNOL TODAY, V18, P286, DOI 10.1016/S0167-5699(97)80025-4; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Zhou H, 2007, TRANSPL P, V39, P3065, DOI 10.1016/j.transproceed.2007.02.098; Zhou JS, 2005, EUR J IMMUNOL, V35, P1530, DOI 10.1002/eji.200425895	55	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34839	34848		10.1074/jbc.M109.035683	http://dx.doi.org/10.1074/jbc.M109.035683			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19833736	Green Published, hybrid			2022-12-25	WOS:000272439600039
J	Menicucci, D; Piarulli, A; Debarnot, U; d'Ascanio, P; Landi, A; Gemignani, A				Menicucci, Danilo; Piarulli, Andrea; Debarnot, Ursula; d'Ascanio, Paola; Landi, Alberto; Gemignani, Angelo			Functional Structure of Spontaneous Sleep Slow Oscillation Activity in Humans	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; LESS-THAN-1 HZ; CORTICAL SYNCHRONIZATION; SYNAPTIC HOMEOSTASIS; NEOCORTICAL NEURONS; WAVE SLEEP; NREM DELTA; IN-VIVO; ELECTROENCEPHALOGRAM; EEG	Background: During non-rapid eye movement (NREM) sleep synchronous neural oscillations between neural silence (down state) and neural activity (up state) occur. Sleep Slow Oscillations (SSOs) events are their EEG correlates. Each event has an origin site and propagates sweeping the scalp. While recent findings suggest a SSO key role in memory consolidation processes, the structure and the propagation of individual SSO events, as well as their modulation by sleep stages and cortical areas have not been well characterized so far. Methodology/Principal Findings: We detected SSO events in EEG recordings and we defined and measured a set of features corresponding to both wave shapes and event propagations. We found that a typical SSO shape has a transition to down state, which is steeper than the following transition from down to up state. We show that during SWS SSOs are larger and more locally synchronized, but less likely to propagate across the cortex, compared to NREM stage 2. Also, the detection number of SSOs as well as their amplitudes and slopes, are greatest in the frontal regions. Although derived from a small sample, this characterization provides a preliminary reference about SSO activity in healthy subjects for 32-channel sleep recordings. Conclusions/Significance: This work gives a quantitative picture of spontaneous SSO activity during NREM sleep: we unveil how SSO features are modulated by sleep stage, site of origin and detection location of the waves. Our measures on SSOs shape indicate that, as in animal models, onsets of silent states are more synchronized than those of neural firing. The differences between sleep stages could be related to the reduction of arousal system activity and to the breakdown of functional connectivity. The frontal SSO prevalence could be related to a greater homeostatic need of the heteromodal association cortices.			Menicucci, D (corresponding author), CNR, Inst Clin Physiol, Via Savi 8, I-56100 Pisa, Italy.	gemignan@dfb.unipi.it	LANDI, ALBERTO/CAE-9552-2022; Gemignani, Angelo/AAC-3308-2022; Landi, Alberto/A-7466-2016	LANDI, ALBERTO/0000-0002-0105-5121; Landi, Alberto/0000-0002-0105-5121; piarulli, andrea/0000-0003-4516-2671; menicucci, danilo/0000-0002-5521-4108; gemignani, angelo/0000-0001-7249-874X; D'ASCANIO, PAOLA/0000-0002-7272-8370				Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Amzica F, 2002, J PHYSIOL-PARIS, V96, P209, DOI 10.1016/S0928-4257(02)00008-6; Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Amzica F, 1998, ELECTROEN CLIN NEURO, V107, P69, DOI 10.1016/S0013-4694(98)00051-0; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Campbell IG, 1996, J NEUROPHYSIOL, V76, P3714, DOI 10.1152/jn.1996.76.6.3714; Campbell IG, 1996, J PHARMACOL EXP THER, V276, P737; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Castellan NJ, 1988, NONPARAMETRIC STAT B; Cisse Y, 2007, NEUROSCIENCE, V147, P272, DOI 10.1016/j.neuroscience.2007.04.025; Cohen L., 1995, TIME FREQUENCY ANAL; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Czisch M, 2004, EUR J NEUROSCI, V20, P566, DOI 10.1111/j.1460-9568.2004.03518.x; Dang-Vu TT, 2008, P NATL ACAD SCI USA, V105, P15160, DOI 10.1073/pnas.0801819105; De Gennaro L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002483; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Massimini M, 2007, P NATL ACAD SCI USA, V104, P8496, DOI 10.1073/pnas.0702495104; Molle M, 2002, J NEUROSCI, V22, P10941; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Simon NR, 2000, BRAIN RES, V860, P64, DOI 10.1016/S0006-8993(00)01974-0; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Vyazovskiy V, 2004, NEUROSCIENCE, V124, P481, DOI 10.1016/j.neuroscience.2003.12.018; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; [No title captured]; [No title captured]	43	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7601	10.1371/journal.pone.0007601	http://dx.doi.org/10.1371/journal.pone.0007601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855839	Green Submitted, Green Published, gold			2022-12-25	WOS:000271147200017
J	Iacovelli, S; Iosue, I; Di Cesare, S; Guttinger, M				Iacovelli, Stefano; Iosue, Ilaria; Di Cesare, Silvia; Guttinger, Maria			Lymphoid EVA1 Expression Is Required for DN1-DN3 Thymocytes Transition	PLOS ONE			English	Article							T-CELL-DIFFERENTIATION; THYMIC MICROENVIRONMENTS; DEVELOPMENTAL PATHWAY; ANTIGEN EVA; LINEAGE; MOUSE; SPECIFICATION; COMMITMENT; INDUCTION; SUBSETS	Background: Thymus organogenesis and T lymphocyte development are accomplished together during fetal life. Proper development and maintenance of thymus architecture depend on signals generated by a sustained crosstalk between developing thymocytes and stromal elements. Any maturation impairment occurring in either cellular component leads to an aberrant thymic development. Gene expression occurring during T lymphocyte differentiation must be coordinated in a spatio-temporal fashion; one way in which this is achieved is through the regulation by cell-cell adhesion and interactions. Principal Findings: We examined the role played by Epithelial V-like Antigen 1 (EVA1), an Ig adhesion molecule expressed on thymus epithelial cells (TEC) and immature thymocytes, in T cell development by employing RNA interference in vitro and in vivo models. Fetal liver derived haematopoietic progenitors depleted of Eva1, displayed a delayed DN1-DN3 transition and failed to generate CD4CD8 double positive T cells in OP9-DL1 coculture system. In addition, we could observe a coordinated Eva1 up-regulation in stromal and haematopoietic cells in coculture control experiments, suggesting a possible EVA1 involvement in TEC-haematopoietic cells crosstalk mechanisms. Similarly, Rag2-gamma c double knock out mice, transplanted with Eva1 depleted haematopoietic progenitors displayed a 10-fold reduction in thymus reconstitution and a time delayed thymocytes maturation compared to controls. Conclusions: Our findings show that modulation of Eva1 expression in thymocytes is crucial for lymphocyte physiological developmental progression and stromal differentiation.			Iacovelli, S (corresponding author), San Raffaele Biomed Sci Pk Fdn, Rome, Italy.	maria.guttinger@spr-r.it	DI CESARE, SILVIA/AAB-5754-2020	DI CESARE, SILVIA/0000-0002-9912-7997; iacovelli, stefano/0000-0003-0806-6365				Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; Anderson MK, 1999, DEVELOPMENT, V126, P3131; DeMonte L, 2007, BIOCHEM BIOPH RES CO, V356, P334, DOI 10.1016/j.bbrc.2007.02.131; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; GOLDSCHNEIDER I, 1986, J EXP MED, V163, P1, DOI 10.1084/jem.163.1.1; Guttinger M, 1998, J CELL BIOL, V141, P1061, DOI 10.1083/jcb.141.4.1061; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; Itoi M, 2001, INT IMMUNOL, V13, P1203, DOI 10.1093/intimm/13.9.1203; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; KYEWSKI BA, 1987, J EXP MED, V166, P520, DOI 10.1084/jem.166.2.520; MILLER JFA, 1967, PHYSIOL REV, V47, P437, DOI 10.1152/physrev.1967.47.3.437; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Patra AK, 2006, J IMMUNOL, V177, P4567, DOI 10.4049/jimmunol.177.7.4567; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Teesalu T, 1998, DEV GENET, V23, P317, DOI 10.1002/(SICI)1520-6408(1998)23:4<317::AID-DVG6>3.0.CO;2-O; Tydell CC, 2007, J IMMUNOL, V179, P421, DOI 10.4049/jimmunol.179.1.421; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; van Ewijk W, 1999, SEMIN IMMUNOL, V11, P57, DOI 10.1006/smim.1998.0158; van Ewijk W, 2000, CURR TOP MICROBIOL, V251, P125; VANEWIJK W, 1991, ANNU REV IMMUNOL, V9, P591, DOI 10.1146/annurev.iy.09.040191.003111; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; WALLIS VJ, 1975, TRANSPLANTATION, V19, P2, DOI 10.1097/00007890-197501000-00002	26	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7586	10.1371/journal.pone.0007586	http://dx.doi.org/10.1371/journal.pone.0007586			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851463	Green Published, Green Submitted, gold			2022-12-25	WOS:000271022300017
J	Patch, K; Stewart, SR; Welch, A; Ward, RE				Patch, Kistie; Stewart, Shannon R.; Welch, Aaron; Ward, Robert E., IV			A Second-Site Noncomplementation Screen for Modifiers of Rho1 Signaling during Imaginal Disc Morphogenesis in Drosophila	PLOS ONE			English	Article							NONMUSCLE MYOSIN FUNCTION; ADHERENS JUNCTIONS; CELL REARRANGEMENT; GENETIC-ANALYSIS; MELANOGASTER; GTPASES; ECDYSONE; GROWTH; ACTIVATION; MECHANISM	Background: Rho1 is a small GTPase of the Ras superfamily that serves as the central component in a highly conserved signaling pathway that regulates tissue morphogenesis during development in all animals. Since there is tremendous diversity in the upstream signals that can activate Rho1 as well as the effector molecules that carry out its functions, it is important to define relevant Rho1-interacting genes for each morphogenetic event regulated by this signaling pathway. Previous work from our lab and others has shown that Rho signaling is necessary for the morphogenesis of leg imaginal discs during metamorphosis in Drosophila, although a comprehensive identification of Rho1-interacting genes has not been attempted for this process. Methodology/Principal Findings: We characterized an amorphic allele of Rho1 that displays a poorly penetrant dominant malformed leg phenotype and is capable of being strongly enhanced by Rho1-interacting heterozygous mutations. We then used this allele in a second-site noncomplementation screen with the Exelixis collection of molecularly defined deficiencies to identify Rho1-interacting genes necessary for leg morphogenesis. In a primary screen of 461 deficiencies collectively uncovering similar to 50% of the Drosophila genome, we identified twelve intervals harboring Rho1-interacting genes. Through secondary screening we identified six Rho1-interacting genes including three that were previously identified (RhoGEF2, broad, and stubbloid), thereby validating the screen. In addition, we identified Cdc42, Rheb and Sc2 as novel Rho1-interacting genes involved in adult leg development. Conclusions/Significance: This screen identified well-known and novel Rho1-interacting genes necessary for leg morphogenesis, thereby increasing our knowledge of this important signaling pathway. We additionally found that Rheb may have a unique function in leg morphogenesis that is independent of its regulation of Tor.			Patch, K (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	robward@ku.edu		Stewart, Shannon/0000-0002-5059-1609; Welch, Aaron Zachary/0000-0002-1502-3630	NCRR NIH HHS [P20 RR015563, P20 RR15563] Funding Source: Medline; NICHD NIH HHS [R01HD047570, R01 HD047570] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047570] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; Bayer CA, 2003, GENETICS, V165, P1417; BRAND AH, 1993, DEVELOPMENT, V118, P401; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Causeret F, 2004, DEVELOPMENT, V131, P2841, DOI 10.1242/dev.01162; Chen GC, 2004, CURR BIOL, V14, P309, DOI 10.1016/j.cub.2004.01.056; Cohen Stephen M., 1993, P747; CONDIC ML, 1991, DEVELOPMENT, V111, P23; Crawford JM, 1998, DEV BIOL, V204, P151, DOI 10.1006/dbio.1998.9061; Fox DT, 2005, DEVELOPMENT, V132, P4819, DOI 10.1242/dev.02056; FRISTROM D, 1976, DEV BIOL, V54, P163, DOI 10.1016/0012-1606(76)90296-7; FRISTROM D, 1975, DEV BIOL, V43, P1, DOI 10.1016/0012-1606(75)90127-X; Fristrom D, 1993, DEV DROSOPHILA MELAN, P843; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Geneva JL, 2000, DEV BIOL, V221, P181, DOI 10.1006/dbio.2000.9671; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; GOTWALS PJ, 1991, GENETICS, V127, P747; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Halsell SR, 1998, GENETICS, V148, P1845; Halsell SR, 2000, GENETICS, V155, P1253; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, IUBMB LIFE, V60, P483, DOI 10.1002/iub.56; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Johndrow JE, 2004, BIOCHEM CELL BIOL, V82, P643, DOI 10.1139/O04-118; KARIM FD, 1991, GENE DEV, V5, P1067, DOI 10.1101/gad.5.6.1067; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le T, 2006, GENETICS, V174, P2255, DOI 10.1534/genetics.106.063461; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Magie CR, 2005, DEV BIOL, V278, P144, DOI 10.1016/j.ydbio.2004.10.022; Magie CR, 1999, DEVELOPMENT, V126, P5353; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Meiri KF, 2005, PHILOS T R SOC B, V360, P1663, DOI 10.1098/rstb.2005.1704; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Mulinari S, 2008, MOL BIOL CELL, V19, P1883, DOI 10.1091/mbc.E07-12-1230; Neufeld TP, 2003, MECH DEVELOP, V120, P1283, DOI 10.1016/j.mod.2003.07.003; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rossman KL, 2005, TRENDS BIOCHEM SCI, V30, P163, DOI 10.1016/j.tibs.2005.02.002; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Taylor J, 2008, DEV BIOL, V313, P739, DOI 10.1016/j.ydbio.2007.11.009; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Ward RE, 2003, GENETICS, V165, P1397; Ward RE, 2003, DEV BIOL, V256, P389, DOI 10.1016/S0012-1606(02)00100-8; Wei L, 2001, DEVELOPMENT, V128, P2953; WOHLWILL AD, 1991, GENETICS, V128, P763; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	56	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7574	10.1371/journal.pone.0007574	http://dx.doi.org/10.1371/journal.pone.0007574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19862331	Green Published, gold, Green Submitted			2022-12-25	WOS:000271022300010
J	Beghin, A; Belin, S; Sleiman, RH; Manquat, SB; Goddard, S; Tabone, E; Jordheim, LP; Treilleux, I; Poupon, MF; Diaz, JJ; Dumontet, C				Beghin, Anne; Belin, Stephane; Sleiman, Rouba Hage; Manquat, Stephanie Brunet; Goddard, Sophie; Tabone, Eric; Jordheim, Lars P.; Treilleux, Isabelle; Poupon, Marie-France; Diaz, Jean-Jacques; Dumontet, Charles			ADP Ribosylation Factor Like 2 (Arl2) Regulates Breast Tumor Aggressivity in Immunodeficient Mice	PLOS ONE			English	Article							TUBULIN FOLDING COFACTORS; PROTEIN PHOSPHATASE 2A; MICROTUBULE DYNAMICS; BUDDING YEAST; E-CADHERIN; CELL-LINE; IN-VITRO; PP2A; BINDING; MORPHOGENESIS	We have previously reported that ADP ribosylation factor like 2 (Arl2), a small GTPase, content influences microtubule dynamics and cell cycle distribution in breast tumor cells, as well as the degree and distribution of phosphorylated P53. Here we show, in two different human breast adenocarcinoma models, that Arl2 content has a major impact on breast tumor cell aggressivity both in vitro and in vivo. Cells with reduced content of Arl2 displayed reduced contact inhibition, increased clonogenic or cluster formation as well as a proliferative advantage over control cells in an in vitro competition assay. These cells also caused larger tumors in SCID mice, a phenotype which was mimicked by the in vivo administration of siRNA directed against Arl2. Cells with increased Arl2 content displayed reduced aggressivity, both in vitro and in vivo, with enhanced necrosis and were also found to contain increased PP2A phosphatase activity. A rt-PCR analysis of fresh human tumor breast samples suggested that low Arl2 expression was associated with larger tumor size and greater risk of lymph node involvement at diagnosis. These data underline the role of Arl2, a small GTPase, as an important regulator of breast tumor cell aggressivity, both in vitro and in vivo.			Beghin, A (corresponding author), INSERM, U590, F-69008 Lyon, France.	charles.dumontet@chu-lyon.fr	Jordheim, Lars Petter/X-7228-2019; DIAZ, Jean-Jacques/H-3018-2014; DIAZ, Jean-Jacques/AAT-3846-2021	Jordheim, Lars Petter/0000-0003-3948-7090; DIAZ, Jean-Jacques/0000-0002-7914-4319; DIAZ, Jean-Jacques/0000-0002-7914-4319; Belin, Stephane/0000-0001-7074-6885; Dumontet, Charles/0000-0003-1875-134X				Antoshechkin I, 2002, DEV CELL, V2, P579, DOI 10.1016/S1534-5807(02)00146-6; Beghin A, 2008, CELL CYCLE, V7, P3074, DOI 10.4161/cc.7.19.6777; Behin A, 2007, EXP CELL RES, V313, P473, DOI 10.1016/j.yexcr.2006.10.024; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Bode CJ, 2003, EMBO REP, V4, P94, DOI 10.1038/sj.embor.embor716; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; FUJIKI H, 1993, ADV CANCER RES, V61, P143, DOI 10.1016/S0065-230X(08)60958-6; Gehringer MM, 2004, FEBS LETT, V557, P1, DOI 10.1016/S0014-5793(03)01447-9; Hoyt MA, 1997, GENETICS, V146, P849; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Jordheim LP, 2004, CLIN CANCER RES, V10, P5614, DOI 10.1158/1078-0432.CCR-04-0506; Kahn RA, 2005, BIOCHEM SOC T, V33, P1269, DOI 10.1042/BST0331269; KAHN RA, 1991, J BIOL CHEM, V266, P2606; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; MESSNER DJ, 2006, J CELL BIOCH; Minshull J, 1996, CURR BIOL, V6, P1609, DOI 10.1016/S0960-9822(02)70784-7; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Radcliffe PA, 2000, FEBS LETT, V468, P84, DOI 10.1016/S0014-5793(00)01202-3; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; SHULTZ T, 2007, FASEB J; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; Takahashi K, 2006, J CELL PHYSIOL, V206, P814, DOI 10.1002/jcp.20524; TIAN GL, 1995, J BIOL CHEM, V270, P23910, DOI 10.1074/jbc.270.41.23910; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tian GL, 1999, J BIOL CHEM, V274, P24054, DOI 10.1074/jbc.274.34.24054; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284	29	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7478	10.1371/journal.pone.0007478	http://dx.doi.org/10.1371/journal.pone.0007478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829707	Green Published, gold			2022-12-25	WOS:000270847800015
J	Schleimann, MH; Moller, JML; Kofod-Olsen, E; Hollsberg, P				Schleimann, Mariane H.; Moller, Janni M. L.; Kofod-Olsen, Emil; Hoellsberg, Per			Direct Repeat 6 from Human Herpesvirus-6B Encodes a Nuclear Protein that Forms a Complex with the Viral DNA Processivity Factor p41	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; BINDING PROTEIN; CODING CONTENT; INFECTION; ACCUMULATION; EXPRESSION; SEQUENCE; FRAGMENT; AGENT; P53	The SalI-L fragment from human herpesvirus 6A (HHV-6A) encodes a protein DR7 that has been reported to produce fibrosarcomas when injected into nude mice, to transform NIH3T3 cells, and to interact with and inhibit the function of p53. The homologous gene in HHV-6B is dr6. Since p53 is deregulated in both HHV-6A and -6B, we characterized the expression of dr6 mRNA and the localization of the translated protein during HHV-6B infection of HCT116 cells. Expression of mRNA from dr6 was inhibited by cycloheximide and partly by phosphonoacetic acid, a known characteristic of herpesvirus early/late genes. DR6 could be detected as a nuclear protein at 24 hpi and accumulated to high levels at 48 and 72 hpi. DR6 located in dots resembling viral replication compartments. Furthermore, a novel interaction between DR6 and the viral DNA processivity factor, p41, could be detected by confocal microscopy and by co-immunoprecipitation analysis. In contrast, DR6 and p53 were found at distinct subcellular locations. Together, our data imply a novel function of DR6 during HHV-6B replication.			Schleimann, MH (corresponding author), Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark.	ph@microbiology.au.dk		Schleimann, Mariane/0000-0001-5147-9523				Aberle SW, 1996, J CLIN MICROBIOL, V34, P3223, DOI 10.1128/JCM.34.12.3223-3225.1996; Ahlqvist J, 2005, J NEUROVIROL, V11, P384, DOI 10.1080/13550280591002379; Braun DK, 1997, CLIN MICROBIOL REV, V10, P521, DOI 10.1128/CMR.10.3.521; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; De Bolle L, 2005, J MED VIROL, V75, P76, DOI 10.1002/jmv.20240; De Bolle L, 2004, FEBS LETT, V560, P25, DOI 10.1016/S0014-5793(04)00035-3; Dominguez G, 1999, J VIROL, V73, P8040, DOI 10.1128/JVI.73.10.8040-8052.1999; GOMPELS UA, 1995, VIROLOGY, V209, P29, DOI 10.1006/viro.1995.1228; Kashanchi F, 1997, ONCOGENE, V14, P359, DOI 10.1038/sj.onc.1200840; KASHANCHI F, 1994, VIROLOGY, V201, P95, DOI 10.1006/viro.1994.1269; Oster B, 2005, J VIROL, V79, P1961, DOI 10.1128/JVI.79.3.1961-1965.2005; Oster B, 2002, J VIROL, V76, P7578, DOI 10.1128/JVI.76.15.7578-7586.2002; Quadt I, 2006, VIRUS RES, V115, P207, DOI 10.1016/j.virusres.2005.09.010; QUINLAN MP, 1984, CELL, V36, P857, DOI 10.1016/0092-8674(84)90035-7; Takemoto M, 2004, J GEN VIROL, V85, P869, DOI 10.1099/vir.0.19626-0; THOMPSON J, 1994, ONCOGENE, V9, P1167; Turcanova VL, 2009, J CLIN VIROL, V46, P15, DOI 10.1016/j.jcv.2009.05.015; YAMANISHI K, 1988, LANCET, V1, P1065; YOSHIKAWA T, 1989, PEDIATRICS, V84, P675; Zerr DM, 2005, NEW ENGL J MED, V352, P768, DOI 10.1056/NEJMoa042207	20	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7457	10.1371/journal.pone.0007457	http://dx.doi.org/10.1371/journal.pone.0007457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829698	Green Published, Green Submitted, gold			2022-12-25	WOS:000270847800005
J	Sung, YM; Xu, XH; Sun, JF; Mueller, D; Sentissi, K; Johnson, P; Urbach, E; Seillier-Moiseiwitsch, F; Johnson, MD; Mueller, SC				Sung, You Me; Xu, Xuehua; Sun, Junfeng; Mueller, Duane; Sentissi, Kinza; Johnson, Peter; Urbach, Elana; Seillier-Moiseiwitsch, Francoise; Johnson, Michael D.; Mueller, Susette C.			Tumor Suppressor Function of Syk in Human MCF10A In Vitro and Normal Mouse Mammary Epithelium In Vivo	PLOS ONE			English	Article							BREAST-CANCER CELLS; PROTEIN-TYROSINE KINASE; MESENCHYMAL TRANSITION; INVADOPODIA FORMATION; MATRIX DEGRADATION; CARCINOMA CELLS; KAPPA-B; VIMENTIN; GROWTH; MODEL	The normal function of Syk in epithelium of the developing or adult breast is not known, however, Syk suppresses tumor growth, invasion, and metastasis in breast cancer cells. Here, we demonstrate that in the mouse mammary gland, loss of one Syk allele profoundly increases proliferation and ductal branching and invasion of epithelial cells through the mammary fat pad during puberty. Mammary carcinomas develop by one year. Syk also suppresses proliferation and invasion in vitro. siRNA or shRNA knockdown of Syk in MCF10A breast epithelial cells dramatically increased proliferation, anchorage independent growth, cellular motility, and invasion, with formation of functional, extracellular matrix-degrading invadopodia. Morphological and gene microarray analysis following Syk knockdown revealed a loss of luminal and differentiated epithelial features with epithelial to mesenchymal transition and a gain in invadopodial cell surface markers CD44, CD49F, and MMP14. These results support the role of Syk in limiting proliferation and invasion of epithelial cells during normal morphogenesis, and emphasize the critical role of Syk as a tumor suppressor for breast cancer. The question of breast cancer risk following systemic anti-Syk therapy is raised since only partial loss of Syk was sufficient to induce mammary carcinomas.			Sung, YM (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	muellers@georgetown.edu	xu, xuehua/R-1163-2019	xu, xuehua/0000-0002-3863-9593; Urbach, Elana/0000-0002-3205-2484; johnson, Michael/0000-0001-6260-7586	NCATS NIH HHS [UL1 TR000101] Funding Source: Medline; NCI NIH HHS [P30 CA051008, 9R01 CA 112673, 1P30-CA-51008, R01 CA112673] Funding Source: Medline; NCRR NIH HHS [1 S10 RR019291-01A2, S10 RR019291, 1S10 RR15768-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA112673, P30CA051008] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015768, S10RR019291] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Akisaka T, 2008, CELL TISSUE RES, V331, P625, DOI 10.1007/s00441-007-0552-x; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Artym VV, 2009, METHOD MOL BIOL, V522, P1; Bebu I, 2008, STAT MED, V27, P2684, DOI 10.1002/sim.3080; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Coopman PJ, 2006, CANCER LETT, V241, P159, DOI 10.1016/j.canlet.2005.11.004; Coopman PJ, 1998, CLIN CANCER RES, V4, P507; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Fillmore C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1673; Gad A, 2008, CELL MOTIL CYTOSKEL, V65, P614, DOI 10.1002/cm.20287; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Gilles C, 1999, J CELL SCI, V112, P4615; Gilles C, 2001, J CELL SCI, V114, P2967; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Li J, 2005, INT J CANCER, V117, P14, DOI 10.1002/ijc.21074; LIU S, 2008, PIGMENT CELL MELANOM; Mahabeleshwar GH, 2003, J BIOL CHEM, V278, P6209, DOI 10.1074/jbc.M208905200; Mandal S, 2008, EXP CELL RES, V314, P3478, DOI 10.1016/j.yexcr.2008.09.013; Masuda ES, 2008, PULM PHARMACOL THER, V21, P461, DOI 10.1016/j.pupt.2007.06.002; Miller F R, 1996, Cancer Treat Res, V83, P243; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Moroni M, 2004, CANCER RES, V64, P7346, DOI 10.1158/0008-5472.CAN-03-3520; Mueller Susette C., 2008, P403, DOI 10.1007/978-0-387-69057-5_21; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Nakahara H, 1996, J BIOL CHEM, V271, P27221, DOI 10.1074/jbc.271.44.27221; Ruschel A, 2004, CELL SIGNAL, V16, P1249, DOI 10.1016/j.cellsig.2004.03.007; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; SOULE HD, 1990, CANCER RES, V50, P6075; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 1997, J EXP MED, V186, P2013, DOI 10.1084/jem.186.12.2013; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Zhang X, 2006, J BIOL CHEM, V281, P6471, DOI 10.1074/jbc.M512666200; Zhang XY, 2009, MOL CANCER RES, V7, P634, DOI 10.1158/1541-7786.MCR-08-0371; Zhu YH, 2007, TOXICOL APPL PHARM, V221, P268, DOI 10.1016/j.taap.2007.03.027	47	33	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7445	10.1371/journal.pone.0007445	http://dx.doi.org/10.1371/journal.pone.0007445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829710	Green Published, Green Submitted, gold			2022-12-25	WOS:000270847800004
J	Himes, RW; Smith, CW				Himes, Ryan W.; Smith, C. Wayne			Tlr2 is critical for diet-induced metabolic syndrome in a murine model	FASEB JOURNAL			English	Article						adipose tissue; hepatic steatosis; insulin resistance; obesity	TOLL-LIKE RECEPTOR-2; INDUCED INSULIN-RESISTANCE; CHAIN FATTY-ACIDS; ADIPOSE-TISSUE; INDUCED OBESITY; CD36; MICE; MACROPHAGE; ACCUMULATION; INFLAMMATION	Obesity and its associated comorbidities, termed metabolic syndrome, are increasingly prevalent, and they pose a serious threat to the health of individuals and populations. Gene-environment interactions have been scrutinized since the kinetics of the increased prevalence of obesity would argue against a purely genetic etiology. Toll-like receptors (TLRs), widely expressed and highly conserved transmembrane receptors, are at the intersection of diet and metabolism, and may therefore be important determinants of weight gain and its sequellae. We sought specifically to determine the role of Tlr2 in the development of obesity and metabolic syndrome utilizing two dietary models that approximate contemporary diet compositions. Using C57BL/6 Hsd mice (wild type, WT) and mice with a targeted mutation in Tlr2 (Tlr2(-/-)), we showed that mice lacking TLR2 are substantially protected from diet-induced adiposity, insulin resistance, hypercholesterolemia, and hepatic steatosis. In adipose tissue, Tlr2 deletion was associated with attenuation of adipocyte hypertrophy, as well as diminished macrophage infiltration and inflammatory cytokine expression.-Himes, R. W., Smith, C. W. Tlr2 is critical for diet-induced metabolic syndrome in a murine model. FASEB J. 24, 731-739 (2010). www.fasebj.org	[Himes, Ryan W.] Texas Childrens Hosp, Sect Pediat Gastroenterol, Texas Childrens Feigin Ctr, Baylor Coll Med,Dept Pediat, Houston, TX 77030 USA; [Himes, Ryan W.] Texas Childrens Hosp, Baylor Coll Med, Gastroenterol Sect, Houston, TX 77030 USA; [Smith, C. Wayne] Texas Childrens Hosp, Baylor Coll Med, Sect Leukocyte Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Himes, RW (corresponding author), Texas Childrens Hosp, Sect Pediat Gastroenterol, Texas Childrens Feigin Ctr, Baylor Coll Med,Dept Pediat, 1102 Bates St,Rm 860B, Houston, TX 77030 USA.	himes@bcm.tmc.edu		Himes, Ryan/0000-0002-0116-2613	National Institutes of Health (NIH) [T32 DK 07644, R01 DK078847]; U.S. Department of Agriculture [ARS 6250-51000-04601A]; Texas Medical Center Digestive Disease Center [P30 DK56338]; Baylor College of Medicine Diabetes and Endocrinology Research Center [DK-079638]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078847, P30DK056338, P30DK079638] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Texas Medical Center Digestive Disease Center; Baylor College of Medicine Diabetes and Endocrinology Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (NIH) institutional research training grant T32 DK 07644, U.S. Department of Agriculture grant ARS 6250-51000-04601A, and NIH grant R01 DK078847. We are grateful for the expert assistance provided by the Mouse Metabolic Research Unit at the Children's Nutrition Research Center, the Texas Medical Center Digestive Disease Center (NIH/National Institute of Diabetes and Digestive and Kidney Diseases Center grant P30 DK56338) and the Baylor College of Medicine Diabetes and Endocrinology Research Center (DK-079638).	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; Air EL, 2007, DIABETES CARE, V30, P3131, DOI 10.2337/dc06-1537; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Caricilli AM, 2008, J ENDOCRINOL, V199, P399, DOI 10.1677/JOE-08-0354; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Clarke SD, 2001, AM J PHYSIOL-GASTR L, V281, pG865, DOI 10.1152/ajpgi.2001.281.4.G865; Coburn CT, 2001, J MOL NEUROSCI, V16, P117, DOI 10.1385/JMN:16:2-3:117; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Fox J, 2007, MOUSE BIOMEDICAL RES, DOI DOI 10.1016/B978-012369454-6/50094-7; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Howard V., 1998, UNBIASED STEREOLOGY; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; Liu X, 2008, ATHEROSCLEROSIS, V196, P146, DOI 10.1016/j.atherosclerosis.2007.03.025; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; McKnight AJ, 1996, J BIOL CHEM, V271, P486, DOI 10.1074/jbc.271.1.486; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; Robker RL, 2004, OBES RES, V12, P936, DOI 10.1038/oby.2004.114; Senn JJ, 2006, J BIOL CHEM, V281, P26865, DOI 10.1074/jbc.M513304200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	36	140	149	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2010	24	3					731	739		10.1096/fj.09-141929	http://dx.doi.org/10.1096/fj.09-141929			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	561KE	19841034	Green Published			2022-12-25	WOS:000274974600009
J	Sunami, T; Byrne, N; Diehl, RE; Funabashi, K; Hall, DL; Ikuta, M; Patel, SB; Shipman, JM; Smith, RF; Takahashi, I; Zugay-Murphy, J; Iwasawa, Y; Lumb, KJ; Munshi, SK; Sharma, S				Sunami, Tomoko; Byrne, Noel; Diehl, Ronald E.; Funabashi, Kaoru; Hall, Dawn L.; Ikuta, Mari; Patel, Sangita B.; Shipman, Jennifer M.; Smith, Robert F.; Takahashi, Ikuko; Zugay-Murphy, Joan; Iwasawa, Yoshikazu; Lumb, Kevin J.; Munshi, Sanjeev K.; Sharma, Sujata			Structural Basis of Human p70 Ribosomal S6 Kinase-1 Regulation by Activation Loop Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PROTEIN-KINASES; DOMAIN; EXPRESSION; INHIBITORS; MECHANISM; CLONING; SELECTIVITY; P70(S6K); SOFTWARE	p70 ribosomal S6 kinase (p70S6K) is a downstream effector of the mTOR signaling pathway involved in cell proliferation, cell growth, cell-cycle progression, and glucose homeostasis. Multiple phosphorylation events within the catalytic, autoinhibitory, and hydrophobic motif domains contribute to the regulation of p70S6K. We report the crystal structures of the kinase domain of p70S6K1 bound to staurosporine in both the unphosphorylated state and in the 3'-phosphoinositide-dependent kinase-1-phosphorylated state in which Thr-252 of the activation loop is phosphorylated. Unphosphorylated p70S6K1 exists in two crystal forms, one in which the p70S6K1 kinase domain exists as a monomer and the other as a domain-swapped dimer. The crystal structure of the partially activated kinase domain that is phosphorylated within the activation loop reveals conformational ordering of the activation loop that is consistent with a role in activation. The structures offer insights into the structural basis of the 3'-phosphoinositide-dependent kinase-1-induced activation of p70S6K and provide a platform for the rational structure-guided design of specific p70S6K inhibitors.	[Sunami, Tomoko; Ikuta, Mari; Iwasawa, Yoshikazu] Banyu Pharmaceut Co Ltd, Dept Chem, Tsukuba, Ibaraki 3002611, Japan; [Funabashi, Kaoru; Takahashi, Ikuko] Banyu Pharmaceut Co Ltd, Dept Canc Res, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan; [Byrne, Noel; Diehl, Ronald E.; Hall, Dawn L.; Patel, Sangita B.; Shipman, Jennifer M.; Smith, Robert F.; Zugay-Murphy, Joan; Lumb, Kevin J.; Munshi, Sanjeev K.; Sharma, Sujata] Merck Res Labs, West Point, PA 19486 USA	Merck & Company; Merck & Company; Novartis; Merck & Company	Sunami, T (corresponding author), Japan Atom Energy Agcy, Mol Struct Biol Grp, Neutron Biol Res Ctr, Quantum Beam Sci Directorate, 2-4 Shirakata Shirane, Tokai, Ibaraki 3191195, Japan.	sunami.tomoko@jaea.go.jp; sujata_sharma@merck.com		Lumb, Kevin/0000-0003-2778-9956				Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Breitenlechner CB, 2005, J MED CHEM, V48, P163, DOI 10.1021/jm049701n; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Dennis PB, 1998, J BIOL CHEM, V273, P14845, DOI 10.1074/jbc.273.24.14845; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Gold MG, 2006, CURR OPIN STRUC BIOL, V16, P693, DOI 10.1016/j.sbi.2006.10.006; Gout I, 1998, J BIOL CHEM, V273, P30061, DOI 10.1074/jbc.273.46.30061; GROVE JR, 1991, MOL CELL BIOL, V11, P5541, DOI 10.1128/MCB.11.11.5541; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Ikuta M, 2007, PROTEIN SCI, V16, P2626, DOI 10.1110/ps.073123707; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; Kornienko M, 2005, ASSAY DRUG DEV TECHN, V3, P661, DOI 10.1089/adt.2005.3.661; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; Le XF, 2003, ONCOGENE, V22, P484, DOI 10.1038/sj.onc.1206175; Lee SJ, 2009, PROTEIN SCI, V18, P304, DOI 10.1002/pro.27; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mol CD, 2004, CURR OPIN DRUG DISC, V7, P639; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pike ACW, 2008, EMBO J, V27, P704, DOI 10.1038/emboj.2008.8; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Zhang WG, 2006, PROTEIN EXPRES PURIF, V46, P414, DOI 10.1016/j.pep.2005.08.012; Zhao B, 2007, PROTEIN SCI, V16, P2761, DOI 10.1110/ps.073161707	33	39	44	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2010	285	7					4587	4594		10.1074/jbc.M109.040667	http://dx.doi.org/10.1074/jbc.M109.040667			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	565FN	19864428	Green Published, hybrid			2022-12-25	WOS:000275274800036
J	Hughes, S; Jenkins, V; Dar, MJ; Engelman, A; Cherepanov, P				Hughes, Siobhan; Jenkins, Victoria; Dar, Mohd Jamal; Engelman, Alan; Cherepanov, Peter			Transcriptional Co-activator LEDGF Interacts with Cdc7-Activator of S-phase Kinase (ASK) and Stimulates Its Enzymatic Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CDC7-RELATED KINASE; IN-VITRO PHOSPHORYLATION; CELL-CYCLE REGULATION; DNA HELICASE ACTIVITY; HIV-1 INTEGRASE; PROTEIN-KINASE; REGULATORY SUBUNIT; CHROMATIN-BINDING; CDC7 KINASE; SACCHAROMYCES-CEREVISIAE	Lens epithelium-derived growth factor (LEDGF) is an important co-factor of human immunodeficiency virus DNA integration; however, its cellular functions are poorly characterized. We now report identification of the Cdc7-activator of S-phase kinase (ASK) heterodimer as a novel interactor of LEDGF. Both kinase subunits co-immunoprecipitated with endogenous LEDGF from human cell extracts. Truncation analyses identified the integrase-binding domain of LEDGF as essential and minimally sufficient for the interaction with Cdc7-ASK. Reciprocally, the interaction required autophosphorylation of the kinase and the presence of 50 C-terminal residues of ASK. The kinase phosphorylated LEDGF in vitro, with Ser-206 being the major target, and LEDGF phosphorylated at this residue could be detected during S phase of the cell cycle. LEDGF potently stimulated the enzymatic activity of Cdc7-ASK, increasing phosphorylation of MCM2 in vitro by more than 10-fold. This enzymatic stimulation as well as phosphorylation of LEDGF depended on the protein-protein interaction. Intriguingly, removing the C-terminal region of ASK, involved in the interaction with LEDGF, resulted in a hyperactive kinase. Our results indicate that the interaction with LEDGF relieves autoinhibition of Cdc7-ASK kinase, imposed by the C terminus of ASK.	[Hughes, Siobhan; Jenkins, Victoria; Cherepanov, Peter] Univ London Imperial Coll Sci Technol & Med, Div Med, London W2 1PG, England; [Dar, Mohd Jamal; Engelman, Alan] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Imperial College London; Harvard University; Dana-Farber Cancer Institute	Cherepanov, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Med, St Marys Campus,Norfolk Pl, London W2 1PG, England.	p.cherepanov@imperial.ac.uk	Cherepanov, Peter P/F-6859-2010	Cherepanov, Peter P/0000-0002-0634-538X	National Institutes of Health [AI039394]; United Kingdom Medical Research Council [G0600009]; Medical Research Council [G0600009] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI039394, R01AI039394] Funding Source: NIH RePORTER; MRC [G0600009] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grant AI039394 (to A. E.). This work was also supported by United Kingdom Medical Research Council Grant G0600009 (to P. C.).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bartholomeeusen K, 2007, J MOL BIOL, V372, P407, DOI 10.1016/j.jmb.2007.06.090; Bartholomeeusen K, 2009, J BIOL CHEM, V284, P11467, DOI 10.1074/jbc.M807781200; Borger DR, 2006, J VIROL, V80, P4292, DOI 10.1128/JVI.80.9.4292-4303.2006; Brown GW, 1999, P NATL ACAD SCI USA, V96, P8443, DOI 10.1073/pnas.96.15.8443; Busschots K, 2007, J MOL BIOL, V365, P1480, DOI 10.1016/j.jmb.2006.10.094; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Daniels T, 2005, PROSTATE, V62, P14, DOI 10.1002/pros.20112; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; DOWELL SJ, 1994, SCIENCE, V265, P1243, DOI 10.1126/science.8066465; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Elderkin S, 2007, MOL CELL, V28, P107, DOI 10.1016/j.molcel.2007.08.009; Engelman A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000046; Farkash-Amar S, 2008, GENOME RES, V18, P1562, DOI 10.1101/gr.079566.108; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Furukohri A, 2003, J BIOCHEM, V134, P447, DOI 10.1093/jb/mvg163; Ganapathy V, 2003, AUTOIMMUN REV, V2, P290, DOI 10.1016/S1568-9972(03)00063-6; Ge H, 1998, EMBO J, V17, P6723, DOI 10.1093/emboj/17.22.6723; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000259; Hayashi MT, 2009, NAT CELL BIOL, V11, P357, DOI 10.1038/ncb1845; Hussey DJ, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-20; Ishimi Y, 2001, J BIOL CHEM, V276, P42744, DOI 10.1074/jbc.M106861200; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Izumoto Y, 1997, BIOCHEM BIOPH RES CO, V238, P26, DOI 10.1006/bbrc.1997.7233; Jares P, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-5; Jares P, 2000, GENE DEV, V14, P1528; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; Katsuragi Y, 2004, MOL BIOL CELL, V15, P1680, DOI 10.1091/mbc.E03-12-0874; Kihara M, 2000, J BIOL CHEM, V275, P35051, DOI 10.1074/jbc.M003491200; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lee JK, 2001, P NATL ACAD SCI USA, V98, P54, DOI 10.1073/pnas.98.1.54; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Maertens GN, 2006, J CELL SCI, V119, P2563, DOI 10.1242/jcs.02995; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Masai H, 2000, BIOCHEM BIOPH RES CO, V275, P228, DOI 10.1006/bbrc.2000.3281; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Montagnoli A, 2002, EMBO J, V21, P3171, DOI 10.1093/emboj/cdf290; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Ogino K, 2001, J BIOL CHEM, V276, P31376, DOI 10.1074/jbc.M102197200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Oshiro G, 1999, MOL CELL BIOL, V19, P4888; Patel PK, 2008, MOL BIOL CELL, V19, P5550, DOI 10.1091/mbc.E08-06-0645; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Sato N, 2003, GENES CELLS, V8, P451, DOI 10.1046/j.1365-2443.2003.00647.x; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Shinohara T, 2002, PROG RETIN EYE RES, V21, P341, DOI 10.1016/S1350-9462(02)00007-1; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08; Stec I, 2000, FEBS LETT, V473, P1, DOI 10.1016/S0014-5793(00)01449-6; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Takeda T, 1999, MOL CELL BIOL, V19, P5535; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Ulm JW, 2007, VIROLOGY, V363, P245, DOI 10.1016/j.virol.2006.09.048; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; White EJ, 2004, P NATL ACAD SCI USA, V101, P17771, DOI 10.1073/pnas.0408170101; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Xu YJ, 2009, J BIOL CHEM, V284, P16016, DOI 10.1074/jbc.M900785200; Yamashita N, 2005, GENES CELLS, V10, P551, DOI 10.1111/j.1365-2443.2005.00857.x; Yokoyama A, 2008, CANCER CELL, V14, P36, DOI 10.1016/j.ccr.2008.05.003; YOON HJ, 1993, MOL BIOL CELL, V4, P195, DOI 10.1091/mbc.4.2.195; Yoshizawa-Sugata N, 2005, J BIOL CHEM, V280, P13062, DOI 10.1074/jbc.M411653200	78	50	50	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					541	554		10.1074/jbc.M109.036491	http://dx.doi.org/10.1074/jbc.M109.036491			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864417	Green Published, hybrid			2022-12-25	WOS:000273070100056
J	Underwood, CR; Garibay, P; Knudsen, LB; Hastrup, S; Peters, GH; Rudolph, R; Reedtz-Runge, S				Underwood, Christina Rye; Garibay, Patrick; Knudsen, Lotte Bjerre; Hastrup, Sven; Peters, Gunther H.; Rudolph, Rainer; Reedtz-Runge, Steffen			Crystal Structure of Glucagon-like Peptide-1 in Complex with the Extracellular Domain of the Glucagon-like Peptide-1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLP-1 RECEPTOR; MOLECULAR RECOGNITION; TERMINAL DOMAIN; LIGAND-BINDING; N-TERMINUS; EXENDIN-4; HORMONE; CONFORMATION; EXPRESSION; AMIDE	GLP-1 (glucagon-like peptide-1) is an incretin released from intestinal L-cells in response to food intake. Activation of the GLP-1 receptor potentiates the synthesis and release of insulin from pancreatic beta-cells in a glucose-dependent manner. The GLP-1 receptor belongs to class B of the G-protein-coupled receptors, a subfamily characterized by a large N-terminal extracellular ligand binding domain. Exendin-4 and GLP-1 are 50% identical, and exendin-4 is a full agonist with similar affinity and potency for the GLP-1 receptor. We recently solved the crystal structure of the GLP-1 receptor extracellular domain in complex with the competitive antagonist exendin-4(9-39). Interestingly, the isolated extra-cellular domain binds exendin-4 with much higher affinity than the endogenous agonist GLP-1. Here, we have solved the crystal structure of the extracellular domain in complex with GLP-1 to 2.1 angstrom resolution. The structure shows that important hydrophobic ligand-receptor interactions are conserved in agonist-and antagonist-bound forms of the extracellular domain, but certain residues in the ligand-binding site adopt a GLP-1-specific conformation. GLP-1 is a kinked but continuous alpha-helix from Thr(13) to Val(33) when bound to the extracellular domain. We supplemented the crystal structure with site-directed mutagenesis to link the structural information of the isolated extracellular domain with the binding properties of the full-length receptor. The data support the existence of differences in the binding modes of GLP-1 and exendin-4 on the full-length GLP-1 receptor.	[Underwood, Christina Rye] Novo Nordisk AS, Dept GLP & Obes Biol 1, DK-2760 Malov, Denmark; [Garibay, Patrick] Novo Nordisk AS, Dept Prot & Peptide Chem, DK-2760 Malov, Denmark; [Knudsen, Lotte Bjerre] Novo Nordisk AS, Dept Diabet Biol & Pharmacol, DK-2760 Malov, Denmark; [Hastrup, Sven] Novo Nordisk AS, Dept Prot Express, DK-2760 Malov, Denmark; [Reedtz-Runge, Steffen] Novo Nordisk AS, Dept Struct & Biophys Chem, DK-2760 Malov, Denmark; [Underwood, Christina Rye; Peters, Gunther H.] Tech Univ Denmark, Dept Chem, MEMPHYS Ctr Biomembrane Phys, DK-2800 Lyngby, Denmark; [Rudolph, Rainer] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany	Novo Nordisk; Novo Nordisk; Novo Nordisk; Novo Nordisk; Novo Nordisk; Technical University of Denmark; Martin Luther University Halle Wittenberg	Reedtz-Runge, S (corresponding author), Novo Nordisk Pk,G8-S-439, DK-2760 Malov, Denmark.	sffr@novonordisk.com	Peters, Günther H.J./T-7100-2017	Peters, Günther H.J./0000-0001-9754-2663; Knudsen, Lotte Bjerre/0000-0002-2439-7116; Underwood, Christina Rye/0000-0002-2333-2177	Novo Nordisk A/S; European Membrane Protein Consortium; Federal State of Saxony-Anhalt [3324 A/0021 L]; Deutsche Forschungsgemeinshaft [SFRB 610/TP A11]	Novo Nordisk A/S(Novo Nordisk); European Membrane Protein Consortium; Federal State of Saxony-Anhalt; Deutsche Forschungsgemeinshaft(German Research Foundation (DFG))	This work was supported in part by a scholarship from Novo Nordisk A/S (to C. R. U.), European Membrane Protein Consortium, the Federal State of Saxony-Anhalt Grant 3324 A/0021 L, and the Deutsche Forschungsgemeinshaft Grant SFRB 610/TP A11.	ADELHORST K, 1994, J BIOL CHEM, V269, P6275; Al-Sabah S, 2003, FEBS LETT, V553, P342, DOI 10.1016/S0014-5793(03)01043-3; Al-Sabah S, 2003, BRIT J PHARMACOL, V140, P339, DOI 10.1038/sj.bjp.0705453; BRAUN W, 1983, J MOL BIOL, V169, P921, DOI 10.1016/S0022-2836(83)80143-0; Chang XQ, 2001, MAGN RESON CHEM, V39, P477, DOI 10.1002/mrc.880; de Maturana RL, 2003, J BIOL CHEM, V278, P10195, DOI 10.1074/jbc.M212147200; de Maturana RL, 2004, PROTEIN PEPTIDE LETT, V11, P15, DOI 10.2174/0929866043478491; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENG J, 1992, J BIOL CHEM, V267, P7402; Flint A, 1998, J CLIN INVEST, V101, P515, DOI 10.1172/JCI990; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; GOKE R, 1988, J ENDOCRINOL, V116, P357, DOI 10.1677/joe.0.1160357; GOKE R, 1993, J BIOL CHEM, V268, P19650; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Graziano MP, 1996, RECEPTOR CHANNEL, V4, P9; Hoare SRJ, 2005, DRUG DISCOV TODAY, V10, P417, DOI 10.1016/S1359-6446(05)03370-2; Inooka H, 2001, NAT STRUCT BIOL, V8, P161, DOI 10.1038/84159; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Lin F, 2009, J MOL MODEL, V15, P53, DOI 10.1007/s00894-008-0372-2; Miller LJ, 2007, BIOCHEM SOC T, V35, P709, DOI 10.1042/BST0350709; Miranda LP, 2008, J MED CHEM, V51, P2758, DOI 10.1021/jm701522b; MOJSOV S, 1986, J BIOL CHEM, V261, P1880; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Murage EN, 2008, BIOORGAN MED CHEM, V16, P10106, DOI 10.1016/j.bmc.2008.10.006; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neidigh JW, 2001, BIOCHEMISTRY-US, V40, P13188, DOI 10.1021/bi010902s; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; ORSKOV C, 1988, ENDOCRINOLOGY, V123, P2009, DOI 10.1210/endo-123-4-2009; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Runge S, 2003, BRIT J PHARMACOL, V138, P787, DOI 10.1038/sj.bjp.0705120; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Runge S, 2007, BIOCHEMISTRY-US, V46, P5830, DOI 10.1021/bi062309m; SCHMIDT WE, 1985, DIABETOLOGIA, V28, P704, DOI 10.1007/BF00291980; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; THORNTON K, 1994, BIOCHEMISTRY-US, V33, P3532, DOI 10.1021/bi00178a009; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; WETTERGREN A, 1993, DIGESTION, V54, P384; Xiao Q, 2001, BIOCHEMISTRY-US, V40, P2860, DOI 10.1021/bi0014498; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270	46	216	255	1	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					723	730		10.1074/jbc.M109.033829	http://dx.doi.org/10.1074/jbc.M109.033829			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19861722	Green Published, hybrid			2022-12-25	WOS:000273070100073
J	La, P; Fernando, AP; Wang, Z; Salahudeen, A; Yang, G; Lin, Q; Wright, CJ; Dennery, PA				La, Ping; Fernando, Amal P.; Wang, Zhi; Salahudeen, Ameen; Yang, Guang; Lin, Qing; Wright, Clyde J.; Dennery, Phyllis A.			Zinc Protoporphyrin Regulates Cyclin D1 Expression Independent of Heme Oxygenase Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; OXIDATIVE STRESS; BREAST-CANCER; MESSENGER-RNA; RECEPTOR GENE; CELLS; BINDING; TRANSCRIPTION; PROMOTER; PROTEIN	Zinc protoporphyrin IX (ZnPP), an endogenous heme analogue that inhibits heme oxygenase (HO) activity, represses tumor growth. It can also translocate into the nucleus and up-regulate heme oxygenase 1 (HMOX1) gene expression. Here, we demonstrate that tumor cell proliferation was inhibited by ZnPP, whereas tin protoporphyrin (SnPP), another equally potent HO-1 inhibitor, had no effect. Microarray analysis on 128 tumorigenesis related genes showed that ZnPP suppressed genes involved in cell proliferation and angiogenesis. Among these genes, CYCLIN D1 (CCND1) was specifically inhibited as were its mRNA and protein levels. Additionally, ZnPP inhibited CCND1 promoter activity through an Sp1 and Egr1 overlapping binding site (S/E). We confirmed that ZnPP modulated the S/E site, at least partially by associating with Sp1 and Egr1 proteins rather than direct binding to DNA targets. Furthermore, administration of ZnPP significantly inhibited cyclin D1 expression and progression of a B-cell leukemia/lymphoma 1 tumor in mice by preferentially targeting tumor cells. These observations show HO independent effects of ZnPP on cyclin D1 expression and tumorigenesis.	[La, Ping; Fernando, Amal P.; Wang, Zhi; Salahudeen, Ameen; Yang, Guang; Lin, Qing; Wright, Clyde J.; Dennery, Phyllis A.] Childrens Hosp Philadelphia, Div Neonatol, Philadelphia, PA 19104 USA; [Lin, Qing; Dennery, Phyllis A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Dennery, PA (corresponding author), Childrens Hosp Philadelphia, Div Neonatol, 34th & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	dennery@email.chop.edu	Dennery, Phyllis/GQG-9113-2022	Dennery, Phyllis/0000-0001-5745-1855; A Salahudeen, Ameen/0000-0001-9037-3481	National Institutes of Health [HL70285-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL70285-01 ( to P. A. D.).	Akuzawa N, 2000, ARTERIOSCL THROM VAS, V20, P377, DOI 10.1161/01.ATV.20.2.377; Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Aref S, 2006, HEMATOLOGY, V11, P31, DOI 10.1080/10245330500322321; Argyris EG, 1999, J BIOL CHEM, V274, P1549, DOI 10.1074/jbc.274.3.1549; Bahouth SW, 2002, MOL PHARMACOL, V61, P379, DOI 10.1124/mol.61.2.379; Barbieri F, 2004, ONCOLOGY-BASEL, V66, P310, DOI 10.1159/000078332; Callanan M, 1996, CRIT REV ONCOGENESIS, V7, P191, DOI 10.1615/CritRevOncog.v7.i3-4.30; Dixon IM, 2005, CHEMBIOCHEM, V6, P123, DOI 10.1002/cbic.200400113; Edinger M, 2003, BLOOD, V101, P640, DOI 10.1182/blood-2002-06-1751; Fang J, 2003, CANCER RES, V63, P3567; Fang J, 2004, INT J CANCER, V109, P1, DOI 10.1002/ijc.11644; Fukada T, 2001, J BIOL CHEM, V276, P25512, DOI 10.1074/jbc.M101354200; Hashemolhosseini S, 1998, J BIOL CHEM, V273, P14424, DOI 10.1074/jbc.273.23.14424; Hirai K, 2007, INT J CANCER, V120, P500, DOI 10.1002/ijc.22287; Hou WH, 2008, BBA-GENE REGUL MECH, V1779, P195, DOI 10.1016/j.bbagrm.2008.01.006; Huang RP, 1997, J CELL BIOCHEM, V66, P489, DOI 10.1002/(SICI)1097-4644(19970915)66:4<489::AID-JCB8>3.0.CO;2-H; Hurley LH, 2006, SEMIN ONCOL, V33, P498, DOI 10.1053/j.seminoncol.2006.04.012; Ikehara M, 2003, ONCOL REP, V10, P137; Iyer JK, 2003, MOL MED, V9, P175, DOI 10.1007/BF03402182; LABBE RF, 1992, CLIN CHEM, V38, P2167; Lee RJ, 1999, J BIOL CHEM, V274, P7341, DOI 10.1074/jbc.274.11.7341; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lin Q, 2007, J BIOL CHEM, V282, P20621, DOI 10.1074/jbc.M607954200; Lin QS, 2008, FREE RADICAL BIO MED, V44, P847, DOI 10.1016/j.freeradbiomed.2007.11.012; Lin SK, 2000, MOL CELL BIOL, V20, P7903, DOI 10.1128/MCB.20.21.7903-7913.2000; Lutton JD, 1997, P NATL ACAD SCI USA, V94, P1432, DOI 10.1073/pnas.94.4.1432; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; Mayerhofer M, 2008, BLOOD, V111, P2200, DOI 10.1182/blood-2006-11-055723; Nenoi M, 2001, CANCER RES, V61, P5885; Nilsson T, 2001, J VIROL, V75, P5796, DOI 10.1128/JVI.75.13.5796-5811.2001; NY L, 1995, BRIT J PHARMACOL, V115, P186, DOI 10.1111/j.1476-5381.1995.tb16337.x; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; PALMA JF, 1994, BLOOD, V84, P1288; Petty WJ, 2003, LUNG CANCER, V41, pS155, DOI 10.1016/S0169-5002(03)00159-4; Ravandi-Kashani F, 2000, LEUKEMIA RES, V24, P469, DOI 10.1016/S0145-2126(00)00008-4; Rodgers PA, 1996, PEDIATR RES, V39, P1041, DOI 10.1203/00006450-199606000-00018; Roy PG, 2006, BREAST, V15, P718, DOI 10.1016/j.breast.2006.02.005; Sattler Martin, 2007, Curr Oncol Rep, V9, P102, DOI 10.1007/s11912-007-0005-4; Serfas L, 1998, ARCH BIOCHEM BIOPHYS, V359, P8, DOI 10.1006/abbi.1998.0887; Shiozawa T, 2004, ONCOGENE, V23, P8603, DOI 10.1038/sj.onc.1207849; Silverman ES, 1997, AM J PHYSIOL-HEART C, V273, pH1415, DOI 10.1152/ajpheart.1997.273.3.H1415; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Stendahl M, 2004, BRIT J CANCER, V90, P1942, DOI 10.1038/sj.bjc.6601831; Tong AJ, 2003, SPECTROCHIM ACTA A, V59, P2967, DOI 10.1016/S1386-1425(03)00132-X; VREMAN HJ, 1988, CLIN CHEM, V34, P2562; Xu Jian-min, 2004, Zhonghua Bing Li Xue Za Zhi, V33, P26; Yan YX, 1997, J BIOL CHEM, V272, P33181, DOI 10.1074/jbc.272.52.33181; Yang G, 2001, BLOOD, V97, P1306, DOI 10.1182/blood.V97.5.1306; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Zhang XH, 2003, AM J PHYSIOL-RENAL, V284, pF1216, DOI 10.1152/ajprenal.00426.2002	50	40	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36302	36311		10.1074/jbc.M109.031641	http://dx.doi.org/10.1074/jbc.M109.031641			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19850937	Green Published, hybrid			2022-12-25	WOS:000272970500032
J	Pedotti, M; Rosini, E; Molla, G; Moschetti, T; Savino, C; Vallone, B; Pollegioni, L				Pedotti, Mattia; Rosini, Elena; Molla, Gianluca; Moschetti, Tommaso; Savino, Carmelinda; Vallone, Beatrice; Pollegioni, Loredano			Glyphosate Resistance by Engineering the Flavoenzyme Glycine Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; MOLECULAR-BASIS; EVOLUTION; PROTEIN	Glycine oxidase from Bacillus subtilis is a homotetrameric flavoprotein of great potential biotechnological use because it catalyzes the oxidative deamination of various amines and D-isomer of amino acids to yield the corresponding alpha-keto acids, ammonia/amine, and hydrogen peroxide. Glyphosate (N-phosphonomethylglycine), a broad spectrum herbicide, is an interesting synthetic amino acid: this compound inhibits 5-enolpyruvylshikimate-3-phosphate synthase in the shikimate pathway, which is essential for the biosynthesis of aromatic amino acids in plants and certain bacteria. In recent years, transgenic crops resistant to glyphosate were mainly generated by overproducing the plant enzyme or by introducing a 5-enolpyruvylshikimate-3- phosphate synthase insensitive to this herbicide. In this work, we propose that the enzymatic oxidation of glyphosate could be an effective alternative to this important biotechnological process. To reach this goal, we used a rational design approach (together with site saturation mutagenesis) to generate a glycine oxidase variant more active on glyphosate than on the physiological substrate glycine. The glycine oxidase containing three point mutations (G51S/A54R/H244A) reaches an up to a 210-fold increase in catalytic efficiency and a 15,000-fold increase in the specificity constant (the k(cat)/K-m ratio between glyphosate and glycine) as compared with wild-type glycine oxidase. The inspection of its three-dimensional structure shows that the alpha 2-alpha 3 loop (comprising residues 50-60 and containing two of the mutated residues) assumes a novel conformation and that the newly introduced residue Arg(54) could be the key residue in stabilizing glyphosate binding and destabilizing glycine positioning in the binding site, thus increasing efficiency on the herbicide.	[Pedotti, Mattia; Rosini, Elena; Molla, Gianluca; Pollegioni, Loredano] Univ Insubria, DBSM, I-21100 Varese, Italy; [Pedotti, Mattia; Rosini, Elena; Molla, Gianluca; Pollegioni, Loredano] Univ Insubria, Politecn Milan, Ctr Interuniv Ric Biotecnol Prote Prot Factory, I-21100 Varese, Italy; [Moschetti, Tommaso; Vallone, Beatrice] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy; [Savino, Carmelinda] CNR, Inst Mol Biol & Pathol, I-00185 Rome, Italy	University of Insubria; Polytechnic University of Milan; University of Insubria; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Pollegioni, L (corresponding author), Univ Insubria, DBSM, Via JH Dunant 3, I-21100 Varese, Italy.	loredano.pollegioni@uninsubria.it	Vallone, Beatrice/F-4174-2012; Rosini, Elena/H-3474-2012	Rosini, Elena/0000-0001-8384-7992; SAVINO, CARMELINDA/0000-0002-1602-4838; VALLONE, Beatrice/0000-0003-0058-9049; Molla, Gianluca/0000-0003-3688-3397; POLLEGIONI, LOREDANO/0000-0003-1733-7243	Fondo di Ateneo per la Ricerca; Consorzio Interuniversitario per le Biotecnologie; Centro di Ricerca in Biotecnologie per la Salute Umana	Fondo di Ateneo per la Ricerca; Consorzio Interuniversitario per le Biotecnologie; Centro di Ricerca in Biotecnologie per la Salute Umana	This work was supported by grants from the Fondo di Ateneo per la Ricerca (to L. P. and G. M.) and by the Consorzio Interuniversitario per le Biotecnologie and the Centro di Ricerca in Biotecnologie per la Salute Umana.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boselli A, 2007, BIOCHIMIE, V89, P1372, DOI 10.1016/j.biochi.2007.04.019; Caldinelli L, 2005, J BIOL CHEM, V280, P22572, DOI 10.1074/jbc.M500549200; Castle LA, 2004, SCIENCE, V304, P1151, DOI 10.1126/science.1096770; DeLano W, 2002, PYMOL 0 99; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; GOLDSBROUGH PB, 1990, PLANT SCI, V72, P53, DOI 10.1016/0168-9452(90)90186-R; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; HOAGLAND RE, 1980, WEED SCI, V28, P393, DOI 10.1017/S0043174500055545; Job V, 2002, J BIOL CHEM, V277, P6985, DOI 10.1074/jbc.M111095200; Job V, 2002, EUR J BIOCHEM, V269, P1456, DOI 10.1046/j.1432-1033.2002.02790.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Mortl M, 2004, J BIOL CHEM, V279, P29718, DOI 10.1074/jbc.M401224200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x; Pline-Srnic W, 2006, WEED TECHNOL, V20, P290, DOI 10.1614/WT-04-131R.1; Pollegioni L, 2005, PROTEIN SCI, V14, P3064, DOI 10.1110/ps.051671705; REDDY KN, 2004, WSSA ABSTR, V44, P116; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Settembre EC, 2003, BIOCHEMISTRY-US, V42, P2971, DOI 10.1021/bi026916v; Siehl DL, 2007, J BIOL CHEM, V282, P11446, DOI 10.1074/jbc.M610267200; Siehl DL, 2005, PEST MANAG SCI, V61, P235, DOI 10.1002/ps.1014; Wagner MA, 2000, BIOCHEMISTRY-US, V39, P8813, DOI 10.1021/bi000349z	26	52	57	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36415	36423		10.1074/jbc.M109.051631	http://dx.doi.org/10.1074/jbc.M109.051631			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19864430	Green Published, hybrid			2022-12-25	WOS:000272970500043
J	Vogel, N; Kluck, CJ; Melzer, N; Schwarzinger, S; Breitinger, U; Seeber, S; Becker, CM				Vogel, Nicolas; Kluck, Christoph J.; Melzer, Nima; Schwarzinger, Stephan; Breitinger, Ulrike; Seeber, Silke; Becker, Cord-Michael			Mapping of Disulfide Bonds within the Amino-terminal Extracellular Domain of the Inhibitory Glycine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; CIRCULAR-DICHROISM SPECTROSCOPY; SECONDARY STRUCTURE ANALYSES; GATED ION-CHANNEL; LIGAND-BINDING; CRYSTAL-STRUCTURE; REDOX AGENTS; SUBUNIT; MODULATION; HOMOLOGY	The strychnine-sensitive glycine receptor (GlyR) is a ligand-gated chloride channel and a member of the superfamily of cysteine loop (Cys-loop) neurotransmitter receptors, which also comprises the nicotinic acetylcholine receptor (nAChR). Within the extracellular domain (ECD), the eponymous Cys-loop harbors two conserved cysteines, assumed to be linked by a superfamily-specific disulfide bond. The GlyR ECD carries three additional cysteine residues, two are predicted to form a second, GlyR-specific bond. The configuration of none of the cysteines of GlyR, however, had been determined directly. Based on a crystal structure of the nAChR alpha 1 ECD, we generated a model of the human GlyR alpha 1 where close proximity of the respective cysteines was consistent with the formation of both the Cys-loop and the GlyR-specific disulfide bonds. To identify native disulfide bonds, the GlyR alpha 1 ECD was heterologously expressed and refolded under oxidative conditions. By matrix-assisted laser desorption ionization time-of-flight mass spectrometry, we detected tryptic fragments of the ECD indicative of disulfide bond formation for both pairs of cysteines, as proposed by modeling. The identity of tryptic fragments was confirmed using chemical modification of cysteine and lysine residues. As evident from circular dichroism spectroscopy, mutagenesis of single cysteines did not impair refolding of the ECD in vitro, whereas it led to partial or complete intracellular retention and consequently to a loss of function of full-length GlyR subunits in human embryonic kidney 293 cells. Our results indicate that the GlyR ECD forms both a Cys-loop and a GlyR-specific disulfide bond. In addition, cysteine residues appear to be important for protein maturation in vivo.	[Vogel, Nicolas; Kluck, Christoph J.; Melzer, Nima; Breitinger, Ulrike; Seeber, Silke; Becker, Cord-Michael] Univ Erlangen Nurnberg, Emil Fischer Zentrum, Inst Biochem, D-91054 Erlangen, Germany; [Schwarzinger, Stephan] Univ Bayreuth, Lehrstuhl Biopolymere, D-95440 Bayreuth, Germany	University of Erlangen Nuremberg; University of Bayreuth	Becker, CM (corresponding author), Fahrstr 17, D-91054 Erlangen, Germany.	cmb@biochem.uni-erlangen.de	Schwarzinger, Stephan/O-4318-2014; Schwarzinger, Stephan/GWV-5819-2022	Schwarzinger, Stephan/0000-0002-0894-5290	European Union [HEALTH-F42008-202088]; Elitenetzwerk Bayern, Lead Structures of Cell Function [K-BM-2003-85]; Deutsche Forschungsgemeinschaft	European Union(European Commission); Elitenetzwerk Bayern, Lead Structures of Cell Function; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by European Union Grant Neurocypres, HEALTH-F42008-202088, Elitenetzwerk Bayern, Lead Structures of Cell Function, Grant K-BM-2003-85, and the Deutsche Forschungsgemeinschaft.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; BECKER CM, 1992, HDB EXPT PHARM, P539; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO;2-7; Breitinger U, 2004, J BIOL CHEM, V279, P1627, DOI 10.1074/jbc.M303811200; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Gay EA, 2007, J PHYSIOL-LONDON, V584, P727, DOI 10.1113/jphysiol.2007.142554; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; KAO PN, 1986, J BIOL CHEM, V261, P8085; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Legendre P, 2002, MOL PHARMACOL, V62, P817, DOI 10.1124/mol.62.4.817; Liu Z, 2008, BIOCHEMISTRY-US, V47, P9803, DOI 10.1021/bi800659x; Oertel J, 2007, J BIOL CHEM, V282, P2798, DOI 10.1074/jbc.M608941200; PAN ZH, 1995, J NEUROSCI, V15, P1384; RAJENDRA S, 1995, EMBO J, V14, P2987, DOI 10.1002/j.1460-2075.1995.tb07301.x; ROJAS L, 1991, BRAIN RES, V551, P10, DOI 10.1016/0006-8993(91)90906-C; RUIZGOMEZ A, 1991, J BIOL CHEM, V266, P559; SUMIKAWA K, 1992, J BIOL CHEM, V267, P6286; Thio LL, 2006, NEUROSCIENCE, V139, P1315, DOI 10.1016/j.neuroscience.2006.01.013; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853	29	12	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36128	36136		10.1074/jbc.M109.043448	http://dx.doi.org/10.1074/jbc.M109.043448			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19861413	Green Published, hybrid			2022-12-25	WOS:000272970500014
J	Yu, HB; Kielczewska, A; Rozek, A; Takenaka, S; Li, YL; Thorson, L; Hancock, REW; Guarna, MM; North, JR; Foster, LJ; Donini, O; Finlay, BB				Yu, Hong Bing; Kielczewska, Agnieszka; Rozek, Annett; Takenaka, Shunsuke; Li, Yuling; Thorson, Lisa; Hancock, Robert E. W.; Guarna, M. Marta; North, John R.; Foster, Leonard J.; Donini, Oreola; Finlay, B. Brett			Sequestosome-1/p62 Is the Key Intracellular Target of Innate Defense Regulator Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERACTING PROTEIN P62; SIGNALING ADAPTER P62; KAPPA-B ACTIVATION; KINASE; DOMAIN; MACROPHAGES; APOPTOSIS; ISOFORMS; MEDIATOR; RECEPTOR	Innate defense regulator-1 (IDR-1) is a synthetic peptide with no antimicrobial activity that enhances microbial infection control while suppressing inflammation. Previously, the effects of IDR-1 were postulated to impact several regulatory pathways including mitogen-activated protein kinase (MAPK) p38 and CCAAT-enhancer-binding protein, but how this was mediated was unknown. Using a combined stable isotope labeling by amino acids in cell culture-proteomics methodology, we identified the cytoplasmic scaffold protein p62 as the molecular target of IDR-1. Direct IDR-1 binding to p62 was confirmed by several biochemical binding experiments, and the p62 ZZ-type zinc finger domain was identified as the IDR-1 binding site. Co-immunoprecipitation analysis of p62 molecular complexes demonstrated that IDR-1 enhanced the tumor necrosis factor alpha-induced p62 receptor-interacting protein 1 (RIP1) complex formation but did not affect tumor necrosis factor alpha-induced p62-protein kinase zeta complex formation. In addition, IDR-1 induced p38 MAPK activity in a p62-dependent manner and increased CCAAT-enhancer-binding protein beta activity, whereas NF-kappa B activity was unaffected. Collectively, these results demonstrate that IDR-1 binding to p62 specifically affects protein-protein interactions and subsequent downstream events. Our results implicate p62 in the molecular mechanisms governing innate immunity and identify p62 as a potential therapeutic target in both infectious and inflammatory diseases.	[Yu, Hong Bing; Li, Yuling; Thorson, Lisa; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Hancock, Robert E. W.; Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; [Kielczewska, Agnieszka; Rozek, Annett; Takenaka, Shunsuke; North, John R.; Donini, Oreola] Inimex Pharmaceut, Vancouver, BC V5A 4T8, Canada; [Guarna, M. Marta; Foster, Leonard J.] Ctr High Throughput Biol, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Finlay, BB (corresponding author), Univ British Columbia, Michael Smith Labs, 2185 E Mall, Vancouver, BC V6T 1Z4, Canada.	bfinlay@interchange.ubc.ca	Hancock, Robert E. W./E-1145-2013	Hancock, Robert E. W./0000-0001-5989-8503; Guarna, Maria Marta/0000-0002-4638-9475	Canadian Institutes of Health Research (CIHR); Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative	This work was supported by operating grants from the Canadian Institutes of Health Research (CIHR) and the Foundation for the National Institute of Health through the Grand Challenges in Global Health Initiative (to B.B.F.).	Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; Duran A, 2008, CANCER CELL, V13, P343, DOI 10.1016/j.ccr.2008.02.001; Hiruma Y, 2009, BLOOD, V113, P4894, DOI 10.1182/blood-2008-08-173948; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Kawai K, 2008, J BIOCHEM, V143, P765, DOI 10.1093/jb/mvn027; Kim JY, 2009, J IMMUNOL, V182, P2131, DOI 10.4049/jimmunol.0802755; Lee TH, 2003, MOL CELL BIOL, V23, P8377, DOI 10.1128/MCB.23.22.8377-8385.2003; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Mookherjee N, 2009, J IMMUNOL, V183, P2688, DOI 10.4049/jimmunol.0802586; Moscat J, 2000, EMBO REP, V1, P399, DOI 10.1093/embo-reports/kvd098; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2006, MOL CELL, V23, P631, DOI 10.1016/j.molcel.2006.08.002; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Poli V, 1998, J BIOL CHEM, V273, P29279, DOI 10.1074/jbc.273.45.29279; Puls A, 1997, P NATL ACAD SCI USA, V94, P6191, DOI 10.1073/pnas.94.12.6191; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Rogers LD, 2007, P NATL ACAD SCI USA, V104, P18520, DOI 10.1073/pnas.0705801104; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Sanz L, 1999, EMBO J, V18, P3044, DOI 10.1093/emboj/18.11.3044; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235	24	55	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36007	36011		10.1074/jbc.C109.073627	http://dx.doi.org/10.1074/jbc.C109.073627			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19850933	Green Published, hybrid			2022-12-25	WOS:000272970500002
J	Hannemann, A; Christie, JK; Flatman, PW				Hannemann, Anke; Christie, Jenny K.; Flatman, Peter W.			Functional Expression of the Na-K-2Cl Cotransporter NKCC2 in Mammalian Cells Fails to Confirm the Dominant-negative Effect of the AF Splice Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL-COTRANSPORTER; CATION-CHLORIDE COTRANSPORTERS; NA+-K+-2CL(-) COTRANSPORTER; REGULATORY PHOSPHORYLATION; SURFACE EXPRESSION; ION-TRANSPORT; TERMINUS; PROTEIN; BUMETANIDE; ISOFORMS	The renal bumetanide-sensitive Na-K-2Cl cotransporter (NKCC2) is the major salt transport pathway in the apical membrane of the mammalian thick ascending limb. It is differentially spliced and the three major variants (A, B, and F) differ in their localization and transport characteristics. Most knowledge about its regulation comes from experiments in Xenopus oocytes as NKCC2 proved difficult to functionally express in a mammalian system. Here we report the cloning and functional expression of untagged and unmodified versions of the major splice variants from ferret kidney (fNKCC2A, -B, and -F) in human embryonic kidney (HEK) 293 cells. Many NKCC2 antibodies used in this study detected high molecular weight forms of the transfected proteins, probably NKCC2 dimers, but not the monomers. Interestingly, monomers were strongly detected by phosphospecific antibodies directed against phosphopeptides in the regulatory N terminus. Bumetanide-sensitive Rb-86 uptake was significantly higher in transfected HEK-293 cells and could be stimulated by incubating cells in a medium containing a low chloride concentration prior the uptake measurements. fNKCC2 was less sensitive to the reduction in chloride concentration than NKCC1. Using HEK-293 cells stably expressing fNKCC2A we also show that co-expression of variant NKCC2AF does not have the dominant-negative effect on NKCC2 Aactivity that was seen in Xenopus oocytes, nor is it trafficked to the cell surface. In addition, fNKCC2AF is neither complex glycosylated nor phosphorylated in its N terminus regulatory region like other variants.	[Hannemann, Anke; Christie, Jenny K.; Flatman, Peter W.] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Flatman, PW (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Hugh Robson Bldg,George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	peter.flatman@ed.ac.uk	Hannemann, Anke/AAE-2445-2019	Hannemann, Anke/0000-0002-2925-1124	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Ares GR, 2008, AM J PHYSIOL-RENAL, V295, pF877, DOI 10.1152/ajprenal.00449.2007; Benziane B, 2007, J BIOL CHEM, V282, P33817, DOI 10.1074/jbc.M700195200; Brunet GM, 2005, J GEN PHYSIOL, V126, P325, DOI 10.1085/jgp.200509334; Castrop H, 2008, AM J PHYSIOL-RENAL, V295, pF859, DOI 10.1152/ajprenal.00106.2008; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Darman RB, 2001, J BIOL CHEM, V276, P34359, DOI 10.1074/jbc.C100368200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Flatman PW, 2007, CLIN SCI, V112, P203, DOI 10.1042/CS20060225; Flatman PW, 2002, BBA-BIOMEMBRANES, V1566, P140, DOI 10.1016/S0005-2736(02)00586-2; Flemmer AW, 2002, J BIOL CHEM, V277, P37551, DOI 10.1074/jbc.M206294200; Gagnon E, 2005, J BIOL CHEM, V280, P32555, DOI 10.1074/jbc.M505511200; Gagnon E, 2002, AM J PHYSIOL-RENAL, V283, pF1046, DOI 10.1152/ajprenal.00107.2002; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Gimenez I, 2002, J BIOL CHEM, V277, P8767, DOI 10.1074/jbc.C200021200; Gimenez I, 2007, J BIOL CHEM, V282, P6540, DOI 10.1074/jbc.M610780200; IGARASHI P, 1995, AM J PHYSIOL-RENAL, V269, pF405, DOI 10.1152/ajprenal.1995.269.3.F405; Isenring P, 1998, J BIOL CHEM, V273, P11295, DOI 10.1074/jbc.273.18.11295; Isenring P, 1997, J BIOL CHEM, V272, P24556, DOI 10.1074/jbc.272.39.24556; Khoudoli G.A., 2004, PROTEOME SCI, V2, P6, DOI DOI 10.1186/1477-5956-2-6; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; Maglova LM, 2004, AM J PHYSIOL-CELL PH, V286, pC1324, DOI 10.1152/ajpcell.00404.2003; Matskevich L, 2005, BBA-BIOMEMBRANES, V1714, P25, DOI 10.1016/j.bbamem.2005.06.001; Moore-Hoon ML, 1998, BBA-BIOMEMBRANES, V1373, P261, DOI 10.1016/S0005-2736(98)00112-6; Oppermann M, 2006, J AM SOC NEPHROL, V17, P2143, DOI 10.1681/ASN.2006040384; Paredes A, 2006, AM J PHYSIOL-RENAL, V290, pF1094, DOI 10.1152/ajprenal.00071.2005; Parvin MN, 2007, BIOCHEMISTRY-US, V46, P9630, DOI 10.1021/bi700881a; PAYNE JA, 1994, P NATL ACAD SCI USA, V91, P4544, DOI 10.1073/pnas.91.10.4544; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Plata C, 2002, J BIOL CHEM, V277, P11004, DOI 10.1074/jbc.M110442200; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Simard CF, 2004, J BIOL CHEM, V279, P40769, DOI 10.1074/jbc.M406458200; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P3039, DOI 10.1097/01.ASN.0000097370.29737.5B; Starremans PGJF, 2003, J AM SOC NEPHROL, V14, P1419, DOI 10.1097/01.ASN.0000064948.39199.A0; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Yang TX, 1996, AM J PHYSIOL-RENAL, V271, pF931, DOI 10.1152/ajprenal.1996.271.4.F931; Zaarour N, 2009, J BIOL CHEM, V284, P21752, DOI 10.1074/jbc.M109.000679	41	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35348	35358		10.1074/jbc.M109.060004	http://dx.doi.org/10.1074/jbc.M109.060004			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19854835	Green Published, hybrid			2022-12-25	WOS:000272645600011
J	Batisse, J; Batisse, C; Budd, A; Bottcher, B; Hurt, E				Batisse, Julien; Batisse, Claire; Budd, Aidan; Boettcher, Bettina; Hurt, Ed			Purification of Nuclear Poly(A)-binding Protein Nab2 Reveals Association with the Yeast Transcriptome and a Messenger Ribonucleoprotein Core Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; ANGSTROM RESOLUTION; RIBOSOMAL-SUBUNIT; EXPORT; COMPLEX; LOCALIZATION; TRANSPORT; PARTICLE; PORE; CYTOPLASM	Nascent mRNAs produced by transcription in the nucleus are subsequently processed and packaged into mRNA ribonucleoprotein particles (messenger ribonucleoproteins (mRNPs)) before export to the cytoplasm. Here, we have used the poly(A)binding protein Nab2 to isolate mRNPs from yeast under conditions that preserve mRNA integrity. Upon Nab2-tandem affinity purification, several mRNA export factors were co-enriched (Yra1, Mex67, THO-TREX) that were present in mRNPs of different size and mRNA length. High-throughput sequencing of the co-precipitated RNAs indicated that Nab2 is associated with the bulk of yeast transcripts with no specificity for different mRNA classes. Electron microscopy revealed that many of the mRNPs have a characteristic elongated structure. Our data suggest that mRNPs, although associated with different mRNAs, have a unifying core structure.	[Batisse, Julien; Hurt, Ed] Univ Heidelberg BZH, Zentrum Biochem, D-69120 Heidelberg, Germany; [Batisse, Claire; Budd, Aidan] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Boettcher, Bettina] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland	Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); University of Edinburgh	Hurt, E (corresponding author), Univ Heidelberg BZH, Zentrum Biochem, Neuenheimer Feld 307, D-69120 Heidelberg, Germany.	ed.hurt@bzh.uni-heidelberg.de	Batisse, Julien/A-4338-2012; Bottcher, Bettina/E-9397-2010; Budd, Aidan/F-8550-2013; Ed Hurt, Dr./AAE-8874-2019	Batisse, Julien/0000-0003-1285-1083; Bottcher, Bettina/0000-0002-7962-4849; Budd, Aidan/0000-0003-0196-9051; Ed Hurt, Dr./0000-0002-4535-8255; BATISSE, Claire/0000-0003-3064-6569	European Grant 3D [LSHG-CT-2005-512028]; Wellcome Trust [087658]	European Grant 3D; Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by the European Grant 3D repertoire (LSHG-CT-2005-512028) and by Wellcome Trust Grant 087658.	Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; ANDERSON JT, 1993, MOL CELL BIOL, V13, P2730, DOI 10.1128/MCB.13.5.2730; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Daneholt B, 2001, P NATL ACAD SCI USA, V98, P7012, DOI 10.1073/pnas.111145498; de Heredia Miguel Lopez, 2004, BMC Biochemistry, V5, P14, DOI 10.1186/1471-2091-5-14; Fasken MB, 2008, J BIOL CHEM, V283, P27130, DOI 10.1074/jbc.M803649200; Fortes P, 2000, MOL CELL, V6, P191, DOI 10.1016/S1097-2765(00)00020-4; Gallardo M, 2003, J BIOL CHEM, V278, P24225, DOI 10.1074/jbc.M302900200; Gilbert W, 2004, MOL CELL, V13, P201, DOI 10.1016/S1097-2765(04)00030-9; Guisbert KK, 2005, RNA, V11, P383, DOI 10.1261/rna.7234205; Hector RE, 2002, EMBO J, V21, P1800, DOI 10.1093/emboj/21.7.1800; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kelly SM, 2007, P NATL ACAD SCI USA, V104, P12306, DOI 10.1073/pnas.0701244104; Kelly SM, 2009, TRAFFIC, V10, P1199, DOI 10.1111/j.1600-0854.2009.00944.x; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Lei EP, 2001, GENE DEV, V15, P1771, DOI 10.1101/gad.892401; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsumoto K, 2003, BIOCHEM BIOPH RES CO, V306, P53, DOI 10.1016/S0006-291X(03)00909-4; MEHLIN H, 1991, EXP CELL RES, V193, P72, DOI 10.1016/0014-4827(91)90539-7; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Nojima T, 2007, J BIOL CHEM, V282, P15645, DOI 10.1074/jbc.M700629200; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; Suntharalingam M, 2004, J BIOL CHEM, V279, P35384, DOI 10.1074/jbc.M402044200; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Tran EJ, 2007, MOL CELL, V28, P850, DOI 10.1016/j.molcel.2007.09.019; Truant R, 1998, MOL CELL BIOL, V18, P1449, DOI 10.1128/MCB.18.3.1449; van den Bogaart G, 2009, NAT CELL BIOL, V11, P350, DOI 10.1038/ncb1844; Vinciguerra P, 2004, CURR OPIN CELL BIOL, V16, P285, DOI 10.1016/j.ceb.2004.03.013; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; WU WW, 2009, J VIS EXP, V24, P1105; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zenklusen D, 2002, MOL CELL BIOL, V22, P8241, DOI 10.1128/MCB.22.23.8241-8253.2002	40	79	79	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34911	34917		10.1074/jbc.M109.062034	http://dx.doi.org/10.1074/jbc.M109.062034			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840948	Green Published, hybrid, Green Accepted			2022-12-25	WOS:000272439600046
J	Schartner, JM; Simonson, WT; Wernimont, SA; Nettenstrom, LM; Huttenlocher, A; Seroogy, CM				Schartner, Jill M.; Simonson, William T.; Wernimont, Sarah A.; Nettenstrom, Lauren M.; Huttenlocher, Anna; Seroogy, Christine M.			Gene Related to Anergy in Lymphocytes (GRAIL) Expression in CD4+T Cells Impairs Actin Cytoskeletal Organization during T Cell/Antigen-presenting Cell Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; SIGNAL-TRANSDUCTION; CYTOKINE PRODUCTION; REGULATORY CELLS; DENDRITIC CELLS; ACTIVATION; LFA-1; PROLIFERATION; INDUCTION; PROTEIN	GRAIL (gene related to anergy in lymphocytes), is an E3 ubiquitin ligase with increased expression in anergic CD4+ T cells. The expression of GRAIL has been shown to be both necessary and sufficient for the induction of T cell (T) anergy. To date, several subsets of anergic T cells have demonstrated altered interactions with antigen-presenting cells (APC) and perturbed TCR-mediated signaling. The role of GRAIL in mediating these aspects of T cell anergy remains unclear. We used flow cytometry and confocal microscopy to examine T/APC interactions in GRAIL-expressing T cells. Increased GRAIL expression resulted in reduced T/APC conjugation efficiency as assessed by flow cytometry. Examination of single T/APC conjugates by confocal microscopy revealed altered polarization of polymerized actin and LFA-1 to the T/APC interface. When GRAIL expression was knocked down, actin polarization to the T/APC interface was restored, demonstrating that GRAIL is necessary for alteration of actin cytoskeletal rearrangement under anergizing conditions. Interestingly, proximal TCR signaling including calcium flux and phosphorylation of Vav were not disrupted by expression of GRAIL in CD4+ T cells. In contrast, interrogation of distal signaling events demonstrated significantly decreased JNK phosphorylation in GRAIL-expressing T cells. In sum, GRAIL expression in CD4+ T cells mediates alterations in the actin cytoskeleton during T/APC interactions. Moreover, in this model, our data dissociates proximal T cell signaling events from functional unresponsiveness. These data demonstrate a novel role for GRAIL in modulating T/APC interactions and provide further insight into the cell biology of anergic T cells.	[Schartner, Jill M.; Nettenstrom, Lauren M.; Huttenlocher, Anna; Seroogy, Christine M.] Univ Wisconsin, Dept Pediat, Div Allergy Immunol & Rheumatol, Madison, WI 53792 USA; [Schartner, Jill M.] Univ Wisconsin, Dept Cellular & Mol Pathol, Madison, WI 53792 USA; [Simonson, William T.; Wernimont, Sarah A.] Univ Wisconsin, Dept Cellular & Mol Biol, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Seroogy, CM (corresponding author), Univ Wisconsin, Dept Pediat, Div Allergy Immunol & Rheumatol, H4-474 CSC,600 Highland Ave, Madison, WI 53792 USA.	cmseroogy@wisc.edu		Wernimont, Sarah/0000-0002-6894-7837	National Institutes of Health [1 R21 AI064234-01]; Midwest Athletes Against Childhood Cancer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwest Athletes Against Childhood Cancer; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1 R21 AI064234-01. This work was also supported by Midwest Athletes Against Childhood Cancer.	Anandasabapathy N, 2003, IMMUNITY, V18, P535, DOI 10.1016/S1074-7613(03)00084-0; Burkhardt JK, 2008, ANNU REV IMMUNOL, V26, P233, DOI 10.1146/annurev.immunol.26.021607.090347; Costa GL, 2000, J IMMUNOL, V164, P3581, DOI 10.4049/jimmunol.164.7.3581; Dahlberg PE, 2007, CLIN EXP IMMUNOL, V149, P226, DOI 10.1111/j.1365-2249.2007.03402.x; DeSilva DR, 1996, J EXP MED, V183, P2017, DOI 10.1084/jem.183.5.2017; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Dushek O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003913; Egawa S, 2008, AM J PHYSIOL-GASTR L, V295, pG163, DOI 10.1152/ajpgi.90242.2008; Fehervari Z, 2004, INT IMMUNOL, V16, P1769, DOI 10.1093/intimm/dxh178; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Hickman SP, 2006, J IMMUNOL, V177, P2186, DOI 10.4049/jimmunol.177.4.2186; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; JENKINS MK, 1990, J IMMUNOL, V144, P16; JENKINS MK, 1987, P NATL ACAD SCI USA, V84, P5409, DOI 10.1073/pnas.84.15.5409; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Jo EK, 2005, J EXP MED, V201, P1733, DOI 10.1084/jem.20042577; Krawczyk C, 2002, IMMUNITY, V16, P331, DOI 10.1016/S1074-7613(02)00291-1; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; Li W, 1996, SCIENCE, V271, P1272, DOI 10.1126/science.271.5253.1272; MacKenzie DA, 2007, J BIOL CHEM, V282, P9696, DOI 10.1074/jbc.M604192200; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; Melino M, 2008, J IMMUNOL, V181, P7300, DOI 10.4049/jimmunol.181.10.7300; Morgan MM, 2001, J IMMUNOL, V167, P5708, DOI 10.4049/jimmunol.167.10.5708; MUELLER DL, 1995, CURR OPIN IMMUNOL, V7, P375, DOI 10.1016/0952-7915(95)80113-8; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; QUILL H, 1987, J IMMUNOL, V138, P3704; Rivas FV, 2004, MOL CELL BIOL, V24, P1628, DOI 10.1128/MCB.24.4.1628-1639.2004; Sabapathy K, 1999, CURR BIOL, V9, P116, DOI 10.1016/S0960-9822(99)80065-7; Schartner JM, 2007, SEMIN IMMUNOL, V19, P188, DOI 10.1016/j.smim.2007.02.010; Sechi AS, 2002, IMMUNOL REV, V189, P98, DOI 10.1034/j.1600-065X.2002.18909.x; Seroogy CM, 2004, J IMMUNOL, V173, P79, DOI 10.4049/jimmunol.173.1.79; Simonson WTN, 2006, J IMMUNOL, V177, P7707, DOI 10.4049/jimmunol.177.11.7707; Su L, 2006, J IMMUNOL, V177, P7559, DOI 10.4049/jimmunol.177.11.7559; Tamir A, 2000, J IMMUNOL, V165, P1243, DOI 10.4049/jimmunol.165.3.1243; Taylor JJ, 2009, J CLIN INVEST, V119, P1019, DOI 10.1172/JCI36534; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; VALITUTTI S, 1995, J EXP MED, V181, P577, DOI 10.1084/jem.181.2.577; Valitutti S, 2008, IMMUNITY, V29, P384, DOI 10.1016/j.immuni.2008.08.002; Wang Y, 2009, J BIOL CHEM, V284, P12645, DOI 10.1074/jbc.M807207200; Wang Y, 2008, INT IMMUNOL, V20, P1119, DOI 10.1093/intimm/dxn070; Wells AD, 2003, J IMMUNOL, V170, P4127, DOI 10.4049/jimmunol.170.8.4127; Yu X, 2000, J IMMUNOL, V164, P3543, DOI 10.4049/jimmunol.164.7.3543	47	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34674	34681		10.1074/jbc.M109.024497	http://dx.doi.org/10.1074/jbc.M109.024497			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19833735	Green Published, hybrid			2022-12-25	WOS:000272439600023
J	Jiao, CY; Delaroche, D; Burlina, F; Alves, ID; Chassaing, G; Sagan, S				Jiao, Chen-Yu; Delaroche, Diane; Burlina, Fabienne; Alves, Isabel D.; Chassaing, Gerard; Sagan, Sandrine			Translocation and Endocytosis for Cell-penetrating Peptide Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOF MASS-SPECTROMETRY; HAMSTER OVARY CELLS; HEPARAN-SULFATE PROTEOGLYCANS; ANTENNAPEDIA HOMEODOMAIN; BIOLOGICAL-MEMBRANES; PLASMA-MEMBRANE; 3RD HELIX; SURFACE; DELIVERY; QUANTIFICATION	Cell-penetrating peptides (CPPs) share the property of cellular internalization. The question of how these peptides reach the cytoplasm of cells is still widely debated. Herein, we have used a mass spectrometry-based method that enables quantification of internalized and membrane-bound peptides. Internalization of the most used CPP was studied at 37 degrees C (endocytosis and translocation) and 4 degrees C (translocation) in wild type and proteoglycan-deficient Chinese hamster ovary cells. Both translocation and endocytosis are internalization pathways used by CPP. The choice of one pathway versus the other depends on the peptide sequence (not the number of positive changes), the extracellular peptide concentration, and the membrane components. There is no relationship between the high affinity of these peptides for the cell membrane and their internalization efficacy. Translocation occurs at low extracellular peptide concentration, whereas endocytosis, a saturable and cooperative phenomenon, is activated at higher concentrations. Translocation operates in a narrow time window, which implies a specific lipid/peptide co-import in cells.	[Sagan, Sandrine] Univ Paris 06, UMR 7203, CNRS, Ecole Normale Super,Lab Biomol, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Sagan, S (corresponding author), Univ Paris 06, UMR 7203, CNRS, Ecole Normale Super,Lab Biomol, 4 Pl Jussieu, F-75005 Paris, France.	sandrine.sagan@upmc.fr	S, SAGAN/I-8132-2013; Alves, Isabel D/R-9613-2016; s, s/HIK-1178-2022; SAGAN, Sandrine/AAA-8537-2022; s, s/GYR-2278-2022; s, s/GVS-3323-2022; QI, DANDAN/GVR-9324-2022; s, s/HHD-0404-2022	S, SAGAN/0000-0003-0083-4411; Alves, Isabel D/0000-0003-3193-2436; Burlina, Fabienne/0000-0002-6042-680X	French Ministere de l'Enseignement Superieur et de la Recherche	French Ministere de l'Enseignement Superieur et de la Recherche	Recipient of a Ph.D. fellowship from the French Ministere de l'Enseignement Superieur et de la Recherche.	Abes R, 2008, NUCLEIC ACIDS RES, V36, P6343, DOI 10.1093/nar/gkn541; Alves ID, 2008, BBA-GEN SUBJECTS, V1780, P948, DOI 10.1016/j.bbagen.2008.04.004; Arbuzova A, 2000, BBA-BIOMEMBRANES, V1464, P35, DOI 10.1016/S0005-2736(99)00243-6; Aubry S, 2009, FASEB J, V23, P2956, DOI 10.1096/fj.08-127563; Aussedat B, 2006, BBA-BIOMEMBRANES, V1758, P375, DOI 10.1016/j.bbamem.2006.01.012; Berlose JP, 1996, EUR J BIOCHEM, V242, P372, DOI 10.1111/j.1432-1033.1996.0372r.x; Bucki R, 2000, BIOCHEMISTRY-US, V39, P5838, DOI 10.1021/bi992403l; Burlina F, 2005, ANGEW CHEM INT EDIT, V44, P4244, DOI 10.1002/anie.200500477; Burlina F, 2006, NAT PROTOC, V1, P200, DOI 10.1038/nprot.2006.30; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Delaroche D, 2007, ANAL CHEM, V79, P1932, DOI 10.1021/ac061108l; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Dupont E, 2007, J BIOL CHEM, V282, P8994, DOI 10.1074/jbc.M609246200; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Fritz VMR, 1997, BBA-GENE STRUCT EXPR, V1354, P153, DOI 10.1016/S0167-4781(97)00117-6; Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x; Gerbal-Chaloin S, 2007, BIOL CELL, V99, P223, DOI 10.1042/BC20060123; Goodyear RJ, 2008, J NEUROSCI, V28, P9939, DOI 10.1523/JNEUROSCI.1124-08.2008; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Hallbrink M, 2004, BBA-BIOMEMBRANES, V1667, P222, DOI 10.1016/j.bbamem.2004.10.009; Haucke V, 2005, BIOCHEM SOC T, V33, P1285, DOI 10.1042/BST0331285; Iglesias-Bartolome R, 2006, FEBS J, V273, P1744, DOI 10.1111/j.1742-4658.2006.05194.x; IOZZO RV, 1987, J BIOL CHEM, V262, P1888; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Kirkpatrick CA, 2007, J CELL SCI, V120, P1829, DOI 10.1242/jcs.03432; Lee HL, 2008, J AM CHEM SOC, V130, P9364, DOI 10.1021/ja710798b; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Puckett CA, 2009, J AM CHEM SOC, V131, P8738, DOI 10.1021/ja9025165; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Saito M, 1999, BBA-MOL CELL BIOL L, V1438, P55, DOI 10.1016/S1388-1981(99)00037-2; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Ter-Avetisyan G, 2009, J BIOL CHEM, V284, P3370, DOI 10.1074/jbc.M805550200; THEODORE L, 1995, J NEUROSCI, V15, P7158; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; Vives E, 2008, BBA-REV CANCER, V1786, P126, DOI 10.1016/j.bbcan.2008.03.001; Watkins CL, 2009, BIOCHEM J, V420, P179, DOI 10.1042/BJ20090042; Wolkers WF, 2003, BBA-BIOMEMBRANES, V1612, P154, DOI 10.1016/S0005-2736(03)00114-7; YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451; Ziegler A, 2008, BIOPHYS J, V94, P2142, DOI 10.1529/biophysj.107.113472; Ziegler A, 2007, BIOCHEMISTRY-US, V46, P8138, DOI 10.1021/bi700416h	44	237	242	2	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33957	33965		10.1074/jbc.M109.056309	http://dx.doi.org/10.1074/jbc.M109.056309			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19833724	Green Published, hybrid			2022-12-25	WOS:000272165200028
J	Katsel, P; Tan, WL; Haroutunian, V				Katsel, Pavel; Tan, Weilun; Haroutunian, Vahram			Gain in Brain Immunity in the Oldest-Old Differentiates Cognitively Normal from Demented Individuals	PLOS ONE			English	Article							MILD ALZHEIMER-DISEASE; GENE-EXPRESSION; SENILE DEMENTIA; NEUROFIBRILLARY TANGLES; MICROGLIAL ACTIVATION; STEREOLOGIC ANALYSIS; CLINICAL DEMENTIA; NEURITIC PLAQUES; ELDERLY SUBJECTS; GLIAL-CELLS	Background: Recent findings suggest that Alzheimer's disease (AD) neuropathological features (neuritic plaques and NFTs) are not strongly associated with dementia in extreme old (over 90 years of age) and compel a search for neurobiological indices of dementia in this rapidly growing segment of the elderly population. We sought to characterize transcriptional and protein profiles of dementia in the oldest-old. Methods and Findings: Gene and protein expression changes relative to non-demented age-matched controls were assessed by two microarray platforms, qPCR and Western blot in different regions of the brains of oldest-old and younger old persons who died at mild or severe stages of dementia. Our results indicate that: i) consistent with recent neuropathological findings, gene expression changes associated with cognitive impairment in oldest-old persons are distinct from those in cognitively impaired youngest-old persons; ii) transcripts affected in young-old subjects with dementia participate in biological pathways related to synaptic function and neurotransmission while transcripts affected in oldest-old subjects with dementia are associated with immune/inflammatory function; iii) upregulation of immune response genes in cognitively intact oldest-old subjects and their subsequent downregulation in dementia suggests a potential protective role of the brain immune-associated system against dementia in the oldest-old; iv) consistent with gene expression profiles, protein expression of several selected genes associated with the inflammatory/immune system in inferior temporal cortex is significantly increased in cognitively intact oldest-old persons relative to cognitively intact young-old persons, but impaired in cognitively compromised oldest-old persons relative to cognitively intact oldest-old controls. Conclusions: These results suggest that disruption of the robust immune homeostasis that is characteristic of oldest-old individuals who avoided dementia may be directly associated with dementia in the oldest-old and contrast with the synaptic and neurotransmitter system failures that typify dementia in younger old persons.			Katsel, P (corresponding author), Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA.	pavel.katsel@mssm.edu			NIA NIH HHS [P01 AG02219, P01 AG002219] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG002219] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; ALMEDA S, 1983, J BIOL CHEM, V258, P785; Avignone E, 2008, J NEUROSCI, V28, P9133, DOI 10.1523/JNEUROSCI.1820-08.2008; Becker-Herman S, 2005, MOL BIOL CELL, V16, P5061, DOI 10.1091/mbc.E05-04-0327; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERCHTOLD NC, 2008, P NATL ACAD SCI US; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blasko I, 2004, AGING CELL, V3, P169, DOI 10.1111/j.1474-9728.2004.00101.x; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouras C, 2006, J NEUROPATH EXP NEUR, V65, P235, DOI 10.1097/01.jnen.0000203077.53080.2c; Budhraja V, 2003, BMC BIOL, V1, DOI 10.1186/1741-7007-1-1; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Cheepsunthorn P, 1998, J COMP NEUROL, V400, P73; CRYSTAL HA, 1982, J NEUROCHEM, V38, P1781, DOI 10.1111/j.1471-4159.1982.tb06665.x; DAVIS AE, 1986, P NATL ACAD SCI USA, V83, P3161, DOI 10.1073/pnas.83.10.3161; Davis KL, 1999, JAMA-J AM MED ASSOC, V281, P1401, DOI 10.1001/jama.281.15.1401; Dracheva S, 2005, J NEUROSCI RES, V79, P868, DOI 10.1002/jnr.20423; EBLY EM, 1994, NEUROLOGY, V44, P1593, DOI 10.1212/WNL.44.9.1593; Erraji-Benchekroun L, 2005, BIOL PSYCHIAT, V57, P549, DOI 10.1016/j.biopsych.2004.10.034; FALKAI P, 1988, BIOL PSYCHIAT, V24, P515, DOI 10.1016/0006-3223(88)90162-X; Farfara D, 2008, J CELL MOL MED, V12, P762, DOI 10.1111/j.1582-4934.2008.00314.x; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Giannakopoulos P, 1996, J NEUROPATH EXP NEUR, V55, P1210, DOI 10.1097/00005072-199612000-00004; Ginsberg Stephen D, 2006, NeuroRx, V3, P302, DOI 10.1016/j.nurx.2006.05.007; Hall CB, 2005, NEUROLOGY, V65, P882, DOI 10.1212/01.wnl.0000176053.98907.3f; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Haroutunian V, 1998, ARCH NEUROL-CHICAGO, V55, P1185, DOI 10.1001/archneur.55.9.1185; Haroutunian V, 1999, ARCH NEUROL-CHICAGO, V56, P713, DOI 10.1001/archneur.56.6.713; Haroutunian V, 2009, NEUROBIOL AGING, V30, P561, DOI 10.1016/j.neurobiolaging.2007.07.021; Haroutunian V, 2008, ARCH NEUROL-CHICAGO, V65, P1211, DOI 10.1001/archneur.65.9.1211; Haroutunian V, 2006, AM J PSYCHIAT, V163, P1834, DOI 10.1176/appi.ajp.163.10.1834; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hatori K, 2002, J NEUROSCI RES, V69, P418, DOI 10.1002/jnr.10304; HAUW JJ, 1986, REV NEUROL, V142, P107; Head E, 2009, NEUROBIOL AGING, V30, P1125, DOI 10.1016/j.neurobiolaging.2007.10.001; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Ho L, 2001, NEUROSCI LETT, V298, P191, DOI 10.1016/S0304-3940(00)01753-5; Imhof A, 2007, J NEUROL SCI, V257, P72, DOI 10.1016/j.jns.2007.01.025; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh Y, 1998, J NEUROL SCI, V157, P73, DOI 10.1016/S0022-510X(98)00050-1; Katsel P, 2005, SCHIZOPHR RES, V79, P157, DOI 10.1016/j.schres.2005.06.007; Katsel P, 2005, SCHIZOPHR RES, V77, P241, DOI 10.1016/j.schres.2005.03.020; Katsel P, 2007, NEUROCHEM RES, V32, P845, DOI 10.1007/s11064-007-9297-x; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luterman JD, 2000, ARCH NEUROL-CHICAGO, V57, P1153, DOI 10.1001/archneur.57.8.1153; Mariani TJ, 2002, FASEB J, V16, P321, DOI 10.1096/fj.02-0351fje; MATTIACE LA, 1990, AM J PATHOL, V136, P1101; MCGEER PL, 1994, ALZ DIS ASSOC DIS, V8, P149, DOI 10.1097/00002093-199408030-00001; Miech RA, 2002, NEUROLOGY, V58, P209, DOI 10.1212/WNL.58.2.209; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P1136, DOI 10.1097/nen.0b013e31815c5efb; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Parachikova A, 2007, NEUROBIOL AGING, V28, P1821, DOI 10.1016/j.neurobiolaging.2006.08.014; Perls T, 2004, TRENDS NEUROSCI, V27, P633, DOI 10.1016/j.tins.2004.07.012; PERLS TT, 1993, J AM GERIATR SOC, V41, P1193, DOI 10.1111/j.1532-5415.1993.tb07302.x; Prohovnik I, 2006, NEUROLOGY, V66, P49, DOI 10.1212/01.wnl.0000191298.68045.50; RITCHIE K, 1995, LANCET, V346, P931, DOI 10.1016/S0140-6736(95)91556-7; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Rogers J, 2000, ANN NY ACAD SCI, V924, P132; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; SCHOENBERG BS, 1987, ANN NEUROL, V22, P724, DOI 10.1002/ana.410220608; Shen Y, 2003, PROG NEUROBIOL, V70, P463, DOI 10.1016/j.pneurobio.2003.08.001; Silver MH, 2002, PSYCHOSOM MED, V64, P493, DOI 10.1097/00006842-200205000-00014; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Streit Wolfgang J., 2005, Current Alzheimer Research, V2, P187, DOI 10.2174/1567205053585765; STYREN SD, 1990, EXP NEUROL, V110, P93, DOI 10.1016/0014-4886(90)90054-V; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Terry RD, 2006, J GERIATR PSYCH NEUR, V19, P125, DOI 10.1177/0891988706291079; Thal DR, 2003, J NEUROPATH EXP NEUR, V62, P1287, DOI 10.1093/jnen/62.12.1287; Thomassen R, 1998, NEUROLOGY, V50, P283, DOI 10.1212/WNL.50.1.283; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; *USCB, 2004, 53 USCB CTR DIS CONT; *USCB, 2002, POP PROJ MIDDL SER; von Gunten A, 2005, EXP NEUROL, V193, P198, DOI 10.1016/j.expneurol.2004.12.005; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; WERNICKE TF, 1994, NEUROLOGY, V44, P250, DOI 10.1212/WNL.44.2.250; Xiang Z, 2006, DIS MARKERS, V22, P95, DOI 10.1155/2006/276239; Yao PJ, 2003, NEUROBIOL DIS, V12, P97, DOI 10.1016/S0969-9961(02)00009-8; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	84	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7642	10.1371/journal.pone.0007642	http://dx.doi.org/10.1371/journal.pone.0007642			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19865478	Green Published, gold, Green Submitted			2022-12-25	WOS:000271232000012
J	Rangel, A; Madronal, N; Masso, AGI; Gavin, R; Llorens, F; Sumoy, L; Torres, JM; Delgado-Garcia, JM; Del Rio, JA				Rangel, Alejandra; Madronal, Noelia; Gruart i Masso, Agnes; Gavin, Rosalina; Llorens, Franc; Sumoy, Lauro; Maria Torres, Juan; Maria Delgado-Garcia, Jose; Antonio Del Rio, Jose			Regulation of GABA(A) and Glutamate Receptor Expression, Synaptic Facilitation and Long-Term Potentiation in the Hippocampus of Prion Mutant Mice	PLOS ONE			English	Article							CA3-CA1 SYNAPSE; RAT HIPPOCAMPUS; DEFICIENT MICE; KNOCKOUT MICE; KAINIC ACID; NULL MICE; PROTEIN; SEIZURES; BEHAVIOR; LTP	Background: Prionopathies are characterized by spongiform brain degeneration, myoclonia, dementia, and periodic electroencephalographic (EEG) disturbances. The hallmark of prioniopathies is the presence of an abnormal conformational isoform (PrPsc) of the natural cellular prion protein (PrPc) encoded by the Prnp gene. Although several roles have been attributed to PrPc, its putative functions in neuronal excitability are unknown. Although early studies of the behavior of Prnp knockout mice described minor changes, later studies report altered behavior. To date, most functional PrPc studies on synaptic plasticity have been performed in vitro. To our knowledge, only one electrophysiological study has been performed in vivo in anesthetized mice, by Curtis and coworkers. They reported no significant differences in paired-pulse facilitation or LTP in the CA1 region after Schaffer collateral/commissural pathway stimulation. Methodology/Principal Findings: Here we explore the role of PrPc expression in neurotransmission and neural excitability using wild-type, Prnp -/- and PrPc-overexpressing mice (Tg20 strain). By correlating histopathology with electrophysiology in living behaving mice, we demonstrate that both Prnp -/- mice but, more relevantly Tg20 mice show increased susceptibility to KA, leading to significant cell death in the hippocampus. This finding correlates with enhanced synaptic facilitation in paired-pulse experiments and hippocampal LTP in living behaving mutant mice. Gene expression profiling using Illumina (TM) microarrays and Ingenuity pathways analysis showed that 129 genes involved in canonical pathways such as Ubiquitination or Neurotransmission were co-regulated in Prnp -/- and Tg20 mice. Lastly, RT-qPCR of neurotransmission-related genes indicated that subunits of GABA(A) and AMPA-kainate receptors are co-regulated in both Prnp -/- and Tg20 mice. Conclusions/Significance: Present results demonstrate that PrPc is necessary for the proper homeostatic functioning of hippocampal circuits, because of its relationships with GABA(A) and AMPA-Kainate neurotransmission. New PrPc functions have recently been described, which point to PrPc as a target for putative therapies in Alzheimer's disease. However, our results indicate that a "gain of function'' strategy in Alzheimer's disease, or a "loss of function'' in prionopathies, may impair PrPc function, with devastating effects. In conclusion, we believe that present data should be taken into account in the development of future therapies.			Rangel, A (corresponding author), Univ Barcelona, Inst Bioengn Catalonia, Barcelona, Spain.	jmdelgar@upo.es; jadelrio@ibec.pcb.ub.es	Gavín, Rosalina/D-4341-2014; Del Rio Fernandez, Jose A/AAD-1121-2020; Sumoy, Lauro/AGZ-3186-2022; del rio, jose antonio/L-9232-2014; Sumoy, Lauro/K-1680-2013; Torres, Juan Maria/L-8768-2013; Delgado-Garcia, Jose M./V-1567-2019	Gavín, Rosalina/0000-0003-1982-2162; Sumoy, Lauro/0000-0003-0005-4618; del rio, jose antonio/0000-0002-5214-4909; Sumoy, Lauro/0000-0003-0005-4618; Torres, Juan Maria/0000-0003-0443-9232; Rangel, Alejandra/0000-0001-6536-6263; , Franc/0000-0002-9756-7497				Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Carleton A, 2001, PFLUG ARCH EUR J PHY, V442, P223, DOI 10.1007/s004240100523; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Chiesa R, 2008, J NEUROSCI, V28, P13258, DOI 10.1523/JNEUROSCI.3109-08.2008; Coitinho AS, 2006, EUR J NEUROSCI, V24, P3255, DOI 10.1111/j.1460-9568.2006.05156.x; Coitinho AS, 2003, NEUROREPORT, V14, P1375, DOI 10.1097/01.wnr.0000078541.07662.90; Colling SB, 1996, NEUROSCI LETT, V209, P49, DOI 10.1016/0304-3940(96)12596-9; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; Curtis J, 2003, NEUROBIOL DIS, V13, P55, DOI 10.1016/S0969-9961(03)00017-2; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ferreiro E, 2006, NEUROBIOL DIS, V23, P669, DOI 10.1016/j.nbd.2006.05.011; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Fukushima F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003993; Gardoni F, 2009, J NEUROSCI, V29, P669, DOI 10.1523/JNEUROSCI.3921-08.2009; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Herms JW, 1995, EUR J NEUROSCI, V7, P2508, DOI 10.1111/j.1460-9568.1995.tb01049.x; Huang SH, 2007, P NATL ACAD SCI USA, V104, P6800, DOI 10.1073/pnas.0608885104; Iihara K, 2001, J NEUROSCI, V21, P2224, DOI 10.1523/JNEUROSCI.21-07-02224.2001; Janssen WGM, 2005, EXP NEUROL, V191, pS28, DOI 10.1016/j.expneurol.2004.08.020; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Khosravani Houman, 2008, J Gen Physiol, V131, pi5, DOI 10.1085/JGP1316OIA5; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lauri SE, 2007, NEUROPHARMACOLOGY, V52, P1, DOI 10.1016/j.neuropharm.2006.06.017; Le Pichon CE, 2009, NAT NEUROSCI, V12, P60, DOI 10.1038/nn.2238; Lee JY, 2000, J NEUROSCI, V20; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lledo PM, 1996, P NATL ACAD SCI USA, V93, P2403, DOI 10.1073/pnas.93.6.2403; Macdonald RL, 2004, BIOCHEM PHARMACOL, V68, P1497, DOI 10.1016/j.bcp.2004.07.029; Madronal N, 2007, J NEUROSCI, V27, P12139, DOI 10.1523/JNEUROSCI.3397-07.2007; Madronal N, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.007.2009; Maglio LE, 2006, BRAIN RES, V1097, P11, DOI 10.1016/j.brainres.2006.04.056; Maglio LE, 2004, MOL BRAIN RES, V131, P58, DOI 10.1016/j.molbrainres.2004.08.004; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; McKhann GM, 2003, NEUROSCIENCE, V122, P551, DOI 10.1016/S0306-4522(03)00562-1; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; McLin JP, 2006, EUR J NEUROSCI, V24, P2191, DOI 10.1111/j.1460-9568.2006.05111.x; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Nicolas O, 2007, FASEB J, V21, P3107, DOI 10.1096/fj.06-7827com; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peng YG, 1997, FUND APPL TOXICOL, V40, P63, DOI 10.1006/faat.1997.2360; Powell AD, 2008, J NEUROSCI, V28, P3877, DOI 10.1523/JNEUROSCI.0675-08.2008; PRUSINER SB, 1994, ANNU REV NEUROSCI, V17, P311, DOI 10.1146/annurev.ne.17.030194.001523; PRUSINER SB, 1986, BIOESSAYS, V5, P281, DOI 10.1002/bies.950050612; Rangel A, 2007, J NEUROSCI RES, V85, P2741, DOI 10.1002/jnr.21215; Roucou X, 2004, J NEUROSCI RES, V75, P153, DOI 10.1002/jnr.10864; Sakudo A, 2006, MINI-REV MED CHEM, V6, P589, DOI 10.2174/138955706776876159; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Schwartzkroin P A, 1986, Adv Neurol, V44, P991; Sokolov MV, 1998, NEUROSCIENCE, V85, P1, DOI 10.1016/S0306-4522(97)00592-7; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Telfeian AE, 2000, NEUROBIOL DIS, V7, P362, DOI 10.1006/nbdi.2000.0294; Thompson CL, 2002, MOL BRAIN RES, V102, P55, DOI 10.1016/S0169-328X(02)00183-3; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Volianskis A, 2003, J PHYSIOL-LONDON, V550, P459, DOI 10.1113/jphysiol.2003.044214; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; WESTAWAY D, 1994, DEGENERATION SKELETA, P117; Whatley SA, 1995, NEUROREPORT, V6, P2333, DOI 10.1097/00001756-199511270-00015; Yang EJ, 2006, J NEUROPHYSIOL, V96, P1683, DOI 10.1152/jn.01332.2005; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	70	50	50	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7592	10.1371/journal.pone.0007592	http://dx.doi.org/10.1371/journal.pone.0007592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855845	Green Submitted, Green Published, gold			2022-12-25	WOS:000271147200013
J	Schroeder, K; Jularic, M; Horsburgh, SM; Hirschhausen, N; Neumann, C; Bertling, A; Schulte, A; Foster, S; Kehrel, BE; Peters, G; Heilmann, C				Schroeder, Katrin; Jularic, Mario; Horsburgh, Samantha M.; Hirschhausen, Nina; Neumann, Claudia; Bertling, Anne; Schulte, Anja; Foster, Simon; Kehrel, Beate E.; Peters, Georg; Heilmann, Christine			Molecular Characterization of a Novel Staphylococcus Aureus Surface Protein (SasC) Involved in Cell Aggregation and Biofilm Accumulation	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEIN; POLYSACCHARIDE INTERCELLULAR ADHESIN; PROTOPLAST TRANSFORMATION; METHICILLIN RESISTANCE; JOINT INFECTIONS; GENOME SEQUENCE; ICA LOCUS; IN-VITRO; EPIDERMIDIS; GENE	Background: Staphylococci belong to the most important pathogens causing implant-associated infections. Colonization of the implanted medical devices by the formation of a three-dimensional structure made of bacteria and host material called biofilm is considered the most critical factor in these infections. To form a biofilm, bacteria first attach to the surface of the medical device, and then proliferate and accumulate into multilayered cell clusters. Biofilm accumulation may be mediated by polysaccharide and protein factors. Methology/Principal Findings: The information on Staphylococcus aureus protein factors involved in biofilm accumulation is limited, therefore, we searched the S. aureus Col genome for LPXTG-motif containing potential surface proteins and chose the so far uncharacterized S. aureus surface protein C (SasC) for further investigation. The deduced SasC sequence consists of 2186 amino acids with a molecular mass of 238 kDa and has features typical of Gram-positive surface proteins, such as an N-terminal signal peptide, a C-terminal LPXTG cell wall anchorage motif, and a repeat region consisting of 17 repeats similar to the domain of unknown function 1542 (DUF1542). We heterologously expressed sasC in Staphylococcus carnosus, which led to the formation of huge cell aggregates indicative of intercellular adhesion and biofilm accumulation. To localize the domain conferring cell aggregation, we expressed two subclones of sasC encoding either the N-terminal domain including a motif that is found in various architectures (FIVAR) or 8 of the DUF1542 repeats. SasC or its N-terminal domain, but not the DUF1542 repeat region conferred production of huge cell aggregates, higher attachment to polystyrene, and enhanced biofilm formation to S. carnosus and S. aureus. SasC does not mediate binding to fibrinogen, thrombospondin-1, von Willebrand factor, or platelets as determined by flow cytometry. Conclusions/Significance: Thus, SasC represents a novel S. aureus protein factor involved in cell aggregation and biofilm formation, which may play an important role in colonization during infection with this important pathogen.			Schroeder, K (corresponding author), Univ Hosp Munster, Inst Med Microbiol, Munster, Germany.	heilmac@uni-muenster.de						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Bateman BT, 2001, INFECT IMMUN, V69, P7851, DOI 10.1128/IAI.69.12.7851-7857.2001; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Clarke SR, 2002, INFECT IMMUN, V70, P6680, DOI 10.1128/IAI.70.12.6680-6687.2002; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dormann D, 2000, BLOOD, V96, P2469, DOI 10.1182/blood.V96.7.2469.h8002469_2469_2478; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FLOCK JI, 1987, EMBO J, V6, P2351, DOI 10.1002/j.1460-2075.1987.tb02511.x; Fournier B, 2000, J BACTERIOL, V182, P3955, DOI 10.1128/JB.182.14.3955-3964.2000; Fujigaki Y, 1998, J PATHOL, V184, P436; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gillaspy A.F., 2006, GRAM POSITIVE PATHOG, P381; GOTZ F, 1987, FEMS MICROBIOL LETT, V40, P285, DOI 10.1016/0378-1097(87)90391-0; GOTZ F, 1983, MOL GEN GENET, V189, P340, DOI 10.1007/BF00337828; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; Hartleib J, 2000, BLOOD, V96, P2149; Heilmann C, 2002, J INFECT DIS, V186, P32, DOI 10.1086/341081; Heilmann C, 1996, INFECT IMMUN, V64, P277, DOI 10.1128/IAI.64.1.277-282.1996; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; HERRMANN M, 1993, J INFECT DIS, V167, P312, DOI 10.1093/infdis/167.2.312; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; HORSBURGH SM, 2002, THESIS U SHEFFIELD S; Hussain M, 1997, INFECT IMMUN, V65, P519, DOI 10.1128/IAI.65.2.519-524.1997; Jefferson KK, 2004, J BACTERIOL, V186, P2449, DOI 10.1128/JB.186.8.2449-2456.2004; JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x; KEHREL B, 1991, BIOCHEM BIOPH RES CO, V179, P985, DOI 10.1016/0006-291X(91)91915-Y; Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x; Komatsuzawa H, 2000, J ANTIMICROB CHEMOTH, V45, P421, DOI 10.1093/jac/45.4.421; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lahav J, 2002, BLOOD, V100, P2472, DOI 10.1182/blood-2001-12-0339; Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554; Lim Y, 2004, J BACTERIOL, V186, P722, DOI 10.1128/JB.186.3.722-729.2004; LOFDAHL S, 1983, P NATL ACAD SCI-BIOL, V80, P697, DOI 10.1073/pnas.80.3.697; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; MACK D, 1992, INFECT IMMUN, V60, P2048, DOI 10.1128/IAI.60.5.2048-2057.1992; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; Niemann S, 2004, CIRCULATION, V110, P193, DOI 10.1161/01.CIR.0000134486.93030.E7; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; PATTI JM, 1992, J BIOL CHEM, V267, P4766; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pratten J, 2001, MICROBES INFECT, V3, P633, DOI 10.1016/S1286-4579(01)01418-6; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046; Sambrook J., 2002, MOL CLONING LAB MANU; Savolainen K, 2001, INFECT IMMUN, V69, P3013, DOI 10.1128/IAI.69.5.3013-3020.2001; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Tung HS, 2000, BIOCHEM J, V345, P611, DOI 10.1042/0264-6021:3450611; UHLEN M, 1984, J BIOL CHEM, V259, P1695; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; WIELAND KP, 1995, GENE, V158, P91, DOI 10.1016/0378-1119(95)00137-U; Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002; Wu SW, 1999, MICROB DRUG RESIST, V5, P9, DOI 10.1089/mdr.1999.5.9; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004; Ziebuhr W, 2001, Contrib Microbiol, V8, P102	68	92	97	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7567	10.1371/journal.pone.0007567	http://dx.doi.org/10.1371/journal.pone.0007567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851500	gold, Green Submitted, Green Published			2022-12-25	WOS:000271022300009
J	Ballesteros, S; Vergu, E; Cazelles, B				Ballesteros, Sebastien; Vergu, Elisabeta; Cazelles, Bernard			Influenza A Gradual and Epochal Evolution: Insights from Simple Models	PLOS ONE			English	Article							CRITICAL COMMUNITY SIZE; POSITIVE SELECTION; DYNAMICS; H3N2; PERSISTENCE; MEASLES; HEMAGGLUTININ; TRANSMISSION; REINFECTION; SEASONALITY	The recurrence of influenza A epidemics has originally been explained by a "continuous antigenic drift" scenario. Recently, it has been shown that if genetic drift is gradual, the evolution of influenza A main antigen, the haemagglutinin, is punctuated. As a consequence, it has been suggested that influenza A dynamics at the population level should be approximated by a serial SIR model. Here, simple models are used to test whether a serial SIR model requires gradual antigenic drift within groups of strains with the same antigenic properties (antigenic clusters). We compare the effect of status based and history based frameworks and the influence of reduced susceptibility and infectivity assumptions on the transient dynamics of antigenic clusters. Our results reveal that the replacement of a resident antigenic cluster by a mutant cluster, as observed in data, is reproduced only by the status based model integrating the reduced infectivity assumption. This combination of assumptions is useful to overcome the otherwise extremely high model dimensionality of models incorporating many strains, but relies on a biological hypothesis not obviously satisfied. Our findings finally suggest the dynamical importance of gradual antigenic drift even in the presence of punctuated immune escape. A more regular renewal of susceptible pool than the one implemented in a serial SIR model should be part of a minimal theory for influenza at the population level.			Ballesteros, S (corresponding author), Ecole Normale Super, CNRS, UPMC ENS AgroParisTech, Unit Ecoevolutionary Math,UMR 7625, Paris, France.	sebastien.ballesteros@biologie.ens.fr	Cazelles, Bernard/B-1572-2013	Cazelles, Bernard/0000-0002-7972-361X				Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Andreasen V, 1997, J MATH BIOL, V35, P825, DOI 10.1007/s002850050079; Andreasen V, 2006, THEOR POPUL BIOL, V70, P164, DOI 10.1016/j.tpb.2006.04.004; BARTLETT MS, 1960, J R STAT SOC SER A-G, V123, P37, DOI 10.2307/2343186; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; BARTLETT MS, 1964, ROY STAT SOC C-APP, V13, P2; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cobey S, 2008, TRENDS ECOL EVOL, V23, P572, DOI 10.1016/j.tree.2008.06.008; COG JR, 2008, VACCINE S3, V26, pC15; Conlan AJK, 2007, P ROY SOC B-BIOL SCI, V274, P1133, DOI 10.1098/rspb.2006.0030; Dawes JHP, 2002, J MATH BIOL, V45, P471, DOI 10.1007/s00285-002-0163-9; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; DIECKMANN U, 2002, PURSUIT VIRULENCE MA; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Du X, 2008, GENOME RES, V18, P178, DOI 10.1101/gr.6969007; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Finkenstadt BF, 2005, STAT MED, V24, P3447, DOI 10.1002/sim.2196; FRANCIS T, 1953, ANN INTERN MED, V39, P203, DOI 10.7326/0003-4819-39-2-203; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Frank S. A., 2002, IMMUNOLOGY EVOLUTION, P33; Galassi M., 2003, GNU SCI LIB REFERENC; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Girvan M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031915; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Gokaydin D, 2007, J R SOC INTERFACE, V4, P137, DOI 10.1098/rsif.2006.0159; Gomes MGM, 2005, J THEOR BIOL, V236, P111, DOI 10.1016/j.jtbi.2005.03.001; Gomes MGM, 2004, J THEOR BIOL, V228, P539, DOI 10.1016/j.jtbi.2004.02.015; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; JANEWAY C, 1999, CURRENT BIOL; Kamo M, 2002, PHYSICA D, V165, P228, DOI 10.1016/S0167-2789(02)00389-5; Keeling M, 2000, P ROY SOC B-BIOL SCI, V267, P385, DOI 10.1098/rspb.2000.1013; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; Keeling MJ, 2002, P ROY SOC B-BIOL SCI, V269, P335, DOI 10.1098/rspb.2001.1898; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kryazhimskiy S, 2007, PLOS COMPUT BIOL, V3, P1513, DOI 10.1371/journal.pcbi.0030159; Lavenu A, 2004, VIRUS RES, V103, P101, DOI 10.1016/j.virusres.2004.02.021; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; MINAYEV P, 2009, J R SOC INTERFACE; Minayev P, 2009, J R SOC INTERFACE, V6, P509, DOI 10.1098/rsif.2008.0333; Nasell I, 2005, THEOR POPUL BIOL, V67, P203, DOI 10.1016/j.tpb.2005.01.002; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Olinky R, 2008, J MATH BIOL, V56, P827, DOI 10.1007/s00285-007-0140-4; PEASE CM, 1987, THEOR POPUL BIOL, V31, P422, DOI 10.1016/0040-5809(87)90014-1; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Recker M, 2007, P NATL ACAD SCI USA, V104, P7711, DOI 10.1073/pnas.0702154104; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Suzuki Y, 2008, GENE, V427, P111, DOI 10.1016/j.gene.2008.09.012; Tria F, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/07/P07008; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, 2003, 211 WHO; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34	65	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7426	10.1371/journal.pone.0007426	http://dx.doi.org/10.1371/journal.pone.0007426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841740	Green Published, gold, Green Submitted			2022-12-25	WOS:000271012900009
J	Kashav, T; Nitharwal, R; Abdulrehman, SA; Gabdoulkhakov, A; Saenger, W; Dhar, SK; Gourinath, S				Kashav, Tara; Nitharwal, Ramgopal; Abdulrehman, S. Arif; Gabdoulkhakov, Azat; Saenger, Wolfram; Dhar, Suman Kumar; Gourinath, Samudrala			Three-Dimensional Structure of N-Terminal Domain of DnaB Helicase and Helicase-Primase Interactions in Helicobacter pylori	PLOS ONE			English	Article							ESCHERICHIA-COLI DNAB; SINGLE-STRANDED-DNA; FUNCTIONAL-CHARACTERIZATION; REPLICATIVE HELICASE; MAXIMUM-LIKELIHOOD; DIFFRACTION DATA; PROTEIN; MECHANISM; BINDING; SEQUENCE	Replication initiation is a crucial step in genome duplication and homohexameric DnaB helicase plays a central role in the replication initiation process by unwinding the duplex DNA and interacting with several other proteins during the process of replication. N-terminal domain of DnaB is critical for helicase activity and for DnaG primase interactions. We present here the crystal structure of the N-terminal domain (NTD) of H. pylori DnaB (HpDnaB) helicase at 2.2 angstrom resolution and compare the structural differences among helicases and correlate with the functional differences. The structural details of NTD suggest that the linker region between NTD and C-terminal helicase domain plays a vital role in accurate assembly of NTD dimers. The sequence analysis of the linker regions from several helicases reveals that they should form four helix bundles. We also report the characterization of H. pylori DnaG primase and study the helicase-primase interactions, where HpDnaG primase stimulates DNA unwinding activity of HpDnaB suggesting presence of helicase-primase cohort at the replication fork. The protein-protein interaction study of C-terminal domain of primase and different deletion constructs of helicase suggests that linker is essential for proper conformation of NTD to interact strongly with HpDnaG. The surface charge distribution on the primase binding surface of NTDs of various helicases suggests that DnaB-DnaG interaction and stability of the complex is most probably charge dependent. Structure of the linker and helicase-primase interactions indicate that HpDnaB differs greatly from E. coli DnaB despite both belong to gram negative bacteria.			Kashav, T (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	sgourinath@mail.jnu.ac.in	Gabdulkhakov, Azat/H-4343-2013	Gabdulkhakov, Azat/0000-0003-1016-5936				Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507; Barcena M, 1998, J MOL BIOL, V283, P809, DOI 10.1006/jmbi.1998.2128; Bird LE, 2000, BIOCHEMISTRY-US, V39, P171, DOI 10.1021/bi9918801; Biswas EE, 1999, BIOCHEMISTRY-US, V38, P10919, DOI 10.1021/bi990048t; BISWAS SB, 1994, BIOCHEMISTRY-US, V33, P11307, DOI 10.1021/bi00203a028; Biswas T, 2008, FEBS J, V275, P3064, DOI 10.1111/j.1742-4658.2008.06460.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; DeLano WL, 2002, PYMOL USERS MANUAL; Donate LE, 2000, J MOL BIOL, V303, P383, DOI 10.1006/jmbi.2000.4132; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREY J, 1984, J MOL BIOL, V179, P171, DOI 10.1016/0022-2836(84)90464-9; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; LANKA E, 1983, NUCLEIC ACIDS RES, V11, P987, DOI 10.1093/nar/11.4.987; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; Manna AC, 1996, CELL, V87, P881, DOI 10.1016/S0092-8674(00)81995-9; Mitkova AV, 2003, J BIOL CHEM, V278, P52253, DOI 10.1074/jbc.M308956200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nitharwal RG, 2007, NUCLEIC ACIDS RES, V35, P2861, DOI 10.1093/nar/gkm167; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Romano M, 2006, NAT CLIN PRACT GASTR, V3, P622, DOI 10.1038/ncpgasthep0634; Scherzinger E, 1997, J BIOL CHEM, V272, P30228, DOI 10.1074/jbc.272.48.30228; Sharma A, 2009, FEBS J, V276, P519, DOI 10.1111/j.1742-4658.2008.06799.x; Soni RK, 2005, BIOCHEM J, V389, P541, DOI 10.1042/BJ20050062; Soni RK, 2003, NUCLEIC ACIDS RES, V31, P6828, DOI 10.1093/nar/gkg895; Su XC, 2006, FEBS J, V273, P4997, DOI 10.1111/j.1742-4658.2006.05495.x; Thirlway J, 2004, NUCLEIC ACIDS RES, V32, P2977, DOI 10.1093/nar/gkh628; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P921, DOI 10.1073/pnas.72.3.921	39	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7515	10.1371/journal.pone.0007515	http://dx.doi.org/10.1371/journal.pone.0007515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841750	Green Published, Green Submitted, gold			2022-12-25	WOS:000271012900013
J	Shen, T; Kuang, YH; Ashby, CR; Lei, Y; Chen, A; Zhou, Y; Chen, X; Tiwari, AK; Hopper-Borge, E; Ouyang, JY; Chen, ZS				Shen, Tong; Kuang, Ye-Hong; Ashby, Charles R., Jr.; Lei, Yu; Chen, Angel; Zhou, Ying; Chen, Xiang; Tiwari, Amit K.; Hopper-Borge, Elizabeth; Ouyang, Jiangyong; Chen, Zhe-Sheng			Imatinib and Nilotinib Reverse Multidrug Resistance in Cancer Cells by Inhibiting the Efflux Activity of the MRP7 (ABCC10)	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; SUBFAMILY-B MEMBER-1; DRUG-RESISTANCE; PROTEIN-7 ABCC10; KINASE INHIBITOR; BINDING; TRANSPORTERS; MUTATIONS; DOCETAXEL; LINES	Background: One of the major mechanisms that could produce resistance to antineoplastic drugs in cancer cells is the ATP binding cassette (ABC) transporters. The ABC transporters can significantly decrease the intracellular concentration of antineoplastic drugs by increasing their efflux, thereby lowering the cytotoxic activity of antineoplastic drugs. One of these transporters, the multiple resistant protein 7 (MRP7, ABCC10), has recently been shown to produce resistance to antineoplastic drugs by increasing the efflux of paclitaxel. In this study, we examined the effects of BCR-Abl tyrosine kinase inhibitors imatinib, nilotinib and dasatinib on the activity and expression of MRP7 in HEK293 cells transfected with MRP7, designated HEK-MRP7-2. Methodology and/or Principal Findings: We report for the first time that imatinib and nilotinib reversed MRP7-mediated multidrug resistance. Our MTT assay results indicated that MRP7 expression in HEK-MRP7-2 cells was not significantly altered by incubation with 5 mu M of imatinib or nilotinib for up to 72 hours. In addition, imatinib and nilotinib (1-5 mu M) produced a significant concentration-dependent reversal of MRP7-mediated multidrug resistance by enhancing the sensitivity of HEK-MRP7-2 cells to paclitaxel and vincristine. Imatinib and nilotinib, at 5 mu M, significantly increased the accumulation of [(3)H]-paclitaxel in HEK-MRP7-2 cells. The incubation of the HEK-MRP7-2 cells with imatinib or nilotinib (5 mu M) also significantly inhibited the efflux of paclitaxel. Conclusions: Imatinib and nilotinib reverse MRP7-mediated paclitaxel resistance, most likely due to their inhibition of the efflux of paclitaxel via MRP7. These findings suggest that imatinib or nilotinib, in combination with other antineoplastic drugs, may be useful in the treatment of certain resistant cancers.			Shen, T (corresponding author), St Johns Univ, Coll Pharm & Allied Hlth Profess, Dept Pharmaceut Sci, Queens, NY USA.	Chenz@stjohns.edu	Shen, Tong/C-8853-2012; Tiwari, Amit/A-3667-2012	Tiwari, Amit/0000-0002-7427-7155; Tiwari, Amit/0000-0002-0275-0724; Chen, Zhe-Sheng/0000-0002-8289-097X				AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; Bradbury PA, 2004, ANTI-CANCER DRUG, V15, P421, DOI 10.1097/01.cad.0000127665.74096.93; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Couture L, 2006, PHARMACOL REV, V58, P244, DOI 10.1124/pr.58.2.7; Dai CL, 2008, CANCER RES, V68, P7905, DOI 10.1158/0008-5472.CAN-08-0499; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Gora-Tybor J, 2008, CURR MED CHEM, V15, P3036, DOI 10.2174/092986708786848578; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hiwase DK, 2008, CLIN CANCER RES, V14, P3881, DOI 10.1158/1078-0432.CCR-07-5095; Hopper-Borge E, 2004, CANCER RES, V64, P4927, DOI 10.1158/0008-5472.CAN-03-3111; Hopper-Borge E, 2009, CANCER RES, V69, P178, DOI 10.1158/0008-5472.CAN-08-1420; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jordanides NE, 2006, BLOOD, V108, P1370, DOI 10.1182/blood-2006-02-003145; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Naramoto H, 2007, INT J ONCOL, V30, P393; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Sumizawa T, 1997, MOL PHARMACOL, V51, P399; TANAKA C, CLIN PHARM IN PRESS; Tiwari AK, 2009, BIOCHEM PHARMACOL, V78, P153, DOI 10.1016/j.bcp.2009.04.002; Wu Chung-Pu, 2008, Curr Mol Pharmacol, V1, P93; Zhou Y, 2009, BIOCHEM PHARMACOL, V77, P993, DOI 10.1016/j.bcp.2008.12.005	26	60	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7520	10.1371/journal.pone.0007520	http://dx.doi.org/10.1371/journal.pone.0007520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841739	Green Published, Green Submitted, gold			2022-12-25	WOS:000271012900015
J	Takeda, Y; Mishima, Y; Fujiwara, T; Sakamoto, H; Inoue, K				Takeda, Yasuaki; Mishima, Yuichiro; Fujiwara, Toshinobu; Sakamoto, Hiroshi; Inoue, Kunio			DAZL Relieves miRNA-Mediated Repression of Germline mRNAs by Controlling Poly(A) Tail Length in Zebrafish	PLOS ONE			English	Article							BINDING PROTEINS; IN-VIVO; TRANSLATION; CELLS; MICRORNAS; COMPONENT; XENOPUS; PLASM; GENE; DIFFERENTIATION	Background: During zebrafish embryogenesis, microRNA (miRNA) miR-430 contributes to restrict Nanos1 and TDRD7 to primordial germ cells (PGCs) by inducing mRNA deadenylation, mRNA degradation, and translational repression of nanos1 and tdrd7 mRNAs in somatic cells. The nanos1 and tdrd7 3'UTRs include cis-acting elements that allow activity in PGCs even in the presence of miRNA-mediated repression. Methodology/Principal Findings: Using a GFP reporter mRNA that was fused with tdrd7 3'UTR, we show that a germline-specific RNA-binding protein DAZ-like (DAZL) can relieve the miR-430-mediated repression of tdrd7 mRNA by inducing poly(A) tail elongation (polyadenylation) in zebrafish. We also show that DAZL enhances protein synthesis via the 3'UTR of dazl mRNA, another germline mRNA targeted by miR-430. Conclusions/Significance: Our present study indicated that DAZL acts as an "anti-miRNA factor'' during vertebrate germ cell development. Our data also suggested that miRNA-mediated regulation can be modulated on specific target mRNAs through the poly(A) tail control.			Takeda, Y (corresponding author), Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan.	kunio@kobe-u.ac.jp	Mishima, Yuichiro/I-3881-2019	Mishima, Yuichiro/0000-0002-1075-9454				Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fox M, 2005, GENOMICS, V85, P92, DOI 10.1016/j.ygeno.2004.10.003; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hashimoto Y, 2004, DEV BIOL, V268, P152, DOI 10.1016/j.ydbio.2003.12.013; Houston DW, 2000, DEVELOPMENT, V127, P447; INOUE K, 1989, GENE DEV, V3, P1472, DOI 10.1101/gad.3.9.1472; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Knaut H, 2002, CURR BIOL, V12, P454, DOI 10.1016/S0960-9822(02)00723-6; Koprunner M, 2001, GENE DEV, V15, P2877; Maegawa S, 2002, GENES CELLS, V7, P971, DOI 10.1046/j.1365-2443.2002.00576.x; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Reynolds N, 2005, HUM MOL GENET, V14, P3899, DOI 10.1093/hmg/ddi414; Reynolds N, 2007, RNA, V13, P974, DOI 10.1261/rna.465507; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Vasudevan S, 2006, GENE DEV, V20, P138, DOI 10.1101/gad.1398906; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Zeng M, 2008, BMB REP, V41, P300, DOI 10.5483/BMBRep.2008.41.4.300	31	68	72	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7513	10.1371/journal.pone.0007513	http://dx.doi.org/10.1371/journal.pone.0007513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838299	Green Published, Green Submitted, gold			2022-12-25	WOS:000270880900014
J	Li, YP; Reznichenko, M; Tribe, RM; Hess, PE; Taggart, M; Kim, H; DeGnore, JP; Gangopadhyay, S; Morgan, KG				Li, Yunping; Reznichenko, Maya; Tribe, Rachel M.; Hess, Philip E.; Taggart, Michael; Kim, HakRim; DeGnore, Jon P.; Gangopadhyay, Samudra; Morgan, Kathleen G.			Stretch Activates Human Myometrium via ERK, Caldesmon and Focal Adhesion Signaling	PLOS ONE			English	Article							SMOOTH-MUSCLE; CELL-MIGRATION; RAT MYOMETRIUM; ALPHA-ACTININ; PHOSPHORYLATION; PROTEIN; KINASE; LABOR; CONTRACTILITY; EXPRESSION	An incomplete understanding of the molecular mechanisms responsible for myometrial activation from the quiescent pregnant state to the active contractile state during labor has hindered the development of effective therapies for preterm labor. Myometrial stretch has been implicated clinically in the initiation of labor and the etiology of preterm labor, but the molecular mechanisms involved in the human have not been determined. We investigated the mechanisms by which gestation-dependent stretch contributes to myometrial activation, by using human uterine samples from gynecologic hysterectomies and Cesarean sections. Here we demonstrate that the Ca requirement for activation of the contractile filaments in human myometrium increases with caldesmon protein content during gestation and that an increase in caldesmon phosphorylation can reverse this inhibitory effect during labor. By using phosphotyrosine screening and mass spectrometry of stretched human myometrial samples, we identify 3 stretch-activated focal adhesion proteins, FAK, p130Cas, and alpha actinin. FAK-Y397, which signals integrin engagement, is constitutively phosphorylated in term human myometrium whereas FAK-Y925, which signals downstream ERK activation, is phosphorylated during stretch. We have recently identified smooth muscle Archvillin (SmAV) as an ERK regulator. A newly produced SmAV-specific antibody demonstrates gestation-specific increases in SmAV protein levels and stretch-specific increases in SmAV association with focal adhesion proteins. Thus, whereas increases in caldesmon levels suppress human myometrium contractility during pregnancy, stretch-dependent focal adhesion signaling, facilitated by the ERK activator SmAV, can contribute to myometrial activation. These results suggest that focal adhesion proteins may present new targets for drug discovery programs aimed at regulation of uterine contractility.			Li, YP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA.	yli1@bidmc.harvard.edu	Taggart, Michael/A-1288-2012; Hess, Philip/A-8577-2013	Hess, Philip/0000-0002-1206-0102; Tribe, Rachel/0000-0003-3675-9978; Taggart, Michael/0000-0002-9981-2783; Morgan, Kathleen/0000-0003-3300-3630	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043054] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL086655, R01HL080003] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL086655, HL86655, R01 HL080003, HL80003] Funding Source: Medline; NICHD NIH HHS [R01 HD043054, HD043054] Funding Source: Medline; Wellcome Trust Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		AFTING EG, 1979, BIOCHEM J, V177, P99, DOI 10.1042/bj1770099; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Craig DH, 2007, AM J PHYSIOL-CELL PH, V293, pC1862, DOI 10.1152/ajpcell.00118.2007; Cunningham FG, 2005, WILLIAMS OBSTET; D'Angelo G, 1999, J BIOL CHEM, V274, P30115, DOI 10.1074/jbc.274.42.30115; Gangopadhyay SS, 2009, J BIOL CHEM, V284, P17607, DOI 10.1074/jbc.M109.002386; Gangopadhyay SS, 2004, J CELL SCI, V117, P5043, DOI 10.1242/jcs.01378; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Goel HL, 2002, CELL BIOL INT, V26, P557, DOI 10.1006/cbir.2002.0878; Huang RJ, 2003, BIOCHEMISTRY-US, V42, P2513, DOI 10.1021/bi0268605; HURD WW, 2008, AM J OBSTET GYNECOL, V198; Kwong L, 2003, MOL CELL BIOL, V23, P933, DOI 10.1128/MCB.23.3.933-949.2003; LAPORTE R, 1998, AM J OBSTET GYNECOL, V180, pS133; Li YP, 2004, AM J PHYSIOL-REG I, V287, pR328, DOI 10.1152/ajpregu.00042.2004; Li YP, 2003, AM J PHYSIOL-REG I, V284, pR192, DOI 10.1152/ajpregu.00290.2002; Li YP, 2007, J CELL BIOCHEM, V100, P129, DOI 10.1002/jcb.21033; Longhurst CM, 1998, CELL MOL LIFE SCI, V54, P514, DOI 10.1007/s000180050180; Macphee DJ, 2000, ENDOCRINOLOGY, V141, P274, DOI 10.1210/en.141.1.274; Morgan KG, 2001, J APPL PHYSIOL, V91, P953, DOI 10.1152/jappl.2001.91.2.953; Oldenhof AD, 2002, AM J PHYSIOL-CELL PH, V283, pC1530, DOI 10.1152/ajpcell.00607.2001; Riley M, 2005, J CELL MOL MED, V9, P122, DOI 10.1111/j.1582-4934.2005.tb00342.x; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Sharma CP, 2004, CELL BIOL INT, V28, P935, DOI 10.1016/j.cellbi.2004.09.006; Shynlova O, 2007, REPRODUCTION, V134, P503, DOI 10.1530/REP-07-0004; Sooranna SR, 2005, J CLIN ENDOCR METAB, V90, P3517, DOI 10.1210/jc.2004-1390; Taggart MJ, 2007, SEMIN CELL DEV BIOL, V18, P296, DOI 10.1016/j.semcdb.2007.05.006; Takizawa N, 2006, J CELL BIOL, V174, P447, DOI 10.1083/jcb.200512051; Triplett JW, 2006, AM J PHYSIOL-CELL PH, V291, pC909, DOI 10.1152/ajpcell.00113.2006; WORD RA, 1993, J CLIN INVEST, V92, P29, DOI 10.1172/JCI116564; Wu X, 2008, J CELL MOL MED, V12, P1360, DOI 10.1111/j.1582-4934.2008.00306.x; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhang ZY, 2006, J BIOL CHEM, V281, P1746, DOI 10.1074/jbc.M509590200	34	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7489	10.1371/journal.pone.0007489	http://dx.doi.org/10.1371/journal.pone.0007489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834610	Green Published, Green Submitted, gold			2022-12-25	WOS:000270880700013
J	Williams, DJ; Puhl, HL; Ikeda, SR				Williams, Damian J.; Puhl, Henry L., III; Ikeda, Stephen R.			Rapid Modification of Proteins Using a Rapamycin-Inducible Tobacco Etch Virus Protease System	PLOS ONE			English	Article							TEV PROTEASE; SUBSTRATE-SPECIFICITY; FLUORESCENT PROTEIN; FRET EFFICIENCY; COMPLEMENTATION; SOLUBILITY; VARIANT; FAMILY; GENE; SITE	Background: The ability to disrupt the function of a specific protein on a rapid time scale provides a powerful tool for biomedical research. Specific proteases provide a potential method to selectively cleave a chosen protein, but rapid control of protease activity is difficult. Methodology/Principal Findings: A heterologous expression system for rapid target-directed proteolysis in mammalian cells was developed. The system consists of an inducible NIa protease from the tobacco etch virus (TEVp) and a chosen protein into which a TEVp substrate recognition sequence (TRS) has been inserted. Inducible activity was conferred to the TEVp using rapamycin-controlled TEVp fragment complementation. TEVp activity was assayed using a FRET-based reporter construct. TEVp expression was well tolerated by mammalian cells and complete cleavage of the substrate was possible. Cleavage at 37 degrees C proceeded exponentially with a time constant of approximately 150 minutes. Attempts to improve cleavage efficiency were hampered by substantial background activity, which was attributed to inherent affinity between the TEVp fragments. A second TEVp assay, based on changes in inactivation of a modified K(V)3.4 channel, showed that functional properties of a channel can be using altered using an inducible TEVp system. Similar levels of background activity and variability were observed in both electrophysiological and FRET assays. Conclusions/Significance: The results suggested that an optimum level of TEVp expression leading to sufficient inducible activity (with minimal background activity) exists but the variability in expression levels between cells makes the present system rather impractical for single cell experiments. The system is likely to be more suitable for experiments in which the cell-to-cell variability is less of an issue; for example, in experiments involving large populations of cells.			Williams, DJ (corresponding author), NIAAA, Lab Mol Physiol, NIH, Bethesda, MD USA.	sikeda@mail.nih.gov		Williams, Damian/0000-0001-5891-6300; Ikeda, Stephen/0000-0002-4088-9508; Puhl, Henry/0000-0003-3095-7201	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000430] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Cabrita LD, 2007, PROTEIN SCI, V16, P2360, DOI 10.1110/ps.072822507; CARRINGTON JC, 1987, J VIROL, V61, P2540, DOI 10.1128/JVI.61.8.2540-2548.1987; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Chen HM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2799171; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; DOUGHERTY WG, 1989, VIROLOGY, V171, P356, DOI 10.1016/0042-6822(89)90603-X; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Fivaz M, 2003, NEURON, V40, P319, DOI 10.1016/S0896-6273(03)00634-2; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Lucast LJ, 2001, BIOTECHNIQUES, V30, P544, DOI 10.2144/01303st06; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Michnick SW, 2000, METHOD ENZYMOL, V328, P208, DOI 10.1016/S0076-6879(00)28399-7; Mondigler M, 1996, J BACTERIOL, V178, P2986, DOI 10.1128/jb.178.10.2986-2988.1996; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nunn CM, 2005, J MOL BIOL, V350, P145, DOI 10.1016/j.jmb.2005.04.013; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Paschon DE, 2005, J MOL BIOL, V353, P26, DOI 10.1016/j.jmb.2005.08.026; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Paulmurugan R, 2005, CANCER RES, V65, P7413, DOI 10.1158/0008-5472.CAN-05-0588; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; RICHARDS FM, 1958, P NATL ACAD SCI USA, V44, P162, DOI 10.1073/pnas.44.2.162; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rollins CT, 2000, P NATL ACAD SCI USA, V97, P7096, DOI 10.1073/pnas.100101997; ROUTTENBERG A, 1995, NATURE, V374, P314, DOI 10.1038/374314b0; Segel I.H., 1976, BIOCH CALCULATIONS S; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; Tozser J, 2005, FEBS J, V272, P514, DOI 10.1111/j.1742-4658.2004.04493.x; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Yang XW, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-13; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhu GY, 1998, J NEUROSCI METH, V81, P73, DOI 10.1016/S0165-0270(98)00019-3	45	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7474	10.1371/journal.pone.0007474	http://dx.doi.org/10.1371/journal.pone.0007474			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19830250	Green Published, gold, Green Submitted			2022-12-25	WOS:000270847800012
J	Schouest, KR; Kurasawa, Y; Furuta, T; Hisamoto, N; Matsumoto, K; Schumacher, JM				Schouest, Katherine R.; Kurasawa, Yasuhiro; Furuta, Tokiko; Hisamoto, Naoki; Matsumoto, Kunihiro; Schumacher, Jill M.			The Germinal Center Kinase GCK-1 Is a Negative Regulator of MAP Kinase Activation and Apoptosis in the C-elegans Germline	PLOS ONE			English	Article							OOCYTE MEIOTIC MATURATION; STE20 GROUP KINASES; CAENORHABDITIS-ELEGANS; PROTEIN-KINASE; HERMAPHRODITE GERMLINE; STE20-RELATED KINASE; SEX DETERMINATION; CELL-GROWTH; LET-60 RAS; PATHWAY	The germinal center kinases (GCK) constitute a large, highly conserved family of proteins that has been implicated in a wide variety of cellular processes including cell growth and proliferation, polarity, migration, and stress responses. Although diverse, these functions have been attributed to an evolutionarily conserved role for GCKs in the activation of ERK, JNK, and p38 MAP kinase pathways. In addition, multiple GCKs from different species promote apoptotic cell death. In contrast to these paradigms, we found that a C. elegans GCK, GCK-1, functions to inhibit MAP kinase activation and apoptosis in the C. elegans germline. In the absence of GCK-1, a specific MAP kinase isoform is ectopically activated and oocytes undergo abnormal development. Moreover, GCK-1-deficient animals display a significant increase in germ cell death. Our results suggest that individual germinal center kinases act in mechanistically distinct ways and that these functions are likely to depend on organ- and developmental-specific contexts.			Schouest, KR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	jschumac@mdanderson.org	Schumacher, Jill/B-2932-2012					Bishop JD, 2005, MOL BIOL CELL, V16, P742, DOI 10.1091/mbc.E04-08-0682; Bradham C, 2006, CELL CYCLE, V5, P824, DOI 10.4161/cc.5.8.2685; BRENNER S, 1974, GENETICS, V77, P71; Burrows AE, 2006, DEVELOPMENT, V133, P697, DOI 10.1242/dev.02241; Ceol CJ, 2006, GENETICS, V173, P709, DOI 10.1534/genetics.106.056465; Chen Z, 2001, J BIOL CHEM, V276, P16070, DOI 10.1074/jbc.M100681200; CHURCH DL, 1995, DEVELOPMENT, V121, P2525; Clifford R, 2000, DEVELOPMENT, V127, P5265; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; Corrigan C, 2005, DEVELOPMENT, V132, P5225, DOI 10.1242/dev.02083; CRITTENDEN SL, 1994, DEVELOPMENT, V120, P2901; Dan I, 2002, J BIOL CHEM, V277, P5929, DOI 10.1074/jbc.M110882200; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Eisenmann DM, 1997, GENETICS, V146, P553; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; GOLDSTEIN P, 1986, MUTAT RES, V174, P99, DOI 10.1016/0165-7992(86)90098-9; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; HACCARD O, 1995, DEV BIOL, V168, P677, DOI 10.1006/dbio.1995.1112; Hansen D, 2004, DEV BIOL, V268, P342, DOI 10.1016/j.ydbio.2003.12.023; Hao W, 2006, J BIOL CHEM, V281, P3075, DOI 10.1074/jbc.M511744200; Hay BA, 2003, DEV CELL, V5, P361, DOI 10.1016/S1534-5807(03)00270-3; Hipfner DR, 2003, PLOS BIOL, V1, P244, DOI 10.1371/journal.pbio.0000035; Hirai S, 1997, J BIOL CHEM, V272, P15167, DOI 10.1074/jbc.272.24.15167; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; Hsu J., 1996, MULTIPLE COMP THEORY; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hughes SC, 2006, J CELL BIOL, V175, P305, DOI 10.1083/jcb.200608009; Hutchison M, 1998, J BIOL CHEM, V273, P28625, DOI 10.1074/jbc.273.44.28625; Kelly WG, 2002, DEVELOPMENT, V129, P479; Kosinski M, 2005, DEVELOPMENT, V132, P3357, DOI 10.1242/dev.01916; Krens SFG, 2006, FEBS LETT, V580, P4984, DOI 10.1016/j.febslet.2006.08.025; Lackner MR, 1998, GENETICS, V150, P103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MH, 2006, EMBO J, V25, P88, DOI 10.1038/sj.emboj.7600901; Lee MH, 2007, GENETICS, V177, P2039, DOI 10.1534/genetics.107.081356; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lieb JD, 1998, CELL, V92, P265, DOI 10.1016/S0092-8674(00)80920-4; Lin JL, 2001, ONCOGENE, V20, P6559, DOI 10.1038/sj.onc.1204818; Ling P, 2008, CELL SIGNAL, V20, P1237, DOI 10.1016/j.cellsig.2007.12.019; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Maller JL, 2001, BIOL CELL, V93, P27, DOI 10.1016/S0248-4900(01)01127-3; McCarter J, 1997, DEV BIOL, V181, P121, DOI 10.1006/dbio.1996.8429; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Meinecke B, 2003, ZYGOTE, V11, P7, DOI 10.1017/S0967199403001023; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Miller MA, 2003, GENE DEV, V17, P187, DOI 10.1101/gad.1028303; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; O'Neill E, 2005, CELL CYCLE, V4, P365, DOI 10.4161/cc.4.3.1531; Ohmachi M, 2002, CURR BIOL, V12, P427, DOI 10.1016/S0960-9822(02)00690-5; Pombo CM, 2007, FRONT BIOSCI-LANDMRK, V12, P850, DOI 10.2741/2107; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; Radu M, 2009, CURR BIOL, V19, pR421, DOI 10.1016/j.cub.2009.04.022; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; SCHEDL T, 1988, GENETICS, V119, P43; Siegfried KR, 2004, GENETICS, V166, P171, DOI 10.1534/genetics.166.1.171; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Tassi E, 1999, J BIOL CHEM, V274, P33287, DOI 10.1074/jbc.274.47.33287; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; WU CL, 1995, J BIOL CHEM, V270, P15984, DOI 10.1074/jbc.270.27.15984	70	9	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7450	10.1371/journal.pone.0007450	http://dx.doi.org/10.1371/journal.pone.0007450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826475	Green Published, Green Submitted, gold			2022-12-25	WOS:000270808700011
J	Rodriguez-Ubreva, FJ; Cariaga-Martinez, AE; Cortes, MA; Romero-De Pablos, M; Ropero, S; Lopez-Ruiz, P; Colas, B				Rodriguez-Ubreva, F. J.; Cariaga-Martinez, A. E.; Cortes, M. A.; Romero-De Pablos, M.; Ropero, S.; Lopez-Ruiz, P.; Colas, B.			Knockdown of protein tyrosine phosphatase SHP-1 inhibits G1/S progression in prostate cancer cells through the regulation of components of the cell-cycle machinery	ONCOGENE			English	Article						prostate cancer; cell cycle; p27; CDK2; SHP-1	GROWTH-FACTOR; DEPENDENT PHOSPHORYLATION; TRANSCRIPTION FACTORS; ANTIGEN RECEPTOR; KINASE-ACTIVITY; CDK INHIBITORS; NUCLEAR IMPORT; ACTIVATION; P27(KIP1); DOMAIN	SHP-1, a haematopoietic cell-specific tyrosine phosphatase, is also expressed in human prostate. In this study, we report that SHP-1 depletion in PC-3 cells induced by small interfering RNAs causes G1 phase cell-cycle arrest accompanied by changes in some components of the cell-cycle machinery. SHP-1 knockdown increases p27(Kip1) (p27) protein stability, its nuclear localization and p27 gene transcription. These effects could be mediated by PI3K-AKT pathway as SHP-1 interacts with PI3K regulating its activity and p110 catalytic subunit phosphorylation. The increase in p27 protein stability could also because of reduced cyclin-dependent kinase (CDK2) activity. SHP-1 knockdown decreases the CDK6 levels, inducing retinoblastoma protein hypophosphorylation, downregulation of cyclin E and thereby a decrease in the CDK2 activity. However, the codepletion of SHP-1 and p27 does not produce re-entry into the cycle, implying that p27 is not required to maintain cell-cycle arrest induced by SHP-1 depletion. The maintenance of the PC-3 cell anti-proliferative response after p27 loss could be because of mislocalization of CDK2 induced by SHP-1 knockdown. This study shows that SHP-1 depletion promotes cell-cycle arrest by modulating the activity of cell-cycle regulators and suggests that SHP-1 may be required for the proper functioning of events governing cell-cycle progression. Oncogene (2010) 29, 345-355; doi:10.1038/onc.2009.329; published online 19 October 2009	[Colas, B.] Univ Alcala de Henares, Fac Med, Dept Bioquim & Biol Mol, E-28871 Madrid, Spain; [Romero-De Pablos, M.] Univ Alcala de Henares, Dept Fisiol, E-28871 Madrid, Spain	Universidad de Alcala; Universidad de Alcala	Colas, B (corresponding author), Univ Alcala de Henares, Fac Med, Dept Bioquim & Biol Mol, Madrid Barcelona Km 33,600, E-28871 Madrid, Spain.	begona.colas@uah.es	Cariaga-Martinez, Ariel Ernesto/M-3619-2018; de Pablos, Montserrat Romero/AAK-3167-2021; Cortés, María Alicia/ABG-3899-2020	Cariaga-Martinez, Ariel Ernesto/0000-0003-1457-995X; de Pablos, Montserrat Romero/0000-0002-2801-6376; Cortés, María Alicia/0000-0001-7765-5302; RODRIGUEZ-UBREVA, JAVIER/0000-0003-4707-4536	Consejeria de Sanidad de Castilla-La Mancha [04077-00]; Fundacion de Investigacion Mutua Madrilena grant; Instituto de Salud Carlos III grant [PI060109]; FPI fellowship, Comunidad de Madrid; Fundacion Carolina; FPI fellowship Consejeria de Educacion de Castilla-La Mancha	Consejeria de Sanidad de Castilla-La Mancha; Fundacion de Investigacion Mutua Madrilena grant; Instituto de Salud Carlos III grant(Instituto de Salud Carlos III); FPI fellowship, Comunidad de Madrid(Comunidad de MadridSpanish Government); Fundacion Carolina; FPI fellowship Consejeria de Educacion de Castilla-La Mancha	We are very grateful to Dr T Sakai (Department of Molecular-Targeting Cancer Prevention, Kyoto Prefectural University of Medicine, Kyoto, Japan) for providing human p27 promoter containing luciferase reporter construct (p27PF) and control empty vector and also to Dr FD Bohmer (Institute of Molecular Cell Biology, Medical Faculty, Friedrich Schiller University, Jena, Germany) for providing GST-SHP-1 wild type. This work was supported by Consejeria de Sanidad de Castilla-La Mancha grant (04077-00); Fundacion de Investigacion Mutua Madrilena grant; Instituto de Salud Carlos III grant (PI060109); FPI fellowship, Comunidad de Madrid (FJ Rodriguez-Ubreva); Fundacion Carolina and FPI fellowship Consejeria de Educacion de Castilla-La Mancha (AE Cariaga-Martinez).	Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Besson A, 2004, NAT REV CANCER, V4, P948, DOI 10.1038/nrc1501; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Caron D, 2008, CANCER LETT, V262, P265, DOI 10.1016/j.canlet.2007.12.012; Chen HE, 1996, MOL CELL BIOL, V16, P3685, DOI 10.1128/mcb.16.7.3685; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Craggs G, 2001, J BIOL CHEM, V276, P23719, DOI 10.1074/jbc.M102846200; Cuevas BD, 2001, J BIOL CHEM, V276, P27455, DOI 10.1074/jbc.M100556200; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; HOFFMANN I, 1994, EMBO J, V13, P4302, DOI 10.1002/j.1460-2075.1994.tb06750.x; Inoue T, 1999, J BIOL CHEM, V274, P32309, DOI 10.1074/jbc.274.45.32309; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Martin-Orozco RM, 2007, NEOPLASIA, V9, P614, DOI 10.1593/neo.07337; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Moore JD, 1999, J CELL BIOL, V144, P213, DOI 10.1083/jcb.144.2.213; Nakagawa H, 2001, FEBS LETT, V508, P53, DOI 10.1016/S0014-5793(01)03021-6; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Pages P, 1999, J BIOL CHEM, V274, P15186, DOI 10.1074/jbc.274.21.15186; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; Pani G, 1996, J EXP MED, V184, P839, DOI 10.1084/jem.184.3.839; Ram PA, 1997, J BIOL CHEM, V272, P17694, DOI 10.1074/jbc.272.28.17694; SEBASTIAN B, 1993, P NATL ACAD SCI USA, V90, P3521, DOI 10.1073/pnas.90.8.3521; Seo DW, 2006, J BIOL CHEM, V281, P3711, DOI 10.1074/jbc.M509932200; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Simoneau M, 2008, J BIOL CHEM, V283, P25544, DOI 10.1074/jbc.M804177200; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Somani AK, 1997, J BIOL CHEM, V272, P21113, DOI 10.1074/jbc.272.34.21113; Su L, 1996, J BIOL CHEM, V271, P10385, DOI 10.1074/jbc.271.17.10385; Tenev T, 2000, EUR J CELL BIOL, V79, P261, DOI 10.1078/S0171-9335(04)70029-1; Valencia AM, 1997, FEBS LETT, V406, P42, DOI 10.1016/S0014-5793(97)00235-4; YI TL, 1993, MOL CELL BIOL, V13, P7577, DOI 10.1128/MCB.13.12.7577; YI TL, 1993, MOL CELL BIOL, V13, P3350, DOI 10.1128/MCB.13.6.3350; You M, 1997, J BIOL CHEM, V272, P23376, DOI 10.1074/jbc.272.37.23376; Yu ZB, 1998, J BIOL CHEM, V273, P3687, DOI 10.1074/jbc.273.6.3687; Zapata PD, 2002, J CLIN ENDOCR METAB, V87, P915, DOI 10.1210/jc.87.2.915; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; 2005, BMC BIOINFORMATICS, V6, P62	44	35	36	0	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2010	29	3					345	355		10.1038/onc.2009.329	http://dx.doi.org/10.1038/onc.2009.329			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	546EO	19838216				2022-12-25	WOS:000273793200004
J	Nakamura, T; Meshitsuka, S; Kitagawa, S; Abe, N; Yamada, J; Ishino, T; Nakano, H; Tsuzuki, T; Doi, T; Kobayashi, Y; Fujii, S; Sekiguchi, M; Yamagata, Y				Nakamura, Teruya; Meshitsuka, Sachiko; Kitagawa, Seiju; Abe, Nanase; Yamada, Junichi; Ishino, Tetsuya; Nakano, Hiroaki; Tsuzuki, Teruhisa; Doi, Takefumi; Kobayashi, Yuji; Fujii, Satoshi; Sekiguchi, Mutsuo; Yamagata, Yuriko			Structural and Dynamic Features of the MutT Protein in the Recognition of Nucleotides with the Mutagenic 8-Oxoguanine Base	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSE PYROPHOSPHATASE; ESCHERICHIA-COLI MUTT; X-RAY ANALYSIS; NUDIX HYDROLASE; CRYSTAL-STRUCTURES; HUMAN MTH1; NUCLEOSIDE TRIPHOSPHATASE; DEINOCOCCUS-RADIODURANS; OXIDIZED NUCLEOTIDES; NH EXCHANGE	Escherichia coli MutT hydrolyzes 8-oxo-dGTP to 8-oxo-dGMP, an event that can prevent the misincorporation of 8-oxoguanine opposite adenine in DNA. Of the several enzymes that recognize 8-oxoguanine, MutT exhibits high substrate specificity for 8-oxoguanine nucleotides; however, the structural basis for this specificity is unknown. The crystal structures of MutT in the apo and holo forms and in the binary and ternary forms complexed with the product 8-oxo-dGMP and 8-oxo-dGMP plus Mn2+, respectively, were determined. MutT strictly recognizes the overall conformation of 8-oxo-dGMP through a number of hydrogen bonds. This recognition mode revealed that 8-oxoguanine nucleotides are discriminated from guanine nucleotides by not only the hydrogen bond between the N7-H and O delta(N119) atoms but also by the syn glycosidic conformation that 8-oxoguanine nucleotides prefer. Nevertheless, these discrimination factors cannot by themselves explain the roughly 34,000-fold difference between the affinity of MutT for 8-oxo-dGMP and dGMP. When the binary complex of MutT with 8-oxo-dGMP is compared with the ligand-free form, ordering and considerable movement of the flexible loops surrounding 8-oxo-dGMP in the binary complex are observed. These results indicate that MutT specifically recognizes 8-oxoguanine nucleotides by the ligand-induced conformational change.	[Nakamura, Teruya; Yamagata, Yuriko] Kumamoto Univ, Grad Sch Pharmaceut Sci, Kumamoto 8620973, Japan; [Meshitsuka, Sachiko; Kitagawa, Seiju; Abe, Nanase; Yamada, Junichi; Ishino, Tetsuya; Nakano, Hiroaki; Doi, Takefumi; Kobayashi, Yuji] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka 5650871, Japan; [Tsuzuki, Teruhisa] Kyushu Univ, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Fujii, Satoshi] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka 4228526, Japan; [Sekiguchi, Mutsuo] Fukuoka Dent Coll, Fukuoka 8140193, Japan	Kumamoto University; Osaka University; Kyushu University; University of Shizuoka; Fukuoka Dental College (FDC)	Yamagata, Y (corresponding author), Kumamoto Univ, Grad Sch Pharmaceut Sci, 5-1 Oe Honmachi, Kumamoto 8620973, Japan.	yamagata@gpo.kumamoto-u.ac.jp		Nakamura, Teruya/0000-0003-2013-3057	Ministry of Education, Culture, Sports, Sciences and Technology of Japan	Ministry of Education, Culture, Sports, Sciences and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research and the National Project for Protein Structural and Functional Analysis from the Ministry of Education, Culture, Sports, Sciences and Technology of Japan.	ABEYGUNAWARDANA C, 1995, BIOCHEMISTRY-US, V34, P14997, DOI 10.1021/bi00046a006; AKIYAMA M, 1989, P NATL ACAD SCI USA, V86, P3949, DOI 10.1073/pnas.86.11.3949; AU KG, 1988, P NATL ACAD SCI USA, V85, P9163, DOI 10.1073/pnas.85.23.9163; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailey S, 2002, STRUCTURE, V10, P589, DOI 10.1016/S0969-2126(02)00746-3; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; BHATNAGAR SK, 1991, J BIOL CHEM, V266, P9050; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Brunger A. T., 1992, SYSTEM XRAY CRYSTALL; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CABRERA M, 1988, J BACTERIOL, V170, P5405, DOI 10.1128/jb.170.11.5405-5407.1988; CAMBILLAU C, 1984, J MOL GRAPHICS, V2, P53, DOI 10.1016/0263-7855(84)80036-3; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; FRICK DN, 1994, J BIOL CHEM, V269, P1794; Fromme JC, 2004, NATURE, V427, P652, DOI 10.1038/nature02306; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; Fujikawa K, 2001, NUCLEIC ACIDS RES, V29, P449, DOI 10.1093/nar/29.2.449; Funahashi J, 2002, J BIOL CHEM, V277, P21792, DOI 10.1074/jbc.M110728200; Gabelli SB, 2007, STRUCTURE, V15, P1014, DOI 10.1016/j.str.2007.06.018; Gabelli SB, 2002, BIOCHEMISTRY-US, V41, P9279, DOI 10.1021/bi0259296; Gabelli SB, 2001, NAT STRUCT BIOL, V8, P467, DOI 10.1038/87647; Gabelli SB, 2004, STRUCTURE, V12, P927, DOI 10.1016/j.str.2004.03.028; Harris TK, 2000, BIOCHEMISTRY-US, V39, P1655, DOI 10.1021/bi9918745; HATAHET Z, 1994, J BIOL CHEM, V269, P18814; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ito R, 2005, BIOCHEMISTRY-US, V44, P6670, DOI 10.1021/bi047550k; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kamiya H, 2001, BIOCHEM BIOPH RES CO, V288, P499, DOI 10.1006/bbrc.2001.5781; Kang LW, 2003, STRUCTURE, V11, P1015, DOI 10.1016/S0969-2126(03)00154-0; Kang LW, 2003, J BACTERIOL, V185, P4110, DOI 10.1128/JB.185.14.4110-4118.2003; KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1403, DOI 10.1021/bi00219a034; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Massiah MA, 2003, BIOCHEMISTRY-US, V42, P10140, DOI 10.1021/bi030105p; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Messing SAJ, 2009, STRUCTURE, V17, P472, DOI 10.1016/j.str.2008.12.022; MICHAELS ML, 1992, P NATL ACAD SCI USA, V89, P7022, DOI 10.1073/pnas.89.15.7022; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Mishima M, 2004, J BIOL CHEM, V279, P33806, DOI 10.1074/jbc.M402393200; Nakamura T, 2004, ACTA CRYSTALLOGR D, V60, P1641, DOI 10.1107/S0907444904016403; Nakamura T, 2006, ACTA CRYSTALLOGR F, V62, P1283, DOI 10.1107/S1744309106049529; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Porello SL, 1998, BIOCHEMISTRY-US, V37, P14756, DOI 10.1021/bi981594+; Ranatunga W, 2004, J MOL BIOL, V339, P103, DOI 10.1016/j.jmb.2004.01.065; Rossmann MG, 1999, ACTA CRYSTALLOGR D, V55, P1631, DOI 10.1107/S0907444999008379; Saenger W., 1984, PRINCIPLES NUCL ACID; Saraswat V, 2004, BIOCHEMISTRY-US, V43, P3404, DOI 10.1021/bi030216o; Saraswat V, 2002, BIOCHEMISTRY-US, V41, P15566, DOI 10.1021/bi020552p; Scarsdale JN, 2006, STRUCTURE, V14, P331, DOI 10.1016/j.str.2005.11.010; She MP, 2006, NAT STRUCT MOL BIOL, V13, P63, DOI 10.1038/nsmb1033; Shen BW, 2003, J MOL BIOL, V332, P385, DOI 10.1016/S0022-2836(03)00954-9; Shimokawa H, 2000, NUCLEIC ACIDS RES, V28, P3240, DOI 10.1093/nar/28.17.3240; Steyert SR, 2008, J BACTERIOL, V190, P8215, DOI 10.1128/JB.01009-08; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; Takano K, 1999, BIOCHEMISTRY-US, V38, P12698, DOI 10.1021/bi9910169; TCHOU J, 1994, J BIOL CHEM, V269, P15318; TCHOU J, 1991, P NATL ACAD SCI USA, V88, P4690, DOI 10.1073/pnas.88.11.4690; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UESUGI S, 1977, J AM CHEM SOC, V99, P2313, DOI 10.1021/ja00449a049; Wakamatsu T, 2008, J BACTERIOL, V190, P1108, DOI 10.1128/JB.01522-07; Wang SS, 2002, ACTA CRYSTALLOGR D, V58, P571, DOI 10.1107/S0907444902001191; Xu WL, 2004, J BACTERIOL, V186, P8380, DOI 10.1128/JB.186.24.8380-8384.2004; Yoshiba S, 2004, J BIOL CHEM, V279, P37163, DOI 10.1074/jbc.M403817200; Zha MW, 2008, J MOL BIOL, V379, P568, DOI 10.1016/j.jmb.2008.04.006; Zha MW, 2006, J MOL BIOL, V364, P1021, DOI 10.1016/j.jmb.2006.09.078	72	38	39	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					444	452		10.1074/jbc.M109.066373	http://dx.doi.org/10.1074/jbc.M109.066373			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864691	hybrid, Green Published			2022-12-25	WOS:000273070100046
J	Kupka, M; Zhang, J; Fu, WL; Tu, JM; Bohm, S; Su, P; Chen, Y; Zhou, M; Scheer, H; Zhao, KH				Kupka, Michaela; Zhang, Juan; Fu, Wei-Lei; Tu, Jun-Ming; Boehm, Stephan; Su, Ping; Chen, Yu; Zhou, Ming; Scheer, Hugo; Zhao, Kai-Hong			Catalytic Mechanism of S-type Phycobiliprotein Lyase CHAPERONE-LIKE ACTION AND FUNCTIONAL AMINO ACID RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO ATTACHMENT; CHROMOPHORE ATTACHMENT; ALPHA-SUBUNIT; BILIN LYASE; BETA-PHYCOCYANIN; GAF DOMAIN; CPCS-I; PHYTOCHROME; CYANOBACTERIUM; PHYCOERYTHROCYANIN	The phycobilin: cysteine 84-phycobiliprotein lyase, CpcS1, catalyzes phycocyanobilin (PCB) and phycoerythrobilin (PEB) attachment at nearly all cysteine 82 binding sites (consensus numbering) of phycoerythrin, phycoerythrocyanin, phycocyanin, and allophycocyanin (Zhao, K. H., Su, P., Tu, J. M., Wang, X., Liu, H., Ploscher, M., Eichacker, L., Yang, B., Zhou, M., and Scheer, H. (2007) Proc. Natl. Acad. Sci. U.S.A. 104, 14300-14305). We now show that CpcS1 binds PCB and PEB rapidly with bi-exponential kinetics (38/119 and 12/8300 ms, respectively). Chromophore binding to the lyase is reversible and much faster than the spontaneous, but low fidelity chromophore addition to the apo-protein in the absence of the lyase. This indicates kinetic control by the enzyme, which then transfers the chromophore to the apo-protein in a slow (tens of minutes) but stereo-and regioselectively corrects the reaction. This mode of action is reminiscent of chaperones but does not require ATP. The amino acid residues Arg-18 and Arg-149 of the lyase are essential for chromophore attachment in vitro and in Escherichia coli, mutations of His-21, His-22, Trp-75, Trp140, and Arg-147 result in reduced activity (<30% of wild type in vitro). Mutants R147Q and W69M were active but had reduced capacity for PCB binding; additionally, with W69M there was loss of fidelity in chromophore attachment. Imidazole is a noncompetitive inhibitor, supporting a bilin-binding function of histidine. Evidence was obtained that CpcS1 also catalyzes exchange of C-beta 84-bound PCB in biliproteins by PEB.	[Zhang, Juan; Tu, Jun-Ming; Su, Ping; Chen, Yu; Zhou, Ming; Zhao, Kai-Hong] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Kupka, Michaela; Tu, Jun-Ming; Boehm, Stephan; Scheer, Hugo] Univ Munich, Dept Biol 1, D-80638 Munich, Germany; [Fu, Wei-Lei; Chen, Yu; Zhou, Ming] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Tu, Jun-Ming; Su, Ping] Hubei Normal Univ, Coll Life Sci, Huangshi 435002, Hubei, Peoples R China	Huazhong Agricultural University; University of Munich; Huazhong University of Science & Technology; Hubei Normal University	Zhao, KH (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	khzhao@163.com			Chinese Scholarship Council; Volkswagen Foundation [I/77900]; Deutsche Forschungsgemeinschaft [SFB 533/TPA1]; National Natural Science Foundation of China [30670489, 30870541]	Chinese Scholarship Council(China Scholarship Council); Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Supported by the Chinese Scholarship Council for a Ph. D. stipendium.; Supported by the Volkswagen Foundation for a Partnership (I/77900).; Supported by the Deutsche Forschungsgemeinschaft (Grant SFB 533/TPA1).; Supported by the National Natural Science Foundation of China (Grants 30670489 and 30870541).	ARCIERO DM, 1988, J BIOL CHEM, V263, P18343; ARCIERO DM, 1988, J BIOL CHEM, V263, P18358; ARCIERO DM, 1988, J BIOL CHEM, V263, P18350; BERKELMAN TR, 1986, ANAL BIOCHEM, V156, P194, DOI 10.1016/0003-2697(86)90173-9; BISWAS A, 2010, RECENT ADV IN PRESS; Blot N, 2009, J BIOL CHEM, V284, P9290, DOI 10.1074/jbc.M809784200; Bohm S, 2007, J BIOL CHEM, V282, P25357, DOI 10.1074/jbc.M702669200; BOGORAD L, 1975, ANNU REV PLANT PHYS, V26, P369, DOI 10.1146/annurev.pp.26.060175.002101; Borucki B, 2003, BIOCHEMISTRY-US, V42, P13684, DOI 10.1021/bi035511n; Borucki B, 2009, BIOCHEMISTRY-US, V48, P6305, DOI 10.1021/bi900436v; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cobley JG, 2002, MOL MICROBIOL, V44, P1517, DOI 10.1046/j.1365-2958.2002.02966.x; Dammeyer T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1121, DOI 10.1039/b807209b; DEFORCE L, 1993, BIOCHEMISTRY-US, V32, P14165, DOI 10.1021/bi00214a014; FAIRCHILD CD, 1994, J BIOL CHEM, V269, P8686; FAIRCHILD CD, 1992, P NATL ACAD SCI USA, V89, P7017, DOI 10.1073/pnas.89.15.7017; Falk H., 1989, CHEM LINEAR OLIGOPYR; FLOWER DR, 1995, J MOL RECOGNIT, V8, P185, DOI 10.1002/jmr.300080304; Frankenberg N, 2001, PLANT CELL, V13, P965, DOI 10.1105/tpc.13.4.965; FUGLISTALLER P, 1981, ARCH MICROBIOL, V129, P268, DOI 10.1007/BF00414696; Gantt E., 2003, LIGHT HARVESTING ANT, P307, DOI DOI 10.1007/978-94-017-2087-8_10; Glazer A. N, 1994, ADV MOL CELL BIOL, V10, P119; GLAZER AN, 1973, J BIOL CHEM, V248, P659; GOSSAUER A, 1979, CHEM BER-RECL, V112, P2243, DOI 10.1002/cber.19791120631; GROSSMAN AR, 1993, MICROBIOL REV, V57, P725, DOI 10.1128/MMBR.57.3.725-749.1993; HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8; Ikeuchi M, 2008, PHOTOCH PHOTOBIO SCI, V7, P1159, DOI 10.1039/b802660m; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamparter T, 2002, P NATL ACAD SCI USA, V99, P11628, DOI 10.1073/pnas.152263999; LING MF, 1995, ANAL BIOCHEM, V230, P167, DOI 10.1006/abio.1995.1452; Nakamura Y, 2003, DNA RES, V10, P137, DOI 10.1093/dnares/10.4.137; Narikawa R, 2008, J MOL BIOL, V380, P844, DOI 10.1016/j.jmb.2008.05.035; Rockwell NC, 2008, BIOCHEMISTRY-US, V47, P7304, DOI 10.1021/bi800088t; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Saunee NA, 2008, J BIOL CHEM, V283, P7513, DOI 10.1074/jbc.M708165200; Scheer H, 2008, MOL MICROBIOL, V68, P263, DOI 10.1111/j.1365-2958.2008.06160.x; SCHEER H, 1977, H-S Z PHYSIOL CHEM, V358, P185, DOI 10.1515/bchm2.1977.358.1.185; Scheer H, 2003, LIGHT HARVESTING ANT, P29; Scheer H., 1982, LIGHT REACTION PATH, P7; Schluchter W.M., 2002, HEME CHLOROPHYLL BIL, P311, DOI DOI 10.1385/1-59259-243-0:311; Schluchter W. M., 1999, PHOTOTROPHIC PROKARY, P83; SCHMIDT G, 1988, PHOTOSYNTHETIC LIGHT, P77; Shen G, 2008, J BIOL CHEM, V283, P7503, DOI 10.1074/jbc.M708164200; Shen G, 2006, J BIOL CHEM, V281, P17768, DOI 10.1074/jbc.M602563200; Sidler W. A., 1994, MOL BIOL CYANOBACTER, P139, DOI [10.1007/978-94-011-0227-8_7, DOI 10.1007/978-94-011-0227-8_7]; Storf M, 2001, BIOCHEMISTRY-US, V40, P12444, DOI 10.1021/bi010776s; STORF M, 2004, THESIS L MAXIMILIANS; Tooley AJ, 2002, J BACTERIOL, V184, P4666, DOI 10.1128/JB.184.17.4666-4671.2002; Tu JM, 2008, PHOTOSYNTH RES, V95, P163, DOI 10.1007/s11120-007-9251-4; Tu JM, 2009, J AM CHEM SOC, V131, P5399, DOI 10.1021/ja9002348; Turkarslan S, 2006, MOL MICROBIOL, V60, P537, DOI 10.1111/j.1365-2958.2006.05148.x; Wu SH, 2000, BIOCHEMISTRY-US, V39, P13487, DOI 10.1021/bi001123z; Zhao KH, 2007, J BIOL CHEM, V282, P34093, DOI 10.1074/jbc.M703038200; Zhao KH, 2007, P NATL ACAD SCI USA, V104, P14300, DOI 10.1073/pnas.0706209104; Zhao KH, 2006, J BIOL CHEM, V281, P8573, DOI 10.1074/jbc.M513796200; Zhao KH, 2006, FEBS J, V273, P1262, DOI 10.1111/j.1742-4658.2006.05149.x; Zhao KH, 2005, BIOCHEMISTRY-US, V44, P8126, DOI 10.1021/bi0500168; Zhao KH, 2005, BBA-BIOENERGETICS, V1706, P81, DOI 10.1016/j.bbabio.2004.09.008; Zhao KH, 2004, BIOCHEMISTRY-US, V43, P11576, DOI 10.1021/bi0491548; Zhao KH, 2004, BBA-BIOENERGETICS, V1657, P131, DOI 10.1016/j.bbabio.2004.04.010; Zhao KH, 2000, FEBS LETT, V469, P9, DOI 10.1016/S0014-5793(00)01245-X	62	15	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36405	36414		10.1074/jbc.M109.056382	http://dx.doi.org/10.1074/jbc.M109.056382			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19864423	Green Published, hybrid			2022-12-25	WOS:000272970500042
J	Sakuraba, Y; Tanaka, R; Yamasato, A; Tanaka, A				Sakuraba, Yasuhito; Tanaka, Ryouichi; Yamasato, Akihiro; Tanaka, Ayumi			Determination of a Chloroplast Degron in the Regulatory Domain of Chlorophyllide a Oxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE RECOGNITION; DEGRADE PROTEINS; B BIOSYNTHESIS; HEMA PROTEIN; CLP PROTEASE; BINDING; GENE; CAO; PROTEOLYSIS; EXPRESSION	Chlorophyll b is one of the major photosynthetic pigments of plants. The regulation of chlorophyll b biosynthesis is important for plants in order to acclimate to changing environmental conditions. In the chloroplast, chlorophyll b is synthesized from chlorophyll a by chlorophyllide a oxygenase (CAO), a Rieske-type monooxygenase. The activity of this enzyme is regulated at the level of protein stability via a feedback mechanism through chlorophyll b. The Clp protease and the N-terminal domain (designated the A domain) of CAO are essential for the regulatory mechanism. In this study, we aimed to identify the specific amino acid residue or the sequence within the A domain that is essential for this regulation. To accomplish this goal, we randomly introduced base substitutions into the A domain and searched for potentially important residues by analyzing 1,000 transformants of Arabidopsis thaliana. However, none of the single amino acid substitutions significantly stabilized CAO. Therefore, we generated serial deletions in the A domain and expressed these deletions in the background of CAO-deficient Arabidopsis mutant. We found that the amino acid sequence (97)QDLLTIMILH(106) is essential for the regulation of the protein stability. We furthermore determined that this sequence induces the destabilization of green fluorescent protein. These results suggest that this sequence serves as a degradation signal that is recognized by proteases functioning in the chloroplast.	[Sakuraba, Yasuhito; Tanaka, Ryouichi; Tanaka, Ayumi] Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan; [Yamasato, Akihiro] Res Inst Biol Sci Okayama, Okayama 7161241, Japan	Hokkaido University	Sakuraba, Y (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Kita Ku, N19 W8, Sapporo, Hokkaido 0600819, Japan.	sakuraba@pop.lowtem.hokudai.ac.jp	Tanaka, Ryouichi/A-4030-2012; Tanaka, Ayumi/D-9003-2012	Tanaka, Ryouichi/0000-0002-5858-5326; Sakuraba, Yasuhito/0000-0002-0432-6767	Ministry of Education, Culture, Sports, Science and Technology, Japan [17770027, 17GS0314]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Ministry of Education, Culture, Sports, Science and Technology, Japan, Grant-in-aid for Scientific Research 17770027 (to R. T.) and Grant-in-Aid for Creative Scientific Research 17GS0314 (to A. T.).	Adam Z, 2000, BIOCHIMIE, V82, P647, DOI 10.1016/S0300-9084(00)00612-X; Adam Z, 2002, TRENDS PLANT SCI, V7, P451, DOI 10.1016/S1360-1385(02)02326-9; Bechtold N, 1998, METH MOL B, V82, P259; BELLEMARE G, 1982, J BIOL CHEM, V257, P7762; BOGUSKI MS, 1986, J LIPID RES, V27, P1011; Bricker TM, 2002, PHOTOSYNTH RES, V72, P131, DOI 10.1023/A:1016128715865; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Chien P, 2007, P NATL ACAD SCI USA, V104, P6590, DOI 10.1073/pnas.0701776104; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; GAUBIER P, 1995, MOL GEN GENET, V249, P58, DOI 10.1007/BF00290236; Gonzalez M, 1998, ACTA BIOCHIM POL, V45, P163, DOI 10.18388/abp.1998_4298; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Harper AL, 2004, PHOTOSYNTH RES, V79, P149, DOI 10.1023/B:PRES.0000015375.40167.76; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hoskins JR, 2006, P NATL ACAD SCI USA, V103, P909, DOI 10.1073/pnas.0509154103; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; HUMPHREYS GO, 1976, MOL GEN GENET, V145, P101, DOI 10.1007/BF00331564; Kanematsu S, 2008, PHOTOCH PHOTOBIO SCI, V7, P1196, DOI 10.1039/b802584n; Kato Y, 2004, PLANTA, V220, P97, DOI 10.1007/s00425-004-1328-0; Komenda J, 2007, PLANT CELL, V19, P2839, DOI 10.1105/tpc.107.053868; Kuttkat A, 1997, J BIOL CHEM, V272, P20451, DOI 10.1074/jbc.272.33.20451; LEVCHENKO I, 1995, GENE DEV, V9, P2399, DOI 10.1101/gad.9.19.2399; Levchenko I, 1997, GENE DEV, V11, P1561, DOI 10.1101/gad.11.12.1561; Majeran W, 2000, PLANT CELL, V12, P137; Masuda T, 2003, PLANT MOL BIOL, V51, P757, DOI 10.1023/A:1022545118212; MELIS A, 1991, BIOCHIM BIOPHYS ACTA, V1058, P87, DOI 10.1016/S0005-2728(05)80225-7; Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120; Nagata N, 2004, PLANTA, V218, P1019, DOI 10.1007/s00425-003-1181-6; Nakagawara E, 2007, PLANT J, V49, P800, DOI 10.1111/j.1365-313X.2006.02996.x; Niwa Y, 1999, PLANT J, V18, P455, DOI 10.1046/j.1365-313X.1999.00464.x; Oster U, 1997, J BIOL CHEM, V272, P9671; Oster U, 2000, PLANT J, V21, P305, DOI 10.1046/j.1365-313x.2000.00672.x; Pattanayak GK, 2005, BIOCHEM BIOPH RES CO, V326, P466, DOI 10.1016/j.bbrc.2004.11.049; Sakamoto W, 2006, ANNU REV PLANT BIOL, V57, P599, DOI 10.1146/annurev.arplant.57.032905.105401; Sakuraba Y, 2007, PLANT PHYSIOL BIOCH, V45, P740, DOI 10.1016/j.plaphy.2007.07.016; Sjogren LLE, 2006, PLANT CELL, V18, P2635, DOI 10.1105/tpc.106.044594; Tanaka A, 1998, P NATL ACAD SCI USA, V95, P12719, DOI 10.1073/pnas.95.21.12719; Tanaka R, 2005, PHOTOSYNTH RES, V85, P327, DOI 10.1007/s11120-005-6807-z; Wang LY, 1999, J BACTERIOL, V181, P6033, DOI 10.1128/JB.181.19.6033-6041.1999; Wang LY, 1999, J BACTERIOL, V181, P1211, DOI 10.1128/JB.181.4.1211-1219.1999; Yamasato A, 2005, PLANT CELL, V17, P1585, DOI 10.1105/tpc.105.031518	44	42	45	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36689	36699		10.1074/jbc.M109.008144	http://dx.doi.org/10.1074/jbc.M109.008144			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19843523	Green Published, hybrid			2022-12-25	WOS:000272970500069
J	Guillot-Sestier, MV; Sunyach, C; Druon, C; Scarzello, S; Checler, F				Guillot-Sestier, Marie-Victoire; Sunyach, Claire; Druon, Charlotte; Scarzello, Sabine; Checler, Frederic			The alpha-Secretase-derived N-terminal Product of Cellular Prion, N1, Displays Neuroprotective Function in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTORS; PRIMARY CULTURED NEURONS; HEK293 HUMAN-CELLS; CASPASE-3 ACTIVATION; TRANSGENIC MICE; WILD-TYPE; ISCHEMIC TOLERANCE; APOPTOTIC STIMULI; SERUM DEPRIVATION; TUMOR SUPPRESSION	Cellular prion protein (PrPc) undergoes a disintegrin-mediated physiological cleavage, generating a soluble amino-terminal fragment (N1), the function of which remained unknown. Recombinant N1 inhibits staurosporine-induced caspase-3 activation by modulating p53 transcription and activity, whereas the PrPc-derived pathological fragment (N2) remains biologically inert. Furthermore, N1 protects retinal ganglion cells from hypoxia-induced apoptosis, reduces the number of terminal deoxynucleotidyltransferase-mediated biotinylated UTP nick end labeling-positive and p53-immunoreactive neurons in a pressure-induced ischemia model of the rat retina and triggers a partial recovery of b-waves but not a-waves of rat electroretino-grams. Our work is the first demonstration that the alpha-secretase-derived PrPc fragment N1, but not N2, displays in vivo and in vitro neuroprotective function by modulating p53 pathway. It further demonstrates that distinct N-terminal cleavage products of PrPc harbor different biological activities underlying the various phenotypes linking PrPc to cell survival.	[Checler, Frederic] CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; CNRS, Inst Neuromed Mol, UMR6097, UNSA,Equipe Labellisee Fdn Rech Med, F-06560 Valbonne, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Checler, F (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	checler@ipmc.cnrs.fr	Checler, Frederic/C-1241-2009	Checler, Frederic/0000-0003-2098-1750; Guillot-Sestier, Marie-Victoire/0000-0001-9674-7114	CNRS; Federation pour la Recherche sur le Cerveau; Fondation pour la Recherche Medicale	CNRS(Centre National de la Recherche Scientifique (CNRS)); Federation pour la Recherche sur le Cerveau; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by CNRS, the Federation pour la Recherche sur le Cerveau, and the Fondation pour la Recherche Medicale.	Atarashi R, 2003, J BIOL CHEM, V278, P28944, DOI 10.1074/jbc.M303655200; Baumann F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006707; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Caetano FA, 2008, J NEUROSCI, V28, P6691, DOI 10.1523/JNEUROSCI.1701-08.2008; Checler F, 2002, TRENDS NEUROSCI, V25, P616, DOI 10.1016/S0166-2236(02)02263-4; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Cisse MA, 2005, J BIOL CHEM, V280, P40624, DOI 10.1074/jbc.M506069200; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Cui QL, 2006, NEUROCHEM INT, V48, P383, DOI 10.1016/j.neuint.2005.11.014; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; da Costa CA, 2002, P NATL ACAD SCI USA, V99, P4043, DOI 10.1073/pnas.062059899; De Sarno P, 2003, J BIOL CHEM, V278, P11086, DOI 10.1074/jbc.M212157200; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; Drisaldi B, 2004, J BIOL CHEM, V279, P55443, DOI 10.1074/jbc.M404794200; Dupiereux I, 2008, J NEUROSCI RES, V86, P653, DOI 10.1002/jnr.21506; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101; Ettaiche M, 1999, INVEST OPHTH VIS SCI, V40, P729; Ettaiche M, 2001, BRAIN RES, V890, P118, DOI 10.1016/S0006-8993(00)03152-8; Ettaiche M, 2006, J NEUROSCI, V26, P5800, DOI 10.1523/JNEUROSCI.0344-06.2006; Gougoumas DD, 2007, J CELL PHYSIOL, V211, P551, DOI 10.1002/jcp.20969; Grabb MC, 1999, J NEUROSCI, V19, P1657; GUAN KL, 1991, J BIOL CHEM, V266, P17026; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Lee DC, 2006, MICROBIOL IMMUNOL, V50, P203, DOI 10.1111/j.1348-0421.2006.tb03787.x; Li AM, 2007, J NEUROSCI, V27, P852, DOI 10.1523/JNEUROSCI.4244-06.2007; Li AM, 2005, J BIOL CHEM, V280, P17430, DOI 10.1074/jbc.C500058200; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; LINDENBOIM L, 1995, J NEUROCHEM, V64, P2491; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Nicolas O, 2007, FASEB J, V21, P3107, DOI 10.1096/fj.06-7827com; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; Paitel E, 2004, J BIOL CHEM, V279, P612, DOI 10.1074/jbc.M310453200; Paitel E, 2003, J BIOL CHEM, V278, P10061, DOI 10.1074/jbc.M211580200; Paitel E, 2002, J NEUROCHEM, V83, P1208, DOI 10.1046/j.1471-4159.2002.01234.x; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Rosenbaum DM, 1998, INVEST OPHTH VIS SCI, V39, P2132; Shmerling D, 1998, CELL, V93, P203, DOI 10.1016/S0092-8674(00)81572-X; Sunyach C, 2003, EMBO J, V22, P3591, DOI 10.1093/emboj/cdg344; Sunyach C, 2005, J NEUROCHEM, V92, P1399, DOI 10.1111/j.1471-4159.2004.02989.x; Sunyach C, 2007, J BIOL CHEM, V282, P1956, DOI 10.1074/jbc.M609663200; Taylor DR, 2007, BIOCHEM J, V402, P17, DOI 10.1042/BJ20061736; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Vassallo N, 2005, BIOCHEM BIOPH RES CO, V332, P75, DOI 10.1016/j.bbrc.2005.04.099; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Vincent B, 2001, J BIOL CHEM, V276, P37743; Vincent B, 1996, J NEUROSCI, V16, P5049; Weise J, 2006, STROKE, V37, P1296, DOI 10.1161/01.STR.0000217262.03192.d4; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Zhang Y, 2006, BIOCHEM BIOPH RES CO, V349, P759, DOI 10.1016/j.bbrc.2006.08.116	59	117	117	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35973	35986		10.1074/jbc.M109.051086	http://dx.doi.org/10.1074/jbc.M109.051086			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850936	hybrid, Green Published			2022-12-25	WOS:000272645600072
J	Tadokoro, T; Ikekita, M; Toda, T; Ito, H; Sato, T; Nakatani, R; Hamaguchi, Y; Furukawa, K				Tadokoro, Tomomi; Ikekita, Masahiko; Toda, Tosifusa; Ito, Hiroko; Sato, Takeshi; Nakatani, Ryunosuke; Hamaguchi, Yu; Furukawa, Kiyoshi			Involvement of Galectin-3 with Vascular Cell Adhesion Molecule-1 in Growth Regulation of Mouse BALB/3T3 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING PROTEIN-35; PSATHYRELLA-VELUTINA LECTIN; BREAST-CARCINOMA CELLS; LINKED OLIGOSACCHARIDES; PHOSPHATIDYLINOSITOL 3-KINASE; STRUCTURAL DETERMINANTS; MEMBRANE-GLYCOPROTEINS; NEUROTROPHIC FACTOR; ENDOGENOUS LECTINS; PROTEOMIC ANALYSIS	beta-Galactose residues on N-glycans have been implicated to be involved in growth regulation of cells. In the present study we compared the galactosylation of cell surface N-glycans of mouse Balb/3T3 cells between 30 and 100% densities and found the beta-1,4-galactosylation of N-glycans increases predominantly in a 100-kDa protein band on lectin blot analysis in combination with digestions by diplococcal beta-galactosidase and N-glycanase. When cells at 100% density were treated with jack bean beta-galactosidase, the incorporation of 5-bromodeoxyuridine into the cells was stimulated in a dose-dependent manner, suggesting the involvement of the galactose residues in growth regulation of cells. A galactose-binding protein was isolated from the plasma membranes of cells at 100% density by affinity chromatography using an asialo-transferrin-Sepharose column and found to be galectin-3 as revealed by mass spectrometric analysis. The addition of recombinant galectin-3 into cells at 50% density inhibited the incorporation of 5-bromodeoxyuridine in a dose-dependent manner, but the inhibition was prevented with haptenic sugar. An immunocytochemical study showed that galectin-3 is present at the surface of cells at 100% density but not at 30% density where it locates inside the cells. Several glycoproteins bind to a galectin-3-immobilized column, a major of which was identified as vascular cell adhesion molecule (VCAM)-1. Immunocytochemical studies showed that some galectin-3 and VCAM-1 co-localize at the surface of cells at 100% density, indicating that the binding of galectin-3 secreted from cells to VCAM-1 is one of the pathways involved in the growth regulation of Balb/3T3 cells.	[Hamaguchi, Yu; Furukawa, Kiyoshi] Nagaoka Univ Technol, Dept Bioengn, Lab Glycobiol, Nagaoka, Niigata 9402188, Japan; [Tadokoro, Tomomi] Japan Sci & Technol Agcy Innovat Plaza Niigata, Nagaoka, Niigata 9402127, Japan; [Ikekita, Masahiko] Tokyo Univ Sci, Grad Sch Sci & Technol, Noda, Chiba 2780022, Japan; [Toda, Tosifusa] Tokyo Metropolitan Inst Gerontol, Prote Collaborat Ctr, Itabashi Ku, Tokyo 1730015, Japan; [Ito, Hiroko] Tokyo Metropolitan Inst Gerontol, Dept Biosignal Res, Itabashi Ku, Tokyo 1730015, Japan	Nagaoka University of Technology; Japan Science & Technology Agency (JST); Tokyo University of Science; Tokyo Metropolitan Institute of Gerontology; Tokyo Metropolitan Institute of Gerontology	Furukawa, K (corresponding author), Nagaoka Univ Technol, Dept Bioengn, Lab Glycobiol, Kamitomioka 1603-1, Nagaoka, Niigata 9402188, Japan.	furukawa@vos.nagaokaut.ac.jp			Ministry of Education, Science, Culture, and Sports of Japan [10680696, 09240104, 14580707]; Japan Science Technology Agency; Nagaoka University of Technology	Ministry of Education, Science, Culture, and Sports of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science Technology Agency(Japan Science & Technology Agency (JST)); Nagaoka University of Technology	This work was supported by Grants-in-aid for Scientific Research 10680696, 09240104, and 14580707 from the Ministry of Education, Science, Culture, and Sports of Japan, by the Research Promotion Fund from the Japan Science Technology Agency, and by Institutional Grants in 2006 and 2007 from Nagaoka University of Technology ( to K. F.).	BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; Bullock SL, 2001, J AM SOC NEPHROL, V12, P515, DOI 10.1681/ASN.V123515; COWLES EA, 1990, J BIOL CHEM, V265, P17706; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DAGHER SF, 1995, P NATL ACAD SCI USA, V92, P1213, DOI 10.1073/pnas.92.4.1213; Deem TL, 2004, BLOOD, V104, P2385, DOI 10.1182/blood-2004-02-0665; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; DWEK RA, 1995, SCIENCE, V269, P1234, DOI 10.1126/science.7652569; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; ENDO T, 1992, J BIOL CHEM, V267, P707; Fischer C, 2005, J BIOL CHEM, V280, P37266, DOI 10.1074/jbc.M411580200; FRIGERI LG, 1990, J BIOL CHEM, V265, P20763; Furtak V, 2001, BIOCHEM BIOPH RES CO, V289, P845, DOI 10.1006/bbrc.2001.6064; Furukawa K, 1999, BBA-GEN SUBJECTS, V1473, P54, DOI 10.1016/S0304-4165(99)00169-5; FURUKAWA K, 1990, INT IMMUNOL, V2, P105, DOI 10.1093/intimm/2.1.105; GRADL G, 1995, CURR BIOL, V5, P526, DOI 10.1016/S0960-9822(95)00105-9; Guo S, 2001, GLYCOBIOLOGY, V11, P813, DOI 10.1093/glycob/11.10.813; HAHN TJ, 1992, J BIOL CHEM, V267, P23982; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochem.73.011303.074043; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Honjo Y, 2001, CLIN CANCER RES, V7, P661; Hughes RC, 2001, BIOCHIMIE, V83, P667; Inohara H, 1998, EXP CELL RES, V245, P294, DOI 10.1006/excr.1998.4253; Irie A, 2005, CLIN CANCER RES, V11, P2962, DOI 10.1158/1078-0432.CCR-04-0861; Jiang JH, 2006, J BIOL CHEM, V281, P9482, DOI 10.1074/jbc.M504489200; John CM, 2003, CLIN CANCER RES, V9, P2374; Kitamura N, 2004, J NEUROSCI RES, V75, P384, DOI 10.1002/jnr.10870; Kitamura N, 2005, P NATL ACAD SCI USA, V102, P2796, DOI 10.1073/pnas.0409344102; Kopitz J, 2001, J BIOL CHEM, V276, P35917, DOI 10.1074/jbc.M105135200; Lazaar AL, 2001, J IMMUNOL, V166, P155, DOI 10.4049/jimmunol.166.1.155; LI SC, 1975, J BIOL CHEM, V250, P6786; Maeda N, 2003, J BIOL CHEM, V278, P18938, DOI 10.1074/jbc.M209673200; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MERKLE RK, 1987, METHOD ENZYMOL, V138, P232; MOUTSATSOS IK, 1986, J CELL BIOL, V102, P477, DOI 10.1083/jcb.102.2.477; MOUTSATSOS IK, 1987, P NATL ACAD SCI USA, V84, P6452, DOI 10.1073/pnas.84.18.6452; Ochieng J, 2002, GLYCOCONJUGATE J, V19, P527, DOI 10.1023/B:GLYC.0000014082.99675.2f; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; PAULSON JC, 1978, J BIOL CHEM, V253, P5617; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; SANTER UV, 1984, CANCER RES, V44, P3730; Sasaki T, 2004, GLYCOBIOLOGY, V14, P357, DOI 10.1093/glycob/cwh043; SATO S, 1992, J BIOL CHEM, V267, P6983; SATO T, 1993, J BIOCHEM-TOKYO, V114, P890, DOI 10.1093/oxfordjournals.jbchem.a124273; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Toda T, 2000, ELECTROPHORESIS, V21, P1814, DOI 10.1002/(SICI)1522-2683(20000501)21:9<1814::AID-ELPS1814>3.3.CO;2-R; van Vliet SJ, 2006, NAT IMMUNOL, V7, P1200, DOI 10.1038/ni1390; VONDERHEIDE RH, 1992, J EXP MED, V175, P1433, DOI 10.1084/jem.175.6.1433; Wang JL, 2004, BBA-GEN SUBJECTS, V1673, P75, DOI 10.1016/j.bbagen.2004.03.013; WIESER RJ, 1990, J CELL BIOL, V111, P2681, DOI 10.1083/jcb.111.6.2681; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737	54	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35556	35563		10.1074/jbc.M109.063339	http://dx.doi.org/10.1074/jbc.M109.063339			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858221	Green Published, hybrid			2022-12-25	WOS:000272645600032
J	Aylon, Y; Yabuta, N; Besserglick, H; Buganim, Y; Rotter, V; Nojima, H; Oren, M				Aylon, Y.; Yabuta, N.; Besserglick, H.; Buganim, Y.; Rotter, V.; Nojima, H.; Oren, M.			Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation	ONCOGENE			English	Article						Ras; p53; Lats2; apoptosis	MAMMARY EPITHELIAL-CELLS; DOWN-REGULATION; PROMOTER HYPERMETHYLATION; DNA HYPERMETHYLATION; GENOMIC INSTABILITY; INDUCED SENESCENCE; P53; P16(INK4A); MUTATIONS; CANCER	The Lats2 tumor suppressor protein has been implicated earlier in promoting p53 activation in response to mitotic apparatus stress, by preventing Mdm2-driven p53 degradation. We now report that Lats2 also has a role in an ATR-Chk1-mediated stress check point in response to oncogenic H-Ras. Activated mutant H-Ras triggers the translocation of Lats2 from centrosomes into the nucleus, coupled with an increase in Lats2 protein levels. This leads to the induction of p53 activity, upregulation of proapoptotic genes, downregulation of antiapoptotic genes and eventually apoptotic cell death. Many of the cells that survive apoptosis undergo senescence. However, a fraction of the cells escape this checkpoint mechanism, despite maintaining a high mutant H-Ras expression. These escapers display increased genome instability, as evidenced by a substantial fraction of cells with micronuclei and cells with polyploid genomes. Interestingly, such cells show markedly reduced levels of Lats2, in conjunction with enhanced hypermethylation of the Lats2 gene promoter. Our findings suggest that Lats2 might have an important role in quenching H-Ras-induced transformation, whereas silencing of Lats2 expression might serve as a mechanism to enable tumor progression. Oncogene (2009) 28, 4469-4479; doi:10.1038/onc.2009.270; published online 26 October 2009	[Aylon, Y.; Besserglick, H.; Buganim, Y.; Rotter, V.; Oren, M.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Yabuta, N.; Nojima, H.] Osaka Univ, Microbial Dis Res Inst, Dept Mol Genet, Osaka, Japan	Weizmann Institute of Science; Osaka University	Oren, M (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, 300 Herzl St, IL-76100 Rehovot, Israel.	moshe.oren@weizmann.ac.il		Oren, Moshe/0000-0003-4311-7172	National Cancer Institute [R37 CA40099]; EC [LSHC-CT-2004-503576]; Dr Miriam and Sheldon Adelson Medical Research Foundation; Yad Abraham Center for Cancer Diagnosis and Therapy; NATIONAL CANCER INSTITUTE [R37CA040099] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EC(European CommissionEuropean Commission Joint Research Centre); Dr Miriam and Sheldon Adelson Medical Research Foundation; Yad Abraham Center for Cancer Diagnosis and Therapy; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Doron Ginsberg, Reuven Agami and Scott Lowe for the generous gift or plasmids and the following people for other help: Lior Golomb (beta-gal staining), Efrat Shema (migration assays) and Sylvia Wilder (excellent technical help). We were supported in part by Grant R37 CA40099 from the National Cancer Institute, EC FP6 Grant LSHC-CT-2004-503576, FP7 funding (ONCOMIRS, agreement 201102), the Dr Miriam and Sheldon Adelson Medical Research Foundation and the Yad Abraham Center for Cancer Diagnosis and Therapy. The EC is not liable for any use that may be made of the information contained herein.	Abulaiti A, 2006, CANCER RES, V66, P10505, DOI 10.1158/0008-5472.CAN-06-2351; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bean GR, 2007, CLIN CANCER RES, V13, P6834, DOI 10.1158/1078-0432.CCR-07-0407; Burri N, 2001, LAB INVEST, V81, P217, DOI 10.1038/labinvest.3780230; Chang HC, 2006, CANCER RES, V66, P8413, DOI 10.1158/0008-5472.CAN-06-0685; DENKO N, 1995, SOMAT CELL MOLEC GEN, V21, P241, DOI 10.1007/BF02255779; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fikaris AJ, 2006, J BIOL CHEM, V281, P34759, DOI 10.1074/jbc.M606737200; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Jiang Z, 2006, NEUROSCI RES, V56, P450, DOI 10.1016/j.neures.2006.09.006; Jimenez-Velasco A, 2005, LEUKEMIA, V19, P2347, DOI 10.1038/sj.leu.2403974; Kim JS, 2007, MOL CELL BIOL, V27, P662, DOI 10.1128/MCB.00537-06; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Lowe SW, 1999, ENDOCR-RELAT CANCER, V6, P45, DOI 10.1677/erc.0.0060045; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; McDermott KM, 2006, PLOS BIOL, V4, P350, DOI 10.1371/journal.pbio.0040051; Milyavsky M, 2003, CANCER RES, V63, P7147; Phelps ED, 2006, AM J PHYSIOL-CELL PH, V290, pC352, DOI 10.1152/ajpcell.00050.2005; Ponzio TA, 2007, J NEUROSCI METH, V164, P149, DOI 10.1016/j.jneumeth.2007.04.012; Pruitt K, 2005, J BIOL CHEM, V280, P23363, DOI 10.1074/jbc.M503083200; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Serrano M, 1997, EXP CELL RES, V237, P7, DOI 10.1006/excr.1997.3824; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Strazisar M, 2009, LUNG CANCER, V64, P257, DOI 10.1016/j.lungcan.2008.09.011; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang W, 2008, CURR OPIN ONCOL, V20, P90, DOI 10.1097/CCO.0b013e3282f31d6f; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yabuta N, 2007, J BIOL CHEM, V282, P19259, DOI 10.1074/jbc.M608562200	36	49	50	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 17	2009	28	50					4469	4479		10.1038/onc.2009.270	http://dx.doi.org/10.1038/onc.2009.270			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DU	19855428	Green Accepted			2022-12-25	WOS:000272876500006
J	Bahtiar, A; Matsumoto, T; Nakamura, T; Akiyama, M; Yogo, K; Ishida-Kitagawa, N; Ogawa, T; Takeya, T				Bahtiar, Anton; Matsumoto, Takahiro; Nakamura, Takashi; Akiyama, Motofusa; Yogo, Keiichiro; Ishida-Kitagawa, Norihiro; Ogawa, Takuya; Takeya, Tatsuo			Identification of a Novel L-Serine Analog That Suppresses Osteoclastogenesis in Vitro and Bone Turnover in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; RECEPTOR ACTIVATOR; NUCLEAR-FACTOR; BASE SYNTHESIS; PALMITOYLTRANSFERASE; METABOLISM; EXPRESSION; ENZYME; RANKL; CELLS	Osteoclasts are multinucleated giant cells with bone resorbing activity. We previously reported that the expression of the transcription factorNFAT2(NFATc1) induced by receptor activator of NF-kappa B ligand (RANKL) is essential for the formation of multinucleated cells. We subsequently identified L-Ser in the differentiation medium as necessary for the expression of NFAT2. Here we searched for serine analogs that antagonize the function of L-Ser and suppress the formation of osteoclasts in bone marrow as well as RAW264 cells. An analog thus identified, H-Ser(tBu)-OMe center dot HCl, appeared to suppress the production of 3-ketodihydrosphingosine by serine palmitoyltransferase, and the expression and localization of RANK, a cognate receptor of RANKL, in membrane lipid rafts was down-regulated in the analog-treated cells. The addition of lactosylceramide, however, rescued the osteoclastic formation. When administered in vivo, the analog significantly increased bone density in mice and prevented high bone turnover induced by treatment with soluble RANKL. These results demonstrate a close connection between the metabolism of L-Ser and bone remodeling and also the potential of the analog as a novel therapeutic tool for bone destruction.	[Bahtiar, Anton; Matsumoto, Takahiro; Nakamura, Takashi; Akiyama, Motofusa; Yogo, Keiichiro; Ishida-Kitagawa, Norihiro; Ogawa, Takuya; Takeya, Tatsuo] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Nara Institute of Science & Technology	Takeya, T (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan.	ttakeya@bs.naist.jp	Bahtiar, Anton/AAE-7874-2021; Ogawa, Takuya/ABC-9628-2020; Akiyama, Motofusa/E-4101-2015	Ogawa, Takuya/0000-0001-9194-3079; Akiyama, Motofusa/0000-0001-6772-0027; Yogo, Keiichiro/0000-0003-2051-6891; Bahtiar, Anton/0000-0002-2924-3677				Akhila JS, 2007, CURR SCI INDIA, V93, P917; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Ha H, 2003, J BIOL CHEM, V278, P18573, DOI 10.1074/jbc.M212626200; Hanada K, 2000, FEBS LETT, V474, P63, DOI 10.1016/S0014-5793(00)01579-9; Hanada K, 2000, J BIOL CHEM, V275, P8409, DOI 10.1074/jbc.275.12.8409; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Ishida N, 2006, J BONE MINER RES, V21, P48, DOI 10.1359/JBMR.051001; Iwamoto T, 2001, J BIOL CHEM, V276, P46031, DOI 10.1074/jbc.M104464200; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Lloyd SAJ, 2008, CALCIFIED TISSUE INT, V82, P361, DOI 10.1007/s00223-008-9133-6; MERRILL AH, 1983, BIOCHIM BIOPHYS ACTA, V754, P284, DOI 10.1016/0005-2760(83)90144-3; Ogawa T, 2006, J BONE MINER METAB, V24, P373, DOI 10.1007/s00774-006-0705-0; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Tomimori Y, 2009, J BONE MINER RES, V24, P1194, DOI [10.1359/JBMR.090217, 10.1359/jbmr.090217]; Vaananen HK, 2008, ARCH BIOCHEM BIOPHYS, V473, P132, DOI 10.1016/j.abb.2008.03.037; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9	21	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34157	34166		10.1074/jbc.M109.058933	http://dx.doi.org/10.1074/jbc.M109.058933			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19837662	hybrid, Green Published			2022-12-25	WOS:000272165200048
J	Riva, A; Pesole, G				Riva, Alberto; Pesole, Graziano			A Unique, Consistent Identifier for Alternatively Spliced Transcript Variants	PLOS ONE			English	Article							DATABASE; RESOURCE; PYRUVATE	Background: As research into alternative splicing reveals the fundamental importance of this phenomenon in the genome expression of higher organisms, there is an increasing need for a standardized, consistent and unique identifier for alternatively spliced isoforms. Such an identifier would be useful to eliminate ambiguities in references to gene isoforms, and would allow for the reliable comparison of isoforms from different sources ( e. g., known genes vs. computational predictions). Commonly used identifiers for gene transcripts prove to be unsuitable for this purpose. Methodology: We propose an algorithm to compute an isoform signature based on the arrangement of exons and introns in a primary transcript. The isoform signature uniquely identifies a transcript structure, and can therefore be used as a key in databases of alternatively spliced isoforms, or to compare alternative splicing predictions produced by different methods. In this paper we present the algorithm to generate isoform signatures, we provide some examples of its application, and we describe a web-based resource to generate isoform signatures and use them in database searches. Conclusions: Isoform signatures are simple, so that they can be easily generated and included in publications and databases, but flexible enough to unambiguously represent all possible isoform structures, including information about coding sequence position and variable transcription start and end sites. We believe that the adoption of isoform signatures can help establish a consistent, unambiguous nomenclature for alternative splicing isoforms. The system described in this paper is freely available at http://genome.ufl.edu/genesig/, and supplementary materials can be found at http://genome.ufl.edu/genesig-files/.			Riva, A (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.	ariva@ufl.edu	Pesole, Graziano/K-5283-2019; Pesole, Graziano/E-9051-2014; Pesole, Graziano/C-1408-2009	Pesole, Graziano/0000-0003-3663-0859; Pesole, Graziano/0000-0003-3663-0859; Riva, Alberto/0000-0001-9150-8333	Telethon [GGP06158] Funding Source: Medline	Telethon(Fondazione Telethon)		Bonizzoni P, 2009, J COMPUT BIOL, V16, P43, DOI 10.1089/cmb.2008.0028; Castrignano T, 2008, BIOINFORMATICS, V24, P1300, DOI 10.1093/bioinformatics/btn113; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; *FIPS, 1801 FIPS; Kim N, 2007, NUCLEIC ACIDS RES, V35, pD93, DOI 10.1093/nar/gkl884; Kreahling J, 2004, TRENDS GENET, V20, P1, DOI 10.1016/j.tig.2003.11.001; Lee BTK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-189; Lee Y, 2007, NUCLEIC ACIDS RES, V35, pD99, DOI 10.1093/nar/gkl992; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Nagasaki H, 2006, BIOINFORMATICS, V22, P1211, DOI 10.1093/bioinformatics/btl067; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	20	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7631	10.1371/journal.pone.0007631	http://dx.doi.org/10.1371/journal.pone.0007631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19865484	Green Published, gold, Green Submitted			2022-12-25	WOS:000271194600015
J	Simonetta, SH; Migliori, ML; Romanowski, A; Golombek, DA				Simonetta, Sergio H.; Laura Migliori, Maria; Romanowski, Andres; Golombek, Diego A.			Timing of Locomotor Activity Circadian Rhythms in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; CLOCK; TEMPERATURE; DROSOPHILA; GENETICS; GENES; LIGHT; ROBUSTNESS; EXPRESSION; HOMOLOGS	Circadian rhythms are driven by endogenous biological clocks and are synchronized to environmental cues. The chronobiological study of Caenorhabditis elegans, an extensively used animal model for developmental and genetic research, might provide fundamental information about the basis of circadian rhythmicity in eukaryotes, due to its ease of use and manipulations, as well as availability of genetic data and mutant strains. The aim of this study is to fully characterize the circadian rhythm of locomotor activity in C. elegans, as well as a means for genetic screening in this nematode and the identification of circadian mutants. We have developed an infrared method to measure locomotor activity in C. elegans and found that, under constant conditions, although inter-individual variability is present, circadian periodicity shows a population distribution of periods centered at 23.9 +/- 0.4 h and is temperature-compensated. Locomotor activity is entrainable by light-dark cycles and by low-amplitude temperature cycles, peaking around the night-day transition and day, respectively. In addition, lin-42(mg152) or lin-42(n1089) mutants (bearing a mutation in the lin-42 gene, homolog to the per gene) exhibit a significantly longer circadian period of 25.2 +/- 0.4 h or 25.6 +/- 0.5 h, respectively. Our results represent a complete description of the locomotor activity rhythm in C. elegans, with a methodology that allowed us to uncover three of the key features of circadian systems: entrainment, free-running and temperature compensation. In addition, abnormal circadian periods in clock mutants suggest a common molecular machinery responsible for circadian rhythmicity. Our analysis of circadian rhythmicity in C. elegans opens the possibility for further screening for circadian mutations in this species.			Simonetta, SH (corresponding author), Univ Nacl Quilmes, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina.	dgolombek@unq.edu.ar	Romanowski, Andres/P-2153-2017	Romanowski, Andres/0000-0003-0737-2408; Golombek, Diego/0000-0002-6291-5586				Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Avivi A, 2002, P NATL ACAD SCI USA, V99, P11718, DOI 10.1073/pnas.182423299; Banerjee D, 2005, DEV CELL, V8, P287, DOI 10.1016/j.devcel.2004.12.006; Boothroyd CE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030054; Branicky R, 2000, BIOESSAYS, V22, P48, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;48::AID-BIES9&gt;3.0.CO;2-F; BRENNER S, 1974, GENETICS, V77, P71; Buckingham Steven D., 2008, Invertebrate Neuroscience, V8, P121, DOI 10.1007/s10158-008-0077-3; BURR AH, 1985, PHOTOCHEM PHOTOBIOL, V41, P577, DOI 10.1111/j.1751-1097.1985.tb03529.x; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Dunlap JC, 1999, GENES CELLS, V4, P1, DOI 10.1046/j.1365-2443.1999.00239.x; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Glaser FT, 2007, COLD SH Q B, V72, P233, DOI 10.1101/sqb.2007.72.046; Gonze D, 2006, CHAOS, V16, DOI 10.1063/1.2211767; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Hasegawa K, 2005, CHRONOBIOL INT, V22, P1, DOI 10.1081/CBI-200038149; HUANG SX, 2004, COMPUTER INTEGRATED, V1, P1; Iwasaki K, 1997, TRENDS GENET, V13, P111, DOI 10.1016/S0168-9525(97)01059-7; IWASAKI K, 1995, P NATL ACAD SCI USA, V92, P10317, DOI 10.1073/pnas.92.22.10317; Janssen T, 2008, J BIOL CHEM, V283, P15241, DOI 10.1074/jbc.M709060200; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; Kippert F, 2002, CURR BIOL, V12, pR47, DOI 10.1016/S0960-9822(01)00670-4; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; LAMPRECHT G, 1986, NSS B, V47, P147; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-5; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; PITTENDRIGH CS, 1981, HDB BEHAVIORAL NEURO, V4, P95; Qin HT, 2006, DEV BIOL, V298, P606, DOI 10.1016/j.ydbio.2006.07.017; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Saigusa T, 2002, CURR BIOL, V12, pR46, DOI 10.1016/S0960-9822(01)00669-8; Simonetta SH, 2008, J COMP PHYSIOL A, V194, P821, DOI 10.1007/s00359-008-0353-z; Simonetta SH, 2007, J NEUROSCI METH, V161, P273, DOI 10.1016/j.jneumeth.2006.11.015; Szewczyk NJ, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-19; Take-uchi M, 2005, MOL BIOL CELL, V16, P1355, DOI 10.1091/mbc.E04-04-0273; Tanaka D, 2007, NEUROPHARMACOLOGY, V53, P157, DOI 10.1016/j.neuropharm.2007.04.017; Tennessen JM, 2006, DEV BIOL, V289, P30, DOI 10.1016/j.ydbio.2005.09.044; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; WRIGHT STW, 1997, SCI ENG GUIDE DIGITA; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174; ZIMMERMAN WF, 1968, J INSECT PHYSIOL, V14, P669, DOI 10.1016/0022-1910(68)90226-6	44	32	36	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7571	10.1371/journal.pone.0007571	http://dx.doi.org/10.1371/journal.pone.0007571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859568	Green Published, gold, Green Submitted			2022-12-25	WOS:000271147400004
J	Wang, L; Wang, YC; Hu, XB; Zhang, BF; Dou, GR; He, F; Gao, F; Feng, F; Liang, YM; Dou, KF; Han, H				Wang, Lin; Wang, Yao-Chun; Hu, Xing-Bin; Zhang, Bing-Fang; Dou, Guo-Rui; He, Fei; Gao, Fang; Feng, Fan; Liang, Ying-Min; Dou, Ke-Feng; Han, Hua			Notch-RBP-J Signaling Regulates the Mobilization and Function of Endothelial Progenitor Cells by Dynamic Modulation of CXCR4 Expression in Mice	PLOS ONE			English	Article							BONE-MARROW-CELLS; LIVER-REGENERATION; NEOVASCULARIZATION CAPACITY; TRANSPLANTATION; ANGIOGENESIS; RECRUITMENT; FIBROSIS; DISEASE; TRAFFICKING; CONTRIBUTE	Bone marrow (BM)-derived endothelial progenitor cells (EPC) have therapeutic potentials in promoting tissue regeneration, but how these cells are modulated in vivo has been elusive. Here, we report that RBP-J, the critical transcription factor mediating Notch signaling, modulates EPC through CXCR4. In a mouse partial hepatectomy (PHx) model, RBP-J deficient EPC showed attenuated capacities of homing and facilitating liver regeneration. In resting mice, the conditional deletion of RBP-J led to a decrease of BM EPC, with a concomitant increase of EPC in the peripheral blood. This was accompanied by a down-regulation of CXCR4 on EPC in BM, although CXCR4 expression on EPC in the circulation was up-regulated in the absence of RBP-J. PHx in RBP-J deficient mice induced stronger EPC mobilization. In vitro, RBP-J deficient EPC showed lowered capacities of adhering, migrating, and forming vessel-like structures in three-dimensional cultures. Over-expression of CXCR4 could at least rescue the defects in vessel formation by the RBP-J deficient EPC. These data suggested that the RBP-J-mediated Notch signaling regulated EPC mobilization and function, at least partially through dynamic modulation of CXCR4 expression. Our findings not only provide new insights into the regulation of EPC, but also have implications for clinical therapies using EPC in diseases.			Wang, L (corresponding author), Fourth Mil Med Univ, Xi Jing Hosp, State Key Lab Canc Biol, Dept Med Genet & Dev Biol, Xian 710032, Peoples R China.	doukef@fmmu.edu.cn; huahan@fmmu.edu.cn	Hu, XB/U-8501-2019	Gao, Fang/0000-0003-1099-8620				Aoki M, 2004, STEM CELLS, V22, P994, DOI 10.1634/stemcells.22-6-994; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asahara T, 2004, AM J PHYSIOL-CELL PH, V287, pC572, DOI 10.1152/ajpcell.00330.2003; Beaudry P, 2007, J PEDIATR SURG, V42, P1190, DOI 10.1016/j.jpedsurg.2007.02.034; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Dalakas E, 2005, FASEB J, V19, P1225, DOI 10.1096/fj.04-2604rev; Dou GR, 2008, FASEB J, V22, P1606, DOI 10.1096/fj.07-9998com; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fujii H, 2002, J HEPATOL, V36, P653, DOI 10.1016/S0168-8278(02)00043-0; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Higashiyama R, 2007, HEPATOLOGY, V45, P213, DOI 10.1002/hep.21477; Houlihan DD, 2008, GASTROENTEROLOGY, V135, P438, DOI 10.1053/j.gastro.2008.05.040; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Nakamura T, 2007, GASTROENTEROLOGY, V133, P91, DOI 10.1053/j.gastro.2007.03.110; Oh IY, 2007, BLOOD, V110, P3891, DOI 10.1182/blood-2006-10-048991; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Sharpe EE, 2006, AM J PATHOL, V168, P1710, DOI 10.2353/ajpath.2006.050556; Taniguchi E, 2006, GASTROENTEROLOGY, V130, P521, DOI 10.1053/j.gastro.2005.10.050; Ueno T, 2006, MED MOL MORPHOL, V39, P16, DOI 10.1007/s00795-006-0311-1; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Wang L, 2009, HEPATOLOGY, V49, P268, DOI 10.1002/hep.22579; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22	32	30	33	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7572	10.1371/journal.pone.0007572	http://dx.doi.org/10.1371/journal.pone.0007572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859544	Green Published, gold, Green Submitted			2022-12-25	WOS:000271147400005
J	Cai, F; Menon, BB; Cannon, GC; Curry, KJ; Shively, JM; Heinhorst, S				Cai, Fei; Menon, Balaraj B.; Cannon, Gordon C.; Curry, Kenneth J.; Shively, Jessup M.; Heinhorst, Sabine			The Pentameric Vertex Proteins Are Necessary for the Icosahedral Carboxysome Shell to Function as a CO2 Leakage Barrier	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; HALOTHIOBACILLUS-NEAPOLITANUS; THIOBACILLUS-NEAPOLITANUS; POLYHEDRAL BODIES; ORGANELLES; FORM; MICROCOMPARTMENT; ULTRASTRUCTURE; SALMONELLA; GENERATE	Background: Carboxysomes are polyhedral protein microcompartments found in many autotrophic bacteria; they encapsulate the CO2 fixing enzyme, ribulose-1,5-bisphosphate carboxylase/oxygenase (RubisCO) within a thin protein shell and provide an environment that enhances the catalytic capabilities of the enzyme. Two types of shell protein constituents are common to carboxysomes and related microcompartments of heterotrophic bacteria, and the genes for these proteins are found in a large variety of bacteria. Methodology/Principal Findings: We have created a Halothiobacillus neapolitanus knockout mutant that does not produce the two paralogous CsoS4 proteins thought to occupy the vertices of the icosahedral carboxysomes and related microcompartments. Biochemical and ultrastructural analyses indicated that the mutant predominantly forms carboxysomes of normal appearance, in addition to some elongated microcompartments. Despite their normal shape, purified mutant carboxysomes are functionally impaired, although the activities of the encapsulated enzymes are not negatively affected. Conclusions/Significance: In the absence of the CsoS4 proteins the carboxysome shell loses its limited permeability to CO2 and is no longer able to provide the catalytic advantage RubisCO derives from microcompartmentalization. This study presents direct evidence that the diffusion barrier property of the carboxysome shell contributes significantly to the biological function of the carboxysome.			Cai, F (corresponding author), Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	sabine.heinhorst@usm.edu			Div Of Molecular and Cellular Bioscience [0818680] Funding Source: National Science Foundation	Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Baker SH, 1998, J BACTERIOL, V180, P4133, DOI 10.1128/JB.180.16.4133-4139.1998; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Cai F, 2008, ARCH MICROBIOL, V189, P141, DOI 10.1007/s00203-007-0305-y; CANNON GC, 1983, ARCH MICROBIOL, V134, P52, DOI 10.1007/BF00429407; Cannon GC, 2003, CURR MICROBIOL, V46, P115, DOI 10.1007/s00284-002-3825-3; Crowley CS, 2008, STRUCTURE, V16, P1324, DOI 10.1016/j.str.2008.05.013; Dou ZC, 2008, J BIOL CHEM, V283, P10377, DOI 10.1074/jbc.M709285200; ENGLISH RS, 1995, APPL ENVIRON MICROB, V61, P3256, DOI 10.1128/AEM.61.9.3256-3260.1995; GANTT E, 1969, J BACTERIOL, V97, P1486, DOI 10.1128/JB.97.3.1486-1493.1969; Havemann GD, 2002, J BACTERIOL, V184, P1253, DOI 10.1128/JB.184.5.1253-1261.2002; Heinhorst S., 2006, COMPLEX INTRACELLULA, P141; Heinhorst S, 2006, J BACTERIOL, V188, P8087, DOI 10.1128/JB.00990-06; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; KLEIN MG, 2009, J MOL BIOL IN PRESS; Menon BB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003570; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; PRICE GD, 1989, PLANT PHYSIOL, V91, P514, DOI 10.1104/pp.91.2.514; PRICE GD, 1991, CAN J BOT, V69, P963, DOI 10.1139/b91-124; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Sagermann M, 2009, P NATL ACAD SCI USA, V106, P8883, DOI 10.1073/pnas.0902324106; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Sawaya MR, 2006, J BIOL CHEM, V281, P7546, DOI 10.1074/jbc.M510464200; Shively JM, 1998, CAN J BOT, V76, P906, DOI 10.1139/b98-088; SHIVELY JM, 1973, J BACTERIOL, V116, P1405, DOI 10.1128/JB.116.3.1405-1411.1973; SHIVELY JM, 1970, J BACTERIOL, V101, P618, DOI 10.1128/JB.101.2.618-627.1970; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	33	79	85	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7521	10.1371/journal.pone.0007521	http://dx.doi.org/10.1371/journal.pone.0007521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844578	Green Published, Green Submitted, gold			2022-12-25	WOS:000271013000008
J	Jacquot, G; Le Rouzic, E; Maidou-Peindara, P; Maizy, M; Lefrere, JJ; Daneluzzi, V; Monteiro, CMR; Hong, DP; Planelles, V; Morand-Joubert, L; Benichou, S				Jacquot, Guillaume; Le Rouzic, Erwann; Maidou-Peindara, Priscilla; Maizy, Marion; Lefrere, Jean-Jacques; Daneluzzi, Vincent; Monteiro-Filho, Carlos M. R.; Hong, Duanping; Planelles, Vicente; Morand-Joubert, Laurence; Benichou, Serge			Characterization of the Molecular Determinants of Primary HIV-1 Vpr Proteins: Impact of the Q65R and R77Q Substitutions on Vpr Functions	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-CYCLE ARREST; NUCLEAR-PORE COMPLEX; DISEASE PROGRESSION; G(2) ARREST; MACROPHAGE INFECTION; VIRION INCORPORATION; MUTATIONAL ANALYSIS; UBIQUITIN LIGASE; IN-VIVO	Although HIV-1 Vpr displays several functions in vitro, limited information exists concerning their relevance during infection. Here, we characterized Vpr variants isolated from a rapid and a long-term non-progressor (LTNP). Interestingly, vpr alleles isolated from longitudinal samples of the LTNP revealed a dominant sequence that subsequently led to diversity similar to that observed in the progressor patient. Most of primary Vpr proteins accumulated at the nuclear envelope and interacted with host-cell partners of Vpr. They displayed cytostatic and proapoptotic activities, although a LTNP allele, harboring the Q65R substitution, failed to bind the DCAF1 subunit of the Cul4a/DDB1 E3 ligase and was inactive. This Q65R substitution correlated with impairment of Vpr docking at the nuclear envelope, raising the possibility of a functional link between this property and the Vpr cytostatic activity. In contradiction with published results, the R77Q substitution, found in LTNP alleles, did not influence Vpr proapoptotic activity.			Jacquot, G (corresponding author), Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France.	laurence.morand-joubert@sat.aphp.fr; serge.benichou@inserm.fr		Benichou, Serge/0000-0003-3602-3530	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI049057, R01AI049057] Funding Source: NIH RePORTER; NIAID NIH HHS [AI49057, R01 AI049057, R56 AI049057] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agostini I, 2002, AIDS RES HUM RETROV, V18, P283, DOI 10.1089/088922202753472856; Andersen JL, 2005, CURR HIV RES, V3, P43, DOI 10.2174/1570162052772988; Andersen JL, 2006, PLOS PATHOG, V2, P1106, DOI 10.1371/journal.ppat.0020127; Bell CM, 2007, AIDS RES HUM RETROV, V23, P322, DOI 10.1089/aid.2006.0181; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Chen MZ, 1999, J VIROL, V73, P3236, DOI 10.1128/JVI.73.4.3236-3245.1999; CHEN R, 2004, J BIOL CHEM; CHIU YL, 2007, ANN REV IMMUNOL; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Fischer A, 2004, AIDS, V18, P1346, DOI 10.1097/00002030-200406180-00018; Fouchier RAM, 1998, J VIROL, V72, P6004, DOI 10.1128/JVI.72.7.6004-6013.1998; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Jacquot G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-84; Lai MY, 2006, CELL CYCLE, V5, P2275, DOI 10.4161/cc.5.19.3317; Lamine A, 2007, AIDS, V21, P1043, DOI 10.1097/QAD.0b013e3280d5a7ac; LANG SM, 1993, J VIROL, V67, P902, DOI 10.1128/JVI.67.2.902-912.1993; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Le Rouzic E, 2002, J BIOL CHEM, V277, P45091, DOI 10.1074/jbc.M207439200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lefrere JJ, 2004, TRANSFUSION, V44, P623, DOI 10.1111/j.1537-2995.2004.00354.x; Lefrere JJ, 1997, BLOOD, V90, P1133, DOI 10.1182/blood.V90.3.1133.1133_1133_1140; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Mahalingam S, 1997, J VIROL, V71, P6339, DOI 10.1128/JVI.71.9.6339-6347.1997; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; MEIER UC, 1995, SCIENCE, V270, P1360, DOI 10.1126/science.270.5240.1360; Mologni D, 2006, AIDS, V20, P567, DOI 10.1097/01.aids.0000210611.60459.0e; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Nishizawa M, 2000, VIROLOGY, V276, P16, DOI 10.1006/viro.2000.0534; NITAHARA K, 2007, J VIROL; Pantaleo G, 1996, ANNU REV MICROBIOL, V50, P825, DOI 10.1146/annurev.micro.50.1.825; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Popov S, 1998, J BIOL CHEM, V273, P13347, DOI 10.1074/jbc.273.21.13347; Py B, 2004, J IMMUNOL, V172, P4008, DOI 10.4049/jimmunol.172.7.4008; Rajan D, 2006, AIDS, V20, P831, DOI 10.1097/01.aids.0000218546.31716.7f; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Selig L, 1999, J VIROL, V73, P592, DOI 10.1128/JVI.73.1.592-600.1999; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; TAN L, 2007, J VIROL; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175; Waldhuber MG, 2003, VIROLOGY, V313, P91, DOI 10.1016/S0042-6822(03)00258-7; WEN X, 2007, J BIOL CHEM; YAO XJ, 1995, J VIROL, V69, P7032, DOI 10.1128/JVI.69.11.7032-7044.1995; Zhou Y, 2000, J VIROL, V74, P6520, DOI 10.1128/JVI.74.14.6520-6527.2000	48	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7514	10.1371/journal.pone.0007514	http://dx.doi.org/10.1371/journal.pone.0007514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838296	Green Published, gold, Green Submitted			2022-12-25	WOS:000270880900015
J	Li, H; MacLean, G; Cameron, D; Clagett-Dame, M; Petkovich, M				Li, Hui; MacLean, Glenn; Cameron, Don; Clagett-Dame, Margaret; Petkovich, Martin			Cyp26b1 Expression in Murine Sertoli Cells Is Required to Maintain Male Germ Cells in an Undifferentiated State during Embryogenesis	PLOS ONE			English	Article							RETINOIC ACID; MITOTIC ARREST; MOUSE; HINDBRAIN; FETAL; RAT; ENZYME; TESTIS	In mammals, germ cells within the developing gonad follow a sexually dimorphic pathway. Germ cells in the murine ovary enter meiotic prophase during embryogenesis, whereas germ cells in the embryonic testis arrest in G0 of mitotic cell cycle and do not enter meiosis until after birth. In mice, retinoic acid (RA) signaling has been implicated in controlling entry into meiosis in germ cells, as meiosis in male embryonic germ cells is blocked by the activity of a RA-catabolizing enzyme, CYP26B1. However, the mechanisms regulating mitotic arrest in male germ cells are not well understood. Cyp26b1 expression in the testes begins in somatic cells at embryonic day (E) 11.5, prior to mitotic arrest, and persists throughout fetal development. Here, we show that Sertoli cell-specific loss of CYP26B1 activity between E15.5 and E16.5, several days after germ cell sex determination, causes male germ cells to exit from G0, re-enter the mitotic cell cycle and initiate meiotic prophase. These results suggest that male germ cells retain the developmental potential to differentiate in meiosis until at least at E15.5. CYP26B1 in Sertoli cells acts as a masculinizing factor to arrest male germ cells in the G0 phase of the cell cycle and prevents them from entering meiosis, and thus is essential for the maintenance of the undifferentiated state of male germ cells during embryonic development.			Li, H (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	petkovic@queensu.ca			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Livera G, 2000, BIOL REPROD, V62, P1303, DOI 10.1095/biolreprod62.5.1303; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; Maclean G, 2009, DEV DYNAM, V238, P732, DOI 10.1002/dvdy.21878; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Nagano R, 2000, ANAT REC, V258, P210; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; O'Shaughnessy PJ, 2007, ENDOCRINOLOGY, V148, P2914, DOI 10.1210/en.2006-1412; Pennimpede T, 2006, AD DEV BIOL, V16, P65, DOI 10.1016/S1574-3349(06)16003-2; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Trautmann E, 2008, CELL CYCLE, V7, P656, DOI 10.4161/cc.7.5.5482; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; White JC, 2000, DEV BIOL, V220, P263, DOI 10.1006/dbio.2000.9635; Wu JW, 2008, ASIAN J ANDROL, V10, P569, DOI 10.1111/j.1745-7262.2008.00408.x; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0	24	61	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7501	10.1371/journal.pone.0007501	http://dx.doi.org/10.1371/journal.pone.0007501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838304	Green Submitted, gold, Green Published			2022-12-25	WOS:000270880900007
J	Hussain, R; Talat, N; Shahid, F; Dawood, G				Hussain, Rabia; Talat, Najeeha; Shahid, Firdaus; Dawood, Ghaffar			Biomarker Changes Associated with Tuberculin Skin Test (TST) Conversion: A Two-Year Longitudinal Follow-Up Study in Exposed Household Contacts	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ALPHA TNF-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; BLOOD-TEST; RESPONSES; IL-10; INTERLEUKIN-6; PREVALENCE; INFECTION; RECOMBINANT	Background: A high prevalence (50-80%) of Tuberculin Skin Test Positivity (TST+ >= 10 mm indurations) has been reported in TB endemic countries. This pool forms a huge reservoir for new incident TB cases. However, immune biomarkers associated with TST conversion are largely unknown. The objective of this study was to identify immune biomarkers associated with TST conversion after acute Mycobacterium tuberculosis (MTB) exposure. Methodology/Principal Findings: A 24 month longitudinal study was carried out in a recently MTB exposed cohort of household contacts (HC = 93; 75% TST+). Control group consisted of unexposed community controls (EC = 59; 46% TST+). Cytokine secretion was assessed in whole blood cultures in response to either mycobacterial culture filtrate (CF) antigens or mitogens (PHA or LPS) using Elisa methodology. Compared to the EC group, the HC group at recruitment (Kruskal-Wallis Test) showed significantly suppressed IFN gamma ( p = 0.0001), raised IL-10 ( p = 0.0005) and raised TNF alpha ( p = 0.001) in response to CF irrespective of their TST status. Seventeen TST-HC, showed TST conversion when retested at 6 months. Post TST conversion (paired t tests) significant increases were observed for CF induced IFN gamma (p = 0.038), IL-10 (p = 0.001) and IL-6 ( p = 0.006). Cytokine responses were also compared in the exposed HC group with either recent infection [(TST converters ( N = 17)] or previous infection [TST+ HC ( N = 54)] at 0, 6, 12 and 24 months using ANOVA on repeated measures. Significant differences between the exposed HC groups were noted only at 6 months. CF induced IFN gamma was higher in previously infected HC group ( p = 0.038) while IL-10 was higher in recently infected HC group ( p = 0.041). Mitogen induced cytokine secretion showed similar differences for different group. Conclusions/Significance: Our results suggest that TST conversion is associated with early increases in IFN gamma and IL-10 responses and precedes latency by several months post exposure.			Hussain, R (corresponding author), Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan.	rabia.hussain@aku.edu	Hussain, Rabia/E-9982-2015					Abebe F, 2006, CLIN EXP IMMUNOL, V143, P180, DOI 10.1111/j.1365-2249.2005.02976.x; Akhtar S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-70; Black GF, 2003, CLIN DIAGN LAB IMMUN, V10, P602, DOI 10.1128/CDLI.10.4.602-611.2003; Black GF, 2001, INT J TUBERC LUNG D, V5, P664; Britton WJ, 2005, TUBERCULOSIS, V85, P137, DOI 10.1016/j.tube.2004.06.003; CROFTON J, 1990, CROFTON DOUGLAS RESP, P395; Demissie A, 2006, INFECT IMMUN, V74, P2817, DOI 10.1128/IAI.74.5.2817-2822.2006; Diel R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-77; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Elliott AM, 2004, T ROY SOC TROP MED H, V98, P660, DOI 10.1016/j.trstmh.2004.01.007; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gaikwad AN, 2008, CLIN EXP IMMUNOL, V151, P414, DOI 10.1111/j.1365-2249.2007.03585.x; Higgins DM, 2009, TUBERCULOSIS, V89, P149, DOI 10.1016/j.tube.2009.01.001; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hussain H, 2003, INT J EPIDEMIOL, V32, P794, DOI 10.1093/ije/dyg247; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; Hussain R, 2001, CLIN EXP IMMUNOL, V123, P210, DOI 10.1046/j.1365-2249.2001.01439.x; Hussain R, 2007, CLIN VACCINE IMMUNOL, V14, P1578, DOI 10.1128/CVI.00289-07; Ito T, 2007, EUR J IMMUNOL, V37, P2847, DOI 10.1002/eji.200737603; Katakura T, 2004, J IMMUNOL, V172, P1407, DOI 10.4049/jimmunol.172.3.1407; Keane J, 2005, RHEUMATOLOGY, V44, P714, DOI 10.1093/rheumatology/keh567; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Leal IS, 1999, INFECT IMMUN, V67, P5747, DOI 10.1128/IAI.67.11.5747-5754.1999; LUE C, 1991, CELL IMMUNOL, V132, P423, DOI 10.1016/0008-8749(91)90039-E; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Rathi SK, 2002, INT J TUBERC LUNG D, V6, P851; Saunders BM, 2000, INFECT IMMUN, V68, P3322, DOI 10.1128/IAI.68.6.3322-3326.2000; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Stenger S, 2002, CURR OPIN IMMUNOL, V14, P452, DOI 10.1016/S0952-7915(02)00355-2; Streeton JA, 1998, INT J TUBERC LUNG D, V2, P443; Talat N, 2009, SCAND J IMMUNOL, V69, P537, DOI 10.1111/j.1365-3083.2009.02250.x; Thakurdas SM, 2004, CLIN EXP IMMUNOL, V136, P320, DOI 10.1111/j.1365-2249.2004.02459.x; WALLIS RS, 1993, INFECT IMMUN, V61, P627, DOI 10.1128/IAI.61.2.627-632.1993; WALLIS RS, 1990, P NATL ACAD SCI USA, V87, P3348, DOI 10.1073/pnas.87.9.3348; Whalen CC, 2006, AM J TROP MED HYG, V75, P55, DOI 10.4269/ajtmh.2006.75.55; *WHO, 2009, REV NAT IMM COV 1980; *WHO, 2007, WHO GLOB TUB CONTR S; *WHO, 2008, WHO REP 2008 COUNTR, P133; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005; 2009, WHO STAT 2009	43	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7444	10.1371/journal.pone.0007444	http://dx.doi.org/10.1371/journal.pone.0007444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826490	Green Published, Green Submitted, gold			2022-12-25	WOS:000270808700008
J	Yamamoto, S; Humle, T; Tanaka, M				Yamamoto, Shinya; Humle, Tatyana; Tanaka, Masayuki			Chimpanzees Help Each Other upon Request	PLOS ONE			English	Article							TOOL-USE; NAIVE CHIMPANZEES; CAPUCHIN MONKEYS; FOOD; ALTRUISM; CONSPECIFICS; COOPERATION; RECIPROCITY; EVOLUTION; MOTHERS	Background: The evolution of altruism has been explained mainly from ultimate perspectives. However, it remains to be investigated from a proximate point of view how and in which situations such social propensity is achieved. We investigated chimpanzees' targeted helping in a tool transfer paradigm, and discuss the similarities and differences in altruism between humans and chimpanzees. Previously it has been suggested that chimpanzees help human experimenters by retrieving an object which the experimenter is trying to reach. In the present study, we investigated the importance of communicative interactions between chimpanzees themselves and the influence of conspecific partner's request on chimpanzees' targeted helping. Methodology/Principal Findings: We presented two tool-use situations ( a stick-use situation and a straw-use situation) in two adjacent booths, and supplied non-corresponding tools to paired chimpanzees in the two booths. For example, a chimpanzee in the stick-use situation was supplied with a straw, and the partner in the straw-use situation possessed a stick. Spontaneous tool transfer was observed between paired chimpanzees. The tool transfer events occurred predominantly following recipients' request. Even without any hope of reciprocation from the partner, the chimpanzees continued to help the partner as long as the partner required help. Conclusions/Significance: These results provide further evidence for altruistic helping in chimpanzees in the absence of direct personal gain or even immediate reciprocation. Our findings additionally highlight the importance of request as a proximate mechanism motivating prosocial behavior in chimpanzees whether between kin or non-kin individuals and the possible confounding effect of dominance on the symmetry of such interactions. Finally, in contrast to humans, our study suggests that chimpanzees rarely perform acts of voluntary altruism. Voluntary altruism in chimpanzees is not necessarily prompted by simple observation of another's struggle to attain a goal and therefore an accurate understanding of others' desires in the absence of communicative signals.			Yamamoto, S (corresponding author), Kyoto Univ, Primate Res Inst, Aichi, Japan.	yamamoto@darwin.c.u-tokyo.ac.jp						Boesch C, 2000, CHIMPANZEES TAI FORE; Brosnan SF, 2009, J COMP PSYCHOL, V123, P181, DOI 10.1037/a0015092; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Celli ML, 2004, INT J PRIMATOL, V25, P1267, DOI 10.1023/B:IJOP.0000043962.60837.16; Cronin KA, 2009, J COMP PSYCHOL, V123, P231, DOI 10.1037/a0015094; De Waal F., 1996, GOOD NATURED; de Waal FBM, 2000, NATURE, V404, P563, DOI 10.1038/35007138; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; DEWAAL FBM, 1989, J HUM EVOL, V18, P433, DOI 10.1016/0047-2484(89)90074-2; Dufour V, 2009, BIOL LETTERS, V5, P172, DOI 10.1098/rsbl.2008.0644; Dugatkin L.A., 1997, COOPERATION ANIMALS; Goodall J., 1986, CHIMPANZEES GOMBE PA; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hattori Y, 2005, J COMP PSYCHOL, V119, P335, DOI 10.1037/0735-7036.119.3.335; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P2363, DOI 10.1098/rspb.2003.2509; Hayashi M, 2005, PRIMATES, V46, P91, DOI 10.1007/s10329-004-0110-z; Hikami K., 1991, Primate Research, V7, P12; Hirata S, 2000, J COMP PSYCHOL, V114, P291, DOI 10.1037/0735-7036.114.3.291; Hirata S, 2003, ANIM COGN, V6, P235, DOI 10.1007/s10071-003-0187-6; Hirata S, 2007, PRIMATES, V48, P13, DOI 10.1007/s10329-006-0022-1; Hockings KJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000886; Jensen K, 2006, P ROY SOC B-BIOL SCI, V273, P1013, DOI 10.1098/rspb.2005.3417; Lakshminarayanan VR, 2008, CURR BIOL, V18, pR999, DOI 10.1016/j.cub.2008.08.057; Matsuzawa T, 2003, ANIM COGN, V6, P199, DOI 10.1007/s10071-003-0199-2; Matsuzawa T, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P557; Matsuzawa T., 2006, COGNITIVE DEV CHIMPA; Melis AP, 2008, ANIM BEHAV, V76, P951, DOI 10.1016/j.anbehav.2008.05.014; Melis AP, 2006, ANIM BEHAV, V72, P275, DOI 10.1016/j.anbehav.2005.09.018; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; OCHIAI T, 1998, P 3 INT C ENV ENR OR, P355; SAVAGERUMBAUGH ES, 1978, BEHAV BRAIN SCI, V1, P539, DOI 10.1017/S0140525X00076536; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; Stevens JR, 2004, P ROY SOC B-BIOL SCI, V271, P451, DOI 10.1098/rspb.2003.2625; Tanaka M, 2009, ANIM COGN, V12, pS19, DOI 10.1007/s10071-009-0270-8; TELEKI G, 1973, PREDATORY BEHAV WILD; Tomonaga M, 2004, JPN PSYCHOL RES, V46, P227, DOI 10.1111/j.1468-5584.2004.00254.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Ueno A, 2004, PRIMATES, V45, P231, DOI 10.1007/s10329-004-0085-9; Van Schaik CP, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P3; Vonk J, 2008, ANIM BEHAV, V75, P1757, DOI 10.1016/j.anbehav.2007.09.036; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Yamamoto S, 2009, ANIM COGN, V12, pS27, DOI 10.1007/s10071-009-0276-2; Yamamoto S, 2009, J COMP PSYCHOL, V123, P242, DOI 10.1037/a0015838; Yamamoto S, 2009, INTERACT STUD, V10, P150, DOI 10.1075/is.10.2.04yam; [No title captured]	48	116	119	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7416	10.1371/journal.pone.0007416	http://dx.doi.org/10.1371/journal.pone.0007416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506WT	19826478	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000270808700005
J	Mandapathil, M; Hilldorfer, B; Szczepanski, MJ; Czystowska, M; Szajnik, M; Ren, J; Lang, S; Jackson, EK; Gorelik, E; Whiteside, TL				Mandapathil, Magis; Hilldorfer, Benedict; Szczepanski, Miroslaw J.; Czystowska, Malgorzata; Szajnik, Marta; Ren, Jin; Lang, Stephan; Jackson, Edwin K.; Gorelik, Elieser; Whiteside, Theresa L.			Generation and Accumulation of Immunosuppressive Adenosine by Human CD4(+)CD25(high)FOXP3(+) Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSE; AUTOIMMUNE-DISEASE; EXTRACELLULAR ATP; PERIPHERAL-BLOOD; DENDRITIC CELLS; TISSUE-DAMAGE; RECEPTORS; CD73; SUPPRESSION; EXPRESSION	Naturally occurring regulatory T cells (nTreg) are crucial for maintaining tolerance to self and thus preventing autoimmune diseases and allograft rejections. In cancer, Treg down-regulate antitumor responses by several distinct mechanisms. This study analyzes the role the adenosinergic pathway plays in suppressive activities of human nTreg. Human CD4(+)CD25(high)FOXP3(+) Treg overexpress CD39 and CD73, ectonucleotidases sequentially converting ATP into AMP and adenosine, which then binds to A(2a) receptors on effector T cells, suppressing their functions. CD4(+)CD39(+) and CD4(+)CD25(high) T cells express low levels of adenosine deaminase (ADA), the enzyme responsible for adenosine breakdown, and of CD26, a surface-bound glycoprotein associated with ADA. In contrast, T effector cells are enriched in CD26/ADA but express low levels of CD39 and CD73. Inhibitors of ectonucleotidase activity (e.g. ARL67156) and antagonists of the A(2a) receptor (e.g. ZM241385) blocked Treg-mediated immunosuppression. The inhibition of ADA activity on effector T cells enhanced Treg-mediated immunosuppression. Thus, human nTreg characterized by the presence of CD39 and the low expression of CD26/ADA are responsible for the generation of adenosine, which plays a major role in Treg-mediated immunosuppression. The data suggest that the adenosinergic pathway represents a potential therapeutic target for regulation of immunosuppression in a broad variety of human diseases.	[Mandapathil, Magis; Hilldorfer, Benedict; Szczepanski, Miroslaw J.; Czystowska, Malgorzata; Szajnik, Marta; Gorelik, Elieser; Whiteside, Theresa L.] Univ Pittsburgh, Inst Canc, Dept Pathol, Pittsburgh, PA 15213 USA; [Ren, Jin; Jackson, Edwin K.] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15260 USA; [Mandapathil, Magis; Lang, Stephan] Univ Duisburg Essen, Dept Otorhinolaryngol, D-45147 Essen, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Duisburg Essen	Whiteside, TL (corresponding author), Univ Pittsburgh, Inst Canc, Dept Pathol, Res Pavil,Hillman Canc Ctr,5117 Ctr Ave,Suite 1-2, Pittsburgh, PA 15213 USA.	whitesidetl@upmc.edu	Mandapathil, Magis/AFL-3260-2022; Czystowska-Kuźmicz, Małgorzata/U-7933-2018; Czystowska-Kuzmicz, Malgorzata/AAC-6989-2020; Czystowska-Kuźmicz, Małgorzata/ABH-3220-2020	Czystowska-Kuźmicz, Małgorzata/0000-0001-9169-6194; Czystowska-Kuźmicz, Małgorzata/0000-0001-9169-6194; Jackson, Edwin/0000-0002-8101-6009	National Institutes of Health [DK079307, DK068575, PO-1 DE12321, PO-1 CA109688]; Philip Morris USA, Inc.; Philip Morris International; Department of Defense [BC051720]; Hillman Foundation; NATIONAL CANCER INSTITUTE [P01CA109688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE012321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068575, P30DK079307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris USA, Inc.; Philip Morris International; Department of Defense(United States Department of Defense); Hillman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK079307 and DK068575 (to E. K. J.) and PO-1 DE12321 and PO-1 CA109688 (to T. W.). This work was also supported by Philip Morris USA, Inc. and Philip Morris International (to M. M.), Department of Defense Grant BC051720, and the Hillman Foundation (to E. G.).	Airas L, 1997, J CELL BIOL, V136, P421, DOI 10.1083/jcb.136.2.421; Aswad F, 2005, J IMMUNOL, V175, P3075, DOI 10.4049/jimmunol.175.5.3075; Baecher-Allan C, 2006, IMMUNOL REV, V212, P203, DOI 10.1111/j.0105-2896.2006.00417.x; Bergmann C, 2007, CANCER IMMUNOL IMMUN, V56, P1429, DOI 10.1007/s00262-007-0280-9; Beyer M, 2008, CURR ONCOL REP, V10, P130, DOI 10.1007/s11912-008-0021-z; Bodor J, 2007, EUR J IMMUNOL, V37, P884, DOI 10.1002/eji.200636510; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Burnstock G, 1997, NEUROPHARMACOLOGY, V36, P1127, DOI 10.1016/S0028-3908(97)00125-1; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Dong RP, 1996, J IMMUNOL, V156, P1349; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Huang CT, 2004, IMMUNITY, V21, P503, DOI 10.1016/j.immuni.2004.08.010; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Kline J, 2008, BONE MARROW TRANSPL, V41, P505, DOI 10.1038/sj.bmt.1705931; Klinger M, 2002, CELL SIGNAL, V14, P99, DOI 10.1016/S0898-6568(01)00235-2; Kobie JJ, 2006, J IMMUNOL, V177, P6780, DOI 10.4049/jimmunol.177.10.6780; la Sala A, 2001, J IMMUNOL, V166, P1611, DOI 10.4049/jimmunol.166.3.1611; Levings MK, 2001, J EXP MED, V193, P1295, DOI 10.1084/jem.193.11.1295; Mandapathil M, 2009, J IMMUNOL METHODS, V346, P55, DOI 10.1016/j.jim.2009.05.004; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Panther E, 2003, BLOOD, V101, P3985, DOI 10.1182/blood-2002-07-2113; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; Raskovalova T, 2005, J IMMUNOL, V175, P4383, DOI 10.4049/jimmunol.175.7.4383; Raskovalova T, 2007, CANCER RES, V67, P5949, DOI 10.1158/0008-5472.CAN-06-4249; Resta R, 1998, IMMUNOL REV, V161, P95, DOI 10.1111/j.1600-065X.1998.tb01574.x; Roncarolo MG, 2001, IMMUNOL REV, V182, P68, DOI 10.1034/j.1600-065X.2001.1820105.x; SCHRADER WP, 1990, J BIOL CHEM, V265, P19312; Sitkovsky MV, 2005, TRENDS IMMUNOL, V26, P299, DOI 10.1016/j.it.2005.04.004; Sitkovsky MV, 2003, BIOCHEM PHARMACOL, V65, P493, DOI 10.1016/S0006-2952(02)01548-4; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Strauss L, 2007, CLIN CANCER RES, V13, P6301, DOI 10.1158/1078-0432.CCR-07-1403; Strauss L, 2007, J IMMUNOL, V178, P320, DOI 10.4049/jimmunol.178.1.320; THOMSON LF, 1990, TISSUE ANTIGENS, V35, P9, DOI 10.1111/j.1399-0039.1990.tb01750.x; Verbsky JW, 2007, CURR OPIN RHEUMATOL, V19, P252, DOI 10.1097/BOR.0b013e3280ad46bb; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	43	283	297	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7176	7186		10.1074/jbc.M109.047423	http://dx.doi.org/10.1074/jbc.M109.047423			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	19858205	Green Published, hybrid			2022-12-25	WOS:000275415600031
J	Takai, KK; Hooper, S; Blackwood, S; Gandhi, R; de Lange, T				Takai, Kaori K.; Hooper, Sarah; Blackwood, Stephanie; Gandhi, Rita; de Lange, Titia			In Vivo Stoichiometry of Shelterin Components	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TELOMERE LENGTH CONTROL; HUMAN-CHROMOSOMES; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; DYSFUNCTIONAL TELOMERES; MAMMALIAN TELOMERES; PROTECTS TELOMERES; DAMAGE RESPONSE; FISSION YEAST; POT1 PROTEINS	Human telomeres bind shelterin, the six-subunit protein complex that protects chromosome ends from the DNA damage response and regulates telomere length maintenance by telomerase. We used quantitative immunoblotting to determine the abundance and stoichiometry of the shelterin proteins in the chromatin-bound protein fraction of human cells. The abundance of shelterin components was similar in primary and transformed cells and was not correlated with telomere length. The duplex telomeric DNA binding factors in shelterin, TRF1 and TRF2, were sufficiently abundant to cover all telomeric DNA in cells with short telomeres. The TPP1.POT1 heterodimer was present 50-100 copies/telomere, which is in excess of its single-stranded telomeric DNA binding sites, indicating that some of the TPP1.POT1 in shelterin is not associated with the single-stranded telomeric DNA. TRF2 and Rap1 were present at 1:1 stoichiometry as were TPP1 and POT1. The abundance of TIN2 was sufficient to allow each TRF1 and TRF2 to bind to TIN2. Remarkably, TPP1 and POT1 were similar to 10-fold less abundant than their TIN2 partner in shelterin, raising the question of what limits the accumulation of TPP1.POT1 at telomeres. Finally, we report that a 10-fold reduction in TRF2 affects the regulation of telomere length but not the protection of telomeres in tumor cell lines.	[Takai, Kaori K.; Hooper, Sarah; Blackwood, Stephanie; Gandhi, Rita; de Lange, Titia] Rockefeller Univ, Cell Biol & Genet Lab, New York, NY 10065 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Cell Biol & Genet Lab, 1230 York Ave, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	National Institutes of Health [CA076027, GM09046, AG016642]; NATIONAL CANCER INSTITUTE [R01CA076027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health grants CA076027, GM09046, and AG016642 (to T.d.L.).	Ancelin K, 2002, MOL CELL BIOL, V22, P3474, DOI 10.1128/MCB.22.10.3474-3487.2002; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bilaud T, 1997, NAT GENET, V17, P236, DOI 10.1038/ng1097-236; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Bryan TM, 1998, EXP CELL RES, V239, P370, DOI 10.1006/excr.1997.3907; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Churikov D, 2008, NAT STRUCT MOL BIOL, V15, P79, DOI 10.1038/nsmb1331; d'Adda di Fagagna F, 2003, NATURE, V426, P194, DOI [10.1038/nature02118, DOI 10.1038/NATURE02118]; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Donigian JR, 2007, J BIOL CHEM, V282, P22662, DOI 10.1074/jbc.M702620200; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; He H, 2006, EMBO J, V25, P5180, DOI 10.1038/sj.emboj.7601294; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Hockemeyer D, 2007, NAT STRUCT MOL BIOL, V14, P754, DOI 10.1038/nsmb1270; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; Kelleher C, 2005, MOL CELL BIOL, V25, P808, DOI 10.1128/MCB.25.2.808-818.2005; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Lei M, 2005, J BIOL CHEM, V280, P20449, DOI 10.1074/jbc.M502212200; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Loayza D, 2004, J BIOL CHEM, V279, P13241, DOI 10.1074/jbc.M312309200; Loayza D, 2003, NATURE, V423, P1013, DOI 10.1038/nature01688; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; O'Connor MS, 2004, J BIOL CHEM, V279, P28585, DOI 10.1074/jbc.M312913200; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; TOMMERUP H, 1994, MOL CELL BIOL, V14, P5777, DOI 10.1128/MCB.14.9.5777; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Xin HW, 2007, NATURE, V445, P559, DOI 10.1038/nature05469; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	54	163	167	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1457	1467		10.1074/jbc.M109.038026	http://dx.doi.org/10.1074/jbc.M109.038026			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19864690	hybrid, Green Published			2022-12-25	WOS:000273258200065
J	Schiller, M; Dennler, S; Anderegg, U; Kokot, A; Simon, JC; Luger, TA; Mauviel, A; Bohm, M				Schiller, Meinhard; Dennler, Sylviane; Anderegg, Ulf; Kokot, Agatha; Simon, Jan C.; Luger, Thomas A.; Mauviel, Alain; Boehm, Markus			Increased cAMP Levels Modulate Transforming Growth Factor-beta/Smad-induced Expression of Extracellular Matrix Components and Other Key Fibroblast Effector Functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DERMAL FIBROBLASTS; MELANOCYTE-STIMULATING HORMONE; COLLAGEN GEL CONTRACTION; DIBUTYRYL-CYCLIC-AMP; GENE COL7A1 PROMOTER; NUCLEAR-PROTEIN CBP; FACTOR-BETA; TGF-BETA; CELL-MIGRATION; TRANSCRIPTIONAL ACTIVATION	cAMP is a key messenger of many hormones and neuropeptides, some of which modulate the composition of extracellular matrix. Treatment of human dermal fibroblasts with dibutyryl cyclic AMP and forskolin antagonized the inductive effects of transforming growth factor-beta (TGF-beta) on the expression of collagen, connective tissue growth factor, tissue inhibitor of matrix metalloproteinase-1, and plasminogen activator inhibitor type I, four prototypical TGF-beta-responsive genes. Increased intracellular cAMP prevented TGF-beta-induced Smad-specific gene transactivation, although TGF-beta-mediated Smad phosphorylation and nuclear translocation remained unaffected. However, increased cAMP levels abolished TGF-beta-induced interaction of Smad3 with its transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP)/p300. Overexpression of the transcriptional co-activator CBP/p300 rescued Smad-specific gene transcription in the presence of cAMP suggesting that sequestration of limited amounts of CBP/p300 by the activated cAMP/CREB pathway is the molecular basis of this inhibitory effect. These findings were extended by two functional assays. Increased intracellular cAMP levels suppressed the inductive activity of TGF-beta to contract mechanically unloaded collagen lattices and resulted in an attenuation of fibroblast migration of mechanically induced cell layer wounds. Of note, cAMP and TGF-beta synergistically induced hyaluronan synthase 2 (HAS2) expression and hyaluronan secretion, presumably via putative CREB-binding sites adjacent to Smad-binding sites within the HAS2 promoter. Our findings identify the cAMP pathway as a potent but differential and promoter-specific regulator of TGF-beta-mediated effects involved in extracellular matrix homeostasis.	[Schiller, Meinhard; Kokot, Agatha; Luger, Thomas A.; Boehm, Markus] Ludwig Boltzmann Inst Cell Biol & Immunobiol Skin, Dept Dermatol, D-48149 Munster, Germany; [Dennler, Sylviane; Mauviel, Alain] Univ Paris 07, INSERM, U697, F-75011 Paris, France; [Anderegg, Ulf; Simon, Jan C.] Univ Leipzig, Med Ctr, Dept Dermatol, D-04103 Leipzig, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Leipzig University	Schiller, M (corresponding author), Univ Hosp Munster, Dept Dermatol, Von Esmarch Str 58, D-48149 Munster, Germany.	schillm@uni-muenster.de; alain.mauviel@inserm.fr	MAUVIEL, Alain/F-6251-2013	Mauviel, Alain/0000-0002-0438-2793	Deutsche Forschungsgemeinschaft Postdoctoral Fellowship Schi [585/2-1]; Institut National du Cancer; Region Ile-de-France; Donation Henriette et Emile Goutiere; Canceropole Ile-de-France; INSERM, France; Deutsche Forschungsgemeinschaft (DFG) [BO 1075/5-1, BO 1075/5-3]	Deutsche Forschungsgemeinschaft Postdoctoral Fellowship Schi(German Research Foundation (DFG)); Institut National du Cancer(Institut National du Cancer (INCA) France); Region Ile-de-France(Region Ile-de-France); Donation Henriette et Emile Goutiere; Canceropole Ile-de-France(Region Ile-de-France); INSERM, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Recipient of Deutsche Forschungsgemeinschaft Postdoctoral Fellowship Schi 585/2-1. Towhomcorrespondencemaybe addressed: University Hospital Munster, Dept. of Dermatology; Von-Esmarch-Str. 58, 48149 Munster, Germany. Tel.: 11-49-251-8356501; Fax: 11-49-251-8356522; E-mail: schillm@uni-muenster.de.; Recipient of a postdoctoral fellowship from Institut National du Cancer and Region Ile-de-France.; Supported by the Donation Henriette et Emile Goutiere, Canceropole Ile-de-France, and INSERM, France. To whom correspondence may be addressed: INSERM U697, Hopital Saint-Louis, 1 Ave. Claude Vellefaux, 75010 Paris, France. Tel.: 33-153-722-069; Fax: 33-153-722-051; E-mail: alain.mauviel@inserm.fr.; Supported by grants from the Deutsche Forschungsgemeinschaft (DFG) BO 1075/5-1 and BO 1075/5-3.	Akool ES, 2005, J BIOL CHEM, V280, P39403, DOI 10.1074/jbc.M504140200; Arnott JA, 2008, BONE, V42, P871, DOI 10.1016/j.bone.2008.01.006; Atfi A, 1997, J BIOL CHEM, V272, P24731, DOI 10.1074/jbc.272.40.24731; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bohm M, 2006, J INVEST DERMATOL, V126, P1966, DOI 10.1038/sj.jid.5700421; Bohm M, 2004, J BIOL CHEM, V279, P6959, DOI 10.1074/jbc.M312549200; Bohm MB, 2005, ENDOCRINOLOGY, V146, P4635, DOI 10.1210/en.2005-0665; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Brennan M, 2003, PHOTOCHEM PHOTOBIOL, V78, P43, DOI 10.1562/0031-8655(2003)078<0043:MMITMC>2.0.CO;2; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cha D, 1996, J INVEST DERMATOL, V106, P590, DOI 10.1111/1523-1747.ep12345083; Choung J, 1998, J CELL BIOCHEM, V71, P254, DOI 10.1002/(SICI)1097-4644(19981101)71:2<254::AID-JCB10>3.3.CO;2-L; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dennler S, 2005, ONCOGENE, V24, P1936, DOI 10.1038/sj.onc.1208343; Edin ML, 2001, EXP CELL RES, V270, P214, DOI 10.1006/excr.2001.5345; Elferink JGR, 1996, GEN PHARMACOL-VASC S, V27, P387, DOI 10.1016/0306-3623(95)00070-4; Feng XH, 1998, GENE DEV, V12, P2153, DOI 10.1101/gad.12.14.2153; Feoktistov I, 2000, MOL PHARMACOL, V58, P903, DOI 10.1124/mol.58.5.903; Ghosh AK, 2001, J BIOL CHEM, V276, P11041, DOI 10.1074/jbc.M004709200; Ghosh AK, 2009, FASEB J, V23, P2968, DOI 10.1096/fj.08-128736; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; HONDA A, 1993, BIOCHEM J, V292, P497, DOI 10.1042/bj2920497; Hottiger MO, 1998, EMBO J, V17, P3124, DOI 10.1093/emboj/17.11.3124; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; IMAI Y, 1994, ENDOCR J, V41, P645, DOI 10.1507/endocrj.41.645; Ionescu AM, 2004, J CELL PHYSIOL, V198, P428, DOI 10.1002/jcp.10421; Itoh H, 2001, AM J PHYSIOL-HEART C, V281, pH359, DOI 10.1152/ajpheart.2001.281.1.H359; IWASAKI T, 1994, J INVEST DERMATOL, V102, P891, DOI 10.1111/1523-1747.ep12383031; Janknecht R, 1998, GENE DEV, V12, P2114, DOI 10.1101/gad.12.14.2114; KEETON MR, 1991, J BIOL CHEM, V266, P23048; KLEWES L, 1994, J CELL PHYSIOL, V160, P539, DOI 10.1002/jcp.1041600317; Kohyama T, 2001, AM J PHYSIOL-LUNG C, V281, pL1257, DOI 10.1152/ajplung.2001.281.5.L1257; Kokot A, 2009, ARTHRITIS RHEUM-US, V60, P592, DOI 10.1002/art.24228; Kolb M, 2001, AM J PHYSIOL-LUNG C, V280, pL1327, DOI 10.1152/ajplung.2001.280.6.L1327; Kopp J, 2005, J BIOL CHEM, V280, P21570, DOI 10.1074/jbc.m502071200; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lai CF, 2000, J BIOL CHEM, V275, P36400, DOI 10.1074/jbc.M002131200; Leask A, 2003, J BIOL CHEM, V278, P13008, DOI 10.1074/jbc.M210366200; Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x; Liu XD, 2003, CELL MOTIL CYTOSKEL, V54, P248, DOI 10.1002/cm.10098; Liu XQ, 2006, MOL PHARMACOL, V70, P1992, DOI 10.1124/mol.106.028951; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makkonen KM, 2009, J BIOL CHEM, V284, P18270, DOI 10.1074/jbc.M109.012492; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Mukai M, 2000, FEBS LETT, V484, P69, DOI 10.1016/S0014-5793(00)02129-3; Poncelet AC, 2001, J BIOL CHEM, V276, P6983, DOI 10.1074/jbc.M006442200; POSTLETHWAITE AE, 1987, J EXP MED, V165, P251, DOI 10.1084/jem.165.1.251; Pullar CE, 2005, WOUND REPAIR REGEN, V13, P405, DOI 10.1111/j.1067-1927.2005.130408.x; Quan TH, 2004, AM J PATHOL, V165, P741, DOI 10.1016/S0002-9440(10)63337-8; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; RAGHOW R, 1987, J CLIN INVEST, V79, P1285, DOI 10.1172/JCI112950; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; Sawaji Y, 2000, CLIN EXP METASTAS, V18, P131, DOI 10.1023/A:1006760021997; Schiller M, 2003, ONCOGENE, V22, P8881, DOI 10.1038/sj.onc.1206871; Schiller M, 2001, J INVEST DERMATOL, V117, P227, DOI 10.1046/j.0022-202x.2001.01412.x; Schiller M, 2004, J DERMATOL SCI, V35, P83, DOI 10.1016/j.jdermsci.2003.12.006; Schmierer B, 2005, MOL CELL BIOL, V25, P9845, DOI 10.1128/MCB.25.22.9845-9858.2005; Schmierer B, 2008, P NATL ACAD SCI USA, V105, P6608, DOI 10.1073/pnas.0710134105; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Spurzem JR, 2002, AM J PHYSIOL-LUNG C, V282, pL1108, DOI 10.1152/ajplung.00148.2001; Sumiyoshi K, 2003, BRIT J DERMATOL, V149, P464, DOI 10.1046/j.1365-2133.2003.05490.x; Tanimoto K, 2004, J DENT RES, V83, P40, DOI 10.1177/154405910408300108; Uchio K, 2004, WOUND REPAIR REGEN, V12, P60, DOI 10.1111/j.1067-1927.2004.012112.x-1; Uitto J, 2000, J DERMATOL SCI, V24, pS60, DOI 10.1016/S0923-1811(00)00143-2; Verrecchia F, 2000, J BIOL CHEM, V275, P30226, DOI 10.1074/jbc.M005310200; Verrecchia F, 2002, J INVEST DERMATOL, V118, P211, DOI 10.1046/j.1523-1747.2002.01641.x; Verrecchia F, 2001, J INVEST DERMATOL, V116, P755, DOI 10.1046/j.1523-1747.2001.01326.x; Verrecchia Franck, 2002, Curr Rheumatol Rep, V4, P143, DOI 10.1007/s11926-002-0010-4; Vindevoghel L, 1998, J BIOL CHEM, V273, P13053, DOI 10.1074/jbc.273.21.13053; Vindevoghel L, 1998, P NATL ACAD SCI USA, V95, P14769, DOI 10.1073/pnas.95.25.14769; WESTERGRENTHORSSON G, 1990, EXP CELL RES, V186, P192, DOI 10.1016/0014-4827(90)90227-2; Zhang Y, 2000, J BIOL CHEM, V275, P16979, DOI 10.1074/jbc.M001526200; Zhou XX, 2007, J ALLERGY CLIN IMMUN, V119, P1388, DOI 10.1016/j.jaci.2007.02.011	77	57	59	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					409	421		10.1074/jbc.M109.038620	http://dx.doi.org/10.1074/jbc.M109.038620			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19858184	hybrid, Green Published			2022-12-25	WOS:000273070100043
J	Anthis, NJ; Haling, JR; Oxley, CL; Memo, M; Wegener, KL; Lim, CJ; Ginsberg, MH; Campbell, ID				Anthis, Nicholas J.; Haling, Jacob R.; Oxley, Camilla L.; Memo, Massimiliano; Wegener, Kate L.; Lim, Chinten J.; Ginsberg, Mark H.; Campbell, Iain D.			beta Integrin Tyrosine Phosphorylation Is a Conserved Mechanism for Regulating Talin-induced Integrin Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; CYTOPLASMIC DOMAIN; SIGNAL-TRANSDUCTION; ALPHA-V-BETA-3 INTEGRIN; ADHESION KINASE; INSIDE-OUT; BINDING; PATHWAYS; CELLS; TAIL	Integrins are large membrane-spanning receptors fundamental to cell adhesion and migration. Integrin adhesiveness for the extracellular matrix is activated by the cytoskeletal protein talin via direct binding of its phosphotyrosine-binding-like F3 domain to the cytoplasmic tail of the beta integrin subunit. The phosphotyrosine-binding domain of the signaling protein Dok1, on the other hand, has an inactivating effect on integrins, a phenomenon that is modulated by integrin tyrosine phosphorylation. Using full-length tyrosine-phosphorylated N-15-labeled beta 3, beta 1A, and beta 7 integrin tails and an NMR-based protein-protein interaction assay, we show that talin1 binds to the NPXY motif and the membrane-proximal portion of beta 3, beta 1A, and beta 7 tails, and that the affinity of this interaction is decreased by integrin tyrosine phosphorylation. Dok1 only interacts weakly with unphosphorylated tails, but its affinity is greatly increased by integrin tyrosine phosphorylation. The Dok1 interaction remains restricted to the integrin NPXY region, thus phosphorylation inhibits integrin activation by increasing the affinity of beta integrin tails for a talin competitor that does not form activating membrane-proximal interactions with the integrin. Key residues governing these specificities were identified by detailed structural analysis, and talin1 was engineered to bind preferentially to phosphorylated integrins by introducing the mutation D372R. As predicted, this mutation affects talin1 localization in live cells in an integrin phosphorylation-specific manner. Together, these results indicate that tyrosine phosphorylation is a common mechanism for regulating integrin activation, despite subtle differences in how these integrins interact with their binding proteins.	[Anthis, Nicholas J.; Oxley, Camilla L.; Memo, Massimiliano; Wegener, Kate L.; Campbell, Iain D.] Univ Oxford, Dept Biochem, Oxford OX1 3DR, England; [Haling, Jacob R.; Lim, Chinten J.; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Oxford; University of California System; University of California San Diego	Anthis, NJ (corresponding author), NIDDK, Chem Phys Lab, NIH, Bldg 5, Bethesda, MD 20892 USA.	nick.anthis@gmail.com; iain.campbell@bioch.ox.ac.uk	Lim, Chinten James/G-3777-2013; Wegener, Kate/E-5077-2010	Lim, Chinten James/0000-0001-6381-7585; Wegener, Kate/0000-0002-1562-6060; Anthis, Nicholas/0000-0002-1881-450X	National Institutes of Health; Wellcome Trust; Rhodes Trust	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Rhodes Trust	This work was supported, in whole or in part, by a National Institutes of Health grant (to M. H. G., I. D. C., and K. L. W.). This work was also supported by grants from the Wellcome Trust (to I. D. C. and C. L. O.) and the Rhodes Trust (to N. J. A.).	Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Blystone SD, 1997, J BIOL CHEM, V272, P28757, DOI 10.1074/jbc.272.45.28757; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Butler B, 2005, J BIOL CHEM, V280, P14556, DOI 10.1074/jbc.M411765200; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Campbell ID, 2004, TRENDS BIOCHEM SCI, V29, P429, DOI 10.1016/j.tibs.2004.06.005; Chandhoke SK, 2004, J CELL SCI, V117, P1431, DOI 10.1242/jcs.00987; Chen H, 2006, GENE DEV, V20, P927, DOI 10.1101/gad.1408306; CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514; Clemmons DR, 2005, MOL ENDOCRINOL, V19, P1, DOI 10.1210/me.2004-0376; Cowan KJ, 2000, J BIOL CHEM, V275, P36423, DOI 10.1074/jbc.M004068200; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gao CL, 2005, J BIOL CHEM, V280, P15422, DOI 10.1074/jbc.M414457200; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; HIRST R, 1986, P NATL ACAD SCI USA, V83, P6470, DOI 10.1073/pnas.83.17.6470; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Hood JD, 2003, J CELL BIOL, V162, P933, DOI 10.1083/jcb.200304105; Hussain A, 2007, PLANTA, V226, P475, DOI 10.1007/s00425-007-0497-z; Huveneers S, 2008, J BIOL CHEM, V283, P13243, DOI 10.1074/jbc.M800927200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jenkins AL, 1998, J BIOL CHEM, V273, P13878, DOI 10.1074/jbc.273.22.13878; JOHANSSON MW, 1994, J CELL BIOL, V126, P1299, DOI 10.1083/jcb.126.5.1299; Kirk RI, 2000, J BIOL CHEM, V275, P30901, DOI 10.1074/jbc.M001908200; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krissansen GW, 2006, EUR J IMMUNOL, V36, P2203, DOI 10.1002/eji.200535324; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Law DA, 1996, J BIOL CHEM, V271, P10811, DOI 10.1074/jbc.271.18.10811; Ling Y, 2005, J BIOL CHEM, V280, P3151, DOI 10.1074/jbc.M411035200; Liu SC, 2000, J CELL SCI, V113, P3563; Lowell CA, 2004, MOL IMMUNOL, V41, P631, DOI 10.1016/j.molimm.2004.04.010; Miller LA, 1999, EUR J IMMUNOL, V29, P1426, DOI 10.1002/(SICI)1521-4141(199905)29:05<1426::AID-IMMU1426>3.0.CO;2-J; Oxley CL, 2008, J BIOL CHEM, V283, P5420, DOI 10.1074/jbc.M709435200; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Sakai T, 2001, P NATL ACAD SCI USA, V98, P3808, DOI 10.1073/pnas.240456398; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Senis YA, 2009, J THROMB HAEMOST, V7, P1718, DOI 10.1111/j.1538-7836.2009.03565.x; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Shaw S K, 1995, Semin Immunol, V7, P335, DOI 10.1016/1044-5323(95)90014-4; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TAMKUN JW, 1986, CELL, V46, P271, DOI 10.1016/0092-8674(86)90744-0; TAPLEY P, 1989, ONCOGENE, V4, P325; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Ulanova M, 2005, AM J PHYSIOL-LUNG C, V288, pL497, DOI 10.1152/ajplung.00246.2004; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wennerberg K, 2000, MOL CELL BIOL, V20, P5758, DOI 10.1128/MCB.20.15.5758-5765.2000; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Xi XD, 2006, J BIOL CHEM, V281, P29426, DOI 10.1074/jbc.C600039200; Zou ZY, 2007, BLOOD, V109, P3284, DOI 10.1182/blood-2006-10-051664	61	94	97	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36700	36710		10.1074/jbc.M109.061275	http://dx.doi.org/10.1074/jbc.M109.061275			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19843520	Green Published, hybrid			2022-12-25	WOS:000272970500070
J	Byrne, RS; Hansch, R; Mendel, RR; Hille, R				Byrne, Robert S.; Haensch, Robert; Mendel, Ralf R.; Hille, Russ			Oxidative Half-reaction of Arabidopsis thaliana Sulfite Oxidase GENERATION OF SUPEROXIDE BY A PEROXISOMAL ENZYME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MILK XANTHINE OXIDASE; RADICAL GENERATION; OXIDIZING ENZYMES; MOLYBDENUM CENTER; LEAF PEROXISOMES; CYTOCHROME-C; DISMUTASE; OXYGEN; IDENTIFICATION; MOLYBDOPTERIN	Vertebrate forms of the molybdenum-containing enzyme sulfite oxidase possess a b-type cytochrome prosthetic group that accepts reducing equivalents from the molybdenum center and passes them on to cytochrome c. The plant form of the enzyme, on the other hand, lacks a prosthetic group other than its molybdenum center and utilizes molecular oxygen as the physiological oxidant. Hydrogen peroxide is the ultimate product of the reaction. Here, we present data demonstrating that superoxide is produced essentially quantitatively both in the course of the reaction of reduced enzyme with O-2 and during steady-state turnover and only subsequently decays (presumably noncatalytically) to form hydrogen peroxide. Rapid-reaction kinetic studies directly following the reoxidation of reduced enzyme demonstrate a linear dependence of the rate constant for the reaction on [O-2] with a second-order rate constant of k(ox) = 8.7 x 10(4) +/- 0.5 x 10(4) M-1 s(-1). When the reaction is carried out in the presence of cytochrome c to follow superoxide generation, biphasic time courses are observed, indicating that a first equivalent of superoxide is generated in the oxidation of the fully reduced Mo(IV) state of the enzyme to Mo(V), followed by a slower oxidation of the Mo(V) state to Mo(VI). The physiological implications of plant sulfite oxidase as a copious generator of superoxide are discussed.	[Byrne, Robert S.; Hille, Russ] Univ Calif Riverside, Dept Mol & Cellular Biochem, Riverside, CA 92521 USA; [Haensch, Robert; Mendel, Ralf R.] Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, D-38106 Braunschweig, Germany	University of California System; University of California Riverside; Braunschweig University of Technology	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, 1462 Boyce Hall, Riverside, CA 92521 USA.	russ.hille@ucr.edu		Hansch, Robert/0000-0003-1310-8419	National Institutes of Health [ES R01 012658]; Deutsche Forschungsgemeinschaft [Ha 3107/4-1]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES R01 012658 (to R. H.) and Deutsche Forschungsgemeinschaft Grant Ha 3107/4-1 (to R. H. and R. R. M).	Aguey-Zinsou KF, 2003, J AM CHEM SOC, V125, P530, DOI 10.1021/ja028293e; BOLANN BJ, 1992, BIOCHIM BIOPHYS ACTA, V1156, P27, DOI 10.1016/0304-4165(92)90091-8; COHEN HJ, 1972, J BIOL CHEM, V247, P7759; COHEN HJ, 1971, J BIOL CHEM, V246, P359; del Rio LA, 1998, PHYSIOL PLANTARUM, V104, P673, DOI 10.1034/j.1399-3054.1998.1040422.x; Eilers T, 2001, J BIOL CHEM, V276, P46989, DOI 10.1074/jbc.M108078200; Feng CJ, 2007, BBA-PROTEINS PROTEOM, V1774, P527, DOI 10.1016/j.bbapap.2007.03.006; Fridovich, 1977, SUPEROXIDE SUPEROXID, P11; FRIDOVICH I, 1970, J BIOL CHEM, V245, P4053; Garton SD, 1997, J AM CHEM SOC, V119, P2590, DOI 10.1021/ja963931c; Hansch R, 2007, PLANT BIOLOGY, V9, P589, DOI 10.1055/s-2007-965433; *HANS ISNTR LTD, 1996, OX PLUS V1 01; Hansch R, 2006, J BIOL CHEM, V281, P6884, DOI 10.1074/jbc.M513054200; Hemann C, 2005, J AM CHEM SOC, V127, P16567, DOI 10.1021/ja0530873; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Kappler U, 2005, J BIOL CHEM, V280, P24999, DOI 10.1074/jbc.M503237200; KESSLER DL, 1972, J BIOL CHEM, V247, P6566; KLUG D, 1972, J BIOL CHEM, V247, P4839; Lopez-Huertas E, 1999, BIOCHEM J, V337, P531, DOI 10.1042/0264-6021:3370531; LopezHuertas E, 1997, FREE RADICAL RES, V26, P497, DOI 10.3109/10715769709097820; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; MCCORD JM, 1968, J BIOL CHEM, V243, P5753; MCCORD JM, 1969, J BIOL CHEM, V244, P6056; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Niknahad H, 2008, CHEM-BIOL INTERACT, V174, P147, DOI 10.1016/j.cbi.2008.05.032; Nowak K, 2004, PLANT CELL PHYSIOL, V45, P1889, DOI 10.1093/pcp/pch212; Schindelin H, 2001, ADV PROTEIN CHEM, V58, P47; Schrader N, 2003, STRUCTURE, V11, P1251, DOI 10.1016/j.str.2003.09.001; STEWART RC, 1985, J BIOL CHEM, V260, P8892; Temple CA, 2000, ARCH BIOCHEM BIOPHYS, V383, P281, DOI 10.1006/abbi.2000.2089	30	31	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35479	35484		10.1074/jbc.M109.067355	http://dx.doi.org/10.1074/jbc.M109.067355			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19875441	hybrid, Green Published			2022-12-25	WOS:000272645600024
J	Kocik, E; Skowronek, KJ; Kasprzak, AA				Kocik, Elzbieta; Skowronek, Krzysztof J.; Kasprzak, Andrzej A.			Interactions between Subunits in Heterodimeric Ncd Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE MOTOR PROTEIN; CRYSTAL-STRUCTURE; PROCESSIVE MOVEMENT; ATP HYDROLYSIS; DIMERIC NCD; IN-VITRO; ONE HEAD; KINESIN; DOMAIN; BINDING	The nonprocessive minus-end-directed kinesin-14 Ncd is involved in the organization of the microtubule (MT) network during mitosis. Only one of the two motor domains is involved in the interaction with the MT. The other head is tethered to the bound one. Here we prepared, purified, and characterized mutated Ncd molecules carrying point mutations in one of the heads, thus producing heterodimeric motors. The mutations tested included substitutions in Switch I and II: R552A, E585A, and E585D; the decoupling mutant N600K; and a deletion in the motor domain in one of the subunits resulting in a single-headed molecule (NcN). These proteins were isolated by two sequential affinity chromatography steps, followed by measurements of their affinities to MT, enzymatic properties, and the velocity of the microtubule gliding test in vitro. Astriking observation is a low affinity of the single-headed NcN for MT both without nucleotides and in the presence of 5'-adenylyl-beta,gamma-imidodiphosphate, implying that the tethered head has a profound effect on the structure of the Ncd-MT complex. Mutated homodimers had no MT-activated ATPase and no motility, whereas NcN had motility comparable with that of the wild type Ncd. Although the heterodimers had one fully active and one inactive head, the ATPase and motility of Ncd heterodimers varied dramatically, clearly demonstrating that interactions between motor domains exist in Ncd. We also show that the bulk property of dimeric proteins that interact with the filament with only one of its heads depends also on the distribution of the filament-interacting subunits.	M Nencki Inst Expt Biol, Dept Biochem, Motor Prot Lab, PL-02093 Warsaw, Poland; [Skowronek, Krzysztof J.] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej		a.kasprzak@nencki.gov.pl	Skowronek, Krzysztof/G-2855-2010; Kasprzak, Andrzej A. A/R-4476-2016	Skowronek, Krzysztof/0000-0001-9973-7085; Kasprzak, Andrzej A. A/0000-0002-3602-5379	Polish Ministry of Science and Higher Education [2P04C 131 29, N301 294137]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported in part by Polish Ministry of Science and Higher Education Grants 2P04C 131 29 and N301 294137.	Adio S, 2006, J BIOL CHEM, V281, P37782, DOI 10.1074/jbc.M605061200; Adio S, 2009, FEBS J, V276, P3641, DOI 10.1111/j.1742-4658.2009.07083.x; Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Chu HMA, 2005, EMBO J, V24, P3214, DOI 10.1038/sj.emboj.7600790; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Foster KA, 1998, J BIOL CHEM, V273, P35307, DOI 10.1074/jbc.273.52.35307; Foster KA, 2001, J BIOL CHEM, V276, P19259, DOI 10.1074/jbc.M008347200; Furuta K, 2008, CURR BIOL, V18, P152, DOI 10.1016/j.cub.2007.12.056; HACKNEY DD, 1994, P NATL ACAD SCI USA, V91, P6865, DOI 10.1073/pnas.91.15.6865; Hajdo L, 2004, ARCH BIOCHEM BIOPHYS, V421, P217, DOI 10.1016/j.abb.2003.11.009; Han Y, 1999, J STRUCT BIOL, V128, P26, DOI 10.1006/jsbi.1999.4162; Hancock WO, 1999, P NATL ACAD SCI USA, V96, P13147, DOI 10.1073/pnas.96.23.13147; HATSUMI M, 1992, J CELL SCI, V101, P547; Hirose K, 1998, J MOL BIOL, V278, P389, DOI 10.1006/jmbi.1998.1709; Hoenger A, 2000, J MOL BIOL, V297, P1087, DOI 10.1006/jmbi.2000.3627; HUANG TG, 1994, J BIOL CHEM, V269, P16493; Karabay A, 1999, BIOCHEMISTRY-US, V38, P1838, DOI 10.1021/bi981850i; Kaseda K, 2002, P NATL ACAD SCI USA, V99, P16058, DOI 10.1073/pnas.252409199; Kaseda K, 2008, EMBO REP, V9, P761, DOI 10.1038/embor.2008.96; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Kozielski F, 1999, STRUCTURE, V7, P1407, DOI 10.1016/S0969-2126(00)80030-1; Krzysiak TC, 2008, J BIOL CHEM, V283, P2078, DOI 10.1074/jbc.M708354200; Kull FJ, 2002, J CELL SCI, V115, P15; LOCKHART A, 1994, EMBO J, V13, P751, DOI 10.1002/j.1460-2075.1994.tb06317.x; Mackey AT, 2000, BIOCHEMISTRY-US, V39, P1346, DOI 10.1021/bi991918+; Marx A, 2008, BIOCHEMISTRY-US, V47, P1848, DOI 10.1021/bi701483h; Naber N, 1997, BIOCHEMISTRY-US, V36, P9681, DOI 10.1021/bi9706881; Oladipo A, 2007, MOL BIOL CELL, V18, P3601, DOI 10.1091/mbc.e06-12-1085; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; Reuther C, 2006, NANO LETT, V6, P2177, DOI 10.1021/nl060922l; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Sablin EP, 1998, NATURE, V395, P813, DOI 10.1038/27463; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Skowronek K, 2002, ANAL BIOCHEM, V300, P185, DOI 10.1006/abio.2001.5456; Smyczynski C, 2000, J MOL BIOL, V295, P325, DOI 10.1006/jmbi.1999.3356; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; TAWADA K, 1991, BIOPHYS J, V59, P343, DOI 10.1016/S0006-3495(91)82228-7; Thoresen T, 2008, BIOCHEMISTRY-US, V47, P9514, DOI 10.1021/bi800747e; Vilfan A, 2001, J MOL BIOL, V312, P1011, DOI 10.1006/jmbi.2001.5020; Wagenbach M, 2008, J CELL BIOL, V183, P617, DOI 10.1083/jcb.200805145; Wendt T, 2003, J MOL BIOL, V333, P541, DOI 10.1016/j.jmb.2003.08.051; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611	47	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35735	35745		10.1074/jbc.M109.024240	http://dx.doi.org/10.1074/jbc.M109.024240			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858211	Green Published, hybrid			2022-12-25	WOS:000272645600051
J	Iwabu, Y; Fujita, H; Kinomoto, M; Kaneko, K; Ishizaka, Y; Tanaka, Y; Sata, T; Tokunaga, K				Iwabu, Yukie; Fujita, Hideaki; Kinomoto, Masanobu; Kaneko, Keiko; Ishizaka, Yukihito; Tanaka, Yoshitaka; Sata, Tetsutaro; Tokunaga, Kenzo			HIV-1 Accessory Protein Vpu Internalizes Cell-surface BST-2/Tetherin through Transmembrane Interactions Leading to Lysosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 VPU; SIMIAN IMMUNODEFICIENCY VIRUS; CLATHRIN-MEDIATED ENDOCYTOSIS; DOWN-MODULATION; PLASMA-MEMBRANE; INHIBITS HIV-1; LIPID RAFTS; RESTRICTION FACTOR; MOLECULAR-CLONING; RAPID DEGRADATION	Bone marrow stromal antigen 2 (BST-2, also known as tetherin) is a recently identified interferon-inducible host restriction factor that can block the production of enveloped viruses by trapping virus particles at the cell surface. This antiviral effect is counteracted by the human immunodeficiency virus type 1 (HIV-1) accessory protein viral protein U (Vpu). Here we show that HIV-1 Vpu physically interacts with BST-2 through their mutual transmembrane domains and leads to the degradation of this host factor via a lysosomal, not proteasomal, pathway. The degradation is partially controlled by a cellular protein, beta-transducin repeat-containing protein (beta TrCP), which is known to be required for the Vpu-induced degradation of CD4. Importantly, targeting of BST-2 by Vpu occurs at the plasma membrane followed by the active internalization of this host protein by Vpu independently of constitutive endocytosis. Thus, the primary site of action of Vpu is the plasma membrane, where Vpu targets and internalizes cell-surface BST-2 through transmembrane interactions, leading to lysosomal degradation, partially in a beta TrCP-dependent manner. Also, we propose the following configuration of BST-2 in tethering virions to the cell surface; each of the dimerized BST-2 molecules acts as a bridge between viral and cell membranes.	[Tokunaga, Kenzo] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan; [Fujita, Hideaki; Tanaka, Yoshitaka] Kyushu Univ, Div Pharmaceut Cell Biol, Grad Sch Pharmaceut Sci, Fukuoka 8128582, Japan; [Ishizaka, Yukihito] Int Med Ctr Japan, Dept Intractable Dis, Tokyo 1628655, Japan	National Institute of Infectious Diseases (NIID); Kyushu University; National Center for Global Health & Medicine - Japan	Tokunaga, K (corresponding author), Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan.	tokunaga@nih.go.jp	Tokunaga, Kenzo/Q-9914-2018	Tokunaga, Kenzo/0000-0002-2625-5322; Fujita, Hideaki/0000-0002-4105-4430	Ministry of Health, Labor, and Welfare of Japan	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by a grant from the Ministry of Health, Labor, and Welfare of Japan.	Barlow KL, 2003, J VIROL, V77, P6879, DOI 10.1128/JVI.77.12.6879-6888.2003; Benmerah A, 2007, TRAFFIC, V8, P970, DOI 10.1111/j.1600-0854.2007.00585.x; Butticaz C, 2007, J VIROL, V81, P1502, DOI 10.1128/JVI.01711-06; COHEN EA, 1988, NATURE, V334, P532, DOI 10.1038/334532a0; Cortes MJ, 2002, J BIOL CHEM, V277, P1770, DOI 10.1074/jbc.M109807200; Courgnaud V, 2002, J VIROL, V76, P8298, DOI 10.1128/JVI.76.16.8298-8309.2002; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; FRIBORG J, 1995, J ACQ IMMUN DEF SYND, V8, P10; Fujita K, 1997, J GEN VIROL, V78, P619, DOI 10.1099/0022-1317-78-3-619; GERAGHTY RJ, 1994, J MED PRIMATOL, V23, P146, DOI 10.1111/j.1600-0684.1994.tb00115.x; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; GOTO T, 1994, BLOOD, V84, P1922; GOTTLINGER HG, 1993, P NATL ACAD SCI USA, V90, P7381, DOI 10.1073/pnas.90.15.7381; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; HUET T, 1990, NATURE, V345, P356, DOI 10.1038/345356a0; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kinomoto M, 2005, J VIROL, V79, P5996, DOI 10.1128/JVI.79.10.5996-6004.2005; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; Kumar KGS, 2003, EMBO J, V22, P5480; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Nguyen DH, 2000, J VIROL, V74, P3264, DOI 10.1128/JVI.74.7.3264-3272.2000; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; Paul M, 1998, J VIROL, V72, P1270, DOI 10.1128/JVI.72.2.1270-1279.1998; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Rollason R, 2009, J CELL BIOL, V184, P721, DOI 10.1083/jcb.200804154; Rong LW, 2009, J VIROL, V83, P7536, DOI 10.1128/JVI.00620-09; SAKAI H, 1995, J GEN VIROL, V76, P2717, DOI 10.1099/0022-1317-76-11-2717; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; Santiago ML, 2002, SCIENCE, V295, P465, DOI 10.1126/science.295.5554.465; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; SCHNEIDER C, 1984, NATURE, V311, P675, DOI 10.1038/311675b0; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; SCHUBERT U, 1994, J MOL BIOL, V236, P16, DOI 10.1006/jmbi.1994.1114; Schubert U, 1998, J VIROL, V72, P2280, DOI 10.1128/JVI.72.3.2280-2288.1998; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; STREBEL K, 1989, J VIROL, V63, P3784, DOI 10.1128/JVI.63.9.3784-3791.1989; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; Tokunaga K, 2001, J VIROL, V75, P6776, DOI 10.1128/JVI.75.15.6776-6785.2001; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; Varthakavi V, 2008, NAT MED, V14, P641, DOI 10.1038/nm1778; Volanti C, 2004, ONCOGENE, V23, P8649, DOI 10.1038/sj.onc.1207871; WILLEY RL, 1992, J VIROL, V66, P226, DOI 10.1128/JVI.66.1.226-234.1992; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; YAO XJ, 1992, J VIROL, V66, P5119, DOI 10.1128/JVI.66.8.5119-5126.1992; YAO XJ, 1993, J ACQ IMMUN DEF SYND, V6, P135	64	181	186	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35060	35072		10.1074/jbc.M109.058305	http://dx.doi.org/10.1074/jbc.M109.058305			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19837671	Green Published, hybrid			2022-12-25	WOS:000272439600060
J	Taniguchi, N				Taniguchi, Naoyuki			From the gamma-Glutamyl Cycle to the Glycan Cycle: A Road with Many Turns and Pleasant Surprises	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYLTRANSFERASE-III; CDNA CLONING; FUCOSYL-TRANSFERASE; RECEPTOR ACTIVATION; CORE FUCOSYLATION; GENE TRANSFECTION; CELL-MIGRATION; RAT-LIVER; CANCER; GROWTH		[Taniguchi, Naoyuki] Osaka Univ, Dept Dis Glyc, Inst Sci & Ind Res, Osaka 5670047, Japan; [Taniguchi, Naoyuki] RIKEN, Syst Glycobiol Res Grp, Dept Biol Chem, Adv Sci Inst, Wako, Saitama 3510198, Japan	Osaka University; RIKEN	Taniguchi, N (corresponding author), Osaka Univ, Dept Dis Glyc, Inst Sci & Ind Res, Osaka 5670047, Japan.	tani@sanken.osaka-u.ac.jp	Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014	Taniguchi, Naoyuki/0000-0001-5889-5968	Ministry of Education, Sports, Culture, Science, and Technology, Japan	Ministry of Education, Sports, Culture, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	I thank my many colleagues who collaborated with me over three decades, many whose names also appear in the list of literature citations. During my stay at Osaka University, many eminent scientists came to visit as visiting professors and contributed to our research and education in our M. D./ Ph. D. program as well. Among them, I thank Professors Dirk van den Eijnden, John Gutteridge, Kunihiko Suzuki, Harold F. Deutsch, Kosaku Uyeda, Takashi Yonetani, Peng George Wong, Mary Anderson, Owen W. Griffith, and William Lennarz, who spent from three weeks to one year as visiting professors and supported our research and the M. D./ Ph. D. program in our faculty. I thank Drs. Vincent C. Hascall, Etorre Appella, Milton Feather, Jianguo Gu, and Eiji Miyoshi and Lisa Jenkins for reading this manuscript prior to submission and for valuable suggestions. I thank Dr. Kazuki Nakajima and Fumi Ota for help in preparing this manuscript. I acknowledge continued grant support from the Japan Society for the Promotion of Science and the Ministry of Education, Sports, Culture, Science, and Technology, Japan ( from 1973 to the present).	Akama R, 2008, PROTEOMICS, V8, P3221, DOI 10.1002/pmic.200800038; GASA S, 1987, J BIOL CHEM, V262, P1230; Granovsky M, 2000, NAT MED, V6, P306; GU JG, 1993, J BIOCHEM, V113, P614, DOI 10.1093/oxfordjournals.jbchem.a124091; Guo HB, 2002, CANCER RES, V62, P6837; HIRAI H, 1973, GANN MONOGRAPH CANCE, V14, P19; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; IKEDA Y, 1995, J BIOL CHEM, V270, P22223, DOI 10.1074/jbc.270.38.22223; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lee SH, 2006, J BIOCHEM, V139, P391, DOI 10.1093/jb/mvj039; LINAKAGAWA T, 2008, J PROTEOME RES, V7, P2222; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; MEISTER A, 1986, MOL PERSPECTIVES CLI, P3; MEISTER A, 1998, GLUTATHIONE CENTENNI, P3; Nakagawa T, 2006, J BIOL CHEM, V281, P29797, DOI 10.1074/jbc.M605697200; NISHIKAWA A, 1992, J BIOL CHEM, V267, P18199; OHNO M, 1992, INT J CANCER, V51, P315, DOI 10.1002/ijc.2910510223; Packer NH, 2008, PROTEOMICS, V8, P8, DOI 10.1002/pmic.200700917; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; SCHACHTER H, 1983, CAN J BIOCHEM CELL B, V61, P1049, DOI 10.1139/o83-134; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Takahashi M, 2008, BBA-GEN SUBJECTS, V1780, P520, DOI 10.1016/j.bbagen.2007.10.019; TAKETA K, 1993, CANCER RES, V53, P5419; TANIGUCHI N, 1974, GANN, V65, P381; Taniguchi N, 1996, GLYCOBIOLOGY, V6, P691, DOI 10.1093/glycob/6.7.691; TANIGUCHI N, 1992, ADV CLIN CHEM, V29, P1, DOI 10.1016/S0065-2423(08)60221-8; Taniguchi N, 1998, ADV ENZYMOL RAMB, V72, P239; Taniguchi N, 2004, P JPN ACAD B-PHYS, V80, P82, DOI 10.2183/pjab.80.82; Taniguchi N, 2001, GLYCOCONJUGATE J, V18, P859, DOI 10.1023/A:1022292223878; TANIGUCHI N, 1989, METHOD ENZYMOL, V179, P397; Taniguchi N., 2002, HDB GLYCOSYLTRANSFER; TANIGUCHI N, 1983, GANN MONOGRAPH CANC, V29, P263; Taniguchi N, 2008, IUBMB LIFE, V60, P703, DOI 10.1002/iub.119; Taniguchi N, 2006, CURR OPIN STRUC BIOL, V16, P561, DOI 10.1016/j.sbi.2006.08.011; Taniguchi N, 2007, NAT CHEM BIOL, V3, P307, DOI 10.1038/nchembio0607-307; Tsuda T, 2000, J BIOL CHEM, V275, P21988, DOI 10.1074/jbc.M003400200; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; YAMASHITA K, 1983, CANCER RES, V43, P5059; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626; YOKOSAWA N, 1981, ONCODEV BIOL MED, V2, P165; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200	46	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34469	34478		10.1074/jbc.X109.023150	http://dx.doi.org/10.1074/jbc.X109.023150			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840938	hybrid, Green Published			2022-12-25	WOS:000272439600001
J	Varfolomeev, E; Alicke, B; Elliott, JM; Zobel, K; West, K; Wong, H; Scheer, JM; Ashkenazi, A; Gould, SE; Fairbrother, WJ; Vucic, D				Varfolomeev, Eugene; Alicke, Bruno; Elliott, J. Michael; Zobel, Kerry; West, Kristina; Wong, Harvey; Scheer, Justin M.; Ashkenazi, Avi; Gould, Stephen E.; Fairbrother, Wayne J.; Vucic, Domagoj			X Chromosome-linked Inhibitor of Apoptosis Regulates Cell Death Induction by Proapoptotic Receptor Agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-DEPENDENT APOPTOSIS; KAPPA-B ACTIVATION; CASPASE ACTIVATION; CANCER-CELLS; ANTIBODY APOMAB; IAP PROTEINS; SMAC; XIAP; MECHANISM; SURVIVAL	Proapoptotic receptor agonists cause cellular demise through the activation of the extrinsic and intrinsic apoptotic pathways. Inhibitor of apoptosis (IAP) proteins block apoptosis induced by diverse stimuli. Here, we demonstrate that IAP antagonists in combination with Fas ligand (FasL) or the death receptor 5 (DR5) agonist antibody synergistically stimulate death in cancer cells and inhibit tumor growth. Single-agent activity of IAP antagonists relies on tumor necrosis factor-alpha signaling. By contrast, blockade of tumor necrosis factor-alpha does not affect the synergistic activity of IAP antagonists with FasL or DR5 agonist antibody. In most cancer cells, proapoptotic receptor agonist-induced cell death depends on amplifying the apoptotic signal via caspase-8-mediated activation of Bid and subsequent activation of the caspase-9-dependent mitochondrial apoptotic pathway. In the investigated cancer cell lines, induction of apoptosis by FasL or DR5 agonist antibody can be inhibited by knockdown of Bid. However, knockdown of X chromosome-linked IAP (XIAP) or antagonism of XIAP allows FasL or DR5 agonist antibody to induce activation of effector caspases efficiently without the need for mitochondrial amplification of the apoptotic signal and thus rescues the effect of Bid knockdown in these cells.	[Varfolomeev, Eugene; Zobel, Kerry; Fairbrother, Wayne J.; Vucic, Domagoj] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Alicke, Bruno; West, Kristina; Gould, Stephen E.] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Elliott, J. Michael; Scheer, Justin M.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Wong, Harvey] Genentech Inc, Dept Drug Metab & Pharmacokinet, San Francisco, CA 94080 USA; [Ashkenazi, Avi] Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Fairbrother, WJ (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, San Francisco, CA 94080 USA.	fairbro@gene.com; domagoj@gene.com	Ashkenazi, Avi/ABG-2712-2020	Ashkenazi, Avi/0000-0002-6890-4589				Adams C, 2008, CELL DEATH DIFFER, V15, P751, DOI 10.1038/sj.cdd.4402306; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Flygare JA, 2009, FUTURE ONCOL, V5, P141, DOI 10.2217/14796694.5.2.141; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Gaither A, 2007, CANCER RES, V67, P11493, DOI 10.1158/0008-5472.CAN-07-5173; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Jin HK, 2008, CLIN CANCER RES, V14, P7733, DOI 10.1158/1078-0432.CCR-08-0670; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kaufmann SH, 2003, ONCOGENE, V22, P7414, DOI 10.1038/sj.onc.1206945; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kaufmann T, 2009, IMMUNITY, V30, P56, DOI 10.1016/j.immuni.2008.10.017; LaCasse EC, 2008, ONCOGENE, V27, P6252, DOI 10.1038/onc.2008.302; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Salvesen GS, 2004, ONCOGENE, V23, P2774, DOI 10.1038/sj.onc.1207522; Scheer JM, 2005, PROTEIN EXPRES PURIF, V41, P148, DOI 10.1016/j.pep.2005.01.008; Scheer JM, 2006, P NATL ACAD SCI USA, V103, P7595, DOI 10.1073/pnas.0602571103; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Shiozaki EN, 2003, MOL CELL, V11, P519, DOI 10.1016/S1097-2765(03)00054-6; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Vogler M, 2009, CANCER RES, V69, P2425, DOI 10.1158/0008-5472.CAN-08-2436; Vucic D, 2007, CLIN CANCER RES, V13, P5995, DOI 10.1158/1078-0432.CCR-07-0729; Walter D, 2008, HEPATOLOGY, V48, P1942, DOI 10.1002/hep.22541; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Zinkel SS, 2005, CELL, V122, P579, DOI 10.1016/j.cell.2005.06.022; Zobel K, 2006, ACS CHEM BIOL, V1, P525, DOI 10.1021/cb600276q	41	47	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34553	34560		10.1074/jbc.M109.040139	http://dx.doi.org/10.1074/jbc.M109.040139			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19854829	Green Published, hybrid			2022-12-25	WOS:000272439600010
J	Djagaeva, I; Doronkin, S				Djagaeva, Inna; Doronkin, Sergey			COP9 Limits Dendritic Branching via Cullin3-Dependent Degradation of the Actin-Crosslinking BTB-Domain Protein Kelch	PLOS ONE			English	Article							SMITH-MAGENIS-SYNDROME; LINKED MENTAL-RETARDATION; UBIQUITIN LIGASES; NEURONAL MORPHOGENESIS; DROSOPHILA OOGENESIS; SENSORY NEURONS; SIGNALOSOME; GENE; MAINTENANCE; PLASTICITY	Components of the COP9 signalosome (CSN), a key member of the conserved 26S proteasome degradation pathway, have been detected to be altered in patients of several debilitating syndromes. These findings suggest that CSN acts in neural circuits, but the exact function of CSN in brain remains unidentified. Previously, using Drosophila peripheral nervous system (PNS) as a model system, we determined that CSN is a critical regulator of dendritic morphogenesis. We found that defects in CSN led to the strikingly contrast phenotype of either reducing or stimulating dendritic branching. In particular, we have reported that CSN stimulates dendritic branching via Cullin1-mediated proteolysis. Here we describe that CSN inhibits dendritic arborization in PNS neurons acting via control of Cullin3 function: loss of Cullin3 causes excessive dendritic branching. We also identified a downstream target for Cullin3-dependent degradation in neurons - the actin-crosslinking BTB-domain protein Kelch. Inappropriate accumulation of Kelch, either due to the impaired Cullin3-dependent turnover, or ectopic expression of Kelch, leads to uncontrolled dendritic branching. These findings indicate that the CSN pathway modulates neuronal network in a multilayer manner, providing the foundation for new insight into the CSN role in human mental retardation disorders and neurodegenerative disease.			Djagaeva, I (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	sdoronki@utmem.edu						Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen Y, 2002, J BIOL CHEM, V277, P30495, DOI 10.1074/jbc.M202076200; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Dailey ME, 1996, J NEUROSCI, V16, P2983; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Djagaeva I, 2005, DEV BIOL, V284, P143, DOI 10.1016/j.ydbio.2005.05.012; DJAGAEVA I, 2009, PLOS ONE IN PRESS; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Elsea SH, 1999, AM J MED GENET, V87, P342, DOI 10.1002/(SICI)1096-8628(19991203)87:4<342::AID-AJMG12>3.3.CO;2-1; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; He Y, 2006, J NEUROSCI, V26, P9975, DOI 10.1523/JNEUROSCI.2595-06.2006; Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j.pneurobio.2004.05.005; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kuazi AD, 2003, J PATHOL, V199, P259, DOI 10.1002/path.1283; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lewis DA, 2003, ANN NY ACAD SCI, V1003, P102, DOI 10.1196/annals.1300.007; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Matus A, 2005, CURR OPIN NEUROBIOL, V15, P67, DOI 10.1016/j.conb.2005.01.015; Mori F, 2005, NEUROPATH APPL NEURO, V31, P53, DOI 10.1111/j.1365-2990.2004.00603.x; Oono K, 2004, NEUROCHEM INT, V45, P765, DOI 10.1016/j.neuint.2004.01.003; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Peyrl A, 2002, ELECTROPHORESIS, V23, P152, DOI 10.1002/1522-2683(200201)23:1<152::AID-ELPS152>3.0.CO;2-T; Pickett J, 2005, J NEUROPATH EXP NEUR, V64, P925, DOI 10.1097/01.jnen.0000186921.42592.6c; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Potocki L, 1999, GENOMICS, V57, P180, DOI 10.1006/geno.1998.5748; Potocki L, 2000, J MED GENET, V37, P428, DOI 10.1136/jmg.37.6.428; Robinson DN, 1997, DEVELOPMENT, V124, P1405; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; Robinson R, 2004, HIGH EDUC, V47, P1, DOI 10.1023/B:HIGH.0000009803.70418.9c; Sarlette A, 2008, J NEUROPATH EXP NEUR, V67, P1055, DOI 10.1097/NEN.0b013e31818b4906; SCHUPBACH T, 1991, GENETICS, V129, P1119; Schwechheimer C, 2004, BBA-MOL CELL RES, V1695, P45, DOI 10.1016/j.bbamcr.2004.09.023; Spires TL, 2004, EUR J NEUROSCI, V19, P2799, DOI 10.1111/j.0953-816X.2004.03374.x; Sweeney NT, 2002, DEV BIOL, V247, P76, DOI 10.1006/dbio.2002.0702; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Urbanska M, 2008, ACTA NEUROBIOL EXP, V68, P264; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	63	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7598	10.1371/journal.pone.0007598	http://dx.doi.org/10.1371/journal.pone.0007598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859546	Green Published, gold, Green Submitted			2022-12-25	WOS:000271147400009
J	Fang, ZA; Wang, GH; Chen, AL; Li, YF; Liu, JP; Li, YY; Bolotin-Fukuhara, M; Bao, WG				Fang, Zi-An; Wang, Guang-Hui; Chen, Ai-Lian; Li, You-Fang; Liu, Jian-Ping; Li, Yu-Yang; Bolotin-Fukuhara, Monique; Bao, Wei-Guo			Gene Responses to Oxygen Availability in Kluyveromyces lactis: an Insight on the Evolution of the Oxygen-Responding System in Yeast	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; DNA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; HYPOXIC GENES; CANDIDA-ALBICANS; COPROPORPHYRINOGEN OXIDASE; TRANSCRIPTIONAL CONTROL; DIFFERENTIAL REGULATION; ANAEROBIC CONDITIONS; NEGATIVE REGULATION	The whole-genome duplication (WGD) may provide a basis for the emergence of the very characteristic life style of Saccharomyces cerevisiae-its fermentation-oriented physiology and its capacity of growing in anaerobiosis. Indeed, we found an over-representation of oxygen-responding genes in the ohnologs of S. cerevisiae. Many of these duplicated genes are present as aerobic/hypoxic(anaerobic) pairs and form a specialized system responding to changing oxygen availability. HYP2/ANB1 and COX5A/COX5B are such gene pairs, and their unique orthologs in the 'non-WGD' Kluyveromyces lactis genome behaved like the aerobic versions of S. cerevisiae. ROX1 encodes a major oxygen-responding regulator in S. cerevisiae. The synteny, structural features and molecular function of putative KlROX1 were shown to be different from that of ROX1. The transition from the K. lactis-type ROX1 to the S. cerevisiae-type ROX1 could link up with the development of anaerobes in the yeast evolution. Bioinformatics and stochastic analyses of the Rox1p-binding site (YYYATTGTTCTC) in the upstream sequences of the S. cerevisiae Rox1p-mediated genes and of the K. lactis orthologs also indicated that K. lactis lacks the specific gene system responding to oxygen limiting environment, which is present in the 'post-WGD' genome of S. cerevisiae. These data suggested that the oxygen-responding system was born for the specialized physiology of S. cerevisiae.			Fang, ZA (corresponding author), Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, Orsay, France.	weiguo.bao@igmors.u-psud.fr		Bolotin-Fukuhara, Monique/0000-0002-5285-5006				AMILLET JM, 1995, CURR GENET, V28, P503, DOI 10.1007/BF00518161; BALASUBRAMANIAN B, 1993, MOL CELL BIOL, V13, P6071, DOI 10.1128/MCB.13.10.6071; Bao WG, 2008, EUKARYOT CELL, V7, P1895, DOI 10.1128/EC.00018-08; Billard P, 1996, J BACTERIOL, V178, P5860, DOI 10.1128/jb.178.20.5860-5866.1996; Bolotin-Fukuhara M, 2000, FEBS LETT, V487, P66, DOI 10.1016/S0014-5793(00)02282-1; BOLOTINFUKUHARA M, 2006, COMP GENOMICS USING, P165; Burke PV, 1997, J BIOL CHEM, V272, P14705, DOI 10.1074/jbc.272.23.14705; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Chen H, 2008, MOL BIOL EVOL, V25, P2513, DOI 10.1093/molbev/msn212; CHEN XJ, 1993, GENETICS, V133, P517; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; COOPER CE, 1991, BIOCHEM CELL BIOL, V69, P586, DOI 10.1139/o91-089; DECKERT J, 1995, MOL CELL BIOL, V15, P6109; Deckert J, 1998, GENETICS, V150, P1429; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; DOOIJES D, 1993, J BIOL CHEM, V268, P24813; Fairhead C, 1996, YEAST, V12, P1439; Feller W., 1970, INTRO PROBABILITY TH, V3; Fontanesi F, 2006, FEMS YEAST RES, V6, P414, DOI 10.1111/j.1567-1364.2005.00011.x; Freire-Picos MA, 2001, YEAST, V18, P1347, DOI 10.1002/yea.787; FREIREPICOS MA, 1995, FEBS LETT, V360, P39, DOI 10.1016/0014-5793(95)00016-3; Fukuhara H, 2003, FEMS YEAST RES, V3, P327, DOI 10.1016/S1567-1356(03)00112-0; Gojkovic Z, 2004, MOL GENET GENOMICS, V271, P387, DOI 10.1007/s00438-004-0995-7; Gonzalez-Dominguez M, 2000, CURR GENET, V38, P171, DOI 10.1007/s002940000146; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; HODGE MR, 1990, MOL CELL BIOL, V10, P5510, DOI 10.1128/MCB.10.10.5510; HODGE MR, 1989, MOL CELL BIOL, V9, P1958, DOI 10.1128/MCB.9.5.1958; Hon T, 2003, J BIOL CHEM, V278, P50771, DOI 10.1074/jbc.M303677200; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kadosh D, 2001, MOL CELL BIOL, V21, P2496, DOI 10.1128/MCB.21.7.2496-2505.2001; Kastaniotis AJ, 2000, MOL CELL BIOL, V20, P7088, DOI 10.1128/MCB.20.19.7088-7098.2000; Kastaniotis AJ, 2000, ADV EXP MED BIOL, V475, P185; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; Keogh RS, 1998, YEAST, V14, P443, DOI 10.1002/(SICI)1097-0061(19980330)14:5<443::AID-YEA243>3.0.CO;2-L; Khalaf RA, 2001, GENETICS, V157, P1503; Klinkenberg LG, 2005, EUKARYOT CELL, V4, P649, DOI 10.1128/EC.4.4.649-660.2005; KOLAROV J, 1990, J BIOL CHEM, V265, P12711; Kwast KE, 2002, J BACTERIOL, V184, P250, DOI 10.1128/JB.184.1.250-265.2002; Kwast KE, 1998, J EXP BIOL, V201, P1177; Li YF, 2007, FEMS YEAST RES, V7, P657, DOI 10.1111/j.1567-1364.2007.00231.x; LOWRY CV, 1986, MOL CELL BIOL, V6, P4145, DOI 10.1128/MCB.6.12.4145; Mennella TA, 2003, EUKARYOT CELL, V2, P1288, DOI 10.1128/EC.2.6.1288-1303.2003; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Moller K, 2001, J BACTERIOL, V183, P2485, DOI 10.1128/JB.183.8.2485-2489.2001; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; NIINO YS, 1995, J BIOL CHEM, V270, P1983, DOI 10.1074/jbc.270.5.1983; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Piskur J, 2004, MOL MICROBIOL, V53, P381, DOI 10.1111/j.1365-2958.2004.04182.x; Piskur J, 2001, TRENDS GENET, V17, P302, DOI 10.1016/S0168-9525(01)02308-3; Rodriguez-Navarro S, 2002, YEAST, V19, P1261, DOI 10.1002/yea.916; SCANNELL DR, 2007, YEAST; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; SCHWELBERGER HG, 1993, J BIOL CHEM, V268, P14018; Seoane S, 2005, J BIOTECHNOL, V118, P149, DOI 10.1016/j.jbiotec.2005.03.003; Sertil O, 2003, NUCLEIC ACIDS RES, V31, P5831, DOI 10.1093/nar/gkg792; Snoek ISI, 2007, YEAST, V24, P1, DOI 10.1002/yea.1430; ter Linde JJM, 1999, J BACTERIOL, V181, P7409, DOI 10.1128/JB.181.24.7409-7413.1999; Ter Linde JJM, 2002, YEAST, V19, P825, DOI 10.1002/yea.879; THORSNESS M, 1989, MOL CELL BIOL, V9, P5702, DOI 10.1128/MCB.9.12.5702; TRUEBLOOD CE, 1988, GENETICS, V120, P671; TRUEBLOOD CE, 1988, MOL CELL BIOL, V8, P4537, DOI 10.1128/MCB.8.10.4537; van Beest M, 2000, J BIOL CHEM, V275, P27266; VERDIERE J, 1991, MOL GEN GENET, V228, P300; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099; ZAGOREC M, 1988, J BIOL CHEM, V263, P9718; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	72	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7561	10.1371/journal.pone.0007561	http://dx.doi.org/10.1371/journal.pone.0007561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855843	gold, Green Submitted, Green Published			2022-12-25	WOS:000271147200006
J	Lucchetta, EM; Carthew, RW; Ismagilov, RF				Lucchetta, Elena M.; Carthew, Richard W.; Ismagilov, Rustem F.			The Endo-siRNA Pathway Is Essential for Robust Development of the Drosophila Embryo	PLOS ONE			English	Article							REPLICATION CHECKPOINT CONTROL; CELL-CYCLE; REGULATORY RNAS; DISTINCT ROLES; MESSENGER-RNAS; HUNCHBACK; SEGMENTATION; EXPRESSION; MICRORNAS; PATTERN	Background: Robustness to natural temperature fluctuations is critical to proper development in embryos and to cellular functions in adult organisms. However, mechanisms and pathways which govern temperature compensation remain largely unknown beyond circadian rhythms. Pathways which ensure robustness against temperature fluctuations may appear to be nonessential under favorable, uniform environmental conditions used in conventional laboratory experiments where there is little variation for which to compensate. The endo-siRNA pathway, which produces small double-stranded RNAs in Drosophila, appears to be nonessential for robust development of the embryo under ambient uniform temperature and to be necessary only for viral defense. Embryos lacking a functional endo-siRNA pathway develop into phenotypically normal adults. However, we hypothesized that small RNAs may regulate the embryo's response to temperature, as a ribonucleoprotein complex has been previously shown to mediate mammalian cell response to heat shock. Principal Findings: Here, we show that the genes DICER-2 and ARGONAUTE2, which code for integral protein components of the endo-siRNA pathway, are essential for robust development and temperature compensation in the Drosophila embryo when exposed to temperature perturbations. The regulatory functions of DICER-2 and ARGONAUTE2 were uncovered by using microfluidics to expose developing Drosophila embryos to a temperature step, in which each half of the embryo develops at a different temperature through developmental cycle 14. Under this temperature perturbation, dicer-2 or argonaute2 embryos displayed abnormal segmentation. The abnormalities in segmentation are presumably due to the inability of the embryo to compensate for temperature-induced differences in rate of development and to coordinate developmental timing in the anterior and posterior halves. A deregulation of the length of nuclear division cycles 10-14 is also observed in dicer-2 embryos at high temperatures. Conclusions: Results presented herein uncover a novel function of the endo-siRNA pathway in temperature compensation and cell cycle regulation, and we hypothesize that the endo-siRNA pathway may regulate the degradation of maternal cell cycle regulators. Endo-siRNAs may have a more general role buffering against environmental perturbations in other organisms.			Lucchetta, EM (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	elucchetta@gmail.com			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077581, R01GM077331, R01GM068743] Funding Source: NIH RePORTER; NIGMS NIH HHS [5R01GM068743-05, R01 GM077331, 1R01GM077331, R01 GM077331-04, R01 GM068743, R01 GM077581] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081; CASANOVA J, 1990, DEVELOPMENT, V110, P621; Chou TB, 1996, GENETICS, V144, P1673; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Edgar BA, 1996, GENE DEV, V10, P1966, DOI 10.1101/gad.10.15.1966; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; Eldar A, 2004, CURR OPIN GENET DEV, V14, P435, DOI 10.1016/j.gde.2004.06.009; Fang G, 2005, MOL BIOL EVOL, V22, P2147, DOI 10.1093/molbev/msi211; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Habayeb MS, 2006, J GEN VIROL, V87, P3045, DOI 10.1099/vir.0.81997-0; Hartwell L, 2004, SCIENCE, V303, P774, DOI 10.1126/science.1094731; Hobert O, 2006, COLD SPRING HARB SYM, V71, P181, DOI 10.1101/sqb.2006.71.006; Hong CI, 2007, P NATL ACAD SCI USA, V104, P1195, DOI 10.1073/pnas.0601378104; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Ji JY, 2004, DEVELOPMENT, V131, P401, DOI 10.1242/dev.00944; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; LEHMANN R, 1987, DEV BIOL, V119, P402, DOI 10.1016/0012-1606(87)90045-5; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Lucchetta EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003651; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Lucchetta EM, 2006, LAB CHIP, V6, P185, DOI 10.1039/b516119c; MARGOLIS JS, 1987, J CELL BIOCHEM, P22; Namba R, 1997, DEVELOPMENT, V124, P1393; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Patel NH, 2001, DEVELOPMENT, V128, P3459; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Sibon OCM, 1999, CURR BIOL, V9, P302, DOI 10.1016/S0960-9822(99)80138-9; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; SON EB, 1896, CELL DEV INHERITANCE; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; SULLIVAN W, 2000, PREPARATION LARVAL A; Takada S, 2007, DEVELOPMENT, V134, P1737, DOI 10.1242/dev.02831; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; Theodosiou NA, 1998, METHODS, V14, P355, DOI 10.1006/meth.1998.0591; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; Tyson JJ, 1999, BIOPHYS J, V77, P2411, DOI 10.1016/S0006-3495(99)77078-5; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; WIESCHAUS E, 1984, ROUX ARCH DEV BIOL, V193, P296, DOI 10.1007/BF00848158	55	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7576	10.1371/journal.pone.0007576	http://dx.doi.org/10.1371/journal.pone.0007576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851503	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000271022300011
J	Lee, JH; Schell, MJ; Roetzheim, R				Lee, Ji-Hyun; Schell, Michael J.; Roetzheim, Richard			Analysis of Group Randomized Trials with Multiple Binary Endpoints and Small Number of Groups	PLOS ONE			English	Article							COMMUNITY-HEALTH CENTERS; LINEAR MIXED MODELS; CANCER; DESIGN; ESTIMATORS; LIKELIHOOD; INFERENCE; ATTENDEES	The group randomized trial (GRT) is a common study design to assess the effect of an intervention program aimed at health promotion or disease prevention. In GRTs, groups rather than individuals are randomized into intervention or control arms. Then, responses are measured on individuals within those groups. A number of analytical problems beset GRT designs. The major problem emerges from the likely positive intraclass correlation among observations of individuals within a group. This paper provides an overview of the analytical method for GRT data and applies this method to a randomized cancer prevention trial, where multiple binary primary endpoints were obtained. We develop an index of extra variability to investigate group-specific effects on response. The purpose of the index is to understand the influence of individual groups on evaluating the intervention effect, especially, when a GRT study involves a small number of groups. The multiple endpoints from the GRT design are analyzed using a generalized linear mixed model and the stepdown Bonferroni method of Holm.			Lee, JH (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	ji-hyun.lee@moffitt.org	Roetzheim, Richard/J-4696-2012		NATIONAL CANCER INSTITUTE [R01CA077282, P30CA076292] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA77282, P30 CA076292, 2P30CA76292-08] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bellamy SL, 2000, STAT METHODS MED RES, V9, P135, DOI 10.1191/096228000672549488; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brown BW, 1997, STAT MED, V16, P2511, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2511::AID-SIM693>3.0.CO;2-4; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Fay MP, 2001, BIOMETRICS, V57, P1198, DOI 10.1111/j.0006-341X.2001.01198.x; Feng ZD, 2001, ANNU REV PUBL HEALTH, V22, P167, DOI 10.1146/annurev.publhealth.22.1.167; HOLM S, 1979, SCAND J STAT, V6, P65; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lu B, 2007, BIOMETRICS, V63, P935, DOI 10.1111/j.1541-0420.2007.00764.x; Murray DM, 2008, JNCI-J NATL CANCER I, V100, P483, DOI 10.1093/jnci/djn066; Murray DM, 2004, AM J PUBLIC HEALTH, V94, P423, DOI 10.2105/AJPH.94.3.423; Murray DM, 1998, DESIGN ANAL GROUP RA; Roetzheim RG, 2005, ANN FAM MED, V3, P109, DOI 10.1370/afm.240; Roetzheim RG, 2004, ANN FAM MED, V2, P294, DOI 10.1370/afm.101; SIMPSON JM, 1995, AM J PUBLIC HEALTH, V85, P1378, DOI 10.2105/AJPH.85.10.1378; Smith PJ, 1997, J CLIN EPIDEMIOL, V50, P137, DOI 10.1016/S0895-4356(96)00338-1; Varnell SP, 2004, AM J PUBLIC HEALTH, V94, P393, DOI 10.2105/AJPH.94.3.393; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554	20	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7265	10.1371/journal.pone.0007265	http://dx.doi.org/10.1371/journal.pone.0007265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509JU	19844579	gold, Green Published, Green Submitted			2022-12-25	WOS:000271013000003
J	Plummer, TW; Ditchfield, PW; Bishop, LC; Kingston, JD; Ferraro, JV; Braun, DR; Hertel, F; Potts, R				Plummer, Thomas W.; Ditchfield, Peter W.; Bishop, Laura C.; Kingston, John D.; Ferraro, Joseph V.; Braun, David R.; Hertel, Fritz; Potts, Richard			Oldest Evidence of Toolmaking Hominins in a Grassland-Dominated Ecosystem	PLOS ONE			English	Article							DIETARY ADAPTATIONS; OLDUVAI GORGE; KOOBI-FORA; EARLY HOMO; EVOLUTION; KENYA; PALEOENVIRONMENTS; HABITAT; BASIN; PALEOECOLOGY	Background: Major biological and cultural innovations in late Pliocene hominin evolution are frequently linked to the spread or fluctuating presence of C-4 grass in African ecosystems. Whereas the deep sea record of global climatic change provides indirect evidence for an increase in C-4 vegetation with a shift towards a cooler, drier and more variable global climatic regime beginning approximately 3 million years ago (Ma), evidence for grassland-dominated ecosystems in continental Africa and hominin activities within such ecosystems have been lacking. Methodology/Principal Findings: We report stable isotopic analyses of pedogenic carbonates and ungulate enamel, as well as faunal data from similar to 2.0 Ma archeological occurrences at Kanjera South, Kenya. These document repeated hominin activities within a grassland-dominated ecosystem. Conclusions/Significance: These data demonstrate what hitherto had been speculated based on indirect evidence: that grassland-dominated ecosystems did in fact exist during the Plio-Pleistocene, and that early Homo was active in open settings. Comparison with other Oldowan occurrences indicates that by 2.0 Ma hominins, almost certainly of the genus Homo, used a broad spectrum of habitats in East Africa, from open grassland to riparian forest. This strongly contrasts with the habitat usage of Australopithecus, and may signal an important shift in hominin landscape usage.			Plummer, TW (corresponding author), Queens Coll, Dept Anthropol, Flushing, NY USA.	thomas.plummer@qc.cuny.edu		Bishop, Laura C/0000-0002-4216-8667				Anton Susan C., 2008, P443, DOI 10.1007/978-0-387-76585-3_20; Bamford MK, 2008, PALAEOGEOGR PALAEOCL, V257, P280, DOI 10.1016/j.palaeo.2007.09.003; BEHRENSMEYER AK, 1995, J HUM EVOL, V29, P247, DOI 10.1006/jhev.1995.1059; Bernor RL, 1999, HUMAN EVOLUT SER, P189; Bishop LC, 1999, HUMAN EVOLUT SER, P216; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; BRAUN DR, 2006, PALEOANTHROPOL A, V14; Cerling TE, 2003, J MAMMAL, V84, P456, DOI 10.1644/1545-1542(2003)084&lt;0456:DOEABB&gt;2.0.CO;2; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; CERLING TE, 1986, QUATERNARY RES, V25, P63, DOI 10.1016/0033-5894(86)90044-X; Cerling TE, 1999, OECOLOGIA, V120, P364, DOI 10.1007/s004420050869; CERLING TE, 1988, PALAEOGEOGR PALAEOCL, V63, P335, DOI 10.1016/0031-0182(88)90104-6; Cerling Thure E., 2003, P605; d'Errico F, 2009, J ARCHAEOL SCI, V36, P1764, DOI 10.1016/j.jas.2009.04.005; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Feakins SJ, 2005, GEOLOGY, V33, P977, DOI 10.1130/G21814.1; Ferraro JV, 2007, THESIS U CALIFORNIA; Harris JM, 2002, J ZOOL, V256, P45, DOI 10.1017/S0952836902000067; HOWELL FC, 1987, J HUM EVOL, V16, P665; Kappelman J, 1997, J HUM EVOL, V32, P229, DOI 10.1006/jhev.1996.0105; Kimbel William H., 2009, P31, DOI 10.1007/978-1-4020-9980-9_4; Kingdon J, 1997, KINGDON FIELD GUIDE; KINGSTON JD, 1994, SCIENCE, V264, P955, DOI 10.1126/science.264.5161.955; Kingston JD, 2007, YEARB PHYS ANTHROPOL, V50, P20, DOI 10.1002/ajpa.20733; Kingston JD, 2007, PALAEOGEOGR PALAEOCL, V243, P272, DOI 10.1016/j.palaeo.2006.08.002; Kingston John D., 1999, P69; LEETHORP JA, 1994, J HUM EVOL, V27, P361, DOI 10.1006/jhev.1994.1050; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; Lieberman DE, 1996, J HUM EVOL, V30, P97, DOI 10.1006/jhev.1996.0008; Lopez-Saez JA, 2009, GEOBIOS-LYON, V42, P503, DOI 10.1016/j.geobios.2008.12.002; Plummer T, 1999, J HUM EVOL, V36, P151, DOI 10.1006/jhev.1998.0256; Plummer T, 2004, YEARB PHYS ANTHROPOL, V47, P118, DOI 10.1002/ajpa.20157; PLUMMER TW, 1994, J HUM EVOL, V27, P47, DOI 10.1006/jhev.1994.1035; Potts R, 2007, VERTEBR PALEOBIOL PA, P25, DOI 10.1007/978-1-4020-3098-7_2; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Potts R., 1988, EARLY HOMINID ACTIVI; Prat S, 2005, J HUM EVOL, V49, P230, DOI 10.1016/j.jhevol.2005.03.009; Quade J, 2004, GEOL SOC AM BULL, V116, P1529, DOI 10.1130/B25358.1; Quinn RL, 2007, J HUM EVOL, V53, P560, DOI 10.1016/j.jhevol.2007.01.013; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; Rightmire G. Philip, 2009, P39, DOI 10.1007/978-1-4020-9980-9_5; Roche Helene, 2009, P135, DOI 10.1007/978-1-4020-9980-9_12; SHIPMAN P, 1998, EVOLUTIONARY HIST RO, P343; Sikes NE, 2007, J HUM EVOL, V53, P574, DOI 10.1016/j.jhevol.2006.12.008; Sikes NE, 1999, J HUM EVOL, V37, P721, DOI 10.1006/jhev.1999.0343; SIKES NE, 1994, J HUM EVOL, V27, P25, DOI 10.1006/jhev.1994.1034; Spencer LM, 1997, J HUM EVOL, V32, P201, DOI 10.1006/jhev.1996.0102; Sponheimer M, 2003, S AFR J SCI, V99, P273; SUSMAN RL, 1991, J ANTHROPOL RES, V47, P129, DOI 10.1086/jar.47.2.3630322; TURNER A, 1993, J HUM EVOL, V24, P301, DOI 10.1006/jhev.1993.1023; van der Merwe NJ, 2003, J HUM EVOL, V44, P581, DOI 10.1016/S0047-2484(03)00050-2; Vrba E.S., 1980, P247; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P24; Walker A., 1993, NARIOKOTOME HOMO ERE; WHEELER PE, 1991, J HUM EVOL, V21, P107, DOI 10.1016/0047-2484(91)90002-D; WoldeGabriel G, 2001, NATURE, V412, P175, DOI 10.1038/35084058; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317; Wynn JG, 2000, J HUM EVOL, V39, P411, DOI 10.1006/jhev.2000.0431	61	79	79	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7199	10.1371/journal.pone.0007199	http://dx.doi.org/10.1371/journal.pone.0007199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509JU	19844568	Green Published, Green Accepted, gold			2022-12-25	WOS:000271013000002
J	Wang, KK; Fang, H; Xiao, DK; Zhu, XH; He, MM; Pan, XL; Shi, JT; Zhang, H; Jia, XH; Du, YZ; Zhang, J				Wang, Kankan; Fang, Hai; Xiao, Dakai; Zhu, Xuehua; He, Miaomiao; Pan, Xiaoling; Shi, Jiantao; Zhang, Hui; Jia, Xiaohong; Du, Yanzhi; Zhang, Ji			Converting Redox Signaling to Apoptotic Activities by Stress-Responsive Regulators HSF1 and NRF2 in Fenretinide Treated Cancer Cells	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ENDOPLASMIC-RETICULUM STRESS; HEAT-SHOCK FACTOR-1; ARSENIC TRIOXIDE; HYDROGEN-PEROXIDE; MYELOID-LEUKEMIA; CARCINOMA-CELLS; GROWTH-FACTOR; DEATH; EXPRESSION	Background: Pharmacological intervention of redox balance in cancer cells often results in oxidative stress-mediated apoptosis, attracting much attention for the development of a new generation of targeted therapy in cancer. However, little is known about mechanisms underlying the conversion from oxidative signaling to downstream activities leading cells to death. Methodology/Principal Findings: We here report a systematic detection of transcriptome changes in response to oxidative signals generated in leukemia cells upon fenretinide treatment, implicating the occurrence of numerous stress-responsive events during the fenretinide induced apoptosis, such as redox response, endoplasmic reticulum stress/unfolded protein response, translational repression and proteasome activation. Moreover, the configuration of these relevant events is primarily orchestrated by stress responsive transcription factors, as typically highlighted by NF-E2-related factor-2 (NRF2) and heat shock factor 1 (HSF1). Several lines of evidence suggest that the coordinated regulation of these transcription factors and thus their downstream genes are involved in converting oxidative signaling into downstream stress-responsive events regulating pro-apoptotic and apoptotic activities at the temporal and spatial levels, typifying oxidative stress-mediated programmed death rather than survival in cancer cells. Conclusions/Significance: This study provides a roadmap for understanding oxidative stress-mediated apoptosis in cancer cells, which may be further developed into more sophisticated therapeutic protocols, as implicated by synergistic induction of cell apoptosis using proteasome inhibitors with fenretinide.			Wang, KK (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China.	jizhang@sibs.ac.cn	Fang, Hai/H-7879-2012					Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Alcivar A, 2003, ONCOGENE, V22, P291, DOI 10.1038/sj.onc.1206099; ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; BI YF, 2009, ENDOCR RELAT CANC; Chou WC, 2004, P NATL ACAD SCI USA, V101, P4578, DOI 10.1073/pnas.0306687101; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Du YZ, 2006, BLOOD, V107, P1582, DOI 10.1182/blood-2005-06-2318; Fang H, 2008, CURR DRUG METAB, V9, P1038, DOI 10.2174/138920008786927802; Goranov BB, 2006, CELL DEATH DIFFER, V13, P676, DOI 10.1038/sj.cdd.4401824; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Kadara H, 2007, CANCER BIOL THER, V6, P705, DOI 10.4161/cbt.6.5.3963; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kitareewan S, 1999, ONCOGENE, V18, P5747, DOI 10.1038/sj.onc.1202981; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; LANOTTE M, 1991, BLOOD, V77, P1080; Lovat PE, 2004, JNCI-J NATL CANCER I, V96, P1288, DOI 10.1093/jnci/djh254; Lovat PE, 2002, CANCER RES, V62, P5158; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Oridate N, 1997, J NATL CANCER I, V89, P1191, DOI 10.1093/jnci/89.16.1191; Romano MF, 2003, CELL DEATH DIFFER, V10, P383, DOI 10.1038/sj.cdd.4401167; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun SY, 1999, CANCER RES, V59, P2493; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trinklein ND, 2004, CELL STRESS CHAPERON, V9, P21, DOI 10.1379/1466-1268(2004)009<0021:TRABOH>2.0.CO;2; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Wu JM, 2001, APOPTOSIS, V6, P377, DOI 10.1023/A:1011342220621; Xiao L, 2003, FEBS LETT, V538, P117, DOI 10.1016/S0014-5793(03)00156-X; Zhang YS, 2004, MOL CANCER THER, V3, P885; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102	45	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7538	10.1371/journal.pone.0007538	http://dx.doi.org/10.1371/journal.pone.0007538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844581	Green Published, gold, Green Submitted			2022-12-25	WOS:000271013000014
J	Wunderlich, K; Mayer, D; Ranadheera, C; Holler, AS; Manz, B; Martin, A; Chase, G; Tegge, W; Frank, R; Kessler, U; Schwemmle, M				Wunderlich, Kerstin; Mayer, Daniel; Ranadheera, Charlene; Holler, Anne-Sophie; Maenz, Benjamin; Martin, Arnold; Chase, Geoffrey; Tegge, Werner; Frank, Ronald; Kessler, Ulrich; Schwemmle, Martin			Identification of a PA-Binding Peptide with Inhibitory Activity against Influenza A and B Virus Replication	PLOS ONE			English	Article							SMALL-MOLECULE ANTAGONISTS; RNA-POLYMERASE; ANTIVIRAL ACTIVITY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SUBUNIT; PROTEIN; ENDONUCLEASE; OSELTAMIVIR; COMPLEX	There is an urgent need for new drugs against influenza type A and B viruses due to incomplete protection by vaccines and the emergence of resistance to current antivirals. The influenza virus polymerase complex, consisting of the PB1, PB2 and PA subunits, represents a promising target for the development of new drugs. We have previously demonstrated the feasibility of targeting the protein-protein interaction domain between the PB1 and PA subunits of the polymerase complex of influenza A virus using a small peptide derived from the PA-binding domain of PB1. However, this influenza A virus-derived peptide did not affect influenza B virus polymerase activity. Here we report that the PA-binding domain of the polymerase subunit PB1 of influenza A and B viruses is highly conserved and that mutual amino acid exchange shows that they cannot be functionally exchanged with each other. Based on phylogenetic analysis and a novel biochemical ELISA-based screening approach, we were able to identify an influenza A-derived peptide with a single influenza B-specific amino acid substitution which efficiently binds to PA of both virus types. This dual-binding peptide blocked the viral polymerase activity and growth of both virus types. Our findings provide proof of principle that protein-protein interaction inhibitors can be generated against influenza A and B viruses. Furthermore, this dual-binding peptide, combined with our novel screening method, is a promising platform to identify new antiviral lead compounds.			Wunderlich, K (corresponding author), Univ Freiburg, Dept Virol, Freiburg, Germany.	martin.schwemmle@uniklinik-freiburg.de	Mayer, Daniel/ABB-5655-2020					Ambroise Y, 2002, CHEM BIOL, V9, P1219, DOI 10.1016/S1074-5521(02)00246-6; BAINE WB, 1980, AM J MED, V68, P181, DOI 10.1016/0002-9343(80)90352-6; Berg T, 2002, P NATL ACAD SCI USA, V99, P3830, DOI 10.1073/pnas.062036999; Berg T, 2008, CURR OPIN DRUG DISC, V11, P666; Brownlee GG, 2002, J VIROL, V76, P7103, DOI 10.1128/JVI.76.14.7103-7113.2002; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Chokephaibulkit K, 2005, PEDIATR INFECT DIS J, V24, P162, DOI 10.1097/01.inf.0000151037.25237.1e; CLARK PS, 1970, J AMER MED ASSOC, V214, P507, DOI 10.1001/jama.214.3.507; Crescenzo-Chaigne B, 1999, VIROLOGY, V265, P342, DOI 10.1006/viro.1999.0059; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Dostmann WRG, 2000, P NATL ACAD SCI USA, V97, P14772, DOI 10.1073/pnas.97.26.14772; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Ghanem A, 2007, J VIROL, V81, P7801, DOI 10.1128/JVI.00724-07; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Iwatsuki-Horimoto K, 2008, VIRUS RES, V135, P161, DOI 10.1016/j.virusres.2008.03.010; Jambrina E, 1997, VIROLOGY, V235, P209, DOI 10.1006/viro.1997.8682; KIM HW, 1979, AM J EPIDEMIOL, V109, P464, DOI 10.1093/oxfordjournals.aje.a112704; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ninio S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000278; NOLAN TF, 1980, J INFECT DIS, V142, P360, DOI 10.1093/infdis/142.3.360; NORTON GP, 1987, VIROLOGY, V156, P204, DOI 10.1016/0042-6822(87)90399-0; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Perales B, 1997, J VIROL, V71, P1381, DOI 10.1128/JVI.71.2.1381-1385.1997; PEREZ DR, 1995, J VIROL, V69, P6932; Perez DR, 2001, J VIROL, V75, P8127, DOI 10.1128/JVI.75.17.8127-8136.2001; Pilger BD, 2004, CHEM BIOL, V11, P647, DOI 10.1016/j.chembiol.2004.01.018; Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996; Schmidtke M, 2001, J VIROL METHODS, V95, P133, DOI 10.1016/S0166-0934(01)00305-6; Schneider U, 2003, J VIROL, V77, P11781, DOI 10.1128/JVI.77.21.11781-11789.2003; SCHWEMMLE M, 1995, VIROLOGY, V206, P545, DOI 10.1016/S0042-6822(95)80071-9; Sugaya N, 2007, CLIN INFECT DIS, V44, P197, DOI 10.1086/509925; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; TUMPEY TM, 2009, ANN REV MICROBIOL; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; White PW, 2003, J BIOL CHEM, V278, P26765, DOI 10.1074/jbc.M303608200; WRIGHT PF, 1980, J INFECT DIS, V141, P430, DOI 10.1093/infdis/141.4.430; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	53	71	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7517	10.1371/journal.pone.0007517	http://dx.doi.org/10.1371/journal.pone.0007517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841738	Green Published, gold, Green Submitted			2022-12-25	WOS:000271012900014
J	Olvera, L; Mendoza-Vargas, A; Flores, N; Olvera, M; Sigala, JC; Gosset, G; Morett, E; Bolivar, F				Olvera, Leticia; Mendoza-Vargas, Alfredo; Flores, Noemi; Olvera, Maricela; Sigala, Juan Carlos; Gosset, Guillermo; Morett, Enrique; Bolivar, Francisco			Transcription Analysis of Central Metabolism Genes in Escherichia coli. Possible Roles of sigma(38) in Their Expression, as a Response to Carbon Limitation	PLOS ONE			English	Article							ENCODES ACETYL-COENZYME; PYRUVATE OXIDASE; STRESS-RESPONSE; PHOSPHOTRANSFERASE SYSTEM; SIGMA(S)-DEPENDENT GENES; NUCLEOTIDE-SEQUENCE; EXPONENTIAL-GROWTH; STATIONARY-PHASE; STRAINS LACKING; ISOMERASE GENE	The phosphoenolpyruvate: carbohydrate transferase system (PTS) transports glucose in Escherichia coli. Previous work demonstrated that strains lacking PTS, such as PB11, grow slow on glucose. PB11 has a reduced expression of glycolytic, and upregulates poxB and acs genes as compared to the parental strain JM101, when growing on glucose. The products of the latter genes are involved in the production of AcetylCoA. Inactivation of rpoS that codes for the RNA polymerase sigma(38) subunit, reduces further (50%) growth of PB11, indicating that sigma(38) plays a central role in the expression of central metabolism genes in slowly growing cells. In fact, transcription levels of glycolytic genes is reduced in strain PB11rpoS(-) as compared to PB11. In this report we studied the role of sigma(70) and sigma(38) in the expression of the complete glycolytic pathway and poxB and acs genes in certain PTS- strains and their rpoS 2 derivatives. We determined the transcription start sites (TSSs) and the corresponding promoters, in strains JM101, PB11, its derivative PB12 that recovered its growth capacity, and in their rpoS(-) derivatives, by 5'RACE and pyrosequencing. In all these genes the presence of sequences resembling sigma 38 recognition sites allowed the proposition that they could be transcribed by both sigma factors, from overlapping putative promoters that initiate transcription at the same site. Fourteen new TSSs were identified in seventeen genes. Besides, more than 30 putative promoters were proposed and we confirmed ten previously reported. In vitro transcription experiments support the functionality of putative dual promoters. Alternatives that could also explain lower transcription levels of the rpoS(-) derivatives are discussed. We propose that the presence if real, of both sigma(70) and sigma(38) dependent promoters in all glycolytic genes and operons could allow a differential transcription of these central metabolism genes by both sigma subunits as an adaptation response to carbon limitation.			Olvera, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular Biocatalisis, Cuernavaca 62191, Morelos, Mexico.	emorett@ibt.unam.mx; bolivar@ibt.unam.mx	Gosset, Guillermo/K-9356-2017; Morett, Enrique/G-3401-2013	Gosset, Guillermo/0000-0003-3127-0911; Sigala Alanis, Juan Carlos/0000-0002-1665-5680; Morett, Enrique/0000-0001-5723-0032	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071962] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM071962-03, R01 GM071962] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdel-Hamid AM, 2001, MICROBIOL-SGM, V147, P1483, DOI 10.1099/00221287-147-6-1483; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Baez-Viveros JL, 2004, BIOTECHNOL BIOENG, V87, P516, DOI 10.1002/bit.20159; BAKER MM, 2001, J MOL BIOL, V305, P689; Bardey V, 2005, MOL MICROBIOL, V57, P1265, DOI 10.1111/j.1365-2958.2005.04762.x; Beatty CM, 2003, J BACTERIOL, V185, P5148, DOI 10.1128/JB.185.17.5148-5157.2003; Becker G, 2001, MOL MICROBIOL, V39, P1153, DOI 10.1046/j.1365-2958.2001.02313.x; Bledig SA, 1996, J BACTERIOL, V178, P280, DOI 10.1128/jb.178.1.280-283.1996; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Bordes P, 2000, MOL MICROBIOL, V35, P845, DOI 10.1046/j.1365-2958.2000.01758.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; CHANG YY, 1994, MOL MICROBIOL, V11, P1019, DOI 10.1111/j.1365-2958.1994.tb00380.x; CHARPENTIER B, 1994, J BACTERIOL, V176, P830, DOI 10.1128/jb.176.3.830-839.1994; Charpentier B, 1998, J BACTERIOL, V180, P6476, DOI 10.1128/JB.180.24.6476-6483.1998; Ciria R, 2004, BIOINFORMATICS, V20, P2307, DOI 10.1093/bioinformatics/bth216; Cunningham L, 1998, FEMS MICROBIOL LETT, V169, P403, DOI 10.1111/j.1574-6968.1998.tb13347.x; CURTIS SJ, 1975, J BACTERIOL, V122, P1189, DOI 10.1128/JB.122.3.1189-1199.1975; DEATH A, 1994, J BACTERIOL, V176, P5101, DOI 10.1128/jb.176.16.5101-5107.1994; Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4; Ferenci T, 2003, TRENDS MICROBIOL, V11, P457, DOI 10.1016/j.tim.2003.08.003; Ferenci T, 2001, ENVIRON MICROBIOL, V3, P605, DOI 10.1046/j.1462-2920.2001.00238.x; Flores N, 2004, J MOL MICROB BIOTECH, V8, P209, DOI 10.1159/000086702; Flores N, 2005, METAB ENG, V7, P70, DOI 10.1016/j.ymben.2004.10.002; Flores N, 1996, NAT BIOTECHNOL, V14, P620, DOI 10.1038/nbt0596-620; Flores N, 2008, J MOL MICROB BIOTECH, V14, P176, DOI 10.1159/000109945; Flores S, 2005, J MOL MICROB BIOTECH, V10, P51, DOI 10.1159/000090348; Flores S, 2002, METAB ENG, V4, P124, DOI 10.1006/mben.2001.0209; FRANKEL D, 1996, ESCHERICHIA COLI SAL, V1, P217; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FROMAN BE, 1989, MOL GEN GENET, V217, P126, DOI 10.1007/BF00330951; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; Gimenez R, 2003, J BACTERIOL, V185, P6448, DOI 10.1128/JB.185.21.6448-6455.2003; Grainger DC, 2008, MOL MICROBIOL, V68, P1366, DOI 10.1111/j.1365-2958.2008.06253.x; HELLINGA HW, 1985, EUR J BIOCHEM, V149, P363, DOI 10.1111/j.1432-1033.1985.tb08934.x; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; HENGGEARONIS R, 1996, ESCHERICHIA COLI SAL, V1, P1497; Hua Q, 2004, APPL ENVIRON MICROB, V70, P2354, DOI 10.1128/AEM.70.4.2354-2366.2004; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; KOLB A, 1995, NUCLEIC ACIDS RES, V23, P819, DOI 10.1093/nar/23.5.819; KUMARI S, 1995, J BACTERIOL, V177, P2878, DOI 10.1128/jb.177.10.2878-2886.1995; Kumari S, 2000, J BACTERIOL, V182, P551, DOI 10.1128/JB.182.2.551-554.2000; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; LENGELER JW, 1999, BIOL PROKARYOTS, P505; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; MARTINEZ K, 2008, MICROB CELL FACT, V7, pR1; MCFALL E, 1996, ESCHERICHIA COLI SAL, V1, P358; Meyer D, 1997, J BACTERIOL, V179, P1298, DOI 10.1128/jb.179.4.1298-1306.1997; Moreau PL, 2004, J BACTERIOL, V186, P7364, DOI 10.1128/JB.186.21.7364-7368.2004; Morett E, 2003, NAT BIOTECHNOL, V21, P790, DOI 10.1038/nbt834; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; PICHERSKY E, 1984, MOL GEN GENET, V195, P314, DOI 10.1007/BF00332765; PONCE E, 1995, J BACTERIOL, V177, P5719, DOI 10.1128/jb.177.19.5719-5722.1995; Postma P.W., 1996, ESCHERICHIA COLI SAL, P1149; QUAIL MA, 1994, MOL MICROBIOL, V12, P95, DOI 10.1111/j.1365-2958.1994.tb00998.x; Rahman M, 2006, BIOTECHNOL BIOENG, V94, P585, DOI 10.1002/bit.20858; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; Saier MH, 2000, J BACTERIOL, V182, P5029, DOI 10.1128/JB.182.18.5029-5035.2000; Sanchez-SanMartin C, 2001, J BACTERIOL, V183, P2823, DOI 10.1128/JB.183.9.2823-2833.2001; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x; SIGALA JC, 2008, J MOL MICRO IN PRESS; SPENCER ME, 1985, MOL GEN GENET, V200, P145, DOI 10.1007/BF00383328; Thouvenot B, 2004, BIOCHEM J, V383, P371, DOI 10.1042/BJ20040792; Typas A, 2007, MOL MICROBIOL, V63, P1296, DOI 10.1111/j.1365-2958.2007.05601.x; Ueguchi C, 2001, J BACTERIOL, V183, P520, DOI 10.1128/JB.183.2.520-527.2001; Vassinova N, 2000, MICROBIOL-SGM, V146, P3171, DOI 10.1099/00221287-146-12-3171; Wade JT, 2006, NAT STRUCT MOL BIOL, V13, P806, DOI 10.1038/nsmb1130; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Wise A, 1996, J BACTERIOL, V178, P2785, DOI 10.1128/jb.178.10.2785-2793.1996; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005	75	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7466	10.1371/journal.pone.0007466	http://dx.doi.org/10.1371/journal.pone.0007466			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838295	Green Published, Green Submitted, gold			2022-12-25	WOS:000270880900003
J	Wang, DH; Cui, ZZ; Zeng, QW; Kuang, H; Wang, LP; Tsien, JZ; Cao, XH				Wang, Deheng; Cui, Zhenzhong; Zeng, Qingwen; Kuang, Hui; Wang, L. Phillip; Tsien, Joe Z.; Cao, Xiaohua			Genetic Enhancement of Memory and Long-Term Potentiation but Not CA1 Long-Term Depression in NR2B Transgenic Rats	PLOS ONE			English	Article							DEPENDENT SYNAPTIC PLASTICITY; HETEROMERIC NMDA RECEPTORS; WORKING-MEMORY; SPATIAL MEMORY; HIPPOCAMPAL; BRAIN; MAGNESIUM; EXPRESSION; SUBTYPES; STARTLE	One major theory in learning and memory posits that the NR2B gene is a universal genetic factor that acts as rate-limiting molecule in controlling the optimal NMDA receptor's coincidence-detection property and subsequent learning and memory function across multiple animal species. If so, can memory function be enhanced via transgenic overexpression of NR2B in another species other than the previously reported mouse species? To examine these crucial issues, we generated transgenic rats in which NR2B is overexpressed in the cortex and hippocampus and investigated the role of NR2B gene in NMDA receptor-mediated synaptic plasticity and memory functions by combining electrophysiological technique with behavioral measurements. We found that overexpression of the NR2B subunit had no effect on CA1-LTD, but rather resulted in enhanced CA1-LTP and improved memory performances in novel object recognition test, spatial water maze, and delayed-to-nonmatch working memory test. Our slices recordings using NR2A- and NR2B-selective antagonists further demonstrate that the larger LTP in transgenic hippocampal slices was due to contribution from the increased NR2B-containing NMDARs. Therefore, our genetic experiments suggest that NR2B at CA1 synapses is not designated as a rate-limiting factor for the induction of long-term synaptic depression, but rather plays a crucial role in initiating the synaptic potentiation. Moreover, our studies provide strong evidence that the NR2B subunit represents a universal rate-limiting molecule for gating NMDA receptor's optimal coincidence-detection property and for enhancing memory function in adulthood across multiple mammalian species.			Wang, DH (corresponding author), E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Labs MOE & STCSM, Shanghai 200062, Peoples R China.	jtsien@mcg.edu; xhcao@brain.ecnu.edu.cn	Kuang, Hui/I-1006-2013	Kuang, Hui/0000-0002-7806-2864; Wang, Deheng/0000-0001-7979-9756	PHS HHS [060236, 024022, 034663] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Berberich S, 2007, NEUROPHARMACOLOGY, V52, P77, DOI 10.1016/j.neuropharm.2006.07.016; Billard JM, 2006, MAGNESIUM RES, V19, P199; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Cao XH, 2007, EUR J NEUROSCI, V25, P1815, DOI 10.1111/j.1460-9568.2007.05431.x; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; DAVIS M, 1986, BEHAV NEUROSCI, V100, P814, DOI 10.1037/0735-7044.100.6.814; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; FALLS WA, 1992, J NEUROSCI, V12, P854; GALLAGHER M, 2000, AMYGDALA; Ghia N, 2000, AM J OBSTET GYNECOL, V183, P940, DOI 10.1067/mob.2000.109045; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hoane MR, 2007, MAGNESIUM RES, V20, P229; Hoane MR, 2005, RESTOR NEUROL NEUROS, V23, P67; Ingram DK, 1996, ANN NY ACAD SCI, V786, P348, DOI 10.1111/j.1749-6632.1996.tb39076.x; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; Nomura Masahiko, 2004, Clin Calcium, V14, P71; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Slutsky I, 2004, NEURON, V44, P835, DOI 10.1016/j.neuron.2004.11.013; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Walker DL, 2008, LEARN MEMORY, V15, P67, DOI 10.1101/lm.798908; WHITWELL RJ, 1904, VIERTELJAHRSCHRIFT S, V2, P1	42	98	101	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7486	10.1371/journal.pone.0007486	http://dx.doi.org/10.1371/journal.pone.0007486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838302	Green Submitted, gold, Green Published			2022-12-25	WOS:000270880900004
J	Spivak, AC; Canuel, EA; Duffy, JE; Richardson, JP				Spivak, Amanda C.; Canuel, Elizabeth A.; Duffy, J. Emmett; Richardson, J. Paul			Nutrient Enrichment and Food Web Composition Affect Ecosystem Metabolism in an Experimental Seagrass Habitat	PLOS ONE			English	Article							SEDIMENT ORGANIC-MATTER; TROPHIC INTERACTIONS; TOP-DOWN; RESOURCE AVAILABILITY; SPECIES-DIVERSITY; GRAZER DIVERSITY; PLANT DIVERSITY; CARBON; PRODUCTIVITY; BIODIVERSITY	Background: Food web composition and resource levels can influence ecosystem properties such as productivity and elemental cycles. In particular, herbivores occupy a central place in food webs as the species richness and composition of this trophic level may simultaneously influence the transmission of resource and predator effects to higher and lower trophic levels, respectively. Yet, these interactions are poorly understood. Methodology/Principal Findings: Using an experimental seagrass mesocosm system, we factorially manipulated water column nutrient concentrations, food chain length, and diversity of crustacean grazers to address two questions: (1) Does food web composition modulate the effects of nutrient enrichment on plant and grazer biomasses and stoichiometry? (2) Do ecosystem fluxes of dissolved oxygen and nutrients more closely reflect above-ground biomass and community structure or sediment processes? Nutrient enrichment and grazer presence generally had strong effects on biomass accumulation, stoichiometry, and ecosystem fluxes, whereas predator effects were weaker or absent. Nutrient enrichment had little effect on producer biomass or net ecosystem production but strongly increased seagrass nutrient content, ecosystem flux rates, and grazer secondary production, suggesting that enhanced production was efficiently transferred from producers to herbivores. Gross ecosystem production (oxygen evolution) correlated positively with above-ground plant biomass, whereas inorganic nutrient fluxes were unrelated to plant or grazer biomasses, suggesting dominance by sediment microbial processes. Finally, grazer richness significantly stabilized ecosystem processes, as predators decreased ecosystem production and respiration only in the zero- and one-species grazer treatments. Conclusions/Significance: Overall, our results indicate that consumer presence and species composition strongly influence ecosystem responses to nutrient enrichment, and that increasing herbivore diversity can stabilize ecosystem flux rates in the face of perturbations.			Spivak, AC (corresponding author), Miami Univ, Dept Zool, Oxford, OH 45056 USA.	Amanda.spivak@muohio.edu	Duffy, J. Emmett/ABF-9200-2020	Duffy, J. Emmett/0000-0001-8595-6391; Spivak, Amanda/0000-0001-6743-0783				Alcoverro T, 2001, MAR ECOL PROG SER, V211, P105, DOI 10.3354/meps211105; Anderson TR, 2005, AM NAT, V165, P1, DOI 10.1086/426598; Arnold TM, 2002, J CHEM ECOL, V28, P1919, DOI 10.1023/A:1020737609151; Bakker ES, 2006, ECOL LETT, V9, P780, DOI 10.1111/j.1461-0248.2006.00925.x; Bardgett RD, 1998, SOIL BIOL BIOCHEM, V30, P1867, DOI 10.1016/S0038-0717(98)00069-8; BEARE MH, 1992, ECOL MONOGR, V62, P569, DOI 10.2307/2937317; Bogren, 2002, DETERMINATION ORTHOP; Borer ET, 2006, ECOLOGY, V87, P2813, DOI 10.1890/0012-9658(2006)87[2813:AICREO]2.0.CO;2; Borer ET, 2005, ECOLOGY, V86, P528, DOI 10.1890/03-0816; Boschker HTS, 1999, LIMNOL OCEANOGR, V44, P309, DOI 10.4319/lo.1999.44.2.0309; Boyer KE, 2009, OIKOS, V118, P1062, DOI 10.1111/j.1600-0706.2009.17252.x; Bruno JF, 2008, ECOLOGY, V89, P2518, DOI 10.1890/07-1345.1; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Canuel EA, 2007, LIMNOL OCEANOGR, V52, P590, DOI 10.4319/lo.2007.52.2.0590; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Chase JM, 2003, OIKOS, V101, P187, DOI 10.1034/j.1600-0706.2003.12062.x; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Dahllof I, 2005, MAR CHEM, V94, P17, DOI 10.1016/j.marchem.2004.07.008; Douglass JG, 2007, MAR ECOL PROG SER, V348, P71, DOI 10.3354/meps07091; Downing AL, 2005, ECOLOGY, V86, P701, DOI 10.1890/03-0239; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Duffy JE, 2005, ECOL LETT, V8, P301, DOI 10.1111/j.1461-0248.2005.00725.x; Duffy JE, 2003, ECOL LETT, V6, P637; Duffy JE, 2001, MAR ECOL PROG SER, V223, P201, DOI 10.3354/meps223201; Duffy JE, 2001, ECOLOGY, V82, P2417; Duffy JE, 2000, ECOL MONOGR, V70, P237, DOI 10.1890/0012-9615(2000)070[0237:SIOGAO]2.0.CO;2; DUFFY JE, 2009, FRONTIERS ECOLOGY EN; Dzialowski AR, 2008, FRESHWATER BIOL, V53, P148, DOI 10.1111/j.1365-2427.2007.01883.x; EDGAR GJ, 1990, J EXP MAR BIOL ECOL, V137, P195, DOI 10.1016/0022-0981(90)90185-F; ELSER JJ, 1995, AQUAT MICROB ECOL, V9, P105, DOI 10.3354/ame009105; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Elser JJ, 1998, ECOSYSTEMS, V1, P120, DOI 10.1007/s100219900009; Forrester GE, 1999, LIMNOL OCEANOGR, V44, P1187, DOI 10.4319/lo.1999.44.5.1187; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Frost PC, 2002, J N AM BENTHOL SOC, V21, P515, DOI 10.2307/1468427; Godbold JA, 2009, OIKOS, V118, P77, DOI 10.1111/j.1600-0706.2008.17072.x; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Halpern BS, 2006, SCIENCE, V312, P1230, DOI 10.1126/science.1128613; Hansen JW, 2000, AQUAT BOT, V66, P281, DOI 10.1016/S0304-3770(99)00078-9; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; Heck KL, 2000, LIMNOL OCEANOGR, V45, P1041, DOI 10.4319/lo.2000.45.5.1041; HEDGES JI, 1984, LIMNOL OCEANOGR, V29, P657, DOI 10.4319/lo.1984.29.3.0657; Hessen DO, 2004, ECOLOGY, V85, P1179, DOI 10.1890/02-0251; Hillebrand H, 2004, ECOL LETT, V7, P192, DOI 10.1111/j.1461-0248.2004.00570.x; Hopkinson Charles S. Jr, 2005, P122, DOI 10.1093/acprof:oso/9780198527084.003.0008; Hughes AR, 2004, MAR ECOL PROG SER, V282, P87, DOI 10.3354/meps282087; Jonsson M, 2002, P ROY SOC B-BIOL SCI, V269, P1047, DOI 10.1098/rspb.2002.1979; Koch EM, 2001, ESTUARIES, V24, P1, DOI 10.2307/1352808; LIAO N, 2002, DETERMINATION AMMONI; MacKay NA, 1998, LIMNOL OCEANOGR, V43, P339, DOI 10.4319/lo.1998.43.2.0339; McGlathery KJ, 2007, MAR ECOL PROG SER, V348, P1, DOI 10.3354/meps07132; MCGLATHERY KJ, 1995, MAR ECOL PROG SER, V122, P239, DOI 10.3354/meps122239; Middelburg Jack J., 2005, P206; Moksnes PO, 2008, OIKOS, V117, P763, DOI 10.1111/j.0030-1299.2008.16521.x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Neubauer SC, 2000, MAR ECOL PROG SER, V199, P13, DOI 10.3354/meps199013; Nixon SW, 2002, ESTUARIES, V25, P782, DOI 10.1007/BF02804905; Nixon SW, 1980, MARINE BENTHIC DYNAM, P219; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Skelly DK, 2002, ECOLOGY, V83, P2097, DOI 10.1890/0012-9658(2002)083[2097:EVAEOI]2.0.CO;2; Smith P., 2001, DETERMINATION NITRAT; Spivak AC, 2007, LIMNOL OCEANOGR, V52, P2595, DOI 10.4319/lo.2007.52.6.2595; Spivak AC, 2009, MAR ECOL PROG SER, V376, P55, DOI 10.3354/meps07813; Stachowicz JJ, 2008, P NATL ACAD SCI USA, V105, P18842, DOI 10.1073/pnas.0806425105; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Taylor RB, 1998, LIMNOL OCEANOGR, V43, P600, DOI 10.4319/lo.1998.43.4.0600; Thebault E, 2003, P NATL ACAD SCI USA, V100, P14949, DOI 10.1073/pnas.2434847100; Valentine JF, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P463; Valiela I, 1995, MARINE ECOLOGICAL PR; Vanni MJ, 2002, ANNU REV ECOL SYST, V33, P341, DOI 10.1146/annurev.ecolsys.33.010802.150519; Vanni MJ, 1997, ECOLOGY, V78, P21; Vanni MJ, 1997, ECOLOGY, V78, P1; Vrede T, 2004, ECOLOGY, V85, P1217, DOI 10.1890/02-0249; Zhang QG, 2006, OIKOS, V114, P385, DOI 10.1111/j.2006.0030-1299.14723.x	81	29	30	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7473	10.1371/journal.pone.0007473	http://dx.doi.org/10.1371/journal.pone.0007473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829713	Green Published, gold, Green Submitted			2022-12-25	WOS:000270847800011
J	Garlapati, S; Wang, CC				Garlapati, Srinivas; Wang, Ching C.			Giardiavirus Internal Ribosome Entry Site Has an Apparently Unique Mechanism of Initiating Translation	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; ENCEPHALOMYOCARDITIS VIRUS-RNA; CAP-INDEPENDENT TRANSLATION; CRICKET PARALYSIS VIRUS; 5 NONCODING REGION; HEPATITIS-C; MESSENGER-RNA; MEDIATED TRANSLATION; LA AUTOANTIGEN; POLIOVIRUS RNA	Giardiavirus (GLV) utilizes an internal ribosome entry site (IRES) for translation initiation in the early branching eukaryote Giardia lamblia. Unlike most of the viral IRESs among higher eukaryotes, which localize primarily within the 5'-untranslated region (UTR), the GLV IRES comprises 253 nts of 5'UTR and the initial 264 nts in the open-reading-frame (ORF). To test if GLV IRES also functions in higher eukaryotic systems, we examined it in rabbit reticulocyte lysate (RRL) and found that it functions much less efficiently than the IRES from the Encephalomyocarditis virus ( EMCV) or Cricket paralysis virus ( CrPV). In contrast, both EMCV-IRES and CrPV-IRESs were inactive in transfected Giardia cells. Structure-function analysis indicated that only the stem-loop U5 from the 5'UTR and the stem-loop 1 plus the downstream box (Dbox) from the ORF of GLV IRES are required for limited IRES function in RRL. Edeine, a translation initiation inhibitor, did not significantly affect the function of GLV IRES in either RRL or Giardia, indicating that a pre-initiation complex is not required for GLV IRES-mediated translation initiation. However, the small ribosomal subunit purified from Giardia did not bind to GLV IRES, indicating that additional protein factors may be necessary. A member of the helicase family IBP1 and two known viral IRES binding proteins La autoantigen and SRp20 have been identified in Giardia that bind to GLV IRES in vitro. These three proteins could be involved in facilitating small ribosome recruitment for initiating translation.			Garlapati, S (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ccwang@cgl.ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030475] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-30475, R01 AI030475] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali N, 1997, P NATL ACAD SCI USA, V94, P2249, DOI 10.1073/pnas.94.6.2249; Bachler M, 1999, RNA, V5, P1509, DOI 10.1017/S1355838299991574; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Bedard KM, 2007, EMBO J, V26, P459, DOI 10.1038/sj.emboj.7601494; Belsham GJ, 2000, TRENDS MICROBIOL, V8, P330, DOI 10.1016/S0966-842X(00)01788-1; Bergamini G, 2000, RNA, V6, P1781, DOI 10.1017/S1355838200001679; Blyn LB, 1996, P NATL ACAD SCI USA, V93, P11115, DOI 10.1073/pnas.93.20.11115; BOROVJAGIN A, 1994, FEBS LETT, V351, P299, DOI 10.1016/0014-5793(94)00848-5; BOUSQUET A, 2009, RNA, V15, P750; CHAMPNEY WS, 1992, INT J BIOCHEM, V24, P1125, DOI 10.1016/0020-711X(92)90383-C; CONSTANTINO D, 2005, RNA, V11, P332; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Costa-Mattioli M, 2004, MOL CELL BIOL, V24, P6861, DOI 10.1128/mcb.24.15.6861-6870.2004; Craig AWB, 1997, MOL CELL BIOL, V17, P163, DOI 10.1128/MCB.17.1.163; Dinos G, 2004, MOL CELL, V13, P113, DOI 10.1016/S1097-2765(04)00002-4; Gamarnik AV, 1997, RNA, V3, P882; Garlapati S, 2005, EUKARYOT CELL, V4, P742, DOI 10.1128/EC.4.4.742-754.2005; Garlapati S, 2004, J BIOL CHEM, V279, P3389, DOI 10.1074/jbc.M307565200; Garlapati S, 2002, RNA, V8, P601, DOI 10.1017/S135583820202071X; Garlapati S, 2001, J MOL BIOL, V308, P623, DOI 10.1006/jmbi.2001.4568; Graff J, 1998, J VIROL, V72, P9668, DOI 10.1128/JVI.72.12.9668-9675.1998; HELLEN CUT, 1993, P NATL ACAD SCI USA, V90, P7642, DOI 10.1073/pnas.90.16.7642; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Herbreteau CH, 2005, NAT STRUCT MOL BIOL, V12, P1001, DOI 10.1038/nsmb1011; Izumi RE, 2004, J VIROL, V78, P3763, DOI 10.1128/JVI.78.7.3763-3776.2004; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Jan E, 2006, VIRUS RES, V119, P16, DOI 10.1016/j.virusres.2005.10.011; Ji H, 2004, P NATL ACAD SCI USA, V101, P16990, DOI 10.1073/pnas.0407402101; Kaminski A, 1995, RNA, V1, P924; Kieft JS, 1999, J MOL BIOL, V292, P513, DOI 10.1006/jmbi.1999.3095; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kim YK, 1999, J GEN VIROL, V80, P3159, DOI 10.1099/0022-1317-80-12-3159; Kolupaeva VG, 1996, RNA, V2, P1199; Kolupaeva VG, 2003, MOL CELL BIOL, V23, P687, DOI 10.1128/MCB.23.2.687-698.2003; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; KOZAK M, 1978, J BIOL CHEM, V253, P6568; Lancaster AM, 2006, RNA, V12, P894, DOI 10.1261/rna.2342306; Li L, 2004, J BIOL CHEM, V279, P14656, DOI 10.1074/jbc.M309879200; Li L, 2001, J VIROL, V75, P10612, DOI 10.1128/JVI.75.22.10612-10622.2001; Locker N, 2006, RNA, V12, P683, DOI 10.1261/rna.2227906; Locker N, 2007, METHOD ENZYMOL, V429, P83, DOI 10.1016/S0076-6879(07)29005-6; Lytle JR, 2001, J VIROL, V75, P7629, DOI 10.1128/JVI.75.16.7629-7636.2001; Martinez-Salas E, 2001, J GEN VIROL, V82, P973, DOI 10.1099/0022-1317-82-5-973; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; MEEROVITCH K, 1989, GENE DEV, V3, P1026, DOI 10.1101/gad.3.7.1026; Merrick WC., 1996, TRANSLATION CONTROL, P31; ODOM OW, 1978, J BIOL CHEM, V253, P1807; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Pfingsten JS, 2006, SCIENCE, V314, P1450, DOI 10.1126/science.1133281; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Ray PS, 2002, NUCLEIC ACIDS RES, V30, P4500, DOI 10.1093/nar/gkf583; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; Semler BL, 2008, TRENDS MICROBIOL, V16, P1, DOI 10.1016/j.tim.2007.11.001; Shirakura T, 2001, MOL BIOCHEM PARASIT, V112, P153, DOI 10.1016/S0166-6851(00)00356-X; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Thompson SR, 2001, P NATL ACAD SCI USA, V98, P12972, DOI 10.1073/pnas.241286698; WANG AL, 1991, PARASITOL TODAY, V7, P76, DOI 10.1016/0169-4758(91)90198-W; WANG AL, 1986, MOL BIOCHEM PARASIT, V21, P269, DOI 10.1016/0166-6851(86)90132-5; WANG AL, 1993, P NATL ACAD SCI USA, V90, P8595, DOI 10.1073/pnas.90.18.8595; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Yu DC, 1998, MOL BIOCHEM PARASIT, V96, P151, DOI 10.1016/S0166-6851(98)00126-1; Yu DC, 1996, RNA, V2, P824; YU DC, 1995, MOL CELL BIOL, V15, P4867	71	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7435	10.1371/journal.pone.0007435	http://dx.doi.org/10.1371/journal.pone.0007435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826476	Green Published, Green Submitted, gold			2022-12-25	WOS:000270808700007
J	Margolin, AA; Ong, SE; Schenone, M; Gould, R; Schreiber, SL; Carr, SA; Golub, TR				Margolin, Adam A.; Ong, Shao-En; Schenone, Monica; Gould, Robert; Schreiber, Stuart L.; Carr, Steven A.; Golub, Todd R.			Empirical Bayes Analysis of Quantitative Proteomics Experiments	PLOS ONE			English	Article							FALSE DISCOVERY RATES; CELL-CULTURE SILAC; MULTIPLEXED PROTEIN QUANTITATION; MASS-SPECTROMETRY; AMINO-ACIDS; GEL-ELECTROPHORESIS; SIGNALING NETWORKS; EXPRESSION; REVEALS; PHOSPHOPROTEOMICS	Background: Advances in mass spectrometry-based proteomics have enabled the incorporation of proteomic data into systems approaches to biology. However, development of analytical methods has lagged behind. Here we describe an empirical Bayes framework for quantitative proteomics data analysis. The method provides a statistical description of each experiment, including the number of proteins that differ in abundance between 2 samples, the experiment's statistical power to detect them, and the false-positive probability of each protein. Methodology/Principal Findings: We analyzed 2 types of mass spectrometric experiments. First, we showed that the method identified the protein targets of small-molecules in affinity purification experiments with high precision. Second, we re-analyzed a mass spectrometric data set designed to identify proteins regulated by microRNAs. Our results were supported by sequence analysis of the 3' UTR regions of predicted target genes, and we found that the previously reported conclusion that a large fraction of the proteome is regulated by microRNAs was not supported by our statistical analysis of the data. Conclusions/Significance: Our results highlight the importance of rigorous statistical analysis of proteomic data, and the method described here provides a statistical framework to robustly and reliably interpret such data.			Margolin, AA (corresponding author), Broad Inst, Harvard & MIT Canc Program, Cambridge, MA USA.	margolin@broad.mit.edu	Carr, Steven A./AAH-8366-2019		NATIONAL CANCER INSTITUTE [RL1CA133834] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084437] Funding Source: NIH RePORTER; NCI NIH HHS [RL1 CA133834, RL1 CA 133834] Funding Source: Medline; NCRR NIH HHS [UL1 RR024924, UL1 RR 024924] Funding Source: Medline; NIGMS NIH HHS [RL1 GM084437, RL1 GM 084437] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Chang JS, 2004, J PROTEOME RES, V3, P1210, DOI 10.1021/pr049886m; Chen XQ, 2008, MOL CELL PROTEOMICS, V7, P2323, DOI 10.1074/mcp.M700575-MCP200; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Efron B, 2005, LOCAL FALSE DISCOVER; Efron B, 2008, STAT SCI, V23, P1, DOI 10.1214/07-STS236; Efron B, 2007, ANN STAT, V35, P1351, DOI 10.1214/009053606000001460; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Everley PA, 2004, MOL CELL PROTEOMICS, V3, P729, DOI 10.1074/mcp.M400021-MCP200; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Guha U, 2008, P NATL ACAD SCI USA, V105, P14112, DOI 10.1073/pnas.0806158105; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hendrickson EL, 2006, ANALYST, V131, P1335, DOI 10.1039/b610957h; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Keenan T, 1998, BIOORGAN MED CHEM, V6, P1309, DOI 10.1016/S0968-0896(98)00125-4; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Kreil DP, 2004, BIOINFORMATICS, V20, P2026, DOI 10.1093/bioinformatics/bth193; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liao JG, 2004, BIOINFORMATICS, V20, P2694, DOI 10.1093/bioinformatics/bth310; Lin WT, 2006, J PROTEOME RES, V5, P2328, DOI 10.1021/pr060132c; Lutz T, 2006, FEBS LETT, V580, P5851, DOI 10.1016/j.febslet.2006.09.049; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marelli M, 2004, J CELL BIOL, V167, P1099, DOI 10.1083/jcb.200404119; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Pan Wei, 2003, Functional & Integrative Genomics, V3, P117; PICKANDS J, 1975, ANN STAT, V3, P119; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rinner O, 2007, NAT BIOTECHNOL, V25, P345, DOI 10.1038/nbt1289; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Saito A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-15; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Xia QW, 2007, INT J MASS SPECTROM, V259, P105, DOI 10.1016/j.ijms.2006.08.004; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	56	42	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7454	10.1371/journal.pone.0007454	http://dx.doi.org/10.1371/journal.pone.0007454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19829701	Green Published, Green Submitted, gold			2022-12-25	WOS:000270808700014
J	Sutton, GM; Begriche, K; Kumar, KG; Gimble, JM; Perez-Tilve, D; Nogueiras, R; McMillan, RP; Hulver, MW; Tschop, MH; Butler, AA				Sutton, Gregory M.; Begriche, Karima; Kumar, K. Ganesh; Gimble, Jeffrey M.; Perez-Tilve, Diego; Nogueiras, Ruben; McMillan, Ryan P.; Hulver, Matthew W.; Tschoep, Matthias H.; Butler, Andrew A.			Central nervous system melanocortin-3 receptors are required for synchronizing metabolism during entrainment to restricted feeding during the light cycle	FASEB JOURNAL			English	Article						hypothalamus; circadian biology; liver metabolism; glucose; ketones	AGOUTI-RELATED PROTEIN; NEURONAL ACTIVATION; BRAIN; OBESITY; CLOCK; FOOD; HYPOTHALAMUS; PATHOGENESIS; MECHANISMS; RHYTHMS	Melanocortin-3 receptors (Mc3rs) in the central nervous system are involved in expression of anticipatory rhythms and synchronizing clocks maintaining circadian rhythms during restricted feeding (RF) [mice housed under a 12-h light-dark cycle with lights on between zeitgeber time (ZT) 0 to ZT12 fed 60% of normal calories between ZT7 and ZT11]. Because the systems governing circadian rhythms are important for adaptation to RF, we investigated whether Mc3rs are required for metabolic adaption to RF. Mc3r(-/-) mice subjected to RF exhibited normal weight loss; however, they developed hyper-insulinemia, glucose intolerance, increased expression of lipogenic genes, and increased ketogenesis relative to controls. Rhythmic expression of transcription factors regulating liver clock activity and energy metabolism (Bmal1, Rev-erb alpha, Pgc1, Foxo1, Hnf4 alpha, and Pck1) was severely compromised in Mc3r(-/-) mice during RF. Inhibition of neural melanocortin receptors by agouti-related peptide also attenuated rhythmicity in the hepatic expression of these genes during RF. Collectively, these data suggest that neural Mc3rs are important for adapting metabolism and maintaining rhythms of liver metabolism during periods when feeding is restricted to the light cycle.-Sutton, G. M., Begriche, K., Kumar, K. G., Gimble, J. M., Perez-Tilve, D., Nogueiras, R., McMillan, R. P., Hulver, M. W., Tschop, M. H., Butler, A. A. Central nervous system melanocortin-3 receptors are required for synchronizing metabolism during entrainment to restricted feeding during the light cycle. FASEB J. 24, 862-872 (2010). www.fasebj.org	[Begriche, Karima; Kumar, K. Ganesh; Butler, Andrew A.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA; [Sutton, Gregory M.; Begriche, Karima; Kumar, K. Ganesh; Butler, Andrew A.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Neuropeptides Lab, Baton Rouge, LA USA; [Gimble, Jeffrey M.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Stem Cell Biol Lab, Baton Rouge, LA USA; [Gimble, Jeffrey M.; Butler, Andrew A.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Clin Nutr Res Unit, Baton Rouge, LA USA; [Perez-Tilve, Diego; Nogueiras, Ruben; Tschoep, Matthias H.] German Inst Human Nutr Potsdam Rehbrucke, Dept Pharmacol, Nuthetal, Germany; [Nogueiras, Ruben; Tschoep, Matthias H.] Univ Cincinnati, Obes Res Ctr, Dept Psychiat, Cincinnati, OH USA; [McMillan, Ryan P.; Hulver, Matthew W.] Virginia Polytech & State Univ, Dept Human Nutr Food & Exercise, Blacksburg, VA USA	Scripps Research Institute; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); University System of Ohio; University of Cincinnati; Virginia Polytechnic Institute & State University	Butler, AA (corresponding author), Scripps Res Inst, Dept Metab & Aging, 130 Scripps Way, Jupiter, FL 33458 USA.	abutler@scripps.edu	Tschoep, Matthias H/I-5443-2014; Nogueiras, Ruben/AAS-9427-2021; Begriche, Karima/Y-9444-2019	Nogueiras, Ruben/0000-0002-9976-9930; Tschoep, Matthias/0000-0002-4744-371X; Begriche, Karima/0000-0002-6378-3861; Butler, Andrew/0000-0001-7196-0170; Perez-Tilve, Diego/0000-0002-0351-4133	National Institutes of Health [DK073189]; Pennington Biomedical Research Foundation; National Institute of Diabetes and Digestive and Kidney Diseases [1P30 DK072476]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073189, P30DK072476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennington Biomedical Research Foundation; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr. Jennifer Rood, Dr. Robert Koza, Dr. Jose Galgani, Brian Goh, Emily Meyer, Armand Centanni, and Xiying Wu for technical assistance. We thank Dr. H. Henry Dong (Rangos Research Center, Children's Hospital of Pittsburgh, Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, PA) for providing the Foxo1 antibody. Funding for this work was provided by the National Institutes of Health (DK073189 to A. A. B.). A. A. B. and J.M.G. acknowledge the support of the Pennington Biomedical Research Foundation and Clinical Nutrition Research Unit Center grant, "Nutritional Programming: Environmental and Molecular Interactions" (1P30 DK072476), sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases. The authors declare that they have no competing interests.	Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Butler AA, 2006, PEPTIDES, V27, P281, DOI 10.1016/j.peptides.2005.02.029; Caspi L, 2007, CELL METAB, V6, P99, DOI 10.1016/j.cmet.2007.07.005; Chen AS, 2000, NAT GENET, V26, P97, DOI 10.1038/79254; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cone RD, 2006, ENDOCR REV, V27, P736, DOI 10.1210/er.2006-0034; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Davidson AJ, 2006, AM J PHYSIOL-REG I, V290, pR1524, DOI 10.1152/ajpregu.00073.2006; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Duez H, 2008, FEBS LETT, V582, P19, DOI 10.1016/j.febslet.2007.08.032; Garfield AS, 2009, TRENDS ENDOCRIN MET, V20, P203, DOI 10.1016/j.tem.2009.02.002; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Gupta RK, 2004, TRENDS MOL MED, V10, P521, DOI 10.1016/j.molmed.2004.09.004; Gutierrez-Juarez R, 2004, J BIOL CHEM, V279, P49704, DOI 10.1074/jbc.M408665200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Johnstone LE, 2006, CELL METAB, V4, P313, DOI 10.1016/j.cmet.2006.08.003; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Kornmann B, 2007, COLD SPRING HARB SYM, V72, P319, DOI 10.1101/sqb.2007.72.041; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Levin BE, 2007, CELL METAB, V6, P252, DOI 10.1016/j.cmet.2007.09.005; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; MacNeil DJ, 2002, EUR J PHARMACOL, V450, P91, DOI 10.1016/S0014-2999(02)01989-1; Mistlberger Ralph E, 2009, J Circadian Rhythms, V7, P3, DOI 10.1186/1740-3391-7-3; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Obici S, 2009, ENDOCRINOLOGY, V150, P2512, DOI 10.1210/en.2009-0409; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Perlemuter G, 2007, NAT CLIN PRACT ENDOC, V3, P458, DOI 10.1038/ncpendmet0505; Peschke E, 2008, J PINEAL RES, V44, P26, DOI 10.1111/j.1600-079X.2007.00519.x; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Ramsey KM, 2009, P NATL ACAD SCI USA, V106, P4069, DOI 10.1073/pnas.0901304106; Robinson SW, 2000, ANNU REV GENET, V34, P687, DOI 10.1146/annurev.genet.34.1.687; ROSELLIREHFUSS L, 1993, P NATL ACAD SCI USA, V90, P8856, DOI 10.1073/pnas.90.19.8856; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; Singru PS, 2007, ENDOCRINOLOGY, V148, P638, DOI 10.1210/en.2006-1233; Small CJ, 2001, DIABETES, V50, P248, DOI 10.2337/diabetes.50.2.248; Staels B, 2006, NAT MED, V12, P54, DOI 10.1038/nm0106-54; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; Storch KF, 2009, P NATL ACAD SCI USA, V106, P6808, DOI 10.1073/pnas.0902063106; Sutton GM, 2006, ENDOCRINOLOGY, V147, P2183, DOI 10.1210/en.2005-1209; Sutton GM, 2008, J NEUROSCI, V28, P12946, DOI 10.1523/JNEUROSCI.3615-08.2008; Wijnen H, 2009, SCIENCE, V324, P598, DOI 10.1126/science.1174132; Zhou L, 2007, CELL METAB, V6, P398, DOI 10.1016/j.cmet.2007.10.008	53	39	39	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2010	24	3					862	872		10.1096/fj.09-142000	http://dx.doi.org/10.1096/fj.09-142000			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	561KE	19837866	Bronze, Green Published			2022-12-25	WOS:000274974600022
J	Humphrey, RK; Yu, SM; Flores, LE; Jhala, US				Humphrey, Rohan K.; Yu, Shu-Mei; Flores, Luis E.; Jhala, Ulupi S.			Glucose Regulates Steady-state Levels of PDX1 via the Reciprocal Actions of GSK3 and AKT Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; HOMEODOMAIN TRANSCRIPTION FACTOR; INSULIN GENE-TRANSCRIPTION; DIABETES-MELLITUS; HOMEOBOX FACTOR; ACTIVATION; PROTEIN; GROWTH; EXPRESSION; PHOSPHORYLATION	The pancreatic beta cell is sensitive to even small changes in PDX1 protein levels; consequently, Pdx1 haploinsufficiency can inhibit beta cell growth and decrease insulin biosynthesis and gene expression, leading to compromised glucose-stimulated insulin secretion. Using metabolic labeling of primary islets and a cultured beta cell line, we show that glucose levels modulate PDX1 protein phosphorylation at a novel C-terminal GSK3 consensus that maps to serines 268 and 272. A decrease in glucose levels triggers increased turnover of the PDX1 protein in a GSK3-dependent manner, such that PDX1 phosphomutants are refractory to the destabilizing effect of low glucose. Glucose-stimulated activation of AKT and inhibition of GSK3 decrease PDX1 phosphorylation and delay degradation. Furthermore, direct pharmacologic inhibition of AKT destabilizes, and inhibition of GSK3 increases PDX1 protein stability. These studies define a novel functional role for the PDX1 C terminus in mediating the effects of glucose and demonstrate that glucose modulates PDX1 stability via the AKT-GSK3 axis.	[Humphrey, Rohan K.; Yu, Shu-Mei; Flores, Luis E.; Jhala, Ulupi S.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92037 USA	University of California System; University of California San Diego	Jhala, US (corresponding author), 3525 John Hopkins Court, San Diego, CA 92121 USA.	ujhala@ucsd.edu		Flores, Luis/0000-0003-1709-8748	National Institutes of Health [R01DK080147]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK080147 (to U. S. J.).; We are deeply grateful to Dr. Marc Montminy (The Salk Institute for Biological Studies, La Jolla, CA) for providing guidance and resources during the PDX1 phosphopeptide mapping studies. We also thank Dr. Greg Korbutt (Alberta Diabetes Institute, Canada) for help with islet isolation, Jill Meisenhelder and the laboratory of Dr. Tony Hunter (The Salk Institute, La Jolla CA) for use of phosphopeptide mapping facilities, and Dr. Doris Stoffers for a critical reading of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Andrali SS, 2008, BIOCHEM J, V415, P1, DOI 10.1042/BJ20081029; Arnott David, 2003, J Biomol Tech, V14, P205; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Bernal-Mizrachi E, 2004, J CLIN INVEST, V114, P928, DOI 10.1172/JCI200420016; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Brissova M, 2005, AM J PHYSIOL-ENDOC M, V288, pE707, DOI 10.1152/ajpendo.00252.2004; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Dutta S, 1998, NATURE, V392, P560, DOI 10.1038/33311; Eto K, 2006, ENDOCRINOLOGY, V147, P2923, DOI 10.1210/en.2005-1336; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gauthier BR, 2004, J BIOL CHEM, V279, P31121, DOI 10.1074/jbc.M405030200; Guo SL, 2009, J BIOL CHEM, V284, P759, DOI 10.1074/jbc.M806314200; Guo X, 2008, GENE DEV, V22, P106, DOI 10.1101/gad.1590908; Han S, 2007, MOL CELL BIOL, V27, P6593, DOI 10.1128/MCB.01573-06; Hani EH, 1999, J CLIN INVEST, V104, pR41, DOI 10.1172/JCI7469; HARLOW E, 2006, ANTIBODIES LAB MANUA; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Jiang J, 2006, CELL CYCLE, V5, P2457, DOI 10.4161/cc.5.21.3406; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Khoo S, 2003, J BIOL CHEM, V278, P32969, DOI 10.1074/jbc.M301198200; Kitamura T, 2002, J CLIN INVEST, V110, P1839, DOI 10.1172/JCI200216857; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Kushner JA, 2002, J CLIN INVEST, V109, P1193, DOI 10.1172/JCI200214439; Liu AH, 2004, MOL CELL BIOL, V24, P4372, DOI 10.1128/MCB.24.10.4372-4383.2004; Liu Z, 2008, DIABETOLOGIA, V51, P623, DOI 10.1007/s00125-007-0914-7; Lu M, 1996, ENDOCRINOLOGY, V137, P2959, DOI 10.1210/en.137.7.2959; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; MEISENHELDER J, 2001, CURRENT PROTOCOLS PR, V2; Mosley AL, 2004, J BIOL CHEM, V279, P54241, DOI 10.1074/jbc.M410379200; Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Ohsugi M, 2004, DIABETES, V53, P1496, DOI 10.2337/diabetes.53.6.1496; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; PEERS B, 1994, MOL ENDOCRINOL, V8, P1798, DOI 10.1210/me.8.12.1798; Peshavaria M, 2000, MOL ENDOCRINOL, V14, P1907, DOI 10.1210/me.14.12.1907; Petersen HV, 1998, FEBS LETT, V431, P362, DOI 10.1016/S0014-5793(98)00776-5; Shapiro AMJ, 1996, CELL TRANSPLANT, V5, P631, DOI 10.1016/S0963-6897(96)00084-X; Sharma S, 1997, MOL CELL BIOL, V17, P2598, DOI 10.1128/MCB.17.5.2598; Srinivasan S, 2002, AM J PHYSIOL-ENDOC M, V283, pE784, DOI 10.1152/ajpendo.00177.2002; Stanojevic V, 2004, ENDOCRINOLOGY, V145, P2918, DOI 10.1210/en.2003-1188; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Tanabe K, 2008, PLOS BIOL, V6, P307, DOI 10.1371/journal.pbio.0060037; Thomas GM, 1999, FEBS LETT, V458, P247, DOI 10.1016/S0014-5793(99)01161-8; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Watada H, 1996, DIABETES, V45, P1478, DOI 10.2337/diabetes.45.11.1478; Weng J, 2001, DIABETOLOGIA, V44, P249, DOI 10.1007/s001250051608; Wu H, 1999, BIOCHEM J, V344, P813, DOI 10.1042/0264-6021:3440813; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039; Xavier GD, 2004, BIOCHEM J, V377, P149, DOI 10.1042/BJ20031260; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	58	48	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2010	285	5					3406	3416		10.1074/jbc.M109.006734	http://dx.doi.org/10.1074/jbc.M109.006734			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	546RR	19833727	hybrid, Green Published			2022-12-25	WOS:000273829000055
J	Allende-Vega, N; Sparks, A; Lane, DP; Saville, MK				Allende-Vega, N.; Sparks, A.; Lane, D. P.; Saville, M. K.			MdmX is a substrate for the deubiquitinating enzyme USP2a	ONCOGENE			English	Article						USP2a; MdmX; Mdm2; p53; ubiquitin; deubiquitinating enzyme	P53 ACTIVATION; DNA-DAMAGE; IN-VIVO; EMBRYONIC LETHALITY; UBIQUITIN LIGASE; PROSTATE-CANCER; TARGETING MDM2; CISPLATIN; CELLS; PATHWAY	It has previously been shown that ubiquitin-specific protease 2a (USP2a) is a regulator of the Mdm2/p53 pathway. USP2a binds to Mdm2 and can deubiquitinate Mdm2 without reversing Mdm2-mediated p53 ubiquitination. Overexpression of USP2a causes accumulation of Mdm2 and promotes p53 degradation. We now show that MdmX is also a substrate for USP2a. MdmX associates with USP2a independently of Mdm2. Ectopic expression of wild-type USP2a but not a catalytic mutant prevents Mdm2-mediated degradation of MdmX. This correlates with the ability of wild-type USP2a to deubiquitinate MdmX. siRNA-mediated knockdown of USP2a in NTERA-2 testicular embryonal carcinoma cells and MCF7 breast cancer cells causes destabilization of MdmX and results in a decrease in MdmX protein levels, showing that endogenous USP2a participates in the regulation of MdmX stability. The therapeutic drug, cisplatin decreases MdmX protein expression. USP2a mRNA and protein levels were also reduced after cisplatin exposure. The magnitude and time course of USP2a downregulation suggests that the reduction in USP2a levels could contribute to the decrease in MdmX expression following treatment with cisplatin. Knockdown of USP2a increases the sensitivity of NTERA-2 cells to cisplatin, raising the possibility that suppression of USP2a in combination with cisplatin may be an approach for cancer therapy. Oncogene (2010) 29, 432-441; doi:10.1038/onc.2009.330; published online 19 October 2009	[Allende-Vega, N.; Sparks, A.; Lane, D. P.; Saville, M. K.] Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, CR UK Cell Transformat Res Grp,Div Mol Med, Dundee DD1 9SY, Scotland	University of Dundee	Saville, MK (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Dept Surg & Mol Oncol, CR UK Cell Transformat Res Grp,Div Mol Med, Level 6, Dundee DD1 9SY, Scotland.	m.k.saville@dundee.ac.uk		Allende-Vega, Nerea/0000-0001-5569-6461; Lane, David/0000-0003-0551-3545	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was funded by Cancer Research UK. Professor David P Lane is a Gibb fellow of Cancer Research UK.	Barboza JA, 2008, MOL CANCER RES, V6, P947, DOI 10.1158/1541-7786.MCR-07-2079; Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Campbell KJ, 2006, CANCER RES, V66, P929, DOI 10.1158/0008-5472.CAN-05-2234; Cullinane C, 1999, BIOCHEMISTRY-US, V38, P6204, DOI 10.1021/bi982685+; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; Dayal S, 2009, J BIOL CHEM, V284, P5030, DOI 10.1074/jbc.M805871200; EVANS GL, 1992, BIOCHEM BIOPH RES CO, V184, P1, DOI 10.1016/0006-291X(92)91149-K; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Finch RA, 2002, CANCER RES, V62, P3221; Francoz S, 2006, P NATL ACAD SCI USA, V103, P3232, DOI 10.1073/pnas.0508476103; Giglio S, 2005, CANCER RES, V65, P9687, DOI 10.1158/0008-5472.CAN-05-0450; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Gousseva N, 2003, GENE EXPRESSION, V11, P163, DOI 10.3727/000000003108749053; Graner E, 2004, CANCER CELL, V5, P253, DOI 10.1016/S1535-6108(04)00055-8; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Honda R, 2000, ONCOGENE, V19, P1473, DOI 10.1038/sj.onc.1203464; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Kawai H, 2003, J BIOL CHEM, V278, P45946, DOI 10.1074/jbc.M308295200; Kruse JJCM, 2007, MUTAT RES-FUND MOL M, V617, P58, DOI 10.1016/j.mrfmmm.2006.12.004; LANE DP, 1990, GENE DEV, V4, P1, DOI 10.1101/gad.4.1.1; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lin HJ, 2001, J BIOL CHEM, V276, P20357, DOI 10.1074/jbc.M008761200; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Park KC, 2002, P NATL ACAD SCI USA, V99, P9733, DOI 10.1073/pnas.152011799; Patton JT, 2006, CANCER RES, V66, P3169, DOI 10.1158/0008-5472.CAN-05-3832; Previati M, 2004, HEARING RES, V196, P8, DOI 10.1016/j.heares.2004.04.009; Priolo C, 2006, CANCER RES, V66, P8625, DOI 10.1158/0008-5472.CAN-06-1374; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Shvarts A, 1996, EMBO J, V15, P5349, DOI 10.1002/j.1460-2075.1996.tb00919.x; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Singh RK, 2007, J BIOL CHEM, V282, P10901, DOI 10.1074/jbc.M610879200; Stevenson LF, 2007, EMBO J, V26, P976, DOI 10.1038/sj.emboj.7601567; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Tanimura S, 1999, FEBS LETT, V447, P5, DOI 10.1016/S0014-5793(99)00254-9; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Uldrijan S, 2007, EMBO J, V26, P102, DOI 10.1038/sj.emboj.7601469; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vassilev LT, 2007, TRENDS MOL MED, V13, P23, DOI 10.1016/j.molmed.2006.11.002; Vichi P, 1997, EMBO J, V16, P7444, DOI 10.1093/emboj/16.24.7444; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wade M, 2006, J BIOL CHEM, V281, P33036, DOI 10.1074/jbc.M605405200; Wade M, 2009, MOL CANCER RES, V7, P1, DOI 10.1158/1541-7786.MCR-08-0423; Wang YV, 2007, P NATL ACAD SCI USA, V104, P12365, DOI 10.1073/pnas.0701497104; Xia MX, 2008, CELL CYCLE, V7, P1604, DOI 10.4161/cc.7.11.5929; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656	56	80	86	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2010	29	3					432	441		10.1038/onc.2009.330	http://dx.doi.org/10.1038/onc.2009.330			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	546EO	19838211				2022-12-25	WOS:000273793200012
J	Ryu, HY; Lee, J; Yang, S; Park, H; Choi, S; Jung, KC; Lee, ST; Seong, JK; Han, IO; Oh, ES				Ryu, Heui-Young; Lee, Jiseon; Yang, Sanghwa; Park, Haein; Choi, Sojoong; Jung, Kyeong-Cheon; Lee, Seung-Taek; Seong, Je-Kyung; Han, Inn-Oc; Oh, Eok-Soo			Syndecan-2 Functions as a Docking Receptor for Pro-matrix Metalloproteinase-7 in Human Colon Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA CELLS; TUMOR INVASION; INTESTINAL TUMORIGENESIS; MESSENGER-RNA; EXPRESSION; MATRILYSIN; METASTASIS; ADHESION; TRANSFORMATION; FIBRONECTIN	Although elevated syndecan-2 expression is known to be crucial for the tumorigenic activity in colon carcinoma cells, how syndecan-2 regulates colon cancer is unclear. In human colon adenocarcinoma tissue samples, we found that both mRNA and protein expression of syndecan-2 were increased, compared with the neighboring normal epithelium, suggesting that syndecan-2 plays functional roles in human colon cancer cells. Consistent with this notion, syndecan-2-overexpressing HT-29 colon adenocarcinoma cells showed enhanced migration/invasion, anchorage-independent growth, and primary tumor formation in nude mice, paralleling their morphological changes into highly tumorigenic cells. In addition, our experiments revealed that syndecan-2 enhanced both expression and secretion of matrix metalloproteinase-7 (MMP-7), directly interacted with pro-MMP-7, and potentiated the enzymatic activity of pro-MMP-7 by activating its processing into the active MMP-7. Collectively, these data strongly suggest that syndecan-2 functions as a docking receptor for pro-MMP-7 in colon cancer cells.	[Oh, Eok-Soo] Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Yang, Sanghwa] Yonsei Univ, Coll Med, Canc Metastasis Res Ctr, Seoul 120749, South Korea; [Jung, Kyeong-Cheon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110799, South Korea; [Lee, Seung-Taek] Yonsei Univ, Coll Sci, Dept Biochem, Seoul 120749, South Korea; [Seong, Je-Kyung] Seoul Natl Univ, Coll Vet Med, Dept Anat & Cell Biol, Seoul 151742, South Korea; [Han, Inn-Oc] Inha Univ, Dept Physiol & Biophys, Coll Med, Inchon 400712, South Korea	Ewha Womans University; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Yonsei University; Seoul National University (SNU); Inha University	Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, Div Life & Pharmaceut Sci, Seoul 120750, South Korea.	OhES@ewha.ac.kr	Jung, Kyeong Choen/C-6068-2011	Jung, Kyeong Choen/0000-0002-7741-7184; Lee, Seung-Taek/0000-0001-7300-9784; Seong, Je Kyung/0000-0003-1177-6958	Ministry of Health & Welfare, Republic of Korea [0420070-1]; Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A090165]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant of the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea ( Grant 0420070-1 to E.S.O.) and a grant of the Korea Healthcare Technology R&D Projects, Ministry for Health, Welfare, and Family Affairs, Republic of Korea ( Grant A090165).	Anttonen A, 2001, LUNG CANCER, V32, P297, DOI 10.1016/S0169-5002(00)00230-0; Bass MD, 2002, BIOCHEM J, V368, P1, DOI 10.1042/BJ20021228; Carey DJ, 1997, BIOCHEM J, V327, P1; Curran S, 1999, J PATHOL, V189, P300, DOI 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Essner JJ, 2006, INT J BIOCHEM CELL B, V38, P152, DOI 10.1016/j.biocel.2005.08.012; Fingleton BM, 1999, APMIS, V107, P102, DOI 10.1111/j.1699-0463.1999.tb01532.x; Han I, 2004, J MOL HISTOL, V35, P319; Jayson GC, 1999, INT J CANCER, V82, P298, DOI 10.1002/(SICI)1097-0215(19990719)82:2<298::AID-IJC23>3.3.CO;2-0; Kim TM, 2005, CLIN CANCER RES, V11, P79; Kim Y, 2003, ONCOGENE, V22, P826, DOI 10.1038/sj.onc.1206068; Lee KH, 2007, EUR SURG RES, V39, P208, DOI 10.1159/000101452; Leeman MF, 2003, J PATHOL, V201, P528, DOI 10.1002/path.1466; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Matsuda K, 2001, CANCER RES, V61, P5562; Miyazaki K, 1999, CANCER CHEMOTH PHARM, V43, pS52, DOI 10.1007/s002800051098; Munesue S, 2002, BIOCHEM J, V363, P201, DOI 10.1042/0264-6021:3630201; Munesue S, 2007, J BIOL CHEM, V282, P28164, DOI 10.1074/jbc.M609812200; Nabeshima K, 2002, PATHOL INT, V52, P255, DOI 10.1046/j.1440-1827.2002.01343.x; Nanki N, 2001, TUMOR BIOL, V22, P390, DOI 10.1159/000050642; Numa F, 2002, INT J ONCOL, V20, P39; Ougolkov AV, 2002, GASTROENTEROLOGY, V122, P60, DOI 10.1053/gast.2002.30306; Park H, 2002, J BIOL CHEM, V277, P29730, DOI 10.1074/jbc.M202435200; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; Rapraeger AC, 2001, SEMIN CELL DEV BIOL, V12, P107, DOI 10.1006/scdb.2000.0239; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Wielockx B, 2004, CYTOKINE GROWTH F R, V15, P111, DOI 10.1016/j.cytogfr.2003.12.001; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Woods A, 1998, MATRIX BIOL, V17, P477, DOI 10.1016/S0945-053X(98)90095-6; YAMAMOTO H, 1994, BIOCHEM BIOPH RES CO, V201, P657, DOI 10.1006/bbrc.1994.1751; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu WH, 2002, GENE DEV, V16, P307, DOI 10.1101/gad.925702; Zellweger T, 2003, PROSTATE, V55, P20, DOI 10.1002/pros.10209	34	57	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35692	35701		10.1074/jbc.M109.054254	http://dx.doi.org/10.1074/jbc.M109.054254			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858218	Green Published, hybrid			2022-12-25	WOS:000272645600047
J	Stepanova, E; Wang, MS; Severinov, K; Borukhov, S				Stepanova, Ekaterina; Wang, Minshi; Severinov, Konstantin; Borukhov, Sergei			Early Transcriptional Arrest at Escherichia coli rplN and ompX Promoters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; CLEAVAGE FACTORS GREA; IN-VIVO; ELONGATION COMPLEXES; TERNARY COMPLEXES; SIGMA(70) SUBUNIT; DNA-REPLICATION; MECHANISM; INITIATION; VITRO	Bacterial transcription elongation factors GreA and GreB stimulate the intrinsic RNase activity of RNA polymerase (RNAP), thus helping the enzyme to read through pausing and arresting sites on DNA. Gre factors also accelerate RNAP transition from initiation to elongation. Here, we characterized the molecular mechanism by which Gre factors facilitate transcription at two Escherichia coli promoters, PrplN and PompX, that require GreA for optimal in vivo activity. Using in vitro transcription assays, KMnO4 footprinting, and Fe2+-induced hydroxyl radical mapping, we show that during transcription initiation at PrplN and PompX in the absence of Gre factors, RNAP falls into a condition of promoter-proximal transcriptional arrest that prevents production of full-length transcripts both in vitro and in vivo. Arrest occurs when RNAP synthesizes 9-14-nucleotide-long transcripts and backtracks by 5-7 (PrplN) or 2-4 (PompX) nucleotides. Initiation factor sigma(70) contributes to the formation of arrested complexes at both promoters. The signal for promoter-proximal arrest at PrplN is bipartite and requires two elements: the extended -10 promoter element and the initial transcribed region from positions +2 to +6. GreA and GreB prevent arrest at PrplN and PompX by inducing cleavage of the 3'-proximal backtracked portion of RNA at the onset of arrested complex formation and stimulate productive transcription by allowing RNAP to elongate the 5'-proximal transcript cleavage products in the presence of substrates. We propose that promoter-proximal arrest is a common feature of many bacterial promoters and may represent an important physiological target of regulation by transcript cleavage factors.	[Stepanova, Ekaterina; Wang, Minshi; Borukhov, Sergei] Univ Med & Dent New Jersey, Sch Osteopath Med Stratford, Dept Cell Biol, Stratford, NJ 08084 USA; [Severinov, Konstantin] Rutgers State Univ, Waksman Inst, Piscataway, NJ 08854 USA; [Stepanova, Ekaterina; Severinov, Konstantin] Russian Acad Sci, Inst Biol Gene, Moscow 119334, Russia; [Severinov, Konstantin] Russian Acad Sci, Inst Mol Genet, Moscow 123182, Russia	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; Russian Academy of Sciences	Borukhov, S (corresponding author), Univ Med & Dent New Jersey, Sch Osteopath Med Stratford, Dept Cell Biol, 2 Med Ctr Dr,Rm 108B, Stratford, NJ 08084 USA.	s.borukhov@umdnj.edu	Severinov, Konstantin/C-8545-2016; Borukhov, Sergei/AAF-3195-2019	Borukhov, Sergei/0000-0002-3517-3003	National Institutes of Health [GM54098, GM59295]; University of Medicine and Dentistry of New Jersey Research Foundation; Presidium of Russian Academy of Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054098, R01GM059295] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Medicine and Dentistry of New Jersey Research Foundation; Presidium of Russian Academy of Sciences(Russian Academy of Sciences); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM54098 ( to S. B.) and GM59295 ( to K. S.), by University of Medicine and Dentistry of New Jersey Research Foundation ( to S. B.), and by the Molecular and Cell Biology Program Grant of the Presidium of Russian Academy of Sciences ( to K. S.).	Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Borukhov S, 2005, MOL MICROBIOL, V55, P1315, DOI 10.1111/j.1365-2958.2004.04481.x; BORUKHOV S, 1993, J BIOL CHEM, V268, P23477; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Brodolin K, 2004, NAT STRUCT MOL BIOL, V11, P551, DOI 10.1038/nsmb768; Craig ML, 1998, J MOL BIOL, V283, P741, DOI 10.1006/jmbi.1998.2129; Epshtein V, 2003, EMBO J, V22, P4719, DOI 10.1093/emboj/cdg452; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; FENG GH, 1994, J BIOL CHEM, V269, P22282; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Goldman SR, 2009, SCIENCE, V324, P927, DOI 10.1126/science.1169237; Hatoum A, 2008, MOL MICROBIOL, V68, P17, DOI 10.1111/j.1365-2958.2008.06138.x; HAWLEY DK, 1993, CELL MOL BIOL RES, V39, P339; HERNANDEZ VJ, 1990, J BIOL CHEM, V265, P11605; Hsu LM, 2006, BIOCHEMISTRY-US, V45, P8841, DOI 10.1021/bi060247u; HSU LM, 1995, P NATL ACAD SCI USA, V92, P11588, DOI 10.1073/pnas.92.25.11588; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kashlev M, 1996, METHOD ENZYMOL, V274, P326; Ko DC, 1998, GENE DEV, V12, P3276, DOI 10.1101/gad.12.20.3276; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Koulich D, 1997, J BIOL CHEM, V272, P7201, DOI 10.1074/jbc.272.11.7201; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Loizos N, 1999, J BIOL CHEM, V274, P23378, DOI 10.1074/jbc.274.33.23378; Mirkin EV, 2006, P NATL ACAD SCI USA, V103, P7276, DOI 10.1073/pnas.0601127103; Mooney RA, 2003, GENE DEV, V17, P2839, DOI 10.1101/gad.1142203; Mustaev A, 1997, P NATL ACAD SCI USA, V94, P6641, DOI 10.1073/pnas.94.13.6641; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Nickels BE, 2004, NAT STRUCT MOL BIOL, V11, P544, DOI 10.1038/nsmb757; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Ring BZ, 1996, CELL, V86, P485, DOI 10.1016/S0092-8674(00)80121-X; RUDD MD, 1994, P NATL ACAD SCI USA, V91, P8057, DOI 10.1073/pnas.91.17.8057; Stepanova E, 2007, J BACTERIOL, V189, P8772, DOI 10.1128/JB.00911-07; SURRATT CK, 1991, P NATL ACAD SCI USA, V88, P7983, DOI 10.1073/pnas.88.18.7983; Susa M, 2006, MOL MICROBIOL, V59, P1807, DOI 10.1111/j.1365-2958.2006.05058.x; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Toulme F, 2000, EMBO J, V19, P6853, DOI 10.1093/emboj/19.24.6853; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Weilbaecher RG, 2003, J BIOL CHEM, V278, P24189, DOI 10.1074/jbc.M211197200; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9	48	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35702	35713		10.1074/jbc.M109.053983	http://dx.doi.org/10.1074/jbc.M109.053983			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19854830	hybrid, Green Published			2022-12-25	WOS:000272645600048
J	Kang, JG; Park, SY; Ji, S; Jang, I; Park, S; Kim, HS; Kim, SM; Yook, JI; Park, YI; Roth, J; Cho, JW				Kang, Jeong Gu; Park, Sang Yoon; Ji, Suena; Jang, Insook; Park, Sujin; Kim, Hyun Sil; Kim, Sung-Min; Yook, Jong In; Park, Yong-Il; Roth, Juergen; Cho, Jin Won			O-GlcNAc Protein Modification in Cancer Cells Increases in Response to Glucose Deprivation through Glycogen Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED N-ACETYLGLUCOSAMINE; RNA-POLYMERASE-II; NUCLEOCYTOPLASMIC PROTEINS; TERMINAL DOMAIN; UP-REGULATION; GLYCOSYLATION; KINASE; AMP; GLCNACYLATION; INHIBITION	When cellular glucose concentrations fall below normal levels, in general the extent of protein O-GlcNAc modification (O-GlcNAcylation) decreases. However, recent reports demonstrated increased O-GlcNAcylation by glucose deprivation in HepG2 and Neuro-2a cells. Here, we report increased O-GlcNAcylation in non-small cell lung carcinoma A549 cells and various other cells in response to glucose deprivation. Although the level of O-GlcNAc transferase was unchanged, the enzyme contained less O-GlcNAc, and its activity was increased. Moreover, O-GlcNAcase activity was reduced. The studied cells contain glycogen, and we show that its degradation in response to glucose deprivation provides a source for UDP-GlcNAc required for increased O-GlcNAcylation under this condition. This required active glycogen phosphorylase and resulted in increased glutamine: fructose-6-phosphate amidotransferase, the first and rate-limiting enzyme in the hexosamine biosynthetic pathway. Interestingly, glucose deprivation reduced the amount of phosphofructokinase 1, a regulatory glycolytic enzyme, and blocked ATP synthesis. These findings suggest that glycogen is the source for increased O-GlcNAcylation but not for generating ATP in response to glucose deprivation and that this may be useful for cancer cells to survive.	[Kang, Jeong Gu; Park, Sang Yoon; Ji, Suena; Jang, Insook; Park, Sujin; Cho, Jin Won] Yonsei Univ, Dept Biol, Seoul 120749, South Korea; [Kim, Hyun Sil; Yook, Jong In] Yonsei Univ, Dept Oral Pathol, Oral Canc Res Inst, Seoul 120749, South Korea; [Roth, Juergen; Cho, Jin Won] Yonsei Univ, World Class Univ Integrated OMICS Biomed Sci, Seoul 120749, South Korea; [Kim, Sung-Min; Park, Yong-Il] Catholic Univ Korea, Dept Biotechnol, Puchon 420743, South Korea; [Kim, Sung-Min; Park, Yong-Il] Catholic Univ Korea, Biomat Engn Res Ctr, Puchon 420743, South Korea	Yonsei University; Yonsei University; Yonsei University; Catholic University of Korea; Catholic University of Korea	Cho, JW (corresponding author), Yonsei Univ, Dept Biol, 134 Shinchon Dong, Seoul 120749, South Korea.	chojw311@yonsei.ac.kr		Kim, Hyun Sil/0000-0003-3614-1764; Yook, Jong In/0000-0002-7318-6112	Korea Science and Engineering Foundation (KOSEF); Ministry of Education, Science, and Technology [R0A-2007-000-20011-0]; Korea Research Foundation [KRF-2006-005J04502]; World Class University [R31-2008-000-10086-0]	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Research Foundation(National Research Foundation of Korea); World Class University	This work was supported by the Korea Science and Engineering Foundation (KOSEF) funded by Ministry of Education, Science, and Technology Grant R0A-2007-000-20011-0, Korea Research Foundation Grant KRF-2006-005J04502, and World Class University Project R31-2008-000-10086-0. This work was made possible through the use of research facilities in the Yonsei Center for Biotechnology.	Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Carling D, 2009, CELL METAB, V9, P7, DOI 10.1016/j.cmet.2008.12.007; Cheung WD, 2008, J BIOL CHEM, V283, P13009, DOI 10.1074/jbc.M801222200; Cheung WD, 2008, J BIOL CHEM, V283, P33935, DOI 10.1074/jbc.M806199200; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Guinez C, 2006, GLYCOBIOLOGY, V16, P22, DOI 10.1093/glycob/cwj041; Guinez C, 2004, BIOCHEM BIOPH RES CO, V319, P21, DOI 10.1016/j.bbrc.2004.04.144; Hruz PW, 2001, MOL MEMBR BIOL, V18, P183; Kang HT, 2003, J BIOL CHEM, V278, P51223, DOI 10.1074/jbc.M307332200; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Konrad RJ, 2002, BIOCHEM BIOPH RES CO, V293, P207, DOI 10.1016/S0006-291X(02)00200-0; Kuo M, 2008, BIOCHIMIE, V90, P679, DOI 10.1016/j.biochi.2008.03.005; Liu K, 2004, J NEUROCHEM, V89, P1044, DOI 10.1111/j.1471-4159.2004.02389.x; Love, 2005, SCI STKE, V2005, DOI DOI 10.1126/STKE.3122005RE13; MATHUPALA SP, 1995, J BIOL CHEM, V270, P16918, DOI 10.1074/jbc.270.28.16918; McBride A, 2009, ACTA PHYSIOL, V196, P99, DOI 10.1111/j.1748-1716.2009.01975.x; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; MONSIGNY M, 1979, EUR J BIOCHEM, V98, P39, DOI 10.1111/j.1432-1033.1979.tb13157.x; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Ngoh GA, 2009, CIRC RES, V104, P41, DOI 10.1161/CIRCRESAHA.108.189431; Rodicio R, 2000, J BIOL CHEM, V275, P40952, DOI 10.1074/jbc.M007131200; Roquemore EP, 1996, BIOCHEMISTRY-US, V35, P3578, DOI 10.1021/bi951918j; Schnier JB, 2003, BIOCHEM BIOPH RES CO, V309, P126, DOI 10.1016/S0006-291X(03)01542-0; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Taylor RP, 2009, J BIOL CHEM, V284, P3425, DOI 10.1074/jbc.M803198200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Walgren JLE, 2003, AM J PHYSIOL-ENDOC M, V284, pE424, DOI 10.1152/ajpendo.00382.2002; Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Ye F, 2004, J BIOCHEM BIOPH METH, V59, P201, DOI 10.1016/j.jbbm.2003.02.001; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zachara NE, 2004, J BIOL CHEM, V279, P30133, DOI 10.1074/jbc.M403773200; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	40	60	66	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34777	34784		10.1074/jbc.M109.026351	http://dx.doi.org/10.1074/jbc.M109.026351			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19833729	Green Published, hybrid			2022-12-25	WOS:000272439600033
J	Kalupov, T; Brillard-Bourdet, M; Dade, S; Serrano, H; Wartelle, J; Guyot, N; Juliano, L; Moreau, T; Belaaouaj, A; Gauthier, F				Kalupov, Timofey; Brillard-Bourdet, Michele; Dade, Sebastien; Serrano, Helene; Wartelle, Julien; Guyot, Nicolas; Juliano, Luiz; Moreau, Thierry; Belaaouaj, Azzaq; Gauthier, Francis			Structural Characterization of Mouse Neutrophil Serine Proteases and Identification of Their Substrate Specificities RELEVANCE TO MOUSE MODELS OF HUMAN INFLAMMATORY DISEASES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HUMAN CATHEPSIN-G; ACUTE LUNG INJURY; CYSTIC-FIBROSIS; CHROMOSOMAL LOCALIZATION; GENOMIC ORGANIZATION; LEUKOCYTE ELASTASE; HUMAN PROTEINASE-3; ANIMAL-MODELS; MURINE MODEL	It is widely accepted that neutrophil serine proteases (NSPs) play a critical role in neutrophil-associated lung inflammatory and tissue-destructive diseases. To investigate NSP pathogenic role(s), various mouse experimental models have been developed that mimic acutely or chronically injured human lungs. We and others are using mouse exposure to cigarette smoke as a model for chronic obstructive pulmonary disease with or without exacerbation. However, the relative contribution of NSPs to lung disease processes as well as their underlying mechanisms remains still poorly understood. And the lack of purified mouse NSPs and their specific substrates have hampered advances in these studies. In this work, we compared mouse and human NSPs and generated three-dimensional models of murine NSPs based on three-dimensional structures of their human homologs. Analyses of these models provided compelling evidence that peptide substrate specificities of human and mouse NSPs are different despite their conserved cleft and close structural resemblance. These studies allowed us to synthesize for the first time novel sensitive fluorescence resonance energy transfer substrates for individual mouse NSPs. Our findings and the newly identified substrates should better our understanding about the role of NSPs in the pathogenesis of cigarette-associated chronic obstructive pulmonary disease as well as other neutrophils-associated inflammatory diseases.	[Wartelle, Julien; Guyot, Nicolas; Belaaouaj, Azzaq; Gauthier, Francis] CHU Reims, Hop Maison Blanche, URCA, INSERM,AVENIR,EA 4303,IFR 53, F-51092 Reims, France; [Kalupov, Timofey; Brillard-Bourdet, Michele; Dade, Sebastien; Serrano, Helene; Moreau, Thierry] Univ Tours, IFR 135, INSERM, U618, F-37032 Tours, France; [Juliano, Luiz] Univ Fed Sao Paulo, Escola Paulista Med, Dept Biofis, BR-0404420 Sao Paulo, Brazil	CHU de Reims; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Reims Champagne-Ardenne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; Universidade Federal de Sao Paulo (UNIFESP)	Belaaouaj, A (corresponding author), CHU Reims, Hop Maison Blanche, URCA, INSERM,AVENIR,EA 4303,IFR 53, 45 Cognacq Jay St, F-51092 Reims, France.	azzaq.belaaouaj@univ-reims.fr; francis.gauthier@univ-tours.fr	Complexos, INCT Fluidos/H-9172-2013; Juliano, Luiz/D-7204-2012; Bentaher, Abderrazzaq/M-4424-2017; A, Bentaher/F-6531-2018	Juliano, Luiz/0000-0002-5589-2822; A, Bentaher/0000-0001-6001-5456; Dade, Sebastien/0000-0001-9329-7496	Agence Nationale de la Recherche (ANR) [ANR-07-PHYSIO-029-01]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by the Agence Nationale de la Recherche (ANR), Contract ANR-07-PHYSIO-029-01.	ANDERSSON KB, 1988, NATURE, V332, P688, DOI 10.1038/332688a0; Attucci S, 2002, BIOCHEM J, V366, P965, DOI 10.1042/BJ20020321; Attucci S, 2006, J PHARMACOL EXP THER, V318, P803, DOI 10.1124/jpet.106.103440; Belaaouaj A, 2002, MICROBES INFECT, V4, P1259, DOI 10.1016/S1286-4579(02)01654-4; Belaaouaj A, 1999, MAMM GENOME, V10, P210; Belaaouaj K, 1997, MAMM GENOME, V8, P5, DOI 10.1007/s003359900337; BIRRER P, 1995, RESPIRATION, V62, P25; BODE W, 1989, BIOCHEMISTRY-US, V28, P1951, DOI 10.1021/bi00431a001; Delacourt C, 2002, AM J RESP CELL MOL, V26, P290, DOI 10.1165/ajrcmb.26.3.4611; ERIKSSON S, 1965, ACTA MED SCAND, VS177, P5; Ganz T, 1999, P ASSOC AM PHYSICIAN, V111, P390, DOI 10.1111/paa.1999.111.5.390; Hajjar E, 2007, FEBS LETT, V581, P5685, DOI 10.1016/j.febslet.2007.11.029; Hirche TO, 2004, AM J RESP CELL MOL, V30, P576, DOI 10.1165/rcmb.2003-0253OC; Hof P, 1996, EMBO J, V15, P5481, DOI 10.1002/j.1460-2075.1996.tb00933.x; HOHN PA, 1989, J BIOL CHEM, V264, P13412; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; JANOFF A, 1985, AM REV RESPIR DIS, V132, P417; Kawabata K, 2002, EUR J PHARMACOL, V451, P1, DOI 10.1016/S0014-2999(02)02182-9; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Korkmaz B, 2008, NAT PROTOC, V3, P991, DOI 10.1038/nprot.2008.63; Korkmaz B, 2007, J BIOL CHEM, V282, P1989, DOI 10.1074/jbc.M608700200; LAFUMA C, 1991, EUR RESPIR J, V4, P1004; Lane AA, 2003, CELL, V115, P305, DOI 10.1016/S0092-8674(03)00852-3; Lee WL, 2001, AM J RESP CRIT CARE, V164, P896, DOI 10.1164/ajrccm.164.5.2103040; Mahadeva R, 2002, THORAX, V57, P908, DOI 10.1136/thorax.57.10.908; Preston GA, 2002, J AM SOC NEPHROL, V13, P2840, DOI 10.1097/01.ASN.0000034911.03334.C3; Rehault S, 1999, J BIOL CHEM, V274, P13810, DOI 10.1074/jbc.274.20.13810; Sandford AJ, 1997, EUR RESPIR J, V10, P1380, DOI 10.1183/09031936.97.10061380; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SERVEAU C, 1992, FEBS LETT, V309, P405, DOI 10.1016/0014-5793(92)80817-Z; Wiesner O, 2005, FEBS LETT, V579, P5305, DOI 10.1016/j.febslet.2005.08.056; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008	32	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34084	34091		10.1074/jbc.M109.042903	http://dx.doi.org/10.1074/jbc.M109.042903			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19833730	Green Published, hybrid			2022-12-25	WOS:000272165200041
J	Robinson, SD; Reynolds, LE; Kostourou, V; Reynolds, AR; da Silva, RG; Tavora, B; Baker, M; Marshall, JF; Hodivala-Dilke, KM				Robinson, Stephen D.; Reynolds, Louise E.; Kostourou, Vassiliki; Reynolds, Andrew R.; da Silva, Rita Graca; Tavora, Bernardo; Baker, Marianne; Marshall, John F.; Hodivala-Dilke, Kairbaan M.			alpha v beta 3 Integrin Limits the Contribution of Neuropilin-1 to Vascular Endothelial Growth Factor-induced Angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR-2; PATHOLOGICAL ANGIOGENESIS; COMPUTATIONAL MODEL; CYTOPLASMIC DOMAIN; TUMOR ANGIOGENESIS; CELL-MIGRATION; BLOOD-VESSELS; VEGF ISOFORMS; ANTI-VEGF; IN-VIVO	Both vascular endothelial growth factor receptors (VEGFR) and integrins are major regulators of VEGF-induced angiogenesis. Previous work has shown that beta 3 integrin can regulate negatively VEGFR2 expression. Here we show that beta 3 integrin can regulate negatively VEGF-mediated angiogenesis by limiting the interaction of the co-receptor NRP1 (neuropilin-1) with VEGFR2. In the presence of alpha v beta 3 integrin, NRP1 contributed minimally to VEGF-induced angiogenic processes in vivo, ex vivo, and in vitro. Conversely, when beta 3 integrin expression is absent or low or its function is blocked with RGD-mimetic inhibitors, VEGF-mediated responses became NRP1-dependent. Indeed, combined inhibition of beta 3 integrin and NRP1 decreased VEGF-mediated angiogenic responses further than individual inhibition of these receptors. We also show that alpha v beta 3 integrin can associate with NRP1 in a VEGF-dependent fashion. Our data suggest that beta 3 integrin may, in part, negatively regulate VEGF signaling by sequestering NRP1 and preventing it from interacting with VEGFR2.	[Tavora, Bernardo; Baker, Marianne; Hodivala-Dilke, Kairbaan M.] Queen Mary Univ London, John Vane Sci Ctr, Inst Canc, Tumour Biol Ctr,Adhes & Angiogenesis Lab, London EC1M 6BQ, England; [Marshall, John F.] Queen Mary Univ London, John Vane Sci Ctr, Inst Canc, Tumour Biol Ctr,Invas & Metastasis Lab, London EC1M 6BQ, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Hodivala-Dilke, KM (corresponding author), Queen Mary Univ London, John Vane Sci Ctr, Inst Canc, Tumour Biol Ctr,Adhes & Angiogenesis Lab, Charterhouse Sq, London EC1M 6BQ, England.	k.hodivala-dilke@qmul.ac.uk		Hodivala-Dilke, Kairbaan/0000-0002-2859-749X; Kostourou, Vassiliki/0000-0001-7053-6247; Marshall, John/0000-0002-0494-2295; Robinson, Stephen/0000-0002-6606-7588	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was supported by a grant from Cancer Research UK.	Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; ANDRADE SP, 1987, BRIT J EXP PATHOL, V68, P755; Barr MP, 2008, INT J ONCOL, V32, P41; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Cebe-Suarez S, 2006, CELL MOL LIFE SCI, V63, P601, DOI 10.1007/s00018-005-5426-3; Eliceiri BP, 2001, CIRC RES, V89, P1104, DOI 10.1161/hh2401.101084; Eliceiri BP, 1998, J CELL BIOL, V140, P1255, DOI 10.1083/jcb.140.5.1255; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Fukasawa M, 2007, CANCER BIOL THER, V6, P1173; Gerhardt H, 2004, DEV DYNAM, V231, P503, DOI 10.1002/dvdy.20148; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Gustafsson E, 2001, J CELL SCI, V114, P671; Guttmann-Raviv N, 2006, CANCER LETT, V231, P1, DOI 10.1016/j.canlet.2004.12.047; Herzog Y, 2001, MECH DEVELOP, V109, P115, DOI 10.1016/S0925-4773(01)00518-4; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jia HY, 2006, J BIOL CHEM, V281, P13493, DOI 10.1074/jbc.M512121200; Kawamura H, 2008, BLOOD, V112, P3638, DOI 10.1182/blood-2007-12-125856; Kawasaki T, 1999, DEVELOPMENT, V126, P4895; Krilleke D, 2007, J BIOL CHEM, V282, P28045, DOI 10.1074/jbc.M700319200; Mac Gabhann F, 2005, AM J PHYSIOL-HEART C, V288, pH2851, DOI 10.1152/ajpheart.01218.2004; Mac Gabhann F, 2007, AM J PHYSIOL-HEART C, V292, pH459, DOI 10.1152/ajpheart.00637.2006; Mahabeleshwar GH, 2006, J EXP MED, V203, P2495, DOI 10.1084/jem.20060807; Maubant S, 2006, BLOOD, V108, P3035, DOI 10.1182/blood-2006-05-023580; May T, 2005, J BIOTECHNOL, V120, P99, DOI 10.1016/j.jbiotec.2005.03.027; MECHTERSHEIMER G, 1994, VIRCHOWS ARCH, V425, P375; Nicosia RF, 1997, AM J PATHOL, V151, P1379; Pan Q, 2007, J BIOL CHEM, V282, P24049, DOI 10.1074/jbc.M703554200; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Perron-Sierra F, 2002, BIOORG MED CHEM LETT, V12, P3291, DOI 10.1016/S0960-894X(02)00696-0; Phillips DR, 2001, THROMB HAEMOSTASIS, V86, P246; Presta M, 2005, ARTERIOSCL THROM VAS, V25, P71, DOI 10.1161/01.ATV.0000148863.24445.b4; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Reynolds AR, 2004, CANCER RES, V64, P8643, DOI 10.1158/0008-5472.CAN-04-2760; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Reynolds LE, 2006, METH MOLEC MED, V120, P503; ROSEN EM, 1997, CIBA F SYMP, V212, P227; ROSEN EM, 1997, CIBA FOUND S, V219, P226; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Schaffner-Reckinger E, 2001, THROMB HAEMOSTASIS, V85, P716, DOI 10.1055/s-0037-1615658; Shraga-Heled N, 2007, FASEB J, V21, P915, DOI 10.1096/fj.06-6277com; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Soker S, 2002, J CELL BIOCHEM, V85, P357, DOI 10.1002/jcb.10140; Soldi R, 1999, EMBO J, V18, P882, DOI 10.1093/emboj/18.4.882; Starzec A, 2007, PEPTIDES, V28, P2397, DOI 10.1016/j.peptides.2007.09.013; Starzec A, 2006, LIFE SCI, V79, P2370, DOI 10.1016/j.lfs.2006.08.005; Strieth S, 2006, INT J CANCER, V119, P423, DOI 10.1002/ijc.21838; Sulpice E, 2008, BLOOD, V111, P2036, DOI 10.1182/blood-2007-04-084269; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takashima S, 2002, P NATL ACAD SCI USA, V99, P3657, DOI 10.1073/pnas.022017899; Thurston G, 1998, AM J PATHOL, V153, P1099, DOI 10.1016/S0002-9440(10)65654-4; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Varner Judith A., 1996, P69; Veeravagu A, 2007, RECENT PAT ANTI-CANC, V2, P59, DOI 10.2174/157489207779561426; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; West H, 2005, DEVELOPMENT, V132, P1855, DOI 10.1242/dev.01732; Wey Jane S, 2004, Clin Adv Hematol Oncol, V2, P37; Whitaker GB, 2001, J BIOL CHEM, V276, P25520, DOI 10.1074/jbc.M102315200; Yuan L, 2002, DEVELOPMENT, V129, P4797	60	70	72	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33966	33981		10.1074/jbc.M109.030700	http://dx.doi.org/10.1074/jbc.M109.030700			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19837659	hybrid, Green Published			2022-12-25	WOS:000272165200029
J	Shukla, U; Hatani, T; Nakashima, K; Ogi, K; Sada, K				Shukla, Upasana; Hatani, Tomoko; Nakashima, Kenji; Ogi, Kazuhiro; Sada, Kiyonao			Tyrosine Phosphorylation of 3BP2 Regulates B Cell Receptor-mediated Activation of NFAT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN 3BP2; PHOSPHOTYROSINE-BINDING DOMAIN; LEUKEMIA RBL-2H3 CELLS; AFFINITY IGE RECEPTOR; ANTIGEN RECEPTOR; KINASE SYK; NEGATIVE REGULATION; GAMMA-CHAIN; SH2 DOMAINS; T-CELLS	Adaptor protein c-Abl SH3 domain-binding protein-2 (3BP2, also referred to SH3BP2) regulates immune receptor-mediated signal transduction. In this report we focused on the molecular mechanism of 3BP2 function in B cell receptor (BCR) signaling. Engagement of BCR induces tyrosine phosphorylation of 3BP2. Genetic analysis demonstrated that Syk is critical for BCR-mediated tyrosine phosphorylation of 3BP2. Mutational analysis of 3BP2 revealed that both Tyr(183) and Src homology 2 (SH2) domain are necessary for 3BP2-mediated BCR-induced activation of nuclear factor of activated T cells (NFAT). Point mutation of Tyr(183) or Arg(486) in the SH2 domain of 3BP2 diminished BCR-mediated tyrosine phosphorylation of 3BP2. Endogenous 3BP2 forms a complex with tyrosine-phosphorylated cellular signaling molecules. Peptide binding experiments demonstrated that only phosphorylated Tyr183 in 3BP2 could form a complex with the SH2 domain(s) of phospholipase C gamma 2 and Vav1 from B cell lysates. These interactions were represented by using bacterial glutathione S-transferase-phospholipase C gamma 2 or -Vav1 SH2 domain. Furthermore, pulldown and Far Western experiments showed that the 3BP2-SH2 domain directly binds to B cell linker protein (BLNK) after BCR stimulation. These results demonstrated that 3BP2 induces the protein complex with cellular signaling molecules through phosphorylation of Tyr(183) and SH2 domain leading to the activation of NFAT in B cells.	[Sada, Kiyonao] Univ Fukui, Div Microbiol, Dept Pathol Sci, Fac Med Sci, Fukui 9101193, Japan; [Hatani, Tomoko; Sada, Kiyonao] Univ Fukui, Org Life Sci Advancement Programs, Fukui 9101193, Japan	University of Fukui; University of Fukui	Sada, K (corresponding author), Univ Fukui, Div Microbiol, Dept Pathol Sci, Fac Med Sci, 23-3 Matsuoka Shimoaizuki, Fukui 9101193, Japan.	ksada@u-fukui.ac.jp	Sada, Kiyonao/H-7373-2015	Sada, Kiyonao/0000-0001-6124-3100	University of Fukui; Takeda Science Foundation; Osaka Medical Research Foundation; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, and Technology, Japan	University of Fukui; Takeda Science Foundation(Takeda Science Foundation (TSF)); Osaka Medical Research Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by research funding from the University of Fukui ( to K. S.), by the Takeda Science Foundation ( to K. S.), by the Osaka Medical Research Foundation for Incurable Diseases and by grants-in-aid from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, and Technology, Japan.	Antony P, 2003, EXP CELL RES, V291, P11, DOI 10.1016/S0014-4827(03)00338-0; Bailet O, 2009, CANCER RES, V69, P2748, DOI 10.1158/0008-5472.CAN-08-2690; Cha HS, 2006, J PHARMACOL EXP THER, V317, P571, DOI 10.1124/jpet.105.097436; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Chen G, 2007, MOL CELL BIOL, V27, P3109, DOI 10.1128/MCB.01014-06; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Chiu CW, 2002, EMBO J, V21, P6461, DOI 10.1093/emboj/cdf658; Chung SC, 2007, J CELL BIOL, V177, P317, DOI 10.1083/jcb.200702050; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Costello PS, 1996, ONCOGENE, V13, P2595; de la Fuente MA, 2006, MOL CELL BIOL, V26, P5214, DOI 10.1128/MCB.00087-06; Deckert M, 1998, IMMUNITY, V9, P595, DOI 10.1016/S1074-7613(00)80657-3; Deckert M, 2006, ADV EXP MED BIOL, V584, P107; Foucault I, 2005, BLOOD, V105, P1106, DOI 10.1182/blood-2003-08-2965; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Goitsuka R, 1998, J IMMUNOL, V161, P5804; Greenberg S, 1996, P NATL ACAD SCI USA, V93, P1103, DOI 10.1073/pnas.93.3.1103; Hao SL, 2003, EMBO J, V22, P4166, DOI 10.1093/emboj/cdg401; Hatani T, 2008, CURR MED CHEM, V15, P549; Ishiai M, 1999, IMMUNITY, V10, P117, DOI 10.1016/S1074-7613(00)80012-6; Krishnan S, 2008, J IMMUNOL, V181, P8145, DOI 10.4049/jimmunol.181.11.8145; KUROSAKI T, 1995, J EXP MED, V182, P1815, DOI 10.1084/jem.182.6.1815; Lupher ML, 1998, J BIOL CHEM, V273, P35273, DOI 10.1074/jbc.273.52.35273; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; Maeno K, 2003, J BIOL CHEM, V278, P24912, DOI 10.1074/jbc.M301201200; Miah SMS, 2004, GENES CELLS, V9, P993, DOI 10.1111/j.1365-2443.2004.00784.x; Miah SMS, 2004, MOL CELL BIOL, V24, P71, DOI 10.1128/MCB.24.1.71-83.2004; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Poole A, 1997, EMBO J, V16, P2333, DOI 10.1093/emboj/16.9.2333; Qu XJ, 2005, BIOCHEMISTRY-US, V44, P3891, DOI 10.1021/bi048353o; Qu XJ, 2004, BLOOD, V103, P1779, DOI 10.1182/blood-2003-07-2260; Rao N, 2001, EMBO J, V20, P7085, DOI 10.1093/emboj/20.24.7085; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Rudd CE, 1999, CELL, V96, P5, DOI 10.1016/S0092-8674(00)80953-8; Sada K, 2002, BLOOD, V100, P2138, DOI 10.1182/blood-2001-12-0340; Sada K, 2001, J BIOCHEM-TOKYO, V130, P177, DOI 10.1093/oxfordjournals.jbchem.a002970; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 2000, IMMUNOL TODAY, V21, P148, DOI 10.1016/S0167-5699(99)01574-1; Ueki Y, 2001, NAT GENET, V28, P125, DOI 10.1038/88832; Ueki Y, 2007, CELL, V128, P71, DOI 10.1016/j.cell.2006.10.047; Williams BL, 1999, EMBO J, V18, P1832, DOI 10.1093/emboj/18.7.1832; Yankee TM, 1999, J IMMUNOL, V163, P5827; Zhang J, 1996, J EXP MED, V184, P71, DOI 10.1084/jem.184.1.71	50	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33719	33728		10.1074/jbc.M109.049999	http://dx.doi.org/10.1074/jbc.M109.049999			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19833725	Green Published, hybrid			2022-12-25	WOS:000272165200002
J	Wang, QY; Yang, MJ; Xiao, JF; Wu, HZ; Wang, X; Lv, YZ; Xu, LL; Zheng, HJ; Wang, SY; Zhao, GP; Liu, Q; Zhang, YX				Wang, Qiyao; Yang, Minjun; Xiao, Jingfan; Wu, Haizhen; Wang, Xin; Lv, Yuanzhi; Xu, Lili; Zheng, Huajun; Wang, Shengyue; Zhao, Guoping; Liu, Qin; Zhang, Yuanxing			Genome Sequence of the Versatile Fish Pathogen Edwardsiella tarda Provides Insights into its Adaptation to Broad Host Ranges and Intracellular Niches	PLOS ONE			English	Article							III SECRETION; PROTEIN SECRETION; VIRULENCE FACTORS; GENE-EXPRESSION; IDENTIFICATION; BIOSYNTHESIS; PREDICTION; SYSTEM; 2-COMPONENT; SIDEROPHORE	Background: Edwardsiella tarda is the etiologic agent of edwardsiellosis, a devastating fish disease prevailing in worldwide aquaculture industries. Here we describe the complete genome of E. tarda, EIB202, a highly virulent and multi-drug resistant isolate in China. Methodology/Principal Findings: E. tarda EIB202 possesses a single chromosome of 3,760,463 base pairs containing 3,486 predicted protein coding sequences, 8 ribosomal rRNA operons, and 95 tRNA genes, and a 43,703 bp conjugative plasmid harboring multi-drug resistant determinants and encoding type IV A secretion system components. We identified a full spectrum of genetic properties related to its genome plasticity such as repeated sequences, insertion sequences, phage-like proteins, integrases, recombinases and genomic islands. In addition, analysis also indicated that a substantial proportion of the E. tarda genome might be devoted to the growth and survival under diverse conditions including intracellular niches, with a large number of aerobic or anaerobic respiration-associated proteins, signal transduction proteins as well as proteins involved in various stress adaptations. A pool of genes for secretion systems, pili formation, nonfimbrial adhesions, invasions and hemagglutinins, chondroitinases, hemolysins, iron scavenging systems as well as the incomplete flagellar biogenesis might feature its surface structures and pathogenesis in a fish body. Conclusion/Significance: Genomic analysis of the bacterium offered insights into the phylogeny, metabolism, drug-resistance, stress adaptation, and virulence characteristics of this versatile pathogen, which constitutes an important first step in understanding the pathogenesis of E. tarda to facilitate construction of a practical effective vaccine used for combating fish edwardsiellosis.			Wang, QY (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	qinliu@ecust.edu.cn; yxzhang@ecust.edu.cn	Yang, Minjun/AGJ-3201-2022; xu, li/GNH-3667-2022	Zhao, Guo-Ping/0000-0002-7621-6620; Yang, Minjun/0000-0002-3324-1498				Abbott SL, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P72, DOI 10.1007/0-387-30746-x_4; AHMAD S, 1990, J BACTERIOL, V172, P1051, DOI 10.1128/jb.172.2.1051-1061.1990; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; BOCKEMUHL J, 1971, PATHOL MICROBIOL, V37, P393, DOI 10.1159/000162341; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Chiu CH, 2005, NUCLEIC ACIDS RES, V33, P1690, DOI 10.1093/nar/gki297; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Du M, 2007, APPL ENVIRON MICROB, V73, P1349, DOI 10.1128/AEM.02243-06; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; GARDNER PP, 2009, NUCLEIC ACIDS RES, V136, pD101; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; JANDA JM, 1991, J CLIN MICROBIOL, V29, P1997, DOI 10.1128/JCM.29.9.1997-2001.1991; JARBOE H H, 1984, Journal of Wildlife Diseases, V20, P352; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; LAINE MJ, 1994, PLASMID, V32, P270, DOI 10.1006/plas.1994.1066; Ling SHM, 2000, MICROBIOL-SGM, V146, P7, DOI 10.1099/00221287-146-1-7; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mohanty BR, 2007, J BIOSCIENCES, V32, P1331, DOI 10.1007/s12038-007-0143-8; MOORE RN, 2001, INFECT IMMUN, V69, P5689; Morohoshi T, 2004, J BIOSCI BIOENG, V98, P274, DOI 10.1016/S1389-1723(04)00281-6; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Okuda J, 2006, MICROB PATHOGENESIS, V41, P226, DOI 10.1016/j.micpath.2006.08.002; Padros F, 2006, J FISH DIS, V29, P87, DOI 10.1111/j.1365-2761.2006.00685.x; Partridge SR, 2003, J BACTERIOL, V185, P6371, DOI 10.1128/JB.185.21.6371-6384.2003; Phillips AD, 1998, FEMS MICROBIOL LETT, V161, P317, DOI 10.1016/S0378-1097(98)00089-5; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Rao PSS, 2003, MICROBIOL-SGM, V149, P2635, DOI 10.1099/mic.0.26478-0; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Sahoo P K, 2000, ASIAN FISH SCI, V13, P357; SAKAI T, 2004, INFECT IMMUN, V72, P1364; Sakai T, 2009, MICROBIOL IMMUNOL, V53, P131, DOI 10.1111/j.1348-0421.2009.00108.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Siddique A, 2002, J BACTERIOL, V184, P1788, DOI 10.1128/JB.184.6.1788-1793.2002; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Sun K, 2009, AQUACULTURE, V289, P134, DOI 10.1016/j.aquaculture.2008.12.021; Tan YP, 2005, MICROBIOL-SGM, V151, P2301, DOI 10.1099/mic.0.28005-0; Tanabe T, 2003, J BACTERIOL, V185, P6938, DOI 10.1128/JB.185.23.6938-6949.2003; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thune RL, 2007, APPL ENVIRON MICROB, V73, P7934, DOI 10.1128/AEM.01115-07; Tu Q, 2003, FEMS MICROBIOL LETT, V221, P269, DOI 10.1016/S0378-1097(03)00204-0; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Wang QY, 2007, ARCH MICROBIOL, V188, P433, DOI 10.1007/s00203-007-0261-6; Wang Y, 2009, J ORTHOP RES, V27, P477, DOI 10.1002/jor.20782; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Williams ML, 2008, J APPL MICROBIOL, V104, P1790, DOI 10.1111/j.1365-2672.2007.03704.x; WONG JD, 1989, J CLIN MICROBIOL, V27, P1797, DOI 10.1128/JCM.27.8.1797-1801.1989; Wortham BW, 2007, ADV EXP MED BIOL, V603, P106; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Xiao JF, 2009, APPL MICROBIOL BIOT, V83, P151, DOI 10.1007/s00253-009-1924-9; Xiao JF, 2008, AQUAC RES, V40, P13, DOI 10.1111/j.1365-2109.2008.02101.x; Zhang M, 2008, MICROBIOL-SGM, V154, P2060, DOI 10.1099/mic.0.2008/017343-0; ZHANG Y, 2007, SYST APPL MICROBIOL, V93, P23	73	187	211	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7646	10.1371/journal.pone.0007646	http://dx.doi.org/10.1371/journal.pone.0007646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19865481	gold, Green Published, Green Submitted			2022-12-25	WOS:000271232000013
J	Tzur, G; Israel, A; Levy, A; Benjamin, H; Meiri, E; Shufaro, Y; Meir, K; Khvalevsky, E; Spector, Y; Rojansky, N; Bentwich, Z; Reubinoff, BE; Galun, E				Tzur, Galit; Israel, Ariel; Levy, Asaf; Benjamin, Hila; Meiri, Eti; Shufaro, Yoel; Meir, Karen; Khvalevsky, Elina; Spector, Yael; Rojansky, Nathan; Bentwich, Zvi; Reubinoff, Benjamin E.; Galun, Eithan			Comprehensive Gene and microRNA Expression Profiling Reveals a Role for microRNAs in Human Liver Development	PLOS ONE			English	Article							HUMAN FETAL LIVER; ANIMAL DEVELOPMENT; MESSENGER-RNAS; IDENTIFICATION; MURINE; MOUSE; DETERMINANTS; MICROARRAYS; SOFTWARE; LIBRARY	Background and Aims: microRNAs (miRNAs) are small noncoding RNAs that regulate cognate mRNAs post-transcriptionally. miRNAs have been implicated in regulating gene expression in embryonic developmental processes, including proliferation and differentiation. The liver is a multifunctional organ, which undergoes rapid changes during the developmental period and relies on tightly-regulated gene expression. Little is known regarding the complex expression patterns of both mRNAs and miRNAs during the early stages of human liver development, and the role of miRNAs in the regulation of this process has not been studied. The aim of this work was to study the impact of miRNAs on gene expression during early human liver development. Methods: Global gene and miRNA expression were profiled in adult and in 9-12w human embryonic livers, using high-density microarrays and quantitative RT-PCR. Results: Embryonic liver samples exhibited a gene expression profile that differentiated upon progression in the developmental process, and revealed multiple regulated genes. miRNA expression profiling revealed four major expression patterns that correlated with the known function of regulated miRNAs. Comparison of the expression of the most regulated miRNAs to that of their putative targets using a novel algorithm revealed a significant anti-correlation for several miRNAs, and identified the most active miRNAs in embryonic and in adult liver. Furthermore, our algorithm facilitated the identification of TGFb-R1 as a novel target gene of let-7. Conclusions: Our results uncover multiple regulated miRNAs and genes throughout human liver development, and our algorithm assists in identification of novel miRNA targets with potential roles in liver development.			Tzur, G (corresponding author), Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	eithang@hadassah.org.il	Galun, Eithan/AAD-9117-2022; Israel, Ariel/AFL-8794-2022; Levy, Asaf/ABA-2623-2020; Shufaro, Yoel/N-6227-2019	Galun, Eithan/0000-0002-6243-6702; Reubinoff, Benjamin/0000-0003-0353-1299; Shufaro, Yoel/0000-0003-2759-5588				Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Arora A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r82; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Einstein M, 2001, MOL CELL BIOL, V21, P5122, DOI 10.1128/MCB.21.15.5122-5131.2001; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grasl-Kraupp B, 1998, HEPATOLOGY, V28, P717, DOI 10.1002/hep.510280318; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Isfort RJ, 1997, J CELL SCI, V110, P3117; Israel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006045; Jochheim A, 2003, DIFFERENTIATION, V71, P62, DOI 10.1046/j.1432-0436.2003.700606.x; Jochheim-Richter A, 2006, DIFFERENTIATION, V74, P167, DOI 10.1111/j.1432-0436.2006.00066.x; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Malhotra K, 1999, NUCLEIC ACIDS RES, V27, P839, DOI 10.1093/nar/27.3.839; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Nierhoff D, 2007, HEPATOLOGY, V46, P535, DOI 10.1002/hep.21721; Reed Steven I., 2006, V42, P147, DOI 10.1007/b136681; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tavian M, 1999, DEVELOPMENT, V126, P793; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tong AW, 2008, CANCER GENE THER, V15, P341, DOI 10.1038/cgt.2008.8; TONG AW, 2008, CANC GENE THER; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zhan M, 2007, EXP HEMATOL, V35, P1015, DOI 10.1016/j.exphem.2007.03.014	44	91	96	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7511	10.1371/journal.pone.0007511	http://dx.doi.org/10.1371/journal.pone.0007511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841744	Green Submitted, gold, Green Published			2022-12-25	WOS:000271012900012
J	Ujvari, B; Madsen, T				Ujvari, Beata; Madsen, Thomas			Short Telomeres in Hatchling Snakes: Erythrocyte Telomere Dynamics and Longevity in Tropical Pythons	PLOS ONE			English	Article							FREE-RANGING PYTHONS; LONG-LIVED BIRDS; LENGTH; HYPOTHESIS; MORTALITY; EVOLUTION; MAMMALS; BLOOD; AGE	Background: Telomere length (TL) has been found to be associated with life span in birds and humans. However, other studies have demonstrated that TL does not affect survival among old humans. Furthermore, replicative senescence has been shown to be induced by changes in the protected status of the telomeres rather than the loss of TL. In the present study we explore whether age- and sex-specific telomere dynamics affect life span in a long-lived snake, the water python (Liasis fuscus). Methodology/Principal Findings: Erythrocyte TL was measured using the Telo TAGGG TL Assay Kit (Roche). In contrast to other vertebrates, TL of hatchling pythons was significantly shorter than that of older snakes. However, during their first year of life hatchling TL increased substantially. While TL of older snakes decreased with age, we did not observe any correlation between TL and age in cross-sectional sampling. In older snakes, female TL was longer than that of males. When using recapture as a proxy for survival, our results do not support that longer telomeres resulted in an increased water python survival/longevity. Conclusions/Significance: In fish high telomerase activity has been observed in somatic cells exhibiting high proliferation rates. Hatchling pythons show similar high somatic cell proliferation rates. Thus, the increase in TL of this group may have been caused by increased telomerase activity. In older humans female TL is longer than that of males. This has been suggested to be caused by high estrogen levels that stimulate increased telomerase activity. Thus, high estrogen levels may also have caused the longer telomeres in female pythons. The lack of correlation between TL and age among old snakes and the fact that longer telomeres did not appear to affect python survival do not support that erythrocyte telomere dynamics has a major impact on water python longevity.			Ujvari, B (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia.	madsen@uow.edu.au	Ujvari, Beata/K-8722-2012; Ujvari, Beata/L-7541-2019	Ujvari, Beata/0000-0003-2391-2988; Ujvari, Beata/0000-0003-2391-2988; Madsen, Thomas/0000-0002-0998-8372				Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bronikowski AM, 2008, AGE, V30, P169, DOI 10.1007/s11357-008-9060-5; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cogger H, 2000, REPTILES AMPHIBIANS; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; Haussmann MF, 2008, MOL BIOL EVOL, V25, P220, DOI 10.1093/molbev/msm244; Haussmann MF, 2005, BIOL LETTERS, V1, P212, DOI 10.1098/rsbl.2005.0301; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Jemielity S, 2007, AGING CELL, V6, P225, DOI 10.1111/j.1474-9726.2007.00279.x; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Klapper W, 1998, FEBS LETT, V434, P409, DOI 10.1016/S0014-5793(98)01020-5; Kyo S, 1999, CANCER RES, V59, P5917; Madsen T, 2000, AUSTRAL ECOL, V25, P670, DOI 10.1046/j.1442-9993.2000.01067.x; Madsen T, 2000, J ANIM ECOL, V69, P952, DOI 10.1046/j.1365-2656.2000.00477.x; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Matsubara K, 2006, P NATL ACAD SCI USA, V103, P18190, DOI 10.1073/pnas.0605274103; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Sambrook J., 2002, MOL CLONING LAB MANU	29	49	50	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7493	10.1371/journal.pone.0007493	http://dx.doi.org/10.1371/journal.pone.0007493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834611	Green Published, gold, Green Submitted			2022-12-25	WOS:000270880700016
J	Kubota, C; Torii, S; Hou, N; Saito, N; Yoshimoto, Y; Imai, H; Takeuchi, T				Kubota, Chisato; Torii, Seiji; Hou, Ni; Saito, Nobuhito; Yoshimoto, Yuhei; Imai, Hideaki; Takeuchi, Toshiyuki			Constitutive Reactive Oxygen Species Generation from Autophagosome/Lysosome in Neuronal Oxidative Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; STRESS; GLUTAMATE; ACTIVATION; AUTOPHAGY; IRON; DEGRADATION; EBSELEN; KINASE; MITOCHONDRIA	Reactive oxygen species (ROS) are involved in several cell death processes, including cerebral ischemic injury. We found that glutamate-induced ROS accumulation and the associated cell death in mouse hippocampal cell lines were delayed by pharmacological inhibition of autophagy or lysosomal activity. Glutamate, however, did not stimulate autophagy, which was assessed by a protein marker, LC3, and neither changes in organization of mitochondria nor lysosomal membrane permeabilization were observed. Fluorescent analyses by a redox probe PF-H(2)TMRos revealed that autophagosomes and/or lysosomes are the major sites for basal ROS generation in addition to mitochondria. Treatments with inhibitors for autophagy and lysosomes decreased their basal ROS production and caused a burst of mitochondrial ROS to be delayed. On the other hand, attenuation of mitochondrial activity by serum depletion or by high cell density culture resulted in the loss of both constitutive ROS production and an ROS burst in mitochondria. Thus, constitutive ROS production within mitochondria and lysosomes enables cells to be susceptible to glutamate-induced oxidative cytotoxicity. Likewise, inhibitors for autophagy and lysosomes reduced neural cell death in an ischemia model in rats. We suggest that cell injury during periods of ischemia is regulated by ROS-generating activity in autophagosomes and/or lysosomes as well as in mitochondria.	[Torii, Seiji] Gunma Univ, Secret Biol Lab, Inst Mol & Cellular Regulat, Dept Mol Med, Maebashi, Gunma 3718512, Japan; [Kubota, Chisato; Saito, Nobuhito; Yoshimoto, Yuhei; Imai, Hideaki] Gunma Univ, Grad Sch Med, Dept Neurosurg, Maebashi, Gunma 3718512, Japan	Gunma University; Gunma University	Torii, S (corresponding author), Gunma Univ, Secret Biol Lab, Inst Mol & Cellular Regulat, Dept Mol Med, 3-39-15 Showa Machi, Maebashi, Gunma 3718512, Japan.	storii@showa.gunma-u.ac.jp; tstake@showa.gunma-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [22591577] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the grants-in-aid and the Global Center of Excellence Program from the Japanese Ministry of Education, Culture, Sports, Science and Technology.	Austin CD, 2005, P NATL ACAD SCI USA, V102, P17987, DOI 10.1073/pnas.0509035102; Chen SR, 2000, FREE RADICAL BIO MED, V28, P1266, DOI 10.1016/S0891-5849(00)00265-3; Chen Y, 2008, CELL DEATH DIFFER, V15, P171, DOI 10.1038/sj.cdd.4402233; Choi BH, 2006, J CELL SCI, V119, P1329, DOI 10.1242/jcs.02837; COYLE JT, 1993, SCIENCE, V262, P689, DOI 10.1126/science.7901908; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; DAVIS JB, 1994, BRAIN RES, V652, P169, DOI 10.1016/0006-8993(94)90334-4; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; Ha JS, 2006, NEUROSCI LETT, V393, P165, DOI 10.1016/j.neulet.2005.09.056; Harraz MM, 2008, STROKE, V39, P286, DOI 10.1161/STROKEAHA.107.511857; Hou N, 2008, ENDOCRINOLOGY, V149, P1654, DOI 10.1210/en.2007-0988; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Imai H, 2003, FREE RADICAL BIO MED, V34, P56, DOI 10.1016/S0891-5849(02)01180-2; Imai H, 2001, STROKE, V32, P2149, DOI 10.1161/hs0901.095725; Johnson SC, 2005, NEUROLOGY, V64, P654; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Komatsu M, 2007, CELL DEATH DIFFER, V14, P887, DOI 10.1038/sj.cdd.4402120; Kurz T, 2008, BBA-GEN SUBJECTS, V1780, P1291, DOI 10.1016/j.bbagen.2008.01.009; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Park HK, 2009, NEUROSCI LETT, V451, P16, DOI 10.1016/j.neulet.2008.12.019; Persson HL, 2003, FREE RADICAL BIO MED, V34, P1295, DOI 10.1016/S0891-5849(03)00106-0; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Ringleb PA, 2002, STROKE, V33, P1437, DOI 10.1161/01.STR.0000015555.21285.DB; SAKAIDA I, 1990, MOL PHARMACOL, V37, P435; Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231; Satoh T, 2004, NEUROSCI LETT, V371, P1, DOI 10.1016/j.neulet.2004.04.055; Scherz-Shouval R, 2007, TRENDS CELL BIOL, V17, P422, DOI 10.1016/j.tcb.2007.07.009; Selim MH, 2004, AGEING RES REV, V3, P345, DOI 10.1016/j.arr.2004.04.001; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Sohn H, 2006, FASEB J, V20, P1248, DOI 10.1096/fj.05-4911fje; Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200; Tan SL, 1998, J NEUROCHEM, V71, P95; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Torii S, 2005, TRAFFIC, V6, P1213, DOI 10.1111/j.1600-0854.2005.00353.x; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Yamashima T, 2004, CELL CALCIUM, V36, P285, DOI 10.1016/j.ceca.2004.03.001; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Yu ZQ, 2003, FREE RADICAL BIO MED, V34, P1243, DOI 10.1016/S0891-5849(03)00109-6	44	112	114	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					667	674		10.1074/jbc.M109.053058	http://dx.doi.org/10.1074/jbc.M109.053058			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19850931	Green Published, hybrid			2022-12-25	WOS:000273070100067
J	Duchardt, F; Ruttekolk, IR; Verdurmen, WPR; Lortat-Jacob, H; Burck, J; Hufnagel, H; Fischer, R; van den Heuvel, M; Lowik, DWPM; Vuister, GW; Ulrich, A; de Waard, M; Brock, R				Duchardt, Falk; Ruttekolk, Ivo R.; Verdurmen, Wouter P. R.; Lortat-Jacob, Hugues; Buerck, Jochen; Hufnagel, Hansjoerg; Fischer, Rainer; van den Heuvel, Maaike; Loewik, Dennis W. P. M.; Vuister, Geerten W.; Ulrich, Anne; de Waard, Michel; Brock, Roland			A Cell-penetrating Peptide Derived from Human Lactoferrin with Conformation-dependent Uptake Efficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; SOLID-STATE NMR; TACHYPLESIN-I; ANTIMICROBIAL ACTIVITY; HUMAN LACTOTRANSFERRIN; CATIONIC PEPTIDE; PLASMA-MEMBRANE; HOST-DEFENSE; AMINO-ACID	The molecular events that contribute to the cellular uptake of cell-penetrating peptides (CPP) are still a matter of intense research. Here, we report on the identification and characterization of a 22-amino acid CPP derived from the human milk protein, lactoferrin. The peptide exhibits a conformation-dependent uptake efficiency that is correlated with efficient binding to heparan sulfate and lipid-induced conformational changes. The peptide contains a disulfide bridge formed by terminal cysteine residues. At concentrations exceeding 10 mu M, this peptide undergoes the same rapid entry into the cytoplasm that was described previously for the arginine-rich CPPs nona-arginine and Tat. Cytoplasmic entry strictly depends on the presence of the disulfide bridge. To better understand this conformation dependence, NMR spectroscopy was performed for the free peptide, and CD measurements were performed for free and lipid-bound peptide. In solution, the peptides showed only slight differences in secondary structure, with a predominantly disordered structure both in the presence and absence of the disulfide bridge. In contrast, in complex with large unilamellar vesicles, the conformation of the oxidized and reduced forms of the peptide clearly differed. Moreover, surface plasmon resonance experiments showed that the oxidized form binds to heparan sulfate with a considerably higher affinity than the reduced form. Consistently, membrane binding and cellular uptake of the peptide were reduced when heparan sulfate chains were removed.	[Ruttekolk, Ivo R.; Verdurmen, Wouter P. R.; de Waard, Michel] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem, NL-6525 GA Nijmegen, Netherlands; [Duchardt, Falk; Hufnagel, Hansjoerg; Fischer, Rainer; Brock, Roland] Univ Tubingen, Interfac Inst Cell Biol, D-72076 Tubingen, Germany; [Lortat-Jacob, Hugues] Univ Grenoble 1, CEA CNRS, Inst Biol Struct, UMR 5075, F-38027 Grenoble 1, France; [Buerck, Jochen; Ulrich, Anne] Forschungszentrum Karlsruhe, Karlsruhe Inst Technol, D-76131 Karlsruhe, Germany; [van den Heuvel, Maaike; Loewik, Dennis W. P. M.] Radboud Univ Nijmegen, Inst Mol & Mat, Dept Bioorgan Chem, NL-6525 AJ Nijmegen, Netherlands; [Vuister, Geerten W.] Radboud Univ Nijmegen, Inst Mol & Mat, Dept Prot Biophys, NL-6525 AJ Nijmegen, Netherlands; [de Waard, Michel] Univ Grenoble 1, INSERM, Grenoble Neurosci Inst, Grp 3,U836, F-38027 Grenoble 1, France	Radboud University Nijmegen; Eberhard Karls University of Tubingen; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Helmholtz Association; Karlsruhe Institute of Technology; Radboud University Nijmegen; Radboud University Nijmegen; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Brock, R (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Biochem 286, Geert Grootepl 28, NL-6525 GA Nijmegen, Netherlands.	R.Brock@ncmls.ru.nl	Brock, Roland/K-2590-2012; Brock, Roland/O-9411-2019; Lowik, Dennis/P-3500-2019; De Waard, Michel/G-7406-2014; Ulrich, Anne S/H-5519-2013; Verdurmen, Wouter/H-7457-2016; Lowik, Dennis WPM/D-6913-2012	Brock, Roland/0000-0003-1395-6127; Lowik, Dennis/0000-0002-9284-837X; De Waard, Michel/0000-0002-2782-9615; Ulrich, Anne S/0000-0001-5571-9483; Verdurmen, Wouter/0000-0002-2463-277X; Lowik, Dennis WPM/0000-0002-9284-837X; Vuister, Geerten/0000-0001-6172-5097	Agence Nationale pour la Recherche; Commissariat a l'Energie Atomique; Volkswagen Foundation (Nachwuchsgruppen an Universitaten)	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Volkswagen Foundation (Nachwuchsgruppen an Universitaten)(Volkswagen)	Supported by the Agence Nationale pour la Recherche (PNANO program) and the Commissariat a l'Energie Atomique (TIMOMA2 program).; Supported by the Volkswagen Foundation (Nachwuchsgruppen an Universitaten).	BELLAMY W, 1992, BIOCHIM BIOPHYS ACTA, V1121, P130, DOI 10.1016/0167-4838(92)90346-F; Buffy JJ, 2003, BIOCHEMISTRY-US, V42, P13725, DOI 10.1021/bi035187w; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Ding GJF, 1998, J BIOL CHEM, V273, P28897, DOI 10.1074/jbc.273.44.28897; Doherty T, 2008, BIOCHEMISTRY-US, V47, P1105, DOI 10.1021/bi701390t; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; Dupont E, 2007, J BIOL CHEM, V282, P8994, DOI 10.1074/jbc.M609246200; ElassRochard E, 1995, BIOCHEM J, V312, P839, DOI 10.1042/bj3120839; Fischer PM, 2001, BIOCONJUGATE CHEM, V12, P825, DOI 10.1021/bc0155115; Foerg C, 2008, J PHARM SCI-US, V97, P144, DOI 10.1002/jps.21117; Gidwani P, 2008, CHEMOTHERAPY, V54, P120, DOI 10.1159/000118664; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; Groenink J, 1999, FEMS MICROBIOL LETT, V179, P217, DOI 10.1016/S0378-1097(99)00414-0; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hallbrink M, 2005, INT J PEPT RES THER, V11, P249, DOI 10.1007/s10989-005-9393-1; Hunter HN, 2005, ANTIMICROB AGENTS CH, V49, P3387, DOI 10.1128/AAC.49.8.3387-3395.2005; Jarvert P, 2007, BIOCHEM SOC T, V35, P770; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kosuge M, 2008, BIOCONJUGATE CHEM, V19, P656, DOI 10.1021/bc700289w; LEGRAND D, 1992, BIOCHEMISTRY-US, V31, P9243, DOI 10.1021/bi00153a018; Legrand D, 2008, ADV EXP MED BIOL, V606, P163, DOI 10.1007/978-0-387-74087-4_6; LEVAY PF, 1995, HAEMATOLOGICA, V80, P252; LEVEUGLE B, 1993, EUR J BIOCHEM, V213, P1205, DOI 10.1111/j.1432-1033.1993.tb17871.x; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Matsuzaki K, 1997, BIOCHEMISTRY-US, V36, P9799, DOI 10.1021/bi970588v; METZBOUTIGUE MH, 1984, EUR J BIOCHEM, V145, P659, DOI 10.1111/j.1432-1033.1984.tb08607.x; Nekhotiaeva N, 2003, FASEB J, V17, P394, DOI 10.1096/fj.03-0449fje; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Peterson NA, 2000, BIOCHEMISTRY-US, V39, P6625, DOI 10.1021/bi0001224; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Ramamoorthy A, 2006, BIOCHEMISTRY-US, V45, P6529, DOI 10.1021/bi052629q; Rojas M, 1998, NAT BIOTECHNOL, V16, P370, DOI 10.1038/nbt0498-370; Selsted ME, 2004, CURR PROTEIN PEPT SC, V5, P365, DOI 10.2174/1389203043379459; Sonnevend A, 2004, PEPTIDES, V25, P29, DOI 10.1016/j.peptides.2003.11.011; Sun XL, 1999, ACTA CRYSTALLOGR D, V55, P403, DOI 10.1107/S0907444998011226; Suzuki YA, 2005, CELL MOL LIFE SCI, V62, P2560, DOI 10.1007/s00018-005-5371-1; Takeshima K, 2003, J BIOL CHEM, V278, P1310, DOI 10.1074/jbc.M208762200; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Valenti P, 2005, CELL MOL LIFE SCI, V62, P2576, DOI 10.1007/s00018-005-5372-0; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadhwani P, 2006, J ORG CHEM, V71, P55, DOI 10.1021/jo051519m; Ward PP, 2004, BIOMETALS, V17, P203, DOI 10.1023/B:BIOM.0000027693.60932.26; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wu MH, 1999, J BIOL CHEM, V274, P29, DOI 10.1074/jbc.274.1.29	49	94	105	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36099	36108		10.1074/jbc.M109.036426	http://dx.doi.org/10.1074/jbc.M109.036426			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858187	Green Published, hybrid			2022-12-25	WOS:000272970500011
J	Galkin, A; Abramov, AY; Frakich, N; Duchen, MR; Moncada, S				Galkin, Alexander; Abramov, Andrey Y.; Frakich, Nanci; Duchen, Michel R.; Moncada, Salvador			Lack of Oxygen Deactivates Mitochondrial Complex I IMPLICATIONS FOR ISCHEMIC INJURY?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; CYTOCHROME-C-OXIDASE; ACTIVE-INACTIVE TRANSITION; NITRIC-OXIDE; ENZYME TRANSITION; S-NITROSATION; ANAEROBIC METABOLISM; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; INTACT-CELLS	For S-nitrosothiols and peroxynitrite to interfere with the activity of mitochondrial complex I, prior transition of the enzyme from its active (A) to its deactive, dormant (D) state is necessary. We now demonstrate accumulation of the D-form of complex I in human epithelial kidney cells after prolonged hypoxia. Upon reoxygenation after hypoxia there was an initial delay in the return of the respiration rate to normal. This was due to the accumulation of the D-form and its slow, substrate-dependent reconversion to the A-form. Reconversion to the A-form could be prevented by prolonged incubation with endogenously generated NO. We propose that the hypoxic transition from the A-form to the D-form of complex I may be protective, because it would act to reduce the electron burst and the formation of free radicals during reoxygenation. However, this may become an early pathophysiological event when NO-dependent formation of S-nitrosothiols or peroxynitrite structurally modifies complex I in its D-form and impedes its return to the active state. These observations provide a mechanism to account for the severe cell injury that follows hypoxia and reoxygenation when accompanied by NO generation.	[Duchen, Michel R.] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Galkin, Alexander; Frakich, Nanci; Moncada, Salvador] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Abramov, Andrey Y.] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London	Galkin, A (corresponding author), Queens Univ Belfast, Sch Biol Sci, MBC, Belfast BT9 7BL, Antrim, North Ireland.	a.galkin@qub.ac.uk	Abramov, Andrey/AAC-6712-2019; Abramov, Andrey Y/H-9053-2012; duchen, michael/A-2116-2009	Abramov, Andrey/0000-0002-7646-7235; Abramov, Andrey Y/0000-0002-7646-7235; duchen, michael/0000-0003-2548-4294	MRC [G0601943] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abramov AY, 2008, BBA-BIOENERGETICS, V1777, P953, DOI 10.1016/j.bbabio.2008.04.017; Andersson U, 1998, BIOCHEM BIOPH RES CO, V249, P512, DOI 10.1006/bbrc.1998.9171; Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X; Borutaite V, 2006, BBA-BIOENERGETICS, V1757, P562, DOI 10.1016/j.bbabio.2006.02.014; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Budinger GRS, 1996, AM J PHYSIOL-LUNG C, V270, pL44, DOI 10.1152/ajplung.1996.270.1.L44; Budinger GRS, 1998, J BIOL CHEM, V273, P3320, DOI 10.1074/jbc.273.6.3320; Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435; CAPALDI RA, 1982, BIOCHIM BIOPHYS ACTA, V694, P291, DOI 10.1016/0304-4157(82)90009-0; CHANCE B, 1988, FEBS LETT, V226, P343, DOI 10.1016/0014-5793(88)81451-0; Chandel NS, 1996, J BIOL CHEM, V271, P18672, DOI 10.1074/jbc.271.31.18672; CHAPPELL JB, 1968, BRIT MED BULL, V24, P150, DOI 10.1093/oxfordjournals.bmb.a070618; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Cooper CE, 2003, BBA-BIOENERGETICS, V1607, P27, DOI 10.1016/j.bbabio.2003.08.003; Dahm CC, 2006, J BIOL CHEM, V281, P10056, DOI 10.1074/jbc.M512203200; Dezfulian C, 2009, CIRCULATION, V120, P897, DOI 10.1161/CIRCULATIONAHA.109.853267; Dlaskova A, 2008, INT J BIOCHEM CELL B, V40, P1792, DOI 10.1016/j.biocel.2008.01.012; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Fato R, 2009, BBA-BIOENERGETICS, V1787, P384, DOI 10.1016/j.bbabio.2008.11.003; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Galkin A, 2007, J BIOL CHEM, V282, P37448, DOI 10.1074/jbc.M707543200; Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200; Gavrikova EV, 1999, FEBS LETT, V455, P36, DOI 10.1016/S0014-5793(99)00850-9; Gostimskaya IS, 2006, BBA-BIOENERGETICS, V1757, P1155, DOI 10.1016/j.bbabio.2006.04.016; Gostimskaya IS, 2003, ANAL BIOCHEM, V313, P46, DOI 10.1016/S0003-2697(02)00534-1; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Hagos Y, 2004, AM J PHYSIOL-RENAL, V286, pF86, DOI 10.1152/ajprenal.00161.2003; Hollis VS, 2003, BBA-BIOENERGETICS, V1607, P191, DOI 10.1016/j.bbabio.2003.09.012; KIMMICH GA, 1991, AM J PHYSIOL, V260, pC1151, DOI 10.1152/ajpcell.1991.260.6.C1151; Kissner R, 2003, IUBMB LIFE, V55, P567, DOI 10.1080/15216540310001628690; KOTLYAR AB, 1990, BIOCHIM BIOPHYS ACTA, V1019, P151, DOI 10.1016/0005-2728(90)90137-S; Lesnefsky EJ, 2006, FASEB J, V20, P1543, DOI 10.1096/fj.05-4535fje; Loskovich MV, 2005, BIOCHEM J, V387, P677, DOI 10.1042/BJ20041703; Maklashina E, 2003, BBA-BIOENERGETICS, V1606, P95, DOI 10.1016/S0005-2728(03)00087-2; Maklashina E, 2004, FEBS LETT, V556, P64, DOI 10.1016/S0014-5793(03)01369-3; Mateo J, 2003, BIOCHEM J, V376, P537, DOI 10.1042/BJ20031155; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Palacios-Callender M, 2004, P NATL ACAD SCI USA, V101, P7630, DOI 10.1073/pnas.0401723101; Palacios-Callender M, 2007, J CELL SCI, V120, P160, DOI 10.1242/jcs.03308; Park LCH, 1999, J NEUROCHEM, V72, P1948, DOI 10.1046/j.1471-4159.1999.0721948.x; Passarella S, 2003, MITOCHONDRION, V2, P319, DOI 10.1016/S1567-7249(03)00008-4; PASSARELLA S, 1987, NEUROCHEM RES, V12, P255, DOI 10.1007/BF00972135; Pearce LL, 2005, NITRIC OXIDE-BIOL CH, V13, P254, DOI 10.1016/j.niox.2005.07.010; Pich MM, 2004, FEBS LETT, V558, P19, DOI 10.1016/S0014-5793(03)01520-5; PISARENKO O, 1988, BIOCHIM BIOPHYS ACTA, V934, P55, DOI 10.1016/0005-2728(88)90119-3; Prime TA, 2009, P NATL ACAD SCI USA, V106, P10764, DOI 10.1073/pnas.0903250106; Riobo NA, 2001, BIOCHEM J, V359, P139, DOI 10.1042/0264-6021:3590139; SANADI DR, 1963, BIOCHEMISTRY-US, V2, P523, DOI 10.1021/bi00903a023; Sanz A, 2006, J BIOENERG BIOMEMBR, V38, P121, DOI 10.1007/s10863-006-9011-8; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; Vinogradov AD, 2005, BIOCHEMISTRY-MOSCOW+, V70, P120, DOI 10.1007/s10541-005-0090-7; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; WINGO WJ, 1975, ANAL CHEM, V47, P351, DOI 10.1021/ac60352a009	54	102	105	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36055	36061		10.1074/jbc.M109.054346	http://dx.doi.org/10.1074/jbc.M109.054346			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19861410	hybrid, Green Published			2022-12-25	WOS:000272970500007
J	Niu, WL; Chen, ZW; Bush-Pelc, LA; Bah, A; Gandhi, PS; Di Cera, E				Niu, Weiling; Chen, Zhiwei; Bush-Pelc, Leslie A.; Bah, Alaji; Gandhi, Prafull S.; Di Cera, Enrico			Mutant N143P Reveals How Na+ Activates Thrombin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MONO-VALENT CATIONS; SODIUM-BINDING-SITE; RESOLUTION CRYSTAL-STRUCTURES; HUMAN ALPHA-THROMBIN; PLASMA PROTEIN-C; SERINE PROTEASES; FACTOR-XA; CATALYTIC-ACTIVITY; S1 SITE; PROTHROMBINASE COMPLEX	The molecular mechanism of thrombin activation by Na+ remains elusive. Its kinetic formulation requires extension of the classical Botts-Morales theory for the action of a modifier on an enzyme to correctly account for the contribution of the E*, E, and E:Na+ forms. The extended scheme establishes that analysis of k(cat) unequivocally identifies allosteric transduction of Na+ binding into enhanced catalytic activity. The thrombin mutant N143P features no Na+-dependent enhancement of k(cat) yet binds Na+ with an affinity comparable to that of wild type. Crystal structures of the mutant in the presence and absence of Na+ confirm that Pro(143) abrogates the important H-bond between the backbone N atom of residue 143 and the carbonyl O atom of Glu(192), which in turn controls the orientation of the Glu(192)-Gly(193) peptide bond and the correct architecture of the oxyanion hole. We conclude that Na+ activates thrombin by securing the correct orientation of the Glu192-Gly193 peptide bond, which is likely flipped in the absence of cation. Absolute conservation of the 143-192 H-bond in trypsin-like proteases and the importance of the oxyanion hole in protease function suggest that this mechanism of Na+ activation is present in all Na+-activated trypsin-like proteases.	[Niu, Weiling; Chen, Zhiwei; Bush-Pelc, Leslie A.; Bah, Alaji; Gandhi, Prafull S.; Di Cera, Enrico] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Di Cera, E (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, Box 8231, St Louis, MO 63110 USA.	enrico@wustl.edu	Niu, Weiling/B-2997-2011		National Institutes of Health [HL49413, HL58141, HL73813, HL95315]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058141, R29HL049413, R01HL073813, R01HL049413, R44HL095315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL49413, HL58141 HL73813, and HL95315 (to E. D. C.). This work was also supported by a postdoctoral fellowship from the American Heart Association (to W. N.)	Ayala YM, 2001, PROTEINS, V45, P107, DOI 10.1002/prot.1130; Bah A, 2009, J BIOL CHEM, V284, P20034, DOI 10.1074/jbc.M109.012344; Bah A, 2006, J BIOL CHEM, V281, P40049, DOI 10.1074/jbc.M608600200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bajaj SP, 2006, J BIOL CHEM, V281, P24873, DOI 10.1074/jbc.M509971200; BANNER DW, 1991, J BIOL CHEM, V266, P20085; Barrette-Ng IH, 2002, J BIOL CHEM, V277, P39960, DOI 10.1074/jbc.M206978200; BIRKTOFT JJ, 1972, J MOL BIOL, V68, P187, DOI 10.1016/0022-2836(72)90210-0; Bobofchak KM, 2005, J BIOL CHEM, V280, P25644, DOI 10.1074/jbc.M503499200; BODE W, 1992, PROTEIN SCI, V1, P426; BOTTS J, 1953, T FARADAY SOC, V49, P696, DOI 10.1039/tf9534900696; Boyer Paul D., 1942, JOUR BIOL CHEM, V146, P673; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Camire RM, 2002, J BIOL CHEM, V277, P37863, DOI 10.1074/jbc.M203692200; Cantwell AM, 2000, J BIOL CHEM, V275, P39827, DOI 10.1074/jbc.C000751200; Carrell CJ, 2006, BIOPHYS CHEM, V121, P177, DOI 10.1016/j.bpc.2005.12.008; Castagnetto JM, 2002, NUCLEIC ACIDS RES, V30, P379, DOI 10.1093/nar/30.1.379; COHN M, 1951, BIOCHIM BIOPHYS ACTA, V7, P153, DOI 10.1016/0006-3002(51)90013-3; CURRAGH EF, 1964, BIOCHEM J, V93, P163, DOI 10.1042/bj0930163; Dang QD, 1997, J BIOL CHEM, V272, P19649, DOI 10.1074/jbc.272.32.19649; Dang QD, 1996, P NATL ACAD SCI USA, V93, P10653, DOI 10.1073/pnas.93.20.10653; DANG QD, 1995, P NATL ACAD SCI USA, V92, P5977, DOI 10.1073/pnas.92.13.5977; Dang QD, 1997, NAT BIOTECHNOL, V15, P146, DOI 10.1038/nbt0297-146; De Filippis V, 2005, BIOCHEM J, V390, P485, DOI 10.1042/BJ20050252; DEGEN SJF, 1995, THROMB HAEMOSTASIS, V73, P203; Di Cera E, 2006, J BIOL CHEM, V281, P1305, DOI 10.1074/jbc.R500023200; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Di Cera E, 2007, PHYS CHEM CHEM PHYS, V9, P1292, DOI 10.1039/b616819a; DiCera E, 1997, CELL MOL LIFE SCI, V53, P701, DOI 10.1007/s000180050091; DICERA E, 1995, J BIOL CHEM, V270, P22089, DOI 10.1074/jbc.270.38.22089; EVANS SA, 1982, J BIOL CHEM, V257, P3014; FEHLHAMMER H, 1975, J MOL BIOL, V98, P683, DOI 10.1016/S0022-2836(75)80004-0; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; FERSHT AR, 1971, J MOL BIOL, V60, P279, DOI 10.1016/0022-2836(71)90294-4; FERSHT AR, 1972, J MOL BIOL, V64, P497, DOI 10.1016/0022-2836(72)90513-X; Gandhi PS, 2008, P NATL ACAD SCI USA, V105, P1832, DOI 10.1073/pnas.0710894105; Gandhi PS, 2009, J BIOL CHEM, V284, P24098, DOI 10.1074/jbc.M109.025403; Gianni S, 2007, BIOPHYS CHEM, V131, P111, DOI 10.1016/j.bpc.2007.09.009; GIBBS CS, 1995, NATURE, V378, P413, DOI 10.1038/378413a0; Griffon N, 2001, BIOPHYS CHEM, V90, P89, DOI 10.1016/S0301-4622(01)00129-6; Guinto ER, 1999, P NATL ACAD SCI USA, V96, P1852, DOI 10.1073/pnas.96.5.1852; Guinto ER, 1996, BIOCHEMISTRY-US, V35, P8800, DOI 10.1021/bi9608828; He XH, 1999, J BIOL CHEM, V274, P4970, DOI 10.1074/jbc.274.8.4970; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Henriksen RA, 1998, BLOOD, V91, P2026, DOI 10.1182/blood.V91.6.2026.2026_2026_2031; Hill T.L., 1977, FREE ENERGY TRANSDUC; IBERS JA, 1980, SCIENCE, V209, P223, DOI 10.1126/science.7384796; Johnson DJD, 2005, BIOCHEM J, V392, P21, DOI 10.1042/BJ20051217; KACHMAR JF, 1953, J BIOL CHEM, V200, P669; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; Korostelev A, 2008, P NATL ACAD SCI USA, V105, P19684, DOI 10.1073/pnas.0810953105; Krem MM, 2003, BIOPHYS CHEM, V100, P315, DOI 10.1016/S0301-4622(02)00289-2; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Lai MT, 1997, J BIOL CHEM, V272, P30275, DOI 10.1074/jbc.272.48.30275; Levigne S, 2007, J BIOL CHEM, V282, P31569, DOI 10.1074/jbc.M704837200; Liu YY, 1999, ANAL BIOCHEM, V267, P331, DOI 10.1006/abio.1998.3014; Marciano DC, 2008, J MOL BIOL, V384, P151, DOI 10.1016/j.jmb.2008.09.009; MIYATA T, 1992, BIOCHEMISTRY-US, V31, P7457, DOI 10.1021/bi00148a005; Monnaie D, 2000, BIOCHEMISTRY-US, V39, P5349, DOI 10.1021/bi9926781; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myles T, 2001, J BIOL CHEM, V276, P25143, DOI 10.1074/jbc.M011324200; NEURATH H, 1957, FED PROC, V16, P791; Nogami K, 2005, J BIOL CHEM, V280, P18476, DOI 10.1074/jbc.M412778200; ORTHNER CL, 1978, ARCH BIOCHEM BIOPHYS, V185, P400, DOI 10.1016/0003-9861(78)90182-0; ORTHNER CL, 1980, ARCH BIOCHEM BIOPHYS, V202, P63, DOI 10.1016/0003-9861(80)90406-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2008, CELL MOL LIFE SCI, V65, P1220, DOI 10.1007/s00018-008-7565-9; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Papaconstantinou ME, 2008, CELL MOL LIFE SCI, V65, P3688, DOI 10.1007/s00018-008-8502-7; Parry MAA, 1998, STRUCT FOLD DES, V6, P1195, DOI 10.1016/S0969-2126(98)00119-1; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Petrovan RJ, 2000, BIOCHEMISTRY-US, V39, P14457, DOI 10.1021/bi0009486; Pineda AO, 2006, J BIOL CHEM, V281, P32922, DOI 10.1074/jbc.M605530200; Pineda AO, 2004, J BIOL CHEM, V279, P31842, DOI 10.1074/jbc.M401756200; Ponnuraj K, 2004, MOL CELL, V14, P17, DOI 10.1016/S1097-2765(04)00160-1; Prasad S, 2003, P NATL ACAD SCI USA, V100, P13785, DOI 10.1073/pnas.2333109100; Prasad S, 2004, J BIOL CHEM, V279, P10103, DOI 10.1074/jbc.M312614200; Reiling KK, 2003, BIOCHEMISTRY-US, V42, P2616, DOI 10.1021/bi020594d; Rezaie AR, 2000, BIOCHEMISTRY-US, V39, P1817, DOI 10.1021/bi992006a; Rezaie AR, 2004, J BIOL CHEM, V279, P48262, DOI 10.1074/jbc.M409964200; Rouy S, 2006, BRIT J HAEMATOL, V132, P770, DOI 10.1111/j.1365-2141.2005.05920.x; RYDEL TJ, 1991, J MOL BIOL, V221, P583, DOI 10.1016/0022-2836(91)80074-5; Scharer K, 2005, ANGEW CHEM INT EDIT, V44, P4400, DOI 10.1002/anie.200500883; Schmidt AE, 2005, J MOL BIOL, V350, P78, DOI 10.1016/j.jmb.2005.04.052; Schmidt AE, 2004, J BIOL CHEM, V279, P29485, DOI 10.1074/jbc.M402971200; Schmidt AE, 2002, J BIOL CHEM, V277, P28987, DOI 10.1074/jbc.M201892200; Stanchev H, 2006, THROMB HAEMOSTASIS, V95, P195; STEINER SA, 1985, BIOCHEMISTRY-US, V24, P1136, DOI 10.1021/bi00326a011; STEINER SA, 1982, BIOCHEMISTRY-US, V21, P4609, DOI 10.1021/bi00262a015; STEINER SA, 1985, BIOCHEMISTRY-US, V24, P609, DOI 10.1021/bi00324a011; STEINER SA, 1980, BIOCHEM BIOPH RES CO, V94, P340, DOI 10.1016/S0006-291X(80)80226-9; SUELTER CH, 1970, SCIENCE, V168, P789, DOI 10.1126/science.168.3933.789; Sun WY, 2001, THROMB HAEMOSTASIS, V85, P651, DOI 10.1055/s-0037-1615648; TAINER J A, 1992, Current Opinion in Biotechnology, V3, P378, DOI 10.1016/0958-1669(92)90166-G; Timm DE, 1997, PROTEIN SCI, V6, P1418, DOI 10.1002/pro.5560060706; Tsiang M, 1996, BIOCHEMISTRY-US, V35, P16449, DOI 10.1021/bi9616108; Underwood MC, 2000, J BIOL CHEM, V275, P36876, DOI 10.1074/jbc.M001386200; Vindigni A, 1996, BIOCHEMISTRY-US, V35, P4417, DOI 10.1021/bi952834d; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; WELLS CM, 1992, BIOCHEMISTRY-US, V31, P11721, DOI 10.1021/bi00162a008; WORKMAN EF, 1978, ARCH BIOCHEM BIOPHYS, V185, P544, DOI 10.1016/0003-9861(78)90199-6; Yun TH, 2003, J BIOL CHEM, V278, P48112, DOI 10.1074/jbc.M306925200; Zhang EL, 1997, BIOPHYS CHEM, V63, P185, DOI 10.1016/S0301-4622(96)02227-2; Zhu GY, 2003, J BIOL CHEM, V278, P2452, DOI 10.1074/jbc.M211042200	105	30	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36175	36185		10.1074/jbc.M109.069500	http://dx.doi.org/10.1074/jbc.M109.069500			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19846563	Green Published, hybrid			2022-12-25	WOS:000272970500019
J	Shih, PC; Yang, MS; Lin, SC; Ho, Y; Hsiao, JC; Wang, DR; Yu, SSF; Chang, W; Tzou, DLM				Shih, Ping-Chen; Yang, Min-Shiang; Lin, Su-Ching; Ho, Yu; Hsiao, Jye-Chian; Wang, Da-Rong; Yu, Steve S. -F.; Chang, Wen; Tzou, Der-Lii M.			A Turn-like Structure "KKPE" Segment Mediates the Specific Binding of Viral Protein A27 to Heparin and Heparan Sulfate on Cell Surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; HERPES-SIMPLEX-VIRUS; VACCINIA VIRUS; ENVELOPE PROTEIN; ENTRY; PROTEOGLYCANS; FUSION; SEQUENCE; VIRION; DOMAIN	Vaccinia viral envelope protein A27 (110 amino acids) specifically interacts with heparin (HP) or heparan sulfate (HS) proteoglycans for cell surface attachment. To examine the binding mechanism, a truncated soluble form of A27 (sA27-aa; residues 21 - 84 of A27) with Cys(71) and Cys(72) mutated to Ala was used as the parent molecule. sA27-aa consists of two structurally distinct domains, a flexible Arg/Lys-rich heparin-binding site (HBS) (residues 21 - 32; (21)STKAAKKPEAKR(32)) and a rigid coiled-coil domain (residues 43 - 84), both essential for the specific binding. As shown by surface plasmon resonance (SPR), the binding affinity of sA27-aa for HP (K-A = 1.25 x 10(8) M-1) was approximately 3 orders of magnitude stronger than that for nonspecific binding, such as to chondroitin sulfate (K-A = 1.65 x 10(5) M-1). Using site-directed mutagenesis of HBS and solution NMR, we identified a "KKPE" segment with a turn-like conformation that mediates specific HP binding. In addition, a double mutant T22K/A25K in which the KKPE segment remained intact showed an extremely high affinity for HP (K-A = 1.9 x 10(11) M-1). Importantly, T22K/A25K retained the binding specificity for HP and HS but not chondroitin sulfate, as shown by in vitro SPR and in vivo cell adhesion and competitive binding assays. Molecular modeling of the HBS was performed by dynamics simulations and provides an explanation of the specific binding mechanism in good agreement with the site-directed mutagenesis and SPR results. We conclude that a turn-like structure introduced by the KKPE segment in vaccinia viral envelope protein A27 is responsible for its specific binding to HP and to HS on cell surfaces.	[Shih, Ping-Chen; Yang, Min-Shiang; Lin, Su-Ching; Ho, Yu; Yu, Steve S. -F.; Tzou, Der-Lii M.] Acad Sinica, Inst Chem, Taipei 11529, Taiwan; [Hsiao, Jye-Chian; Chang, Wen] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Wang, Da-Rong] Fu Jen Catholic Univ, Dept Chem, Taipei 242, Taiwan; [Tzou, Der-Lii M.] Natl Chia Yi Univ, Dept Appl Chem, Chiayi 60004, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Fu Jen Catholic University; National Chiayi University	Tzou, DLM (corresponding author), 128 Acad Rd, Taipei 11529, Taiwan.	tzou@ccvax.sinica.edu.tw	Chang, Wen/AAA-5076-2021; Lin, Su-Ching/E-3571-2015; Yu, Steve Sheng-Fa/E-4866-2015; Tzou, Der-Lii M/E-9499-2015	Chang, Wen/0000-0003-3369-083X; Yu, Steve Sheng-Fa/0000-0002-3462-065X; Tzou, Der-Lii M/0000-0002-3755-8230	National Science Council [97-2113-M-001-020-MY3]; Academia Sinica	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by National Science Council Grant 97-2113-M-001-020-MY3 and by the Academia Sinica.	Adamson A. W., 1960, PHYS CHEM SURFACES, P457; BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; BERMAN P, 1987, CELL, V51, P135, DOI 10.1016/0092-8674(87)90018-3; Cain SA, 2005, J BIOL CHEM, V280, P30526, DOI 10.1074/jbc.M501390200; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866; Ching YC, 2009, J VIROL, V83, P6464, DOI 10.1128/JVI.02295-08; Chung CS, 1998, J VIROL, V72, P1577, DOI 10.1128/JVI.72.2.1577-1585.1998; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; ESCH F, 1985, P NATL ACAD SCI USA, V82, P6507, DOI 10.1073/pnas.82.19.6507; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; FROMM JR, 1995, ARCH BIOCHEM BIOPHYS, V323, P279, DOI 10.1006/abbi.1995.9963; GOEBEL SJ, 1990, VIROLOGY, V179, P247, DOI 10.1016/0042-6822(90)90294-2; GOSPODAROWICZ D, 1986, ENDOCRINOLOGY, V118, P82, DOI 10.1210/endo-118-1-82; GRUENHEID S, 1993, J VIROL, V67, P93, DOI 10.1128/JVI.67.1.93-100.1993; Hakansson S, 2003, BIOCHEMISTRY-US, V42, P8999, DOI 10.1021/bi020715+; Ho Y, 2005, J MOL BIOL, V349, P1060, DOI 10.1016/j.jmb.2005.04.024; Hsiao JC, 1998, J VIROL, V72, P8374, DOI 10.1128/JVI.72.10.8374-8379.1998; Izmailyan RA, 2006, J VIROL, V80, P8402, DOI 10.1128/JVI.00624-06; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; Kay LE, 1997, BIOCHEM CELL BIOL, V75, P1, DOI 10.1139/o97-023; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Lin CL, 2000, J VIROL, V74, P3353, DOI 10.1128/JVI.74.7.3353-3365.2000; Lin TH, 2002, J BIOL CHEM, V277, P20949, DOI 10.1074/jbc.M110403200; LINDAHL U, 1994, THROMB RES, V75, P1, DOI 10.1016/0049-3848(94)90136-8; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; MARGALIT H, 1993, J BIOL CHEM, V268, P19228; Moon AF, 2004, J BIOL CHEM, V279, P45185, DOI 10.1074/jbc.M405013200; Moss B, 2007, FIELDS VIROLOGY; NEWCOMER ME, 1984, EMBO J, V3, P1451, DOI 10.1002/j.1460-2075.1984.tb01995.x; NEWCOMER ME, 1984, J BIOL CHEM, V259, P5230; Nichols RJ, 2008, J VIROL, V82, P10247, DOI 10.1128/JVI.01035-08; Osmond RIW, 2002, ANAL BIOCHEM, V310, P199, DOI 10.1016/S0003-2697(02)00396-2; PANTOLIANO MW, 1994, BIOCHEMISTRY-US, V33, P10229, DOI 10.1021/bi00200a003; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; RODRIGUEZ D, 1993, J VIROL, V67, P3435, DOI 10.1128/JVI.67.6.3435-3440.1993; Salmivirta M, 1996, FASEB J, V10, P1270, DOI 10.1096/fasebj.10.11.8836040; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Senkevich TG, 2005, P NATL ACAD SCI USA, V102, P18572, DOI 10.1073/pnas.0509239102; TAKAHASHI T, 1994, VIROLOGY, V202, P844, DOI 10.1006/viro.1994.1406; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; WISHART DS, 1994, METHOD ENZYMOL, V239, P363	43	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36535	36546		10.1074/jbc.M109.037267	http://dx.doi.org/10.1074/jbc.M109.037267			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858217	Green Published, hybrid			2022-12-25	WOS:000272970500055
J	Zhao, B; Lei, L; Vassylyev, DG; Lin, X; Cane, DE; Kelly, SL; Yuan, H; Lamb, DC; Waterman, MR				Zhao, Bin; Lei, Li; Vassylyev, Dmitry G.; Lin, Xin; Cane, David E.; Kelly, Steven L.; Yuan, Hang; Lamb, David C.; Waterman, Michael R.			Crystal Structure of Albaflavenone Monooxygenase Containing a Moonlighting Terpene Synthase Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-COELICOLOR A3(2); TRANS-BETA-FARNESENE; SESQUITERPENE SYNTHASES; ARISTOLOCHENE SYNTHASE; BIFUNCTIONAL ENZYMES; ALARM PHEROMONE; IDENTIFICATION; BIOSYNTHESIS; CYCLIZATION; VOLATILES	Albaflavenone synthase (CYP170A1) is a monooxygenase catalyzing the final two steps in the biosynthesis of this antibiotic in the soil bacterium, Streptomyces coelicolor A3(2). Interestingly, CYP170A1 shows no stereo selection forming equal amounts of two albaflavenol epimers, each of which is oxidized in turn to albaflavenone. To explore the structural basis of the reaction mechanism, we have studied the crystal structures of both ligand-free CYP170A1 (2.6 angstrom) and complex of endogenous substrate (epi-isozizaene) with CYP170A1 (3.3 angstrom). The structure of the complex suggests that the proximal epi-isozizaene molecules may bind to the heme iron in two orientations. In addition, much to our surprise, we have found that albaflavenone synthase also has a second, completely distinct catalytic activity corresponding to the synthesis of farnesene isomers from farnesyl diphosphate. Within the cytochrome P450 alpha-helical domain both the primary sequence and x-ray structure indicate the presence of a novel terpene synthase active site that is moonlighting on the P450 structure. This includes signature sequences for divalent cation binding and an alpha-helical barrel. This barrel is unusual because it consists of only four helices rather than six found in all other terpene synthases. Mutagenesis establishes that this barrel is essential for the terpene synthase activity of CYP170A1 but not for the monooxygenase activity. This is the first bifunctional P450 discovered to have another active site moonlighting on it and the first time a terpene synthase active site is found moonlighting on another protein.	[Zhao, Bin; Lei, Li; Yuan, Hang; Waterman, Michael R.] Vanderbilt Univ, Dept Biochem, Sch Med, Struct Biol Ctr, Nashville, TN 37232 USA; [Zhao, Bin; Lei, Li; Yuan, Hang; Waterman, Michael R.] Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA; [Vassylyev, Dmitry G.] Univ Alabama, Sch Med, Dept Biochem, Birmingham, AL 35294 USA; [Vassylyev, Dmitry G.] Univ Alabama, Sch Med, Dept Mol Genet, Birmingham, AL 35294 USA; [Vassylyev, Dmitry G.] Univ Alabama, Sch Dent, Dept Mol Genet, Birmingham, AL 35294 USA; [Vassylyev, Dmitry G.] Univ Alabama, Sch Dent, Dept Biochem, Birmingham, AL 35294 USA; [Lin, Xin; Cane, David E.] Brown Univ, Dept Chem, Providence, RI 02912 USA; [Kelly, Steven L.; Lamb, David C.] Swansea Univ, Sch Med, Inst Life Sci, Swansea SA2 8PP, W Glam, Wales	Vanderbilt University; Vanderbilt University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Brown University; Swansea University	Zhao, B (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Struct Biol Ctr, 864 Robinson Res Bldg,23rd & Pierce Ave, Nashville, TN 37232 USA.	bin.zhao@vanderbilt.edu	Vassylyev, Dmitry/A-9005-2008		National Institutes of Health [GM69970, ES00267, GM30301, GM75252, GM74840]; Royal Society; Leverhulme Trust; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030301, R01GM074840, R01GM075252, R01GM069970, R37GM030301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); Leverhulme Trust(Leverhulme Trust); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM69970 (to M. R. W.), ES00267 (to M. R. W.), GM30301 (to D. E. C.), and GM75252 and GM74840 (to D. G. V.) and by the Royal Society and a Leverhulme Trust fellowship (to D. C. L.).	Agger SA, 2008, J BACTERIOL, V190, P6084, DOI 10.1128/JB.00759-08; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; BOWERS WS, 1972, SCIENCE, V177, P1121, DOI 10.1126/science.177.4054.1121; CANE DE, 1990, CHEM REV, V90, P1089, DOI 10.1021/cr00105a002; Caruthers JM, 2000, J BIOL CHEM, V275, P25533, DOI 10.1074/jbc.M000433200; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; DUFFIELD RM, 1983, J CHEM ECOL, V9, P277, DOI 10.1007/BF00988045; EDWARDS LJ, 1973, NATURE, V241, P126, DOI 10.1038/241126b0; GELB MH, 1982, BIOCHEMISTRY-US, V21, P370, DOI 10.1021/bi00531a026; Gomez A, 2003, BIOINFORMATICS, V19, P895, DOI 10.1093/bioinformatics/btg111; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; James CL, 2002, BIOCHEMISTRY-US, V41, P3720, DOI 10.1021/bi015909o; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jiang JY, 2007, NAT CHEM BIOL, V3, P711, DOI 10.1038/nchembio.2007.29; Jurgens A, 2004, AM J BOT, V91, P1969, DOI 10.3732/ajb.91.12.1969; Juuti JT, 1998, J MOL BIOL, V279, P347, DOI 10.1006/jmbi.1998.1772; Khandeparker R, 2008, J IND MICROBIOL BIOT, V35, P635, DOI 10.1007/s10295-008-0342-9; Krings U, 2006, J AGR FOOD CHEM, V54, P9079, DOI 10.1021/jf062089j; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Lin X, 2006, J AM CHEM SOC, V128, P6022, DOI 10.1021/ja061292s; Little DB, 2002, ARCH BIOCHEM BIOPHYS, V402, P120, DOI 10.1016/S0003-9861(02)00068-1; MEEK TD, 1985, BIOCHEMISTRY-US, V24, P678, DOI 10.1021/bi00324a021; Moore BD, 2004, TRENDS PLANT SCI, V9, P221, DOI 10.1016/j.tplants.2004.03.005; Nagradova N, 2003, IUBMB LIFE, V55, P459, DOI 10.1080/15216540310001602805; NARHI LO, 1987, J BIOL CHEM, V262, P6683; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; OMURA T, 1964, J BIOL CHEM, V239, P2370; Picaud S, 2005, PHYTOCHEMISTRY, V66, P961, DOI 10.1016/j.phytochem.2005.03.027; Pichersky E, 2006, SCIENCE, V311, P808, DOI 10.1126/science.1118510; Rowland P, 2006, J BIOL CHEM, V281, P7614, DOI 10.1074/jbc.M511232200; Rupasinghe S, 2006, FEBS LETT, V580, P6338, DOI 10.1016/j.febslet.2006.10.043; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Shishova EY, 2007, BIOCHEMISTRY-US, V46, P1941, DOI 10.1021/bi0622524; Starks CM, 1997, SCIENCE, V277, P1815, DOI 10.1126/science.277.5333.1815; TARSHIS LC, 1994, BIOCHEMISTRY-US, V33, P10871, DOI 10.1021/bi00202a004; TESH RB, 1992, J MED ENTOMOL, V29, P226, DOI 10.1093/jmedent/29.2.226; TURLINGS TCJ, 1991, J CHEM ECOL, V17, P2235, DOI 10.1007/BF00988004; Zhao B, 2008, J BIOL CHEM, V283, P8183, DOI 10.1074/jbc.M710421200	41	61	65	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36711	36719		10.1074/jbc.M109.064683	http://dx.doi.org/10.1074/jbc.M109.064683			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858213	hybrid, Green Published			2022-12-25	WOS:000272970500071
J	Brown, LJ; Longacre, MJ; Hasan, NM; Kendrick, MA; Stoker, SW; MacDonald, MJ				Brown, Laura J.; Longacre, Melissa J.; Hasan, Noaman M.; Kendrick, Mindy A.; Stoker, Scott W.; MacDonald, Michael J.			Chronic Reduction of the Cytosolic or Mitochondrial NAD(P)-malic Enzyme Does Not Affect Insulin Secretion in a Rat Insulinoma Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; NAD(P)&-DEPENDENT MALIC ENZYME; SHORT-INTERFERING RNAS; ATP-CITRATE LYASE; PENTOSE CYCLE; PYRUVATE-CARBOXYLASE; GLUCOSE-METABOLISM; METHYL SUCCINATE; MAMMALIAN-CELLS; ISLET CELLS	The cytosolic malic enzyme (ME1) has been suggested to augment insulin secretion via the malate-pyruvate and/or citrate-pyruvate shuttles, through the production of NADPH or other metabolites. We used selectable vectors expressing short hairpin RNA (shRNA) to stably decrease Me1 mRNA levels by 80-86% and ME1 enzyme activity by 78-86% with either of two shRNAs in the INS-1 832/13 insulinoma cell line. Contrary to published short term ME1 knockdown experiments, our long term targeted cells showed normal insulin secretion in response to glucose or to glutamine plus 2-aminobicyclo[2,2,1]heptane-2- carboxylic acid. We found no increase in the mRNAs and enzyme activities of the cytosolic isocitrate dehydrogenase or glucose-6-phosphate dehydrogenase, which also produce cytosolic NADPH. There was no compensatory induction of the mRNAs for the mitochondrial malic enzymes Me2 or Me3. Interferon pathway genes induced in preliminary small interfering RNA experiments were not induced in the long term shRNA experiments. We repeated our study with an improved vector containing Tol2 transposition sequences to produce a higher rate of stable transferents and shortened time to testing, but this did not alter the results. We similarly used stably expressed shRNA to reduce mitochondrial NAD(P)-malic enzyme (Me2) mRNA by up to 95%, with severely decreased ME2 protein and a 90% decrease in enzyme activity. Insulin release to glucose or glutamine plus 2-aminobicyclo[2,2,1]heptane-2-carboxylic acid remained normal. The maintenance of robust insulin secretion after lowering expression of either one of these malic enzymes is consistent with the redundancy of pathways of pyruvate cycling and/ or cytosolic NADPH production in insulinoma cells.	[Brown, Laura J.; Longacre, Melissa J.; Hasan, Noaman M.; Kendrick, Mindy A.; Stoker, Scott W.; MacDonald, Michael J.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Brown, LJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA.	ljbrown@pediatrics.wisc.edu		MacDonald, Michael/0000-0002-0201-9245	National Institutes of Health [DK28348]; Oscar C. Rennebohm Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028348, R55DK028348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oscar C. Rennebohm Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK28348. This work was also supported by the Oscar C. Rennebohm Foundation.	ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; ASHCROFT SJ, 1970, BIOCHEM J, V119, P5, DOI 10.1042/bj1190005; ASHCROFT SJ, 1972, BIOCHEM J, V126, P525, DOI 10.1042/bj1260525; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; BROWN LJ, 1994, J BIOL CHEM, V269, P14363; Castanotto D, 2007, NUCLEIC ACIDS RES, V35, P5154, DOI 10.1093/nar/gkm543; El Ouaamari A, 2008, DIABETES, V57, P2708, DOI 10.2337/db07-1614; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Fedorov Y, 2005, NAT METHODS, V2, P241, DOI 10.1038/nmeth0405-241; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; GARDNER RS, 1974, ANAL BIOCHEM, V59, P272, DOI 10.1016/0003-2697(74)90033-5; GIROIX MH, 1985, FEBS LETT, V185, P1, DOI 10.1016/0014-5793(85)80728-6; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Guay C, 2007, J BIOL CHEM, V282, P35657, DOI 10.1074/jbc.M707294200; Hasan NM, 2008, J BIOL CHEM, V283, P28048, DOI 10.1074/jbc.M804170200; Heart E, 2007, BIOCHEM J, V403, P197, DOI 10.1042/BJ20061209; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Jiang N, 2007, MAMM GENOME, V18, P508, DOI 10.1007/s00335-007-9011-y; Joseph JW, 2007, J BIOL CHEM, V282, P31592, DOI 10.1074/jbc.M706080200; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Koga A, 2001, GENES GENET SYST, V76, P1, DOI 10.1266/ggs.76.1; Li CH, 2008, J BIOL CHEM, V283, P17238, DOI 10.1074/jbc.M709235200; Liu YQ, 2002, J BIOL CHEM, V277, P39163, DOI 10.1074/jbc.M207157200; Lovis P, 2008, BIOL CHEM, V389, P305, DOI 10.1515/BC.2008.026; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MacDonald MJ, 2007, J BIOL CHEM, V282, P6043, DOI 10.1074/jbc.M606652200; MacDonald MJ, 2009, ARCH BIOCHEM BIOPHYS, V488, P100, DOI 10.1016/j.abb.2009.07.004; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1993, ARCH BIOCHEM BIOPHYS, V305, P205, DOI 10.1006/abbi.1993.1413; MacDonald MJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE302, DOI 10.1152/ajpendo.00041.2002; MACDONALD MJ, 1982, ARCH BIOCHEM BIOPHYS, V213, P643, DOI 10.1016/0003-9861(82)90594-X; MacDonald MJ, 2001, MOL CELL BIOCHEM, V220, P117, DOI 10.1023/A:1010821821921; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; MANDELLA RD, 1975, J BIOL CHEM, V250, P5877; MATSCHIN.FM, 1968, DIABETES, V17, P475, DOI 10.2337/diab.17.8.475; MOREADITH RW, 1984, J BIOL CHEM, V259, P6215; MOREADITH RW, 1984, J BIOL CHEM, V259, P6222; NAGEL WO, 1980, J BIOL CHEM, V255, P3849; Pebernard S, 2004, DIFFERENTIATION, V72, P103, DOI 10.1111/j.1432-0436.2004.07202001.x; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Robbins MA, 2006, NAT BIOTECHNOL, V24, P566, DOI 10.1038/nbt1206; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; SAUER LA, 1980, J BIOL CHEM, V255, P3844; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; SENER A, 1984, BIOCHEM J, V220, P433, DOI 10.1042/bj2200433; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; SNYDER PJ, 1970, AM J PHYSIOL, V219, P876, DOI 10.1152/ajplegacy.1970.219.4.876; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209	62	25	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35359	35367		10.1074/jbc.M109.040394	http://dx.doi.org/10.1074/jbc.M109.040394			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858194	Green Published, hybrid			2022-12-25	WOS:000272645600012
J	Firtina, Z; Danysh, BP; Bai, XY; Gould, DB; Kobayashi, T; Duncan, MK				Firtina, Zeynep; Danysh, Brian P.; Bai, Xiaoyang; Gould, Douglas B.; Kobayashi, Takehiro; Duncan, Melinda K.			Abnormal Expression of Collagen IV in Lens Activates Unfolded Protein Response Resulting in Cataract	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER-STRESS; MESSENGER-RNA; COL4A1 MUTATION; TRANSLATIONAL CONTROL; CONGENITAL CATARACT; MOLECULAR-GENETICS; ALPORT-SYNDROME; ATF6; XBP1	Human diseases caused by mutations in extracellular matrix genes are often associated with an increased risk of cataract and lens capsular rupture. However, the underlying mechanisms of cataract pathogenesis in these conditions are still unknown. Using two different mouse models, we show that the accumulation of collagen chains in the secretory pathway activates the stress signaling pathway termed unfolded protein response (UPR). Transgenic mice expressing ectopic Col4a3 and Col4a4 genes in the lens exhibited activation of IRE1, ATF6, and PERK associated with expansion of the endoplasmic reticulum and attenuation of general protein translation. The expression of the transgenes had adverse effects on lens fiber cell differentiation and eventually induced cell death in a group of transgenic fiber cells. In Col4a1(+/Delta ex40) mutant mice, the accumulation of mutant chains also caused low levels of UPR activation. However, cell death was not induced in mutant lenses, suggesting that low levels of UPR activation are not proapoptotic. Collectively, the results provide in vivo evidence for a role of UPR in cataract formation in response to accumulation of terminally unfolded proteins in the endoplasmic reticulum.	[Duncan, Melinda K.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Bai, Xiaoyang; Gould, Douglas B.] Univ Calif San Francisco, Inst Human Genet, Dept Ophthalmol & Anat, San Francisco, CA 94143 USA; [Kobayashi, Takehiro] Niigata Univ, Grad Sch Med & Dent Sci, Dept Homeostat Regulat & Dev, Niigata 9518510, Japan	University of Delaware; University of California System; University of California San Francisco; Niigata University	Duncan, MK (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.	duncanm@udel.edu	KARAGONLAR, ZEYNEP FIRTINA/AAB-1723-2020; Longo, Kenneth A/A-5631-2010	KARAGONLAR, ZEYNEP FIRTINA/0000-0002-6608-365X; Danysh, Brian/0000-0001-6839-6337; Duncan, Melinda/0000-0003-1570-322X	National Institutes of Health, NEI [EY015279, EY02162]; Idea Networks of Biomedical Research Excellence Program [P20 RR16472]; Sigma Xi-NAS; That Man May See and Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016472] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002162, R01EY015279] Funding Source: NIH RePORTER	National Institutes of Health, NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Idea Networks of Biomedical Research Excellence Program; Sigma Xi-NAS; That Man May See and Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health, NEI, Grants EY015279 (to M. K. D.) and EY02162 (to D. B. G.). The University of Delaware Core Imaging facility was supported by Idea Networks of Biomedical Research Excellence Program Grant P20 RR16472.; Recipient of a Sigma Xi-NAS grant-in-aid.; Recipient of grants from That Man May See and Research to Prevent Blindness.	Ameri K, 2004, BLOOD, V103, P1876, DOI 10.1182/blood-2003-06-1859; Baryshev M, 2004, J MOL ENDOCRINOL, V32, P903, DOI 10.1677/jme.0.0320903; BASSNETT S, 2004, DEV OCULAR LENS, P214; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bommiasamy H, 2009, J CELL SCI, V122, P1626, DOI 10.1242/jcs.045625; Breedveld G, 2006, J MED GENET, V43, P490, DOI 10.1136/jmg.2005.035584; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brian G, 2001, B WORLD HEALTH ORGAN, V79, P249; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Choi-Kwon S, 2005, CEREBROVASC DIS, V19, P84, DOI 10.1159/000082784; Colville DJ, 1997, OPHTHALMIC GENET, V18, P161, DOI 10.3109/13816819709041431; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P487; de Almeida SF, 2007, J IMMUNOL, V178, P3612, DOI 10.4049/jimmunol.178.6.3612; Duncan MK, 2000, INVEST OPHTH VIS SCI, V41, P464; Duncan MK, 2004, INVEST OPHTH VIS SCI, V45, P3589, DOI 10.1167/iovs.04-0151; Ellwein LB, 2002, ARCH OPHTHALMOL-CHIC, V120, P804; Favor J, 2007, GENETICS, V175, P725, DOI 10.1534/genetics.106.064733; Francis PJ, 2000, J MED GENET, V37, P481, DOI 10.1136/jmg.37.7.481; FUHRMANN C, 1984, HISTOCHEMISTRY, V80, P153, DOI 10.1007/BF00679990; GARADI R, 1984, INVEST OPHTH VIS SCI, V25, P147; Gould DB, 2005, SCIENCE, V308, P1167, DOI 10.1126/science.1109418; Gould DB, 2007, HUM MOL GENET, V16, P798, DOI 10.1093/hmg/ddm024; Gow A, 2003, NEUROMOL MED, V4, P73, DOI 10.1385/NMM:4:1-2:73; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hong M, 2004, J BIOL CHEM, V279, P11354, DOI 10.1074/jbc.M309804200; Hutnik C M, 1999, Curr Opin Ophthalmol, V10, P22, DOI 10.1097/00055735-199902000-00005; Ikesugi K, 2006, EXP EYE RES, V83, P508, DOI 10.1016/j.exer.2006.01.033; Imaizumi K, 2001, BBA-MOL BASIS DIS, V1536, P85, DOI 10.1016/S0925-4439(01)00049-7; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Junk AK, 2000, ARCH OPHTHALMOL-CHIC, V118, P895; Kato T, 1998, JPN J OPHTHALMOL, V42, P401, DOI 10.1016/S0021-5155(98)00031-8; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2004, TRENDS BIOCHEM SCI, V29, P152, DOI 10.1016/j.tibs.2004.01.004; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kelley PB, 2002, MATRIX BIOL, V21, P415, DOI 10.1016/S0945-053X(02)00014-8; Knowlton AA, 2007, CARDIOVASC RES, V73, P1, DOI 10.1016/j.cardiores.2006.11.002; Kobayashi T, 2003, KIDNEY INT, V64, P1986, DOI 10.1046/j.1523-1755.2003.00323.x; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kuemmel TA, 1996, J SUBMICR CYTOL PATH, V28, P537; Kuszak JR, 2004, EXP EYE RES, V78, P673, DOI 10.1016/j.exer.2003.09.016; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Mitchell CA, 1998, DEV DYNAM, V213, P322, DOI 10.1002/(SICI)1097-0177(199811)213:3<322::AID-AJA8>3.0.CO;2-E; Moore AT, 2004, BRIT J OPHTHALMOL, V88, P2, DOI 10.1136/bjo.88.1.2; Mulhern ML, 2006, INVEST OPHTH VIS SCI, V47, P3951, DOI 10.1167/iovs.06-0193; Opdenaker LM, 2009, J CELL BIOCHEM, V107, P473, DOI 10.1002/jcb.22145; PAPACONSTANTINOU J, 1967, SCIENCE, V156, P338, DOI 10.1126/science.156.3773.338; PIATIGORSKY J, 1972, J CELL BIOL, V55, P82, DOI 10.1083/jcb.55.1.82; PIATIGORSKY J, 1981, DIFFERENTIATION, V19, P134, DOI 10.1111/j.1432-0436.1981.tb01141.x; PIATIGORSKY J, 1992, J BIOL CHEM, V267, P4277; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Rauschert N, 2008, LAB INVEST, V88, P375, DOI 10.1038/labinvest.2008.2; Reed NA, 2001, J IMMUNOL METHODS, V253, P243, DOI 10.1016/S0022-1759(01)00374-X; Reneker LW, 2004, INVEST OPHTH VIS SCI, V45, P4083, DOI 10.1167/iovs.03-1270; Ron D, 2004, J CELL BIOL, V167, P23, DOI 10.1083/jcb.200408117; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Sargon MF, 1999, OPHTHALMOLOGICA, V213, P30, DOI 10.1159/000027390; Schroder M, 2006, CURR MOL MED, V6, P5, DOI 10.2174/156652406775574569; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; SEERY CM, 1990, AM J OPHTHALMOL, V110, P143, DOI 10.1016/S0002-9394(14)76982-X; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shiels A, 2007, ARCH OPHTHALMOL-CHIC, V125, P165, DOI 10.1001/archopht.125.2.165; Sibon I, 2007, ANN NEUROL, V62, P177, DOI 10.1002/ana.21191; Snead MP, 1999, J MED GENET, V36, P353; Southwood CM, 2002, NEURON, V36, P585, DOI 10.1016/S0896-6273(02)01045-0; Spierer A, 1998, J PEDIAT OPHTH STRAB, V35, P281; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200; Szegezdi E, 2003, ANN NY ACAD SCI, V1010, P186, DOI 10.1196/annals.1299.032; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Thomas M, 2005, J BIOL CHEM, V280, P21264, DOI 10.1074/jbc.M500144200; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Vahedi K, 2007, STROKE, V38, P1461, DOI 10.1161/STROKEAHA.106.475194; Van Agtmael T, 2005, HUM MOL GENET, V14, P3161, DOI 10.1093/hmg/ddi348; van der Knaap MS, 2006, ANN NEUROL, V59, P504, DOI 10.1002/ana.20715; Wang XH, 2004, INVEST OPHTH VIS SCI, V45, P3608, DOI 10.1167/iovs.04-0423; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wilson ME, 2006, J AAPOS, V10, P182, DOI 10.1016/j.jaapos.2005.09.008; Wilson R, 2005, J BIOL CHEM, V280, P15544, DOI 10.1074/jbc.M410758200; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; ZIGMAN S, 1985, BIOL BULL, V189, P213	95	63	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35872	35884		10.1074/jbc.M109.060384	http://dx.doi.org/10.1074/jbc.M109.060384			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858219	Green Published, hybrid			2022-12-25	WOS:000272645600063
J	Michailidis, E; Marchand, B; Kodama, EN; Singh, K; Matsuoka, M; Kirby, KA; Ryan, EM; Sawani, AM; Nagy, E; Ashida, N; Mitsuya, H; Parniak, MA; Sarafianos, SG				Michailidis, Eleftherios; Marchand, Bruno; Kodama, Eiichi N.; Singh, Kamlendra; Matsuoka, Masao; Kirby, Karen A.; Ryan, Emily M.; Sawani, Ali M.; Nagy, Eva; Ashida, Noriyuki; Mitsuya, Hiroaki; Parniak, Michael A.; Sarafianos, Stefan G.			Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4 '-Ethynyl-2-fluoro-2 '-deoxyadenosine Triphosphate, a Translocation-defective Reverse Transcriptase Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DNA-POLYMERASE; NUCLEOSIDE ANALOGS; 3'-AZIDO-3'-DEOXYTHYMIDINE AZT; MOLECULAR-MECHANISMS; EXCISION PHENOTYPE; SELECTIVE ACTION; IN-VITRO; TYPE-1; RESISTANCE	Nucleoside reverse transcriptase inhibitors (NRTIs) are employed in first line therapies for the treatment of human immunodeficiency virus (HIV) infection. They generally lack a 3'-hydroxyl group, and thus when incorporated into the nascent DNA they prevent further elongation. In this report we show that 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA), a nucleoside analog that retains a 3'-hydroxyl moiety, inhibited HIV-1 replication in activated peripheral blood mononuclear cells with an EC50 of 0.05 nM, a potency several orders of magnitude better than any of the current clinically used NRTIs. This exceptional antiviral activity stems in part from a mechanism of action that is different from approved NRTIs. Reverse transcriptase (RT) can use EFdA-5'-triphosphate (EFdA-TP) as a substrate more efficiently than the natural substrate, dATP. Importantly, despite the presence of a 3'-hydroxyl, the incorporated EFdA monophosphate (EFdA-MP) acted mainly as a de facto terminator of further RT-catalyzed DNA synthesis because of the difficulty of RT translocation on the nucleic acid primer possessing 3'-terminal EFdA-MP. EFdA-TP is thus a translocation-defective RT inhibitor (TDRTI). This diminished translocation kept the primer 3'-terminal EFdA-MP ideally located to undergo phosphorolytic excision. However, net phosphorolysis was not substantially increased, because of the apparently facile reincorporation of the newly excised EFdA-TP. Our molecular modeling studies suggest that the 4'-ethynyl fits into a hydrophobic pocket defined by RT residues Ala-114, Tyr-115, Phe-160, and Met-184 and the aliphatic chain of Asp-185. These interactions, which contribute to both enhanced RT utilization of EFdA-TP and difficulty in the translocation of 3'-terminal EFdA-MP primers, underlie the mechanism of action of this potent antiviral nucleoside.	[Michailidis, Eleftherios; Marchand, Bruno; Singh, Kamlendra; Kirby, Karen A.; Ryan, Emily M.; Sawani, Ali M.; Sarafianos, Stefan G.] Univ Missouri, Dept Mol Microbiol & Immunol, Christopher Bond Life Sci Ctr, Columbia, MO 65211 USA; [Kodama, Eiichi N.; Matsuoka, Masao] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Nagy, Eva; Parniak, Michael A.] Univ Pittsburgh, Dept Mol Genet & Biochem, Pittsburgh, PA 15261 USA; [Ashida, Noriyuki] Yamasa Corp, Chiba 2880056, Japan; [Mitsuya, Hiroaki] Kumamoto Univ, Dept Hematol & Infect Dis, Kumamoto 8608556, Japan; [Mitsuya, Hiroaki] NIH, Expt Retrovirol Sect, HIV AIDS Malignancy Branch, Bethesda, MD 20892 USA	University of Missouri System; University of Missouri Columbia; Kyoto University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kumamoto University; National Institutes of Health (NIH) - USA	Sarafianos, SG (corresponding author), 471D Christopher S Bond Life Sci Ctr,1201 Rollins, Columbia, MO 65211 USA.	sarafianoss@missouri.edu	Kodama, Eiichi N/C-4032-2009	Kodama, Eiichi N/0000-0002-6622-2752; Michailidis, Eleftherios/0000-0002-9907-4346; Kirby, Karen A./0000-0003-2468-4796; Sarafianos, Stefan G/0000-0002-5840-154X; Matsuoka, Masao/0000-0002-0473-754X	National Institutes of Health [AI076119, AI074389, AI076119-S1, AI076119-02S1, AI079801]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074389, R21AI079801, R33AI079801, R01AI076119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI076119, AI074389, AI076119-S1, and AI076119-02S1 ( to S. G. S.) and AI079801 ( to M. A. P.).	Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Biaglow JE, 1997, RADIAT RES, V148, P181, DOI 10.2307/3579576; Boyer PL, 2007, J MOL BIOL, V371, P873, DOI 10.1016/j.jmb.2007.05.043; Boyer PL, 2005, J MOL BIOL, V345, P441, DOI 10.1016/j.jmb.2004.10.021; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; CHEN MS, 1992, J BIOL CHEM, V267, P257; CHEN MS, 1993, BIOCHEMISTRY-US, V32, P6002, DOI 10.1021/bi00074a011; De Clercq E, 2007, Verh K Acad Geneeskd Belg, V69, P81; Deval J, 2009, DRUGS, V69, P151, DOI 10.2165/00003495-200969020-00002; Di Pasquale F, 2008, J AM CHEM SOC, V130, P10748, DOI 10.1021/ja8028284; Feng JY, 2004, ANTIMICROB AGENTS CH, V48, P1300, DOI 10.1128/AAC.48.4.1300-1306.2004; Gallois-Montbrun S, 2002, J BIOL CHEM, V277, P39953, DOI 10.1074/jbc.M206360200; Hammer SM, 2006, JAMA-J AM MED ASSOC, V296, P827, DOI 10.1001/jama.296.7.827; Hattori S, 2009, ANTIMICROB AGENTS CH, V53, P3887, DOI 10.1128/AAC.00270-09; Hsu CH, 2007, ANTIMICROB AGENTS CH, V51, P1687, DOI 10.1128/AAC.01432-06; Kawamoto A, 2008, INT J BIOCHEM CELL B, V40, P2410, DOI 10.1016/j.biocel.2008.04.007; Kodama EI, 2001, ANTIMICROB AGENTS CH, V45, P1539, DOI 10.1128/AAC.45.5.1539-1546.2001; LEGRICE SFJ, 1990, EUR J BIOCHEM, V187, P307, DOI 10.1111/j.1432-1033.1990.tb15306.x; MAAG H, 1994, J MED CHEM, V37, P431, DOI 10.1021/jm00030a001; MAAG H, 1992, J MED CHEM, V35, P1440, DOI 10.1021/jm00086a013; Marchand B, 2003, J BIOL CHEM, V278, P35362, DOI 10.1074/jbc.M304262200; Marchand B, 2007, ANTIMICROB AGENTS CH, V51, P2911, DOI 10.1128/AAC.00314-07; Meyer PR, 1999, MOL CELL, V4, P35, DOI 10.1016/S1097-2765(00)80185-9; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Moscolini M, 2008, ANTIVIR THER, V13, P1097; Nakata H, 2007, ANTIMICROB AGENTS CH, V51, P2701, DOI 10.1128/AAC.00277-07; Nitanda T, 2005, ANTIMICROB AGENTS CH, V49, P3355, DOI 10.1128/AAC.49.8.3355-3360.2005; Ohrui Hiroshi, 2001, Current Drug Targets - Infectious Disorders, V1, P1, DOI 10.2174/1568005013343218; Ohrui Hiroshi, 2006, Nucleic Acids Symp Ser (Oxf), P1; Parniak M A, 2000, Adv Pharmacol, V49, P67; Quan YD, 1998, NUCLEIC ACIDS RES, V26, P5692, DOI 10.1093/nar/26.24.5692; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; Sarafianos SG, 2009, J MOL BIOL, V385, P693, DOI 10.1016/j.jmb.2008.10.071; Schinazi RF, 2006, ANTIVIR RES, V71, P322, DOI 10.1016/j.antiviral.2006.03.012; Sharma PL, 2004, CURR TOP MED CHEM, V4, P895, DOI 10.2174/1568026043388484; Siddiqui MA, 2004, J MED CHEM, V47, P5041, DOI 10.1021/jm049550o; Sluis-Cremer N, 2005, J BIOL CHEM, V280, P29047, DOI 10.1074/jbc.M503166200; Sluis-Cremer N, 2000, CELL MOL LIFE SCI, V57, P1408, DOI 10.1007/PL00000626; Sluis-Cremer N, 2008, VIRUS RES, V134, P147, DOI 10.1016/j.virusres.2008.01.002; STEWART JJP, 1989, J COMPUT CHEM, V10, P209, DOI 10.1002/jcc.540100208; Strerath M, 2002, J AM CHEM SOC, V124, P11230, DOI 10.1021/ja027060k; Summerer D, 2005, BIOORG MED CHEM LETT, V15, P869, DOI 10.1016/j.bmcl.2004.12.072; Tanaka Hiromichi, 2005, Antiviral Chemistry & Chemotherapy, V16, P217; Tchesnokov EP, 2008, J BIOL CHEM, V283, P34218, DOI 10.1074/jbc.M806797200; Tong WJ, 1997, BIOCHEMISTRY-US, V36, P5749, DOI 10.1021/bi962410z; Tuske S, 2004, NAT STRUCT MOL BIOL, V11, P469, DOI 10.1038/nsmb760; White KL, 2006, ANTIVIR THER, V11, P155; Yang GW, 2008, ANTIMICROB AGENTS CH, V52, P2035, DOI 10.1128/AAC.00083-08; Yang GW, 2007, ANTIVIR RES, V73, P185, DOI 10.1016/j.antiviral.2006.10.002	50	98	100	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35681	35691		10.1074/jbc.M109.036616	http://dx.doi.org/10.1074/jbc.M109.036616			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19837673	Green Published, hybrid			2022-12-25	WOS:000272645600046
J	Villalonga, P; de Mattos, SF; Ridley, AJ				Villalonga, Priam; Fernandez de Mattos, Silvia; Ridley, Anne J.			RhoE Inhibits 4E-BP1 Phosphorylation and eIF4E Function Impairing Cap-dependent Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-MYC; ROCK-I; ACTIN CYTOSKELETON; PROTEIN-SYNTHESIS; BINDING PARTNER; MTOR; EIF-4E; EXPRESSION; RAPTOR; OVEREXPRESSION	The Rho GTPase family member RhoE inhibits RhoA/ROCK signaling to promote actin stress fiber and focal adhesion disassembly. We have previously reported that RhoE also inhibits cell cycle progression and Ras-induced transformation, specifically preventing cyclin D1 translation. Here we investigate the molecular mechanisms underlying those observations. RhoE inhibits the phosphorylation of the translational repressor 4E-BP1 in response to extracellular stimuli. However, RhoE does not affect the activation of mTOR, the major kinase regulating 4E-BP1 phosphorylation, as indicated by the phosphorylation levels of the mTOR substrate S6K, the dynamics of mTOR/Raptor association, and the observation that RhoE, as opposed to rapamycin, does not impair cellular growth. Interestingly, RhoE prevents the release of the eukaryotic initiation factor eIF4E from 4E-BP1, inhibiting cap-dependent translation. Accordingly, RhoE also inhibits the expression and the transcriptional activity of the eIF4E target c-Myc. Consistent with its crucial role in cell proliferation, we show that eIF4E can rescue both cell cycle progression and Ras-induced transformation in RhoE-expressing cells, indicating that the inhibition of eIF4E function is critical to mediate the anti-proliferative effects of RhoE.	[Villalonga, Priam; Fernandez de Mattos, Silvia] Univ Illes Balears, Inst Univ Invest Ciencies Salut IUNICS, Canc Cell Biol Grp, E-07122 Illes Balears, Spain; UCL, Ludwig Inst Canc Res, London W1W 7BS, England; [Villalonga, Priam; Fernandez de Mattos, Silvia] Univ Illes Balears, Dept Biol Fonamental, E-07122 Illes Balears, Spain; [Ridley, Anne J.] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England	Universitat de les Illes Balears; Ludwig Institute for Cancer Research; University of London; University College London; Universitat de les Illes Balears; University of London; King's College London	Villalonga, P (corresponding author), Univ Illes Balears, Inst Univ Invest Ciencies Salut IUNICS, Canc Cell Biol Grp, Edifici Cient Tecn,Ctra Valldemossa Km 7-5, E-07122 Illes Balears, Spain.	priam.villalonga@uib.es	Villalonga, Priam/K-4350-2014; de Mattos, Silvia Fernández/K-5153-2014	Villalonga, Priam/0000-0002-7190-6884; de Mattos, Silvia Fernández/0000-0003-4144-3687; Ridley, Anne/0000-0001-8186-5708	AICR Project Grant; Spanish "Ministerio de Educacion y Ciencia"; "Junta de Balears-AECC"; BBSRC [BB/E004083/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E004083/2] Funding Source: researchfish	AICR Project Grant; Spanish "Ministerio de Educacion y Ciencia"(Spanish Government); "Junta de Balears-AECC"; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by an AICR Project Grant (to A.J.R. and P.V.), a Ramon y Cajal fellowship from the Spanish "Ministerio de Educacion y Ciencia" (to P. V.), and funding from the "Junta de Balears-AECC" (to P.V.).; <SUP>1</SUP> A Ramon y Cajal Fellow (Ministerio de Ciencia e Innovacion, Spain). To whom correspondence should be addressed: Institut Universitari d'Investigacio en Ciencies de la Salut (IUNICS), Edifici Cientificotecnic, Ctra. Valldemossa Km7.5, Illes Balears, Spain. Tel.: 34-971-173004; Fax: 34-971-259501; E-mail: priam.villalonga@uib.es.; <SUP>2</SUP> A Ramon y Cajal Fellow (Ministerio de Ciencia e Innovacion, Spain).	Bektic J, 2005, PROSTATE, V64, P332, DOI 10.1002/pros.20243; Bjornsti MA, 2004, CANCER CELL, V5, P519, DOI 10.1016/j.ccr.2004.05.027; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carter PS, 1999, ONCOGENE, V18, P4326, DOI 10.1038/sj.onc.1202890; Chardin P, 2006, NAT REV MOL CELL BIO, V7, P54, DOI 10.1038/nrm1788; Chardin P, 2003, CURR BIOL, V13, pR702, DOI 10.1016/j.cub.2003.08.042; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Gingras AC, 2001, GENE DEV, V15, P2852; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Guasch RM, 1998, MOL CELL BIOL, V18, P4761, DOI 10.1128/MCB.18.8.4761; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Heesom KJ, 2001, CURR BIOL, V11, P1374, DOI 10.1016/S0960-9822(01)00422-5; Herbert TP, 2002, J BIOL CHEM, V277, P11591, DOI 10.1074/jbc.M110367200; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KOROMILAS AE, 1992, EMBO J, V11, P4153, DOI 10.1002/j.1460-2075.1992.tb05508.x; LAZARISKARATZAS A, 1992, MOL CELL BIOL, V12, P1234, DOI 10.1128/MCB.12.3.1234; Li BDL, 1997, CANCER-AM CANCER SOC, V79, P2385; Lin CJ, 2008, CANCER RES, V68, P5326, DOI 10.1158/0008-5472.CAN-07-5876; Lynch M, 2004, J BIOL CHEM, V279, P3327, DOI 10.1074/jbc.M310872200; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Ongusaha PP, 2006, CURR BIOL, V16, P2466, DOI 10.1016/j.cub.2006.10.056; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poch E, 2007, EXP CELL RES, V313, P719, DOI 10.1016/j.yexcr.2006.11.006; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Riento K, 2005, EMBO J, V24, P1170, DOI 10.1038/sj.emboj.7600612; Riento K, 2003, MOL CELL BIOL, V23, P4219, DOI 10.1128/MCB.23.12.4219-4229.2003; Riento K, 2005, BIOCHEM SOC T, V33, P649, DOI 10.1042/BST0330649; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; Rosenwald IB, 1999, ONCOGENE, V18, P2507, DOI 10.1038/sj.onc.1202563; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Stoneley M, 2000, MOL CELL BIOL, V20, P1162, DOI 10.1128/MCB.20.4.1162-1169.2000; Stoneley M, 2000, NUCLEIC ACIDS RES, V28, P687, DOI 10.1093/nar/28.3.687; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Vervoorts J, 2003, EMBO REP, V4, P484, DOI 10.1038/sj.embor.embor821; Villalonga P, 2004, MOL CELL BIOL, V24, P7829, DOI 10.1128/MCB.24.18.7829-7840.2004; Villalonga P, 2006, GROWTH FACTORS, V24, P159, DOI 10.1080/08977190600560651; Wennerberg K, 2003, CURR BIOL, V13, P1106, DOI 10.1016/S0960-9822(03)00418-4; Zhang CY, 2007, ANN SURG ONCOL, V14, P2628, DOI 10.1245/s10434-007-9457-x	46	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35287	35296		10.1074/jbc.M109.050120	http://dx.doi.org/10.1074/jbc.M109.050120			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850923	hybrid, Green Published			2022-12-25	WOS:000272645600005
J	Wilczek, C; Chayka, O; Plachetka, A; Klempnauer, KH				Wilczek, Carola; Chayka, Olesya; Plachetka, Annette; Klempnauer, Karl-Heinz			Myb-induced Chromatin Remodeling at a Dual Enhancer/Promoter Element Involves Non-coding RNA Transcription and Is Disrupted by Oncogenic Mutations of v-myb	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; C-MYB; POINT MUTATIONS; MIM-1 GENE; C/EBP-BETA; SYNERGISTIC ACTIVATION; TARGET GENE; A-MYB; CELLS; DIFFERENTIATION	The oncogene v-myb of avian myeloblastosis virus (AMV) encodes a transcription factor (v-Myb) that transforms myelomonocytic cells by deregulating the expression of specific target genes. v-myb has acquired its oncogenic potential by truncation as well as by a number of point mutations of its cellular progenitor c-myb. As a result of these changes, the target gene spectrum v-Myb differs from that of c-Myb. We recently showed that the chicken mim-1 gene, a c-Myb target gene that is not activated by v-Myb harbors a powerful cell type-specific and Myb-inducible enhancer in addition to a Myb-responsive promoter. We now show that Myb-dependent activation of the mim-1 gene is accompanied by extensive remodeling of the nucleosomal architecture at the enhancer. We found that the mim-1 enhancer region also harbors a promoter whose activity is stimulated by Myb and which directs the transcription of an apparently non-coding RNA. Furthermore, our data show that the oncogenic mutations of AMV have disrupted the ability of v-Myb to induce remodeling of chromatin structure at the mim-1 enhancer. Together, our results demonstrate for the first time directly that Myb induces alterations of the nucleosomal organization at a relevant target site and provide new insight into the functional consequences of the oncogenic amino acid substitutions.	[Wilczek, Carola; Chayka, Olesya; Plachetka, Annette; Klempnauer, Karl-Heinz] Univ Munster, Inst Biochem, D-48149 Munster, Germany	University of Munster	Klempnauer, KH (corresponding author), Univ Munster, Inst Biochem, Wilhlem Klemm Str 2, D-48149 Munster, Germany.	klempna@uni-muenster.de			Deutsche Forschungsgemeinschaft; Graduate School of Chemistry (GSC-MS)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Graduate School of Chemistry (GSC-MS)	This work was supported in part by the Deutsche Forschungsgemeinschaft and by fellowships from the Graduate School of Chemistry (GSC-MS) (to O.C. and A.P.).	BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; Brendeford EM, 1997, J BIOL CHEM, V272, P4436, DOI 10.1074/jbc.272.7.4436; BURK O, 1993, EMBO J, V12, P2027, DOI 10.1002/j.1460-2075.1993.tb05852.x; BURK O, 1991, EMBO J, V10, P3713, DOI 10.1002/j.1460-2075.1991.tb04939.x; Burk O, 1997, EMBO J, V16, P1371, DOI 10.1093/emboj/16.6.1371; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chayka O, 2005, MOL CELL BIOL, V25, P499, DOI 10.1128/MCB.25.1.499-511.2005; Chen J, 2006, ONCOGENE, V25, P2758, DOI 10.1038/sj.onc.1209295; De Guzman RN, 2006, J MOL BIOL, V355, P1005, DOI 10.1016/j.jmb.2005.09.059; DINI PW, 1995, J VIROL, V69, P2515, DOI 10.1128/JVI.69.4.2515-2524.1995; Facchinetti V, 1997, BIOCHEM J, V324, P729, DOI 10.1042/bj3240729; IBANEZ CE, 1990, MOL CELL BIOL, V10, P2285, DOI 10.1128/MCB.10.5.2285; INTRONA M, 1990, CELL, V63, P1287, DOI 10.1016/0092-8674(90)90424-D; Ivanova O, 2007, NUCLEIC ACIDS RES, V35, P7237, DOI 10.1093/nar/gkm675; KLEMPNAUER KH, 1989, GENE DEV, V3, P1582, DOI 10.1101/gad.3.10.1582; KLEMPNAUER KH, 1983, CELL, V33, P345, DOI 10.1016/0092-8674(83)90416-6; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lang G, 2005, ONCOGENE, V24, P1375, DOI 10.1038/sj.onc.1208301; Lefevre P, 2008, MOL CELL, V32, P129, DOI 10.1016/j.molcel.2008.07.023; Leverson JD, 1998, MOL CELL, V1, P203, DOI 10.1016/S1097-2765(00)80021-0; Lipsick JS, 1999, ONCOGENE, V18, P3047, DOI 10.1038/sj.onc.1202745; Liu F, 2006, ONCOGENE, V25, P795, DOI 10.1038/sj.onc.1209105; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Mink S, 1996, MOL CELL BIOL, V16, P1316; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Mo XM, 2005, GENE DEV, V19, P2447, DOI 10.1101/gad.355405; NESS SA, 1993, GENE DEV, V7, P749, DOI 10.1101/gad.7.5.749; NESS SA, 1989, CELL, V59, P1115, DOI 10.1016/0092-8674(89)90767-8; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Plachetka A, 2008, MOL CELL BIOL, V28, P2102, DOI 10.1128/MCB.01943-07; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Rushton JJ, 2003, ONCOGENE, V22, P308, DOI 10.1038/sj.onc.1206131; Schlichter U, 2001, ONCOGENE, V20, P231, DOI 10.1038/sj.onc.1204071; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; WESTON K, 1989, CELL, V58, P85, DOI 10.1016/0092-8674(89)90405-4; Worpenberg S, 1997, ONCOGENE, V15, P213, DOI 10.1038/sj.onc.1201179; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038	37	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35314	35324		10.1074/jbc.M109.066175	http://dx.doi.org/10.1074/jbc.M109.066175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19841477	hybrid, Green Published			2022-12-25	WOS:000272645600008
J	Zhu, K; Zhang, YM; Rock, CO				Zhu, Kun; Zhang, Yong-Mei; Rock, Charles O.			Transcriptional Regulation of Membrane Lipid Homeostasis in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; FATTY-ACID BIOSYNTHESIS; ANTIBIOTIC-ACTIVITY; ENZYMATIC-SYNTHESIS; DEACETYLASE LPXC; GENE-EXPRESSION; COENZYME-A; FADR; INHIBITION; METABOLISM	The biophysical properties of membrane phospholipids are controlled by the composition of their constituent fatty acids and are tightly regulated in Escherichia coli. The FabR (fatty acid biosynthesis repressor) transcriptional repressor controls the proportion of unsaturated fatty acids in the membrane by regulating the expression of the fabB (beta-ketoacyl-ACP synthase I) and fabA (beta-hydroxydecanoyl-ACP dehydratase/isomerase) genes. FabR binding to a DNA palindrome located within the promoters of the fabB and fabA genes required the presence of an unsaturated acyl-acyl carrier protein (ACP) or acyl-CoA and was antagonized by saturated acyl-ACP or acyl-CoA. The FabR-dependent repression of fabB and fabA by exogenous unsaturated fatty acids confirmed the role for FabR in responding to the acyl-CoA pool composition, and the perturbation of the unsaturated: saturated acyl-ACP ratio using a specific inhibitor of lipid A formation verified FabR-dependent regulation of fabB by the acyl-ACP composition in vivo. Thus, FabR plays a key role in controlling the membrane biophysical properties by regulating gene expression in response to the composition of the long-chain acyl-thioester pool. This mechanism ensures that a balanced composition of fatty acids is available for incorporation into the membrane via the PlsB/PlsC acyltransferases.	[Zhu, Kun; Zhang, Yong-Mei; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	charles.rock@stjude.org			National Institutes of Health [GM 34496]; Cancer Center (CORE) [CA 21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034496, R01GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center (CORE); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM 34496, Cancer Center (CORE) Support Grant CA 21765, and the American Lebanese Syrian Associated Charities.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barb AW, 2007, P NATL ACAD SCI USA, V104, P18433, DOI 10.1073/pnas.0709412104; Barb AW, 2007, BIOCHEMISTRY-US, V46, P3793, DOI 10.1021/bi6025165; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOOTH BR, 1980, BIOCHEM BIOPH RES CO, V94, P1029, DOI 10.1016/0006-291X(80)90522-7; Campbell JW, 2002, J BACTERIOL, V184, P3759, DOI 10.1128/JB.184.13.3759-3764.2002; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; CRONAN JE, 2008, ECOSALESCHERICHIA CO; DAGNOLO G, 1973, BIOCHIM BIOPHYS ACTA, V326, P155, DOI 10.1016/0005-2760(73)90241-5; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Feng YJ, 2009, J BIOL CHEM, V284, P29526, DOI 10.1074/jbc.M109.023440; HENRY MF, 1992, CELL, V70, P671, DOI 10.1016/0092-8674(92)90435-F; Hutter B, 2004, ANTIMICROB AGENTS CH, V48, P2838, DOI 10.1128/AAC.48.8.2838-2844.2004; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; JACKOWSKI S, 1983, J BIOL CHEM, V258, P5186; JACKOWSKI S, 1987, J BIOL CHEM, V262, P7927; Jerga A, 2009, J BIOL CHEM, V284, P15364, DOI 10.1074/jbc.C109.002410; KASS LR, 1967, P NATL ACAD SCI USA, V58, P1168, DOI 10.1073/pnas.58.3.1168; LAU C, 1983, J BIOL CHEM, V258, P3027; Lu YJ, 2006, MOL MICROBIOL, V59, P551, DOI 10.1111/j.1365-2958.2005.04951.x; McClerren AL, 2005, BIOCHEMISTRY-US, V44, P16574, DOI 10.1021/bi0518186; RAMAN N, 1995, J BIOL CHEM, V270, P1092, DOI 10.1074/jbc.270.3.1092; ROCK CO, 1979, J BIOL CHEM, V254, P7123; ROCK CO, 1982, J BIOL CHEM, V257, P10759; Schujman GE, 2003, DEV CELL, V4, P663, DOI 10.1016/S1534-5807(03)00123-0; Schujman GE, 2008, MOL MICROBIOL, V68, P987, DOI 10.1111/j.1365-2958.2008.06202.x; Schujman GE, 2006, EMBO J, V25, P4074, DOI 10.1038/sj.emboj.7601284; VALLARI DS, 1987, J BIOL CHEM, V262, P2468; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200; Zhang YM, 2002, J BIOL CHEM, V277, P15558, DOI 10.1074/jbc.M201399200; Zhang YM, 2008, J LIPID RES, V49, P1867, DOI 10.1194/jlr.R800005-JLR200; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhang YM, 2007, MOL MICROBIOL, V66, P622, DOI 10.1111/j.1365-2958.2007.05934.x; Zhu K, 2006, MOL MICROBIOL, V60, P260, DOI 10.1111/j.1365-2958.2006.05088.x	37	54	58	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34880	34888		10.1074/jbc.M109.068239	http://dx.doi.org/10.1074/jbc.M109.068239			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19854834	hybrid, Green Published			2022-12-25	WOS:000272439600043
J	Wang, XF; Lin, G; Martins-Taylor, K; Zeng, H; Xu, RH				Wang, Xiaofang; Lin, Ge; Martins-Taylor, Kristen; Zeng, Hui; Xu, Ren-He			Inhibition of Caspase-mediated Anoikis Is Critical for Basic Fibroblast Growth Factor-sustained Culture of Human Pluripotent Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAINTAIN PLURIPOTENCY; INDUCED APOPTOSIS; SELF-RENEWAL; DIFFERENTIATION; FGF; MAINTENANCE; DERIVATION; PATHWAYS; SURVIVAL	Apoptosis and proliferation are two dynamically and tightly regulated processes that together maintain the homeostasis of renewable tissues. Anoikis is a subtype of apoptosis induced by detachment of adherent cells from the extracellular matrix. By using the defined mTeSR1 medium and collecting freshly detached cells, we found here that human pluripotent stem (PS) cells including embryonic stem (ES) cells and induced pluripotent stem cells are subject to constant anoikis in culture, which is escalated in the absence of basic fibroblast growth factor (bFGF). Withdrawal of bFGF also promotes apoptosis and differentiation of the remaining adherent cells without affecting their cell cycle progression. Insulinlike growth factor 2 (IGF2) has previously been reported to act downstream of FGF signaling to support self-renewal of human ES cells. However, we found that IGF2 cannot substitute bFGF in the TeSR1-supported culture, although endogenous IGF signaling is required to sustain self-renewal of human ES cells. On the other hand, all of the bFGF withdrawal effects observed here can be markedly prevented by the caspase inhibitor z-VAD-FMK. We further demonstrated that the bFGF-repressed anoikis is dependent on activation of ERK and AKT and associated with inhibition of Bcl-2-interacting mediator of cell death and the caspase-ROCK1-myosin signaling. Anoikis is independent of pre-detachment apoptosis and differentiation of the cells. Because previous studies of human PS cells have been focused on attached cells, our findings revealed a neglected role of bFGF in sustaining self-renewal of human PS cells: preventing them from anoikis via inhibition of caspase activation.	[Wang, Xiaofang; Lin, Ge; Martins-Taylor, Kristen; Zeng, Hui; Xu, Ren-He] Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Genet & Dev Biol, Farmington, CT 06030 USA; [Zeng, Hui] Cent S Univ, Xiang Ya Hosp, Dept Hematol, Changsha 410008, Hunan, Peoples R China	University of Connecticut; Central South University	Xu, RH (corresponding author), Univ Connecticut, Ctr Hlth, Stem Cell Inst, Dept Genet & Dev Biol, 263 Farmington Ave, Farmington, CT 06030 USA.	renhexu@uchc.edu	Xu, Ren-He/AAK-7392-2021; Xu, Ren-He/M-3125-2016	Martins-Taylor, Kristen/0000-0002-7004-5867	Connecticut Stem Cell Research Grants [06SCB14, 06SCD02]	Connecticut Stem Cell Research Grants	This work was supported by Connecticut Stem Cell Research Grants 06SCB14 and 06SCD02 (to R.X.).	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Dvorak P, 2005, FOLIA HISTOCHEM CYTO, V43, P203; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Filipczyk AA, 2007, STEM CELL RES, V1, P45, DOI 10.1016/j.scr.2007.09.002; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Kang HB, 2005, STEM CELLS DEV, V14, P395, DOI 10.1089/scd.2005.14.395; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; MASON IJ, 1994, CELL, V78, P547, DOI 10.1016/0092-8674(94)90520-7; Mayshar Y, 2008, STEM CELLS, V26, P767, DOI 10.1634/stemcells.2007-1037; McDevitt TC, 2008, CURR OPIN BIOTECH, V19, P527, DOI 10.1016/j.copbio.2008.08.005; Mills JC, 1999, J CELL BIOL, V146, P703, DOI 10.1083/jcb.146.4.703; Minambres R, 2006, J CELL SCI, V119, P271, DOI 10.1242/jcs.02723; Peluso JJ, 2003, BIOCHEM PHARMACOL, V66, P1363, DOI 10.1016/S0006-2952(03)00486-6; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Valentijn AJ, 2004, BIOCHEM SOC T, V32, P421, DOI 10.1042/BST0320421; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeng H, 2009, STEM CELLS, V27, P2435, DOI 10.1002/stem.192	43	54	60	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34054	34064		10.1074/jbc.M109.052290	http://dx.doi.org/10.1074/jbc.M109.052290			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19828453	Green Published, hybrid			2022-12-25	WOS:000272165200038
J	Pan, D; Zhang, LQ				Pan, Deng; Zhang, Liqing			An Atlas of the Speed of Copy Number Changes in Animal Gene Families and Its Implications	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; COMPARATIVE GENOMICS; SEQUENCE DIVERGENCE; DNA LOSS; EVOLUTION; DUPLICATION; EUKARYOTES; EXPANSION; REVEALS; MAMMALS	The notion that gene duplications generating new genes and functions is commonly accepted in evolutionary biology. However, this assumption is more speculative from theory rather than well proven in genome-wide studies. Here, we generated an atlas of the rate of copy number changes (CNCs) in all the gene families of ten animal genomes. We grouped the gene families with similar CNC dynamics into rate pattern groups (RPGs) and annotated their function using a novel bottom-up approach. By comparing CNC rate patterns, we showed that most of the species-specific CNC rates groups are formed by gene duplication rather than gene loss, and most of the changes in rates of CNCs may be the result of adaptive evolution. We also found that the functions of many RPGs match their biological significance well. Our work confirmed the role of gene duplication in generating novel phenotypes, and the results can serve as a guide for researchers to connect the phenotypic features to certain gene duplications.			Pan, D (corresponding author), Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA.	lqzhang@vt.edu	Pan, Deng/F-1794-2011					Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Bai YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r11; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Danchin EGJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-5; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Furano AV, 2004, TRENDS GENET, V20, P9, DOI 10.1016/j.tig.2003.11.006; Graves JAM, 2002, TRENDS GENET, V18, P517, DOI 10.1016/S0168-9525(02)02772-5; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Harrison PM, 2003, NUCLEIC ACIDS RES, V31, P1033, DOI 10.1093/nar/gkg169; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Jiang J., 1998, P INT C RES COMP LIN; Karuppasamy M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r52; Killian JK, 2001, MAMM GENOME, V12, P513, DOI 10.1007/s003350020026; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Lopez-Bigas N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r33; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Pan D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r158; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Petrov DA, 1998, MOL BIOL EVOL, V15, P293, DOI 10.1093/oxfordjournals.molbev.a025926; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; R Development Core Team, 2006, R LANG ENV STAT COMP; Raible F, 2004, CURR BIOL, V14, pR106, DOI 10.1016/j.cub.2004.01.015; Roest Crollius H, 2005, GENOME RES, V15, P1675, DOI 10.1101/gr.3735805; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Wakefield MJ, 2003, EMBO REP, V4, P143, DOI 10.1038/sj.embor.embor739; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	34	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7342	10.1371/journal.pone.0007342	http://dx.doi.org/10.1371/journal.pone.0007342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851465	gold, Green Published, Green Submitted			2022-12-25	WOS:000271022300001
J	Zanic, M; Stear, JH; Hyman, AA; Howard, J				Zanic, Marija; Stear, Jeffrey H.; Hyman, Anthony A.; Howard, Jonathon			EB1 Recognizes the Nucleotide State of Tubulin in the Microtubule Lattice	PLOS ONE			English	Article							PLUS-END TRACKING; DYNAMICS; PROTEIN; COMPLEX; GTP; FORMS; MCAK	Plus-end-tracking proteins (+TIPs) are localized at the fast-growing, or plus end, of microtubules, and link microtubule ends to cellular structures. One of the best studied +TIPs is EB1, which forms comet-like structures at the tips of growing microtubules. The molecular mechanisms by which EB1 recognizes and tracks growing microtubule ends are largely unknown. However, one clue is that EB1 can bind directly to a microtubule end in the absence of other proteins. Here we use an in vitro assay for dynamic microtubule growth with two-color total-internal-reflection-fluorescence imaging to investigate binding of mammalian EB1 to both stabilized and dynamic microtubules. We find that under conditions of microtubule growth, EB1 not only tip tracks, as previously shown, but also preferentially recognizes the GMPCPP microtubule lattice as opposed to the GDP lattice. The interaction of EB1 with the GMPCPP microtubule lattice depends on the E-hook of tubulin, as well as the amount of salt in solution. The ability to distinguish different nucleotide states of tubulin in microtubule lattice may contribute to the end-tracking mechanism of EB1.			Zanic, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	howard@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Howard, Jonathon/J-7492-2016; Hyman, Tony/F-1923-2011; Howard, Jonathon/D-4229-2011	Hyman, Anthony A/0000-0003-3664-154X; Howard, Jonathon/0000-0003-0086-1196; Howard, Jonathon/0000-0003-0086-1196; Zanic, Marija/0000-0002-5127-5819; Stear, Jeffrey/0000-0002-2255-8297				Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Ashford AJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P205; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005; des Georges A, 2008, NAT STRUCT MOL BIOL, V15, P1102, DOI 10.1038/nsmb.1482; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Sandall S, 2006, CELL, V127, P1179, DOI 10.1016/j.cell.2006.09.049; Severin FF, 1997, NATURE, V388, P888, DOI 10.1038/42270; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019	21	115	115	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7585	10.1371/journal.pone.0007585	http://dx.doi.org/10.1371/journal.pone.0007585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851462	Green Published, gold, Green Submitted			2022-12-25	WOS:000271022300016
J	Johansen, KK; Wang, L; Aasly, JO; White, LR; Matson, WR; Henchcliffe, C; Beal, MF; Bogdanov, M				Johansen, Krisztina K.; Wang, Lei; Aasly, Jan O.; White, Linda R.; Matson, Wayne R.; Henchcliffe, Claire; Beal, M. Flint; Bogdanov, Mikhail			Metabolomic Profiling in LRRK2-Related Parkinson's Disease	PLOS ONE			English	Article								Background: Mutations in LRRK2 gene represent the most common known genetic cause of Parkinson's disease (PD). Methodology/Principal Findings: We used metabolomic profiling to identify biomarkers that are associated with idiopathic and LRRK2 PD. We compared plasma metabolomic profiles of patients with PD due to the G2019S LRRK2 mutation, to asymptomatic family members of these patients either with or without G2019S LRRK2 mutations, and to patients with idiopathic PD, as well as non-related control subjects. We found that metabolomic profiles of both idiopathic PD and LRRK2 PD subjects were clearly separated from controls. LRRK2 PD patients had metabolomic profiles distinguishable from those with idiopathic PD, and the profiles could predict whether the PD was secondary to LRRK2 mutations or idiopathic. Metabolomic profiles of LRRK2 PD patients were well separated from their family members, but there was a slight overlap between family members with and without LRRK2 mutations. Both LRRK2 and idiopathic PD patients showed significantly reduced uric acid levels. We also found a significant decrease in levels of hypoxanthine and in the ratios of major metabolites of the purine pathway in plasma of PD patients. Conclusions/Significance: These findings show that LRRK2 patients with the G2019S mutation have unique metabolomic profiles that distinguish them from patients with idiopathic PD. Furthermore, asymptomatic LRRK2 carriers can be separated from gene negative family members, which raises the possibility that metabolomic profiles could be useful in predicting which LRRK2 carriers will eventually develop PD. The results also suggest that there are aberrations in the purine pathway in PD which may occur upstream from uric acid.			Johansen, KK (corresponding author), Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway.	mbb2002@med.cornell.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS060262] Funding Source: NIH RePORTER; NINDS NIH HHS [1R21NS060262, R21 NS060262] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aasly JO, 2005, ANN NEUROL, V57, P762, DOI 10.1002/ana.20456; Annanmaki T, 2007, MOVEMENT DISORD, V22, P1133, DOI 10.1002/mds.21502; ASCHERIO A, 2009, ARCH NEUROL; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Bras JM, 2005, MOVEMENT DISORD, V20, P1653, DOI 10.1002/mds.20682; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Brucke T, 2000, J NEUROL, V247, P2; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; Di Leo A, 2007, ANN ONCOL, V18, P8, DOI 10.1093/annonc/mdm533; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Eriksson L., 2001, MULTI MEGAVARIATE DA; Gamache PH, 2004, J AM SOC MASS SPECTR, V15, P1717, DOI 10.1016/j.jasms.2004.08.016; Gao X, 2008, AM J EPIDEMIOL, V167, P831, DOI 10.1093/aje/kwm385; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goldwurm S, 2006, PARKINSONISM RELAT D, V12, P410, DOI 10.1016/j.parkreldis.2006.04.001; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; Griffin JL, 2006, PHARMACOGENOMICS, V7, P1095, DOI 10.2217/14622416.7.7.1095; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Holmes E, 2006, PLOS MED, V3, P1420, DOI 10.1371/journal.pmed.0030327; Khan NL, 2005, BRAIN, V128, P2786, DOI 10.1093/brain/awh667; Kim YJ, 2002, MOVEMENT DISORD, V17, P303, DOI 10.1002/mds.10042; Klein C, 2007, NEUROLOGY, V69, P2093, DOI 10.1212/01.wnl.0000271880.27321.a7; Kristal BS, 1998, ANAL BIOCHEM, V263, P18, DOI 10.1006/abio.1998.2831; Kristal BS, 1999, ARCH BIOCHEM BIOPHYS, V370, P22, DOI 10.1006/abbi.1999.1387; Lesage S, 2005, ANN NEUROL, V58, P784, DOI 10.1002/ana.20636; LEWITT PA, 1992, NEUROLOGY, V42, P2111, DOI 10.1212/WNL.42.11.2111; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Rozen S, 2005, METABOLOMICS, V1, P101, DOI 10.1007/s11306-005-4810-1; Rubingh CM, 2006, METABOLOMICS, V2, P53, DOI 10.1007/s11306-006-0022-6; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Shi HL, 2002, ANAL BIOCHEM, V302, P239, DOI 10.1006/abio.2001.5568; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Underwood BR, 2006, BRAIN, V129, P877, DOI 10.1093/brain/awl027; Vigneau-Callahan KE, 2001, J NUTR, V131, p924S, DOI 10.1093/jn/131.3.924S; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6	40	119	125	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7551	10.1371/journal.pone.0007551	http://dx.doi.org/10.1371/journal.pone.0007551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847307	Green Published, Green Submitted, gold			2022-12-25	WOS:000271022000015
J	Becquet, R; Bland, R; Leroy, V; Rollins, NC; Ekouevi, DK; Coutsoudis, A; Dabis, F; Coovadia, HM; Salamon, R; Newell, ML				Becquet, Renaud; Bland, Ruth; Leroy, Valeriane; Rollins, Nigel C.; Ekouevi, Didier K.; Coutsoudis, Anna; Dabis, Francois; Coovadia, Hoosen M.; Salamon, Roger; Newell, Marie-Louise			Duration, Pattern of Breastfeeding and Postnatal Transmission of HIV: Pooled Analysis of Individual Data from West and South African Cohorts	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-DOSE NEVIRAPINE; COTE-DIVOIRE; UNINFECTED WOMEN; INFECTED MOTHERS; RANDOMIZED-TRIAL; POTENTIAL METHOD; DITRAME PLUS; ZIDOVUDINE	Background: Both breastfeeding pattern and duration are associated with postnatal HIV acquisition; their relative contribution has not been reliably quantified. Methodology and Principal Findings: Pooled data from 2 cohorts: in urban West Africa where breastfeeding cessation at 4 months was recommended but exclusive breastfeeding was rare (Ditrame Plus, DP); in rural South Africa where high rates of exclusive breastfeeding were achieved, but with longer duration (Vertical Transmission Study, VTS). 18-months HIV postnatal transmission (PT) was estimated by Kaplan-Meier in infants who were HIV negative, and assumed uninfected, at age >1 month. Censoring with (to assess impact of mode of breastfeeding) and without (to assess effect of breastfeeding duration) breastfeeding cessation considered as a competing event. Of 1195 breastfed infants, not HIV-infected perinatally, 38% DP and 83% VTS children were still breastfed at age 6 months. By age 3 months, 66% of VTS children were exclusively breastfed since birth and 55% of DP infants predominantly breastfed (breastmilk+water-based drinks). 18-month PT risk (95% CI) in VTS was double that in DP: 9% (7-11) and 5% (3-8), respectively (p = 0.03). However, once duration of breastfeeding was allowed for in a competing risk analysis assuming that all children would have been breastfed for 18-month, the estimated PT risk was 16% (8-28) in DP and 14% (10-18) in VTS (p = 0.32). 18-months PT risk was 3.9% (2.3-6.5) among infants breastfed for less than 6 months, and 8.7% (6.8-11.0) among children breastfed for more than 6 months; crude hazard ratio (HR): 2.1 (1.2-3.7), p = 0.02; adjusted HR 1.8 (0.9-3.4), p = 0.06. In individual analyses of PT rates for specific breastfeeding durations, risks among children exclusively breastfed were very similar to those in children predominantly breastfed for the same period. Children exposed to solid foods during the first 2 months of life were 2.9 (1.1-8.0) times more likely to be infected postnatally than children never exposed to solids this early (adjusted competing risk analysis, p = 0.04). Conclusions: Breastfeeding duration is a major determinant of postnatal HIV transmission. The PT risk did not differ between exclusively and predominantly breastfed children; the negative effect of mixed breastfeeding with solids on PT were confirmed.			Becquet, R (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa.	Renaud.Becquet@isped.u-bordeaux2.fr	EKOUEVI, Didier K/E-7960-2014; DABIS, FRANCOIS/S-9298-2019; Leroy, Valeriane/F-8129-2013; Becquet, Renaud/F-4837-2013; Newell, Marie-Louise/AAE-8222-2019; Leroy, Valeriane/GQB-1102-2022; Leroy, Valeriane/AAO-5175-2020	DABIS, FRANCOIS/0000-0002-1614-8857; Leroy, Valeriane/0000-0003-3542-8616; Becquet, Renaud/0000-0003-3277-0985; Newell, Marie-Louise/0000-0002-1074-7699; Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Bland, Ruth/0000-0003-1675-9268	Wellcome Trust [063009/Z/00/2, 050524] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alioum A, 2003, AM J EPIDEMIOL, V158, P596, DOI 10.1093/aje/kwg188; Alioum A, 2001, STAT MED, V20, P3539, DOI 10.1002/sim.1076; Bahl R, 2005, B WORLD HEALTH ORGAN, V83, P418; Becquet R, 2006, PEDIATRICS, V117, pE701, DOI 10.1542/peds.2005-1911; Becquet R, 2005, JAIDS-J ACQ IMM DEF, V40, P600, DOI 10.1097/01.qai.0000171726.17436.82; BECQUET R, 2007, FUTURE HIV THERAPY, V1, P17; Becquet R, 2007, CURR OPIN HIV AIDS, V2, P361, DOI 10.1097/COH.0b013e3282cecef4; Becquet R, 2007, PLOS MED, V4, P139, DOI 10.1371/journal.pmed.0040017; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Bland RM, 2007, CLIN INFECT DIS, V45, P1502, DOI 10.1086/523320; Bland RM, 2007, B WORLD HEALTH ORGAN, V85, P289, DOI 10.2471/BLT.06.032441; Bland RM, 2003, ARCH DIS CHILD, V88, P778, DOI 10.1136/adc.88.9.778; Bland RM, 2002, ACTA PAEDIATR, V91, P704, DOI 10.1080/080352502760069151; Bland RM, 2008, AIDS, V22, P883, DOI 10.1097/QAD.0b013e3282f768de; Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; CAMES C, 2006, 16 INT AIDS C TOR CA; Cassol S, 1997, J CLIN MICROBIOL, V35, P2795, DOI 10.1128/JCM.35.11.2795-2801.1997; Colvin M, 2007, B WORLD HEALTH ORGAN, V85, P466, DOI 10.2471/BLT.06.033639; COOVADIA H, 2007, LANCET, V369, P1607; Coutinho SB, 2005, LANCET, V366, P1094, DOI 10.1016/S0140-6736(05)67421-1; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; Cox D. R., 1984, ANAL SURVIVAL DATA; CREEK T, 2007, 14 C RETR OPP INF LO; Dabis F, 2005, AIDS, V19, P309; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Gaillard P, 2001, STAT MED, V20, P3525, DOI 10.1002/sim.1092; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Israel-Ballard K, 2007, JAIDS-J ACQ IMM DEF, V45, P318; Jeffery BS, 2000, J TROP PEDIATRICS, V46, P219, DOI 10.1093/tropej/46.4.219; JOHNSON W, 2006, CHALLENGE PROVIDING; Joly P, 1999, COMPUT METH PROG BIO, V60, P225, DOI 10.1016/S0169-2607(99)00018-8; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KUHN L, 2008, N ENGL J MED; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Leroy V, 2005, AIDS, V19, P1865, DOI 10.1097/01.aids.0000188423.02786.55; Leroy V, 2003, AIDS, V17, P1493, DOI 10.1097/00002030-200307040-00010; Leroy V, 2007, JAIDS-J ACQ IMM DEF, V44, P77, DOI 10.1097/01.qai.0000243115.37035.97; Luzuriaga K, 2006, LANCET, V368, P511, DOI 10.1016/S0140-6736(06)69159-9; Magoni M, 2005, AIDS, V19, P433, DOI 10.1097/01.aids.0000161773.29029.c0; Mofenson LM, 2000, LANCET, V355, P2237, DOI 10.1016/S0140-6736(00)02415-6; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Oddy Wendy H, 2002, Breastfeed Rev, V10, P5; Poggensee G, 2004, TROP MED INT HEALTH, V9, P477, DOI 10.1111/j.1365-3156.2004.01214.x; POPKIN BM, 1990, PEDIATRICS, V86, P874; Rollins NC, 2007, JAIDS-J ACQ IMM DEF, V44, P321, DOI 10.1097/QAI.0b013e31802ea4b0; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Rouet F, 2001, AIDS, V15, P1849, DOI 10.1097/00002030-200109280-00015; Taha TE, 2007, J INFECT DIS, V196, P10, DOI 10.1086/518511; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; THOMAS T, 2007, 14 C RETR OPP INF LO; THOMAS T, 2008, 15 C RETR OPP INF BO; TONWE G, 2007, PLOS MED, V4, pE257; [WHO UNICEF UNAIDS], 2000, HIV INF FEED COUNS T; WHO, 2001, BREASTF REPL FEED PR; *WHO, 2007, CONS STAT WHO HIV IN; *WHO, 2004, HIV TRANSM BREASTF R; WHO & UNICEF (World Health Organization & UNICEF), 1993, BREASTF COUNS TRAIN; World Health Organization, 2004, GUID PRINC FEED NONB; World Health Organization, 1991, IND ASS BREAST FEED	63	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7397	10.1371/journal.pone.0007397	http://dx.doi.org/10.1371/journal.pone.0007397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834601	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000270880700004
J	Ndjomou, J; Park, IW; Liu, Y; Mayo, LD; He, JJ				Ndjomou, Jean; Park, In-woo; Liu, Ying; Mayo, Lindsey D.; He, Johnny J.			Up-Regulation of Hepatitis C Virus Replication and Production by Inhibition of MEK/ERK Signaling	PLOS ONE			English	Article							SUBGENOMIC RNA REPLICATION; PROTEIN-KINASES; PATHWAY; ERK; CASCADE; GENOME; CELLS; PHOSPHORYLATION; ACTIVATION; INDUCTION	Background: Viruses interact with and exploit the host cellular machinery for their multiplication and propagation. The MEK/ERK signaling pathway positively regulates replication of many RNA viruses. However, whether and how this signaling pathway affects hepatitis C virus (HCV) replication and production is not well understood. Methods and Results: In this study, we took advantage of two well-characterized MEK/ERK inhibitors and MEK/ERK dominant negative mutants and investigated the roles of the MEK/ERK signaling pathway in HCV gene expression and replication. We showed that inhibition of MEK/ERK signaling enhanced HCV gene expression, plus-and minus-strand RNA synthesis, and virus production. In addition, we showed that this enhancement was independent of interferon-alpha (IFN-alpha) antiviral activity and did not require prior activation of the MEK/ERK signaling pathway. Furthermore, we showed that only MEK and ERK-2 but not ERK-1 was involved in HCV replication, likely through regulation of HCV RNA translation. Conclusions: Taken together, these results demonstrate a negative regulatory role of the MEK/ERK signaling pathway in HCV replication and suggest a potential risk in targeting this signaling pathway to treat and prevent neoplastic transformation of HCV-infected liver cells.			Ndjomou, J (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	jjhe@iupui.edu						Battcock SA, 2006, J VIROL, V80, P4422, DOI 10.1128/JVI.80.9.4422-4430.2006; Cai YY, 2007, J VIROL, V81, P446, DOI 10.1128/JVI.01705-06; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frese M, 2001, J GEN VIROL, V82, P723, DOI 10.1099/0022-1317-82-4-723; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Huang Y, 2006, HEPATOLOGY, V43, P81, DOI 10.1002/hep.21011; Ichikawa T, 2002, BIOCHEM BIOPH RES CO, V294, P414, DOI 10.1016/S0006-291X(02)00502-8; Jackson MW, 2006, J BIOL CHEM, V281, P16814, DOI 10.1074/jbc.M511617200; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Katze MG, 2000, VIROLOGY, V278, P501, DOI 10.1006/viro.2000.0662; Kim SJ, 2004, J BIOL CHEM, V279, P50031, DOI 10.1074/jbc.M408617200; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Luo HL, 2002, J VIROL, V76, P3365, DOI 10.1128/JVI.76.7.3365-3373.2002; Murata T, 2005, VIROLOGY, V340, P105, DOI 10.1016/j.virol.2005.06.015; Ndjomou J, 2007, BIOCHEM BIOPH RES CO, V359, P57, DOI 10.1016/j.bbrc.2007.05.073; Neddermann P, 2004, J VIROL, V78, P13306, DOI 10.1128/JVI.78.23.13306-13314.2004; Planz O, 2001, J VIROL, V75, P4871, DOI 10.1128/JVI.75.10.4871-4877.2001; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Reed KE, 1998, J VIROL, V72, P6199, DOI 10.1128/JVI.72.7.6199-6206.1998; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Seeff LB, 1997, HEPATOLOGY, V26, pS21, DOI 10.1002/hep.510260704; Smith KD, 2006, J VIROL, V80, P1110, DOI 10.1128/JVI.80.3.1110-1120.2006; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132; Yang XY, 1999, J VIROL, V73, P3460, DOI 10.1128/JVI.73.4.3460-3466.1999; Zheng YY, 2003, J VIROL, V77, P7707, DOI 10.1128/JVI.77.14.7707-7712.2003; Zhu HZ, 2003, J VIROL, V77, P5493, DOI 10.1128/JVI.77.9.5493-5498.2003	31	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7498	10.1371/journal.pone.0007498	http://dx.doi.org/10.1371/journal.pone.0007498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834602	gold, Green Published, Green Submitted			2022-12-25	WOS:000270880700019
J	Oyagi, A; Oida, Y; Kakefuda, K; Shimazawa, M; Shioda, N; Moriguchi, S; Kitaichi, K; Nanba, D; Yamaguchi, K; Furuta, Y; Fukunaga, K; Higashiyama, S; Hara, H				Oyagi, Atsushi; Oida, Yasuhisa; Kakefuda, Kenichi; Shimazawa, Masamitsu; Shioda, Norifumi; Moriguchi, Shigeki; Kitaichi, Kiyoyuki; Nanba, Daisuke; Yamaguchi, Kazumasa; Furuta, Yasuhide; Fukunaga, Kohji; Higashiyama, Shigeki; Hara, Hideaki			Generation and Characterization of Conditional Heparin-Binding EGF-Like Growth Factor Knockout Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FACTOR HB-EGF; RAT-BRAIN; SCHIZOPHRENIC-PATIENTS; PREPULSE INHIBITION; ABNORMAL EXPRESSION; DENDRITIC SPINES; TRANSGENIC MICE; CELL-MIGRATION; IN-VIVO	Recently, neurotrophic factors and cytokines have been shown to be associated in psychiatric disorders, such as schizophrenia, bipolar disorder, and depression. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a member of the EGF family, serves as a neurotrophic molecular and plays a significant role in the brain. We generated mice in which HB-EGF activity is disrupted specifically in the ventral forebrain. These knockout mice showed (a) behavioral abnormalities similar to those described in psychiatric disorders, which were ameliorated by typical or atypical antipsychotics, (b) altered dopamine and serotonin levels in the brain, (c) decreases in spine density in neurons of the prefrontal cortex, (d) reductions in the protein levels of the NR1 subunit of the N-methyl-D-aspartate (NMDA) receptor and post-synaptic protein-95 (PSD-95), (e) decreases in the EGF receptor, and in the calcium/calmodulin-dependent protein kinase II (CaMK II) signal cascade. These results suggest the alterations affecting HB-EGF signaling could comprise a contributing factor in psychiatric disorder.			Oyagi, A (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp	Fukunaga, Kohji/AAI-8811-2021	Fukunaga, Kohji/0000-0001-8526-2824				ADAMSON ED, 1984, DEV BIOL, V103, P62, DOI 10.1016/0012-1606(84)90007-1; BARNARD JA, 1995, GASTROENTEROLOGY, V108, P564, DOI 10.1016/0016-5085(95)90087-X; CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140; Cicchetti D, 1999, DEV PSYCHOPATHOL, V11, P375, DOI 10.1017/S0954579499002114; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; Farkas LM, 2002, J NEURAL TRANSM, V109, P267, DOI 10.1007/s007020200022; FERRARI G, 1991, J NEUROSCI RES, V30, P493, DOI 10.1002/jnr.490300306; FILE SE, 1978, BRIT J PHARMACOL, V62, pP425; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Futamura T, 2002, MOL PSYCHIATR, V7, P673, DOI 10.1038/sj.mp.4001081; Futamura T, 2003, MOL PSYCHIATR, V8, P19, DOI 10.1038/sj.mp.4001138; Gainetdinov RR, 2001, P NATL ACAD SCI USA, V98, P11047, DOI 10.1073/pnas.191353298; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; GOMEZPINILLA F, 1988, BRAIN RES, V438, P385, DOI 10.1016/0006-8993(88)91369-8; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Harvey PD, 2004, J CLIN PSYCHIAT, V65, P361; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Hayase Y, 1998, BRAIN RES, V784, P163, DOI 10.1016/S0006-8993(97)01325-5; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; ISHIYAMA J, 1991, NEUROSCI RES, V12, P403, DOI 10.1016/0168-0102(91)90071-6; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jin KL, 2002, J NEUROSCI, V22, P5365; Kiuchi S, 2006, CYTOGENET GENOME RES, V115, P51, DOI 10.1159/000094801; Kornblum HI, 1999, EUR J NEUROSCI, V11, P3236, DOI 10.1046/j.1460-9568.1999.00744.x; Linn GS, 2003, PSYCHOPHARMACOLOGY, V169, P234, DOI 10.1007/s00213-003-1533-8; Mine N, 2005, DEVELOPMENT, V132, P4317, DOI 10.1242/dev.02030; Mishima K, 1996, NEUROSCI LETT, V213, P153; Miyamoto Y, 2004, EUR J NEUROSCI, V19, P151, DOI 10.1111/j.1460-9568.2004.03086.x; Moore H, 1999, BIOL PSYCHIAT, V46, P40, DOI 10.1016/S0006-3223(99)00078-5; MORRISON RS, 1987, SCIENCE, V238, P72, DOI 10.1126/science.3498986; Mouri A, 2007, MOL PHARMACOL, V71, P1598, DOI 10.1124/mol.106.032961; Nabeshima T, 2006, ANN NY ACAD SCI, V1086, P160, DOI 10.1196/annals.1377.003; Nakagawa T, 1998, DEV BRAIN RES, V108, P263, DOI 10.1016/S0165-3806(98)00057-1; NASRALLAH HA, 1991, BIOL PSYCHIAT, V29, P1, DOI 10.1016/0006-3223(91)90205-Z; Nishi E, 2001, EMBO J, V20, P3342, DOI 10.1093/emboj/20.13.3342; NODA Y, 1995, EUR J PHARMACOL, V286, P291, DOI 10.1016/0014-2999(95)00464-X; Oliver G, 1995, DEVELOPMENT, V121, P4045; PEREIRA A, 2009, J MOL NEUROSCI; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Sakaue M, 2003, PSYCHOPHARMACOLOGY, V170, P73, DOI 10.1007/s00213-003-1515-x; Sams-Dodd F, 1998, NEUROPSYCHOPHARMACOL, V18, P293; SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843; Satoh Y, 2007, J NEUROSCI, V27, P10765, DOI 10.1523/JNEUROSCI.0117-07.2007; Takahashi M, 2000, MOL PSYCHIATR, V5, P293, DOI 10.1038/sj.mp.4000718; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; WATANABE T, 1994, J BIOL CHEM, V269, P9966; Winograd-Gurvich C, 2006, BRAIN RES BULL, V70, P312, DOI 10.1016/j.brainresbull.2006.06.007; YAN T, 2009, J PSYCHOPHARMACOL; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	56	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7461	10.1371/journal.pone.0007461	http://dx.doi.org/10.1371/journal.pone.0007461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19829704	Green Submitted, Green Published, gold			2022-12-25	WOS:000270808700020
J	Soh, J; Okumura, N; Lockwood, WW; Yamamoto, H; Shigematsu, H; Zhang, W; Chari, R; Shames, DS; Tang, XM; MacAulay, C; Varella-Garcia, M; Vooder, T; Wistuba, II; Lam, S; Brekken, R; Toyooka, S; Minna, JD; Lam, WL; Gazdar, AF				Soh, Junichi; Okumura, Naoki; Lockwood, William W.; Yamamoto, Hiromasa; Shigematsu, Hisayuki; Zhang, Wei; Chari, Raj; Shames, David S.; Tang, Ximing; MacAulay, Calum; Varella-Garcia, Marileila; Vooder, Tonu; Wistuba, Ignacio I.; Lam, Stephen; Brekken, Rolf; Toyooka, Shinichi; Minna, John D.; Lam, Wan L.; Gazdar, Adi F.			Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells	PLOS ONE			English	Article							ACQUIRED UNIPARENTAL DISOMY; BRONCHIAL EPITHELIAL-CELLS; FACTOR RECEPTOR GENE; LUNG-CANCER PATIENTS; COLORECTAL-CANCER; SIGNALING PATHWAY; EGFR; GEFITINIB; LINES; EXPRESSION	Background: Activating mutations in one allele of an oncogene (heterozygous mutations) are widely believed to be sufficient for tumorigenesis. However, mutant allele specific imbalance (MASI) has been observed in tumors and cell lines harboring mutations of oncogenes. Methodology/Principal Findings: We determined 1) mutational status, 2) copy number gains (CNGs) and 3) relative ratio between mutant and wild type alleles of KRAS, BRAF, PIK3CA and EGFR genes by direct sequencing and quantitative PCR assay in over 400 human tumors, cell lines, and xenografts of lung, colorectal, and pancreatic cancers. Examination of a public database indicated that homozygous mutations of five oncogenes were frequent (20%) in 833 cell lines of 12 tumor types. Our data indicated two major forms of MASI: 1) MASI with CNG, either complete or partial; and 2) MASI without CNG (uniparental disomy; UPD), due to complete loss of wild type allele. MASI was a frequent event in mutant EGFR (75%) and was due mainly to CNGs, while MASI, also frequent in mutant KRAS (58%), was mainly due to UPD. Mutant: wild type allelic ratios at the genomic level were precisely maintained after transcription. KRAS mutations or CNGs were significantly associated with increased ras GTPase activity, as measured by ELISA, and the two molecular changes were synergistic. Of 237 lung adenocarcinoma tumors, the small number with both KRAS mutation and CNG were associated with shortened survival. Conclusions: MASI is frequently present in mutant EGFR and KRAS tumor cells, and is associated with increased mutant allele transcription and gene activity. The frequent finding of mutations, CNGs and MASI occurring together in tumor cells indicates that these three genetic alterations, acting together, may have a greater role in the development or maintenance of the malignant phenotype than any individual alteration.			Soh, J (corresponding author), Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA.	Adi.Gazdar@UTSouthwestern.edu	Lockwood, William W/A-2879-2009; MacAulay, Calum/K-1795-2016; Chari, Raj/G-3285-2019; SOH, Junichi/B-2388-2011; Soh, Junichi/AAV-1053-2020; Soh, Junichi/AAT-7095-2021; Chari, Rajagopal/B-6980-2008	Soh, Junichi/0000-0001-8532-7915; Soh, Junichi/0000-0001-8532-7915; MacAulay, Calum/0000-0003-4440-2792	NATIONAL CANCER INSTITUTE [P50CA070907, U01CA084971] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA084971, P50CA70907, P50 CA070907, U01CA084971] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Asano H, 2006, CLIN CANCER RES, V12, P43, DOI 10.1158/1078-0432.CCR-05-0934; Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; BOS JL, 1989, CANCER RES, V49, P4682; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chari R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-324; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cutz JC, 2006, CLIN CANCER RES, V12, P4043, DOI 10.1158/1078-0432.CCR-06-0252; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Endoh H, 2006, J THORAC ONCOL, V1, P629; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; Fitzgibbon J, 2005, CANCER RES, V65, P9152, DOI 10.1158/0008-5472.CAN-05-2017; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; GAZDAR AF, 2008, CANCER PREV RES, V1, P5; Gupta M, 2008, GENE CHROMOSOME CANC, V47, P729, DOI 10.1002/gcc.20573; HERRMANN BG, 1987, METHOD ENZYMOL, V152, P180; Hirsch FR, 2007, ANN ONCOL, V18, P752, DOI 10.1093/annonc/mdm003; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Melcher R, 2007, CYTOGENET GENOME RES, V118, P214, DOI 10.1159/000108303; MITSUDOMI T, 1991, ONCOGENE, V6, P1353; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pratilas CA, 2008, CANCER RES, V68, P9375, DOI 10.1158/0008-5472.CAN-08-2223; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Soh J, 2008, J THORAC ONCOL, V3, P340, DOI 10.1097/JTO.0b013e318168d20a; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Uchiyama M, 2003, INT J CANCER, V107, P962, DOI 10.1002/ijc.11493; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Walsh CS, 2008, CLIN CANCER RES, V14, P7645, DOI 10.1158/1078-0432.CCR-08-1291; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yuen ST, 2002, CANCER RES, V62, P6451; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	45	172	179	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7464	10.1371/journal.pone.0007464	http://dx.doi.org/10.1371/journal.pone.0007464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826477	Green Submitted, Green Published, gold			2022-12-25	WOS:000270808700022
J	Wang, YQ; Abu Irqeba, A; Ayalew, M; Suntay, K				Wang, Yuqi; Abu Irqeba, Ameair; Ayalew, Mihretu; Suntay, Kristina			Sumoylation of Transcription Factor Tec1 Regulates Signaling of Mitogen-Activated Protein Kinase Pathways in Yeast	PLOS ONE			English	Article							FUSION-DIRECTED SUMOYLATION; INVASIVE GROWTH; MAPK; SPECIFICITY; PHEROMONE; TRANSDUCTION; PHOSPHORYLATION; KSS1; DEGRADATION; STRESS	Tec1 is a transcription factor in the yeast mitogen-activated protein kinase ( MAPK) pathway that controls invasive growth. Previously we reported that a fraction of Tec1 protein is sumoylated on residue lysine 54 in normally growing cells. Here we describe regulation and functional consequences of Tec1 sumoylation. We found that activation of Kss1, the MAPK that directly activates Tec1, results in a decrease in Tec1 sumoylation and a concurrent increase of Tec1 transcriptional activity. Consistent with a role of sumoylation in inhibiting Tec1 activity, specifically increasing sumoylation of Tec1 by fusing it to the sumoylating enzyme Ubc9 leads to a dramatic decrease of Tec1 transcriptional activity. Invasive growth is also compromised in Tec1-Ubc9. In contrast, fusing sumoylation-site mutant Tec1, i.e., Tec1 K54R, to Ubc9 did not significantly alter transcriptional activation and had a less effect on invasive growth. Taken together, these findings provide evidence for regulated sumoylation as a mechanism to modulate the activity of Tec1 and validate Ubc9 fusion-directed sumoylation as a useful approach for studying protein sumoylation.			Wang, YQ (corresponding author), St Louis Univ, Dept Biol, St Louis, MO 63103 USA.	ywang8@slu.edu		Abu Irqeba, Ameair/0000-0002-6664-8892				BALLARD MJ, 1991, EMBO J, V10, P3753, DOI 10.1002/j.1460-2075.1991.tb04944.x; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Baur M, 1997, MOL CELL BIOL, V17, P4330, DOI 10.1128/MCB.17.8.4330; Breitkreutz A, 2002, TRENDS CELL BIOL, V12, P254, DOI 10.1016/S0962-8924(02)02284-5; Bruckner S, 2004, CURR GENET, V46, P331, DOI 10.1007/s00294-004-0545-1; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; Dhanasekaran DN, 2007, ONCOGENE, V26, P3097, DOI 10.1038/sj.onc.1210395; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; ERREDE B, 1989, GENE DEV, V3, P1349, DOI 10.1101/gad.3.9.1349; Esch RK, 2006, EUKARYOT CELL, V5, P2147, DOI 10.1128/EC.00270-06; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hao N, 2008, J BIOL CHEM, V283, P33798, DOI 10.1074/jbc.C800179200; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Niedenthal R, 2007, BIOCHEM SOC T, V35, P1430, DOI 10.1042/BST0351430; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Shock TR, 2009, EUKARYOT CELL, V8, P606, DOI 10.1128/EC.00005-09; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Truckses DM, 2004, SCIENCE, V306, P1509, DOI 10.1126/science.1104677; Wang YQ, 2006, J BIOL CHEM, V281, P1964, DOI 10.1074/jbc.M508985200; Wang YQ, 2004, SCIENCE, V306, P1508, DOI 10.1126/science.1104568; Wang YQ, 2008, J BIOL CHEM, V283, P1954, DOI 10.1074/jbc.M705682200; Westfall PJ, 2004, SCIENCE, V306, P1511, DOI 10.1126/science.1104879; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5	37	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7456	10.1371/journal.pone.0007456	http://dx.doi.org/10.1371/journal.pone.0007456			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826484	Green Published, Green Submitted, gold			2022-12-25	WOS:000270808700016
J	Hanker, AB; Mitin, N; Wilder, RS; Henske, EP; Tamanoi, F; Cox, AD; Der, CJ				Hanker, A. B.; Mitin, N.; Wilder, R. S.; Henske, E. P.; Tamanoi, F.; Cox, A. D.; Der, C. J.			Differential requirement of CAAX-mediated posttranslational processing for Rheb localization and signaling	ONCOGENE			English	Article						Rheb; mTOR; Ras converting enzyme 1 (Rce1); isoprenylcysteine carboxyl methyltransferase (Icmt); S-trans, trans-farnesylthiosalicylic acid (FTS)	TUBEROUS SCLEROSIS COMPLEX; BREAST-CANCER CELLS; FARNESYLTRANSFERASE INHIBITORS; FARNESYLTHIOSALICYLIC ACID; MAMMALIAN TARGET; MEMBRANE ASSOCIATION; FISSION YEAST; HUMAN-DISEASE; RHO GTPASES; ACTIVE RAS	The Rheb1 and Rheb2 small GTPases and their effector mTOR are aberrantly activated in human cancer and are attractive targets for anti-cancer drug discovery. Rheb is targeted to endomembranes via its C-terminal CAAX (C = cysteine, A = aliphatic, X = terminal amino acid) motif, a substrate for posttranslational modification by a farnesyl isoprenoid. After farnesylation, Rheb undergoes two additional CAAX-signaled processing steps, Ras converting enzyme 1 (Rce1)-catalyzed cleavage of the AAX residues and isoprenylcysteine carboxyl methyltransferase (Icmt)-mediated carboxylmethylation of the farnesylated cysteine. However, whether these postprenylation processing steps are required for Rheb signaling through mTOR is not known. We found that Rheb1 and Rheb2 localize primarily to the endoplasmic reticulum and Golgi apparatus. We determined that Icmt and Rce1 processing is required for Rheb localization, but is dispensable for Rheb-induced activation of the mTOR substrate p70 S6 kinase (S6K). Finally, we evaluated whether farnesylthiosalicylic acid (FTS) blocks Rheb localization and function. Surprisingly, FTS prevented S6K activation induced by a constitutively active mTOR mutant, indicating that FTS inhibits mTOR at a level downstream of Rheb. We conclude that inhibitors of Icmt and Rce1 will not block Rheb function, but FTS could be a promising treatment for Rheb- and mTOR-dependent cancers. Oncogene (2010) 29, 380-391; doi:10.1038/onc.2009.336; published online 19 October 2009	[Mitin, N.; Wilder, R. S.; Cox, A. D.; Der, C. J.] Univ N Carolina, Dept Pharmacol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Hanker, A. B.; Cox, A. D.; Der, C. J.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Wilder, R. S.; Tamanoi, F.] Univ N Carolina, Dept Radiat Oncol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Henske, E. P.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA USA; [Tamanoi, F.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90024 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Brigham & Women's Hospital; Harvard Medical School; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Der, CJ (corresponding author), Univ N Carolina, Dept Pharmacol, Lineberger Comprehens Canc Ctr, 450 W Dr, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu	Hanker, Ariella/M-7136-2019; Mitin, Natalia/E-8043-2012	Hanker, Ariella/0000-0002-8655-8341; Der, Channing/0000-0002-7751-2747; Cox, Adrienne D./0000-0002-4901-2454	National Institutes of Health [CA042978, CA109550, CA67771, CA41996]; Department of Defense Breast Cancer Research Program predoctoral fellowship [BC061107]; NATIONAL CANCER INSTITUTE [R01CA041996, R01CA109550, R01CA042978, U19CA067771] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program predoctoral fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Yoel Kloog, Said Sebti, and Andrew Hamilton for inhibitors, Lawrence Quilliam and Mark Philips for providing plasmid constructs, Stephen Young for MEF cell lines deficient in Rce1 and Icmt, and the UNC Michael Hooker Microscopy Facility for imaging assistance. This research was supported by grants from the National Institutes of Health to CJD (CA042978), ADC (CA109550), CJD and ADC (CA67771), and FT (CA41996). ABH was supported by a Department of Defense Breast Cancer Research Program predoctoral fellowship (BC061107).	Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Astrinidis A, 2005, ONCOGENE, V24, P7475, DOI 10.1038/sj.onc.1209090; Basso AD, 2005, J BIOL CHEM, V280, P31101, DOI 10.1074/jbc.M503763200; Blum R, 2008, RECENT PAT ANTI-CANC, V3, P31; Bodemann BO, 2008, NAT REV CANCER, V8, P133, DOI 10.1038/nrc2296; Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Chakraborty S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-163; Chenette EJ, 2006, MOL BIOL CELL, V17, P3108, DOI 10.1091/mbc.E05-09-0896; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Cox AD, 2002, CURR OPIN PHARMACOL, V2, P388, DOI 10.1016/S1471-4892(02)00181-9; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Gau CL, 2005, MOL CANCER THER, V4, P918, DOI 10.1158/1535-7163.MCT-04-0347; Gromov PS, 1995, FEBS LETT, V377, P221, DOI 10.1016/0014-5793(95)01349-0; Haklai R, 1998, BIOCHEMISTRY-US, V37, P1306, DOI 10.1021/bi972032d; Heo WD, 2003, CELL, V113, P315; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Jiang H, 2008, ONCOGENE, V27, P5729, DOI 10.1038/onc.2008.180; Kloog Y, 2004, SEMIN CANCER BIOL, V14, P253, DOI 10.1016/j.semcancer.2004.04.004; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Law BK, 2000, J BIOL CHEM, V275, P10796, DOI 10.1074/jbc.275.15.10796; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Ma DZ, 2008, J BIOL CHEM, V283, P25963, DOI 10.1074/jbc.M802356200; Maehama T, 2008, J BIOL CHEM, V283, P35053, DOI 10.1074/jbc.M805822200; MAROM M, 1995, J BIOL CHEM, V270, P22263, DOI 10.1074/jbc.270.38.22263; Mavrakis KJ, 2008, GENE DEV, V22, P2178, DOI 10.1101/gad.1690808; McMahon LP, 2005, MOL ENDOCRINOL, V19, P175, DOI 10.1210/me.2004-0305; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Nakase Y, 2006, GENETICS, V173, P569, DOI 10.1534/genetics.106.056895; Nardella C, 2008, GENE DEV, V22, P2172, DOI 10.1101/gad.1699608; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rotblat B, 2008, METHOD ENZYMOL, V439, P467, DOI 10.1016/S0076-6879(07)00432-6; Rowell CA, 1997, J BIOL CHEM, V272, P14093, DOI 10.1074/jbc.272.22.14093; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sato T, 2008, METHOD ENZYMOL, V438, P307, DOI 10.1016/S0076-6879(07)38021-X; Sebti SM, 2003, NAT REV CANCER, V3, P945, DOI 10.1038/nrc1234; Takahashi K, 2005, J BIOL CHEM, V280, P32768, DOI 10.1074/jbc.M506280200; Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Weis B, 1999, ONCOGENE, V18, P2579, DOI 10.1038/sj.onc.1202602; Whyte DB, 1997, J BIOL CHEM, V272, P14459, DOI 10.1074/jbc.272.22.14459; Wienecke R, 1996, ONCOGENE, V13, P913; Winter-Vann AM, 2005, NAT REV CANCER, V5, P405, DOI 10.1038/nrc1612; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yue W, 2005, INT J CANCER, V117, P746, DOI 10.1002/ijc.21222; Yue W, 2007, J STEROID BIOCHEM, V106, P102, DOI 10.1016/j.jsbmb.2007.05.008	54	67	69	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2010	29	3					380	391		10.1038/onc.2009.336	http://dx.doi.org/10.1038/onc.2009.336			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	546EO	19838215	Green Submitted, Green Accepted			2022-12-25	WOS:000273793200007
J	Fernandez-Zapico, ME; van Velkinburgh, JC; Gutierrez-Aguilar, R; Neve, B; Froguel, P; Urrutia, R; Stein, R				Fernandez-Zapico, Martin E.; van Velkinburgh, Jennifer C.; Gutierrez-Aguilar, Ruth; Neve, Bernadette; Froguel, Philippe; Urrutia, Raul; Stein, Roland			MODY7 Gene, KLF11, Is a Novel p300-dependent Regulator of Pdx-1 (MODY4) Transcription in Pancreatic Islet beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMEODOMAIN PROTEIN IDX-1; NUCLEAR FACTOR 3-BETA; GROWTH-REGULATION; P300 COACTIVATOR; EXPRESSION; PROMOTER; DIFFERENTIATION; REGION; MICE; REPRESSORS	Pdx-1 (pancreatic-duodenal homeobox-1), a MODY4 homeodomain transcription factor, serves as a master regulator in the pancreas because of its importance during organogenesis and in adult islet insulin-producing beta cell activity. Here, we show that KLF11, an SP/Kruppel-like (SP/KLF) transcription factor, mutated in French maturity onset diabetes of the young patients (MODY7), regulates Pdx-1 transcription in beta cells through two evolutionarily conserved GC-rich motifs in conserved Area II, a control region essential to islet beta cell-enriched expression. These regulatory elements, termed GC1 (human base pair -2061/-2055) and GC2 (-2036/-2027), are also nearly identical to the consensus KLF11 binding sequence defined here by random oligonucleotide binding analysis. KLF11 specifically associates with Area II in chromatin immunoprecipitation assays, while preventing binding to GC1- and/or GC2-compromised Pdx1-driven reporter activity in beta cell lines. Mechanistically, we find that KLF11 interacts with the coactivator p300 via its zinc finger domain in vivo to mediate Pdx-1 activation. Together, our data identified a hierarchical regulatory cascade for these two MODY genes, suggesting that gene regulation in MODY is more complex than anticipated previously. Furthermore, because KLF11 like most MODY-associated transcription factors uses p300, these data further support a role for this coactivator as a critical chromatin link in forms of type 2 diabetes.	[Fernandez-Zapico, Martin E.; Stein, Roland] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [van Velkinburgh, Jennifer C.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Gutierrez-Aguilar, Ruth; Neve, Bernadette; Froguel, Philippe] Inst Pasteur, Inst Biol, CNRS, UMR 8090, F-59019 Lille, France; [Neve, Bernadette; Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London SW7 2AZ, England; [Urrutia, Raul] Mayo Clin, Gastroenterol Res Unit, Rochester, MN 55905 USA	Mayo Clinic; Vanderbilt University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Imperial College London; Mayo Clinic	Stein, R (corresponding author), Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA.	roland.stein@vanderbilt.edu	FROGUEL, Philippe/O-6799-2017; Neve, Bernadette/J-6008-2014; van Velkinburgh, Jennifer/D-7205-2015	FROGUEL, Philippe/0000-0003-2972-0784; Neve, Bernadette/0000-0003-1516-1379; van Velkinburgh, Jennifer/0000-0002-4592-2397	USPHS [P60 DK20593]; French National Research Agency [ANR-06-BLAN-0236]; European Regional Development Fund; Region Nord-Pas de Calais grants;  [RO1 DK-50203];  [5T32 CA09385-18];  [CA125127];  [CA136526];  [DK 52913]; MRC [G0600331] Funding Source: UKRI; Medical Research Council [G0600331] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA136526, T32CA009385, R03CA125127, P50CA102701, P50CA097274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052913, R01DK050203, R01DK052913, P60DK020593] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); French National Research Agency(French National Research Agency (ANR)); European Regional Development Fund(European Commission); Region Nord-Pas de Calais grants(Region Hauts-de-France); ; ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant P60 DK20593 from USPHS and Grant RO1 DK-50203 (to R. S.), Training Grant 5T32 CA09385-18 (to J. C. V. V.), Grants CA125127 and CA136526 (to M. E. F.-Z.), and Grant DK 52913 (to R. U.). This work was also supported by French National Research Agency Grant ANR-06-BLAN-0236, European Regional Development Fund, and Region Nord-Pas de Calais grants (to P. F. and B. N.).	Ahlgren U, 1996, DEVELOPMENT, V122, P1409; Artner I, 2007, P NATL ACAD SCI USA, V104, P3853, DOI 10.1073/pnas.0700013104; Babu DA, 2007, MOL GENET METAB, V92, P43, DOI 10.1016/j.ymgme.2007.06.008; Ban N, 2002, DIABETES, V51, P1409, DOI 10.2337/diabetes.51.5.1409; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Cissell MA, 2003, J BIOL CHEM, V278, P751, DOI 10.1074/jbc.M205905200; Clocquet AR, 2000, DIABETES, V49, P1856, DOI 10.2337/diabetes.49.11.1856; De Graeve F, 2003, GENE, V314, P55, DOI 10.1016/S0378-1119(03)00720-0; Eeckhoute J, 2001, MOL ENDOCRINOL, V15, P1200, DOI 10.1210/me.15.7.1200; Ellenrieder V, 2004, GASTROENTEROLOGY, V127, P607, DOI 10.1053/j.gastro.2004.05.018; Fernandez-Zapico ME, 2003, EMBO J, V22, P4748, DOI 10.1093/emboj/cdg470; Fujitani Y, 2006, GENE DEV, V20, P253, DOI 10.1101/gad.1360106; Gerrish K, 2004, MOL ENDOCRINOL, V18, P533, DOI 10.1210/me.2003-0371; Gerrish K, 2000, J BIOL CHEM, V275, P3485, DOI 10.1074/jbc.275.5.3485; Gerrish K, 2001, J BIOL CHEM, V276, P47775, DOI 10.1074/jbc.M109244200; Hussain MA, 1999, J BIOL CHEM, V274, P28950, DOI 10.1074/jbc.274.41.28950; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kaczynski JA, 2002, BIOCHEM J, V366, P873, DOI 10.1042/BJ20020388; Katz JP, 2002, DEVELOPMENT, V129, P2619; Keller DM, 2007, J BIOL CHEM, V282, P32084, DOI 10.1074/jbc.M700899200; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Offield MF, 1996, DEVELOPMENT, V122, P983; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Qiu Y, 2002, MOL CELL BIOL, V22, P412, DOI 10.1128/MCB.22.2.412-420.2002; Samaras SE, 2003, J BIOL CHEM, V278, P12263, DOI 10.1074/jbc.M210801200; Samaras SE, 2002, MOL CELL BIOL, V22, P4702, DOI 10.1128/MCB.22.13.4702-4713.2002; Sharma A, 1999, DIABETES, V48, P507, DOI 10.2337/diabetes.48.3.507; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Stanojevic V, 2004, ENDOCRINOLOGY, V145, P2918, DOI 10.1210/en.2003-1188; Stoffers DA, 1999, ENDOCRINOLOGY, V140, P5374, DOI 10.1210/en.140.11.5374; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Truty MJ, 2009, J BIOL CHEM, V284, P6291, DOI 10.1074/jbc.M807791200; Van Velkinburgh JC, 2005, J BIOL CHEM, V280, P38438, DOI 10.1074/jbc.M508594200; Wiebe PO, 2007, MOL CELL BIOL, V27, P4093, DOI 10.1128/MCB.01978-06; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001	39	75	80	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36482	36490		10.1074/jbc.M109.028852	http://dx.doi.org/10.1074/jbc.M109.028852			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19843526	hybrid, Green Published			2022-12-25	WOS:000272970500050
J	Torrie, LS; Wyllie, S; Spinks, D; Oza, SL; Thompson, S; Harrison, JR; Gilbert, IH; Wyatt, PG; Fairlamb, AH; Frearson, JA				Torrie, Leah S.; Wyllie, Susan; Spinks, Daniel; Oza, Sandra L.; Thompson, Stephen; Harrison, Justin R.; Gilbert, Ian H.; Wyatt, Paul G.; Fairlamb, Alan H.; Frearson, Julie A.			Chemical Validation of Trypanothione Synthetase A POTENTIAL DRUG TARGET FOR HUMAN TRYPANOSOMIASIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFRICAN TRYPANOSOMES; REDUCTASE; BRUCEI; GLUTATHIONE; METABOLISM; BIOSYNTHESIS; SENSITIVITY; LEISHMANIA; SPERMIDINE; INHIBITORS	In the search for new therapeutics for the treatment of human African trypanosomiasis, many potential drug targets in Trypanosoma brucei have been validated by genetic means, but very few have been chemically validated. Trypanothione synthetase (TryS; EC 6.3.1.9; spermidine/glutathionylspermidine: glutathione ligase (ADP-forming)) is one such target. To identify novel inhibitors of T. brucei TryS, we developed an in vitro enzyme assay, which was amenable to high throughput screening. The subsequent screen of a diverse compound library resulted in the identification of three novel series of TryS inhibitors. Further chemical exploration resulted in leads with nanomolar potency, which displayed mixed, uncompetitive, and allosteric-type inhibition with respect to spermidine, ATP, and glutathione, respectively. Representatives of all three series inhibited growth of bloodstream T. brucei in vitro. Exposure to one of our lead compounds (DDD86243; 2 x EC50 for 72 h) decreased intracellular trypanothione levels to <10% of wild type. In addition, there was a corresponding 5-fold increase in the precursor metabolite, glutathione, providing strong evidence that DDD86243 was acting on target to inhibit TryS. This was confirmed with wild-type, TryS single knock-out, and TryS-overexpressing cell lines showing expected changes in potency to DDD86243. Taken together, these data provide initial chemical validation of TryS as a drug target in T. brucei.	[Frearson, Julie A.] Univ Dundee, Coll Life Sci, James Black Ctr, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland	University of Dundee	Frearson, JA (corresponding author), Univ Dundee, Coll Life Sci, James Black Ctr, Div Biol Chem & Drug Discovery, Dow St, Dundee DD1 5EH, Scotland.	j.a.frearson@dundee.ac.uk	Wyllie, Susan/AAI-4430-2021; Fairlamb, Alan/A-5272-2009	Fairlamb, Alan/0000-0001-5134-0329; Wyatt, Paul/0000-0002-0397-245X; Oza, Sandra/0000-0001-9404-7931; Wyllie, Susan/0000-0001-8810-5605; Gilbert, Ian/0000-0002-5238-1314	Wellcome Trust [WT077705, WT079838, WT083481]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grants WT077705, WT079838, and WT083481.	Ariyanayagam MR, 2005, BIOCHEM J, V391, P425, DOI 10.1042/BJ20050911; Augustyns K, 2001, CURR PHARM DESIGN, V7, P1117, DOI 10.2174/1381612013397564; Barrett MP, 1999, PARASITOL TODAY, V15, P136, DOI 10.1016/S0169-4758(99)01414-3; BENSON TJ, 1992, BIOCHEM J, V286, P9, DOI 10.1042/bj2860009; Cogan EB, 1999, ANAL BIOCHEM, V271, P29, DOI 10.1006/abio.1999.4100; Comini M, 2003, BIOL CHEM, V384, P653, DOI 10.1515/BC.2003.072; Comini MA, 2004, FREE RADICAL BIO MED, V36, P1289, DOI 10.1016/j.freeradbiomed.2004.02.008; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; Fairlamb AH, 2003, TRENDS PARASITOL, V19, P488, DOI 10.1016/j.pt.2003.09.002; Frearson JA, 2007, TRENDS PARASITOL, V23, P589, DOI 10.1016/j.pt.2007.08.019; Fyfe PK, 2008, J BIOL CHEM, V283, P17672, DOI 10.1074/jbc.M801850200; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Krauth-Siegel RL, 2003, BIOL CHEM, V384, P539, DOI 10.1515/BC.2003.062; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Muller S, 2003, TRENDS PARASITOL, V19, P320, DOI 10.1016/S1471-4922(03)00141-7; Oza SL, 2008, FEBS J, V275, P5408, DOI 10.1111/j.1742-4658.2008.06670.x; Oza SL, 2002, J BIOL CHEM, V277, P35853, DOI 10.1074/jbc.M204403200; Oza SL, 2003, MOL BIOCHEM PARASIT, V131, P25, DOI 10.1016/S0166-6851(03)00176-2; Patterson S, 2009, CHEMMEDCHEM, V4, P1341, DOI 10.1002/cmdc.200900098; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; SHIM H, 1988, J GEN MICROBIOL, V134, P807; SPINKS D, 2009, Patent No. 9098112; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Wilkinson SR, 2003, J BIOL CHEM, V278, P31640, DOI 10.1074/jbc.M303035200; Wyllie S, 2009, MOL MICROBIOL, V74, P529, DOI 10.1111/j.1365-2958.2009.06761.x; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	28	59	59	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36137	36145		10.1074/jbc.M109.045336	http://dx.doi.org/10.1074/jbc.M109.045336			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19828449	Green Published, hybrid			2022-12-25	WOS:000272970500015
J	Bonnet, N; Standley, KN; Bianchi, EN; Stadelmann, V; Foti, M; Conway, SJ; Ferrari, SL				Bonnet, Nicolas; Standley, Kara N.; Bianchi, Estelle N.; Stadelmann, Vincent; Foti, Michelangelo; Conway, Simon J.; Ferrari, Serge L.			The Matricellular Protein Periostin Is Required for Sost Inhibition and the Anabolic Response to Mechanical Loading and Physical Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIODONTAL-LIGAMENT; PARATHYROID-HORMONE; IN-VIVO; BONE-FORMATION; OVARIECTOMIZED RATS; THERAPEUTIC TARGETS; GENE-EXPRESSION; MESSENGER-RNA; EXERCISE; MICE	Periostin (gene Postn) is a secreted extracellular matrix protein involved in cell recruitment and adhesion and plays an important role in odontogenesis. In bone, periostin is preferentially expressed in the periosteum, but its functional significance remains unclear. We investigated Postn(-/-) mice and their wild type littermates to elucidate the role of periostin in the skeletal response to moderate physical activity and direct axial compression of the tibia. Furthermore, we administered a sclerostin-blocking antibody to these mice in order to demonstrate the influence of sustained Sost expression in their altered bone phenotypes. Cancellous and cortical bone microarchitecture as well as bending strength were altered in Postn(-/-) compared with Postn(+/+) mice. Exercise and axial compression both significantly increased bone mineral density and trabecular and cortical microarchitecture as well as biomechanical properties of the long bones in Postn(-/-) mice by increasing the bone formation activity, particularly at the periosteum. These changes correlated with an increase of periostin expression and a consecutive decrease of Sost in the stimulated bones. In contrast, mechanical stimuli had no effect on the skeletal properties of Postn(-/-) mice, where base- line expression of Sost levels were higher than Postn(+/+) and remained unchanged following axial compression. In turn, the concomitant injection of sclerostin-blocking antibody rescued the bone biomechanical response in Postn(-/-) mice. Taken together, these results indicate that the matricellular periostin protein is required for Sost inhibition and thereby plays an important role in the determination of bone mass and microstructural in response to loading.	[Bonnet, Nicolas] Univ Hosp Geneva, Dept Rehabil & Geriatr, World Hlth Org Collaborating Ctr Osteoporosis Pre, Div Bone Dis,Serv Bone Dis, CH-1211 Geneva 14, Switzerland; [Foti, Michelangelo] Univ Hosp Geneva, Dept Cellular Physiol & Metab, CH-1211 Geneva 14, Switzerland; [Standley, Kara N.; Conway, Simon J.] Indiana Univ Sch Med, Wells Ctr Pediat Res, Riley Heart Res Ctr, Indianapolis, IN 46202 USA; [Stadelmann, Vincent] Ecole Polytech Fed Lausanne, Lab Biomech Orthoped, CH-1015 Lausanne, Switzerland	University of Geneva; World Health Organization; University of Geneva; Indiana University System; Indiana University Bloomington; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Bonnet, N (corresponding author), Univ Hosp Geneva, Dept Rehabil & Geriatr, World Hlth Org Collaborating Ctr Osteoporosis Pre, Div Bone Dis,Serv Bone Dis, Rue Micheli du Crest 24, CH-1211 Geneva 14, Switzerland.	Nicolas.bonnet@unige.ch	Ferrari, Serge/ABD-2730-2020; Stadelmann, Vincent A./X-1543-2018	Ferrari, Serge/0000-0002-1372-4417; Stadelmann, Vincent/0000-0002-8741-2184; Foti, Michelangelo/0000-0001-7199-4135; Bonnet, Nicolas/0000-0001-9832-5767	National Institutes of Health [R01HL060714, R01HL092508, T32 HL079995]; Swiss National Science Foundation [3100A0-116633/1, 310030-120280]; European Community [HEALTH-F2-2008-201099]; Riley Children's Foundation; Indiana University Department of Pediatrics/Cardiology; Societe Francaise de Rhumatologie; GRIO; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060714, T32HL079995, R01HL092508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Community(European Commission); Riley Children's Foundation; Indiana University Department of Pediatrics/Cardiology; Societe Francaise de Rhumatologie; GRIO; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL060714 and R01HL092508 (to S. J. C.) and T32 HL079995 (to K. S.). These studies were also supported by Swiss National Science Foundation Grants 3100A0-116633/1 (to S. L. F.) and 310030-120280 (to M. F.), by the seventh Framework program of the European Community (HEALTH-F2-2008-201099) (to S. L. F.), the Riley Children's Foundation (to S. J. C.), and the Indiana University Department of Pediatrics/Cardiology (to S. J. C.). This work was further supported by a grant from the "Societe Francaise de Rhumatologie" and the GRIO (to N. B.).	Afanador E, 2005, ARCH ORAL BIOL, V50, P1023, DOI 10.1016/j.archoralbio.2005.04.002; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Bao SD, 2004, CANCER CELL, V5, P329, DOI 10.1016/S1535-6108(04)00081-9; BARENGOLTS EI, 1994, BONE MINER, V26, P133, DOI 10.1016/S0169-6009(08)80058-X; Baril P, 2007, ONCOGENE, V26, P2082, DOI 10.1038/sj.onc.1210009; Bonnet N, 2007, J APPL PHYSIOL, V103, P524, DOI 10.1152/japplphysiol.01319.2006; BOURRIN S, 1995, J BONE MINER RES, V10, P1745; Bouxsein ML, 2005, J BONE MINER RES, V20, P635, DOI 10.1359/JBMR.041204; CHAMBERS TJ, 1993, BONE MINER, V20, P167, DOI 10.1016/S0169-6009(08)80025-6; de Souza RL, 2005, J BONE MINER RES, V20, P2159, DOI 10.1359/JBMR.050812; Dorn GW, 2007, NEW ENGL J MED, V357, P1552, DOI 10.1056/NEJMcibr074816; Engelke K, 2006, OSTEOPOROSIS INT, V17, P133, DOI 10.1007/s00198-005-1938-9; FERRETTI JL, 1995, CALCIFIED TISSUE INT, V57, P399, DOI 10.1007/BF00301939; Foti M, 1997, MOL BIOL CELL, V8, P1377, DOI 10.1091/mbc.8.7.1377; FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104; Gillan L, 2002, CANCER RES, V62, P5358; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x; Horiuchi K, 1999, J BONE MINER RES, V14, P1239, DOI 10.1359/jbmr.1999.14.7.1239; Huang CZ, 2008, INT J PRECIS ENG MAN, V9, P11; Iida-Klein A, 2003, J CLIN DENSITOM, V6, P25, DOI 10.1385/JCD:6:1:25; Iwamoto J, 1999, BONE, V24, P163, DOI 10.1016/S8756-3282(98)00189-6; Iwamoto J, 1998, J Orthop Sci, V3, P257, DOI 10.1007/s007760050051; Kashimaa TG, 2009, HUM PATHOL, V40, P226, DOI 10.1016/j.humpath.2008.07.008; Katsuragi N, 2004, CIRCULATION, V110, P1806, DOI 10.1161/01.CIR.0000142607.33398.54; Kii I, 2006, BIOCHEM BIOPH RES CO, V342, P766, DOI 10.1016/j.bbrc.2006.02.016; Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6; Li XD, 2009, J BONE MINER RES, V24, P578, DOI 10.1359/JBMR.081206; Li X, 2007, J BIOL CHEM, V282, P33086, DOI 10.1074/jbc.M705194200; Litvin J, 2006, CARDIOVASC PATHOL, V15, P24, DOI 10.1016/j.carpath.2005.09.001; Litvin J, 2005, ANAT REC PART A, V287A, P1205, DOI 10.1002/ar.a.20237; Litvin J, 2004, J CELL BIOCHEM, V92, P1044, DOI 10.1002/jcb.20115; Miyauchi A, 2006, J BONE MINER METAB, V24, P498, DOI 10.1007/s00774-006-0716-x; Nakazawa T, 2004, J ORTHOP RES, V22, P520, DOI 10.1016/j.orthres.2003.10.007; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Norris RA, 2008, DEV BIOL, V316, P200, DOI 10.1016/j.ydbio.2008.01.003; Norris RA, 2007, J CELL BIOCHEM, V101, P695, DOI 10.1002/jcb.21224; Ogita M, 2008, ENDOCRINOLOGY, V149, P5713, DOI 10.1210/en.2008-0369; Onyia JE, 2005, J CELL BIOCHEM, V95, P403, DOI 10.1002/jcb.20438; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Phillips JA, 2008, MATRIX BIOL, V27, P609, DOI 10.1016/j.matbio.2008.05.003; Rios H, 2005, MOL CELL BIOL, V25, P11131, DOI 10.1128/MCB.25.24.11131-11144.2005; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Robling A. G., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P249; Robling AG, 2002, FASEB J, V16, P324, DOI 10.1096/fj.02-0393fje; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Ruan K, 2009, CELL MOL LIFE SCI, V66, P2219, DOI 10.1007/s00018-009-0013-7; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Seeman E, 2002, LANCET, V359, P1841, DOI 10.1016/S0140-6736(02)08706-8; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Shimazaki M, 2008, J EXP MED, V205, P295, DOI 10.1084/jem.20071297; Sinaki Mehrsheed, 2007, Phys Med Rehabil Clin N Am, V18, P593, DOI 10.1016/j.pmr.2007.04.002; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Stadelmann VA, 2009, COMPUT METHOD BIOMEC, V12, P95, DOI [10.1080/10255840802178053, 10.1080/10255840903077287]; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; Waarsing JH, 2004, BONE, V34, P163, DOI 10.1016/j.bone.2003.08.012; Waarsing JH, 2002, 9 C INT SOC BON MORP; Wilde J, 2003, CELL TISSUE RES, V312, P345, DOI 10.1007/s00441-002-0664-2; Zehnacker Carol Hamilton, 2007, J Geriatr Phys Ther, V30, P79; Zhu SM, 2009, J CELL PHYSIOL, V218, P584, DOI 10.1002/jcp.21633	61	153	159	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35939	35950		10.1074/jbc.M109.060335	http://dx.doi.org/10.1074/jbc.M109.060335			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19837663	Green Published, hybrid			2022-12-25	WOS:000272645600069
J	Hsu, TL; Cheng, SC; Yang, WB; Chin, SW; Chen, BH; Huang, MT; Hsieh, SL; Wong, CH				Hsu, Tsui-Ling; Cheng, Shih-Chin; Yang, Wen-Bin; Chin, See-Wen; Chen, Bo-Hua; Huang, Ming-Ting; Hsieh, Shie-Liang; Wong, Chi-Huey			Profiling Carbohydrate-Receptor Interaction with Recombinant Innate Immunity Receptor-Fc Fusion Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE MANNOSE RECEPTOR; BETA-GLUCAN RECEPTOR; C-TYPE LECTIN; FUCOSE-CONTAINING GLYCOPROTEINS; LUCIDUM REISHI POLYSACCHARIDES; PATTERN-RECOGNITION RECEPTOR; FUNGUS GANODERMA-LUCIDUM; HUMAN DENDRITIC CELLS; TOLL-LIKE RECEPTORS; DC-SIGN	The recognition of bacteria, viruses, fungi, and other microbes is controlled by host immune cells, which are equipped with many innate immunity receptors, such as Toll-like receptors, C-type lectin receptors, and immunoglobulin-like receptors. Our studies indicate that the immune modulating properties of many herbal drugs, for instance, the medicinal fungus Reishi (Ganoderma lucidum) and Cordyceps sinensis, could be attributed to their polysaccharide components. These polysaccharides specifically interact with and activate surface receptors involved in innate immunity. However, due to the complexity of polysaccharides and their various sources from medicinal fungi, quantitative analysis of medicinal polysaccharide extracts with regard to their functions represents a major challenge. To profile carbohydrate-immune receptor interactions, the extracellular domains of 17 receptors were cloned as Fc-fusion proteins, such that their interactions with immobilized polysaccharides could be probed in an enzyme-linked immunosorbent assay. The results show that several innate immune receptors, including Dectin-1, DC-SIGN, Langerin, Kupffer cell receptor, macrophage mannose receptor, TLR2, and TLR4, interact with the polysaccharide extracts from G. lucidum (GLPS). This analysis revealed distinct polysaccharide profiles from different sources of medicinal fungi, and the innate immune receptor-based enzyme-linked immunosorbent assay described here can serve as a high-throughput profiling method for the characterization and quality control of medicinal polysaccharides. It also provides a means to dissect the molecular mechanism of medicinal polysaccharide-induced immunomodulation events.	[Cheng, Shih-Chin; Huang, Ming-Ting; Hsieh, Shie-Liang] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Hsu, Tsui-Ling; Yang, Wen-Bin; Chin, See-Wen; Chen, Bo-Hua; Hsieh, Shie-Liang; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Hsieh, Shie-Liang] Taipei Vet Gen Hosp, Immunol Res Ctr, Taipei 112, Taiwan; [Wong, Chi-Huey] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Wong, Chi-Huey] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Taipei Veterans General Hospital; Scripps Research Institute; Scripps Research Institute	Hsieh, SL (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, 155 Li Nong St,Sect 2, Taipei 112, Taiwan.	slhsieh@ym.edu.tw; chwong@gate.sinica.edu.tw	Hsieh, Shie-Liang Edmond/ABA-9184-2021; CHENG, SHIH-CHIN/M-3773-2019; Hsu, Tsui-Ling/H-6704-2015; Hsu, Tsui-Ling/AAE-8821-2019	CHENG, SHIH-CHIN/0000-0003-1251-8774; Hsu, Tsui-Ling/0000-0002-2912-3261	National Sciences Council, Taiwan [95-2320-B-010-040-MY3]; Taipei Veterans General Hospital, Taiwan [V96S5-001]; Taiwan Merit Scholarship [TMS-094-1-B-003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	National Sciences Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); Taiwan Merit Scholarship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Sciences Council, Taiwan, Grant 95-2320-B-010-040-MY3, Taipei Veterans General Hospital, Taiwan, Grant V96S5-001 ( to S. L. H.), and Taiwan Merit Scholarship TMS-094-1-B-003 ( to T. L. H.).	Aderem A, 2000, NATURE, V406, P782, DOI 10.1038/35021228; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Athman R, 2004, CURR OPIN MICROBIOL, V7, P25, DOI 10.1016/j.mib.2003.12.013; Balon TW, 2002, J ALTERN COMPLEM MED, V8, P315, DOI 10.1089/10755530260128005; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Buenz EJ, 2005, J ETHNOPHARMACOL, V96, P19, DOI 10.1016/j.jep.2004.09.029; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Chan WK, 2007, INT IMMUNOL, V19, P891, DOI 10.1093/intimm/dxm061; Chen HS, 2004, BIOORGAN MED CHEM, V12, P5595, DOI 10.1016/j.bmc.2004.08.003; Chen ML, 2008, ANGEW CHEM INT EDIT, V47, P8627, DOI 10.1002/anie.200803377; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Coombs PJ, 2006, GLYCOBIOLOGY, V16, p1C, DOI 10.1093/glycob/cwj126; Daws MR, 2003, J IMMUNOL, V171, P594, DOI 10.4049/jimmunol.171.2.594; East L, 2002, J BIOL CHEM, V277, P50469, DOI 10.1074/jbc.M208985200; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; Fadden AJ, 2003, GLYCOBIOLOGY, V13, P529, DOI 10.1093/glycob/cwg068; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; Herre J, 2004, MOL IMMUNOL, V40, P869, DOI 10.1016/j.molimm.2003.10.007; Hsu HY, 2004, J IMMUNOL, V173, P5989, DOI 10.4049/jimmunol.173.10.5989; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; LEHRMAN MA, 1986, J BIOL CHEM, V261, P7412; LEHRMAN MA, 1986, J BIOL CHEM, V261, P7426; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Lien E J, 1990, Prog Drug Res, V34, P395; Lin KI, 2006, J BIOL CHEM, V281, P24111, DOI 10.1074/jbc.M601106200; Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200; McDonald C, 2005, J BIOL CHEM, V280, P20177, DOI 10.1074/jbc.R500001200; MIYAZAKI T, 1982, CARBOHYD RES, V109, P290, DOI 10.1016/0008-6215(82)84047-0; Palma AS, 2006, J BIOL CHEM, V281, P5771, DOI 10.1074/jbc.M511461200; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Seidenfaden R, 2003, MOL CELL BIOL, V23, P5908, DOI 10.1128/MCB.23.16.5908-5918.2003; Shao BM, 2004, BIOCHEM BIOPH RES CO, V323, P133, DOI 10.1016/j.bbrc.2004.08.069; Sheikh H, 2000, J CELL SCI, V113, P1021; Shiao MS, 2003, CHEM REC, V3, P172, DOI 10.1002/tcr.10058; STAHL PD, 1990, AM J RESP CELL MOL, V2, P317, DOI 10.1165/ajrcmb/2.4.317; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Stambach NS, 2003, GLYCOBIOLOGY, V13, P401, DOI 10.1093/glycob/cwg045; Su YP, 2005, J BIOL CHEM, V280, P32811, DOI 10.1074/jbc.M503457200; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Tada H, 2002, MICROBIOL IMMUNOL, V46, P503, DOI 10.1111/j.1348-0421.2002.tb02727.x; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; USUI T, 1983, CARBOHYD RES, V115, P273, DOI 10.1016/0008-6215(83)88159-2; Wang SY, 1997, INT J CANCER, V70, P699, DOI 10.1002/(SICI)1097-0215(19970317)70:6&lt;699::AID-IJC12&gt;3.0.CO;2-5; Wang YY, 2002, BIOORGAN MED CHEM, V10, P1057, DOI 10.1016/S0968-0896(01)00377-7; Watson AA, 2007, J BIOL CHEM, V282, P3165, DOI 10.1074/jbc.M610383200; Willment JA, 2001, J BIOL CHEM, V276, P43818, DOI 10.1074/jbc.M107715200; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P289, DOI 10.1089/acm.1998.4.3-289; Zhu JS, 1998, J ALTERN COMPLEM MED, V4, P429, DOI 10.1089/acm.1998.4.429	59	58	61	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34479	34489		10.1074/jbc.M109.065961	http://dx.doi.org/10.1074/jbc.M109.065961			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19837675	hybrid, Green Published			2022-12-25	WOS:000272439600002
J	Szajnik, M; Szczepanski, MJ; Czystowska, M; Elishaev, E; Mandapathil, M; Nowak-Markwitz, E; Spaczynski, M; Whiteside, TL				Szajnik, M.; Szczepanski, M. J.; Czystowska, M.; Elishaev, E.; Mandapathil, M.; Nowak-Markwitz, E.; Spaczynski, M.; Whiteside, T. L.			TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer	ONCOGENE			English	Article						ovarian cancer; paclitaxel; TLR4; MyD88	TOLL-LIKE RECEPTORS; CELL-LINES; EPITHELIAL-CELLS; CARCINOMA; TAXOL; GENE; EXPRESSION; APOPTOSIS; OVEREXPRESSION; INTERLEUKIN-6	Toll-like receptors (TLRs) expressed on immune cells trigger inflammatory responses. TLRs are also expressed on ovarian cancer (OvCa) cells, but the consequences of signaling by the TLR4/MyD88 pathway in these cells are unclear. Here, TLR4 and MyD88 expression in OvCa tissues (n = 20) and cell lines (OVCAR3, SKOV3, AD10, A2780 and CP70) was evaluated by reverse transcriptase-PCR, western blots and immunohistochemistry. Cell growth, apoptosis, nuclear factor-kappa B (NF-kappa B) translocation, IRAK4 and TRIF expression and cJun phosphorylation were measured following tumor cell exposure to the TLR4 ligands, lipopolysaccharide (LPS) or paclitaxel (PTX). Culture supernatants were tested for cytokine levels. TLR4 was expressed in all tumors, tumor cell lines and normal epithelium. MyD88 was detectable in tumor tissues and in 3/5 OvCa lines but not in normal cells. In MyD88(+) SCOV3 cells, LPS or PTX binding to TLR4 induced IRAK4 activation and cJun phosphorylation, activated the NF-kappa B pathway and promoted interleukin (IL)-8, IL-6, vascular endothelial growth factor and monocyte chemotactic protein-1 production and resistance to drug-induced apoptosis. Silencing of TLR4 in SCOV3 cells with small interference RNA resulted in phosphorylated-cJun (p-cJun) downregulation and a loss of PTX resistance. In PTX-sensitive, MyD88(neg) A2780 cells, TLR4 stimulation upregulated TRIF, and TLR4 silencing eliminated this effect. Thus, TLR4/MyD88 signaling supports OvCa progression and chemoresistance, promoting immune escape. Oncogene (2009) 28, 4353-4363; doi: 10.1038/onc.2009.289; published online 12 October 2009	[Whiteside, T. L.] Univ Pittsburgh, Dept Pathol, Inst Canc, Sch Med, Pittsburgh, PA 15232 USA; [Szajnik, M.; Spaczynski, M.] Poznan Univ Med Sci, Dept Gynecol Oncol, Poznan, Poland; [Szczepanski, M. J.; Nowak-Markwitz, E.] Poznan Univ Med Sci, Dept Clin Immunol, Poznan, Poland	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Poznan University of Medical Sciences; Poznan University of Medical Sciences	Whiteside, TL (corresponding author), Univ Pittsburgh, Dept Pathol, Inst Canc, Sch Med, 5117 Ctr Ave,Suite 1-27, Pittsburgh, PA 15232 USA.	whitesidetl@upmc.edu	Mandapathil, Magis/AFL-3260-2022; Czystowska-Kuźmicz, Małgorzata/U-7933-2018; Czystowska-Kuzmicz, Malgorzata/AAC-6989-2020; Czystowska-Kuźmicz, Małgorzata/ABH-3220-2020	Czystowska-Kuźmicz, Małgorzata/0000-0001-9169-6194; Czystowska-Kuźmicz, Małgorzata/0000-0001-9169-6194	NIH [PO1 CA109688, NO1-HB37165]; National Heart Lung and Blood Institute (NHLBI); NATIONAL CANCER INSTITUTE [P01CA109688] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B Hilldorfer for technical assistance and the Centre for Biologic Imaging at the University of Pittsburgh for assistance in performing confocal microscopy. This study was supported in part by NIH Grants PO1 CA109688 (TLW) and NO1-HB37165 (TLW) and by Heidi L Browning Ovarian Cancer Research Scholar Fund. Dr Szajnik was supported by the fellowship from the PACT Program of the National Heart Lung and Blood Institute (NHLBI).	Backhed F, 2003, MICROBES INFECT, V5, P951, DOI 10.1016/S1286-4579(03)00189-8; Bayry J, 2004, P NATL ACAD SCI USA, V101, P14210, DOI 10.1073/pnas.0402183101; BEHRENS BC, 1987, CANCER RES, V47, P414; Berek JS, 1999, ANN ONCOL, V10, P87, DOI 10.1023/A:1008323922057; Blagosklonny MV, 1999, INT J CANCER, V83, P151, DOI 10.1002/(SICI)1097-0215(19991008)83:2<151::AID-IJC1>3.0.CO;2-5; Brewer MA, 2003, CLIN CANCER RES, V9, P20; Byrd-Leifer CA, 2001, EUR J IMMUNOL, V31, P2448, DOI 10.1002/1521-4141(200108)31:8&lt;2448::AID-IMMU2448&gt;3.0.CO;2-N; Chuang TH, 2001, BBA-GENE STRUCT EXPR, V1518, P157, DOI 10.1016/S0167-4781(00)00289-X; Cimoli G, 2004, BBA-REV CANCER, V1705, P103, DOI 10.1016/j.bbcan.2004.10.001; Cuello M, 2001, GYNECOL ONCOL, V81, P380, DOI 10.1006/gyno.2001.6194; Duan ZF, 1999, GENE, V229, P75, DOI 10.1016/S0378-1119(99)00042-6; Duan ZF, 2003, CLIN CANCER RES, V9, P2778; Eskan MA, 2008, J IMMUNOL, V180, P1818, DOI 10.4049/jimmunol.180.3.1818; Fitzpatrick FA, 2003, INT IMMUNOPHARMACOL, V3, P1699, DOI 10.1016/j.intimp.2003.08.007; Fukata M, 2008, ONCOGENE, V27, P234, DOI 10.1038/sj.onc.1210908; Gallardo D, 1996, CANCER RES, V56, P4891; Girling JE, 2007, IMMUNOL CELL BIOL, V85, P481, DOI 10.1038/sj.icb.7100086; He WG, 2007, MOL IMMUNOL, V44, P2850, DOI 10.1016/j.molimm.2007.01.022; Hefler LA, 2003, CANCER RES, V63, P3066; Hollstein M, 1997, Recent Results Cancer Res, V143, P369; Huang X, 2005, INVEST OPHTH VIS SCI, V46, P4209, DOI 10.1167/iovs.05-0185; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Kassim SK, 2004, CLIN BIOCHEM, V37, P363, DOI 10.1016/j.clinbiochem.2004.01.014; Kawasaki K, 2001, J ENDOTOXIN RES, V7, P232, DOI 10.1177/09680519010070030701; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Kreuz S, 2004, J CELL BIOL, V166, P369, DOI 10.1083/jcb.200401036; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Lauzon NM, 2006, CELL IMMUNOL, V241, P102, DOI 10.1016/j.cellimm.2006.08.004; Lokshin AE, 2006, GYNECOL ONCOL, V102, P244, DOI 10.1016/j.ygyno.2005.12.011; MacRedmond R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-116; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Marupudi NI, 2007, EXPERT OPIN DRUG SAF, V6, P609, DOI 10.1517/14740338.6.5.609; MCCLURE N, 1994, LANCET, V344, P235, DOI 10.1016/S0140-6736(94)93001-5; Molteni M, 2006, CANCER LETT, V235, P75, DOI 10.1016/j.canlet.2005.04.006; Penson RT, 2000, INT J GYNECOL CANCER, V10, P33, DOI 10.1046/j.1525-1438.2000.00003.x; Petty R, 1998, Pathol Oncol Res, V4, P97; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Siervo-Sassi RR, 2003, CANCER LETT, V190, P61, DOI 10.1016/S0304-3835(02)00579-7; Strauss L, 2007, J IMMUNOL, V178, P320, DOI 10.4049/jimmunol.178.1.320; Szczepanski M, 2007, EUR ARCH OTO-RHINO-L, V264, P525, DOI 10.1007/s00405-006-0215-7; Szczepanski MJ, 2009, CANCER RES, V69, P3105, DOI 10.1158/0008-5472.CAN-08-3838; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeda K, 2007, SEMIN IMMUNOL, V19, P24; Takeuchi O, 1999, GENE, V231, P59, DOI 10.1016/S0378-1119(99)00098-0; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Taxman DJ, 2003, CANCER RES, V63, P5095; Wang TH, 2006, ONCOGENE, V25, P4857, DOI 10.1038/sj.onc.1209498; Yusuf RZ, 2003, CURR CANCER DRUG TAR, V3, P1, DOI 10.2174/1568009033333754; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	49	176	199	1	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 10	2009	28	49					4353	4363		10.1038/onc.2009.289	http://dx.doi.org/10.1038/onc.2009.289			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DT	19826413	Green Accepted			2022-12-25	WOS:000272876400004
J	Lee, C; Tibbetts, AS; Kramer, G; Appling, DR				Lee, Changkeun; Tibbetts, Anne S.; Kramer, Gisela; Appling, Dean R.			Yeast AEP3p Is an Accessory Factor in Initiation of Mitochondrial Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE MITOCHONDRIA; TRANSFER-RNA TRANSFORMYLASE; MESSENGER-RNA; PROTEIN-SYNTHESIS; RIBONUCLEIC-ACID; TERMINAL DOMAIN; GENE; PURIFICATION; BINDING; COX1	Initiation of protein synthesis in mitochondria and chloroplasts normally uses a formylated initiator methionyl-tRNA (fMet-tRNA(f)(Met)). However, mitochondrial protein synthesis in Saccharomyces cerevisiae can initiate with nonformylated Met-tRNA(f)(Met), as demonstrated in yeast mutants in which the nuclear gene encoding mitochondrial methionyl-tRNA formyltransferase (FMT1) has been deleted. The role of formylation of the initiator tRNA is not known, but in vitro formylation increases binding of Met-tRNA(f)(Met) to translation initiation factor 2 (IF2). We hypothesize the existence of an accessory factor that assists mitochondrial IF2 (mIF2) in utilizing unformylated Met-tRNA(f)(Met). This accessory factor might be unnecessary when formylated Met-tRNA(f)(Met) is present but becomes essential when only the unformylated species are available. Using a synthetic petite genetic screen in yeast, we identified a mutation in the AEP3 gene that caused a synthetic respiratory-defective phenotype together with Delta fmt1. The same aep3 mutation also caused a synthetic respiratory defect in cells lacking formylated Met-tRNA(f)(Met) due to loss of the MIS1 gene that encodes the mitochondrial C-1-tetrahydrofolate synthase. The AEP3 gene encodes a peripheral mitochondrial inner membrane protein that stabilizes mitochondrially encoded ATP6/8 mRNA. Here we show that the AEP3 protein (Aep3p) physically interacts with yeast mIF2 both in vitro and in vivo and promotes the binding of unformylated initiator tRNA to yeast mIF2. We propose that Aep3p functions as an accessory initiation factor in mitochondrial protein synthesis.	[Appling, Dean R.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Appling, DR (corresponding author), Univ Texas Austin, Dept Chem & Biochem, 1 Univ Stn A5300, Austin, TX 78712 USA.	dappling@mail.utexas.edu			United States Army Research Office [W911NF-07-1-0040]	United States Army Research Office	This work was supported by United States Army Research Office Grant W911NF-07-1-0040.	Allen GS, 2007, MOL MICROBIOL, V63, P941, DOI 10.1111/j.1365-2958.2006.05574.x; APPLING DR, 1985, J BIOL CHEM, V260, P1248; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan SY, 2003, J BIOL CHEM, V278, P43051, DOI 10.1074/jbc.M308696200; Davies SMK, 2009, FEBS LETT, V583, P1853, DOI 10.1016/j.febslet.2009.04.048; DICKERMA.HW, 1967, J BIOL CHEM, V242, P1522; Ellis TP, 2004, J BIOL CHEM, V279, P15728, DOI 10.1074/jbc.M314162200; EPLER JL, 1970, BIOCHEMISTRY-US, V9, P3575, DOI 10.1021/bi00820a011; FELDMAN F, 1974, J BIOL CHEM, V249, P3702; GALPER JB, 1969, BIOCHEM BIOPH RES CO, V34, P205, DOI 10.1016/0006-291X(69)90633-0; Garofalo C, 2005, ARCH BIOCHEM BIOPHYS, V439, P113, DOI 10.1016/j.abb.2005.05.003; Garofalo C, 2003, ARCH BIOCHEM BIOPHYS, V413, P243, DOI 10.1016/S0003-9861(03)00119-X; Gaur R, 2008, MOL CELL, V29, P180, DOI 10.1016/j.molcel.2007.11.021; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gresham D, 2006, SCIENCE, V311, P1932, DOI 10.1126/science.1123726; GUALERZI CO, 1991, J BIOL CHEM, V266, P16356; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; HALBREICH A, 1971, P NATL ACAD SCI USA, V68, P294, DOI 10.1073/pnas.68.2.294; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kirksey TJ, 1996, ARCH BIOCHEM BIOPHYS, V333, P251, DOI 10.1006/abbi.1996.0388; Koc EC, 2002, J BIOL CHEM, V277, P35541, DOI 10.1074/jbc.M202498200; Krause K, 2004, MOL BIOL CELL, V15, P2674, DOI 10.1091/mbc.E04-02-0126; Kristelly R, 2004, J BIOL CHEM, V279, P47352, DOI 10.1074/jbc.M406056200; LAALAMI S, 1991, BIOCHIMIE, V73, P1557, DOI 10.1016/0300-9084(91)90191-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laursen BS, 2005, MICROBIOL MOL BIOL R, V69, P101, DOI 10.1128/MMBR.69.1.101-123.2005; Li Y, 2000, J BACTERIOL, V182, P2886, DOI 10.1128/JB.182.10.2886-2892.2000; LIAO HX, 1991, J BIOL CHEM, V266, P20714; Ma JH, 1996, J BIOL CHEM, V271, P5805, DOI 10.1074/jbc.271.10.5805; MANTHEY GM, 1995, EMBO J, V14, P4031, DOI 10.1002/j.1460-2075.1995.tb00074.x; Moreno JI, 2009, CURR GENET, V55, P475, DOI 10.1007/s00294-009-0260-z; MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x; Naithani S, 2003, MOL BIOL CELL, V14, P324, DOI 10.1091/mbc.E02-08-0490; Nouet C, 2007, GENETICS, V175, P1105, DOI 10.1534/genetics.106.063883; OGUR M, 1957, SCIENCE, V125, P928, DOI 10.1126/science.125.3254.928; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Pearson BM, 2002, YEAST, V19, P123, DOI 10.1002/yea.809; Perez-Martinez X, 2008, CURR TOP MED CHEM, V8, P1335, DOI 10.2174/156802608786141124; Rackham O, 2009, NUCLEIC ACIDS RES, V37, P5859, DOI 10.1093/nar/gkp627; Ray P, 2008, J BIOL CHEM, V283, P9681, DOI 10.1074/jbc.M710294200; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Rodeheffer MS, 2003, J BIOL CHEM, V278, P18695, DOI 10.1074/jbc.M301399200; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; SHANNON KW, 1988, J BIOL CHEM, V263, P7717; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Simonetti A, 2008, NATURE, V455, P416, DOI 10.1038/nature07192; Spencer AC, 2005, BBA-PROTEINS PROTEOM, V1750, P69, DOI 10.1016/j.bbapap.2005.03.009; Spremulli LL, 2004, PROG NUCLEIC ACID RE, V77, P211, DOI 10.1016/S0079-6603(04)77006-3; SUNDARI RM, 1976, J BIOL CHEM, V251, P3338; Szkaradkiewicz K, 2000, EUR J BIOCHEM, V267, P4290, DOI 10.1046/j.1432-1327.2000.01480.x; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; Takeuchi N, 1998, J BIOL CHEM, V273, P15085, DOI 10.1074/jbc.273.24.15085; Tavares-Carreon F, 2008, J BIOL CHEM, V283, P1472, DOI 10.1074/jbc.M708437200; Tibbetts AS, 2003, J BIOL CHEM, V278, P31774, DOI 10.1074/jbc.M304962200; Tibbetts AS, 2000, J BIOL CHEM, V275, P20920, DOI 10.1074/jbc.M909851199; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Vial L, 2003, BIOCHEMISTRY-US, V42, P932, DOI 10.1021/bi026901x; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200; Westermann B, 2001, METHOD CELL BIOL, V65, P429, DOI 10.1016/S0091-679X(01)65025-8; Williams EH, 2007, GENETICS, V175, P1117, DOI 10.1534/genetics.106.064576; Woodson JD, 2008, NAT REV GENET, V9, P383, DOI 10.1038/nrg2348	63	15	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34116	34125		10.1074/jbc.M109.055350	http://dx.doi.org/10.1074/jbc.M109.055350			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19843529	hybrid, Green Published			2022-12-25	WOS:000272165200044
J	Roca, H; Varsos, ZS; Sud, S; Craig, MJ; Ying, C; Pienta, KJ				Roca, Hernan; Varsos, Zachary S.; Sud, Sudha; Craig, Matthew J.; Ying, Chi; Pienta, Kenneth J.			CCL2 and Interleukin-6 Promote Survival of Human CD11b(+) Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-ASSOCIATED MACROPHAGES; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MANNOSE RECEPTOR; PROSTATE-CANCER; ALTERNATIVE ACTIVATION; IN-VIVO; DEATH; PROGRESSION; CASPASE-8; APOPTOSIS	CCL2 and interleukin (IL)-6 are among the most prevalent cytokines in the tumor microenvironment, with expression generally correlating with tumor progression and metastasis. CCL2 and IL-6 induced expression of each other in CD11b(+) cells isolated from human peripheral blood. It was demonstrated that both cytokines induce up-regulation of the antiapoptotic proteins cFLIPL (cellular caspase-8 (FLICE)-like inhibitory protein), Bcl-2, and Bcl-X-L and inhibit the cleavage of caspase-8 and subsequent activation of the caspase-cascade, thus protecting cells from apoptosis under serum deprivation stress. Furthermore, both cytokines induced hyperactivation of autophagy in these cells. Upon CCL2 or IL-6 stimulation, CD11b(+) cells demonstrated a significant increase in the mannose receptor (CD206) and the CD14(+)/CD206(+) double-positive cells, suggesting a polarization of macrophages toward the CD206(+) M2-type phenotype. Caspase-8 inhibitors mimicked the cytokine-induced up-regulation of autophagy and M2 polarization. Furthermore, E64D and leupeptin, which are able to function as inhibitors of autophagic degradation, reversed the effect of caspase-8 inhibitors in the M2-macrophage polarization, indicating a role of autophagy in this mechanism. Additionally, in patients with advanced castrate-resistant prostate cancer, metastatic lesions exhibited an increased CD14(+)/CD206(+) double-positive cell population compared with normal tissues. Altogether, these findings suggest a role for CCL2 and IL-6 in the survival of myeloid monocytes recruited to the tumor microenvironment and their differentiation toward tumor-promoting M2-type macrophages via inhibition of caspase-8 cleavage and enhanced autophagy.	[Roca, Hernan; Varsos, Zachary S.; Pienta, Kenneth J.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Sud, Sudha; Craig, Matthew J.; Ying, Chi; Pienta, Kenneth J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Pienta, Kenneth J.] Univ Michigan, Michigan Ctr Translat Pathol, Ann Arbor, MI 48109 USA; [Roca, Hernan; Varsos, Zachary S.; Sud, Sudha; Craig, Matthew J.; Ying, Chi; Pienta, Kenneth J.] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Roca, H (corresponding author), 1500 E Med Ctr Dr,7431 CCC, Ann Arbor, MI 48109 USA.	rocach@umich.edu	Pienta, Kenneth/E-7679-2015	Pienta, Kenneth/0000-0002-4138-2186	National Institutes of Health [CA093900, P50 CA69568]; American Cancer Society Clinical Research; Cancer Center [P30CA46592]; Southwest Oncology Group [CA32102]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [P01CA093900, P30CA046592, U10CA032102, P50CA069568] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Clinical Research(American Cancer Society); Cancer Center; Southwest Oncology Group; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA093900 (to K.J.P.). This work was also supported by American Cancer Society Clinical Research Professorship, National Institutes of Health SPORE in Prostate Cancer Grant P50 CA69568, Cancer Center Grant P30CA46592, Southwest Oncology Group Grant CA32102, and funds from the Prostate Cancer Foundation (to K.J.P.).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bell BD, 2008, P NATL ACAD SCI USA, V105, P16677, DOI 10.1073/pnas.0808597105; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Brigati C, 2002, CLIN EXP METASTAS, V19, P247, DOI 10.1023/A:1015587423262; Cavarretta IT, 2007, ONCOGENE, V26, P2822, DOI 10.1038/sj.onc.1210097; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Conti I, 2004, SEMIN CANCER BIOL, V14, P149, DOI 10.1016/j.semcancer.2003.10.009; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Devitt A, 1998, NATURE, V392, P505, DOI 10.1038/33169; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Katsenelson NS, 2001, MODERN PATHOL, V14, P40, DOI 10.1038/modpathol.3880254; Kiener PA, 1997, J EXP MED, V185, P1511, DOI 10.1084/jem.185.8.1511; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; KRUSKAL BA, 1992, J EXP MED, V176, P1673, DOI 10.1084/jem.176.6.1673; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Loberg RD, 2007, CANCER RES, V67, P9417, DOI 10.1158/0008-5472.CAN-07-1286; Loberg RD, 2006, NEOPLASIA, V8, P578, DOI 10.1593/neo.06280; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; MANTOVANI A, 1992, IMMUNOL TODAY, V13, P265, DOI 10.1016/0167-5699(92)90008-U; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P155, DOI 10.1016/j.semcancer.2003.10.001; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; MANTOVANI A, 1994, LAB INVEST, V71, P5; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Menetrier-Caux C, 1998, BLOOD, V92, P4778, DOI 10.1182/blood.V92.12.4778; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nowicki A, 1996, INT J CANCER, V65, P112, DOI 10.1002/(SICI)1097-0215(19960103)65:1<112::AID-IJC19>3.3.CO;2-R; Perlman H, 1999, J EXP MED, V190, P1679, DOI 10.1084/jem.190.11.1679; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Roca H, 2008, J BIOL CHEM, V283, P25057, DOI 10.1074/jbc.M801073200; Roca H, 2008, AUTOPHAGY, V4, P969, DOI 10.4161/auto.6822; SHEPHERD VL, 1990, AM J RESP CELL MOL, V2, P335, DOI 10.1165/ajrcmb/2.4.335; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; SIEGALL CB, 1990, CANCER RES, V50, P7786; STAHL P, 1980, CELL, V19, P207, DOI 10.1016/0092-8674(80)90402-X; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Tricot G, 2000, LANCET, V355, P248, DOI 10.1016/S0140-6736(00)00019-2; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645	49	375	386	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34342	34354		10.1074/jbc.M109.042671	http://dx.doi.org/10.1074/jbc.M109.042671			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19833726	Green Published, hybrid			2022-12-25	WOS:000272165200064
J	Zhao, JP; Zhang, YJ; Ithychanda, SS; Tu, YZ; Chen, K; Qin, J; Wu, CY				Zhao, Jianping; Zhang, Yongjun; Ithychanda, Sujay Subbayya; Tu, Yizeng; Chen, Ka; Qin, Jun; Wu, Chuanyue			Migfilin Interacts with Src and Contributes to Cell-Matrix Adhesion-mediated Survival Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY KINASES; CRYSTAL-STRUCTURE; C-SRC; REGULATES ANOIKIS; CANCER-CELLS; INTEGRINS; APOPTOSIS; GROWTH; BETA; ACTIVATION	Integrin-mediated cell-extracellular matrix (ECM) adhesion is essential for protection of epithelial cells against apoptosis, but the underlying mechanism is incompletely understood. Here we show that migfilin, an integrin-proximal adaptor protein, interacts with Src and contributes to cell-ECM-mediated survival signaling. Loss of cell-ECM adhesion markedly reduces the migfilin level in untransformed epithelial cells and concomitantly induces apoptosis. Overexpression of migfilin substantially desensitizes cell detachment-induced apoptosis. Conversely, depletion of migfilin promotes apoptosis despite the presence of cell-ECM adhesion. At the molecular level migfilin directly interacts with Src, and the migfilin binding surface overlaps with the inhibitory intramolecular interaction sites in Src. Consequently, the binding of migfilin activates Src, resulting in suppression of apoptosis. Our results reveal a novel mechanism by which cell-ECM adhesion regulates Src activation and survival signaling. This migfilin-mediated signaling pathway is dysfunctional in multiple types of carcinoma cells, which likely contributes to aberrant Src activation and anoikis resistance in the cancerous cells.	[Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Sch Med, Pittsburgh, PA 15261 USA; [Ithychanda, Sujay Subbayya; Qin, Jun] Cleveland Clin Fdn, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cleveland Clinic Foundation	Wu, CY (corresponding author), Univ Pittsburgh, Dept Pathol, Sch Med, 707B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	carywu@pitt.edu	Zhao, Jianping/K-5242-2012; Ithychanda, Sujay Subbayya/C-7792-2011; Qin, Jun/D-5559-2009	Ithychanda, Sujay Subbayya/0000-0001-8979-246X; Qin, Jun/0000-0002-2647-9270	National Institutes of Health [GM65188, DK54639, GM62823]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188, R01GM062823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM65188 and DK54639 (to C.W.) and GM62823 (to J.Q.).	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Belsches-Jablonski AP, 2001, ONCOGENE, V20, P1465, DOI 10.1038/sj.onc.1204205; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Chen K, 2008, J BIOL CHEM, V283, P2508, DOI 10.1074/jbc.M707307200; Chiarugi P, 2008, BIOCHEM PHARMACOL, V76, P1352, DOI 10.1016/j.bcp.2008.07.023; Coll ML, 2002, ONCOGENE, V21, P2908, DOI 10.1038/sj.onc.1205388; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DONG Z, 2002, SCI STKE, pPL7; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Ke N, 2004, CANCER RES, V64, P8208, DOI 10.1158/0008-5472.CAN-04-2134; Kloeker S, 2004, J BIOL CHEM, V279, P6824, DOI 10.1074/jbc.M307978200; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Larjava H, 2008, EMBO REP, V9, P1203, DOI 10.1038/embor.2008.202; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Montanez E, 2008, GENE DEV, V22, P1325, DOI 10.1101/gad.469408; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Russello SV, 2004, FRONT BIOSCI-LANDMRK, V9, P139; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Thomas JW, 1998, J BIOL CHEM, V273, P577, DOI 10.1074/jbc.273.1.577; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Van Slyke P, 2005, MOL CELL BIOL, V25, P3831, DOI 10.1128/MCB.25.9.3831-3841.2005; Wang SC, 2001, ONCOGENE, V20, P6960, DOI 10.1038/sj.onc.1204873; Wei L, 2004, ONCOGENE, V23, P9052, DOI 10.1038/sj.onc.1208091; Williams JC, 1997, J MOL BIOL, V274, P757, DOI 10.1006/jmbi.1997.1426; Windham TC, 2002, ONCOGENE, V21, P7797, DOI 10.1038/sj.onc.1205989; Wu CY, 2005, J CELL SCI, V118, P659, DOI 10.1242/jcs.01639; Wu Y, 2002, ONCOGENE, V21, P6801, DOI 10.1038/sj.onc.1205849; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 2008, J BIOL CHEM, V283, P19112, DOI 10.1074/jbc.M709882200; Yamaki N, 2007, EXP CELL RES, V313, P2821, DOI 10.1016/j.yexcr.2007.05.010; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; YU H, 1993, FEBS LETT, V324, P87, DOI 10.1016/0014-5793(93)81538-B; Zhang YJ, 2006, J BIOL CHEM, V281, P12397, DOI 10.1074/jbc.M512107200; Zhang YJ, 2009, J CELL BIOL, V184, P785, DOI 10.1083/jcb.200810155	54	31	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34308	34320		10.1074/jbc.M109.045021	http://dx.doi.org/10.1074/jbc.M109.045021			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19833732	Green Published, hybrid			2022-12-25	WOS:000272165200061
J	Heim, KC; Gamsby, JJ; Hever, MP; Freemantle, SJ; Loros, JJ; Dunlap, JC; Spinella, MJ				Heim, Kelly C.; Gamsby, Joshua J.; Hever, Mary P.; Freemantle, Sarah J.; Loros, Jennifer J.; Dunlap, Jay C.; Spinella, Michael J.			Retinoic Acid Mediates Long-Paced Oscillations in Retinoid Receptor Activity: Evidence for a Potential Role for RIP140	PLOS ONE			English	Article							TRANSCRIPTIONAL COREPRESSOR RIP140; INTERACTING PROTEIN-140; NUCLEAR RECEPTOR; ANDROGEN RECEPTOR; OXIDATIVE-METABOLISM; NEGATIVE-FEEDBACK; ESTROGEN; BINDING; GENE; EXPRESSION	Background: Mechanisms that underlie oscillatory transcriptional activity of nuclear receptors (NRs) are incompletely understood. Evidence exists for rapid, cyclic recruitment of coregulatory complexes upon activation of nuclear receptors. RIP140 is a NR coregulator that represses the transactivation of agonist-bound nuclear receptors. Previously, we showed that RIP140 is inducible by all-trans retinoic acid ( RA) and mediates limiting, negative-feedback regulation of retinoid signaling. Methodology and Findings: Here we report that in the continued presence of RA, long-paced oscillations of retinoic acid receptor (RAR) activity occur with a period ranging from 24 to 35 hours. Endogenous expression of RIP140 and other RA-target genes also oscillate in the presence of RA. Cyclic retinoid receptor transactivation is ablated by constitutive overexpression of RIP140. Further, depletion of RIP140 disrupts cyclic expression of the RA target gene HOXA5. Evidence is provided that RIP140 may limit RAR signaling in a selective, non-redundant manner in contrast to the classic NR coregulators NCoR1 and SRC1 that are not RA-inducible, do not cycle, and may be partially redundant in limiting RAR activity. Finally, evidence is provided that RIP140 can repress and be induced by other nuclear receptors in a manner that suggests potential participation in other NR oscillations. Conclusions and Significance: We provide evidence for novel, long-paced oscillatory retinoid receptor activity and hypothesize that this may be paced in part, by RIP140. Oscillatory NR activity may be involved in mediating hormone actions of physiological and pathological importance.			Heim, KC (corresponding author), Dept Pharmacol & Toxicol, Hanover, NH 03755 USA.	Michael.Spinella@Dartmouth.EDU	Dunlap, Jay/L-6232-2013; Spinella, Michael/B-7210-2014; Loros, Jennifer/B-6293-2014; Gamsby, Joshua J/H-9606-2014	Dunlap, Jay/0000-0003-1577-0457; 	NCI NIH HHS [R01 CA104312, R21 CA124817, T32-CA-009658, R21-CA124817, T32 CA009658, R01-CA104312] Funding Source: Medline; NIGMS NIH HHS [R37 GM034985, R01 GM034985, GM083336, GM034985, R01 GM083336, R01 GM034985-25] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA124817, R01CA104312, T32CA009658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083336, R01GM034985, R37GM034985] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoyagi S, 2008, MOL CELL ENDOCRINOL, V280, P1, DOI 10.1016/j.mce.2007.08.016; Augereau P, 2006, MOL PHARMACOL, V69, P1338, DOI 10.1124/mol.105.017376; Augereau P, 2006, J STEROID BIOCHEM, V102, P51, DOI 10.1016/j.jsbmb.2006.09.005; Buletic Z, 2006, CRIT REV EUKAR GENE, V16, P193, DOI 10.1615/CritRevEukarGeneExpr.v16.i3.10; Carascossa S, 2006, MOL ENDOCRINOL, V20, P1506, DOI 10.1210/me.2005-0286; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen YX, 2004, MOL CELL ENDOCRINOL, V226, P43, DOI 10.1016/j.mce.2004.07.001; Debevec D, 2007, MOL ENDOCRINOL, V21, P1581, DOI 10.1210/me.2007-0103; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Gamsby JJ, 2009, J BIOL RHYTHM, V24, P193, DOI 10.1177/0748730409334748; Gurevich I, 2007, TOXICOL APPL PHARM, V223, P288, DOI 10.1016/j.taap.2007.05.019; Heim KC, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-57; Herzog B, 2007, MOL ENDOCRINOL, V21, P2687, DOI 10.1210/me.2007-0213; Hu XL, 2004, J BIOL CHEM, V279, P319, DOI 10.1074/jbc.M307621200; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kerley JS, 2001, BIOCHEM BIOPH RES CO, V285, P969, DOI 10.1006/bbrc.2001.5274; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Lahav G, 2008, ADV EXP MED BIOL, V641, P28; Lee CH, 1999, J BIOL CHEM, V274, P31320, DOI 10.1074/jbc.274.44.31320; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; LEROY P, 1991, P NATL ACAD SCI USA, V88, P10138, DOI 10.1073/pnas.88.22.10138; Lin R, 2002, MOL ENDOCRINOL, V16, P1243, DOI 10.1210/me.16.6.1243; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Loots G, 2007, BIOINFORMATICS, V23, P122, DOI 10.1093/bioinformatics/btl546; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Nichol D, 2006, J BIOL CHEM, V281, P32140, DOI 10.1074/jbc.M604803200; Niles RM, 2004, MUTAT RES-FUND MOL M, V555, P81, DOI 10.1016/j.mrfmmm.2004.05.020; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Subramaniam N, 1999, J BIOL CHEM, V274, P18121, DOI 10.1074/jbc.274.25.18121; Teboul M, 2008, MOL ENDOCRINOL, V22, P2573, DOI 10.1210/me.2007-0521; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wei LN, 2000, J BIOL CHEM, V275, P40782, DOI 10.1074/jbc.M004821200; White KA, 2003, J BIOL CHEM, V278, P43889, DOI 10.1074/jbc.C300374200; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039	50	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7639	10.1371/journal.pone.0007639	http://dx.doi.org/10.1371/journal.pone.0007639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862326	Green Submitted, Green Published, gold			2022-12-25	WOS:000271194600017
J	Linker, RA; Brechlin, P; Jesse, S; Steinacker, P; Lee, DH; Asif, AR; Jahn, O; Tumani, H; Gold, R; Otto, M				Linker, Ralf A.; Brechlin, Peter; Jesse, Sarah; Steinacker, Petra; Lee, D. H.; Asif, Abdul R.; Jahn, Olaf; Tumani, Hayrettin; Gold, Ralf; Otto, Markus			Proteome Profiling in Murine Models of Multiple Sclerosis: Identification of Stage Specific Markers and Culprits for Tissue Damage	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CLINICALLY ISOLATED SYNDROMES; FIBRILLARY ACIDIC PROTEIN; INTRATHECAL IGM-SYNTHESIS; ANTIMYELIN ANTIBODIES; NERVOUS-SYSTEM; RISK; CNS; GENE; MICE	The identification of new biomarkers is of high interest for the prediction of the disease course and also for the identification of pathomechanisms in multiple sclerosis ( MS). To specify markers of the chronic disease phase, we performed proteome profiling during the later phase of myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis (MOG-EAE, day 35 after immunization) as a model disease mimicking many aspects of secondary progressive MS. In comparison to healthy controls, high resolution 2 dimensional gel electrophoresis revealed a number of regulated proteins, among them glial fibrilary acidic protein (GFAP). Phase specific up-regulation of GFAP in chronic EAE was confirmed by western blotting and immunohistochemistry. Protein levels of GFAP were also increased in the cerebrospinal fluid of MS patients with specificity for the secondary progressive disease phase. In a next step, proteome profiling of an EAE model with enhanced degenerative mechanisms revealed regulation of alpha-internexin, syntaxin binding protein 1, annexin V and glutamate decarboxylase in the ciliary neurotrophic factor ( CNTF) knockout mouse. The identification of these proteins implicate an increased apoptosis and enhanced axonal disintegration and correlate well the described pattern of tissue injury in CNTF-/- mice which involve oligodendrocyte (OL) apoptosis and axonal injury. In summary, our findings underscore the value of proteome analyses as screening method for stage specific biomarkers and for the identification of new culprits for tissue damage in chronic autoimmune demyelination.			Linker, RA (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, D-4630 Bochum, Germany.	markus.otto@uni-ulm.de	Linker, Ralf/AAD-8884-2020; Asif, Abdul Rahman/G-7924-2011; Otto, Markus/F-4304-2015; Jahn, Olaf/AAD-8212-2020; Asif, Abdul R./A-9432-2016	Otto, Markus/0000-0003-4273-4267; Jahn, Olaf/0000-0002-3397-8924; Asif, Abdul R./0000-0002-8581-3187				Alt C, 2005, BRAIN PATHOL, V15, P1; Asif AR, 2006, J PROTEOME RES, V5, P954, DOI 10.1021/pr0504586; Balboni I, 2006, ANNU REV IMMUNOL, V24, P391, DOI 10.1146/annurev.immunol.24.021605.090709; Bielekova B, 2004, BRAIN, V127, P1463, DOI 10.1093/brain/awh176; Brechlin P, 2008, PROTEOMICS, V8, P4357, DOI 10.1002/pmic.200800375; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; Brex PA, 2001, J NEUROL NEUROSUR PS, V70, P390, DOI 10.1136/jnnp.70.3.390; Comabella M, 2007, J NEUROIMMUNOL, V187, P1, DOI 10.1016/j.jneuroim.2007.02.009; Duzhak T, 2003, CELL MOL BIOL, V49, P723; Fossey SC, 2007, J MOL DIAGN, V9, P197, DOI 10.2353/jmoldx.2007.060147; Giovannoni G, 2006, DIS MARKERS, V22, P187, DOI 10.1155/2006/509476; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Ibrahim SM, 2005, CURR OPIN NEUROL, V18, P231, DOI 10.1097/01.wco.0000169738.06664.3b; Ibrahim SM, 2001, BRAIN, V124, P1927, DOI 10.1093/brain/124.10.1927; Jahn O, 2006, ANAL BIOANAL CHEM, V386, P92, DOI 10.1007/s00216-006-0592-1; KOTHAVALE A, 1995, GLIA, V14, P216, DOI 10.1002/glia.440140307; Kroner A, 2005, ANN NEUROL, V58, P50, DOI 10.1002/ana.20514; Kuhle J, 2007, J NEUROL, V254, P160, DOI 10.1007/s00415-006-0299-4; Lassmann H, 2003, BRAIN, V126, P1347, DOI 10.1093/brain/awg127; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Liedtke W, 1998, AM J PATHOL, V152, P251; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Liu T, 2007, J PROTEOME RES, V6, P2565, DOI 10.1021/pr070012k; Lutterotti A, 2007, CURR MED CHEM, V14, P1956; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053; Mergia E, 2003, CELL SIGNAL, V15, P189, DOI 10.1016/S0898-6568(02)00078-5; Norgren N, 2004, NEUROLOGY, V63, P1586, DOI 10.1212/01.WNL.0000142988.49341.D1; Petzold A, 2004, J IMMUNOL METHODS, V287, P169, DOI 10.1016/j.jim.2004.01.015; Petzold A, 2003, J NEUROIMMUNOL, V138, P45, DOI 10.1016/S0165-5728(03)00092-4; Petzold A, 2002, BRAIN, V125, P1462, DOI 10.1093/brain/awf165; Rauer S, 2006, J NEUROL NEUROSUR PS, V77, P739, DOI 10.1136/jnnp.2005.077784; Rejdak K, 2004, NEUROLOGY, V63, P1439; Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859; Schneider R, 2007, EUR J NEUROL, V14, P907, DOI 10.1111/j.1468-1331.2007.01871.x; Schott P, 2008, BASIC RES CARDIOL, V103, P232, DOI 10.1007/s00395-008-0696-1; Steinacker P, 2005, MOL CELL BIOL, V25, P1339, DOI 10.1128/MCB.25.4.1339-1346.2005; Sturzebecher S, 2003, BRAIN, V126, P1419, DOI 10.1093/brain/awg147; Tastet C, 2003, ELECTROPHORESIS, V24, P1787, DOI 10.1002/elps.200305400; Tintore M, 2006, NEUROLOGY, V67, P968, DOI 10.1212/01.wnl.0000237354.10144.ec; Villar LM, 2005, J CLIN INVEST, V115, P187, DOI 10.1172/JCI200522833; Villar LM, 2003, ANN NEUROL, V53, P222, DOI 10.1002/ana.10441; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Werner P, 2000, ADV RES NEURODEGENER, V8, P375; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077	47	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7624	10.1371/journal.pone.0007624	http://dx.doi.org/10.1371/journal.pone.0007624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19865482	Green Published, gold			2022-12-25	WOS:000271194600013
J	Roeth, JF; Sawyer, JK; Wilner, DA; Peifer, M				Roeth, Jeremiah F.; Sawyer, Jessica K.; Wilner, Daniel A.; Peifer, Mark			Rab11 Helps Maintain Apical Crumbs and Adherens Junctions in the Drosophila Embryonic Ectoderm	PLOS ONE			English	Article							MESSENGER-RNA LOCALIZATION; E-CADHERIN TRAFFICKING; CELL-CELL ADHESION; P120 CATENIN; EPITHELIAL MORPHOGENESIS; POLARITY; MEMBRANE; ENDOCYTOSIS; HOMOLOG; COMPLEX	Background: Tissue morphogenesis and organogenesis require that cells retain stable cell-cell adhesion while changing shape and moving. One mechanism to accommodate this plasticity in cell adhesion involves regulated trafficking of junctional proteins. Methodology/ Principal Findings: Here we explored trafficking of junctional proteins in two well-characterized model epithelia, the Drosophila embryonic ectoderm and amnioserosa. We find that DE-cadherin, the transmembrane protein of adherens junctions, is actively trafficked through putative vesicles, and appears to travel through both Rab5-positive and Rab11-positive structures. We manipulated the functions of Rab11 and Rab5 to examine the effects on junctional stability and morphogenesis. Reducing Rab11 function, either using a dominant negative construct or loss of function alleles, disrupts integrity of the ectoderm and leads to loss of adherens junctions. Strikingly, the apical junctional regulator Crumbs is lost before AJs are destabilized, while the basolateral protein Dlg remains cortical. Altering Rab5 function had less dramatic effects, not disrupting adherens junction integrity but affecting dorsal closure. Conclusions/Significance: We contrast our results with what others saw when disrupting other trafficking regulators, and when disrupting Rab function in other tissues; together these data suggest distinct mechanisms regulate junctional stability and plasticity in different tissues.			Roeth, JF (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	peifer@unc.edu	Tsai, Yu-Chen/B-5852-2008	Sawyer, Jessica/0000-0001-9026-0559; Peifer, Mark/0000-0003-1412-3987; Wilner, David/0000-0003-1526-7587	NIGMS NIH HHS [R01 GM047857, R01GM47857] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047857] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beronja S, 2005, J CELL BIOL, V169, P635, DOI 10.1083/jcb.200410081; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Blankenship JT, 2007, J CELL SCI, V120, P3099, DOI 10.1242/jcs.004770; Bloor JW, 2002, DEVELOPMENT, V129, P3173; Bogard N, 2007, DEVELOPMENT, V134, P3413, DOI 10.1242/dev.008466; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Cao J, 2008, J CELL BIOL, V182, P301, DOI 10.1083/jcb.200712036; Chen N, 2003, NEUROSCIENCE, V120, P163, DOI 10.1016/S0306-4522(03)00259-8; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Chiasson CM, 2009, MOL BIOL CELL, V20, P1970, DOI 10.1091/mbc.E08-07-0735; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Delva E, 2009, TRAFFIC, V10, P259, DOI 10.1111/j.1600-0854.2008.00862.x; Desclozeaux M, 2008, AM J PHYSIOL-CELL PH, V295, pC545, DOI 10.1152/ajpcell.00097.2008; Dollar G, 2002, DEVELOPMENT, V129, P517; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Fox DT, 2007, DEVELOPMENT, V134, P567, DOI 10.1242/dev.02748; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Fujita Yasuyuki, 2005, Novartis Found Symp, V269, P144; Fujita Y, 2006, METHOD ENZYMOL, V407, P359, DOI 10.1016/S0076-6879(05)07030-8; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Jankovics F, 2001, GENETICS, V158, P1177; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kerman BE, 2008, DEV BIOL, V320, P278, DOI 10.1016/j.ydbio.2008.05.541; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; Lien WH, 2006, CURR OPIN CELL BIOL, V18, P499, DOI 10.1016/j.ceb.2006.07.001; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Magie CR, 1999, DEVELOPMENT, V126, P5353; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Pacquelet A, 2003, J CELL BIOL, V160, P313, DOI 10.1083/jcb.200207160; Pelissier A, 2003, CURR BIOL, V13, P1848, DOI 10.1016/j.cub.2003.10.023; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Pettitt J, 2003, J CELL BIOL, V162, P15, DOI 10.1083/jcb.200212136; Prekeris Rytis, 2003, ScientificWorldJournal, V3, P870; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Sasikumar S, 2009, GENESIS, V47, P32, DOI 10.1002/dvg.20441; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Shaye DD, 2008, NAT CELL BIOL, V10, P964, DOI 10.1038/ncb1756; Shimizu H, 2003, J CELL SCI, V116, P3583, DOI 10.1242/jcs.00676; Suzuki SC, 2008, DEV GROWTH DIFFER, V50, pS119, DOI 10.1111/j.1440-169X.2008.01002.x; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Tiwari AK, 2009, EUR J CELL BIOL, V88, P445, DOI 10.1016/j.ejcb.2009.02.188; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Warner SJ, 2009, J CELL BIOL, V187, P119, DOI [10.1083/jcb.200906047, 10.1083/jcb.200901029]; Wieschaus E., 1986, P199; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008	68	75	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7634	10.1371/journal.pone.0007634	http://dx.doi.org/10.1371/journal.pone.0007634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862327	gold, Green Published, Green Submitted			2022-12-25	WOS:000271194600016
J	Riddell, C; Adams, S; Schmid-Hempel, P; Mallon, EB				Riddell, Carolyn; Adams, Sally; Schmid-Hempel, Paul; Mallon, Eamonn B.			Differential Expression of Immune Defences Is Associated with Specific Host-Parasite Interactions in Insects	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE GENES; FIBRINOGEN-RELATED PROTEINS; DROSOPHILA-MELANOGASTER; EVOLUTIONARY ECOLOGY; APIS-MELLIFERA; INFECTION; CRITHIDIA; BACTERIAL; PATHWAY; SYSTEMS	Recent ecological studies in invertebrates show that the outcome of an infection is dependent on the specific pairing of host and parasite. Such specificity contrasts the long-held view that invertebrate innate immunity depends on a broad-spectrum recognition system. An important question is whether this specificity is due to the immune response rather than some other interplay between host and parasite genotypes. By measuring the expression of putative bumblebee homologues of antimicrobial peptides in response to infection by their gut trypanosome Crithidia bombi, we demonstrate that expression differences are associated with the specific interactions.			Riddell, C (corresponding author), Univ Leicester, Dept Biol, Leicester, Leics, England.	paul.schmid-hempel@env.ethz.ch	Mallon, Eamonn/H-1834-2011	Mallon, Eamonn/0000-0002-4198-4611; Adams, Sally/0000-0002-3353-7459; Riddell, Carolyn/0000-0003-0089-9135	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Boulanger N, 2004, INFECT IMMUN, V72, P7140, DOI 10.1128/IAI.72.12.7140-7146.2004; Boulanger N, 2002, INSECT BIOCHEM MOLEC, V32, P369, DOI 10.1016/S0965-1748(02)00029-2; Boulanger N, 2001, INSECT BIOCHEM MOLEC, V31, P129, DOI 10.1016/S0965-1748(00)00096-5; Boulanger N, 2006, TRENDS PARASITOL, V22, P262, DOI 10.1016/j.pt.2006.04.003; Du Pasquier L, 2005, SCIENCE, V309, P1826, DOI 10.1126/science.1118828; Evans JD, 2005, EVOLUTION, V59, P2270, DOI 10.1111/j.0014-3820.2005.tb00935.x; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Hauton C, 2007, BIOESSAYS, V29, P1138, DOI 10.1002/bies.20650; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Schluns H, 2007, INSECT MOL BIOL, V16, P753, DOI 10.1111/j.1365-2583.2007.00768.x; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schmid-Hempel P, 1999, EVOLUTION, V53, P426, DOI 10.1111/j.1558-5646.1999.tb03778.x; Schmid-Hempel P, 2004, PARASITOLOGY, V129, P147, DOI 10.1017/S0031182004005542; Schmid-Hempel P, 2005, BIOESSAYS, V27, P1026, DOI 10.1002/bies.20282; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Wang XG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-114; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Zhang SM, 2004, GENE, V341, P255, DOI 10.1016/j.gene.2004.07.003	21	47	47	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7621	10.1371/journal.pone.0007621	http://dx.doi.org/10.1371/journal.pone.0007621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859547	Green Published, gold			2022-12-25	WOS:000271147400017
J	Wu, HQ; Ye, CT; Ramirez, D; Manjunath, N				Wu, Haoquan; Ye, Chunting; Ramirez, Danielle; Manjunath, N.			Alternative Processing of Primary microRNA Transcripts by Drosha Generates 5 ' End Variation of Mature microRNA	PLOS ONE			English	Article							C-ELEGANS; RNA-INTERFERENCE; POSTTRANSCRIPTIONAL REGULATION; MICROPROCESSOR COMPLEX; DICER; EXPRESSION; MATURATION; ENZYME; DROSOPHILA; CLEAVAGE	Background: It is generally believed that the miRNA processing machinery ensures the generation of a mature miRNA with a fixed sequence, particularly at its 59 end. However, we and others have recently noted that the ends of a given mature miRNA are not absolutely fixed, but subject to variation. Neither the significance nor the mechanism behind the generation of such miRNA polymorphism is understood. miR-142 is an abundantly expressed miRNA in hematopoietic cells and exhibits a high frequency of 59 end polymorphism. Methodology/Principal Findings: Here we show that a shift in the Drosha processing of pri-miRNA generates multiple forms of miR-142s in vivo with differing 59 ends that might target different genes. Sequence analysis of several pre-miRNA ends cloned from T cells reveals that unlike many other pri-miRNAs that are processed into a single pre-miRNA, pri-miR-142 is processed into 3 distinct pre-miR-142s. Dicer processing studies suggest that each of the 3 pre-miR-142s is processed into a distinct double-stranded miRNA, giving rise to 4 mature miRNA variants that might regulate different target gene pools. Conclusions/Significance: Thus, alternative Drosha processing might be a novel mechanism for diversification of the miRNA target gene pool.			Wu, HQ (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Infect Dis Res, Dept Biomed Sci,Paul L Foster Sch Med, El Paso, TX USA.	haoquan.wu@ttuhsc.edu; manjunath.swamy@ttuhsc.edu		Wu, Haoquan/0000-0001-9386-3187	PHS HHS [U01A1075419] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basyuk E, 2003, NUCLEIC ACIDS RES, V31, P6593, DOI 10.1093/nar/gkg855; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chivukula RR, 2008, TRENDS BIOCHEM SCI, V33, P474, DOI 10.1016/j.tibs.2008.06.008; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Ye XC, 2007, J BIOL CHEM, V282, P28373, DOI 10.1074/jbc.M705208200; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	53	103	105	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7566	10.1371/journal.pone.0007566	http://dx.doi.org/10.1371/journal.pone.0007566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859542	Green Submitted, Green Published, gold			2022-12-25	WOS:000271147400002
J	Salehzada, T; Cambier, L; Thi, NV; Manchon, L; Regnier, L; Bisbal, C				Salehzada, Tamim; Cambier, Linda; Thi, Nga Vu; Manchon, Laurent; Regnier, Laetitia; Bisbal, Catherine			Endoribonuclease L (RNase L) Regulates the Myogenic and Adipogenic Potential of Myogenic Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SKELETAL-MUSCLE REGENERATION; BINDING PROTEIN; SATELLITE CELLS; TRANSCRIPTIONAL REPRESSOR; MUSCULAR-DYSTROPHY; INTERFERON SYSTEM; C2C12 MYOBLASTS; GENE-EXPRESSION; SELF-RENEWAL	Skeletal muscle maintenance and repair involve several finely coordinated steps in which pluripotent stem cells are activated, proliferate, exit the cell cycle and differentiate. This process is accompanied by activation of hundreds of muscle-specific genes and repression of genes associated with cell proliferation or pluripotency. Mechanisms controlling myogenesis are precisely coordinated and regulated in time to allow the sequence of activation/inactivation of genes expression. Muscular differentiation is the result of the interplay between several processes such as transcriptional induction, transcriptional repression and mRNA stability. mRNA stability is now recognized as an essential mechanism of control of gene expression. For instance, we previously showed that the endoribonuclease L (RNase L) and its inhibitor (RLI) regulates MyoD mRNA stability and consequently muscle differentiation. We now performed global gene expression analysis by SAGE to identify genes that were down-regulated upon activation of RNase L in C2C12 myogenic cells, a model of satellite cells. We found that RNase L regulates mRNA stability of factors implicated in the control of pluripotency and cell differentiation. Moreover, inappropriate RNase L expression in C2C12 cells led to inhibition of myogenesis and differentiation into adipocytes even when cells were grown in conditions permissive for muscle differentiation. Conversely, over-expression of RLI allowed muscle differentiation of myogenic C2C12 cells even in non permissive conditions. These findings reveal the central role of RNase L and RLI in controlling gene expression and cell fate during myogenesis. Our data should provide valuable insights into the mechanisms that control muscle stem cell differentiation and into the mechanism of metaplasia observed in aging or muscular dystrophy where adipose infiltration of muscle occurs.			Salehzada, T (corresponding author), Univ Montpellier 1, CHU Arnaud de Villeneuve, EA4202, INSERM ESPRI Muscle & Pathol 25, Montpellier, France.	Catherine.bisbal@inserm.fr	Bisbal, Catherine/I-6984-2016; Linda, Cambier/AAL-9928-2020	Bisbal, Catherine/0000-0003-1086-020X; Linda, Cambier/0000-0001-9482-1413; MANCHON, Laurent/0000-0001-9242-4385				Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Alisi A, 2008, CELL SIGNAL, V20, P534, DOI 10.1016/j.cellsig.2007.11.006; Arnold HH, 1996, INT J DEV BIOL, V40, P345; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; BIRNBAUM M, 1990, DIFFERENTIATION, V45, P138, DOI 10.1111/j.1432-0436.1990.tb00467.x; BIRNBAUM M, 1993, VIROLOGY, V194, P865, DOI 10.1006/viro.1993.1332; BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; BISBAL C, 1987, BIOCHEMISTRY-US, V26, P5172, DOI 10.1021/bi00390a041; Bisbal C, 2000, MOL CELL BIOL, V20, P4959, DOI 10.1128/MCB.20.14.4959-4969.2000; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Castelli JC, 1998, CELL DEATH DIFFER, V5, P313, DOI 10.1038/sj.cdd.4400352; Cheng M, 2008, AM J PHYSIOL-CELL PH, V294, pC1183, DOI 10.1152/ajpcell.00568.2007; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; COOK JS, 1988, P NATL ACAD SCI USA, V85, P2949, DOI 10.1073/pnas.85.9.2949; De Rossi M, 2000, INT IMMUNOL, V12, P1329, DOI 10.1093/intimm/12.9.1329; Dulor JP, 1998, FEBS LETT, V439, P89, DOI 10.1016/S0014-5793(98)01216-2; FLOYDSMITH G, 1981, SCIENCE, V212, P1030, DOI 10.1126/science.6165080; Formigli L, 2005, J CELL SCI, V118, P1161, DOI 10.1242/jcs.01695; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; GARD DL, 1980, CELL, V19, P263, DOI 10.1016/0092-8674(80)90408-0; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Holst D, 2003, EXP CELL RES, V288, P168, DOI 10.1016/S0014-4827(03)00179-4; Hovanessian AG, 2007, BIOCHIMIE, V89, P779, DOI 10.1016/j.biochi.2007.02.003; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Huang HY, 2005, BIOCHEM BIOPH RES CO, V338, P1185, DOI 10.1016/j.bbrc.2005.10.057; KACHINSKY AM, 1994, DEV BIOL, V165, P216, DOI 10.1006/dbio.1994.1248; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Khabar KSA, 2007, BIOCHIMIE, V89, P761, DOI 10.1016/j.biochi.2007.02.008; KIESS M, 1995, ONCOGENE, V10, P61; Kim SW, 2001, J BIOL CHEM, V276, P10199, DOI 10.1074/jbc.M010640200; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kobayashi O, 1996, NEUROLOGY, V46, P815, DOI 10.1212/WNL.46.3.815; Kronfeld-Kinar Y, 1999, CELL GROWTH DIFFER, V10, P201; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Le Roy F, 2007, CELL DEATH DIFFER, V14, P1406, DOI 10.1038/sj.cdd.4402130; Le Roy F, 2005, NAT STRUCT MOL BIOL, V12, P505, DOI 10.1038/nsmb944; Malathi K, 2005, P NATL ACAD SCI USA, V102, P14533, DOI 10.1073/pnas.0507551102; Malathi K, 2004, CANCER RES, V64, P9144, DOI 10.1158/0008-5472.CAN-04-2226; Marden FA, 2005, SKELETAL RADIOL, V34, P140, DOI 10.1007/s00256-004-0825-3; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Melchior K, 2008, BIOL CHEM, V389, P897, DOI 10.1515/BC.2008.108; Milligan L, 2000, ONCOGENE, V19, P5810, DOI 10.1038/sj.onc.1203965; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Pandey Mitali, 2004, RNA Biol, V1, P21; Pereira RC, 2007, BONE, V40, P619, DOI 10.1016/j.bone.2006.09.028; Piquemal D, 2002, GENOMICS, V80, P361, DOI 10.1006/geno.2002.6836; Remels AH, 2007, CLIN CHEST MED, V28, P537, DOI 10.1016/j.ccm.2007.06.003; SALZBERG S, 1995, EXP CELL RES, V220, P509; Salzberg S, 2000, EXP CELL RES, V254, P45, DOI 10.1006/excr.1999.4721; SALZBERG S, 1995, EXP CELL RES, V219, P223, DOI 10.1006/excr.1995.1222; Sbrana F, 2008, AM J PHYSIOL-CELL PH, V295, pC160, DOI 10.1152/ajpcell.00014.2008; Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Taylor-Jones JM, 2002, MECH AGEING DEV, V123, P649, DOI 10.1016/S0047-6374(01)00411-0; Te Velthuis Aartjan J W, 2007, PLoS One, V2, pe189, DOI 10.1371/journal.pone.0000189; TEBOUL L, 1995, J BIOL CHEM, V270, P28183, DOI 10.1074/jbc.270.47.28183; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Ura H, 2008, J BIOL CHEM, V283, P9713, DOI 10.1074/jbc.M707275200; Vallenius T, 2004, EXP CELL RES, V293, P117, DOI 10.1016/j.yexcr.2003.09.004; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wagatsuma A, 2006, EXP PHYSIOL, V91, P747, DOI 10.1113/expphysiol.2006.033662; Wang H, 2002, J INTERF CYTOK RES, V22, P729, DOI 10.1089/10799900260100231; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; WHITAKER JR, 1980, ANAL BIOCHEM, V109, P156, DOI 10.1016/0003-2697(80)90024-X; WRESCHNER DH, 1982, EUR J BIOCHEM, V124, P261; WRESCHNER DH, 1981, NUCLEIC ACIDS RES, V9, P1571, DOI 10.1093/nar/9.7.1571; YAFFE D, 1977, DIFFERENTIATION, V7, P159, DOI 10.1111/j.1432-0436.1977.tb01507.x; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	83	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7563	10.1371/journal.pone.0007563	http://dx.doi.org/10.1371/journal.pone.0007563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851509	Green Published, gold, Green Submitted			2022-12-25	WOS:000271022300008
J	Kahai, S; Lee, SC; Lee, DY; Yang, J; Li, MH; Wang, CH; Jiang, ZD; Zhang, Y; Peng, C; Yang, BB				Kahai, Shireen; Lee, Shao-Chen; Lee, Daniel Y.; Yang, Jennifer; Li, Minhui; Wang, Chia-Hui; Jiang, Zide; Zhang, Yaou; Peng, Chun; Yang, Burton B.			MicroRNA miR-378 Regulates Nephronectin Expression Modulating Osteoblast Differentiation by Targeting GalNT-7	PLOS ONE			English	Article							STEM-CELL DIVISION; PRODUCT SECRETION; G3 DOMAIN; GLYCOSAMINOGLYCAN MODIFICATION; EMBRYONIC-DEVELOPMENT; INSULIN-SECRETION; GENE-REGULATION; BREAST-CANCER; GROWTH; MIRNA	MicroRNAs (miRNAs) are small fragments of single-stranded RNA containing 18-24 nucleotides, and are generated from endogenous transcripts. MicroRNAs function in post-transcriptional gene silencing by targeting the 3'-untranslated region (UTR) of mRNAs, resulting in translational repression. We have developed a system to study the role of miRNAs in cell differentiation. We have found that one of the miRNAs tested in our system (miR-378, also called miR-378*) plays a role in modulating nephronectin-mediated differentiation in the osteoblastic cell line, MC3T3-E1. Nephronectin is an extracellular matrix protein, and we have demonstrated that its over-expression enhanced osteoblast differentiation and bone nodule formation. Furthermore, we found that the nephronectin 3'-untranslated region (3'UTR) contains a binding site for miR-378. Stable transfection of MC3T3-E1 cells with miR-378 inhibited cell differentiation. MC3T3-E1 cells stably transfected with nephronectin exhibited higher rates of differentiation and nodule formation as compared with cells transfected with nephronectin containing the 3'UTR in the early stages of development, suggesting that endogenous miR-378 is present and active. However, in the later stages of MC3T3-E1 development, the differentiation rates were opposite, with higher rates of differentiation and nodule formation in the cells over-expressing the 3'UTR of nephronectin. This appeared to be the consequence of competition between nephronectin and UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalac-tosaminyltransferase 7 (GalNAc-T7 or GalNT7) for miR-378 binding, resulting in increased GalNT7 activity, which in turn lead to increased nephronectin glycosylation and product secretion, thereby resulting in a higher rate of osteoblast differentiation.			Kahai, S (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada.	byang@sri.utoronto.ca			Canadian Institutes of Health Research [MOP89931] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; BINETTE F, 1994, J BIOL CHEM, V269, P19116; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen LW, 2002, J BIOL CHEM, V277, P2657, DOI 10.1074/jbc.M101153200; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kawasaki H, 2003, NATURE, V426, P100, DOI 10.1038/nature02141; Kiani C, 2001, BIOCHEM J, V354, P199, DOI 10.1042/0264-6021:3540199; Laneve P, 2007, P NATL ACAD SCI USA, V104, P7957, DOI 10.1073/pnas.0700071104; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; LI Z, 2008, P NATL ACAD SCI US; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mello CC, 2004, NAT MED, V10, P1297, DOI 10.1038/nm1204-1297; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Morton SU, 2008, P NATL ACAD SCI USA, V105, P17830, DOI 10.1073/pnas.0804673105; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Poliseno L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002542; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rubartelli A, 1997, EUR J IMMUNOL, V27, P1893, DOI 10.1002/eji.1830270812; Ruvkun G, 2006, SCIENCE, V311, P36; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Salter KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001908; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang BL, 2000, J BIOL CHEM, V275, P21255, DOI 10.1074/jbc.M001443200; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang Y, 1998, J BIOL CHEM, V273, P33054, DOI 10.1074/jbc.273.49.33054; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	63	139	145	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7535	10.1371/journal.pone.0007535	http://dx.doi.org/10.1371/journal.pone.0007535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844573	gold, Green Published, Green Submitted			2022-12-25	WOS:000271013000013
J	Bilodeau, M; MacRae, T; Gaboury, L; Laverdure, JP; Hardy, MP; Mayotte, N; Paradis, V; Harton, S; Perreault, C; Sauvageau, G				Bilodeau, Melanie; MacRae, Tara; Gaboury, Louis; Laverdure, Jean-Philippe; Hardy, Marie-Pierre; Mayotte, Nadine; Paradis, Veronique; Harton, Sebastien; Perreault, Claude; Sauvageau, Guy			Analysis of Blood Stem Cell Activity and Cystatin Gene Expression in a Mouse Model Presenting a Chromosomal Deletion Encompassing Csta and Stfa2l1	PLOS ONE			English	Article							STEFIN-A; PROGNOSTIC-SIGNIFICANCE; CYSTEINE CATHEPSINS; GASTRIC-CARCINOMA; TISSUE-LEVELS; CANCER; MICE; METASTASIS; PROTEIN; OVEREXPRESSION	The cystatin protein superfamily is characterized by the presence of conserved sequences that display cysteine protease inhibitory activity (e.g., towards cathepsins). Type 1 and 2 cystatins are encoded by 25 genes of which 23 are grouped in 2 clusters localized on mouse chromosomes 16 and 2. The expression and essential roles of most of these genes in mouse development and hematopoiesis remain poorly characterized. In this study, we describe a set of quantitative real-time PCR assays and a global expression profile of cystatin genes in normal mouse tissues. Benefiting from our collection of DelES embryonic stem cell clones harboring large chromosomal deletions (to be reported elsewhere), we selected a clone in which a 95-kb region of chromosome 16 is missing (Del(16qB3 Delta/+)). In this particular clone, 2 cystatin genes, namely Csta and Stfa2l1 are absent along with 2 other genes (Fam162a, Ccdc58) and associated intergenic regions. From this line, we established a new homozygous mutant mouse model (Del(16qB3 Delta/16qB3 Delta)) to assess the in vivo biological functions of the 2 deleted cystatins. Stfa2l1 gene expression is high in wild-type fetal liver, bone marrow, and spleen, while Csta is ubiquitously expressed. Homozygous Del(16qB3 Delta/16qB3 Delta) animals are phenotypically normal, fertile, and not overtly susceptible to spontaneous or irradiation-induced tumor formation. The hematopoietic stem and progenitor cell activity in these mutant mice are also normal. Interestingly, quantitative real-time PCR expression profiling reveals a marked increase in the expression levels of Stfa2l1/Csta phylogenetically-related genes (Stfa1, Stfa2, and Stfa3) in Del(16qB3 Delta/16qB3 Delta) hematopoietic tissues, suggesting that these candidate genes might be contributing to compensatory mechanisms. Overall, this study presents an optimized approach to globally monitor cystatin gene expression as well as a new mouse model deficient in Stfa2l1/Csta genes, expanding the available tools to dissect cystatin roles under normal and pathological conditions.			Bilodeau, M (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada.	guy.sauvageau@umontreal.ca	Perreault, Claude/A-7220-2008	Perreault, Claude/0000-0001-9453-7383; Bilodeau, Melanie/0000-0001-7648-1021; Sauvageau, Guy/0000-0002-4333-7266	Canadian Institutes of Health Research [82814] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Bijl J, 2008, ONCOGENE, V27, P6356, DOI 10.1038/onc.2008.233; Bilodeau M, 2007, NAT METHODS, V4, P263, DOI 10.1038/NMETH1011; Cho YE, 2009, HUM PATHOL, V40, P975, DOI 10.1016/j.humpath.2008.12.007; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Jackson RJ, 2003, CANCER RES, V63, P3021; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee MJ, 2004, MOL CELL BIOL, V24, P3918, DOI 10.1128/MCB.24.9.3918-3927.2004; Li WD, 2005, CLIN CANCER RES, V11, P8753, DOI 10.1158/1078-0432.CCR-05-0597; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; MLINARICRASCAN I, 1994, AM J PATHOL, V145, P902; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Parker BS, 2008, J PATHOL, V214, P337, DOI 10.1002/path.2265; Primoz S, 2008, HISTOPATHOLOGY, V53, P612, DOI 10.1111/j.1365-2559.2008.03142.x; Roesch-Ely M, 2007, ONCOGENE, V26, P54, DOI 10.1038/sj.onc.1209770; Roper RJ, 2003, J IMMUNOL, V170, P5886, DOI 10.4049/jimmunol.170.12.5886; Russo A, 2000, CLIN CANCER RES, V6, P178; Sauvageau G, 1997, IMMUNITY, V6, P13, DOI 10.1016/S1074-7613(00)80238-1; Sauvageau M, 2008, BLOOD, V111, P790, DOI 10.1182/blood-2007-07-098236; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Werle B, 2006, ONCOL REP, V16, P647; Zavasnik-Bergant T, 2006, TISSUE ANTIGENS, V67, P349, DOI 10.1111/j.1399-0039.2006.00585.x; Zavasnik-Bergant T, 2008, FRONT BIOSCI-LANDMRK, V13, P4625, DOI 10.2741/3028	28	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7500	10.1371/journal.pone.0007500	http://dx.doi.org/10.1371/journal.pone.0007500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838297	Green Submitted, Green Published, gold			2022-12-25	WOS:000270880900006
J	Safadi, SS; Shaw, GS				Safadi, Susan S.; Shaw, Gary S.			Differential Interaction of the E3 Ligase Parkin with the Proteasomal Subunit S5a and the Endocytic Protein Eps15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-LIKE DOMAIN; TRIPLE-RESONANCE NMR; JUVENILE PARKINSONISM; BINDING DOMAINS; ALPHA-SYNUCLEIN; GENE-PRODUCT; DISEASE; MOTIF; SPECTROSCOPY; RECOGNITION	Parkin is a multidomain E3 ligase associated with autosomal recessive Parkinson disease. The N-terminal ubiquitin-like domain (Ubld) of parkin functions with the S5a proteasomal subunit, positioning substrate proteins for degradation. In addition the parkin Ubld recruits the endocytotic protein Eps15, allowing the E3 ligase to ubiquinate Eps15 distal from its parkin-interacting site. The recognition sequences in the S5a subunit and Eps15 for the parkin Ubld are ubiquitin-interacting motifs (UIM). Each protein has two UIM sequences separated by a 50-residue spacer in S5a, but only similar to 5 residues in Eps15. In this work we used NMR spectroscopy to determine how the parkin Ubld recognizes the proteasomal subunit S5a compared with Eps15, a substrate for ubiquitination. We show that Eps15 contains two flexible alpha-helices each encompassing a UIM sequence. The alpha-helix surrounding UIM II is longer than that for UIM I, a situation that is reversed from S5a. Furthermore, we show the parkin Ubld preferentially binds to UIM I in the S5a subunit. This interaction is strongly diminished in a K48A substitution, found near the center of the S5a interacting surface on the parkin Ubld. In contrast to S5a, parkin recruits Eps15 using both its UIM sequences resulting in a larger interaction surface that includes residues from beta 1 and beta 2, not typically known to interact with UIM sequences. These results show that the parkin Ubld uses differential surfaces to recruit UIM regions from the S5a proteasomal subunit compared with Eps15 involved in cell signaling.	[Safadi, Susan S.; Shaw, Gary S.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Shaw, GS (corresponding author), Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada.	gshaw1@uwo.ca	Shaw, Gary S./C-7656-2009	Shaw, Gary S./0000-0002-4685-9625	Canadian Institutes of Health Research; Canada Research Chairs Program; Canadian Institutes of Health Research Doctoral Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Canadian Institutes of Health Research Doctoral Scholarship(Canadian Institutes of Health Research (CIHR))	This work was supported by research and maintenance grants from the Canadian Institutes of Health Research (to G.S.S.), an award from the Canada Research Chairs Program (to G.S.S.), and a Canadian Institutes of Health Research Doctoral Scholarship (to S.S.S.).	Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dev KK, 2003, NEUROPHARMACOLOGY, V45, P1, DOI 10.1016/S0028-3908(02)00337-4; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; HAAS AL, 1985, J BIOL CHEM, V260, P2464; Harris RK, 2002, SOLID STATE NUCL MAG, V22, P458, DOI 10.1006/snmr.2002.0063; Hartmann-Petersen R, 2004, SEMIN CELL DEV BIOL, V15, P247, DOI 10.1016/j.semcdb.2003.12.006; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; Hodgins R, 1996, J BIOL CHEM, V271, P28766, DOI 10.1074/jbc.271.46.28766; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Hristova VA, 2009, J BIOL CHEM, V284, P14978, DOI 10.1074/jbc.M808700200; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Imai Y, 2001, CELL, V105, P891, DOI 10.1016/S0092-8674(01)00407-X; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Masutani C, 1997, MOL CELL BIOL, V17, P6915, DOI 10.1128/MCB.17.12.6915; Matsumine H, 1997, AM J HUM GENET, V60, P588; Morett E, 1999, TRENDS BIOCHEM SCI, V24, P229, DOI 10.1016/S0968-0004(99)01381-X; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Regan-Klapisz E, 2005, J CELL SCI, V118, P4437, DOI 10.1242/jcs.02571; Safadi SS, 2007, BIOCHEMISTRY-US, V46, P14162, DOI 10.1021/bi7016969; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Sato S, 2006, EMBO J, V25, P211, DOI 10.1038/sj.emboj.7600774; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Tashiro M, 2003, J BIOMOL NMR, V25, P153, DOI 10.1023/A:1022254432039; Uchiki T, 2009, J BIOL CHEM, V284, P12622, DOI 10.1074/jbc.M900556200; Walters KJ, 2002, BIOCHEMISTRY-US, V41, P1767, DOI 10.1021/bi011892y; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Wang QH, 2004, J BIOMOL NMR, V30, P231, DOI 10.1023/B:JNMR.0000048944.73308.6c; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	52	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1424	1434		10.1074/jbc.M109.041970	http://dx.doi.org/10.1074/jbc.M109.041970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19875440	hybrid, Green Published			2022-12-25	WOS:000273258200062
J	Phelps, CB; Wang, RR; Choo, SS; Gaudet, R				Phelps, Christopher B.; Wang, Ruiqi R.; Choo, Shelly S.; Gaudet, Rachelle			Differential Regulation of TRPV1, TRPV3, and TRPV4 Sensitivity through a Conserved Binding Site on the Ankyrin Repeat Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONSELECTIVE CATION CHANNEL; GATED ION-CHANNEL; INTRACELLULAR ATP; 2-AMINOETHOXYDIPHENYL BORATE; ACTIVATION; CALMODULIN; CALCIUM; THERMOSENSATION; RESIDUES; PROTEIN	Transient receptor potential vanilloid (TRPV) channels, which include the thermosensitive TRPV1-V4, have large cytoplasmic regions flanking the transmembrane domain, including an N-terminal ankyrin repeat domain. We show that a multiligand binding site for ATP and calmodulin previously identified in the TRPV1 ankyrin repeat domain is conserved in TRPV3 and TRPV4, but not TRPV2. Accordingly, TRPV2 is insensitive to intracellular ATP, while, as previously observed with TRPV1, a sensitizing effect of ATP on TRPV4 required an intact binding site. In contrast, ATP reduced TRPV3 sensitivity and potentiation by repeated agonist stimulations. Thus, ATP and calmodulin, acting through this conserved binding site, are key players in generating the different sensitivity and adaptation profiles of TRPV1, TRPV3, and TRPV4. Our results suggest that competing interactions of ATP and calmodulin influence channel sensitivity to fluctuations in calcium concentration and perhaps even metabolic state. Different feedback mechanisms likely arose because of the different physiological stimuli or temperature thresholds of these channels.	[Phelps, Christopher B.; Wang, Ruiqi R.; Choo, Shelly S.; Gaudet, Rachelle] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Gaudet, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	gaudet@mcb.harvard.edu	Gaudet, Rachelle/I-4133-2014; Gaudet, Rachelle/Y-3985-2019	Gaudet, Rachelle/0000-0002-9177-054X; Gaudet, Rachelle/0000-0002-9177-054X; Wang, Ruiqi Rachel/0000-0002-5099-8177	National Institutes of Health [R01GM081340]; American Heart Association [0335134N]; Klingenstein Award; McKnight Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081340] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Klingenstein Award(Klingenstein Philanthropies); McKnight Scholar Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM081340. This work was also supported by American Heart Association Grant (Scientist Development Grant 0335134N) and a Klingenstein Award and a McKnight Scholar Award (to R. G.).	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Accardi A, 2008, J GEN PHYSIOL, V131, P104, DOI 10.1085/jgp.200709953; Ataullakhanov FI, 2002, BIOSCIENCE REP, V22, P501, DOI 10.1023/A:1022069718709; Bryan J, 2007, PFLUG ARCH EUR J PHY, V453, P703, DOI 10.1007/s00424-006-0116-z; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Chung MK, 2005, J BIOL CHEM, V280, P15928, DOI 10.1074/jbc.M500596200; Chung MK, 2004, J NEUROSCI, V24, P5177, DOI 10.1523/JNEUROSCI.0934-04.2004; Dattilo M, 2008, MOL PHARMACOL, V73, P42, DOI 10.1124/mol.107.040899; Gaudet R, 2008, MOL BIOSYST, V4, P372, DOI 10.1039/b801481g; Grandl J, 2008, NAT NEUROSCI, V11, P1007, DOI 10.1038/nn.2169; Guler AD, 2002, J NEUROSCI, V22, P6408; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Jin XS, 2006, J BIOL CHEM, V281, P25006, DOI 10.1074/jbc.C600153200; Koplas PA, 1997, J NEUROSCI, V17, P3525; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lee H, 2005, PFLUG ARCH EUR J PHY, V451, P160, DOI 10.1007/s00424-005-1438-y; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; McCleverty CJ, 2006, PROTEIN SCI, V15, P2201, DOI 10.1110/ps.062357206; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Myers BR, 2008, NEURON, V58, P362, DOI 10.1016/j.neuron.2008.04.012; Neeper MP, 2007, J BIOL CHEM, V282, P15894, DOI 10.1074/jbc.M608287200; Nijenhuis T, 2005, PFLUG ARCH EUR J PHY, V451, P181, DOI 10.1007/s00424-005-1430-6; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Phelps CB, 2008, BIOCHEMISTRY-US, V47, P2476, DOI 10.1021/bi702109w; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Strotmann R, 2003, J BIOL CHEM, V278, P26541, DOI 10.1074/jbc.M302590200; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; TAYLOR JS, 1991, P NATL ACAD SCI USA, V88, P6810, DOI 10.1073/pnas.88.15.6810; Thebault S, 2008, J BIOL CHEM, V283, P19999, DOI 10.1074/jbc.M800167200; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Vennekens R, 2008, CURR PHARM DESIGN, V14, P18; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xiao R, 2008, J BIOL CHEM, V283, P6162, DOI 10.1074/jbc.M706535200; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1	44	121	123	4	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					731	740		10.1074/jbc.M109.052548	http://dx.doi.org/10.1074/jbc.M109.052548			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864432	Green Published, hybrid			2022-12-25	WOS:000273070100074
J	Kobori, T; Smith, GD; Sandford, R; Edwardson, JM				Kobori, Toshiro; Smith, Graham D.; Sandford, Richard; Edwardson, J. Michael			The Transient Receptor Potential Channels TRPP2 and TRPC1 Form a Heterotetramer with a 2:2 Stoichiometry and an Alternating Subunit Arrangement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROSCOPY REVEALS; GENE; POLYCYSTIN-1; RELEASE; ENCODES; PKD2	There is functional evidence that polycystin-2 (TRPP2) interacts with other members of the transient receptor potential family, including TRPC1 and TRPV4. Here we have used atomic force microscopy to study the structure of the TRPP2 homomer and the interaction between TRPP2 and TRPC1. The molecular volumes of both Myc-tagged TRPP2 and V5-tagged TRPC1 isolated from singly transfected tsA 201 cells indicated that they assembled as homotetramers. The molecular volume of the protein isolated from cells expressing both TRPP2 and TRPC1 was intermediate between the volumes of the two homomers, suggesting that a heteromer was being formed. The distribution of angles between pairs of anti-Myc antibodies bound to TRPP2 particles had a large peak close to 90 degrees and a smaller peak close to 180 degrees, consistent with the assembly of TRPP2 as a homotetramer. In contrast, the corresponding angle distributions for decoration of the TRPP2-TRPC1 heteromer by either anti-Myc or anti-V5 antibodies had predominant peaks close to 180 degrees. This decoration pattern indicates a TRPP2: TRPC1 subunit stoichiometry of 2:2 and an alternating subunit arrangement.	[Kobori, Toshiro; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Smith, Graham D.; Sandford, Richard] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Edwardson, JM (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	jme1000@cam.ac.uk			National Agriculture and Food Research Organization (Japan); National Institutes of Health Research Cambridge medical Research Centre	National Agriculture and Food Research Organization (Japan); National Institutes of Health Research Cambridge medical Research Centre(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by a National Agriculture and Food Research Organization (Japan) Overseas Research Grant.; Supported by the National Institutes of Health Research Cambridge medical Research Centre.	Bai CX, 2008, EMBO REP, V9, P472, DOI 10.1038/embor.2008.29; Barrera NP, 2008, MOL PHARMACOL, V73, P960, DOI 10.1124/mol.107.042481; Barrera NP, 2007, BIOPHYS J, V93, P505, DOI 10.1529/biophysj.106.101048; Barrera NP, 2007, BIOCHEM BIOPH RES CO, V358, P1086, DOI 10.1016/j.bbrc.2007.05.039; Barrera NP, 2005, P NATL ACAD SCI USA, V102, P12595, DOI 10.1073/pnas.0503253102; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Boumechache M, 2009, J BIOL CHEM, V284, P13446, DOI 10.1074/jbc.M901255200; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Delmas P, 2004, FASEB J, V18, P740, DOI 10.1096/fj.03-0319fje; Geng L, 2008, P NATL ACAD SCI USA, V105, P15920, DOI 10.1073/pnas.0805062105; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Hofmann T, 2002, P NATL ACAD SCI USA, V99, P7461, DOI 10.1073/pnas.102596199; HUGHES J, 1995, NAT GENET, V10, P151, DOI 10.1038/ng0695-151; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Moiseenkova-Bell VY, 2008, P NATL ACAD SCI USA, V105, P7451, DOI 10.1073/pnas.0711835105; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tsiokas L, 1999, P NATL ACAD SCI USA, V96, P3934, DOI 10.1073/pnas.96.7.3934; Wegierski T, 2009, EMBO J, V28, P490, DOI 10.1038/emboj.2008.307; Yoder Bradley K., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010362; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zhang P, 2009, HUM MOL GENET, V18, P1238, DOI 10.1093/hmg/ddp024	32	67	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35507	35513		10.1074/jbc.M109.060228	http://dx.doi.org/10.1074/jbc.M109.060228			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850920	hybrid, Green Published			2022-12-25	WOS:000272645600027
J	Shen, B; Smith, RS; Hsu, YT; Chao, L; Chao, J				Shen, Bo; Smith, Robert S., Jr.; Hsu, Yi-Te; Chao, Lee; Chao, Julie			Kruppel-like Factor 4 Is a Novel Mediator of Kallistatin in Inhibiting Endothelial Inflammation via Increased Endothelial Nitric-oxide Synthase Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KALLIKREIN-BINDING PROTEIN; TNF-ALPHA; IDENTIFICATION; CELLS; ANGIOGENESIS; APOPTOSIS; RECEPTOR; TISSUES; CLONING; FLUIDS	Kallistatin is a plasma protein that exhibits pleiotropic effects in vasodilation, anti-angiogenesis, and anti-inflammation. To isolate a kallistatin-binding protein that mediates the vascular actions of kallistatin, we screened and identified a positive clone from a human heart cDNA expression library by using an alkaline phosphatase-kallistatin fusion protein binding assay. Sequence analysis revealed that kallistatin-binding protein is human Kruppel-like factor 4 (KLF4). KLF4 was localized on the plasma membrane of HEK-293 cells and endothelial cells over-expressing KLF4. KLF4 and kallistatin complex formation was identified in endothelial cells by immunoprecipitation followed by immunoblotting. We showed that kallistatin inhibits tumor necrosis factor-alpha-induced NF-kappa B activation, as well as vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1 expression in endothelial cells, whereas knockdown of KLF4 by small interfering RNA oligonucleotide abolished the effect of kallistatin. Kallistatin increased endothelial nitric-oxide synthase (eNOS) expression and nitric oxide levels, and these effects were also blocked by KLF4 small interfering RNA oligonucleotide. Moreover, inhibition of eNOS by RNA interference or by NOS inhibitor abolished the blocking effect of kallistatin on vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1 expression. In summary, we identified KLF4 as a kallistatin-binding protein, which has a novel role in mediating the anti-inflammatory actions of kallistatin via increasing eNOS expression in endothelial cells. This study provides a new target for modulating endothelial function in vascular disease.	[Shen, Bo; Smith, Robert S., Jr.; Hsu, Yi-Te; Chao, Lee; Chao, Julie] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	Medical University of South Carolina	Chao, J (corresponding author), Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.	chaoj@musc.edu			National Institutes of Health [HL-44083, C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-44083 and C06 RR015455.	Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; BAUTISTA AP, 1994, AM J PHYSIOL, V266, pG783, DOI 10.1152/ajpgi.1994.266.5.G783; Brembeck FH, 2000, J BIOL CHEM, V275, P28230; Brennan LA, 2003, CIRC RES, V92, P683, DOI 10.1161/01.RES.0000063424.28903.BB; CARLOS TM, 1994, BLOOD, V84, P2068; CHAI KX, 1993, J BIOL CHEM, V268, P24498; Chao J, 1992, Agents Actions Suppl, V38 ( Pt 1), P174; CHAO J, 1986, BIOCHEM J, V239, P325, DOI 10.1042/bj2390325; Chao JL, 1996, J LAB CLIN MED, V127, P612, DOI 10.1016/S0022-2143(96)90152-3; Chao JL, 1997, J CLIN INVEST, V100, P11, DOI 10.1172/JCI119502; Chao J, 2006, HUM GENE THER, V17, P1201, DOI 10.1089/hum.2006.17.1201; Chen LM, 1997, LIFE SCI, V60, P1431, DOI 10.1016/S0024-3205(97)00094-5; Chen X, 2008, MOL THER, V16, P333, DOI 10.1038/sj.mt.6300365; CLANCY RM, 1992, J CLIN INVEST, V90, P1116, DOI 10.1172/JCI115929; DAVENPECK KL, 1994, GASTROENTEROLOGY, V107, P1050, DOI 10.1016/0016-5085(94)90229-1; DE CR, 1995, J CLIN INVEST, V96, P60; Flanagan JG, 2000, METHOD ENZYMOL, V327, P198, DOI 10.1016/S0076-6879(00)27277-7; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; Gao L, 2008, LAB INVEST, V88, P1157, DOI 10.1038/labinvest.2008.85; Goebeler M, 1997, IMMUNOLOGY, V91, P450, DOI 10.1046/j.1365-2567.1997.00263.x; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Hatcher HC, 1997, INVEST OPHTH VIS SCI, V38, P658; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Kim JY, 2008, J BIOL CHEM, V283, P137, DOI 10.1074/jbc.M704746200; Ma JX, 1996, CURR EYE RES, V15, P1117, DOI 10.3109/02713689608995143; Martin J, 2007, CURR PHARM DESIGN, V13, P1751, DOI 10.2174/138161207780831248; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; McCormick SM, 2001, P NATL ACAD SCI USA, V98, P8955, DOI 10.1073/pnas.171259298; Miao RQ, 2006, P NATL ACAD SCI USA, V103, P10997, DOI 10.1073/pnas.0602427103; Miao RQ, 2000, CIRC RES, V86, P418, DOI 10.1161/01.RES.86.4.418; Miao RQ, 2003, AM J PHYSIOL-CELL PH, V284, pC1604, DOI 10.1152/ajpcell.00524.2002; Miao RQ, 2002, BLOOD, V100, P3245, DOI 10.1182/blood-2002-01-0185; Nakashima Y, 1998, ARTERIOSCL THROM VAS, V18, P842, DOI 10.1161/01.ATV.18.5.842; Ortiz PA, 2003, AM J PHYSIOL-REG I, V284, pR628, DOI 10.1152/ajpregu.00401.2002; Shen B, 2008, HYPERTENSION, V51, P1358, DOI 10.1161/HYPERTENSIONAHA.107.108514; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Soundararajan S, 2008, CANCER RES, V68, P2358, DOI 10.1158/0008-5472.CAN-07-5723; Soundararajan S, 2009, MOL PHARMACOL, V76, P984, DOI 10.1124/mol.109.055947; Tai SC, 2004, ARTERIOSCL THROM VAS, V24, P405, DOI 10.1161/01.ATV.0000109171.50229.33; Wang CR, 2005, ARTHRITIS RHEUM-US, V52, P1319, DOI 10.1002/art.20991; Yet SF, 1998, J BIOL CHEM, V273, P1026, DOI 10.1074/jbc.273.2.1026; Zhang CH, 2006, ARTERIOSCL THROM VAS, V26, P475, DOI 10.1161/01.ATV.0000201932.32678.7e	42	70	79	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35471	35478		10.1074/jbc.M109.046813	http://dx.doi.org/10.1074/jbc.M109.046813			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858207	Green Published, hybrid			2022-12-25	WOS:000272645600023
J	Mira, A; Isella, C; Renzulli, T; Cantarella, D; Martelli, ML; Medico, E				Mira, A.; Isella, C.; Renzulli, T.; Cantarella, D.; Martelli, M. L.; Medico, E.			The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer	ONCOGENE			English	Article						Gab2; anchorage independence; metastasis; microarray; breast cancer	RECEPTOR TYROSINE KINASE; PROGNOSTIC SIGNATURE; EXPRESSION SIGNATURE; HEMATOPOIETIC-CELLS; HISTOLOGIC GRADE; PROTEIN GAB2; GROWTH; SRC; ACTIVATION; INTEGRINS	Acquisition of independence from anchorage to the extracellular matrix is a critical event for onset and progression of solid cancers. To identify and characterize new genes conferring anchorage independence, we transduced MCF10A human normal breast cells with a retroviral cDNA expression library and selected them by growth in suspension. Microarray analysis targeted on library-derived transcripts revealed robust and reproducible enrichment, after selection, of cDNAs encoding the scaffolding adaptor Gab2. Gab2 was confirmed to strongly promote anchorage-independent growth when overexpressed. Interestingly, downregulation by RNA interference of endogenous Gab2 in neoplastic cells did not affect their adherent growth, but abrogated their growth in soft agar. Gab2-driven anchorage independence was found to specifically involve activation of the Src-Stat3 signaling axis. A transcriptional 'signature' of 205 genes was obtained from GAB2-transduced, anchorage-independent MCF10A cells, and found to contain two main functional modules, controlling proliferation and cell adhesion/migration/invasion, respectively. Extensive validation on breast cancer data sets showed that the GAB2 signature provides a robust prognostic classifier for breast cancer metastatic relapse, largely independent from existing clinical and genomic indicators and from estrogen receptor status. This work highlights a pivotal role for GAB2 and its transcriptional targets in anchorage-independent growth and breast cancer metastatic progression. Oncogene (2009) 28, 4444-4455; doi:10.1038/onc.2009.296; published online 19 October 2009	[Medico, E.] Univ Torino, Dept Oncol Sci, Inst Canc Res & Treatment, Sch Med, I-10060 Turin, Italy; Univ Torino, Lab Funct Genom, Inst Canc Res & Treatment, Sch Med, I-10060 Turin, Italy	University of Turin; University of Turin	Medico, E (corresponding author), Univ Torino, Dept Oncol Sci, Inst Canc Res & Treatment, Sch Med, Str Prov 142,Km 3,95, I-10060 Turin, Italy.	enzo.medico@ircc.it	Medico, Enzo/AAC-3185-2021; Isella, Claudio/F-7327-2012	Medico, Enzo/0000-0002-3917-2438; Isella, Claudio/0000-0003-0679-4756; CANTARELLA, DANIELA/0000-0001-6135-2032; Mira, Alessia/0000-0002-8456-8159	AIRC; EC [503438]; CNR-MIUR; FIRB-MIUR; Ministero della Salute, Regione Piemonte; Foundations CRT and 'Compagnia di San Paolo'	AIRC(Fondazione AIRC per la ricerca sul cancro); EC(European CommissionEuropean Commission Joint Research Centre); CNR-MIUR(Ministry of Education, Universities and Research (MIUR)Consiglio Nazionale delle Ricerche (CNR)); FIRB-MIUR(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Ministero della Salute, Regione Piemonte(Regione PiemonteMinistry of Health, Italy); Foundations CRT and 'Compagnia di San Paolo'(Compagnia di San Paolo)	We thank Barbara Martinoglio and Roberta Porporato for technical assistance. We thank Simona Destefanis, Antonella Cignetto and Michela Bruno for secretarial assistance. This research was supported by grants from AIRC, the EC (contract no. 503438 'TRANSFOG'), CNR-MIUR, FIRB-MIUR, Ministero della Salute, Regione Piemonte and the Foundations CRT and 'Compagnia di San Paolo.'	Ariga N, 2001, INT J CANCER, V95, P67, DOI 10.1002/1097-0215(20010120)95:1<67::AID-IJC1012>3.0.CO;2-U; Bennett HL, 2008, ONCOGENE, V27, P2693, DOI 10.1038/sj.onc.1210928; Berrier AL, 2007, J CELL PHYSIOL, V213, P565, DOI 10.1002/jcp.21237; Bouscary D, 2001, ONCOGENE, V20, P2197, DOI 10.1038/sj.onc.1204317; Brummer T, 2006, J BIOL CHEM, V281, P626, DOI 10.1074/jbc.M509567200; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Cooley J, 2001, BIOCHEMISTRY-US, V40, P15762, DOI 10.1021/bi0113925; Daly RJ, 2002, ONCOGENE, V21, P5175, DOI 10.1038/sj.onc.1205522; Danen EHJ, 2001, J CELL PHYSIOL, V189, P1, DOI 10.1002/jcp.1137; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; ffrench-Constant C, 2004, TRENDS CELL BIOL, V14, P678, DOI 10.1016/j.tcb.2004.10.005; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Gu HH, 1998, MOL CELL, V2, P729, DOI 10.1016/S1097-2765(00)80288-9; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hess Viviane, 2008, Ther Umsch, V65, P201, DOI 10.1024/0040-5930.65.4.201; Horst B, 2009, AM J PATHOL, V174, P1524, DOI 10.2353/ajpath.2009.080543; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Ke Y, 2007, ONCOGENE, V26, P4951, DOI 10.1038/sj.onc.1210315; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kong M, 2003, J BIOL CHEM, V278, P5837, DOI 10.1074/jbc.M208286200; Laird AD, 2003, MOL CANCER THER, V2, P461; Liu Y, 2001, MOL CELL BIOL, V21, P3047, DOI 10.1128/MCB.21.9.3047-3056.2001; Martelli ML, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-254; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Ni S, 2007, MOL CELL BIOL, V27, P3708, DOI 10.1128/MCB.01838-06; Nishida K, 1999, BLOOD, V93, P1809, DOI 10.1182/blood.V93.6.1809.406k35_1809_1816; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Roux KJ, 2005, MOL BIOL CELL, V16, P1142, DOI 10.1091/mbc.E04-07-0551; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Schwartz MA, 1999, CURR OPIN CELL BIOL, V11, P197, DOI 10.1016/S0955-0674(99)80026-X; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; SOULE HD, 1990, CANCER RES, V50, P6075; TIRESALJ M, 2006, NAT MED, V12, P114; Tsatsanis C, 2004, ANN NY ACAD SCI, V1028, P168, DOI 10.1196/annals.1322.019; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wessels LFA, 2005, BIOINFORMATICS, V21, P3755, DOI 10.1093/bioinformatics/bti429; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu M, 2006, J BIOL CHEM, V281, P28615, DOI 10.1074/jbc.M603742200; Yuan K, 2008, PATHOL ONCOL RES, V14, P145, DOI 10.1007/s12253-008-9036-x; Zatkova A, 2006, GENE CHROMOSOME CANC, V45, P798, DOI 10.1002/gcc.20344; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; Zhang X, 2006, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2005/01/003	51	16	17	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	DEC 17	2009	28	50					4444	4455		10.1038/onc.2009.296	http://dx.doi.org/10.1038/onc.2009.296			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	534DU	19838208	Green Submitted			2022-12-25	WOS:000272876500004
J	Granneman, JG; Moore, HPH; Krishnamoorthy, R; Rathod, M				Granneman, James G.; Moore, Hsiao-Ping H.; Krishnamoorthy, Rukmani; Rathod, Miloni			Perilipin Controls Lipolysis by Regulating the Interactions of AB-hydrolase Containing 5 (Abhd5) and Adipose Triglyceride Lipase (Atgl)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; CHANARIN-DORFMAN-SYNDROME; LIPID DROPLETS; STIMULATED LIPOLYSIS; PROTEIN TRAFFICKING; MEDIATED LIPOLYSIS; ADIPOCYTES; CGI-58; TISSUE; PHOSPHORYLATION	The mobilization of stored lipid by hormones is a fundamental function of fat cells, and there is strong evidence that perilipin (Plin), a lipid droplet scaffold, and adipose tissue triglyceride lipase (Atgl), a triglyceride-specific lipase, play critical roles. Previous work suggested that Abhd5, a protein activator of Atgl, coordinates with Plin in controlling basal and stimulated lipolysis; however, the underlying mechanism is controversial. The present experiments investigated protein trafficking and interactions among Plin, Atgl, and Abhd5 in live cells. The results demonstrate that Plin binds Abhd5 with high affinity and thereby suppresses the interaction of Abhd5 with Atgl. Sequestration of Abhd5 appears to a major mechanism by which Plin reduces basal lipolysis. Phosphorylation of Plin on serine 492 or serine 517 rapidly releases Abhd5 from Plin, allowing Abhd5 to directly interact with Atgl. Imaging experiments demonstrated that the Plin-dependent interaction of Abhd5 and Atgl occurs mainly, but not exclusively, on lipid droplets that contain Plin.	[Granneman, James G.; Krishnamoorthy, Rukmani; Rathod, Miloni] Wayne State Univ, Sch Med, CIMER, Detroit, MI 48201 USA; [Moore, Hsiao-Ping H.] Lawrence Technol Univ, Southfield, MI 48075 USA	Wayne State University	Granneman, JG (corresponding author), Wayne State Univ, Sch Med, CIMER, 550 E Canfield, Detroit, MI 48201 USA.	jgranne@med.wayne.edu			National Institutes of Health [DK 62292, DK76629]; American Diabetes Association [RA29]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062292, R56DK062292, R01DK076629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 62292 and DK76629. This work was also supported by American Diabetes Association Grant RA29 and by a grant from the Department of Veterans Affairs.	Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brasaemle DL, 2009, MOL CELL BIOCHEM, V326, P15, DOI 10.1007/s11010-008-9998-8; Brasaemle DL, 2000, J BIOL CHEM, V275, P38486, DOI 10.1074/jbc.M007322200; Granneman JG, 2008, TRENDS ENDOCRIN MET, V19, P3, DOI 10.1016/j.tem.2007.10.006; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Marcinkiewicz A, 2006, J BIOL CHEM, V281, P11901, DOI 10.1074/jbc.M600171200; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; Mottillo EP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1188, DOI 10.1152/ajpendo.00051.2007; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2007, J LIPID RES, V48, P1078, DOI 10.1194/jlr.M600493-JLR200; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zhang HH, 2003, J BIOL CHEM, V278, P51535, DOI 10.1074/jbc.M309591200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	27	251	260	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34538	34544		10.1074/jbc.M109.068478	http://dx.doi.org/10.1074/jbc.M109.068478			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19850935	Green Published, hybrid			2022-12-25	WOS:000272439600008
J	Jarnaess, E; Stokka, AJ; Kvissel, AK; Skalhegg, BS; Torgersen, KM; Scott, JD; Carlson, CR; Tasken, K				Jarnaess, Elisabeth; Stokka, Anne Jorunn; Kvissel, Anne-Katrine; Skalhegg, Bjorn S.; Torgersen, Knut Martin; Scott, John D.; Carlson, Cathrine R.; Tasken, Kjetil			Splicing Factor Arginine/Serine-rich 17A (SFRS17A) Is an A-kinase Anchoring Protein That Targets Protein Kinase A to Splicing Factor Compartments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY SUBUNIT RII; CATALYTIC SUBUNIT; SIGNALING PATHWAY; MOLECULAR-BASIS; SITE SELECTION; BINDING; LOCALIZATION; EXPRESSION; SPECIFICITY; IDENTIFICATION	Protein kinase A (PKA) is targeted to distinct subcellular localizations by specific protein kinase A anchoring proteins (AKAPs). AKAPs are divided into subclasses based on their ability to bind type I or type II PKA or both. Dual-specificity AKAPs were recently reported to have an additional PKA binding determinant called the RI specifier region. A bioinformatic search with the consensus RI specifier region identified a novel AKAP, the splicing factor arginine/serine-rich 17A (SFRS17A). Here, we show by a variety of protein interaction assays that SFRS17A binds both type I and type II PKA in vitro and inside cells, demonstrating that SFRS17A is a dual-specific AKAP. Moreover, immunofluorescence experiments show that SFRS17A colocalizes with the catalytic subunit of PKA as well as the splicing factor SC35 in splicing factor compartments. Using the E1A minigene splicing assay, we found that expression of wild type SFRS17A conferred regulation of E1A alternative splicing, whereas the mutant SFRS17A, which is unable to bind PKA, did not. Our data suggest that SFRS17A is an AKAP involved in regulation of pre-mRNA splicing possibly by docking a pool of PKA in splicing factor compartments.	[Jarnaess, Elisabeth; Stokka, Anne Jorunn; Torgersen, Knut Martin; Carlson, Cathrine R.; Tasken, Kjetil] Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway; [Jarnaess, Elisabeth; Stokka, Anne Jorunn; Torgersen, Knut Martin; Tasken, Kjetil] Univ Oslo, Ctr Mol Med Norway, Nord European Mol Biol Lab Partnership, N-0317 Oslo, Norway; [Kvissel, Anne-Katrine; Skalhegg, Bjorn S.] Univ Oslo, Dept Nutr, N-0317 Oslo, Norway; [Kvissel, Anne-Katrine; Skalhegg, Bjorn S.] Univ Oslo, Dept Biochem, Inst Basic Med Sci, N-0317 Oslo, Norway; [Scott, John D.] Univ Washington, Sch Med, Howard Hughes Med Inst, Dept Pharmacol, Seattle, WA 98195 USA	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Tasken, K (corresponding author), Univ Oslo, Biotechnol Ctr Oslo, POB 1125, N-0317 Oslo, Norway.	kjetil.tasken@biotek.uio.no	Skålhegg, Bjørn Steen/AAZ-2976-2021	Skålhegg, Bjørn Steen/0000-0002-3481-8084; Tasken, Kjetil/0000-0003-2841-4697	Norwegian Functional Genomics Program; Research Council of Norway; Norwegian Cancer Society; Novo Nordic Foundation; European Union [037189]; National Institutes of Health [DK54441]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK054441] Funding Source: NIH RePORTER	Norwegian Functional Genomics Program(Research Council of Norway); Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Novo Nordic Foundation(Novo Nordisk Foundation); European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the Norwegian Functional Genomics Program, the Research Council of Norway, the Norwegian Cancer Society, Novo Nordic Foundation, and European Union Grant 037189 (thera-cAMP). This work was also supported, in part by National Institutes of Health Grant DK54441 (to J.D.S.).	Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Angelo R, 1998, J BIOL CHEM, V273, P14633, DOI 10.1074/jbc.273.23.14633; Banky P, 2003, J MOL BIOL, V330, P1117, DOI 10.1016/S0022-2836(03)00552-7; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; CARR DW, 1991, J BIOL CHEM, V266, P14188; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; CUMMING R, 1981, NEUROSCIENCE, V6, P953, DOI 10.1016/0306-4522(81)90176-7; DellAcqua ML, 1997, J BIOL CHEM, V272, P12881, DOI 10.1074/jbc.272.20.12881; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; DURGERIAN S, 1989, J BIOL CHEM, V264, P9807; Ellison Jay W., 1992, Human Molecular Genetics, V1, P691; FLETCHER WH, 1986, J BIOL CHEM, V261, P5504; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; GE H, 1991, CELL, V66, P373, DOI 10.1016/0092-8674(91)90626-A; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Gronholm M, 2003, J BIOL CHEM, V278, P41167, DOI 10.1074/jbc.M306149200; Gupte RS, 2006, EXP CELL RES, V312, P796, DOI 10.1016/j.yexcr.2005.11.033; Gupte RS, 2005, CANCER BIOL THER, V4, P429; Gupte RS, 2005, CELL CYCLE, V4, P323; Hausken ZE, 1998, METH MOL B, V88, P47; Hausken ZE, 1996, BIOCHEM SOC T, V24, P986, DOI 10.1042/bst0240986; HAUSKEN ZE, 1994, J BIOL CHEM, V269, P24245; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Hillman RT, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r8; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Huang LJS, 1997, P NATL ACAD SCI USA, V94, P11184, DOI 10.1073/pnas.94.21.11184; Jarnaess E, 2007, BIOCHEM SOC T, V35, P931, DOI 10.1042/BST0350931; Jarnaess E, 2008, J BIOL CHEM, V283, P33708, DOI 10.1074/jbc.M804807200; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; KUETTEL MR, 1985, J CELL BIOL, V101, P965, DOI 10.1083/jcb.101.3.965; Kussel-Andermann P, 2000, J BIOL CHEM, V275, P29654, DOI 10.1074/jbc.M004393200; Kvissel AK, 2007, EXP CELL RES, V313, P2795, DOI 10.1016/j.yexcr.2007.05.014; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lau YFC, 2000, MOL CARCINOGEN, V27, P308, DOI 10.1002/(SICI)1098-2744(200004)27:4<308::AID-MC9>3.0.CO;2-R; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Liu J, 2006, J BIOL CHEM, V281, P38879, DOI 10.1074/jbc.M608820200; Mangs AH, 2006, NUCLEIC ACIDS RES, V34, P4976, DOI 10.1093/nar/gkl660; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Reinton N, 2000, DEV BIOL, V223, P194, DOI 10.1006/dbio.2000.9725; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; ULFENDAHL PJ, 1987, EMBO J, V6, P2037, DOI 10.1002/j.1460-2075.1987.tb02468.x; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; Xie JY, 2003, P NATL ACAD SCI USA, V100, P8776, DOI 10.1073/pnas.1432696100	56	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35154	35164		10.1074/jbc.M109.056465	http://dx.doi.org/10.1074/jbc.M109.056465			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840947	Green Published, hybrid			2022-12-25	WOS:000272439600069
J	Horner, JR; Goodwin, MB				Horner, John R.; Goodwin, Mark B.			Extreme Cranial Ontogeny in the Upper Cretaceous Dinosaur Pachycephalosaurus	PLOS ONE			English	Article							RELATIVE GROWTH; ORNITHISCHIA; HISTOLOGY; SYNONOMY	Background: Extended neoteny and late stage allometric growth increase morphological disparity between growth stages in at least some dinosaurs. Coupled with relatively low dinosaur density in the Upper Cretaceous of North America, ontogenetic transformational representatives are often difficult to distinguish. For example, many hadrosaurids previously reported to represent relatively small lambeosaurine species were demonstrated to be juveniles of the larger taxa. Marginocephalians (pachycephalosaurids + ceratopsids) undergo comparable and extreme cranial morphological change during ontogeny. Methodology/Principal Findings: Cranial histology, morphology and computer tomography reveal patterns of internal skull development that show the purported diagnostic characters for the pachycephalosaurids Dracorex hogwartsia and Stygimoloch spinifer are ontogenetically derived features. Coronal histological sections of the frontoparietal dome of an adult Pachycephalosaurus wyomingensis reveal a dense structure composed of metaplastic bone with a variety of extremely fibrous and acellular tissue. Coronal histological sections and computer tomography of a skull and frontoparietal dome of Stygimoloch spinifer reveal an open intrafrontal suture indicative of a subadult stage of development. These dinosaurs employed metaplasia to rapidly grow and change the size and shape of their horns, cranial ornaments and frontoparietal domes, resulting in extreme cranial alterations during late stages of growth. We propose that Dracorex hogwartsia, Stygimoloch spinifer and Pachycephalosaurus wyomingensis are the same taxon and represent an ontogenetic series united by shared morphology and increasing skull length. Conclusions/Significance: Dracorex hogwartsia (juvenile) and Stygimoloch spinifer (subadult) are reinterpreted as younger growth stages of Pachycephalosaurus wyomingensis (adult). This synonymy reduces the number of pachycephalosaurid taxa from the Upper Cretaceous of North America and demonstrates the importance of cranial ontogeny in evaluating dinosaur diversity and taxonomy. These growth stages reflect a continuum rather than specific developmental steps defined by "known'' terminal morphologies.			Horner, JR (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	jhorner@montana.edu		Goodwin, Mark/0000-0001-7127-439X				BAKKER RT, 2006, LATE CRETACEOUS VERT, V35, P331; Brown B., 1940, Annals of the New York Academy of Sciences, V40, P133; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; DODSON P, 1976, J PALEONTOL, V50, P929; Francillon-Vieillot H., 1990, P471; GALIANO H, 2001, DINO PRESS, V4, P2; GALTON PM, 1983, CAN J EARTH SCI, V20, P462, DOI 10.1139/e83-043; GIFFIN EB, 1989, J PALEONTOL, V63, P525, DOI 10.1017/S0022336000019739; Goodwin M, 2004, J VERTEBR PALEONTOL, V24, p65A; Goodwin MB, 2004, PALEOBIOLOGY, V30, P253, DOI 10.1666/0094-8373(2004)030<0253:CHOPOM>2.0.CO;2; Goodwin MB, 1998, J VERTEBR PALEONTOL, V18, P363, DOI 10.1080/02724634.1998.10011064; HAINES RW, 1968, J ANAT, V103, P527; Horner J, 2007, J VERTEBR PALEONTOL, V27, p92A; Horner JR, 2008, J VERTEBR PALEONTOL, V28, P134, DOI 10.1671/0272-4634(2008)28[134:OOCEIT]2.0.CO;2; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; HUXLEY JS, 1932, PROBLEMS RELATIVE GR, P312; LEVRATCALVIAC V, 1986, AM J ANAT, V176, P437, DOI 10.1002/aja.1001760406; Main RP, 2005, PALEOBIOLOGY, V31, P291, DOI 10.1666/0094-8373(2005)031[0291:TEAFOT]2.0.CO;2; MOSS ML, 1969, ACTA ANAT, V73, P510; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Parsons T.S., 1969, BIOL REPTILIA, VI, P81, DOI DOI 10.1093/ICB/ICP063; Reid R.E.H., 1996, Brigham Young University Geology Studies, V41, P25; ROZHDESTVENSKY AK, 1965, PALEONTOL ZH, V13, P95; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Sereno Paul C., 2000, P480; Sullivan RM, 2003, J VERTEBR PALEONTOL, V23, P181, DOI 10.1671/0272-4634(2003)23[181:ROTDSL]2.0.CO;2; SULLIVAN RM, 2006, LATE CRETACEOUS VERT, V35, P347; Sullivan R, 2007, J VERTEBR PALEONTOL, V27, p154A; Vickaryous MK, 2008, J MORPHOL, V269, P398, DOI 10.1002/jmor.10575; Williamson T.E., 2005, NEW MEXICO GEOLOGY, V27, P45; Williamson TE, 2002, J VERTEBR PALEONTOL, V22, P779, DOI 10.1671/0272-4634(2002)022[0779:ANGODP]2.0.CO;2; Zylberberg L., 1992, BONE BONE METAB MINE, V4, P171	32	104	107	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7626	10.1371/journal.pone.0007626	http://dx.doi.org/10.1371/journal.pone.0007626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859556	gold, Green Published, Green Submitted			2022-12-25	WOS:000271147400018
J	Perrot, O; Laroche, D; Pozzo, T; Marie, C				Perrot, Olivier; Laroche, Davy; Pozzo, Thierry; Marie, Christine			Quantitative Assessment of Stereotyped and Challenged Locomotion after Lesion of the Striatum: A 3D Kinematic Study in Rats	PLOS ONE			English	Article							NIGRA PARS RETICULATA; BASAL GANGLIA; TREADMILL LOCOMOTION; MOTOR CORTEX; HINDLIMB KINEMATICS; PARKINSONS-DISEASE; QUINOLINIC ACID; GAIT ASYMMETRY; BRAIN-LESION; STROKE	Background: Although the striatum is in position to regulate motor function, the role of the structure in locomotor behaviour is poorly understood. Therefore, a detailed analysis of locomotion-and obstacle avoidance-related parameters was performed after unilateral lesion of the striatum in rats. Methods and Results: Using the three dimensional motion capture technology, kinematics of walking and clearing obstacles, head and body orientation were analyzed before and up to 60 days after the lesion. Recordings were performed in treadmill running rats with or without obstacles attached to the treadmill belt. The lesion, which was induced by the direct injection of the mitochondrial toxin malonate into the left caudoputamen resulted in the complete destruction of the dorsal striatum. During the first three days following the lesion, rats were unable to run on the treadmill. Thereafter, rats showed normal looking locomotion, yet the contralesional limbs exhibited changes in length and timing parameters, and were overflexed. Moreover, the head of lesioned rats was orientated towards the side of the lesion, and their postural vertical shifted towards the contralesional side. During obstructed running, the contralesional limbs when they were leading the crossing manoeuvre stepped on the obstacle rather than to overcome obstacle without touching it, yet more frequently with the forelimb than the hindlimb. Unsuccessful crossings appeared to be due to a paw placement farther away from the front of the obstacles, and not to an inappropriate limb elevation. Importantly, deficit in locomotor behaviour did not regress over the time. Conclusion: Our results argue that the striatum of one hemisphere controls kinematics of contralateral limbs during stereotyped locomotion and plays a prominent role in the selection of the right motor program so that these limbs successfully cross over obstacle.			Perrot, O (corresponding author), Univ Bourgogne, INSERM, Motr Plast U887, Dijon, France.	chmarie@u-bourgogne.fr	Laroche, Davy/K-4298-2015	Laroche, Davy/0000-0003-1599-4258; Pozzo, Thierry/0000-0002-0585-7965; marie, christine/0000-0003-3724-0713				ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Alexander LD, 2009, STROKE, V40, P537, DOI 10.1161/STROKEAHA.108.527374; Armstrong DM, 1996, CAN J PHYSIOL PHARM, V74, P443, DOI 10.1139/cjpp-74-4-443; BENECKE R, 1987, BRAIN, V110, P361, DOI 10.1093/brain/110.2.361; Berger MF, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-23; Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; BROWN LL, 1992, P NATL ACAD SCI USA, V89, P7403, DOI 10.1073/pnas.89.16.7403; Brown LL, 1997, CURR OPIN NEUROBIOL, V7, P157, DOI 10.1016/S0959-4388(97)80003-7; CLARKE KA, 1986, PHYSIOL BEHAV, V38, P345, DOI 10.1016/0031-9384(86)90105-8; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Couto PA, 2008, J NEUROSCI METH, V173, P193, DOI 10.1016/j.jneumeth.2008.06.006; Da Cunha C, 2008, BEHAV BRAIN RES, V189, P364, DOI 10.1016/j.bbr.2008.01.012; Dawes H, 2008, EXP BRAIN RES, V186, P325, DOI 10.1007/s00221-007-1237-0; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Demougeot C, 2001, J NEUROCHEM, V77, P408, DOI 10.1046/j.1471-4159.2001.00285.x; Deniau JM, 1996, NEUROSCIENCE, V73, P761, DOI 10.1016/0306-4522(96)00088-7; DENOTTER AR, 2005, EXP BRAIN RES, V92, P161; Dietz V, 2008, BRAIN, V131, P3421, DOI 10.1093/brain/awn263; Drew T, 1996, CAN J PHYSIOL PHARM, V74, P426, DOI 10.1139/cjpp-74-4-426; Drew T, 2002, BRAIN RES REV, V40, P178, DOI 10.1016/S0165-0173(02)00200-X; Drew T, 2008, BRAIN RES REV, V57, P199, DOI 10.1016/j.brainresrev.2007.07.017; Duhamel A, 2004, GAIT POSTURE, V20, P204, DOI 10.1016/j.gaitpost.2003.09.010; Filipe VM, 2006, J NEUROSCI METH, V153, P55, DOI 10.1016/j.jneumeth.2005.10.006; GARCIA RE, 1986, BRAIN RES, V396, P47; Garnier C, 2008, BEHAV BRAIN RES, V186, P57, DOI 10.1016/j.bbr.2007.07.023; GREENE JG, 1993, J NEUROCHEM, V61, P1151, DOI 10.1111/j.1471-4159.1993.tb03634.x; Greene JG, 1996, J NEUROCHEM, V66, P637; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Hebb MO, 1999, NEUROSCIENCE, V90, P413, DOI 10.1016/S0306-4522(98)00433-3; Henderson JM, 2005, BEHAV BRAIN RES, V160, P267, DOI 10.1016/j.bbr.2004.12.008; Hikosaka O, 2007, PROG BRAIN RES, V160, P209, DOI 10.1016/S0079-6123(06)60012-5; Karl JM, 2008, BRAIN RES BULL, V77, P42, DOI 10.1016/j.brainresbull.2008.04.012; Lafosse C, 2004, NEUROREPORT, V15, P887, DOI 10.1097/00001756-200404090-00031; Lajoie K, 2007, J NEUROPHYSIOL, V97, P2339, DOI 10.1152/jn.01196.2006; MARSHALL JF, 1980, J COMP PHYSIOL PSYCH, V94, P833, DOI 10.1037/h0077825; Metz GAS, 1998, BEHAV BRAIN RES, V96, P37, DOI 10.1016/S0166-4328(97)00195-2; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; MIKLYAEVA EI, 1995, BRAIN RES, V681, P23, DOI 10.1016/0006-8993(95)00277-W; Millerot-Serrurot E, 2007, NEUROCHEM INT, V50, P328, DOI 10.1016/j.neuint.2006.08.016; MIYASHITA N, 1995, NEUROREPORT, V6, P1257, DOI 10.1097/00001756-199506090-00007; Muir GD, 1999, BEHAV BRAIN RES, V103, P45, DOI 10.1016/S0166-4328(99)00018-2; Patterson KK, 2008, ARCH PHYS MED REHAB, V89, P304, DOI 10.1016/j.apmr.2007.08.142; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Said CM, 1999, ARCH PHYS MED REHAB, V80, P1054, DOI 10.1016/S0003-9993(99)90060-6; SCHALLERT T, 1983, PHARMACOL BIOCHEM BE, V18, P753, DOI 10.1016/0091-3057(83)90019-9; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; SEITZ RJ, 1992, EUR J NEUROSCI, V4, P154, DOI 10.1111/j.1460-9568.1992.tb00862.x; Shi LH, 2004, EXP BRAIN RES, V157, P303, DOI 10.1007/s00221-004-1844-y; Sparrow WA, 1996, HUM MOVEMENT SCI, V15, P605, DOI 10.1016/0167-9457(96)00022-X; Takakusaki K, 2003, NEUROSCIENCE, V119, P293, DOI 10.1016/S0306-4522(03)00095-2; Takakusaki K, 2008, BRAIN RES REV, V57, P192, DOI 10.1016/j.brainresrev.2007.06.024; Takakusaki Kaoru, 2009, Rinsho Shinkeigaku, V49, P325; Thota AK, 2005, J NEUROTRAUM, V22, P442, DOI 10.1089/neu.2005.22.442; Wagner J, 2008, EXP BRAIN RES, V191, P247, DOI 10.1007/s00221-008-1520-8; Wang YG, 2008, J CEREBR BLOOD F MET, V28, P1936, DOI 10.1038/jcbfm.2008.82	57	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7616	10.1371/journal.pone.0007616	http://dx.doi.org/10.1371/journal.pone.0007616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859550	Green Submitted, gold, Green Published			2022-12-25	WOS:000271147400015
J	Marshall, JL; Huestis, DL; Hiromasa, Y; Wheeler, S; Oppert, C; Marshall, SA; Tomich, JM; Oppert, B				Marshall, Jeremy L.; Huestis, Diana L.; Hiromasa, Yasuaki; Wheeler, Shanda; Oppert, Cris; Marshall, Susan A.; Tomich, John M.; Oppert, Brenda			Identification, RNAi Knockdown, and Functional Analysis of an Ejaculate Protein that Mediates a Postmating, Prezygotic Phenotype in a Cricket	PLOS ONE			English	Article							SEMINAL FLUID PROTEIN; DOUBLE-STRANDED-RNA; DROSOPHILA-MELANOGASTER; POSITIVE SELECTION; ALLONEMOBIUS-FASCIATUS; REPRODUCTIVE ISOLATION; MOLECULAR EVOLUTION; SEXUAL-DIMORPHISM; GENE; HYBRIDIZATION	Postmating, prezygotic phenotypes, especially those that underlie reproductive isolation between closely related species, have been a central focus of evolutionary biologists over the past two decades. Such phenotypes are thought to evolve rapidly and be nearly ubiquitous among sexually reproducing eukaryotes where females mate with multiple partners. Because these phenotypes represent interplay between the male ejaculate and female reproductive tract, they are fertile ground for reproductive senescence-as ejaculate composition and female physiology typically change over an individual's life span. Although these phenotypes and their resulting dynamics are important, we have little understanding of the proteins that mediate these phenotypes, particularly for species groups where postmating, prezygotic traits are the primary mechanism of reproductive isolation. Here, we utilize proteomics, RNAi, mating experiments, and the Allonemobius socius complex of crickets, whose members are primarily isolated from one another by postmating, prezygotic phenotypes (including the ability of a male to induce a female to lay eggs), to demonstrate that one of the most abundant ejaculate proteins (a male accessory gland-biased protein similar to a trypsin-like serine protease) decreases in abundance over a male's reproductive lifetime and mediates the induction of egg-laying in females. These findings represent one of the first studies to identify a protein that plays a role in mediating both a postmating, prezygotic isolation pathway and reproductive senescence.			Marshall, JL (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	cricket@ksu.edu	Marshall, Jeremy/D-1436-2013	Huestis, Diana/0000-0001-6649-4785; TOMICH, JOHN/0000-0001-7848-8307				Andres JA, 2006, MOL BIOL EVOL, V23, P1574, DOI 10.1093/molbev/msl020; Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Arnqvist Goran, 2005, pUnpaginated; Baines JF, 2008, MOL BIOL EVOL, V25, P1639, DOI 10.1093/molbev/msn111; Chapman T, 2003, P NATL ACAD SCI USA, V100, P9923, DOI 10.1073/pnas.1631635100; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Civetta A, 2003, MOL BIOL EVOL, V20, P21, DOI 10.1093/molbev/msg002; Clark NL, 2006, REPRODUCTION, V131, P11, DOI 10.1530/rep.1.00357; Doherty JA, 1996, ANIM BEHAV, V51, P981, DOI 10.1006/anbe.1996.0101; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Dzitoyeva S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-33; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; GREGORY PG, 1993, ANN ENTOMOL SOC AM, V86, P694, DOI 10.1093/aesa/86.6.694; GREGORY PG, 1994, EVOLUTION, V48, P705, DOI [10.2307/2410480, 10.1111/j.1558-5646.1994.tb01355.x]; Gregory PG, 1998, ENTOMOL EXP APPL, V87, P263, DOI 10.1023/A:1003280322549; Henkel R, 2005, FERTIL STERIL, V84, P1430, DOI 10.1016/j.fertnstert.2005.05.020; HOWARD DJ, 1991, EVOLUTION, V45, P1120, DOI 10.1111/j.1558-5646.1991.tb04379.x; Howard DJ, 1998, EVOLUTION, V52, P511, DOI 10.1111/j.1558-5646.1998.tb01650.x; HOWARD DJ, 1986, ANN ENTOMOL SOC AM, V79, P472, DOI 10.1093/aesa/79.3.472; HOWARD DJ, 1986, EVOLUTION, V40, P34, DOI 10.1111/j.1558-5646.1986.tb05715.x; Howard DJ, 1998, ENDLESS FORMS, P279; Lehmann GUC, 2009, BIOL J LINN SOC, V96, P354, DOI 10.1111/j.1095-8312.2008.01129.x; Lung O, 2002, GENETICS, V160, P211; Lycett GJ, 2006, INSECT MOL BIOL, V15, P321, DOI 10.1111/j.1365-2583.2006.00647.x; Maestro JL, 2006, ARCH INSECT BIOCHEM, V62, P73, DOI 10.1002/arch.20123; Marshall JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000720; Marshall JL, 2004, EVOLUTION, V58, P2409, DOI 10.1111/j.0014-3820.2004.tb00871.x; MAYS D L, 1971, Florida Entomologist, V54, P113, DOI 10.2307/3493557; Meyering-Vos M, 2006, INSECT BIOCHEM MOLEC, V36, P492, DOI 10.1016/j.ibmb.2006.03.008; Moller AP, 2009, J EVOLUTION BIOL, V22, P334, DOI 10.1111/j.1420-9101.2008.01650.x; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Neubaum DM, 1999, GENETICS, V153, P845; Palumbi SR, 1999, P NATL ACAD SCI USA, V96, P12632, DOI 10.1073/pnas.96.22.12632; Pizzari T, 2008, TRENDS ECOL EVOL, V23, P131, DOI 10.1016/j.tree.2007.12.003; Qazi MCB, 2003, J EXP BIOL, V206, P3521, DOI 10.1242/jeb.00585; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Si Sheng-li, 2000, Acta Entomologica Sinica, V43, P120; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2007, BIOL LETTERS, V3, P520, DOI 10.1098/rsbl.2007.0328; SWANSON WJ, 1995, P NATL ACAD SCI USA, V92, P4957, DOI 10.1073/pnas.92.11.4957; Swanson WJ, 2002, ANNU REV ECOL SYST, V33, P161, DOI 10.1146/annurev.ecolsys.33.010802.150439; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; Tram U, 1999, GENETICS, V153, P837; Turner LM, 2006, MOL BIOL EVOL, V23, P1656, DOI 10.1093/molbev/msl035; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; Wolf KN, 2000, BIOL REPROD, V63, P179, DOI 10.1095/biolreprod63.1.179; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7; Wong A, 2008, MOL BIOL EVOL, V25, P497, DOI 10.1093/molbev/msm270; Zajitschek F, 2009, AM NAT, V173, P792, DOI 10.1086/598486; Zhang Z, 2004, MOL BIOL EVOL, V21, P2130, DOI 10.1093/molbev/msh223; Zhou XG, 2006, P NATL ACAD SCI USA, V103, P4499, DOI 10.1073/pnas.0508866103	54	44	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7537	10.1371/journal.pone.0007537	http://dx.doi.org/10.1371/journal.pone.0007537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851502	gold, Green Submitted, Green Published			2022-12-25	WOS:000271022300005
J	Pozharskaya, V; Torres-Gonzalez, E; Rojas, M; Gal, A; Amin, M; Dollard, S; Roman, J; Stecenko, AA; Mora, AL				Pozharskaya, Veronika; Torres-Gonzalez, Edilson; Rojas, Mauricio; Gal, Anthony; Amin, Minal; Dollard, Sheila; Roman, Jesse; Stecenko, Arlene A.; Mora, Ana L.			Twist: A Regulator of Epithelial-Mesenchymal Transition in Lung Fibrosis	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; BARR-VIRUS DNA; GENE-EXPRESSION; UP-REGULATION; N-CADHERIN; TGF-BETA; IN-VIVO; CELLS; DISEASE; CANCER	Background: Several studies have implicated viral infection as an important factor in the pathogenesis of IPF and related fibrotic lung disorders. Viruses are thought to cause epithelial cell injury and promote epithelial-mesenchymal transition (EMT), a process whereby differentiated epithelial cells undergo transition to a mesenchymal phenotype, and considered a source of fibroblasts in the setting of lung injury. We have demonstrated an association between the epithelial injury caused by chronic herpes virus infection with the murine gamma-herpes virus, MHV68, and lung fibrosis. We hypothesize that EMT in this model of virus-induced pulmonary fibrosis is driven by the expression of the transcription factor Twist. Methods/Findings: In vitro MHV68 infection of murine lung epithelial cells induced expression of Twist, and mesenchymal markers. Stable overexpression of Twist promoted EMT in MLE15 lung epithelial cells. Transient knockdown expression of Twist resulted in preservation of epithelial phenotype after in vitro MHV68 infection. In concordance, high expression of Twist was found in lung epithelial cells of MHV68 infected mice, but not in mock infected mice. Alveolar epithelial cells from lung tissue of idiopathic pulmonary fibrosis (IPF) patients were strongly positive for Twist. These cells demonstrated features of EMT with low expression of E-cadherin and upregulation of the mesenchymal marker N-cadherin. Finally, IPF tissue with high Twist protein levels was also positive for the herpesvirus, EBV. Conclusions/Significance: We conclude that Twist contributes to EMT in the model of virus-induced pulmonary fibrosis. We speculate that in some IPF cases, gamma-herpes virus infection with EBV might be a source of injury precipitating EMT through the expression of Twist.			Pozharskaya, V (corresponding author), Emory Univ, Dept Pediat, Div Pulm Allergy Immunol Cyst Fibrosis & Sleep, Atlanta, GA 30322 USA.	amora@emory.edu			NCATS NIH HHS [UL1 TR000454] Funding Source: Medline; NHLBI NIH HHS [R21 HL080284, K01 HL073154, R21 HL 080284-01] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL073154, R21HL080284] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahn JW, 2002, J VIROL, V76, P6244, DOI 10.1128/JVI.76.12.6244-6256.2002; Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Dong YF, 2007, MOL ENDOCRINOL, V21, P2805, DOI 10.1210/me.2007-0199; EGAN JJ, 1995, THORAX, V50, P1234, DOI 10.1136/thx.50.12.1234; Geiger T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001574; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; Howe LR, 2003, CANCER RES, V63, P1906; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kelly BG, 2002, AM J RESP CRIT CARE, V166, P510, DOI 10.1164/rccm.2103058; Kida Y, 2007, J HISTOCHEM CYTOCHEM, V55, P661, DOI 10.1369/jhc.6A7157.2007; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Li Tian-yu, 2007, Zhonghua Wai Ke Za Zhi, V45, P1491; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lok S S, 2000, Monaldi Arch Chest Dis, V55, P146; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; MALIZIA AP, 2008, AM J PHYSL LUNG CELL; Meneghin A, 2007, J CLIN INVEST, V117, P530, DOI 10.1172/JCI30595; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Mora AL, 2005, AM J PHYSIOL-LUNG C, V289, pL711, DOI 10.1152/ajplung.00007.2005; Mora AL, 2007, AM J RESP CRIT CARE, V175, P1139, DOI 10.1164/rccm.200610-1426OC; Niesner U, 2008, J EXP MED, V205, P1889, DOI 10.1084/jem.20072468; Ryan JL, 2004, J MOL DIAGN, V6, P378, DOI 10.1016/S1525-1578(10)60535-1; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Stewart JP, 1999, AM J RESP CRIT CARE, V159, P1336, DOI 10.1164/ajrccm.159.4.9807077; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Studer Sean M, 2007, Proc Am Thorac Soc, V4, P85, DOI 10.1513/pats.200607-139JG; Tabata T, 2008, AM J PATHOL, V172, P1127, DOI 10.2353/ajpath.2008.070448; Tang YW, 2003, J CLIN MICROBIOL, V41, P2633, DOI 10.1128/JCM.41.6.2633-2640.2003; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Tsukamoto K, 2000, THORAX, V55, P958, DOI 10.1136/thorax.55.11.958; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, CELL CYCLE, V7, P2090, DOI 10.4161/cc.7.14.6324; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang Z, 2007, BIOCHEM BIOPH RES CO, V358, P925, DOI 10.1016/j.bbrc.2007.05.023; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	41	100	107	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7559	10.1371/journal.pone.0007559	http://dx.doi.org/10.1371/journal.pone.0007559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851501	Green Published, Green Submitted, gold			2022-12-25	WOS:000271022300006
J	Mazzoni, P; Wexler, NS				Mazzoni, Pietro; Wexler, Nancy S.			Parallel Explicit and Implicit Control of Reaching	PLOS ONE			English	Article							CEREBRAL GLUCOSE-METABOLISM; LINKING BASAL GANGLIA; AGE-OF-ONSET; HUNTINGTONS-DISEASE; NEUROPSYCHOLOGICAL MANIFESTATIONS; PARKINSONS-DISEASE; RECEPTOR-BINDING; MEMORY-SYSTEMS; MOTOR; CARRIERS	Background: Human movement can be guided automatically (implicit control) or attentively (explicit control). Explicit control may be engaged when learning a new movement, while implicit control enables simultaneous execution of multiple actions. Explicit and implicit control can often be assigned arbitrarily: we can simultaneously drive a car and tune the radio, seamlessly allocating implicit or explicit control to either action. This flexibility suggests that sensorimotor signals, including those that encode spatially overlapping perception and behavior, can be accurately segregated to explicit and implicit control processes. Methodology/Principal Findings: We tested human subjects' ability to segregate sensorimotor signals to parallel control processes by requiring dual (explicit and implicit) control of the same reaching movement and testing for interference between these processes. Healthy control subjects were able to engage dual explicit and implicit motor control without degradation of performance compared to explicit or implicit control alone. We then asked whether segregation of explicit and implicit motor control can be selectively disrupted by studying dual-control performance in subjects with no clinically manifest neurologic deficits in the presymptomatic stage of Huntington's disease (HD). These subjects performed successfully under either explicit or implicit control alone, but were impaired in the dual-control condition. Conclusion/Significance: The human nervous system can exert dual control on a single action, and is therefore able to accurately segregate sensorimotor signals to explicit and implicit control. The impairment observed in the presymptomatic stage of HD points to a possible crucial contribution of the striatum to the segregation of sensorimotor signals to multiple control processes.			Mazzoni, P (corresponding author), Columbia Univ, Dept Neurol, Motor Performance Lab, New York, NY 10027 USA.	pm125@columbia.edu		Lauwereyns, Jan/0000-0003-0551-2550; Mazzoni, Pietro/0000-0002-7367-8811	NINDS NIH HHS [R01 NS049206] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049206] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Antonini A, 1996, BRAIN, V119, P2085, DOI 10.1093/brain/119.6.2085; Aylward EH, 1996, ARCH NEUROL-CHICAGO, V53, P1293, DOI 10.1001/archneur.1996.00550120105023; Baars BJ, 2003, TRENDS COGN SCI, V7, P166, DOI 10.1016/S1364-6613(03)00056-1; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Badgaiyan RD, 2000, HUM BRAIN MAPP, V9, P38, DOI 10.1002/(SICI)1097-0193(2000)9:1<38::AID-HBM4>3.0.CO;2-T; Bock O, 2005, EXP BRAIN RES, V160, P259, DOI 10.1007/s00221-004-2133-5; Bonfiglioli C, 1998, NEUROPSYCHOLOGIA, V36, P1203, DOI 10.1016/S0028-3932(97)00171-1; Brandt J, 2002, J INT NEUROPSYCH SOC, V8, P918, DOI 10.1017/S1355617702870060; Brown RG, 2001, BRAIN, V124, P2188, DOI 10.1093/brain/124.11.2188; Craufurd D., 2002, HUNTINGTONS DIS, P62; de Boo GM, 1999, J CLIN EXP NEUROPSYC, V21, P831; Delval A, 2008, MOVEMENT DISORD, V23, P1446, DOI 10.1002/mds.22125; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Eversheim U, 2001, LEARN MEMORY, V8, P183, DOI 10.1101/lm.39301; Foerde K, 2006, P NATL ACAD SCI USA, V103, P11778, DOI 10.1073/pnas.0602659103; Gabrieli JDE, 1997, NEUROPSYCHOLOGY, V11, P272, DOI 10.1037/0894-4105.11.2.272; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; GRAFTON ST, 1992, ARCH NEUROL-CHICAGO, V49, P1161, DOI 10.1001/archneur.1992.00530350075022; Graybiel A M, 1991, Curr Opin Neurobiol, V1, P644, DOI 10.1016/S0959-4388(05)80043-1; Heyder K, 2004, ACTA PSYCHOL, V115, P271, DOI 10.1016/j.actpsy.2003.12.010; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Huang VS, 2007, J NEUROPHYSIOL, V97, P3976, DOI 10.1152/jn.01281.2006; Inoue K, 2000, NEUROIMAGE, V11, P505, DOI 10.1006/nimg.2000.0554; Kirkwood SC, 2000, J NEUROL NEUROSUR PS, V69, P773, DOI 10.1136/jnnp.69.6.773; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Krakauer JW, 2004, J NEUROPHYSIOL, V91, P924, DOI 10.1152/jn.00675.2003; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Lawrence AD, 1998, BRAIN, V121, P1343, DOI 10.1093/brain/121.7.1343; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; MAZZIOTTA JC, 1987, NEW ENGL J MED, V316, P357, DOI 10.1056/NEJM198702123160701; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Mullen R, 2007, BRIT J PSYCHOL, V98, P141, DOI 10.1348/000712606X114336; O'Shea S, 2002, PHYS THER, V82, P888, DOI 10.1093/ptj/82.9.888; Plotnik M, 2009, J NEUROL NEUROSUR PS, V80, P347, DOI 10.1136/jnnp.2008.157362; Poldrack RA, 2005, J NEUROSCI, V25, P5356, DOI 10.1523/JNEUROSCI.3880-04.2005; Postle BR, 1999, COGNITIVE BRAIN RES, V8, P107, DOI 10.1016/S0926-6410(99)00010-5; Reber A.S., 1993, IMPLICIT LEARNING TA; Rosas HD, 2003, NEUROLOGY, V60, P1615, DOI 10.1212/01.WNL.0000065888.88988.6E; ROSENBERG NK, 1995, J MED GENET, V32, P600, DOI 10.1136/jmg.32.8.600; ROTHLIND JC, 1993, ARCH NEUROL-CHICAGO, V50, P799, DOI 10.1001/archneur.1993.00540080010005; Rubinsztein DC, 1997, P NATL ACAD SCI USA, V94, P3872, DOI 10.1073/pnas.94.8.3872; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; SHOULSON I, 1975, ANNU REV MED, V26, P419, DOI 10.1146/annurev.me.26.020175.002223; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; SPRENGELMEYER R, 1995, BRAIN, V118, P145, DOI 10.1093/brain/118.1.145; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; STRAUSS ME, 1990, ARCH NEUROL-CHICAGO, V47, P905, DOI 10.1001/archneur.1990.00530080093016; Szmalec A, 2007, Q J EXP PSYCHOL, V60, P1116, DOI 10.1080/17470210600896484; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Weeks RA, 1996, ANN NEUROL, V40, P49, DOI 10.1002/ana.410400110; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Wu T, 2004, J NEUROPHYSIOL, V91, P1690, DOI 10.1152/jn.01052.2003; YOUNG AB, 1986, NEUROLOGY, V36, P244, DOI 10.1212/WNL.36.2.244	61	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7557	10.1371/journal.pone.0007557	http://dx.doi.org/10.1371/journal.pone.0007557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509MN	19847295	Green Submitted, Green Published, gold			2022-12-25	WOS:000271022000019
J	Traglia, M; Sala, C; Masciullo, C; Cverhova, V; Lori, F; Pistis, G; Bione, S; Gasparini, P; Ulivi, S; Ciullo, M; Nutile, T; Bosi, E; Sirtori, M; Mignogna, G; Rubinacci, A; Buetti, I; Camaschella, C; Petretto, E; Toniolo, D				Traglia, Michela; Sala, Cinzia; Masciullo, Corrado; Cverhova, Valeria; Lori, Francesca; Pistis, Giorgio; Bione, Silvia; Gasparini, Paolo; Ulivi, Sheila; Ciullo, Marina; Nutile, Teresa; Bosi, Emanuele; Sirtori, Marcella; Mignogna, Giovanna; Rubinacci, Alessandro; Buetti, Iwan; Camaschella, Clara; Petretto, Enrico; Toniolo, Daniela			Heritability and Demographic Analyses in the Large Isolated Population of Val Borbera Suggest Advantages in Mapping Complex Traits Genes	PLOS ONE			English	Article							GENETICALLY ISOLATED POPULATION; ERASMUS RUCPHEN FAMILY; FOUNDER POPULATION; METABOLIC SYNDROME; SUSCEPTIBILITY LOCUS; QUANTITATIVE TRAITS; INSULIN-RESISTANCE; IRON OVERLOAD; VARIANTS; SARDINIA	Background: Isolated populations are a useful resource for mapping complex traits due to shared stable environment, reduced genetic complexity and extended Linkage Disequilibrium (LD) compared to the general population. Here we describe a large genetic isolate from the North West Apennines, the mountain range that runs through Italy from the North West Alps to the South. Methodology/Principal Findings: The study involved 1,803 people living in 7 villages of the upper Borbera Valley. For this large population cohort, data from genealogy reconstruction, medical questionnaires, blood, anthropometric and bone status QUS parameters were evaluated. Demographic and epidemiological analyses indicated a substantial genetic component contributing to each trait variation as well as overlapping genetic determinants and family clustering for some traits. Conclusions/Significance: The data provide evidence for significant heritability of medical relevant traits that will be important in mapping quantitative traits. We suggest that this population isolate is suitable to identify rare variants associated with complex phenotypes that may be difficult to study in larger but more heterogeneous populations.			Traglia, M (corresponding author), Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy.	daniela.toniolo@hsr.it	Camaschella, Clara/A-3289-2015; Toniolo, Daniela/AAE-2969-2019; Traglia, Michela/AAX-5816-2020; Sala, Cinzia Felicita/AAN-1900-2020; Gasparini, Paolo/B-6173-2014; Ciullo, Marina/AAE-3041-2020; Ulivi, Sheila/H-3700-2013; Rubinacci, Alessandro/AAF-6627-2020; Rubinacci, Alessandro/ABG-5732-2020	Toniolo, Daniela/0000-0001-9545-6032; Ciullo, Marina/0000-0002-9621-9984; Ulivi, Sheila/0000-0003-3606-835X; Rubinacci, Alessandro/0000-0003-1736-0531; Bione, Silvia/0000-0002-3924-4606; Gasparini, Paolo/0000-0002-0859-0856; Venkatasubramanian, Siddharth/0000-0002-5860-0768; NUTILE, TERESA/0000-0001-7062-8352; s, hema/0000-0002-3440-9475	MRC [MC_U120097112] Funding Source: UKRI; Medical Research Council [MC_U120097112] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Angius A, 2001, HUM GENET, V109, P198, DOI 10.1007/s004390100557; Arcos-Burgos M, 2002, CLIN GENET, V61, P233, DOI 10.1034/j.1399-0004.2002.610401.x; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Brudevold R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003547; Cappello N, 1996, ANN HUM GENET, V60, P125, DOI 10.1111/j.1469-1809.1996.tb01183.x; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Ciullo M, 2006, HUM MOL GENET, V15, P1735, DOI 10.1093/hmg/ddl097; Colonna V, 2007, HUM HERED, V64, P123, DOI 10.1159/000101964; Falchi M, 2008, BIOINFORMATICS, V24, P724, DOI 10.1093/bioinformatics/btm617; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Grundy SM, 2004, ENDOCRIN METAB CLIN, V33, pIX, DOI 10.1016/S0889-8529(04)00035-0; Henneman P, 2008, J MED GENET, V45, P572, DOI 10.1136/jmg.2008.058388; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Kallio SP, 2009, HUM MOL GENET, V18, P1670, DOI 10.1093/hmg/ddp073; Kinjo M, 2007, J CLIN ENDOCR METAB, V92, P4161, DOI 10.1210/jc.2007-0757; Marroni F, 2008, HUM HERED, V65, P175, DOI 10.1159/000109734; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; Njajou OT, 2006, HUM HERED, V61, P222, DOI 10.1159/000094777; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Tepper BJ, 2008, OBESITY, V16, P2289, DOI 10.1038/oby.2008.357; TRECARTIN RF, 1981, J CLIN INVEST, V68, P1012, DOI 10.1172/JCI110323; Varilo T, 2004, CURR OPIN GENET DEV, V14, P316, DOI 10.1016/j.gde.2004.04.008; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; YAMAGUCHI T, 2009, ASS COMPONENTS METAB	29	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7554	10.1371/journal.pone.0007554	http://dx.doi.org/10.1371/journal.pone.0007554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847309	Green Published, gold, Green Submitted			2022-12-25	WOS:000271022000016
J	Rignell-Hydbom, A; Lidfeldt, J; Kiviranta, H; Rantakokko, P; Samsioe, G; Agardh, CD; Rylander, L				Rignell-Hydbom, Anna; Lidfeldt, Jonas; Kiviranta, Hannu; Rantakokko, Panu; Samsioe, Goran; Agardh, Carl-David; Rylander, Lars			Exposure to p,p '-DDE: A Risk Factor for Type 2 Diabetes	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; POLYCHLORINATED-BIPHENYLS; SERUM CONCENTRATIONS; NATIONAL-HEALTH; ASSOCIATION; MELLITUS; DIOXINS; CONSUMPTION; CHEMICALS; OBESITY	Background: Persistent organic pollutants (POPs), such as PCBs, DDT and dioxins have in several cross-sectional studies shown strong associations with type 2 diabetes mellitus. Reversed causality can however not be excluded. The aim of this case-control study was to evaluate whether POPs concentration is a risk factor for type 2 diabetes. Methodology/Principal Findings: A case-control study was performed within a well-defined cohort of women, age 50-59 years, from the Southern part of Sweden. Biomarkers for POP exposure, 2,2',4,4',5,5'-hexachlorobiphenyl (CB-153) and 1,1-dichloro-2,2-bis (p-chlorophenyl)-ethylene (p,p'-DDE) were analyzed in stored serum samples, which were collected at the baseline examination when the cohort was established. For 107 out of the 371 cases, serum samples were stored at least three years before their type 2 diabetes was diagnosed. In this data set, CB-153 and p, p'-DDE were not associated with an increased risk to develop type 2 diabetes. However, when only the cases (n = 39) that were diagnosed more than six years after the baseline examination and their controls were studied, the women in the highest exposed quartile showed an increased risk to develop type 2 diabetes (OR of 1.6 [95% 0.61, 4.0] for CB-153 and 5.5 [95% CI 1.2, 25] for p,p '-DDE). Conclusions/Significance: The results from the present case-control study, including a follow-up design, confirms that p, p'-DDE exposure can be a risk factor for type 2 diabetes.			Rignell-Hydbom, A (corresponding author), Lund Univ, Univ Hosp, Dept Lab Med, Div Occupat & Environm Med, Lund, Sweden.	anna.rignell-hydbom@med.lu.se		Rylander, Lars/0000-0001-8288-8207; Kiviranta, Hannu/0000-0002-7168-1611				Alonso-Magdalena P, 2005, ENVIRON HEALTH PERSP, V113, P969, DOI 10.1289/ehp.8002; Bernard A, 2002, INT J TOXICOL, V21, P333, DOI 10.1080/10915810290096540; Chen JW, 2008, ENVIRON RES, V107, P245, DOI 10.1016/j.envres.2008.01.004; Codru N, 2007, ENVIRON HEALTH PERSP, V115, P1442, DOI 10.1289/ehp.10315; ENAN E, 1994, J BIOCHEM TOXICOL, V9, P97, DOI 10.1002/jbt.2570090207; Everett CJ, 2007, ENVIRON RES, V103, P413, DOI 10.1016/j.envres.2006.11.002; Fierens S, 2003, BIOMARKERS, V8, P529, DOI 10.1080/1354750032000158420; Gavin JR, 1997, DIABETES CARE, V20, P1183; Glynn AW, 2000, SCI TOTAL ENVIRON, V263, P197, DOI 10.1016/S0048-9697(00)00703-8; Grandjean P, 2008, ENVIRON SCI TECHNOL, V42, P6991, DOI 10.1021/es800778q; Grimvall E, 1997, ARCH ENVIRON CON TOX, V32, P329, DOI 10.1007/s002449900193; Jones OAH, 2008, LANCET, V371, P287, DOI 10.1016/S0140-6736(08)60147-6; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Lee DH, 2007, DIABETES CARE, V30, P1596, DOI 10.2337/dc07-0072; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lidfeldt J, 2001, EUR J EPIDEMIOL, V17, P943, DOI 10.1023/A:1016291426124; LIU H, 1992, MOL CELL ENDOCRINOL, V87, P19, DOI 10.1016/0303-7207(92)90229-Y; Longnecker MP, 2000, EPIDEMIOLOGY, V11, P44, DOI 10.1097/00001648-200001000-00010; Mensah GA, 2004, CARDIOL CLIN, V22, P485, DOI 10.1016/j.ccl.2004.06.005; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; OLSEN H, 1994, ENVIRON HEALTH PERSP, V102, P454, DOI 10.2307/3432040; Rantakokko P, 2009, J CHROMATOGR A, V1216, P897, DOI 10.1016/j.chroma.2008.12.013; Rasier G, 2006, MOL CELL ENDOCRINOL, V254, P187, DOI 10.1016/j.mce.2006.04.002; Rignell-Hydbom A, 2007, HUM EXP TOXICOL, V26, P447, DOI 10.1177/0960327107076886; Rylander Lars, 2005, Environ Health, V4, P28, DOI 10.1186/1476-069X-4-28; Sjodin A, 2000, ENVIRON HEALTH PERSP, V108, P1035, DOI 10.2307/3434955; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Sweeney MH, 1997, TERATOGEN CARCIN MUT, V17, P241, DOI 10.1002/(SICI)1520-6866(1997)17:4/5<241::AID-TCM6>3.0.CO;2-I; Turyk M, 2009, CHEMOSPHERE, V75, P674, DOI 10.1016/j.chemosphere.2008.12.035; Uemura H, 2008, ENVIRON RES, V108, P63, DOI 10.1016/j.envres.2008.06.002; Vasiliu O, 2006, EPIDEMIOLOGY, V17, P352, DOI 10.1097/01.ede.0000220553.84350.c5; VIRTANEN HE, 2002, TOXICOL APPL PHARM, V2, P501; Wada K, 2007, J PHARMACOL SCI, V105, P133, DOI 10.1254/jphs.FM0070034; Wang SL, 2008, DIABETES CARE, V31, P1574, DOI 10.2337/dc07-2449	35	103	111	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7503	10.1371/journal.pone.0007503	http://dx.doi.org/10.1371/journal.pone.0007503			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838294	Green Published, gold, Green Submitted			2022-12-25	WOS:000270880900008
J	Seney, ML; Kelly, DA; Goldman, BD; Sumbera, R; Forger, NG				Seney, Marianne L.; Kelly, Diane A.; Goldman, Bruce D.; Sumbera, Radim; Forger, Nancy G.			Social Structure Predicts Genital Morphology in African Mole-Rats	PLOS ONE			English	Article							STRIATED PENILE MUSCLES; LEVATOR ANI; SEXUAL-DIFFERENTIATION; HETEROCEPHALUS-GLABER; COLONY FORMATION; EUSOCIALITY; CRYPTOMYS; FAMILY; COPULATION; MECHANISMS	Background: African mole-rats (Bathyergidae, Rodentia) exhibit a wide range of social structures, from solitary to eusocial. We previously found a lack of sex differences in the external genitalia and morphology of the perineal muscles associated with the phallus in the eusocial naked mole-rat. This was quite surprising, as the external genitalia and perineal muscles are sexually dimorphic in all other mammals examined. We hypothesized that the lack of sex differences in naked mole-rats might be related to their unusual social structure. Methodology/Principal Findings: We compared the genitalia and perineal muscles in three African mole-rat species: the naked mole-rat, the solitary silvery mole-rat, and the Damaraland mole-rat, a species considered to be eusocial, but with less reproductive skew than naked mole-rats. Our findings support a relationship between social structure, mating system, and sexual differentiation. Naked mole-rats lack sex differences in genitalia and perineal morphology, silvery mole-rats exhibit sex differences, and Damaraland mole-rats are intermediate. Conclusions/Significance: The lack of sex differences in naked mole-rats is not an attribute of all African mole-rats, but appears to have evolved in relation to their unusual social structure and reproductive biology.			Seney, ML (corresponding author), Univ Massachusetts, Ctr Neuroendocrine Studies, Amherst, MA 01003 USA.	marianne.seney@gmail.com	Šumbera, Radim/D-9072-2016; Seney, Marianne L/AAT-3810-2020	Šumbera, Radim/0000-0001-8658-9378; Seney, Marianne L/0000-0002-6401-9494	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH072825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS058258] Funding Source: NIH RePORTER; NIMH NIH HHS [K02 MH072825] Funding Source: Medline; NINDS NIH HHS [F31 NS058258] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], [No title captured]; Bennett N.C., 2000, AFRICAN MOLE RATS EC; BOONSTRA R, 1993, J MAMMAL, V74, P224, DOI 10.2307/1381924; Braude S, 2000, BEHAV ECOL, V11, P7, DOI 10.1093/beheco/11.1.7; Brett R.A., 1991, P97; Burda H, 2000, BEHAV ECOL SOCIOBIOL, V47, P293, DOI 10.1007/s002650050669; CIHAK R, 1970, J ANAT, V106, P93; Ciszek D, 2000, BEHAV ECOL, V11, P1, DOI 10.1093/beheco/11.1.1; DARWIN CR, 1871, PRINCIPLES SEXUAL SE, P253; Drea CM, 2008, J MORPHOL, V269, P451, DOI 10.1002/jmor.10594; Faulkes CG, 2004, MOL ECOL, V13, P613, DOI 10.1046/j.1365-294X.2004.02099.x; FAULKES CG, 1994, J REPROD FERTIL, V100, P411; FAULKES CG, 1990, J REPROD FERTIL, V88, P559; Faulkes CG, 2001, TRENDS ECOL EVOL, V16, P184, DOI 10.1016/S0169-5347(01)02116-4; Glickman SE, 2006, TRENDS ENDOCRIN MET, V17, P349, DOI 10.1016/j.tem.2006.09.005; GRAY H, 1918, ANATOMY HUMAN BODY, P424; HART BL, 1972, ANAT REC, V173, P1, DOI 10.1002/ar.1091730101; HART BL, 1983, PHYSIOL BEHAV, V31, P807, DOI 10.1016/0031-9384(83)90277-9; HAYES KJ, 1965, ACTA ENDOCRINOL-COP, V48, P337, DOI 10.1530/acta.0.0480337; HILL WCO, 1957, P ZOOL SOC LOND, V128, P456; HOLMES GM, 1994, PHYSIOL BEHAV, V55, P255, DOI 10.1016/0031-9384(94)90131-7; Holmes MM, 2007, P NATL ACAD SCI USA, V104, P10548, DOI 10.1073/pnas.0610344104; Ingram CM, 2004, MOL PHYLOGENET EVOL, V31, P997, DOI 10.1016/j.ympev.2003.11.004; Jacobs DS, 1998, S AFR J ZOOL, V33, P189; Jarvis J.U.M., 1991, P66; JARVIS JUM, 1993, BEHAV ECOL SOCIOBIOL, V33, P253, DOI 10.1007/BF02027122; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; JARVIS JUM, 1994, TRENDS ECOL EVOL, V9, P47, DOI 10.1016/0169-5347(94)90267-4; KARACAN I, 1983, SCIENCE, V220, P1080, DOI 10.1126/science.6844930; Kock D, 2006, ZOOTAXA, P51, DOI 10.11646/zootaxa.1142.1.4; Lacey E.A., 1991, P275; MARGULIS SW, 1995, HORM BEHAV, V29, P227, DOI 10.1006/hbeh.1995.1017; MATTHEWS L. HARRISON, 1939, PHIL TRANS ROY SOC LONDON SER B BIOL SCI, V230, P1; MCKENNA KE, 1986, J COMP NEUROL, V248, P532, DOI 10.1002/cne.902480406; Nickel R, 1973, VISCERA DOMESTIC ANI; Parag A, 2006, J ZOOL, V270, P323, DOI 10.1111/j.1469-7998.2006.00141.x; PATZENHAUEROVA H, BEHAV ECOL SOC UNPUB; Peroulakis ME, 2002, J NEUROBIOL, V51, P33, DOI 10.1002/neu.10039; Poortmans A, 1998, ANAT REC, V251, P20, DOI 10.1002/(SICI)1097-0185(199805)251:1<20::AID-AR5>3.0.CO;2-I; REEVE HK, 1990, P NATL ACAD SCI USA, V87, P2496, DOI 10.1073/pnas.87.7.2496; SACHS BD, 1982, J REPROD FERTIL, V66, P433, DOI 10.1530/jrf.0.0660433; SCHMIDT MH, 1993, SLEEP, V16, P171, DOI 10.1093/sleep/16.2.171; Seney M, 2006, J NEUROBIOL, V66, P1354, DOI 10.1002/neu.20314; SHAPIRO LE, 1991, BRAIN RES, V541, P232, DOI 10.1016/0006-8993(91)91023-T; Short R.V., 1979, Advances in the Study of Behavior, V9, P131, DOI 10.1016/S0065-3454(08)60035-2; Sumbera R, 2003, J MAMMAL, V84, P278, DOI 10.1644/1545-1542(2003)084<0278:RBOASS>2.0.CO;2; Sumbera R, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P221, DOI 10.1007/978-3-540-69276-8_16; Tullberg T., 1899, NOVA ACTA REG SOC, V3, P1; WILSON JD, 1980, BIOL REPROD, V22, P9, DOI 10.1095/biolreprod22.1.9	49	27	27	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7477	10.1371/journal.pone.0007477	http://dx.doi.org/10.1371/journal.pone.0007477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829697	Green Submitted, Green Published, gold			2022-12-25	WOS:000270847800014
J	Yang, J; Parsons, J; Nicolay, NH; Caporali, S; Harrington, CF; Singh, R; Finch, D; D'Atri, S; Farmer, PB; Johnston, PG; McKenna, WG; Dianov, G; Sharma, RA				Yang, J.; Parsons, J.; Nicolay, N. H.; Caporali, S.; Harrington, C. F.; Singh, R.; Finch, D.; D'Atri, S.; Farmer, P. B.; Johnston, P. G.; McKenna, W. G.; Dianov, G.; Sharma, R. A.			Cells deficient in the base excision repair protein, DNA polymerase beta, are hypersensitive to oxaliplatin chemotherapy	ONCOGENE			English	Article						DNA repair; colorectal cancer; malignant melanoma	CANCER; LINES; OVEREXPRESSION; EXPRESSION; RESISTANT; CISPLATIN; APOPTOSIS; BREAKAGE; DAMAGE	A significant proportion of human cancers overexpress DNA polymerase beta (Pol beta), the major DNA polymerase involved in base excision repair. The underlying mechanism and biological consequences of overexpression of this protein are unknown. We examined whether Pol beta, expressed at levels found in tumor cells, is involved in the repair of DNA damage induced by oxaliplatin treatment and whether the expression status of this protein alters the sensitivity of cells to oxaliplatin. DNA damage induced by oxaliplatin treatment of HCT116 and HT29 colon cancer cells was observed to be associated with the stabilization of Pol beta protein on chromatin. In comparison with HCT116 colon cancer cells, isogenic oxaliplatin-resistant (HCT-OR) cells were found to have higher constitutive levels of Pol beta protein, faster in vitro repair of a DNA substrate containing a single nucleotide gap and faster repair of 1,2-GG oxaliplatin adduct levels in cells. In HCT-OR cells, small interfering RNA knockdown of Pol beta delayed the repair of oxaliplatin-induced DNA damage. In a different model system, Pol beta-deficient fibroblasts were less able to repair 1,2-GG oxaliplatin adducts and were hypersensitive to oxaliplatin treatment compared with isogenic Pol beta-expressing cells. Consistent with previous studies, Pol beta-deficient mouse fibroblasts were not hypersensitive to cisplatin treatment. These data provide the first link between oxaliplatin sensitivity and DNA repair involving Pol beta. They demonstrate that Pol beta modulates the sensitivity of cells to oxaliplatin treatment. Oncogene (2010) 29, 463-468; doi:10.1038/onc.2009.327; published online 19 October 2009	[Yang, J.; Parsons, J.; Nicolay, N. H.; Finch, D.; McKenna, W. G.; Dianov, G.; Sharma, R. A.] Univ Oxford, Canc Res UK Med Res Council, Gray Inst Radiat Oncol & Biol, Oxford OX3 7DQ, Oxon, England; [Caporali, S.; D'Atri, S.] IRCCS, Ist Dermopat Immacolata, Oncol Mol Lab, Rome, Italy; [Harrington, C. F.] Univ Surrey, Fac Hlth & Med Sci, Ctr Clin Sci & Measurement, Trace Element Lab, Surrey, England; [Singh, R.; Farmer, P. B.] Univ Leicester, Bioctr, Canc Biomarkers & Prevent Grp, Leicester, Leics, England; [Johnston, P. G.] Queens Univ Belfast, Inst Hlth Sci, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland	Cancer Research UK; University of Oxford; IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Surrey; University of Leicester; Queens University Belfast	Sharma, RA (corresponding author), Univ Oxford, Churchill Hosp, Gray Inst Radiat Oncol & Biol, Old Rd Campus Res Bldg, Oxford OX3 7DQ, Oxon, England.	grigory.dianov@rob.ox.ac.uk; ricky.sharma@rob.ox.ac.uk	Singh, Raj/A-5398-2011; Singh, Raj/HDN-1244-2022; D'Atri, Stefania/K-6039-2016; Harrington, Chris F/M-3453-2018	Harrington, Chris F/0000-0003-4101-556X; Parsons, Jason/0000-0002-5052-1125; D'Atri, Stefania/0000-0001-9852-7377	Cancer Research UK; UK Medical Research Council; Higher Education Funding Council for England; UK Biotechnology and Biological Sciences Research Council; NIHR Biomedical Research Centre, Oxford, UK; MRC [G0700730] Funding Source: UKRI; Cancer Research UK [8971] Funding Source: researchfish; Medical Research Council [G0700730] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIHR Biomedical Research Centre, Oxford, UK(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Drs Tomas Lindahl and Peter McHugh for comments on the paper. This study was supported by Cancer Research UK, the UK Medical Research Council, the Higher Education Funding Council for England, the Research Equipment Initiative of the UK Biotechnology and Biological Sciences Research Council and the NIHR Biomedical Research Centre, Oxford, UK.	Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Bergoglio V, 2001, ONCOGENE, V20, P6181, DOI 10.1038/sj.onc.1204743; Boyer J, 2004, CLIN CANCER RES, V10, P2158, DOI 10.1158/1078-0432.CCR-03-0362; Boyer J, 2006, CANCER RES, V66, P2765, DOI 10.1158/0008-5472.CAN-05-2693; Canitrot Y, 1999, FASEB J, V13, P1107, DOI 10.1096/fasebj.13.9.1107; Dianova II, 2001, BIOCHEMISTRY-US, V40, P12639, DOI 10.1021/bi011117i; Horton JK, 2002, DNA REPAIR, V1, P317, DOI 10.1016/S1568-7864(02)00008-3; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Le Pla RC, 2007, CHEM RES TOXICOL, V20, P1177, DOI 10.1021/tx700088j; Ochs K, 2002, CANCER RES, V62, P1524; Ochs K, 1999, CANCER RES, V59, P1544; Parsons JL, 2008, MOL CELL, V29, P477, DOI 10.1016/j.molcel.2007.12.027; Rixe O, 1996, BIOCHEM PHARMACOL, V52, P1855, DOI 10.1016/S0006-2952(97)81490-6; Servant L, 2002, J BIOL CHEM, V277, P50046, DOI 10.1074/jbc.M207101200; Shibuya K, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-37; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Srivastava DK, 1999, CARCINOGENESIS, V20, P1049, DOI 10.1093/carcin/20.6.1049; Starcevic D, 2004, CELL CYCLE, V3, P998; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Vaisman A, 2000, J BIOL CHEM, V275, P13017, DOI 10.1074/jbc.275.17.13017; Woodhouse BC, 2008, DNA REPAIR, V7, P932, DOI 10.1016/j.dnarep.2008.03.017; ZMUDZKA BZ, 1988, NUCLEIC ACIDS RES, V16, P9587, DOI 10.1093/nar/16.20.9587	22	44	46	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2010	29	3					463	468		10.1038/onc.2009.327	http://dx.doi.org/10.1038/onc.2009.327			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	546EO	19838217				2022-12-25	WOS:000273793200015
J	Warren, DT; Tajsic, T; Mellad, JA; Searles, R; Zhang, QP; Shanahan, CM				Warren, Derek T.; Tajsic, Tamara; Mellad, Jason A.; Searles, Richelle; Zhang, Qiuping; Shanahan, Catherine M.			Novel Nuclear Nesprin-2 Variants Tether Active Extracellular Signal-regulated MAPK1 and MAPK2 at Promyelocytic Leukemia Protein Nuclear Bodies and Act to Regulate Smooth Muscle Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; RETINOBLASTOMA GENE-PRODUCT; LAMIN-A; SPATIOTEMPORAL CONTROL; BINDING-PROTEIN; ENVELOPE; CYTOSKELETON; KINASE; ANCHORAGE; MEMBRANE	Nuclear and cytoplasmic scaffold proteins have been shown to be essential for temporal and spatial organization, as well as the fidelity, of MAPK signaling pathways. In this study we show that nesprin-2 is a novel extracellular signal-regulated MAPK 1 and 2 (ERK1/2) scaffold protein that serves to regulate nuclear signaling by tethering these kinases at promyelocytic leukemia protein nuclear bodies (PML NBs). Using immunofluorescence microscopy, GST pull-down and immunoprecipitation, we show that nesprin-2, ERK1/2, and PML colocalize and bind to form a nuclear complex. Interference of nesprin-2 function, by either siRNA-mediated knockdown or overexpression of a dominant negative nesprin-2 fragment, augmented ERK1/2 nuclear signaling shown by increased SP1 activity and ELK1 phosphorylation. The functional outcome of nesprin-2 disruption and the resultant sustained ERK1/2 signal was increased proliferation. Importantly, these activities were not induced by previously identified nuclear envelope (NE)-targeted nesprin-2 isoforms but rather were mediated by novel nuclear isoforms that lacked the KASH domain. Taken together, this study suggests that nesprin-2 is a novel intranuclear scaffold, essential for nuclear ERK1/2 signaling fidelity and cell cycle progression.	[Warren, Derek T.; Mellad, Jason A.; Searles, Richelle; Zhang, Qiuping; Shanahan, Catherine M.] Kings Coll London, Div Cardiovasc Med, British Heart Fdn Ctr, London SE5 9NU, England; [Tajsic, Tamara] Addenbrookes Hosp, Dept Med, Cambridge CB2 ZQQ, England	University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital	Warren, DT (corresponding author), Kings Coll London, Div Cardiovasc Med, James Black Ctr, 125 Coldharbour Lane, London SE5 9NU, England.	derek.warren@kcl.ac.uk	Zhang, Qiuping/L-3522-2019	Zhang, Qiuping/0000-0002-4000-3957; Shanahan, Catherine/0000-0002-8352-8171; Warren, Derek/0000-0003-0346-7450	British Heart Foundation (BHF) Program [RG/05/001]; British Heart Foundation [RG/09/008/27923] Funding Source: researchfish	British Heart Foundation (BHF) Program(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation (BHF) Program Grant RG/05/001 (to C.M.S.).	Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Bing HT, 2006, J CELL BIOCHEM, V99, P1343, DOI 10.1002/jcb.20999; Burack WR, 2005, J BIOL CHEM, V280, P3832, DOI 10.1074/jbc.M410031200; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Costa M, 2006, J CELL SCI, V119, P4952, DOI 10.1242/jcs.03272; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; Locher R, 2002, HYPERTENSION, V39, P645, DOI 10.1161/hy0202.103473; Luke Y, 2008, J CELL SCI, V121, P1887, DOI 10.1242/jcs.019075; MANCINI MA, 1994, P NATL ACAD SCI USA, V91, P418, DOI 10.1073/pnas.91.1.418; Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; OZAKI T, 1994, ONCOGENE, V9, P2649; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; PAGES G, 1993, P NATL ACAD SCI USA, V90, P8319, DOI 10.1073/pnas.90.18.8319; Pekovic V, 2007, J CELL BIOL, V176, P163, DOI 10.1083/jcb.200606139; Pouyssegur J, 2003, EUR J BIOCHEM, V270, P3291, DOI 10.1046/j.1432-1033.2003.03707.x; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Tamama K, 2008, STEM CELLS DEV, V17, P897, DOI 10.1089/scd.2007.0155; Warren Derek T., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009294; Wheeler MA, 2007, EXP CELL RES, V313, P2845, DOI 10.1016/j.yexcr.2007.03.025; Wilhelmsen K, 2006, J CELL SCI, V119, P5021, DOI 10.1242/jcs.03295; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zhen YY, 2002, J CELL SCI, V115, P3207	36	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1311	1320		10.1074/jbc.M109.032557	http://dx.doi.org/10.1074/jbc.M109.032557			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19861416	hybrid, Green Published			2022-12-25	WOS:000273258200052
J	Huang, CJ; Gurlo, T; Haataja, L; Costes, S; Daval, M; Ryazantsev, S; Wu, XJ; Butler, AE; Butler, PC				Huang, Chang-jiang; Gurlo, Tatyana; Haataja, Leena; Costes, Safia; Daval, Marie; Ryazantsev, Sergey; Wu, Xiuji; Butler, Alexandra E.; Butler, Peter C.			Calcium-activated Calpain-2 Is a Mediator of Beta Cell Dysfunction and Apoptosis in Type 2 Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET AMYLOID POLYPEPTIDE; ENDOPLASMIC-RETICULUM STRESS; ALPHA-II-SPECTRIN; ALZHEIMERS-DISEASE; TRANSGENIC MICE; MOUSE MODEL; MEMBRANE DISRUPTION; MECHANISM; RELEASE; CHANNEL	The islet in type 2 diabetes (T2DM) and the brain in neurodegenerative diseases share progressive cell dysfunction, increased apoptosis, and accumulation of locally expressed amyloidogenic proteins (islet amyloid polypeptide (IAPP) in T2DM). Excessive activation of the Ca2+-sensitive protease calpain-2 has been implicated as a mediator of oligomer-induced cell death and dysfunction in neurodegenerative diseases. To establish if human IAPP toxicity is mediated by a comparable mechanism, we overexpressed human IAPP in rat insulinoma cells and freshly isolated human islets. Pancreas was also obtained at autopsy from humans with T2DM and nondiabetic controls. We report that overexpression of human IAPP leads to the formation of toxic oligomers and increases beta cell apoptosis mediated by increased cytosolic Ca2+ and hyperactivation of calpain-2. Cleavage of alpha-spectrin, a marker of calpain hyperactivation, is increased in beta cells in T2DM. We conclude that overactivation of Ca2+-calpain pathways contributes to beta cell dysfunction and apoptosis in T2DM.	[Huang, Chang-jiang; Gurlo, Tatyana; Haataja, Leena; Costes, Safia; Daval, Marie; Wu, Xiuji; Butler, Alexandra E.; Butler, Peter C.] Univ Calif Los Angeles, David Geffen Sch Med, Larry Hillblom Islet Res Ctr, Los Angeles, CA 90024 USA; [Ryazantsev, Sergey] Univ Calif Los Angeles, Calif Nano Syst Inst, Electron Imaging Ctr Nanomachines, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Butler, PC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Larry Hillblom Islet Res Ctr, 900 Vet Ave,24-130 Warren Hall, Los Angeles, CA 90095 USA.	pbutler@mednet.ucla.edu	, Costes/AAC-2820-2020	, Costes/0000-0001-8323-1207; Butler, Alexandra/0000-0002-5762-3917; butler, peter/0000-0002-2981-8979	National Institutes of Health [DK059579]; Larry L. Hillblom Foundation [2007-D-003-NET]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Larry L. Hillblom Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK059579. This work was also supported by The Larry L. Hillblom Foundation Grant 2007-D-003-NET.	Bevers MB, 2008, J CEREBR BLOOD F MET, V28, P655, DOI 10.1038/sj.jcbfm.9600595; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Casas S, 2008, DIABETOLOGIA, V51, P2252, DOI 10.1007/s00125-008-1111-z; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Cowan CM, 2008, J NEUROSCI, V28, P12725, DOI 10.1523/JNEUROSCI.4619-08.2008; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; DUMM CLAG, 1994, VIRCHOWS ARCH, V425, P73; Dutta S, 2002, BIOL CHEM, V383, P785, DOI 10.1515/BC.2002.082; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; EPSTEIN PN, 1992, ENDOCRINOLOGY, V130, P1387, DOI 10.1210/en.130.3.1387; Ferreiro E, 2008, NEUROBIOL DIS, V30, P331, DOI 10.1016/j.nbd.2008.02.003; Giunti R, 2007, ARCH BIOCHEM BIOPHYS, V462, P115, DOI 10.1016/j.abb.2007.03.039; Grant RJ, 2009, NEUROSCIENCE, V158, P558, DOI 10.1016/j.neuroscience.2008.10.023; GURLO T, 2010, AM J PATHOL; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Hood JL, 2004, J BIOL CHEM, V279, P43126, DOI 10.1074/jbc.M408100200; Huang CJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE1656, DOI 10.1152/ajpendo.00318.2007; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; Janson J, 1999, DIABETES, V48, P491, DOI 10.2337/diabetes.48.3.491; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; Johnson GVW, 1997, BIOESSAYS, V19, P1011, DOI 10.1002/bies.950191111; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Khemtemourian L, 2008, EXP DIABETES RES, DOI 10.1155/2008/421287; Kuwako K, 2002, MOL BRAIN RES, V107, P166, DOI 10.1016/S0169-328X(02)00489-8; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Matveyenko AV, 2006, ILAR J, V47, P225, DOI 10.1093/ilar.47.3.225; MICHELANGELI F, 1995, J VIROL, V69, P3838, DOI 10.1128/JVI.69.6.3838-3847.1995; Mirzabekov TA, 1996, J BIOL CHEM, V271, P1988, DOI 10.1074/jbc.271.4.1988; NAGATA E, 1994, NEUROSCIENCE, V61, P983, DOI 10.1016/0306-4522(94)90418-9; Norberg E, 2008, CELL DEATH DIFFER, V15, P1857, DOI 10.1038/cdd.2008.123; Paschen W, 2003, CELL CALCIUM, V33, P83, DOI 10.1016/S0143-4160(02)00195-1; Pereira C, 2004, J MOL NEUROSCI, V23, P97, DOI 10.1385/JMN:23:1-2:097; Pettigrew LC, 1996, J CEREBR BLOOD F MET, V16, P1189, DOI 10.1097/00004647-199611000-00013; Piwocka K, 2006, BLOOD, V107, P4003, DOI 10.1182/blood-2005-04-1523; Rajgopal Y, 2002, NEUROSCI LETT, V321, P187, DOI 10.1016/S0304-3940(02)00063-0; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; RARDON DP, 1990, CIRC RES, V67, P84, DOI 10.1161/01.RES.67.1.84; Resende R, 2008, J NEUROSCI RES, V86, P2091, DOI 10.1002/jnr.21648; Ryazantsev S, 2007, MOL GENET METAB, V90, P393, DOI 10.1016/j.ymgme.2006.11.006; Saisho Y, 2009, AM J PHYSIOL-ENDOC M, V296, pE89, DOI 10.1152/ajpendo.90697.2008; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Siman R, 2005, J CEREBR BLOOD F MET, V25, P1433, DOI 10.1038/sj.jcbfm.9600138; Song YQ, 2007, HUM MOL GENET, V16, P2960, DOI 10.1093/hmg/ddm256; Sparr E, 2004, FEBS LETT, V577, P117, DOI 10.1016/j.febslet.2004.09.075; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Takano J, 2005, J BIOL CHEM, V280, P16175, DOI 10.1074/jbc.M414552200; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; Van Coppenolle F, 2004, J CELL SCI, V117, P4135, DOI 10.1242/jcs.01274; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Young SH, 1999, AM J PHYSIOL-GASTR L, V276, pG1204, DOI 10.1152/ajpgi.1999.276.5.G1204	56	71	73	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					339	348		10.1074/jbc.M109.024190	http://dx.doi.org/10.1074/jbc.M109.024190			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19861418	Green Published, hybrid			2022-12-25	WOS:000273070100035
J	Hata, S; Fujishige, S; Araki, Y; Kato, N; Araseki, M; Nishimura, M; Hartmann, D; Saftig, P; Fahrenholz, F; Taniguchi, M; Urakami, K; Akatsu, H; Martins, RN; Yamamoto, K; Maeda, M; Yamamoto, T; Nakaya, T; Gandy, S; Suzuki, T				Hata, Saori; Fujishige, Sayaka; Araki, Yoichi; Kato, Naoko; Araseki, Masahiko; Nishimura, Masaki; Hartmann, Dieter; Saftig, Paul; Fahrenholz, Falk; Taniguchi, Miyako; Urakami, Katsuya; Akatsu, Hiroyasu; Martins, Ralph N.; Yamamoto, Kazuo; Maeda, Masahiro; Yamamoto, Tohru; Nakaya, Tadashi; Gandy, Sam; Suzuki, Toshiharu			Alcadein Cleavages by Amyloid beta-Precursor Protein (APP) alpha- and gamma-Secretases Generate Small Peptides, p3-Alcs, Indicating Alzheimer Disease-related gamma-Secretase Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESENILIN-1 MUTATIONS; EARLY-ONSET; CONVERTING-ENZYME; METABOLISM; ASSOCIATION; MEMBRANE; FAMILY; PHOSPHORYLATION; DIFFERENTIATION; A-BETA(42)	Alcadeins (Alcs) constitute a family of neuronal type I membrane proteins, designated Alc(alpha), Alc(beta), and Alc(gamma). The Alcs express in neurons dominantly and largely colocalize with the Alzheimer amyloid precursor protein (APP) in the brain. Alcs and APP show an identical function as a cargo receptor of kinesin-1. Moreover, proteolytic processing of Alc proteins appears highly similar to that of APP. We found that APP alpha-secretases ADAM 10 and ADAM 17 primarily cleave Alc proteins and trigger the subsequent secondary intramembranous cleavage of Alc C-terminal fragments by a presenilin-dependent gamma-secretase complex, thereby generating "APP p3-like" and non-aggregative Alc peptides (p3-Alcs). Wedetermined the complete amino acid sequence of p3-Alc(alpha), p3-Alc(beta), and p3-Alc(gamma), whose major species comprise 35, 37, and 31 amino acids, respectively, in human cerebrospinal fluid. We demonstrate here that variant p3-Alc C termini are modulated by FAD-linked presenilin 1 mutations increasing minor beta-amyloid species A beta 42, and these mutations alter the level of minor p3-Alc species. However, the magnitudes of C-terminal alteration of p3-Alc(alpha), p3-Alc(beta), and p3-Alc(gamma) were not equivalent, suggesting that one type of gamma-secretase dysfunction does not appear in the phenotype equivalently in the cleavage of type I membrane proteins. Because these C-terminal alterations are detectable in human cerebrospinal fluid, the use of a substrate panel, including Alcs and APP, may be effective to detect gamma-secretase dysfunction in the prepathogenic state of Alzheimer disease subjects.	[Gandy, Sam] Mt Sinai Sch Med, Alzheimers Dis Res Ctr, Dept Neurol, New York, NY 10029 USA; [Gandy, Sam] Mt Sinai Sch Med, Alzheimers Dis Res Ctr, Dept Psychiat, New York, NY 10029 USA; [Hata, Saori; Fujishige, Sayaka; Araki, Yoichi; Kato, Naoko; Araseki, Masahiko; Yamamoto, Tohru; Nakaya, Tadashi; Suzuki, Toshiharu] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Neurosci, Sapporo, Hokkaido 0600812, Japan; [Nishimura, Masaki] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Neurol Unit, Otsu, Shiga 5202192, Japan; [Hartmann, Dieter] Univ Bonn, Dept Anat, D-53115 Bonn, Germany; [Saftig, Paul] Univ Kiel, Inst Biochem, D-2300 Kiel, Germany; [Fahrenholz, Falk] Johannes Gutenberg Univ Mainz, Inst Biochem, D-6500 Mainz, Germany; [Taniguchi, Miyako; Urakami, Katsuya] Tottori Univ, Fac Med, Sch Hlth Sci, Dept Regulat Biol, Yonago, Tottori 6838503, Japan; [Akatsu, Hiroyasu] Fukushimura Hosp, Choju Med Inst, Toyohashi, Aichi 4418124, Japan; [Martins, Ralph N.] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Sir James McCusker Alzheimers Dis Res Unit, Joondalup, WA 6027, Australia; [Martins, Ralph N.] Edith Cowan Univ, Sch Exercise Biomed & Hlth Sci, Ctr Excellence Alzheimers Dis Res & Care, Joondalup, WA 6027, Australia; [Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; [Maeda, Masahiro] Immunobiol Labs Co Ltd, Fujioka 3750005, Japan; [Gandy, Sam] James J Peters Vet Adm Med Ctr, Bronx, NY 10468 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Hokkaido University; Shiga University of Medical Science; University of Bonn; University of Kiel; Johannes Gutenberg University of Mainz; Tottori University; Edith Cowan University; Edith Cowan University; University of Tokyo; Immuno-Biological Laboratories Co. Ltd.; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Gandy, S (corresponding author), Mt Sinai Sch Med, Alzheimers Dis Res Ctr, Dept Neurol, New York, NY 10029 USA.	samuel.gandy@mssm.edu; tsuzuki@pharm.hokudai.ac.jp	Saftig, Paul/A-7966-2010; Yamamoto, Tohru/A-3801-2012; Hata, Saori/A-3829-2012; Suzuki, Toshiharu/B-5342-2013; Hata, Saori/AAP-9634-2020	Yamamoto, Tohru/0000-0002-1652-0233; Martins, Ralph/0000-0002-4828-9363	National Institutes of Health, NIA [R01 AG23611, P01 AG10491, P50 AG005138]; Ministry of Education, Science, Culture, Sports, and Technology, Japan [20023001]; NATIONAL INSTITUTE ON AGING [P01AG010491, P50AG005138, R01AG023611] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Ministry of Education, Science, Culture, Sports, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health, NIA, Grants R01 AG23611, P01 AG10491, and P50 AG005138 (to S. G.). This work was also supported in part by Grants-in-aid for Scientific Research on Priority Areas 20023001 (to T. S.) from the Ministry of Education, Science, Culture, Sports, and Technology, Japan.	Allinson TMJ, 2004, EUR J BIOCHEM, V271, P2539, DOI 10.1111/j.1432-1033.2004.04184.x; Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Ando K, 1999, J NEUROSCI, V19, P4421; Araki Y, 2004, J BIOL CHEM, V279, P24343, DOI 10.1074/jbc.M401925200; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Devi G, 2000, ARCH NEUROL-CHICAGO, V57, P1454, DOI 10.1001/archneur.57.10.1454; Endres K, 2005, FEBS J, V272, P5808, DOI 10.1111/j.1742-4658.2005.04976.x; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Goddard DR, 2001, GLIA, V34, P267, DOI 10.1002/glia.1060; Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hoerndli FJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004880; Ikeda DD, 2008, P NATL ACAD SCI USA, V105, P5260, DOI 10.1073/pnas.0711894105; Kanai M, 1998, ANN NEUROL, V44, P17, DOI 10.1002/ana.410440108; Kauwe JSK, 2007, ANN NEUROL, V61, P446, DOI 10.1002/ana.21099; Kwok JBJ, 1997, NEUROREPORT, V8, P1537, DOI 10.1097/00001756-199704140-00043; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Ludwig A, 2009, TRAFFIC, V10, P572, DOI 10.1111/j.1600-0854.2009.00886.x; Moehlmann T, 2002, P NATL ACAD SCI USA, V99, P8025, DOI 10.1073/pnas.112686799; Saito Y, 2008, J BIOL CHEM, V283, P35763, DOI 10.1074/jbc.M801353200; Sano Y, 2006, J BIOL CHEM, V281, P37853, DOI 10.1074/jbc.M609312200; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Suzuki T, 2008, J BIOL CHEM, V283, P29633, DOI 10.1074/jbc.R800003200; Taru H, 2009, J ALZHEIMERS DIS, V18, P253, DOI 10.3233/JAD-2009-1148; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vogt L, 2001, MOL CELL NEUROSCI, V17, P151, DOI 10.1006/mcne.2000.0937	31	39	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36024	36033		10.1074/jbc.M109.057497	http://dx.doi.org/10.1074/jbc.M109.057497			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19864413	Green Published, hybrid			2022-12-25	WOS:000272970500004
J	Hu, JC; Bengrine, A; Lis, A; Awayda, MS				Hu, John Cong; Bengrine, Abderrahmane; Lis, Agnieszka; Awayda, Mouhamed S.			Alternative Mechanism of Activation of the Epithelial Na+ Channel by Cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE EXPRESSION; SODIUM-CHANNELS; GAMMA-SUBUNIT; SUBSTRATE-SPECIFICITY; FEEDBACK-REGULATION; ENAC; TRYPSIN; PEPTIDE; SERINE; FURIN	We examined activation of the human epithelial sodium channel (ENaC) by cleavage. We focused on cleavage of alpha ENaC using the serine protease subtilisin. Trimeric channels formed with alpha FM, a construct with point mutations in both furin cleavage sites (R178A/R204A), exhibited marked reduction in spontaneous cleavage and an similar to 10-fold decrease in amiloride-sensitive whole cell conductance as compared with alpha WT (2.2 versus 21.2 microsiemens (mu S)). Both alpha WT and alpha FM were activated to similar levels by subtilisin cleavage. Channels formed with alpha FD, a construct that deleted the segment between the two furin sites (Delta 175-204), exhibited an intermediate conductance of 13.2 mu S. More importantly, alpha FD retained the ability to be activated by subtilisin to 108.8 +/- 20.9 mu S, a level not significantly different from that of subtilisin activated alpha WT (125.6 +/- 23.9). Therefore, removal of the tract between the two furin sites is not the main mechanism of channel activation. In these experiments the levels of the cleaved 22-kDa N-terminal fragment of alpha was low and did not match those of the C-terminal 65-kDa fragment. This indicated that cleavage may activate ENaC by the loss of the smaller fragment and the first transmembrane domain. This was confirmed in channels formed with alpha LD, a construct that extended the deleted sequence of alpha FD by 17 amino acids (Delta 175-221). Channels with alpha LD were uncleaved, exhibited low baseline activity (4.1 mu S), and were insensitive to subtilisin. Collectively, these data support an alternative hypothesis of ENaC activation by cleavage that may involve the loss of the first transmembrane domain from the channel complex.	[Hu, John Cong; Bengrine, Abderrahmane; Lis, Agnieszka; Awayda, Mouhamed S.] SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Awayda, MS (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, 124 Sherman Hall,3435 Main St, Buffalo, NY 14214 USA.	awayda@buffalo.edu			National Institutes of Health [DK55626]; John R. Oishei Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John R. Oishei Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK55626. This work was also supported by the John R. Oishei Foundation.	Adachi M, 2001, J AM SOC NEPHROL, V12, P1114, DOI 10.1681/ASN.V1261114; Andersen Olaf S., 2007, V400, P543; Awayda Mouhamed S., 2006, V337, P101; Awayda MS, 2000, J GEN PHYSIOL, V115, P559, DOI 10.1085/jgp.115.5.559; Awayda MS, 2002, AM J PHYSIOL-CELL PH, V283, pC1122, DOI 10.1152/ajpcell.00142.2002; Awayda MS, 1996, J GEN PHYSIOL, V108, P49, DOI 10.1085/jgp.108.1.49; Bengrine A, 2007, J BIOL CHEM, V282, P26884, DOI 10.1074/jbc.M611829200; Bengrine A, 2007, FASEB J, V21, P1189, DOI 10.1096/fj.06-6046com; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Carattino MD, 2006, J BIOL CHEM, V281, P18901, DOI 10.1074/jbc.M604109200; Diakov A, 2008, J PHYSIOL-LONDON, V586, P4587, DOI 10.1113/jphysiol.2008.154435; DURIEUX ME, 1994, FEBS LETT, V337, P235, DOI 10.1016/0014-5793(94)80198-3; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Frindt G, 1996, AM J PHYSIOL-RENAL, V270, pF371, DOI 10.1152/ajprenal.1996.270.2.F371; Frindt G, 2009, AM J PHYSIOL-RENAL, V297, pF1249, DOI 10.1152/ajprenal.00401.2009; Garcia-Caballero A, 2008, J GEN PHYSIOL, V132, P521, DOI 10.1085/jgp.200810030; Gosalia DN, 2005, MOL CELL PROTEOMICS, V4, P626, DOI 10.1074/mcp.M500004-MCP200; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hedstrom L, 1996, BIOL CHEM, V377, P465; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; KAM CM, 1995, ARCH BIOCHEM BIOPHYS, V316, P808, DOI 10.1006/abbi.1995.1108; Kelkar DA, 2007, BBA-BIOMEMBRANES, V1768, P1103, DOI 10.1016/j.bbamem.2007.01.016; Lee KJB, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031917; Lee KJB, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.021909; Liu W, 2005, J STRUCT BIOL, V150, P23, DOI 10.1016/j.jsb.2004.12.007; Lundbaek JA, 1999, BIOPHYS J, V76, P889, DOI 10.1016/S0006-3495(99)77252-8; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Nesterov V, 2008, AM J PHYSIOL-RENAL, V295, pF1052, DOI 10.1152/ajprenal.00031.2008; Ruan B, 2008, BIOCHEMISTRY-US, V47, P6628, DOI 10.1021/bi800089f; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; SVENNINGSEN P, 2009, AM J PHYSL IN PRESS; Svenningsen P, 2009, J AM SOC NEPHROL, V20, P299, DOI 10.1681/ASN.2008040364; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vallet VR, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133588	42	14	14	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36334	36345		10.1074/jbc.M109.032870	http://dx.doi.org/10.1074/jbc.M109.032870			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858199	hybrid, Green Published			2022-12-25	WOS:000272970500035
J	Jiang, R; Kim, EH; Gong, JH; Kwon, HM; Kim, CH; Ryu, KH; Park, JW; Kurokawa, K; Zhang, JH; Gubb, D; Lee, BL				Jiang, Rui; Kim, Eun-Hye; Gong, Ji-Hee; Kwon, Hyun-Mi; Kim, Chan-Hee; Ryu, Kyoung-Hwa; Park, Ji-Won; Kurokawa, Kenji; Zhang, Jinghai; Gubb, David; Lee, Bok-Luel			Three Pairs of Protease-Serpin Complexes Cooperatively Regulate the Insect Innate Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDOGLYCAN RECOGNITION PROTEIN; GRAM-POSITIVE BACTERIA; INHIBITORY SPECIFICITY; PROTEOLYTIC CASCADE; MANDUCA-SEXTA; HOST-DEFENSE; TOLL PATHWAY; DROSOPHILA; ACTIVATION; MELANIZATION	Serpins are known to be necessary for the regulation of several serine protease cascades. However, the mechanisms of how serpins regulate the innate immune responses of invertebrates are not well understood due to the uncertainty of the identity of the serine proteases targeted by the serpins. We recently reported the molecular activation mechanisms of three serine protease-mediated Toll and melanin synthesis cascades in a large beetle, Tenebrio molitor. Here, we purified three novel serpins (SPN40, SPN55, and SPN48) from the hemolymph of T. molitor. These serpins made specific serpin-serine protease pairs with three Toll cascade-activating serine proteases, such as modular serine protease, Spatzle-processing enzyme-activating enzyme, and Spatzle-processing enzyme and cooperatively blocked the Toll signaling cascade and beta-1,3-glucan-mediated melanin biosynthesis. Also, the levels of SPN40 and SPN55 were dramatically increased in vivo by the injection of a Toll ligand, processed Spatzle, into Tenebrio larvae. This increase in SPN40 and SPN55 levels indicates that these serpins function as inducible negative feedback inhibitors. Unexpectedly, SPN55 and SPN48 were cleaved at Tyr and Glu residues in reactive center loops, respectively, despite being targeted by trypsin-like Spatzle-processing enzyme-activating enzyme and Spatzle-processing enzyme. These cleavage patterns are also highly similar to those of unusual mammalian serpins involved in blood coagulation and blood pressure regulation, and they may contribute to highly specific and timely inactivation of detrimental serine proteases during innate immune responses. Taken together, these results demonstrate the specific regulatory evidences of innate immune responses by three novel serpins.	[Kurokawa, Kenji; Lee, Bok-Luel] Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea; [Jiang, Rui; Zhang, Jinghai] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 110016, Peoples R China; [Gubb, David] CIC bioGUNE, Funct Genom Unit, Derio 48160, Spain	Pusan National University; Shenyang Pharmaceutical University; CIC bioGUNE	Lee, BL (corresponding author), Pusan Natl Univ, Coll Pharm, Natl Res Lab Def Prot, Pusan 609735, South Korea.	brlee@pusan.ac.kr	Jiang, Rui/F-9248-2011; Gubb, David/F-9793-2011	Jiang, Rui/0000-0002-5580-9822	National Research Foundation of Korea [M10861020001-08N6102-00110, 20080576001]; BK21 program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071945, P01HL060231] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); BK21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grant M10861020001-08N6102-00110 and Bioscience Grant 20080576001 from the National Research Foundation of Korea. This work was also partially supported by the BK21 program.	Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; BJORK I, 1982, J BIOL CHEM, V257, P2406; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Chen VC, 2000, J BIOL CHEM, V275, P38457, DOI 10.1074/jbc.M005605200; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Han JH, 2000, FEBS LETT, V468, P194, DOI 10.1016/S0014-5793(00)01224-2; Hashimoto C, 2003, DEV CELL, V5, P945, DOI 10.1016/S1534-5807(03)00338-1; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; JESTY J, 1979, J BIOL CHEM, V254, P44; Kan H, 2008, J BIOL CHEM, V283, P25316, DOI 10.1074/jbc.M804364200; Kanost Michael R, 2004, Immunol Rev, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x; Kim CH, 2008, J BIOL CHEM, V283, P7599, DOI 10.1074/jbc.M710216200; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Ligoxygakis P, 2003, CURR BIOL, V13, P2097, DOI 10.1016/j.cub.2003.10.062; Ligoxygakis P, 2002, EMBO J, V21, P6330, DOI 10.1093/emboj/cdf661; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Nash P, 1998, J BIOL CHEM, V273, P20982, DOI 10.1074/jbc.273.33.20982; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Richer MJ, 2004, P NATL ACAD SCI USA, V101, P10560, DOI 10.1073/pnas.0401406101; Roh KB, 2009, J BIOL CHEM, V284, P19474, DOI 10.1074/jbc.M109.007419; SALVESEN GS, 1985, J BIOL CHEM, V260, P2432; Scherfer C, 2008, DEV BIOL, V323, P189, DOI 10.1016/j.ydbio.2008.08.030; Tang H, 2008, DEV CELL, V15, P617, DOI 10.1016/j.devcel.2008.08.017; Zhang R, 2003, J BIOL CHEM, V278, P42072, DOI 10.1074/jbc.M307475200; Zou Z, 2005, J BIOL CHEM, V280, P14341, DOI 10.1074/jbc.M500570200	32	81	91	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35652	35658		10.1074/jbc.M109.071001	http://dx.doi.org/10.1074/jbc.M109.071001			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858208	Green Published, hybrid			2022-12-25	WOS:000272645600043
J	Maitra, U; Singh, N; Gan, L; Ringwood, L; Li, LW				Maitra, Urmila; Singh, Neeraj; Gan, Lu; Ringwood, Lorna; Li, Liwu			IRAK-1 Contributes to Lipopolysaccharide-induced Reactive Oxygen Species Generation in Macrophages by Inducing NOX-1 Transcription and Rac1 Activation and Suppressing the Expression of Antioxidative Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED KINASE-1; NF-KAPPA-B; GENE-EXPRESSION; IL-1 RECEPTOR; NADPH OXIDASE; INNATE-IMMUNITY; DEPENDENT PHOSPHORYLATION; INTERLEUKIN-1; MICROGLIA; PROTEIN	Inflammatory stimulants such as bacterial endotoxin (lipopolysaccharide (LPS)) are known to induce tissue damage and injury partly through the induction of reactive oxygen species (ROS). Although it is recognized that the induction of ROS in macrophages by LPS depends upon the expression and activation of NADPH oxidase, as well as the suppression of antioxidative enzymes involved in ROS clearance, the underlying molecular mechanisms are poorly defined. In this study, we examined the contribution of the interleukin-1 receptor-associated kinase 1 (IRAK-1) to LPS-induced generation of ROS. We observed that LPS induced significantly less ROS in IRAK-1(-/-) macrophages, indicating that IRAK-1 is critically involved in the induction of ROS. Mechanistically, we observed that IRAK-1 is required for LPS-induced expression of NOX-1, a key component of NADPH oxidase, via multiple transcription factors, including p65/RelA, C/EBP beta, and C/EBP delta. On the other hand, we demonstrated that IRAK-1 associated with and activated small GTPase Rac1, a known activator of NOX-1 oxidase enzymatic activity. IRAK-1 forms a close complex with Rac1 via a novel LWPPPP motif within the variable region of IRAK-1. On the other hand, we also observed that IRAK-1 is required for LPS-mediated suppression of peroxisome proliferator-activated receptor alpha and PGC-1 alpha, nuclear factors essential for the expression of antioxidative enzymes such as GPX3 and catalase. Consequently, injection of LPS causes significantly less plasma lipid peroxidation in IRAK-1(-/-) mice compared with wild type mice. Taken together, our study reveals IRAK-1 as a novel component involved in the generation of ROS induced by LPS.	[Maitra, Urmila; Gan, Lu; Ringwood, Lorna; Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Singh, Neeraj; Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biomed Sci & Pathobiol, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Li, LW (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol, Life Sci 1 Bldg,Washington St, Blacksburg, VA 24061 USA.	lwli@vt.edu	Gan, Lu/L-5395-2014	Li, Liwu/0000-0001-8870-5299	National Institutes of Health [AI50089, AI64414]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050089, R01AI064414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI50089 and AI64414.	Adachi Y, 2008, ONCOGENE, V27, P4921, DOI 10.1038/onc.2008.133; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bokoch GM, 2006, ANTIOXID REDOX SIGN, V8, P1533, DOI 10.1089/ars.2006.8.1533; Bol GF, 2000, FEBS LETT, V477, P73, DOI 10.1016/S0014-5793(00)01759-2; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Cheng G, 2006, J BIOL CHEM, V281, P17718, DOI 10.1074/jbc.M512751200; Cheret C, 2008, J NEUROSCI, V28, P12039, DOI 10.1523/JNEUROSCI.3568-08.2008; Chung SS, 2009, MOL CELL BIOL, V29, P20, DOI 10.1128/MCB.00544-08; Ciarrocchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004404; Cooke EL, 2001, BIOCHEM J, V359, P403, DOI 10.1042/0264-6021:3590403; Deng C, 2003, J IMMUNOL, V170, P2833, DOI 10.4049/jimmunol.170.6.2833; Feingold KR, 2008, J LIPID RES, V49, P2179, DOI 10.1194/jlr.M800233-JLR200; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Hu J, 2002, J IMMUNOL, V168, P3910, DOI 10.4049/jimmunol.168.8.3910; Huang YS, 2004, J BIOL CHEM, V279, P51697, DOI 10.1074/jbc.M410369200; Jacob CO, 2009, P NATL ACAD SCI USA, V106, P6256, DOI 10.1073/pnas.0901181106; Jefferies C, 2001, MOL CELL BIOL, V21, P4544, DOI 10.1128/MCB.21.14.4544-4552.2001; Kawahara T, 2005, AM J PHYSIOL-CELL PH, V288, pC450, DOI 10.1152/ajpcell.00319.2004; KLUCIS E, 1984, MOL CELL BIOCHEM, V65, P73; Knop J, 1998, EUR J IMMUNOL, V28, P3100, DOI 10.1002/(SICI)1521-4141(199810)28:10<3100::AID-IMMU3100>3.0.CO;2-7; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Lakoski SG, 2007, EXP MOL PATHOL, V82, P280, DOI 10.1016/j.yexmp.2007.02.002; Li Liwu, 2004, Curr Drug Targets Inflamm Allergy, V3, P81, DOI 10.2174/1568010043483863; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Maitra U, 2009, MOL CELL BIOL, V29, P5989, DOI 10.1128/MCB.00541-09; Neumann D, 2007, BIOCHEM BIOPH RES CO, V354, P1089, DOI 10.1016/j.bbrc.2007.01.104; Nguyen H, 2003, J INTERF CYTOK RES, V23, P183, DOI 10.1089/107999003765027384; O'Neill L, 2000, BIOCHEM SOC T, V28, P557, DOI 10.1042/bst0280557; Pietila TE, 2007, J IMMUNOL, V178, P253, DOI 10.4049/jimmunol.178.1.253; Qin LY, 2005, GLIA, V52, P78, DOI 10.1002/glia.20225; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; Singh A, 2009, J IMMUNOL, V182, P6410, DOI 10.4049/jimmunol.0802512; Song YJ, 2006, P NATL ACAD SCI USA, V103, P2689, DOI 10.1073/pnas.0511096103; Su JM, 2007, CELL SIGNAL, V19, P1596, DOI 10.1016/j.cellsig.2007.02.009; Thomas JA, 2003, AM J PHYSIOL-HEART C, V285, pH597, DOI 10.1152/ajpheart.0655.2001; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wang DM, 2008, MOL IMMUNOL, V45, P3902, DOI 10.1016/j.molimm.2008.06.023; Wiesel P, 2000, CIRCULATION, V102, P3015, DOI 10.1161/01.cir.102.24.3015; YOSHIKAWA T, 1994, CIRC SHOCK, V42, P53	41	84	87	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35403	35411		10.1074/jbc.M109.059501	http://dx.doi.org/10.1074/jbc.M109.059501			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850916	Green Published, hybrid			2022-12-25	WOS:000272645600016
J	Eisinger, DA; Ammer, H				Eisinger, Daniela A.; Ammer, Hermann			Down-regulation of c-Cbl by Morphine Accounts for Persistent ERK1/2 Signaling in delta-Opioid Receptor-expressing HEK293 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-COUPLED RECEPTORS; EGF RECEPTOR; KINASE; PHOSPHORYLATION; BETA; SRC; UBIQUITINATION; MEMBRANE; INTERNALIZATION	Opioids display ligand-specific differences in the time course of ERK1/2 signaling. Whereas full agonists, like etorphine, induce only transient activation of ERK1/2, the partial agonist morphine mediates persistent stimulation of mitogenic signaling. Here we report that in stably delta-opioid receptor (DOR)-expressing HEK293 (HEK/DOR) cells, the transient nature of etorphine-induced ERK1/2 signaling is due to desensitization of epidermal growth factor (EGF) receptor-mediated activation of the Ras/Raf-1/ERK1/2 cascade. Desensitization of ERK1/2 activity by etorphine is associated with down-regulation of EGF receptors, an effect mediated by the ubiquitin ligase c-Cbl. In contrast, chronic morphine treatment failed to desensitize EGF receptors, resulting in unimpeded ERK1/2 signaling. The failure of morphine to desensitize ERK1/2 signaling is mediated by persistent activation of c-Src, which induces degradation of c-Cbl. The role of c-Src in opioid-specific ERK1/2 signaling is further demonstrated by pretreatment of the cells with PP2 and SKI-I as well as overexpression of a dominant negative c-Src mutant (c-Src(dn)) or a c-Src-resistant c-Cbl mutant (CblY3F), both of which facilitate desensitization of ERK1/2 signaling by morphine. Conversely, overexpression of c-Src as well as down-regulation of c-Cbl by small interfering RNA results in persistent etorphine-induced stimulation of ERK1/2 activity. Subcellular fractionation experiments finally attributed the ability of morphine to persistently activate c-Src to its redistribution from Triton X-100-insensitive membrane rafts to DOR and EGF receptor containing high density membrane compartments implicated in ERK1/2 signaling. These results demonstrate that agonist-specific differences in the temporal and spatial pattern of c-Src activation determine the kinetics of DOR-mediated regulation of ERK1/2 signaling.	[Eisinger, Daniela A.; Ammer, Hermann] Univ Munich, Inst Pharmacol Toxicol & Pharm, D-80539 Munich, Germany	University of Munich	Eisinger, DA (corresponding author), Univ Munich, Inst Pharmacol Toxicol & Pharm, Koeniginstr 16, D-80539 Munich, Germany.	eisinger@lrz.uni-muenchen.de		Ammer, Hermann/0000-0003-4935-0207				Adachi T, 2002, J CELL PHYSIOL, V192, P151, DOI 10.1002/jcp.10124; AMMER H, 1993, BIOCHEM J, V295, P263, DOI 10.1042/bj2950263; Andre A, 2008, BBA-BIOMEMBRANES, V1778, P1483, DOI 10.1016/j.bbamem.2008.03.017; Audet N, 2005, J BIOL CHEM, V280, P7808, DOI 10.1074/jbc.M411695200; Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; Belcheva MM, 2002, J PHARMACOL EXP THER, V303, P909, DOI 10.1124/jpet.102.038554; Belcheva MM, 2003, MOL PHARMACOL, V64, P1391, DOI 10.1124/mol.64.6.1391; Berhow MT, 1996, J NEUROSCI, V16, P4707; Burke P, 2001, MOL BIOL CELL, V12, P1897, DOI 10.1091/mbc.12.6.1897; CARR DJJ, 1995, IMMUNOPHARMACOLOGY, V31, P59, DOI 10.1016/0162-3109(95)00033-6; Chakrabarti S, 2003, MOL BRAIN RES, V119, P144, DOI 10.1016/j.molbrainres.2003.09.002; Chakrabarti S, 2003, P NATL ACAD SCI USA, V100, P13686, DOI 10.1073/pnas.2335885100; Chakrabarti S, 2001, P NATL ACAD SCI USA, V98, P4209, DOI 10.1073/pnas.071031798; COOPER JA, 1986, MOL CELL BIOL, V6, P4467, DOI 10.1128/MCB.6.12.4467; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; de Diesbach P, 2008, EXP CELL RES, V314, P1465, DOI 10.1016/j.yexcr.2008.01.015; de Melker AA, 2001, J CELL SCI, V114, P2167; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Eisinger DA, 2004, J PHARMACOL EXP THER, V309, P776, DOI 10.1124/jpet.103.061788; Eisinger DA, 2002, J NEUROSCI, V22, P10192; Eisinger DA, 2008, CELL SIGNAL, V20, P2324, DOI 10.1016/j.cellsig.2008.09.002; Ferrer-Alcon M, 2004, MOL BRAIN RES, V121, P114, DOI 10.1016/j.molbrainres.2003.11.009; Freedman NJ, 2002, J BIOL CHEM, V277, P48261, DOI 10.1074/jbc.M204431200; Grewal JS, 2001, J BIOL CHEM, V276, P27335, DOI 10.1074/jbc.M103578200; Gupta K, 2002, CANCER RES, V62, P4491; Gurevich VV, 2008, MOL PHARMACOL, V74, P312, DOI 10.1124/mol.108.049015; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Huang P, 2007, BIOCHEM PHARMACOL, V73, P534, DOI 10.1016/j.bcp.2006.10.032; Jacob C, 2005, J BIOL CHEM, V280, P16076, DOI 10.1074/jbc.M500109200; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Kim J, 2003, BIOCHEMISTRY-US, V42, P2887, DOI 10.1021/bi026942t; Kodama H, 2002, J MOL CELL CARDIOL, V34, P139, DOI 10.1006/jmcc.2001.1496; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Levitt ES, 2009, J BIOL CHEM, V284, P22108, DOI 10.1074/jbc.M109.030411; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li KW, 2006, PROTEOMICS, V6, P2003, DOI 10.1002/pmic.200500045; Lin FT, 1998, J BIOL CHEM, V273, P31640, DOI 10.1074/jbc.273.48.31640; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Liu YT, 2007, J CELL PHYSIOL, V211, P205, DOI 10.1002/jcp.20924; Mao JR, 2002, J NEUROSCI, V22, P7650; Marie N, 2008, CELL SIGNAL, V20, P1209, DOI 10.1016/j.cellsig.2008.02.010; Martini L, 2007, CURR OPIN NEUROBIOL, V17, P556, DOI 10.1016/j.conb.2007.10.004; Narita M, 2002, NEUROSCI LETT, V324, P97, DOI 10.1016/S0304-3940(02)00141-6; Oksvold MP, 2003, ONCOGENE, V22, P8509, DOI 10.1038/sj.onc.1207117; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Pennock S, 2008, MOL CELL BIOL, V28, P3020, DOI 10.1128/MCB.01809-07; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Roepstorff K, 2008, HISTOCHEM CELL BIOL, V129, P563, DOI 10.1007/s00418-008-0401-3; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Rubio I, 2006, BIOCHEM J, V398, P243, DOI 10.1042/BJ20060160; Sood A, 2001, ENDOCR RES, V27, P215, DOI 10.1081/ERC-100107182; Swaminathan G, 2006, J CELL PHYSIOL, V209, P21, DOI 10.1002/jcp.20694; Tanowitz M, 2002, J BIOL CHEM, V277, P50219, DOI 10.1074/jbc.C200536200; Tegeder I, 2004, PHARMACOL REV, V56, P351, DOI 10.1124/pr.56.3.2; Tian GC, 2001, BIOCHEMISTRY-US, V40, P7084, DOI 10.1021/bi0100586; Timpson P, 2005, CANCER RES, V65, P3273, DOI 10.1158/0008-5472.CAN-04-2118; Xue LZ, 1998, CELL SIGNAL, V10, P339, DOI 10.1016/S0898-6568(98)00011-4; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhang J, 1999, J RECEPT SIGNAL TR R, V19, P301, DOI 10.3109/10799899909036653; Zhang L, 2009, J BIOL CHEM, V284, P1990, DOI 10.1074/jbc.M807971200; Zheng H, 2008, P NATL ACAD SCI USA, V105, P9421, DOI 10.1073/pnas.0802253105; Zheng H, 2008, MOL PHARMACOL, V73, P178, DOI 10.1124/mol.107.039842; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	65	11	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34819	34828		10.1074/jbc.M109.042937	http://dx.doi.org/10.1074/jbc.M109.042937			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19828455	hybrid, Green Published			2022-12-25	WOS:000272439600037
J	Zhang, SM; Gerhard, GS				Zhang, Shiming; Gerhard, Glenn S.			Heme Mediates Cytotoxicity from Artemisinin and Serves as a General Anti-Proliferation Target	PLOS ONE			English	Article							ANTIMALARIAL-DRUG ARTEMISININ; PHOTODYNAMIC THERAPY; TOPOISOMERASE-I; CANCER-CELLS; MALARIAL PARASITE; LEISHMANIA-DONOVANI; INFECTED MICE; BREAST-CANCER; HOST-CELLS; CORALYNE	Heme (Fe2+ protoporphyrin IX) is an essential molecule that has been implicated the potent antimalarial action of artemisinin and its derivatives, although the source and nature of the heme remain controversial. Artemisinins also exhibit selective cytotoxicity against cancer cells in vitro and in vivo. We demonstrate that intracellular heme is the physiologically relevant mediator of the cytotoxic effects of artemisinins. Increasing intracellular heme synthesis through the addition of aminolevulinic acid, protoporphyrin IX, or transferrin-bound iron increased the cytotoxicity of dihydroartemisinin, while decreasing heme synthesis through the addition of succinyl acetone decreased its cytotoxic activity. A simple and robust high throughput assay was developed to screen chemical compounds that were capable of interacting with heme. A natural products library was screened which identified the compound coralyne, in addition to artemisinin, as a heme interacting compound with heme synthesis dependent cytotoxic activity. These results indicate that cellular heme may serve a general target for the development of both anti-parasitic and anti-cancer therapeutics.			Zhang, SM (corresponding author), Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA.	gsgerhard@geisinger.edu	Hua, QX/HGE-3640-2022					Avery MA, 2003, J MED CHEM, V46, P4244, DOI 10.1021/jm030181q; Berger TG, 2005, ONCOL REP, V14, P1599; Bhadra K, 2008, DNA CELL BIOL, V27, P675, DOI 10.1089/dna.2008.0779; Bilia AR, 2002, LIFE SCI, V70, P769, DOI 10.1016/S0024-3205(01)01447-3; Bonday ZQ, 1997, J BIOL CHEM, V272, P21839, DOI 10.1074/jbc.272.35.21839; Bonday ZQ, 2000, NAT MED, V6, P898, DOI 10.1038/78659; Cortazar TM, 2007, EXP PARASITOL, V116, P475, DOI 10.1016/j.exppara.2007.02.018; Creek DJ, 2008, ANTIMICROB AGENTS CH, V52, P1291, DOI 10.1128/AAC.01033-07; Dell'Eva R, 2004, BIOCHEM PHARMACOL, V68, P2359, DOI 10.1016/j.bcp.2004.08.021; DEMATTEIS F, 1983, FEBS LETT, V159, P127, DOI 10.1016/0014-5793(83)80430-X; Di Iorio E. E., 1981, METHOD ENZYMOL, P57; Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412; Efferth T, 2004, FREE RADICAL BIO MED, V37, P998, DOI 10.1016/j.freeradbiomed.2004.06.023; Efferth T, 2003, MOL PHARMACOL, V64, P382, DOI 10.1124/mol.64.2.382; Efferth T, 2001, INT J ONCOL, V18, P767; Efferth T, 2007, PLANTA MED, V73, P299, DOI 10.1055/s-2007-967138; Egan TJ, 2004, J INORG BIOCHEM, V98, P144, DOI 10.1016/j.jinorgbio.2003.09.007; Fukuda H, 2005, INT J BIOCHEM CELL B, V37, P272, DOI 10.1016/j.biocel.2004.04.018; GARDNER LC, 1988, J BIOL CHEM, V263, P6676; Gatto B, 1996, CANCER RES, V56, P2795; Haddad RE, 2003, J AM CHEM SOC, V125, P1253, DOI 10.1021/ja0280933; Huang XJ, 2007, J PHARM PHARMACOL, V59, P849, DOI 10.1211/jpp.59.6.0011; Huynh C, 2008, CELL MICROBIOL, V10, P293, DOI 10.1111/j.1462-5822.2007.01095.x; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; ISLAM MM, 2009, J PHYS CHEM B; Jean-Moreno V, 2006, EXP PARASITOL, V112, P21, DOI 10.1016/j.exppara.2005.08.014; Jefford CW, 2001, CURR MED CHEM, V8, P1803, DOI 10.2174/0929867013371608; Jones M, 2009, BIOORG MED CHEM LETT, V19, P2033, DOI 10.1016/j.bmcl.2009.02.028; Kinnamon KE, 1998, AM J TROP MED HYG, V58, P804, DOI 10.4269/ajtmh.1998.58.804; Kwok JC, 2002, CRIT REV ONCOL HEMAT, V42, P65, DOI 10.1016/S1040-8428(01)00213-X; Lai H, 2006, CANCER LETT, V231, P43, DOI 10.1016/j.canlet.2005.01.019; LAI H, 1995, CANCER LETT, V91, P41, DOI 10.1016/0304-3835(94)03716-V; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Makhey D, 1996, BIOORGAN MED CHEM, V4, P781, DOI 10.1016/0968-0896(96)00054-5; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Mercer AE, 2009, CURR OPIN DRUG DISC, V12, P125; Meshnick SR, 1996, MICROBIOL REV, V60, P301, DOI 10.1128/MMBR.60.2.301-315.1996; MESHNICK SR, 1991, MOL BIOCHEM PARASIT, V49, P181, DOI 10.1016/0166-6851(91)90062-B; Moore CM, 2009, NAT CLIN PRACT UROL, V6, P18, DOI 10.1038/ncpuro1274; Mu DG, 2008, CANCER CHEMOTH PHARM, V61, P639, DOI 10.1007/s00280-007-0517-5; Pandey AV, 1999, J BIOL CHEM, V274, P19383, DOI 10.1074/jbc.274.27.19383; Parapini S, 2004, FEBS LETT, V575, P91, DOI 10.1016/j.febslet.2004.08.039; PASTERNACK RF, 1985, BIOCHEMISTRY-US, V24, P5443, DOI 10.1021/bi00341a024; Peng Q, 1997, CANCER-AM CANCER SOC, V79, P2282; Posner GH, 2004, J MED CHEM, V47, P1299, DOI 10.1021/jm0303711; Reungpatthanaphong P, 2002, BIOL PHARM BULL, V25, P1555, DOI 10.1248/bpb.25.1555; Robert A, 2005, P NATL ACAD SCI USA, V102, P13676, DOI 10.1073/pnas.0500972102; Sah JF, 2002, J BIOL CHEM, V277, P14902, DOI 10.1074/jbc.M200107200; Sekhon BK, 2008, ASSAY DRUG DEV TECHN, V6, P711, DOI 10.1089/adt.2008.148; Selmeczi K, 2004, FEBS LETT, V556, P245, DOI 10.1016/S0014-5793(03)01448-0; Sen R, 2007, J MED MICROBIOL, V56, P1213, DOI 10.1099/jmm.0.47364-0; Sinclair PR, 2001, HEPATOLOGY, V33, P406, DOI 10.1053/jhep.2001.21409; SINCLAIR PR, 1990, ARCH BIOCHEM BIOPHYS, V282, P386, DOI 10.1016/0003-9861(90)90133-J; Singh NP, 2006, INTEGR CANCER THER, V5, P391, DOI 10.1177/1534735406295311; Singh NP, 2004, ANTICANCER RES, V24, P2277; Singh NP, 2001, LIFE SCI, V70, P49, DOI 10.1016/S0024-3205(01)01372-8; SUNDAR SN, 2008, CARCINOGENESIS; Tekwani BL, 2005, COMB CHEM HIGH T SCR, V8, P63, DOI 10.2174/1386207053328101; Tracz MJ, 2007, J AM SOC NEPHROL, V18, P414, DOI 10.1681/ASN.2006080894; Vogt A, 2005, J BIOL CHEM, V280, P19078, DOI 10.1074/jbc.M501467200; Wang J, 2008, PHARMACOLOGY, V82, P148, DOI 10.1159/000148261; Wang LK, 1996, CHEM RES TOXICOL, V9, P75, DOI 10.1021/tx950080y; Willoughby JA, 2009, J BIOL CHEM, V284, P2203, DOI 10.1074/jbc.M804491200; WILSON WD, 1976, J MED CHEM, V19, P1261, DOI 10.1021/jm00232a020; YANG DM, 1993, PARASITOLOGY, V106, P7, DOI 10.1017/S0031182000074758; ZEECHENG KY, 1974, J MED CHEM, V17, P347, DOI 10.1021/jm00249a020; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang SM, 2008, BIOORGAN MED CHEM, V16, P7853, DOI 10.1016/j.bmc.2008.02.034	69	66	75	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7472	10.1371/journal.pone.0007472	http://dx.doi.org/10.1371/journal.pone.0007472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862332	Green Published, Green Submitted, gold			2022-12-25	WOS:000271194600003
J	Cardinali, B; Castellani, L; Fasanaro, P; Basso, A; Alema, S; Martelli, F; Falcone, G				Cardinali, Beatrice; Castellani, Loriana; Fasanaro, Pasquale; Basso, Annalisa; Alema, Stefano; Martelli, Fabio; Falcone, Germana			Microrna-221 and Microrna-222 Modulate Differentiation and Maturation of Skeletal Muscle Cells	PLOS ONE			English	Article							GENE-EXPRESSION; TYROSINE KINASE; MYOGENESIS; MIR-222; MYOD; PROLIFERATION; TRANSCRIPTION; DOWNSTREAM; RAS; P27	Background: MicroRNAs (miRNAs) are a class of small non-coding RNAs that have recently emerged as important regulators of gene expression. They negatively regulate gene expression post-transcriptionally by translational repression and target mRNA degradation. miRNAs have been shown to play crucial roles in muscle development and in regulation of muscle cell proliferation and differentiation. Methodology/Principal Findings: By comparing miRNA expression profiling of proliferating myoblasts versus differentiated myotubes, a number of modulated miRNAs, not previously implicated in regulation of myogenic differentiation, were identified. Among these, miR-221 and miR-222 were strongly down-regulated upon differentiation of both primary and established myogenic cells. Conversely, miR-221 and miR-222 expression was restored in post-mitotic, terminally differentiated myotubes subjected to Src tyrosine kinase activation. By the use of specific inhibitors we provide evidence that expression of miR-221 and miR-222 is under the control of the Ras-MAPK pathway. Both in myoblasts and in myotubes, levels of the cell cycle inhibitor p27 inversely correlated with miR-221 and miR-222 expression, and indeed we show that p27 mRNA is a direct target of these miRNAs in myogenic cells. Ectopic expression of miR-221 and miR-222 in myoblasts undergoing differentiation induced a delay in withdrawal from the cell cycle and in myogenin expression, followed by inhibition of sarcomeric protein accumulation. When miR-221 and miR-222 were expressed in myotubes undergoing maturation, a profound alteration of myofibrillar organization was observed. Conclusions/Significance: miR-221 and miR-222 have been found to be modulated during myogenesis and to play a role both in the progression from myoblasts to myocytes and in the achievement of the fully differentiated phenotype. Identification of miRNAs modulating muscle gene expression is crucial for the understanding of the circuits controlling skeletal muscle differentiation and maintenance.			Cardinali, B (corresponding author), CNR, Ist Biol Cellulare, I-00016 Monterotondo, Italy.	gfalcone@ibc.cnr.it	Falcone, Germana/A-3735-2016; Cardinali, Beatrice/M-8862-2015; Martelli, Fabio/AAL-3788-2020	Cardinali, Beatrice/0000-0002-3333-3384; Martelli, Fabio/0000-0002-8624-7738; Castellani, Loriana/0000-0002-8519-3504; Alema, Stefano/0000-0002-9869-6354; Falcone, Germana/0000-0002-3508-7623				Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Caporossi D, 2003, FREE RADICAL BIO MED, V35, P1355, DOI 10.1016/j.freeradbiomed.2003.08.008; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Castellani L, 1996, J CELL SCI, V109, P1335; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Ciuffini L, 2008, ONCOGENE, V27, P528, DOI 10.1038/sj.onc.1210665; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; FALCONE G, 1991, MOL CELL BIOL, V11, P3331, DOI 10.1128/MCB.11.6.3331; Falcone G, 2003, ONCOGENE, V22, P8302, DOI 10.1038/sj.onc.1206915; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; FORNARI F, 2008, ONCOGENE; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Johnson D, 1998, ONCOGENE, V16, P2017, DOI 10.1038/sj.onc.1201727; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; LASSAR AB, 1989, CELL, V58, P659, DOI 10.1016/0092-8674(89)90101-3; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Messina G, 2005, MOL BIOL CELL, V16, P1469, DOI 10.1091/mbc.e04-07-0612; Pajalunga D, 2007, CELL CYCLE, V6, P1415; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Perry RLS, 2001, MOL CELL, V8, P291, DOI 10.1016/S1097-2765(01)00302-1; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Russo S, 1997, ONCOGENE, V14, P63, DOI 10.1038/sj.onc.1200805; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Tiainen M, 1996, CELL GROWTH DIFFER, V7, P1039; Vaccarello G, 2006, J MOL BIOL, V356, P578, DOI 10.1016/j.jmb.2005.12.024; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006	48	167	182	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7607	10.1371/journal.pone.0007607	http://dx.doi.org/10.1371/journal.pone.0007607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859555	Green Published, Green Submitted, gold			2022-12-25	WOS:000271147400011
J	Nakagawa, H; Suzuki, H; Machida, S; Suzuki, J; Ohashi, K; Jin, M; Miyamoto, S; Terasaki, AG				Nakagawa, Hiroyuki; Suzuki, Hiroshi; Machida, Satoshi; Suzuki, Junko; Ohashi, Kazuyo; Jin, Mingyue; Miyamoto, Shigeaki; Terasaki, Asako G.			Contribution of the LIM Domain and Nebulin-Repeats to the Interaction of Lasp-2 with Actin Filaments and Focal Adhesions	PLOS ONE			English	Article							BINDING PROTEIN; CELL-MIGRATION; SH3 DOMAINS; LAMELLIPODIA; FILOPODIA; ORGANIZATION; EXPRESSION; MOTILITY; GENE; IDENTIFICATION	Lasp-2 binds to actin filaments and concentrates in the actin bundles of filopodia and lamellipodia in neural cells and focal adhesions in fibroblastic cells. Lasp-2 has three structural regions: a LIM domain, a nebulin-repeat region, and an SH3 domain; however, the region(s) responsible for its interactions with actin filaments and focal adhesions are still unclear. In this study, we revealed that the N-terminal fragment from the LIM domain to the first nebulin-repeat module (LIM-n1) retained actin-binding activity and showed a similar subcellular localization to full-length lasp-2 in neural cells. The LIM domain fragment did not interact with actin filaments or localize to actin filament bundles. In contrast, LIM-n1 showed a clear subcellular localization to filopodial actin bundles. Although truncation of the LIM domain caused the loss of F-actin binding activity and the accumulation of filopodial actin bundles, these truncated fragments localized to focal adhesions. These results suggest that lasp-2 interactions with actin filaments are mediated through the cooperation of the LIM domain and the first nebulin-repeat module in vitro and in vivo. Actin filament binding activity may be a major contributor to the subcellular localization of lasp-2 to filopodia but is not crucial for lasp-2 recruitment to focal adhesions.			Nakagawa, H (corresponding author), Fukuoka Univ, Fac Sci, Div Biol, Fukuoka 81401, Japan.	hnakagawa@fukuoka-u.ac.jp						Block J, 2008, J MICROSC-OXFORD, V231, P506, DOI 10.1111/j.1365-2818.2008.02063.x; Chew CS, 2008, AM J PHYSIOL-GASTR L, V295, pG37, DOI 10.1152/ajpgi.90247.2008; Chew CS, 2002, J CELL SCI, V115, P4787, DOI 10.1242/jcs.00174; Chew CS, 1998, AM J PHYSIOL-CELL PH, V275, pC56, DOI 10.1152/ajpcell.1998.275.1.C56; Deng XA, 2008, CELL MOTIL CYTOSKEL, V65, P827, DOI 10.1002/cm.20304; Grubinger M, 2004, FEBS LETT, V557, P88, DOI 10.1016/S0014-5793(03)01451-0; JIN JP, 1991, J BIOL CHEM, V266, P21215; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Katoh M, 2003, INT J MOL MED, V12, P405; Khurana B, 2002, EMBO J, V21, P5331, DOI 10.1093/emboj/cdf550; Li B, 2004, J BIOL CHEM, V279, P20401, DOI 10.1074/jbc.M310304200; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Lukoyanova N, 2002, CURR BIOL, V12, P383, DOI 10.1016/S0960-9822(02)00678-4; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mayer BJ, 2001, J CELL SCI, V114, P1253; Nakagawa H, 2006, FEBS LETT, V580, P3223, DOI 10.1016/j.febslet.2006.04.082; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Nakagawa H, 2001, J CELL SCI, V114, P1555; Nozumi M, 2003, J CELL SCI, V116, P239, DOI 10.1242/jcs.00233; Panaviene Z, 2007, CELL TISSUE RES, V327, P353, DOI 10.1007/s00441-006-0305-2; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Schreiber VR, 1998, MOL MED, V4, P675, DOI 10.1007/BF03401929; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Strasser A, 2006, EJC SUPPL, V4, P3, DOI 10.1016/S1359-6349(06)70010-6; Suyama R, 2009, DEVELOPMENT, V136, P95, DOI 10.1242/dev.027698; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Terasaki AG, 2004, BIOCHEM BIOPH RES CO, V313, P48, DOI 10.1016/j.bbrc.2003.11.085; Terasaki AG, 2006, CYTOGENET GENOME RES, V112, P141, DOI 10.1159/000087526; Terasaki AG, 2008, BBA-GENE REGUL MECH, V1779, P51, DOI 10.1016/j.bbagrm.2007.08.001; TOMASETTO C, 1995, GENOMICS, V28, P367, DOI 10.1006/geno.1995.1163; Tran TC, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-45; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wang K, 1996, J BIOL CHEM, V271, P4304; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Zieseniss A, 2008, CELL MOTIL CYTOSKEL, V65, P59, DOI 10.1002/cm.20244	37	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7530	10.1371/journal.pone.0007530	http://dx.doi.org/10.1371/journal.pone.0007530			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851499	Green Submitted, Green Published, gold			2022-12-25	WOS:000271022300003
J	Brooks, KK; Liang, B; Watts, JL				Brooks, Kyleann K.; Liang, Bin; Watts, Jennifer L.			The Influence of Bacterial Diet on Fat Storage in C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; ESCHERICHIA-COLI; REGULATES FAT; LIFE-SPAN; INSULIN; ACID; GENE; BIOSYNTHESIS; PATHWAY; MODEL	Background: The nematode Caenorhabditis elegans has emerged as an important model for studies of the regulation of fat storage. C. elegans feed on bacteria, and various strains of E. coli are commonly used in research settings. However, it is not known whether particular bacterial diets affect fat storage and metabolism. Methodology/Principal Findings: Fat staining of fixed nematodes, as well as biochemical analysis of lipid classes, revealed considerable differences in fat stores in C. elegans growing on four different E. coli strains. Fatty acid composition and carbohydrate levels differ in the E. coli strains examined in these studies, however these nutrient differences did not appear to have a causative effect on fat storage levels in worms. Analysis of C. elegans strains carrying mutations disrupting neuroendocrine and other fat-regulatory pathways demonstrated that the intensity of Nile Red staining of live worms does not correlate well with biochemical methods of fat quantification. Several neuroendocrine pathway mutants and eating defective mutants show higher or lower fat storage levels than wild type, however, these mutants still show differences in fat stores when grown on different bacterial strains. Of all the mutants tested, only pept-1 mutants, which lack a functional intestinal peptide transporter, fail to show differential fat stores. Furthermore, fatty acid analysis of triacylglycerol stores reveals an inverse correlation between total fat stores and the levels of 15-methylpalmitic acid, derived from leucine catabolism. Conclusions: These studies demonstrate that nutritional cues perceived in the intestine regulate fat storage levels independently of neuroendocrine cues. The involvement of peptide transport and the accumulation of a fatty acid product derived from an amino acid suggest that specific peptides or amino acids may provide nutritional signals regulating fat metabolism and fat storage levels.			Brooks, KK (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	jwatts@wsu.edu	Watts, Jennifer/AAC-7425-2020	Watts, Jennifer/0000-0003-4349-0639	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074114] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK74114, R01 DK074114] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; BRENNER S, 1974, GENETICS, V77, P71; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Carroll K, 2004, NAT REV MOL CELL BIO, V5, P55, DOI 10.1038/nrm1278; Dasgupta S, 1998, MOL MICROBIOL, V28, P629, DOI 10.1046/j.1365-2958.1998.00828.x; Davis MW, 1995, J NEUROSCI, V15, P8408; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kang CH, 2009, GENE DEV, V23, P12, DOI 10.1101/gad.1723409; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kleemann GA, 2009, MOL CELL ENDOCRINOL, V299, P51, DOI 10.1016/j.mce.2008.10.048; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kniazeva M, 2008, GENE DEV, V22, P2102, DOI 10.1101/gad.1692008; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Meissner B, 2004, J BIOL CHEM, V279, P36739, DOI 10.1074/jbc.M403415200; MORRIS DL, 1948, SCIENCE, V107, P254, DOI 10.1126/science.107.2775.254; Mukhopadhyay A, 2005, CELL METAB, V2, P35, DOI 10.1016/j.cmet.2005.06.004; Mukhopadhyay A, 2007, EMBO REP, V8, P931, DOI 10.1038/sj.embor.7401055; Mullaney BC, 2009, BBA-MOL CELL BIOL L, V1791, P474, DOI 10.1016/j.bbalip.2008.12.013; NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, P13; Nicholas HR, 2004, MOL IMMUNOL, V41, P479, DOI 10.1016/j.molimm.2004.03.037; OKU H, 1988, J BIOL CHEM, V263, P18386; Panowski SH, 2009, TRENDS ENDOCRIN MET, V20, P259, DOI 10.1016/j.tem.2009.03.006; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Raizen DM, 2006, GENETICS, V173, P177, DOI 10.1534/genetics.106.057380; Savage-Dunn C., 2005, TGF BETA SIGNALING, P1, DOI [10.1895/wormbook.1.22.1, DOI 10.1895/WORMB00K.1.22.1]; Schroeder LK, 2007, MOL BIOL CELL, V18, P995, DOI 10.1091/mbc.E06-08-0685; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Spanier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006279; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P299; Watts JL, 2006, DEV BIOL, V292, P381, DOI 10.1016/j.ydbio.2006.01.013; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; WATTS JL, 2009, TRENDS ENDOCRINOL ME; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	47	197	213	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7545	10.1371/journal.pone.0007545	http://dx.doi.org/10.1371/journal.pone.0007545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844570	Green Published, gold, Green Submitted			2022-12-25	WOS:000271013000018
J	Funada, J; Betts, TR; Hodson, L; Humphreys, SM; Timperley, J; Frayn, KN; Karpe, F				Funada, Junichi; Betts, Tim R.; Hodson, Leanne; Humphreys, Sandy M.; Timperley, Jon; Frayn, Keith N.; Karpe, Fredrik			Substrate Utilization by the Failing Human Heart by Direct Quantification Using Arterio-Venous Blood Sampling	PLOS ONE			English	Article							MYOCARDIAL FATTY-ACID; GENE-EXPRESSION; ADIPOSE-TISSUE; GLUCOSE-UPTAKE; METABOLISM; FAILURE	Metabolic substrate utilization of the human failing heart is an area of controversy. The purpose of this study is to directly quantify myocardial substrate utilization in moderately severe heart failure, type 2 diabetes and healthy controls using simultaneous coronary sinus and arterial blood sampling. Patients with heart failure (n = 9, mean NYHA 2.7 +/- 0.5), with type 2 diabetes (n = 5) and with normal heart function (n = 10) were studied after an overnight fast in connection with electrophysiological investigations/treatments. A systemic infusion of [(2)H(2)] palmitate allowed for the calculation of absolute palmitate extraction across the heart. Blood samples were analysed for non-esterified fatty acids, triacylglycerol, glycerol, glucose, pyruvate, lactate, 3-hydroxybutyrate, and blood gases after simultaneous sampling of arterial and coronary sinus blood. Arterio-coronary sinus metabolite concentration differences and fractional extractions for all substrates were similar between the groups. The absolute NEFA uptakes assessed by [(2)H(2)] palmitate extraction were also similar between the groups. Using direct measurements of metabolic substrate uptake by arterio-venous difference technique, the compensated human failing heart does not appear to have reduced myocardial fatty acid uptake.			Funada, J (corresponding author), Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England.	Fredrik.Karpe@ocdem.ox.ac.uk		Karpe, Fredrik/0000-0002-2751-1770; Hodson, Leanne/0000-0002-2648-6526; Betts, Timothy/0000-0001-9063-9905	Wellcome Trust [nr 082345] Funding Source: Medline; Medical Research Council [G0600717B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abozguia K, 2006, NAT CLIN PRACT CARD, V3, P490, DOI 10.1038/ncpcardio0583; Bickerton AST, 2007, DIABETES, V56, P168, DOI 10.2337/db06-0822; BLAIN JM, 1956, AM J MED, V20, P820, DOI 10.1016/0002-9343(56)90203-0; Davila-Roman VG, 2002, J AM COLL CARDIOL, V40, P271, DOI 10.1016/S0735-1097(02)01967-8; FERRANNINI E, 1993, AM J PHYSIOL, V264, pE308, DOI 10.1152/ajpendo.1993.264.2.E308; HARIHARAN R, 1995, CIRCULATION, V91, P2435, DOI 10.1161/01.CIR.91.9.2435; Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536, DOI 10.1038/ncpcardio0319; Korvald C, 2000, AM J PHYSIOL-HEART C, V278, pH1345, DOI 10.1152/ajpheart.2000.278.4.H1345; LASSERS BW, 1972, EUR J CLIN INVEST, V2, P348, DOI 10.1111/j.1365-2362.1972.tb00661.x; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Taegtmeyer H, 2004, ANN NY ACAD SCI, V1015, P202, DOI 10.1196/annals.1302.017; Taylor M, 2001, J NUCL MED, V42, P55; Wallhaus TR, 2001, CIRCULATION, V103, P2441	14	36	36	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7533	10.1371/journal.pone.0007533	http://dx.doi.org/10.1371/journal.pone.0007533			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844574	Green Published, Green Submitted, gold			2022-12-25	WOS:000271013000011
J	Ansseau, E; Laoudj-Chenivesse, D; Marcowycz, A; Tassin, A; Vanderplanck, C; Sauvage, S; Barro, M; Mahieu, I; Leroy, A; Leclercq, I; Mainfroid, V; Figlewicz, D; Mouly, V; Butler-Browne, G; Belayew, A; Coppee, F				Ansseau, Eugenie; Laoudj-Chenivesse, Dalila; Marcowycz, Aline; Tassin, Alexandra; Vanderplanck, Celine; Sauvage, Sebastien; Barro, Marietta; Mahieu, Isabelle; Leroy, Axelle; Leclercq, India; Mainfroid, Veronique; Figlewicz, Denise; Mouly, Vincent; Butler-Browne, Gillian; Belayew, Alexandra; Coppee, Frederique			DUX4c Is Up-Regulated in FSHD. It Induces the MYF5 Protein and Human Myoblast Proliferation	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; 4Q35 LOCUS; GENE-EXPRESSION; CANDIDATE GENE; D4Z4; REGION; MUSCLE; REPEAT; DNA; EVOLUTION	Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contractions of the D4Z4 repeat array in 4q35. We have previously identified a double homeobox gene (DUX4) within each D4Z4 unit that encodes a transcription factor expressed in FSHD but not control myoblasts. DUX4 and its target genes contribute to the global dysregulation of gene expression observed in FSHD. We have now characterized the homologous DUX4c gene mapped 42 kb centromeric of the D4Z4 repeat array. It encodes a 47-kDa protein with a double homeodomain identical to DUX4 but divergent in the carboxyl-terminal region. DUX4c was detected in primary myoblast extracts by Western blot with a specific antiserum, and was induced upon differentiation. The protein was increased about 2-fold in FSHD versus control myotubes but reached 2-10-fold induction in FSHD muscle biopsies. We have shown by Western blot and by a DNA-binding assay that DUX4c overexpression induced the MYF5 myogenic regulator and its DNA-binding activity. DUX4c might stabilize the MYF5 protein as we detected their interaction by co-immunoprecipitation. In keeping with the known role of Myf5 in myoblast accumulation during mouse muscle regeneration DUX4c over-expression activated proliferation of human primary myoblasts and inhibited their differentiation. Altogether, these results suggested that DUX4c could be involved in muscle regeneration and that changes in its expression could contribute to the FSHD pathology.			Ansseau, E (corresponding author), Univ Mons, Mol Biol Lab, B-7000 Mons, Belgium.	frederique.coppee@umons.ac.be	Mouly, Gillian/G-6595-2017; BELAYEW, Alexandra/D-5205-2013	BELAYEW, Alexandra/0000-0001-5115-2424; Mouly, Vincent/0000-0003-3809-4033; butler-browne, gillian/0000-0002-3431-242X				Alexiadis V, 2007, BBA-GENE STRUCT EXPR, V1769, P29, DOI 10.1016/j.bbaexp.2006.11.006; Beckers MC, 2001, GENE, V264, P51, DOI 10.1016/S0378-1119(00)00602-8; Booth HAF, 2007, GENE, V387, P7, DOI 10.1016/j.gene.2006.07.034; BOSNAKOVSKI D, 2008, EXP NEUROL; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bouju S, 1999, NEUROMUSCULAR DISORD, V9, P3, DOI 10.1016/S0960-8966(98)00087-X; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; Butz M, 2003, J NEUROL, V250, P932, DOI 10.1007/s00415-003-1116-y; Castillo-Davis CI, 2005, TRENDS GENET, V21, P533, DOI 10.1016/j.tig.2005.08.001; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Chtarto A, 2007, EXP NEUROL, V204, P387, DOI 10.1016/j.expneurol.2006.11.014; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; Coppee F, 2004, FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: CLINICAL MEDICINE AND MOLECULAR CELL BIOLOGY, P117; Ding H, 1998, HUM MOL GENET, V7, P1681, DOI 10.1093/hmg/7.11.1681; DIXIT M, 2007, FASEB J, V21; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dmitriev P, 2009, NEUROMUSCULAR DISORD, V19, P17, DOI 10.1016/j.nmd.2008.09.004; Doucet Christine, 2005, BMC Biochem, V6, P27, DOI 10.1186/1471-2091-6-27; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Hanel ML, 2009, DEV DYNAM, V238, P1502, DOI 10.1002/dvdy.21830; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Holterman CE, 2005, SEMIN CELL DEV BIOL, V16, P575, DOI 10.1016/j.semcdb.2005.07.004; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; KAWAMURA S, 2006, HUM MOL GENET; Kirsch S, 2005, GENOME RES, V15, P195, DOI 10.1101/gr.3302705; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Laoudj-Chenivesse D, 2005, J MOL MED, V83, P216, DOI 10.1007/s00109-004-0583-7; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; Lemmers RJLF, 2003, NEUROLOGY, V61, P178, DOI 10.1212/01.WNL.0000078889.51444.81; Lemmers RJLF, 1998, HUM MOL GENET, V7, P1207, DOI 10.1093/hmg/7.8.1207; LUNT PW, 1995, HUM MOL GENET, V4, P1243; LUNT PW, 1995, HUM MOL GENET, V4, P951, DOI 10.1093/hmg/4.5.951; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Nicolas N, 1998, CR ACAD SCI III-VIE, V321, P355, DOI 10.1016/S0764-4469(98)80298-9; Pandya S, 2008, PHYS THER, V88, P105, DOI 10.2522/ptj.20070104; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Petrov A, 2008, GENOME RES, V18, P39, DOI 10.1101/gr.6620908; Pirozhkova I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003389; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Rijkers T, 2004, J MED GENET, V41, P826, DOI 10.1136/jmg.2004.019364; Schmidt J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005288; Tawil R, 1996, ANN NEUROL, V39, P744, DOI 10.1002/ana.410390610; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; van der Maarel SM, 2007, BBA-MOL BASIS DIS, V1772, P186, DOI 10.1016/j.bbadis.2006.05.009; van der Maarel SM, 2005, AM J HUM GENET, V76, P375, DOI 10.1086/428361; van Geel M, 2002, GENOMICS, V79, P210, DOI 10.1006/geno.2002.6690; van Geel M, 2000, CYTOGENET CELL GENET, V88, P316, DOI 10.1159/000015518; van Overveld PGM, 2005, ANN NEUROL, V58, P569, DOI 10.1002/ana.20625; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P581, DOI 10.1093/hmg/5.5.581; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; WRIGHT TJ, 1993, HUM MOL GENET, V2, P1673, DOI 10.1093/hmg/2.10.1673; Wuebbles RD, 2009, DIS MODEL MECH, V2, P267, DOI 10.1242/dmm.002261; Yamane A, 2004, EUR J ORAL SCI, V112, P177, DOI 10.1111/j.0909-8836.2004.00106.x; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	61	46	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7482	10.1371/journal.pone.0007482	http://dx.doi.org/10.1371/journal.pone.0007482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829708	gold, Green Submitted, Green Published			2022-12-25	WOS:000270847800016
J	Thoennissen, NH; O'Kelly, J; Lu, D; Iwanski, GB; La, DT; Abbassi, S; Leiter, A; Karlan, B; Mehta, R; Koeffler, HP				Thoennissen, N. H.; O'Kelly, J.; Lu, D.; Iwanski, G. B.; La, D. T.; Abbassi, S.; Leiter, A.; Karlan, B.; Mehta, R.; Koeffler, H. P.			Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway	ONCOGENE			English	Article						capsaicin; EGFR/HER-2 pathway; cell-cycle arrest; apoptosis	ACTIVATED PROTEIN-KINASE; RECEPTOR-GAMMA; GROWTH; INDUCTION; RESISTANCE; HER2; PHOSPHORYLATION; DEGRADATION; ANTAGONISTS; INHIBITORS	Capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide) is an ingredient of chili peppers with inhibitory effects against cancer cells of different origin. We examined the activity of capsaicin on breast cancer cells in vitro and in vivo. The drug potently inhibited growth of ER-positive (MCF-7, T47D, BT-474) and ER-negative (SKBR-3, MDA-MB231) breast cancer cell lines, which was associated with G(0)/G(1) cell-cycle arrest, increased levels of apoptosis and reduced protein expression of human epidermal growth factor receptor (EGFR), HER-2, activated extracellular-regulated kinase (ERK) and cyclin D1. In contrast, cell-cycle regulator p27(KIP1), caspase activity as well as poly-ADP ribose polymerase (PARP) cleavage were increased. Notably, capsaicin blocked breast cancer cell migration in vitro and decreased by 50% the size of MDA-MB231 breast cancer tumors growing orthotopically in immunodeficient mice without noticeable drug side effects. in vivo activation of ERK was clearly decreased, as well as expression of HER-2 and cyclin D1, whereas caspase activity and PARP cleavage products were increased in tumors of drug-treated mice. Besides, capsaicin potently inhibited the development of preneoplastic breast lesions by up to 80% without evidence of toxicity. Our data indicate that capsaicin is a novel modulator of the EGFR/HER-2 pathway in both ER-positive and-negative breast cancer cells with a potential role in the treatment and prevention of human breast cancer. Oncogene (2010) 29, 285-296; doi:10.1038/onc.2009.335; published online 26 October 2009	[Thoennissen, N. H.; O'Kelly, J.; Lu, D.; Iwanski, G. B.; La, D. T.; Abbassi, S.; Leiter, A.; Koeffler, H. P.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol Oncol, Los Angeles, CA 90048 USA; [Karlan, B.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90048 USA; [Mehta, R.] IIT, Res Inst, Div Carcinogenesis & Chemoprevent, Chicago, IL 60616 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Illinois Institute of Technology	Thoennissen, NH (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Sch Med, Div Hematol Oncol, 8700 Beverly Blvd,AC 1069, Los Angeles, CA 90048 USA.	Nils.Thoennissen@cshs.org	Abbassi, Sam/AAF-7646-2021		Deutsche Forschungsgemeinschaft, Bonn, Germany [TH 1438/1-1]; Woman Cancer Institute of Cedars-Sinai Medical Center, Los Angeles, CA, USA; Jung-Stiftung fur Wissenschaft und Forschung, Hamburg, Germany	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); Woman Cancer Institute of Cedars-Sinai Medical Center, Los Angeles, CA, USA; Jung-Stiftung fur Wissenschaft und Forschung, Hamburg, Germany	NH Thoennissen's work was supported by the Deutsche Forschungsgemeinschaft, Bonn, Germany (TH 1438/1-1); B Karlan by the Woman Cancer Institute of Cedars-Sinai Medical Center, Los Angeles, CA, USA and GB Iwanski by the Jung-Stiftung fur Wissenschaft und Forschung, Hamburg, Germany. HP Koeffler is the holder of the Mark Goodson endowed Chair in Oncology Research and is a member of the Jonsson Cancer and Molecular Biology Institute, UCLA, Los Angeles, CA, USA.	Athanasiou A, 2007, BIOCHEM BIOPH RES CO, V354, P50, DOI 10.1016/j.bbrc.2006.12.179; Carraway KL, 2006, CANCER CELL, V10, P93, DOI 10.1016/j.ccr.2006.07.015; Chen FL, 2008, CLIN CANCER RES, V14, P6730, DOI 10.1158/1078-0432.CCR-08-0581; *COUNC EUR, 2001, 48 M STRASB 2 6 APR; Eckert LB, 2004, CANCER RES, V64, P4585, DOI 10.1158/0008-5472.CAN-04-0396; Fukazawa H, 2002, MOL CANCER THER, V1, P303; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Hail N, 2002, JNCI-J NATL CANCER I, V94, P1281, DOI 10.1093/jnci/94.17.1281; Ito K, 2004, CANCER RES, V64, P1071, DOI 10.1158/0008-5472.CAN-03-1670; Johnson W, 2007, INT J TOXICOL, V26, P3, DOI 10.1080/10915810601163939; Jung MY, 2001, CANCER LETT, V165, P139, DOI 10.1016/S0304-3835(01)00426-8; Kawada M, 1997, ONCOGENE, V15, P629, DOI 10.1038/sj.onc.1201228; Kim CS, 2004, J MED FOOD, V7, P267, DOI 10.1089/jmf.2004.7.267; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Krueger JS, 2001, ONCOGENE, V20, P4209, DOI 10.1038/sj.onc.1204541; Kumagai T, 2003, J NATL CANCER I, V95, P896, DOI 10.1093/jnci/95.12.896; Lavoie J N, 1996, Prog Cell Cycle Res, V2, P49; Lo YC, 2005, WORLD J GASTROENTERO, V11, P6254, DOI 10.3748/wjg.v11.i40.6254; Magkou C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2103; Mehta RG, 2000, J NATL CANCER I, V92, P418, DOI 10.1093/jnci/92.5.418; Mehta RG, 2001, J NATL CANCER I, V93, P1103, DOI 10.1093/jnci/93.14.1103; Menard S, 2003, ONCOGENE, V22, P6570, DOI 10.1038/sj.onc.1206779; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; MONSEREENUSORN Y, 1982, CRC CR REV TOXICOL, V10, P321, DOI 10.3109/10408448209003371; Montgomery RB, 2005, CANCER RES, V65, P650; Mori A, 2006, CANCER RES, V66, P3222, DOI 10.1158/0008-5472.CAN-05-0087; MORRE DJ, 1995, P NATL ACAD SCI USA, V92, P1831, DOI 10.1073/pnas.92.6.1831; Morris GJ, 2008, J NATL MED ASSOC, V100, P698, DOI 10.1016/S0027-9684(15)31344-4; Rock E, 2003, J NUTR, V133, p3785S, DOI 10.1093/jn/133.11.3785S; Sanchez AM, 2006, APOPTOSIS, V11, P89, DOI 10.1007/s10495-005-3275-z; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Schafer JM, 2002, J STEROID BIOCHEM, V83, P75, DOI 10.1016/S0960-0760(02)00251-0; Sivaraman VS, 1997, J CLIN INVEST, V99, P1478, DOI 10.1172/JCI119309; Solit DB, 2002, CLIN CANCER RES, V8, P986; TAIKKOO Y, 1999, ANN NY ACAD SCI, V889, P157, DOI DOI 10.1111/J.1749-6632.1999.TB08734.X; Tuoya, 2006, LIFE SCI, V78, P1515, DOI 10.1016/j.lfs.2005.07.019	37	113	125	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2010	29	2					285	296		10.1038/onc.2009.335	http://dx.doi.org/10.1038/onc.2009.335			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	544IU	19855437				2022-12-25	WOS:000273650000011
J	Hernandez, A; Madina, BR; Ro, K; Wohlschlegel, JA; Willard, B; Kinter, MT; Cruz-Reyes, J				Hernandez, Alfredo; Madina, Bhaskara Reddy; Ro, Kevin; Wohlschlegel, James A.; Willard, Belinda; Kinter, Mike T.; Cruz-Reyes, Jorge			REH2 RNA Helicase in Kinetoplastid Mitochondria RIBONUCLEOPROTEIN COMPLEXES AND ESSENTIAL MOTIFS FOR UNWINDING AND GUIDE RNA (gRNA) BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IDENTIFICATION TECHNOLOGY; PENTATRICOPEPTIDE REPEAT PROTEINS; TRYPANOSOMA-BRUCEI MITOCHONDRIA; DIRECTED ENDONUCLEASE CLEAVAGE; INDUCIBLE EXPRESSION SYSTEM; ROUND-U-INSERTION; MESSENGER-RNA; EDITING COMPLEX; SHOTGUN PROTEOMICS; MASS-SPECTROMETRY	Regulation of gene expression in kinetoplastid mitochondria is largely post-transcriptional and involves the orchestration of polycistronic RNA processing, 3'-terminal maturation, RNA editing, turnover, and translation; however, these processes remain poorly studied. Core editing complexes and their U-insertion/deletion activities are relatively well characterized, and a battery of ancillary factors has recently emerged. This study characterized a novel DExH-box RNA helicase, termed here REH2 (RNA editing associated helicase 2), in unique ribonucleoprotein complexes that exhibit unwinding and guide RNA binding activities, both of which required a double-stranded RNA-binding domain (dsRBD) and a functional helicase motif I of REH2. REH2 complexes and recently identified related particles share a multiprotein core but are distinguished by several differential polypeptides. Finally, REH2 associates transiently, via RNA, with editing complexes, mitochondrial ribosomes, and several ancillary factors that control editing and RNA stability. We propose that these putative higher order structures coordinate mitochondrial gene expression.	[Cruz-Reyes, Jorge] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Ro, Kevin; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Willard, Belinda; Kinter, Mike T.] Cleveland Clin Fdn, Dept Cell Biol, Cleveland, OH 44195 USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cleveland Clinic Foundation	Cruz-Reyes, J (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	cruzrey@tamu.edu	Cruz-Reyes, Jorge/GQP-1338-2022; Hernandez, Alfredo/AAV-5584-2021; Hernandez, Alfredo J/ABC-8311-2020	Hernandez, Alfredo J/0000-0002-0903-8932; Kinter, Michael/0000-0001-7409-8918; Cruz-Reyes, Jorge/0000-0003-0545-1508	National Institutes of Health [GM067130]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067130] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067130 (to J.C.-R.).	Acestor N, 2009, RNA, V15, P277, DOI 10.1261/rna.1353209; Aphasizhev R, 2003, RNA, V9, P62, DOI 10.1261/rna.2134303; Aphasizhev R, 2003, EMBO J, V22, P913, DOI 10.1093/emboj/cdg083; Aphasizhev R, 2002, CELL, V108, P637, DOI 10.1016/S0092-8674(02)00647-5; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; BLUM B, 1990, CELL, V60, P189, DOI 10.1016/0092-8674(90)90735-W; BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O; Carnes J, 2008, MOL CELL BIOL, V28, P122, DOI 10.1128/MCB.01374-07; Carnes J, 2007, METHOD ENZYMOL, V424, P25, DOI 10.1016/S0076-6879(07)24002-9; Cifuentes-Rojas C, 2005, NUCLEIC ACIDS RES, V33, P6610, DOI 10.1093/nar/gki943; Cifuentes-Rojas C, 2007, J BIOL CHEM, V282, P4265, DOI 10.1074/jbc.M605554200; Cruz-Reyes J, 2007, METHOD ENZYMOL, V424, P107, DOI 10.1016/S0076-6879(07)24005-4; CruzReyes J, 1996, P NATL ACAD SCI USA, V93, P8901, DOI 10.1073/pnas.93.17.8901; CRUZREYES J, 2008, PROTEIN PROTEIN RNA, P71; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Etheridge RD, 2008, EMBO J, V27, P1596, DOI 10.1038/emboj.2008.87; FABRE A, 1990, PHOTOBIOCHEMISTRY NU, P379; Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596; Fisk JC, 2008, J BIOL CHEM, V283, P23016, DOI 10.1074/jbc.M801021200; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Hashimi H, 2008, RNA, V14, P970, DOI 10.1261/rna.888808; Hashimi H, 2009, RNA, V15, P588, DOI 10.1261/rna.1411809; Hermann T, 1997, NUCLEIC ACIDS RES, V25, P2311, DOI 10.1093/nar/25.12.2311; Hernandez A, 2008, J MOL BIOL, V381, P35, DOI 10.1016/j.jmb.2008.05.003; Jankowsky E, 2000, NUCLEIC ACIDS RES, V28, P333, DOI 10.1093/nar/28.1.333; Jankowsky E, 2007, NATURE, V449, P999, DOI 10.1038/449999a; Koslowsky Donna J, 2004, RNA Biol, V1, P28; Koslowsky DJ, 2009, TRENDS PARASITOL, V25, P252, DOI 10.1016/j.pt.2009.03.008; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; McManus MT, 2001, RNA, V7, P167, DOI 10.1017/S1355838201002072; Miller MM, 2006, RNA, V12, P1292, DOI 10.1261/rna.2331506; Mingler MK, 2006, MOL BIOCHEM PARASIT, V150, P37, DOI 10.1016/j.molbiopara.2006.06.006; Missel A, 1997, MOL CELL BIOL, V17, P4895, DOI 10.1128/MCB.17.9.4895; Muller UF, 2001, EMBO J, V20, P1394, DOI 10.1093/emboj/20.6.1394; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Panigrahi AK, 2007, METHOD ENZYMOL, V424, P3, DOI 10.1016/S0076-6879(07)24001-7; Pelletier M, 2003, RNA, V9, P457, DOI 10.1261/rna.2160803; Pusnik M, 2007, MOL CELL BIOL, V27, P6876, DOI 10.1128/MCB.00708-07; Reifur L, 2008, RNA, V14, P2195, DOI 10.1261/rna.1144508; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016; Rusche LN, 1997, EMBO J, V16, P4069, DOI 10.1093/emboj/16.13.4069; Sacharidou A, 2006, RNA, V12, P1219, DOI 10.1261/rna.2295706; SEIWERT SD, 1994, SCIENCE, V266, P114, DOI 10.1126/science.7524149; SIMPSON L, 2009, PROTIST IN PRESS; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Vondruskova E, 2005, J BIOL CHEM, V280, P2429, DOI 10.1074/jbc.M405933200; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weng J, 2008, MOL CELL, V32, P198, DOI 10.1016/j.molcel.2008.08.023; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wohlschlegel James A., 2009, V497, P33, DOI 10.1007/978-1-59745-566-4_3; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e; Yu LE, 2006, RNA, V12, P1050, DOI 10.1261/rna.3406; Zikova A, 2008, MOL CELL PROTEOMICS, V7, P1286, DOI 10.1074/mcp.M700490-MCP200	56	45	46	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1220	1228		10.1074/jbc.M109.051862	http://dx.doi.org/10.1074/jbc.M109.051862			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19850921	Green Published, hybrid			2022-12-25	WOS:000273258200044
J	Shi, FX; Cheng, YF; Wang, XL; Edge, ASB				Shi, Fuxin; Cheng, Yen-fu; Wang, Xiaohui L.; Edge, Albert S. B.			beta-Catenin Up-regulates Atoh1 Expression in Neural Progenitor Cells by Interaction with an Atoh1 3 ' Enhancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING NERVOUS-SYSTEM; EAR HAIR-CELLS; INNER-EAR; WNT/BETA-CATENIN; STEM-CELLS; NEURONAL DIFFERENTIATION; INTESTINAL CRYPTS; COLON-CANCER; MATH1; MORPHOGENESIS	Atoh1, a basic helix-loop-helix transcription factor, plays a critical role in the differentiation of several epithelial and neural cell types. We found that beta-catenin, the key mediator of the canonical Wnt pathway, increased expression of Atoh1 in mouse neuroblastoma cells and neural progenitor cells, and baseline Atoh1 expression was decreased by siRNA directed at beta-catenin. The up-regulation of Atoh1 was caused by an interaction of beta-catenin with the Atoh1 enhancer that could be demonstrated by chromatin immunoprecipitation. We found that two putative Tcf-Lef sites in the 3' enhancer of the Atoh1 gene displayed an affinity for beta-catenin and were critical for the activation of Atoh1 transcription because mutation of either site decreased expression of a reporter gene downstream of the enhancer. Tcf-Lef co-activators were found in the complex that bound to these sites in the DNA together with beta-catenin. Inhibition of Notch signaling, which has previously been shown to induce bHLH transcription factor expression, increased beta-catenin expression in progenitor cells of the nervous system. Because this could be a mechanism for up-regulation of Atoh1 after inhibition of Notch, we tested whether siRNA to beta-catenin prevented the increase in Atoh1 and found that beta-catenin expression was required for increased expression of Atoh1 after Notch inhibition.	[Shi, Fuxin; Cheng, Yen-fu; Edge, Albert S. B.] Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, Boston, MA 02114 USA; [Shi, Fuxin; Edge, Albert S. B.] Harvard Univ, Sch Med, Dept Otol & Laryngol, Boston, MA 02115 USA; [Cheng, Yen-fu; Edge, Albert S. B.] Harvard & MIT, Div Hlth Sci & Technol, Program Speech & Hearing Biosci & Technol, Cambridge, MA 02139 USA; [Wang, Xiaohui L.] Boston Univ, Sch Med, Dept Internal Med, Boston, MA 02118 USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Harvard University; Boston University	Edge, ASB (corresponding author), Massachusetts Eye & Ear Infirm, Eaton Peabody Lab, 243 Charles St, Boston, MA 02114 USA.	albert_edge@meei.harvard.edu	Edge, Albert/Q-5448-2019	Cheng, Yen-Fu/0000-0003-1995-5854	National Institutes of Health [R01 DC007174, P30 DC05209]; NIDCD; Hamilton H. Kellogg and Mildred H. Kellogg Charitable Trust; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007174, P30DC005209] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Hamilton H. Kellogg and Mildred H. Kellogg Charitable Trust; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DC007174 and P30 DC05209 from the NIDCD and by the Hamilton H. Kellogg and Mildred H. Kellogg Charitable Trust.	Berezovska O, 2000, J NEUROCHEM, V75, P583, DOI 10.1046/j.1471-4159.2000.0750583.x; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Corrales CE, 2006, J NEUROBIOL, V66, P1489, DOI 10.1002/neu.20310; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Fritzsch B, 2005, HEARING RES, V206, P52, DOI 10.1016/j.heares.2004.11.025; Helms AW, 2000, DEVELOPMENT, V127, P1185; Helms AW, 2001, MOL CELL NEUROSCI, V17, P671, DOI 10.1006/mcne.2000.0969; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Hirata H, 2001, EMBO J, V20, P4454, DOI 10.1093/emboj/20.16.4454; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Jeon SJ, 2007, MOL CELL NEUROSCI, V34, P59, DOI 10.1016/j.mcn.2006.10.003; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Leow CC, 2004, CANCER RES, V64, P6050, DOI 10.1158/0008-5472.CAN-04-0290; Lumpkin EA, 2003, GENE EXPR PATTERNS, V3, P389, DOI 10.1016/S1567-133X(03)00089-9; Lyu J, 2003, J BIOL CHEM, V278, P13487, DOI 10.1074/jbc.M300591200; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Pinto D, 2005, EXP CELL RES, V306, P357, DOI 10.1016/j.yexcr.2005.02.022; Proweller A, 2006, CANCER RES, V66, P7438, DOI 10.1158/0008-5472.CAN-06-0793; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Stevens CB, 2003, DEV BIOL, V261, P149, DOI 10.1016/S0012-1606(03)00297-5; Tsuchiya K, 2007, GASTROENTEROLOGY, V132, P208, DOI 10.1053/j.gastro.2006.10.031; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Noort M, 2007, BLOOD, V110, P2778, DOI 10.1182/blood-2007-05-092445; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789	36	87	101	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					392	400		10.1074/jbc.M109.059055	http://dx.doi.org/10.1074/jbc.M109.059055			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864427	Green Published, hybrid			2022-12-25	WOS:000273070100041
J	Yasuhara, R; Yuasa, T; Williams, JA; Byers, SW; Shah, S; Pacifici, M; Iwamoto, M; Enomoto-Iwamoto, M				Yasuhara, Rika; Yuasa, Takahito; Williams, Julie A.; Byers, Stephen W.; Shah, Salim; Pacifici, Maurizio; Iwamoto, Masahiro; Enomoto-Iwamoto, Motomi			Wnt/beta-Catenin and Retinoic Acid Receptor Signaling Pathways Interact to Regulate Chondrocyte Function and Matrix Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; NUCLEAR RECEPTORS; GROWTH-PLATE; DEVELOPMENTAL REGULATION; ARTICULAR CHONDROCYTES; MOUSE EMBRYO; WNT; DIFFERENTIATION; CELLS; EXPRESSION	Activation of the Wnt/beta-catenin and retinoid signaling pathways is known to tilt cartilage matrix homeostasis toward catabolism. Here, we investigated possible interactions between these pathways. We found that all-trans-retinoic acid (RA) treatment of mouse epiphyseal chondrocytes in culture did increase Wnt/beta-catenin signaling in the absence or presence of exogenous Wnt3a, as revealed by lymphoid enhancer factor/T-cell factor/beta-catenin reporter activity and beta-catenin nuclear accumulation. This stimulation was accompanied by increased gene expression of Wnt proteins and receptors and was inhibited by co-treatment with Dickkopf-related protein-1, an extracellular inhibitor of Wnt/beta-catenin signaling, suggesting that RA modulates Wnt signaling at Wnt cell surface receptor level. RA also enhanced matrix loss triggered by Wnt/beta-catenin signaling, whereas treatment with a retinoid antagonist reduced it. Interestingly, overexpression of retinoic acid receptor gamma (RAR gamma) strongly inhibited Wnt/beta-catenin signaling in retinoid-free cultures, whereas small interfering RNA-mediated silencing of endogenous RAR gamma expression strongly increased it. Small interfering RNA-mediated silencing of RAR alpha or RAR beta had minimal effects. Co-immunoprecipitation and two-hybrid assays indicated that RAR gamma interacts with beta-catenin and induces dissociation of beta-catenin from lymphoid enhancer factor in retinoid-free cultures. The N-terminal domain (AF-1) of RAR gamma but not the C-terminal domain (AF-2) was required for association with beta-catenin, whereas both AF-1 and AF-2 were necessary for inhibition of beta-catenin transcriptional activity. Taken together, our data indicate that the Wnt and retinoid signaling pathways do interact in chondrocytes, and their cross-talks and cross-regulation play important roles in the regulation of cartilage matrix homeostasis.	[Yasuhara, Rika; Yuasa, Takahito; Williams, Julie A.; Pacifici, Maurizio; Iwamoto, Masahiro; Enomoto-Iwamoto, Motomi] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Byers, Stephen W.; Shah, Salim] Georgetown Univ, Sch Med, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Byers, Stephen W.; Shah, Salim] Georgetown Univ, Sch Med, Dept Oncol, Mol & Cellular Biol Div, Washington, DC 20007 USA; [Byers, Stephen W.; Shah, Salim] Georgetown Univ, Sch Med, Dept Biochem, Mol & Cellular Biol Div, Washington, DC 20007 USA	Jefferson University; Georgetown University; Georgetown University; Georgetown University	Iwamoto, M (corresponding author), 1015 Walnut St,Curtis 501, Philadelphia, PA 19107 USA.	Masahiro.iwamoto@jefferson.edu; Motomi.iwamoto@jefferson.edu		Yasuhara, Rika/0000-0003-2282-6295	National Institutes of Health [AR050507, AG025868, AR056837, CA129813]; NATIONAL CANCER INSTITUTE [R01CA129813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056837, R01AR050507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AR050507 (to M. E. I.), AG025868 (to M. P.), AR056837 (to M. I.), and CA129813 (to S. W. B.).	Ballock R. Tracy, 2003, Birth Defects Research, V69, P123, DOI 10.1002/bdrc.10014; BALLOCK RT, 1994, J CELL PHYSIOL, V159, P340, DOI 10.1002/jcp.1041590217; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Beehler BC, 2003, J RHEUMATOL, V30, P355; Byers S, 1996, ENDOCRINOLOGY, V137, P3265, DOI 10.1210/en.137.8.3265; Chun JS, 2008, BMB REP, V41, P485, DOI 10.5483/BMBRep.2008.41.7.485; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; DOLLE P, 1989, NATURE, V342, P702, DOI 10.1038/342702a0; Dong YF, 2007, MOL ENDOCRINOL, V21, P2805, DOI 10.1210/me.2007-0199; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; Evans CH, 2004, GENE THER, V11, P379, DOI 10.1038/sj.gt.3302196; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fedi P, 1999, J BIOL CHEM, V274, P19465, DOI 10.1074/jbc.274.27.19465; Flannery CR, 1999, MATRIX BIOL, V18, P225, DOI 10.1016/S0945-053X(99)00024-4; FUKUO K, 1986, J BIOCHEM-TOKYO, V99, P385, DOI 10.1093/oxfordjournals.jbchem.a135493; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Guo XZ, 2004, GENE DEV, V18, P2404, DOI 10.1101/gad.1230704; Hartmann C, 2007, MOL CELLS, V24, P177; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoffman LM, 2006, J CELL BIOL, V174, P101, DOI 10.1083/jcb.200604150; HORTON JE, 1978, SCIENCE, V199, P1342, DOI 10.1126/science.204011; IWAMOTO M, 1994, MICROSC RES TECHNIQ, V28, P483, DOI 10.1002/jemt.1070280604; IWAMOTO M, 1993, EXP CELL RES, V207, P413, DOI 10.1006/excr.1993.1209; Katoh M, 2002, INT J MOL MED, V10, P683; Kawakami Y, 2001, CELL, V104, P891, DOI 10.1016/S0092-8674(01)00285-9; Kawakami Y, 1996, DEVELOPMENT, V122, P3557; Koyama E, 1999, DEV BIOL, V208, P375, DOI 10.1006/dbio.1999.9207; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Liu T, 2002, J BIOL CHEM, V277, P30887, DOI 10.1074/jbc.M203852200; LOHNES D, 1994, DEVELOPMENT, V120, P2723; Lu DS, 2005, P NATL ACAD SCI USA, V102, P18567, DOI 10.1073/pnas.0509316102; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; MENDELSOHN C, 1992, DEV BIOL, V152, P50, DOI 10.1016/0012-1606(92)90155-A; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Mollard R, 2000, MECH DEVELOP, V94, P223, DOI 10.1016/S0925-4773(00)00303-8; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Niederreither K, 2002, NAT GENET, V31, P84, DOI 10.1038/ng876; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Rodriguez-Leon J, 1999, NAT CELL BIOL, V1, P125, DOI 10.1038/10098; Rodriguez-Lopez J, 2007, ANN RHEUM DIS, V66, P1052, DOI 10.1136/ard.2006.065938; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Schakman O, 2008, ENDOCRINOLOGY, V149, P3900, DOI 10.1210/en.2008-0439; Shah S, 2003, J BIOL CHEM, V278, P48137, DOI 10.1074/jbc.M307154200; Shum ASW, 1999, MECH DEVELOP, V84, P17, DOI 10.1016/S0925-4773(99)00059-3; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Tata JR, 2002, NAT REV MOL CELL BIO, V3, P702, DOI 10.1038/nrm914; Valdes AM, 2007, ARTHRITIS RHEUM-US, V56, P137, DOI 10.1002/art.22301; von Schroeder HP, 1998, J ORTHOP RES, V16, P355, DOI 10.1002/jor.1100160312; Weston AD, 2003, J CELL BIOL, V161, P223, DOI 10.1083/jcb.200211117; Weston AD, 2002, J CELL BIOL, V158, P39, DOI 10.1083/jcb.200112029; Weston Andrea D., 2003, Birth Defects Research, V69, P156, DOI 10.1002/bdrc.10010; Williams JA, 2009, DEV BIOL, V328, P315, DOI 10.1016/j.ydbio.2009.01.031; Xiao JH, 2003, J BIOL CHEM, V278, P29954, DOI 10.1074/jbc.M304761200; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0; Yuasa T, 2008, LAB INVEST, V88, P264, DOI 10.1038/labinvest.3700747; Zhu M, 2009, J BONE MINER RES, V24, P12, DOI 10.1359/JBMR.080901	60	68	75	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					317	327		10.1074/jbc.M109.053926	http://dx.doi.org/10.1074/jbc.M109.053926			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19858186	hybrid, Green Published			2022-12-25	WOS:000273070100033
J	Armstrong, SP; Caunt, CJ; Fowkes, RC; Tsaneva-Atanasova, K; McArdle, CA				Armstrong, Stephen P.; Caunt, Christopher J.; Fowkes, Robert C.; Tsaneva-Atanasova, Krasimira; McArdle, Craig A.			Pulsatile and Sustained Gonadotropin-releasing Hormone (GnRH) Receptor Signaling DOES THE Ca2+/NFAT SIGNALING PATHWAY DECODE GnRH PULSE FREQUENCY?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-DEPENDENT INTERNALIZATION; DUAL-SPECIFICITY PHOSPHATASES; SUBUNIT GENE-TRANSCRIPTION; C-TERMINAL TAIL; LUTEINIZING-HORMONE; DIFFERENTIAL REGULATION; PULSE-FREQUENCY; SPATIOTEMPORAL REGULATION; ALPHA-T3-1 GONADOTROPES; RECOMBINANT ADENOVIRUS	Gonadotropin-releasing hormone (GnRH) acts via 7 transmembrane region receptors on gonadotrophs to stimulate synthesis and secretion of the luteinizing hormone and follicle-stimulating hormone. It is secreted in pulses, and its effects depend on pulse frequency, but decoding mechanisms are unknown. Here we have used (nuclear factor of activated T-cells 2 (NFAT2)-emerald fluorescent protein) to monitor GnRH signaling. Increasing [Ca2+](i) causes calmodulin/calcineurin-dependent nuclear NFAT translocation, a response involving proteins (calmodulins and NFATs) that decode frequency in other systems. Using live cell imaging, pulsatile GnRH caused dose- and frequency-dependent increases in nuclear NFAT2-emerald fluorescent protein, and at low frequency, translocation simply tracked GnRH exposure (albeit with slower kinetics). At high frequency (30-min intervals), failure to return to basal conditions before repeat stimulation caused integrative tracking, illustrating how the relative dynamics of up- and downstream signals can increase efficiency of GnRH action. Mathematical modeling predicted desensitization of GnRH effects on [Ca2+](i) and that desensitization would increase with dose, frequency, and receptor number, but no such desensitization was seen in HeLa and/or L beta T2 cells possibly because pulsatile GnRH did not reduce receptor expression (measured by immunofluorescence). GnRH also caused dose-and frequency-dependent activation of alpha GSU, luteinizing hormone beta, and follicle-stimulating hormone beta luciferase reporters, effects that were blocked by calcineurin inhibition. Pulsatile GnRH also activated an NFAT-responsive luciferase reporter, but this response was directly related to cumulative pulse duration. This together with the lack of desensitization of translocation responses suggests that NFAT may mediate GnRH action but is not a genuine decoder of GnRH pulse frequency.	[Armstrong, Stephen P.; Caunt, Christopher J.; McArdle, Craig A.] Univ Bristol, Dept Clin Sci S Bristol, Labs Integrat Neurosci & Endocrinol, Bristol BS1 3NY, Avon, England; [Fowkes, Robert C.] Univ London Royal Vet Coll, Endocrine Signalling Grp, London NW1 0TU, England; [Tsaneva-Atanasova, Krasimira] Univ Bristol, Dept Engn Math, Bristol Ctr Appl Nonlinear Math, Bristol BS8 1TR, Avon, England	University of Bristol; University of London; University of London Royal Veterinary College; University of Bristol	McArdle, CA (corresponding author), Univ Bristol, Dept Clin Sci S Bristol, Labs Integrat Neurosci & Endocrinol, Whitson St, Bristol BS1 3NY, Avon, England.	craig.mcardle@bristol.ac.uk	McArdle, Craig/AAQ-5660-2021; Fowkes, Robert/HHT-0664-2022; Fowkes, Robert/AAI-4756-2020; Tsaneva-Atanasova, Krasimira T/AAG-6766-2019	McArdle, Craig/0000-0003-4836-5351; Fowkes, Robert/0000-0002-2222-2056; Tsaneva-Atanasova, Krasimira T/0000-0002-6294-7051	Wellcome Trust [084588, 078407]; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Wellcome Trust Grants 084588 and 078407 (to C.A.M.) and a Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom doctoral training grant award (to the University of Bristol Laboratories for Integrative Neuroscience and Endocrinology).	Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Armstrong SP, 2009, MOL ENDOCRINOL, V23, P510, DOI 10.1210/me.2008-0333; Bedecarrats GY, 2003, ENDOCRINOLOGY, V144, P1802, DOI 10.1210/en.2002-221140; BELCHETZ PE, 1978, SCIENCE, V202, P631, DOI 10.1126/science.100883; Berridge MJ, 2006, BIOCHEM SOC T, V34, P228, DOI 10.1042/BST0340228; Burger LL, 2008, BIOL REPROD, V79, P947, DOI 10.1095/biolreprod.108.070987; Burger LL, 2004, J MOL ENDOCRINOL, V33, P559, DOI 10.1677/jme.1.01600; BURGER LL, 2009, BIOL REPROD; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Caunt CJ, 2006, J BIOL CHEM, V281, P2701, DOI 10.1074/jbc.M507242200; CONN PM, 1994, ANNU REV MED, V45, P391, DOI 10.1146/annurev.med.45.1.391; Craske H, 1999, P NATL ACAD SCI USA, V96, P4426, DOI 10.1073/pnas.96.8.4426; Crowley W F Jr, 1985, Recent Prog Horm Res, V41, P473; DALKIN AC, 1989, ENDOCRINOLOGY, V125, P917, DOI 10.1210/endo-125-2-917; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Ferris HA, 2006, BIOL REPROD, V74, P993, DOI 10.1095/biolreprod.105.049049; Finch AR, 2008, J ENDOCRINOL, V196, P353, DOI 10.1677/JOE-07-0471; Finch AR, 2009, AM J PHYSIOL-CELL PH, V297, pC591, DOI 10.1152/ajpcell.00166.2009; Finch AR, 2004, J CLIN ENDOCR METAB, V89, P1823, DOI 10.1210/jc.2003-030787; Gardner S, 2009, NEUROENDOCRINOLOGY, V89, P241, DOI 10.1159/000165377; Graham KE, 1999, J ENDOCRINOL, V162, pR1, DOI 10.1677/joe.0.162R001; HAISENLEDER DJ, 1991, ENDOCRINOLOGY, V128, P509, DOI 10.1210/endo-128-1-509; Haisenleder DJ, 2003, ENDOCRINOLOGY, V144, P2768, DOI 10.1210/en.2002-0168; Haisenleder DJ, 2003, ENDOCRINOLOGY, V144, P2409, DOI 10.1210/en.2002-0013; HANSON PI, 1994, NEURON, V12, P943, DOI 10.1016/0896-6273(94)90306-9; Heding A, 2000, ENDOCRINOLOGY, V141, P299, DOI 10.1210/en.141.1.299; Hislop JN, 2005, J MOL ENDOCRINOL, V35, P177, DOI 10.1677/jme.1.01809; Hislop JN, 2001, J BIOL CHEM, V276, P39685, DOI 10.1074/jbc.M104542200; Hislop JN, 2000, ENDOCRINOLOGY, V141, P4564, DOI 10.1210/en.141.12.4564; Holdstock JG, 1996, MOL ENDOCRINOL, V10, P1308, DOI 10.1210/me.10.11.1308; KAISER UB, 1993, ENDOCRINOLOGY, V133, P931, DOI 10.1210/en.133.2.931; Kaiser UB, 1995, P NATL ACAD SCI USA, V92, P12280, DOI 10.1073/pnas.92.26.12280; Karakoula A, 2008, EUR J PHARMACOL, V587, P16, DOI 10.1016/j.ejphar.2008.03.047; Krakauer DC, 2002, J THEOR BIOL, V218, P457, DOI 10.1006/jtbi.2002.3092; Lawson MA, 2007, MOL ENDOCRINOL, V21, P1175, DOI 10.1210/me.2006-0392; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Lim S, 2007, MOL CELL BIOL, V27, P4105, DOI 10.1128/MCB.00248-07; Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Maru BS, 2009, BONE, V44, P102, DOI 10.1016/j.bone.2008.09.016; MCARDLE CA, 1992, MOL CELL NEUROSCI, V3, P124, DOI 10.1016/1044-7431(92)90016-U; Mermelstein PG, 2001, P NATL ACAD SCI USA, V98, P15342, DOI 10.1073/pnas.211563998; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Naor Z, 2009, FRONT NEUROENDOCRIN, V30, P10, DOI 10.1016/j.yfrne.2008.07.001; Oosterom J, 2005, ASSAY DRUG DEV TECHN, V3, P143, DOI 10.1089/adt.2005.3.143; Schally AV, 1999, PEPTIDES, V20, P1247, DOI 10.1016/S0196-9781(99)00130-8; SHUPNIK MA, 1990, MOL ENDOCRINOL, V4, P1444, DOI 10.1210/mend-4-10-1444; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Tsutsumi R, 2009, ENDOCR J, V56, P729, DOI 10.1507/endocrj.K09E-185; Turgeon JL, 1996, MOL ENDOCRINOL, V10, P439, DOI 10.1210/me.10.4.439; Washington Talitha M, 2004, Theor Biol Med Model, V1, P9, DOI 10.1186/1742-4682-1-9; WEISS J, 1990, MOL ENDOCRINOL, V4, P557, DOI 10.1210/mend-4-4-557; Willars GB, 1999, J BIOL CHEM, V274, P30146, DOI 10.1074/jbc.274.42.30146; Willars GB, 2001, J BIOL CHEM, V276, P3123, DOI 10.1074/jbc.M008916200; Wojcikiewicz RJH, 2003, J BIOL CHEM, V278, P940, DOI 10.1074/jbc.M206607200; Wurmbach E, 2001, J BIOL CHEM, V276, P47195, DOI 10.1074/jbc.M108716200; YASIN M, 1995, ENDOCRINOLOGY, V136, P1559, DOI 10.1210/en.136.4.1559; Zhang T, 2006, J MOL ENDOCRINOL, V36, P41, DOI 10.1677/jme.1.01881	60	40	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35746	35757		10.1074/jbc.M109.063917	http://dx.doi.org/10.1074/jbc.M109.063917			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858197	Green Published, hybrid			2022-12-25	WOS:000272645600052
J	Jacobson, AD; Zhang, NY; Xu, P; Han, KJ; Noone, S; Peng, JM; Liu, CW				Jacobson, Andrew D.; Zhang, Nan-Yan; Xu, Ping; Han, Ke-Jun; Noone, Seth; Peng, Junmin; Liu, Chang-Wei			The Lysine 48 and Lysine 63 Ubiquitin Conjugates Are Processed Differently by the 26 S Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B ACTIVATION; LINEAR POLYUBIQUITIN CHAINS; ANAPHASE-PROMOTING COMPLEX; DEUBIQUITINATING ENZYME; QUANTITATIVE-ANALYSIS; PROTEOLYTIC PATHWAY; MASS-SPECTROMETRY; DNA-REPAIR; RECOGNITION; DEGRADATION	The role of Lys-63 ubiquitin chains in targeting proteins for proteasomal degradation is still obscure. We systematically compared proteasomal processing of Lys-63 ubiquitin chains with that of the canonical proteolytic signal, Lys-48 ubiquitin chains. Quantitative mass spectrometric analysis of ubiquitin chains in HeLa cells determines that the levels of Lys-63 ubiquitin chains are insensitive to short-time proteasome inhibition. Also, the Lys-48/Lys-63 ratio in the 26 S proteasome-bound fraction is 1.7-fold more than that in the cell lysates, likely because some cellular Lys-63 ubiquitin conjugates are sequestered by Lys-63 chain-specific binding proteins. In vitro, Lys-48 and Lys-63 ubiquitin chains bind the 26 S proteasome comparably, whereas Lys-63 chains are deubiquitinated 6-fold faster than Lys- 48 chains. Also, Lys-63 tetraubiquitin-conjugated UbcH10 is rapidly deubiquitinated into the monoubiquitinated form, whereas Lys- 48 tetraubiquitin targets UbcH10 for degradation. Furthermore, we found that both the ubiquitin aldehyde- and 1,10-phenanthroline- sensitive deubiquitinating activities of the 26 S proteasome contribute to Lys-48- and Lys-63-linkage deubiquitination, albeit the inhibitory extents are different. Together, our findings suggest that compared with Lys-48 chains, cellular Lys-63 chains have less proteasomal accessibility, and proteasome-bound Lys-63 chains are more rapidly deubiquitinated, which could cause inefficient degradation of Lys-63 conjugates.	[Liu, Chang-Wei] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Xu, Ping; Peng, Junmin] Emory Univ, Ctr Neurodegenerat Dis, Dept Human Genet, Atlanta, GA 30322 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Emory University	Liu, CW (corresponding author), Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, 12801 E 17th Ave,Box 6511,Mail Stop 8101, Aurora, CO 80045 USA.	changwei.liu@ucdenver.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648	National Institutes of Health [AG025688]; American Heart Association; March of Dimes Basil O'Connor Award; American Cancer Society; Cancer League of Colorado; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); March of Dimes Basil O'Connor Award(March of Dimes); American Cancer Society(American Cancer Society); Cancer League of Colorado; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG025688 (to J. P.). This work was also supported by grants from the American Heart Association, a March of Dimes Basil O'Connor Award, the American Cancer Society, and the Cancer League of Colorado (to C.-W.L.).	Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Catic A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000679; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Cooper EM, 2009, EMBO J, V28, P621, DOI 10.1038/emboj.2009.27; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hanna J, 2006, CELL, V127, P99, DOI 10.1016/j.cell.2006.07.038; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hofmann RM, 2001, J BIOL CHEM, V276, P27936, DOI 10.1074/jbc.M103378200; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; MA CP, 1994, J BIOL CHEM, V269, P3539; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xu P, 2006, BBA-PROTEINS PROTEOM, V1764, P1940, DOI 10.1016/j.bbapap.2006.09.004; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	46	95	97	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35485	35494		10.1074/jbc.M109.052928	http://dx.doi.org/10.1074/jbc.M109.052928			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858201	hybrid, Green Published			2022-12-25	WOS:000272645600025
J	Guo, HB; Johnson, H; Randolph, M; Pierce, M				Guo, Hua-Bei; Johnson, Heather; Randolph, Matthew; Pierce, Michael			Regulation of Homotypic Cell-Cell Adhesion by Branched N-Glycosylation of N-cadherin Extracellular EC2 and EC3 Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PROPELLER DOMAIN; SIGNALING PATHWAY; BREAST-CANCER; INTERCELLULAR-ADHESION; HOMOPHILIC ADHESION; BIOLOGICAL FUNCTION; CONTACT-INHIBITION; EXPRESSION; METASTASIS; RECEPTOR	The effects of altering N-cadherin N-glycosylation on several cadherin-mediated cellular behaviors were investigated using small interfering RNA and site-directed mutagenesis. In HT1080 fibrosarcoma cells, small interfering RNA-directed knockdown of N-acetylglucosaminyltransferase V (GnT-V), a glycosyltransferase up-regulated by oncogene signaling, caused decreased expression of N-linked beta(1,6)-branched glycans expressed on N-cadherin, resulting in enhanced N-cadherin-mediated cell-cell adhesion, but had no effect on N-cadherin expression on the cell surface. This effect on adhesion was accompanied by decreased cell migration and invasion, opposite of the effects observed when GnT-V was overexpressed in these cells (Guo, H. B., Lee, I., Kamar, M., and Pierce, M. (2003) J. Biol. Chem. 278, 52412-52424). A detailed study using site-directed mutagenesis demonstrated that three of the eight putative N-glycosylation sites in the N-cadherin sequence showed N-glycan expression. Moreover, all three of these sites, located in the extracellular domains EC2 and EC3, were shown by leucoagglutinating phytohemagglutinin binding to express at least some beta(1,6)-branched glycans, products of GnT-V activity. Deletion of these sites had no effect on cadherin levels on the cell surface but led to increased stabilization of cell-cell contacts, cell-cell adhesion-mediated intracellular signaling, and reduced cell migration. We show for the first time that these deletions had little effect on formation of the N-cadherin-catenin complex but instead resulted in increased N-cadherin cis-dimerization. Branched N-glycan expression at three sites in the EC2 and -3 domains regulates N-cadherin-mediated cell-cell contact formation, outside-in signaling, and cell migration and is probably a significant contributor to the increase in the migratory/invasive phenotype of cancer cells that results when GnT-V activity is up-regulated by oncogene signaling.	[Guo, Hua-Bei; Johnson, Heather; Randolph, Matthew; Pierce, Michael] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, Athens, GA 30605 USA	University System of Georgia; University of Georgia	Guo, HB (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA.	hbguo@uga.edu; hawkeye@uga.edu			National Institutes of Health, NCI [RO1CA64462]; NATIONAL CANCER INSTITUTE [R01CA064462] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health, NCI, Grant RO1CA64462.	Abbott KL, 2008, J BIOL CHEM, V283, P33026, DOI 10.1074/jbc.M803646200; BIRCHMEIER W, 1994, BBA-REV CANCER, V1198, P11, DOI 10.1016/0304-419X(94)90003-5; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; BROCKHAUSEN I, 1988, BIOCHEM CELL BIOL, V66, P1134, DOI 10.1139/o88-131; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; CHANEY W, 1989, J CELL BIOL, V109, P2089, DOI 10.1083/jcb.109.5.2089; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Chothia C, 1997, ANNU REV BIOCHEM, V66, P823, DOI 10.1146/annurev.biochem.66.1.823; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Granovsky M, 2000, NAT MED, V6, P306; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; Guo HB, 2005, J BIOL CHEM, V280, P8332, DOI 10.1074/jbc.M413532200; Guo HB, 2003, J BIOL CHEM, V278, P52412, DOI 10.1074/jbc.M308837200; Guo HB, 2002, CANCER RES, V62, P6837; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; Guo HB, 2009, GLYCOBIOLOGY, V19, P547, DOI 10.1093/glycob/cwp023; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P10231, DOI 10.1073/pnas.172380699; Haussinger D, 2004, EMBO J, V23, P1699, DOI 10.1038/sj.emboj.7600192; Hazan RB, 2000, J CELL BIOL, V148, P779, DOI 10.1083/jcb.148.4.779; Hazan RB, 1996, CELL ADHES COMMUN, V4, P399, DOI 10.3109/15419069709004457; HIRANO S, 1992, CELL, V70, P293, DOI 10.1016/0092-8674(92)90103-J; Irby RB, 2002, CANCER RES, V62, P2669; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; Kitada T, 2001, J BIOL CHEM, V276, P475, DOI 10.1074/jbc.M006689200; Koch AW, 1999, CURR OPIN STRUC BIOL, V9, P275, DOI 10.1016/S0959-440X(99)80038-4; Levenberg S, 1998, CELL ADHES COMMUN, V6, P161, DOI 10.3109/15419069809004473; Levenberg S, 1999, ONCOGENE, V18, P869, DOI 10.1038/sj.onc.1202396; Li G, 2001, CANCER RES, V61, P3819; Li Ke, 2009, Ai Zheng, V28, P8; Liwosz A, 2006, J BIOL CHEM, V281, P23138, DOI 10.1074/jbc.M512621200; Nagi C, 2005, BREAST CANCER RES TR, V94, P225, DOI 10.1007/s10549-005-7727-5; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Niessen CM, 2008, BBA-BIOMEMBRANES, V1778, P562, DOI 10.1016/j.bbamem.2007.12.015; Nita-Lazar M, 2009, CANCER RES, V69, P5673, DOI 10.1158/0008-5472.CAN-08-4512; Pece S, 2000, J BIOL CHEM, V275, P41227, DOI 10.1074/jbc.M006578200; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Rappl A, 2008, J CELL SCI, V121, P4089, DOI 10.1242/jcs.027995; Ray K, 1998, J BIOL CHEM, V273, P34558, DOI 10.1074/jbc.273.51.34558; Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907; SALOMON D, 1992, J CELL SCI, V102, P7; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; Seelentag WKF, 1998, CANCER RES, V58, P5559; Shan WS, 2004, J BIOL CHEM, V279, P55914, DOI 10.1074/jbc.M407827200; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; Shan WS, 1999, BIOPHYS CHEM, V82, P157, DOI 10.1016/S0301-4622(99)00115-5; Suyama K, 2002, CANCER CELL, V2, P301, DOI 10.1016/S1535-6108(02)00150-2; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200; Vagin O, 2008, J BIOL CHEM, V283, P2192, DOI 10.1074/jbc.M704713200; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Yagi T, 2000, GENE DEV, V14, P1169; Yamamoto H, 2000, CANCER RES, V60, P134; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; YOSHIMURA M, 1995, P NATL ACAD SCI USA, V92, P8754, DOI 10.1073/pnas.92.19.8754; Youn YH, 2006, INVEST OPHTH VIS SCI, V47, P2675, DOI 10.1167/iovs.05-1335; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106; Zhao HB, 2008, ACTA BIOCH BIOPH SIN, V40, P140, DOI 10.1111/j.1745-7270.2008.00380.x	64	64	67	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34986	34997		10.1074/jbc.M109.060806	http://dx.doi.org/10.1074/jbc.M109.060806			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19846557	Green Published, hybrid			2022-12-25	WOS:000272439600054
J	Li, DQ; Reddy, SDN; Pakala, SB; Wu, XF; Zhang, YP; Rayala, SK; Kumar, R				Li, Da-Qiang; Reddy, Sirigiri Divijendra Natha; Pakala, Suresh B.; Wu, Xifeng; Zhang, Yanping; Rayala, Suresh K.; Kumar, Rakesh			MTA1 Coregulator Regulates p53 Stability and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; UBIQUITIN LIGASE COP1; METASTASIS-ASSOCIATED PROTEIN-1; SQUAMOUS-CELL CARCINOMA; DNA-DAMAGE; INDIVIDUAL CELLS; GENOTOXIC STRESS; MDM2; APOPTOSIS; EXPRESSION	Although metastasis-associated protein 1 (MTA1) has recently been shown as a DNA damage responsive protein, the underlying mechanism for its role in DNA double-strand break (DSB) repair remains unknown. Here, we show that MTA1 controls p53 stability through inhibiting its ubiquitination by E3 ubiquitin ligases mouse double minute 2 (Mdm2) and constitutive photomorphogenic protein 1 (COP1). The underlying mechanisms involve the ability of MTA1 to compete with COP1 to bind to p53 and/or to destabilize COP1 and Mdm2. Consequently, MTA1 regulates the p53-dependent transcription of p53R2, a direct p53 target gene for supplying nucleotides to repair damaged DNA. Depletion of MTA1 impairs p53-dependent p53R2 transcription and compromises DNA repair. Interestingly, these events could be reversed by MTA1 reintroduction, indicating that MTA1 interjects into the p53-dependent DNA repair. Given the fact that MTA1 is widely up-regulated in human cancers, these findings in conjunction with our earlier finding of a crucial role of MTA1 in DSB repair suggest an inherent role of the MTA1-p53-p53R2 pathway in DNA damage response in cancer cells.	[Li, Da-Qiang; Reddy, Sirigiri Divijendra Natha; Pakala, Suresh B.; Rayala, Suresh K.; Kumar, Rakesh] George Washington Univ, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [Li, Da-Qiang; Reddy, Sirigiri Divijendra Natha; Pakala, Suresh B.; Rayala, Suresh K.; Kumar, Rakesh] George Washington Univ, Inst Coregulator Biol, Washington, DC 20037 USA; [Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Zhang, Yanping] Univ N Carolina, Radiat Oncol & Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	George Washington University; George Washington University; University of Texas System; UTMD Anderson Cancer Center; University of North Carolina; University of North Carolina Chapel Hill	Kumar, R (corresponding author), George Washington Univ, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendranathareddy/A-9857-2010; sirigiri, divijendra reddy/E-1031-2017	Kumar, Rakesh/0000-0001-7664-0803; sirigiri, divijendra reddy/0000-0003-4657-2285; Rayala, Suresh/0000-0003-4394-4450; Pakala, Suresh Babu/0000-0002-5679-4837	National Institutes of Health [CA98823, CA98823-S1]; NATIONAL CANCER INSTITUTE [R01CA100302, R01CA127770, R01CA098823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA98823 and CA98823-S1 ( to R. K.).	Ashcroft M, 2000, MOL CELL BIOL, V20, P3224, DOI 10.1128/MCB.20.9.3224-3233.2000; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Colman MS, 2000, MUTAT RES-REV MUTAT, V462, P179, DOI 10.1016/S1383-5742(00)00035-1; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Devlin HL, 2008, MOL CANCER RES, V6, P808, DOI 10.1158/1541-7786.MCR-07-2027; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; Dornan D, 2006, SCIENCE, V313, P1122, DOI 10.1126/science.1127335; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; FORD JM, 1995, P NATL ACAD SCI USA, V92, P8876, DOI 10.1073/pnas.92.19.8876; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Itahana K, 2007, CANCER CELL, V12, P355, DOI 10.1016/j.ccr.2007.09.007; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; Li G, 1996, AM J PATHOL, V148, P1113; Li W, 2008, FEBS LETT, V582, P869, DOI 10.1016/j.febslet.2008.02.013; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; McMasters KM, 1996, ONCOGENE, V13, P1731; MIYASHITA T, 1995, CELL, V80, P293; Moon HE, 2007, ONCOL REP, V18, P1311; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Qian HL, 2005, CLIN EXP METASTAS, V22, P653, DOI 10.1007/s10585-006-9005-2; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Therrien JP, 1999, P NATL ACAD SCI USA, V96, P15038, DOI 10.1073/pnas.96.26.15038; TOH Y, 1994, J BIOL CHEM, V269, P22958; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; Yokomakura N, 2007, ONCOL REP, V18, P561; Zurer I, 2004, CARCINOGENESIS, V25, P11, DOI 10.1093/carcin/bgg186	44	40	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34545	34552		10.1074/jbc.M109.056499	http://dx.doi.org/10.1074/jbc.M109.056499			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19837670	hybrid, Green Published			2022-12-25	WOS:000272439600009
J	Li, J; Kato, M; Chuang, DT				Li, Jun; Kato, Masato; Chuang, David T.			Pivotal Role of the C-terminal DW-motif in Mediating Inhibition of Pyruvate Dehydrogenase Kinase 2 by Dichloroacetate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROLIPOYL ACETYLTRANSFERASE; PHOSPHORYLATION SITES; MAMMALIAN PYRUVATE; METABOLIC SWITCH; LIPOYL DOMAIN-2; COMPLEX; PYRUVATE-DEHYDROGENASE-KINASE-2; EXPRESSION; HYPOXIA; CANCER	The mitochondrial pyruvate dehydrogenase complex (PDC) is down-regulated by phosphorylation catalyzed by pyruvate dehydrogenase kinase (PDK) isoforms 1-4. Overexpression of PDK isoforms and therefore reduced PDC activity prevails in cancer and diabetes. In the present study, we investigated the role of the invariant C-terminal DW-motif in inhibition of human PDK2 by dichloroacetate (DCA). Substitutions were made in the DW-motif (Asp-382 and Trp-383) and its interacting residues (Tyr-145 and Arg-149) in the other subunit of PDK2 homodimer. Single and double mutants show 20-60% residual activities that are not stimulated by the PDC core. The R149A and Y145F/R149A mutants show drastic increases in apparent IC50 values for DCA, whereas binding affinities for DCA are comparable with wild-type PDK2. Both R149A and Y145F variants exhibit increased similar affinities for ADP and ATP, mimicking the effects of DCA. The R149A and the DW-motif mutations (D382A/W383A) forestall binding of the lipoyl domain of PDC to these mutants, analogous to wild-type PDK2 in the presence of DCA and ADP. In contrast, the binding of a dihydrolipoamide mimetic AZD7545 is largely unaffected in these PDK2 variants. Our results illuminate the pivotal role of the DW-motif in mediating communications between the DCA-, the nucleotide-, and the lipoyl domain-binding sites. This signaling network locks PDK2 in the inactive closed conformation, which is in equilibrium with the active open conformation without DCA and ADP. These results implicate the DW-motif anchoring site as a drug target for the inhibition of aberrant PDK activity in cancer and diabetes.	[Li, Jun; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kato, Masato; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chuang, DT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	David.Chuang@UTSouthwestern.edu			National Institutes of Health [DK62306, DK26758]; Welch Foundation [I-1286]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026758, R01DK062306, R56DK062306] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK62306 and DK26758. This work was also supported by Welch Foundation Grant I-1286.	Baker JC, 2000, J BIOL CHEM, V275, P15773, DOI 10.1074/jbc.M909488199; Bao HY, 2004, BIOCHEMISTRY-US, V43, P13432, DOI 10.1021/bi049488x; Bersin RM, 1997, AM HEART J, V134, P841, DOI 10.1016/S0002-8703(97)80007-5; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; Cairns RA, 2007, P NATL ACAD SCI USA, V104, P9445, DOI 10.1073/pnas.0611662104; Green T, 2008, J BIOL CHEM, V283, P15789, DOI 10.1074/jbc.M800311200; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Harris RA, 1997, J BIOL CHEM, V272, P19746, DOI 10.1074/jbc.272.32.19746; Harris RA, 2001, ADV ENZYME REGUL, V41, P269, DOI 10.1016/S0065-2571(00)00020-0; Henderson GN, 1997, J CLIN PHARMACOL, V37, P416, DOI 10.1002/j.1552-4604.1997.tb04319.x; Hiromasa Y, 2006, J BIOL CHEM, V281, P12568, DOI 10.1074/jbc.M513514200; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Kato M, 2005, EMBO J, V24, P1763, DOI 10.1038/sj.emboj.7600663; Kato M, 2007, STRUCTURE, V15, P992, DOI 10.1016/j.str.2007.07.001; Kato M, 2008, STRUCTURE, V16, P1849, DOI 10.1016/j.str.2008.10.010; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Klyuyeva A, 2008, BIOCHEMISTRY-US, V47, P8358, DOI 10.1021/bi800631h; Klyuyeva A, 2007, FEBS LETT, V581, P2988, DOI 10.1016/j.febslet.2007.05.052; Knoechel TR, 2006, BIOCHEMISTRY-US, V45, P402, DOI 10.1021/bi051402s; Kolobova E, 2001, BIOCHEM J, V358, P69, DOI 10.1042/0264-6021:3580069; Korotchkina LG, 2001, J BIOL CHEM, V276, P37223, DOI 10.1074/jbc.M103069200; Korotchkina LG, 2001, J BIOL CHEM, V276, P5731, DOI 10.1074/jbc.M007558200; Koukourakis MI, 2005, NEOPLASIA, V7, P1, DOI 10.1593/neo.04373; LIU SJ, 1995, J BIOL CHEM, V270, P793, DOI 10.1074/jbc.270.2.793; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Mayers RM, 2003, BIOCHEM SOC T, V31, P1165; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; PATEL MS, 1990, FASEB J, V4, P3224, DOI 10.1096/fasebj.4.14.2227213; PRATT ML, 1979, J BIOL CHEM, V254, P7191; RADKE GA, 1993, BIOCHEM BIOPH RES CO, V190, P982, DOI 10.1006/bbrc.1993.1146; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; ROCHE TE, 1974, BIOCHEM BIOPH RES CO, V59, P1341, DOI 10.1016/0006-291X(74)90461-6; Roche TE, 2003, EUR J BIOCHEM, V270, P1050, DOI 10.1046/j.1432-1033.2003.03468.x; SALE GJ, 1981, EUR J BIOCHEM, V120, P535, DOI 10.1111/j.1432-1033.1981.tb05733.x; Stacpoole P, 1989, Compr Ther, V15, P28; Steussy CN, 2001, J BIOL CHEM, V276, P37443, DOI 10.1074/jbc.M104285200; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; TEAGUE WM, 1979, BIOCHEM BIOPH RES CO, V87, P244, DOI 10.1016/0006-291X(79)91672-3; Tso SC, 2006, J BIOL CHEM, V281, P27197, DOI 10.1074/jbc.M604339200; Tuganova A, 2002, BIOCHEM J, V366, P129, DOI 10.1042/BJ20020301; WARBURG O, 1956, SCIENCE, V124, P269; WHITEHOUSE S, 1974, BIOCHEM J, V141, P761, DOI 10.1042/bj1410761; Wu PF, 1998, BIOCHEM J, V329, P197, DOI 10.1042/bj3290197; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200; YEAMAN SJ, 1978, BIOCHEMISTRY-US, V17, P2364, DOI 10.1021/bi00605a017	48	24	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34458	34467		10.1074/jbc.M109.065557	http://dx.doi.org/10.1074/jbc.M109.065557			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19833728	Green Published, hybrid			2022-12-25	WOS:000272165200075
J	Sharma, AK; Ali, A; Gogna, R; Singh, AK; Pati, U				Sharma, Anuj Kumar; Ali, Amjad; Gogna, Rajan; Singh, Amir Kumar; Pati, Uttam			p53 Amino-Terminus Region (1-125) Stabilizes and Restores Heat Denatured p53 Wild Phenotype	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; PROLINE-RICH DOMAIN; DNA-BINDING; MUTANT P53; TRANSACTIVATION DOMAIN; MOLECULAR CHAPERONE; CONFORMATIONAL PHENOTYPE; GROWTH SUPPRESSION; CANCER-CELLS; N-TERMINUS	Background: The intrinsically disordered N-ter domain (NTD) of p53 encompasses approximately hundred amino acids that contain a transactivation domain (1-73) and a proline-rich domain (64-92) and is responsible for transactivation function and apoptosis. It also possesses an auto-inhibitory function as its removal results in remarkable reduction in dissociation of p53 from DNA. Principal Findings/Methodology: In this report, we have discovered that p53-NTD spanning amino acid residues 1-125 (NTD125) interacted with WT p53 and stabilized its wild type conformation under physiological and elevated temperatures, both in vitro and in cellular systems. NTD125 prevented irreversible thermal aggregation of heat denatured p53, enhanced p21-5'-DBS binding and further restored DBS binding activity of heat-denatured p53, in vitro, in a dose-dependent manner. In vivo ELISA and immunoprecipitation analysis of NTD125-transfected cells revealed that NTD125 shifted equilibrium from p53 mutant to wild type under heat stress conditions. Further, NTD125 initiated nuclear translocation of cytoplasmic p53 in transcriptionally active state in order to activate p53 downstream genes such as p21, Bax, PUMA, Noxa and SUMO. Conclusion/Significance: Here, we showed that a novel chaperone-like activity resides in p53-N-ter region. This study might have significance in understanding the role of p53-NTD in p53 stabilization, conformational activation and apoptosis under heat-stress conditions.			Sharma, AK (corresponding author), Jawaharlal Nehru Univ, Transcript & Human Biol Lab, Sch Biotechnol, New Delhi 110067, India.	uttam@mail.jnu.ac.in	Sharma, Anuj/G-3043-2011; Pati, Uttam/L-9345-2019	Sharma, Anuj/0000-0001-5061-9731; GOGNA, RAJAN/0000-0001-7304-7692; SINGH, Amir/0000-0003-2814-2759				Baptiste N, 2002, ONCOGENE, V21, P9, DOI 10.1038/sj/onc/1205015; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Beretta GL, 2008, MINI-REV MED CHEM, V8, P856, DOI 10.2174/138955708785132774; Bhattacharyya J, 1999, J BIOL CHEM, V274, P15505, DOI 10.1074/jbc.274.22.15505; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Bykov VJN, 2005, J BIOL CHEM, V280, P30384, DOI 10.1074/jbc.M501664200; Bykov VJN, 2003, EUR J CANCER, V39, P1828, DOI 10.1016/S0959-8049(03)00454-4; Cain C, 2000, J BIOL CHEM, V275, P39944, DOI 10.1074/jbc.M002509200; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Cregan SP, 2004, J NEUROSCI, V24, P10003, DOI 10.1523/JNEUROSCI.2114-04.2004; Dawson R, 2003, J MOL BIOL, V332, P1131, DOI 10.1016/j.jmb.2003.08.008; Di Lello P, 2006, MOL CELL, V22, P731, DOI 10.1016/j.molcel.2006.05.007; Dunker AK, 2007, STRUCTURE, V15, P1026, DOI 10.1016/j.str.2007.08.001; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; Gaitonde SV, 2000, ONCOGENE, V19, P4042, DOI 10.1038/sj.onc.1203756; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hansen S, 1996, J BIOL CHEM, V271, P3917; Hansen S, 1998, J MOL BIOL, V275, P575, DOI 10.1006/jmbi.1997.1507; Hegyi H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000017; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Issaeva N, 2003, P NATL ACAD SCI USA, V100, P13303, DOI 10.1073/pnas.1835733100; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Kim AL, 1999, J BIOL CHEM, V274, P34924, DOI 10.1074/jbc.274.49.34924; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Ma BY, 2000, PROTEIN ENG, V13, P617, DOI 10.1093/protein/13.9.617; Matas D, 2001, EMBO J, V20, P4163, DOI 10.1093/emboj/20.15.4163; Matsumoto S, 2002, J BIOL CHEM, V277, P34959, DOI 10.1074/jbc.M203038200; MILNER J, 1990, ONCOGENE, V5, P1683; Muller-Tiemann BF, 1998, P NATL ACAD SCI USA, V95, P6079, DOI 10.1073/pnas.95.11.6079; Okorokov AL, 2006, EMBO J, V25, P5191, DOI 10.1038/sj.emboj.7601382; Park SM, 2002, J BIOL CHEM, V277, P28512, DOI 10.1074/jbc.M111971200; Protopopova M, 2003, CELL CYCLE, V2, P592, DOI 10.4161/cc.2.6.501; Roth J, 2000, ONCOGENE, V19, P1834, DOI 10.1038/sj.onc.1203500; RYAN JJ, 1994, LEUKEMIA RES, V18, P617, DOI 10.1016/0145-2126(94)90043-4; Sabapathy K, 1997, EMBO J, V16, P6217, DOI 10.1093/emboj/16.20.6217; Sakamuro D, 1997, ONCOGENE, V15, P887, DOI 10.1038/sj.onc.1201263; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; Seo YR, 2002, P NATL ACAD SCI USA, V99, P14548, DOI 10.1073/pnas.212319799; Toledo F, 2007, MOL CELL BIOL, V27, P1425, DOI 10.1128/MCB.00999-06; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tripathi V, 2007, J BIOL CHEM, V282, P28441, DOI 10.1074/jbc.M703698200; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Walerych D, 2004, J BIOL CHEM, V279, P48836, DOI 10.1074/jbc.M407601200; Wawrzynow B, 2007, J BIOL CHEM, V282, P32603, DOI 10.1074/jbc.M702767200; Xirodimas DP, 1999, J BIOL CHEM, V274, P28042, DOI 10.1074/jbc.274.39.28042; ZERRAHN J, 1992, ONCOGENE, V7, P1371; Zhu JH, 2000, J BIOL CHEM, V275, P39927, DOI 10.1074/jbc.M005676200; Zylicz M, 2001, EMBO J, V20, P4634, DOI 10.1093/emboj/20.17.4634	49	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7159	10.1371/journal.pone.0007159	http://dx.doi.org/10.1371/journal.pone.0007159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847292	gold, Green Submitted, Green Published			2022-12-25	WOS:000271022000003
J	Le Hellard, S; Havik, B; Espeseth, T; Breilid, H; Lovlie, R; Luciano, M; Gow, AJ; Harris, SE; Starr, JM; Wibrand, K; Lundervold, AJ; Porteous, DJ; Bramham, CR; Deary, IJ; Reinvang, I; Steen, VM				Le Hellard, Stephanie; Havik, Bjarte; Espeseth, Thomas; Breilid, Harald; Lovlie, Roger; Luciano, Michelle; Gow, Alan J.; Harris, Sarah E.; Starr, John M.; Wibrand, Karin; Lundervold, Astri J.; Porteous, David J.; Bramham, Clive R.; Deary, Ian J.; Reinvang, Ivar; Steen, Vidar M.			Variants in Doublecortin- and Calmodulin Kinase Like 1, a Gene Up-Regulated by BDNF, Are Associated with Memory and General Cognitive Abilities	PLOS ONE			English	Article							CONVERGENT FUNCTIONAL GENOMICS; LONG-TERM POTENTIATION; COPY-NUMBER VARIATION; BIPOLAR-DISORDER; HIPPOCAMPAL ACTIVITY; SYNAPTIC PLASTICITY; EPISODIC MEMORY; CANDIDATE GENES; PROTEIN-KINASE; IDENTIFICATION	Background: Human memory and general cognitive abilities are complex functions of high heritability and wide variability in the population. The brain-derived neurotrophic factor (BDNF) plays an important role in mammalian memory formation. Methodology / Principal Finding: Based on the identification of genes markedly up-regulated during BDNF-induced synaptic consolidation in the hippocampus, we selected genetic variants that were tested in three independent samples, from Norway and Scotland, of adult individuals examined for cognitive abilities. In all samples, we show that markers in the doublecortin-and calmodulin kinase like 1 (DCLK1) gene, are significantly associated with general cognition (IQ scores) and verbal memory function, resisting multiple testing. DCLK1 is a complex gene with multiple transcripts which vary in expression and function. We show that the short variants are all up-regulated after BDNF treatment in the rat hippocampus, and that they are expressed in the adult human brain (mostly in cortices and hippocampus). We demonstrate that several of the associated variants are located in potential alternative promoter-and cis-regulatory elements of the gene and that they affect BDNF-mediated expression of short DCLK1 transcripts in a reporter system. Conclusion: These data present DCLK1 as a functionally pertinent gene involved in human memory and cognitive functions.			Le Hellard, S (corresponding author), Univ Bergen, Dept Clin Med, Bergen Mental Hlth Res Ctr, Bergen, Norway.	stephanie.hellard@med.uib.no	Lundervold, Astri/AAH-9796-2021; Deary, Ian J/C-6297-2009; Gow, Alan J/A-6070-2009; Porteous, David J/C-7289-2013; Porteous, David/AAA-3446-2021; Starr, John/C-8951-2011; Luciano, Michelle/F-7277-2010; Bramham, Clive/Q-1854-2018	Lundervold, Astri/0000-0002-6819-6164; Deary, Ian J/0000-0002-1733-263X; Gow, Alan J/0000-0002-3320-4531; Porteous, David J/0000-0003-1249-6106; Porteous, David/0000-0003-1249-6106; Luciano, Michelle/0000-0003-0935-7682; Bramham, Clive/0000-0001-5958-7115; Le Hellard, Stephanie/0000-0002-8085-051X	Medical Research Council [G0700704B, G9900991B] Funding Source: researchfish; Medical Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline; Chief Scientist Office [CZB/4/505, ETM/55] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Chief Scientist Office		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aukes MF, 2009, BIOL PSYCHIAT, V65, P527, DOI 10.1016/j.biopsych.2008.09.020; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Burgess HA, 2002, J BIOL CHEM, V277, P17696, DOI 10.1074/jbc.M111981200; Christoforou A, 2007, MOL PSYCHIATR, V12, P1011, DOI 10.1038/sj.mp.4002003; Craddock N, 2009, TRENDS GENET, V25, P99, DOI 10.1016/j.tig.2008.12.002; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Deary IJ, 2001, TRENDS COGN SCI, V5, P127, DOI 10.1016/S1364-6613(00)01621-1; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Dempster E, 2005, AM J MED GENET B, V134B, P73, DOI 10.1002/ajmg.b.30150; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Engels BM, 2004, MOL BRAIN RES, V120, P103, DOI 10.1016/j.molbrainres.2003.10.006; Espeseth T, 2006, COGN AFFECT BEHAV NE, V6, P31, DOI 10.3758/CABN.6.1.31; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glahn DC, 2004, BIPOLAR DISORD, V6, P171, DOI 10.1111/j.1399-5618.2004.00113.x; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; GORDON D, 2004, CURRENT PROTOCOLS BI; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P49, DOI 10.1093/schbul/sbl055; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Harris SE, 2006, MOL PSYCHIATR, V11, P505, DOI 10.1038/sj.mp.4001799; Hill SK, 2008, SCHIZOPHRENIA BULL, V34, P743, DOI 10.1093/schbul/sbn027; Holback S, 2005, J NEUROCHEM, V95, P1059, DOI 10.1111/j.1471-4159.2005.03440.x; Huentelman MJ, 2007, HUM MOL GENET, V16, P1469, DOI 10.1093/hmg/ddm097; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kandel ER, 2007, SEARCH MEMORY EMERGE; Kovas Y, 2006, TRENDS COGN SCI, V10, P198, DOI 10.1016/j.tics.2006.03.001; Le Hellard S, 2009, MOL PSYCHIATR, V14, P308, DOI 10.1038/sj.mp.4002133; Le-Niculescu H, 2007, NEUROSCI BIOBEHAV R, V31, P897, DOI 10.1016/j.neubiorev.2007.05.008; Le-Niculescu H, 2007, AM J MED GENET B, V144B, P129, DOI 10.1002/ajmg.b.30481; Le-Niculescu H, 2009, AM J MED GENET B, V150B, P155, DOI 10.1002/ajmg.b.30887; LEHELLARD S, 2008, MOL PSYCHIATR, DOI DOI 10.1038/MP.2008.1110; Lezak MD, 1995, NEUROPSYCHOLOGICAL T; Lin PT, 2000, J NEUROSCI, V20, P9152; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; PETRYSHEN TL, 2009, MOL PSYCHIATR, DOI DOI 10.1038/MP.2009.1024; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Raven JC, 1977, MANUAL RAVENS PROGR; Rozen S, 2000, Methods Mol Biol, V132, P365; Schenk GJ, 2007, EUR J NEUROSCI, V26, P3411, DOI 10.1111/j.1460-9568.2007.05956.x; Scottish Council for Research in Education, 1949, TREND SCOTT INT COMP; Silverman MA, 1999, J BIOL CHEM, V274, P2631, DOI 10.1074/jbc.274.5.2631; Sossey-Alaoui K, 1999, GENOMICS, V56, P121, DOI 10.1006/geno.1998.5718; Tan YL, 2005, SCHIZOPHR RES, V77, P355, DOI 10.1016/j.schres.2005.03.012; Tanaka T, 2006, CEREB CORTEX, V16, pI69, DOI 10.1093/cercor/bhk005; Terracciano A, 2010, MOL PSYCHIATR, V15, P647, DOI 10.1038/mp.2008.113; Vreugdenhil E, 2001, EUR NEUROPSYCHOPHARM, V11, P423, DOI 10.1016/S0924-977X(01)00119-5; Vreugdenhil E, 2007, EUR J NEUROSCI, V25, P635, DOI 10.1111/j.1460-9568.2007.05318.x; Weschler D., 1999, WESCHLER ABBREVIATED; Weschler D, 1987, WESCHLER MEMORY SCAL; WESCHLER D, 1998, WMS IIIUK ADM SCORIN; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; ZIGMOND SH, 1993, CELL MOTIL CYTOSKEL, V25, P309, DOI 10.1002/cm.970250402	61	28	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7534	10.1371/journal.pone.0007534	http://dx.doi.org/10.1371/journal.pone.0007534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844571	gold, Green Published, Green Submitted			2022-12-25	WOS:000271013000012
J	Rudi, K; Odegard, K; Lokken, TT; Wilson, R				Rudi, Knut; Odegard, Kristin; Lokken, Tine Therese; Wilson, Robert			A Feeding Induced Switch from a Variable to a Homogenous State of the Earthworm Gut Microbiota within a Host Population	PLOS ONE			English	Article							SOIL; COMMUNITIES; BACTERIA; LUMBRICIDAE; HABITAT; CASTS	Background: The distribution pattern of the earthworm gut microbiota at the host population level is of fundamental importance to understand host-microbiota interactions. Our current understanding of these interactions is very limited. Since feeding represents a main perturbation of the gut microbiota, we determined the effect of a single dose of feed on the microbiota associated with an earthworm population in a simulated microenvironment. Methodology: Earthworms were sampled 0, 1 and 7 days after feeding. We determined the overall composition of the earthworm-associated microbiota by 16S rRNA gene cloning and sequencing. Based on the 16S rRNA gene data we constructed quantitative PCR's (Q-PCR) for the seven most dominating bacterial groups. Principal Findings: Q-PCR revealed low density and highly variable microbiota among the earthworms before feeding, while a high-density homologous microbiota resulted from feeding. We found that the microbiota 1 day after feeding was more equal to the microbiota after 7 days than before feeding. Furthermore, we found that the gut microbiota was very distinct from that of the bedding and the feed. Significance: The homogenous population response represents fundamental new knowledge about earthworm gut associated bacteria.			Rudi, K (corresponding author), Hedmark Univ Coll, Hamar, Norway.	knut.rudi@hihm.no	Rudi, Knut/AAZ-9858-2020					Berget I, 2008, COMPUT STAT DATA AN, V52, P2403, DOI 10.1016/j.csda.2007.10.020; Bjornstad A, 2004, HEREDITAS, V141, P149, DOI 10.1111/j.1601-5223.2004.01816.x; BOUCHE MB, 1983, REV ECOL BIOL SOL, V20, P49; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; COOPER EL, 2005, IMMUNOL LETT; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; Darwin C., 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; Davidson SK, 2008, ISME J, V2, P510, DOI 10.1038/ismej.2008.16; DEANGELIS DL, 1987, ECOL MONOGR, V57, P1, DOI 10.2307/1942636; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Drake HL, 2007, ANNU REV MICROBIOL, V61, P169, DOI 10.1146/annurev.micro.61.080706.093139; Egert M, 2004, FEMS MICROBIOL ECOL, V48, P187, DOI 10.1016/j.femsec.2004.01.007; Furlong MA, 2002, APPL ENVIRON MICROB, V68, P1265, DOI 10.1128/AEM.68.3.1265-1279.2002; Horn MA, 2003, APPL ENVIRON MICROB, V69, P1662, DOI 10.1128/AEM.69.3.1662-1669.2003; Jimenez JJ, 2000, PEDOBIOLOGIA, V44, P677, DOI 10.1078/S0031-4056(04)70081-5; Khomyakov NV, 2007, MICROBIOLOGY+, V76, P45, DOI 10.1134/S0026261707010079; Knapp BA, 2008, B ENTOMOL RES, V98, P271, DOI 10.1017/S0007485308006056; Kvell K, 2007, CLIN DEV IMMUNOL, P1, DOI 10.1155/2007/83671; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; NECHITAYLO T, 2006, THESIS TU CAROLOWILH; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rastall RA, 2004, J NUTR, V134, p2022S, DOI 10.1093/jn/134.8.2022S; Rudi K, 2007, APPL ENVIRON MICROB, V73, P2727, DOI 10.1128/AEM.01205-06; Rudi K, 2006, INT J SYST EVOL MICR, V56, P1565, DOI 10.1099/ijs.0.63936-0; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Singleton DR, 2003, SOIL BIOL BIOCHEM, V35, P1547, DOI 10.1016/S0038-0717(03)00244-X; Stainier DYR, 2005, SCIENCE, V307, P1902, DOI 10.1126/science.1108709	31	15	17	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7528	10.1371/journal.pone.0007528	http://dx.doi.org/10.1371/journal.pone.0007528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841743	gold, Green Published, Green Submitted			2022-12-25	WOS:000271012900017
J	Chatelain, FC; Gazzarrini, S; Fujiwara, Y; Arrigoni, C; Domigan, C; Ferrara, G; Pantoja, C; Thiel, G; Moroni, A; Minor, DL				Chatelain, Franck C.; Gazzarrini, Sabrina; Fujiwara, Yuichiro; Arrigoni, Cristina; Domigan, Courtney; Ferrara, Giuseppina; Pantoja, Carlos; Thiel, Gerhard; Moroni, Anna; Minor, Daniel L., Jr.			Selection of Inhibitor-Resistant Viral Potassium Channels Identifies a Selectivity Filter Site that Affects Barium and Amantadine Block	PLOS ONE			English	Article							KCSA K+ CHANNEL; PROTON CHANNEL; IN-VITRO; MOLECULAR EVOLUTION; STRUCTURAL BASIS; VOLTAGE SENSOR; ION CHANNELS; PORE HELIX; VIRUS; PROTEIN	Background: Understanding the interactions between ion channels and blockers remains an important goal that has implications for delineating the basic mechanisms of ion channel function and for the discovery and development of ion channel directed drugs. Methodology/Principal Findings: We used genetic selection methods to probe the interaction of two ion channel blockers, barium and amantadine, with the miniature viral potassium channel Kcv. Selection for Kcv mutants that were resistant to either blocker identified a mutant bearing multiple changes that was resistant to both. Implementation of a PCR shuffling and backcrossing procedure uncovered that the blocker resistance could be attributed to a single change, T63S, at a position that is likely to form the binding site for the inner ion in the selectivity filter (site 4). A combination of electrophysiological and biochemical assays revealed a distinct difference in the ability of the mutant channel to interact with the blockers. Studies of the analogous mutation in the mammalian inward rectifier Kir2.1 show that the T -> S mutation affects barium block as well as the stability of the conductive state. Comparison of the effects of similar barium resistant mutations in Kcv and Kir2.1 shows that neighboring amino acids in the Kcv selectivity filter affect blocker binding. Conclusions/Significance: The data support the idea that permeant ions have an integral role in stabilizing potassium channel structure, suggest that both barium and amantadine act at a similar site, and demonstrate how genetic selections can be used to map blocker binding sites and reveal mechanistic features.			Chatelain, FC (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	daniel.minor@ucsf.edu	moroni, anna/H-2097-2014; Arrigoni, Cristina/AAG-8176-2020; Fujiwara, Yuichiro/GOP-2340-2022	moroni, anna/0000-0002-1860-406X; Fujiwara, Yuichiro/0000-0002-9628-4073; gazzarrini, sabrina/0000-0003-3062-7536; CHATELAIN, Franck C./0000-0002-8426-8893; Arrigoni, Cristina/0000-0003-1917-1750; Thiel, Gerhard/0000-0002-2335-1351				Abenavoli A, 2009, J GEN PHYSIOL, V134, P219, DOI 10.1085/jgp.200910266; Alagem N, 2003, BIOPHYS J, V85, P300, DOI 10.1016/S0006-3495(03)74475-0; ANDERSON JA, 1994, SYM SOC EXP BIOL, P85; ASHCROFT FM, 1991, BRIT J PHARMACOL, V104, P579, DOI 10.1111/j.1476-5381.1991.tb12472.x; Balss J, 2008, P NATL ACAD SCI USA, V105, P12313, DOI 10.1073/pnas.0805709105; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; Bulaj G, 2008, CURR OPIN CHEM BIOL, V12, P441, DOI 10.1016/j.cbpa.2008.07.012; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Chen J, 2005, BIOCHEM BIOPH RES CO, V326, P887, DOI 10.1016/j.bbrc.2004.11.125; Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y; DORNMAIR K, 1990, J BIOL CHEM, V265, P18907; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DUFF KC, 1993, BIOCHIM BIOPHYS ACTA, V1145, P149, DOI 10.1016/0005-2736(93)90392-D; Dunlop J, 2008, NAT REV DRUG DISCOV, V7, P358, DOI 10.1038/nrd2552; Gazzarrini S, 2009, BIOCHEM J, V420, P295, DOI 10.1042/BJ20090095; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Guizouarn H, 2001, J PHYSIOL-LONDON, V535, P497, DOI 10.1111/j.1469-7793.2001.t01-1-00497.x; Heginbotham L, 1997, BIOCHEMISTRY-US, V36, P10335, DOI 10.1021/bi970988i; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Kaczorowski GJ, 2008, J GEN PHYSIOL, V131, P399, DOI 10.1085/jgp.200709946; Kang M, 2004, P NATL ACAD SCI USA, V101, P5318, DOI 10.1073/pnas.0307824100; Krishnan MN, 2008, BIOCHEMISTRY-US, V47, P5354, DOI 10.1021/bi702281p; Krishnan MN, 2005, J GEN PHYSIOL, V126, P271, DOI 10.1085/jgp.200509323; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Kwok TCY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000067; Lai HC, 2005, NEURON, V47, P395, DOI 10.1016/j.neuron.2005.06.019; Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu Q, 2008, COMB CHEM HIGH T SCR, V11, P185, DOI 10.2174/138620708783877735; Minor DL, 2009, MOL BIOSYST, V5, P802, DOI 10.1039/b901708a; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Nakamura RL, 1997, J BIOL CHEM, V272, P1011, DOI 10.1074/jbc.272.2.1011; Pagliuca C, 2007, BIOCHEMISTRY-US, V46, P1079, DOI 10.1021/bi061530w; Pinto LH, 2007, MOL BIOSYST, V3, P18, DOI 10.1039/b611613m; Plugge B, 2000, SCIENCE, V287, P1641, DOI 10.1126/science.287.5458.1641; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Roux B, 2005, NEURON, V47, P777, DOI 10.1016/j.neuron.2005.08.031; Roux B, 2005, ANNU REV BIOPH BIOM, V34, P153, DOI 10.1146/annurev.biophys.34.040204.144655; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sanguinetti MC, 2005, TRENDS PHARMACOL SCI, V26, P119, DOI 10.1016/j.tips.2005.01.003; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shim JW, 2007, FEBS LETT, V581, P1027, DOI 10.1016/j.febslet.2007.02.005; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Subczynski WK, 1998, J PHARM SCI-US, V87, P1249, DOI 10.1021/js970381n; Syeda R, 2008, J AM CHEM SOC, V130, P15543, DOI 10.1021/ja804968g; TANG WM, 1995, MOL BIOL CELL, V6, P1231, DOI 10.1091/mbc.6.9.1231; Wang JF, 2004, BIOCHEM BIOPH RES CO, V324, P212, DOI 10.1016/j.bbrc.2004.09.039; Wang S, 2009, J BIOL CHEM, V284, P2854, DOI 10.1074/jbc.M807474200; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Yohannan S, 2007, J MOL BIOL, V366, P806, DOI 10.1016/j.jmb.2006.11.081; Zaks-Makhina E, 2004, MOL PHARMACOL, V65, P214, DOI 10.1124/mol.65.1.214; Zaks-Makhina E, 2009, J BIOL CHEM, V284, P15432, DOI 10.1074/jbc.M901586200; Zhou M, 2004, J MOL BIOL, V338, P839, DOI 10.1016/j.jmb.2004.03.020; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	65	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7496	10.1371/journal.pone.0007496	http://dx.doi.org/10.1371/journal.pone.0007496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834614	Green Submitted, Green Published, gold			2022-12-25	WOS:000270880700018
J	Linnertz, C; Saucier, L; Ge, DL; Cronin, KD; Burke, JR; Browndyke, JN; Hulette, CM; Welsh-Bohmer, KA; Chiba-Falek, O				Linnertz, Colton; Saucier, Laura; Ge, Dongliang; Cronin, Kenneth D.; Burke, James R.; Browndyke, Jeffrey N.; Hulette, Christine M.; Welsh-Bohmer, Kathleen A.; Chiba-Falek, Ornit			Genetic Regulation of alpha-Synuclein mRNA Expression in Various Human Brain Tissues	PLOS ONE			English	Article							SPORADIC PARKINSONS-DISEASE; LOCUS TRIPLICATION; SEQUENCE-ANALYSIS; ALLELIC VARIATION; SUBSTANTIA-NIGRA; SNCA GENE; NACP-REP1; MUTATION; DUPLICATION; SUSCEPTIBILITY	Genetic variability across the SNCA locus has been repeatedly associated with susceptibility to sporadic Parkinson's disease (PD). Accumulated evidence emphasizes the importance of SNCA dosage and expression levels in PD pathogenesis. However whether genetic variability in the SNCA gene modulates the risk to develop sporadic PD via regulation of SNCA expression remained elusive. We studied the effect of PD risk-associated variants at SNCA 5' and 3' regions on SNCA-mRNA levels in vivo in 228 human brain samples from three structures differentially vulnerable to PD pathology (substantia-nigra, temporal-and frontal-cortex) obtained from 144 neurologically normal cadavers. The extensively characterized PD-associated promoter polymorphism, Rep1, had an effect on SNCA-mRNA levels. Homozygous genotype of the 'protective', Rep1-259 bp allele, was associated with lower levels of SNCA-mRNA relative to individuals that carried at least one copy of the PD-risk associated alleles, amounting to an average decrease of similar to 40% and >50% in temporal-cortex and substantia-nigra, respectively. Furthermore, SNPs tagging the SNCA 3'-untranslated-region also showed effects on SNCA-mRNA levels in both the temporal-cortex and the substantia-nigra, although, in contrast to Rep1, the 'decreased-risk' alleles were correlated with increased SNCA-mRNA levels. Similar to Rep1 findings, no difference in SNCA-mRNA level was seen with different SNCA 3'SNP alleles in the frontal-cortex, indicating there is brain-region specificity of the genetic regulation of SNCA expression. We provide evidence for functional consequences of PD-associated SNCA gene variants in disease relevant brain tissues, suggesting that genetic regulation of SNCA expression plays an important role in the development of the disease.			Linnertz, C (corresponding author), Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA.	o.chibafalek@duke.edu	Burke, James R/E-4245-2016; Browndyke, Jeffrey/AAE-7292-2021; Welsh-Bohmer, Kathleen/AAA-3178-2020	Burke, James R/0000-0002-3408-7787; Browndyke, Jeffrey/0000-0002-8573-7073	NIA NIH HHS [P30 AG028377] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Braak H, 2007, ACTA NEUROPATHOL, V114, P231, DOI 10.1007/s00401-007-0244-3; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chiba-Falek O, 2005, AM J HUM GENET, V76, P478, DOI 10.1086/428655; Chiba-Falek O, 2003, HUM GENET, V113, P426, DOI 10.1007/s00439-003-1002-9; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; CRONIN KD, 2009, HUM MOL GENET; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; Dachsel JC, 2007, MOVEMENT DISORD, V22, P293, DOI 10.1002/mds.21223; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Fuchs J, 2008, FASEB J, V22, P1327, DOI 10.1096/fj.07-9348com; Grundemann J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn084; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Kingsbury AE, 2004, MOVEMENT DISORD, V19, P162, DOI 10.1002/mds.10683; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Lewis J, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-19; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; Mellick GD, 2005, NEUROSCI LETT, V375, P112, DOI 10.1016/j.neulet.2004.10.078; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Mizuta I, 2006, HUM MOL GENET, V15, P1151, DOI 10.1093/hmg/ddl030; Mizuta I, 2002, J NEUROL NEUROSUR PS, V73, P350, DOI 10.1136/jnnp.73.3.350; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Myhre R, 2008, ACTA NEUROL SCAND, V118, P320, DOI 10.1111/j.1600-0404.2008.01019.x; Neystat M, 1999, MOVEMENT DISORD, V14, P417, DOI 10.1002/1531-8257(199905)14:3<417::AID-MDS1005>3.0.CO;2-X; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Parsian A, 1998, NEUROLOGY, V51, P1757, DOI 10.1212/WNL.51.6.1757; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Touchman JW, 2001, GENOME RES, V11, P78, DOI 10.1101/gr.165801; Winkler S., 2007, NEUROLOGY; Xia Y, 1996, ANN NEUROL, V40, P207, DOI 10.1002/ana.410400212; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	42	67	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7480	10.1371/journal.pone.0007480	http://dx.doi.org/10.1371/journal.pone.0007480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834617	Green Published, Green Submitted, gold			2022-12-25	WOS:000270880700008
J	Martins, GG; Rifes, P; Amandio, R; Rodrigues, G; Palmeirim, I; Thorsteinsdottir, S				Martins, Gabriel G.; Rifes, Pedro; Amandio, Rita; Rodrigues, Gabriela; Palmeirim, Isabel; Thorsteinsdottir, Solveig			Dynamic 3D Cell Rearrangements Guided by a Fibronectin Matrix Underlie Somitogenesis	PLOS ONE			English	Article							PRESOMITIC MESODERM; CHICK-EMBRYO; GENE-EXPRESSION; MOUSE EMBRYOS; BRANCHING MORPHOGENESIS; VERTEBRATE SEGMENTATION; MORPHOLOGICAL BOUNDARY; SOMITIC SEGMENTATION; NOTOCHORD FORMATION; ADHESION MOLECULES	Somites are transient segments formed in a rostro-caudal progression during vertebrate development. In chick embryos, segmentation of a new pair of somites occurs every 90 minutes and involves a mesenchyme-to-epithelium transition of cells from the presomitic mesoderm. Little is known about the cellular rearrangements involved, and, although it is known that the fibronectin extracellular matrix is required, its actual role remains elusive. Using 3D and 4D imaging of somite formation we discovered that somitogenesis consists of a complex choreography of individual cell movements. Epithelialization starts medially with the formation of a transient epithelium of cuboidal cells, followed by cell elongation and reorganization into a pseudostratified epithelium of spindle-shaped epitheloid cells. Mesenchymal cells are then recruited to this medial epithelium through accretion, a phenomenon that spreads to all sides, except the lateral side of the forming somite, which epithelializes by cell elongation and intercalation. Surprisingly, an important contribution to the somite epithelium also comes from the continuous egression of mesenchymal cells from the core into the epithelium via its apical side. Inhibition of fibronectin matrix assembly first slows down the rate, and then halts somite formation, without affecting pseudopodial activity or cell body movements. Rather, cell elongation, centripetal alignment, N-cadherin polarization and egression are impaired, showing that the fibronectin matrix plays a role in polarizing and guiding the exploratory behavior of somitic cells. To our knowledge, this is the first 4D in vivo recording of a full mesenchyme-to-epithelium transition. This approach brought new insights into this event and highlighted the importance of the extracellular matrix as a guiding cue during morphogenesis.			Martins, GG (corresponding author), Univ Lisbon, Fac Ciencias, Dept Biol Anim, Ctr Biol Ambiental, Lisbon, Portugal.	gaby@fc.ul.pt; solveig@fc.ul.pt	Rodrigues, Gabriela/A-1909-2013; Martins, Gabriel G/AAG-4074-2020; Rodrigues, Gabriela/GQH-1711-2022; Palmeirim, Isabel/F-4522-2012; Thorsteinsdottir, Solveig/ABG-4504-2021; Martins, Gabriel G/A-1538-2012; Thorsteinsdottir, Solveig/M-3561-2013	Rodrigues, Gabriela/0000-0002-0598-4040; Martins, Gabriel G/0000-0002-6506-9776; Thorsteinsdottir, Solveig/0000-0002-9018-3431; Martins, Gabriel G/0000-0002-6506-9776; Thorsteinsdottir, Solveig/0000-0002-9018-3431; Palmeirim, Isabel/0000-0003-2282-7829; Rifes, Pedro/0000-0002-9963-3291	Fundação para a Ciência e a Tecnologia [POCI/BIA-BCM/59201/2004] Funding Source: FCT	Fundação para a Ciência e a Tecnologia		Andrade Raquel P., 2007, Birth Defects Research, V81, P65, DOI 10.1002/bdrc.20094; BELLAIRS R, 1979, J EMBRYOL EXP MORPH, V51, P227; BELLAIRS R, 1978, J EMBRYOL EXP MORPH, V46, P207; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472; Davidson LA, 2008, DEV DYNAM, V237, P2684, DOI 10.1002/dvdy.21600; Davidson LA, 2006, CURR BIOL, V16, P833, DOI 10.1016/j.cub.2006.03.038; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; DUBAND JL, 1987, J CELL BIOL, V104, P1361, DOI 10.1083/jcb.104.5.1361; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Freitas C, 2001, DEVELOPMENT, V128, P5139; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; GeorgesLabouesse EN, 1996, DEV DYNAM, V207, P145, DOI 10.1002/(SICI)1097-0177(199610)207:2<145::AID-AJA3>3.0.CO;2-H; Ghajar CM, 2008, HISTOCHEM CELL BIOL, V130, P1105, DOI 10.1007/s00418-008-0537-1; Gossler A, 1998, CURR TOP DEV BIOL, V38, P225; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Kragtorp KA, 2006, DEVELOPMENT, V133, P685, DOI 10.1242/dev.02230; Kragtorp KA, 2007, DEV DYNAM, V236, P2713, DOI 10.1002/dvdy.21280; KUHL U, 1982, DEV BIOL, V93, P344, DOI 10.1016/0012-1606(82)90122-1; Kulesa PM, 2002, SCIENCE, V298, P991, DOI 10.1126/science.1075544; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Larsen M, 2006, J CELL SCI, V119, P3376, DOI 10.1242/jcs.03079; LASH JW, 1984, J EXP ZOOL, V232, P197, DOI 10.1002/jez.1402320207; LASH JW, 1986, SOMITES DEV EMBRYOS, P201; LIPTON BH, 1974, DEV BIOL, V38, P73, DOI 10.1016/0012-1606(74)90260-7; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; McLaren A, 2005, DIFFERENTIATION, V73, P435, DOI 10.1111/j.1432-0436.2005.00049.x; Meyer S, 2005, INT J ONCOL, V27, P1197; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Nakaya Y, 2004, DEV CELL, V7, P425, DOI 10.1016/j.devcel.2004.08.003; Ohashi T, 2002, J CELL SCI, V115, P1221; OSTROVSKY D, 1983, CELL DIFFER DEV, V13, P217, DOI 10.1016/0045-6039(83)90092-1; PACKARD DS, 1976, DEV BIOL, V53, P36, DOI 10.1016/0012-1606(76)90207-4; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Palmeirim I, 1998, DEV GENET, V23, P77, DOI 10.1002/(SICI)1520-6408(1998)23:1<77::AID-DVG8>3.0.CO;2-3; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056; Rifes P, 2007, DEVELOPMENT, V134, P3155, DOI 10.1242/dev.003665; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Saga Y, 2007, DEV DYNAM, V236, P1450, DOI 10.1002/dvdy.21143; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sato Y, 2002, DEVELOPMENT, V129, P3633; SAUSEDO RA, 1993, ANAT REC, V237, P58, DOI 10.1002/ar.1092370107; SAUSEDO RA, 1994, ANAT REC, V239, P103, DOI 10.1002/ar.1092390112; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; Shook DR, 2008, J EXP ZOOL PART B, V310B, P85, DOI 10.1002/jez.b.21198; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Stockdale FE, 2000, DEV DYNAM, V219, P304, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1057>3.0.CO;2-5; THORSTEINSDOTTIR S, 1992, ANAT RECORD, V232, P141, DOI 10.1002/ar.1092320116; Trinh LA, 2004, DEV CELL, V6, P371; Uyen HD, 2002, J CELL SCI, V115, P3073; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P7467, DOI 10.1073/pnas.0902859106; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Williams LW, 1910, AM J ANAT, V11, P55, DOI 10.1002/aja.1000110103; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	71	50	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7429	10.1371/journal.pone.0007429	http://dx.doi.org/10.1371/journal.pone.0007429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829711	Green Published, gold			2022-12-25	WOS:000270847800001
J	Bradford, HN; Micucci, JA; Krishnaswamy, S				Bradford, Harlan N.; Micucci, Joseph A.; Krishnaswamy, Sriram			Regulated Cleavage of Prothrombin by Prothrombinase REPOSITIONING A CLEAVAGE SITE REVEALS THE UNIQUE KINETIC BEHAVIOR OF THE ACTION OF PROTHROMBINASE ON ITS COMPOUND SUBSTRATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VA HEAVY-CHAIN; FACTOR-XA; MACROMOLECULAR SUBSTRATE; CATALYZED ACTIVATION; EXOSITE BINDING; MEIZOTHROMBIN; COMPLEX; SPECIFICITY; CONFORMATIONS; SELECTIVITY	Prothrombinase converts prothrombin to thrombin via cleavage at Arg(320) followed by cleavage at Arg(271). Exosite-dependent binding of prothrombin to prothrombinase facilitates active site docking by Arg(320) and initial cleavage at this site. Precise positioning of the Arg(320) site for cleavage is implied by essentially normal cleavage at Arg(320) in recombinant prothrombin variants bearing additional Arg side chains either one or two residues away. However, mutation of Arg(320) to Gln reveals that prothrombinase can cleave prothrombin following Arg side chains shifted by as many as two residues N-terminal to the 320 position at near normal rates. Further repositioning leads to a loss in cleavage at this region with an abrupt shift toward slow cleavage at Arg(271). In contrast, the binding constant for the active site docking step is strongly dependent on the sequence preceding the scissile bond as well as position. Large effects on binding only yield minor changes in rate until the binding constant passes a threshold value. This behavior is expected for a substrate that can engage the enzyme through mutually exclusive active site docking reactions followed by cleavage to yield different products. Cleavage site specificity as well as the ordered action of prothrombinase on its compound substrate is regulated by the thermodynamics of active site engagement of the individual sites as well as competition between alternate cleavage sites for active site docking.	[Bradford, Harlan N.; Micucci, Joseph A.; Krishnaswamy, Sriram] Childrens Hosp Philadelphia, Joseph Stokes Res Inst, Philadelphia, PA 19104 USA; [Krishnaswamy, Sriram] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia; University of Pennsylvania	Krishnaswamy, S (corresponding author), Childrens Hosp Philadelphia, Joseph Stokes Res Inst, 310 Abramson,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	skrishna@mail.med.upenn.edu	Krishnaswamy, Sriram/Z-4380-2019	Bradford, Harlan/0000-0001-5582-278X	National Institutes of Health [HL-74124, HL-47465]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074124, R01HL047465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-74124 and HL-47465 (to S. K.).	Akhavan S, 1999, BRIT J HAEMATOL, V105, P667, DOI 10.1046/j.1365-2141.1999.01423.x; Baugh RJ, 1996, J BIOL CHEM, V271, P16126, DOI 10.1074/jbc.271.27.16126; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Bianchini EP, 2002, J BIOL CHEM, V277, P20527, DOI 10.1074/jbc.M201139200; Boskovic DS, 2000, J BIOL CHEM, V275, P38561, DOI 10.1074/jbc.M006637200; Boskovic DS, 2004, J BIOL CHEM, V279, P20786, DOI 10.1074/jbc.M400469200; BOSKOVIC DS, 1990, J BIOL CHEM, V265, P10497; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; Bukys MA, 2006, J BIOL CHEM, V281, P39194, DOI 10.1074/jbc.M604482200; Camire R.M., 2006, HEMOSTASIS THROMBOSI, P59; Camire RM, 2002, J BIOL CHEM, V277, P37863, DOI 10.1074/jbc.M203692200; Camire RM, 2000, BIOCHEMISTRY-US, V39, P14322, DOI 10.1021/bi001074q; Collados MT, 1997, THROMB RES, V85, P465, DOI 10.1016/S0049-3848(97)00036-4; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; EVANS SA, 1982, J BIOL CHEM, V257, P3014; Hacisalihoglu A, 2007, J BIOL CHEM, V282, P32974, DOI 10.1074/jbc.M706529200; Hsu HJ, 2008, J BIOL CHEM, V283, P12343, DOI 10.1074/jbc.M708843200; Khan AR, 1998, PROTEIN SCI, V7, P815; Kim PY, 2007, J BIOL CHEM, V282, P32568, DOI 10.1074/jbc.M701781200; Krishnaswamy S, 2005, J THROMB HAEMOST, V3, P54, DOI 10.1111/j.1538-7836.2004.01021.x; KRISHNASWAMY S, 1986, J BIOL CHEM, V261, P8977; KRISHNASWAMY S, 1990, J BIOL CHEM, V265, P3708; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lee CJ, 2008, J THROMB HAEMOST, V6, P83; LOTTENBERG R, 1986, BIOCHIM BIOPHYS ACTA, V874, P326, DOI 10.1016/0167-4838(86)90032-4; LOTTENBERG R, 1983, BIOCHIM BIOPHYS ACTA, V742, P558, DOI 10.1016/0167-4838(83)90273-X; Lu WP, 2003, ANAL BIOCHEM, V316, P58, DOI 10.1016/S0003-2697(03)00034-4; MANN KG, 1981, METHOD ENZYMOL, V80, P286; MANN KG, 1988, ANNU REV BIOCHEM, V57, P915, DOI 10.1146/annurev.bi.57.070188.004411; MANN KG, 1990, BLOOD, V76, P1; Mann M, 2003, CHEST, V124, P70, DOI 10.1378/chest.124.1.70; Martin PD, 1997, STRUCTURE, V5, P1681, DOI 10.1016/S0969-2126(97)00314-6; NESHEIM ME, 1979, BIOCHEMISTRY-US, V18, P996, DOI 10.1021/bi00573a010; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; PADMANABHAN K, 1993, J MOL BIOL, V232, P947, DOI 10.1006/jmbi.1993.1441; PRICE PA, 1983, METHOD ENZYMOL, V91, P13; ROSING J, 1988, THROMB HAEMOSTASIS, V60, P355; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Toso R, 2006, J BIOL CHEM, V281, P8773, DOI 10.1074/jbc.M511419200; Toso R, 2004, J BIOL CHEM, V279, P21643, DOI 10.1074/jbc.M402107200; VIJAYALAKSHMI J, 1994, PROTEIN SCI, V3, P2254, DOI 10.1002/pro.5560031211; WALKER RK, 1994, J BIOL CHEM, V269, P27441	44	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					328	338		10.1074/jbc.M109.070334	http://dx.doi.org/10.1074/jbc.M109.070334			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19858193	hybrid, Green Published			2022-12-25	WOS:000273070100034
J	Malhotra, S; Kovats, S; Zhang, WG; Coggeshall, KM				Malhotra, Shikha; Kovats, Susan; Zhang, Weiguo; Coggeshall, K. Mark			Vav and Rac Activation in B Cell Antigen Receptor Endocytosis Involves Vav Recruitment to the Adapter Protein LAB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; INOSITOL PHOSPHATASE SHIP; FC-GAMMA-RIIB; T-CELLS; TYROSINE PHOSPHORYLATION; DIFFERENTIAL REGULATION; SIGNALING PATHWAYS; SH2 DOMAIN; GTPASES; INTERNALIZATION	The signal transduction events supporting B cell antigen receptor (BCR) endocytosis are not well understood. We have identified a pathway supporting BCR internalization that begins with tyrosine phosphorylation of the adapter protein LAB. Phosphorylated LAB recruits a complex of Grb2-dynamin and the guanine nucleotide exchange factor Vav. Vav is required for activation of the small GTPases Rac1 and Rac2. All these proteins contribute to (and dynamin, Vav, and Rac1/2 are required for) BCR endocytosis and presentation of antigen to T cells. This is the first description of a sequential signal transduction pathway from BCR to internalization and antigen presentation.	[Malhotra, Shikha; Coggeshall, K. Mark] Univ Oklahoma, Immunobiol & Canc Program, Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Malhotra, Shikha; Coggeshall, K. Mark] Univ Oklahoma, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Kovats, Susan] Oklahoma Med Res Fdn, Arthritis & Immunol Program, Oklahoma City, OK 73104 USA; [Zhang, Weiguo] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation; Duke University	Coggeshall, KM (corresponding author), Univ Oklahoma, Immunobiol & Canc Program, Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA.	mark-coggeshall@omrf.ouhsc.edu		Kovats, Susan/0000-0001-5479-9952	NIAID NIH HHS [R01 AI056156] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056156] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Barr VA, 2006, TRAFFIC, V7, P1143, DOI 10.1111/j.1600-0854.2006.00464.x; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Brauweiler A, 2000, J EXP MED, V191, P1545, DOI 10.1084/jem.191.9.1545; Brdicka T, 2002, J EXP MED, V196, P1617, DOI 10.1084/jem.20021405; Cambier JC, 2007, NAT REV IMMUNOL, V7, P633, DOI 10.1038/nri2133; CHALUPNY NJ, 1993, EMBO J, V12, P2691, DOI 10.1002/j.1460-2075.1993.tb05930.x; CLARK EA, 1994, NATURE, V367, P425, DOI 10.1038/367425a0; Croker BA, 2002, J IMMUNOL, V168, P3376, DOI 10.4049/jimmunol.168.7.3376; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; Davanture S, 2005, J IMMUNOL, V175, P3140, DOI 10.4049/jimmunol.175.5.3140; DIDSBURY J, 1989, J BIOL CHEM, V264, P16378; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Fattakhova G, 2006, TRAFFIC, V7, P673, DOI 10.1111/j.1600-0854.2006.00423.x; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Gupta N, 2007, SEMIN CELL DEV BIOL, V18, P616, DOI 10.1016/j.semcdb.2007.07.009; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Harwood NE, 2008, IMMUNITY, V28, P609, DOI 10.1016/j.immuni.2008.04.007; Heo J, 2005, BIOCHEMISTRY-US, V44, P6573, DOI 10.1021/bi047443q; Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105; Jacob A, 1999, J BIOL CHEM, V274, P13704, DOI 10.1074/jbc.274.19.13704; Janssen E, 2003, NAT IMMUNOL, V4, P117, DOI 10.1038/ni882; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KATZAV S, 1994, J BIOL CHEM, V269, P32579; Kim YM, 2006, P NATL ACAD SCI USA, V103, P3327, DOI 10.1073/pnas.0511315103; Knaus UG, 1998, J BIOL CHEM, V273, P21512, DOI 10.1074/jbc.273.34.21512; Koonpaew S, 2004, J BIOL CHEM, V279, P11229, DOI 10.1074/jbc.M311394200; Malhotra S, 2009, J BIOL CHEM, V284, P24088, DOI 10.1074/jbc.M109.014209; McGavin MKH, 2001, J EXP MED, V194, P1777, DOI 10.1084/jem.194.12.1777; McGee K, 2001, FEBS LETT, V509, P59, DOI 10.1016/S0014-5793(01)03139-8; MIKI H, 1994, J BIOL CHEM, V269, P5489; Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932; Miletic AV, 2006, J BIOL CHEM, V281, P38257, DOI 10.1074/jbc.M608913200; Montagnac G, 2005, J IMMUNOL, V174, P5562, DOI 10.4049/jimmunol.174.9.5562; Movilla N, 2001, ONCOGENE, V20, P8057, DOI 10.1038/sj.onc.1205000; Mutch CM, 2007, INT IMMUNOL, V19, P19, DOI 10.1093/intimm/dxl118; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; Paavilainen VO, 2004, TRENDS CELL BIOL, V14, P386, DOI 10.1016/j.tcb.2004.05.002; Paz PE, 2001, BIOCHEM J, V356, P461, DOI 10.1042/0264-6021:3560461; Phee H, 2001, MOL CELL BIOL, V21, P8615, DOI 10.1128/MCB.21.24.8615-8625.2001; Raab M, 1997, IMMUNITY, V6, P155, DOI 10.1016/S1074-7613(00)80422-7; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sharma S, 2009, J IMMUNOL, V182, P329, DOI 10.4049/jimmunol.182.1.329; SHIMONKEVITZ R, 1984, J IMMUNOL, V133, P2067; Smit L, 1996, J BIOL CHEM, V271, P8564, DOI 10.1074/jbc.271.15.8564; Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Thrasher AJ, 2002, NAT REV IMMUNOL, V2, P635, DOI 10.1038/nri884; Tridandapani S, 1999, J IMMUNOL, V162, P1408; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Vedham V, 2005, MOL CELL BIOL, V25, P4211, DOI 10.1128/MCB.25.10.4211-4220.2005; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wang Y, 2005, MOL CELL BIOL, V25, P4455, DOI 10.1128/MCB.25.11.4455-4465.2005; WEBB CF, 1989, J IMMUNOL, V143, P3934; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Yohannan J, 1999, J BIOL CHEM, V274, P18769, DOI 10.1074/jbc.274.26.18769; Zhang WG, 1999, INT IMMUNOL, V11, P943, DOI 10.1093/intimm/11.6.943	60	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36202	36212		10.1074/jbc.M109.040089	http://dx.doi.org/10.1074/jbc.M109.040089			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858206	hybrid, Green Published			2022-12-25	WOS:000272970500022
J	Chen, X; Stitt, BL				Chen, Xin; Stitt, Barbara L.			ADP but Not P-i Dissociation Contributes to Rate Limitation for Escherichia coli Rho	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINATION FACTOR-RHO; TRANSCRIPTION TERMINATION; RNA-BINDING; PROTEIN-RHO; OLIGONUCLEOTIDE COFACTORS; CONFORMATIONAL-CHANGES; ATPASE ACTIVATION; HYDROLYTIC SITES; RELEASE; PROTECTION	To define the molecular mechanism by which ATP hydrolysis powers the 5'-> 3' travel of homohexameric Escherichia coli transcription termination factor Rho along RNA, rates for association and dissociation of non-RNA substrates and products were measured. Rapid mix/chemical quench and stopped-flow spectrofluorometry measurements were carried out with Rho and [gamma-P-32] ATP, mantADP, or fluorescently tagged E. coli phosphate-binding protein. The results indicate that the Pi off-rate is not rate limiting, but at similar to 90 s(-1), the ADP dissociation rate is comparable to the 30 s(-1) k(cat). Previous results indicate that the chemistry step of ATP hydrolysis by Rho is at least 10-fold faster than the overall catalytic cycle. The as yet unmeasured RNA dissociation step, which could be associated with a protein conformation change, might also be a rate-limiting factor.	[Stitt, Barbara L.] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Stitt, BL (corresponding author), Temple Univ, Sch Med, Dept Biochem, 3440 N Broad St, Philadelphia, PA 19140 USA.	stitt@temple.edu			National Institutes of Health [GM60247]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60247.	Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; Banerjee S, 2006, J MICROBIOL, V44, P11; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; BEAR DG, 1988, J MOL BIOL, V199, P623, DOI 10.1016/0022-2836(88)90306-3; Browne RJ, 2005, J BIOL CHEM, V280, P13300, DOI 10.1074/jbc.M500222200; Brune M, 1998, BIOCHEMISTRY-US, V37, P10370, DOI 10.1021/bi9804277; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; Burgess BR, 2001, J BIOL CHEM, V276, P4182, DOI 10.1074/jbc.M007066200; Chen X, 2004, J BIOL CHEM, V279, P16301, DOI 10.1074/jbc.M313640200; CHEN X, 2004, THESIS TEMPLE U; GALLUPPI GR, 1980, J MOL BIOL, V138, P513, DOI 10.1016/S0022-2836(80)80016-7; GEISELMANN J, 1992, BIOCHEMISTRY-US, V31, P111, DOI 10.1021/bi00116a017; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; GLYNN IM, 1964, BIOCHEM J, V90, P147, DOI 10.1042/bj0900147; GRUBMEYER C, 1981, J BIOL CHEM, V256, P3718; Jameson DM, 1997, METHOD ENZYMOL, V278, P363; JENCKS WP, 1969, CATALYSIS CHEM ENZYM, P564; Jeong YJ, 2004, J BIOL CHEM, V279, P18370, DOI 10.1074/jbc.M309162200; Johnson K. A., 1992, ENZYMES, P1; JOHNSON KA, 1995, METHOD ENZYMOL, V249, P38; Kim DE, 2001, J BIOL CHEM, V276, P13902, DOI 10.1074/jbc.M011043200; Mancini EJ, 2004, CELL, V118, P743, DOI 10.1016/j.cell.2004.09.007; MOTT JE, 1985, P NATL ACAD SCI USA, V82, P88, DOI 10.1073/pnas.82.1.88; NEHRKE KW, 1992, NUCLEIC ACIDS RES, V20, P6107, DOI 10.1093/nar/20.22.6107; NOSSAL NG, 1966, J BIOL CHEM, V241, P3055; Penefsky H S, 1979, Methods Enzymol, V56, P527; RICHARDSON JP, 1982, J BIOL CHEM, V257, P5760; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Rose I A, 1980, Methods Enzymol, V64, P47; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Stitt BL, 1998, J BIOL CHEM, V273, P26477, DOI 10.1074/jbc.273.41.26477; Stitt BL, 2001, BIOCHEMISTRY-US, V40, P2276, DOI 10.1021/bi002253a; STITT BL, 1988, J BIOL CHEM, V263, P11130; Sukal S, 2001, BIOCHEMISTRY-US, V40, P15009, DOI 10.1021/bi015735a; WANG Y, 1993, J BIOL CHEM, V268, P13940; WANG Y, 1993, J BIOL CHEM, V268, P13947; Wei RR, 2001, J MOL BIOL, V314, P1007, DOI 10.1006/jmbi.2000.5207; Wei RR, 2001, J BIOL CHEM, V276, P28380, DOI 10.1074/jbc.M102444200; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x	41	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33773	33780		10.1074/jbc.M109.056473	http://dx.doi.org/10.1074/jbc.M109.056473			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19837672	hybrid, Green Published			2022-12-25	WOS:000272165200007
J	Xu, XM; Lin, H; Latijnhouwers, M; Moller, SG				Xu, Xiang Ming; Lin, Hong; Latijnhouwers, Maita; Moller, Simon Geir			Dual Localized AtHscB Involved in Iron Sulfur Protein Biogenesis in Arabidopsis	PLOS ONE			English	Article							CLUSTER BIOSYNTHETIC SCAFFOLD; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; THALIANA; CHLOROPLASTS; MECHANISMS; EUKARYOTES; FERREDOXIN; BACTERIA; GENE	Background: Iron-sulfur clusters are ubiquitous structures which act as prosthetic groups for numerous proteins involved in several fundamental biological processes including respiration and photosynthesis. Although simple in structure both the assembly and insertion of clusters into apoproteins requires complex biochemical pathways involving a diverse set of proteins. In yeast, the J-type chaperone Jac1 plays a key role in the biogenesis of iron sulfur clusters in mitochondria. Methodology/Principal Findings: In this study we demonstrate that AtHscB from Arabidopsis can rescue the Jac1 yeast knockout mutant suggesting a role for AtHscB in iron sulfur protein biogenesis in plants. In contrast to mitochondrial Jac1, AtHscB localizes to both mitochondria and the cytosol. AtHscB interacts with AtIscU1, an Isu-like scaffold protein involved in iron-sulfur cluster biogenesis, and through this interaction AtIscU1 is most probably retained in the cytosol. The chaperone AtHscA can functionally complement the yeast Ssq1knockout mutant and its ATPase activity is enhanced by AtHscB and AtIscU1. Interestingly, AtHscA is also localized in both mitochondria and the cytosol. Furthermore, AtHscB is highly expressed in anthers and trichomes and an AtHscB T-DNA insertion mutant shows reduced seed set, a waxless phenotype and inappropriate trichome development as well as dramatically reduced activities of the iron-sulfur enzymes aconitase and succinate dehydrogenase. Conclusions: Our data suggest that AtHscB together with AtHscA and AtIscU1 plays an important role in the biogenesis of iron-sulfur proteins in both mitochondria and the cytosol.			Xu, XM (corresponding author), Univ Stavanger, Ctr Organelle Res, Fac Sci & Technol, Stavanger, Norway.	simon.g.moller@uis.no		Moller, Simon/0000-0002-0460-3592	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Amann K, 2004, PLANT CELL, V16, P3084, DOI 10.1105/tpc.104.024935; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Barras F, 2005, ADV MICROB PHYSIOL, V50, P41, DOI 10.1016/S0065-2911(05)50002-X; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bych K, 2008, J BIOL CHEM, V283, P35797, DOI 10.1074/jbc.M807303200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Craig EA, 2002, CELL MOL LIFE SCI, V59, P1658, DOI 10.1007/PL00012493; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Frazzon APG, 2007, PLANT MOL BIOL, V64, P225, DOI 10.1007/s11103-007-9147-x; Frazzon J, 2002, BIOCHEM SOC T, V30, P680, DOI 10.1042/BST0300680; Frazzon J, 2003, CURR OPIN CHEM BIOL, V7, P166, DOI 10.1016/S1367-5931(03)00021-8; Hjorth E, 2005, FEBS LETT, V579, P1129, DOI 10.1016/j.febslet.2004.12.084; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kessler D, 2005, PHOTOSYNTH RES, V86, P391, DOI 10.1007/s11120-005-5913-2; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; Kushnir S, 2001, PLANT CELL, V13, P89, DOI 10.1105/tpc.13.1.89; Leon G, 2007, PLANT PHYSIOL, V143, P1534, DOI 10.1104/pp.106.095158; Leon S, 2005, FEBS LETT, V579, P1930, DOI 10.1016/j.febslet.2005.02.038; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; Leon S, 2002, BIOCHEM J, V366, P557, DOI 10.1042/BJ20020322; Lezhneva L, 2004, PLANT J, V37, P174, DOI 10.1046/j.1365-313X.2003.01952.x; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Merchant S, 1998, ANNU REV PLANT PHYS, V49, P25, DOI 10.1146/annurev.arplant.49.1.25; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Pilon Marinus, 2006, Genet Eng (N Y), V27, P101, DOI 10.1007/0-387-25856-6_7; Pilon-Smits EAH, 2002, PLANT PHYSIOL, V130, P1309, DOI [10.1104/pp.102.010280, 10.1104/pp.010280]; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Silberg JJ, 2000, J BIOL CHEM, V275, P7779, DOI 10.1074/jbc.275.11.7779; Stehling Oliver, 2007, Methods Mol Biol, V372, P325, DOI 10.1007/978-1-59745-365-3_24; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; TSUGAMA D, 2009, BIOTECHNOL LETT; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Voisine C, 2001, P NATL ACAD SCI USA, V98, P1483, DOI 10.1073/pnas.98.4.1483; Xu XM, 2008, CHEMBIOCHEM, V9, P2355, DOI 10.1002/cbic.200800384; Xu XM, 2006, EMBO J, V25, P900, DOI 10.1038/sj.emboj.7600968; Xu XM, 2005, J BIOL CHEM, V280, P6648, DOI 10.1074/jbc.M413082200; Xu XM, 2004, P NATL ACAD SCI USA, V101, P9143, DOI 10.1073/pnas.0400799101; Yabe T, 2006, BIOCHEM BIOPH RES CO, V340, P1047, DOI 10.1016/j.bbrc.2005.12.104; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Yabe T, 2008, J MOL BIOL, V381, P160, DOI 10.1016/j.jmb.2008.05.072; Ye H, 2006, J BIOL CHEM, V281, P8958, DOI 10.1074/jbc.M512737200; Ye H, 2005, PLANTA, V220, P602, DOI 10.1007/s00425-004-1388-1; Ye H, 2006, NEW PHYTOL, V171, P285, DOI 10.1111/j.1469-8137.2006.01751.x; 2007, J BIOL CHEM, V282, P18254	58	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7662	10.1371/journal.pone.0007662	http://dx.doi.org/10.1371/journal.pone.0007662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19865480	Green Submitted, Green Published, gold			2022-12-25	WOS:000271232000016
J	Strandberg, L; Verdrengh, M; Enge, M; Andersson, N; Amu, S; Onnheim, K; Benrick, A; Brisslert, M; Bylund, J; Bokarewa, M; Nilsson, S; Jansson, JO				Strandberg, Louise; Verdrengh, Margareta; Enge, Maria; Andersson, Niklas; Amu, Sylvie; Onnheim, Karin; Benrick, Anna; Brisslert, Mikael; Bylund, Johan; Bokarewa, Maria; Nilsson, Staffan; Jansson, John-Olov			Mice Chronically Fed High-Fat Diet Have Increased Mortality and Disturbed Immune Response in Sepsis	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; NECROSIS-FACTOR-ALPHA; INDUCED OBESITY; ADIPOSE-TISSUE; BONE-MARROW; IKK-BETA; INFLAMMATION; DEFICIENCY; ACTIVATION; LEPTIN	Background: Sepsis is a potentially deadly disease that often is caused by gram-positive bacteria, in particular Staphylococcus aureus ( S. aureus). As there are few effective therapies for sepsis, increased basic knowledge about factors predisposing is needed. Methodology/Principal Findings: The purpose of this study was to study the effect of Western diet on mortality induced by intravenous S. aureus inoculation and the immune functions before and after bacterial inoculation. Here we show that C57Bl/6 mice on high-fat diet (HFD) for 8 weeks, like genetically obese Ob/Ob mice on low-fat diet (LFD), have increased mortality during S. aureus-induced sepsis compared with LFD-fed C57Bl/6 controls. Bacterial load in the kidneys 5-7 days after inoculation was increased 10-fold in HFD-fed compared with LFD-fed mice. At that time, HFD-fed mice had increased serum levels and fat mRNA expression of the immune suppressing cytokines interleukin-1 receptor antagonist (IL-1Ra) and IL-10 compared with LFD-fed mice. In addition, HFD-fed mice had increased serum levels of the pro-inflammatory IL-1 beta. Also, HFD-fed mice with and without infection had increased levels of macrophages in fat. The proportion and function of phagocytosing granulocytes, and the production of reactive oxygen species (ROS) by peritoneal lavage cells were decreased in HFD-fed compared with LFD-fed mice. Conclusions: Our findings imply that chronic HFD disturb several innate immune functions in mice, and impairs the ability to clear S. aureus and survive sepsis.			Strandberg, L (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol Endocrinol, Sahlgrenska Acad, Gothenburg, Sweden.	JOJ@medic.gu.se	Bokarewa, Maria I/A-8114-2019; Grahnemo, Louise/H-9407-2017	Bokarewa, Maria I/0000-0001-9424-5145; Grahnemo, Louise/0000-0001-5276-6612; Brisslert, Mikael/0000-0002-1412-5600; Nilsson, Staffan/0000-0003-4748-0446; Andersson, Niklas/0000-0002-3493-7358; Amu, Sylvie/0000-0001-9593-7952; Granhagen Onnheim, Karin/0000-0001-5415-6842				Amar S, 2007, P NATL ACAD SCI USA, V104, P20466, DOI 10.1073/pnas.0710335105; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Ashare A, 2005, AM J PHYSIOL-LUNG C, V288, pL633, DOI 10.1152/ajplung.00231.2004; Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Bjorkman L, 2008, ARTHRITIS RHEUM-US, V58, P2931, DOI 10.1002/art.23941; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carlsson G, 2006, ACTA PAEDIATR, V95, P1526, DOI 10.1080/08035250601087607; Chida D, 2006, DIABETES, V55, P971, DOI 10.2337/diabetes.55.04.06.db05-1250; Chonchol M, 2006, SEMIN DIALYSIS, V19, P291, DOI 10.1111/j.1525-139X.2006.00175.x; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Dahlgren Claes, 2007, V412, P349, DOI 10.1007/978-1-59745-467-4_23; Deitch EA, 1998, SHOCK, V9, P1, DOI 10.1097/00024382-199801000-00001; Dixon JB, 2006, OBES SURG, V16, P251, DOI 10.1381/096089206776116453; Faggioni R, 1999, AM J PHYSIOL-REG I, V276, pR136, DOI 10.1152/ajpregu.1999.276.1.R136; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fessler BJ, 2002, BEST PRACT RES CL RH, V16, P281, DOI 10.1053/berh.2001.0226; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; James WPT, 2008, OBES REV, V9, P6, DOI 10.1111/j.1467-789X.2007.00432.x; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Juge-Aubry CE, 2004, J CLIN ENDOCR METAB, V89, P2652, DOI 10.1210/jc.2003-031219; Juge-Aubry CE, 2005, CYTOKINE, V29, P270, DOI 10.1016/j.cyto.2004.10.017; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mikuls TR, 2003, BEST PRACT RES CL RH, V17, P729, DOI 10.1016/S1521-6942(03)00041-X; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Reed JA, 2005, J CLIN INVEST, V115, P3035, DOI 10.1172/JCI25681; Robinson SW, 2000, ANNU REV GENET, V34, P687, DOI 10.1146/annurev.genet.34.1.687; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Saito T, 2001, J DENT RES, V80, P1631, DOI 10.1177/00220345010800070701; Scheel-Toellner D, 2004, BLOOD, V104, P2557, DOI 10.1182/blood-2004-01-0191; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shamshiev AT, 2007, J EXP MED, V204, P441, DOI 10.1084/jem.20061737; Song GY, 1999, SURGERY, V126, P378, DOI 10.1016/S0039-6060(99)70180-7; STARKIE R, 2003, FASEB J; Strandberg L, 2006, J CLIN ENDOCR METAB, V91, P2749, DOI 10.1210/jc.2005-2786; Verdrengh M, 1997, INFECT IMMUN, V65, P2517, DOI 10.1128/IAI.65.7.2517-2521.1997; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; WHO, 2003, WHO TECH REP SER, V916, P1; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	55	72	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7605	10.1371/journal.pone.0007605	http://dx.doi.org/10.1371/journal.pone.0007605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19865485	Green Submitted, Green Published, gold			2022-12-25	WOS:000271194600009
J	Yu, SB; Franceschi, RT; Luo, M; Fan, J; Jiang, D; Cao, HL; Kwon, TG; Lai, YM; Zhang, J; Patrene, K; Hankenson, K; Roodman, GD; Xiao, GZ				Yu, Shibing; Franceschi, Renny T.; Luo, Min; Fan, Jie; Jiang, Di; Cao, Huiling; Kwon, Tae-Geon; Lai, Yumei; Zhang, Jian; Patrene, Kenneth; Hankenson, Kurt; Roodman, G. David; Xiao, Guozhi			Critical Role of Activating Transcription Factor 4 in the Anabolic Actions of Parathyroid Hormone in Bone	PLOS ONE			English	Article							OSTEOCALCIN GENE-EXPRESSION; MULTIPLE SIGNALING PATHWAYS; RAT OSTEOBLASTIC CELLS; PROTEIN-KINASE; C-FOS; MESSENGER-RNA; CLEIDOCRANIAL DYSPLASIA; TARGETED DISRUPTION; FACTOR OSTERIX; IN-VITRO	Parathyroid hormone (PTH) is a potent anabolic agent for the treatment of osteoporosis. However, its mechanism of action in osteoblast and bone is not well understood. In this study, we show that the anabolic actions of PTH in bone are severely impaired in both growing and adult ovariectomized mice lacking bone-related activating transcription factor 4 (ATF4). Our study demonstrates that ATF4 deficiency suppresses PTH-stimulated osteoblast proliferation and survival and abolishes PTH-induced osteoblast differentiation, which, together, compromise the anabolic response. We further demonstrate that the PTH-dependent increase in osteoblast differentiation is correlated with ATF4-dependent up-regulation of Osterix. This regulation involves interactions of ATF4 with a specific enhancer sequence in the Osterix promoter. Furthermore, actions of PTH on Osterix require this same element and are associated with increased binding of ATF4 to chromatin. Taken together these experiments establish a fundamental role for ATF4 in the anabolic actions of PTH on the skeleton.			Yu, SB (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	xiaog@upmc.edu	Hankenson, Kurt/AFS-9417-2022; Hankenson, Kurt/ABI-1547-2020; ZHANG, JIAN/Q-6334-2018; YU, SHIBING/B-7648-2012	Hankenson, Kurt/0000-0001-6361-143X; Kwon, Tae-Geon/0000-0003-2799-0510	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072230] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR059647] Funding Source: Medline; NIDDK NIH HHS [R01 DK072230-02, R01 DK072230-04, R01 DK072230-03, R01 DK072230, R01 DK072230-01A2, DK072230, R01 DK072230-02S1] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Banerjee C, 1996, P NATL ACAD SCI USA, V93, P4968, DOI 10.1073/pnas.93.10.4968; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Boguslawski G, 2000, J BIOL CHEM, V275, P999, DOI 10.1074/jbc.275.2.999; Boudreaux JM, 1996, J BIOL CHEM, V271, P7508, DOI 10.1074/jbc.271.13.7508; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carpio L, 2001, AM J PHYSIOL-ENDOC M, V281, pE489, DOI 10.1152/ajpendo.2001.281.3.E489; Chen C, 2004, J BIOL CHEM, V279, P29121, DOI 10.1074/jbc.M313000200; Chen HL, 2002, J BIOL CHEM, V277, P19374, DOI 10.1074/jbc.M108913200; Cole JA, 1999, ENDOCRINOLOGY, V140, P5771, DOI 10.1210/en.140.12.5771; DALONZO RC, 2001, J BIOL CHEM, V18, P18; Datta NS, 2007, J BONE MINER RES, V22, P951, DOI 10.1359/JBMR.070328; Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221; DEMPSTER DW, 1993, ENDOCR REV, V14, P690, DOI 10.1210/er.14.6.690; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Hettmann T, 2000, DEV BIOL, V222, P110, DOI 10.1006/dbio.2000.9699; HOCK JM, 1988, ENDOCRINOLOGY, V122, P2899, DOI 10.1210/endo-122-6-2899; Hurley MM, 2006, BIOCHEM BIOPH RES CO, V341, P989, DOI 10.1016/j.bbrc.2006.01.044; Iida-Klein A, 2005, J ENDOCRINOL, V186, P549, DOI 10.1677/joe.1.06270; Iida-Klein A, 2002, J BONE MINER RES, V17, P808, DOI 10.1359/jbmr.2002.17.5.808; Jiang D, 2004, J BIOL CHEM, V279, P5329, DOI 10.1074/jbc.M311547200; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kaback LA, 2008, J CELL BIOCHEM, V105, P219, DOI 10.1002/jcb.21816; Karsenty G, 2000, SEMIN CELL DEV BIOL, V11, P343, DOI 10.1006/scdb.2000.0188; Koh AJ, 1999, ENDOCRINOLOGY, V140, P3154, DOI 10.1210/en.140.7.3154; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Krishnan V, 2003, MOL ENDOCRINOL, V17, P423, DOI 10.1210/me.2002-0225; Liu F, 2007, BONE, V40, P1135, DOI 10.1016/j.bone.2006.12.003; McCauley LK, 1997, ENDOCRINOLOGY, V138, P5427, DOI 10.1210/en.138.12.5427; McCauley LK, 2001, ENDOCRINOLOGY, V142, P1975, DOI 10.1210/en.142.5.1975; MCCAULEY LK, 1995, J BONE MINER RES, V10, P1243, DOI 10.1002/jbmr.5650100815; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918; Miyakoshi N, 2001, ENDOCRINOLOGY, V142, P4349, DOI 10.1210/en.142.10.4349; MOSEKILDE L, 1995, BONE, V16, P223, DOI 10.1016/8756-3282(94)00033-V; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Ogata Y, 2000, MATRIX BIOL, V19, P395, DOI 10.1016/S0945-053X(00)00085-8; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PARTRIDGE NC, 1981, ENDOCRINOLOGY, V108, P213, DOI 10.1210/endo-108-1-213; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715; SCHMIDT IU, 1995, ENDOCRINOLOGY, V136, P5127, DOI 10.1210/en.136.11.5127; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Swarthout JT, 2001, J BIOL CHEM, V276, P7586, DOI 10.1074/jbc.M007400200; Tanaka S, 2004, J BONE MINER RES, V19, P1813, DOI 10.1359/JBMR.040808; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; TOMINAGA H, 2008, MOL BIOL CELL; van der Horst G, 2005, J BONE MINER RES, V20, P2233, DOI 10.1359/JBMR.050821; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Wang BL, 2006, J ENDOCRINOL INVEST, V29, P101, DOI 10.1007/BF03344081; Wang YH, 2005, J BONE MINER RES, V20, P5, DOI 10.1359/JBMR.041016; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yu SB, 2008, ENDOCRINOLOGY, V149, P1960, DOI 10.1210/en.2007-1573; Yu SB, 2008, J BIOL CHEM, V283, P5542, DOI 10.1074/jbc.M705653200; Yu XP, 1997, ENDOCRINOLOGY, V138, P3085, DOI 10.1210/en.138.8.3085; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang XY, 2008, J CELL BIOCHEM, V105, P885, DOI 10.1002/jcb.21888; Zhao WG, 2000, J CLIN INVEST, V106, P941, DOI 10.1172/JCI10158	73	55	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7583	10.1371/journal.pone.0007583	http://dx.doi.org/10.1371/journal.pone.0007583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851510	gold, Green Published			2022-12-25	WOS:000271022300014
J	Borot, F; Vieu, DL; Faure, G; Fritsch, J; Colas, J; Moriceau, S; Baudouin-Legros, M; Brouillard, F; Ayala-Sanmartin, J; Touqui, L; Chanson, M; Edelman, A; Ollero, M				Borot, Florence; Vieu, Diane-Lore; Faure, Grazyna; Fritsch, Janine; Colas, Julien; Moriceau, Sandra; Baudouin-Legros, Maryvonne; Brouillard, Franck; Ayala-Sanmartin, Jesus; Touqui, Lhousseine; Chanson, Marc; Edelman, Aleksander; Ollero, Mario			Eicosanoid Release Is Increased by Membrane Destabilization and CFTR Inhibition in Calu-3 Cells	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); TRANSMEMBRANE CONDUCTANCE REGULATOR; NECROSIS-FACTOR-RECEPTOR; INNATE IMMUNE-RESPONSE; CYSTIC-FIBROSIS; EPITHELIAL-CELLS; GENE-EXPRESSION; PULMONARY INFLAMMATION; COX-2 EXPRESSION; LIPID RAFTS	The antiinflammatory protein annexin-1 (ANXA1) and the adaptor S100A10 (p11), inhibit cytosolic phospholipase A2 (cPLA2 alpha) by direct interaction. Since the latter is responsible for the cleavage of arachidonic acid at membrane phospholipids, all three proteins modulate eicosanoid production. We have previously shown the association of ANXA1 expression with that of CFTR, the multifactorial protein mutated in cystic fibrosis. This could in part account for the abnormal inflammatory status characteristic of this disease. We postulated that CFTR participates in the regulation of eicosanoid release by direct interaction with a complex containing ANXA1, p11 and cPLA2 alpha. We first analyzed by plasmon surface resonance the in vitro binding of CFTR to the three proteins. A significant interaction between p11 and the NBD1 domain of CFTR was found. We observed in Calu-3 cells a rapid and partial redistribution of all four proteins in detergent resistant membranes (DRM) induced by TNF-alpha. This was concomitant with increased IL-8 synthesis and cPLA2 alpha activation, ultimately resulting in eicosanoid (PGE2 and LTB4) overproduction. DRM destabilizing agent methyl-beta-cyclodextrin induced further cPLA2 alpha activation and eicosanoid release, but inhibited IL-8 synthesis. We tested in parallel the effect of short exposure of cells to CFTR inhibitors Inh172 and Gly-101. Both inhibitors induced a rapid increase in eicosanoid production. Longer exposure to Inh172 did not increase further eicosanoid release, but inhibited TNF-alpha-induced relocalization to DRM. These results show that (i) CFTR may form a complex with cPLA2 alpha and ANXA1 via interaction with p11, (ii) CFTR inhibition and DRM disruption induce eicosanoid synthesis, and (iii) suggest that the putative cPLA2/ANXA1/p11/CFTR complex may participate in the modulation of the TNF-alpha-induced production of eicosanoids, pointing to the importance of membrane composition and CFTR function in the regulation of inflammation mediator synthesis.			Borot, F (corresponding author), Univ Paris 05, INSERM, U845, Fac Med Paris Descartes, Paris, France.	mario.ollero@inserm.fr	Ollero, Mario/AAJ-3545-2020; Ollero, Mario/Q-6147-2018	Chanson, Marc/0000-0001-8104-2090; Ollero, Mario/0000-0003-3590-706X				Ayala-Sanmartin J, 2000, BIOCHEMISTRY-US, V39, P15190, DOI 10.1021/bi000764r; Bailleux A, 2004, BIOCHEM J, V378, P307, DOI 10.1042/BJ20031014; BAJMOCZI M, 2009, AM J PHYSL CELL PHYS; BASTIAN BC, 1993, J INVEST DERMATOL, V101, P359, DOI 10.1111/1523-1747.ep12365541; Bensalem N, 2005, MOL CELL PROTEOMICS, V4, P1591, DOI 10.1074/mcp.M500019-MCP200; BESANCON F, 1994, AM J PHYSIOL-CELL PH, V267, pC1398, DOI 10.1152/ajpcell.1994.267.5.C1398; Borthwick LA, 2007, MOL BIOL CELL, V18, P3388, DOI 10.1091/mbc.E07-02-0126; Brouillard F, 2001, CANCER RES, V61, P1693; Brouillard F, 2001, J BIOL CHEM, V276, P9486, DOI 10.1074/jbc.M006636200; Brouillard F, 2008, PROTEOM CLIN APPL, V2, P264, DOI 10.1002/prca.200780018; Buckland AG, 1998, BIOCHEM J, V329, P369; Cabrera-Poch N, 2004, J BIOL CHEM, V279, P28592, DOI 10.1074/jbc.M312242200; CHAP H, 1991, M S-MED SCI, V7, P8, DOI 10.4267/10608/4270; Chmiel JF, 2002, CLIN REV ALLERG IMMU, V23, P5, DOI 10.1385/CRIAI:23:1:005; Choi YA, 2004, EXP MOL MED, V36, P78, DOI 10.1038/emm.2004.11; de Coupade C, 2001, AM J PATHOL, V159, P1435, DOI 10.1016/S0002-9440(10)62530-8; DEBBAGHI A, 1992, J IMMUNOL, V149, P1374; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dudez T, 2008, BBA-MOL CELL RES, V1783, P779, DOI 10.1016/j.bbamcr.2008.01.007; Ganster RW, 2005, J INTERF CYTOK RES, V25, P707, DOI 10.1089/jir.2005.25.707; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Habib A, 2007, FASEB J, V21, P1665, DOI 10.1096/fj.06-6766com; Haggie PM, 2007, J BIOL CHEM, V282, P31422, DOI 10.1074/jbc.M705296200; Harder T, 2007, CURR OPIN IMMUNOL, V19, P470, DOI 10.1016/j.coi.2007.05.002; Hsieh HL, 2008, BBA-MOL CELL RES, V1783, P1563, DOI 10.1016/j.bbamcr.2008.03.016; Hueber AO, 2003, CELL DEATH DIFFER, V10, P7, DOI 10.1038/sj.cdd.4401155; HUGHES LK, 2004, VIRTUAL REPOSITORY C; Jupp OJ, 2003, BIOCHEM J, V374, P453, DOI 10.1042/BJ20030705; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Kim SW, 2001, J BIOL CHEM, V276, P15712, DOI 10.1074/jbc.M009905200; Klapisz E, 2000, J LIPID RES, V41, P1680; Koehler DR, 2004, AM J RESP CELL MOL, V31, P377, DOI 10.1165/rcmb.2004-0124TR; KONSTAN MW, 1993, AM REV RESPIR DIS, V148, P896, DOI 10.1164/ajrccm/148.4_Pt_1.896; Koumanov KS, 2004, SUB CELL BIOCHEM, V37, P153; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; La M, 2001, FASEB J, V15, P2247, DOI 10.1096/fj.01-0196com; Lipecka J, 2006, J PHARMACOL EXP THER, V317, P500, DOI 10.1124/jpet.105.097667; Liu J, 2005, J ALLERGY CLIN IMMUN, V115, P493, DOI 10.1016/j.jaci.2004.11.010; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Medjane S, 2005, AM J PHYSIOL-LUNG C, V289, pL816, DOI 10.1152/ajplung.00466.2004; Meli R, 2000, LIFE SCI, V67, P2845, DOI 10.1016/S0024-3205(00)00871-7; Moon S, 1997, AM J PHYSIOL-LUNG C, V273, pL1208, DOI 10.1152/ajplung.1997.273.6.L1208; Ollero M, 2006, PROTEOMICS, V6, P4084, DOI 10.1002/pmic.200600028; PEREZ A, 2007, CELL MOL PHYSL, V292, pL383; Rao S, 2006, ARCH DIS CHILD, V91, P786, DOI 10.1136/adc.2004.069419; Ratjen F, 2006, PAEDIATR RESPIR REV, V7, pS70, DOI 10.1016/j.prrv.2006.04.170; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rosenstein BJ, 1998, LANCET, V351, P277, DOI 10.1016/S0140-6736(97)09174-5; Rubin BK, 2003, CHEST, V123, P1792, DOI 10.1378/chest.123.6.1792; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; TOUQUI L, 1986, NATURE, V321, P177, DOI 10.1038/321177a0; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; WALLNER BP, 1986, NATURE, V320, P77, DOI 10.1038/320077a0; Wang D, 2008, PFLUG ARCH EUR J PHY, V456, P929, DOI 10.1007/s00424-008-0460-2; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145; Yu H, 2000, INFECT IMMUN, V68, P2142, DOI 10.1128/IAI.68.4.2142-2147.2000	59	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7116	10.1371/journal.pone.0007116	http://dx.doi.org/10.1371/journal.pone.0007116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847291	Green Published, gold, Green Submitted			2022-12-25	WOS:000271022000002
J	Bommer, GT; Feng, Y; Iura, A; Giordano, TJ; Kuick, R; Kadikoy, H; Sikorski, D; Wu, R; Cho, KR; Fearon, ER				Bommer, Guido T.; Feng, Ying; Iura, Ayaka; Giordano, Thomas J.; Kuick, Rork; Kadikoy, Hueseyin; Sikorski, Deanna; Wu, Rong; Cho, Kathleen R.; Fearon, Eric R.			IRS1 Regulation by Wnt/beta-Catenin Signaling and Varied Contribution of IRS1 to the Neoplastic Phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; COLORECTAL-CANCER CELLS; BETA-CATENIN; C-MYC; NUCLEAR TRANSLOCATION; GENE-EXPRESSION; INSULIN-RECEPTOR-SUBSTRATE-1 IRS-1; TUMOR-SUPPRESSOR; BINDING-SITES; COLON-CANCER	Dysregulation of beta-catenin levels and localization and constitutive activation of beta-catenin/TCF (T cell factor)-regulated gene expression occur in many cancers, including the majority of colorectal carcinomas and a subset of ovarian endometrioid adenocarcinomas. Based on the results of microarray-based gene expression profiling we found the insulin receptor substrate 1 (IRS1) gene as one of the most highly up-regulated genes upon ectopic expression of a mutant, constitutively active form of beta-catenin in the rat kidney epithelial cell line RK3E. We demonstrate expression of IRS1 can be directly activated by beta-catenin, likely in part via beta-catenin/TCF binding to TCF consensus binding elements located in the first intron and downstream of the IRS1 transcriptional start site. Consistent with the proposal that beta-catenin is an important regulator of IRS1 expression in vivo, we observed that IRS1 is highly expressed in many cancers with constitutive stabilization of beta-catenin, such as colorectal carcinomas and ovarian endometrioid adenocarcinomas. Using a short hairpin RNA approach to abrogate IRS1 expression and function, we found that IRS1 function is required for efficient de novo neoplastic transformation by beta-catenin in RK3E cells. Our findings add to the growing body of data implicating IRS1 as a critical signaling component in cancer development and progression.	[Fearon, Eric R.] Univ Michigan, Sch Med, Div Mol Med & Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Iura, Ayaka; Giordano, Thomas J.; Wu, Rong; Cho, Kathleen R.; Fearon, Eric R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Fearon, Eric R.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Giordano, Thomas J.; Kuick, Rork; Cho, Kathleen R.; Fearon, Eric R.] Univ Michigan, Ctr Canc, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Fearon, ER (corresponding author), Univ Michigan, Sch Med, Div Mol Med & Genet, Dept Internal Med, 109 Zina Pitcher Pl,1504 BSRB, Ann Arbor, MI 48109 USA.	fearon@umich.edu	Bommer, Guido/A-8425-2011	Bommer, Guido/0000-0001-6898-4884; Cho, Kathleen/0000-0003-0500-9998; Giordano, Thomas/0000-0003-0641-8873; Saito, Ayaka/0000-0002-9916-0463	National Institutes of Health [CA085463, CA094172, RO1CA94172, CA046592]; Region Bruxelles-Capitale [IRSIB BB2B 2008-1-01]; NATIONAL CANCER INSTITUTE [R01CA094172, R01CA085463, P30CA046592] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Region Bruxelles-Capitale; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA085463 (to E. R. F.), CA094172 and RO1CA94172 (to K. R. C.), and CA046592 (to the University of Michigan Comprehensive Cancer Center core facility support), and the Region Bruxelles-Capitale Grant IRSIB BB2B 2008-1-01 (to G. T. B.).	ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Chang Q, 2002, CANCER RES, V62, P6035; Chen J, 2005, J BIOL CHEM, V280, P29912, DOI 10.1074/jbc.M504516200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Cristofanelli B, 2000, ONCOGENE, V19, P3245, DOI 10.1038/sj.onc.1203664; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; DAMBROSIO C, 1995, CELL GROWTH DIFFER, V6, P557; Dearth RK, 2007, CELL CYCLE, V6, P705, DOI 10.4161/cc.6.6.4035; Dearth RK, 2006, MOL CELL BIOL, V26, P9302, DOI 10.1128/MCB.00260-06; Drakas R, 2004, P NATL ACAD SCI USA, V101, P9272, DOI 10.1073/pnas.0403328101; Easton JB, 2006, CANCER CELL, V9, P153, DOI 10.1016/j.ccr.2006.02.027; Feng Y, 2003, CANCER RES, V63, P8726; Feng Y, 2007, CANCER RES, V67, P482, DOI 10.1158/0008-5472.CAN-06-2314; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; Hassan AB, 2000, CANCER RES, V60, P1070; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; Herbst A, 2009, GASTROENTEROLOGY, V137, P639, DOI 10.1053/j.gastro.2009.04.049; Hovanes K, 2001, NAT GENET, V28, P53, DOI 10.1038/88264; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kolligs FT, 2000, GENE DEV, V14, P1319; Kolligs FT, 2002, CANCER CELL, V1, P145, DOI 10.1016/S1535-6108(02)00035-1; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Li X, 2007, ONCOGENE, V26, P4489, DOI 10.1038/sj.onc.1210241; Louro ID, 2002, CANCER RES, V62, P5867; Ma ZF, 2006, MOL CELL BIOL, V26, P9338, DOI 10.1128/MCB.01032-06; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Prisco M, 2002, J BIOL CHEM, V277, P32078, DOI 10.1074/jbc.M204658200; Prokunina-Olsson L, 2009, HUM MOL GENET, V18, P3795, DOI 10.1093/hmg/ddp321; Ramocki NM, 2008, ENDOCRINOLOGY, V149, P261, DOI 10.1210/en.2007-0869; Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Shedden K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-26; Shi B, 2006, J CELL PHYSIOL, V207, P706, DOI 10.1002/jcp.20613; Shi B, 2007, J BIOL CHEM, V282, P32582, DOI 10.1074/jbc.M702806200; Slattery ML, 2004, CANCER EPIDEM BIOMAR, V13, P1206; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Sun HZ, 2008, J CELL PHYSIOL, V215, P725, DOI 10.1002/jcp.21352; Surmacz E, 1995, CLIN CANCER RES, V1, P1429; Tanaka S, 1996, J CLIN INVEST, V98, P2100, DOI 10.1172/JCI119016; Tanaka S, 1996, CANCER RES, V56, P3391; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Tseng YH, 2002, J BIOL CHEM, V277, P31601, DOI 10.1074/jbc.M202932200; Tu X, 2003, HORM METAB RES, V35, P734; Valentinis B, 2001, J CLIN PATHOL-MOL PA, V54, P133, DOI 10.1136/mp.54.3.133; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wu A, 2008, ONCOGENE, V27, P397, DOI 10.1038/sj.onc.1210636; Wu A, 2003, J CELL PHYSIOL, V195, P453, DOI 10.1002/jcp.10261; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08	56	42	43	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					1928	1938		10.1074/jbc.M109.060319	http://dx.doi.org/10.1074/jbc.M109.060319			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19843521	hybrid, Green Published			2022-12-25	WOS:000273429100039
J	Chung, NPY; Breun, SKJ; Bashirova, A; Baumann, JG; Martin, TD; Karamchandani, JM; Rausch, JW; Le Grice, SFJ; Wu, L; Carrington, M; KewalRamani, VN				Chung, Nancy P. Y.; Breun, Sabine K. J.; Bashirova, Arman; Baumann, Joerg G.; Martin, Thomas D.; Karamchandani, Jaideep M.; Rausch, Jason W.; Le Grice, Stuart F. J.; Wu, Li; Carrington, Mary; KewalRamani, Vineet N.			HIV-1 Transmission by Dendritic Cell-specific ICAM-3-grabbing Nonintegrin (DC-SIGN) Is Regulated by Determinants in the Carbohydrate Recognition Domain That Are Absent in Liver/Lymph Node-SIGN (L-SIGN)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C-TYPE LECTIN; RESPIRATORY SYNDROME CORONAVIRUS; T-CELLS; ENDOTHELIAL-CELLS; ADHESION RECEPTOR; STRUCTURAL BASIS; TRANS-INFECTION; BINDING-SITES; DENGUE VIRUS	In this study, we identify determinants in dendritic cell-specific ICAM-3-grabbing nonintegrin (DC-SIGN) necessary for human immunodeficiency virus, type 1 (HIV-1), transmission. Although human B cell lines expressing DC-SIGN efficiently capture and transmit HIV-1 to susceptible target cells, cells expressing the related molecule liver/lymph node-specific ICAM-3-grabbing nonintegrin (L-SIGN) do not. To understand the differences between DC-SIGN and L-SIGN that affect HIV-1 interactions, we developed Raji B cell lines expressing different DC-SIGN/L-SIGN chimeras. Testing of the chimeras demonstrated that replacement of the DC-SIGN carbohydrate-recognition domain (CRD) with that of L-SIGN was sufficient to impair virus binding and prevent transmission. Conversely, the ability to bind and transmit HIV-1 was conferred to L-SIGN chimeras containing the DC-SIGN CRD. We identified Trp-258 in the DC-SIGN CRD to be essential for HIV-1 transmission. Although introduction of a K270W mutation at the same position in L-SIGN was insufficient for HIV-1 binding, an L-SIGN mutant molecule with K270W and a C-terminal DC-SIGN CRD subdomain transmitted HIV-1. These data suggest that DC-SIGN structural elements distinct from the oligosaccharide-binding site are required for HIV-1 glycoprotein selectivity.	[Chung, Nancy P. Y.; Martin, Thomas D.; Karamchandani, Jaideep M.; Rausch, Jason W.; Le Grice, Stuart F. J.; KewalRamani, Vineet N.] NCI, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA; [Breun, Sabine K. J.; Baumann, Joerg G.] Fraunhofer Inst Cell Therapy & Immunol, D-04103 Leipzig, Germany; [Bashirova, Arman; Carrington, Mary] NCI, Canc & Inflammat Program, Expt Immunol Lab, SAIC Frederick,NIH, Frederick, MD 21702 USA; [Wu, Li] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fraunhofer Gesellschaft; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Medical College of Wisconsin	KewalRamani, VN (corresponding author), NCI, HIV Drug Resistance Program, NIH, 1050 Boyles St, Frederick, MD 21702 USA.	vineet@mail.nih.gov	Wu, Li/E-4330-2011; KewalRamani, Vineet/V-5084-2019; Wu, Li/ABB-2813-2020	Wu, Li/0000-0002-5468-2487; Wu, Li/0000-0002-5468-2487; Martin, Thomas/0000-0002-7491-8274	National Institutes of Health [HHSN261200800001E]; NCI Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010791, ZIABC010485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant HHSN261200800001E from NCI, NCI Intramural Research Program, and NCI Center for Cancer Research.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Arrighi JF, 2004, J EXP MED, V200, P1279, DOI 10.1084/jem.20041356; Arrighi JF, 2004, J VIROL, V78, P10848, DOI 10.1128/JVI.78.20.10848-10855.2004; Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Biggins JE, 2004, VIROLOGY, V324, P194, DOI 10.1016/j.virol.2004.03.026; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Geijtenbeek TBH, 1999, BLOOD, V94, P754, DOI 10.1182/blood.V94.2.754.414k11_754_764; Geijtenbeek TBH, 2002, J BIOL CHEM, V277, P11314, DOI 10.1074/jbc.M111532200; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Gurney KB, 2005, J VIROL, V79, P5762, DOI 10.1128/JVI.79.9.5762-5773.2005; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Hong PWP, 2002, J VIROL, V76, P12855, DOI 10.1128/JVI.76.24.12855-12865.2002; Jeffers SA, 2004, P NATL ACAD SCI USA, V101, P15748, DOI 10.1073/pnas.0403812101; Lee B, 2001, J VIROL, V75, P12028, DOI 10.1128/JVI.75.24.12028-12038.2001; Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003; Lozach PY, 2004, J BIOL CHEM, V279, P32035, DOI 10.1074/jbc.M402296200; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Pohlmann S, 2001, TRENDS IMMUNOL, V22, P643, DOI 10.1016/S1471-4906(01)02081-6; Pohlmann S, 2001, J VIROL, V75, P10523, DOI 10.1128/JVI.75.21.10523-10526.2001; Pohlmann S, 2001, J VIROL, V75, P4664, DOI 10.1128/JVI.75.10.4664-4672.2001; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Rappocciolo G, 2006, PLOS PATHOG, V2, P691, DOI 10.1371/journal.ppat.0020070; Sanders RW, 2002, J VIROL, V76, P7812, DOI 10.1128/JVI.76.15.7812-7821.2002; Schaefer M, 2008, J IMMUNOL, V180, P6836, DOI 10.4049/jimmunol.180.10.6836; Snyder GA, 2005, J VIROL, V79, P4589, DOI 10.1128/JVI.79.8.4589-4598.2005; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Trumpfheller C, 2003, INT IMMUNOL, V15, P289, DOI 10.1093/intimm/dxg030; Turville SG, 2001, BLOOD, V98, P2482, DOI 10.1182/blood.V98.8.2482; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; Wang JH, 2007, J VIROL, V81, P2497, DOI 10.1128/JVI.01970-06; Wu L, 2004, VIROLOGY, V318, P17, DOI 10.1016/j.virol.2003.09.028; Wu L, 2002, J VIROL, V76, P5905, DOI 10.1128/JVI.76.12.5905-5914.2002; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Wu Li, 2004, Retrovirology, V1, P14, DOI 10.1186/1742-4690-1-14; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004	50	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2100	2112		10.1074/jbc.M109.030619	http://dx.doi.org/10.1074/jbc.M109.030619			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19833723	Green Published, hybrid			2022-12-25	WOS:000273429100054
J	Edwin, F; Anderson, K; Patel, TB				Edwin, Francis; Anderson, Kimberly; Patel, Tarun B.			HECT Domain-containing E3 Ubiquitin Ligase Nedd4 Interacts with and Ubiquitinates Sprouty2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR RECEPTOR STIMULATION; TUMOR-SUPPRESSOR PTEN; WW DOMAIN; C-TERMINUS; TYROSINE PHOSPHORYLATION; CELL-PROLIFERATION; GENE-EXPRESSION; B-RAF; GROWTH; INHIBITION	Sprouty (Spry) proteins are important regulators of receptor tyrosine kinase signaling in development and disease. Alterations in cellular Spry content have been associated with certain forms of cancers and also in cardiovascular diseases. Thus, understanding the mechanisms that regulate cellular Spry levels are important. Herein, we demonstrate that Spry1 and Spry2, but not Spry3 or Spry4, associate with the HECT domain family E3 ubiquitin ligase, Nedd4. The Spry2/Nedd4 association involves the WW domains of Nedd4 and requires phosphorylation of the Mnk2 kinase sites, Ser(112) and Ser(121), on Spry2. The phospho-Ser(112/121) region on Spry2 that binds WW domains of Nedd4 is a novel non-canonical WW domain binding region that does not contain Pro residues after phospho-Ser. Endogenous and overexpressed Nedd4 polyubiquitinate Spry2 via Lys(48) on ubiquitin and decrease its stability. Silencing of endogenous Nedd4 increased the cellular Spry2 content and attenuated fibroblast growth factor-elicited ERK1/2 activation that was reversed when elevations in Spry2 levels were prevented by Spry2-specific small interfering RNA. Mnk2 silencing decreased Spry2-Nedd4 interactions and also augmented the ability of Spry2 to inhibit fibroblast growth factor signaling. This is the first report demonstrating the regulation of cellular Spry content and its ability to modulate receptor tyrosine kinase signaling by a HECT domain-containing E3 ubiquitin ligase.	[Edwin, Francis; Anderson, Kimberly; Patel, Tarun B.] Loyola Univ Chicago, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA	Loyola University Chicago	Patel, TB (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA.	tpatel7@lumc.edu			National Institutes of Health [GM 073181]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 073181.	Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Ahn Y, 2008, BIOCHEM J, V412, P331, DOI 10.1042/BJ20071403; Aranda S, 2008, MOL CELL BIOL, V28, P5899, DOI 10.1128/MCB.00394-08; Bhandari D, 2007, J BIOL CHEM, V282, P36971, DOI 10.1074/jbc.M705085200; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Bloethner S, 2005, CARCINOGENESIS, V26, P1224, DOI 10.1093/carcin/bgi066; Brady SC, 2009, CANCER RES, V69, P6773, DOI 10.1158/0008-5472.CAN-08-4447; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Chambers D, 2000, MECH DEVELOP, V91, P361, DOI 10.1016/S0925-4773(99)00288-9; Chandramouli S, 2008, J BIOL CHEM, V283, P1679, DOI 10.1074/jbc.M705457200; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Chrestensen CA, 2007, GENES CELLS, V12, P1133, DOI 10.1111/j.1365-2443.2007.01122.x; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Edwin F, 2008, J BIOL CHEM, V283, P3181, DOI 10.1074/jbc.M706567200; Edwin F, 2009, MOL PHARMACOL, V76, P679, DOI 10.1124/mol.109.055848; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Guo CS, 2008, CELL SIGNAL, V20, P1471, DOI 10.1016/j.cellsig.2008.04.001; Guy GR, 2003, J CELL SCI, V116, P3061, DOI 10.1242/jcs.00652; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818; Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Laziz I, 2007, GROWTH FACTORS, V25, P151, DOI 10.1080/08977190701723166; Lee CC, 2004, ONCOGENE, V23, P5193, DOI 10.1038/sj.onc.1207646; Lin W, 2002, MECH DEVELOP, V113, P163, DOI 10.1016/S0925-4773(02)00018-7; Lito P, 2009, J BIOL CHEM, V284, P848, DOI 10.1074/jbc.M808045200; Lo TL, 2006, CANCER LETT, V242, P141, DOI 10.1016/j.canlet.2005.12.032; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Minowada G, 1999, DEVELOPMENT, V126, P4465; Minowada G, 2009, AM J RESP CELL MOL, V40, P31, DOI 10.1165/rcmb.2008-0147OC; Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040; Ng C, 2008, EMBO J, V27, P804, DOI 10.1038/emboj.2008.18; Poppleton HM, 2004, BIOCHEM BIOPH RES CO, V323, P98, DOI 10.1016/j.bbrc.2004.08.070; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; Sutterluty H, 2007, MOL CANCER RES, V5, P509, DOI 10.1158/1541-7786.MCR-06-0273; Sweet SMM, 2008, ANAL CHEM, V80, P6650, DOI 10.1021/ac800963a; Taniguchi K, 2007, BIOCHEM BIOPH RES CO, V352, P896, DOI 10.1016/j.bbrc.2006.11.107; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Warburton David, 2008, Proc Am Thorac Soc, V5, P703, DOI 10.1513/pats.200801-012AW; Weston AD, 2000, MECH DEVELOP, V94, P247, DOI 10.1016/S0925-4773(00)00299-9; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yigzaw Y, 2003, J BIOL CHEM, V278, P284, DOI 10.1074/jbc.M210359200; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Zhang CX, 2005, ARTERIOSCL THROM VAS, V25, P533, DOI 10.1161/01.ATV.0000155461.50450.5a; Zhang SB, 2001, MECH DEVELOP, V109, P367, DOI 10.1016/S0925-4773(01)00526-3	64	35	35	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					255	264		10.1074/jbc.M109.030882	http://dx.doi.org/10.1074/jbc.M109.030882			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864419	Green Published, hybrid			2022-12-25	WOS:000273070100027
J	Bruske, EI; Sendfeld, F; Schneider, A				Bruske, Ellen Inga; Sendfeld, Franziska; Schneider, Andre			Thiolated tRNAs of Trypanosoma brucei Are Imported into Mitochondria and Dethiolated after Import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC TRANSFER-RNA; THIO-MODIFICATION; ANTICODON; SYSTEM; CODON; EUKARYOTES; BIOGENESIS; EXPRESSION; REQUIRES; BASE	All mitochondrial tRNAs in Trypanosoma brucei derive from cytosolic tRNAs that are in part imported into mitochondria. Some trypanosomal tRNAs are thiolated in a compartment-specific manner. We have identified three proteins required for the thio modification of cytosolic tRNA(Gln), tRNA(Glu), and tRNA(Lys). RNA interference-mediated ablation of these proteins results in the cytosolic accumulation non-thio-modified tRNAs but does not increase their import. Moreover, in vitro import experiments showed that both thio-modified and non-thio-modified tRNA(Glu) can efficiently be imported into mitochondria. These results indicate that unlike previously suggested the cytosol-specific thio modifications do not function as antideterminants for mitochondrial tRNA import. Consistent with these results we showed by using inducible expression of a tagged tRNA(Glu) that it is mainly the thiolated form that is imported in vivo. Unexpectedly, the imported tRNA becomes dethiolated after import, which explains why the non-thiolated form is enriched in mitochondria. Finally, we have identified two genes required for thiolation of imported tRNA(Trp) whose wobble nucleotide is subject to mitochondrial C to U editing. Interestingly, down-regulation of thiolation resulted in an increase of edited tRNA(Trp) but did not affect growth.	[Bruske, Ellen Inga; Sendfeld, Franziska; Schneider, Andre] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	University of Bern	Schneider, A (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.	andre.schneider@ibc.unibe.ch			Swiss National Foundation [3100A0_121937]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by Grant 3100A0_121937 (to A. S.) from the Swiss National Foundation.	Adhya S, 2008, INT J BIOCHEM CELL B, V40, P2681, DOI 10.1016/j.biocel.2007.10.025; Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Alfonzo JD, 1999, EMBO J, V18, P7056, DOI 10.1093/emboj/18.24.7056; Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Bouzaidi-Tiali N, 2007, EMBO J, V26, P4302, DOI 10.1038/sj.emboj.7601857; Charriere F, 2006, P NATL ACAD SCI USA, V103, P6847, DOI 10.1073/pnas.0602362103; Crain PF, 2002, RNA, V8, P752, DOI 10.1017/S1355838202022045; Dewez M, 2008, P NATL ACAD SCI USA, V105, P5459, DOI 10.1073/pnas.0709404105; Esseiva AC, 2004, MOL BIOL CELL, V15, P2750, DOI 10.1091/mbc.E03-11-0821; HANCOCK K, 1990, J BIOL CHEM, V265, P19208; HAUSER R, 1995, EMBO J, V14, P4212, DOI 10.1002/j.1460-2075.1995.tb00095.x; HAUSNER TP, 1990, GENE DEV, V4, P2146, DOI 10.1101/gad.4.12a.2146; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; IGLOI GL, 1988, BIOCHEMISTRY-US, V27, P3842, DOI 10.1021/bi00410a048; IGLOI GL, 1987, METHOD ENZYMOL, V155, P433; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kaneko T, 2003, EMBO J, V22, P657, DOI 10.1093/emboj/cdg066; Kapushoc ST, 2000, J BIOL CHEM, V275, P37907, DOI 10.1074/jbc.M007838200; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; McCulloch Richard, 2004, Methods Mol Biol, V262, P53; Nakai Y, 2004, J BIOL CHEM, V279, P12363, DOI 10.1074/jbc.M312448200; Nakai Y, 2008, J BIOL CHEM, V283, P27469, DOI 10.1074/jbc.M804043200; Nakai Y, 2007, MOL CELL BIOL, V27, P2841, DOI 10.1128/MCB.01321-06; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Numata T, 2006, NATURE, V442, P419, DOI 10.1038/nature04896; Paris Z, 2009, RNA, V15, P1398, DOI 10.1261/rna.1589109; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Schneider A, 2001, INT J PARASITOL, V31, P1403, DOI 10.1016/S0020-7519(01)00296-X; Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7; SCHNEIDER A, 1994, NUCLEIC ACIDS RES, V22, P3699, DOI 10.1093/nar/22.18.3699; Schneider A, 1996, NUCLEIC ACIDS RES, V24, P1225, DOI 10.1093/nar/24.7.1225; Schneider Andre, 2007, Methods Mol Biol, V372, P67, DOI 10.1007/978-1-59745-365-3_5; Simpson AGB, 2004, CURR BIOL, V14, pR693, DOI 10.1016/j.cub.2004.08.038; SIMPSON AM, 1989, NUCLEIC ACIDS RES, V17, P5427, DOI 10.1093/nar/17.14.5427; Suzuki T, 2005, TOP CURR GENET, V12, P23, DOI 10.1007/b106361; Tan THP, 2002, MOL CELL BIOL, V22, P3707, DOI 10.1128/MCB.22.11.3707-3716.2002; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Vinogradova E, 2009, NUCLEIC ACIDS RES, V37, P1521, DOI 10.1093/nar/gkn1073; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wohlgamuth-Benedum JM, 2009, J BIOL CHEM, V284, P23947, DOI 10.1074/jbc.M109.029421; Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794	44	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36491	36499		10.1074/jbc.M109.064527	http://dx.doi.org/10.1074/jbc.M109.064527			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19875444	hybrid, Green Published			2022-12-25	WOS:000272970500051
J	Lechauve, C; Bouzhir-Sima, L; Yamashita, T; Marden, MC; Vos, MH; Lieb, U; Kiger, L				Lechauve, Christophe; Bouzhir-Sima, Latifa; Yamashita, Taku; Marden, Michael C.; Vos, Marten H.; Lieb, Ursula; Kiger, Laurent			Heme Ligand Binding Properties and Intradimer Interactions in the Full-length Sensor Protein Dos from Escherichia coli and Its Isolated Heme Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECT OXYGEN SENSOR; REGULATED PHOSPHODIESTERASE; EC DOS; RESONANCE RAMAN; PAS DOMAIN; BRADYRHIZOBIUM-JAPONICUM; CRYSTAL-STRUCTURE; DISTAL SIDE; CATALYSIS; MUTANTS	Dos from Escherichia coli is a bacterial gas sensor protein comprising a heme-containing gas sensor domain and a phosphodiesterase catalytic domain. Using a combination of static light scattering and gel filtration experiments, we established that, as are many other sensor proteins, the full-length protein is dimeric. The full-length dimer (association constant < 10 nM) is more stable than the dimeric heme domain (association constant similar to 1 mu M), and the dimer interface presumably includes both sensor and catalytic domains. Ultrafast spectroscopic studies showed little influence of the catalytic domain on kinetic processes in the direct vicinity of the heme. By contrast, the properties of ligand (CO and O-2) binding to the heme in the sensor domain, occurring on a microsecond to second time scale, were found to be influenced by (i) the presence of the catalytic domain, (ii) the dimerization state, and in dimers, (iii) the ligation state of the other subunit. These results imply allosteric interactions within dimers. Steady-state titrations demonstrated marked cooperativity in oxygen binding to both the full-length protein and the isolated heme domain, a feature not reported to date for any dimeric sensor protein. Analysis of a variety of time-resolved experiments showed that Met-95 plays a major role in the intradimer interactions. The intrinsic binding and dissociation rates of Met-95 to the heme were modulated similar to 10-fold by intradimer and sensor-catalytic domain interactions. Dimerization effects were also observed for cyanide binding to the ferric heme domains, suggesting a similar role for Met-95 in ferric proteins.	[Bouzhir-Sima, Latifa; Yamashita, Taku; Vos, Marten H.; Lieb, Ursula] Ecole Polytech, CNRS, Lab Opt & Biosci, F-91128 Palaiseau, France; [Lechauve, Christophe; Marden, Michael C.; Kiger, Laurent] Univ Paris 06, INSERM, U779, F-94276 Le Kremlin Bicetre, France; [Lechauve, Christophe; Marden, Michael C.; Kiger, Laurent] Univ Paris 11, INSERM, U779, F-94276 Le Kremlin Bicetre, France; [Bouzhir-Sima, Latifa; Yamashita, Taku; Vos, Marten H.; Lieb, Ursula] INSERM, U696, F-91228 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm)	Vos, MH (corresponding author), Ecole Polytech, CNRS, Lab Opt & Biosci, F-91128 Palaiseau, France.	marten.vos@polytechnique.edu; Laurent.Kiger@inserm.fr	Marden, Michael C/G-3139-2012; Lechauve, Christophe/AAH-8873-2019; Kiger, Laurent/Q-1686-2018; Marden, Michael/AAA-5923-2020	Marden, Michael C/0000-0002-5254-6385; Vos, Marten/0000-0003-0493-4831; LIEBL, Ursula/0000-0003-0869-4388	INSERM; De legation Generale pour l'Armement (DGA) [07.34.004]; Universites Paris VI et XI	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); De legation Generale pour l'Armement (DGA); Universites Paris VI et XI	This work was supported by INSERM, De legation Generale pour l'Armement (DGA) Contract 07.34.004, and Universites Paris VI et XI.	Ayers RA, 2008, BIOCHEMISTRY-US, V47, P12078, DOI 10.1021/bi801254c; Balland V, 2005, J BIOL CHEM, V280, P15279, DOI 10.1074/jbc.M413928200; Chan MK, 2001, CURR OPIN CHEM BIOL, V5, P216, DOI 10.1016/S1367-5931(00)00193-9; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Cusanovich MA, 2003, BIOCHEMISTRY-US, V42, P4759, DOI 10.1021/bi020690e; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; El-Mashtoly SF, 2008, J BIOL CHEM, V283, P19000, DOI 10.1074/jbc.M801262200; El-Mashtoly SF, 2007, J AM CHEM SOC, V129, P3556, DOI 10.1021/ja0669777; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; GILLESGONZALEZ MA, 1994, BIOCHEMISTRY-US, V33, P8067, DOI 10.1021/bi00192a011; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; Gonzalez G, 2002, BIOCHEMISTRY-US, V41, P8414, DOI 10.1021/bi025845x; Hao B, 2002, BIOCHEMISTRY-US, V41, P12952, DOI 10.1021/bi020144l; HAYASHI A, 1973, BIOCHIM BIOPHYS ACTA, V310, P309, DOI 10.1016/0005-2795(73)90110-4; Hirata S, 2003, EUR J BIOCHEM, V270, P4771, DOI 10.1046/j.1432-1033.2003.03879.x; Ishitsuka Y, 2008, BIOCHEMISTRY-US, V47, P8874, DOI 10.1021/bi800248c; Ito S, 2009, J INORG BIOCHEM, V103, P989, DOI 10.1016/j.jinorgbio.2009.04.009; Jain R, 2003, J BIOL INORG CHEM, V8, P1, DOI 10.1007/s00775-002-0405-8; Kurokawa H, 2004, J BIOL CHEM, V279, P20186, DOI 10.1074/jbc.M314199200; Liebl U, 2003, BIOCHEMISTRY-US, V42, P6527, DOI 10.1021/bi027359f; Liebl U, 2002, P NATL ACAD SCI USA, V99, P12771, DOI 10.1073/pnas.192311699; Park HJ, 2004, BIOCHEMISTRY-US, V43, P2738, DOI 10.1021/bi035980p; Royer WE, 1997, J BIOL CHEM, V272, P5689, DOI 10.1074/jbc.272.9.5689; Sasakura Y, 2006, ACCOUNTS CHEM RES, V39, P37, DOI 10.1021/ar0501525; Sasakura Y, 2002, J BIOL CHEM, V277, P23821, DOI 10.1074/jbc.M202738200; Sato A, 2002, J BIOL CHEM, V277, P32650, DOI 10.1074/jbc.M204559200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taguchi S, 2004, J BIOL CHEM, V279, P3340, DOI 10.1074/jbc.M301013200; Takahashi H, 2006, CHEM LETT, V35, P970, DOI 10.1246/cl.2006.970; Tanaka A, 2007, J BIOL CHEM, V282, P21301, DOI 10.1074/jbc.M701920200; Tanaka A, 2008, BIOCHEMISTRY-US, V47, P13438, DOI 10.1021/bi8012017; Tomita T, 2002, BIOCHEMISTRY-US, V41, P4819, DOI 10.1021/bi0158831; Uzan J, 2004, BIOPHYS J, V87, P1196, DOI 10.1529/biophysj.104.042168; Vos MH, 2008, BIOCHEMISTRY-US, V47, P5718, DOI 10.1021/bi800288z; Watanabe M, 2002, BIOCHEM BIOPH RES CO, V299, P169, DOI 10.1016/S0006-291X(02)02621-9; Yamashita T, 2008, J BIOL CHEM, V283, P2344, DOI 10.1074/jbc.M708123200; Yoshimura T, 2003, J BIOL CHEM, V278, P53105, DOI 10.1074/jbc.M304408200; Yoshimura-Suzuki T, 2005, J BACTERIOL, V187, P6678, DOI 10.1128/JB.187.19.6678-6682.2005	38	23	24	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36146	36159		10.1074/jbc.M109.066811	http://dx.doi.org/10.1074/jbc.M109.066811			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19864414	Green Published, hybrid			2022-12-25	WOS:000272970500016
J	Li, B; Xi, HK; Diehl, L; Lee, WP; Sturgeon, L; Chinn, J; DeForge, L; Kelley, RF; Wiesmann, C; Campagne, MV; Sidhu, SS				Li, Bing; Xi, Hongkang; Diehl, Lauri; Lee, Wyne P.; Sturgeon, Lizette; Chinn, Jason; DeForge, Laura; Kelley, Robert F.; Wiesmann, Christian; Campagne, Menno van Lookeren; Sidhu, Sachdev S.			Improving Therapeutic Efficacy of a Complement Receptor by Structure-based Affinity Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALTERNATIVE PATHWAY; CONFORMATIONAL-CHANGES; 2 PARTS; IMMUNOLOGY; CONVERTASE; ACTIVATION; ARTHRITIS; SELECTION; INSIGHTS; DISEASES	CRIg is a recently discovered complement C3 receptor expressed on a subpopulation of tissue-resident macrophages. The extracellular IgV domain of CRIg (CRIg-ECD) holds considerable promise as a potential therapeutic because it selectively inhibits the alternative pathway of complement by binding to C3b and inhibiting proteolytic activation of C3 and C5. However, CRIg binds weakly to the convertase subunit C3b (K-D = 1.1 mu M), and thus a relatively high concentration of protein is required to reach nearly complete complement inhibition. To improve therapeutic efficacy while minimizing risk of immunogenicity, we devised a phage display strategy to evolve a high affinity CRIg-ECD variant with a minimal number of mutations. Using the crystal structure of CRIg in complex with C3b as a guide for library design, we isolated a CRIg-ECD double mutant (Q64R/M86Y, CRIg-v27) that showed increased binding affinity and improved complement inhibitory activity relative to CRIg-ECD. In a mouse model of arthritis, treatment with a Fc fusion of CRIg-v27 resulted in a significant reduction in clinical scores compared with treatment with an Fc fusion of CRIg-ECD. This study clearly illustrates how phage display technology and structural information can be combined to generate proteins with nearly natural sequences that act as potent complement inhibitors with greatly improved therapeutic efficacy.	[Xi, Hongkang; Lee, Wyne P.; Campagne, Menno van Lookeren] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Kelley, Robert F.] Genentech Inc, Dept Antibody Engn, San Francisco, CA 94080 USA; [Diehl, Lauri] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Sturgeon, Lizette; Chinn, Jason; DeForge, Laura] Genentech Inc, Dept Assay & Automat Technol, San Francisco, CA 94080 USA; [Wiesmann, Christian] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Sidhu, Sachdev S.] Univ Toronto, Banting & Best Dept Med Res, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; University of Toronto	Campagne, MV (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	menno@gene.com; sachdev.sidhu@utoronto.ca		Wiesmann, Christian/0000-0002-4092-9880				Barthelemy PA, 2008, J BIOL CHEM, V283, P3639, DOI 10.1074/jbc.M708536200; Fellouse FAS, 2007, MAKING USING ANTIBOD, P157; Gotze O, 1976, Adv Immunol, V24, P1, DOI 10.1016/S0065-2776(08)60328-4; Gros P, 2008, NAT REV IMMUNOL, V8, P48, DOI 10.1038/nri2231; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Janssen BJC, 2007, J BIOL CHEM, V282, P29241, DOI 10.1074/jbc.M704587200; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Jha P, 2007, MOL IMMUNOL, V44, P3901, DOI 10.1016/j.molimm.2007.06.145; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Katschke KJ, 2007, J EXP MED, V204, P1319, DOI 10.1084/jem.20070432; Katschke KJ, 2009, J BIOL CHEM, V284, P10473, DOI 10.1074/jbc.M809106200; Kim DD, 2006, CLIN IMMUNOL, V118, P127, DOI 10.1016/j.clim.2005.10.014; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Maccioni M, 2002, J EXP MED, V195, P1071, DOI 10.1084/jem.20011941; MULLEREBERHARD HJ, 1972, J EXP MED, V135, P1003, DOI 10.1084/jem.135.4.1003; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Torreira E, 2009, P NATL ACAD SCI USA, V106, P882, DOI 10.1073/pnas.0810860106; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263	23	8	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35605	35611		10.1074/jbc.M109.035170	http://dx.doi.org/10.1074/jbc.M109.035170			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19833734	Green Published, hybrid			2022-12-25	WOS:000272645600038
J	Yi, SJ; Groffen, J; Heisterkamp, N				Yi, Sun-Ju; Groffen, John; Heisterkamp, Nora			Transglutaminase 2 Regulates the GTPase-activating Activity of Bcr	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE TRANSGLUTAMINASE; RHO-GTPASES; TRANSAMIDATION ACTIVITY; SIGNALING PATHWAY; IN-VIVO; PROTEIN; BINDING; CELLS; ABR; MACROPHAGES	Transglutaminase 2 (TG2) is a multifunctional protein that has been implicated in numerous pathologies including that of neurodegeneration and celiac disease, but the molecular interactions that mediate its diverse activities are largely unknown. Bcr and the closely related Abr negatively regulate the small G-protein Rac:loss of their combined function in vivo results in increased reactivity of innate immune cells. Bcr and Abr are GTPase-activating proteins that catalyze the hydrolysis of the GTP bound to Rac. However, how the Bcr and Abr GTPase-activating activity is regulated is not precisely understood. We here report a novel mechanism of regulation through direct protein-protein interaction with TG2. TG2 bound to the Rac-binding pocket in the GTPase-activating domains of Bcr and Abr, blocked Bcr activity and, through this mechanism, increased levels of active GTP-bound Rac and EGF-stimulated membrane ruffling. TG2 exists in at least two different conformations. Interestingly, experiments using TG2 mutants showed that Bcr exhibits preferential binding to the non-compacted conformation of TG2, in which its catalytic domain is exposed, but trans-amidation is not needed for the interaction. Thus, TG2 regulates levels of cellular GTP-bound Rac and actin cytoskeletal reorganization through a new mechanism involving direct inhibition of Bcr GTPase-activating activity.	[Yi, Sun-Ju; Groffen, John; Heisterkamp, Nora] Childrens Hosp Los Angeles, Div Hematol Oncol, Sect Mol Carcinogenesis, Los Angeles, CA 90027 USA; [Yi, Sun-Ju; Groffen, John; Heisterkamp, Nora] Childrens Hosp, Saban Res Inst, Los Angeles, CA 90027 USA; [Groffen, John; Heisterkamp, Nora] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California	Heisterkamp, N (corresponding author), Childrens Hosp Los Angeles, Div Hematol Oncol, Sect Mol Carcinogenesis, Ms 54,4650 Sunset Blvd, Los Angeles, CA 90027 USA.	heisterk@hsc.usc.edu	Heisterkamp, Nora/C-1698-2012	Heisterkamp, Nora/0000-0003-2769-2273	Public Health Service, National Institutes of Health [HL071945, HL060231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL060231, R01HL071945] Funding Source: NIH RePORTER	Public Health Service, National Institutes of Health(United States Department of Health & Human ServicesUnited States Public Health ServiceNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by Public Health Service, National Institutes of Health, Grants HL071945 and HL060231.	Antonyak MA, 2009, J BIOL CHEM, V284, P17914, DOI 10.1074/jbc.M109.013037; Baek KJ, 2001, J BIOL CHEM, V276, P5591, DOI 10.1074/jbc.M008252200; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Benard V, 2002, METHOD ENZYMOL, V345, P349; Bernards A, 2005, GROWTH FACTORS, V23, P143, DOI 10.1080/08977190500130480; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Cho YJ, 2005, BIOCHEM BIOPH RES CO, V333, P1276, DOI 10.1016/j.bbrc.2005.06.030; Cho YJ, 2007, MOL CELL BIOL, V27, P899, DOI 10.1128/MCB.00756-06; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; Cunnick JM, 2009, MOL CELL BIOL, V29, P5742, DOI 10.1128/MCB.00357-09; Dai Y, 2008, J PHARMACOL EXP THER, V326, P153, DOI 10.1124/jpet.107.135046; Datta S, 2006, BIOCHEMISTRY-US, V45, P13163, DOI 10.1021/bi0606795; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; Feng JF, 1999, BIOCHEMISTRY-US, V38, P10743, DOI 10.1021/bi9905009; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Griffin M, 2002, BIOCHEM J, V368, P377, DOI 10.1042/BJ20021234; Guilluy C, 2007, J BIOL CHEM, V282, P2918, DOI 10.1074/jbc.M604195200; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HEISTERKAMP N, 2001, CHRONIC MYELOID LEUK, P3; Janiak A, 2006, MOL BIOL CELL, V17, P1606, DOI 10.1091/mbc.E05-06-0549; Kaartinen V, 2001, DEVELOPMENT, V128, P4217; Kweon SM, 2008, J BIOL CHEM, V283, P3023, DOI 10.1074/jbc.M705513200; Lahoz A, 2008, GENE DEV, V22, P1724, DOI 10.1101/gad.1691408; Liu SP, 2002, P NATL ACAD SCI USA, V99, P2743, DOI 10.1073/pnas.042454899; Mishra S, 2003, ONCOGENE, V22, P8255, DOI 10.1038/sj.onc.1207156; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; NOH DY, 1995, BBA-REV CANCER, V1242, P99, DOI 10.1016/0304-419X(95)00006-0; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Singh US, 2001, EMBO J, V20, P2413, DOI 10.1093/emboj/20.10.2413; Toth B, 2009, J IMMUNOL, V182, P2084, DOI 10.4049/jimmunol.0803444; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Yi SJ, 2004, BIOCHEM BIOPH RES CO, V325, P819, DOI 10.1016/j.bbrc.2004.10.122; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863	36	9	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35645	35651		10.1074/jbc.M109.062240	http://dx.doi.org/10.1074/jbc.M109.062240			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19840940	Green Published, hybrid			2022-12-25	WOS:000272645600042
J	Liu, M; Wan, ZL; Chu, YC; Aladdin, H; Klaproth, B; Choquette, M; Hua, QX; Mackin, RB; Rao, JS; De Meyts, P; Katsoyannis, PG; Arvan, P; Weiss, MA				Liu, Ming; Wan, Zhu-li; Chu, Ying-Chi; Aladdin, Hassan; Klaproth, Birgit; Choquette, Meredith; Hua, Qing-xin; Mackin, Robert B.; Rao, J. Sunil; De Meyts, Pierre; Katsoyannis, Panayotis G.; Arvan, Peter; Weiss, Michael A.			Crystal Structure of a "Nonfoldable" Insulin IMPAIRED FOLDING EFFICIENCY DESPITE NATIVE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GROWTH-FACTOR-I; DISULFIDE-FORMING PATHWAY; RECEPTOR-BINDING SURFACE; PANCREATIC BETA-CELLS; A20-A21 PEPTIDE-BOND; AKITA DIABETIC MOUSE; ENDOPLASMIC-RETICULUM; BIOLOGICAL-ACTIVITY; HUMAN PROINSULIN; POSSIBLE INVOLVEMENT	Protein evolution is constrained by folding efficiency ("foldability") and the implicit threat of toxic misfolding. A model is provided by proinsulin, whose misfolding is associated with beta-cell dysfunction and diabetes mellitus. An insulin analogue containing a subtle core substitution (Leu(A16) -> Val) is biologically active, and its crystal structure recapitulates that of the wild-type protein. As a seeming paradox, however, Val(A16) blocks both insulin chain combination and the in vitro refolding of proinsulin. Disulfide pairing in mammalian cell culture is likewise inefficient, leading to misfolding, endoplasmic reticular stress, and proteosome-mediated degradation. Val(A16) destabilizes the native state and so presumably perturbs a partial fold that directs initial disulfide pairing. Substitutions elsewhere in the core similarly destabilize the native state but, unlike Val(A16), preserve folding efficiency. We propose that Leu(A16) stabilizes nonlocal interactions between nascent alpha-helices in the A-and B-domains to facilitate initial pairing of Cys(A20) and Cys(B19), thus surmounting their wide separation in sequence. Although Val(A16) is likely to destabilize this proto-core, its structural effects are mitigated once folding is achieved. Classical studies of insulin chain combination in vitro have illuminated the impact of off-pathway reactions on the efficiency of native disulfide pairing. The capability of a polypeptide sequence to fold within the endoplasmic reticulum may likewise be influenced by kinetic or thermodynamic partitioning among on-and off-pathway disulfide intermediates. The properties of [Val(A16)] insulin and [Val(A16)] proinsulin demonstrate that essential contributions of conserved residues to folding may be inapparent once the native state is achieved.	[Liu, Ming; Arvan, Peter] Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Wan, Zhu-li; Hua, Qing-xin; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Chu, Ying-Chi; Katsoyannis, Panayotis G.] NYU, Dept Pharmacol & Biol Chem, Mt Sinai Sch Med, New York, NY 10029 USA; [Aladdin, Hassan; Klaproth, Birgit; De Meyts, Pierre] Hagedorn Res Inst, Receptor Syst Biol Lab, DK-2820 Gentofte, Denmark; [Choquette, Meredith; Mackin, Robert B.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Rao, J. Sunil] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; Case Western Reserve University; Icahn School of Medicine at Mount Sinai; New York University; Novo Nordisk; Hagedorn Research Institute; Creighton University; Case Western Reserve University	Arvan, P (corresponding author), Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	parvan@umichigan.edu; michael.weiss@case.edu		De Meyts, Pierre/0000-0001-6214-0824; Liu, Ming/0000-0003-2665-4072	National Institutes of Health [DK052085, DK48280, DK56673, DK0697674]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048280, R01DK052085, R01DK056673] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK052085 (to R.B.M.), DK48280 (to P.A.), DK56673 (to P.G.K.), and DK0697674 (to M.A.W.). This work was also supported by the American Diabetes Association (to M.A.W.). This article is a contribution from the Cleveland Center for Membrane and Structural Biology.	BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BALDWIN TO, 1993, J BIOL CHEM, V268, P10766; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; BREMS DN, 1990, BIOCHEMISTRY-US, V29, P9289, DOI 10.1021/bi00491a026; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzozowski AM, 2002, BIOCHEMISTRY-US, V41, P9389, DOI 10.1021/bi020084j; Chance R. E., 1981, PEPTIDES SYNTHESIS S, P721; CHU YC, 1987, BIOCHEMISTRY-US, V26, P6966, DOI 10.1021/bi00396a016; CHU YC, 1987, BIOCHEMISTRY-US, V26, P6975, DOI 10.1021/bi00396a018; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Creighton TE, 1997, BIOL CHEM, V378, P731; Dai Y, 1996, BBA-PROTEIN STRUCT M, V1296, P63, DOI 10.1016/0167-4838(96)00054-4; DILL KA, 1997, NAT STRUCT BIOL, V4, P19, DOI DOI 10.1038/NSB0197-10; Dinner AR, 1999, PROTEINS, V35, P34, DOI 10.1002/(SICI)1097-0134(19990401)35:1<34::AID-PROT4>3.0.CO;2-Q; Dobson Christopher M., 1999, Current Opinion in Structural Biology, V9, P92, DOI 10.1016/S0959-440X(99)80012-8; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; ERIKSSON AE, 1992, SCIENCE, V255, P178, DOI 10.1126/science.1553543; Feng YG, 2003, J MOL BIOL, V330, P821, DOI 10.1016/S0022-2836(03)00660-0; FRANK BH, 1972, DIABETES, V21, P486, DOI 10.2337/diab.21.2.S486; FRANK BH, 1968, BIOCHEM BIOPH RES CO, V32, P155, DOI 10.1016/0006-291X(68)90362-8; FRANK BH, 1983, MUNCH MED WSCHR S1, V125, pS14; GALLOWAY JA, 1992, DIABETES CARE, V15, P666, DOI 10.2337/diacare.15.5.666; Guo ZY, 2001, BIOL CHEM, V382, P443, DOI 10.1515/BC.2001.054; HOBER S, 1992, BIOCHEMISTRY-US, V31, P1749, DOI 10.1021/bi00121a024; HOBER S, 1994, BIOCHEMISTRY-US, V33, P6758, DOI 10.1021/bi00188a003; Hober S, 1997, BIOCHEMISTRY-US, V36, P4616, DOI 10.1021/bi9611265; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 2006, J BIOL CHEM, V281, P28131, DOI 10.1074/jbc.M602616200; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; Hua QX, 1996, J MOL BIOL, V259, P297, DOI 10.1006/jmbi.1996.0320; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Hua QX, 2002, J BIOL CHEM, V277, P43443, DOI 10.1074/jbc.M206107200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; Hua QX, 2001, BIOCHEMISTRY-US, V40, P12299, DOI 10.1021/bi011021o; HUANG XF, 1995, J BIOL CHEM, V270, P20417, DOI 10.1074/jbc.270.35.20417; HUANG XF, 1994, J BIOL CHEM, V269, P20838; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Jia XY, 2003, PROTEIN SCI, V12, P2412, DOI 10.1110/ps.0389303; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; KATSOYANNIS PG, 1966, SCIENCE, V154, P1509, DOI 10.1126/science.154.3756.1509; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2003, J BIOL CHEM, V278, P14798, DOI 10.1074/jbc.M212070200; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Mackin RB, 2003, PROTEIN EXPRES PURIF, V27, P210, DOI 10.1016/S1046-5928(02)00643-5; MILLER JA, 1993, BIOCHEMISTRY-US, V32, P5203, DOI 10.1021/bi00070a032; Milner SJ, 1999, BIOTECHNOL BIOENG, V62, P693; Mirny LA, 1998, P NATL ACAD SCI USA, V95, P4976, DOI 10.1073/pnas.95.9.4976; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; NARHI LO, 1993, BIOCHEMISTRY-US, V32, P5214, DOI 10.1021/bi00070a033; Oliveberg M, 2005, Q REV BIOPHYS, V38, P245, DOI 10.1017/S0033583506004185; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Onuchic JN, 1996, FOLD DES, V1, P441, DOI 10.1016/S1359-0278(96)00060-0; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Pace CN, 2000, PROTEINS, P1; PADMANABHAN S, 1990, NATURE, V344, P268, DOI 10.1038/344268a0; PEKAR AH, 1972, BIOCHEMISTRY-US, V11, P4013, DOI 10.1021/bi00772a001; Qiao ZS, 2003, J BIOL CHEM, V278, P17800, DOI 10.1074/jbc.M300906200; Qiao ZS, 2001, BIOCHEMISTRY-US, V40, P2662, DOI 10.1021/bi001613r; Ron D, 2002, J CLIN INVEST, V109, P443, DOI 10.1172/JC1200215020; ROY M, 1990, J BIOL CHEM, V265, P5448; SHAKHNOVICH E, 1991, PHYS REV LETT, V67, P1665, DOI 10.1103/PhysRevLett.67.1665; SIEBER P, 1978, H-S Z PHYSIOL CHEM, V359, P113; SNELL CR, 1975, J BIOL CHEM, V250, P6291; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Steiner D F, 1969, Recent Prog Horm Res, V25, P207; STEINER DF, 1978, DIABETES, V27, P145, DOI 10.2337/diab.27.1.S145; STEINER DF, 1988, HORM METAB RES, V20, P443, DOI 10.1055/s-2007-1010855; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STEINER DF, 1967, T NEW YORK ACAD SCI, V30, P60, DOI 10.1111/j.2164-0947.1967.tb02452.x; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; TANG JG, 1990, BIOCHEM J, V268, P429, DOI 10.1042/bj2680429; Tiana G, 2000, PROTEINS, V39, P244, DOI 10.1002/(SICI)1097-0134(20000515)39:3<244::AID-PROT70>3.0.CO;2-#; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Vajdos FF, 2001, BIOCHEMISTRY-US, V40, P11022, DOI 10.1021/bi0109111; van den Akker F, 1999, ACTA CRYSTALLOGR D, V55, P206, DOI 10.1107/S0907444998007161; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wang Y, 2001, BIOTECHNOL BIOENG, V73, P74, DOI 10.1002/1097-0290(20010405)73:1<74::AID-BIT1038>3.0.CO;2-V; WEISS MA, 1990, BIOCHEMISTRY-US, V29, P8389, DOI 10.1021/bi00488a028; Weiss MA, 2002, BIOCHEMISTRY-US, V41, P809, DOI 10.1021/bi011839+; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; Weiss MA, 2001, J BIOL CHEM, V276, P40018, DOI 10.1074/jbc.M104634200; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Xu B, 2002, PROTEIN SCI, V11, P104, DOI 10.1110/ps.ps.32102; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Xu JA, 1998, PROTEIN SCI, V7, P158, DOI 10.1002/pro.5560070117; Yan H, 2003, PROTEIN SCI, V12, P768, DOI 10.1110/ps.0237203; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang ZJ, 2008, PROTEIN J, V27, P192, DOI 10.1007/s10930-007-9124-x; Zuber C, 2004, FASEB J, V18, P917, DOI 10.1096/fj.03-1210fje	107	27	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35259	35272		10.1074/jbc.M109.046888	http://dx.doi.org/10.1074/jbc.M109.046888			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19850922	hybrid, Green Published			2022-12-25	WOS:000272439600078
J	Nahid, MA; Pauley, KM; Satoh, M; Chan, EKL				Nahid, Md A.; Pauley, Kaleb M.; Satoh, Minoru; Chan, Edward K. L.			miR-146a Is Critical for Endotoxin-induced Tolerance IMPLICATION IN INNATE IMMUNITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; RECEPTOR-ASSOCIATED KINASE; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; HUMAN MONOCYTES; SIGNALING PROTEINS; MONONUCLEAR-CELLS; DOWN-REGULATION; INDUCTION; LIPOPOLYSACCHARIDE	The human toll-like receptor 4 (TLR4) pathway is activated in response to lipopolysaccharide (LPS), and subsequent signal transductions lead to the production of cytokines such as tumor necrosis factor-alpha (TNF-alpha) by innate immune cells. Defects in innate immune response may contribute to the overproduction of TNF-alpha leading to systemic inflammation and diseases. Thus, the innate immune response needs to be tightly regulated by elaborate mechanisms to control its onset and termination. LPS tolerance is a state of hyporesponsiveness to subsequent LPS challenge and is achieved by monocytic cells after prolonged exposure to LPS. In this report, kinetics of endotoxin-responsive microRNAs expression analysis revealed a unique pattern of gradual increase for miR-146a starting 4 h after LPS stimulation in THP-1 cells and continued up to 35-fold over 24 h. Conversely, TNF-alpha increased up to 4 h and then decreased gradually implicating a negative correlation with miR-146a progression. The characteristic up-regulation of miR-146a toward subsequent LPS challenge in THP-1 cells was studied. Strikingly, microRNA expression analysis during the tolerized state of THP-1 cells showed only miR-146a overexpression suggesting its important role in LPS tolerance. In addition, LPS tolerance was dependent on a LPS-priming dose and associated miR-146a up-regulation. LPS-tolerized cells were observed to regain responsiveness in TNF-alpha production 22 h after LPS removal correlating with a decrease in miR-146a level. Transfection of miR-146a into THP-1 cells mimicked LPS priming, whereas transfection of miR-146a inhibitor largely abolished LPS tolerance. Thus our studies demonstrated that miR-146a is critical for the in vitro monocytic cell-based endotoxin tolerance.	[Nahid, Md A.; Pauley, Kaleb M.; Chan, Edward K. L.] Univ Florida, Dept Oral Biol, Gainesville, FL 32610 USA; [Pauley, Kaleb M.] Univ Florida, Dept Oral & Maxillofacial Diagnost Sci, Gainesville, FL 32610 USA; [Satoh, Minoru] Univ Florida, Dept Med, Div Clin Immunol & Rheumatol, Gainesville, FL 32610 USA; [Satoh, Minoru] Univ Florida, Dept Pathol, Div Clin Immunol & Rheumatol, Gainesville, FL 32610 USA; [Satoh, Minoru] Univ Florida, Dept Immunol, Div Clin Immunol & Rheumatol, Gainesville, FL 32610 USA; [Satoh, Minoru] Univ Florida, Dept Lab Med, Div Clin Immunol & Rheumatol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Chan, EKL (corresponding author), 1600 SW Archer Rd, Gainesville, FL 32610 USA.	echan@ufl.edu	Satoh, Minoru/E-2421-2011; Chan, Edward K. L./B-5671-2009	Chan, Edward K. L./0000-0003-3938-9503	National Institutes of Health (NIH) [AI47859]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI047859, R01AI047859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [T32DE007200] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by National Institutes of Health (NIH) Grant AI47859. This work was also supported by a grant from the Lupus Research Institute.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; BEESON PB, 1947, J EXP MED, V86, P29, DOI 10.1084/jem.86.1.29; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; BEUTLER B, 1987, NEW ENGL J MED, V316, P379; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Cavaillon JM, 2003, J ENDOTOXIN RES, V9, P101, DOI 10.1179/096805103125001487; Chan EKL, 2009, ARTHRITIS RHEUM, V60, P912, DOI 10.1002/art.24421; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; HAAS JG, 1990, P NATL ACAD SCI USA, V87, P9563, DOI 10.1073/pnas.87.24.9563; Heagy W, 2003, SHOCK, V19, P321, DOI 10.1097/00024382-200304000-00005; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Jacinto R, 2002, J IMMUNOL, V168, P6136, DOI 10.4049/jimmunol.168.12.6136; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; LARUE KEA, 1994, J EXP MED, V180, P2269, DOI 10.1084/jem.180.6.2269; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONNEMANN G, 1989, EUR J IMMUNOL, V19, P1531, DOI 10.1002/eji.1830190903; Mastroeni P, 1999, INFECT IMMUN, V67, P478, DOI 10.1128/IAI.67.2.478-483.1999; MATHISON JC, 1990, J CLIN INVEST, V85, P1108, DOI 10.1172/JCI114542; MCCALL CE, 1993, J CLIN INVEST, V91, P853, DOI 10.1172/JCI116306; Medvedev AE, 2001, J IMMUNOL, V167, P2257, DOI 10.4049/jimmunol.167.4.2257; Murphey ED, 2007, SHOCK, V27, P289, DOI 10.1097/01.shk.0000245024.93740.28; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Perry MM, 2008, J IMMUNOL, V180, P5689, DOI 10.4049/jimmunol.180.8.5689; RANDOW F, 1995, J EXP MED, V181, P1887, DOI 10.1084/jem.181.5.1887; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; Shishodia S, 2002, J BIOCHEM MOL BIOL, V35, P28; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang YJ, 2009, ARTHRITIS RHEUM-US, V60, P1065, DOI 10.1002/art.24436; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Ulevitch R J, 1989, Prog Clin Biol Res, V299, P193; West MA, 2002, CRIT CARE MED, V30, pS64, DOI 10.1097/00003246-200201001-00009; ZIEGLERHEITBROCK HWL, 1992, IMMUNOLOGY, V75, P264; ZUCKERMAN SH, 1989, J IMMUNOL, V143, P1223	45	312	331	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34590	34599		10.1074/jbc.M109.056317	http://dx.doi.org/10.1074/jbc.M109.056317			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840932	hybrid, Green Published			2022-12-25	WOS:000272439600014
J	Nelson, TJ; Cui, CH; Luo, Y; Alkon, DL				Nelson, Thomas J.; Cui, Changhai; Luo, Yuan; Alkon, Daniel L.			Reduction of beta-Amyloid Levels by Novel Protein Kinase C epsilon Activators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; REGULATED SECRETION; CONVERTING-ENZYME; PKC-EPSILON; ALPHA; CLEAVAGE; BINDING; DELTA; PHOSPHORYLATION; BRYOSTATIN-1	Isoform-specific protein kinase C (PKC) activators may be useful as therapeutic agents for the treatment of Alzheimer disease. Three new epsilon-specific PKC activators, made by cyclopropanation of polyunsaturated fatty acids, have been developed. These activators, AA-CP4, EPA-CP5, and DHA-CP6, activate PKC epsilon in a dose-dependent manner. Unlike PKC activators that bind to the 1,2-diacylglycerol-binding site, such as bryostatin and phorbol esters, which produce prolonged down-regulation, the new activators produced sustained activation of PKC. When applied to cells expressing human APPSwe/PS1 delta, which produce large quantities of beta-amyloid peptide (A beta), DCP-LA and DHA-CP6 reduced the intracellular and secreted levels of A beta by 60-70%. In contrast to the marked activation of alpha-secretase produced by PKC activators in fibroblasts, the PKC activators produced only a moderate and transient activation of alpha-secretase in neuronal cells. However, they activated endothelin-converting enzyme to 180% of control levels, suggesting that the A beta-lowering ability of these PKC epsilon activators is caused by increasing the rate of A beta degradation by endothelin-converting enzyme and not by activating nonamyloidogenic amyloid precursor protein metabolism.	[Nelson, Thomas J.; Cui, Changhai; Alkon, Daniel L.] Blanchette Rockefeller Neurosci Inst, Morgantown, WV 26506 USA; [Luo, Yuan] Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Nelson, TJ (corresponding author), Blanchette Rockefeller Neurosci Inst, 8 Med Ctr Dr, Morgantown, WV 26506 USA.	tjnelson@brneurosci.org						Ahmed Z, 2006, FASEB J, V20, P1939, DOI 10.1096/fj.05-5339fje; Barnes PJ, 1997, LIFE SCI, V60, P1015, DOI 10.1016/S0024-3205(97)00042-8; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; Caccamo A, 2006, NEURON, V49, P671, DOI 10.1016/j.neuron.2006.01.020; Choi DS, 2006, P NATL ACAD SCI USA, V103, P8215, DOI 10.1073/pnas.0509725103; Silva OABDE, 2009, J NEUROCHEM, V108, P319, DOI 10.1111/j.1471-4159.2008.05770.x; DENMARK SE, 1991, J ORG CHEM, V56, P6974, DOI 10.1021/jo00025a007; Du XY, 1997, J NEUROCHEM, V68, P564; Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101; ETCHEBERRIGARAY R, 1992, P NATL ACAD SCI USA, V89, P7184, DOI 10.1073/pnas.89.15.7184; FURUKAWA J, 1968, TETRAHEDRON, V24, P53, DOI 10.1016/0040-4020(68)89007-6; Hongpaisan J, 2007, P NATL ACAD SCI USA, V104, P19571, DOI 10.1073/pnas.0709311104; Jin GX, 2002, ANAL BIOCHEM, V302, P269, DOI 10.1006/abio.2001.5549; Johnson GD, 2000, ANAL BIOCHEM, V286, P112, DOI 10.1006/abio.2000.4772; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; Kuzirian AM, 2006, BIOL BULL-US, V210, P201, DOI 10.2307/4134558; Lallemend F, 2005, J CELL SCI, V118, P4511, DOI 10.1242/jcs.02572; Lanni C, 2004, EUR J BIOCHEM, V271, P3068, DOI 10.1111/j.1432-1033.2004.04240.x; LEACH KL, 1985, CANCER RES, V45, P1958; Lee HW, 1997, MOL PHARMACOL, V51, P439; Lorenzo PS, 1999, CANCER RES, V59, P6137; Lu ZM, 1997, MOL CELL BIOL, V17, P3418, DOI 10.1128/MCB.17.6.3418; Marcello E, 2008, EUR J PHARMACOL, V585, P109, DOI 10.1016/j.ejphar.2007.11.083; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; NELSON TJ, 1995, J NEUROCHEM, V65, P2350; Petanceska SS, 2000, J NEUROCHEM, V74, P1878, DOI 10.1046/j.1471-4159.2000.0741878.x; Racchi M, 2003, MOL PSYCHIATR, V8, P209, DOI 10.1038/sj.mp.4001204; Rankin SL, 2008, BRAIN RES, V1217, P10, DOI 10.1016/j.brainres.2008.03.076; Rossner S, 1998, J NEUROCHEM, V71, P757; Rossner S, 1998, PROG NEUROBIOL, V56, P541, DOI 10.1016/S0301-0082(98)00044-6; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Shirai Y, 2008, FEBS J, V275, P3988, DOI 10.1111/j.1742-4658.2008.06556.x; Sun MK, 2008, P NATL ACAD SCI USA, V105, P13620, DOI 10.1073/pnas.0805952105; Sun MK, 2005, EUR J PHARMACOL, V512, P43, DOI 10.1016/j.ejphar.2005.02.028; Tanaka A, 2003, BIOORG MED CHEM LETT, V13, P1037, DOI 10.1016/S0960-894X(03)00089-1; Thinakaran G, 1996, J BIOL CHEM, V271, P9390, DOI 10.1074/jbc.271.16.9390; van Kolen K, 2008, J NEUROCHEM, V104, P1, DOI 10.1111/j.1471-4159.2007.04986.x; VanDeMark KL, 2009, J PHARMACOL EXP THER, V329, P532, DOI 10.1124/jpet.108.150128; Wang DH, 2008, BEHAV PHARMACOL, V19, P245, DOI 10.1097/FBP.0b013e3282feb0d2; WETSEL WC, 1992, J CELL BIOL, V117, P121, DOI 10.1083/jcb.117.1.121; Zampieri N, 2006, BIOCHEM SOC T, V34, P607, DOI 10.1042/BST0340607; Zhu GF, 2001, BIOCHEM BIOPH RES CO, V285, P997, DOI 10.1006/bbrc.2001.5273	44	51	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34514	34521		10.1074/jbc.M109.016683	http://dx.doi.org/10.1074/jbc.M109.016683			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19850930	Green Published, hybrid			2022-12-25	WOS:000272439600005
J	Du, YZ; Nomura, Y; Liu, ZQ; Huang, ZY; Dong, K				Du, Yuzhe; Nomura, Yoshiko; Liu, Zhiqi; Huang, Zachary Y.; Dong, Ke			Functional Expression of an Arachnid Sodium Channel Reveals Residues Responsible for Tetrodotoxin Resistance in Invertebrate Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IONIC CURRENTS; POLYORCHIS-PENICILLATUS; CONFERS TETRODOTOXIN; HYDROZOAN JELLYFISH; GENE; DROSOPHILA; DIVERSITY; NEURONS; INSENSITIVITY; MECHANISMS	Tetrodotoxin (TTX) is a potent blocker of voltage-gated sodium channels, but not all sodium channels are equally sensitive to inhibition by TTX. The molecular basis of differential TTX sensitivity of mammalian sodium channels has been largely elucidated. In contrast, our knowledge about the sensitivity of invertebrate sodium channels to TTX remains poor, in part because of limited success in functional expression of these channels. In this study, we report the functional characterization in Xenopus oocytes of the first non-insect, invertebrate voltage-gated sodium channel from the varroa mite (Varroa destructor), an ecto-parasite of the honeybee. This arachnid sodium channel activates and inactivates rapidly with half-maximal activation at -18 mV and half-maximal fast inactivation at -29 mV. Interestingly, this arachnid channel showed surprising TTX resistance. TTX blocked this channel with an IC50 of 1 mu M. Subsequent site-directed mutagenesis revealed two residues, Thr-1674 and Ser-1967, in the pore-forming region of domains III and IV, respectively, which were responsible for the observed resistance to inhibition by TTX. Furthermore, sequence comparison and additional amino acid substitutions suggested that sequence polymorphisms at these two positions could be a widespread mechanism for modulating TTX sensitivity of sodium channels in diverse invertebrates.	[Dong, Ke] Michigan State Univ, Dept Entomol, Genet Program, E Lansing, MI 48824 USA; Michigan State Univ, Dept Entomol, Neurosci Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Dong, K (corresponding author), Michigan State Univ, Dept Entomol, Genet Program, E Lansing, MI 48824 USA.	dongk@msu.edu	Huang, Zachary/D-5485-2011	Huang, Zachary/0000-0001-5354-5547	National Institutes of Health [GM057440]; United States Department of Agriculture Cooperative State Research, Education and Extension Service [2004-35607-14866]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Cooperative State Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM057440 and National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education and Extension Service Grant 2004-35607-14866.	ANDERSON PAV, 1987, J EXP BIOL, V133, P231; BACKX PH, 1992, SCIENCE, V257, P248, DOI 10.1126/science.1321496; BLAIR KL, 1993, J EXP BIOL, V185, P267; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Dib-Hajj S, 2002, TRENDS NEUROSCI, V25, P253, DOI 10.1016/S0166-2236(02)02150-1; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; FENG GP, 1995, CELL, V82, P1001, DOI 10.1016/0092-8674(95)90279-1; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; Geffeney SL, 2005, NATURE, V434, P759, DOI 10.1038/nature03444; Goldin AL, 2002, J EXP BIOL, V205, P575; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; HEINEMANN SH, 1992, NATURE, V356, P441, DOI 10.1038/356441a0; HILLE B, 1992, IONIC CHANNELS EXCIT, P59; KLEINHAUS AL, 1995, J NEUROBIOL, V27, P419, DOI 10.1002/neu.480270313; Liu ZQ, 2004, P NATL ACAD SCI USA, V101, P11862, DOI 10.1073/pnas.0307695101; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; MEECH RW, 1993, J NEUROPHYSIOL, V69, P884, DOI 10.1152/jn.1993.69.3.884; Nagahora H, 2000, BIOCHEM BIOPH RES CO, V275, P558, DOI 10.1006/bbrc.2000.3290; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; NODA M, 1989, FEBS LETT, V259, P213, DOI 10.1016/0014-5793(89)81531-5; Olson RO, 2008, INSECT BIOCHEM MOLEC, V38, P604, DOI 10.1016/j.ibmb.2008.01.003; SATIN J, 1992, SCIENCE, V256, P1202, DOI 10.1126/science.256.5060.1202; Schlief T, 1996, EUR BIOPHYS J BIOPHY, V25, P75, DOI 10.1007/s002490050020; Sivilotti L, 1997, FEBS LETT, V409, P49, DOI 10.1016/S0014-5793(97)00479-1; SODERLUND DM, 2006, SODIUM CHANNEL COMPR, V5, P1; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; Soong TW, 2006, TRENDS GENET, V22, P621, DOI 10.1016/j.tig.2006.08.010; Spafford JD, 1996, J EXP BIOL, V199, P941; Spafford JD, 1998, BIOCHEM BIOPH RES CO, V244, P772, DOI 10.1006/bbrc.1998.8332; Tan J, 2002, INSECT BIOCHEM MOLEC, V32, P445, DOI 10.1016/S0965-1748(01)00122-9; Tan JG, 2005, MOL PHARMACOL, V67, P513, DOI 10.1124/mol.104.006205; Tan JG, 2002, J NEUROSCI, V22, P5300; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; Venkatesh B, 2005, CURR BIOL, V15, P2069, DOI 10.1016/j.cub.2005.10.068; Wang RW, 2003, INSECT BIOCHEM MOLEC, V33, P733, DOI 10.1016/S0965-1748(03)00068-7; Zhou W, 2004, NEURON, V42, P101, DOI 10.1016/S0896-6273(04)00148-5	36	25	27	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33869	33875		10.1074/jbc.M109.045690	http://dx.doi.org/10.1074/jbc.M109.045690			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19828457	Green Published, hybrid			2022-12-25	WOS:000272165200019
J	Lonne, GK; Masoumi, KC; Lennartsson, J; Larsson, C				Lonne, Gry Kalstad; Masoumi, Katarzyna Chmielarska; Lennartsson, Johan; Larsson, Christer			Protein Kinase C delta Supports Survival of MDA-MB-231 Breast Cancer Cells by Suppressing the ERK1/2 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR CELLS; PROTEOLYTIC ACTIVATION; PKC-EPSILON; INDUCED APOPTOSIS; REGULATORY DOMAIN; ONCOGENIC RAS; MCF-7 CELLS; DEATH; PHOSPHORYLATION; NEUROBLASTOMA	Mechanisms that mediate apoptosis resistance are attractive therapeutic targets for cancer. Protein kinase C delta (PKC delta) is considered a pro-apoptotic factor in many cell types. In breast cancer, however, it has shown both pro-survival and pro-apoptotic effects. Here, we report for the first time that down-regulation of PKC delta per se leads to apoptosis of MDA-MB-231 cells. Inhibition of MEK1/2 by either PD98059 or U0126 suppressed the induction of apoptosis of PKC delta-depleted MDA-MB-231 cells but did not support survival of MCF-7 or MDA-MB-468 cells. Basal ERK1/2 phosphorylation was substantially higher in MDA-MB-231 cells than in the other cell lines. PKC delta depletion led to even higher ERK1/2 phosphorylation levels and also to lower expression levels of the ERK1/2 phosphatase MKP3. Depletion of MKP3 led to apoptosis and higher levels of ERK1/2 phosphorylation, suggesting that this may be a mechanism mediating the effect of PKC delta down-regulation. However, PKC delta silencing also induced increased MEK1/2 phosphorylation, indicating that PKC delta regulates ERK1/2 phosphorylation both upstream and downstream. Moreover, PKC delta silencing led to increased levels of the E3 ubiquitin ligase Nedd4, which is a potential regulator of MKP3, because down-regulation led to increased MKP3 levels. Our results highlight PKC delta as a potential target for therapy of breast cancers with high activity of the ERK1/2 pathway.	[Larsson, Christer] Lund Univ, Malmo Univ Hosp, Dept Lab Med, Ctr Mol Pathol, SE-20502 Malmo, Sweden; [Lonne, Gry Kalstad; Masoumi, Katarzyna Chmielarska; Larsson, Christer] Lund Univ, Dept Lab Med, Ctr Mol Pathol, SE-20502 Malmo, Sweden; [Lennartsson, Johan] Uppsala Univ, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden	Lund University; Skane University Hospital; Lund University; Ludwig Institute for Cancer Research; Uppsala University	Larsson, C (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Lab Med, Ctr Mol Pathol, Entrance 78,3rd Floor, SE-20502 Malmo, Sweden.	christer.larsson@med.lu.se		Masoumi, Katarzyna/0000-0002-9277-6505	Swedish Cancer Society; Swedish Research Council; Children's Cancer Foundation of Sweden; Malmo University Hospital Research Funds; Kock Foundation; Crafoord Foundation; Ollie and Elof Ericsson Foundation; Gunnar Nilsson Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Children's Cancer Foundation of Sweden(Swedish Cancer Society); Malmo University Hospital Research Funds; Kock Foundation; Crafoord Foundation; Ollie and Elof Ericsson Foundation(Ericsson); Gunnar Nilsson Foundation	This work was supported by grants from The Swedish Cancer Society, The Swedish Research Council, The Children's Cancer Foundation of Sweden, Malmo University Hospital Research Funds, and the Kock, Crafoord, Ollie and Elof Ericsson, and Gunnar Nilsson Foundations.	Alonso-Escolano D, 2006, J PHARMACOL EXP THER, V318, P373, DOI 10.1124/jpet.106.103358; Basu A, 2002, J BIOL CHEM, V277, P41850, DOI 10.1074/jbc.M205997200; Basu A, 1999, BIOCHEMISTRY-US, V38, P4245, DOI 10.1021/bi982854q; Basu A, 2001, BIOCHEM BIOPH RES CO, V280, P883, DOI 10.1006/bbrc.2000.4209; Blass M, 2002, MOL CELL BIOL, V22, P182, DOI 10.1128/MCB.22.1.182-195.2002; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; Grossoni VC, 2007, MOL CARCINOGEN, V46, P381, DOI 10.1002/mc.20287; Hoppe J, 2001, EXP CELL RES, V266, P64, DOI 10.1006/excr.2001.5211; Jurek A, 2009, J BIOL CHEM, V284, P4626, DOI 10.1074/jbc.M808490200; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kiley SC, 1999, ONCOGENE, V18, P6748, DOI 10.1038/sj.onc.1203101; Kiley SC, 1999, CANCER RES, V59, P3230; Koriyama H, 1999, CELL SIGNAL, V11, P831, DOI 10.1016/S0898-6568(99)00055-8; KOZMA SC, 1987, NUCLEIC ACIDS RES, V15, P5963; Lee YJ, 2003, BBA-MOL CELL RES, V1593, P219, DOI 10.1016/S0167-4889(02)00392-0; Lu DM, 2007, APOPTOSIS, V12, P1893, DOI 10.1007/s10495-007-0111-7; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; Mayo MW, 1997, SCIENCE, V278, P1812, DOI 10.1126/science.278.5344.1812; McCracken MA, 2003, MOL CANCER THER, V2, P273; Mirzoeva OK, 2009, CANCER RES, V69, P565, DOI 10.1158/0008-5472.CAN-08-3389; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Nabha SM, 2005, ONCOGENE, V24, P3166, DOI 10.1038/sj.onc.1208502; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Okhrimenko H, 2005, CANCER RES, V65, P7301, DOI 10.1158/0008-5472.CAN-05-1064; Pan Q, 2005, CANCER RES, V65, P8366, DOI 10.1158/0008-5472.CAN-05-0553; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Pedram A, 2006, MOL BIOL CELL, V17, P2125, DOI 10.1091/mbc.E05-11-1013; Pettersson F, 2004, ONCOGENE, V23, P7053, DOI 10.1038/sj.onc.1207956; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Schmitt CA, 2003, NAT REV CANCER, V3, P286, DOI 10.1038/nrc1044; Schultz A, 2003, CELL DEATH DIFFER, V10, P662, DOI 10.1038/sj.cdd.4401235; Sivaprasad U, 2007, CELL DEATH DIFFER, V14, P851, DOI 10.1038/sj.cdd.4402077; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wang XT, 2000, J BIOL CHEM, V275, P39435, DOI 10.1074/jbc.M004583200; Warmka JK, 2004, J BIOL CHEM, V279, P33085, DOI 10.1074/jbc.M403120200; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Xia SH, 2007, J BIOL CHEM, V282, P13199, DOI 10.1074/jbc.M610225200; Yonekawa H, 2008, FEBS J, V275, P4005, DOI 10.1111/j.1742-4658.2008.06558.x; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidman R, 1999, J CELL BIOL, V145, P713, DOI 10.1083/jcb.145.4.713; Zhang JD, 2005, J CELL BIOCHEM, V96, P522, DOI 10.1002/jcb.20535	46	41	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33456	33465		10.1074/jbc.M109.036186	http://dx.doi.org/10.1074/jbc.M109.036186			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19833733	Green Published, hybrid			2022-12-25	WOS:000272028500052
J	Lee, WH; Atienza-Herrero, J; Abagyan, R; Marsden, BD				Lee, Wen Hwa; Atienza-Herrero, Julian; Abagyan, Ruben; Marsden, Brian D.			SGC - Structural Biology and Human Health: A New Approach to Publishing Structural Biology Results	PLOS ONE			English	Article							PROMOTE PROTEIN STABILITY; DRUG DISCOVERY; GENOMICS; DESIGN; CRYSTALLIZATION; VISUALIZATION; INHIBITORS; IMPACT; PROBES; TOOL				Lee, WH (corresponding author), Univ Oxford, SGC, Oxford, England.	wenhwa.lee@sgc.ox.ac.uk	Lee, Wen Hwa/GZA-8183-2022; Lee, Wen Hwa/G-1250-2013	Lee, Wen Hwa/0000-0002-4098-5225; Lee, Wen Hwa/0000-0002-4098-5225	CIHR Funding Source: Medline; Wellcome Trust Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abagyan R, 2006, TRENDS BIOCHEM SCI, V31, P76, DOI 10.1016/j.tibs.2005.12.006; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; [Anonymous], 2006, NAT STRUCT MOL BIOL, V13, P93, DOI 10.1038/nsmb0206-93; Autin L, 2007, NUCLEIC ACIDS RES, V35, pW483, DOI 10.1093/nar/gkm277; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Chen V. B., 2009, PROTEIN SCI; Congreve M, 2005, DRUG DISCOV TODAY, V10, P895, DOI 10.1016/S1359-6446(05)03484-7; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Edwards A, 2008, DRUG DISCOV TODAY, V13, P731, DOI 10.1016/j.drudis.2008.04.011; Edwards A, 2009, ANNU REV BIOCHEM, V78, P541, DOI 10.1146/annurev.biochem.78.070907.103305; Edwards AM, 2009, NAT CHEM BIOL, V5, P436, DOI 10.1038/nchembio0709-436; Gileadi Opher, 2007, Journal of Structural and Functional Genomics, V8, P107, DOI 10.1007/s10969-007-9027-2; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Hodis E, 2007, TRENDS BIOCHEM SCI, V32, P199, DOI 10.1016/j.tibs.2007.03.008; Hodis E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r121; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janin J, 2007, STRUCTURE, V15, P1347, DOI 10.1016/j.str.2007.10.005; Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195; Kumar P, 2008, TRENDS BIOCHEM SCI, V33, P408, DOI 10.1016/j.tibs.2008.06.004; Maiti R, 2005, NUCLEIC ACIDS RES, V33, pW358, DOI 10.1093/nar/gki485; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oprea TI, 2009, NAT CHEM BIOL, V5, P441, DOI 10.1038/nchembio0709-441; Porollo A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-316; RICHARDSON DC, 1992, PROTEIN SCI, V1, P3; Sali Andrej, 1998, Nature Structural Biology, V5, P1029, DOI 10.1038/4136; Terwilliger TC, 1998, PROTEIN SCI, V7, P1851, DOI 10.1002/pro.5560070901; Terwilliger TC, 2009, ANNU REV BIOPHYS, V38, P371, DOI 10.1146/annurev.biophys.050708.133740; THOMPSON WJ, 1992, J MED CHEM, V35, P1685, DOI 10.1021/jm00088a003; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Weigelt J, 2009, EMBO REP, V10, P941, DOI 10.1038/embor.2009.193; Wlodawer A, 2002, ANNU REV MED, V53, P595, DOI 10.1146/annurev.med.53.052901.131947; 2009, J BIOL CHEM, V284, P21101	34	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7675	10.1371/journal.pone.0007675	http://dx.doi.org/10.1371/journal.pone.0007675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19847312	Green Published, Green Submitted, gold			2022-12-25	WOS:000271012900018
J	Lin, YC; Schlievert, PM; Anderson, MJ; Fair, CL; Schaefers, MM; Muthyala, R; Peterson, ML				Lin, Ying-Chi; Schlievert, Patrick M.; Anderson, Michele J.; Fair, Christina L.; Schaefers, Matthew M.; Muthyala, Ramaiah; Peterson, Marnie L.			Glycerol Monolaurate and Dodecylglycerol Effects on Staphylococcus aureus and Toxic Shock Syndrome Toxin-1 In Vitro and In Vivo	PLOS ONE			English	Article							STREPTOCOCCUS-FAECIUM ATCC-9790; FATTY-ACIDS; SIGNAL-TRANSDUCTION; EXOTOXIN PRODUCTION; AUTOLYSIN ACTIVITY; GROWTH; AGENTS; BIOSYNTHESIS; PATHOGENESIS; ANTIBIOTICS	Background: Glycerol monolaurate (GML), a 12 carbon fatty acid monoester, inhibits Staphylococcus aureus growth and exotoxin production, but is degraded by S. aureus lipase. Therefore, dodecylglycerol (DDG), a 12 carbon fatty acid monoether, was compared in vitro and in vivo to GML for its effects on S. aureus growth, exotoxin production, and stability. Methodology/Principal Findings: Antimicrobial effects of GML and DDG (0 to 500 mg/ml) on 54 clinical isolates of S. aureus, including pulsed-field gel electrophoresis (PFGE) types USA200, USA300, and USA400, were determined in vitro. A rabbit Wiffle ball infection model assessed GML and DDG (1 mg/ml instilled into the Wiffle ball every other day) effects on S. aureus (MN8) growth (inoculum 3X10(8) CFU/ml), toxic shock syndrome toxin-1 (TSST-1) production, tumor necrosis factor-alpha (TNF-alpha) concentrations and mortality over 7 days. DDG (50 and 100 mg/ml) inhibited S. aureus growth in vitro more effectively than GML (p < 0.01) and was stable to lipase degradation. Unlike GML, DDG inhibition of TSST-1 was dependent on S. aureus growth. GML-treated (4 of 5; 80%) and DDG-treated rabbits (2 of 5; 40%) survived after 7 days. Control rabbits (5 of 5; 100%) succumbed by day 4. GML suppressed TNF-alpha at the infection site on day 7; however, DDG did not (< 10 ng/ml versus 80 ng/ml, respectively). Conclusions/Significance: These data suggest that DDG was stable to S. aureus lipase and inhibited S. aureus growth at lower concentrations than GML in vitro. However, in vivo GML was more effective than DDG by reducing mortality, and suppressing TNF-alpha, S. aureus growth and exotoxin production, which may reduce toxic shock syndrome. GML is proposed as a more effective anti-staphylococcal topical anti-infective candidate than DDG, despite its potential degradation by S. aureus lipase.			Lin, YC (corresponding author), Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA.	peter377@umn.edu	Lin, Ying-Chi/V-7851-2019; Schaefers, Matthew/AAU-8213-2021	Lin, Ying-Chi/0000-0003-0335-3402; Schaefers, Matthew/0000-0001-7454-4180; Schlievert, Patrick/0000-0001-8314-9369	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073366, R01AI074283] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-074283, R01 AI074283, R01 AI073366-01A2, R01 AI073366, R01 AI074283-21] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boguniewicz M, 2006, J ALLERGY CLIN IMMUN, V118, P40, DOI 10.1016/j.jaci.2006.04.044; BRISSETTE JL, 1986, J BIOL CHEM, V261, P6338; Chuang Yu-Yu, 2005, Paediatr Drugs, V7, P11, DOI 10.2165/00148581-200507010-00002; De Bels D, 2005, J ANTIMICROB CHEMOTH, V55, P812, DOI 10.1093/jac/dki068; Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; HAYNES MP, 1994, ANTIMICROB AGENTS CH, V38, P1523, DOI 10.1128/AAC.38.7.1523; Hill DR, 2005, J APPL PHYSIOL, V99, P1582, DOI 10.1152/japplphysiol.01422.2004; HOLLAND KT, 1994, J ANTIMICROB CHEMOTH, V33, P41, DOI 10.1093/jac/33.1.41; Jarman A, 2007, BURNS, V33, P1051, DOI 10.1016/j.burns.2006.10.001; Johnson W, 2004, INT J TOXICOL, V23, P55, DOI 10.1080/10915810490499064; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23; Kelsey JA, 2006, LIPIDS, V41, P951, DOI 10.1007/s11745-006-5048-z; Kenny JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004344; Kitahara T, 2004, BIOL PHARM BULL, V27, P1321, DOI 10.1248/bpb.27.1321; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Limbago B, 2009, J CLIN MICROBIOL, V47, P1344, DOI 10.1128/JCM.02264-08; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; McNamara PJ, 2009, ANTIMICROB AGENTS CH, V53, P1898, DOI 10.1128/AAC.01293-08; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Peterson ML, 2006, BIOCHEMISTRY-US, V45, P2387, DOI 10.1021/bi051992u; Preuss HG, 2005, MOL CELL BIOCHEM, V272, P29, DOI 10.1007/s11010-005-6604-1; PROJAN SJ, 1994, J BACTERIOL, V176, P4204, DOI 10.1128/jb.176.14.4204-4209.1994; Ruzin A, 2000, J BACTERIOL, V182, P2668, DOI 10.1128/JB.182.9.2668-2671.2000; Schlievert PM, 2008, ANTIMICROB AGENTS CH, V52, P4448, DOI 10.1128/AAC.00989-08; Schlievert PM, 2007, OBSTET GYNECOL, V109, p74S; Schlievert PM, 2007, ANTIMICROB AGENTS CH, V51, P3056, DOI 10.1128/AAC.01295-06; SCHLIEVERT PM, 1988, METHOD ENZYMOL, V165, P339; SCHLIEVERT PM, 1984, J INFECT DIS, V149, P471, DOI 10.1093/infdis/149.3.471; SCHLIEVERT PM, 1992, ANTIMICROB AGENTS CH, V36, P626, DOI 10.1128/AAC.36.3.626; SCHLIEVERT PM, 1983, J INFECT DIS, V147, P236, DOI 10.1093/infdis/147.2.236; SCOTT DF, 1983, INFECT IMMUN, V39, P383, DOI 10.1128/IAI.39.1.383-387.1983; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Stevens DL, 2006, CLIN INFECT DIS, V42, P729, DOI 10.1086/500265; Tenover FC, 2008, J CLIN MICROBIOL, V46, P2837, DOI 10.1128/JCM.00480-08; TODD JK, 1987, J INFECT DIS, V155, P673, DOI 10.1093/infdis/155.4.673; Trop M, 2004, BURNS, V30, P176, DOI 10.1016/j.burns.2003.10.001; VED HS, 1984, J BIOL CHEM, V259, P8122; VED HS, 1990, LIPIDS, V25, P119, DOI 10.1007/BF02562216; VED HS, 1984, J BIOL CHEM, V259, P8115; WEBER N, 1985, J LIPID RES, V26, P1412; Yarwood JM, 2000, J CLIN MICROBIOL, V38, P1797, DOI 10.1128/JCM.38.5.1797-1803.2000; Yarwood JM, 2002, J BACTERIOL, V184, P1095, DOI 10.1128/jb.184.4.1095-1101.2002	46	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7499	10.1371/journal.pone.0007499	http://dx.doi.org/10.1371/journal.pone.0007499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838303	Green Published, gold, Green Submitted			2022-12-25	WOS:000270880900005
J	Graves, N; Courtney, M; Edwards, H; Chang, A; Parker, A; Finlayson, K				Graves, Nicholas; Courtney, Mary; Edwards, Helen; Chang, Anne; Parker, Anthony; Finlayson, Kathleen			Cost-Effectiveness of an Intervention to Reduce Emergency Re-Admissions to Hospital among Older Patients	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CHRONIC HEART-FAILURE; EFFECTIVENESS ACCEPTABILITY CURVES; HEALTH-CARE; ECONOMIC-EVALUATION; TECHNOLOGY-ASSESSMENT; MANAGEMENT PROGRAM; EFFICIENCY; EQUITY; VALUES	Background: The objective is to estimate the cost-effectiveness of an intervention that reduces hospital re-admission among older people at high risk. A cost-effectiveness model to estimate the costs and health benefits of the intervention was implemented. Methodology/Principal Findings: The model used data from a randomised controlled trial conducted in an Australian tertiary metropolitan hospital. Participants were acute medical admissions aged >65 years with at least one risk factor for re-admission: multiple comorbidities,impaired functionality, aged >75 years, recent multiple admissions, poor social support, history of depression. The intervention was a comprehensive nursing and physiotherapy assessment and an individually tailored program of exercise strategies and nurse home visits with telephone follow-up; commencing in hospital and continuing following discharge for 24 weeks. The change to cost outcomes, including the costs of implementing the intervention and all subsequent use of health care services, and, the change to health benefits, represented by quality adjusted life years, were estimated for the intervention as compared to existing practice. The mean change to total costs and quality adjusted life years for an average individual over 24 weeks participating in the intervention were: cost savings of $333 (95% Bayesian credible interval $-1,932: 1,282) and 0.118 extra quality adjusted life years ( 95% Bayesian credible interval 0.1:0.136). The mean net-monetary-benefit per individual for the intervention group compared to the usual care condition was $7,907 (95% Bayesian credible interval $5,959:$9,995) for the 24 week period. Conclusions/Significance: The estimation model that describes this intervention predicts cost savings and improved health outcomes. A decision to remain with existing practices causes unnecessary costs and reduced health. Decision makers should consider adopting this program for elderly hospitalised patients.			Graves, N (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Publ Hlth, Brisbane, Qld 4001, Australia.	n.graves@qut.edu.au	Chang, Anne M/A-3425-2009; Edwards, Helen E/I-9554-2012; Finlayson, Kathleen/D-1108-2012; Edwards, Helen/GPX-3511-2022; Graves, Nicholas/A-3052-2011	Chang, Anne M/0000-0003-3409-874X; Finlayson, Kathleen/0000-0002-5743-2731; Edwards, Helen/0000-0002-4451-0577; Graves, Nicholas/0000-0002-5559-3267				*AIHW, 2004, RES AG CAR AUSTR 200; Australian Institute of Health and Welfare, 2006, AUSTR HOSP STAT 2004; Australian Institute of Health & Welfare, 2007, AUSTR HOSP STAT 2005; BIRCH S, 1992, J HEALTH ECON, V11, P279, DOI 10.1016/0167-6296(92)90004-K; Brazier J, 1999, HLTH TECHNOL ASSESS, V3; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Briggs AH, 2001, HEALTH ECON, V10, P179, DOI 10.1002/hec.584; Capomolla S, 2002, J AM COLL CARDIOL, V40, P1259, DOI 10.1016/S0735-1097(02)02140-X; Claxton K, 2005, HEALTH ECON, V14, P339, DOI 10.1002/hec.985; Coast J, 2004, BRIT MED J, V329, P1233, DOI 10.1136/bmj.329.7476.1233; Cookson R, 2003, HEALTH ECON, V12, P891, DOI 10.1002/hec.847; Courtney M, 2009, J AM GERIATR SOC, V57, P395, DOI 10.1111/j.1532-5415.2009.02138.x; Del Sindaco D, 2007, J CARDIOVASC MED, V8, P324, DOI 10.2459/JCM.0b013e32801164cb; *DEP HLTH AG, 2007, COMPL MED BEN SCHED; Donaldson C, 2002, BRIT MED J, V325, P891, DOI 10.1136/bmj.325.7369.891; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Elixhauser A, 2000, AHRQ PUBLICATION; Epstein DM, 2007, MED DECIS MAKING, V27, P128, DOI 10.1177/0272989X06297396; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Gray AM, 2006, MED DECIS MAKING, V26, P18, DOI 10.1177/0272989X05284108; Ho YL, 2007, J FORMOS MED ASSOC, V106, P313, DOI 10.1016/S0929-6646(09)60258-8; Hoch JS, 2002, HEALTH ECON, V11, P415, DOI 10.1002/hec.678; Jackson TJ, 2007, MED J AUSTRALIA, V187, P262, DOI 10.5694/j.1326-5377.2007.tb01238.x; Karmel R., 2007, B AUSTR I HLTH WELFA, V53; Krupnick A.J., 2004, VALUING HLTH OUTCOME; Kwok T, 2008, J CLIN NURS, V17, P109, DOI 10.1111/j.1365-2702.2007.01978.x; Latour CHM, 2007, J PSYCHOSOM RES, V62, P363, DOI 10.1016/j.jpsychores.2006.10.016; Layard R., 1994, COST BENEFIT ANAL; Mistiaen P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004510.pub3; *NAT HLTH SERV, 2006, HES ONL HOSP EP STAT; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Parker S. G., 2005, DO CURRENT DISCHARGE; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Ryan M, 2001, Health Technol Assess, V5, P1; Sampietro-Colom L, 2004, INT J TECHNOL ASSESS, V20, P145, DOI 10.1017/S0266462304000923; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; SHIROIWA T, 2009, HLTH EC; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Stinnett AA, 1996, J HEALTH ECON, V15, P641, DOI 10.1016/S0167-6296(96)00493-6; Sugden R., 1978, PRINCIPLES PRACTICAL; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Trueman P, 2001, PHARMACOECONOMICS, V19, P609, DOI 10.2165/00019053-200119060-00001; WAGSTAFF A, 1991, J HEALTH ECON, V10, P21, DOI 10.1016/0167-6296(91)90015-F	45	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7455	10.1371/journal.pone.0007455	http://dx.doi.org/10.1371/journal.pone.0007455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506WT	19829702	Green Published, gold, Green Submitted			2022-12-25	WOS:000270808700015
J	Yang, HY; Chen, CW				Yang, Han-Yu; Chen, Carton W.			Extracellular and Intracellular Polyphenol Oxidases Cause Opposite Effects on Sensitivity of Streptomyces to Phenolics: A Case of Double-Edged Sword	PLOS ONE			English	Article							ARGININE TRANSLOCATION PATHWAY; TYROSINASE GENE; CHROMOSOMAL DNA; MELC OPERON; EXPRESSION; COPPER; OXIDATION; CLONING; DIFFERENTIATION; ANTIBIOTICUS	Many but not all species of Streptomyces species harbour a bicistronic melC operon, in which melC2 encodes an extracellular tyrosinase (a polyphenol oxidase) and melC1 encodes a helper protein. On the other hand, a melC-homologous operon (melD) is present in all sequenced Streptomyces chromosomes and could be isolated by PCR from six other species tested. Bioinformatic analysis showed that melC and melD have divergently evolved toward different functions. MelD2, unlike tyrosinase (MelC2), is not secreted, and has a narrower substrate spectrum. Deletion of melD caused an increased sensitivity to several phenolics that are substrates of MelD2. Intracellularly, MelD2 presumably oxidizes the phenolics, thus bypassing spontaneous copper-dependent oxidation that generates DNA-damaging reactive oxygen species. Surprisingly, melC+ strains were more sensitive rather than less sensitive to phenolics than melC 2 strains. This appeared to be due to conversion of the phenolics by MelC2 to more hydrophobic and membrane-permeable quinones. We propose that the conserved melD operon is involved in defense against phenolics produced by plants, and the sporadically present melC operon probably plays an aggressive role in converting the phenolics to the more permeable quinones, thus fending off less tolerant competing microbes (lacking melD) in the phenolic-rich rhizosphere.			Yang, HY (corresponding author), Dept Life Sci, Taipei, Taiwan.	cwchen@ym.edu.tw	Chen, Carton W/GVS-7763-2022	Chen, Carton W/0000-0001-8891-1623				ARAI T, 1972, APPL MICROBIOL, V23, P402, DOI 10.1128/AEM.23.2.402-406.1972; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; CHEN CW, 1992, J BACTERIOL, V174, P7762, DOI 10.1128/JB.174.23.7762-7769.1992; CHEN LY, 1992, J BIOL CHEM, V267, P20100; Claus H, 2006, SYST APPL MICROBIOL, V29, P3, DOI 10.1016/j.syapm.2005.07.012; Conant JB, 1924, J AM CHEM SOC, V46, P1858, DOI 10.1021/ja01673a014; CRAMERI R, 1984, CAN J MICROBIOL, V30, P1058, DOI 10.1139/m84-165; Endo K, 2001, J ANTIBIOT, V54, P789, DOI 10.7164/antibiotics.54.789; GREGORY KF, 1964, J BACTERIOL, V87, P1287, DOI 10.1128/JB.87.6.1287-1294.1964; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HINTERMANN G, 1985, MOL GEN GENET, V200, P422, DOI 10.1007/BF00425726; Hirakawa K, 2002, CHEM RES TOXICOL, V15, P76, DOI 10.1021/tx010121s; HIROCHIKA H, 1984, EMBO J, V3, P761, DOI 10.1002/j.1460-2075.1984.tb01881.x; HOPWOOD DA, 1983, J GEN MICROBIOL, V129, P2257; Hsiao NH, 2008, ANTON LEEUW INT J G, V93, P1, DOI 10.1007/s10482-007-9175-1; Ikeda K, 1996, J BIOCHEM-TOKYO, V120, P1141; Kahn V, 1999, J FOOD BIOCHEM, V23, P263, DOI 10.1111/j.1745-4514.1999.tb00019.x; KATZ E, 1983, J GEN MICROBIOL, V129, P2703; KATZ E, 1988, CAN J MICROBIOL, V34, P1297, DOI 10.1139/m88-227; KAWAMOTO S, 1993, J FERMENT BIOENG, V76, P345, DOI 10.1016/0922-338X(93)90020-9; Keijser BJF, 2000, J MOL MICROB BIOTECH, V2, P565; KIESER HM, 1992, J BACTERIOL, V174, P5496, DOI 10.1128/JB.174.17.5496-5507.1992; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kirby R, 2006, ADV APPL MICROBIOL, V58, P125, DOI 10.1016/S0065-2164(05)58004-3; LEE YHW, 1988, GENE, V65, P71, DOI 10.1016/0378-1119(88)90418-0; LERCH K, 1972, PATHOL MICROBIOL, V38, P24, DOI 10.1159/000162371; LEU WM, 1989, GENE, V84, P267; LEU WM, 1992, J BIOL CHEM, V267, P20108; Li L, 2002, PLANTA, V215, P239, DOI 10.1007/s00425-002-0750-4; LI WH, 1985, MOL BIOL EVOL, V2, P150; LI YB, 1993, CARCINOGENESIS, V14, P1303, DOI 10.1093/carcin/14.7.1303; LI YB, 1995, CHEM-BIOL INTERACT, V94, P101, DOI 10.1016/0009-2797(94)03326-4; Lin YS, 1997, MOL MICROBIOL, V26, P709, DOI 10.1046/j.1365-2958.1997.5991975.x; LIN YS, 1993, MOL MICROBIOL, V10, P923, DOI 10.1111/j.1365-2958.1993.tb00964.x; LYR H, 1962, NATURE, V195, P289, DOI 10.1038/195289a0; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; MERCADOBLANCO J, 1993, J BACTERIOL, V175, P5403, DOI 10.1128/JB.175.17.5403-5410.1993; Orenes-Pinero E, 2006, ENZYME MICROB TECH, V39, P158, DOI 10.1016/j.enzmictec.2006.03.001; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Pinero S, 2007, J MOL MICROB BIOTECH, V13, P35, DOI 10.1159/000103595; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J., 2001, MOL CLONING; Schaerlaekens K, 2001, J BACTERIOL, V183, P6727, DOI 10.1128/JB.183.23.6727-6732.2001; SCHREMPF H, 1982, J BACTERIOL, V151, P701, DOI 10.1128/JB.151.2.701-707.1982; SCHREMPF H, 1983, MOL GEN GENET, V189, P501, DOI 10.1007/BF00325917; SHIRLING EB, 1970, ACTINOMYCETALES, P79; Streffer K, 2001, ANAL CHIM ACTA, V427, P201, DOI 10.1016/S0003-2670(00)01040-0; Suzuki H, 2006, J BIOL CHEM, V281, P30251, DOI 10.1074/jbc.M605726200; Thipyapong P, 2004, PLANTA, V220, P105, DOI 10.1007/s00425-004-1330-6; Thipyapong P, 2007, MOLECULES, V12, P1569, DOI 10.3390/12081569; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOUSSAINT O, 1987, BIOCHEMISTRY-US, V26, P8567, DOI 10.1021/bi00400a011; Ueda K, 2000, ANTON LEEUW INT J G, V78, P263, DOI 10.1023/A:1010220614293; Ueda K, 1997, J ANTIBIOT, V50, P693, DOI 10.7164/antibiotics.50.693; WAKSMAN SA, 1948, BERGEYS MANUAL DETER, P892; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; WILLIAMS ST, 1983, J GEN MICROBIOL, V129, P1743; YU TW, 1993, J BACTERIOL, V175, P1847, DOI 10.1128/JB.175.6.1847-1852.1993; Zhu DQ, 2005, J BACTERIOL, V187, P3180, DOI 10.1128/JB.187.9.3180-3187.2005	60	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7462	10.1371/journal.pone.0007462	http://dx.doi.org/10.1371/journal.pone.0007462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826489	gold, Green Published, Green Submitted			2022-12-25	WOS:000270808700021
J	Mileo, AM; Abbruzzese, C; Mattarocci, S; Bellacchio, E; Pisano, P; Federico, A; Maresca, V; Picardo, M; Giorgi, A; Maras, B; Schinina, ME; Paggi, MG				Mileo, Anna M.; Abbruzzese, Claudia; Mattarocci, Stefano; Bellacchio, Emanuele; Pisano, Paola; Federico, Antonio; Maresca, Vittoria; Picardo, Mauro; Giorgi, Alessandra; Maras, Bruno; Schinina, M. Eugenia; Paggi, Marco G.			Human Papillomavirus-16 E7 Interacts with Glutathione S-Transferase P1 and Enhances Its Role in Cell Survival	PLOS ONE			English	Article							PEPTIDE-SYNTHESIS; CANCER; IDENTIFICATION; APOPTOSIS; PROTEINS; VIRUSES; LINE; KERATINOCYTES; SENSITIVITY; MECHANISMS	Background: Human Papillomavirus (HPV)-16 is a paradigm for "high-risk'' HPVs, the causative agents of virtually all cervical carcinomas. HPV E6 and E7 viral genes are usually expressed in these tumors, suggesting key roles for their gene products, the E6 and E7 oncoproteins, in inducing malignant transformation. Methodology/Principal Findings: By protein-protein interaction analysis, using mass spectrometry, we identified glutathione S-transferase P1-1 (GSTP1) as a novel cellular partner of the HPV-16 E7 oncoprotein. Following mapping of the region in the HPV-16 E7 sequence that is involved in the interaction, we generated a three-dimensional molecular model of the complex between HPV-16 E7 and GSTP1, and used this to engineer a mutant molecule of HPV-16 E7 with strongly reduced affinity for GSTP1. When expressed in HaCaT human keratinocytes, HPV-16 E7 modified the equilibrium between the oxidized and reduced forms of GSTP1, thereby inhibiting JNK phosphorylation and its ability to induce apoptosis. Using GSTP1-deficient MCF-7 cancer cells and siRNA interference targeting GSTP1 in HaCaT keratinocytes expressing either wild-type or mutant HPV-16 E7, we uncovered a pivotal role for GSTP1 in the pro-survival program elicited by its binding with HPV-16 E7. Conclusions/Significance: This study provides further evidence of the transforming abilities of this oncoprotein, setting the groundwork for devising unique molecular tools that can both interfere with the interaction between HPV-16 E7 and GSTP1 and minimize the survival of HPV-16 E7-expressing cancer cells.			Mileo, AM (corresponding author), Regina Elena Inst Canc Res, CRS, Dept Dev, Therapeut Programs, Rome, Italy.	marco.paggi@gmail.com	Maras, Bruno/A-2020-2010; Bellacchio, Emanuele/AAH-9255-2019; Paggi, Marco G./K-3494-2018; maresca, vittoria/J-3272-2016; Abbruzzese, Claudia/U-7576-2017; Federico, Antonio/H-8871-2017; Picardo, Mauro/A-6978-2011; Mileo, Anna Maria/J-3667-2016	maresca, vittoria/0000-0001-9239-6978; Abbruzzese, Claudia/0000-0003-3301-9421; Federico, Antonio/0000-0001-9650-2256; Picardo, Mauro/0000-0003-4899-6639; Mileo, Anna Maria/0000-0002-1970-3297; Bellacchio, Emanuele/0000-0002-2757-849X	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; AWASTHI S, 1993, BIOCHIM BIOPHYS ACTA, V1164, P173, DOI 10.1016/0167-4838(93)90245-M; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; Chen C, 1999, CARCINOGENESIS, V20, P699, DOI 10.1093/carcin/20.4.699; Claiborne A., 1985, CRC HDB METHODS OXYG, P283; Cumming RC, 2001, NAT MED, V7, P814, DOI 10.1038/89937; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Dang DT, 2005, CANCER RES, V65, P9485, DOI 10.1158/0008-5472.CAN-05-1930; De Luca A, 2003, CANCER RES, V63, P1430; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; FRIEDL F, 1970, P SOC EXP BIOL MED, V135, P543; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Helt AM, 2003, CARCINOGENESIS, V24, P159, DOI 10.1093/carcin/24.2.159; Henderson CJ, 1998, CHEM-BIOL INTERACT, V112, P69, DOI 10.1016/S0009-2797(97)00176-2; Jentzsch AM, 1996, FREE RADICAL BIO MED, V20, P251, DOI 10.1016/0891-5849(95)02043-8; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Lavia P, 2003, ONCOGENE, V22, P6508, DOI 10.1038/sj.onc.1206861; Lin XH, 2003, CANCER RES, V63, P498; LOBELLO M, 1990, FEBS LETT, V263, P389, DOI 10.1016/0014-5793(90)81421-J; MAEJI NJ, 1990, J IMMUNOL METHODS, V134, P23; Magal SS, 1998, INT J CANCER, V75, P96; Marchese C, 2003, ONCOGENE, V22, P2422, DOI 10.1038/sj.onc.1206301; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; McLaughlin-Drubin ME, 2008, BBA-MOL BASIS DIS, V1782, P127, DOI 10.1016/j.bbadis.2007.12.005; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Mignogna G, 2005, J PROTEOME RES, V4, P1361, DOI 10.1021/pr0500511; MOSCOW JA, 1989, MOL PHARMACOL, V36, P22; Mouret S, 2005, EXP DERMATOL, V14, P401, DOI 10.1111/j.0906-6705.2005.00296.x; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; PASSI S, 1991, Journal of Dermatological Science, V2, P171, DOI 10.1016/0923-1811(91)90064-5; PATRICK DR, 1994, J BIOL CHEM, V269, P6842; PATTILLO R A, 1977, Science (Washington D C), V196, P1456, DOI 10.1126/science.867042; Pfister Herbert, 2003, J Natl Cancer Inst Monogr, P52; RICCI G, 1991, J BIOL CHEM, V266, P21409; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SEEDORF K, 1987, EMBO J, V6, P139, DOI 10.1002/j.1460-2075.1987.tb04731.x; Severino A, 2007, J CELL PHYSIOL, V212, P118, DOI 10.1002/jcp.21011; Shim JH, 2005, PROTEOMICS, V5, P2112, DOI 10.1002/pmic.200401106; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; SPITZ DR, 1989, ANAL BIOCHEM, V179, P8, DOI 10.1016/0003-2697(89)90192-9; TEW KD, 1994, CANCER RES, V54, P4313; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200; Whiteside MA, 2008, CANCER-AM CANCER SOC, V113, P2981, DOI 10.1002/cncr.23750; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	49	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7254	10.1371/journal.pone.0007254	http://dx.doi.org/10.1371/journal.pone.0007254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19826491	gold, Green Published, Green Submitted			2022-12-25	WOS:000270808300001
J	Drake, PMW; Barbi, T; Drever, MR; van Dolleweerd, CJ; Porter, AJR; Ma, JKC				Drake, Pascal M. W.; Barbi, Tommaso; Drever, Matthew R.; van Dolleweerd, Craig J.; Porter, Andrew J. R.; Ma, Julian K. -C.			Generation of transgenic plants expressing antibodies to the environmental pollutant microcystin-LR	FASEB JOURNAL			English	Article						phytoremediation; rhizosecretion	CYANOBACTERIAL HEPATOTOXINS; PHAGE DISPLAY; PROTEIN; GROWTH; TRANSFORMATION; TOXICITY; GENES	We describe the engineering, regeneration, and characterization of transgenic tobacco plants expressing a recombinant antibody specific to microcystin-LR (MC-LR), the environmental toxin pollutant produced by species of cyanobacteria. The antibody was created by a genetic fusion of the antigen-binding regions of the microcystin-specific single-chain antibody, 3A8, with constant regions from the murine IgG1 kappa, Guy's 13. IgG transgenes were controlled by a leader peptide that targets the transgene products to the secretory pathway and also allows for rhizosecretion. The antibody, extracted from the leaves or rhizosecreted into hydroponic medium by transgenic plants, was shown to have functional binding to MC-LR. Antibody yields in transgenic plant leaves reached a maximum of 64 mu g/g leaf fresh weight (0.6% total soluble protein), and the rate of antibody rhizosecretion reached a maximum of 5 mu g/g root dry weight/24 h. Rhizosecreted antibody bound to MC-LR in hydroponic medium, and transgenic plants grew more efficiently on medium containing MC-LR compared to wild-type controls. This proof of concept paves the way for applications to produce diagnostic antibodies to microcystin-LR, remove it from the environment by phytoremediation, or enhance yields in crops exposed to MC-LR.-Drake, P. M. W., Barbi, T., Drever, M. R., van Dolleweerd, C. J., Porter, A. J. R., Ma, J. K.-C. Generation of transgenic plants expressing antibodies to the environmental pollutant microcystin-LR. FASEB J. 24, 882-890 (2010). www.fasebj.org	[Drake, Pascal M. W.] St Georges Univ London, Mol Immunol Unit, Ctr Infect, Dept Cellular & Mol Med,Jenner Wing, London SW17 0RF, England; [Drever, Matthew R.; Porter, Andrew J. R.] Univ Aberdeen, Dept Mol & Cell Biol, Foresterhill Sch Med Sci, Aberdeen, Scotland	St Georges University London; University of London; University College London; University of Aberdeen	Drake, PMW (corresponding author), St Georges Univ London, Mol Immunol Unit, Ctr Infect, Dept Cellular & Mol Med,Jenner Wing, Room 2-148,Floor 2, London SW17 0RF, England.	pdrake@sgul.ac.uk		Drake, Pascal/0000-0002-6181-0600; Ma, Julian/0000-0003-0767-0042; van Dolleweerd, Craig/0000-0002-1380-6930	Sir Joseph Hotung; St. George's University of London/Royal Holloway University of London	Sir Joseph Hotung; St. George's University of London/Royal Holloway University of London	We are grateful to Mark Smedley (John Innes Institute, Norwich, UK) for supplying the pGreen vector. We also thank Sir Joseph Hotung for funding P. M. W. D. and J. K.-C. M. T. B. is funded by a joint St. George's University of London/Royal Holloway University of London Ph.D. studentship.	Borisjuk NV, 1999, NAT BIOTECHNOL, V17, P466, DOI 10.1038/8643; CANGELOSI GA, 1991, METHOD ENZYMOL, V204, P384; DENEVE M, 1993, TRANSGENIC RES, V2, P227, DOI 10.1007/BF01977353; Drake PMW, 2009, FASEB J, V23, P3581, DOI 10.1096/fj.09-131771; Drake PMW, 2002, FASEB J, V16, P1855, DOI 10.1096/fj.02-0148com; Drake PMW, 2003, PLANT MOL BIOL, V52, P233, DOI 10.1023/A:1023909331482; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; HAMVAS MM, 2003, AQUAT TOXICOL, V62, P1; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Harada Ken-Ichi, 1996, Natural Toxins, V4, P277; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Kurki-Helasmo K, 1998, TOXICON, V36, P1921, DOI 10.1016/S0041-0101(98)00114-7; MA JKC, 1995, SCIENCE, V268, P716, DOI 10.1126/science.7732380; MA JKC, 1994, EUR J IMMUNOL, V24, P131, DOI 10.1002/eji.1830240120; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Majsterek I, 2004, COMP BIOCHEM PHYS C, V139, P175, DOI 10.1016/j.cca.2004.10.007; McElhiney J, 2000, FEMS MICROBIOL LETT, V193, P83; McElhiney J, 2005, TOXICOL APPL PHARM, V203, P219, DOI 10.1016/j.taap.2004.06.002; McElhiney J, 2002, APPL ENVIRON MICROB, V68, P5288, DOI 10.1128/AEM.68.11.5288-5295.2002; McElhiney J, 2001, TOXICON, V39, P1411, DOI 10.1016/S0041-0101(01)00100-3; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; OWEN M, 1992, BIO-TECHNOL, V10, P790, DOI 10.1038/nbt0792-790; Pouria S, 1998, LANCET, V352, P21, DOI 10.1016/S0140-6736(97)12285-1; ROGERS SG, 1987, METHOD ENZYMOL, V153, P253; Schultz PG, 2002, NATURE, V418, P485, DOI 10.1038/418485a; Ueno Y, 1996, CARCINOGENESIS, V17, P1317, DOI 10.1093/carcin/17.6.1317; Villani ME, 2009, PLANT BIOTECHNOL J, V7, P59, DOI 10.1111/j.1467-7652.2008.00371.x; Weiss Y, 2006, NAT BIOTECHNOL, V24, P713, DOI 10.1038/nbt1213; Wojcik T, 2008, CURR MED CHEM, V15, P1606, DOI 10.2174/092986708784911533	31	10	10	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2010	24	3					882	890		10.1096/fj.09-140848	http://dx.doi.org/10.1096/fj.09-140848			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	561KE	19841035				2022-12-25	WOS:000274974600024
J	Minhas, N; Xue, ML; Fukudome, K; Jackson, CJ				Minhas, Nikita; Xue, Meilang; Fukudome, Kenji; Jackson, Christopher J.			Activated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function	FASEB JOURNAL			English	Article						endothelial cells; smooth muscle cells; sepsis; permeability; barrier integrity	SEVERE SEPSIS; HUMAN KERATINOCYTES; HEALING PHENOTYPE; TYROSINE KINASE; TIE2 RECEPTOR; SEPTIC SHOCK; IN-VITRO; ANGIOGENESIS; CELLS; IDENTIFICATION	Activated protein C (APC) is an anticoagulant, approved as a treatment for severe sepsis, that can prevent apoptosis, inflammation, and vascular leakage. The aim of this study was to investigate whether APC protects endothelial barrier function through the angiopoietin (Ang)/Tie2 axis. APC significantly up-regulated gene and protein expression of Tie2 and Ang1 in a dose (0.01-10 mu g/ml)- and time (0.5-24h)-dependent manner in human umbilical vein endothelial cells (HUVECs). Interestingly, it markedly inhibited Ang2 with an IC50 of similar to 0.1 mu g/ml. HUVEC permeability, measured using Evans blue dye transfer, was significantly reduced in the presence of APC, and, in concordance, the tight junction associated protein zona occludens (ZO)-1 was up-regulated and localized peripherally around cells, compared with controls. Smooth muscle cell migration toward APC-stimulated HUVECs was elevated compared with un-stimulated cells. Blocking antibodies and small interfering (si) RNA treatment, compared with isotype (IgG) or scrambled siRNA controls, showed that APC requires 3 receptors, the endothelial protein C receptor, protease-activated receptor 1, and Tie2 to perform all these barrier stabilization functions. In summary, this study demonstrates that APC has novel effects on the Ang/Tie2 axis, which enhance endothelial barrier function and are likely to contribute to its therapeutic effect in sepsis and other diseases associated with vascular leakage.-Minhas, N., Xue, M., Fukudome, K., Jackson, C. J. Activated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function. FASEB J. 24, 873-881 (2010). www.fasebj.org	[Minhas, Nikita; Xue, Meilang; Jackson, Christopher J.] Univ Sydney, Royal N Shore Hosp, Sutton Arthrit Res Labs, Inst Bone & Joint Res,Kolling Inst, St Leonards, NSW 2065, Australia; [Fukudome, Kenji] Saga Med Sch, Dept Immunol, Saga, Japan	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Saga University	Jackson, CJ (corresponding author), Univ Sydney, Royal N Shore Hosp, Sutton Arthrit Res Labs, Inst Bone & Joint Res,Kolling Inst, Level 10,Kolling Bldg, St Leonards, NSW 2065, Australia.	cjackson@med.usyd.edu.au		Xue, Meilang/0000-0002-8563-7216; Jackson, Christopher/0000-0002-9234-9116	National Health and Medical Research Council of Australia; Rebecca Cooper Medical Research Foundation; Northern Sydney Area Health Service	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Rebecca Cooper Medical Research Foundation; Northern Sydney Area Health Service	We thank the Royal North Shore Hospital Maternity Unit for providing umbilical cords. Funding was provided by the National Health and Medical Research Council of Australia, the Rebecca Cooper Medical Research Foundation, and the Northern Sydney Area Health Service.	ANDERSON JM, 1989, J CELL BIOL, V109, P1047, DOI 10.1083/jcb.109.3.1047; Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Bae JS, 2007, P NATL ACAD SCI USA, V104, P2867, DOI 10.1073/pnas.0611493104; Baker WF, 1999, SEMIN THROMB HEMOST, V25, P387, DOI 10.1055/s-2007-994942; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bohlin Kath, 1996, Methods in Cell Science, V18, P329, DOI 10.1007/BF00127910; Chen JX, 2008, ARTERIOSCL THROM VAS, V28, P1606, DOI 10.1161/ATVBAHA.108.169235; Childs EW, 2008, AM J PHYSIOL-HEART C, V294, pH2285, DOI 10.1152/ajpheart.01361.2007; Crowley SR, 1996, HEART LUNG, V25, P124, DOI 10.1016/S0147-9563(96)80114-2; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; FIJNVANDRAAT K, 1995, THROMB HAEMOSTASIS, V73, P15; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; FUKUDOME K, 1994, J BIOL CHEM, V269, P26486; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; Ganter MT, 2008, ANN SURG, V247, P320, DOI 10.1097/SLA.0b013e318162d616; Griffin JH, 2002, SEMIN HEMATOL, V39, P197, DOI 10.1053/shem.2002.34093; Harfouche R, 2003, FASEB J, V17, P1523, DOI 10.1096/fj.02-0698fje; Harfouche R, 2006, AM J PHYSIOL-HEART C, V291, pH1635, DOI 10.1152/ajpheart.01318.2005; Hughes DP, 2003, CIRC RES, V92, P630, DOI 10.1161/01.RES.0000063422.38690.DC; Iivanainen E, 2003, FASEB J, V17, P1609, DOI 10.1096/fj.02-0939com; Jackson C, 2008, EXPERT OPIN BIOL TH, V8, P1109, DOI 10.1517/14712598.8.8.1109 ; Jackson CJ, 2005, WOUND REPAIR REGEN, V13, P284, DOI 10.1111/j.1067-1927.2005.00130311.x; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Lay AJ, 2007, BLOOD, V109, P1984, DOI 10.1182/blood-2006-07-037945; Li X, 2008, BLOOD, V111, P3489, DOI 10.1182/blood-2007-05-092148; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Murakami K, 1997, AM J PHYSIOL-LUNG C, V272, pL197, DOI 10.1152/ajplung.1997.272.2.L197; Orfanos SE, 2007, CRIT CARE MED, V35, P199, DOI 10.1097/01.CCM.0000251640.77679.D7; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; PATTERSON CE, 1992, J APPL PHYSIOL, V72, P865, DOI 10.1152/jappl.1992.72.3.865; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Uchiba M, 2004, CIRC RES, V95, P34, DOI 10.1161/01.RES.0000133680.87668.FA; Wada H, 2005, BLOOD COAGUL FIBRIN, V16, P17, DOI 10.1097/00001721-200501000-00003; Wang YL, 2007, EYE, V21, P1501, DOI 10.1038/sj.eye.6702716; Whitmont K, 2008, ARCH DERMATOL, V144, P1479, DOI 10.1001/archderm.144.11.1479; Witzenbichler B, 2005, CIRCULATION, V111, P97, DOI 10.1161/01.CIR.0000151287.08202.8E; Xue ML, 2009, J CELL MOL MED, V13, P749, DOI 10.1111/j.1582-4934.2008.00359.x; Xue ML, 2005, J INVEST DERMATOL, V125, P1279, DOI 10.1111/j.0022-202X.2005.23952.x; Xue ML, 2004, EXP CELL RES, V299, P119, DOI 10.1016/j.yexcr.2004.05.015; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08	44	68	69	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2010	24	3					873	881		10.1096/fj.09-134445	http://dx.doi.org/10.1096/fj.09-134445			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	561KE	19858095				2022-12-25	WOS:000274974600023
J	Chandarlapaty, S; Scaltriti, M; Angelini, P; Ye, Q; Guzman, M; Hudis, CA; Norton, L; Solit, DB; Arribas, J; Baselga, J; Rosen, N				Chandarlapaty, S.; Scaltriti, M.; Angelini, P.; Ye, Q.; Guzman, M.; Hudis, C. A.; Norton, L.; Solit, D. B.; Arribas, J.; Baselga, J.; Rosen, N.			Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth	ONCOGENE			English	Article						p95-HER2; Trastuzumab; breast cancer; HER2	BREAST-CANCER CELLS; MAMMARY EPITHELIUM; ANTITUMOR-ACTIVITY; FACTOR RECEPTOR; KINASE DOMAIN; NEU ONCOGENE; CYCLIN D1; HER2; EXPRESSION; MICE	The anti-HER2 antibody Trastuzumab (Herceptin) has been proven to be effective in the treatment of HER2-overexpressing breast cancer; resistance, however, invariably emerges in metastatic tumors. The expression of p95-HER2, a form of HER2 with a truncated extracellular domain that lacks the Trastuzumab binding epitope, has been implicated as a mechanism of resistance to the antibody. We utilized an in vivo tumor model that overexpresses p95-HER2 and showed it to be resistant to the signaling and antitumor effects of Trastuzumab. We find that both full-length and p95-HER2 interact with the HSP90 chaperone protein and are degraded in tumor cells exposed to HSP90 inhibitors in tissue culture and in vivo. Loss of expression of p95-HER2 is accompanied by downregulation of the phosphoinositide-3 kinase/AKT and extracellular signal-regulated kinase signaling pathways and inhibition of cell proliferation. Chronic administration of HSP90 inhibitors in vivo results in sustained loss of HER2 and p95-HER2 expression and inhibition of AKT activation, together with induction of apoptosis and complete inhibition of tumor growth in Trastuzumab-resistant, p95-HER2-overexpressing models. Thus, p95-HER2 is an HSP90 client protein, the expression and function of which can be effectively suppressed in vivo by HSP90 inhibitors. HSP90 inhibition is therefore a potentially effective therapeutic strategy for p95-HER2-mediated Trastuzumab-resistant breast cancer. Oncogene (2010) 29, 325-334; doi:10.1038/onc.2009.337; published online 26 October 2009	[Chandarlapaty, S.; Hudis, C. A.; Norton, L.; Solit, D. B.; Rosen, N.] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, Dept Med, New York, NY 10065 USA; [Scaltriti, M.; Guzman, M.; Baselga, J.] Vall dHebron Univ Hosp, Med Oncol Serv, Barcelona, Spain; [Angelini, P.; Arribas, J.] Vall dHebron Univ Hosp, Med Oncol Res Program, Barcelona, Spain; [Angelini, P.; Arribas, J.] Autonomous Univ Barcelona, Dept Biochem & Mol Biol, Bellaterra, Spain; [Solit, D. B.; Rosen, N.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Arribas, J.] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Memorial Sloan Kettering Cancer Center; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Memorial Sloan Kettering Cancer Center; ICREA	Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol, Dept Med, 1275 York Ave,Room Z-1760, New York, NY 10065 USA.	rosenn@mskcc.org	Arribas, Joaquin/M-4482-2014; Rosen, Neal/ABF-2677-2020; Solit, David B./AAC-5309-2019; Hudis, Clifford/AAW-9482-2021	Arribas, Joaquin/0000-0002-0504-0664; Hudis, Clifford/0000-0001-7144-8791; Norton, Larry/0000-0003-3701-9250	National Institute of Health Program [P01-CA094060]; Breast Cancer Research Foundation; Arlene Taub; ASCO Foundation Young Investigator Award; NATIONAL CANCER INSTITUTE [P01CA094060] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institute of Health Program; Breast Cancer Research Foundation; Arlene Taub; ASCO Foundation Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICREA(ICREA)	We thank Gail Lewis Phillips and Mark Sliwkowski for providing the Fo5 tumors for this study. We also thank Elisa DeStanchina and Wai Wong for their assistance with animal studies. This work is supported by the National Institute of Health Program Grant P01-CA094060, the Breast Cancer Research Foundation and the generous support of Arlene Taub. S Chandarlapaty is supported by an ASCO Foundation Young Investigator Award.	Anido J, 2006, EMBO J, V25, P3234, DOI 10.1038/sj.emboj.7601191; Baselga J, 1998, CANCER RES, V58, P2825; Basso AD, 2002, ONCOGENE, V21, P1159, DOI 10.1038/sj.onc.1205184; Benezra R, 2005, COLD SH Q B, V70, P375, DOI 10.1101/sqb.2005.70.006; Berns K, 2007, CANCER CELL, V12, P395, DOI 10.1016/j.ccr.2007.08.030; Chandarlapaty S, 2008, CLIN CANCER RES, V14, P240, DOI 10.1158/1078-0432.CCR-07-1667; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Cuello M, 2001, CANCER RES, V61, P4892; Finkle D, 2004, CLIN CANCER RES, V10, P2499, DOI 10.1158/1078-0432.CCR-03-0448; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hermanto U, 2001, ONCOGENE, V20, P7551, DOI 10.1038/sj.onc.1204964; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Lane HA, 2000, MOL CELL BIOL, V20, P3210, DOI 10.1128/MCB.20.9.3210-3223.2000; Lu YH, 2001, JNCI-J NATL CANCER I, V93, P1852, DOI 10.1093/jnci/93.24.1852; MODI S, 2008, ASCO 2008 ANN CHIC I; Modi S, 2007, J CLIN ONCOL, V25, P5410, DOI 10.1200/JCO.2007.11.7960; Molina MA, 2002, CLIN CANCER RES, V8, P347; Molina MA, 2001, CANCER RES, V61, P4744; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Munster PN, 2002, CANCER RES, V62, P3132; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Pedersen K, 2009, MOL CELL BIOL, V29, P3319, DOI 10.1128/MCB.01803-08; Pegram MD, 2000, SEMIN ONCOL, V27, P21; Phillips GDL, 2008, CANCER RES, V68, P9280, DOI 10.1158/0008-5472.CAN-08-1776; RICE J, 2008, AACR ANN M SAN DIEG; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Saez R, 2006, CLIN CANCER RES, V12, P424, DOI 10.1158/1078-0432.CCR-05-1807; Sawai A, 2008, CANCER RES, V68, P589, DOI 10.1158/0008-5472.CAN-07-1570; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Shattuck DL, 2008, CANCER RES, V68, P1471, DOI 10.1158/0008-5472.CAN-07-5962; She QB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003065; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tikhomirov O, 2003, CANCER RES, V63, P39; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Xia WL, 2004, ONCOGENE, V23, P646, DOI 10.1038/sj.onc.1207166; Xu WP, 2001, J BIOL CHEM, V276, P3702, DOI 10.1074/jbc.M006864200; Yakes FM, 2002, CANCER RES, V62, P4132; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	42	99	99	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2010	29	3					325	334		10.1038/onc.2009.337	http://dx.doi.org/10.1038/onc.2009.337			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	546EO	19855434	Green Accepted			2022-12-25	WOS:000273793200002
J	Koczor, CA; Shokolenko, IN; Boyd, AK; Balk, SP; Wilson, GL; LeDoux, SP				Koczor, Christopher A.; Shokolenko, Inna N.; Boyd, Amy K.; Balk, Shawn P.; Wilson, Glenn L.; LeDoux, Susan P.			Mitochondrial DNA Damage Initiates a Cell Cycle Arrest by a Chk2-associated Mechanism in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE EXCISION-REPAIR; HUMAN 8-OXOGUANINE GLYCOSYLASE; INDUCED OXIDATIVE STRESS; PROTEIN-KINASE; INDUCED APOPTOSIS; MTDNA DAMAGE; PATHWAY; OLIGODENDROCYTES; ACTIVATION; RADIATION	Previous work from our laboratory has focused on mitochondrial DNA (mtDNA) repair and cellular viability. However, other events occur prior to the initiation of apoptosis in cells. Because of the importance of mtDNA in ATP production and of ATP in fuel cell cycle progression, we asked whether mtDNA damage was an upstream signal leading to cell cycle arrest. Using quantitative alkaline Southern blot technology, we found that exposure to menadione produced detectable mtDNA damage in HeLa cells that correlated with an S phase cell cycle arrest. To determine whether mtDNA damage was causatively linked to the observed cell cycle arrest, experiments were performed utilizing a MTS-hOGG1-Tat fusion protein to target the hOGG1 repair enzyme to mitochondria and enhance mtDNA repair. The results revealed that the transduction of MTS-hOGG1-Tat into HeLa cells alleviated the cell cycle block following an oxidative insult. Furthermore, mechanistic studies showed that Chk2 phosphorylation was enhanced following menadione exposure. Treatment of the HeLa cells with the hOGG1 fusion protein prior to menadione exposure resulted in an increase in the rate of Chk2 dephosphorylation. These results strongly support a direct link between mtDNA damage and cell cycle arrest.	[Koczor, Christopher A.; Shokolenko, Inna N.; Boyd, Amy K.; Balk, Shawn P.; Wilson, Glenn L.; LeDoux, Susan P.] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA	University of South Alabama	LeDoux, SP (corresponding author), 307 Univ Blvd,MSB1200, Mobile, AL 36688 USA.	sledoux@usouthal.edu		Koczor, Christopher/0000-0003-3565-7953				Abbott DW, 1999, J BIOL CHEM, V274, P2732, DOI 10.1074/jbc.274.5.2732; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; de Souza-Pinto NC, 2008, DNA REPAIR, V7, P1098, DOI 10.1016/j.dnarep.2008.03.011; Dobson AW, 2000, J BIOL CHEM, V275, P37518, DOI 10.1074/jbc.M000831200; Druzhyna NM, 2005, J BIOL CHEM, V280, P21673, DOI 10.1074/jbc.m411531200; Druzhyna NM, 2003, GLIA, V42, P370, DOI 10.1002/glia.10230; Fortini P, 2003, BIOCHIMIE, V85, P1053, DOI 10.1016/j.biochi.2003.11.003; Grishko V, 2005, FREE RADICAL BIO MED, V38, P755, DOI 10.1016/j.freeradbiomed.2004.11.023; Harrison JF, 2005, NUCLEIC ACIDS RES, V33, P4660, DOI 10.1093/nar/gki759; Heideker J, 2007, CELL CYCLE, V6, P3058, DOI 10.4161/cc.6.24.5100; Hollensworth SB, 2000, FREE RADICAL BIO MED, V28, P1161, DOI 10.1016/S0891-5849(00)00214-8; LeDoux SP, 1998, GLIA, V24, P304, DOI 10.1002/(SICI)1098-1136(199811)24:3<304::AID-GLIA4>3.3.CO;2-J; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; Martinez-Alvarado P, 2001, BIOCHEM BIOPH RES CO, V283, P1069, DOI 10.1006/bbrc.2001.4907; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Paris I, 2005, J NEUROCHEM, V92, P1021, DOI 10.1111/j.1471-4159.2004.02931.x; Paris I, 2008, NEUROTOX RES, V13, P221, DOI 10.1007/BF03033505; Rachek LI, 2002, J BIOL CHEM, V277, P44932, DOI 10.1074/jbc.M208770200; ShimodaMatsubayashi S, 1996, BIOCHEM BIOPH RES CO, V226, P561, DOI 10.1006/bbrc.1996.1394; Shokolenko IN, 2005, DNA REPAIR, V4, P511, DOI 10.1016/j.dnarep.2004.11.009; Singh KK, 2006, ANN NY ACAD SCI, V1067, P182, DOI 10.1196/annals.1354.022; Spiteller G, 2002, ANN NY ACAD SCI, V959, P30, DOI 10.1111/j.1749-6632.2002.tb02080.x; Tombes RM, 1998, BIOCHEM J, V330, P1451; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001	25	42	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36191	36201		10.1074/jbc.M109.036020	http://dx.doi.org/10.1074/jbc.M109.036020			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19840931	hybrid, Green Published			2022-12-25	WOS:000272970500021
J	Torres, R; Ramirez, JC				Torres, Raul; Ramirez, Juan C.			A Chemokine Targets the Nucleus: Cxcl12-Gamma Isoform Localizes to the Nucleolus in Adult Mouse Heart	PLOS ONE			English	Article							CELL-DERIVED FACTOR-1; RECEPTOR CXCR4; MESSENGER-RNA; EXPRESSION; SDF-1; INTRACRINE; PROTEIN; TRANSLATION; SURVIVAL; AUG	Chemokines are extracellular mediators of complex regulatory circuits involved principally in cell-to-cell communication. Most studies to date of the essential chemokine Cxcl12 (Sdf-1) have focused on the ubiquitously expressed secreted isoforms alpha and beta. Here we show that, unlike these isoforms and all other known chemokines, the alternatively transcribed c isoform is an intracellular protein that localizes to the nucleolus in differentiated mouse Cardiac tissue. Our results demonstrate that nucleolar transportation is encoded by a nucleolar-localization signal in the unique carboxy-terminal region of Sdf-1 gamma, and is competent both in vivo and in vitro. The molecular mechanism underlying these unusual chemokine properties involves cardiac-specific transcription of an mRNA containing a unique short-leader sequence lacking the signal peptide and translation from a non-canonical CUG codon. Our results provide an example of genome economy even for essential and highly conserved genes such as Cxcl12, and suggest that chemokines can exert tissue specific functions unrelated to cell-to-cell communication.			Torres, R (corresponding author), Fdn CNIC Natl Ctr Cardiovasc Res, Tech Unit Gene Targeting, Viral Vector Facil, Madrid, Spain.	jcramirez@cnic.es	Ruiz, Raul Torres/J-1649-2018; Ramírez, Juan Carlos/B-7979-2015	Ruiz, Raul Torres/0000-0001-9606-0398; 				Altenburg JD, 2007, J VIROL, V81, P8140, DOI 10.1128/JVI.00268-07; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Baggiolini M, 2000, IMMUNOL REV, V177, P5, DOI 10.1034/j.1600-065X.2000.17722.x; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Delrieu I, 2000, FEBS LETT, V468, P6, DOI 10.1016/S0014-5793(00)01189-3; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Fiaschi-Taesch NM, 2003, ENDOCRINOLOGY, V144, P407, DOI 10.1210/en.2002-220818; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Gleichmann M, 2000, EUR J NEUROSCI, V12, P1857, DOI 10.1046/j.1460-9568.2000.00048.x; Gortz A, 2002, J IMMUNOL, V169, P1387, DOI 10.4049/jimmunol.169.3.1387; Gudlaugsdottir S, 2007, GENETICA, V131, P299, DOI 10.1007/s10709-007-9139-4; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; Jans DA, 1998, BIOESSAYS, V20, P400, DOI 10.1002/(SICI)1521-1878(199805)20:5<400::AID-BIES7>3.0.CO;2-R; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; KIEFER P, 1994, EMBO J, V13, P4126, DOI 10.1002/j.1460-2075.1994.tb06730.x; Kijowski J, 2001, STEM CELLS, V19, P453, DOI 10.1634/stemcells.19-5-453; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Martindill DMJ, 2007, NAT CELL BIOL, V9, P1131, DOI 10.1038/ncb1633; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nguyen MTA, 2001, ENDOCRINOLOGY, V142, P694, DOI 10.1210/en.142.2.694; Ochs RL, 1998, METHOD CELL BIOL, V53, P303; Petit I, 2005, J CLIN INVEST, V115, P168, DOI 10.1172/JCI200521773; Pillarisetti K, 2001, INFLAMMATION, V25, P293, DOI 10.1023/A:1012808525370; Risebro CA, 2006, DEVELOPMENT, V133, P4595, DOI 10.1242/dev.02625; Rueda P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002543; Segret A, 2007, J HISTOCHEM CYTOCHEM, V55, P141, DOI 10.1369/jhc.6A7050.2006; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Sierra MD, 2004, BLOOD, V103, P2452; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	45	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7570	10.1371/journal.pone.0007570	http://dx.doi.org/10.1371/journal.pone.0007570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859557	gold, Green Published, Green Submitted			2022-12-25	WOS:000271147400003
J	Salminen, NH; May, PJC; Alku, P; Tiitinen, H				Salminen, Nelli H.; May, Patrick J. C.; Alku, Paavo; Tiitinen, Hannu			A Population Rate Code of Auditory Space in the Human Cortex	PLOS ONE			English	Article							INFERIOR COLLICULUS; SOUND LOCALIZATION; INTERAURAL TIME; STIMULUS AZIMUTH; SUPERIOR OLIVE; RECEPTIVE-FIELDS; SPATIAL LOCATION; CORTICAL-NEURONS; NEURAL CODE; CAT	Background: Previous work on the human auditory cortex has revealed areas specialized in spatial processing but how the neurons in these areas represent the location of a sound source remains unknown. Methodology/Principal Findings: Here, we performed a magnetoencephalography (MEG) experiment with the aim of revealing the neural code of auditory space implemented by the human cortex. In a stimulus-specific adaptation paradigm, realistic spatial sound stimuli were presented in pairs of adaptor and probe locations. We found that the attenuation of the N1m response depended strongly on the spatial arrangement of the two sound sources. These location-specific effects showed that sounds originating from locations within the same hemifield activated the same neuronal population regardless of the spatial separation between the sound sources. In contrast, sounds originating from opposite hemifields activated separate groups of neurons. Conclusions/Significance: These results are highly consistent with a rate code of spatial location formed by two opponent populations, one tuned to locations in the left and the other to those in the right. This indicates that the neuronal code of sound source location implemented by the human auditory cortex is similar to that previously found in other primates.			Salminen, NH (corresponding author), Aalto Univ, Dept Biomed Engn & Computat Sci, Helsinki, Finland.	nelli.salminen@tkk.fi	Alku, Paavo/E-2400-2012; May, Patrick JC/E-1786-2015	May, Patrick JC/0000-0002-3954-0421; Alku, Paavo/0000-0002-8173-9418				Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; AITKIN LM, 1987, J NEUROPHYSIOL, V57, P1185, DOI 10.1152/jn.1987.57.4.1185; AITKIN LM, 1985, J NEUROPHYSIOL, V53, P43, DOI 10.1152/jn.1985.53.1.43; Barone P, 1996, J NEUROPHYSIOL, V75, P1206, DOI 10.1152/jn.1996.75.3.1206; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; BENSON DA, 1981, BRAIN RES, V219, P249, DOI 10.1016/0006-8993(81)90290-0; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; BRUGGE JF, 1973, J NEUROPHYSIOL, V36, P1138, DOI 10.1152/jn.1973.36.6.1138; BUTLER RA, 1972, NEUROPSYCHOLOGIA, V10, P219, DOI 10.1016/0028-3932(72)90063-2; BUTLER RA, 1968, J ACOUST SOC AM, V44, P945, DOI 10.1121/1.1911233; CHAN JCK, 1987, J NEUROPHYSIOL, V58, P543, DOI 10.1152/jn.1987.58.3.543; CLAREY JC, 1995, J NEUROPHYSIOL, V74, P961, DOI 10.1152/jn.1995.74.3.961; Delgutte B, 1999, J NEUROPHYSIOL, V81, P2833, DOI 10.1152/jn.1999.81.6.2833; Deouell LY, 2007, NEURON, V55, P985, DOI 10.1016/j.neuron.2007.08.019; EISENMAN LM, 1974, BRAIN RES, V75, P203, DOI 10.1016/0006-8993(74)90742-2; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; Groh JM, 2003, J COGNITIVE NEUROSCI, V15, P1217, DOI 10.1162/089892903322598166; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; IVARSSON C, 1988, J NEUROPHYSIOL, V59, P586, DOI 10.1152/jn.1988.59.2.586; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; KING AJ, 1987, J NEUROPHYSIOL, V57, P596, DOI 10.1152/jn.1987.57.2.596; KNUDSEN EI, 1978, J NEUROPHYSIOL, V41, P870, DOI 10.1152/jn.1978.41.4.870; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; Krumbholz K, 2005, CEREB CORTEX, V15, P317, DOI 10.1093/cercor/bhh133; Krumbholz K, 2007, J NEUROPHYSIOL, V97, P1649, DOI 10.1152/jn.00560.2006; KUWADA S, 1987, J NEUROPHYSIOL, V57, P1338, DOI 10.1152/jn.1987.57.5.1338; LEIMAN AL, 1972, EXP NEUROL, V35, P431, DOI 10.1016/0014-4886(72)90114-8; LIEGEOISCHAUVEL C, 1994, ELECTROEN CLIN NEURO, V92, P204, DOI 10.1016/0168-5597(94)90064-7; Lutkenhoner B, 1998, AUDIOL NEURO-OTOL, V3, P191, DOI 10.1159/000013790; McAlpine D, 2003, TRENDS NEUROSCI, V26, P347, DOI 10.1016/S0166-2236(03)00140-1; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; Middlebrooks JC, 2002, NEUROSCIENTIST, V8, P73, DOI 10.1177/107385840200800112; MIDDLEBROOKS JC, 1981, J NEUROSCI, V1, P107, DOI 10.1523/JNEUROSCI.01-01-00107.1981; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Middlebrooks JC, 1998, J NEUROPHYSIOL, V80, P863, DOI 10.1152/jn.1998.80.2.863; MIDDLEBROOKS JC, 1984, J NEUROSCI, V4, P2621; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; PALMER AR, 1982, NATURE, V299, P248, DOI 10.1038/299248a0; Palomaki K, 2000, NEUROREPORT, V11, P1535, DOI 10.1097/00001756-200005150-00033; Palomaki KJ, 2005, COGNITIVE BRAIN RES, V24, P364, DOI 10.1016/j.cogbrainres.2005.02.013; Palomaki KJ, 2002, COGNITIVE BRAIN RES, V14, P294, DOI 10.1016/S0926-6410(02)00132-5; REALE RA, 1990, J NEUROPHYSIOL, V64, P1247, DOI 10.1152/jn.1990.64.4.1247; Recanzone GH, 2000, P NATL ACAD SCI USA, V97, P11829, DOI 10.1073/pnas.97.22.11829; ROSE JE, 1966, J NEUROPHYSIOL, V29, P288, DOI 10.1152/jn.1966.29.2.288; Samson FK, 2000, J NEUROPHYSIOL, V84, P1330, DOI 10.1152/jn.2000.84.3.1330; SHAMMA SA, 1989, J ACOUST SOC AM, V86, P989, DOI 10.1121/1.398734; Stecker GC, 2005, PLOS BIOL, V3, P520, DOI 10.1371/journal.pbio.0030078; STILLMAN RD, 1971, EXP NEUROL, V32, P404, DOI 10.1016/0014-4886(71)90007-0; STUMPF E, 1992, EXP BRAIN RES, V88, P158, DOI 10.1007/BF02259137; SULLIVAN WE, 1986, P NATL ACAD SCI USA, V83, P8400, DOI 10.1073/pnas.83.21.8400; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Tiitinen H, 2006, NEUROSCI LETT, V396, P17, DOI 10.1016/j.neulet.2005.11.018; Tollin DJ, 2002, J NEUROSCI, V22, P1454, DOI 10.1523/JNEUROSCI.22-04-01454.2002; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Ungan P, 2001, CLIN NEUROPHYSIOL, V112, P485, DOI 10.1016/S1388-2457(00)00550-2; Uutela K, 1999, NEUROIMAGE, V10, P173, DOI 10.1006/nimg.1999.0454; van BERGEIJK WILLEM A., 1962, JOUR ACOUSTICAL SOC AMER, V34, P1431, DOI 10.1121/1.1918364; von Bekesy G, 1930, PHYS Z, V31, P824; VONBEKESY, 1960, EXPT HERARING; Warren JD, 2003, J NEUROSCI, V23, P5799; Werner-Reiss U, 2008, J NEUROSCI, V28, P3747, DOI 10.1523/JNEUROSCI.5044-07.2008; Woods TM, 2006, J NEUROPHYSIOL, V96, P3323, DOI 10.1152/jn.00392.2006; Xu L, 1998, J NEUROPHYSIOL, V80, P882, DOI 10.1152/jn.1998.80.2.882; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904	71	64	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7600	10.1371/journal.pone.0007600	http://dx.doi.org/10.1371/journal.pone.0007600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855836	Green Submitted, Green Published, gold			2022-12-25	WOS:000271147200016
J	Sato, N; Yamaguchi, Y				Sato, Naoyuki; Yamaguchi, Yoko			A Computational Predictor of Human Episodic Memory Based on a Theta Phase Precession Network	PLOS ONE			English	Article							HIERARCHICAL COGNITIVE MAP; HIPPOCAMPAL NETWORK; SPATIAL MEMORY; PLACE; EEG; DEPENDENCE; SEQUENCES; CELLS; TASK; REPRESENTATION	In the rodent hippocampus, a phase precession phenomena of place cell firing with the local field potential (LFP) theta is called "theta phase precession'' and is considered to contribute to memory formation with spike time dependent plasticity (STDP). On the other hand, in the primate hippocampus, the existence of theta phase precession is unclear. Our computational studies have demonstrated that theta phase precession dynamics could contribute to primate-hippocampal dependent memory formation, such as object-place association memory. In this paper, we evaluate human theta phase precession by using a theory-experiment combined analysis. Human memory recall of object-place associations was analyzed by an individual hippocampal network simulated by theta phase precession dynamics of human eye movement and EEG data during memory encoding. It was found that the computational recall of the resultant network is significantly correlated with human memory recall performance, while other computational predictors without theta phase precession are not significantly correlated with subsequent memory recall. Moreover the correlation is larger than the correlation between human recall and traditional experimental predictors. These results indicate that theta phase precession dynamics are necessary for the better prediction of human recall performance with eye movement and EEG data. In this analysis, theta phase precession dynamics appear useful for the extraction of memory-dependent components from the spatio-temporal pattern of eye movement and EEG data as an associative network. Theta phase precession may be a common neural dynamic between rodents and humans for the formation of environmental memories.			Sato, N (corresponding author), Future Univ Hakodate, Sch Syst Informat Sci, Dept Complex Syst, Hakodate, Hokkaido, Japan.	satonao@fun.ac.jp						Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BURGESS N, 1994, NEURAL NETWORKS, V7, P1065, DOI 10.1016/S0893-6080(05)80159-5; Cave C B, 1991, Hippocampus, V1, P329, DOI 10.1002/hipo.450010323; Croft RJ, 2000, NEUROPHYSIOL CLIN, V30, P5, DOI 10.1016/S0987-7053(00)00055-1; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Everitt B. S., 2001, CLUSTER ANAL; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Kerr KM, 2007, HIPPOCAMPUS, V17, P697, DOI 10.1002/hipo.20315; King JA, 2002, HIPPOCAMPUS, V12, P811, DOI 10.1002/hipo.10070; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Matsumura N, 1999, J NEUROSCI, V19, P2381; MCNAMARA TP, 1989, J EXP PSYCHOL LEARN, V15, P211, DOI 10.1037/0278-7393.15.2.211; Mishkin M, 1997, PHILOS T R SOC B, V352, P1461, DOI 10.1098/rstb.1997.0132; Molter C, 2008, HIPPOCAMPUS, V18, P919, DOI 10.1002/hipo.20450; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Petitti D. B., 2000, METAANALYSIS DECISIO, P94; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; Sato N, 2005, HIPPOCAMPUS, V15, P963, DOI 10.1002/hipo.20110; Sato N, 2003, NEURAL COMPUT, V15, P2379, DOI 10.1162/089976603322362400; SATO N, NEUROREPORT IN PRESS; Sato N, 2007, NEUROREPORT, V18, P419, DOI 10.1097/WNR.0b013e3280586760; Sato N, 2009, COGN NEURODYNAMICS, V3, P131, DOI 10.1007/s11571-008-9074-9; Sato N, 2008, ADVANCES IN COGNITIVE NEURODYNAMICS, PROCEEDINGS, P429, DOI 10.1007/978-1-4020-8387-7_73; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; Stepankova K, 2004, NEUROPSYCHOLOGIA, V42, P1017, DOI 10.1016/j.neuropsychologia.2004.01.002; STEWART M, 1991, BRAIN RES, V538, P59, DOI 10.1016/0006-8993(91)90376-7; Summerfield C, 2005, NEUROIMAGE, V24, P692, DOI 10.1016/j.neuroimage.2004.09.012; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Wagatsuma H, 2004, NEURAL COMPUT, V16, P2665, DOI 10.1162/0899766042321742; Wu ZH, 2004, BIOL CYBERN, V90, P113, DOI 10.1007/s00422-003-0454-2; Yamaguchi Y, 2003, BIOL CYBERN, V89, P1, DOI 10.1007/s00422-003-0415-9	40	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7536	10.1371/journal.pone.0007536	http://dx.doi.org/10.1371/journal.pone.0007536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851508	Green Published, gold, Green Submitted			2022-12-25	WOS:000271022300004
J	Broderick, T; MacKay, DJC				Broderick, Tamara; MacKay, David J. C.			Fast and Flexible Selection with a Single Switch	PLOS ONE			English	Article							COMMUNICATION	Selection methods that require only a single-switch input, such as a button click or blink, are potentially useful for individuals with motor impairments, mobile technology users, and individuals wishing to transmit information securely. We present a single-switch selection method, "Nomon,'' that is general and efficient. Existing single-switch selection methods require selectable options to be arranged in ways that limit potential applications. By contrast, traditional operating systems, web browsers, and free-form applications (such as drawing) place options at arbitrary points on the screen. Nomon, however, has the flexibility to select any point on a screen. Nomon adapts automatically to an individual's clicking ability; it allows a person who clicks precisely to make a selection quickly and allows a person who clicks imprecisely more time to make a selection without error. Nomon reaps gains in information rate by allowing the specification of beliefs (priors) about option selection probabilities and by avoiding tree-based selection schemes in favor of direct (posterior) inference. We have developed both a Nomon-based writing application and a drawing application. To evaluate Nomon's performance, we compared the writing application with a popular existing method for single-switch writing (row-column scanning). Novice users wrote 35% faster with the Nomon interface than with the scanning interface. An experienced user (author TB, with > 10 hours practice) wrote at speeds of 9.3 words per minute with Nomon, using 1.2 clicks per character and making no errors in the final text.			Broderick, T (corresponding author), Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA.	tab@stat.berkeley.edu						Baljko M., 2006, P ASSETS 2006, P18; DAMPER RI, 1984, APPL ERGON, V15, P289, DOI 10.1016/0003-6870(84)90201-1; Esser J., 1994, AAC, V10, P237, DOI [DOI 10.1080/07434619412331276940, 10.1080/07434619412331276940]; Evreinov G, 2004, LECT NOTES COMPUT SC, V3118, P836; HORN EM, 1996, AUGMENTATIVE ALTERNA, V12, P23, DOI DOI 10.1080/07434619612331277448; *ITU, 2004, M1677 ITUR; Kilgarriff Adam, 1998, BNC DATABASE WORD FR; Koester H H, 1994, Assist Technol, V6, P42; KOESTER HH, 1996, AUGMENTATIVE ALTERNA, V12, P155, DOI DOI 10.1080/07434619612331277608; Kristensson PO, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P567; Lesher G W, 1998, IEEE Trans Rehabil Eng, V6, P415, DOI 10.1109/86.736156; MACKAY DJ, 2007, ANOTHER ONE BUTTON D; MACKAY DJ, 2006, DASHERS ONE BUTTON D; MacKay DJC, 2004, AIP CONF PROC, V735, P207, DOI 10.1063/1.1835215; MacKenzie IS, 2002, LECT NOTES COMPUT SC, V2411, P195; MACKENZIE IS, 2003, CHI 03 HUM FACT COMP, P00754, DOI DOI 10.1145/765891.765971; MEAD JMG, 2009, EFFICIENT COMMUNICAT; MIZUKO M, 1991, J SPEECH HEAR RES, V34, P43, DOI 10.1044/jshr.3401.43; PETERSEN K, 2000, AUGMENTATIVE ALTERNA, V16, P27, DOI DOI 10.1080/07434610012331278884; Ratcliff A., 1994, AAC, V10, P67, DOI [DOI 10.1080/07434619412331276770, 10.1080/07434619412331276770]; *SENS SOFTW INT LT, 2008, GRID 2 VERS 2 4; Silverman B.W., 1986, DENSITY ESTIMATION S; Simpson R C, 1999, IEEE Trans Rehabil Eng, V7, P464, DOI 10.1109/86.808950; *SUN JAV DESKT SYS, 2004, GOK MAN V 2 3; Szeto A., 1993, AUGMENTATIVE ALTERNA, V9, P229; Venkatagiri Horabail, 1999, AUGMENT ALTERN COMM, V15, P126; Wagner BT, 2006, J SPEECH LANG HEAR R, V49, P113, DOI 10.1044/1092-4388(2006/009); WAGNER RA, 1974, J ACM, V21, P168, DOI 10.1145/321796.321811; Wand M. P., 1994, KERNEL SMOOTHING; Ward D. J., 2000, UIST. Proceedings of the 13th Annual ACM Symposium on User Interface Software and Technology, P129, DOI 10.1145/354401.354427; Ward DJ, 2002, NATURE, V418, P838, DOI 10.1038/418838a; *WORDS INC, 2004, EZ KEYS XP PROD SPEC; *WORDS INC, 2000, EZ KEYS US MAN	33	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7481	10.1371/journal.pone.0007481	http://dx.doi.org/10.1371/journal.pone.0007481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847300	Green Published, gold, Green Submitted			2022-12-25	WOS:000271022000006
J	Jimenez-Dalmaroni, MJ; Xiao, NM; Corper, AL; Verdino, P; Ainge, GD; Larsen, DS; Painter, GF; Rudd, PM; Dwek, RA; Hoebe, K; Beutler, B; Wilson, IA				Jimenez-Dalmaroni, Maximiliano J.; Xiao, Nengming; Corper, Adam L.; Verdino, Petra; Ainge, Gary D.; Larsen, Dave S.; Painter, Gavin F.; Rudd, Pauline M.; Dwek, Raymond A.; Hoebe, Kasper; Beutler, Bruce; Wilson, Ian A.			Soluble CD36 Ectodomain Binds Negatively Charged Diacylglycerol Ligands and Acts as a Co-Receptor for TLR2	PLOS ONE			English	Article							B SCAVENGER RECEPTOR; MYCOBACTERIAL PHOSPHATIDYLINOSITOL MANNOSIDE; CRYSTAL-STRUCTURE; LIPOPOLYSACCHARIDE LPS; LIPOTEICHOIC ACID; CD14; CELLS; ATHEROSCLEROSIS; PROTEIN; IDENTIFICATION	Background: Cluster of differentiation 36 (CD36) is a transmembrane glycoprotein involved in many biological processes, such as platelet biology, angiogenesis and in the aetiopathology of atherosclerosis and cardiovascular diseases. Toll-like receptors (TLRs) are one of the most important receptors of the innate immune system. Their main function is the recognition of conserved structure of microorganisms. This recognition triggers signaling pathways that activate transcription of cytokines and co-stimulatory molecules which participate in the generation of an immune response against microbes. In particular, TLR2 has been shown to recognize a broad range of ligands. Recently, we showed that CD36 serves as a co-receptor for TLR2 and enhances recognition of specific diacylglycerides derived from bacteria. Methodology/Principal Findings: Here, we investigate the mechanism by which CD36 contributes to ligand recognition and activation of TLR2 signaling pathway. We show that the ectodomain of murine CD36 (mCD36ED) directly interacts with negatively charged diacylglycerol ligands, which explains the specificity and selectivity of CD36 as a TLR2 co-receptor. We also show that mCD36ED amplifies the pro-inflammatory response to lipoteichoic acid in macrophages of wild-type mice and restores the pro-inflammatory response of macrophages from mice deficient in CD36 (oblivious), but not from mice deficient in cluster of differentiation 14 (CD14) (heedless). Conclusion/Significance: These data indicate that the CD36 ectodomain is the only relevant domain for activation of TLR2 signaling pathway and that CD36 and CD14 have a non-redundant role for loading ligands onto TLR2 in the plasma-membrane. The pro-inflammatory role of soluble CD36 can be relevant in the activation of the immune response against pathogens, as well as in the progression of chronic diseases. Therefore, an increased level of soluble forms of CD36, which has been reported to be increased in type II diabetic patients, could accelerate atherosclerosis by increasing the pro-inflammatory response to diacylglycerol ligands.			Jimenez-Dalmaroni, MJ (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH USA.	kasper.hoebe@cchmc.org; bruce@scripps.edu; wilson@scripps.edu	Eckhardt, Erik/G-1567-2010; Larsen, David S/A-6367-2014	Larsen, David S/0000-0002-3563-1086; Hoebe, Kasper/0000-0002-3626-8098; Jimenez-Dalmaroni, Maximiliano Javier/0000-0001-5468-6982	NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042266, P01AI070167, R01AI042266] Funding Source: NIH RePORTER; NCI NIH HHS [CA58896, R01 CA058896] Funding Source: Medline; NIAID NIH HHS [AI42266, R37 AI042266, AI070167-01, R01 AI042266, P01 AI070167] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ainge GD, 2006, BIOORGAN MED CHEM, V14, P7615, DOI 10.1016/j.bmc.2006.07.003; Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Basu D, 2000, J IMMUNOL, V164, P5788, DOI 10.4049/jimmunol.164.11.5788; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Bodart V, 2002, CIRC RES, V90, P844, DOI 10.1161/01.RES.0000016164.02525.B4; Boullier A, 2005, J LIPID RES, V46, P969, DOI 10.1194/jlr.M400496-JLR200; Collot-Teixeira S, 2007, CARDIOVASC RES, V75, P468, DOI 10.1016/j.cardiores.2007.03.010; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Glintborg D, 2008, DIABETES CARE, V31, P328, DOI 10.2337/dc07-1424; Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Hancock K, 2008, J IMMUNOL METHODS, V330, P130, DOI 10.1016/j.jim.2007.08.002; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864; Latz E, 2003, J ENDOTOXIN RES, V9, P375, DOI 10.1179/096805103225003303; Martin CA, 2007, PROTEIN SCI, V16, P2531, DOI 10.1110/ps.073007207; Means TK, 1999, J IMMUNOL, V163, P3920; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; Nicholson AC, 2000, ANN NY ACAD SCI, V902, P128; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Ohgami N, 2001, ANN NY ACAD SCI, V947, P350; Ohgami N, 2002, J DIABETES COMPLICAT, V16, P56, DOI 10.1016/S1056-8727(01)00208-2; Patel SN, 2007, J IMMUNOL, V178, P3954, DOI 10.4049/jimmunol.178.6.3954; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Platt N, 1998, CHEM BIOL, V5, pR193, DOI 10.1016/S1074-5521(98)90156-9; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rasmussen JT, 1998, EUR J BIOCHEM, V257, P488, DOI 10.1046/j.1432-1327.1998.2570488.x; Reiher FK, 2002, INT J CANCER, V98, P682, DOI 10.1002/ijc.10247; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Silverstein RL, 2000, CURR OPIN LIPIDOL, V11, P483, DOI 10.1097/00041433-200010000-00006; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Tapping RI, 2003, J ENDOTOXIN RES, V9, P264, DOI 10.1179/096805103225001477; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Verdino P, 2008, J IMMUNOL, V180, P2313, DOI 10.4049/jimmunol.180.4.2313; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; WURFEL MM, 1995, J EXP MED, V181, P1743, DOI 10.1084/jem.181.5.1743; Zajonc DM, 2006, J IMMUNOL, V177, P4577, DOI 10.4049/jimmunol.177.7.4577	56	68	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7411	10.1371/journal.pone.0007411	http://dx.doi.org/10.1371/journal.pone.0007411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847289	Green Submitted, Green Published, gold			2022-12-25	WOS:000271022000004
J	Lee, MY; Huang, JP; Chen, YY; Aplin, JD; Wu, YH; Chen, CY; Chen, PC; Chen, CP				Lee, Ming-Yi; Huang, Jian-Pei; Chen, Yi-Yung; Aplin, John D.; Wu, Yi-Hsin; Chen, Chia-Yu; Chen, Pei-Chun; Chen, Chie-Pein			Angiogenesis in Differentiated Placental Multipotent Mesenchymal Stromal Cells Is Dependent on Integrin alpha(5)beta(1)	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HUMAN FETOPLACENTAL VASCULOGENESIS; STEM-CELLS; EXTRACELLULAR-MATRIX; HEMATOPOIETIC STEM; FUNCTIONAL EXPRESSION; VASCULAR DEVELOPMENT; GENE-EXPRESSION; MOUSE EMBRYOS; MICE LACKING	Human placental multipotent mesenchymal stromal cells (hPMSCs) can be isolated from term placenta, but their angiogenic ability and the regulatory pathways involved are not known. hPMSCs were shown to express integrins alpha(v), alpha(4), alpha(5), beta(1), beta(3), and beta(5) and could be induced to differentiate into cells expressing endothelial markers. Increases in cell surface integrins a(5) and beta(1), but not alpha(4), alpha(v)beta(3), or alpha(v)beta(5), accompanied endothelial differentiation. Vascular endothelial growth factor-A augmented the effect of fibronectin in enhancing adhesion and migration of differentiated hPMSC through integrin alpha(5)beta(1), but not alpha(v)beta(3) or alpha(v)beta(5). Formation of capillary-like structures in vitro from differentiated cells was inhibited by pre-treatment with function-blocking antibodies to integrins alpha(5) and beta(1). When hPMSCs were seeded onto chick chorioallantoic membranes (CAM), human von Willebrand factor-positive cells were observed to engraft in the chick endothelium. CAMs transplanted with differentiated hPMSCs had a greater number of vessels containing human cells and more incorporated cells per vessel compared to CAMs transplanted with undifferentiated hPMSCs, and overall angiogenesis was enhanced more by the differentiated cells. Function-blocking antibodies to integrins alpha(5) and beta(1) inhibited angiogenesis in the CAM assay. These results suggest that differentiated hPMSCs may contribute to blood vessel formation, and this activity depends on integrin alpha(5)beta(1).			Lee, MY (corresponding author), Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.	cpchen@ms2.mmh.org.tw	CHEN, CHEN/HDM-6657-2022; Aplin, John/AET-4363-2022	Lee, Ming-Yi/0000-0001-7742-9508; Aplin, John/0000-0001-8777-9261				Alviano F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-11; Astrof S, 2007, DEV BIOL, V311, P11, DOI 10.1016/j.ydbio.2007.07.005; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Barry F, 2001, BIOCHEM BIOPH RES CO, V289, P519, DOI 10.1006/bbrc.2001.6013; Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Battula VL, 2008, DIFFERENTIATION, V76, P326, DOI 10.1111/j.1432-0436.2007.00225.x; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Bloch W, 1997, J CELL BIOL, V139, P265, DOI 10.1083/jcb.139.1.265; Bortoloso E, 2004, EUR J ENDOCRINOL, V150, P799, DOI 10.1530/eje.0.1500799; Breier G, 1996, TRENDS CELL BIOL, V6, P454, DOI 10.1016/0962-8924(96)84935-X; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; CHALLIER JC, 2001, CELL MOL BIOL, V47; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004; Chen CP, 2009, HUM REPROD, V24, P154, DOI 10.1093/humrep/den356; Chen CP, 2003, PLACENTA, V24, P316, DOI 10.1053/plac.2002.0904; Chen CP, 2002, AM J OBSTET GYNECOL, V187, P764, DOI 10.1067/mob.2002.125243; Clark RAF, 1996, AM J PATHOL, V148, P1407; Dao MA, 1998, BLOOD, V92, P4612, DOI 10.1182/blood.V92.12.4612.424k04_4612_4621; Demir R, 2007, ACTA HISTOCHEM, V109, P257, DOI 10.1016/j.acthis.2007.02.008; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; Dye JF, 2004, ENDOTHELIUM-J ENDOTH, V11, P151, DOI 10.1080/10623320490512093; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Eliceiri BP, 2001, CURR OPIN CELL BIOL, V13, P563, DOI 10.1016/S0955-0674(00)00252-0; ELICES MJ, 1994, J CLIN INVEST, V93, P405, DOI 10.1172/JCI116975; Feistritzer C, 2004, AM J RESP CELL MOL, V30, P729, DOI 10.1165/rcmb.2003-0314OC; Feng L, 1999, RADIOLOGY, V212, P655, DOI 10.1148/radiology.212.3.r99au28655; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Gang EJ, 2006, CYTOTHERAPY, V8, P215, DOI 10.1080/14653240600735933; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Huang XZ, 2000, MOL CELL BIOL, V20, P755, DOI 10.1128/MCB.20.3.755-759.2000; HURLEY RW, 1995, J CLIN INVEST, V96, P511, DOI 10.1172/JCI118063; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Ishikane S, 2008, STEM CELLS, V26, P2625, DOI 10.1634/stemcells.2008-0236; Jiang WG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-16; Kale S, 2004, FASEB J, V18, P270, DOI 10.1096/fj.04-1604fje; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Kim S, 2000, J BIOL CHEM, V275, P33920, DOI 10.1074/jbc.M003668200; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Liao WB, 2009, TRANSPLANTATION, V87, P350, DOI 10.1097/TP.0b013e318195742e; Magnussen A, 2005, CANCER RES, V65, P2712, DOI 10.1158/0008-5472.CAN-04-2691; Mayhew TM, 2004, PLACENTA, V25, P127, DOI 10.1016/j.placenta.2003.10.010; Milner R, 2002, MOL CELL NEUROSCI, V20, P616, DOI 10.1006/mcne.2002.1151; Muether PS, 2007, EXP EYE RES, V85, P356, DOI 10.1016/j.exer.2007.06.004; Nishishita T, 2004, BIOCHEM BIOPH RES CO, V325, P24, DOI 10.1016/j.bbrc.2004.10.003; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Parsons-Wingerter P, 2005, AM J PATHOL, V167, P193, DOI 10.1016/S0002-9440(10)62965-3; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Portmann-Lanz CB, 2006, AM J OBSTET GYNECOL, V194, P664, DOI 10.1016/j.ajog.2006.01.101; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Senger DR, 1996, AM J PATHOL, V149, P293; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Taverna D, 2001, CANCER RES, V61, P5255; Umeda N, 2006, MOL PHARMACOL, V69, P1820, DOI 10.1124/mol.105.020941; van der Loo JCM, 1998, J CLIN INVEST, V102, P1051, DOI 10.1172/JCI3687; Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042; Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; Wu CC, 2008, J BIOMECH, V41, P813, DOI 10.1016/j.jbiomech.2007.11.008; YANG JT, 1993, DEVELOPMENT, V119, P1093; Yang S, 1999, AM J PATHOL, V155, P887, DOI 10.1016/S0002-9440(10)65188-7; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098; YODER MC, 1995, EXP HEMATOL, V23, P961; Zhang Y, 2004, EXP HEMATOL, V32, P657, DOI 10.1016/j.exphem.2004.04.001	76	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e6913	10.1371/journal.pone.0006913	http://dx.doi.org/10.1371/journal.pone.0006913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847290	Green Published, gold, Green Submitted			2022-12-25	WOS:000271022000001
J	Plaskon, NE; Adelman, ZN; Myles, KM				Plaskon, Nicole E.; Adelman, Zach N.; Myles, Kevin M.			Accurate Strand-Specific Quantification of Viral RNA	PLOS ONE			English	Article							REAL-TIME PCR; HEPATITIS-C; VIRUS-RNA; RT-PCR; REPLICATION; QUANTITATION; POLYMERASE; CELLS; LIVER	The presence of full-length complements of viral genomic RNA is a hallmark of RNA virus replication within an infected cell. As such, methods for detecting and measuring specific strands of viral RNA in infected cells and tissues are important in the study of RNA viruses. Strand-specific quantitative real-time PCR (ssqPCR) assays are increasingly being used for this purpose, but the accuracy of these assays depends on the assumption that the amount of cDNA measured during the quantitative PCR (qPCR) step accurately reflects amounts of a specific viral RNA strand present in the RT reaction. To specifically test this assumption, we developed multiple ssqPCR assays for the positive-strand RNA virus o'nyong-nyong (ONNV) that were based upon the most prevalent ssqPCR assay design types in the literature. We then compared various parameters of the ONNV-specific assays. We found that an assay employing standard unmodified virus-specific primers failed to discern the difference between cDNAs generated from virus specific primers and those generated through false priming. Further, we were unable to accurately measure levels of ONNV (-) strand RNA with this assay when higher levels of cDNA generated from the (+) strand were present. Taken together, these results suggest that assays of this type do not accurately quantify levels of the anti-genomic strand present during RNA virus infectious cycles. However, an assay permitting the use of a tag-specific primer was able to distinguish cDNAs transcribed from ONNV (-) strand RNA from other cDNAs present, thus allowing accurate quantification of the anti-genomic strand. We also report the sensitivities of two different detection strategies and chemistries, SYBR(R) Green and DNA hydrolysis probes, used with our tagged ONNV-specific ssqPCR assays. Finally, we describe development, design and validation of ssqPCR assays for chikungunya virus (CHIKV), the recent cause of large outbreaks of disease in the Indian Ocean region.			Plaskon, NE (corresponding author), Virginia Tech, Fralin Life Sci Inst, Dept Entomol, Blacksburg, VA 24061 USA.	mylesk@vt.edu		Adelman, Zach/0000-0001-5901-7171	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077726] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI077726-02, AI077726, R01 AI077726] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afonina I, 2007, BIOTECHNIQUES, V43, P770, DOI 10.2144/000112631; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Anwar A, 2006, ANAL BIOCHEM, V352, P120, DOI 10.1016/j.ab.2006.01.046; Bartolome J, 2007, J VIROL, V81, P7710, DOI 10.1128/JVI.02750-06; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Castillo I, 2006, CLIN INFECT DIS, V43, P1277, DOI 10.1086/508198; Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864; Gu CJ, 2007, VIRUS GENES, V34, P289, DOI 10.1007/s11262-006-0019-2; GUNJI T, 1994, ARCH VIROL, V134, P293, DOI 10.1007/BF01310568; Hashimoto Y, 2008, J INVERTEBR PATHOL, V98, P243, DOI 10.1016/j.jip.2008.02.002; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Kim KH, 2004, VIROLOGY, V323, P153, DOI 10.1016/j.virol.2004.03.009; Komurian-Pradel F, 2004, J VIROL METHODS, V116, P103, DOI 10.1016/j.jviromet.2003.10.004; Lin L, 2002, J VIROL METHODS, V100, P97, DOI 10.1016/S0166-0934(01)00399-8; Peyrefitte CN, 2003, J VIROL METHODS, V113, P19, DOI 10.1016/S0166-0934(03)00218-0; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Purcell MK, 2006, J VIROL METHODS, V132, P18, DOI 10.1016/j.jviromet.2005.08.017; Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132; SAWICKI DL, 1980, J VIROL, V34, P108, DOI 10.1128/JVI.34.1.108-118.1980; SHIRAKO Y, 1994, J VIROL, V68, P1874, DOI 10.1128/JVI.68.3.1874-1885.1994; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Timofeeva AV, 2001, BIOTECHNIQUES, V30, P22, DOI 10.2144/01301bm02; Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Yuki N, 2006, J HEPATOL, V44, P302, DOI 10.1016/j.jhep.2005.10.014	26	73	75	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7468	10.1371/journal.pone.0007468	http://dx.doi.org/10.1371/journal.pone.0007468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847293	Green Published, Green Submitted, gold			2022-12-25	WOS:000271022000005
J	Simon-Sanchez, J; Seelaar, H; Bochdanovits, Z; Deeg, DJH; van Swieten, JC; Heutink, P				Simon-Sanchez, Javier; Seelaar, Harro; Bochdanovits, Zoltan; Deeg, Dorly J. H.; van Swieten, John C.; Heutink, Peter			Variation at GRN 3 '-UTR rs5848 Is Not Associated with a Risk of Frontotemporal Lobar Degeneration in Dutch Population	PLOS ONE			English	Article							DEMENTIA; MUTATIONS; PROGRANULIN; PREVALENCE; PATHOLOGY; TDP-43	Background: A single nucleotide polymorphism (rs5848) located in the 3'- untranslated region of GRN has recently been associated with a risk of frontotemporal lobar degeneration (FTLD) in North American population particularly in pathologically confirmed cases with neural inclusions immunoreactive for ubiquitin and TAR DNA-binding protein 43 (TDP-43), but negative for tau and alpha-synuclein (FTLD-TDP). Methodology/Principal Findings: In an effort to replicate these results in a different population, rs5848 was genotyped in 256 FTLD cases and 1695 controls from the Netherlands. Single SNP gender-adjusted logistic regression analysis revealed no significant association between variation at rs5848 and FTLD. Fisher's exact test, failed to find any significant association between rs5848 and a subset of 23 pathology confirmed FTLD-TDP cases. Conclusions/Significance: The evidence presented here suggests that variation at rs5848 does not contribute to the etiology of FTLD in the Dutch population.			Simon-Sanchez, J (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Med Genom, Amsterdam, Netherlands.	p.heutink@vumc.nl		van Swieten, John/0000-0001-6278-6844; Heutink, Peter/0000-0001-5218-1737; Simon Sanchez, Javier/0000-0001-5141-5829				Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bergmann M, 1996, ACTA NEUROPATHOL, V92, P170, DOI 10.1007/s004010050505; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Deeg DJH, 2002, J CLIN EPIDEMIOL, V55, P319, DOI 10.1016/S0895-4356(01)00475-9; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Gijselinck I, 2008, HUM MUTAT, V29, P1373, DOI 10.1002/humu.20785; Graff-Radford NR, 2007, SEMIN NEUROL, V27, P48, DOI 10.1055/s-2006-956755; Mackenzie IRA, 2006, ACTA NEUROPATHOL, V112, P539, DOI 10.1007/s00401-006-0138-9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pickering-Brown SM, 2002, BRAIN, V125, P732, DOI 10.1093/brain/awf069; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; ROLLINSON S, 2009, NEUROBIOL AGING; Rollinson S, 2009, NEUROBIOL AGING, V30, P656, DOI 10.1016/j.neurobiolaging.2009.01.009; Rosso SM, 2003, BRAIN, V126, P2016, DOI 10.1093/brain/awg204; Seelaar H, 2008, NEUROLOGY, V71, P1220, DOI 10.1212/01.wnl.0000319702.37497.72; Seelaar H, 2007, BRAIN, V130, P1375, DOI 10.1093/brain/awm024; Snowden JS, 2002, BRIT J PSYCHIAT, V180, P140, DOI 10.1192/bjp.180.2.140; Stevens M, 1998, NEUROLOGY, V50, P1541, DOI 10.1212/WNL.50.6.1541; VISWANATHAN J, 2008, AM J MED GENET B	22	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7494	10.1371/journal.pone.0007494	http://dx.doi.org/10.1371/journal.pone.0007494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847305	Green Published, gold			2022-12-25	WOS:000271022000008
J	Milton, JG; Ohira, T; Cabrera, JL; Fraiser, RM; Gyorffy, JB; Ruiz, FK; Strauss, MA; Balch, EC; Marin, PJ; Alexander, JL				Milton, John G.; Ohira, Toru; Luis Cabrera, Juan; Fraiser, Ryan M.; Gyorffy, Janelle B.; Ruiz, Ferrin K.; Strauss, Meredith A.; Balch, Elizabeth C.; Marin, Pedro J.; Alexander, Jeffrey L.			Balancing with Vibration: A Prelude for "Drift and Act" Balance Control	PLOS ONE			English	Article							HUMAN POSTURAL SWAY; DELAYED FEEDBACK-CONTROL; MOTOR-EVOKED-POTENTIALS; INVERTED PENDULUM; PARAMETRIC-EXCITATION; AMPLITUDE CONTROL; MUSCLE VIBRATION; NOISE; SYSTEMS; MODEL	Stick balancing at the fingertip is a powerful paradigm for the study of the control of human balance. Here we show that the mean stick balancing time is increased by about two-fold when a subject stands on a vibrating platform that produces vertical vibrations at the fingertip (0.001 m, 15-50 Hz). High speed motion capture measurements in three dimensions demonstrate that vibration does not shorten the neural latency for stick balancing or change the distribution of the changes in speed made by the fingertip during stick balancing, but does decrease the amplitude of the fluctuations in the relative positions of the fingertip and the tip of the stick in the horizontal plane, A(x, y). The findings are interpreted in terms of a time-delayed "drift and act" control mechanism in which controlling movements are made only when controlled variables exceed a threshold, i.e. the stick survival time measures the time to cross a threshold. The amplitude of the oscillations produced by this mechanism can be decreased by parametric excitation. It is shown that a plot of the logarithm of the vibration-induced increase in stick balancing skill, a measure of the mean first passage time, versus the standard deviation of the A(x, y) fluctuations, a measure of the distance to the threshold, is linear as expected for the times to cross a threshold in a stochastic dynamical system. These observations suggest that the balanced state represents a complex time-dependent state which is situated in a basin of attraction that is of the same order of size. The fact that vibration amplitude can benefit balance control raises the possibility of minimizing risk of falling through appropriate changes in the design of footwear and roughness of the walking surfaces.			Milton, JG (corresponding author), Claremont Coll, Joint Sci Dept, Claremont, CA USA.	jmilton@jsd.claremont.edu	CABRERA, Juan Luis/B-5442-2009; Milton, John G/H-7320-2012	CABRERA, Juan Luis/0000-0003-4523-8373; MARIN, PEDRO J/0000-0001-7536-6005				ACHESON D, 1998, CALCULUS CHAOS INTRO; [Anonymous], 1983, J ACOUST SOC AM; Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; Atay FM, 1998, J SOUND VIB, V218, P333, DOI 10.1006/jsvi.1998.1843; Bormann R, 2004, NEUROCOMPUTING, V58, P517, DOI 10.1016/j.neucom.2004.01.089; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Cabrera JL, 2006, CONDENS MATTER PHYS, V9, P373, DOI 10.5488/CMP.9.2.373; Cabrera J. L., 2004, NONLINEAR STUDIES, V11, P305; Cabrera JL, 2004, CHAOS, V14, P691, DOI 10.1063/1.1785453; Cabrera JL, 2004, FLUCT NOISE LETT, V4, pL107, DOI 10.1142/S0219477504001719; Cabrera JL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158702; CHIN C, 1995, INT J BIFURCAT CHAOS, V5, P971, DOI 10.1142/S0218127495000739; Cluff T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005998; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Eurich CW, 1996, PHYS REV E, V54, P6681, DOI 10.1103/PhysRevE.54.6681; Foss J, 1997, PHYS REV E, V55, P4536, DOI 10.1103/PhysRevE.55.4536; Gawthrop P, 2009, BIOL CYBERN, V101, P131, DOI 10.1007/s00422-009-0325-6; Griffin M.J., 1998, FUNDAMENTALS NOISE V, P179; GUCKENHEIMER J, 1995, IEEE T AUTOMAT CONTR, V40, P321, DOI 10.1109/9.341802; Hijmans JM, 2008, J REHABIL RES DEV, V45, P1441, DOI 10.1682/JRRD.2008.02.0023; HOFFMANN ER, 1992, ERGONOMICS, V35, P37, DOI 10.1080/00140139208967796; Ibrahim RA, 2006, NONLINEAR DYNAM, V46, P387, DOI 10.1007/s11071-006-9031-2; Insperger T, 2006, IEEE T CONTR SYST T, V14, P974, DOI 10.1109/TCST.2006.876938; Jenkins G., 1968, SPECTRAL ANAL ITS AP; Jordan MJ, 2005, J STRENGTH COND RES, V19, P459, DOI 10.1519/13293.1; Kawazoe Y., 2008, J SYSTEM DESIGN DYNA, V2, P1351; Kossev A, 2001, CLIN NEUROPHYSIOL, V112, P453, DOI 10.1016/S1388-2457(01)00473-4; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Landry M, 2005, SIAM J APPL DYN SYST, V4, P333, DOI 10.1137/030600461; Loram ID, 2005, J PHYSIOL-LONDON, V564, P281, DOI 10.1113/jphysiol.2004.073437; Loram ID, 2005, J PHYSIOL-LONDON, V564, P295, DOI 10.1113/jphysiol.2004.076307; Loram ID, 2001, J PHYSIOL-LONDON, V532, P879, DOI 10.1111/j.1469-7793.2001.0879e.x; Lumbantobing H, 2004, J FLUID STRUCT, V19, P221, DOI 10.1016/j.jfluidstructs.2003.12.006; Luo J, 2005, SPORTS MED, V35, P23, DOI 10.2165/00007256-200535010-00003; Maccari A, 2008, J SOUND VIB, V317, P20, DOI 10.1016/j.jsv.2008.03.029; Masani K, 2008, J NEUROPHYSIOL, V100, P1465, DOI 10.1152/jn.00801.2007; Milton JG, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/48001; Milton JG, 2004, J CLIN NEUROPHYSIOL, V21, P134, DOI 10.1097/00004691-200405000-00002; Milton J, 2009, CHAOS, V19, DOI 10.1063/1.3141429; Milton J, 2009, PHILOS T R SOC A, V367, P1181, DOI 10.1098/rsta.2008.0257; Morris K.A., 2001, INTRO FEEDBACK CONTR; Moss F, 2003, NATURE, V425, P911, DOI 10.1038/425911a; Newell KM, 1997, EXP BRAIN RES, V113, P158, DOI 10.1007/BF02454152; Peli E, 2003, EXP BRAIN RES, V149, P431, DOI 10.1007/s00221-003-1383-y; Pippard A. B., 1987, European Journal of Physics, V8, P203, DOI 10.1088/0143-0807/8/3/012; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; PROSKE U, 1993, PROG NEUROBIOL, V41, P705, DOI 10.1016/0301-0082(93)90032-N; ROLL JP, 1988, INT CONGR SER, V812, P155; Shumway-Cook A., 2001, MOTOR CONTROL THEORY, V2nd; Sieber J, 2004, PHYSICA D, V197, P332, DOI 10.1016/j.physd.2004.07.007; SIEBER J, 2004, BIFURCATION ANAL INV, P85; Siggelkow S, 1999, MUSCLE NERVE, V22, P1544, DOI 10.1002/(SICI)1097-4598(199911)22:11<1544::AID-MUS9>3.3.CO;2-#; Stepan G., 1989, PITMAN RESEARCHNOTES, V210; Stepan G, 2006, ANNU REV CONTROL, V30, P159, DOI 10.1016/j.arcontrol.2006.08.002; Stepan G, 2009, PHILOS T R SOC A, V367, P1195, DOI 10.1098/rsta.2008.0278; Straw A., 2008, FRONTIERS NEUROINFOR, V11, DOI 10.3389.neuro.11.004:2008; Tang JS, 2009, NONLINEAR ANAL-THEOR, V71, P2491, DOI 10.1016/j.na.2009.01.130; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Yamada N, 1995, HUM MOVEMENT SCI, V14, P711, DOI 10.1016/0167-9457(95)00032-1; [No title captured]	64	57	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7427	10.1371/journal.pone.0007427	http://dx.doi.org/10.1371/journal.pone.0007427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841741	gold, Green Published, Green Submitted			2022-12-25	WOS:000271012900010
J	Dixit, A; Yi, L; Gowthaman, R; Torkamani, A; Schork, NJ; Verkhivker, GM				Dixit, Anshuman; Yi, Lin; Gowthaman, Ragul; Torkamani, Ali; Schork, Nicholas J.; Verkhivker, Gennady M.			Sequence and Structure Signatures of Cancer Mutation Hotspots in Protein Kinases	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; C-KIT; SOMATIC MUTATIONS; ACTIVATION LOOP; CRYSTAL-STRUCTURE; CONFORMATIONAL TRANSITIONS; NUCLEOTIDE POLYMORPHISMS; MOLECULAR-MECHANISMS; CATALYTIC DOMAIN	Protein kinases are the most common protein domains implicated in cancer, where somatically acquired mutations are known to be functionally linked to a variety of cancers. Resequencing studies of protein kinase coding regions have emphasized the importance of sequence and structure determinants of cancer-causing kinase mutations in understanding of the mutation-dependent activation process. We have developed an integrated bioinformatics resource, which consolidated and mapped all currently available information on genetic modifications in protein kinase genes with sequence, structure and functional data. The integration of diverse data types provided a convenient framework for kinome-wide study of sequence-based and structure-based signatures of cancer mutations. The database-driven analysis has revealed a differential enrichment of SNPs categories in functional regions of the kinase domain, demonstrating that a significant number of cancer mutations could fall at structurally equivalent positions (mutational hotspots) within the catalytic core. We have also found that structurally conserved mutational hotspots can be shared by multiple kinase genes and are often enriched by cancer driver mutations with high oncogenic activity. Structural modeling and energetic analysis of the mutational hotspots have suggested a common molecular mechanism of kinase activation by cancer mutations, and have allowed to reconcile the experimental data. According to a proposed mechanism, structural effect of kinase mutations with a high oncogenic potential may manifest in a significant destabilization of the autoinhibited kinase form, which is likely to drive tumorigenesis at some level. Structure-based functional annotation and prediction of cancer mutation effects in protein kinases can facilitate an understanding of the mutation-dependent activation process and inform experimental studies exploring molecular pathology of tumorigenesis.			Dixit, A (corresponding author), Univ Kansas, Ctr Bioinformat, Grad Program Bioinformat, Lawrence, KS 66045 USA.	verk@ku.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471; Gowthaman, Ragul/0000-0002-0008-6401; Schork, Nicholas/0000-0003-0920-5013	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR025774] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abu-Duhier FM, 2001, BRIT J HAEMATOL, V113, P983, DOI 10.1046/j.1365-2141.2001.02850.x; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arora K, 2007, P NATL ACAD SCI USA, V104, P18496, DOI 10.1073/pnas.0706443104; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Banavali NK, 2007, PROTEINS, V67, P1096, DOI 10.1002/prot.21334; Banavali NK, 2009, PROTEINS, V74, P378, DOI 10.1002/prot.22153; Bardelli A, 1998, P NATL ACAD SCI USA, V95, P14379, DOI 10.1073/pnas.95.24.14379; Berteotti A, 2009, J AM CHEM SOC, V131, P244, DOI 10.1021/ja806846q; Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boutet Emmanuel, 2007, V406, P89; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cheetham GMT, 2004, CURR OPIN STRUC BIOL, V14, P700, DOI 10.1016/j.sbi.2004.10.011; Cherry M, 2004, CURR MED CHEM, V11, P663, DOI 10.2174/0929867043455792; Chiara F, 2003, J BIOL CHEM, V278, P29352, DOI 10.1074/jbc.M302404200; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Conde L, 2004, NUCLEIC ACIDS RES, V32, pW242, DOI 10.1093/nar/gkh438; Corbin AS, 2003, BLOOD, V101, P4611, DOI 10.1182/blood-2002-12-3659; Cranston AN, 2006, CANCER RES, V66, P10179, DOI 10.1158/0008-5472.CAN-06-0884; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Dixit A, 2009, BIOPHYS J, V96, P858, DOI 10.1016/j.bpj.2008.10.041; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Ferrao PT, 2003, LEUKEMIA RES, V27, P547, DOI 10.1016/S0145-2126(02)00272-2; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Foster R, 2004, J MOL GRAPH MODEL, V23, P139, DOI 10.1016/j.jmgm.2004.04.003; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Fu YN, 2008, ONCOGENE, V27, P957, DOI 10.1038/sj.onc.1210684; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Gujral TS, 2006, ANN NY ACAD SCI, V1073, P234, DOI 10.1196/annals.1353.025; Gujral TS, 2006, CANCER RES, V66, P10741, DOI 10.1158/0008-5472.CAN-06-3329; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; IZARZUGAZA JM, 2009, PROTEINS IN PRESS; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Kaminker JS, 2007, CANCER RES, V67, P465, DOI 10.1158/0008-5472.CAN-06-1736; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Krallinger M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S1; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Lai AZ, 2007, ENDOCR PATHOL, V18, P57, DOI 10.1007/s12022-007-0009-5; Lander ES, 2000, SCIENCE, V287, P1777, DOI 10.1126/science.287.5459.1777; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lorenzato A, 2002, CANCER RES, V62, P7025; Loriaux MM, 2008, BLOOD, V111, P4788, DOI 10.1182/blood-2007-07-101394; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Madhusudan S, 2004, CLIN BIOCHEM, V37, P618, DOI 10.1016/j.clinbiochem.2004.05.006; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Maritano D, 2000, ONCOGENE, V19, P1354, DOI 10.1038/sj.onc.1203431; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Miller M, 2001, PROTEINS, V44, P32, DOI 10.1002/prot.1069; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Morotti A, 2002, ONCOGENE, V21, P4885, DOI 10.1038/sj.onc.1205622; Nakaigawa N, 2000, ONCOGENE, V19, P2996, DOI 10.1038/sj.onc.1203628; Neuwald AF, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-157; NEUWALD AF, 1995, PROTEIN SCI, V4, P1618, DOI 10.1002/pro.5560040820; Niedner RH, 2006, PROTEINS, V63, P78, DOI 10.1002/prot.20825; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ortutay C, 2005, HUM MUTAT, V25, P435, DOI 10.1002/humu.20166; Ozkirimli E, 2006, PROTEIN SCI, V15, P1051, DOI 10.1110/ps.051999206; Ozkirimli E, 2008, PROTEIN SCI, V17, P1871, DOI 10.1110/ps.037457.108; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Papakyriakou A, 2009, PROTEINS, V76, P375, DOI 10.1002/prot.22353; Parmigiani G, 2009, GENOMICS, V93, P17, DOI 10.1016/j.ygeno.2008.07.005; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Parthiban V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-54; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rebholz-Schuhmann D, 2004, NUCLEIC ACIDS RES, V32, P135, DOI 10.1093/nar/gkh162; Richardson CJ, 2009, NUCLEIC ACIDS RES, V37, pD824, DOI 10.1093/nar/gkn832; Sawyer Tomi K., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P449, DOI 10.2174/1568011043352830; Sawyers CL, 2003, GENE DEV, V17, P2998, DOI 10.1101/gad.1152403; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Schiering N, 2003, P NATL ACAD SCI USA, V100, P12654, DOI 10.1073/pnas.1734128100; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sensi M, 2006, ONCOGENE, V25, P3357, DOI 10.1038/sj.onc.1209379; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Sherry ST, 1999, GENOME RES, V9, P677; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sridhar R, 2000, PHARM RES-DORDR, V17, P1345, DOI 10.1023/A:1007507224529; Stenberg KAE, 2000, NUCLEIC ACIDS RES, V28, P369, DOI 10.1093/nar/28.1.369; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Tan A, 2006, CLIN CHEM, V52, P2250, DOI 10.1373/clinchem.2006.068205; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Torkamani A, 2007, BIOINFORMATICS, V23, P2918, DOI 10.1093/bioinformatics/btm437; Torkamani A, 2009, CANCER LETT, V281, P117, DOI 10.1016/j.canlet.2008.11.008; Torrent M, 2004, J MOL GRAPH MODEL, V23, P153, DOI 10.1016/j.jmgm.2004.05.002; Tyner JW, 2009, LEUKEMIA, V23, P406, DOI 10.1038/leu.2008.187; Valiaho J, 2006, HUM MUTAT, V27, P1209, DOI 10.1002/humu.20410; Vendome J, 2005, J MED CHEM, V48, P6194, DOI 10.1021/jm050231m; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang WR, 2006, P NATL ACAD SCI USA, V103, P3563, DOI 10.1073/pnas.0600048103; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yang S, 2009, P NATL ACAD SCI USA, V106, P3776, DOI 10.1073/pnas.0808261106; Yang S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000047; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318; Zhou TJ, 2007, CHEM BIOL DRUG DES, V70, P171, DOI 10.1111/j.1747-0285.2007.00556.x; Zou J, 2008, PROTEINS, V72, P323, DOI 10.1002/prot.21928	140	57	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7485	10.1371/journal.pone.0007485	http://dx.doi.org/10.1371/journal.pone.0007485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834613	Green Published, Green Submitted, gold			2022-12-25	WOS:000270880700010
J	da Silva, ANMR; Nascimento, EJM; Cordeiro, MT; Gil, LHVG; Abath, FGC; Montenegro, SML; Marques, ETA				Rangel da Silva, Andrea N. M.; Nascimento, Eduardo J. M.; Cordeiro, Marli Tenorio; Gil, Laura H. V. G.; Abath, Frederico G. C.; Montenegro, Silvia M. L.; Marques, Ernesto T. A., Jr.			Identification of Continuous Human B-Cell Epitopes in the Envelope Glycoprotein of Dengue Virus Type 3 (DENV-3)	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; SYNTHETIC PEPTIDE; NEUTRALIZING ANTIBODY; REACTIVE EPITOPES; SWISS-MODEL; DOMAIN-III; PROTEIN; DETERMINANTS; RECOGNITION; PREDICTION	Background: Dengue virus infection is a growing global public health concern in tropical and subtropical regions of the world. Dengue vaccine development has been hampered by concerns that cross-reactive immunological memory elicited by a candidate vaccine could increase the risk of development of more severe clinical forms. One possible strategy to reduce risks associated with a dengue vaccine is the development of a vaccine composed of selected critical epitopes of each of the serotypes. Methodology/Principal Findings: Synthetic peptides were used to identify B-cell epitopes in the envelope (E) glycoprotein of dengue virus type 3 (DENV-3). Eleven linear, immunodominant epitopes distributed in five regions at amino acid (aa) positions: 51-65, 71-90, 131-170, 196-210 and 246-260 were identified by employing an enzyme-linked immunosorbent assay (ELISA), using a pool of human sera from dengue type 3 infected individuals. Peptides 11 (aa51-65), 27 and 28 (aa131-150) also reacted with dengue 1 (DENV-1) and dengue 2 (DENV-2) patient sera as analyzed through the ROC curves generated for each peptide by ELISA and might have serotype specific diagnostic potential. Mice immunized against each one of the five immunogenic regions showed epitopes 51-65, 131-170, 196-210 and 246-260 elicited the highest antibody response and epitopes 131-170, 196-210 and 246-260, elicited IFN-gamma production and T CD4+ cell response, as evaluated by ELISA and ELISPOT assays respectively. Conclusions/Significance: Our study identified several useful immunodominant IgG-specific epitopes on the envelope of DENV-3. They are important tools for understanding the mechanisms involved in antibody dependent enhancement and immunity. If proven protective and safe, in conjunction with others well-documented epitopes, they might be included into a candidate epitope-based vaccine.			da Silva, ANMR (corresponding author), Fiocruz MS, Aggeu Magalhaes Res Ctr, Virol & Expt Therapy Lab, Recife, PE, Brazil.	marques@pitt.edu	Gil, Laura Helena Vega Gonzales/AAX-5319-2021; Marques, Ernesto T. A/L-4967-2013; Publica, Inct Saude/J-9544-2013; montenegro, silvia/AAD-9090-2020; Nascimento, Eduardo/J-4590-2014; Marques, Ernesto/L-4514-2013	Gil, Laura Helena Vega Gonzales/0000-0002-8796-6080; Marques, Ernesto T. A/0000-0003-3826-9358; Nascimento, Eduardo/0000-0002-9851-2332; Marques, Ernesto/0000-0003-3826-9358	NIAID NIH HHS [U19 AI05641] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AnandaRao R, 2005, VIRUS RES, V112, P60, DOI 10.1016/j.virusres.2005.03.022; Apt D, 2006, VACCINE, V24, P335, DOI 10.1016/j.vaccine.2005.07.100; Beasley DWC, 2001, VIROLOGY, V279, P447, DOI 10.1006/viro.2000.0721; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004; Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003; HECHAVARRIA A, 2002, MANUAL PROCEDIMIENTO; Hombach J, 2005, VACCINE, V23, P5205, DOI 10.1016/j.vaccine.2004.11.040; Huang JH, 1999, J MED VIROL, V57, P1, DOI 10.1002/(SICI)1096-9071(199901)57:1&lt;1::AID-JMV1&gt;3.0.CO;2-T; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; MATHEWS JH, 1991, J VIROL, V65, P5141, DOI 10.1128/JVI.65.10.5141-5148.1991; Matsui K, 2009, VIROLOGY, V384, P16, DOI 10.1016/j.virol.2008.11.013; Miagostovich MP, 2002, BRAZ J MED BIOL RES, V35, P869, DOI 10.1590/S0100-879X2002000800002; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Reynolds J, 2009, CLIN EXP IMMUNOL, V155, P311, DOI 10.1111/j.1365-2249.2008.03833.x; Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200; ROEHRIG JT, 1992, J VIROL, V66, P3385, DOI 10.1128/JVI.66.6.3385-3390.1992; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Serafin IL, 2001, ARCH VIROL, V146, P2469, DOI 10.1007/s007050170017; SINGH B, 1980, J IMMUNOL, V124, P1336; Thullier P, 2001, J GEN VIROL, V82, P1885, DOI 10.1099/0022-1317-82-8-1885; Wu HC, 2003, J GEN VIROL, V84, P2771, DOI 10.1099/vir.0.19228-0; Wu HC, 2001, J CLIN MICROBIOL, V39, P977, DOI 10.1128/JCM.39.3.977-982.2001; Yamada KI, 2002, J CLIN VIROL, V24, P203, DOI 10.1016/S1386-6532(01)00250-5; Zhang GL, 2005, NUCLEIC ACIDS RES, V33, pW172, DOI 10.1093/nar/gki452; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019	37	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7425	10.1371/journal.pone.0007425	http://dx.doi.org/10.1371/journal.pone.0007425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19826631	Green Published, gold, Green Submitted			2022-12-25	WOS:000270808300008
J	Grundtman, C; Bruton, J; Yamada, T; Ostberg, T; Pisetsky, DS; Harris, HE; Andersson, U; Lundberg, IE; Westerblad, H				Grundtman, Cecilia; Bruton, Joseph; Yamada, Takashi; Ostberg, Therese; Pisetsky, David S.; Harris, Helena Erlandsson; Andersson, Ulf; Lundberg, Ingrid E.; Westerblad, Hakan			Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies	FASEB JOURNAL			English	Article						MHC class 1; muscle weakness; Ca2+; cytokines; muscle fatigue	GROUP BOX CHROMOSOMAL-PROTEIN-1; MHC CLASS-I; RHEUMATOID-ARTHRITIS; INCREASED-EXPRESSION; ANTIGEN-EXPRESSION; POLYMYOSITIS; DERMATOMYOSITIS; MEDIATOR; TISSUE; ACTIVATION	Idiopathic inflammatory myopathies (IIMs) are heterogeneous rheumatic disorders of unknown cause characterized by muscle weakness, inflammatory cell infiltrates, and major histocompatibility complex (MHC) class I expression on muscle fibers. The nonhistone nuclear protein alarmin high-mobility group box 1 protein (HMGB1) has been detected extranuclearly in muscle biopsies from patients with IIMs. We hypothesize that HMGB1 has a central role in the cause of muscle weakness, particularly in the early phases of IIMs. Experiments were performed on skeletal muscle fibers isolated from adult mice, which were exposed to recombinant interferon (IFN)-gamma or HMGB1. The myoplasmic free [Ca2+] was measured. Stimulation with IFN-gamma resulted in increased HMGB1 expression in muscle nuclei and the myoplasm. Exposure to HMGB1 induced a reversible up-regulation of MHC class I in the muscle fibers. However, HMGB1 exposure caused an irreversible decrease in Ca2+ release from the sarcoplasmic reticulum during fatigue, induced by repeated tetanic contractions. HMGB1 and MHC class I were frequently colocalized in the myoplasm of muscle fibers in muscle biopsies from patients with early IIMs. However, HMGB1-expressing fibers outnumbered fibers expressing MHC class I. Our data indicate that HMGB1 could be an early inducer of skeletal muscle dysfunction in IIMs.-Grundtman, C., Bruton, J., Yamada, T., Ostberg, T., Pisetsky, D. S., Harris, H. E., Andersson, U., Lundberg, I. E., Westerblad, H. Effects of HMGB1 on in vitro responses of isolated muscle fibers and functional aspects in skeletal muscles of idiopathic inflammatory myopathies. FASEB J. 24, 570-578 (2010). www.fasebj.org	[Grundtman, Cecilia; Ostberg, Therese; Harris, Helena Erlandsson; Lundberg, Ingrid E.] Karolinska Univ Hosp Solna, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Ostberg, Therese; Andersson, Ulf] Karolinska Univ Hosp Solna, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Bruton, Joseph; Yamada, Takashi; Westerblad, Hakan] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Pisetsky, David S.] Duke Univ, Med Ctr, Div Rheumatol & Immunol, Durham, NC USA; [Pisetsky, David S.] Durham Vet Adm Hosp, Med Res Serv, Durham, NC USA	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Duke University	Grundtman, C (corresponding author), Innsbruck Med Univ, Lab Autoimmun, Div Expt Pathophysiol & Immunol, Schopfstr 41, A-6020 Innsbruck, Austria.	cecilia.grundtman@i-med.ac.at	Yamada, Takashi/U-8443-2019; Yamada, Takashi/AAZ-6212-2021; Andersson, Ulf/ABD-5162-2021	Yamada, Takashi/0000-0003-1797-3880; Yamada, Takashi/0000-0003-1797-3880; Andersson, Ulf/0000-0003-0316-3860; Bruton, Joseph/0000-0002-6985-099X; Lundberg, Ingrid/0000-0002-6068-9212; Westerblad, Hakan/0000-0002-8180-3029	Myositis Association; Swedish Research Council; Stockholm County Council; Karolinska Institutet; Swedish Rheumatism Association; King Gustaf V 80 Year Foundation; Freemason Lodge Barnhuset, Stockholm; European Union [LSH-018661]; Lupus Research Institute; Veterans Affairs Merit Review; Michele Foundation	Myositis Association; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Rheumatism Association; King Gustaf V 80 Year Foundation; Freemason Lodge Barnhuset, Stockholm; European Union(European Commission); Lupus Research Institute; Veterans Affairs Merit Review(US Department of Veterans Affairs); Michele Foundation	This study was supported by grants from the Myositis Association; the Swedish Research Council; the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and the Karolinska Institutet; the Swedish Rheumatism Association; the King Gustaf V 80 Year Foundation; Funds at the Karolinska Institutet; Freemason Lodge Barnhuset, Stockholm; the European Union Sixth Framework Programme (project AutoCure; LSH-018661); the Lupus Research Institute; Veterans Affairs Merit Review; and the Michele Foundation. The authors thank Associate Professor Inger Nennesmo for the histopathology evaluation of the muscle biopsies.	af Klint E, 2005, ARTHRITIS RHEUM-US, V52, P3880, DOI 10.1002/art.21488; Allen DG, 2008, J APPL PHYSIOL, V104, P296, DOI 10.1152/japplphysiol.00908.2007; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Andrade FH, 1998, J PHYSIOL-LONDON, V509, P565, DOI 10.1111/j.1469-7793.1998.565bn.x; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; ARAHATA K, 1984, ANN NEUROL, V16, P193, DOI 10.1002/ana.410160206; Aydin J, 2009, HUM MOL GENET, V18, P278, DOI 10.1093/hmg/ddn355; BOHAN A, 1975, NEW ENGL J MED, V292, P403, DOI 10.1056/NEJM197502202920807; BOHAN A, 1975, NEW ENGL J MED, V292, P344, DOI 10.1056/NEJM197502132920706; Campana L, 2008, CURR OPIN IMMUNOL, V20, P518, DOI 10.1016/j.coi.2008.04.012; Cea G, 2002, BRAIN, V125, P1635, DOI 10.1093/brain/awf163; De Mori R, 2007, ARTERIOSCL THROM VAS, V27, P2377, DOI 10.1161/ATVBAHA.107.153429; Dorph C, 2001, J RHEUMATOL, V28, P1591; Ek M, 2006, ARTHRITIS RHEUM, V54, P2289, DOI 10.1002/art.21969; EMSLIESMITH AM, 1989, HUM PATHOL, V20, P224, DOI 10.1016/0046-8177(89)90128-7; ENGEL AG, 1990, RES P ARNMD, V68, P141; Englund P, 2002, ARTHRITIS RHEUM, V46, P1044, DOI 10.1002/art.10140; Englund P, 2001, AM J PATHOL, V159, P1263, DOI 10.1016/S0002-9440(10)62513-8; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Grundtman C, 2008, ARTHRITIS RHEUM, V58, P3224, DOI 10.1002/art.23884; Grundtman C, 2007, ARTHRITIS RHEUM, V56, P674, DOI 10.1002/art.22388; Hamada T, 2008, ARTHRITIS RHEUM-US, V58, P2675, DOI 10.1002/art.23729; HOHLFELD R, 1991, NEUROLOGY, V41, P2015, DOI 10.1212/WNL.41.12.2015-c; ISENBERG DA, 1986, CLIN EXP IMMUNOL, V63, P450; Jiang W, 2008, ANN RHEUM DIS, V67, P727, DOI 10.1136/ard.2007.074484; Kokkola R, 2002, ARTHRITIS RHEUM, V46, P2598, DOI 10.1002/art.10540; Levy RM, 2007, AM J PHYSIOL-REG I, V293, pR1538, DOI 10.1152/ajpregu.00272.2007; Liu YW, 1997, AM J PHYSIOL-CELL PH, V273, pC1915, DOI 10.1152/ajpcell.1997.273.6.C1915; Lundberg I, 1997, ARTHRITIS RHEUM, V40, P865, DOI 10.1002/art.1780400514; Martins AS, 2008, J PHYSIOL-LONDON, V586, P197, DOI 10.1113/jphysiol.2007.146571; Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103; Nagaraju K, 1998, CLIN EXP IMMUNOL, V113, P407; Nagaraju K, 1999, CLIN IMMUNOL, V92, P161, DOI 10.1006/clim.1999.4743; Nyberg P, 2000, J RHEUMATOL, V27, P940; Olsen NJ, 1997, ARTHRIT CARE RES, V10, P200, DOI 10.1002/art.1790100308; PEDROL E, 1995, CLIN NEUROPATHOL, V14, P179; Peltz ED, 2009, SHOCK, V32, P17, DOI 10.1097/SHK.0b013e3181997173; Plomgaard P, 2005, EXERC IMMUNOL REV, V11, P53; PLOTZ PH, 1989, ANN INTERN MED, V111, P143, DOI 10.7326/0003-4819-111-2-143; Popovic K, 2005, ARTHRITIS RHEUM, V52, P3639, DOI 10.1002/art.21398; Porto A, 2006, FASEB J, V20, P2565, DOI 10.1096/fj.06-5867fje; Qiu J, 2008, J CEREBR BLOOD F MET, V28, P927, DOI 10.1038/sj.jcbfm.9600582; Reid MB, 2001, J APPL PHYSIOL, V90, P724, DOI 10.1152/jappl.2001.90.2.724; Salomonsson S, 2009, MUSCLE NERVE, V39, P674, DOI 10.1002/mus.21129; Sundberg E, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2387; Taniguchi N, 2003, ARTHRITIS RHEUM, V48, P971, DOI 10.1002/art.10859; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Tzeng HP, 2008, AM J PHYSIOL-HEART C, V294, pH1490, DOI 10.1152/ajpheart.00910.2007; Ulfgren AK, 2004, ARTHRITIS RHEUM, V50, P1586, DOI 10.1002/art.20220; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248	50	61	62	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					570	578		10.1096/fj.09-144782	http://dx.doi.org/10.1096/fj.09-144782			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19837864				2022-12-25	WOS:000274045000024
J	Lee, YS; Lee, S; Demeler, B; Molineux, IJ; Johnson, KA; Yin, YW				Lee, Young-Sam; Lee, Sujin; Demeler, Borries; Molineux, Ian J.; Johnson, Kenneth A.; Yin, Y. Whitney			Each Monomer of the Dimeric Accessory Protein for Human Mitochondrial DNA Polymerase Has a Distinct Role in Conferring Processivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; III HOLOENZYME; SUBUNIT; GAMMA; PURIFICATION; BACTERIOPHAGE-T7; MUTATIONS; BINDING; PRIMASE	The accessory protein polymerase (pol) gamma B of the human mitochondrial DNA polymerase stimulates the synthetic activity of the catalytic subunit. pol gamma B functions by both accelerating the polymerization rate and enhancing polymerase-DNA interaction, thereby distinguishing itself from the accessory subunits of other DNA polymerases. The molecular basis for the unique functions of human pol gamma B lies in its dimeric structure, where the pol gamma B monomer proximal to pol gamma A in the holoenzyme strengthens the interaction with DNA, and the distal pol gamma B monomer accelerates the reaction rate. We further show that human pol gamma B exhibits a catalytic subunit- and substrate DNA-dependent dimerization. By duplicating the monomeric pol gamma B of lower eukaryotes, the dimeric mammalian proteins confer additional processivity to the holoenzyme polymerase.	[Lee, Young-Sam; Lee, Sujin; Molineux, Ian J.; Johnson, Kenneth A.; Yin, Y. Whitney] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Molineux, Ian J.] Univ Texas Austin, Sect Mol Genet & Microbiol, Austin, TX 78712 USA; [Johnson, Kenneth A.; Yin, Y. Whitney] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; [Demeler, Borries] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health San Antonio	Yin, YW (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, 2500 Speedway,MBB 3-422, Austin, TX 78712 USA.	whitney.yin@mail.utexas.edu		Demeler, Borries/0000-0002-2414-9518	National Institutes of Health [GM032095, GM044613, GM083703]; Welch Foundation [F-1604, F-1592]; NIH [RR022200]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR022200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032095, R01GM083703, R01GM044613] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM032095 (to I.J.M.), GM044613 (to K.A.J.), and GM083703 (to Y.W.Y.). This work was also supported by Welch Foundation Grants F-1604 and F-1592 (to K.A.J. and Y.W.Y., respectively). Continuing development of the UltraScan software is supported by NIH Grant RR022200 (to B.D.).	Appleton BA, 2004, MOL CELL, V15, P233, DOI 10.1016/j.molcel.2004.06.018; BROOKES E, 2009, EUR BIOPHYS J; BROOKES E, 2007, GECCO P ACM NEW YORK; Carrodeguas JA, 2002, J BIOL CHEM, V277, P50008, DOI 10.1074/jbc.M207030200; Carrodeguas JA, 2001, MOL CELL, V7, P43, DOI 10.1016/S1097-2765(01)00153-8; Demeler B, 2004, ANAL BIOCHEM, V335, P279, DOI 10.1016/j.ab.2004.08.039; Demeler B, 2008, COLLOID POLYM SCI, V286, P129, DOI 10.1007/s00396-007-1699-4; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; DURCHSCHLAG H, 1986, SPECIFIC VOLUMES BIO, P45; Fan L, 1999, P NATL ACAD SCI USA, V96, P9527, DOI 10.1073/pnas.96.17.9527; Farge G, 2007, NUCLEIC ACIDS RES, V35, P902, DOI 10.1093/nar/gkl1116; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hamdan SM, 2005, P NATL ACAD SCI USA, V102, P5096, DOI 10.1073/pnas.0501637102; HORI K, 1979, J BIOL CHEM, V254, P1591; HUBER HE, 1987, J BIOL CHEM, V262, P16224; Johnson AA, 2000, BIOCHEMISTRY-US, V39, P1702, DOI 10.1021/bi992104w; Johnson AA, 2001, J BIOL CHEM, V276, P38097; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Kollberg G, 2006, J NEUROPATH EXP NEUR, V65, P758, DOI 10.1097/01.jnen.0000229987.17548.6e; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Lee YS, 2009, CELL, V139, P312, DOI 10.1016/j.cell.2009.07.050; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MCHENRY C, 1977, J BIOL CHEM, V252, P6478; WERNETTE CM, 1986, J BIOL CHEM, V261, P4764; Yakubovskaya E, 2006, J BIOL CHEM, V281, P374, DOI 10.1074/jbc.M509730200; Yan L, 2004, J MOL CELL CARDIOL, V37, P921, DOI 10.1016/j.yjmcc.2004.06.012; Zuccola HJ, 2000, MOL CELL, V5, P267, DOI 10.1016/S1097-2765(00)80422-0	30	33	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1490	1499		10.1074/jbc.M109.062752	http://dx.doi.org/10.1074/jbc.M109.062752			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19858216	hybrid, Green Published			2022-12-25	WOS:000273258200068
J	Chowanadisai, W; Bauerly, KA; Tchaparian, E; Wong, A; Cortopassi, GA; Rucker, RB				Chowanadisai, Winyoo; Bauerly, Kathryn A.; Tchaparian, Eskouhie; Wong, Alice; Cortopassi, Gino A.; Rucker, Robert B.			Pyrroloquinoline Quinone Stimulates Mitochondrial Biogenesis through cAMP Response Element-binding Protein Phosphorylation and Increased PGC-1 alpha Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; COACTIVATOR PGC-1; HEPATIC GLUCONEOGENESIS; GENE-EXPRESSION; FATTY-ACIDS; MICE; CREB; CELLS; TRANSCRIPTION; BRAIN	Bioactive compounds reported to stimulate mitochondrial biogenesis are linked to many health benefits such increased longevity, improved energy utilization, and protection from reactive oxygen species. Previously studies have shown that mice and rats fed diets lacking in pyrroloquinoline quinone (PQQ) have reduced mitochondrial content. Therefore, we hypothesized that PQQ can induce mitochondrial biogenesis in mouse hepatocytes. Exposure of mouse Hepa1-6 cells to 10-30 mu M PQQ for 24-48 h resulted in increased citrate synthase and cytochrome c oxidase activity, Mitotracker staining, mitochondrial DNA content, and cellular oxygen respiration. The induction of this process occurred through the activation of cAMP response element-binding protein (CREB) and peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha), a pathway known to regulate mitochondrial biogenesis. PQQ exposure stimulated phosphorylation of CREB at serine 133, activated the promoter of PGC-1 alpha, and increased PGC-1 alpha mRNA and protein expression. PQQ did not stimulate mitochondrial biogenesis after small interfering RNA-mediated reduction in either PGC-1 alpha or CREB expression. Consistent with activation of the PGC-1 alpha pathway, PQQ increased nuclear respiratory factor activation (NRF-1 and NRF-2) and Tfam, TFB1M, and TFB2M mRNA expression. Moreover, PQQ protected cells from mitochondrial inhibition by rotenone, 3-nitro-propionic acid, antimycin A, and sodium azide. The ability of PQQ to stimulate mitochondrial biogenesis accounts in part for action of this compound and suggests that PQQ may be beneficial in diseases associated with mitochondrial dysfunction.	[Chowanadisai, Winyoo; Bauerly, Kathryn A.; Rucker, Robert B.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Tchaparian, Eskouhie] Amgen Inc, San Francisco, CA 94080 USA; [Wong, Alice] Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA; [Cortopassi, Gino A.] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA	University of California System; University of California Davis; Amgen; University of California System; University of California Davis; University of California System; University of California Davis	Rucker, RB (corresponding author), Univ Calif Davis, Dept Nutr, 3135 Meyer Hall,1 Shields Ave, Davis, CA 95616 USA.	rbrucker@ucdavis.edu			Mitsubishi Gas Chemical Co; University of California Davis Center for Health and Nutrition Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035747] Funding Source: NIH RePORTER	Mitsubishi Gas Chemical Co; University of California Davis Center for Health and Nutrition Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Mitsubishi Gas Chemical Co. and the University of California Davis Center for Health and Nutrition Research.	AIZENMAN E, 1992, J NEUROSCI, V12, P2362; Bauerly KA, 2006, BBA-GEN SUBJECTS, V1760, P1741, DOI 10.1016/j.bbagen.2006.07.009; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Cao WH, 2004, MOL CELL BIOL, V24, P3057, DOI 10.1128/MCB.24.7.3057-3067.2004; Carter CS, 2007, APPL PHYSIOL NUTR ME, V32, P954, DOI 10.1139/H07-085; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; Choi YS, 2002, BBA-GENE STRUCT EXPR, V1574, P200, DOI 10.1016/S0167-4781(01)00361-X; Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200; Das S, 2008, PHARM RES-DORDR, V25, P2593, DOI 10.1007/s11095-008-9677-1; Davis JM, 2009, AM J PHYSIOL-REG I, V296, pR1071, DOI 10.1152/ajpregu.90925.2008; Debray FG, 2008, CURR OPIN PEDIATR, V20, P471, DOI 10.1097/MOP.0b013e328306ebb6; Felton LM, 2005, NATURE, V433, pE10, DOI 10.1038/nature03322; GALLOP PM, 1989, TRENDS BIOCHEM SCI, V14, P343, DOI 10.1016/0968-0004(89)90169-2; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hara H, 2007, NEUROCHEM RES, V32, P489, DOI 10.1007/s11064-006-9257-x; He K, 2003, BIOCHEM PHARMACOL, V65, P67, DOI 10.1016/S0006-2952(02)01453-3; Herzig RP, 2000, J BIOL CHEM, V275, P13134, DOI 10.1074/jbc.275.17.13134; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Herzig S, 2003, NATURE, V426, P190, DOI 10.1038/nature02110; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; JENSEN FE, 1994, NEUROSCIENCE, V62, P399, DOI 10.1016/0306-4522(94)90375-1; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kasahara T, 2003, NATURE, V422, P832, DOI 10.1038/422832a; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; KUMAZAWA T, 1995, BIOCHEM J, V307, P331, DOI 10.1042/bj3070331; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Liang HY, 2007, ANN NY ACAD SCI, V1100, P264, DOI 10.1196/annals.1395.028; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu JK, 2005, NUTR NEUROSCI, V8, P67, DOI 10.1080/10284150500047161; Liu ZB, 2007, J NEUROCHEM, V103, P2690, DOI 10.1111/j.1471-4159.2007.04954.x; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; MARTIN PM, 1978, ENDOCRINOLOGY, V103, P1860, DOI 10.1210/endo-103-5-1860; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mitchell AE, 1999, ANAL BIOCHEM, V269, P317, DOI 10.1006/abio.1999.4039; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c; Nunome K, 2008, BIOL PHARM BULL, V31, P1321, DOI 10.1248/bpb.31.1321; Ohwada K, 2008, J CLIN BIOCHEM NUTR, V42, P29, DOI 10.3164/jcbn.2008005; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; Rantanen A, 2001, MAMM GENOME, V12, P787, DOI 10.1007/s00335-001-2052-8; Rasbach KA, 2008, J PHARMACOL EXP THER, V325, P536, DOI 10.1124/jpet.107.134882; Rasbach KA, 2007, BIOCHEM BIOPH RES CO, V355, P734, DOI 10.1016/j.bbrc.2007.02.023; Rucker R, 2005, NATURE, V433, pE10, DOI 10.1038/nature03323; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Ryu H, 2005, P NATL ACAD SCI USA, V102, P13915, DOI 10.1073/pnas.0502878102; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Schulz JB, 1996, NEUROCHEM INT, V29, P167, DOI 10.1016/0197-0186(95)00122-0; Semple RK, 2004, INT J OBESITY, V28, P176, DOI 10.1038/sj.ijo.0802482; SMIDT CR, 1991, P SOC EXP BIOL MED, V197, P27; Smith TS, 1997, BRAIN RES, V765, P183, DOI 10.1016/S0006-8993(97)00429-0; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stancanelli R, 2007, J PHARMACEUT BIOMED, V44, P980, DOI 10.1016/j.jpba.2007.03.025; Steinberg F, 2003, EXP BIOL MED, V228, P160, DOI 10.1177/153537020322800205; STEINBERG FM, 1994, J NUTR, V124, P744, DOI 10.1093/jn/124.5.744; Stites T, 2006, J NUTR, V136, P390, DOI 10.1093/jn/136.2.390; Stites TE, 2000, J NUTR, V130, P719, DOI 10.1093/jn/130.4.719; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Vankoningsloo S, 2006, J CELL SCI, V119, P1266, DOI 10.1242/jcs.02848; Westphal CH, 2007, TRENDS BIOCHEM SCI, V32, P555, DOI 10.1016/j.tibs.2007.09.008; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhang PX, 2005, FEBS LETT, V579, P1446, DOI 10.1016/j.febslet.2005.01.046; Zhang YH, 2006, BRAIN RES, V1094, P200, DOI 10.1016/j.brainres.2006.03.111	72	151	170	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					142	152		10.1074/jbc.M109.030130	http://dx.doi.org/10.1074/jbc.M109.030130			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19861415	Green Published, hybrid			2022-12-25	WOS:000273070100015
J	Sarkar, MK; Paul, K; Blair, DF				Sarkar, Mayukh K.; Paul, Koushik; Blair, David F.			Subunit Organization and Reversal-associated Movements in the Flagellar Switch of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE CROSS-LINKING; SALMONELLA-TYPHIMURIUM; CRYSTAL-STRUCTURE; PROTEIN FLIG; C-RING; REGULATED UNDEREXPRESSION; MUTATIONAL ANALYSIS; BACTERIAL FLAGELLA; GENERATING UNITS; MOTB PROTEIN	Bacterial flagella contain a rotor-mounted protein complex termed the switch complex that functions in flagellar assembly, rotation, and clockwise/counterclockwise direction control. In Escherichia coli and Salmonella, the switch complex contains the proteins FliG, FliM, and FliN and corresponds structurally with the C-ring in the flagellar basal body. Certain features of subunit organization in the switch complex have been deduced previously, but details of subunit organization in the lower part of the C-ring and the molecular movements responsible for motor switching remain unclear. In this study, we use cross-linking, binding, and mutational experiments to examine subunit organization in the bottom of the C-ring and to probe movements that occur upon switching. The results show that FliN tetramers alternate with FliM C-terminal domains to form the bottom of the C-ring in an arrangement that closely reproduces the major features observed in electron microscopic reconstructions. When motors were switched to clockwise rotation by a repellent stimulus, cross-link yields were altered in a pattern indicating relative movement of FliN and FliM(C). These results are discussed in the framework of a structurally grounded hypothesis for the switching mechanism.	[Sarkar, Mayukh K.; Paul, Koushik; Blair, David F.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Blair, DF (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	blair@bioscience.utah.edu	Sarkar, Mayukh/AAH-3655-2021	Sarkar, Mayukh/0000-0002-7974-2300	National Institutes of Health, NIGMS [R01 GM64664, GM64116]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064664] Funding Source: NIH RePORTER	National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM64664 from NIGMS and Grant GM64116.	BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BLAIR DF, 1991, J BACTERIOL, V173, P4049, DOI 10.1128/jb.173.13.4049-4055.1991; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; BLOCK SM, 1984, NATURE, V309, P470, DOI 10.1038/309470a0; Braun TF, 2001, BIOCHEMISTRY-US, V40, P13051, DOI 10.1021/bi011264g; BROWN D A, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1388, DOI 10.1073/pnas.71.4.1388; Brown PN, 2007, J BACTERIOL, V189, P305, DOI 10.1128/JB.01281-06; Brown PN, 2005, J BACTERIOL, V187, P2890, DOI 10.1128/JB.187.8.2890-2902.2005; Brown PN, 2002, EMBO J, V21, P3225, DOI 10.1093/emboj/cdf332; CHUN SY, 1988, SCIENCE, V239, P276, DOI 10.1126/science.2447650; DEAN GE, 1984, J BACTERIOL, V159, P991, DOI 10.1128/JB.159.3.991-999.1984; DEMOT R, 1994, MOL MICROBIOL, V12, P333; Dyer CM, 2009, J MOL BIOL, V388, P71, DOI 10.1016/j.jmb.2009.02.004; GLAGOLEV AN, 1978, NATURE, V272, P280, DOI 10.1038/272280a0; Gonzalez-Pedrajo B, 2006, MOL MICROBIOL, V60, P984, DOI 10.1111/j.1365-2958.2006.05149.x; HIROTA N, 1983, J BIOL CHEM, V258, P577; IRIKURA VM, 1993, J BACTERIOL, V175, P802, DOI 10.1128/JB.175.3.802-810.1993; KAWAGISHI I, 1995, J BACTERIOL, V177, P5158, DOI 10.1128/jb.177.17.5158-5160.1995; KHAN IH, 1992, P NATL ACAD SCI USA, V89, P5956, DOI 10.1073/pnas.89.13.5956; Kihara M, 1996, J BACTERIOL, V178, P4582, DOI 10.1128/jb.178.15.4582-4589.1996; Kihara M, 2000, J BACTERIOL, V182, P3022, DOI 10.1128/JB.182.11.3022-3028.2000; LARSEN SH, 1974, P NATL ACAD SCI USA, V71, P1239, DOI 10.1073/pnas.71.4.1239; LEE GF, 1994, J BIOL CHEM, V269, P29920; Lee SY, 2001, NAT STRUCT BIOL, V8, P52; Lloyd SA, 1996, J BACTERIOL, V178, P223, DOI 10.1128/jb.178.1.223-231.1996; Lowder BJ, 2005, J BACTERIOL, V187, P5640, DOI 10.1128/JB.187.16.5640-5647.2005; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; MANSON MD, 1977, P NATL ACAD SCI USA, V74, P3060, DOI 10.1073/pnas.74.7.3060; Mathews MAA, 1998, J BACTERIOL, V180, P5580, DOI 10.1128/JB.180.21.5580-5590.1998; McMurry JL, 2006, BIOCHEMISTRY-US, V45, P11790, DOI 10.1021/bi0605890; MORRISON TB, 1994, P NATL ACAD SCI USA, V91, P5485, DOI 10.1073/pnas.91.12.5485; OOSAWA K, 1994, J BACTERIOL, V176, P3683, DOI 10.1128/JB.176.12.3683-3691.1994; Park SY, 2006, P NATL ACAD SCI USA, V103, P11886, DOI 10.1073/pnas.0602811103; Paul K, 2006, J BACTERIOL, V188, P2502, DOI 10.1128/JB.188.7.2502-2511.2006; Paul K, 2006, J BACTERIOL, V188, P5240, DOI 10.1128/JB.00110-06; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; SOCKETT H, 1992, J BACTERIOL, V174, P793, DOI 10.1128/jb.174.3.793-806.1992; STADER J, 1986, J BACTERIOL, V166, P244, DOI 10.1128/jb.166.1.244-252.1986; Tang H, 1996, J MOL BIOL, V261, P209, DOI 10.1006/jmbi.1996.0453; TANG H, 1995, J BACTERIOL, V177, P3496, DOI 10.1128/jb.177.12.3496-3503.1995; TANG H, 1995, J BACTERIOL, V177, P3485, DOI 10.1128/jb.177.12.3485-3495.1995; Thomas D, 2001, J BACTERIOL, V183, P6404, DOI 10.1128/JB.183.21.6404-6412.2001; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Toker AS, 1997, J MOL BIOL, V273, P623, DOI 10.1006/jmbi.1997.1335; VOGLER AP, 1991, J BACTERIOL, V173, P3564, DOI 10.1128/jb.173.11.3564-3572.1991; YAMAGUCHI S, 1986, J BACTERIOL, V168, P1172, DOI 10.1128/jb.168.3.1172-1179.1986; YAMAGUCHI S, 1986, J BACTERIOL, V166, P187, DOI 10.1128/jb.166.1.187-193.1986; ZHAO RB, 1995, J MOL BIOL, V251, P400, DOI 10.1006/jmbi.1995.0443; Zhao RH, 1996, J MOL BIOL, V261, P195, DOI 10.1006/jmbi.1996.0452; Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436; Zhou JD, 1998, J BACTERIOL, V180, P2729, DOI 10.1128/JB.180.10.2729-2735.1998	51	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					675	684		10.1074/jbc.M109.068676	http://dx.doi.org/10.1074/jbc.M109.068676			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19858188	Green Published, hybrid			2022-12-25	WOS:000273070100068
J	Bedhomme, M; Zaffagnini, M; Marchand, CH; Gao, XH; Moslonka-Lefebvre, M; Michelet, L; Decottignies, P; Lemaire, SD				Bedhomme, Mariette; Zaffagnini, Mirko; Marchand, Christophe H.; Gao, Xing-Huang; Moslonka-Lefebvre, Mathieu; Michelet, Laure; Decottignies, Paulette; Lemaire, Stephane D.			Regulation by Glutathionylation of Isocitrate Lyase from Chlamydomonas reinhardtii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN S-GLUTATHIONYLATION; ESCHERICHIA-COLI; THIOREDOXIN REDUCTASE; SACCHAROMYCES-CEREVISIAE; ACTIVE-SITE; ACID CYCLE; GLUTAREDOXINS; ARABIDOPSIS; MECHANISMS; REVEALS	Post-translational modification of protein cysteine residues is emerging as an important regulatory and signaling mechanism. We have identified numerous putative targets of redox regulation in the unicellular green alga Chlamydomonas reinhardtii. One enzyme, isocitrate lyase (ICL), was identified both as a putative thioredoxin target and as an S-thiolated protein in vivo. ICL is a key enzyme of the glyoxylate cycle that allows growth on acetate as a sole source of carbon. The aim of the present study was to clarify the molecular mechanism of the redox regulation of Chlamydomonas ICL using a combination of biochemical and biophysical methods. The results clearly show that purified C. reinhardtii ICL can be inactivated by glutathionylation and reactivated by glutaredoxin, whereas thioredoxin does not appear to regulate ICL activity, and no inter-or intramolecular disulfide bond could be formed under any of the conditions tested. Glutathionylation of the protein was investigated by mass spectrometry analysis, Western blotting, and site-directed mutagenesis. The enzyme was found to be protected from irreversible oxidative inactivation by glutathionylation of its catalytic Cys(178), whereas a second residue, Cys(247), becomes artifactually glutathionylated after prolonged incubation with GSSG. The possible functional significance of this post-translational modification of ICL in Chlamydomonas and other organisms is discussed.	[Bedhomme, Mariette; Zaffagnini, Mirko; Gao, Xing-Huang; Moslonka-Lefebvre, Mathieu; Michelet, Laure; Lemaire, Stephane D.] Univ Paris 11, CNRS, UMR 8618, Inst Biotechnol Plantes, F-91405 Orsay, France; [Marchand, Christophe H.; Decottignies, Paulette] Univ Paris 11, CNRS, UMR 8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Lemaire, SD (corresponding author), Univ Paris 11, CNRS, UMR 8618, Inst Biotechnol Plantes, Batiment 630, F-91405 Orsay, France.	stephane.lemaire@u-psud.fr	Gao, XingHuang/G-8579-2017; Lemaire, Stéphane D/A-3530-2008; MARCHAND, Christophe H/B-5854-2008	Lemaire, Stéphane D/0000-0001-6442-0547; MARCHAND, Christophe H/0000-0002-0729-3841; Zaffagnini, Mirko/0000-0001-5115-0859	Agence Nationale de la Recherche [ANR-08-BLAN-0153]	Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche Grant ANR-08-BLAN-0153.	Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; Barrett WC, 1999, BIOCHEMISTRY-US, V38, P6699, DOI 10.1021/bi990240v; Britton KL, 2001, ACTA CRYSTALLOGR D, V57, P1209, DOI 10.1107/S0907444901008642; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820; Chaves RS, 1997, GENE, V198, P165, DOI 10.1016/S0378-1119(97)00311-9; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; DIEHL P, 1994, J BACTERIOL, V176, P927, DOI 10.1128/jb.176.3.927-931.1994; Dixon DP, 2005, BIOCHEMISTRY-US, V44, P7696, DOI 10.1021/bi047324a; Dixon DP, 2005, PLANT PHYSIOL, V138, P2233, DOI 10.1104/pp.104.058917; DURRANT I, 1990, NATURE, V346, P297, DOI 10.1038/346297a0; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fernandes AP, 2005, J BIOL CHEM, V280, P24544, DOI 10.1074/jbc.M500678200; Findlay VJ, 2006, CANCER RES, V66, P6800, DOI 10.1158/0008-5472.CAN-06-0484; Gallogly MM, 2008, BIOCHEMISTRY-US, V47, P11144, DOI 10.1021/bi800966v; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Gao XH, 2009, MOL PLANT, V2, P218, DOI 10.1093/mp/ssn072; Gelhaye E, 2004, P NATL ACAD SCI USA, V101, P14545, DOI 10.1073/pnas.0405282101; Gelhaye E, 2003, FEBS LETT, V555, P443, DOI 10.1016/S0014-5793(03)01301-2; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; JACQUOT JP, 1994, J MOL BIOL, V235, P1357, DOI 10.1006/jmbi.1994.1091; Jung CH, 1996, ARCH BIOCHEM BIOPHYS, V335, P61, DOI 10.1006/abbi.1996.0482; Koh CS, 2008, J BIOL CHEM, V283, P23062, DOI 10.1074/jbc.M802093200; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Lee JW, 2007, P NATL ACAD SCI USA, V104, P8743, DOI 10.1073/pnas.0702081104; Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101; Marchand C, 2006, PROTEOMICS, V6, P6528, DOI 10.1002/pmic.200600443; Marteyn B, 2009, MOL MICROBIOL, V71, P520, DOI 10.1111/j.1365-2958.2008.06550.x; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Michelet L, 2005, P NATL ACAD SCI USA, V102, P16478, DOI 10.1073/pnas.0507498102; Michelet L, 2008, J BIOL CHEM, V283, P21571, DOI 10.1074/jbc.M802331200; Michelet L, 2006, PHOTOSYNTH RES, V89, P225, DOI 10.1007/s11120-006-9096-2; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; MONTRICHARD F, 2009, PROTEOMICS, V72, P452; NIMMO HG, 1989, BIOCHEM J, V261, P431, DOI 10.1042/bj2610431; Park JW, 2009, J BIOL CHEM, V284, P23364, DOI 10.1074/jbc.M109.021394; Petridou S, 1997, PLANT MOL BIOL, V33, P381, DOI 10.1023/A:1005728411921; Popova TN, 1998, BBA-BIOENERGETICS, V1364, P307, DOI 10.1016/S0005-2728(98)00008-5; Rehman A, 1997, CURR MICROBIOL, V35, P267, DOI 10.1007/s002849900251; Reichheld JP, 2007, PLANT CELL, V19, P1851, DOI 10.1105/tpc.107.050849; ROBERTSON AGS, 1995, BIOCHEM J, V305, P239, DOI 10.1042/bj3050239; Rouhier N, 2008, ANNU REV PLANT BIOL, V59, P143, DOI 10.1146/annurev.arplant.59.032607.092811; Rua J, 2002, FUNGAL GENET BIOL, V35, P223, DOI 10.1006/fgbi.2001.1324; Schnarrenberger C, 2002, EUR J BIOCHEM, V269, P868, DOI 10.1046/j.0014-2956.2001.02722.x; Serrano JA, 2001, BBA-GENE STRUCT EXPR, V1520, P154, DOI 10.1016/S0167-4781(01)00263-9; Sharma V, 2000, NAT STRUCT BIOL, V7, P663, DOI 10.1038/77964; Sicard-Roselli C, 2004, EUR J BIOCHEM, V271, P3481, DOI 10.1111/j.1432-1033.2004.04279.x; STEIN M, 1995, PLANT MOL BIOL, V28, P487, DOI 10.1007/BF00020396; Tarrago L, 2009, J BIOL CHEM, V284, P18963, DOI 10.1074/jbc.M109.015487; Taylor KM, 1996, BIOCHEM J, V319, P255, DOI 10.1042/bj3190255; VANNI P, 1990, COMP BIOCHEM PHYS B, V95, P431, DOI 10.1016/0305-0491(90)90002-B; Watanabe S, 2004, MICROBIOL-SGM, V150, P3393, DOI 10.1099/mic.0.27201-0; Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200; Zaffagnini M, 2007, FEBS J, V274, P212, DOI 10.1111/j.1742-4658.2006.05577.x; ZHANG JZ, 1993, MOL GEN GENET, V238, P177, DOI 10.1007/BF00279545	57	36	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36282	36291		10.1074/jbc.M109.064428	http://dx.doi.org/10.1074/jbc.M109.064428			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19847013	Green Published, hybrid			2022-12-25	WOS:000272970500030
J	Igarashi, K; Koivula, A; Wada, M; Kimura, S; Penttila, M; Samejima, M				Igarashi, Kiyohiko; Koivula, Anu; Wada, Masahisa; Kimura, Satoshi; Penttila, Merja; Samejima, Masahiro			High Speed Atomic Force Microscopy Visualizes Processive Movement of Trichoderma reesei Cellobiohydrolase I on Crystalline Cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID-SEQUENCE SIMILARITIES; PHANEROCHAETE-CHRYSOSPORIUM; BINDING MODULES; HYDROLYSIS; CEL7A; CLASSIFICATION; IDENTIFICATION; MICROCRYSTALS; DEGRADATION; CELLOBIOSE	Fungal cellobiohydrolases act at liquid-solid interfaces. They have the ability to hydrolyze cellulose chains of a crystalline substrate because of their two-domain structure, i.e. cellulose-binding domain and catalytic domain, and unique active site architecture. However, the details of the action of the two domains on crystalline cellulose are still unclear. Here, we present real time observations of Trichoderma reesei (Tr) cellobiohydrolase I (Cel7A) molecules sliding on crystalline cellulose, obtained with a high speed atomic force microscope. The average velocity of the sliding movement on crystalline cellulose was 3.5 nm/s, and interestingly, the catalytic domain without the cellulose-binding domain moved with a velocity similar to that of the intact TrCel7A enzyme. However, no sliding of a catalytically inactive enzyme (mutant E212Q) or a variant lacking tryptophan at the entrance of the active site tunnel (mutant W40A) could be detected. This indicates that, besides the hydrolysis of glycosidic bonds, the loading of a cellulose chain into the active site tunnel is also essential for the enzyme movement.	[Igarashi, Kiyohiko; Wada, Masahisa; Kimura, Satoshi; Samejima, Masahiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan; [Koivula, Anu; Penttila, Merja] VTT Tech Res Ctr Finland, Espoo 02044, VTT, Finland	University of Tokyo; VTT Technical Research Center Finland	Igarashi, K (corresponding author), 1-1-1 Yayoi,Bunkyo Ku, Tokyo 1138657, Japan.	aquarius@mail.ecc.u-tokyo.ac.jp	Penttilä, Merja E/A-4710-2013; Igarashi, Kiyohiko/E-6799-2016	Igarashi, Kiyohiko/0000-0001-5152-7177; Penttila, Merja/0000-0002-6929-1032; Koivula, Anu/0000-0002-7600-5700	Japanese Ministry of Education, Culture, Sports, and Technology [19688016, 21688023]; Shin-Nippon Oil Co., Ltd.; Japan Society for the Promotion of Science [17380102]; New Energy and Industrial Technology Development Organization [07003004-0]	Japanese Ministry of Education, Culture, Sports, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Shin-Nippon Oil Co., Ltd.; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by Grants-in-aid for Scientific Research 19688016 and 21688023 from the Japanese Ministry of Education, Culture, Sports, and Technology (to K. I.), a grant for feasibility study from Shin-Nippon Oil Co., Ltd. (to K. I.), Grant-in-aid for Scientific Research 17380102 from the Japan Society for the Promotion of Science (to M. S.), and Grant for Development of Technology for High Efficiency Bioenergy Conversion Project 07003004-0 from the New Energy and Industrial Technology Development Organization (to M. S.).	ABUJA PM, 1989, BIOCHEM BIOPH RES CO, V165, P615, DOI 10.1016/S0006-291X(89)80010-5; Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Barr BK, 1996, BIOCHEMISTRY-US, V35, P586, DOI 10.1021/bi9520388; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; CHANZY H, 1985, FEBS LETT, V184, P285, DOI 10.1016/0014-5793(85)80623-2; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Henrissat B, 1998, FEBS LETT, V425, P352, DOI 10.1016/S0014-5793(98)00265-8; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HON DNS, 1994, CELLULOSE, V1, P1, DOI 10.1007/BF00818796; Igarashi K, 1998, EUR J BIOCHEM, V253, P101, DOI 10.1046/j.1432-1327.1998.2530101.x; Igarashi K, 2008, APPL ENVIRON MICROB, V74, P5628, DOI 10.1128/AEM.00812-08; Igarashi K, 2006, FEBS J, V273, P2869, DOI 10.1111/j.1742-4658.2006.05299.x; Imai T, 1998, FEBS LETT, V432, P113, DOI 10.1016/S0014-5793(98)00845-X; KAMMERMEIER H, 1993, BASIC RES CARDIOL, V88, P380, DOI 10.1007/BF00795405; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Kolomeisky AB, 2007, ANNU REV PHYS CHEM, V58, P675, DOI 10.1146/annurev.physchem.58.032806.104532; KRAULIS PJ, 1989, BIOCHEMISTRY-US, V28, P7241, DOI 10.1021/bi00444a016; Lee I, 2000, ULTRAMICROSCOPY, V82, P213, DOI 10.1016/S0304-3991(99)00158-8; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; LINDER M, 1995, PROTEIN SCI, V4, P1056, DOI 10.1002/pro.5560040604; Linder M, 1997, J BIOTECHNOL, V57, P15, DOI 10.1016/S0168-1656(97)00087-4; Mulakala C, 2005, PROTEINS, V60, P598, DOI 10.1002/prot.20547; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Sinnott ML, 1998, BIOCHEM SOC T, V26, P160, DOI 10.1042/bst0260160; SRISODSUK M, 1993, J BIOL CHEM, V268, P20756; Stahlberg J, 1996, J MOL BIOL, V264, P337, DOI 10.1006/jmbi.1996.0644; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Teeri TT, 1997, TRENDS BIOTECHNOL, V15, P160, DOI 10.1016/S0167-7799(97)01032-9; Teeri TT, 1998, BIOCHEM SOC T, V26, P173, DOI 10.1042/bst0260173; TEWARI YB, 1989, J BIOL CHEM, V264, P3966; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Voutilainen SP, 2008, BIOTECHNOL BIOENG, V101, P515, DOI 10.1002/bit.21940; VRSANSKA M, 1992, CARBOHYD RES, V227, P19, DOI 10.1016/0008-6215(92)85058-8; Wolfenden R, 2008, J AM CHEM SOC, V130, P7548, DOI 10.1021/ja802206s	37	207	215	2	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36186	36190		10.1074/jbc.M109.034611	http://dx.doi.org/10.1074/jbc.M109.034611			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858200	Green Published, hybrid			2022-12-25	WOS:000272970500020
J	Nishimura, T; Kohara, M; Izumi, K; Kasama, Y; Hirata, Y; Huang, Y; Shuda, M; Mukaidani, C; Takano, T; Tokunaga, Y; Nuriya, H; Satoh, M; Saito, M; Kai, C; Tsukiyama-Kohara, K				Nishimura, Tomohiro; Kohara, Michinori; Izumi, Kosuke; Kasama, Yuri; Hirata, Yuichi; Huang, Ying; Shuda, Masahiro; Mukaidani, Chise; Takano, Takashi; Tokunaga, Yuko; Nuriya, Hideko; Satoh, Masaaki; Saito, Makoto; Kai, Chieko; Tsukiyama-Kohara, Kyoko			Hepatitis C Virus Impairs p53 via Persistent Overexpression of 3 beta-Hydroxysterol Delta 24-Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; HEPATOCELLULAR-CARCINOMA; ALZHEIMERS-DISEASE; VIRAL-HEPATITIS; LIVER-CANCER; APOPTOSIS; MDM2; EXPRESSION; INFECTION; GENE	Persistent infection with hepatitis C virus (HCV) induces tumorigenicity in hepatocytes. To gain insight into the mechanisms underlying this process, we generated monoclonal antibodies on a genome-wide scale against an HCV-expressing human hepatoblastoma-derived cell line, RzM6-LC, showing augmented tumorigenicity. We identified 3 beta-hydroxysterol Delta 24-reductase (DHCR24) from this screen and showed that its expression reflected tumorigenicity. HCV induced the DHCR24 overexpression in human hepatocytes. Ectopic or HCV-induced DHCR24 overexpression resulted in resistance to oxidative stress-induced apoptosis and suppressed p53 activity. DHCR24 overexpression in these cells paralleled the increased interaction between p53 and MDM2 (also known as HDM2), a p53-specific E3 ubiquitin ligase, in the cytoplasm. Persistent DHCR24 overexpression did not alter the phosphorylation status of p53 but resulted in decreased acetylation of p53 at lysine residues 373 and 382 in the nucleus after treatment with hydrogen peroxide. Taken together, these results suggest that DHCR24 is elevated in response to HCV infection and inhibits the p53 stress response by stimulating the accumulation of the MDM2-p53 complex in the cytoplasm and by inhibiting the acetylation of p53 in the nucleus.	[Nishimura, Tomohiro; Kasama, Yuri; Tokunaga, Yuko; Satoh, Masaaki; Saito, Makoto; Tsukiyama-Kohara, Kyoko] Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Expt Phylaxiol, Kumamoto 8608556, Japan; [Nishimura, Tomohiro] Kikuchi Res Ctr, Chemoserotherapeut Res Inst, Kumamoto 8691298, Japan; [Kohara, Michinori; Hirata, Yuichi; Shuda, Masahiro; Takano, Takashi; Nuriya, Hideko] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 1568506, Japan; [Izumi, Kosuke; Huang, Ying; Kai, Chieko] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Minato Ku, Tokyo 1088639, Japan; [Mukaidani, Chise] PhoenixBio Co Ltd, Study Serv Dept, Higashihiroshima 7390046, Japan	Kumamoto University; Tokyo Metropolitan Institute of Medical Science; University of Tokyo; PHOENIXBIO CO. LTD.	Tsukiyama-Kohara, K (corresponding author), Kumamoto Univ, Fac Med & Pharmaceut Sci, Dept Expt Phylaxiol, 1-1-1 Honjo, Kumamoto 8608556, Japan.	kkohara@kumamoto-u.ac.jp	SHUDA, MASAHIRO/F-5505-2011; SHUDA, MASAHIRO/N-8239-2019	SHUDA, MASAHIRO/0000-0003-0595-2572; SHUDA, MASAHIRO/0000-0003-0595-2572	Ministry of Health and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Cooperative Research Project on Clinical and Epidemiological Studies of Emerging and Re-emerging Infectious Disease; Hayashi Memorial Foundation for Female Natural Scientists	Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Cooperative Research Project on Clinical and Epidemiological Studies of Emerging and Re-emerging Infectious Disease; Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported by grants from the Ministry of Health and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, the Cooperative Research Project on Clinical and Epidemiological Studies of Emerging and Re-emerging Infectious Diseases, and the Hayashi Memorial Foundation for Female Natural Scientists.	Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bonaccorsi L, 2008, LAB INVEST, V88, P1049, DOI 10.1038/labinvest.2008.80; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Di Stasi D, 2005, INT J CANCER, V115, P224, DOI 10.1002/ijc.20885; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; GRAKOUI A, 1993, J VIROL, V67, P1385, DOI 10.1128/JVI.67.3.1385-1395.1993; Greeve I, 2000, J NEUROSCI, V20, P7345; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Iivonen S, 2002, NEUROSCIENCE, V113, P301, DOI 10.1016/S0306-4522(02)00180-X; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Kiyosawa K, 2004, GASTROENTEROLOGY, V127, pS17, DOI 10.1053/j.gastro.2004.09.012; Kobet E, 2000, P NATL ACAD SCI USA, V97, P12547, DOI 10.1073/pnas.97.23.12547; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kuehnle K, 2008, MOL CELL BIOL, V28, P539, DOI 10.1128/MCB.00584-07; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Malmlof M, 2007, J BIOL CHEM, V282, P2288, DOI 10.1074/jbc.M604953200; MIYASHITA T, 1995, CELL, V80, P293; Ohkubo S, 2006, J BIOL CHEM, V281, P16943, DOI 10.1074/jbc.M601388200; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Pekow JR, 2007, CANCER-AM CANCER SOC, V109, P2490, DOI 10.1002/cncr.22701; Roth J, 1998, EMBO J, V17, P554, DOI 10.1093/emboj/17.2.554; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Tanaka T, 2004, J MED VIROL, V72, P223, DOI 10.1002/jmv.10566; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; Tsukiyama-Kohara K, 2004, J BIOL CHEM, V279, P14531, DOI 10.1074/jbc.M312822200; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; TSUKIYAMAKOHARA K, 1992, J VIROL, V66, P1476, DOI 10.1128/JVI.66.3.1476-1483.1992; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Watanabe T, 2006, GENE THER, V13, P883, DOI 10.1038/sj.gt.3302734; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Wu CW, 2004, NATURE, V432, P640, DOI 10.1038/nature03173; Yamamoto H, 2007, GENES CELLS, V12, P461, DOI 10.1111/j.1365-2443.2007.01065.x; Yasui K, 1998, J VIROL, V72, P6048, DOI 10.1128/JVI.72.7.6048-6055.1998; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yuan ZM, 1999, J BIOL CHEM, V274, P1883, DOI 10.1074/jbc.274.4.1883	41	50	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36442	36452		10.1074/jbc.M109.043232	http://dx.doi.org/10.1074/jbc.M109.043232			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19861417	hybrid, Green Published			2022-12-25	WOS:000272970500046
J	Vollmuth, F; Blankenfeldt, W; Geyer, M				Vollmuth, Friederike; Blankenfeldt, Wulf; Geyer, Matthias			Structures of the Dual Bromodomains of the P-TEFb-activating Protein Brd4 at Atomic Resolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT TRANSCRIPTIONAL ELONGATION; ACETYLATED HISTONE H4; T-BINDING DOMAIN; CRYSTAL-STRUCTURE; 7SK SNRNP; HIV-1 TAT; RECOGNITION; DROSOPHILA; COMPONENT; COMPLEX	Brd4 is a member of the bromodomains and extra terminal domain (BET) family of proteins that recognize acetylated chromatin structures through their bromodomains and act as transcriptional activators. Brd4 functions as an associated factor and positive regulator of P-TEFb, a Cdk9-cyclin T heterodimer that stimulates transcriptional elongation by RNA polymerase II. Here, the crystal structures of the two bromodomains of Brd4 (BD1 and BD2) were determined at 1.5 and 1.2 angstrom resolution, respectively. Complex formation of BD1 with a histone H3 tail polypeptide encompassing residues 12 - 19 showed binding of the N zeta-acetylated lysine 14 to the conserved asparagine 140 of Brd4. In contrast, in BD2 the N-terminal linker sequence was found to interact with the binding site for acetylated lysines of the adjacent molecule to form continuous strings in the crystal lattice. This assembly shows for the first time a different binding ligand than acetylated lysine indicating that also other sequence compositions may be able to form similar interaction networks. Isothermal titration calorimetry revealed best binding of BD1 to H3 and of BD2 to H4 acetylated lysine sequences, suggesting alternating histone recognition specificities. Intriguingly, an acetylated lysine motif from cyclin T1 bound similarly well to BD2. Whereas the structure of Brd2 BD1 suggested its dimer formation, both Brd4 bromodomains appeared monomeric in solution as shown by size exclusion chromatography and mutational analyses.	[Geyer, Matthias] Max Planck Inst Mol Physiol, Dept Phys Biochem, Abt Phys Biochem, D-44227 Dortmund, Germany	Max Planck Society	Geyer, M (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, Abt Phys Biochem, Otto Hahn Str 11, D-44227 Dortmund, Germany.	matthias.geyer@mpi-dortmund.mpg.de	Blankenfeldt, Wulf/F-8877-2010	Blankenfeldt, Wulf/0000-0001-9886-9668; Geyer, Matthias/0000-0002-7718-5002	Deutsche Forschungsgemeinschaft [GE-976/5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Grant GE-976/5 from the Deutsche Forschungsgemeinschaft (to M. G.).	Abbate EA, 2006, MOL CELL, V24, P877, DOI 10.1016/j.molcel.2006.11.002; Anand K, 2008, NAT STRUCT MOL BIOL, V15, P1287, DOI 10.1038/nsmb.1513; Barboric M, 2007, NUCLEIC ACIDS RES, V35, P2003, DOI 10.1093/nar/gkm063; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Beck S, 1992, DNA Seq, V2, P203, DOI 10.3109/10425179209020804; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Cho SY, 2009, EMBO J, V28, P1407, DOI 10.1038/emboj.2009.99; CHUA P, 1995, MOL CELL BIOL, V15, P3685; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Dames SA, 2007, P NATL ACAD SCI USA, V104, P14312, DOI 10.1073/pnas.0701848104; Denis GV, 1996, GENE DEV, V10, P261, DOI 10.1101/gad.10.3.261; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Farina A, 2004, MOL CELL BIOL, V24, P9059, DOI 10.1128/MCB.24.20.9059-9069.2004; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; HAYNES SR, 1992, NUCLEIC ACIDS RES, V20, P2603, DOI 10.1093/nar/20.10.2603; He N, 2008, MOL CELL, V29, P588, DOI 10.1016/j.molcel.2008.01.003; Huang B, 2009, MOL CELL BIOL, V29, P1375, DOI 10.1128/MCB.01365-08; Hudson BP, 2000, J MOL BIOL, V304, P355, DOI 10.1006/jmbi.2000.4207; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jones MH, 1997, GENOMICS, V45, P529, DOI 10.1006/geno.1997.5000; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061; Lin YJ, 2008, PROTEIN SCI, V17, P2174, DOI 10.1110/ps.037580.108; Liu Y, 2008, BIOCHEMISTRY-US, V47, P6403, DOI 10.1021/bi8001659; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Markert A, 2008, EMBO REP, V9, P569, DOI 10.1038/embor.2008.72; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura Y, 2007, J BIOL CHEM, V282, P4193, DOI 10.1074/jbc.M605971200; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schonichen A, 2006, J BIOL CHEM, V281, P5084, DOI 10.1074/jbc.M509226200; Schulte A, 2005, J BIOL CHEM, V280, P24968, DOI 10.1074/jbc.M501431200; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Thorpe KL, 1997, GENE, V200, P177, DOI 10.1016/S0378-1119(97)00415-0; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	51	94	115	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36547	36556		10.1074/jbc.M109.033712	http://dx.doi.org/10.1074/jbc.M109.033712			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19828451	Green Published, hybrid			2022-12-25	WOS:000272970500056
J	Mancuso, DJ; Kotzbauer, P; Wozniak, DF; Sims, HF; Jenkins, CM; Guan, SP; Han, XL; Yang, K; Sun, G; Malik, I; Conyers, S; Green, KG; Schmidt, RE; Gross, RW				Mancuso, David J.; Kotzbauer, Paul; Wozniak, David F.; Sims, Harold F.; Jenkins, Christopher M.; Guan, Shaoping; Han, Xianlin; Yang, Kui; Sun, Gang; Malik, Ibrahim; Conyers, Sara; Green, Karen G.; Schmidt, Robert E.; Gross, Richard W.			Genetic Ablation of Calcium-independent Phospholipase A(2)gamma Leads to Alterations in Hippocampal Cardiolipin Content and Molecular Species Distribution, Mitochondrial Degeneration, Autophagy, and Cognitive Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; SHOTGUN LIPIDOMICS; CALORIC RESTRICTION; MASS-SPECTROMETRY; BARTH-SYNDROME; UBIQUITIN; BRAIN; A(2); ACCUMULATION; INVOLVEMENT	Genetic ablation of calcium-independent phospholipase A(2)gamma (iPLA(2)gamma) results in profound alterations in hippocampal phospholipid metabolism and mitochondrial phospholipid homeostasis resulting in enlarged and degenerating mitochondria leading to autophagy and cognitive dysfunction. Shotgun lipidomics demonstrated multiple alterations in hippocampal lipid metabolism in iPLA(2)gamma(-/-) mice including: 1) a markedly elevated hippocampal cardiolipin content with an altered molecular species composition characterized by a shift to shorter chain length molecular species; 2) alterations in both choline and ethanolamine glycerophospholipids, including a decreased plasmenylethanolamine content; 3) increased oxidized phosphatidylethanolamine molecular species; and 4) an increased content of ceramides. Electron microscopic examination demonstrated the presence of enlarged heteromorphic lamellar structures undergoing degeneration accompanied by the presence of ubiquitin positive spheroid inclusion bodies. Purification of these enlarged heteromorphic lamellar structures by buoyant density centrifugation and subsequent SDS-PAGE and proteomics identified them as degenerating mitochondria. Collectively, these results identify the obligatory role of iPLA(2)gamma in neuronal mitochondrial lipid metabolism and membrane structure demonstrating that iPLA(2)gamma loss of function results in a mitochondrial neurodegenerative disorder characterized by degenerating mitochondria, autophagy, and cognitive dysfunction.	[Mancuso, David J.; Sims, Harold F.; Jenkins, Christopher M.; Guan, Shaoping; Han, Xianlin; Yang, Kui; Sun, Gang; Gross, Richard W.] Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Kotzbauer, Paul; Wozniak, David F.; Schmidt, Robert E.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Sch Med, Cardiovasc Res Ctr, St Louis, MO 63110 USA; [Mancuso, David J.; Sims, Harold F.; Jenkins, Christopher M.; Guan, Shaoping; Han, Xianlin; Yang, Kui; Sun, Gang; Gross, Richard W.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Kotzbauer, Paul; Gross, Richard W.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA; [Green, Karen G.; Schmidt, Robert E.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kotzbauer, Paul; Malik, Ibrahim] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Wozniak, David F.; Conyers, Sara] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Gross, Richard W.] Washington Univ, Dept Chem, St Louis, MO 63105 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Gross, RW (corresponding author), Washington Univ, Sch Med, Div Bioorgan Chem & Mol Pharmacol, 660 S Euclid Ave,Campus Box 8020, St Louis, MO 63110 USA.	rgross@wustl.edu		Malik, Ibrahim/0000-0003-2048-2097	National Institutes of Health [PO1 HL57278, RO1 HL41250, DK19645-28, P60 DK020579, NS48924]; Juvenile Diabetes Research Foundation [1-2005-1085, 1-2008-193]; NIA, NIH [R01 AG23168]; NIH Neuroscience Blueprint Center Core [P30 NS057105]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057278, R01HL041250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, P30DK056341, R37DK019645, R01DK019645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048924, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023168] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIA, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH Neuroscience Blueprint Center Core(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL57278 (to R. W. G.), RO1 HL41250 (to R. W. G.), DK19645-28 (to R. E. S.), P60 DK020579 (to R. E. S.), and NS48924 (to P. T. K.). This work was also supported by Juvenile Diabetes Research Foundation Grants 1-2005-1085 and 1-2008-193 (to R. E. S.), NIA, NIH Grant R01 AG23168 (to X. H.), and NIH Neuroscience Blueprint Center Core Grant P30 NS057105 (to D. F. W.). Downloaded from www.jbc.org at unknown institution, on December 14, 2009	Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P5075, DOI 10.1073/pnas.0401030101; Ando H, 2006, BIOCHEM J, V394, P43, DOI 10.1042/BJ20051419; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Beckett CS, 2008, LIPIDS, V43, P775, DOI 10.1007/s11745-008-3201-6; Breen EP, 2006, J BIOL CHEM, V281, P2114, DOI 10.1074/jbc.M511575200; Calabrese V, 2001, NEUROCHEM RES, V26, P739, DOI 10.1023/A:1010955807739; Cedars A, 2009, J CARDIOVASC PHARM, V53, P277; Cheng H, 2008, BIOCHEMISTRY-US, V47, P5869, DOI 10.1021/bi7023282; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Domingues MRM, 2008, CHEM PHYS LIPIDS, V156, P1, DOI 10.1016/j.chemphyslip.2008.07.003; Droge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x; Farooqui AA, 2006, NEUROSCIENTIST, V12, P245, DOI 10.1177/1073858405285923; Fukuyama R, 2002, J BIOL CHEM, V277, P41455, DOI 10.1074/jbc.M204176200; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; Garlid KD, 1996, J BIOL CHEM, V271, P2615, DOI 10.1074/jbc.271.5.2615; Ginsberg L, 1998, J NEUROCHEM, V70, P2533; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goodenowe DB, 2007, J LIPID RES, V48, P2485, DOI 10.1194/jlr.P700023-JLR200; Green JT, 2008, J LIPID RES, V49, P939, DOI 10.1194/jlr.R700017-JLR200; Gross RW, 2005, PROSTAG OTH LIPID M, V77, P52, DOI 10.1016/j.prostaglandins.2004.09.005; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Han XL, 2008, RAPID COMMUN MASS SP, V22, P2115, DOI 10.1002/rcm.3595; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han Xianlin, 2005, Current Alzheimer Research, V2, P65, DOI 10.2174/1567205052772786; Han XL, 2006, J LIPID RES, V47, P864, DOI 10.1194/jlr.D500044-JLR200; Han XL, 2005, BIOCHEMISTRY-US, V44, P16684, DOI 10.1021/bi051908a; Han XL, 2005, EXPERT REV PROTEOMIC, V2, P253, DOI 10.1586/14789450.2.2.253; Han XL, 2004, BIOCHEMISTRY-US, V43, P15584, DOI 10.1021/bi048307o; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Jenkins CM, 2009, CARDIOVASC RES, V82, P240, DOI 10.1093/cvr/cvn346; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Keil U, 2004, J BIOL CHEM, V279, P50310, DOI 10.1074/jbc.M405600200; Khateeb S, 2006, AM J HUM GENET, V79, P942, DOI 10.1086/508572; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Lehtinen MK, 2006, CURR MOL MED, V6, P871, DOI 10.2174/156652406779010786; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mackenzie IRA, 2005, J NEUROPATH EXP NEUR, V64, P730, DOI 10.1097/01.jnen.0000174335.27708.0a; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Malik I, 2008, AM J PATHOL, V172, P406, DOI 10.2353/ajpath.2008.070823; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Mancuso DJ, 2007, J BIOL CHEM, V282, P9216, DOI 10.1074/jbc.M607307200; Mancuso DJ, 2004, EUR J BIOCHEM, V271, P4709, DOI 10.1111/j.1432-1033.2004.04435.x; Mancuso DJ, 2000, J BIOL CHEM, V275, P9937, DOI 10.1074/jbc.275.14.9937; Mazzocco MMM, 2007, J DEV BEHAV PEDIATR, V28, P22, DOI 10.1097/01.DBP.0000257519.79803.90; Menard C, 2007, HIPPOCAMPUS, V17, P1109, DOI 10.1002/hipo.20343; Mokhova EN, 2005, BIOCHEMISTRY-MOSCOW+, V70, P159, DOI 10.1007/s10541-005-0096-1; Muhlig-Versen M, 2005, J NEUROSCI, V25, P2865, DOI 10.1523/JNEUROSCI.5097-04.2005; Murakami M, 2005, J BIOL CHEM, V280, P14028, DOI 10.1074/jbc.M413766200; Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004; Petrucelli L, 2004, ANN MED, V36, P315, DOI 10.1080/07853890410031948; Phillis John W., 2003, Critical Reviews in Neurobiology, V15, P61, DOI 10.1615/CritRevNeurobiol.v15.i1.30; Sastre J, 2000, FREE RADICAL RES, V32, P189, DOI 10.1080/10715760000300201; Schaeffer EL, 2005, J NEURAL TRANSM, V112, P641, DOI 10.1007/s00702-005-0301-9; SCHERRER LA, 1989, MOL CELL BIOCHEM, V88, P97; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; St-Gelais F, 2004, HIPPOCAMPUS, V14, P319, DOI 10.1002/hipo.10176; Sullivan PG, 2004, J BIOL CHEM, V279, P20699, DOI 10.1074/jbc.M313579200; Sun GY, 2004, J LIPID RES, V45, P205, DOI 10.1194/jlr.R300016-JLR200; Upadhya SC, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S12; Wakabayashi T, 2000, PATHOL INT, V50, P20, DOI 10.1046/j.1440-1827.2000.01002.x; Wolf MJ, 1995, FEBS LETT, V377, P358, DOI 10.1016/0014-5793(95)01371-7; Wozniak DF, 2007, NEUROBIOL DIS, V26, P14, DOI 10.1016/j.nbd.2006.11.014; Wozniak DF, 2004, NEUROBIOL DIS, V17, P403, DOI 10.1016/j.nbd.2004.08.006; Yan W, 2005, J BIOL CHEM, V280, P26669, DOI 10.1074/jbc.M502358200; Yanagida K, 2007, J BIOL CHEM, V282, P5814, DOI 10.1074/jbc.M610767200; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd; Zhang J, 2005, AM J PHYSIOL-HEART C, V288, pH954, DOI 10.1152/ajpheart.00756.2004; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhou JM, 2009, J BIOL CHEM, V284, P18106, DOI 10.1074/jbc.M109.003236	77	74	74	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35632	35644		10.1074/jbc.M109.055194	http://dx.doi.org/10.1074/jbc.M109.055194			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19840936	hybrid, Green Published			2022-12-25	WOS:000272645600041
J	Ogura, K; Yamasaki, M; Yamada, T; Mikami, B; Hashimoto, W; Murata, K				Ogura, Kohei; Yamasaki, Masayuki; Yamada, Takashi; Mikami, Bunzo; Hashimoto, Wataru; Murata, Kousaku			Crystal Structure of Family 14 Polysaccharide Lyase with pH-dependent Modes of Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HALIOTIS-DISCUS-HANNAI; ALGINATE LYASE; CELL-WALL; PSEUDOMONAS-AERUGINOSA; SUBSTRATE RECOGNITION; CDNA CLONING; VIRUS PBCV-1; PROTEIN; ACID; ABALONE	The Chlorella virus enzyme vAL-1 (38 kDa), a member of polysaccharide lyase family 14, degrades the Chlorella cell wall by cleaving the glycoside bond of the glucuronate residue (GlcA) through a beta-elimination reaction. The enzyme consists of an N-terminal cell wall-attaching domain (11 kDa) and a C-terminal catalytic module (27 kDa). Here, we show the enzyme characteristics of vAL-1, especially its pH-dependent modes of action, and determine the structure of the catalytic module. vAL-1 also exhibited alginate lyase activity at alkaline pH, and truncation of the N-terminal domain increased the lyase activity by 50-fold at pH 7.0. The truncated form vAL-1(S) released di- to hexasaccharides from alginate at pH 7.0, whereas disaccharides were preferentially generated at pH 10.0. This indicates that vAL-1(S) shows two pH-dependent modes of action: endo-and exotypes. The x-ray crystal structure of vAL-1(S) at 1.2 angstrom resolution showed two antiparallel beta-sheets with a deep cleft showing a beta-jelly roll fold. The structure of GlcA-bound vAL-1(S) at pH 7.0 and 10.0 was determined: GlcA was found to be bound outside and inside the cleft at pH 7.0 and 10.0, respectively. This suggests that the electric charges at the active site greatly influence the binding mode of substrates and regulate endo/exo activity. Site-directed mutagenesis demonstrated that vAL-1(S) has a specific amino acid arrangement distinct from other alginate lyases crucial for catalysis. This is, to our knowledge, the first study in which the structure of a family 14 polysaccharide lyase with two different modes of action has been determined.	[Ogura, Kohei; Hashimoto, Wataru; Murata, Kousaku] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Uji, Kyoto 6110011, Japan; [Yamasaki, Masayuki; Mikami, Bunzo] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Uji, Kyoto 6110011, Japan; [Yamada, Takashi] Hiroshima Univ, Grad Sch Adv Sci Matter, Dept Mol Biotechnol, Higashihiroshima 7398530, Japan	Kyoto University; Kyoto University; Hiroshima University	Murata, K (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Uji, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Program for Promotion of Basic Research Activities for Innovative Bioscience in Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for Promotion of Basic Research Activities for Innovative Bioscience in Japan	This work was supported, in part, by a Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists ( to K.O.) and by Grants-in-aid ( to W. H., B. M., and K. M.) and Targeted Proteins Research Program funding ( to W. H., B. M., and K. M.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. A part of this work was supported by the funds from Program for Promotion of Basic Research Activities for Innovative Bioscience in Japan ( to K. M.).	Alkawash MA, 2006, APMIS, V114, P131, DOI 10.1111/j.1600-0463.2006.apm_356.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GACESA P, 1988, CARBOHYD POLYM, V8, P161, DOI 10.1016/0144-8617(88)90001-X; Gazzarrini S, 2004, J BIOL CHEM, V279, P28443, DOI 10.1074/jbc.M401184200; HASHIMOTO W, 2009, BIOENGINEER IN PRESS; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Kang M, 2004, P NATL ACAD SCI USA, V101, P5318, DOI 10.1073/pnas.0307824100; KAPAUN E, 1992, PHYTOCHEMISTRY, V31, P3103, DOI 10.1016/0031-9422(92)83453-6; Konno N, 2009, FEBS LETT, V583, P1323, DOI 10.1016/j.febslet.2009.03.034; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LINHARDT RJ, 1986, APPL BIOCHEM BIOTECH, V12, P135; May Thomas B., 1994, Trends in Microbiology, V2, P151, DOI 10.1016/0966-842X(94)90664-5; MEINKE A, 1995, J BIOL CHEM, V270, P4383, DOI 10.1074/jbc.270.9.4383; MEINTS RH, 1988, VIROLOGY, V164, P15, DOI 10.1016/0042-6822(88)90614-9; MEINTS RH, 1984, VIROLOGY, V138, P341, DOI 10.1016/0042-6822(84)90358-1; Mikami B, 2002, ACTA CRYSTALLOGR A, V58, pC271, DOI 10.1107/S0108767302095831; Miyake O, 2004, J BACTERIOL, V186, P2891, DOI 10.1128/JB.186.9.2891-2896.2004; Ochiai A, 2009, J BIOL CHEM, V284, P10181, DOI 10.1074/jbc.M807799200; Ogura K, 2008, J MOL BIOL, V380, P373, DOI 10.1016/j.jmb.2008.05.008; Onimatsu H, 2004, VIROLOGY, V319, P71, DOI 10.1016/j.virol.2003.10.030; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pages S, 2001, J BIOL CHEM, V276, P33652, DOI 10.1074/jbc.M105770200; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Plugge B, 2000, SCIENCE, V287, P1641, DOI 10.1126/science.287.5458.1641; PREISS J, 1962, J BIOL CHEM, V237, P309; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shimizu E, 2003, CARBOHYD RES, V338, P2841, DOI 10.1016/j.carres.2003.08.009; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Suda K, 1999, FEMS MICROBIOL LETT, V180, P45, DOI 10.1016/S0378-1097(99)00459-0; Sugimoto I, 2004, FEBS LETT, V559, P51, DOI 10.1016/S0014-5793(04)00022-5; Sugimoto I, 2000, VIROLOGY, V277, P119, DOI 10.1006/viro.2000.0590; Suzuki H, 2006, CARBOHYD RES, V341, P1809, DOI 10.1016/j.carres.2006.04.032; Suzuki K, 2003, EUR J BIOCHEM, V270, P771, DOI 10.1046/j.1432-1033.2003.03443.x; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; VANETTEN JL, 1991, MICROBIOL REV, V55, P586, DOI 10.1128/MMBR.55.4.586-620.1991; WEISSBACH A, 1959, J BIOL CHEM, V234, P705; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; YAMADA T, 1991, APPL ENVIRON MICROB, V57, P3433, DOI 10.1128/AEM.57.12.3433-3437.1991; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075	44	49	51	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35572	35579		10.1074/jbc.M109.068056	http://dx.doi.org/10.1074/jbc.M109.068056			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19846561	Green Published, hybrid			2022-12-25	WOS:000272645600034
J	Song, DS; Tu, Z; Lee, FS				Song, Daisheng; Tu, Zheng; Lee, Frank S.			Human ISCA1 Interacts with IOP1/NARFL and Functions in Both Cytosolic and Mitochondrial Iron-Sulfur Protein Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLUSTER BIOGENESIS; WD40 PROTEIN; HOMEOSTASIS; MATURATION; SCAFFOLD; SYSTEM; COMPONENT; MATRIX; IOP1	Iron-sulfur proteins play an essential role in many biologic processes. Hence, understanding their assembly is an important goal. In Escherichia coli, the protein IscA is a product of the isc (iron-sulfur cluster) operon and functions in the iron-sulfur cluster assembly pathway in this organism. IscA is conserved in evolution, but its function in mammalian cells is not known. Here, we provide evidence for a role for a human homologue of IscA, named IscA1, in iron-sulfur protein biogenesis. We observe that small interfering RNA knockdown of IscA1 in HeLa cells leads to decreased activity of two mitochondrial iron-sulfur enzymes, succinate dehydrogenase and mitochondrial aconitase, as well as a cytosolic iron-sulfur enzyme, cytosolic aconitase. IscA1 is observed both in cytosolic and mitochondrial fractions. We find that IscA1 interacts with IOP1 (iron-only hydrogenase-like protein 1)/NARFL (nuclear prelamin A recognition factor-like), a cytosolic protein that plays a role in the cytosolic iron-sulfur protein assembly pathway. We therefore propose that human IscA1 plays an important role in both mitochondrial and cytosolic iron-sulfur cluster biogenesis, and a notable component of the latter is the interaction between IscA1 and IOP1.	[Lee, Frank S.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Stellar Chance Labs 605, Philadelphia, PA 19104 USA	University of Pennsylvania	Lee, FS (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Stellar Chance Labs 605, 422 Curie Blvd, Philadelphia, PA 19104 USA.	franklee@mail.med.upenn.edu		Lee, Frank/0000-0003-2511-1834	National Institutes of Health [R01-GM71459]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01-GM71459 (to F.S.L.).	Agar JN, 2000, BIOCHEMISTRY-US, V39, P7856, DOI 10.1021/bi000931n; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Brazzolotto X, 1999, J BIOL CHEM, V274, P21625, DOI 10.1074/jbc.274.31.21625; Cozar-Castellano I, 2004, BBA-PROTEINS PROTEOM, V1700, P179, DOI 10.1016/j.bbapap.2004.05.004; DAUM G, 1982, J BIOL CHEM, V257, P3028; Ding H, 2004, J BIOL CHEM, V279, P37499, DOI 10.1074/jbc.M404533200; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fosset C, 2006, J BIOL CHEM, V281, P25398, DOI 10.1074/jbc.M602979200; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; HALLBERG EM, 1993, MOL CELL BIOL, V13, P3050, DOI 10.1128/MCB.13.5.3050; Huang JH, 2007, BIOCHEM J, V401, P341, DOI 10.1042/BJ20060635; Jensen LT, 2000, MOL CELL BIOL, V20, P3918, DOI 10.1128/MCB.20.11.3918-3927.2000; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Johnstone RW, 1998, J BIOL CHEM, V273, P10880, DOI 10.1074/jbc.273.18.10880; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kaut A, 2000, J BIOL CHEM, V275, P15955, DOI 10.1074/jbc.M909502199; Krebs C, 2001, BIOCHEMISTRY-US, V40, P14069, DOI 10.1021/bi015656z; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Luban Jeremy, 1995, Current Opinion in Biotechnology, V6, P59, DOI 10.1016/0958-1669(95)80010-7; Minczuk M, 2002, NUCLEIC ACIDS RES, V30, P5074, DOI 10.1093/nar/gkf647; Pelzer W, 2000, FEBS LETT, V476, P134, DOI 10.1016/S0014-5793(00)01711-7; ROSEN H, 1987, J BIOL CHEM, V262, P15004; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Song DS, 2008, J BIOL CHEM, V283, P9231, DOI 10.1074/jbc.M708077200; Stehling O, 2008, MOL CELL BIOL, V28, P5517, DOI 10.1128/MCB.00545-08; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003	28	40	42	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35297	35307		10.1074/jbc.M109.040014	http://dx.doi.org/10.1074/jbc.M109.040014			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19864422	hybrid, Green Published			2022-12-25	WOS:000272645600006
J	Ithychanda, SS; Hsu, D; Li, HH; Yan, LD; Liu, DW; Das, M; Plow, EF; Qin, J				Ithychanda, Sujay Subbayya; Hsu, Dennis; Li, Hanhan; Yan, Linda; Liu, Darwen; Das, Mitali; Plow, Edward F.; Qin, Jun			Identification and Characterization of Multiple Similar Ligand-binding Repeats in Filamin IMPLICATION ON FILAMIN-MEDIATED RECEPTOR CLUSTERING AND CROSS-TALK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; MOLECULAR-BASIS; PHOSPHORYLATION; CYTOSKELETON; COMPETITION; MIGFILIN	The actin-binding protein filamin links membrane receptors to the underlying cytoskeleton. The cytoplasmic domains of these membrane receptors have been shown to bind to various filamin immunoglobulin repeats. Notably, among 24 human filamin repeats, repeat 17 was reported to specifically bind to platelet receptor glycoprotein Ib alpha and repeat 21 to integrins. However, a complete sequence alignment of all 24 human filamin repeats reveals that repeats 17 and 21 actually belong to a distinct filamin repeat subgroup ( containing repeats 4, 9, 12, 17, 19, 21, and 23) that shares a conserved ligand-binding site. Using isothermal calorimetry and NMR analyses, we show that all repeats in this subgroup can actually bind glycoprotein Ib alpha, integrins, and a cytoskeleton regulator migfilin in similar manners. These data provide a new view on the ligand specificity of the filamin repeats. They also suggest a multiple ligand binding mechanism where similar repeats within a filamin monomer may promote receptor clustering or receptor cross-talking for regulation of the cytoskeleton organization and diverse filamin-mediated cellular activities.	[Ithychanda, Sujay Subbayya; Yan, Linda; Liu, Darwen; Das, Mitali; Plow, Edward F.; Qin, Jun] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA; [Hsu, Dennis; Li, Hanhan; Qin, Jun] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Qin, J (corresponding author), Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, NB20,9500 Euclid Ave, Cleveland, OH 44195 USA.	qinj@ccf.org	Ithychanda, Sujay Subbayya/C-7792-2011; Qin, Jun/D-5559-2009	Ithychanda, Sujay Subbayya/0000-0001-8979-246X; Yan, Linda/0000-0003-4270-9045; Qin, Jun/0000-0002-2647-9270	National Institutes of Health [R01 GM62823, P01 HL073311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL073311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM62823 and P01 HL073311 (to J.Q. and E.F.P.).	Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Feng SJ, 2005, J BIOL CHEM, V280, P6709, DOI 10.1074/jbc.M413590200; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Goldmann WH, 2000, BIOCHEM BIOPH RES CO, V271, P553, DOI 10.1006/bbrc.2000.2653; Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200; Ithychanda SS, 2009, J BIOL CHEM, V284, P4713, DOI 10.1074/jbc.M807719200; Jimenez-Baranda S, 2007, NAT CELL BIOL, V9, P838, DOI 10.1038/ncb1610; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Lad Y, 2007, EMBO J, V26, P3993, DOI 10.1038/sj.emboj.7601827; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; LARKIN MA, 2007, CLUSTALW CLUSTALX VE, V23, P947; Nakamura F, 2006, BLOOD, V107, P1925, DOI 10.1182/blood-2005-10-3964; Nakamura F, 2007, J CELL BIOL, V179, P1011, DOI 10.1083/jcb.200707073; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Pudas R, 2005, STRUCTURE, V13, P111, DOI 10.1016/j.str.2004.10.014; Robertson SP, 2005, CURR OPIN GENET DEV, V15, P301, DOI 10.1016/j.gde.2005.04.001; SHARMA CP, 1995, J IMMUNOL, V154, P3461; Takafuta T, 2003, J BIOL CHEM, V278, P12175, DOI 10.1074/jbc.M209339200; Takala H, 2008, BLOOD, V112, P1853, DOI 10.1182/blood-2007-12-127795; Travis MA, 2004, FEBS LETT, V569, P185, DOI 10.1016/j.febslet.2004.04.099; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6	25	59	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35113	35121		10.1074/jbc.M109.060954	http://dx.doi.org/10.1074/jbc.M109.060954			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19828450	hybrid, Green Published			2022-12-25	WOS:000272439600065
J	Kim, YC; Wu, SY; Lim, HS; Chiang, CM; Kodadek, T				Kim, Young-Chan; Wu, Shwu-Yuan; Lim, Hyun-Suk; Chiang, Cheng-Ming; Kodadek, Thomas			Non-proteolytic Regulation of p53-mediated Transcription through Destabilization of the Activator.Promoter Complex by the Proteasomal ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGGERED CROSS-LINKING; TATA-BINDING PROTEIN; RNA-POLYMERASE-II; PEPTOID INHIBITOR; 20S PROTEASOME; IN-VIVO; ACTIVATION; UBIQUITIN; P53; TURNOVER	It has been shown previously that sub-complexes of the 26 S proteasome can regulate gene expression via non-proteolytic mechanisms. One such mechanism is the disruption of activator.promoter complexes in an ATP-dependent fashion, which was discovered in the context of the yeast Gal4 system. This activity strongly inhibits Gal4-driven gene expression unless the activator is mono-ubiquitylated, which protects it from the ATPases. To address whether this paradigm is also applicable to medically important mammalian transcriptional activators we report here a study of the interaction of the proteasomal ATPases with p53. It is shown that p53 binds directly to the ATPases via its C-terminal tetramerization and regulatory domain and that p53.promoter complexes are indeed vulnerable to ATPase-dependent disruption by the ATPase complex in vitro. Knockdown of one of the ATPases, Rpt6, in living cells results in increased occupancy of the p21waf1 promoter by p53 and increased expression of the gene, consistent with the idea that the proteasomal ATPases negatively regulate p53 function in a non-proteolytic fashion.	[Kodadek, Thomas] Scripps Florida Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Kodadek, Thomas] Scripps Florida Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Kim, Young-Chan; Lim, Hyun-Suk; Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Div Translat Res, Dept Internal Med, Dallas, TX 75390 USA; [Kim, Young-Chan; Lim, Hyun-Suk; Kodadek, Thomas] Univ Texas SW Med Ctr Dallas, Div Translat Res, Dept Mol Biol, Dallas, TX 75390 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dept Biochem, Dallas, TX 75390 USA; [Wu, Shwu-Yuan; Chiang, Cheng-Ming] Univ Texas SW Med Ctr Dallas, Simmons Comprehens Canc Ctr, Dept Pharmacol, Dallas, TX 75390 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kodadek, T (corresponding author), Scripps Florida Res Inst, Dept Chem, 130 Scripps Way, Jupiter, FL 33458 USA.	Kodadek@scripps.edu	Moon, Heejo/F-5355-2013	Kodadek, Thomas/0000-0003-1930-4795	National Institutes of Health [GM71833, CA103867, CA124760]; NATIONAL CANCER INSTITUTE [R01CA124760, R01CA103867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM71833 ( to T. K.) and CA103867 and CA124760 ( to C. M. C.).	Archer CT, 2008, J BIOL CHEM, V283, P21789, DOI 10.1074/jbc.M803075200; Archer CT, 2008, J BIOL CHEM, V283, P12614, DOI 10.1074/jbc.M801050200; Archer CT, 2005, MOL BIOSYST, V1, P366, DOI 10.1039/b510019d; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Bhat KP, 2008, MOL IMMUNOL, V45, P2214, DOI 10.1016/j.molimm.2007.12.001; Brady KL, 2005, J BIOL CHEM, V280, P26743, DOI 10.1074/jbc.M502677200; Bres V, 2003, NAT CELL BIOL, V5, P754, DOI 10.1038/ncb1023; Brooks CL, 2004, CELL CYCLE, V3, P436; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Corton JC, 1998, J BIOL CHEM, V273, P13776, DOI 10.1074/jbc.273.22.13776; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Gillette TG, 2004, P NATL ACAD SCI USA, V101, P5904, DOI 10.1073/pnas.0305411101; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Greer SF, 2003, NAT IMMUNOL, V4, P1074, DOI 10.1038/ni985; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Kodadek T, 2006, CELL, V127, P261, DOI 10.1016/j.cell.2006.10.002; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Lim HS, 2007, J AM CHEM SOC, V129, P12936, DOI 10.1021/ja075469+; Lim HS, 2007, J AM CHEM SOC, V129, P7750, DOI 10.1021/ja072027p; Lin L, 2005, ONCOGENE, V24, P3385, DOI 10.1038/sj.onc.1208554; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; MELCHER K, 1995, MOL CELL BIOL, V15, P2839; Morris MC, 2003, NATURE, V423, P1009, DOI 10.1038/nature01720; Nalley K, 2006, NATURE, V442, P1054, DOI 10.1038/nature05067; Nawaz Z, 2004, MOL ENDOCRINOL, V18, P493, DOI 10.1210/me.2003-0388; Rasti M, 2006, EMBO J, V25, P2710, DOI 10.1038/sj.emboj.7601169; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Sulahian R, 2006, NUCLEIC ACIDS RES, V34, P1351, DOI 10.1093/nar/gkl012; SWAFFIELD JC, 1995, NATURE, V374, P88, DOI 10.1038/374088a0; Tansey WP, 2001, GENE DEV, V15, P1045, DOI 10.1101/gad.896501; Thomas MC, 2005, MOL CELL, V17, P251, DOI 10.1016/j.molcel.2004.12.016; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Yang E, 2002, J BIOL CHEM, V277, P13455, DOI 10.1074/jbc.M112038200; Zhu Q, 2007, ONCOGENE, V26, P4199, DOI 10.1038/sj.onc.1210191	41	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34522	34530		10.1074/jbc.M109.017277	http://dx.doi.org/10.1074/jbc.M109.017277			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19846554	Green Published, hybrid			2022-12-25	WOS:000272439600006
J	Cho, JH; Jung, DK; Lee, K; Rhee, S				Cho, Jang-Hee; Jung, Du-Kyo; Lee, Kyoung; Rhee, Sangkee			Crystal Structure and Functional Analysis of the Extradiol Dioxygenase LapB from a Long-chain Alkylphenol Degradation Pathway in Pseudomonas	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATECHOL 2,3-DIOXYGENASE; DEPENDENT DIOXYGENASES; OXYGEN ACTIVATION; RING-CLEAVAGE; MECHANISM; 1,2-DIOXYGENASE; CATALYSIS; BINDING	LapB is a non-heme Fe(II)-dependent 2,3-dioxygenase that catalyzes the second step of a long-chain alkylphenol (lap) degradation pathway in Pseudomonas sp. KL28 and belongs to the superfamily of type I extradiol dioxygenases. In this study, the crystal structures of substrate-free LapB and its complexes with a substrate or product were determined, along with a functional analysis of the active site residues. Structural features of the homotetramer are similar to those of other type I extradiol dioxygenases. In particular, the active site is located in the C-domain of each monomer, with a 2-His-1-carboxylate motif as the first coordination shell to iron ion. A comparison of three different structures in the catalytic cycle indicated catalysis-related local conformational changes in the active site. Specifically, the active site loop containing His-248 exhibits positional changes upon binding of the substrate and establishes a hydrogen-bonding network with Tyr-257, which is near the hydroxyl group of the substrate. Kinetic analysis of the mutant enzymes H248A, H248N, and Y257F showed that these three mutant enzymes are inactive, suggesting that this hydrogen-bonding network plays a crucial role in catalysis by deprotonating the incoming substrate and leaving it in a monoanionic state. Additional functional analysis of His-201, by using H201A and H201N mutants, near the dioxygen-binding site also supports its role as base and acid catalyst in the late stage of catalysis. We also noticed a disordered-to-ordered structural transition in the C-terminal region, resulting in the opening or closing of the active site. These results provide detailed insights into the structural and functional features of an extradiol dioxygenase that can accommodate a wide range of alkylcatechols.	[Rhee, Sangkee] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 151921, South Korea; [Rhee, Sangkee] Seoul Natl Univ, Ctr Agr Biomat, Seoul 151921, South Korea; [Rhee, Sangkee] Seoul Natl Univ, Ctr Fugal Pathogenesis, Seoul 151921, South Korea; [Lee, Kyoung] Changwon Natl Univ, Dept Microbiol, Kyongnam 641773, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Changwon National University	Rhee, S (corresponding author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Rm 7117 Bldg 200, Seoul 151921, South Korea.	srheesnu@snu.ac.kr			Korea Science and Engineering Foundation (KOSEF) [R01-2007-000-21067-0, R11-2008-062-01002-0]; Ministry of Science and Technology, Republic of Korea	Korea Science and Engineering Foundation (KOSEF)(Korea Science and Engineering Foundation); Ministry of Science and Technology, Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by Korea Science and Engineering Foundation (KOSEF) Grants R01-2007-000-21067-0 and R11-2008-062-01002-0 and by a grant from Crop Functional Genomics Center of the 21st Century Frontier Research Program funded by the Ministry of Science and Technology, Republic of Korea.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bugg TDH, 2008, CURR OPIN CHEM BIOL, V12, P134, DOI 10.1016/j.cbpa.2007.12.007; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emerson JP, 2008, P NATL ACAD SCI USA, V105, P7347, DOI 10.1073/pnas.0711179105; GIGER W, 1984, SCIENCE, V225, P623, DOI 10.1126/science.6740328; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Groce SL, 2005, BIOCHEMISTRY-US, V44, P7175, DOI 10.1021/bi050180v; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Jeong JJ, 2003, MICROBIOL-SGM, V149, P3265, DOI 10.1099/mic.0.26628-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kita A, 1999, STRUCTURE, V7, P25, DOI 10.1016/S0969-2126(99)80006-9; Kovaleva EG, 2007, ACCOUNTS CHEM RES, V40, P475, DOI 10.1021/ar700052v; Kovaleva EG, 2008, BIOCHEMISTRY-US, V47, P11168, DOI 10.1021/bi801459q; Kovaleva EG, 2008, NAT CHEM BIOL, V4, P186, DOI 10.1038/nchembio.71; Kovaleva EG, 2007, SCIENCE, V316, P453, DOI 10.1126/science.1134697; Lipscomb JD, 2008, CURR OPIN STRUC BIOL, V18, P644, DOI 10.1016/j.sbi.2008.11.001; Mendel S, 2004, BIOCHEMISTRY-US, V43, P13390, DOI 10.1021/bi048518t; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610; Siegbahn PEM, 2004, J AM CHEM SOC, V126, P8919, DOI 10.1021/ja0493805; Takeo M, 2007, J BIOSCI BIOENG, V104, P309, DOI 10.1263/jbb.104.309; Vaillancourt FH, 2002, J AM CHEM SOC, V124, P2485, DOI 10.1021/ja0174682; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; Vetting MW, 2004, J BACTERIOL, V186, P1945, DOI 10.1128/JB.186.7.1945-1958.2004; Viggiani A, 2004, J BIOL CHEM, V279, P48630, DOI 10.1074/jbc.M406243200; Weisel M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-7	27	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34321	34330		10.1074/jbc.M109.031054	http://dx.doi.org/10.1074/jbc.M109.031054			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19828456	Green Published, hybrid			2022-12-25	WOS:000272165200062
J	Geiben-Lynn, R; Greenland, JR; Frimpong-Boateng, K; Letvin, NL				Geiben-Lynn, Ralf; Greenland, John R.; Frimpong-Boateng, Kwesi; Letvin, Norman L.			Non-classical Natural Killer T Cells Modulate Plasmid DNA Vaccine Antigen Expression and Vaccine-elicited Immune Responses by MCP-1 Secretion after Interaction with a beta 2-Microglobulin-independent CD1d	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GATA-3; V-ALPHA-14 NKT CELLS; IN-VIVO; TUMOR-IMMUNITY; ULCERATIVE-COLITIS; MOUSE MODEL; MICE; DISTINCT; ACTIVATION; INDUCTION	The magnitude and durability of a plasmid DNA vaccine-induced immune response is shaped by immune effector molecules at the site of vaccination. In the present study, we show that antigen expression is modified by type II NKT cells, after interaction with a beta 2-microglobulin-independent CD1d receptor. After activation, during the first days following plasmid DNA vaccination, NKT cells release IL-5 and MCP-1, leading to a T helper 0 (T(H)0) cytokine/chemokine profile and a stronger CD8(+)/CD4(+) T cell immune response. Our data indicate that this phenomenon was induced through the strong T(H)1 chemokine MCP-1 during the early phases of plasmid DNA vaccination because injecting the type II NKT cell-associated MCP-1 during the first 5 days led to 2-3-fold increases in vaccine-elicited T cell responses. This study demonstrates a critical role for NKT cells in plasmid DNA vaccine-induced immune responses. Manipulation of NKT cell function or co-administration of MCP-1 may represent novel methods for enhancing immune responses to plasmid DNA vaccines.	[Geiben-Lynn, Ralf] Harvard Univ, Sch Med, Div Viral Pathogenesis, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Geiben-Lynn, R (corresponding author), Harvard Univ, Sch Med, Div Viral Pathogenesis, Beth Israel Deaconess Med Ctr, 3 Blackfan Circle E CLS,Rm 1028, Boston, MA 02215 USA.	rgeibenl@bidmc.harvard.edu	Greenland, John R/AAR-6030-2021	Greenland, John R/0000-0003-1422-8367	National Institutes of Health [AI067854]; NIAID Center for HIV/AIDS Vaccine Immunology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, U01AI067854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Center for HIV/AIDS Vaccine Immunology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI067854 ( to N.L.L.) from the NIAID Center for HIV/AIDS Vaccine Immunology.	Amano M, 1998, J IMMUNOL, V161, P1710; Baron JL, 2002, IMMUNITY, V16, P583, DOI 10.1016/S1074-7613(02)00305-9; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; BECKMAN EM, 1995, IMMUNOL TODAY, V16, P349, DOI 10.1016/0167-5699(95)80154-5; BERNABEU C, 1984, NATURE, V308, P642, DOI 10.1038/308642a0; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bottino C, 2000, HUM IMMUNOL, V61, P1, DOI 10.1016/S0198-8859(99)00162-7; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; Brutkiewicz RR, 2002, CRIT REV ONCOL HEMAT, V41, P287, DOI 10.1016/S1040-8428(01)00198-6; CARDELL S, 1995, J EXP MED, V182, P993, DOI 10.1084/jem.182.4.993; Chang DH, 2008, BLOOD, V112, P1308, DOI 10.1182/blood-2008-04-149831; Chang YJ, 2007, P NATL ACAD SCI USA, V104, P10299, DOI 10.1073/pnas.0703824104; Chargui J, 2001, TRANSPLANT P, V33, P3833, DOI 10.1016/S0041-1345(01)02623-9; Crowe NY, 2003, J IMMUNOL, V171, P4020, DOI 10.4049/jimmunol.171.8.4020; Di Santo JP, 2008, EUR J IMMUNOL, V38, P2948, DOI 10.1002/eji.200838830; Duarte N, 2004, J IMMUNOL, V173, P3112, DOI 10.4049/jimmunol.173.5.3112; Fuss IJ, 2008, MUCOSAL IMMUNOL, V1, pS31, DOI 10.1038/mi.2008.40; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; GALLIN JI, 1974, BLOOD, V43, P201, DOI 10.1182/blood.V43.2.201.201; Geiben-Lynn R, 2008, CLIN VACCINE IMMUNOL, V15, P691, DOI 10.1128/CVI.00418-07; Geiben-Lynn R, 2008, BLOOD, V112, P4585, DOI 10.1182/blood-2008-06-165803; Greenland JR, 2007, J IMMUNOL, V178, P5652, DOI 10.4049/jimmunol.178.9.5652; Greenland JR, 2005, MOL THER, V12, P164, DOI 10.1016/j.ymthe.2005.01.021; Gumperz JE, 2002, J EXP MED, V195, P625, DOI 10.1084/jem.20011786; Hovav AH, 2007, J VIROL, V81, P74, DOI 10.1128/JVI.01269-06; Ikehara Y, 2000, J CLIN INVEST, V105, P1761, DOI 10.1172/JCI8922; Ito K, 2000, P NATL ACAD SCI USA, V97, P740, DOI 10.1073/pnas.97.2.740; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Johnson TR, 2003, J IMMUNOL, V170, P2037, DOI 10.4049/jimmunol.170.4.2037; Kakimi K, 2000, J EXP MED, V192, P921, DOI 10.1084/jem.192.7.921; Kawakami K, 2001, J IMMUNOL, V167, P6525, DOI 10.4049/jimmunol.167.11.6525; Kim HS, 1999, J BIOL CHEM, V274, P9289, DOI 10.1074/jbc.274.14.9289; Koh YI, 2008, J IMMUNOL, V181, P4560, DOI 10.4049/jimmunol.181.7.4560; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Kronenberg M, 2005, ANNU REV IMMUNOL, V23, P877, DOI 10.1146/annurev.immunol.23.021704.115742; Lee PT, 2002, J EXP MED, V195, P637, DOI 10.1084/jem.20011908; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Matsuda JL, 2003, P NATL ACAD SCI USA, V100, P8395, DOI 10.1073/pnas.1332805100; Miyamoto K, 2001, NATURE, V413, P531, DOI 10.1038/35097097; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Norris PJ, 2002, J MOL MED, V80, P397, DOI 10.1007/s00109-002-0337-3; Orlans FB, 1997, ETHICS BEHAV, V7, P163, DOI 10.1207/s15327019eb0702_7; Ortaldo JR, 2004, J IMMUNOL, V172, P943, DOI 10.4049/jimmunol.172.2.943; Park SH, 1998, J IMMUNOL, V160, P3128; Perou CM, 1996, NAT GENET, V13, P303, DOI 10.1038/ng0796-303; RODER J, 1979, NATURE, V278, P451, DOI 10.1038/278451a0; Sada-Ovalle I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000239; Seino K, 2001, P NATL ACAD SCI USA, V98, P2577, DOI 10.1073/pnas.041608298; Seino K, 2005, J EXP MED, V202, P1623, DOI 10.1084/jem.20051600; SHIRAHATA T, 1994, J VET MED SCI, V56, P293, DOI 10.1292/jvms.56.293; Smiley ST, 1997, SCIENCE, V275, P977, DOI 10.1126/science.275.5302.977; Smyth MJ, 2002, CURR OPIN IMMUNOL, V14, P165, DOI 10.1016/S0952-7915(02)00316-3; Smyth MJ, 2000, NAT IMMUNOL, V1, P459, DOI 10.1038/82698; Sonoda KH, 2001, J IMMUNOL, V166, P42, DOI 10.4049/jimmunol.166.1.42; Stan AC, 2001, EUR J IMMUNOL, V31, P301, DOI 10.1002/1521-4141(200101)31:1<301::AID-IMMU301>3.0.CO;2-K; Terabe M, 2000, NAT IMMUNOL, V1, P515, DOI 10.1038/82771; Van Rhijn I, 2004, P NATL ACAD SCI USA, V101, P13578, DOI 10.1073/pnas.0402838101; Wang ZY, 2006, J IMMUNOL, V176, P880, DOI 10.4049/jimmunol.176.2.880; Wilson SB, 2003, NAT REV IMMUNOL, V3, P211, DOI 10.1038/nri1028; Zeng DF, 1999, J EXP MED, V189, P1073, DOI 10.1084/jem.189.7.1073; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	62	5	6	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33800	33806		10.1074/jbc.M109.019638	http://dx.doi.org/10.1074/jbc.M109.019638			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19833737	Green Published, hybrid			2022-12-25	WOS:000272165200011
J	Chapron, G; Wielgus, R; Quenette, PY; Camarra, JJ				Chapron, Guillaume; Wielgus, Robert; Quenette, Pierre-Yves; Camarra, Jean-Jacques			Diagnosing Mechanisms of Decline and Planning for Recovery of an Endangered Brown Bear (Ursus arctos) Population	PLOS ONE			English	Article							SEXUALLY SELECTED INFANTICIDE; ADULT MALE MORTALITY; GRIZZLY BEARS; REINTRODUCTION; CONSERVATION; SEGREGATION; STRATEGIES; TELEMETRY; CARNIVORE; SURVIVAL	Background: The usual paradigm for translocations is that they should not take place in declining populations until the causes(s) of the decline has been reversed. This approach sounds intuitive, but may not apply in cases where population decline is caused by behavioral or demographic mechanisms that could only be reversed by translocation itself. Methodology/Principal Findings: We analyzed a decade of field data for Pyrenean brown bears (Ursus arctos) from two small populations: the growing Central population - created from a previous translocation and the endemic Western population - believed to be declining because of excessive human-caused mortality. We found that adult survival rates for both populations were as high as those observed for most other protected brown bear populations. However, the Western population had much lower reproductive success than the Central population. Adult breeding sex ratio was male-biased in the Western population and female-biased in the Central population. Our results exclude high anthropogenic mortality as a cause for population decline in the West but support low reproductive success, which could result from sexually selected infanticide induced by a male-biased adult sex ratio or inbreeding depression. Using a stochastic demographic model to compute how many bears should be released to ensure viability, we show that the Western population could recover provided adequate numbers of new females are translocated. Conclusions/Significance: We suggest that a translocation could take place, even if the decline has not yet been reversed, if the translocation itself removes the biological mechanisms behind the decline. In our case, the ultimate cause of low reproductive success remained unknown ( infanticide or inbreeding), but our proposed translocation strategies should eliminate the proximate cause ( low reproductive success) of the decline and ensure population recovery and viability.			Chapron, G (corresponding author), Swedish Univ Agr Sci, Grimso Wildlife Res Stn, Dept Ecol, Riddarhyttan, Sweden.	gchapron@carnivoreconservation.org						Arquilliere A, 1998, ORYX, V32, P8, DOI 10.1046/j.1365-3008.1998.00007.x; Barnes VG, 1998, URSUS-SERIES, V10, P1; Bellemain E, 2006, P ROY SOC B-BIOL SCI, V273, P283, DOI 10.1098/rspb.2005.3331; Bellemain E, 2006, ETHOLOGY, V112, P238, DOI 10.1111/j.1439-0310.2006.01152.x; Breitenmoser U, 2001, CONSERV BIOL SER, V5, P241; CAMARRA JJ, 1995, M BROWN BEAR EC LIFE; CAMARRA JJ, 1992, 9 INT BEAR C GREN; CAMARRA JJ, 1992, MONITORING TECHNIQUE; CAMARRA JJ, 1999, B MENSUEL ONCFS, V249, P24; CASE JT, 2000, ILLUSTRATED GUIDE TH; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; CAUSSIMONT G, 2002, ETUDE CONSERVATION C, P30; CETTO E, 2005, 16 INT C BEAR RES MA; Chapron G, 2003, CR BIOL, V326, pS174, DOI 10.1016/S1631-0691(03)00055-6; CHASSIN N, 2003, ASPECTS JURIDIQUES C; Couturier M.A.J., 1954, OURS BRUN; *DIREN MID PYR, 2001, B4320096518 DIREN MI; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; Graf JA, 2006, ANIM CONSERV, V9, P398, DOI 10.1111/j.1469-1795.2006.00048.x; HEISEY DM, 1985, J WILDLIFE MANAGE, V49, P668, DOI 10.2307/3801692; ILANY G, 1991, MASA ACHER, V20, P54; ILANY G, 1991, MASA ACHER, V19, P45; IUCN/SSC Re-introduction Specialist Group, 1998, IUCN GUID RE INTR; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Laikre L, 1996, BIOL CONSERV, V76, P69, DOI 10.1016/0006-3207(95)00084-4; Lande R., 2003, OXFORD SERIES ECOLOG; Legendre S, 1995, J APPL STAT, V22, P817, DOI 10.1080/02664769524649; LEPELTIER S, 2005, COMMUNICATION OFFICI; McCallum H., 2000, METH ECOL; McLellan BN, 2005, URSUS, V16, P141, DOI 10.2192/1537-6176(2005)016[0141:SSIIGB]2.0.CO;2; *MEDD, 2005, RENF POP OURS BRUNS; Miller B, 1999, ANIM CONSERV, V2, P59, DOI 10.1111/j.1469-1795.1999.tb00049.x; Morris WF, 2002, QUANTITATIVE CONSERV; Paetkau D, 1998, MOL ECOL, V7, P1283, DOI 10.1046/j.1365-294x.1998.00440.x; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P7, DOI 10.2307/3801296; Quenette PY, 2001, URSUS-SERIES, V12, P115; QUENETTE PY, 2000, BILAN SCI TECHNIQUE; REICHMANN A, 1990, MORTALITY 5 CUBS BOR; Saether BE, 1998, OIKOS, V83, P403, DOI 10.2307/3546856; Schwartz Charles C., 2003, Ursus (Knoxville), V14, P109; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; SKALSKI RJ, 2005, WILDLIFE DEMOGRAPHY; Stoen OG, 2006, OECOLOGIA, V148, P356, DOI 10.1007/s00442-006-0384-5; Swenson JE, 2001, URSUS-SERIES, V12, P81; Swenson JE, 2001, URSUS-SERIES, V12, P69; Swenson JE, 2003, ANIMAL BEHAVIOR AND WILDLIFE CONSERVATION, P171; Swenson JE, 1998, J ANIM ECOL, V67, P819, DOI 10.1046/j.1365-2656.1998.00248.x; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Tufto J, 1999, P ROY SOC B-BIOL SCI, V266, P961, DOI 10.1098/rspb.1999.0730; Wielgus RB, 2001, BIOL CONSERV, V98, P293, DOI 10.1016/S0006-3207(00)00168-3; Wielgus RB, 2000, BIOL CONSERV, V93, P145, DOI 10.1016/S0006-3207(99)00152-4; Wielgus RB, 2002, BIOL CONSERV, V106, P381, DOI 10.1016/S0006-3207(01)00265-8; WIELGUS RB, 1994, BIOL CONSERV, V67, P161, DOI 10.1016/0006-3207(94)90362-X; WIELGUS RB, 1995, J WILDLIFE MANAGE, V59, P552, DOI 10.2307/3802462; WIELGUS RB, 1994, J WILDLIFE MANAGE, V58, P405, DOI 10.2307/3809310	56	19	20	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7568	10.1371/journal.pone.0007568	http://dx.doi.org/10.1371/journal.pone.0007568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862319	gold, Green Published			2022-12-25	WOS:000271194600004
J	Young, LC; Vanderlip, C; Duffy, DC; Afanasyev, V; Shaffer, SA				Young, Lindsay C.; Vanderlip, Cynthia; Duffy, David C.; Afanasyev, Vsevolod; Shaffer, Scott A.			Bringing Home the Trash: Do Colony-Based Differences in Foraging Distribution Lead to Increased Plastic Ingestion in Laysan Albatrosses?	PLOS ONE			English	Article							DEBRIS; ACCUMULATION; NORTH; SHEARWATERS; GEOLOCATION; STRATEGY	When searching for prey, animals should maximize energetic gain, while minimizing energy expenditure by altering their movements relative to prey availability. However, with increasing amounts of marine debris, what once may have been 'optimal' foraging strategies for top marine predators, are leading to sub-optimal diets comprised in large part of plastic. Indeed, the highly vagile Laysan albatross (Phoebastria immutabilis) which forages throughout the North Pacific, are well known for their tendency to ingest plastic. Here we examine whether Laysan albatrosses nesting on Kure Atoll and Oahu Island, 2,150 km apart, experience different levels of plastic ingestion. Twenty two geolocators were deployed on breeding adults for up to two years. Regurgitated boluses of undigestable material were also collected from chicks at each site to compare the amount of plastic vs. natural foods. Chicks from Kure Atoll were fed almost ten times the amount of plastic compared to chicks from Oahu despite boluses from both colonies having similar amounts of natural food. Tracking data indicated that adults from either colony did not have core overlapping distributions during the early half of the breeding period and that adults from Kure had a greater overlap with the putative range of the Western Garbage Patch corroborating our observation of higher plastic loads at this colony. At-sea distributions also varied throughout the year suggesting that Laysan albatrosses either adjusted their foraging behavior according to constraints on time away from the nest or to variation in resources. However, in the non-breeding season, distributional overlap was greater indicating that the energy required to reach the foraging grounds was less important than the total energy available. These results demonstrate how a marine predator that is not dispersal limited alters its foraging strategy throughout the reproductive cycle to maximize energetic gain and how this has led to differences in plastic ingestion.			Young, LC (corresponding author), Univ Hawaii, Dept Zool, Ecol Evolut & Conservat Biol Program, Honolulu, HI 96822 USA.	lindsay@pacificrimconservation.com	Shaffer, Scott A/D-5015-2009	Shaffer, Scott A/0000-0002-7751-5059; Duffy, David/0000-0002-0498-9632	NERC [bas010011] Funding Source: UKRI; Natural Environment Research Council [bas010011] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Auman HJ, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P239; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Dameron OJ, 2007, MAR POLLUT BULL, V54, P423, DOI 10.1016/j.marpolbul.2006.11.019; Fernandez P, 2001, J ZOOL, V254, P391, DOI 10.1017/S0952836901000899; Fritz H, 2003, P ROY SOC B-BIOL SCI, V270, P1143, DOI 10.1098/rspb.2003.2350; FRY DM, 1987, MAR POLLUT BULL, V18, P339, DOI 10.1016/S0025-326X(87)80022-X; Harrison CS., 1990, SEABIRDS HAWAII; Hasunuma K., 1978, J OCEANOGR, V34, P160, DOI DOI 10.1007/BF02108654; Hill Roger D., 1994, P227; Hyrenbach KD, 2002, MAR ECOL PROG SER, V233, P283, DOI 10.3354/meps233283; KAPPES M, 2009, THESIS U CALIFORNIA; KAPPES MA, 2009, PROG OCEANO IN PRESS; KUBOTA M, 1994, J PHYS OCEANOGR, V24, P1059, DOI 10.1175/1520-0485(1994)024<1059:AMFTAO>2.0.CO;2; Matsumura S., 1997, MARINE DEBRIS SOURCE, P15, DOI [10.1007/978-1-4613-8486-1_3, DOI 10.1007/978-1-4613-8486-1_3]; Naughton MB, 2007, CONSERVATION ACTION; Orians G.H., 1979, P155; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Pichel WG, 2007, MAR POLLUT BULL, V54, P1207, DOI 10.1016/j.marpolbul.2007.04.010; Pinaud D, 2005, J ANIM ECOL, V74, P852, DOI 10.1111/j.1365-2656.2005.00984.x; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Robards Martin D., 1997, P71; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; SCHOENER TW, 1979, AM NAT, V114, P902, DOI 10.1086/283537; SCHREIBER BA, 2001, BIOL MARINE BIRDS; Shaffer SA, 2005, MAR BIOL, V147, P833, DOI 10.1007/s00227-005-1631-8; Shaffer SA, 2003, FUNCT ECOL, V17, P66, DOI 10.1046/j.1365-2435.2003.00705.x; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shaffer SA, 2009, MAR ECOL PROG SER, V391, P209, DOI 10.3354/meps07932; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Sievert P.R., 1993, STATUS ECOLOGY CONSE, P212; Stephens D.W., 1986, pi; Weimerskirch H, 1997, ECOLOGY, V78, P2051; WEIMERSKIRCH H, 1993, AUK, V110, P325; Weimerskirch H, 2008, MAR ECOL PROG SER, V362, P291, DOI 10.3354/meps07424; Wilson R.P., 1992, P131; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Young LC, 2008, BIOL LETTERS, V4, P323, DOI 10.1098/rsbl.2008.0191; Young LC, 2009, WILSON J ORNITHOL, V121, P722, DOI 10.1676/08-150.1; [No title captured]	41	69	70	1	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7623	10.1371/journal.pone.0007623	http://dx.doi.org/10.1371/journal.pone.0007623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862322	Green Published, Green Accepted, gold			2022-12-25	WOS:000271194600012
J	Joo, J; Christensen, L; Warner, K; States, L; Kang, HG; Vo, K; Lawlor, ER; May, WA				Joo, Jay; Christensen, Laura; Warner, Kegan; States, Leith; Kang, Hyung-Gyoo; Vo, Kieuhoa; Lawlor, Elizabeth R.; May, William A.			GLI1 Is a Central Mediator of EWS/FLI1 Signaling in Ewing Tumors	PLOS ONE			English	Article							SONIC HEDGEHOG; TRANSCRIPTION FACTORS; INHIBITION; GROWTH; GENE; SUPPRESSOR; TARGET; CANCER; CELLS; REVEALS	The Ewing Sarcoma Family Tumors (ESFT) consist of the classical pathologic entities of Ewing Sarcoma and peripheral Primitive Neuroectodermal Tumor. Occurring largely in the childhood through young adult years, these tumors have an unsurpassed propensity for metastasis and have no defined cell of origin. The biology of these aggressive malignancies centers around EWS/FLI1 and related EWS/ETS chimeric transcription factors, which are largely limited to this tumor class. Much progress has been made in the identification of a network of loci whose expression is modulated by EWS/FLI1 and its congeners. To date, little progress has been made in reconstructing the sequence of direct and indirect events that produce this network of modulated loci. The recent identification of GLI1 as an upregulated target of EWS/ETS transcription factors suggests a target which may be a more central mediator in the ESFT signaling network. In this paper, we further define the relationship of EWS/FLI1 expression and GLI1 upregulation in ESFT. This relationship is supported with data from primary tumor specimens. It is consistently observed across multiple ESFT cell lines and with multiple means of EWS/FLI1 inhibition. GLI1 inhibition affects tumor cell line phenotype whether shRNA or endogenous or pharmacologic inhibitors are employed. As is seen in model transformation systems, GLI1 upregulation by EWS/FLI1 appears to be independent of Hedgehog stimulation. Consistent with a more central role in ESFT pathogenesis, several known EWS/FLI1 targets appear to be targeted through GLI1. These findings further establish a central role for GLI1 in the pathogenesis of Ewing Tumors.			Joo, J (corresponding author), Childrens Hosp Los Angeles, Dept Pediat, Div Hematol Oncol, Los Angeles, CA 90027 USA.	wmay@chla.usc.edu			NCI NIH HHS [R01 CA090666, CA90666] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090666] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Gustafsson MK, 2002, GENE DEV, V16, P114, DOI 10.1101/gad.940702; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kang J.-S., 2007, SCI STKE, V2007, DOI [DOI 10.1126/STKE.4032007PE50, 10.1126/stke.4032007pe50]; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; LAUTH M, 2007, ONCOGENE; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Potikyan G, 2007, CANCER RES, V67, P6675, DOI 10.1158/0008-5472.CAN-06-4140; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sasai K, 2006, CANCER RES, V66, P4215, DOI 10.1158/0008-5472.CAN-05-4505; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Testaz S, 2001, P NATL ACAD SCI USA, V98, P12521, DOI 10.1073/pnas.221108698; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Zhang JS, 2004, CANCER RES, V64, P6026, DOI 10.1158/0008-5472.CAN-03-2594; Zwerner JP, 2008, ONCOGENE, V27, P3282, DOI 10.1038/sj.onc.1210991	34	54	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7608	10.1371/journal.pone.0007608	http://dx.doi.org/10.1371/journal.pone.0007608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859563	Green Published, Green Submitted, gold			2022-12-25	WOS:000271147400012
J	Stanton, SJ; Beehner, JC; Saini, EK; Kuhn, CM; LaBar, KS				Stanton, Steven J.; Beehner, Jacinta C.; Saini, Ekjyot K.; Kuhn, Cynthia M.; LaBar, Kevin S.			Dominance, Politics, and Physiology: Voters' Testosterone Changes on the Night of the 2008 United States Presidential Election	PLOS ONE			English	Article							IMPLICIT POWER MOTIVATION; SALIVARY TESTOSTERONE; HUMAN MALES; COMPETITION; AGGRESSION; CORTISOL; HORMONES; ABILITY; WOMEN; SERUM	Background: Political elections are dominance competitions. When men win a dominance competition, their testosterone levels rise or remain stable to resist a circadian decline; and when they lose, their testosterone levels fall. However, it is unknown whether this pattern of testosterone change extends beyond interpersonal competitions to the vicarious experience of winning or losing in the context of political elections. Women's testosterone responses to dominance competition outcomes are understudied, and to date, a clear pattern of testosterone changes in response to winning and losing dominance competitions has not emerged. Methodology/Principal Findings: The present study investigated voters' testosterone responses to the outcome of the 2008 United States Presidential election. 183 participants provided multiple saliva samples before and after the winner was announced on Election Night. The results show that male Barack Obama voters (winners) had stable post-outcome testosterone levels, whereas testosterone levels dropped in male John McCain and Robert Barr voters (losers). There were no significant effects in female voters. Conclusions/Significance: The findings indicate that male voters exhibit biological responses to the realignment of a country's dominance hierarchy as if they participated in an interpersonal dominance contest.			Stanton, SJ (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27706 USA.	klabar@duke.edu	Beehner, Jacinta/E-8467-2012	Beehner, Jacinta/0000-0001-6566-6872; Saini, Ekjyot/0000-0002-5254-6422				Altemeyer, 1996, AUTHORITARIAN SPECTE; Altemeyer B, 2004, J SOC PSYCHOL, V144, P421, DOI 10.3200/SOCP.144.4.421-448; ALTEMEYER B, 1998, 20 ITEM RWA SC UNPUB; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Bateup HS, 2002, EVOL HUM BEHAV, V23, P181, DOI 10.1016/S1090-5138(01)00100-3; Bernhardt PC, 1998, PHYSIOL BEHAV, V65, P59, DOI 10.1016/S0031-9384(98)00147-4; BOOTH A, 1989, HORM BEHAV, V23, P556, DOI 10.1016/0018-506X(89)90042-1; DABBS JM, 1991, PHYSIOL BEHAV, V49, P815, DOI 10.1016/0031-9384(91)90323-G; Daly M, 2001, Nebr Symp Motiv, V47, P1; DEWAAL F, 1982, CHIMPANZEE POLITICS; Edwards DA, 2006, PHYSIOL BEHAV, V87, P135, DOI 10.1016/j.physbeh.2005.09.007; Fodor EM, 2008, J APPL SOC PSYCHOL, V38, P215; Granger DA, 2004, PSYCHONEUROENDOCRINO, V29, P1229, DOI 10.1016/j.psyneuen.2004.02.005; KHANDAWOOD FS, 1984, AM J OBSTET GYNECOL, V148, P441; MAZUR A, 1992, SOC PSYCHOL QUART, V55, P70, DOI 10.2307/2786687; MAZUR A, 1980, HORM BEHAV, V14, P236, DOI 10.1016/0018-506X(80)90032-X; Mazur A, 1997, EVOL HUM BEHAV, V18, P317, DOI 10.1016/S1090-5138(97)00013-5; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; MAZUR A, 1985, SOC FORCES, V64, P377; Mehta PH, 2006, HORM BEHAV, V50, P684, DOI 10.1016/j.yhbeh.2006.07.001; MENDELSON JH, 1977, J PHARMACOL EXP THER, V202, P676; NAVARRO MA, 1986, CLIN CHEM, V32, P231; Nisbett Richard E., 1996, CULTURE HONOR PSYCHO; Oliveira T, 2009, PSYCHONEUROENDOCRINO, V34, P1056, DOI 10.1016/j.psyneuen.2009.02.006; Oyegbile TO, 2005, HORM BEHAV, V48, P259, DOI 10.1016/j.yhbeh.2005.04.007; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SAPOLSKY RM, 1991, PSYCHONEUROENDOCRINO, V16, P281, DOI 10.1016/0306-4530(91)90015-L; Schultheiss O.C., 2009, METHODS NEUROBIOLOGY, P17; Schultheiss OC, 2004, HORM BEHAV, V46, P592, DOI 10.1016/j.yhbeh.2004.07.005; Schultheiss OC, 2003, HORM BEHAV, V43, P293, DOI 10.1016/S0018-506X(03)00003-5; Schultheiss OC, 2005, J PERS SOC PSYCHOL, V88, P174, DOI 10.1037/0022-3514.88.1.174; SMITH RG, 1979, FERTIL STERIL, V31, P513; Stanton SJ, 2007, HORM BEHAV, V52, P571, DOI 10.1016/j.yhbeh.2007.07.002; Stanton SJ, 2009, J RES PERS, V43, P942, DOI 10.1016/j.jrp.2009.04.001; van Anders SM, 2007, PHYSIOL BEHAV, V90, P634, DOI 10.1016/j.physbeh.2006.11.017; Wirth MM, 2007, PHYSIOL BEHAV, V90, P496, DOI 10.1016/j.physbeh.2006.10.016	37	73	73	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7543	10.1371/journal.pone.0007543	http://dx.doi.org/10.1371/journal.pone.0007543			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509JU	19844583	Green Submitted, Green Published, gold			2022-12-25	WOS:000271013000017
J	Banerji, A; Ghosh, I				Banerji, Anirban; Ghosh, Indira			Revisiting the Myths of Protein Interior: Studying Proteins with Mass-Fractal Hydrophobicity-Fractal and Polarizability-Fractal Dimensions	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; MOLECULAR-DYNAMICS; RIBONUCLEASE-A; BETA-HAIRPIN; SIDE-CHAIN; PACKING; STABILITY; CORE; SEQUENCES; MODEL	A robust marker to describe mass, hydrophobicity and polarizability distribution holds the key to deciphering structural and folding constraints within proteins. Since each of these distributions is inhomogeneous in nature, the construct should be sensitive in describing the patterns therein. We show, for the first time, that the hydrophobicity and polarizability distributions in protein interior follow fractal scaling. It is found that (barring 'all-alpha') all the major structural classes of proteins have an amount of unused hydrophobicity left in them. This amount of untapped hydrophobicity is observed to be greater in thermophilic proteins, than that in their (structurally aligned) mesophilic counterparts. 'All-beta'(thermophilic, mesophilic alike) proteins are found to have maximum amount of unused hydrophobicity, while 'all-alpha' proteins have been found to have minimum polarizability. A non-trivial dependency is observed between dielectric constant and hydrophobicity distributions within (alpha+beta) and 'all-alpha' proteins, whereas absolutely no dependency is found between them in the 'all-beta' class. This study proves that proteins are not as optimally packed as they are supposed to be. It is also proved that origin of alpha-helices are possibly not hydrophobic but electrostatic; whereas beta-sheets are predominantly hydrophobic in nature. Significance of this study lies in protein engineering studies; because it quantifies the extent of packing that ensures protein functionality. It shows that myths regarding protein interior organization might obfuscate our knowledge of actual reality. However, if the later is studied with a robust marker of strong mathematical basis, unknown correlations can still be unearthed; which help us to understand the nature of hydrophobicity, causality behind protein folding, and the importance of anisotropic electrostatics in stabilizing a highly complex structure named 'proteins'.			Banerji, A (corresponding author), Univ Pune, Bioinformat Ctr, Pune, Maharashtra, India.	indirag@mail.jnu.ac.in	ghosh, indira/H-5008-2019					Akasaka K, 2001, BIOCHEMISTRY-US, V40, P8665, DOI 10.1021/bi010312u; ALLEN JP, 1982, BIOPHYS J, V38, P299, DOI 10.1016/S0006-3495(82)84562-1; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; ARTECA GA, 1995, CAN J CHEM, V73, P241, DOI 10.1139/v95-033; Ba XW, 2002, MACROMOLECULES, V35, P4193, DOI 10.1021/ma011436h; Bachmann M, 2004, J CHEM PHYS, V120, P6779, DOI 10.1063/1.1651055; Banerji A, 2009, EUR BIOPHYS J BIOPHY, V38, P577, DOI 10.1007/s00249-009-0409-1; BARRETT AJ, 1988, MACROMOLECULES, V21, P1141, DOI 10.1021/ma00182a048; BEHE MJ, 1991, P NATL ACAD SCI USA, V88, P4195, DOI 10.1073/pnas.88.10.4195; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bonvin AMJJ, 2000, J MOL BIOL, V296, P255, DOI 10.1006/jmbi.1999.3446; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Burke HB, 2005, CANCER INFORM, V1, P15; Carter CW, 2001, J MOL BIOL, V311, P625, DOI 10.1006/jmbi.2001.4906; Chakrabarti P, 2001, PROG BIOPHYS MOL BIO, V76, P1, DOI 10.1016/S0079-6107(01)00005-0; Dabora JM, 1996, BIOCHEMISTRY-US, V35, P11951, DOI 10.1021/bi9611671; DAYANTIS J, 1994, PHYS REV B, V49, P3217, DOI 10.1103/PhysRevB.49.3217; DEWEY TG, 1994, P NATL ACAD SCI USA, V91, P12101, DOI 10.1073/pnas.91.25.12101; Dewey TG, 1999, PHYS REV E, V60, P4652, DOI 10.1103/PhysRevE.60.4652; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Dwyer Donard S, 2005, BMC Chem Biol, V5, P2, DOI 10.1186/1472-6769-5-2; Elking D, 2007, J COMPUT CHEM, V28, P1261, DOI 10.1002/jcc.20574; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Enright MB, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011912; Finucane MD, 1999, BIOCHEMISTRY-US, V38, P11613, DOI 10.1021/bi990766f; Fitzkee NC, 2005, TRENDS BIOCHEM SCI, V30, P73, DOI 10.1016/j.tibs.2004.12.005; Flory P. J., 1953, PRINCIPLES POLYM CHE, P428; Galzitskaya OV, 2008, PROTEINS, V70, P329, DOI 10.1002/prot.21619; Gao J, 2008, BIOPOLYMERS, V89, P1174, DOI 10.1002/bip.21072; GLYAKINA A, 2007, MOL BIOL J, V41, P4; GOLDSTEIN H, 1962, CLASSICAL MECHANICS, P149; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hecht MH, 2004, PROTEIN SCI, V13, P1711, DOI 10.1110/ps.04690804; HECHT MH, 1983, P NATL ACAD SCI-BIOL, V80, P2676, DOI 10.1073/pnas.80.9.2676; HELMAN JS, 1984, PHYS REV LETT, V53, P1195, DOI 10.1103/PhysRevLett.53.1195; Higo J, 1997, PROTEIN ENG, V10, P373, DOI 10.1093/protein/10.4.373; Hildebrand PW, 2005, BIOPHYS J, V88, P1970, DOI 10.1529/biophysj.104.049585; HUBBARD SJ, 1995, CURR OPIN BIOTECH, V6, P375, DOI 10.1016/0958-1669(95)80065-4; Irback A, 2001, J BIOL PHYS, V27, P169, DOI 10.1023/A:1013155018382; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Jefferson ER, 2006, J MOL BIOL, V364, P1118, DOI 10.1016/j.jmb.2006.09.042; Kajander T, 2003, PROTEIN SCI, V12, P1855, DOI 10.1110/ps.0388503; Karplus M, 2000, J PHYS CHEM B, V104, P11, DOI 10.1021/jp993555t; KARPUSAS M, 1989, P NATL ACAD SCI USA, V86, P8237, DOI 10.1073/pnas.86.21.8237; Kaya H, 2000, PHYS REV LETT, V85, P4823, DOI 10.1103/PhysRevLett.85.4823; Koshi JM, 1997, PROTEINS, V27, P336, DOI 10.1002/(SICI)1097-0134(199703)27:3<336::AID-PROT2>3.0.CO;2-B; Kuhn LA, 1995, PROTEINS, V23, P536, DOI 10.1002/prot.340230408; Lee CY, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.042901; LEWIS M, 1985, SCIENCE, V230, P1163, DOI 10.1126/science.4071040; Liang J, 2001, BIOPHYS J, V81, P751, DOI 10.1016/S0006-3495(01)75739-6; LIM WA, 1989, NATURE, V339, P31, DOI 10.1038/339031a0; Lumry R., 1975, C INT CNRS EAU SYST, V246, P55; MACDONALD M, 1986, CAN J PHYS, V64, P1353, DOI 10.1139/p86-239; MCCAMMON JA, 1983, J AM CHEM SOC, V105, P2232, DOI 10.1021/ja00346a022; Medini D, 2003, J CHEM PHYS, V118, P2405, DOI 10.1063/1.1533785; MILLHAUSER GL, 1988, P NATL ACAD SCI USA, V85, P1503, DOI 10.1073/pnas.85.5.1503; Munson M, 1996, PROTEIN SCI, V5, P1584, DOI 10.1002/pro.5560050813; Olumee Z, 1998, J PHYS CHEM B, V102, P6118, DOI 10.1021/jp981123x; Pande VS, 1999, P NATL ACAD SCI USA, V96, P9062, DOI 10.1073/pnas.96.16.9062; PERUTZ MF, 1978, SCIENCE, V201, P1187, DOI 10.1126/science.694508; Phillips JC, 2009, P NATL ACAD SCI USA, V106, P3113, DOI 10.1073/pnas.0811308105; Phillips JC, 2009, P NATL ACAD SCI USA, V106, P3107, DOI 10.1073/pnas.0811262106; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; REIDHAAROLSON JF, 1988, SCIENCE, V241, P53, DOI 10.1126/science.3388019; Reuveni S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.208101; Richards FM, 1997, CELL MOL LIFE SCI, V53, P790, DOI 10.1007/s000180050100; Rother K, 2003, BIOINFORMATICS, V19, P2112, DOI 10.1093/bioinformatics/btg292; Russo D, 2002, BIOPHYS J, V83, P2792, DOI 10.1016/S0006-3495(02)75288-0; Samuel D, 2000, J BIOL CHEM, V275, P34968, DOI 10.1074/jbc.M005147200; SHUDE Y, 2007, J MOL BIOL, V368, P230; Sivaraman T, 1997, BIOCHEM J, V321, P457, DOI 10.1042/bj3210457; Song XY, 2002, J CHEM PHYS, V116, P9359, DOI 10.1063/1.1474582; SOSNICK TR, 1992, BIOCHEMISTRY-US, V31, P8329, DOI 10.1021/bi00150a029; STEINBACH PJ, 1991, BIOCHEMISTRY-US, V30, P3988, DOI 10.1021/bi00230a026; Taverna DM, 2002, PROTEINS, V46, P105, DOI 10.1002/prot.10016; TISSEN JTWM, 1994, ACTA CRYSTALLOGR D, V50, P569, DOI 10.1107/S0907444993013332; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Voges D, 1998, J CHEM PHYS, V108, P2219, DOI 10.1063/1.475602; Vogl T, 1997, BIOCHEMISTRY-US, V36, P1657, DOI 10.1021/bi962163z; WEST MW, 1995, PROTEIN SCI, V4, P2032, DOI 10.1002/pro.5560041008; Xiao M, 1998, BIOPHYS J, V74, pA131; Zhang JF, 2003, J CHEM PHYS, V118, P6102, DOI 10.1063/1.1554395; ZYDNEY AL, 2001, MEMBRANE SEPARATIONS, P280	87	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7361	10.1371/journal.pone.0007361	http://dx.doi.org/10.1371/journal.pone.0007361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834622	gold, Green Submitted, Green Published			2022-12-25	WOS:000270880700002
J	Favier, B; LeMaoult, J; Lesport, E; Carosella, ED				Favier, Benoit; LeMaoult, Joel; Lesport, Emilie; Carosella, Edgardo D.			ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse	FASEB JOURNAL			English	Article						cytoskeleton; inhibitory receptor; immunological synapse	NATURAL-KILLER-CELLS; ALDRICH-SYNDROME PROTEIN; IMMUNOLOGICAL SYNAPSE; HLA-G; TRANSCRIPT-2 ILT2; IMMUNE SYNAPSES; DENDRITIC CELLS; INNATE IMMUNITY; T-CELLS; CYTOTOXICITY	Natural killer (NK) cells play a crucial role in the antitumoral responses through cytolytic function and cytokine production. Expression of HLA-G at the surface of tumoral cells confers a protection against NK-cell cytolysis through its interaction with the ILT2 inhibitory receptor. Even though the role of this interaction on the inhibition of NK-cell cytotoxicity is well established, its effect on the molecular events occurring at the NK/target-cell synapse is not well characterized. We found that the interaction of the inhibitory receptor ILT2 with HLA-G inhibited the polarization of NK-cell lytic granules and the microtubule organizing center (MTOC) as well as the accumulation of filamentous actin (F-actin) at the area of contact. However, it did not affect the recruitment of the activatory receptor CD2 at the NK/target-cell interface. Even though CD2 was accumulated to the NK-cell synapse, the interaction of ILT2 with HLA-G efficiently inhibited intracellular calcium mobilization and IFN-gamma polarized production of NK cells. These results indicate that while the ILT2/HLA-G interaction leads to the inhibition of NK-cell functions, it displays differential effects on cytoskeleton reorganization and CD2 localization at the NK-cell synapse.-Favier, B., LeMaoult, J., Lesport, E., Carosella, E. D. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell-activating synapse. FASEB J. 24, 689-699 (2010). www.fasebj.org	[Favier, Benoit; LeMaoult, Joel; Lesport, Emilie; Carosella, Edgardo D.] Hop St Louis, CEA, Serv Rech Hematoimmunol I2BM, Inst Univ Hematol, F-75010 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; CEA; UDICE-French Research Universities; Universite Paris Cite	Favier, B (corresponding author), Hop St Louis, CEA, Serv Rech Hematoimmunol I2BM, Inst Univ Hematol, 1 Ave Claude Vellefaux, F-75010 Paris, France.	benoit.favier@cea.fr	LeMaoult, Joel/E-9583-2011; FAVIER, Benoit/W-7379-2019	Lesport, Emilie/0000-0001-8078-2361; LeMaoult, Joel/0000-0002-4513-9482	Comissariat a l'Energie Atomique (CEA); Ile France	Comissariat a l'Energie Atomique (CEA)(French Atomic Energy Commission); Ile France	This work was supported by the Comissariat a l'Energie Atomique (CEA) and Ile France. We thank N. Setterblad and the Service Commun d'Imagerie Cellulaire et Moleculaire for their help. We also thank Sylvie Sousa for technical assistance.	Badour K, 2003, IMMUNITY, V18, P141, DOI 10.1016/S1074-7613(02)00516-2; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Bryceson YT, 2005, J EXP MED, V202, P1001, DOI 10.1084/jem.20051143; Butler B, 2008, NAT IMMUNOL, V9, P887, DOI 10.1038/ni.1630; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Carlin LM, 2001, J EXP MED, V194, P1507, DOI 10.1084/jem.194.10.1507; Carosella ED, 2008, BLOOD, V111, P4862, DOI 10.1182/blood-2007-12-127662; Davis Daniel M., 2000, Science Progress, V83, P303; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Davis DM, 2004, TRENDS IMMUNOL, V25, P323, DOI 10.1016/j.it.2004.03.007; Davis DM, 2002, TRENDS IMMUNOL, V23, P356, DOI 10.1016/S1471-4906(02)02243-3; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Dietrich J, 2001, J IMMUNOL, V166, P2514, DOI 10.4049/jimmunol.166.4.2514; Espagnolle N, 2007, INT IMMUNOL, V19, P239, DOI 10.1093/intimm/dxl141; Favier B, 2007, TISSUE ANTIGENS, V69, P150, DOI 10.1111/j.1399-0039.2006.763_6.x; Favier B, 2007, TISSUE ANTIGENS, V69, P207, DOI 10.1111/j.1399-0039.2006.00757.x; Gismondi A, 2000, J IMMUNOL, V164, P2272, DOI 10.4049/jimmunol.164.5.2272; Graham DB, 2006, J IMMUNOL, V177, P2349, DOI 10.4049/jimmunol.177.4.2349; Hamerman JA, 2005, CURR OPIN IMMUNOL, V17, P29, DOI 10.1016/j.coi.2004.11.001; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Le Gal FA, 1999, INT IMMUNOL, V11, P1351, DOI 10.1093/intimm/11.8.1351; LeMaoult J, 2005, FASEB J, V19, P662, DOI 10.1096/fj.04-1617fje; Malorni W, 2003, J IMMUNOL, V171, P4195, DOI 10.4049/jimmunol.171.8.4195; Menier C, 2002, INT J CANCER, V100, P63, DOI 10.1002/ijc.10460; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Orange JS, 2003, P NATL ACAD SCI USA, V100, P14151, DOI 10.1073/pnas.1835830100; Orange JS, 2002, P NATL ACAD SCI USA, V99, P11351, DOI 10.1073/pnas.162376099; Riteau B, 2001, J IMMUNOL, V166, P5018, DOI 10.4049/jimmunol.166.8.5018; Rouas-Freiss N, 2007, SEMIN CANCER BIOL, V17, P413, DOI 10.1016/j.semcancer.2007.07.003; RouasFreiss N, 1997, P NATL ACAD SCI USA, V94, P11520, DOI 10.1073/pnas.94.21.11520; Schleinitz N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003278; Shiroishi M, 2003, P NATL ACAD SCI USA, V100, P8856, DOI 10.1073/pnas.1431057100; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stinchcombe JC, 2003, SEMIN IMMUNOL, V15, P301, DOI 10.1016/j.smim.2003.09.003; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; Tassi I, 2006, IMMUNOL REV, V214, P92, DOI 10.1111/j.1600-065X.2006.00463.x; Trotta R, 2007, J EXP MED, V204, P2397, DOI 10.1084/jem.20070419; VELY F, 2005, SCI STKE, pCM7; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vyas YM, 2001, J IMMUNOL, V167, P4358, DOI 10.4049/jimmunol.167.8.4358; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Wulfing C, 2003, P NATL ACAD SCI USA, V100, P7767, DOI 10.1073/pnas.1336920100	44	85	96	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAR	2010	24	3					689	699		10.1096/fj.09-135194	http://dx.doi.org/10.1096/fj.09-135194			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	561KE	19841038				2022-12-25	WOS:000274974600005
J	Tolu, S; Avale, ME; Nakatani, H; Pons, S; Parnaudeau, S; Tronche, F; Vogt, A; Monyer, H; Vogel, R; de Chaumont, F; Olivo-Marin, JC; Changeux, JP; Maskos, U				Tolu, Stefania; Avale, M. Elena; Nakatani, Hiroko; Pons, Stephanie; Parnaudeau, Sebastien; Tronche, Francois; Vogt, Angelika; Monyer, Hannah; Vogel, Roland; de Chaumont, Fabrice; Olivo-Marin, Jean-Christophe; Changeux, Jean-Pierre; Maskos, Uwe			A versatile system for the neuronal subtype specific expression of lentiviral vectors	FASEB JOURNAL			English	Article						ventral tegmental area; VTA; eGFP; stereotactic injection; cell-type specific reexpression; Cre/loxP recombination system	SITE-SPECIFIC RECOMBINATION; ENHANCED TRANSGENE EXPRESSION; VENTRAL TEGMENTAL AREA; CENTRAL-NERVOUS-SYSTEM; MEDIATED GENE-TRANSFER; IN-VIVO; TRANSDUCTION PATTERNS; DNA RECOMBINATION; MOUSE-BRAIN; MICE	Lentiviral expression vectors are powerful tools for gene therapy and long-term gene expression/repression in the mammalian brain. However, no specificity of transduction has been reported so far in the central nervous system. Here we have developed a novel system to achieve a neuronal subtype specific expression in either dopaminergic (DA) or GABAergic neurons. We employed a delivery strategy by which the transgene is not expressed until its activation by Cre recombinase. We successfully tested the system in vitro and then used this novel lentivector, containing loxP sites, in 2 different transgenic mouse lines expressing Cre either in DA or in GABAergic neurons. In both lines the reporter gene was detected exclusively in Cre-positive cells, demonstrating that with this experimental approach we were able to achieve completely specific expression of transgenes delivered by lentiviral vectors. This universal system can be applied to all neural subtypes making use of the growing number of specific Cre driver lines.-Tolu, S., Avale, M. E., Nakatani, H., Pons, S., Parnaudeau, S., Tronche, F., Vogt, A., Monyer, H., Vogel, R., de Chaumont, F., Olivo-Marin, J.-C., Changeux, J.-P., Maskos, U. A versatile system for the neuronal subtype specific expression of lentiviral vectors. FASEB J. 24, 723-730 (2010). www.fasebj.org	[Tolu, Stefania; Avale, M. Elena; Nakatani, Hiroko; Pons, Stephanie; Changeux, Jean-Pierre; Maskos, Uwe] Inst Pasteur, CNRS, Unite Neurobiol Integrat Syst Cholinerg, URA 2182, F-75724 Paris 15, France; [Parnaudeau, Sebastien; Tronche, Francois] UPMC, CNRS, Coll France, UMR7224, Paris, France; [Vogt, Angelika; Monyer, Hannah] Interdisciplinary Ctr Neurosci, Dept Clin Neurobiol, Heidelberg, Germany; [Vogel, Roland] Hop La Pitie Salpetriere, CNRS, UMR 7225, Paris, France; [Vogel, Roland] Hop La Pitie Salpetriere, INSERM, UMRS 975, Equipe Biotechnol & Biotherapie, Paris, France; [de Chaumont, Fabrice; Olivo-Marin, Jean-Christophe] Inst Pasteur, CNRS, Unite Anal Images Quantitat, URA 2582, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; Sorbonne Universite; Ruprecht Karls University Heidelberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Maskos, U (corresponding author), Inst Pasteur, CNRS, Unite Neurobiol Integrat Syst Cholinerg, URA 2182, 25 Rue Dr Roux, F-75724 Paris 15, France.	umaskos@pasteur.fr	TRONCHE, François/F-3895-2011; Olivo-Marin, Jean-Christophe/K-4428-2015	Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; Tolu, Stefania/0000-0002-0928-5810; Avale, Maria Elena/0000-0002-0251-0093; de Chaumont, Fabrice/0000-0001-7613-7204	Agence Nationale pour la Recherche; Institut Pasteur; College de France; Centre National de la Recherche Scientifique CNRS [URA 2182]; Association de Recherche sur le Cancer (ARC); Institut National du Cancer (INCa); Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie (MILDT); Fondation pour la Recherche Medicale (FRM); European Commission; ANR-Neuro-GRADA; EU-STREP-PheCOMP; MILDT; Region of Sardinia; Fondation pour la Recherche Medicale FRM	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Institut Pasteur(European Commission); College de France; Centre National de la Recherche Scientifique CNRS(Centre National de la Recherche Scientifique (CNRS)); Association de Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie (MILDT); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Commission(European CommissionEuropean Commission Joint Research Centre); ANR-Neuro-GRADA(French National Research Agency (ANR)); EU-STREP-PheCOMP; MILDT; Region of Sardinia(Regione Sardegna); Fondation pour la Recherche Medicale FRM(Fondation pour la Recherche Medicale)	This work was supported by grants from the Agence Nationale pour la Recherche (ANR Neuroscience, Neurologie et Psychiatrie 2005), Institut Pasteur, the College de France, the Centre National de la Recherche Scientifique CNRS URA 2182, the Association de Recherche sur le Cancer (ARC), the Institut National du Cancer (INCa), Mission Interministerielle de Lutte contre la Drogue et la Toxicomanie (MILDT), the Fondation pour la Recherche Medicale (FRM), and European Commission contracts NIDE and Nicotine and Aging to U. M. and J.-P. C. F. T. was supported by ANR-Neuro-GRADA, EU-STREP-PheCOMP, and MILDT grants. MENRT and College de France supported S. P. S. T. acknowledges the support of the Region of Sardinia and Fondation pour la Recherche Medicale FRM.	Baekelandt V, 2002, HUM GENE THER, V13, P841, DOI 10.1089/10430340252899019; Blomer U, 1997, J VIROL, V71, P6641; CARLSSON A, 1993, ADV NEUROL, V60, P1; CHARNEAU P, 1992, J VIROL, V66, P2814, DOI 10.1128/JVI.66.5.2814-2820.1992; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; Colin A, 2009, GLIA, V57, P667, DOI 10.1002/glia.20795; CUNNINGHAM MG, 1993, J NEUROSCI METH, V47, P105, DOI 10.1016/0165-0270(93)90026-N; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Fuchs EC, 2001, P NATL ACAD SCI USA, V98, P3571, DOI 10.1073/pnas.051631898; Galimi F, 2002, CURR TOP MICROBIOL, V261, P245; Goldman-Rakic P S, 1998, Adv Pharmacol, V42, P707; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Ikawa M, 2003, MOL THER, V8, P666, DOI 10.1016/S1525-0016(03)00240-5; Jakobsson J, 2006, MOL THER, V13, P484, DOI 10.1016/j.ymthe.2005.11.012; Jakobsson J, 2003, J NEUROSCI RES, V73, P876, DOI 10.1002/jnr.10719; Kaczmarczyk SJ, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e56; Kafri T, 1999, J VIROL, V73, P576, DOI 10.1128/JVI.73.1.576-584.1999; Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Mitrophanous KA, 1999, GENE THER, V6, P1808, DOI 10.1038/sj.gt.3301023; Nair-Roberts RG, 2008, NEUROSCIENCE, V152, P1024, DOI 10.1016/j.neuroscience.2008.01.046; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; Paxinos G., 2001, MOUSE BRAIN STEREOTA; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sirven A, 2001, MOL THER, V3, P438, DOI 10.1006/mthe.2001.0282; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Turiault M, 2007, FEBS J, V274, P3568, DOI 10.1111/j.1742-4658.2007.05886.x; Verma IM, 2005, ANNU REV BIOCHEM, V74, P711, DOI 10.1146/annurev.biochem.74.050304.091637; Watson DJ, 2002, MOL THER, V5, P528, DOI 10.1006/mthe.2002.0584; Wong LF, 2004, MOL THER, V9, P101, DOI 10.1016/j.ymthe.2003.09.017; Wong LF, 2006, HUM GENE THER, V17, P1, DOI 10.1089/hum.2006.17.1; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	45	26	26	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2010	24	3					723	730		10.1096/fj.09-139790	http://dx.doi.org/10.1096/fj.09-139790			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	561KE	19858094				2022-12-25	WOS:000274974600008
J	Lemjabbar-Alaoui, H; van Zante, A; Singer, MS; Xue, Q; Wang, YQ; Tsay, D; He, B; Jablons, DM; Rosen, SD				Lemjabbar-Alaoui, H.; van Zante, A.; Singer, M. S.; Xue, Q.; Wang, Y-Q; Tsay, D.; He, B.; Jablons, D. M.; Rosen, S. D.			Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis	ONCOGENE			English	Article						lung cancer; Sulf-2; sulfatase; heparan sulfate proteoglycans	WNT SIGNALING PATHWAY; CANCER-CELLS; HUMAN BREAST; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; WNT/BETA-CATENIN; IN-VIVO; GROWTH; ACTIVATION; BINDING	Heparan sulfate (HS) proteoglycans (HSPGs) bind to multiple growth factors/morphogens and regulate their signaling. 6-O-sulfation (6S) of glucosamine within HS chains is critical for many of these ligand interactions. Sulf-1 and Sulf-2, which are extracellular neutral-pH sulfatases, provide a novel post-synthetic mechanism for regulation of HSPG function by removing 6S from intact HS chains. The Sulfs can thereby modulate several signaling pathways, including the promotion of Wnt signaling. We found induction of SULF2 transcripts and Sulf-2 protein in human lung adenocarcinoma and squamous cell carcinoma, the two major classes of nonsmall-cell lung carcinomas (NSCLCs). We confirmed widespread Sulf-2 protein expression in tumor cells of 10/10 surgical specimens of human lung squamous carcinomas. We studied five Sulf-2(+) NSCLC cell lines, including two, which were derived by cigarette-smoke transformation of bronchial epithelial cells. shRNA-mediated Sulf-2 knockdown in these lines caused an increase in 6S on their cell surface and in parallel reversed their transformed phenotype in vitro, eliminated autocrine Wnt signaling and strongly blunted xenograft tumor formation in nude mice. Conversely, forced Sulf-2 expression in non-malignant bronchial epithelial cells produced a partially transformed phenotype. Our findings support an essential role for Sulf-2 in lung cancer, the leading cancer killer. Oncogene (2010) 29, 635-646; doi: 10.1038/onc.2009.365; published online 26 October 2009	[Lemjabbar-Alaoui, H.; Singer, M. S.; Xue, Q.; Wang, Y-Q; Tsay, D.; Rosen, S. D.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [van Zante, A.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [He, B.; Jablons, D. M.] Univ Calif San Francisco, Ctr Comprehens Canc, Dept Surg, Thorac Oncol Lab, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Rosen, SD (corresponding author), Univ Calif San Francisco, Dept Anat, 513 Parnassus Ave,Box 0452, San Francisco, CA 94143 USA.	steven.rosen@ucsf.edu		Rosen, Steven/0000-0002-6245-701X	University of California [17RT-0216, NIH P01 AI053194, NIH R21 CA122025]; Susan Komen Breast Cancer Foundation [PDF0402844, NIH RO1 HL075602]; NIH [RO1 HL075602, R01CA125030]; The Larry Hall and Zygielbaum Memorial Trust; The Kazan, McClain, Edises, Abrams, Fernandez, Lyons & Farrise Foundation; NATIONAL CANCER INSTITUTE [R01CA125030, R21CA122025] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI053194] Funding Source: NIH RePORTER	University of California(University of California System); Susan Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Larry Hall and Zygielbaum Memorial Trust; The Kazan, McClain, Edises, Abrams, Fernandez, Lyons & Farrise Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RB4CD12 was a kind gift from Drs Guido Jenniskens and Toin van Kuppevelt of Nijmegen Medical Center. We thank Dr Roman Nawroth for preliminary work with lung cancer cell lines. We thank Drs Zena Werb, Joanna Phillips and Inna Maltseva for comments on the paper. This work was performed with support from the Tobacco-Related Disease Research Program of the University of California Grant 17RT-0216, NIH P01 AI053194 and NIH R21 CA122025; Susan Komen Breast Cancer Foundation PDF0402844 to SDR; NIH RO1 HL075602 to Dr Zena Werb; The Larry Hall and Zygielbaum Memorial Trust, and The Kazan, McClain, Edises, Abrams, Fernandez, Lyons & Farrise Foundation to DMJ and NIH R01CA125030 to BH.	Ai XB, 2003, J CELL BIOL, V162, P341, DOI 10.1083/jcb.200212083; Ai XB, 2007, DEVELOPMENT, V134, P3327, DOI 10.1242/dev.007674; Aikawa T, 2008, J CLIN INVEST, V118, P89, DOI 10.1172/JCI32412; Alexander CM, 2000, NAT GENET, V25, P329, DOI 10.1038/77108; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brickman YG, 1998, J BIOL CHEM, V273, P4350, DOI 10.1074/jbc.273.8.4350; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Castro NP, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2157; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dai YM, 2005, J BIOL CHEM, V280, P40066, DOI 10.1074/jbc.M508136200; Danesin C, 2006, J NEUROSCI, V26, P5037, DOI 10.1523/JNEUROSCI.0715-06.2006; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Derksen PWB, 2004, P NATL ACAD SCI USA, V101, P6122, DOI 10.1073/pnas.0305855101; Dhoot GK, 2001, SCIENCE, V293, P1663, DOI 10.1126/science.293.5535.1663; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Freeman SD, 2008, DEV BIOL, V320, P436, DOI 10.1016/j.ydbio.2008.05.554; Furuuchi K, 2000, AM J PATHOL, V156, P1997, DOI 10.1016/S0002-9440(10)65072-9; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gallagher JT, 2001, J CLIN INVEST, V108, P357, DOI 10.1172/JCI13713; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Groen RWJ, 2008, CANCER RES, V68, P6969, DOI 10.1158/0008-5472.CAN-08-1322; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; Habuchi H, 2007, J BIOL CHEM, V282, P15578, DOI 10.1074/jbc.M607434200; Hoang BH, 2004, INT J CANCER, V109, P106, DOI 10.1002/ijc.11677; Holst CR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000575; HOSSAIN MM, 2009, GLYCOBIOLOGY; Huang CL, 2008, EUR J CANCER, V44, P2680, DOI 10.1016/j.ejca.2008.08.004; HUGUET EL, 1994, CANCER RES, V54, P2615; Janssens N, 2004, TUMOR BIOL, V25, P161, DOI 10.1159/000081098; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim J, 2007, J THORAC CARDIOV SUR, V133, P733, DOI 10.1016/j.jtcvs.2006.09.053; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kudo Y, 2006, CANCER RES, V66, P6928, DOI 10.1158/0008-5472.CAN-05-4540; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Lai JP, 2004, GASTROENTEROLOGY, V126, P231, DOI 10.1053/j.gastro.2003.09.043; Lai JP, 2003, J BIOL CHEM, V278, P23107, DOI 10.1074/jbc.M302203200; Lamanna WC, 2008, J BIOL CHEM, V283, P27724, DOI 10.1074/jbc.M802130200; Langsdorf A, 2007, DEV BIOL, V311, P464, DOI 10.1016/j.ydbio.2007.08.053; Lemjabbar-Alaoui H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000093; Li JS, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-14; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lum DH, 2007, MOL CELL BIOL, V27, P678, DOI 10.1128/MCB.01279-06; Mazieres J, 2004, CANCER RES, V64, P4717, DOI 10.1158/0008-5472.CAN-04-1389; Mikami I, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-53; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Morimoto-Tomita M, 2002, J BIOL CHEM, V277, P49175, DOI 10.1074/jbc.M205131200; Nakashima T, 2008, ONCOL REP, V19, P203; Nawroth R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000392; Ohgaki H, 2004, CANCER LETT, V207, P197, DOI 10.1016/j.canlet.2003.10.020; Osada H, 2002, ONCOGENE, V21, P7421, DOI 10.1038/sj.onc.1205802; Parish CR, 2001, BBA-REV CANCER, V1471, pM99, DOI 10.1016/S0304-419X(01)00017-8; Ratzka A, 2008, DEV DYNAM, V237, P339, DOI 10.1002/dvdy.21423; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Schlange T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1769; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sunaga N, 2001, GENE CHROMOSOME CANC, V30, P316, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1097>3.0.CO;2-9; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Tang RH, 2009, J BIOL CHEM, V284, P21505, DOI 10.1074/jbc.M109.028472; Uchimura Kenji, 2006, BMC Biochem, V7, P2, DOI 10.1186/1471-2091-7-2; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Vlodavsky I, 2007, CURR PHARM DESIGN, V13, P2057; Wang SW, 2004, P NATL ACAD SCI USA, V101, P4833, DOI 10.1073/pnas.0401028101; Winn RA, 2006, J BIOL CHEM, V281, P26943, DOI 10.1074/jbc.M604145200; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844	70	103	107	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 4	2010	29	5					635	646		10.1038/onc.2009.365	http://dx.doi.org/10.1038/onc.2009.365			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	551QI	19855436	Green Submitted, Green Accepted			2022-12-25	WOS:000274223700002
J	Lefebvre, JS; Marleau, S; Milot, V; Levesque, T; Picard, S; Flamand, N; Borgeat, P				Lefebvre, Julie S.; Marleau, Sylvie; Milot, Valerie; Levesque, Tania; Picard, Serge; Flamand, Nicolas; Borgeat, Pierre			Toll-like receptor ligands induce polymorphonuclear leukocyte migration: key roles for leukotriene B-4 and platelet-activating factor	FASEB JOURNAL			English	Article						inflammation; lipid mediators; transendothelial migration; mouse air-pouch model; endothelial cells	HUMAN-ENDOTHELIAL-CELLS; CYTOSOLIC PHOSPHOLIPASE A(2); HUMAN NEUTROPHILS; INNATE IMMUNE; LUNG INJURY; BIOSYNTHESIS; INHIBITION; INVOLVEMENT; INTERLEUKIN-8; RECRUITMENT	Activation of toll-like receptors (TLRs) and polymorphonuclear leukocyte (PMN) accumulation at infection sites are critical events of host defense. The involvement of leukotriene (LT) B-4 and platelet-activating factor (PAF) in TLR ligand-induced activation of inflammatory cell functions is essentially unknown. Using an in vitro model of human PMN migration through human endothelial cell monolayers, we demonstrate that prototypic ligands of TLR1/2, 2/6, 3, 4, 5, and 7/8 promote PMN migration, an effect markedly inhibited by 3 LTB4 receptor antagonists (70-80% inhibition at 100 nM compared to vehicle-treated cells), 3 PAF receptor antagonists (20-50% inhibition at 10 nM), 3 LT biosynthesis inhibitors (75-85% inhibition at 100 nM), and 1 cytosolic phospholipase A(2)alpha (cPLA(2)alpha) inhibitor (90% inhibition at 1 mu M). Accordingly, selected TLR ligands caused Ser-505- phosphorylation of cPLA(2)alpha and measurable LTB4 and PAF biosynthesis in the transmigration assay. As negative controls, interleukin-8- and formyl-methionylleucyl-phenylalanine-elicited migration in vitro was not inhibited either by an LTB4 receptor antagonist or by the cPLA(2)alpha inhibitor. Finally, LTB4 and PAF receptor antagonists inhibited (up to similar to 65% at optimal doses) TLR ligand-induced PMN infiltration in the mouse air-pouch model. These studies unravel the critical involvement of de novo LTB4 and PAF biosynthesis in PMN migration elicited by TLR ligands.-Lefebvre, J. S., Marleau, S., Milot, V., Levesque, T., Picard, S., Flamand, N., Borgeat, P. Toll-like receptor ligands induce polymorphonuclear leukocyte migration: key roles for leukotriene B-4 and platelet-activating factor. FASEB J. 24, 637-647 (2010). www.fasebj.org	[Lefebvre, Julie S.; Milot, Valerie; Levesque, Tania; Picard, Serge; Borgeat, Pierre] Ctr Hosp Univ Quebec, Ctr Rech Rhumatol & Immunol, Quebec City, PQ G1V 4G2, Canada; [Lefebvre, Julie S.; Milot, Valerie; Levesque, Tania; Picard, Serge; Flamand, Nicolas; Borgeat, Pierre] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Marleau, Sylvie] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Flamand, Nicolas] Inst Univ Cardiol & Pneumol Quebec, Ctr Rech, Quebec City, PQ, Canada	Laval University; Laval University; Universite de Montreal; Laval University	Borgeat, P (corresponding author), Ctr Hosp Univ Quebec, Ctr Rech Rhumatol & Immunol, 2705 Laurier Blvd,Rm T1-49, Quebec City, PQ G1V 4G2, Canada.	pierre.borgeat@crchul.ulaval.ca	Flamand, Nicolas/H-5823-2019	Flamand, Nicolas/0000-0001-5944-7200	Canadian Institute for Health Research; Canadian Arthritis Network	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Arthritis Network	This work was supported by the Canadian Institute for Health Research (P. B. and S. M.). J.S.L. received a fellowship from the Canadian Institute for Health Research, and V. M. received a fellowship from the Canadian Arthritis Network. The authors thank Maurice Dufour and Isabelle Dubuc for technical assistance.	Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848; Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Andonegui G, 2002, J IMMUNOL, V169, P2111, DOI 10.4049/jimmunol.169.4.2111; Aomatsu K, 2008, IMMUNOLOGY, V123, P171, DOI 10.1111/j.1365-2567.2007.02684.x; BANNATYNE RM, 1977, J INFECT DIS, V136, P469, DOI 10.1093/infdis/136.4.469; Belanger C, 2008, IMMUNOLOGY, V124, P295, DOI 10.1111/j.1365-2567.2007.02767.x; Benjamim CF, 2005, J IMMUNOL, V174, P1616, DOI 10.4049/jimmunol.174.3.1616; BUSSOLINO F, 1987, J IMMUNOL, V139, P2439; Cepinskas G, 1999, J CELL SCI, V112, P1937; Chen M, 2006, J EXP MED, V203, P837, DOI 10.1084/jem.20052371; Chen NN, 2001, J NEUROIMMUNOL, V120, P94, DOI 10.1016/S0165-5728(01)00415-5; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; CLAESSON HE, 1988, EUR J BIOCHEM, V173, P93, DOI 10.1111/j.1432-1033.1988.tb13971.x; Fasano MB, 1998, CLIN IMMUNOL IMMUNOP, V87, P304, DOI 10.1006/clin.1998.4545; Flamand N, 2004, BRIT J PHARMACOL, V141, P552, DOI 10.1038/sj.bjp.0705654; Flamand N, 2002, MOL PHARMACOL, V62, P250, DOI 10.1124/mol.62.2.250; FONTEH AN, 1993, J IMMUNOL, V151, P339; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; Gautam N, 1998, BRIT J PHARMACOL, V125, P1109, DOI 10.1038/sj.bjp.0702186; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Hattermann K, 2007, FASEB J, V21, P1575, DOI 10.1096/fj.06-7457com; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; HOPKINS NK, 1984, BIOCHIM BIOPHYS ACTA, V805, P30, DOI 10.1016/0167-4889(84)90033-8; Kim ND, 2006, J EXP MED, V203, P829, DOI 10.1084/jem.20052349; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Krump E, 1997, J EXP MED, V186, P1401, DOI 10.1084/jem.186.8.1401; Kurose I, 1997, AM J PHYSIOL-HEART C, V272, pH2976, DOI 10.1152/ajpheart.1997.272.6.H2976; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; LIN AH, 1982, J CLIN INVEST, V70, P1058, DOI 10.1172/JCI110693; MACLOUF J, 1989, BLOOD, V74, P703; MCDONALD PP, 1993, J IMMUNOL, V151, P6399; MCDONALD PP, 1994, BRIT J PHARMACOL, V111, P852, DOI 10.1111/j.1476-5381.1994.tb14816.x; MOILANEN E, 1993, INFLAMMATION, V17, P705, DOI 10.1007/BF00920475; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Nagase T, 2003, AM J PHYSIOL-LUNG C, V284, pL720, DOI 10.1152/ajplung.00396.2002; Nohgawa M, 1997, J LEUKOCYTE BIOL, V62, P203, DOI 10.1002/jlb.62.2.203; Opitz B, 2007, THROMB HAEMOSTASIS, V98, P319, DOI 10.1160/TH06-12-0694; PALMBLAD J, 1994, J IMMUNOL, V152, P262; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; Sabroe I, 2005, CLIN INFECT DIS, V41, pS421, DOI 10.1086/431992; SALARI H, 1985, INFLAMMATION, V9, P127, DOI 10.1007/BF00917585; Scott MJ, 2004, CLIN DIAGN LAB IMMUN, V11, P936, DOI 10.1128/CDLI.11.5.936-941.2004; Sheahan T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000240; SILVESTRO L, 1994, SEMIN THROMB HEMOST, V20, P214, DOI 10.1055/s-2007-1001905; SURETTE ME, 1993, J EXP MED, V178, P1347, DOI 10.1084/jem.178.4.1347; TAKAHASHI M, 1995, CARDIOVASC RES, V29, P670; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Wagner H, 2006, ADV IMMUNOL, V91, P159, DOI 10.1016/S0065-2776(06)91004-9; Wilde I, 2007, MED MICROBIOL IMMUN, V196, P61, DOI 10.1007/s00430-006-0027-9; ZIMMERMAN GA, 1990, J CELL BIOL, V110, P529, DOI 10.1083/jcb.110.2.529	54	26	29	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					637	647		10.1096/fj.09-135624	http://dx.doi.org/10.1096/fj.09-135624			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19843712				2022-12-25	WOS:000274045000031
J	Tan, KM; Clancy, S; Borovilos, M; Zhou, M; Horer, S; Moy, S; Volkart, LL; Sassoon, J; Baumann, U; Joachimiak, A				Tan, Kemin; Clancy, Shonda; Borovilos, Maria; Zhou, Min; Hoerer, Stefan; Moy, Shiu; Volkart, Lour L.; Sassoon, Judyth; Baumann, Ulrich; Joachimiak, Andrzej			The Mannitol Operon Repressor MtlR Belongs to a New Class of Transcription Regulators in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLETE GENOME SEQUENCE; PHOSPHOTRANSFERASE SYSTEM; NUCLEOTIDE-SEQUENCE; HIGH-THROUGHPUT; BINDING-SITES; LARGE-SCALE; ENZYME-II; PROTEIN; DEHYDROGENASE; TRANSPORT	Many bacteria express phosphoenolpyruvate-dependent phosphotransferase systems (PTS). The mannitol-specific PTS catalyze the uptake and phosphorylation of D-mannitol. The uptake system comprises several genes encoded in the single operon. The expression of the mannitol operon is regulated by a proposed transcriptional factor, mannitol operon repressor (MtlR) that was first studied in Escherichia coli. Here we report the first crystal structures of MtlR from Vibrio parahemeolyticus (Vp-MtlR) and its homolog YggD protein from Shigella flexneri (Sf-YggD). MtlR and YggD belong to the same protein family (Pfam05068). Although Vp-MtlR and Sf-YggD share low sequence identity (22%), their overall structures are very similar, representing a novel all alpha-helical fold, and indicate similar function. However, their lack of any known DNA-binding structural motifs and their unfavorable electrostatic properties imply that MtlR/YggD are unlikely to bind a specific DNA operator directly as proposed earlier. This structural observation is further corroborated by in vitro DNA-binding studies of E. coli MtlR (Ec-MtlR), which detected no interaction of Ec-MtlR with the well characterized mannitol operator/promoter region. Therefore, MtlR/YggD belongs to a new class of transcription factors in bacteria that may regulate gene expression indirectly as a part of a larger transcriptional complex.	[Tan, Kemin; Clancy, Shonda; Borovilos, Maria; Zhou, Min; Moy, Shiu; Volkart, Lour L.; Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Tan, Kemin; Clancy, Shonda; Borovilos, Maria; Zhou, Min; Moy, Shiu; Volkart, Lour L.; Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA; [Hoerer, Stefan; Sassoon, Judyth; Baumann, Ulrich] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Bern	Joachimiak, A (corresponding author), Argonne Natl Lab, Biosci Div, Midwest Ctr Struct Genom, 9700 S Cass Ave, Argonne, IL 60439 USA.	andrzejj@anl.gov	Baumann, Ulrich/B-1220-2013		National Institutes of Health [GM074942]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074942. This work was also supported by the United States Department of Energy, Office of Biological and Environmental Research, under Contract DE-AC02-06CH11357. This work was created by UChicago Argonne, LLC, Operator of Argonne National Laboratory.	Ahmad S, 2004, J MOL BIOL, V341, P65, DOI 10.1016/j.jmb.2004.05.058; ANDERSON WF, 1981, NATURE, V290, P754, DOI 10.1038/290754a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barabote RD, 2005, MICROBIOL MOL BIOL R, V69, P608, DOI 10.1128/MMBR.69.4.608-634.2005; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Behrens S, 2001, MICROBIOL-SGM, V147, P75, DOI 10.1099/00221287-147-1-75; BERKOWIT.D, 1971, J BACTERIOL, V105, P232, DOI 10.1128/JB.105.1.232-240.1971; Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415; BRANDEN C, 1991, INTRO PROTEIN STRUCT, P36; Chiu CH, 2005, NUCLEIC ACIDS RES, V33, P1690, DOI 10.1093/nar/gki297; DAVIS T, 1988, MOL MICROBIOL, V2, P405, DOI 10.1111/j.1365-2958.1988.tb00045.x; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felder CE, 1997, J MOL GRAPH MODEL, V15, P318, DOI 10.1016/S1093-3263(98)00005-9; FIGGE RM, 1994, J BACTERIOL, V176, P840, DOI 10.1128/jb.176.3.840-847.1994; GEORGE AJT, 1995, J IMMUNOL METHODS, V183, P51, DOI 10.1016/0022-1759(95)00031-5; Henstra SA, 1996, J BACTERIOL, V178, P5586, DOI 10.1128/jb.178.19.5586-5591.1996; Henstra SA, 1999, J BIOL CHEM, V274, P4754, DOI 10.1074/jbc.274.8.4754; Henstra SA, 2000, J BIOL CHEM, V275, P7037, DOI 10.1074/jbc.275.10.7037; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Honeyman AL, 2000, MICROBIOL-SGM, V146, P1565, DOI 10.1099/00221287-146-7-1565; JIANG W, 1990, MOL MICROBIOL, V4, P2003, DOI 10.1111/j.1365-2958.1990.tb02050.x; Kim YC, 2008, NAT METHODS, V5, P853, DOI 10.1038/nmeth1008-853; Kim Youngchang, 2004, Journal of Structural and Functional Genomics, V5, P111, DOI 10.1023/B:JSFG.0000029206.07778.fc; LEE CA, 1983, J BIOL CHEM, V258, P761; LENGELER J, 1975, J BACTERIOL, V124, P39, DOI 10.1128/JB.124.1.39-47.1975; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Luscombe NM, 2000, GENOME BIOL, V1; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otte S, 2003, J BACTERIOL, V185, P2267, DOI 10.1128/JB.185.7.2267-2276.2003; Otte S, 2001, FEMS MICROBIOL LETT, V194, P221, DOI 10.1016/S0378-1097(00)00534-6; PEDERSEN LC, 1995, BIOCHEMISTRY-US, V34, P13305, DOI 10.1021/bi00041a005; RAMSEIER TM, 1995, MOL MICROBIOL, V16, P1157, DOI 10.1111/j.1365-2958.1995.tb02339.x; RAMSEIER TM, 1995, MICROBIOL-SGM, V141, P1901, DOI 10.1099/13500872-141-8-1901; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Rubio I, 1997, BIOTECHNIQUES, V22, P269, DOI 10.2144/97222bm15; SAIER MH, 1994, MOL MICROBIOL, V13, P755; Sassoon J, 2001, ACTA CRYSTALLOGR D, V57, P711, DOI 10.1107/S0907444901002542; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Song YJ, 2004, DNA RES, V11, P179, DOI 10.1093/dnares/11.3.179; Stawiski EW, 2003, J MOL BIOL, V326, P1065, DOI 10.1016/S0022-2836(03)00031-7; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; van Montfort RLM, 1998, STRUCTURE, V6, P377, DOI 10.1016/S0969-2126(98)00039-2; Watanabe S, 2003, J BACTERIOL, V185, P4816, DOI 10.1128/JB.185.16.4816-4824.2003; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Yang F, 2005, NUCLEIC ACIDS RES, V33, P6445, DOI 10.1093/nar/gki954; Yu CF, 2007, BIOCHEM BIOPH RES CO, V362, P1001, DOI 10.1016/j.bbrc.2007.08.102	51	10	12	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36670	36679		10.1074/jbc.M109.062679	http://dx.doi.org/10.1074/jbc.M109.062679			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19840941	Green Published, hybrid			2022-12-25	WOS:000272970500067
J	Winkler, M; Kuhlgert, S; Hippler, M; Happe, T				Winkler, Martin; Kuhlgert, Sebastian; Hippler, Michael; Happe, Thomas			Characterization of the Key Step for Light-driven Hydrogen Evolution in Green Algae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; CHLAMYDOMONAS-REINHARDTII; FERREDOXIN-NADP(+) REDUCTASE; CLOSTRIDIUM-ACETOBUTYLICUM; THIOREDOXIN REDUCTASE; ANGSTROM RESOLUTION; ONLY HYDROGENASES; CRYSTAL-STRUCTURE; IRON HYDROGENASE; TRANSFER COMPLEX	Under anaerobic conditions, several species of green algae perform a light-dependent hydrogen production catalyzed by a special group of [FeFe] hydrogenases termed HydA. Although highly interesting for biotechnological applications, the direct connection between photosynthetic electron transport and hydrogenase activity is still a matter of speculation. By establishing an in vitro reconstitution system, we demonstrate that the photosynthetic ferredoxin (PetF) is essential for efficient electron transfer between photosystem I and HydA1. To investigate the electrostatic interaction process and electron transfer between PetF and HydA1, we performed site-directed mutagenesis. Kinetic analyses with several site-directed mutagenesis variants of HydA1 and PetF enabled us to localize the respective contact sites. These experiments in combination with in silico docking analyses indicate that electrostatic interactions between the conserved HydA1 residue Lys(396) and the C terminus of PetF as well as between the PetF residue Glu(122) and the N-terminal amino group of HydA1 play a major role in complex formation and electron transfer. Mapping of relevant HydA1 and PetF residues constitutes an important basis for manipulating the physiological photosynthetic electron flow in favor of light-driven H-2 production.	[Winkler, Martin; Happe, Thomas] Ruhr Univ Bochum, Lehrstuhl Biochem Pflanzen, AG Photobiotechnol, D-44801 Bochum, Germany; [Kuhlgert, Sebastian; Hippler, Michael] Univ Munster, Inst Biochem & Biotechnol Pflanzen, D-49143 Munster, Germany	Ruhr University Bochum; University of Munster	Happe, T (corresponding author), Ruhr Univ Bochum, Lehrstuhl Biochem Pflanzen, AG Photobiotechnol, Univ Str 150, D-44801 Bochum, Germany.	thomas.happe@rub.de		Happe, Thomas/0000-0003-1206-5234; Michael, Hippler/0000-0001-9670-6101	Deutsche Forschungsgemeinschaft (DFG) [HI 739/4-1, SFB 480]; European Union/Energy Network SolarH2 FP7 [212508]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Union/Energy Network SolarH2 FP7(European Commission)	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants HI 739/4-1 and SFB 480 (to T. H. and M. W., respectively) and the European Union/Energy Network SolarH2 FP7 Contract 212508 (to T. H.).	Bes MT, 1999, STRUCT FOLD DES, V7, P1201, DOI 10.1016/S0969-2126(00)80054-4; Chang CH, 2007, BIOPHYS J, V93, P3034, DOI 10.1529/biophysj.107.108589; CINCO RM, 1993, PHOTOSYNTH RES, V38, P27, DOI 10.1007/BF00015058; COLVERT KK, 1983, ARCH BIOCHEM BIOPHYS, V225, P936, DOI 10.1016/0003-9861(83)90108-X; DEPASCALIS AR, 1993, PROTEIN SCI, V2, P1126, DOI 10.1002/pro.5560020707; Fischer N, 1998, EMBO J, V17, P849, DOI 10.1093/emboj/17.4.849; Florin L, 2001, J BIOL CHEM, V276, P6125, DOI 10.1074/jbc.M008470200; Fukuyama K, 2004, PHOTOSYNTH RES, V81, P289, DOI 10.1023/B:PRES.0000036882.19322.0a; Girbal L, 2005, APPL ENVIRON MICROB, V71, P2777, DOI 10.1128/AEM.71.5.2777-2781.2005; Happe T, 2002, TRENDS PLANT SCI, V7, P246, DOI 10.1016/S1360-1385(02)02274-4; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; HAPPE T, 1994, EUR J BIOCHEM, V222, P769, DOI 10.1111/j.1432-1033.1994.tb18923.x; Happe T, 2002, EUR J BIOCHEM, V269, P1022, DOI 10.1046/j.0014-2956.2001.02743.x; Hemschemeier A, 2008, PLANTA, V227, P397, DOI 10.1007/s00425-007-0626-8; Hippler M, 1997, BIOCHEMISTRY-US, V36, P6343, DOI 10.1021/bi970082c; Hurley JK, 1997, BIOCHEMISTRY-US, V36, P11100, DOI 10.1021/bi9709001; Jacobs J, 2009, FEBS LETT, V583, P325, DOI 10.1016/j.febslet.2008.12.018; Jacquot JP, 1997, FEBS LETT, V400, P293, DOI 10.1016/S0014-5793(96)01407-X; Kamp C, 2008, BBA-BIOENERGETICS, V1777, P410, DOI 10.1016/j.bbabio.2008.02.002; Krippahl L, 2003, PROTEINS, V52, P19, DOI 10.1002/prot.10387; Kurisu G, 2001, NAT STRUCT BIOL, V8, P117, DOI 10.1038/84097; Lo Conte L, 1999, J MOL BIOL, V285, P2177; MAYHEW SG, 1969, J BIOL CHEM, V244, P2830; Mayoral T, 2005, PROTEINS, V59, P592, DOI 10.1002/prot.20450; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Melis A, 2004, PHOTOSYNTH RES, V80, P401, DOI 10.1023/B:PRES.0000030421.31730.cb; Melis A, 2000, PLANT PHYSIOL, V122, P127, DOI 10.1104/pp.122.1.127; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Morales R, 2000, EMBO REP, V1, P271, DOI 10.1093/embo-reports/kvd057; Morales R, 1999, BIOCHEMISTRY-US, V38, P15764, DOI 10.1021/bi991578s; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Palma PN, 2005, FEBS LETT, V579, P4585, DOI 10.1016/j.febslet.2005.07.027; Peters JW, 1999, CURR OPIN STRUC BIOL, V9, P670, DOI 10.1016/S0959-440X(99)00028-7; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Saitoh T, 2006, J BIOL CHEM, V281, P10482, DOI 10.1074/jbc.M510530200; Terauchi AM, 2009, J BIOL CHEM, V284, P25867, DOI 10.1074/jbc.M109.023622; von Abendroth G, 2008, INT J HYDROGEN ENERG, V33, P6076, DOI 10.1016/j.ijhydene.2008.07.122; Winkler M, 2002, BBA-GENE STRUCT EXPR, V1576, P330, DOI 10.1016/S0167-4781(02)00239-7; Wykoff DD, 1998, PLANT PHYSIOL, V117, P129, DOI 10.1104/pp.117.1.129; Xu XF, 2006, FEBS LETT, V580, P6714, DOI 10.1016/j.febslet.2006.11.027; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895	41	95	95	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36620	36627		10.1074/jbc.M109.053496	http://dx.doi.org/10.1074/jbc.M109.053496			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19846550	Green Published, hybrid			2022-12-25	WOS:000272970500062
J	Cheng, CY; Yang, J; Taylor, SS; Blumenthal, DK				Cheng, Cecilia Y.; Yang, Jie; Taylor, Susan S.; Blumenthal, Donald K.			Sensing Domain Dynamics in Protein Kinase A-I alpha Complexes by Solution X-ray Scattering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE MASS-SPECTROMETRY; SMALL-ANGLE SCATTERING; SITE MUTATIONS DEFINE; SUBUNIT RI-ALPHA; REGULATORY SUBUNIT; BIOLOGICAL MACROMOLECULES; CATALYTIC SUBUNIT; STRUCTURE REVEALS; CAMP; PKA	The catalytic (C) and regulatory (R) subunits of protein kinase A are exceptionally dynamic proteins. Interactions between the R- and C-subunits are regulated by cAMP binding to the two cyclic nucleotide-binding domains in the R-subunit. Mammalian cells express four different isoforms of the R-subunit (RI alpha, RI beta, RII alpha, and RII beta) that all interact with the C-subunit in different ways. Here, we investigate the dynamic behavior of protein complexes between RI alpha and C-subunits using small angle x-ray scattering. We show that a single point mutation in RI alpha, R333K (which alters the cAMP-binding properties of Domain B) results in a compact shape compared with the extended shape of the wild-type R.C complex. A double mutant complex that disrupts the interaction site between the C-subunit and Domain B in RI alpha, RI alpha(AB)R333K.C(K285P), results in a broader P(r) curve that more closely resembles the P(r) profiles of wild-type complexes. These results together suggest that interactions between RI alpha Domain B and the C-subunit in the RI alpha.C complex involve large scale dynamics that can be disrupted by single point mutations in both proteins. In contrast to RI alpha.C complexes. Domain B in the RII beta.C heterodimer is not dynamic and is critical for both inhibition and complex formation. Our study highlights the functional differences of domain dynamics between protein kinase A isoforms, providing a framework for elucidating the global organization of each holoenzyme and the cross-talk between the R- and C-subunits.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92037 USA; [Taylor, Susan S.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92037 USA; [Taylor, Susan S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Blumenthal, Donald K.] Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah	Blumenthal, DK (corresponding author), 112 Skaggs Hall, Salt Lake City, UT 84112 USA.	Don.Blumenthal@pharm.utah.edu		Blumenthal, Donald/0000-0002-8614-1167	National Institutes of Health [GM34921, GM08326]; American Heart Association [07015019Y]; United States Department of Energy [DE-FG02-05ER64026]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008326, R01GM034921] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM34921 (to S. S. T.) and GM08326 (to C. Y. C.). This work was also supported in part by American Heart Association (Western States Affiliate) Grant 07015019Y (to C. Y. C.).; We thank Dr. Michael Deal (University of California, San Diego) for providing the C-subunit protein used in these studies and Dr. Dennis Winge (University of Utah) for performing the amino acid analyses. We also thank Jon Steichen for helpful discussions on the manuscript. We thank Dr. Jill Trewhella for the generous use of laboratory facilities at the University of Utah. X-ray scattering data were collected at the University of Utah using facilities that are supported by the United States Department of Energy Grant DE-FG02-05ER64026 (to Jill Trewhella).	Amieux PS, 1997, J BIOL CHEM, V272, P3993, DOI 10.1074/jbc.272.7.3993; Amieux PS, 2002, ANN NY ACAD SCI, V968, P75, DOI 10.1111/j.1749-6632.2002.tb04328.x; Anand GS, 2007, J MOL BIOL, V374, P487, DOI 10.1016/j.jmb.2007.09.035; Arnsten AFT, 2005, TRENDS MOL MED, V11, P121, DOI 10.1016/j.molmed.2005.01.006; Bertherat J, 2009, J CLIN ENDOCR METAB, V94, P2085, DOI 10.1210/jc.2008-2333; Chen TC, 1998, LAB INVEST, V78, P165; Dayal AK, 1996, ARTHRITIS RHEUM-US, V39, P23, DOI 10.1002/art.1780390104; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Groussin L, 2006, J CLIN ENDOCR METAB, V91, P1943, DOI 10.1210/jc.2005-2708; Gullingsrud J, 2006, STRUCTURE, V14, P141, DOI 10.1016/j.str.2005.09.019; Hamuro Y, 2004, J MOL BIOL, V340, P1185, DOI 10.1016/j.jmb.2004.05.042; Heller WT, 2002, BIOCHEMISTRY-US, V41, P15654, DOI 10.1021/bi026687c; Herberg FW, 1996, BIOCHEMISTRY-US, V35, P2934, DOI 10.1021/bi951647c; HERBERG FW, 1993, PROTEIN ENG, V6, P771, DOI 10.1093/protein/6.7.771; Horvath A, 2008, CLIN CANCER RES, V14, P388, DOI 10.1158/1078-0432.CCR-07-1155; Huang LJS, 1998, J BIOL CHEM, V273, P26739, DOI 10.1074/jbc.273.41.26739; KAMMER GM, 1994, J CLIN INVEST, V94, P422, DOI 10.1172/JCI117340; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Kennedy EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004746; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; KREBS EG, 1979, ANNU REV BIOCHEM, V48, P923, DOI 10.1146/annurev.bi.48.070179.004423; MURPHY CS, 1985, SOMAT CELL MOLEC GEN, V11, P605, DOI 10.1007/BF01534725; Prowse CN, 2001, J BIOL CHEM, V276, P40817, DOI 10.1074/jbc.M105860200; STEINBERG RA, 1987, J BIOL CHEM, V262, P2664; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vigil D, 2006, J MOL BIOL, V357, P880, DOI 10.1016/j.jmb.2006.01.006; Vigil D, 2004, J MOL BIOL, V337, P1183, DOI 10.1016/j.jmb.2004.02.028; Vigil D, 2005, J BIOL CHEM, V280, P35521, DOI 10.1074/jbc.M506769200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wu J, 2004, STRUCTURE, V12, P1057, DOI 10.1016/j.str.2004.03.022; Yang J, 2009, J BIOL CHEM, V284, P6241, DOI 10.1074/jbc.M805862200; Zawadzki KM, 2004, J BIOL CHEM, V279, P7029, DOI 10.1074/jbc.M310804200	37	18	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35916	35925		10.1074/jbc.M109.059493	http://dx.doi.org/10.1074/jbc.M109.059493			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19837668	hybrid, Green Submitted, Green Published			2022-12-25	WOS:000272645600067
J	Khan, MA; Yumak, H; Goss, DJ				Khan, Mateen A.; Yumak, Hasan; Goss, Dixie J.			Kinetic Mechanism for the Binding of eIF4F and Tobacco Etch Virus Internal Ribosome Entry Site RNA EFFECTS OF eIF4B AND POLY(A)- BINDING PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-SYNTHESIS INITIATION; CAP-INDEPENDENT TRANSLATION; GENOME-LINKED PROTEIN; MESSENGER-RNA; POLY(A)-BINDING PROTEIN; STOPPED-FLOW; POLY(A) TAIL; FACTOR 4F; FACTOR 4G; ANALOGS	The wheat germ eukaryotic translation initiation factor (eIF) 4F binds tightly to the mRNA internal ribosome entry site (IRES) of tobacco etch virus (TEV) to promote translation initiation. When eIF4F is limiting, TEV is preferentially translated compared with host cell mRNA. To gain insight into the dynamic process of protein synthesis initiation and the mechanism of binding, the kinetics of eIF4F binding to TEV IRES were examined. The association rate constant (k(on)) and dissociation rate constant (k(off)) for eIF4F binding to IRES were 59 +/- 2.1 mu M-1 s(-1) and 12.9 +/- 0.3 s(-1), respectively, comparable with the rates for capped RNA. Binding of eIF4E or eIF4F to the cap of mRNA is the rate-limiting step for initiation of cap-dependent protein synthesis. The concentration dependence of the reactions suggested a simple one-step association mechanism. However, the association rate was reduced more than 10-fold when KCl concentration was increased from 50 to 300 mM, whereas the dissociation rate constant was increased 2-fold. The addition of eIF4B and poly(A)-binding protein enhanced the association rate of eIF4F similar to 3-fold. These results suggest a mechanism where eIF4F initially binds electrostatically, followed by a conformational change to further stabilize binding. Poly(A)-binding protein and eIF4B mainly affect the eIF4F/TEV association rate. These results demonstrate the first direct kinetic measurements of translation initiation factor binding to an IRES.	CUNY Hunter Coll, Dept Chem & Biochem, New York, NY 10065 USA; CUNY, Grad Ctr, New York, NY USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System	Goss, DJ (corresponding author), CUNY Hunter Coll, Dept Chem, New York, NY 10065 USA.	dgoss@hunter.cuny.edu		Khan, Mateen A./0000-0002-2300-4595	National Institutes of Health Research Center in Minority Institution [RR-03037]; National Science Foundation [MCB 0814051]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003037] Funding Source: NIH RePORTER	National Institutes of Health Research Center in Minority Institution(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Research Center in Minority Institution Award RR-03037. This work was also supported by National Science Foundation Grant MCB 0814051 (to D. J. G.).	Blachut-Okrasinska E, 2000, EUR BIOPHYS J BIOPHY, V29, P487, DOI 10.1007/s002490000096; Blachut-Okrasinska E, 2007, BIOPHYS CHEM, V129, P289, DOI 10.1016/j.bpc.2007.06.009; Borman AM, 1997, VIROLOGY, V237, P129, DOI 10.1006/viro.1997.8761; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARBERRY SE, 1989, BIOCHEMISTRY-US, V28, P8078, DOI 10.1021/bi00446a017; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P1624, DOI 10.1021/bi00220a026; CARBERRY SE, 1991, BIOCHEMISTRY-US, V30, P4542, DOI 10.1021/bi00232a025; CARRINGTON JC, 1990, J VIROL, V64, P1590, DOI 10.1128/JVI.64.4.1590-1597.1990; Cheng S, 2007, J BIOL CHEM, V282, P25247, DOI 10.1074/jbc.M702193200; Cheng SJ, 2006, J BIOL CHEM, V281, P24351, DOI 10.1074/jbc.M605404200; Dlugosz M, 2003, EUR BIOPHYS J BIOPHY, V31, P608, DOI 10.1007/s00249-002-0258-7; DOUGHERTY WG, 1988, ANNU REV PHYTOPATHOL, V26, P123, DOI 10.1146/annurev.py.26.090188.001011; Gallie DR, 2002, PLANT MOL BIOL, V50, P949, DOI 10.1023/A:1021220910664; GALLIE DR, 1995, GENE, V165, P233, DOI 10.1016/0378-1119(95)00521-7; Gallie DR, 1998, GENE, V216, P1, DOI 10.1016/S0378-1119(98)00318-7; Gallie DR, 2001, J VIROL, V75, P12141, DOI 10.1128/JVI.75.24.12141-12152.2001; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; Hershey JWB, 2000, COLD SPRING HARBOR M, V39, P33; JANG SK, 1988, J VIROL, V62, P2636, DOI 10.1128/JVI.62.8.2636-2643.1988; Katsamba PS, 2001, J BIOL CHEM, V276, P21476, DOI 10.1074/jbc.M101624200; Khan MA, 2005, BIOCHEMISTRY-US, V44, P4510, DOI 10.1021/bi047298g; Khan MA, 2004, BIOCHEMISTRY-US, V43, P9092, DOI 10.1021/bi049602b; Khan MA, 2008, BBA-GENE REGUL MECH, V1779, P622, DOI 10.1016/j.bbagrm.2008.07.004; Khan MA, 2008, J BIOL CHEM, V283, P1340, DOI 10.1074/jbc.M703356200; Khan MA, 2006, J BIOL CHEM, V281, P28002, DOI 10.1074/jbc.M605479200; LAX SR, 1986, METHOD ENZYMOL, V118, P109; Le H, 1997, J BIOL CHEM, V272, P16247, DOI 10.1074/jbc.272.26.16247; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Matsuo H, 1997, NAT STRUCT BIOL, V4, P717, DOI 10.1038/nsb0997-717; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; MINICH WB, 1994, P NATL ACAD SCI USA, V91, P7668, DOI 10.1073/pnas.91.16.7668; Morley SJ, 2001, PROG MOLEC, V27, P1; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; PETTERSSON RF, 1977, NATURE, V268, P270, DOI 10.1038/268270a0; Pilipenko EV, 2000, GENE DEV, V14, P2028; Ray S, 2006, J BIOL CHEM, V281, P35826, DOI 10.1074/jbc.M605762200; SHA M, 1995, J BIOL CHEM, V270, P29904; Slepenkov SV, 2008, J BIOL CHEM, V283, P25227, DOI 10.1074/jbc.M801786200; Slepenkov SV, 2006, J BIOL CHEM, V281, P14927, DOI 10.1074/jbc.M601653200; Sonenberg N, 1996, TRANSLATIONAL CONTRO, P245; Svitkin YV, 1999, J VIROL, V73, P3467, DOI 10.1128/JVI.73.4.3467-3472.1999; Tarun SZ, 1996, EMBO J, V15, P7168, DOI 10.1002/j.1460-2075.1996.tb01108.x; Tomoo K, 2003, J MOL BIOL, V328, P365, DOI 10.1016/S0022-2836(03)00314-0; VANHEERDEN A, 1994, J BIOL CHEM, V269, P17454; Wei CC, 1998, BIOCHEMISTRY-US, V37, P1910, DOI 10.1021/bi9724570; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; YISRAELI JK, 1989, METHOD ENZYMOL, V180, P42; Zeenko V, 2005, J BIOL CHEM, V280, P26813, DOI 10.1074/jbc.M503576200	53	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35461	35470		10.1074/jbc.M109.038463	http://dx.doi.org/10.1074/jbc.M109.038463			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858189	hybrid, Green Published			2022-12-25	WOS:000272645600022
J	Kubota, H; Mikhailenko, SV; Okabe, H; Taguchi, H; Ishiwata, S				Kubota, Hiroaki; Mikhailenko, Sergey V.; Okabe, Harumi; Taguchi, Hideki; Ishiwata, Shin'ichi			D-loop of Actin Differently Regulates the Motor Function of Myosins II and V	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBTILISIN-CLEAVED ACTIN; F-ACTIN; CONFORMATIONAL-CHANGES; PROCESSIVE MOVEMENT; DICTYOSTELIUM ACTIN; BINDING LOOP; COORDINATION; FILAMENTS; FORCE; MODEL	To gain more information on the manner of actin-myosin interaction, we examined how the motile properties of myosins II and V are affected by the modifications of the DNase I binding loop (D-loop) of actin, performed in two different ways, namely, the proteolytic digestion with subtilisin and the M47A point mutation. In an in vitro motility assay, both modifications significantly decreased the gliding velocity on myosin II-heavy meromyosin due to a weaker generated force but increased it on myosin V. On the other hand, single molecules of myosin V "walked" with the same velocity on both the wild-type and modified actins; however, the run lengths decreased sharply, correlating with a lower affinity of myosin for actin due to the D-loop modifications. The difference between the single-molecule and the ensemble measurements with myosin V indicates that in an in vitro motility assay the non-coordinated multiple myosin V molecules impose internal friction on each other via binding to the same actin filament, which is reduced by the weaker binding to the modified actins. These results show that the D-loop strongly modulates the force generation by myosin II and the processivity of myosin V, presumably affecting actin-myosin interaction in the actomyosin-ADP center dot P-i state of both myosins.	[Kubota, Hiroaki; Mikhailenko, Sergey V.; Okabe, Harumi; Ishiwata, Shin'ichi] Waseda Univ, Dept Phys, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Taguchi, Hideki] Univ Tokyo, Dept Med Genome Sci, Grad Sch Frontier Sci, Chiba 2778562, Japan; [Ishiwata, Shin'ichi] Waseda Univ, Adv Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	Waseda University; University of Tokyo; Waseda University	Ishiwata, S (corresponding author), Waseda Univ, Dept Phys, Fac Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	ishiwata@waseda.jp	taguchi, hideki/AAM-2663-2021; Kubota, Hiroaki/AAP-2859-2020; Taguchi, Hideki/B-6946-2009	taguchi, hideki/0000-0002-6612-9339; Kubota, Hiroaki/0000-0002-6339-8568; Taguchi, Hideki/0000-0002-6612-9339	21st Century Centers of Excellence Program; "Academic Frontier" Project	21st Century Centers of Excellence Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Academic Frontier" Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research (A), the 21st Century Centers of Excellence Program, and the "Academic Frontier" Project (to S.I.).	Ali MY, 2002, NAT STRUCT BIOL, V9, P464, DOI 10.1038/nsb803; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Cheney RE, 1998, METHOD ENZYMOL, V298, P3, DOI 10.1016/S0076-6879(98)98003-X; DANTZIG JA, 1992, J PHYSIOL-LONDON, V451, P247, DOI 10.1113/jphysiol.1992.sp019163; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Hodges AR, 2007, J BIOL CHEM, V282, P27192, DOI 10.1074/jbc.M703968200; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Kawai M, 2006, J PHYSIOL-LONDON, V574, P877, DOI 10.1113/jphysiol.2006.111708; KIESSLING P, 1995, BIOCHEMISTRY-US, V34, P14834, DOI 10.1021/bi00045a026; Kim E, 1996, BIOPHYS J, V70, P1439, DOI 10.1016/S0006-3495(96)79703-5; KONDO H, 1976, J BIOCHEM-TOKYO, V79, P159, DOI 10.1093/oxfordjournals.jbchem.a131043; Kozuka J, 2006, NAT CHEM BIOL, V2, P83, DOI 10.1038/nchembio763; Kuznetsova I, 1996, FEBS LETT, V383, P105, DOI 10.1016/0014-5793(96)00238-4; LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Muhlrad A, 2004, J MOL BIOL, V342, P1559, DOI 10.1016/j.jmb.2004.08.010; Oguchi Y, 2008, P NATL ACAD SCI USA, V105, P7714, DOI 10.1073/pnas.0800564105; ORLOVA A, 1995, J MOL BIOL, V245, P582, DOI 10.1006/jmbi.1994.0048; Purcell TJ, 2005, P NATL ACAD SCI USA, V102, P13873, DOI 10.1073/pnas.0506441102; Rief M, 2000, P NATL ACAD SCI USA, V97, P9482, DOI 10.1073/pnas.97.17.9482; Saeki K, 1996, BIOCHEMISTRY-US, V35, P14465, DOI 10.1021/bi961292c; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; SCHWYTER D, 1989, BIOCHEMISTRY-US, V28, P5889, DOI 10.1021/bi00440a027; SCHWYTER DH, 1990, J CELL BIOL, V111, P465, DOI 10.1083/jcb.111.2.465; SUTOH K, 1991, P NATL ACAD SCI USA, V88, P7711, DOI 10.1073/pnas.88.17.7711; TOYOSHIMA YY, 1987, NATURE, V328, P536, DOI 10.1038/328536a0; Uemura S, 2003, NAT STRUCT BIOL, V10, P308, DOI 10.1038/nsb911; Uemura S, 2004, NAT STRUCT MOL BIOL, V11, P877, DOI 10.1038/nsmb806; Veigel C, 2005, NAT CELL BIOL, V7, P861, DOI 10.1038/ncb1287; Volkmann N, 2005, MOL CELL, V19, P595, DOI 10.1016/j.molcel.2005.07.015; WEEDS AG, 1971, NATURE, V234, P85, DOI 10.1038/234085a0; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	33	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35251	35258		10.1074/jbc.M109.013565	http://dx.doi.org/10.1074/jbc.M109.013565			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840951	Green Published, hybrid			2022-12-25	WOS:000272439600077
J	Matsuda, F; Shinbo, Y; Oikawa, A; Hirai, MY; Fiehn, O; Kanaya, S; Saito, K				Matsuda, Fumio; Shinbo, Yoko; Oikawa, Akira; Hirai, Masami Yokota; Fiehn, Oliver; Kanaya, Shigehiko; Saito, Kazuki			Assessment of Metabolome Annotation Quality: A Method for Evaluating the False Discovery Rate of Elemental Composition Searches	PLOS ONE			English	Article							NEUTRAL LOSS COMPOSITIONS; TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; PRODUCT IONS; IDENTIFICATION; DECONVOLUTION; INTEGRATION; LIPIDOMICS; DIVERSITY; REVEALS	Background: In metabolomics researches using mass spectrometry (MS), systematic searching of high-resolution mass data against compound databases is often the first step of metabolite annotation to determine elemental compositions possessing similar theoretical mass numbers. However, incorrect hits derived from errors in mass analyses will be included in the results of elemental composition searches. To assess the quality of peak annotation information, a novel methodology for false discovery rates (FDR) evaluation is presented in this study. Based on the FDR analyses, several aspects of an elemental composition search, including setting a threshold, estimating FDR, and the types of elemental composition databases most reliable for searching are discussed. Methodology/Principal Findings: The FDR can be determined from one measured value (i.e., the hit rate for search queries) and four parameters determined by Monte Carlo simulation. The results indicate that relatively high FDR values (30-50%) were obtained when searching time-of-flight (TOF)/MS data using the KNApSAcK and KEGG databases. In addition, searches against large all-in-one databases (e. g., PubChem) always produced unacceptable results (FDR>70%). The estimated FDRs suggest that the quality of search results can be improved not only by performing more accurate mass analysis but also by modifying the properties of the compound database. A theoretical analysis indicates that FDR could be improved by using compound database with smaller but higher completeness entries. Conclusions/Significance: High accuracy mass analysis, such as Fourier transform (FT)-MS, is needed for reliable annotation (FDR<10%). In addition, a small, customized compound database is preferable for high-quality annotation of metabolome data.			Matsuda, F (corresponding author), RIKEN, Plant Sci Ctr, Metabolome Res Grp, Kanagawa, Japan.	ksaito@psc.riken.jp	Oikawa, Akira/D-2715-2017; Hirai, Masami Y/D-5319-2009; Saito, Kazuki/D-2670-2009	Hirai, Masami Y/0000-0003-0802-6208; Saito, Kazuki/0000-0001-6310-5342				Abate-Shen C, 2009, NATURE, V457, P799, DOI 10.1038/457799a; Bino RJ, 2004, TRENDS PLANT SCI, V9, P418, DOI 10.1016/j.tplants.2004.07.004; Bocker S, 2008, BIOINFORMATICS, V24, pI49, DOI 10.1093/bioinformatics/btn270; Bottcher C, 2008, PLANT PHYSIOL, V147, P2107, DOI 10.1104/pp.108.117754; Choi H, 2008, J PROTEOME RES, V7, P47, DOI 10.1021/pr700747q; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Dixon RA, 2003, PHYTOCHEMISTRY, V62, P815, DOI 10.1016/S0031-9422(02)00712-4; Dunn WB, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/011001; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; GIAVALISCO P, 2009, ANAL CHEM IN PRESS; Grange AH, 2006, RAPID COMMUN MASS SP, V20, P89, DOI 10.1002/rcm.2277; Grange AH, 2008, RAPID COMMUN MASS SP, V22, P2375, DOI 10.1002/rcm.3619; Hegeman AD, 2007, ANAL CHEM, V79, P6912, DOI 10.1021/ac070346t; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Iijima Y, 2008, PLANT J, V54, P949, DOI 10.1111/j.1365-313X.2008.03434.x; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kaufmann A, 2007, RAPID COMMUN MASS SP, V21, P2003, DOI 10.1002/rcm.3035; Kiefer P, 2008, ANAL BIOCHEM, V382, P94, DOI 10.1016/j.ab.2008.07.010; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kind T, 2007, ANAL BIOCHEM, V363, P185, DOI 10.1016/j.ab.2007.01.028; Koulman A, 2009, RAPID COMMUN MASS SP, V23, P1411, DOI 10.1002/rcm.4015; Madalinski G, 2008, ANAL CHEM, V80, P3291, DOI 10.1021/ac7024915; Matsuda F, 2009, PLANT J, V57, P555, DOI 10.1111/j.1365-313X.2008.03705.x; Moco S, 2007, TRAC-TREND ANAL CHEM, V26, P855, DOI 10.1016/j.trac.2007.08.003; Oikawa A, 2006, PLANT PHYSIOL, V142, P398, DOI 10.1104/pp.106.080317; Ojanpera S, 2006, RAPID COMMUN MASS SP, V20, P1161, DOI 10.1002/rcm.2429; Scheltema RA, 2008, PROTEOMICS, V8, P4647, DOI 10.1002/pmic.200800314; Schmidt J, 2007, PHYTOCHEMISTRY, V68, P189, DOI 10.1016/j.phytochem.2006.10.003; Schwab W, 2003, PHYTOCHEMISTRY, V62, P837, DOI 10.1016/S0031-9422(02)00723-9; Shinbo Y, 2006, BIOTECH AGR FOREST, V57, P165; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Suzuki H, 2008, PHYTOCHEMISTRY, V69, P99, DOI 10.1016/j.phytochem.2007.06.017; Suzuki S, 2005, RAPID COMMUN MASS SP, V19, P3500, DOI 10.1002/rcm.2220; Tabb DL, 2008, J PROTEOME RES, V7, P45, DOI 10.1021/pr700728t; Takahashi H, 2008, ANAL BIOANAL CHEM, V391, P2769, DOI 10.1007/s00216-008-2195-5; Watanabe M, 2008, PLANT PHYSIOL, V146, P310, DOI 10.1104/pp.107.106831; Werner E, 2008, J CHROMATOGR B, V871, P143, DOI 10.1016/j.jchromb.2008.07.004; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000	42	49	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7490	10.1371/journal.pone.0007490	http://dx.doi.org/10.1371/journal.pone.0007490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19847304	gold, Green Published, Green Submitted			2022-12-25	WOS:000270880700014
J	Thorgersen, EB; Hellerud, BC; Nielsen, EW; Barratt-Due, A; Fure, H; Lindstad, JK; Pharo, A; Fosse, E; Tonnessen, TI; Johansen, HT; Castellheim, A; Mollnes, TE				Thorgersen, Ebbe Billmann; Hellerud, Bernt Christian; Nielsen, Erik Waage; Barratt-Due, Andreas; Fure, Hilde; Lindstad, Julie Katrine; Pharo, Anne; Fosse, Erik; Tonnessen, Tor Inge; Johansen, Harald Thidemann; Castellheim, Albert; Mollnes, Tom Eirik			CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs	FASEB JOURNAL			English	Article						gram-negative bacteria; inflammation; innate immunity; lipopolysaccharide	TUMOR-NECROSIS-FACTOR; ANTI-CD14 ANTIBODY; OXIDATIVE BURST; C5A RECEPTOR; GELATINASE; COAGULATION; MODEL; INTERLEUKIN-10; COMPLEMENT; IC14	Sepsis is a severe infection-induced systemic inflammatory syndrome. Inhibition of downstream inflammatory mediators of sepsis, e.g., TNF-alpha, has failed in clinical trials. The aim of this study was to investigate the effects of inhibiting CD14, a key upstream innate immunity molecule, on the early inflammatory and hemostatic responses in a pig model of gram-negative sepsis. The study comprised two arms, whole live Escherichia coli bacteria and E. coli lipopolysaccharide (LPS) (n=25 and n=9 animals, respectively). The animals were allocated into treatment (anti-CD14) and control (IgG isotype or saline) groups. Inflammatory, hemostatic, physiological, and microbiological parameters were measured. The proinflammatory cytokines TNF-alpha, IL-1 beta, IL-6, and IL-8, but not the anti-inflammatory cytokine IL-10, were efficiently inhibited by anti-CD14. Furthermore, anti-CD14 preserved the leukocyte count and significantly reduced granulocyte enzyme matrix metalloproteinase-9 release and expression of the granulocyte membrane activation molecule wCD11R3 (pig CD11b). The hemostatic markers thrombin-antithrombin III complexes and plasminogen activator inhibitor-1 were significantly attenuated. Anti-CD14 did not affect LPS or E. coli DNA levels. This study documents that CD14 inhibition efficiently attenuates the proinflammatory cytokine response and granulocyte activation and reverses the procoagulant state but does not interfere with LPS levels or bacterial counts in E. coli-induced sepsis.-Thorgersen, E. B., Hellerud, B. C., Nielsen, E. W., Barratt-Due, A., Fure, H., Lindstad, J. K., Pharo, A., Fosse, E., Tonnessen, T. I., Johansen, H. T., Castell-heim, A., Mollnes, T. E. CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs. FASEB J. 24, 712-722 (2010). www.fasebj.org	[Thorgersen, Ebbe Billmann; Hellerud, Bernt Christian; Barratt-Due, Andreas; Lindstad, Julie Katrine; Pharo, Anne; Castellheim, Albert; Mollnes, Tom Eirik] Univ Hosp, Rikshosp, Inst Immunol, N-0027 Oslo, Norway; [Fosse, Erik; Tonnessen, Tor Inge] Univ Hosp, Rikshosp, Intervent Ctr, N-0027 Oslo, Norway; [Tonnessen, Tor Inge] Univ Hosp, Rikshosp, Dept Anesthesiol, N-0027 Oslo, Norway; [Nielsen, Erik Waage] Nordland Hosp, Dept Anesthesiol, Bodo, Norway; [Fure, Hilde] Nordland Hosp, Somat Res Lab, Bodo, Norway; [Nielsen, Erik Waage] Univ Tromso, Inst Clin Med, Tromso, Norway; [Johansen, Harald Thidemann] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway	University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; UiT The Arctic University of Tromso; University of Oslo	Thorgersen, EB (corresponding author), Univ Hosp, Rikshosp, Inst Immunol, N-0027 Oslo, Norway.	ebbtho@rr-research.no	Mollnes, Tom/ABI-5183-2020; BARRATT-DUE, ANDREAS/AAG-9102-2019	Johansen, Harald Thidemann/0000-0001-6617-1732	U.S. National Institutes of Health [R01 EB003968-01A1]; Helse Sor-Ost [2008036]; Research Council of Norway; Norwegian Council on Cardiovascular Disease; Odd Fellows Foundation; Family Blix Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003968] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helse Sor-Ost; Research Council of Norway(Research Council of Norway); Norwegian Council on Cardiovascular Disease; Odd Fellows Foundation; Family Blix Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors thank Kjersti Wendt, Hilde Nilsen, and Carmen Louwerens for excellent technical assistance and Dorte Christiansen for growing and preparing the bacteria. This work was supported by U.S. National Institutes of Health grant R01 EB003968-01A1, Helse Sor-Ost grant 2008036, the Research Council of Norway, the Norwegian Council on Cardiovascular Disease, the Odd Fellows Foundation, and the Family Blix Foundation.	Adib-Conquy M, 2003, AM J RESP CRIT CARE, V168, P158, DOI 10.1164/rccm.200209-1077OC; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Barboni B, 2000, BIOL REPROD, V63, P858, DOI 10.1095/biolreprod63.3.858; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Brekke OL, 2007, J LEUKOCYTE BIOL, V81, P1404, DOI 10.1189/jlb.0806538; Castellheim A, 2008, SCAND J IMMUNOL, V68, P75, DOI 10.1111/j.1365-3083.2008.02122.x; Cavaillon JM, 2005, J ENDOTOXIN RES, V11, P311, DOI 10.1179/096805105X58733; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Dubois B, 2002, EUR J IMMUNOL, V32, P2163, DOI 10.1002/1521-4141(200208)32:8<2163::AID-IMMU2163>3.0.CO;2-Q; Frevert CW, 2000, J IMMUNOL, V164, P5439, DOI 10.4049/jimmunol.164.10.5439; Goldfarb RD, 2005, SHOCK, V24, P75, DOI 10.1097/01.shk.0000191337.01036.b7; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Hu JL, 2005, BIOCHEM PHARMACOL, V70, P535, DOI 10.1016/j.bcp.2005.04.047; JANEWAY CA, 1992, IMMUNOL TODAY, V13, P11, DOI 10.1016/0167-5699(92)90198-G; LEIBOVICI L, 1995, QJM-INT J MED, V88, P181; Leturcq DJ, 1996, J CLIN INVEST, V98, P1533, DOI 10.1172/JCI118945; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Levi M, 2006, CRIT CARE, V10, DOI 10.1186/cc4975; Makowski GS, 1996, ANAL BIOCHEM, V236, P353, DOI 10.1006/abio.1996.0179; Marshall JC, 2003, NAT REV DRUG DISCOV, V2, P391, DOI 10.1038/nrd1084; Marshall JC, 2008, J LEUKOCYTE BIOL, V83, P471, DOI 10.1189/jlb.0607380; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; MASURE S, 1991, EUR J BIOCHEM, V198, P391, DOI 10.1111/j.1432-1033.1991.tb16027.x; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Michie HR, 1998, J ANTIMICROB CHEMOTH, V41, P47, DOI 10.1093/jac/41.suppl_1.47; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Mollnes TE, 2002, BLOOD, V100, P1869; Mollnes TE, 2008, ADV EXP MED BIOL, V632, P253, DOI 10.1007/978-0-387-78952-1_18; Oberholzer A, 2005, SHOCK, V23, P488, DOI 10.1097/01.shk.0000163802.46355.59; Olszyna DP, 2003, EUR CYTOKINE NETW, V14, P158; Opal SM, 2003, CRIT CARE MED, V31, P929, DOI 10.1097/01.CCM.0000054870.25767.EE; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Panacek EA, 2004, CRIT CARE MED, V32, P2173, DOI 10.1097/01.CCM.0000145229.59014.6c; PATEL RT, 1994, BRIT J SURG, V81, P1306, DOI 10.1002/bjs.1800810914; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rahimi AAR, 2005, J IMMUNOL, V174, P7823, DOI 10.4049/jimmunol.174.12.7823; Renckens R, 2006, J IMMUNOL, V176, P3735, DOI 10.4049/jimmunol.176.6.3735; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Saetre T, 2000, BLOOD COAGUL FIBRIN, V11, P433, DOI 10.1097/00001721-200007000-00006; Sandanger O, 2009, J IMMUNOL, V182, P588, DOI 10.4049/jimmunol.182.1.588; Schimke J, 1998, P NATL ACAD SCI USA, V95, P13875, DOI 10.1073/pnas.95.23.13875; Sriskandan S, 2008, J PATHOL, V214, P211, DOI 10.1002/path.2274; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Tang AH, 2007, J LEUKOCYTE BIOL, V82, P282, DOI 10.1189/jlb.1206752; Thorgersen EB, 2009, INFECT IMMUN, V77, P725, DOI 10.1128/IAI.01305-08; Triantafilou M, 2004, BIOCHEM J, V381, P527, DOI 10.1042/BJ20040172; Ulevitch RJ, 2001, CRIT CARE MED, V29, pS8, DOI 10.1097/00003246-200107001-00004; van Furth AM, 1999, INFECT IMMUN, V67, P3714, DOI 10.1128/IAI.67.8.3714-3718.1999; VANDEVENTER SJH, 1990, BLOOD, V76, P2520; Verbon A, 2003, J INFECT DIS, V187, P55, DOI 10.1086/346043; Verbon A, 2001, J IMMUNOL, V166, P3599, DOI 10.4049/jimmunol.166.5.3599; WAAGE A, 1987, LANCET, V1, P355; Wang E, 2000, J INFECT DIS, V182, P1255, DOI 10.1086/315811	55	51	56	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2010	24	3					712	722		10.1096/fj.09-140798	http://dx.doi.org/10.1096/fj.09-140798			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	561KE	19841036	Green Published			2022-12-25	WOS:000274974600007
J	Sachdev, D; Zhang, X; Matise, I; Gaillard-Kelly, M; Yee, D				Sachdev, D.; Zhang, X.; Matise, I.; Gaillard-Kelly, M.; Yee, D.			The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival	ONCOGENE			English	Article						cancer metastasis; type I IGF receptor; antibodies against IGF1R; invasion; circulating tumor cells; survival	BREAST-CANCER; MONOCLONAL-ANTIBODY; CELLS; VIVO; EXPRESSION; INHIBITOR; COMBINATION; INVOLVEMENT; ACTIVATION; THERAPY	The type I insulin-like growth factor receptor (IGF1R) regulates multiple aspects of malignancy and is the target of several drugs currently in clinical trials. Although the function of IGF1R in proliferation and survival is well studied, the regulation of metastasis by IGF1R is not as clearly delineated. Previous work showed that disruption of IGF1R signaling by overexpression of a dominant-negative IGF1R inhibited metastasis. To establish a clinically applicable approach to inhibition of metastasis by targeting IGF1R, we examined the effect of an inhibitory antibody against IGF1R, EM164 and its humanized version, AVE1642, on metastasis of cancer cells. EM164 and AVE1642 did not affect primary tumor growth of MDA-435A/LCC6 cells but inhibited metastasis of these cells. Consistent with this inhibition in the formation of metastatic nodules, disruption of IGF1R also resulted in a decreased number of circulating tumor cells in blood of tumor-bearing mice. Disruption of IGF1R with a dominant-negative construct or antibody inhibited invasion across Matrigel in vitro. When tumor cells were directly injected into the circulation through the lateral tail vein of mice, IGF1R disruption also resulted in significant reduction of pulmonary nodules, suggesting that regulation of invasion is not the only function of IGF1R signaling. Further, disruption of IGF1R rendered cells more susceptible to anoikis. Thus, IGF1R regulated metastasis independently of tumor growth. The multiple phenotypes regulated by IGF1R must be considered during development of this therapeutic strategy as inhibition of metastasis independent of inhibition of tumor growth is not easily assessed in phase II clinical trials. Oncogene (2010) 29, 251-262; doi:10.1038/onc.2009.316; published online 19 October 2009	[Sachdev, D.; Zhang, X.; Matise, I.; Yee, D.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Sachdev, D.; Yee, D.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Matise, I.] Univ Minnesota, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Gaillard-Kelly, M.] Sanofi Aventis, Antony, France	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Sanofi-Aventis	Sachdev, D (corresponding author), Univ Minnesota, Mason Canc Ctr, Mayo Mail Code 806,420 Delaware St SE, Minneapolis, MN 55455 USA.	sachd003@umn.edu		Yee, Douglas/0000-0002-3387-4009	NIH [R01 CA074285, P30 CA077598PHS]; National Cancer Institute [P30 CA77398]; Prospect Creek Foundation; NATIONAL CANCER INSTITUTE [R01CA077398, P30CA077598, R01CA074285] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Prospect Creek Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge ImmunoGen Inc. for providing us with EM164 and the isotype-matched control antibody (anti-CD20), sanofi-aventis for AVE1642 (the humanized version of EM164), and the National Cell Culture Center (NCCC), a division of Biovest International, Fridley, MN, USA, for producing supernatant containing scFv-Fc from NSO 3b1Fc 1F12 cells in spinner cultures. We thank Nicole Kirchoff and the staff of the Comparative Pathology Shared Resource of the Masonic Cancer Center, University of Minnesota. We thank Sarah Thuriot and Alissa Pelzer for assistance with the care of the mice. We also thank Michael Franklin for editorial assistance. This work was supported by NIH R01 CA074285 (D Yee), NIH P30 CA077598PHS Cancer Center Support Grant P30 CA77398 from the National Cancer Institute and the Prospect Creek Foundation.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Baserga R, 2005, EXPERT OPIN THER TAR, V9, P753, DOI 10.1517/14728222.9.4.753; BOYUM A, 1964, NATURE, V204, P793, DOI 10.1038/204793a0; Burtrum D, 2003, CANCER RES, V63, P8912; Byron SA, 2006, BRIT J CANCER, V95, P1220, DOI 10.1038/sj.bjc.6603354; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cohen BD, 2005, CLIN CANCER RES, V11, P2063, DOI 10.1158/1078-0432.CCR-04-1070; Dearth RK, 2006, MOL CELL BIOL, V26, P9302, DOI 10.1128/MCB.00260-06; Dunn SE, 1998, CANCER RES, V58, P3353; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Gibson SL, 2007, CELL CYCLE, V6, P631, DOI 10.4161/cc.6.6.3987; Gupta GP, 2005, COLD SH Q B, V70, P149, DOI 10.1101/sqb.2005.70.018; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Haluska P, 2006, CANCER RES, V66, P362, DOI 10.1158/0008-5472.CAN-05-1107; Haluska P, 2007, CLIN CANCER RES, V13, P5834, DOI 10.1158/1078-0432.CCR-07-1118; Higano CS, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.08.8146; Jackson JG, 2001, ONCOGENE, V20, P7318, DOI 10.1038/sj.onc.1204920; Jackson JG, 1998, J BIOL CHEM, V273, P9994, DOI 10.1074/jbc.273.16.9994; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karp DD, 2007, J CLIN ONCOL, V25; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonessa F, 1996, BRIT J CANCER, V73, P154, DOI 10.1038/bjc.1996.29; Li SL, 2000, CANCER IMMUNOL IMMUN, V49, P243, DOI 10.1007/s002620000115; Lopez T, 2002, CANCER CELL, V1, P339, DOI 10.1016/S1535-6108(02)00055-7; Maloney EK, 2003, CANCER RES, V63, P5073; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagle JA, 2004, MOL CELL BIOL, V24, P9726, DOI 10.1128/MCB.24.22.9726-9735.2004; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; Plymate SR, 1997, ENDOCRINOLOGY, V138, P1728, DOI 10.1210/en.138.4.1728; Plymate SR, 2004, PROSTATE, V61, P276, DOI 10.1002/pros.20099; Radisky ES, 2007, REV ENDOCR METAB DIS, V8, P279, DOI 10.1007/s11154-007-9037-1; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Ravid D, 2005, ONCOGENE, V24, P1338, DOI 10.1038/sj.onc.1208337; Reinmuth N, 2002, LAB INVEST, V82, P1377, DOI 10.1097/01.LAB.0000032411.41603.C2; Rowinsky EK, 2007, CLIN CANCER RES, V13, p5549S, DOI 10.1158/1078-0432.CCR-07-1109; Sachdev D, 2006, CANCER RES, V66, P2391, DOI 10.1158/0008-5472.CAN-05-3126; Sachdev D, 2004, J BIOL CHEM, V279, P5017, DOI 10.1074/jbc.M305403200; Sachdev D, 2003, CANCER RES, V63, P627; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Tolcher AW, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.3582; Townson JL, 2003, CURR MOL MED, V3, P631, DOI 10.2174/1566524033479483; TWENTYMAN PR, 1987, BRIT J CANCER, V56, P279, DOI 10.1038/bjc.1987.190; Valentinis B, 1999, ONCOGENE, V18, P1827, DOI 10.1038/sj.onc.1202471; van Golen CM, 2006, CANCER RES, V66, P6570, DOI 10.1158/0008-5472.CAN-05-1448; Wu JD, 2006, CLIN CANCER RES, V12, P6153, DOI 10.1158/1078-0432.CCR-06-0443; Wu YP, 2003, CANCER RES, V63, P4384; Wu YP, 2002, CANCER RES, V62, P1030; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Zhang XH, 2002, CANCER RES, V62, P4369	52	75	77	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2010	29	2					251	262		10.1038/onc.2009.316	http://dx.doi.org/10.1038/onc.2009.316			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	544IU	19838209	Green Accepted			2022-12-25	WOS:000273650000008
J	Gump, JM; June, RK; Dowdy, SF				Gump, Jacob M.; June, Ronald K.; Dowdy, Steven F.			Revised Role of Glycosaminoglycans in TAT Protein Transduction Domain-mediated Cellular Transduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; ARGININE-RICH PEPTIDES; PENETRATING PEPTIDES; SURFACE PROTEOGLYCANS; DELIVERY; CELLS; MACROPINOCYTOSIS; MECHANISMS; INTERNALIZATION; BINDING	Cellular uptake of the human immunodeficiency virus TAT protein transduction domain (PTD), or cell-penetrating peptide, has previously been surmised to occur in a manner dependent on the presence of heparan sulfate proteoglycans that are expressed ubiquitously on the cell surface. These acidic polysaccharides form a large pool of negative charge on the cell surface that TAT PTD binds avidly. Additionally, sulfated glycans have been proposed to aid in the interaction of TAT PTD and other arginine-rich PTDs with the cell membrane, perhaps aiding their translocation across the membrane. Surprisingly, however, TAT PTD-mediated induction of macropinocytosis and cellular transduction occurs in the absence of heparan sulfate and sialic acid. Using labeled TAT PTD peptides and fusion proteins, in addition to TAT PTD-Cre recombination-based phenotypic assays, we show that transduction occurs efficiently in mutant Chinese hamster ovary cell lines deficient in glycosaminoglycans and sialic acids. Similar results were obtained in cells where glycans were enzymatically removed. In contrast, enzymatic removal of proteins from the cell surface completely ablated TAT PTD-mediated transduction. Our findings support the hypothesis that acidic glycans form a pool of charge that TAT PTD binds on the cell surface, but this binding is independent of the PTD-mediated transduction mechanism and the induction of macropinocytotic uptake by TAT PTD.	[Gump, Jacob M.; June, Ronald K.; Dowdy, Steven F.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego	Dowdy, SF (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Howard Hughes Med Inst, 9500 Gilman Dr,GPL 231B,MC 0686, La Jolla, CA 92093 USA.	sdowdy@ucsd.edu	Gump, Jacob/F-9731-2011		Howard Hughes Medical Institute; Leukemia and Lymphoma Society; Pardee Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Pardee Foundation	Supported by the Howard Hughes Medical Institute, the Leukemia and Lymphoma Society, and the Pardee Foundation.	Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; El-Andaloussi S, 2005, CURR PHARM DESIGN, V11, P3597, DOI 10.2174/138161205774580796; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Elson-Schwab L, 2007, J BIOL CHEM, V282, P13585, DOI 10.1074/jbc.M700463200; ESKO JD, 1987, J BIOL CHEM, V262, P12189; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; ESKO JD, 1992, ADV EXP MED BIOL, V313, P97; Fischer R, 2005, CHEMBIOCHEM, V6, P2126, DOI 10.1002/cbic.200500044; Goun EA, 2006, CHEMBIOCHEM, V7, P1497, DOI 10.1002/cbic.200600171; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Hakansson S, 2001, PROTEIN SCI, V10, P2138, DOI 10.1110/ps.23401; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Meade BR, 2007, ADV DRUG DELIVER REV, V59, P134, DOI 10.1016/j.addr.2007.03.004; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nakase I, 2008, ADV DRUG DELIVER REV, V60, P598, DOI 10.1016/j.addr.2007.10.006; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Nascimento FD, 2007, J BIOL CHEM, V282, P21349, DOI 10.1074/jbc.M604876200; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; Richard JP, 2005, J BIOL CHEM, V280, P15300, DOI 10.1074/jbc.M401604200; Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313; Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200; Silhol M, 2002, EUR J BIOCHEM, V269, P494, DOI 10.1046/j.0014-2956.2001.02671.x; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Violini S, 2002, BIOCHEMISTRY-US, V41, P12652, DOI 10.1021/bi026097e; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996	28	104	112	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1500	1507		10.1074/jbc.M109.021964	http://dx.doi.org/10.1074/jbc.M109.021964			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19858185	Green Published, hybrid			2022-12-25	WOS:000273258200069
J	Zorina, Y; Iyengar, R; Bromberg, KD				Zorina, Yana; Iyengar, Ravi; Bromberg, Kenneth D.			Cannabinoid 1 Receptor and Interleukin-6 Receptor Together Induce Integration of Protein Kinase and Transcription Factor Signaling to Trigger Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC TYROSINE KINASE; PC12 CELLS; GROWTH-FACTOR; NEURONAL DIFFERENTIATION; CEREBROSPINAL-FLUID; PHOSPHATASE; ACTIVATION; PATHWAY; GP130; SHP-2	Activation of the G(o/i)-coupled cannabinoid 1 receptor (CB1R) has been shown to induce neurite outgrowth in Neuro2A cells through activation of Src kinase and STAT3 transcription factor. Signaling by the interleukin 6 receptor (IL-6R) also activates STAT3 through Jak kinase. We studied if signals from the two pathways could be integrated in a synergistic manner to trigger neurite outgrowth in Neuro2A cells. At low concentrations, when agonist at either receptor by itself has no effect, we found that CB1R and IL-6R stimulation together induced synergistic neurite outgrowth. Signal integration requires activation of transcription factors by Src, Jak, and mitogen-activated protein kinases. Mitogen-activated protein kinase can be activated by both receptors and shows enhanced early activation in the presence of both ligands. CREB and STAT3 transcription factors are required for synergy and show enhanced DNA-binding activity when both receptors are activated. STAT3 plays a critical role in integration of the signals downstream of the two receptors. When both pathways are activated, STAT3 phosphorylation is sustained for 6 h. This prolonged activation of STAT3 requires deactivation of SHP2 phosphatase. Reduction of SHP2 levels by RNA interference results in greater synergy in neurite outgrowth. Simultaneous knockdown of both SHP2 and STAT3 blocks the synergistic triggering of neurite outgrowth, indicating that STAT3 is downstream of SHP2. CB1R and IL-6R co-stimulation enhanced the differentiation of rat cortical neuron primary cultures. These results provide a mechanism where multiple protein kinases and transcription factors interact to integrate signals from G protein-coupled and cytokine receptor evoke neurite outgrowth in Neuro2A cells.	[Zorina, Yana; Iyengar, Ravi; Bromberg, Kenneth D.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Bromberg, KD (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, 1 Gustave Levy Pl,Box 1215, New York, NY 10029 USA.	Kenneth.bromberg@mssm.edu		Zorina, Yana/0000-0002-0200-2742	National Institutes of Health [GM5408, P50GM071558, T32 CA88796]; American Cancer Society Spirit of Birmingham; Johnson Memorial Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [T32CA088796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508, T32GM062754, P50GM071558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Spirit of Birmingham; Johnson Memorial Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM5408, P50GM071558, and T32 CA88796 (to K.D.B.). This work was also supported by an American Cancer Society Spirit of Birmingham and Johnson Memorial Postdoctoral Fellowship Award.	Ali C, 2000, J CEREBR BLOOD F MET, V20, P956, DOI 10.1097/00004647-200006000-00008; Arthur DB, 2006, BIOCHEM BIOPH RES CO, V347, P678, DOI 10.1016/j.bbrc.2006.06.141; Barua D, 2007, BIOPHYS J, V92, P2290, DOI 10.1529/biophysj.106.093484; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Cai DM, 1999, NEURON, V22, P89, DOI 10.1016/S0896-6273(00)80681-9; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Cao ZX, 2006, J NEUROSCI, V26, P5565, DOI 10.1523/JNEUROSCI.0815-06.2006; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; Diez del Corral R, 2001, NAT REV NEUROSCI, V2, P835; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; FENG GS, 1993, SCIENCE, V259, P1611; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Groemping Y, 2005, BIOCHEM J, V386, P401, DOI 10.1042/BJ20041835; GUSCHIN D, 1995, EMBO J, V14, P1421, DOI 10.1002/j.1460-2075.1995.tb07128.x; Hans VHJ, 1999, J CEREBR BLOOD F MET, V19, P184, DOI 10.1097/00004647-199902000-00010; He JCJ, 2005, J BIOL CHEM, V280, P33426, DOI 10.1074/jbc.M502812200; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Horton AR, 1998, EUR J NEUROSCI, V10, P673, DOI 10.1046/j.1460-9568.1998.00079.x; Ihara S, 1996, J BIOCHEM, V120, P865; Jordan JD, 2005, J BIOL CHEM, V280, P11413, DOI 10.1074/jbc.M411521200; Kim HK, 1998, MOL CELL BIOL, V18, P1525, DOI 10.1128/MCB.18.3.1525; Kiyono M, 2000, J BIOL CHEM, V275, P5441, DOI 10.1074/jbc.275.8.5441; Kunioku H, 2001, NEUROSCI LETT, V309, P13, DOI 10.1016/S0304-3940(01)02012-2; Kuroda H, 2001, MED PEDIATR ONCOL, V36, P118, DOI 10.1002/1096-911X(20010101)36:1<118::AID-MPO1028>3.0.CO;2-R; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Lehmann U, 2003, J BIOL CHEM, V278, P661, DOI 10.1074/jbc.M210552200; Lu W, 2001, MOL CELL, V8, P759, DOI 10.1016/S1097-2765(01)00369-0; MOCCHETTI I, 1995, J NEUROTRAUM, V12, P853, DOI 10.1089/neu.1995.12.853; Morris VA, 2008, J VIROL, V82, P8771, DOI 10.1128/JVI.00766-08; Muller T, 1998, ACTA NEUROL SCAND, V98, P142; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nimnual AS, 2003, NAT CELL BIOL, V5, P236, DOI 10.1038/ncb938; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; PENG ZY, 1995, ONCOGENE, V11, P1955; PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897; Ram PT, 2000, SCIENCE, V287, P142, DOI 10.1126/science.287.5450.142; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; SATOH T, 1988, MOL CELL BIOL, V8, P3546, DOI 10.1128/MCB.8.8.3546; Schaper F, 1998, BIOCHEM J, V335, P557, DOI 10.1042/bj3350557; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; STRAUSS S, 1992, LAB INVEST, V66, P223; SUGIMOTO S, 1994, J BIOL CHEM, V269, P13614; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; Walter AO, 1999, ONCOGENE, V18, P1911, DOI 10.1038/sj.onc.1202513; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; WEI W, 1994, GENE, V151, P279, DOI 10.1016/0378-1119(94)90671-8; Wu YY, 2000, J BIOL CHEM, V275, P2147, DOI 10.1074/jbc.275.3.2147; Wu YY, 1996, J BIOL CHEM, V271, P13033, DOI 10.1074/jbc.271.22.13033; Wu YY, 1996, J BIOL CHEM, V271, P13023, DOI 10.1074/jbc.271.22.13023; Yin TG, 1997, J BIOL CHEM, V272, P1032, DOI 10.1074/jbc.272.2.1032; Zhong J, 1999, J NEUROSCI, V19, P4305; Zong CS, 2000, J BIOL CHEM, V275, P15099, DOI 10.1074/jbc.M000089200	58	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 8	2010	285	2					1358	1370		10.1074/jbc.M109.049841	http://dx.doi.org/10.1074/jbc.M109.049841			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	539MH	19861414	Green Published, hybrid			2022-12-25	WOS:000273258200056
J	Lee, JJ; Lee, JH; Ko, YG; Hong, SI; Lee, JS				Lee, J-J; Lee, J-H; Ko, Y-G; Hong, S. I.; Lee, J-S			Prevention of premature senescence requires JNK regulation of Bcl-2 and reactive oxygen species	ONCOGENE			English	Article						premature senescence; JNK; Bcl-2; ROS; DNA damage	CELL-CYCLE PROGRESSION; PROTEIN-KINASE; KAPPA-B; PHOSPHORYLATION; APOPTOSIS; INHIBITION; CANCER; ACTIVATION; INDUCTION; ARREST	Premature senescence is considered as a cellular defense mechanism to prevent tumorigenesis. Although recent evidences show that c-Jun N-terminal kinase (JNK) is involved in the senescence process, the mechanism for this regulation is not fully understood. Here, we examined the role of JNK in premature senescence of tumor cells. Treatment of cells with the JNK-specific inhibitor SP600125 caused phenotypical changes of senescence and triggered a rapid increase in mitochondrial reactive oxygen species (ROS) production and DNA-damage response (DDR) in MCF7 breast carcinoma cells. ROS generation was attributed to the suppression of B-cell lymphoma-2 (Bcl-2) phosphorylation, and resulted in DNA damage and p53 activation. Bax did not change their localization to the mitochondria, which is required for apoptosis. The essential roles of JNK and phosphorylated Bcl-2 in preventing premature senescence were confirmed using RNA interference and ectopic expression of mutants of Bcl-2, including phosphomimetic and nonphosphorylatable forms. These findings were evidenced in H460 lung carcinoma cells and primary human embryonic fibroblasts. Altogether, our results showed that loss of JNK activity triggers a Bcl-2/ROS/DDR signaling cascade that ultimately leads to premature senescence, indicating that basal JNK activity is essential in preventing premature senescence. Oncogene (2010) 29, 561-575; doi: 10.1038/onc.2009.355; published online 26 October 2009	[Lee, J-J; Lee, J-S] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea; [Lee, J-J; Ko, Y-G] Korea Univ, Grad Sch Life Sci & Biotechnol, Seoul, South Korea; [Lee, J-H] Catholic Univ, Coll Med, Dept Biochem, Seoul, South Korea; [Hong, S. I.] Korea Inst Radiol & Med Sci, Dept Lab Med & Clin Pathol, Seoul 139706, South Korea	Korea Institute of Radiological & Medical Sciences; Korea University; Catholic University of Korea; Korea Institute of Radiological & Medical Sciences	Lee, JS (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Canc Res, 75 Nowongil, Seoul 139706, South Korea.	jaeslee@kcch.re.kr			Korean government (MEST)	Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	We thank Professor WS May of the University of Florida, USA for the kind gift of Bcl-2 mutant constructs and Professor J-Y Lee of the Hallym University, Korea for the kind supply of HEF cells. This work was supported by the Nuclear Research & Development Program of the Korea Science and Engineering Foundation (KOSEF) grant funded by the Korean government (MEST).	Autret A, 2007, J VIROL, V81, P7504, DOI 10.1128/JVI.02690-06; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bihani T, 2007, J BIOL CHEM, V282, P2666, DOI 10.1074/jbc.M608127200; Bubici C, 2006, ONCOGENE, V25, P6731, DOI 10.1038/sj.onc.1209936; Bulgin D, 2006, THYROID, V16, P217, DOI 10.1089/thy.2006.16.217; Byun HO, 2009, CANCER RES, V69, P4638, DOI 10.1158/0008-5472.CAN-08-4042; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Chan SHH, 2006, FREE RADICAL BIO MED, V40, P2028, DOI 10.1016/j.freeradbiomed.2006.01.032; Crescenzi E, 2003, BIOCHEM J, V375, P263, DOI 10.1042/BJ20030868; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Deng XM, 2006, MOL CELL BIOL, V26, P4421, DOI 10.1128/MCB.01647-05; Deng XM, 2004, P NATL ACAD SCI USA, V101, P153, DOI 10.1073/pnas.2533920100; Deng XM, 2003, BLOOD, V102, P3179, DOI 10.1182/blood-2003-04-1027; Deng XM, 2001, J BIOL CHEM, V276, P23681, DOI 10.1074/jbc.M100279200; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Du LH, 2005, ONCOGENE, V24, P107, DOI 10.1038/sj.onc.1208189; Du LH, 2004, J BIOL CHEM, V279, P11957, DOI 10.1074/jbc.M304935200; Furukawa Y, 2000, J BIOL CHEM, V275, P21661, DOI 10.1074/jbc.M906893199; GEWIRTZ DA, 2008, BIOCHEM PHARMACOL, V76, P957; GOLETZ TJ, 1994, COLD SPRING HARB SYM, V59, P59, DOI 10.1101/SQB.1994.059.01.009; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; HALDAR S, 1995, P NATL ACAD SCI USA, V92, P4507, DOI 10.1073/pnas.92.10.4507; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Huang STJ, 2002, FASEB J, V16, DOI 10.1096/fj.01-0852com; Jones KR, 2005, INT J RADIAT BIOL, V81, P445, DOI 10.1080/09553000500168549; Kerr LE, 2007, ONCOGENE, V26, P2554, DOI 10.1038/sj.onc.1210044; Kim HS, 2005, MECH AGEING DEV, V126, P1255, DOI 10.1016/j.mad.2005.07.002; Kramer DL, 2001, CANCER RES, V61, P7754; Macip S, 2002, EMBO J, V21, P2180, DOI 10.1093/emboj/21.9.2180; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Mallette FA, 2007, GENE DEV, V21, P43, DOI 10.1101/gad.1487307; Marchetti A, 2004, CELL DEATH DIFFER, V11, P596, DOI 10.1038/sj.cdd.4401368; Mates J M, 1999, Front Biosci, V4, pD339; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; Muller IM, 2005, MOL PHARMACOL, V67, P1684, DOI 10.1124/mol.104.004234; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Oliva JL, 2008, J BIOL CHEM, V283, P5466, DOI 10.1074/jbc.M707576200; Oruetxebarria I, 2004, J BIOL CHEM, V279, P3807, DOI 10.1074/jbc.M309333200; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Park HS, 2001, EMBO J, V20, P446, DOI 10.1093/emboj/20.3.446; Qian YJ, 2008, J BIOL CHEM, V283, P2896, DOI 10.1074/jbc.M708624200; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Roninson IB, 2003, CANCER RES, V63, P2705; Roninson IB, 2002, CANCER LETT, V179, P1, DOI 10.1016/S0304-3835(01)00847-3; Ruas M, 2007, MOL CELL BIOL, V27, P4273, DOI 10.1128/MCB.02286-06; Ruvolo PP, 1998, J BIOL CHEM, V273, P25436, DOI 10.1074/jbc.273.39.25436; Schmitt Estelle, 2007, Journal of Zhejiang University-Science B, V8, P377, DOI 10.1631/jzus.2007.B0377; Sharpless NE, 2004, EXP GERONTOL, V39, P1751, DOI 10.1016/j.exger.2004.06.025; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25; Tafani M, 2002, J BIOL CHEM, V277, P49569, DOI 10.1074/jbc.M208915200; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Tombor B, 2003, BIOCHEM BIOPH RES CO, V303, P800, DOI 10.1016/S0006-291X(03)00402-9; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Vigneron A, 2005, CANCER RES, V65, P8927, DOI 10.1158/0008-5472.CAN-05-0461; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Xia HHX, 2006, CANCER LETT, V241, P268, DOI 10.1016/j.canlet.2005.10.031; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zamzami N, 1998, ONCOGENE, V16, P1055, DOI 10.1038/sj.onc.1201864; Zhang P, 2006, ONCOGENE, V25, P7758, DOI 10.1038/sj.onc.1209744; Zimmermann AK, 2007, J BIOL CHEM, V282, P29296, DOI 10.1074/jbc.M702853200	67	45	46	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2010	29	4					561	575		10.1038/onc.2009.355	http://dx.doi.org/10.1038/onc.2009.355			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	549WH	19855432				2022-12-25	WOS:000274084600009
J	Jensen, PR; Peitersen, T; Karlsson, M; in't Zandt, R; Gisselsson, A; Hansson, G; Meier, S; Lerche, MH				Jensen, Pernille R.; Peitersen, Torben; Karlsson, Magnus; in't Zandt, Rene; Gisselsson, Anna; Hansson, Georg; Meier, Sebastian; Lerche, Mathilde H.			Tissue-specific Short Chain Fatty Acid Metabolism and Slow Metabolic Recovery after Ischemia from Hyperpolarized NMR in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-13 MAGNETIC-RESONANCE; RAT SKELETAL-MUSCLE; COENZYME-A; CARNITINE ACETYLTRANSFERASE; PROSTATE-CANCER; ACETATE; OXIDATION; SPECTROSCOPY; REPERFUSION; HEARTS	Mechanistic details of mammalian metabolism in vivo and dynamic metabolic changes in intact organisms are difficult to monitor because of the lack of spatial, chemical, or temporal resolution when applying traditional analytical tools. These limitations can be addressed by sensitivity enhancement technology for fast in vivo NMR assays of enzymatic fluxes in tissues of interest. We apply this methodology to characterize organ-specific short chain fatty acid metabolism and the changes of carnitine and coenzyme A pools in ischemia reperfusion. This is achieved by assaying acetyl-CoA synthetase and acetyl-carnitine transferase catalyzed transformations in vivo. The fast and predominant flux of acetate and propionate signal into acyl-carnitine pools shows the efficient buffering of free CoA levels. Sizeable acetyl-carnitine formation from exogenous acetate is even found in liver, where acetyl-CoA synthetase and acetylcarnitine transferase activities have been assumed sequestered in different compartments. In vivo assays of altered acetate metabolism were applied to characterize pathological changes of acetate metabolism upon ischemia. Coenzyme pools in ischemic skeletal muscle are reduced in vivo even 1 h after disturbing muscle perfusion. Impaired mitochondrial metabolism and slow restoration of free CoA are corroborated by assays employing fumarate to show persistently reduced tricarboxylic acid (TCA) cycle activity upon ischemia. In the same animal model, anaerobic metabolism of pyruvate and tissue perfusion normalize faster than mitochondrial bioenergetics.	[Jensen, Pernille R.; Peitersen, Torben; Karlsson, Magnus; in't Zandt, Rene; Gisselsson, Anna; Hansson, Georg; Lerche, Mathilde H.] Imagnia AB, S-20041 Malmo, Sweden; [Meier, Sebastian] Carlsberg Lab, DK-2500 Copenhagen, Denmark		Lerche, MH (corresponding author), Imagnia AB, Box 8225, S-20041 Malmo, Sweden.	mathilde.lerche@imagnia.se	Jensen, Pernille Rose/AAX-5696-2020; Jensen, Pernille Rose/J-8648-2016; Karlsson, Magnus/AAZ-1768-2021; Jensen, Pernille Rose/GQQ-6261-2022; Meier, Sebastian/A-4279-2015; Lerche, Mathilde Hauge/J-5487-2017	Jensen, Pernille Rose/0000-0003-4359-848X; Jensen, Pernille Rose/0000-0003-4359-848X; Jensen, Pernille Rose/0000-0003-4359-848X; Meier, Sebastian/0000-0003-3761-3217; Karlsson, Magnus/0000-0001-7738-1700; Lerche, Mathilde Hauge/0000-0002-5899-2781; in 't Zandt, Rene/0000-0002-3610-9513	GE HealthCare	GE HealthCare(General ElectricGE Healthcare)	This work was supported by a commercial research grant from GE HealthCare.	Aharinejad S, 2001, TRANSPLANTATION, V72, P1043, DOI 10.1097/00007890-200109270-00011; Albers MJ, 2008, CANCER RES, V68, P8607, DOI 10.1158/0008-5472.CAN-08-0749; Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; BAHL JJ, 1987, ANNU REV PHARMACOL, V27, P257, DOI 10.1146/annurev.pa.27.040187.001353; Bertocci LA, 1999, J APPL PHYSIOL, V86, P2077, DOI 10.1152/jappl.1999.86.6.2077; Bertocci LA, 1997, J APPL PHYSIOL, V83, P32, DOI 10.1152/jappl.1997.83.1.32; BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; BLOISI W, 1990, EUR J BIOCHEM, V189, P539, DOI 10.1111/j.1432-1033.1990.tb15520.x; BROWN M, 1987, CIRCULATION, V76, P687, DOI 10.1161/01.CIR.76.3.687; Calvani M, 2000, BASIC RES CARDIOL, V95, P75, DOI 10.1007/s003950050167; CERDAN S, 1990, J BIOL CHEM, V265, P12916; Chen AP, 2008, MAGN RESON IMAGING, V26, P721, DOI 10.1016/j.mri.2008.01.002; Chen AP, 2007, MAGN RESON MED, V58, P1099, DOI 10.1002/mrm.21256; Cordente AG, 2004, J BIOL CHEM, V279, P33899, DOI 10.1074/jbc.M402685200; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; ENGEL AG, 1973, SCIENCE, V179, P899, DOI 10.1126/science.179.4076.899; FARRELL SO, 1984, J BIOL CHEM, V259, P3089; Fujino T, 2001, J BIOL CHEM, V276, P11420, DOI 10.1074/jbc.M008782200; Golman K, 2008, MAGN RESON MED, V59, P1005, DOI 10.1002/mrm.21460; Golman K, 2006, CANCER RES, V66, P10855, DOI 10.1158/0008-5472.CAN-06-2564; Golman K, 2006, P NATL ACAD SCI USA, V103, P11270, DOI 10.1073/pnas.0601319103; GROPLER RJ, 1993, J AM COLL CARDIOL, V22, P1587, DOI 10.1016/0735-1097(93)90582-L; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hoerter J, 2004, CIRCULATION, V110, P528, DOI 10.1161/01.CIR.0000137824.30476.0E; HULSMANN WC, 1992, MOL CELL BIOCHEM, V116, P125, DOI 10.1007/BF01270579; IDELLWENGER JA, 1978, J BIOL CHEM, V253, P4310; ILICETO S, 1995, J AM COLL CARDIOL, V26, P380, DOI 10.1016/0735-1097(95)80010-E; Jensen PR, 2009, CHEM COMMUN, P5168, DOI 10.1039/b910626j; KOBAYASHI A, 1994, J MOL CELL CARDIOL, V26, P499, DOI 10.1006/jmcc.1994.1060; KOBAYASHI K, 1983, J MOL CELL CARDIOL, V15, P359, DOI 10.1016/0022-2828(83)90320-6; KUDO N, 1995, J BIOL CHEM, V270, P17513, DOI 10.1074/jbc.270.29.17513; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; MALLOY CR, 1990, AM J PHYSIOL, V259, pH987, DOI 10.1152/ajpheart.1990.259.3.H987; MALLOY CR, 1990, BIOCHEMISTRY-US, V29, P6756, DOI 10.1021/bi00481a002; Merritt ME, 2008, MAGN RESON MED, V60, P1029, DOI 10.1002/mrm.21760; MINKLER PE, 1995, ANAL BIOCHEM, V231, P315, DOI 10.1006/abio.1995.0057; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1016/S1352-8661(01)00111-9; North BJ, 2007, TRENDS BIOCHEM SCI, V32, P1, DOI 10.1016/j.tibs.2006.11.002; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; Oyama N, 2002, J NUCL MED, V43, P181; Pouteau E, 1998, J NUTR, V128, P111, DOI [10.1093/jn/128.12.2659S, 10.1093/jn/128.12.2651S, 10.1093/jn/128.12.2654S]; Pouteau E, 1996, AM J PHYSIOL-ENDOC M, V271, pE58, DOI 10.1152/ajpendo.1996.271.1.E58; Ramsay Rona R., 2004, Molecular Aspects of Medicine, V25, P475, DOI 10.1016/j.mam.2004.06.002; REBOUCHE CJ, 1986, ANNU REV NUTR, V6, P41, DOI 10.1146/annurev.nu.06.070186.000353; ROBITAILLE PML, 1993, J BIOL CHEM, V268, P26296; Schroeder MA, 2008, P NATL ACAD SCI USA, V105, P12051, DOI 10.1073/pnas.0805953105; Schroeder MA, 2009, FASEB J, V23, P2529, DOI 10.1096/fj.09-129171; SHEPHERD D, 1969, BIOCHEM J, V114, P597, DOI 10.1042/bj1140597; SHUG AL, 1978, ARCH BIOCHEM BIOPHYS, V187, P25, DOI 10.1016/0003-9861(78)90003-6; Stephens FB, 2007, J PHYSIOL-LONDON, V581, P431, DOI 10.1113/jphysiol.2006.125799; Szczepaniak L, 1996, MAGN RESON MED, V36, P451, DOI 10.1002/mrm.1910360318; 't Zandt HJAI, 1999, NMR BIOMED, V12, P327, DOI 10.1002/(SICI)1099-1492(199910)12:6<327::AID-NBM570>3.0.CO;2-9; WHITMER JT, 1978, J BIOL CHEM, V253, P4305; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yamamoto J, 2004, J BIOL CHEM, V279, P16954, DOI 10.1074/jbc.M312079200; Yoshii Y, 2009, CANCER SCI, V100, P821, DOI 10.1111/j.1349-7006.2009.01099.x; Zammit VA, 1999, PROG LIPID RES, V38, P199, DOI 10.1016/S0163-7827(99)00002-8	57	68	74	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36077	36082		10.1074/jbc.M109.066407	http://dx.doi.org/10.1074/jbc.M109.066407			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19861411	Green Published, hybrid			2022-12-25	WOS:000272970500009
J	Titz, A; Butschi, A; Henrissat, B; Fan, YY; Hennet, T; Razzazi-Fazeli, E; Hengartner, MO; Wilson, IBH; Kunzler, M; Aebi, M				Titz, Alexander; Butschi, Alex; Henrissat, Bernard; Fan, Yao-Yun; Hennet, Thierry; Razzazi-Fazeli, Ebrahim; Hengartner, Michael O.; Wilson, Iain B. H.; Kuenzler, Markus; Aebi, Markus			Molecular Basis for Galactosylation of Core Fucose Residues in Invertebrates IDENTIFICATION OF CAENORHABDITIS ELEGANS N-GLYCAN CORE alpha 1,6-FUCOSIDE beta 1,4-GALACTOSYLTRANSFERASE GALT-1 AS A MEMBER OF A NOVEL GLYCOSYLTRANSFERASE FAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPRINOPSIS-CINEREA; COPRINUS-CINEREUS; DROSOPHILA-MELANOGASTER; PHYLOGENETIC TREES; TOXIN RESISTANCE; PROTEIN; GALECTINS; SEQUENCE; LECTINS; ACETYLGLUCOSAMINE	Galectin CGL2 from the ink cap mushroom Coprinopsis cinerea displays toxicity toward the model nematode Caenorhabditis elegans. A mutation in a putative glycosyltransferase-encoding gene resulted in a CGL2-resistant C. elegans strain characterized by N-glycans lacking the beta 1,4-galactoside linked to the alpha 1,6-linked core fucose. Expression of the corresponding GALT-1 protein in insect cells was used to demonstrate a manganese-dependent galactosyltransferase activity. In vitro, the GALT-1 enzyme showed strong selectivity for acceptors with alpha 1,6-linked N-glycan core fucosides and required Golgi-dependent modifications on the oligosaccharide antennae for optimal synthesis of the Gal-beta 1,4-fucose structure. Phylogenetic analysis of the GALT-1 protein sequence identified a novel glycosyltransferase family (GT92) with members widespread among eukarya but absent in mammals.	[Titz, Alexander; Fan, Yao-Yun; Kuenzler, Markus; Aebi, Markus] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland; [Butschi, Alex; Hengartner, Michael O.] Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland; [Henrissat, Bernard] CNRS, UMR6098, F-13288 Marseille, France; [Henrissat, Bernard] Univ Aix Marseille 1, F-13288 Marseille, France; [Henrissat, Bernard] Univ Aix Marseille 2, F-13288 Marseille, France; [Hennet, Thierry] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Razzazi-Fazeli, Ebrahim] Univ Vet Med, VetOMICS Core Facil Prote & Metabol Studies, A-1210 Vienna, Austria; [Wilson, Iain B. H.] Univ Bodenkultur Wien, Dept Chem, A-1190 Vienna, Austria	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; University of Zurich; University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna	Aebi, M (corresponding author), ETH, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	markus.aebi@micro.biol.ethz.ch	Hengartner, Michael O/E-6235-2011; Fan, YaoYun/AAS-5920-2020; Henrissat, Bernard/J-2475-2012; Titz, Alexander/E-6701-2010; Wilson, Iain/B-3326-2009	Henrissat, Bernard/0000-0002-3434-8588; Titz, Alexander/0000-0001-7408-5084; Wilson, Iain/0000-0001-8996-1518; Kunzler, Markus/0000-0003-1275-0629; Hengartner, Michael/0000-0002-7584-596X; Razzazi-Fazeli, Ebrahim/0000-0002-3343-0301	Swiss National Science Foundation [3100A3-116827, 31003A-105541]; Roche Research Foundation; EMBO [ASTF-377.00-2008]; ETH Zurich; Austrian Fonds zur Forderung der Wissenschaftlichen Forschung [P18447]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Roche Research Foundation; EMBO(European Molecular Biology Organization (EMBO)); ETH Zurich(ETH Zurich); Austrian Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF))	This work was supported by Swiss National Science Foundation Grants 3100A3-116827 (to M. K., M. J., and M. A.) and 31003A-105541 (to M. A.), the Roche Research Foundation (to A. T.), EMBO Grant ASTF-377.00-2008 (to A. T.), ETH Zurich, and Austrian Fonds zur Forderung der Wissenschaftlichen Forschung Grant P18447 (to I. B. H. W.).	BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Barrows BD, 2006, METHOD ENZYMOL, V417, P340, DOI 10.1016/S0076-6879(06)17021-4; Boulianne RP, 2000, MICROBIOL-SGM, V146, P1841, DOI 10.1099/00221287-146-8-1841; BRENNER S, 1974, GENETICS, V77, P71; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cooper DNW, 1997, J BIOL CHEM, V272, P1514, DOI 10.1074/jbc.272.3.1514; Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; Fares H, 2002, TRAFFIC, V3, P11, DOI 10.1034/j.1600-0854.2002.30103.x; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Hanneman AJ, 2006, GLYCOBIOLOGY, V16, P874, DOI 10.1093/glycob/cwl011; Hansen SF, 2009, J PROTEOME RES, V8, P743, DOI 10.1021/pr800808m; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Klyosov AA, 2008, GALECTINS; Lis H, 1998, CHEM REV, V98, P637, DOI 10.1021/cr940413g; Miyoshi Eiji, 2002, P259; Muller R, 2002, J BIOL CHEM, V277, P32417, DOI 10.1074/jbc.C200381200; Paschinger K, 2004, J BIOL CHEM, V279, P49588, DOI 10.1074/jbc.M408978200; Paschinger K, 2005, GLYCOBIOLOGY, V15, P463, DOI 10.1093/glycob/cwi028; Paschinger K, 2008, CARBOHYD RES, V343, P2041, DOI 10.1016/j.carres.2007.12.018; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Praitis V, 2001, GENETICS, V157, P1217; Rini J., 2009, ESSENTIALS GLYCOBIOL, P63; Roitinger A, 1998, GLYCOCONJUGATE J, V15, P89, DOI 10.1023/A:1006951802623; SAMBROOK J, 2000, MOL CLONING LAB MANU; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Strohalm M, 2008, RAPID COMMUN MASS SP, V22, P905, DOI 10.1002/rcm.3444; Takahashi N, 2003, EUR J BIOCHEM, V270, P2627, DOI 10.1046/j.1432-1033.2003.03636.x; Takeuchi T, 2008, GLYCOBIOLOGY, V18, P882, DOI 10.1093/glycob/cwn077; Vasta GR, 2009, NAT REV MICROBIOL, V7, P424, DOI 10.1038/nrmicro2146; VOYNOW JA, 1991, J BIOL CHEM, V266, P21572; Walti MA, 2008, J MOL BIOL, V379, P146, DOI 10.1016/j.jmb.2008.03.062; Walser PJ, 2005, FUNGAL GENET BIOL, V42, P293, DOI 10.1016/j.fgb.2004.12.004; Walser PJ, 2004, STRUCTURE, V12, P689, DOI 10.1016/j.str.2004.03.002; Walti MA, 2006, EUKARYOT CELL, V5, P732, DOI 10.1128/EC.5.4.732-744.2006; Wicker N, 2001, MOL BIOL EVOL, V18, P1435, DOI 10.1093/oxfordjournals.molbev.a003929; Wiggins CAR, 1998, P NATL ACAD SCI USA, V95, P7945, DOI 10.1073/pnas.95.14.7945; Wuhrer M, 2004, BIOCHEM J, V378, P625, DOI 10.1042/BJ20031380; Zhang Y, 1997, GLYCOBIOLOGY, V7, P1153, DOI 10.1093/glycob/7.8.1153; Zhu SX, 2004, BIOCHEM J, V382, P995, DOI 10.1042/BJ20040793	46	39	43	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36223	36233		10.1074/jbc.M109.058354	http://dx.doi.org/10.1074/jbc.M109.058354			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858195	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000272970500024
J	Jong, YJI; Kumar, V; O'Malley, KL				Jong, Yuh-Jiin I.; Kumar, Vikas; O'Malley, Karen L.			Intracellular Metabotropic Glutamate Receptor 5 (mGluR5) Activates Signaling Cascades Distinct from Cell Surface Counterparts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR CALCIUM; PROTEIN-KINASE; NEURONS; TRANSCRIPTION; ELK-1; BRAIN; RAT; PHOSPHORYLATION; IDENTIFICATION; MITOCHONDRIA	G-protein-coupled receptors are thought to transmit extracellular signals to the cytoplasm from their position on the cell surface. Some receptors, including the metabotropic glutamate receptor 5 (mGluR5), are also highly expressed on intracellular membranes where they serve unknown functions. Here, we show that activation of cell surface versus intracellular mGluR5 results in unique Ca2+ signatures leading to unique cellular responses. Specifically, activation of either cell surface or intracellular mGluR5 leads to JNK, Ca2+/calmodulin-dependent protein kinase (CaMK), and cyclic adenosine 3',5'-monophosphate-responsive element-binding protein phosphorylation, whereas activation of only intracellular mGluR5 leads to ERK1/2 and Elk-1 phosphorylation. Using pharmacological and genetic approaches, the present findings support a role for CaMK kinase in mediating mGluR5-dependent cyclic adenosine 3',5'-monophosphate-responsive element-binding protein phosphorylation, whereas CaMKII is upstream of intracellular mGluR5-mediated Elk-1 phosphorylation. Consistent with models showing Elk-1 regulating cascades of gene expression, the known Elk-1 targets c-fos and egr1 were up-regulated following intracellular mGluR5 activation, whereas a representative non-Elk-1 target, c-jun, was not. These findings emphasize that glutamate not only serves as a neurotransmitter for cell surface receptors but, when transported into the cell, can also activate intracellular receptors such as mGluR5. Glutamate activation of intracellular mGluR5 serves an important role in the regulation of nuclear Ca2+, transcriptional activation, and gene expression necessary for physiological processes such as synaptic plasticity.	[Jong, Yuh-Jiin I.; Kumar, Vikas; O'Malley, Karen L.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	O'Malley, KL (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	omalleyk@pcg.wustl.edu			NIMH [MH57817, MH69646]; Neuroscience Blueprint Core [NS057105]; The Bakewell Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH069646, R01MH057817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Neuroscience Blueprint Core; The Bakewell Family Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH57817 and MH69646 from the NIMH and Neuroscience Blueprint Core Grant NS057105 to Washington University. This work was also supported by The Bakewell Family Foundation.	Alonso MT, 2006, CELL CALCIUM, V40, P513, DOI 10.1016/j.ceca.2006.08.013; Chen CC, 2004, J CELL BIOCHEM, V93, P1063, DOI 10.1002/jcb.20257; Dolmetsch Ricardo, 2003, Sci STKE, V2003, pPE4; Eder A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-57; Galmiche A, 2008, J BIOL CHEM, V283, P14857, DOI 10.1074/jbc.M709098200; Gerasimenko O, 2004, J CELL SCI, V117, P3087, DOI 10.1242/jcs.01295; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Gonzalez MI, 2007, J NEUROCHEM, V103, P1917, DOI 10.1111/j.1471-4159.2007.04881.x; Hubert GW, 2001, J NEUROSCI, V21, P1838, DOI 10.1523/JNEUROSCI.21-06-01838.2001; Hudmon A, 2002, BIOCHEM J, V364, P593, DOI 10.1042/BJ20020228; Jong YJI, 2005, J BIOL CHEM, V280, P30469, DOI 10.1074/jbc.M501775200; Kingston AE, 2002, NEUROSCI LETT, V330, P127, DOI 10.1016/S0304-3940(02)00751-6; Klein C, 2008, FRONT BIOSCI-LANDMRK, V13, P1206, DOI 10.2741/2756; Klein J, 1997, NEUROPHARMACOLOGY, V36, P305, DOI 10.1016/S0028-3908(97)00024-5; Kumar V, 2008, J BIOL CHEM, V283, P14072, DOI 10.1074/jbc.M708551200; Lavaur J, 2007, J NEUROSCI, V27, P14448, DOI 10.1523/JNEUROSCI.2279-07.2007; Lopez-Bendito G, 2002, CEREB CORTEX, V12, P625, DOI 10.1093/cercor/12.6.625; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; McKenna MC, 2007, J NEUROSCI RES, V85, P3347, DOI 10.1002/jnr.21444; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; Nieoullon A, 2006, J NEUROCHEM, V98, P1007, DOI 10.1111/j.1471-4159.2006.03978.x; O'Malley KL, 2003, J BIOL CHEM, V278, P28210, DOI 10.1074/jbc.M300792200; Olstad E, 2007, J CEREBR BLOOD F MET, V27, P811, DOI 10.1038/sj.jcbfm.9600400; Pusl T, 2002, J BIOL CHEM, V277, P27517, DOI 10.1074/jbc.M203002200; Rozen S, 2000, Methods Mol Biol, V132, P365; Shaw PE, 2003, INT J BIOCHEM CELL B, V35, P1210, DOI 10.1016/S1357-2725(03)00031-1; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Wang JQ, 2007, J NEUROCHEM, V100, P1, DOI 10.1111/j.1471-4159.2006.04208.x; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Xiong TC, 2008, CELL CALCIUM, V43, P29, DOI 10.1016/j.ceca.2007.02.005; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	34	95	95	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35827	35838		10.1074/jbc.M109.046276	http://dx.doi.org/10.1074/jbc.M109.046276			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19840937	Green Published, hybrid			2022-12-25	WOS:000272645600059
J	Ng, SS; Mahmoudi, T; Danenberg, E; Bejaoui, I; de Lau, W; Korswagen, HC; Schutte, M; Clevers, H				Ng, Ser Sue; Mahmoudi, Tokameh; Danenberg, Esther; Bejaoui, Ines; de Lau, Wim; Korswagen, Hendrik C.; Schutte, Mieke; Clevers, Hans			Phosphatidylinositol 3-Kinase Signaling Does Not Activate the Wnt Cascade	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOGEN-SYNTHASE KINASE-3; HOX GENE-EXPRESSION; CANCER CELL-LINES; C-ELEGANS; TRANSCRIPTIONAL ACTIVATION; WNT/BETA-CATENIN; PROTEIN-KINASE; BETA-CATENIN; HUMAN BREAST; MIGRATION	Mutational activation of the phosphatidylinositol 3-kinase (PI3K) pathway occurs in a wide variety of tumors, whereas activating Wnt pathway mutants are predominantly found in colon cancer. Because GSK3 is a key component of both pathways, it is widely assumed that active PI3K signaling feeds positively into the Wnt pathway by protein kinase B (PKB)-mediatefd inhibition of GSK3. In addition, PKB has been proposed to modulate the canonical Wnt signaling through direct stabilization and nuclear localization of beta-catenin. Here, we show that compartmentalization by Axin of GSK3 prohibits cross-talk between the PI3K and Wnt pathways and that Wnt-mediated transcriptional activity is not modulated by activation of the PI3K/PKB pathway.	[Clevers, Hans] Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Schutte, Mieke] Erasmus Univ, Med Ctr, Josephine Nefkens Inst Be414, Dept Med Oncol, NL-300 DR Rotterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC	Clevers, H (corresponding author), Hubrecht Inst KNAW, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Korswagen, Hendrik/I-8782-2012	Ng, Ser Sue/0000-0001-9873-9433; Danenberg, Esther/0000-0002-1799-4457				Ch'ng' Q, 2003, GENETICS, V164, P1355; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Harris J, 1996, DEVELOPMENT, V122, P3117; Harte D, 1998, J NONLINEAR SCI, V8, P581, DOI 10.1007/s003329900060; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Korswagen HC, 2002, GENE DEV, V16, P1291, DOI 10.1101/gad.981802; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Maloof JN, 1999, DEVELOPMENT, V126, P37; McManus EJ, 2005, EMBO J, V24, P1571, DOI 10.1038/sj.emboj.7600633; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; SALSER SJ, 1992, NATURE, V355, P255, DOI 10.1038/355255a0; Silhankova M, 2007, CURR OPIN GENET DEV, V17, P320, DOI 10.1016/j.gde.2007.05.007; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stambolic V, 1996, CURR BIOL, V6, P1664, DOI 10.1016/S0960-9822(02)70790-2; SUTHERLAND C, 1994, FEBS LETT, V338, P37, DOI 10.1016/0014-5793(94)80112-6; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; van de Wetering M, 2001, CANCER RES, V61, P278; Vlietstra RJ, 1998, CANCER RES, V58, P2720; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016	27	40	40	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35308	35313		10.1074/jbc.M109.078261	http://dx.doi.org/10.1074/jbc.M109.078261			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19850932	Green Published, hybrid			2022-12-25	WOS:000272645600007
J	Zhang, T; Li, YY; Yu, YK; Zou, P; Jiang, YQ; Sun, DX				Zhang, Tao; Li, Yanyan; Yu, Yanke; Zou, Peng; Jiang, Yiqun; Sun, Duxin			Characterization of Celastrol to Inhibit Hsp90 and Cdc37 Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; KAPPA-B KINASE; CO-CHAPERONE; ANTITUMOR AGENT; ATPASE ACTIVITY; WITHAFERIN-A; BINDING SITE; CANCER-CELLS; GELDANAMYCIN; NOVOBIOCIN	The molecular chaperone heat shock protein 90 (Hsp90) is required for the stabilization and conformational maturation of various oncogenic proteins in cancer. The loading of protein kinases to Hsp90 is actively mediated by the cochaperone Cdc37. The crucial role of the Hsp90-Cdc37 complex has made it an exciting target for cancer treatment. In this study, we characterize Hsp90 and Cdc37 interaction and drug disruption using a reconstituted protein system. The GST pull-down assay and ELISA assay show that Cdc37 binds to ADP-bound/nucleotidefree Hsp90 but not ATP-bound Hsp90. Celastrol disrupts Hsp90-Cdc37 complex formation, whereas the classical Hsp90 inhibitors (e.g. geldanamycin) have no effect. Celastrol inhibits Hsp90 ATPase activity without blocking ATP binding. Proteolytic fingerprinting indicates celastrol binds to Hsp90 C-terminal domain to protect it from trypsin digestion. These data suggest that celastrol may represent a new class of Hsp90 inhibitor by modifying Hsp90 C terminus to allosterically regulate its chaperone activity and disrupt Hsp90-Cdc37 complex.	[Zhang, Tao; Li, Yanyan; Yu, Yanke; Zou, Peng; Jiang, Yiqun; Sun, Duxin] Univ Michigan, Coll Pharm, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sun, DX (corresponding author), 428 Church St,Rm 2020, Ann Arbor, MI 48109 USA.	duxins@umich.edu	Zou, Peng/F-1097-2011; Sun, Duxin/AAA-1774-2022; Zhang, Tao/A-7339-2012; Zou, Peng/J-9300-2015; Yu, Yanke/E-4919-2012	Zou, Peng/0000-0002-7940-5056	National Institutes of Health [R01 CA 120023]; UM Cancer Center Research Grant (Munn); UM Cancer Center Core; NATIONAL CANCER INSTITUTE [R01CA120023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UM Cancer Center Research Grant (Munn); UM Cancer Center Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA 120023. This work was also supported by a UM Cancer Center Research Grant (Munn), and UM Cancer Center Core Grant (to D. S.).	ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033; Allan RK, 2006, J BIOL CHEM, V281, P7161, DOI 10.1074/jbc.M512406200; Blagg BSJ, 2006, MED RES REV, V26, P310, DOI 10.1002/med.20052; Caplan AJ, 2007, TRENDS CELL BIOL, V17, P87, DOI 10.1016/j.tcb.2006.12.002; Chiosis G, 2006, ACS CHEM BIOL, V1, P279, DOI 10.1021/cb600224w; Cortajarena AL, 2008, ACS CHEM BIOL, V3, P161, DOI 10.1021/cb700260z; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; FUSKA J, 1984, NEOPLASMA, V31, P31; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Hartson SD, 2000, BIOCHEMISTRY-US, V39, P7631, DOI 10.1021/bi000315r; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; Heath Elisabeth I, 2005, Clin Prostate Cancer, V4, P138, DOI 10.3816/CGC.2005.n.024; Holmes JL, 2008, CANCER RES, V68, P1187, DOI 10.1158/0008-5472.CAN-07-3268; Huang FC, 1998, BIOORG MED CHEM LETT, V8, P1883, DOI 10.1016/S0960-894X(98)00331-X; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Kaileh M, 2007, J BIOL CHEM, V282, P4253, DOI 10.1074/jbc.M606728200; Kamal A, 2004, TRENDS MOL MED, V10, P283, DOI 10.1016/j.molmed.2004.04.006; Kuduk SD, 2000, BIOORG MED CHEM LETT, V10, P1303, DOI 10.1016/S0960-894X(00)00208-0; Kuduk SD, 1999, BIOORG MED CHEM LETT, V9, P1233, DOI 10.1016/S0960-894X(99)00185-7; LAI BT, 1984, MOL CELL BIOL, V4, P2802, DOI 10.1128/MCB.4.12.2802; Lee JH, 2006, BIOCHEM PHARMACOL, V72, P1311, DOI 10.1016/j.bcp.2006.08.014; Lee P, 2004, MOL BIOL CELL, V15, P1785, DOI 10.1091/mbc.E03-07-0480; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Mandler R, 2002, BIOCONJUGATE CHEM, V13, P786, DOI 10.1021/bc010124g; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Martinez-Ruiz A, 2005, P NATL ACAD SCI USA, V102, P8525, DOI 10.1073/pnas.0407294102; Mimnaugh EG, 1996, J BIOL CHEM, V271, P22796, DOI 10.1074/jbc.271.37.22796; MINAMI Y, 1991, J BIOL CHEM, V266, P10099; Neckers L, 2006, HANDB EXP PHARM, V172, P259; Neckers L, 2003, CURR MED CHEM, V10, P733, DOI 10.2174/0929867033457818; NGASSAPA O, 1994, J NAT PROD, V57, P1, DOI 10.1021/np50103a001; Onuoha SC, 2008, J MOL BIOL, V379, P732, DOI 10.1016/j.jmb.2008.02.013; Pacey S, 2006, HANDB EXP PHARM, V172, P331; Pearl LH, 2005, CURR OPIN GENET DEV, V15, P55, DOI 10.1016/j.gde.2004.12.011; Peng C, 2007, BLOOD, V110, P678, DOI 10.1182/blood-2006-10-054098; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; REED SI, 1980, GENETICS, V95, P561; Richter K, 2003, J BIOL CHEM, V278, P10328, DOI 10.1074/jbc.M213094200; Roe SM, 2004, CELL, V116, P87, DOI 10.1016/S0092-8674(03)01027-4; Ronnen EA, 2006, INVEST NEW DRUG, V24, P543, DOI 10.1007/s10637-006-9208-z; SCHUNUR RC, 1995, J MED CHEM, V38, P3813; SCHUR RC, 1995, J MED CHEM, V38, P3806; Schwarze SR, 2003, CANCER RES, V63, P4614; Shao J, 2001, J BIOL CHEM, V276, P206, DOI 10.1074/jbc.M007583200; Shao JY, 2003, J BIOL CHEM, V278, P38117, DOI 10.1074/jbc.C300330200; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Smith JR, 2009, ONCOGENE, V28, P157, DOI 10.1038/onc.2008.380; Smith JR, 2009, CELL CYCLE, V8, P362, DOI 10.4161/cc.8.3.7531; Solit DB, 2008, DRUG DISCOV TODAY, V13, P38, DOI 10.1016/j.drudis.2007.10.007; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Sreeramulu S, 2009, ANGEW CHEM INT EDIT, V48, P5853, DOI 10.1002/anie.200900929; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Stepanova L, 2000, ONCOGENE, V19, P2186, DOI 10.1038/sj.onc.1203561; Sullivan W, 1997, J BIOL CHEM, V272, P8007, DOI 10.1074/jbc.272.12.8007; Sullivan WP, 2002, J BIOL CHEM, V277, P45942, DOI 10.1074/jbc.M207754200; SUPKO JG, 1995, CANCER CHEMOTH PHARM, V36, P305, DOI 10.1007/BF00689048; Terasawa K, 2005, J BIOCHEM, V137, P443, DOI 10.1093/jb/mvi056; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Wandinger SK, 2008, J BIOL CHEM, V283, P18473, DOI 10.1074/jbc.R800007200; Ward BK, 2002, J BIOL CHEM, V277, P40799, DOI 10.1074/jbc.M207097200; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yi F, 2008, ACS CHEM BIOL, V3, P645, DOI 10.1021/cb800162x; YU Y, 2009, BIOCH PHARM IN PRESS; Yun BG, 2004, BIOCHEMISTRY-US, V43, P8217, DOI 10.1021/bi0497998; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zhang W, 2004, J MOL BIOL, V340, P891, DOI 10.1016/j.jmb.2004.05.007; Zhao RM, 2005, BIOCHEM CELL BIOL, V83, P703, DOI 10.1139/O05-158	75	148	157	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35381	35389		10.1074/jbc.M109.051532	http://dx.doi.org/10.1074/jbc.M109.051532			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858214	hybrid, Green Published			2022-12-25	WOS:000272645600014
J	Evangelista, KD; Andrich, F; de Rezende, FF; Niland, S; Cordeiro, MN; Horlacher, T; Castelli, R; Schmidt-Hederich, A; Seeberger, PH; Sanchez, EF; Richardson, M; de Figueiredo, SG; Eble, JA				Evangelista, Karla de Santana; Andrich, Filipe; de Rezende, Flavia Figueiredo; Niland, Stephan; Cordeiro, Marta N.; Horlacher, Tim; Castelli, Riccardo; Schmidt-Hederich, Alletta; Seeberger, Peter H.; Sanchez, Eladio F.; Richardson, Michael; de Figueiredo, Suely Gomes; Eble, Johannes A.			Plumieribetin, a Fish Lectin Homologous to Mannose-binding B-type Lectins, Inhibits the Collagen-binding alpha 1 beta 1 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCORPIONFISH SCORPAENA-PLUMIERI; PLANT-LECTINS; TAKIFUGU-RUBRIPES; CRYSTAL-STRUCTURE; CELL-ADHESION; VENOM; PURIFICATION; DISINTEGRINS; RHODOCETIN; COMPLEXES	Recently, a few fish proteins have been described with a high homology to B-type lectins of monocotyledonous plants. Because of their mannose binding activity, they have been ascribed a role in innate immunity. By screening various fish venoms for their integrin inhibitory activity, we isolated a homologous protein from the fin stings and skin mucus of the scorpionfish (Scorpaena plumieri). This protein inhibits alpha 1 beta 1 integrin binding to basement membrane collagen IV. By protein chemical and spectroscopic means, we demonstrated that this fish protein, called plumieribetin, is a homotetramer and contains a high content of anti-parallel beta strands, similar to the mannose-binding monocot B-lectins. It lacks both N-linked glycoconjugates and common O-glycan motifs. Despite its B-lectin-like structure, plumieribetin binds to alpha 1 beta 1 integrin irrespective of N-glycosylation, suggesting a direct protein-protein interaction. This interaction is independent of divalent cations. On the cellular level, plumieribetin failed to completely detach hepatocarcinoma HepG2 cells and primary arterial smooth muscle cells from the collagen IV fragment CB3. However, plumieribetin weakened the cell-collagen contacts, reduced cell spreading, and altered the actin cytoskeleton, after the compensating alpha 1 beta 1 integrin was blocked. The integrin inhibiting effect of plumieribetin adds a new function to the B-lectin family, which is known for pathogen defense.	[Evangelista, Karla de Santana; de Rezende, Flavia Figueiredo; Niland, Stephan; Schmidt-Hederich, Alletta; Eble, Johannes A.] Frankfurt Univ Hosp, Dept Vasc Matrix Biol, Ctr Mol Med, D-60590 Frankfurt, Germany; [Andrich, Filipe; de Figueiredo, Suely Gomes] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, ES, Brazil; [Andrich, Filipe] Univ Fed Minas Gerais, Dept Physiol & Biophys, Lab Venenos & Toxinas Anim, Dept Biochem & Immunol,Inst Biol Sci, Belo Horizonte, MG, Brazil; [Cordeiro, Marta N.; Sanchez, Eladio F.; Richardson, Michael] Ezequiel Dias Fdn, Ctr Res & Dev, BR-30510010 Belo Horizonte, MG, Brazil; [Horlacher, Tim; Castelli, Riccardo; Seeberger, Peter H.] ETH, Swiss Fed Inst Technol, Organ Chem Lab, CH-8093 Zurich, Switzerland	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Universidade Federal do Espirito Santo; Universidade Federal de Minas Gerais; Swiss Federal Institutes of Technology Domain; ETH Zurich	Eble, JA (corresponding author), Frankfurt Univ Hosp, Dept Vasc Matrix Biol, Ctr Mol Med, Bldg 9,Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	Eble@med.uni-frankfurt.de	Sanchez, Eladio Flores/E-6942-2013	Flores Sanchez, Eladio Oswaldo/0000-0003-1637-9345	Deutsche Forschungsgemeinschaft [Eb177/4-2, SFB815]; German-Brazilian Exchange Program PROBRAL of the German Academic Exchange Service [D/05/30352]; CAPES [250/06]; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [24000/01]; ETH Zurich; Schweizerischer Nationalfonds	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German-Brazilian Exchange Program PROBRAL of the German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); ETH Zurich(ETH Zurich); Schweizerischer Nationalfonds(Swiss National Science Foundation (SNSF))	This work was supported by Deutsche Forschungsgemeinschaft Grants Eb177/4-2 and SFB815 (to J.A.E.), German-Brazilian Exchange Program PROBRAL of the German Academic Exchange Service Grant D/05/30352, CAPES Process 250/06, Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado de Minas Gerais Edital 24000/01, and funds from the ETH Zurich and the Schweizerischer Nationalfonds.	Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Bachhawat K, 2001, BIOCHEMISTRY-US, V40, P7291, DOI 10.1021/bi0027783; BALZARINI J, 1991, ANTIMICROB AGENTS CH, V35, P410, DOI 10.1128/AAC.35.3.410; Barre A, 2001, BIOCHIMIE, V83, P645, DOI 10.1016/S0300-9084(01)01315-3; Boletini-Santos D, 2008, TOXICON, V51, P585, DOI 10.1016/j.toxicon.2007.11.011; Bouckaert J, 1999, CURR OPIN STRUC BIOL, V9, P572, DOI 10.1016/S0959-440X(99)00007-X; Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Carrijo LC, 2005, TOXICON, V45, P843, DOI 10.1016/j.toxicon.2005.01.021; Chandra NR, 1999, J MOL BIOL, V285, P1157, DOI 10.1006/jmbi.1998.2353; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+; Eble JA, 2005, CURR PHARM DESIGN, V11, P867, DOI 10.2174/1381612053381738; Eble JA, 2003, J BIOL CHEM, V278, P26488, DOI 10.1074/jbc.M301860200; Eble JA, 2002, MATRIX BIOL, V21, P547, DOI 10.1016/S0945-053X(02)00068-9; EBLE JA, 1993, EMBO J, V12, P4795, DOI 10.1002/j.1460-2075.1993.tb06168.x; Eble JA, 2001, OSTEOARTHR CARTILAGE, V9, pS131, DOI 10.1053/joca.2001.0455; Eble JA, 2001, J BIOL CHEM, V276, P12274, DOI 10.1074/jbc.M009338200; EBLE JA, 2001, METHODS CELL MATRIX, P223; Gardner H, 2003, MOL B INT U, P25; GARNIER P, 1995, TOXICON, V33, P143, DOI 10.1016/0041-0101(94)00151-W; Haddad V, 2003, TOXICON, V42, P79, DOI 10.1016/S0041-0101(03)00103-X; HESTER G, 1995, NAT STRUCT BIOL, V2, P472, DOI 10.1038/nsb0695-472; Hester G, 1996, J MOL BIOL, V262, P516, DOI 10.1006/jmbi.1996.0532; Horlacher T, 2008, CHEM SOC REV, V37, P1414, DOI 10.1039/b708016f; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; LOW KSY, 1993, TOXICON, V31, P1471, DOI 10.1016/0041-0101(93)90212-2; Loyo J, 2008, INVEST CLIN, V49, P299; Morita T, 2005, TOXICON, V45, P1099, DOI 10.1016/j.toxicon.2005.02.021; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Ratner DM, 2002, EUR J ORG CHEM, V2002, P826; Rini JM, 1999, CURR OPIN STRUC BIOL, V9, P578, DOI 10.1016/S0959-440X(99)00008-1; Rosenow Felix, 2008, Neoplasia, V10, P168, DOI 10.1593/neo.07898; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; SCHAEFFE.RC, 1971, TOXICON, V9, P69, DOI 10.1016/0041-0101(71)90045-6; SPENCER R, 2005, VET IMMUNOL IMMUNOP, V108, P111; Theakston RDG, 2002, TOXICON, V40, P579, DOI 10.1016/S0041-0101(01)00244-6; Tsutsui S, 2006, COMP BIOCHEM PHYS B, V143, P514, DOI 10.1016/j.cbpb.2006.01.005; Tsutsui S, 2003, J BIOL CHEM, V278, P20882, DOI 10.1074/jbc.M301038200; Tsutsui S, 2006, COMP BIOCHEM PHYS D, V1, P122, DOI 10.1016/j.cbd.2005.09.005; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Wood SD, 1999, ACTA CRYSTALLOGR D, V55, P1264, DOI 10.1107/S0907444999005326; WRIGHT CS, 1990, J BIOL CHEM, V265, P1676; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040	48	30	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34747	34759		10.1074/jbc.M109.002873	http://dx.doi.org/10.1074/jbc.M109.002873			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19850917	Green Published, hybrid			2022-12-25	WOS:000272439600030
J	Singleton, PA; Pendyala, S; Gorshkova, IA; Mambetsariev, N; Moitra, J; Garcia, JGN; Natarajan, V				Singleton, Patrick A.; Pendyala, Srikanth; Gorshkova, Irina A.; Mambetsariev, Nurbek; Moitra, Jaideep; Garcia, Joe G. N.; Natarajan, Viswanathan			Dynamin 2 and c-Abl Are Novel Regulators of Hyperoxia-mediated NADPH Oxidase Activation and Reactive Oxygen Species Production in Caveolin-enriched Microdomains of the Endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; TYROSINE KINASE; NAD(P)H OXIDASE; ANGIOTENSIN-II; LIPID RAFTS; PHOSPHORYLATION; RECEPTOR; SRC; GENERATION; TRANSACTIVATION	Reactive oxygen species (ROS) generation, particularly by the endothelial NADPH oxidase family of proteins, plays a major role in the pathophysiology associated with lung inflammation, ischemia/reperfusion injury, sepsis, hyperoxia, and ventilator-associated lung injury. We examined potential regulators of ROS production and discovered that hyperoxia treatment of human pulmonary artery endothelial cells induced recruitment of the vesicular regulator, dynamin 2, the non-receptor tyrosine kinase, c-Abl, and the NADPH oxidase subunit, p47(phox), to caveolin-enriched microdomains (CEMs). Silencing caveolin-1 (which blocks CEM formation) and/or c-Abl expression with small interference RNA inhibited hyperoxia-mediated tyrosine phosphorylation and association of dynamin 2 with p47(phox) and ROS production. In addition, treatment of human pulmonary artery endothelial cells with dynamin 2 small interfering RNA or the dynamin GTPase inhibitor, Dynasore, attenuated hyperoxia-mediated ROS production and p47(phox) recruitment to CEMs. Using purified recombinant proteins, we observed that c-Abl tyrosine-phosphorylated dynamin 2, and this phosphorylation increased p47(phox)/dynamin 2 association (change in the dissociation constant (K-d) from 85.8 to 6.9 nM). Furthermore, exposure of mice to hyperoxia increased ROS production, c-Abl activation, dynamin 2 association with p47(phox), and pulmonary leak, events that were attenuated in the caveolin-1 knock-out mouse confirming a role for CEMs in ROS generation. These results suggest that hyperoxia induces c-Abl-mediated dynamin 2 phosphorylation required for recruitment of p47(phox) to CEMs and subsequent ROS production in lung endothelium.	[Singleton, Patrick A.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago	Singleton, PA (corresponding author), Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Pritzker Sch Med, GCIS Bldg,Suite W403E,929 E 57th St, Chicago, IL 60637 USA.	psinglet@medicine.bsd.uchicago.edu	Garcia, Joe GN/E-8862-2010		National Institutes of Health [RO1-HL 095723, RO1 HL 085553, PO1-HL 58064]; American Heart Association [0730277N]; American Lung Association [RG-75229-N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064, R01HL095723, R01HL085553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Lung Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL 095723 (to P.A.S.), RO1 HL 085553 (to V.N.), and PO1-HL 58064 (to J.G.N., V.N., and P.A.S.). This work was also supported by American Heart Association National Scientist Development Grant 0730277N (to P.A.S.) and by American Lung Association National Biomedical Research Grant RG-75229-N (to P.A.S.).	Cadwallader KA, 2002, J IMMUNOL, V169, P3336, DOI 10.4049/jimmunol.169.6.3336; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; Frank PG, 2007, CURR PHARM DESIGN, V13, P1761, DOI 10.2174/138161207780831202; Furstoss O, 2002, EMBO J, V21, P514, DOI 10.1093/emboj/21.4.514; Garcia JGN, 2001, J CLIN INVEST, V108, P689, DOI 10.1172/JCI12450; Hantschel O, 2004, NAT REV MOL CELL BIO, V5, P33, DOI 10.1038/nrm1280; Hu GC, 2008, AM J PHYSIOL-LUNG C, V294, pL178, DOI 10.1152/ajplung.00263.2007; Jin Y, 2008, AM J RESP CELL MOL, V39, P171, DOI 10.1165/rcmb.2007-0323OC; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Lau ATY, 2008, J CELL BIOCHEM, V104, P657, DOI 10.1002/jcb.21655; Lee CS, 2006, NAT CELL BIOL, V8, P477, DOI 10.1038/ncb1401; Li XA, 2005, TRENDS CARDIOVAS MED, V15, P92, DOI 10.1016/j.tcm.2005.04.001; Lin J, 2008, ONCOGENE, V27, P4385, DOI 10.1038/onc.2008.86; Murata T, 2007, J EXP MED, V204, P2373, DOI 10.1084/jem.20062340; Parinandi NL, 2003, AM J PHYSIOL-LUNG C, V284, pL26, DOI 10.1152/ajplung.00123.2002; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P841, DOI [10.1089/ars.2008.2231, 10.1089/ARS.2008.2231]; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Pries A. R., 2006, V176, P1; Ray R, 2005, CLIN SCI, V109, P217, DOI 10.1042/CS20050067; Robinson JM, 2008, HISTOCHEM CELL BIOL, V130, P281, DOI 10.1007/s00418-008-0461-4; Sanguinetti AR, 2003, CELL SIGNAL, V15, P289, DOI 10.1016/S0898-6568(02)00090-6; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Schlunck G, 2004, MOL BIOL CELL, V15, P256, DOI 10.1091/mbc.E03-01-0019; Selemidis S, 2008, PHARMACOL THERAPEUT, V120, P254, DOI 10.1016/j.pharmthera.2008.08.005; Shajahan AN, 2004, J BIOL CHEM, V279, P20392, DOI 10.1074/jbc.M308710200; Singleton PA, 2004, EXP CELL RES, V295, P102, DOI 10.1016/j.yexcr.2003.12.025; Singleton PA, 2007, J BIOL CHEM, V282, P30643, DOI 10.1074/jbc.M702573200; Singleton PA, 2006, J BIOL CHEM, V281, P34381, DOI 10.1074/jbc.M603680200; Singleton PA, 2009, CIRC RES, V104, P978, DOI 10.1161/CIRCRESAHA.108.193367; Sirvent A, 2008, BIOL CELL, V100, P617, DOI 10.1042/BC20080020; Sun XG, 2000, J BIOL CHEM, V275, P17237, DOI 10.1074/jbc.C000099200; Touyz RM, 2003, ARTERIOSCL THROM VAS, V23, P981, DOI 10.1161/01.ATV.0000069236.27911.68; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Ushio-Fukai M, 2005, CIRC RES, V97, P829, DOI 10.1161/01.RES.0000185322.46009.F5; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Utomo A, 2006, J IMMUNOL, V177, P6388, DOI 10.4049/jimmunol.177.9.6388; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Wunderlich C, 2008, J MOL CELL CARDIOL, V44, P938, DOI 10.1016/j.yjmcc.2008.02.275; Yao Q, 2005, J MOL BIOL, V348, P491, DOI 10.1016/j.jmb.2005.02.003; Yung Lai Ming, 2006, Cardiovascular & Hematological Disorders - Drug Targets, V6, P1; Zhang DX, 2007, AM J PHYSIOL-HEART C, V292, pH2023, DOI 10.1152/ajpheart.01283.2006; Zuo L, 2005, ARTERIOSCL THROM VAS, V25, P1824, DOI 10.1161/01.ATV.0000175295.09607.18	47	30	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34964	34975		10.1074/jbc.M109.013771	http://dx.doi.org/10.1074/jbc.M109.013771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19833721	Green Published, hybrid			2022-12-25	WOS:000272439600052
J	Hu, C; Zhang, R; Wang, CR; Wang, J; Ma, XJ; Lu, JY; Qin, W; Hou, XH; Wang, C; Bao, YQ; Xiang, KS; Jia, WP				Hu, Cheng; Zhang, Rong; Wang, Congrong; Wang, Jie; Ma, Xiaojing; Lu, Jingyi; Qin, Wen; Hou, Xuhong; Wang, Chen; Bao, Yuqian; Xiang, Kunsan; Jia, Weiping			PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 Are Associated with Type 2 Diabetes in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; EUROPEAN POPULATIONS; GENETIC-VARIANTS; INSULIN-RELEASE; RISK LOCI; SUSCEPTIBILITY; REPLICATION; GLUCOSE; MELLITUS	Background: Recent advance in genetic studies added the confirmed susceptible loci for type 2 diabetes to eighteen. In this study, we attempt to analyze the independent and joint effect of variants from these loci on type 2 diabetes and clinical phenotypes related to glucose metabolism. Methods/Principal Findings: Twenty-one single nucleotide polymorphisms ( SNPs) from fourteen loci were successfully genotyped in 1,849 subjects with type 2 diabetes and 1,785 subjects with normal glucose regulation. We analyzed the allele and genotype distribution between the cases and controls of these SNPs as well as the joint effects of the susceptible loci on type 2 diabetes risk. The associations between SNPs and type 2 diabetes were examined by logistic regression. The associations between SNPs and quantitative traits were examined by linear regression. The discriminative accuracy of the prediction models was assessed by area under the receiver operating characteristic curves. We confirmed the effects of SNPs from PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 on risk for type 2 diabetes, with odds ratios ranging from 1.114 to 1.406 ( P value range from 0.0335 to 1.37E-12). But no significant association was detected between SNPs from WFS1, FTO, JAZF1, TSPAN8-LGR5, THADA, ADAMTS9, NOTCH2-ADAM30 and type 2 diabetes. Analyses on the quantitative traits in the control subjects showed that THADA SNP rs7578597 was association with 2-h insulin during oral glucose tolerance tests (P = 0.0005, empirical P = 0.0090). The joint effect analysis of SNPs from eleven loci showed the individual carrying more risk alleles had a significantly higher risk for type 2 diabetes. And the type 2 diabetes patients with more risk allele tended to have earlier diagnostic ages (P = 0.0006). Conclusions/Significance: The current study confirmed the association between PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 and type 2 diabetes. These type 2 diabetes risk loci contributed to the disease additively.			Hu, C (corresponding author), Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	Hu, Cheng/C-3346-2008; 王, 从容/HDM-0959-2022; Wang, Congrong/AAL-8178-2020; Jia, Weiping/B-7483-2012	Hu, Cheng/0000-0003-4314-2386; 王, 从容/0000-0002-8645-1114; 				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Drieschner N, 2007, GENE, V403, P110, DOI 10.1016/j.gene.2007.06.029; Franks PW, 2008, DIABETOLOGIA, V51, P458, DOI 10.1007/s00125-007-0887-6; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gloyn AL, 2001, BEST PRACT RES CL EN, V15, P293, DOI 10.1053/beem.2001.0147; Grarup N, 2008, DIABETES, V57, P2534, DOI 10.2337/db08-0436; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Horikawa Y, 2008, J CLIN ENDOCR METAB, V93, P3136, DOI 10.1210/jc.2008-0452; HU C, 2009, DIABETOLOGIA; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Wang CR, 2009, DIABETES, V58, P1023, DOI 10.2337/db08-1064; Wasson J, 2008, DIABETOLOGIA, V51, P391, DOI 10.1007/s00125-007-0920-9; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	26	134	146	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7643	10.1371/journal.pone.0007643	http://dx.doi.org/10.1371/journal.pone.0007643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862325	Green Published, Green Submitted, gold			2022-12-25	WOS:000271194600020
J	Davies, P; Brown, DR				Davies, Paul; Brown, David R.			Manganese Enhances Prion Protein Survival in Model Soils and Increases Prion Infectivity to Cells	PLOS ONE			English	Article							METAL-BINDING; SCRAPIE VIRUS; FATE; ADSORPTION; DISEASE; COPPER; MONTMORILLONITE; PATHOGENESIS; INITIATE; TSES	Prion diseases are considered to be transmissible. The existence of sporadic forms of prion diseases such as scrapie implies an environmental source for the infectious agent. This would suggest that under certain conditions the prion protein, the accepted agent of transmission, can survive in the environment. We have developed a novel technique to extract the prion protein from soil matrices. Previous studies have suggested that environmental manganese is a possible risk factor for prion diseases. We have shown that exposure to manganese is a soil matrix causes a dramatic increase in prion protein survival (similar to 10 fold) over a two year period. We have also shown that manganese increases infectivity of mouse passaged scrapie to culture cells by 2 logs. These results clearly verify that manganese is a risk factor for both the survival of the infectious agent in the environment and its transmissibility.			Davies, P (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssdrb@bath.ac.uk		Davies, Paul/0000-0001-8022-2719	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abollino O, 2008, APPL CLAY SCI, V38, P227, DOI 10.1016/j.clay.2007.04.002; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; BOST M, 2002, PRION DIS COPPER MET, P119; Brazier MW, 2008, J BIOL CHEM, V283, P12831, DOI 10.1074/jbc.M709820200; Brown DR, 2000, EMBO J, V19, P1180, DOI 10.1093/emboj/19.6.1180; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Chihota CM, 2004, VET REC, V154, P809, DOI 10.1136/vr.154.26.809; Cooke CM, 2007, ENVIRON SCI TECHNOL, V41, P811, DOI 10.1021/es0618189; Davies P, 2009, BIOCHEMISTRY-US, V48, P2610, DOI 10.1021/bi900170n; Deer W. A., 1992, INTRO ROCK FORMING M; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gale P, 2001, J APPL MICROBIOL, V91, P563, DOI 10.1046/j.1365-2672.2001.01466.x; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Hesketh S, 2007, J ANIM SCI, V85, P1596, DOI 10.2527/jas.2006-714; Hesketh S, 2008, MOL CELL NEUROSCI, V37, P590, DOI 10.1016/j.mcn.2007.12.008; Imrie CE, 2009, ENVIRON GEOCHEM HLTH, V31, P133, DOI 10.1007/s10653-008-9172-y; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Kralovicova S, 2009, MOL CELL NEUROSCI, V41, P135, DOI 10.1016/j.mcn.2009.02.002; Leita L, 2006, SOIL BIOL BIOCHEM, V38, P1638, DOI 10.1016/j.soilbio.2005.11.018; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Nishida Y, 2003, Z NATURFORSCH C, V58, P752; Norde W, 2000, J BIOTECHNOL, V79, P259, DOI 10.1016/S0168-1656(00)00242-X; PENNINGTON JAT, 1991, J AM DIET ASSOC, V91, P179; Polano M, 2008, BIOCHEM BIOPH RES CO, V367, P323, DOI 10.1016/j.bbrc.2007.12.143; Prusiner SB, 1996, TRENDS BIOCHEM SCI, V21, P482, DOI 10.1016/S0968-0004(96)10063-3; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Purdey M, 2005, MED HYPOTHESES, V65, P448, DOI 10.1016/j.mehy.2005.03.018; Purdey M, 2004, MED HYPOTHESES, V63, P211, DOI 10.1016/j.mehy.2004.02.041; Purdey M, 2001, MED HYPOTHESES, V57, P29, DOI 10.1054/mehy.2001.1305; Purdey M, 2000, MED HYPOTHESES, V54, P278, DOI 10.1054/mehy.1999.0836; Ragnarsdottir KV, 2006, J GEOCHEM EXPLOR, V88, P228, DOI 10.1016/j.gexplo.2005.08.046; Revault M, 2005, BBA-GEN SUBJECTS, V1724, P367, DOI 10.1016/j.bbagen.2005.05.005; Rigou P, 2006, ENVIRON SCI TECHNOL, V40, P1497, DOI 10.1021/es0516965; Roy G, 2000, CLAY MINER, V35, P335, DOI 10.1180/000985500546800; Russo F, 2009, J GEN VIROL, V90, P275, DOI 10.1099/vir.0.003251-0; Saunders SE, 2008, PRION, V2, P162, DOI 10.4161/pri.2.4.7951; Servagent-Noinville S, 2000, J COLLOID INTERF SCI, V221, P273, DOI 10.1006/jcis.1999.6576; Stumm W., CHEM SOLID WATER INT; Thackray AM, 2002, BIOCHEM J, V362, P253, DOI 10.1042/0264-6021:3620253; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Vasina EN, 2005, BIOMACROMOLECULES, V6, P3425, DOI 10.1021/bm050492d; Wiggins RC, 2009, NEUROCHEM RES, V34, P158, DOI 10.1007/s11064-008-9741-6; Wong BS, 2001, J NEUROCHEM, V78, P1400, DOI 10.1046/j.1471-4159.2001.00522.x; Wong BS, 2001, PANMINERVA MED, V43, P283	47	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7518	10.1371/journal.pone.0007518	http://dx.doi.org/10.1371/journal.pone.0007518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844576	Green Published, gold, Green Submitted			2022-12-25	WOS:000271013000006
J	Di Serio, F; Gisel, A; Navarro, B; Delgado, S; Martinez de Alba, AE; Donvito, G; Flores, R				Di Serio, Francesco; Gisel, Andreas; Navarro, Beatriz; Delgado, Sonia; Martinez de Alba, Angel-Emilio; Donvito, Giacinto; Flores, Ricardo			Deep Sequencing of the Small RNAs Derived from Two Symptomatic Variants of a Chloroplastic Viroid: Implications for Their Genesis and for Pathogenesis	PLOS ONE			English	Article							IN-VITRO; INFECTED PLANTS; ROLLING CIRCLE; SELF-CLEAVAGE; PEACH CALICO; REPLICATION; PATHWAY; VIVO; HETEROGENEITY; PATHOGENICITY	Northern-blot hybridization and low-scale sequencing have revealed that plants infected by viroids, non-protein-coding RNA replicons, accumulate 21-24 nt viroid-derived small RNAs (vd-sRNAs) similar to the small interfering RNAs, the hallmarks of RNA silencing. These results strongly support that viroids are elicitors and targets of the RNA silencing machinery of their hosts. Low-scale sequencing, however, retrieves partial datasets and may lead to biased interpretations. To overcome this restraint we have examined by deep sequencing (Solexa-Illumina) and computational approaches the vd-sRNAs accumulating in GF-305 peach seedlings infected by two molecular variants of Peach latent mosaic viroid (PLMVd) inciting peach calico (albinism) and peach mosaic. Our results show in both samples multiple PLMVd-sRNAs, with prevalent 21-nt (+) and (2) RNAs presenting a biased distribution of their 5' nucleotide, and adopting a hotspot profile along the genomic (+) and (2) RNAs. Dicer-like 4 and 2 (DCL4 and DCL2, respectively), which act hierarchically in antiviral defense, likely also mediate the genesis of the 21- and 22-nt PLMVd-sRNAs. More specifically, because PLMVd replicates in plastids wherein RNA silencing has not been reported, DCL4 and DCL2 should dice the PLMVd genomic RNAs during their cytoplasmic movement or the PLMVd-dsRNAs generated by a cytoplasmic RNA-dependent RNA polymerase (RDR), like RDR6, acting in concert with DCL4 processing. Furthermore, given that vd-sRNAs derived from the 12-14-nt insertion containing the pathogenicity determinant of peach calico are underrepresented, it is unlikely that symptoms may result from the accidental targeting of host mRNAs by vd-sRNAs from this determinant guiding the RNA silencing machinery.			Di Serio, F (corresponding author), CNR, Ist Virol Vegetale, I-70126 Bari, Italy.	rflores@ibmcp.upv.es	Martínez de Alba, Ángel Emilio/B-1935-2013; Donvito, Giacinto/AAC-9872-2020; Flores, Ricardo/K-2788-2014; Navarro, Beatriz/B-9128-2015; Gisel, Andreas/AAW-2335-2020; Di Serio, Francesco/I-5191-2012	Martínez de Alba, Ángel Emilio/0000-0002-1198-3415; Donvito, Giacinto/0000-0002-0628-1080; Flores, Ricardo/0000-0002-3033-5077; Navarro, Beatriz/0000-0001-8981-1018; Di Serio, Francesco/0000-0003-2822-704X; GISEL, ANDREAS/0000-0001-7218-9488				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros S, 1999, J GEN VIROL, V80, P2239, DOI 10.1099/0022-1317-80-8-2239; Ambros S, 1998, J VIROL, V72, P7397; Barba M, 2009, J PLANT PATHOL, V91, P243; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; BRANCH AD, 1988, P NATL ACAD SCI USA, V85, P9128, DOI 10.1073/pnas.85.23.9128; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Bussiere F, 1999, J VIROL, V73, P6353; Bussiere F, 2000, J VIROL, V74, P2647, DOI 10.1128/JVI.74.6.2647-2654.2000; Carbonell A, 2008, VIROLOGY, V371, P44, DOI 10.1016/j.virol.2007.09.031; DAROS JA, 1994, P NATL ACAD SCI USA, V91, P12813, DOI 10.1073/pnas.91.26.12813; Daros JA, 2002, EMBO J, V21, P749, DOI 10.1093/emboj/21.4.749; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Delgado S, 2005, J VIROL, V79, P12934, DOI 10.1128/JVI.79.20.12934-12943.2005; Diaz-Pendon JA, 2008, ANNU REV PHYTOPATHOL, V46, P303, DOI 10.1146/annurev.phyto.46.081407.104746; Diener TO, 2003, NAT REV MICROBIOL, V1, P75, DOI 10.1038/nrmicro736; Ding B, 2007, MOL PLANT MICROBE IN, V20, P7, DOI 10.1094/MPMI-20-0007; Ding B, 2009, ANNU REV PHYTOPATHOL, V47, P105, DOI 10.1146/annurev-phyto-080508-081927; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Eamens A, 2008, PLANT PHYSIOL, V147, P456, DOI 10.1104/pp.108.117275; Flores R, 2000, ADV VIRUS RES, V55, P271, DOI 10.1016/S0065-3527(00)55006-4; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Flores R, 2006, MOL PLANT PATHOL, V7, P209, DOI [10.1111/j.1364-3703.2006.00332.x, 10.1111/J.1364-3703.2006.00332.X]; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; Gago S, 2005, RNA, V11, P1073, DOI 10.1261/rna.2230605; Gago S, 2009, SCIENCE, V323, P1308, DOI 10.1126/science.1169202; Gas ME, 2007, PLOS PATHOG, V3, P1813, DOI 10.1371/journal.ppat.0030182; Gomez G, 2007, PLANT J, V51, P1041, DOI 10.1111/j.1365-313X.2007.03203.x; Gomez G, 2009, TRENDS PLANT SCI, V14, P264, DOI 10.1016/j.tplants.2009.03.002; GROSS HJ, 1978, NATURE, V273, P203, DOI 10.1038/273203a0; HERNANDEZ C, 1992, P NATL ACAD SCI USA, V89, P3711, DOI 10.1073/pnas.89.9.3711; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Ho T, 2007, FEBS LETT, V581, P3267, DOI 10.1016/j.febslet.2007.06.022; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; HUTCHINS CJ, 1986, NUCLEIC ACIDS RES, V14, P3627, DOI 10.1093/nar/14.9.3627; Itaya A, 2001, MOL PLANT MICROBE IN, V14, P1332, DOI 10.1094/MPMI.2001.14.11.1332; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kim VN, 2008, CELL, V133, P25, DOI 10.1016/j.cell.2008.03.015; Landry P, 2005, J VIROL, V79, P6540, DOI 10.1128/JVI.79.10.6540-6543.2005; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Machida S, 2007, J GEN VIROL, V88, P3452, DOI 10.1099/vir.0.83228-0; Malfitano M, 2003, VIROLOGY, V313, P492, DOI 10.1016/S0042-6822(03)00315-5; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Markarian N, 2004, ARCH VIROL, V149, P397, DOI 10.1007/s00705-003-0215-5; Martin R, 2007, VIROLOGY, V367, P135, DOI 10.1016/j.virol.2007.05.011; Martinez de Alba AE, 2003, J VIROL, V77, P9685, DOI 10.1128/JVI.77.17.9685-9694.2003; Martinez de Alba AE, 2002, J VIROL, V76, P13094, DOI 10.1128/JVI.76.24.13094-13096.2002; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Navarro B, 1997, P NATL ACAD SCI USA, V94, P11262, DOI 10.1073/pnas.94.21.11262; Omarov RT, 2007, P NATL ACAD SCI USA, V104, P1714, DOI 10.1073/pnas.0608117104; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pantaleo V, 2007, J VIROL, V81, P3797, DOI 10.1128/JVI.02383-06; Papaefthimiou I, 2001, NUCLEIC ACIDS RES, V29, P2395, DOI 10.1093/nar/29.11.2395; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Ramachandran V, 2008, TRENDS PLANT SCI, V13, P368, DOI 10.1016/j.tplants.2008.03.008; Rodio ME, 2007, PLANT CELL, V19, P3610, DOI 10.1105/tpc.106.049775; Rodio ME, 2006, J GEN VIROL, V87, P231, DOI 10.1099/vir.0.81356-0; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Schwind N, 2009, MOL PLANT PATHOL, V10, P459, DOI [10.1111/J.1364-3703.2009.00546.X, 10.1111/j.1364-3703.2009.00546.x]; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; St-Pierre P, 2009, VIROLOGY, V383, P178, DOI 10.1016/j.virol.2008.11.008; Takeda A, 2005, EMBO J, V24, P3147, DOI 10.1038/sj.emboj.7600776; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Tsagris EM, 2008, CELL MICROBIOL, V10, P2168, DOI 10.1111/j.1462-5822.2008.01231.x; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Wang MB, 2004, P NATL ACAD SCI USA, V101, P3275, DOI 10.1073/pnas.0400104101; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474	71	59	62	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7539	10.1371/journal.pone.0007539	http://dx.doi.org/10.1371/journal.pone.0007539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19847296	Green Published, gold, Green Submitted			2022-12-25	WOS:000271013000015
J	Salomon, R; Malach, R; Lamy, D				Salomon, Roy; Malach, Rafael; Lamy, Dominique			Involvement of the Intrinsic/Default System in Movement-Related Self Recognition	PLOS ONE			English	Article							PERSPECTIVE-TAKING; FACE RECOGNITION; FUNCTIONAL NEUROANATOMY; PARIETAL CORTEX; DEFAULT MODE; HUMAN BRAIN; MOTOR; FMRI; AWARENESS; EMOTION	The question of how people recognize themselves and separate themselves from the environment and others has long intrigued philosophers and scientists. Recent findings have linked regions of the 'default brain' or 'intrinsic system' to self-related processing. We used a paradigm in which subjects had to rely on subtle sensory-motor synchronization differences to determine whether a viewed movement belonged to them or to another person, while stimuli and task demands associated with the "responded self" and "responded other" conditions were precisely matched. Self recognition was associated with enhanced brain activity in several ROIs of the intrinsic system, whereas no differences emerged within the extrinsic system. This self-related effect was found even in cases where the sensory-motor aspects were precisely matched. Control conditions ruled out task difficulty as the source of the differential self-related effects. The findings shed light on the neural systems underlying bodily self recognition.			Salomon, R (corresponding author), Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel.	royesal@gmail.com	Salomon, Roy/N-8249-2015	Salomon, Roy/0000-0002-6688-617X				AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Balslev D, 2006, NEUROIMAGE, V31, P308, DOI 10.1016/j.neuroimage.2005.11.037; Bermudez S.I., 2020, 10 HL LHC COLL M CER; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Bundick T, 2000, J NEUROL NEUROSUR PS, V68, P83, DOI 10.1136/jnnp.68.1.83; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Christensen MS, 2007, CEREB CORTEX, V17, P1906, DOI 10.1093/cercor/bhl101; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Damasio A, 2003, ANN NY ACAD SCI, V1001, P253, DOI 10.1196/annals.1279.014; Damasio A. R., 1999, FEELING WHAT HAPPENS; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Daprati E, 2000, NEUROCASE, V6, P477, DOI 10.1080/13554790008402718; David N, 2006, J COGNITIVE NEUROSCI, V18, P898, DOI 10.1162/jocn.2006.18.6.898; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Decety J, 2003, CONSCIOUS COGN, V12, P577, DOI 10.1016/S1053-8100(03)00076-X; Dennett D.C., 1991, CONSCIOUSNESS EXPLAI; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; FARRER C, 2007, CEREBRAL CORTEX; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gilboa A, 2004, CEREB CORTEX, V14, P1214, DOI 10.1093/cercor/bhh082; GOLDBERG I, CONSCIOUSNE IN PRESS; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Goldberg I, 2008, CONSCIOUS COGN, V17, P587, DOI 10.1016/j.concog.2007.10.003; GOLLAND Y, NEUROPSYCHOLOGIA; Golland Y, 2007, CEREB CORTEX, V17, P766, DOI 10.1093/cercor/bhk030; Green DM, 1966, SIGNAL DETECTION THE; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Heller R, 2007, NEUROIMAGE, V37, P1178, DOI 10.1016/j.neuroimage.2007.05.051; HUME D, 1978, 1739 TREATISE HUMAN; Jackson PL, 2004, CURR OPIN NEUROBIOL, V14, P259, DOI 10.1016/j.conb.2004.01.020; James W., 1890, PRINCIPLES PSYCHOL; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kircher TTJ, 2003, CONSCIOUS COGN, V12, P656, DOI 10.1016/S1053-8100(03)00071-0; Kircher TTJ, 2002, NEUROPSYCHOLOGIA, V40, P683, DOI 10.1016/S0028-3932(01)00138-5; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; LEIGUARDA R, 1993, J NEUROL NEUROSUR PS, V56, P788, DOI 10.1136/jnnp.56.7.788; Leube DT, 2003, CONSCIOUS COGN, V12, P597, DOI 10.1016/S1053-8100(03)00079-5; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; MacDonald PA, 2003, CEREB CORTEX, V13, P962, DOI 10.1093/cercor/13.9.962; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panksepp J, 2003, BRAIN COGNITION, V52, P4, DOI 10.1016/S0278-2626(03)00003-4; Platek SA, 2002, SCHIZOPHR RES, V57, P81, DOI 10.1016/S0920-9964(01)00310-3; Platek SM, 2004, COGNITIVE BRAIN RES, V19, P114, DOI 10.1016/j.cogbrainres.2003.11.014; POPE KS, 1976, REGULATION STREAM CO, P101; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Sala CMSD., 1998, COGN NEUROPSYCHIATRY, V3, P191, DOI [DOI 10.1080/135468098396143, 10.1080/135468098396143]; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Schubert T, 1998, NEUROREPORT, V9, P3171, DOI 10.1097/00001756-199810050-00009; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Sirigu A, 2004, NAT NEUROSCI, V7, P80, DOI 10.1038/nn1160; Spence SA, 2002, COGN NEUROPSYCHIATRY, P211, DOI 10.1080/13546800244000094; Spence SA, 1997, BRAIN, V120, P1997, DOI 10.1093/brain/120.11.1997; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; Tournoux P., 1988, COPLANAR STEREOTAXIC; Tsakiris M, 2005, COGNITION, V96, P215, DOI 10.1016/j.cognition.2004.08.002; Turk DJ, 2003, ANN NY ACAD SCI, V1001, P65, DOI 10.1196/annals.1279.005; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799	85	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7527	10.1371/journal.pone.0007527	http://dx.doi.org/10.1371/journal.pone.0007527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509JU	19844584	Green Published, gold			2022-12-25	WOS:000271013000010
J	Eryilmaz, J; Pan, P; Amaya, MF; Allali-Hassani, A; Dong, AP; Adams-Cioaba, MA; MacKenzie, F; Vedadi, M; Min, JR				Eryilmaz, Jitka; Pan, Patricia; Amaya, Maria F.; Allali-Hassani, Abdellah; Dong, Aiping; Adams-Cioaba, Melanie A.; MacKenzie, Farrell; Vedadi, Masoud; Min, Jinrong			Structural Studies of a Four-MBT Repeat Protein MBTD1	PLOS ONE			English	Article							POLYCOMB GROUP PROTEIN; METHYL-LYSINE-BINDING; HISTONE H3; TRANSCRIPTIONAL REPRESSOR; ZINC-FINGER; CHROMODOMAIN; RECOGNITION; L3MBTL1; DOMAINS; TUDOR	Background: The Polycomb group (PcG) of proteins is a family of important developmental regulators. The respective members function as large protein complexes involved in establishment and maintenance of transcriptional repression of developmental control genes. MBTD1, Malignant Brain Tumor domain-containing protein 1, is one such PcG protein. MBTD1 contains four MBT repeats. Methodology/Principal Findings: We have determined the crystal structure of MBTD1 (residues 130-566aa covering the 4 MBT repeats) at 2.5 angstrom resolution by X-ray crystallography. The crystal structure of MBTD1 reveals its similarity to another four-MBT-repeat protein L3MBTL2, which binds lower methylated lysine histones. Fluorescence polarization experiments confirmed that MBTD1 preferentially binds mono- and di-methyllysine histone peptides, like L3MBTL1 and L3MBTL2. All known MBT-peptide complex structures characterized to date do not exhibit strong histone peptide sequence selectivity, and use a "cavity insertion recognition mode" to recognize the methylated lysine with the deeply buried methyl-lysine forming extensive interactions with the protein while the peptide residues flanking methyl-lysine forming very few contacts [1]. Nevertheless, our mutagenesis data based on L3MBTL1 suggested that the histone peptides could not bind to MBT repeats in any orientation. Conclusions: The four MBT repeats in MBTD1 exhibits an asymmetric rhomboid architecture. Like other MBT repeat proteins characterized so far, MBTD1 binds mono- or dimethylated lysine histones through one of its four MBT repeats utilizing a semi-aromatic cage.			Eryilmaz, J (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	jr.min@utoronto.ca	Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130	CIHR Funding Source: Medline; Wellcome Trust Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Grimm C, 2007, EMBO REP, V8, P1031, DOI 10.1038/sj.embor.7401085; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; KALAKONDA N, 2008, ONCOGENE; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lechtenberg BC, 2009, PROTEIN SCI, V18, P657, DOI 10.1002/pro.51; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NADY N, 2008, TRENDS BIOCH SCI; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Santiveri CM, 2008, J MOL BIOL, V382, P1107, DOI 10.1016/j.jmb.2008.07.081; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Trojer P, 2009, J BIOL CHEM, V284, P8395, DOI 10.1074/jbc.M807818200; WISMAR J, 1995, MECH DEVELOP, V53, P141, DOI 10.1016/0925-4773(95)00431-9; Wismar J, 2001, FEBS LETT, V507, P119, DOI 10.1016/S0014-5793(01)02959-3; Wu SM, 2007, FEBS LETT, V581, P3289, DOI 10.1016/j.febslet.2007.06.025	28	45	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7274	10.1371/journal.pone.0007274	http://dx.doi.org/10.1371/journal.pone.0007274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841675	Green Published, Green Submitted, gold			2022-12-25	WOS:000271012900005
J	Yuen, RKC; Avila, L; Penaherrera, MS; von Dadelszen, P; Lefebvre, L; Kobor, MS; Robinson, WP				Yuen, Ryan K. C.; Avila, Luana; Penaherrera, Maria S.; von Dadelszen, Peter; Lefebvre, Louis; Kobor, Michael S.; Robinson, Wendy P.			Human Placental-Specific Epipolymorphism and its Association with Adverse Pregnancy Outcomes	PLOS ONE			English	Article							HUMAN GENE-EXPRESSION; DNA METHYLATION; HUMAN GENOME; GERMLINE EPIMUTATION; EPIGENETIC VARIATION; COLORECTAL-CANCER; ALLELIC VARIATION; PATTERNS; CELLS; VARIABILITY	Interindividual variation in DNA-methylation level is widespread in the human genome, despite its critical role in regulating gene expression. The nature of this variation, including its tissue-specific nature, and the role it may play in human phenotypic variation and disease is still poorly characterized. The placenta plays a critical role in regulating fetal growth and development in ways that have lifelong effects on health. To identify genes with a high degree of interindividual DNA methylation variation in the human placenta, we surveyed the human genome using the Illumina GoldenGate Methylation Cancer panel targeting 1505 CpG sites of 807 genes. While many sites show a continuous pattern of methylation levels, WNT2, TUSC3 and EPHB4 were identified to have a polymorphic "on-or-off'' pattern of DNA methylation variation at their promoter region which was confirmed by pyrosequencing. Methylation of these genes can be found in 7%-25% of over 100 placentas tested. The methylation state at the promoter of these genes is concordant with mRNA allelic expression. In three informative cases TUSC3 was observed to be methylated on the maternal allele, and it is thus possible this represents a polymorphically imprinted gene. Furthermore, TUSC3 promoter methylation showed evidence for association with preeclampsia. A biological significance of these methylation allelic polymorphisms (MAPs) to human placental diversity is further implied by their placental specificity and absence in mouse. An extended study of blood suggests that MAPs may also be found in other tissues, implicating their utility for tissue-specific association with complex disorders. The identification of such "epipolymorphism'' in other tissues and their use in association studies, should improve our understanding of interindividual phenotypic variability and complex disease susceptibility.			Yuen, RKC (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	wprobins@interchange.ubc.ca	Robinson, Wendy/AAB-6420-2020; von Dadelszen, Peter/AAP-7480-2021; Yuen, Ryan K. C./J-4876-2012; Robinson, Wendy P/I-9590-2014; Lefebvre, Louis/O-9309-2016	Robinson, Wendy/0000-0002-2010-6174; Yuen, Ryan K. C./0000-0001-7273-4968; Robinson, Wendy P/0000-0002-2010-6174; Lefebvre, Louis/0000-0001-5664-9480; von Dadelszen, Peter/0000-0003-4136-3070; Kobor, Michael/0000-0003-4140-1743	Canadian Institutes of Health Research [GMH-79041] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009; Busque L, 1996, BLOOD, V88, P59; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Cheung VG, 2008, AM J HUM GENET, V82, P1357, DOI 10.1016/j.ajhg.2008.05.003; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Constancia M, 2004, NATURE, V432, P53, DOI 10.1038/432053a; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Hachwell E, 2007, TRENDS GENET, V23, P588, DOI 10.1016/j.tig.2007.08.010; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; JINNO Y, 1994, NAT GENET, V6, P305, DOI 10.1038/ng0394-305; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; McMinn J, 2006, PLACENTA, V27, P119, DOI 10.1016/j.placenta.2004.12.003; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Novakovic B, 2008, MOL HUM REPROD, V14, P547, DOI 10.1093/molehr/gan046; Pak BJ, 1998, PLACENTA, V19, P483, DOI 10.1016/S0143-4004(98)91041-4; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Red-Horse K, 2005, DEVELOPMENT, V132, P4097, DOI 10.1242/dev.01971; Sandovici I, 2003, HUM MOL GENET, V12, P1569, DOI 10.1093/hmg/ddg167; Sandovici I, 2005, HUM MOL GENET, V14, P2135, DOI 10.1093/hmg/ddi218; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Sontia Bruno, 2007, Pathophysiology, V14, P205, DOI 10.1016/j.pathophys.2007.09.005; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Spencer HG, 2000, ANNU REV GENET, V34, P457, DOI 10.1146/annurev.genet.34.1.457; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542; Yan H, 2004, CURR OPIN ONCOL, V16, P39, DOI 10.1097/00001622-200401000-00008; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	45	57	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7389	10.1371/journal.pone.0007389	http://dx.doi.org/10.1371/journal.pone.0007389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838307	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000270880900001
J	Gonzalez, MA; Baraloto, C; Engel, J; Mori, SA; Petronelli, P; Riera, B; Roger, A; Thebaud, C; Chave, J				Gonzalez, Mailyn Adriana; Baraloto, Christopher; Engel, Julien; Mori, Scott A.; Petronelli, Pascal; Riera, Bernard; Roger, Aurelien; Thebaud, Christophe; Chave, Jerome			Identification of Amazonian Trees with DNA Barcodes	PLOS ONE			English	Article							LAND PLANTS; FOREST; COMMUNITY; DIVERSITY; EVOLUTION; REGIONS; LIFE; CHLOROPLAST; ACCURATE; TAXONOMY	Background: Large-scale plant diversity inventories are critical to develop informed conservation strategies. However, the workload required for classic taxonomic surveys remains high and is particularly problematic for megadiverse tropical forests. Methodology/Principal Findings: Based on a comprehensive census of all trees in two hectares of a tropical forest in French Guiana, we examined whether plant DNA barcoding could contribute to increasing the quality and the pace of tropical plant biodiversity surveys. Of the eight plant DNA markers we tested (rbcLa, rpoC1, rpoB, matK, ycf5, trnL, psbA-trnH, ITS), matK and ITS had a low rate of sequencing success. More critically, none of the plastid markers achieved a rate of correct plant identification greater than 70%, either alone or combined. The performance of all barcoding markers was noticeably low in few species-rich clades, such as the Laureae, and the Sapotaceae. A field test of the approach enabled us to detect 130 molecular operational taxonomic units in a sample of 252 juvenile trees. Including molecular markers increased the identification rate of juveniles from 72% (morphology alone) to 96% (morphology and molecular) of the individuals assigned to a known tree taxon. Conclusion/Significance: We conclude that while DNA barcoding is an invaluable tool for detecting errors in identifications and for identifying plants at juvenile stages, its limited ability to identify collections will constrain the practical implementation of DNA-based tropical plant biodiversity programs.			Gonzalez, MA (corresponding author), Univ Toulouse 3, Lab Evolut & Divers Biol, F-31062 Toulouse, France.	chave@cict.fr	Thébaud, Christophe/N-3916-2016; RIERA, Bernard/ABG-1318-2020; Baraloto, Christopher/ABG-2500-2020; 赵, 鹏/B-8401-2009	Thébaud, Christophe/0000-0002-8586-1234; RIERA, Bernard/0000-0002-5320-9671; Baraloto, Christopher/0000-0001-7322-8581; Engel, Julien/0000-0002-8078-9309				Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0812297106, 10.1073/pnas.0905845106]; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; BONGERS F, 2001, NOURAGUES DYNAMICS P; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Chanderbali AS, 2001, ANN MO BOT GARD, V88, P104, DOI 10.2307/2666133; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Couvreur TLP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-54; de Castilho CV, 2006, BIOTROPICA, V38, P555, DOI 10.1111/j.1744-7429.2006.00172.x; Deguilloux MF, 2002, P ROY SOC B-BIOL SCI, V269, P1039, DOI 10.1098/rspb.2002.1982; Devey DS, 2009, TAXON, V58, P7, DOI 10.1002/tax.581003; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Friar EA, 2005, METHOD ENZYMOL, V395, P3; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hubbell SP, 2008, P NATL ACAD SCI USA, V105, P11498, DOI 10.1073/pnas.0801915105; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2008, BIOTROPICA, V40, P405, DOI 10.1111/j.1744-7429.2008.00426.x; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Linder HP, 2008, PHILOS T R SOC B, V363, P3097, DOI 10.1098/rstb.2008.0075; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; MORI SA, 1987, ANN MO BOT GARD, V74, P321, DOI 10.2307/2399402; Mori SA, 2007, AM J BOT, V94, P289, DOI 10.3732/ajb.94.3.289; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Pitman NCA, 2008, BIOTROPICA, V40, P525, DOI 10.1111/j.1744-7429.2008.00424.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; SMITH N, 2004, FLOWERING PLANTS NEO; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Swenson U, 2005, CLADISTICS, V21, P101, DOI 10.1111/j.1096-0031.2005.00056.x; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011	65	160	180	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7483	10.1371/journal.pone.0007483	http://dx.doi.org/10.1371/journal.pone.0007483			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834612	Green Published, gold			2022-12-25	WOS:000270880700009
J	Rhodes, P; Craigon, J; Gray, C; Rhind, SM; Loughna, PT; Gardner, DS				Rhodes, Philip; Craigon, Jim; Gray, Clint; Rhind, Stuart M.; Loughna, Paul T.; Gardner, David S.			Adult-Onset Obesity Reveals Prenatal Programming of Glucose-Insulin Sensitivity in Male Sheep Nutrient Restricted during Late Gestation	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; CATCH-UP GROWTH; DUTCH FAMINE; MATERNAL UNDERNUTRITION; DIETARY RESTRICTION; METABOLIC SYNDROME; SKELETAL-MUSCLE; BLOOD-PRESSURE; LATER LIFE; EXPOSURE	Background: Obesity invokes a range of metabolic disturbances, but the transition from a poor to excessive nutritional environment may exacerbate adult metabolic dysfunction. The current study investigated global maternal nutrient restriction during early or late gestation on glucose tolerance and insulin sensitivity in the adult offspring when lean and obese. Methods/Principal Findings: Pregnant sheep received adequate (1.0M; CE, n = 6) or energy restricted (0.7M) diet during early (1-65 days; LEE, n = 6) or late (65-128 days; LEL, n = 7) gestation ( term,147 days). Subsequent offspring remained on pasture until 1.5 years when all received glucose and insulin tolerance tests (GTT & ITT) and body composition determination by dual energy x-ray absorptiometry (DXA). All animals were then exposed to an obesogenic environment for 6-7 months and all protocols repeated. Prenatal dietary treatment had no effect on birth weight or on metabolic endpoints when animals were 'lean' ( 1.5 years). Obesity revealed generalised metabolic 'inflexibility' and insulin resistance; characterised by blunted excursions of plasma NEFA and increased insulin(AUC) ( from 133 to 341 [s.e.d. 26] ng.ml(-1).120 mins) during a GTT, respectively. For LEL vs. CE, the peak in plasma insulin when obese was greater (7.8 vs. 4.7 [s.e.d.1.1] ng.ml(-1)) and was exacerbated by offspring sex (i.e. 9.8 vs. 4.4 [s.e.d. 1.16] ng. ml(-1); LEL male vs. CE male, respectively). Acquisition of obesity also significantly influenced the plasma lipid and protein profile to suggest, overall, greater net lipogenesis and reduced protein metabolism. Conclusions: This study indicates generalised metabolic dysfunction with adult-onset obesity which also exacerbates and 'reveals' programming of glucose-insulin sensitivity in male offspring prenatally exposed to maternal undernutrition during late gestation. Taken together, the data suggest that metabolic function appears little compromised in young prenatally 'programmed' animals so long as weight is adequately controlled. Nutritional excess in adulthood exacerbates any programmed phenotype, indicating greater vigilance over weight control is required for those individuals exposed to nutritional thrift during gestation.			Rhodes, P (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Loughborough, England.	david.gardner@nottingham.ac.uk	Loughna, Paul/B-7918-2012; Biguzzi, Felipe A/E-4724-2015; Gardner, David S/A-7484-2010	Gardner, David S/0000-0002-6490-2412; Loughna, Paul/0000-0002-5162-9613; Craigon, Jim/0000-0003-4570-5138				Alderman G., 1993, EN PROT REQ RUM ADV; Allender S, 2007, OBES REV, V8, P467, DOI 10.1111/j.1467-789X.2007.00394.x; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BERGMAN EN, 1989, AM J PHYSIOL, V257, pE772, DOI 10.1152/ajpendo.1989.257.5.E772; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; BROCKMAN RP, 1975, AM J PHYSIOL, V229, P1338, DOI 10.1152/ajplegacy.1975.229.5.1338; Budge H, 2008, FASEB J, V22; Chevalier S, 2006, DIABETES, V55, P675, DOI 10.2337/diabetes.55.03.06.db05-1117; Cleal JK, 2007, P NATL ACAD SCI USA, V104, P9529, DOI 10.1073/pnas.0610373104; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Daniel ZCTR, 2007, J ANIM SCI, V85, P1565, DOI 10.2527/jas.2006-743; Delavaud C, 2000, J ENDOCRINOL, V165, P519, DOI 10.1677/joe.0.1650519; Demetrius L, 2004, J GERONTOL A-BIOL, V59, P902, DOI 10.1093/gerona/59.9.B902; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Dodic M, 2001, CIRC RES, V89, P623, DOI 10.1161/hh1901.097086; Dulloo AG, 2008, BEST PRACT RES CL EN, V22, P155, DOI 10.1016/j.beem.2007.08.001; ELMES MJ, 2008, BR J NUTR, P1; Fahey AJ, 2005, J ANIM SCI, V83, P2330; Fahey AJ, 2005, J ANIM SCI, V83, P2564; FESTING MFW, 2004, DESIGN ANIMAL EXPT R; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Gardner DS, 2007, CURR DRUG TARGETS, V8, P894; Gardner DS, 2005, AM J PHYSIOL-REG I, V289, pR947, DOI 10.1152/ajpregu.00120.2005; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gopalakrishnan GS, 2004, AM J PHYSIOL-REG I, V287, pR12, DOI 10.1152/ajpregu.00687.2003; Gower BA, 2002, J CLIN ENDOCR METAB, V87, P2218, DOI 10.1210/jc.87.5.2218; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HAMMOND JJ, 1976, HAMMONDS FARM ANIMAL; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Kim SP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1581, DOI 10.1152/ajpendo.00351.2006; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; McMullen S, 2005, HYPERTENSION, V46, P1374, DOI 10.1161/01.HYP.0000188702.96256.46; Norton L, 2007, ACTA PHYSIOL, V189, P233, DOI 10.1111/j.1748-1716.2006.01639.x; Ojeda NB, 2007, HYPERTENSION, V50, P679, DOI 10.1161/HYPERTENSIONAHA.107.091785; Owens JA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1879, DOI 10.1152/ajpendo.00706.2006; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Ozanne SE, 2005, DIABETOLOGIA, V48, P547, DOI 10.1007/s00125-005-1669-7; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Phelan JP, 2005, AGEING RES REV, V4, P339, DOI 10.1016/j.arr.2005.06.001; Poore KR, 2007, AM J PHYSIOL-ENDOC M, V292, pE32, DOI 10.1152/ajpendo.00253.2006; Poore KR, 2002, DIABETOLOGIA, V45, P1247, DOI 10.1007/s00125-002-0849-y; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; ROBINSON JJ, 1983, FEEDING EWE MILTON K; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Roseboom TJ, 2000, HEART, V84, P595, DOI 10.1136/heart.84.6.595; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Sasaki S., 2002, Animal Science Journal, V73, P423, DOI 10.1046/j.1344-3941.2002.00059.x; Saver AA, 2004, AM J CLIN NUTR, V80, P199; Sebert SP, 2009, ENDOCRINOLOGY, V150, P634, DOI 10.1210/en.2008-0542; SEBERT SP, 2008, ENDOCRINOLOGY; Sinclair KD, 2008, REPROD BIOMED ONLINE, V16, P859, DOI 10.1016/S1472-6483(10)60153-8; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Wells JCK, 2006, INT J OBESITY, V30, P1506, DOI 10.1038/sj.ijo.0803402; Williams PJ, 2007, KIDNEY INT, V72, P279, DOI 10.1038/sj.ki.5002276	63	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7393	10.1371/journal.pone.0007393	http://dx.doi.org/10.1371/journal.pone.0007393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826474	Green Published, gold			2022-12-25	WOS:000270808700001
J	Robinson, JP; VanBrocklin, MW; Guilbeault, AR; Signorelli, DL; Brandner, S; Holmen, SL				Robinson, J. P.; VanBrocklin, M. W.; Guilbeault, A. R.; Signorelli, D. L.; Brandner, S.; Holmen, S. L.			Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation	ONCOGENE			English	Article						glioma; BRAF; KRas; Akt; Ink4a; Arf	SPINDLE-CELL GLIOBLASTOMA; LEUKOSIS-SARCOMA VIRUSES; CENTRAL-NERVOUS-SYSTEM; B-RAF GENE; PROTEIN-KINASE; NEGATIVE REGULATION; PATHWAY ACTIVATION; NEURAL PROGENITORS; TUMOR SUPPRESSION; CYCLE ARREST	Mutations in receptor tyrosine kinase (RTK) growth factor receptors (epidermal growth factor receptor, platelet-derived growth factor receptor, MET and ERBB2), which result in downstream activation of the RAS/RAF/MEK/ERK mitogen-activated protein kinase (MAPK) pathway and PI(3)K/Akt pathway, are found in almost all high-grade gliomas and MAPK signaling is necessary for continued glioma maintenance. In addition, BRAF is mutated in the majority of low-grade gliomas and its expression and activity is significantly increased in the majority of high-grade gliomas. Although the importance of RTKs and RAS signaling in glioma development has been shown, the role of BRAF has yet to be characterized. We evaluated the effect of activated BRAF in glioma formation using the retroviral replication-competent avian leukosis virus long terminal repeat, splice acceptor (RCAS)/TVA system to transfer genes encoding activated forms of BRAF, KRas, Akt and Cre to nestin-expressing neural progenitor cells in Ink4a/Arf(lox/lox) mice in vivo. Although expression of activated BRAF alone is not sufficient for tumorigenesis, the combination of activated BRAF and Akt or BRAF with Ink4a/Arf loss is transforming. Interestingly, activated BRAF generates gliomas with characteristics similar to activated KRas in the context of Akt but not Ink4a/Arf loss. Our studies show a role for BRAF activation and signaling in glioma development and as potential target for glioma therapy. Oncogene (2010) 29, 335-344; doi:10.1038/onc.2009.333; published online 26 October 2009	[Robinson, J. P.; VanBrocklin, M. W.; Guilbeault, A. R.; Signorelli, D. L.; Holmen, S. L.] Nevada Canc Inst, Drug Dev Dept, Las Vegas, NV 89135 USA; [Brandner, S.] UCL, Inst Neurol, Dept Neurogenerat Dis, Div Neuropathol, London, England	University of California System; University of California San Diego; University of London; University College London	Holmen, SL (corresponding author), Nevada Canc Inst, Drug Dev Dept, 1 Breakthrough Way,Lab 3, Las Vegas, NV 89135 USA.	sholmen@nvcancer.org	Brandner, Sebastian/J-4562-2014	Brandner, Sebastian/0000-0002-9821-0342; Robinson, James/0000-0002-6585-0116	Nevada Cancer Institute; National Brain Tumor Foundation; American Cancer Society [RSG-06-198-01-TBE]; NATIONAL CANCER INSTITUTE [R01CA121118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073870, R01NS075155] Funding Source: NIH RePORTER	Nevada Cancer Institute(University of California System); National Brain Tumor Foundation; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Nevada Cancer Institute, the National Brain Tumor Foundation, and RSG-06-198-01-TBE from the American Cancer Society. We thank Nick Henderson and Robert Kirsh for animal husbandry. We also thank Eric Holland, Martin McMahon, and Ronald DePinho for the reagents. SLH designed the research; JPR, MWV and SLH performed the research; SB performed the pathological analysis; DLS and ARG provided technical support; JPR and SLH prepared the images and wrote the paper.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; BARNIER JV, 1995, J BIOL CHEM, V270, P23381, DOI 10.1074/jbc.270.40.23381; Basto D, 2005, ACTA NEUROPATHOL, V109, P207, DOI 10.1007/s00401-004-0936-x; Bromberg-White JL, 2004, J VIROL, V78, P4914, DOI 10.1128/JVI.78.9.4914-4916.2004; Chin L, 1998, TRENDS BIOCHEM SCI, V23, P291, DOI 10.1016/S0968-0004(98)01236-5; Chong H, 2001, EMBO J, V20, P3716, DOI 10.1093/emboj/20.14.3716; DAHLSTRAND J, 1992, CANCER RES, V52, P5334; Dai C, 2003, CANCER J, V9, P72, DOI 10.1097/00130404-200303000-00002; Dai CK, 2005, NEOPLASIA, V7, P397, DOI 10.1593/neo.04691; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Guan KL, 2000, J BIOL CHEM, V275, P27354; HAMEL W, 1993, J NEURO-ONCOL, V16, P159, DOI 10.1007/BF01324703; Hill JR, 1999, ARCH NEUROL-CHICAGO, V56, P439, DOI 10.1001/archneur.56.4.439; Hmitou I, 2007, MOL CELL BIOL, V27, P31, DOI 10.1128/MCB.01265-06; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Holland EC, 1998, GENE DEV, V12, P3644, DOI 10.1101/gad.12.23.3644; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Holmen SL, 1999, J VIROL, V73, P10051, DOI 10.1128/JVI.73.12.10051-10060.1999; Holmen SL, 2005, CANCER RES, V65, P8250, DOI 10.1158/0008-5472.CAN-05-1173; Hu XY, 2005, NEOPLASIA, V7, P356, DOI 10.1593/neo.04595; Jeuken J, 2007, ACTA NEUROPATHOL, V114, P121, DOI 10.1007/s00401-007-0239-0; Jones DTW, 2009, ONCOGENE, V28, P2119, DOI 10.1038/onc.2009.73; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; JONES H, 1991, NEUROPATH APPL NEURO, V17, P177, DOI 10.1111/j.1365-2990.1991.tb00713.x; KLEIHUES P, 1993, BRAIN PATHOL, V3, P255, DOI 10.1111/j.1750-3639.1993.tb00752.x; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lyustikman Y, 2008, NEOPLASIA, V10, P501, DOI 10.1593/neo.08206; Marino S, 2000, GENE DEV, V14, P994; Mizoguchi M, 2004, BRAIN PATHOL, V14, P372, DOI 10.1111/j.1750-3639.2004.tb00080.x; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; PAULUS W, 1992, NEUROPATH APPL NEURO, V18, P207; Pfister S, 2008, J CLIN INVEST, V118, P1739, DOI 10.1172/JCI33656; Pritchard CA, 1996, CURR BIOL, V6, P614, DOI 10.1016/S0960-9822(02)00548-1; QUELLE DE, 1995, CELL, V83, P993; Reis RM, 2000, AM J PATHOL, V156, P425, DOI 10.1016/S0002-9440(10)64746-3; Riemenschneider MJ, 2006, CANCER RES, V66, P5618, DOI 10.1158/0008-5472.CAN-06-0364; Roussel MF, 1999, ONCOGENE, V18, P5311, DOI 10.1038/sj.onc.1202998; Schaefer-Klein J, 1998, VIROLOGY, V248, P305, DOI 10.1006/viro.1998.9291; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; SMITH EJ, 1979, AVIAN DIS, V23, P698, DOI 10.2307/1589746; STANTON VP, 1989, MOL CELL BIOL, V9, P639, DOI 10.1128/MCB.9.2.639; Uhrbom L, 2005, CANCER RES, V65, P2065, DOI 10.1158/0008-5472.CAN-04-3588; Uhrbom L, 2002, CANCER RES, V62, P5551; VanBrocklin MW, 2009, CANCER RES, V69, P1985, DOI 10.1158/0008-5472.CAN-08-3934; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Wojnowski L, 1997, NAT GENET, V16, P293, DOI 10.1038/ng0797-293; Wojnowski L, 1998, MECH DEVELOP, V76, P141, DOI 10.1016/S0925-4773(98)00111-7	51	63	68	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2010	29	3					335	344		10.1038/onc.2009.333	http://dx.doi.org/10.1038/onc.2009.333			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	546EO	19855433	Green Accepted			2022-12-25	WOS:000273793200003
J	Zheng, HY; Nagaraja, GM; Kaur, P; Asea, EE; Asea, A				Zheng, Hongying; Nagaraja, Ganachari M.; Kaur, Punit; Asea, Edwina E.; Asea, Alexzander			Chaperokine Function of Recombinant Hsp72 Produced in Insect Cells Using a Baculovirus Expression System Is Retained	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; TOLL-LIKE RECEPTORS; TUMOR-NECROSIS-FACTOR; IMMUNE-RESPONSE; MURINE MACROPHAGES; CANCER-IMMUNOTHERAPY; ANTIGEN PRESENTATION; EXTRACELLULAR HSP72; PEPTIDE COMPLEXES; ADAPTIVE IMMUNITY	Extracellular heat shock protein 72 (Hsp72; inducible form of the 70-kDa heat shock protein) plays a critical role in innate and adaptive immune responses and has shown promise as an ideal adjuvant for the optimization of antigen-specific anti-tumor vaccines. Recent studies suggest that to correctly elucidate the mechanisms by which Hsp72 exerts its beneficial effects in vitro, great care must be taken to ensure that endotoxin by-products do not invalidate the findings. In this study, we have taken advantage of the baculovirus expression vector system for production of endotoxin-free recombinant Hsp72. The coding sequence of human hsp72 was recombined into the baculovirus immediately downstream of the strong polyhedron gene promoter. Ninety-six h post-infection of Sf9 insect cells with recombinant baculovirus, maximal levels of Hsp72 protein were detected. The recombinant human Hsp72 was purified by affinity chromatography from insect cells, and purity was confirmed by SDS-PAGE and mass spectrometry. The purified human recombinant Hsp72(bv) (Hsp72 produced using the BEVS) was demonstrated to have no endotoxin contamination and was shown to have stimulated potent calcium flux in the human monocytic cell line. Furthermore, recombinant Hsp72(bv) enhanced the tolerance of neuroblastoma cells to heat stress-induced cell death and displayed classical chaperokine functions including augmentation of inflammatory cytokine productions in mouse splenocytes. The production of functional, endotoxin-free recombinant human Hsp72(bv) in insect cells is inexpensive and convenient and eliminates the need of special procedures for endotoxin depletion. Endotoxin-free recombinant human Hsp72(bv) can now be used to unlock the important role Hsp72 plays in modulating immune function.	[Asea, Alexzander] Scott & White Mem Hosp & Clin, Div Investigat Pathol, Temple, TX 76508 USA; Texas A&M Hlth Sci Ctr, Coll Med, Temple, TX 76508 USA	Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Asea, A (corresponding author), 1901 S 1st St,Bldg 205, Temple, TX 76508 USA.	aasea@swmail.sw.org	Asea, Alexzander/X-6432-2019; Asea, Alexzander A/I-4112-2013	Asea, Alexzander A/0000-0003-3592-3481	National Institutes of Health [RO1CA91889]; Scott & White Memorial Hospital and Clinic; TX A& M Health Science Center College of Medicine; Central Texas Veterans Health Administration; Cain Foundation; NATIONAL CANCER INSTITUTE [R01CA091889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scott & White Memorial Hospital and Clinic; TX A& M Health Science Center College of Medicine; Central Texas Veterans Health Administration; Cain Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant RO1CA91889. This work was also supported by institutional support from Scott & White Memorial Hospital and Clinic, TX A& M Health Science Center College of Medicine, the Central Texas Veterans Health Administration, and an endowment from the Cain Foundation (to A. A.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Asea A, 2000, CELL STRESS CHAPERON, V5, P425, DOI 10.1379/1466-1268(2000)005<0425:HPBAPN>2.0.CO;2; Asea A, 2002, J BIOL CHEM, V277, P15028, DOI 10.1074/jbc.M200497200; Asea A, 2005, EXERC IMMUNOL REV, V11, P34; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Asea A, 2008, NOVART FDN SYMP, V291, P179; Asea Alexzander, 2008, V183, P111; Asea Alexzander, 2006, Current Immunology Reviews, V2, P209, DOI 10.2174/157339506778018514; Asea Alexzander, 2008, Novartis Found Symp, V291, P173; Asea Alexzander A. A., 2007, V1, P3; Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO;2-C; Bendz H, 2007, J BIOL CHEM, V282, P31688, DOI 10.1074/jbc.M704129200; Calderwood SK, 2005, EUR J IMMUNOL, V35, P2518, DOI 10.1002/eji.200535002; Castelli C, 2004, CANCER IMMUNOL IMMUN, V53, P227, DOI 10.1007/s00262-003-0481-9; Gao BC, 2004, BIOCHEM BIOPH RES CO, V317, P1149, DOI 10.1016/j.bbrc.2004.03.160; Gao BC, 2003, J BIOL CHEM, V278, P22523, DOI 10.1074/jbc.M303161200; Gao BC, 2003, J BIOL CHEM, V278, P174, DOI 10.1074/jbc.M208742200; Guzhova I, 2001, BRAIN RES, V914, P66, DOI 10.1016/S0006-8993(01)02774-3; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Johnson JD, 2005, J APPL PHYSIOL, V99, P1789, DOI 10.1152/japplphysiol.00390.2005; Kaur P, 2010, HEAT SHOCK PROTEINS, V4, P153, DOI 10.1007/978-90-481-2976-8_8; Lehner T, 2000, EUR J IMMUNOL, V30, P594, DOI 10.1002/1521-4141(200002)30:2<594::AID-IMMU594>3.3.CO;2-T; Li ZH, 2002, CURR OPIN IMMUNOL, V14, P45, DOI 10.1016/S0952-7915(01)00297-7; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; MacAry PA, 2004, IMMUNITY, V20, P95, DOI 10.1016/S1074-7613(03)00357-1; MAGGI E, 1992, J IMMUNOL, V148, P2142; Manjili MH, 2004, EXPERT OPIN BIOL TH, V4, P363, DOI 10.1517/14712598.4.3.363; MCLEISH KR, 1989, INFLAMMATION, V13, P681, DOI 10.1007/BF00914312; Menoret A, 2004, METHODS, V32, P7, DOI 10.1016/S1046-2023(03)00180-4; Noessner E, 2002, J IMMUNOL, V169, P5424, DOI 10.4049/jimmunol.169.10.5424; Panjwani NN, 2002, J IMMUNOL, V168, P2997, DOI 10.4049/jimmunol.168.6.2997; Pockley AG, 2003, LANCET, V362, P469, DOI 10.1016/S0140-6736(03)14075-5; Possee RD., 1992, BACULOVIRUS EXPRESSI; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Srivastava PK, 1998, IMMUNITY, V8, P657, DOI 10.1016/S1074-7613(00)80570-1; SRIVASTAVA PK, 1994, EXPERIENTIA, V50, P1054, DOI 10.1007/BF01923461; SRIVASTAVA PK, 1994, CURR OPIN IMMUNOL, V6, P728, DOI 10.1016/0952-7915(94)90076-0; SRIVASTAVA PK, 1994, IMMUNOGENETICS, V39, P93; Summers MD, 2006, ADV VIRUS RES, V68, P3, DOI 10.1016/S0065-3527(06)68001-9; SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2; Takakura Y, 2007, CURR OPIN MOL THER, V9, P385; Vabulas RM, 2002, J BIOL CHEM, V277, P15107, DOI 10.1074/jbc.M111204200; Vabulas RM, 2002, CURR TOP MICROBIOL, V270, P169; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Ye ZY, 2007, J BIOL CHEM, V282, P4479, DOI 10.1074/jbc.M606802200	48	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					349	356		10.1074/jbc.M109.024612	http://dx.doi.org/10.1074/jbc.M109.024612			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19861412	hybrid, Green Published			2022-12-25	WOS:000273070100036
J	Cardarelli, F; Bizzarri, R; Serresi, M; Albertazzi, L; Beltram, F				Cardarelli, Francesco; Bizzarri, Ranieri; Serresi, Michela; Albertazzi, Lorenzo; Beltram, Fabio			Probing Nuclear Localization Signal-Importin alpha Binding Equilibria in Living Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE-RICH MOTIF; PROTEIN IMPORT; IN-VIVO; TRANSPORT-PROPERTIES; FLUORESCENT PROTEIN; BETA; RAN; RECOGNITION; SEQUENCE; IDENTIFICATION	The regulated process of protein import into the nucleus of a eukaryotic cell is mediated by specific nuclear localization signals (NLSs) that are recognized by protein-import receptors. In this study, we present fluorescence-based methods to quantitatively address the physicochemical details of NLS recognition by the receptor protein importin alpha (Imp alpha) in living cells. First, by combining fluorescence recovery after photobleaching measurements and protein-concentration calibration, we quantitatively define nuclear import saturability and afford an affinity value for NLS-Imp alpha binding. Second, by fluorescence lifetime imaging microscopy, we directly monitor the occurrence of NLS-Imp alpha interaction and measure its effective dissociation constant (K-D) in the actual cellular environment. Our kinetic and thermodynamic analyses independently indicate that the subsaturation of Imp alpha with the expressed NLS cargo regulates nuclear import rates in living cells, in contrast to what can be predicted on the basis of available in vitro data. Finally, our experiments also provide evidence for the regulation of nuclear import mediated by the intrasteric importin beta-binding domain of Imp alpha and yield the first estimate of its autoinhibition energy in living cells.	[Cardarelli, Francesco; Bizzarri, Ranieri; Serresi, Michela; Albertazzi, Lorenzo; Beltram, Fabio] Scuola Normale Super Pisa, I-56126 Pisa, Italy; [Cardarelli, Francesco; Bizzarri, Ranieri; Serresi, Michela; Albertazzi, Lorenzo; Beltram, Fabio] CNR, Ist Nazl Fis Mat, I-56126 Pisa, Italy; [Bizzarri, Ranieri; Serresi, Michela; Albertazzi, Lorenzo; Beltram, Fabio] Ctr Nanotechnol Innovat, IIT NEST, I-56126 Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); Istituto Italiano di Tecnologia - IIT	Cardarelli, F (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Fluorescence Dynam Lab, Irvine, CA 92697 USA.	f.cardarelli@sns.it	Beltram, Fabio/F-2920-2013; Bizzarri, Ranieri/H-1779-2011; Beltram, Fabio/L-9486-2019; Bizzarri, Ranieri/ABH-8343-2020; Albertazzi, Lorenzo/E-8323-2013	Beltram, Fabio/0000-0002-6081-436X; Bizzarri, Ranieri/0000-0002-8222-2672; Beltram, Fabio/0000-0002-6081-436X; Albertazzi, Lorenzo/0000-0002-6837-0812	Italian Ministry for University and Research under the framework of "Fondo per gli Investimenti della Ricerca di Base" [RBLA03ER38]	Italian Ministry for University and Research under the framework of "Fondo per gli Investimenti della Ricerca di Base"	This work was partially supported by the Italian Ministry for University and Research under the framework of "Fondo per gli Investimenti della Ricerca di Base" Project RBLA03ER38.	Albertazzi L, 2009, PHOTOCHEM PHOTOBIOL, V85, P287, DOI 10.1111/j.1751-1097.2008.00435.x; Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Brown CM, 2008, J MICROSC-OXFORD, V229, P78, DOI 10.1111/j.1365-2818.2007.01871.x; Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Ciciarello M, 2004, J CELL SCI, V117, P6511, DOI 10.1242/jcs.01569; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Floer M, 1997, J BIOL CHEM, V272, P19538, DOI 10.1074/jbc.272.31.19538; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x; Harreman MT, 2003, J BIOL CHEM, V278, P5854, DOI 10.1074/jbc.M210951200; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Hu W, 1999, J BIOL CHEM, V274, P15820, DOI 10.1074/jbc.274.22.15820; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Miyamoto Y, 2002, EMBO J, V21, P5833, DOI 10.1093/emboj/cdf569; PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0; Percipalle P, 1999, J MOL BIOL, V292, P263, DOI 10.1006/jmbi.1999.3077; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Riddick G, 2005, J CELL BIOL, V168, P1027, DOI 10.1083/jcb.200409024; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Schwoebel ED, 2002, J CELL BIOL, V157, P963, DOI 10.1083/jcb.200111077; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370	31	34	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36638	36646		10.1074/jbc.M109.036699	http://dx.doi.org/10.1074/jbc.M109.036699			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19858191	Green Published, hybrid			2022-12-25	WOS:000272970500064
J	Duc, C; Cellier, F; Lobreaux, S; Briat, JF; Gaymard, F				Duc, Celine; Cellier, Francoise; Lobreaux, Stephane; Briat, Jean-Francois; Gaymard, Frederic			Regulation of Iron Homeostasis in Arabidopsis thaliana by the Clock Regulator Time for Coffee	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISRUPTS CIRCADIAN-RHYTHMS; GENE-EXPRESSION; FERRITIN GENE; OXIDATIVE STRESS; SOUTHERN-OCEAN; PLANT-GROWTH; PROTEIN; TRANSCRIPTION; LIGHT; DEGRADATION	In plants, iron homeostasis is tightly regulated to supply sufficient amounts of this metal for an optimal growth while preventing excess accumulation to avoid oxidative stress. To identify new regulators of iron homeostasis, a luciferase-based genetic screen using the Arabidopsis AtFer1 ferritin promoter as a target was developed. This screen identified TIME FOR COFFEE(TIC) as a regulator of AtFer1 gene expression. TIC was previously described as a nuclear regulator of the circadian clock. Mutants in the TIC gene exhibited a chlorotic phenotype rescued by exogenous iron addition and are hypersensitive to iron during the early stages of development. We showed that iron overload-responsive genes are regulated by TIC and by the central oscillator of the circadian clock. TIC represses their expression under low iron conditions, and its activity requires light and light/dark cycles. Regarding AtFer1, this repression is independent of the previously characterized cis-acting element iron-dependent regulatory sequence, known to be involved in AtFer1 repression. These results showed that the regulation of iron homeostasis in plants is a major output of the TIC-and central oscillator-dependent signaling pathways.	[Duc, Celine; Cellier, Francoise; Briat, Jean-Francois; Gaymard, Frederic] Univ Montpellier 2, Inst Natl Rech Agron, CNRS, Lab Biochim & Physiol Mol Plantes,UMR 5004, F-34060 Montpellier 1, France; [Lobreaux, Stephane] Univ Grenoble 1, Ctr Rech Macromol Organisees, Lab Plastes & Differenciat Cellulaire, F-38041 Grenoble 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Gaymard, F (corresponding author), 2 Pl Viala, F-34060 Montpellier 1, France.	gaymard@supagro.inra.fr	duc, celine/F-1372-2015	duc, celine/0000-0001-7426-4541	Institut National de la Recherche Agronomique; CNRS; Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche [BCMS166]	Institut National de la Recherche Agronomique; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	This work was supported by the Institut National de la Recherche Agronomique, the CNRS, and Action Concertee Incitative "Biologie Cellulaire Moleculaire et Structurale" Grant BCMS166 from the Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche.	Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Arnaud N, 2006, J BIOL CHEM, V281, P23579, DOI 10.1074/jbc.M602135200; Baena-Gonzalez E, 2008, TRENDS PLANT SCI, V13, P474, DOI 10.1016/j.tplants.2008.06.006; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Baruah A, 2009, PLANT J, V60, P22, DOI 10.1111/j.1365-313X.2009.03935.x; Baruah A, 2009, PLANT MOL BIOL, V70, P547, DOI 10.1007/s11103-009-9491-0; Beinert H, 1978, Methods Enzymol, V54, P435; Bhalerao RP, 1999, P NATL ACAD SCI USA, V96, P5322, DOI 10.1073/pnas.96.9.5322; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; BRIAT J, 2005, IRON NUTR PLANTS RHI; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; Briat JF, 2010, ANN BOT-LONDON, V105, P811, DOI 10.1093/aob/mcp128; Briat JF, 1995, BIOL CELL, V84, P69, DOI 10.1016/0248-4900(96)81320-7; CADENAS E, 1989, ANNU REV BIOCHEM, V58, P79, DOI 10.1146/annurev.bi.58.070189.000455; Carre IA, 2002, J EXP BOT, V53, P1551, DOI 10.1093/jxb/erf027; Cassar N, 2007, SCIENCE, V317, P1067, DOI 10.1126/science.1144602; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Covington MF, 2001, PLANT CELL, V13, P1305, DOI 10.1105/tpc.13.6.1305; Curie C, 2003, ANNU REV PLANT BIOL, V54, P183, DOI 10.1146/annurev.arplant.54.031902.135018; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dellagi A, 2005, PLANT J, V43, P262, DOI 10.1111/j.1365-313X.2005.02451.x; Ding Z, 2007, PLANT CELL, V19, P1522, DOI 10.1105/tpc.106.047241; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Farras R, 2001, EMBO J, V20, P2742, DOI 10.1093/emboj/20.11.2742; Fourcroy P, 2004, PLANT PHYSIOL, V134, P605, DOI 10.1104/pp.103.029876; GUERINOT ML, 1994, PLANT PHYSIOL, V104, P815, DOI 10.1104/pp.104.3.815; Hall A, 2003, PLANT CELL, V15, P2719, DOI 10.1105/tpc.013730; Kim SA, 2007, FEBS LETT, V581, P2273, DOI 10.1016/j.febslet.2007.04.043; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu XL, 2001, PLANT CELL, V13, P1293, DOI 10.1105/tpc.13.6.1293; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; LOBREAUX S, 1991, BIOCHEM J, V274, P601, DOI 10.1042/bj2740601; LOBREAUX S, 1995, PLANT J, V8, P443, DOI 10.1046/j.1365-313X.1995.08030443.x; MacKinney G, 1941, J BIOL CHEM, V140, P315; Mas P, 2005, INT J DEV BIOL, V49, P491, DOI 10.1387/ijdb.041968pm; Mas P, 2008, TRENDS CELL BIOL, V18, P273, DOI 10.1016/j.tcb.2008.03.005; McWatters HG, 2007, PLANT PHYSIOL, V144, P391, DOI 10.1104/pp.107.096206; McWatters HG, 2000, NATURE, V408, P716, DOI 10.1038/35047079; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Patton EE, 1998, TRENDS GENET, V14, P236, DOI 10.1016/S0168-9525(98)01473-5; Petit JM, 2001, J BIOL CHEM, V276, P5584, DOI 10.1074/jbc.M005903200; Petit JM, 2001, BIOCHEM J, V359, P575, DOI 10.1042/0264-6021:3590575; Pilon M, 2009, CURR OPIN PLANT BIOL, V12, P347, DOI 10.1016/j.pbi.2009.04.011; Ravet K, 2009, MOL PLANT, V2, P1095, DOI 10.1093/mp/ssp041; Ravet K, 2009, PLANT J, V57, P400, DOI 10.1111/j.1365-313X.2008.03698.x; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Somers DE, 1998, DEVELOPMENT, V125, P485; Tarantino D, 2003, PLANTA, V217, P709, DOI 10.1007/s00425-003-1038-z; Van Wuytswinkel O, 1999, PLANT J, V17, P93, DOI 10.1046/j.1365-313X.1999.00349.x; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; VILLARREAL AS, 2009, 20 INT C AR RES ED U; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6	58	59	63	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36271	36281		10.1074/jbc.M109.059873	http://dx.doi.org/10.1074/jbc.M109.059873			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19828447	hybrid, Green Published			2022-12-25	WOS:000272970500029
J	Deriy, LV; Gomez, EA; Zhang, GP; Beacham, DW; Hopson, JA; Gallan, AJ; Shevchenko, PD; Bindokas, VP; Nelson, DJ				Deriy, Ludmila V.; Gomez, Erwin A.; Zhang, Guangping; Beacham, Daniel W.; Hopson, Jessika A.; Gallan, Alexander J.; Shevchenko, Pavel D.; Bindokas, Vytautas P.; Nelson, Deborah J.			Disease-causing Mutations in the Cystic Fibrosis Transmembrane Conductance Regulator Determine the Functional Responses of Alveolar Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNELS; MAST-CELLS; PHAGOSOMAL ACIDIFICATION; PSEUDOMONAS-AERUGINOSA; HUMAN-NEUTROPHILS; NECROTIC CELLS; MICE; CFTR; EXOCYTOSIS; G551D	Alveolar macrophages (AMs) play a major role in host defense against microbial infections in the lung. To perform this function, these cells must ingest and destroy pathogens, generally in phagosomes, as well as secrete a number of products that signal other immune cells to respond. Recently, we demonstrated that murine alveolar macrophages employ the cystic fibrosis transmembrane conductance regulator (CFTR) Cl- channel as a determinant in lysosomal acidification (Di, A., Brown, M. E., Deriy, L. V., Li, C., Szeto, F. L., Chen, Y., Huang, P., Tong, J., Naren, A. P., Bindokas, V., Palfrey, H. C., and Nelson, D. J. (2006) Nat. Cell Biol. 8, 933-944). Lysosomes and phagosomes in murine cftr(-/-) AMs failed to acidify, and the cells were deficient in bacterial killing compared with wild type controls. Cystic fibrosis is caused by mutations in CFTR and is characterized by chronic lung infections. The information about relationships between the CFTR genotype and the disease phenotype is scarce both on the organismal and cellular level. The most common disease-causing mutation, Delta F508, is found in 70% of patients with cystic fibrosis. The mutant protein fails to fold properly and is targeted for proteosomal degradation. G551D, the second most common mutation, causes loss of function of the protein at the plasma membrane. In this study, we have investigated the impact of CFTR Delta F508 and G551D on a set of core intracellular functions, including organellar acidification, granule secretion, and microbicidal activity in the AM. Utilizing primary AMs from wild type, cftr(-/-), as well as mutant mice, we show a tight correlation between CFTR genotype and levels of lysosomal acidification, bacterial killing, and agonist-induced secretory responses, all of which would be expected to contribute to a significant impact on microbial clearance in the lung.	[Deriy, Ludmila V.; Gomez, Erwin A.; Zhang, Guangping; Hopson, Jessika A.; Gallan, Alexander J.; Shevchenko, Pavel D.; Bindokas, Vytautas P.; Nelson, Deborah J.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; [Beacham, Daniel W.] Mol Probes Invitrogen Labeling & Detect Technol, Eugene, OR 97402 USA	University of Chicago	Nelson, DJ (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, 947 E 58th St,AB 500 MC 0926, Chicago, IL 60637 USA.	nelson@uchicago.edu	Zhang, Guang-Ping/T-2664-2019; Zhang, Guang-Ping/C-8300-2011	Zhang, Guang-Ping/0000-0002-1620-0221; Zhang, Guang-Ping/0000-0002-1620-0221; Ralph, Jessika/0000-0001-8065-8993	National Institutes of Health; NIGMS [RO1 GM36823]; Cystic Fibrosis Foundation [O6PO]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK027651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health grant and Grant RO1 GM36823 from NIGMS. This work was also supported by Cystic Fibrosis Foundation Grant O6PO (to D. J. N.).	BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; Barg S, 2001, J CELL SCI, V114, P2145; Barriere H, 2009, MOL BIOL CELL, V20, P3125, DOI 10.1091/mbc.E09-01-0061; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bompadre SG, 2008, J BIOL CHEM, V283, P5364, DOI 10.1074/jbc.M709417200; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Bruscia EM, 2009, AM J RESP CELL MOL, V40, P295, DOI 10.1165/rcmb.2008-0170OC; BUTOR C, 1995, J CELL SCI, V108, P2213; Delaney SJ, 1996, EMBO J, V15, P955, DOI 10.1002/j.1460-2075.1996.tb00432.x; Demaurex N, 2002, NEWS PHYSIOL SCI, V17, P1; Di A, 2002, NAT CELL BIOL, V4, P279, DOI 10.1038/ncb771; Di AK, 2003, MOL BIOL CELL, V14, P2016, DOI 10.1091/mbc.e02-09-0626; Di AK, 2001, J BIOL CHEM, V276, P37124, DOI 10.1074/jbc.M105038200; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Downey GP, 1999, J BIOL CHEM, V274, P28436, DOI 10.1074/jbc.274.40.28436; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Grabe M, 2001, J GEN PHYSIOL, V117, P329, DOI 10.1085/jgp.117.4.329; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; Haggie PM, 2007, J BIOL CHEM, V282, P31422, DOI 10.1074/jbc.M705296200; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Henson Peter M, 2006, Proc Am Thorac Soc, V3, P512; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Krysko DV, 2006, CELL DEATH DIFFER, V13, P2011, DOI 10.1038/sj.cdd.4401900; Krysko DV, 2006, APOPTOSIS, V11, P1709, DOI 10.1007/s10495-006-9527-8; Lamothe J, 2008, MICROBIOL-SGM, V154, P3825, DOI 10.1099/mic.0.2008/023200-0; Li JN, 2007, J LEUKOCYTE BIOL, V81, P328, DOI 10.1189/jlb.0206124; LINDAU M, 1986, NATURE, V319, P150, DOI 10.1038/319150a0; Mani M, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.003.2009; MATTHEWS G, 1989, J PHYSIOL-LONDON, V418, P105, DOI 10.1113/jphysiol.1989.sp017830; McMorran BJ, 2001, AM J PHYSIOL-LUNG C, V281, pL740, DOI 10.1152/ajplung.2001.281.3.L740; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Morris MR, 2005, CLIN EXP IMMUNOL, V142, P68, DOI [10.1111/j.1365-2249.2005.02893.x, 10.1111/j.1365-2249.2005.02893.X]; NUSSE O, 1988, J CELL BIOL, V107, P2117, DOI 10.1083/jcb.107.6.2117; ORCI L, 1987, CELL, V49, P865, DOI 10.1016/0092-8674(87)90624-6; Painter RG, 2006, BIOCHEMISTRY-US, V45, P10260, DOI 10.1021/bi060490t; Plans V, 2009, PFLUG ARCH EUR J PHY, V458, P23, DOI 10.1007/s00424-008-0597-z; Poschet J, 2002, TRENDS MOL MED, V8, P512, DOI 10.1016/S1471-4914(02)02414-0; Poschet JF, 2001, P NATL ACAD SCI USA, V98, P13972, DOI 10.1073/pnas.241182598; Russell DG, 2009, NAT REV IMMUNOL, V9, P594, DOI 10.1038/nri2591; Steinberg BE, 2007, P NATL ACAD SCI USA, V104, P9523, DOI 10.1073/pnas.0700783104; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thomas GR, 2000, J IMMUNOL, V164, P3870, DOI 10.4049/jimmunol.164.7.3870; van Heeckeren AM, 2004, AM J PHYSIOL-LUNG C, V287, pL944, DOI 10.1152/ajplung.00387.2003; Wang F, 2000, J PHYSIOL-LONDON, V524, P637, DOI 10.1111/j.1469-7793.2000.00637.x; Weisz OA, 2003, TRAFFIC, V4, P57, DOI 10.1034/j.1600-0854.2003.40201.x; Wu LC, 2004, GASTROENTEROLOGY, V126, P488, DOI 10.1053/j.gastro.2003.11.011; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x	53	93	94	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35926	35938		10.1074/jbc.M109.057372	http://dx.doi.org/10.1074/jbc.M109.057372			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19837664	Green Published, hybrid			2022-12-25	WOS:000272645600068
J	Mutoh, S; Osabe, M; Inoue, K; Moore, R; Pedersen, L; Perera, L; Rebolloso, Y; Sueyoshi, T; Negishi, M				Mutoh, Shingo; Osabe, Makoto; Inoue, Kaoru; Moore, Rick; Pedersen, Lee; Perera, Lalith; Rebolloso, Yvette; Sueyoshi, Tatsuya; Negishi, Masahiko			Dephosphorylation of Threonine 38 Is Required for Nuclear Translocation and Activation of Human Xenobiotic Receptor CAR (NR1I3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSTITUTIVE ACTIVE/ANDROSTANE RECEPTOR; MOUSE PRIMARY HEPATOCYTES; DRUG-METABOLISM; X-RECEPTOR; CYP2B GENE; LIVER; HETERODIMER; INDUCTION	Upon activation by therapeutics, the nuclear xenobiotic/constitutive active/androstane receptor (CAR) regulates various liver functions ranging from drug metabolism and excretion to energy metabolism. CAR can also be a risk factor for developing liver diseases such as hepatocellular carcinoma. Here we have characterized the conserved threonine 38 of human CAR as the primary residue that regulates nuclear translocation and activation of CAR. Protein kinase C phosphorylates threonine 38 located on the alpha-helix spanning from residues 29-42 that constitutes a part of the first zinc finger and continues into the region between the zinc fingers. Molecular dynamics study has revealed that this phosphorylation may destabilize this helix, thereby inactivating CAR binding to DNA as well as sequestering it in the cytoplasm. We have found, in fact, that helix-stabilizing mutations reversed the effects of phosphorylation. Immunohistochemical study using an anti-phosphothreonine 38 peptide antibody has, in fact, demonstrated that the classic CAR activator phenobarbital dephosphorylates the corresponding threonine 48 of mouse CAR in the cytoplasm of mouse liver and translocates CAR into the nucleus. These results define CAR as a cell signal-regulated constitutive active nuclear receptor. These results also provide phosphorylation/dephosphorylation of the threonine as the primary drug target for CAR activation.	[Mutoh, Shingo; Osabe, Makoto; Inoue, Kaoru; Moore, Rick; Sueyoshi, Tatsuya; Negishi, Masahiko] NIEHS, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Pedersen, Lee; Perera, Lalith] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Rebolloso, Yvette] NIEHS, Cellular & Mol Pathol Branch, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Negishi, M (corresponding author), NIEHS, Reprod & Dev Toxicol Lab, NIH, Res Triangle Pk, NC 27709 USA.	negishi@niehs.nih.gov	Perera, Lalith/ABB-9995-2021; Pedersen, Lee G/E-3405-2013; Negishi, Masahiko/F-7805-2019; perera, Lalith/B-6879-2012	Pedersen, Lee G/0000-0003-1262-9861; Negishi, Masahiko/0000-0002-2076-8928; perera, Lalith/0000-0003-0823-1631	National Institutes of Health Intramural Research Program [Z01ES71005-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES080040, ZIAES043010] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Z01ES71005-01 through the NIEHS.	Case D. A., 2008, AMBER MOL DYNAMICS P, P10; Finn RD, 2009, BIOCHEM J, V417, P43, DOI 10.1042/BJ20080740; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; Honkakoski P, 1998, BIOCHEM J, V330, P889, DOI 10.1042/bj3300889; Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652; Hosseinpour F, 2006, MOL PHARMACOL, V69, P1095, DOI 10.1124/mol.105.019505; Kawamoto T, 1999, MOL CELL BIOL, V19, P6318; Koike C, 2007, MOL PHARMACOL, V71, P1217, DOI 10.1124/mol.107.034538; Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8; Maglich JM, 2009, J LIPID RES, V50, P439, DOI 10.1194/jlr.M800226-JLR200; Pascussi JM, 2008, ANNU REV PHARMACOL, V48, P1, DOI 10.1146/annurev.pharmtox.47.120505.105349; Qatanani M, 2005, CURR DRUG METAB, V6, P329, DOI 10.2174/1389200054633899; Scheer N, 2008, J CLIN INVEST, V118, P3228, DOI 10.1172/JCI35483; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Sun K, 2007, MOL ENDOCRINOL, V21, P1297, DOI 10.1210/me.2006-0300; Xu RX, 2004, MOL CELL, V16, P919, DOI 10.1016/j.molcel.2004.11.042; Yamamoto Y, 2004, CANCER RES, V64, P7197, DOI 10.1158/0008-5472.CAN-04-1459; Yoshinari K, 2003, FEBS LETT, V548, P17, DOI 10.1016/S0014-5793(03)00720-8; Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001	20	104	111	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34785	34792		10.1074/jbc.M109.048108	http://dx.doi.org/10.1074/jbc.M109.048108			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19858220	Green Published, hybrid			2022-12-25	WOS:000272439600034
J	Takeuchi, K; Kiefer, P; Reimmann, C; Keel, C; Dubuis, C; Rolli, J; Vorholt, JA; Haas, D				Takeuchi, Kasumi; Kiefer, Patrick; Reimmann, Cornelia; Keel, Christoph; Dubuis, Christophe; Rolli, Joelle; Vorholt, Julia A.; Haas, Dieter			Small RNA-dependent Expression of Secondary Metabolism Is Controlled by Krebs Cycle Function in Pseudomonas fluorescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLACK ROOT-ROT; BIOCONTROL FACTOR EXPRESSION; GRAM-NEGATIVE BACTERIA; III SECRETION SYSTEM; EXOPRODUCT FORMATION; BIOLOGICAL-CONTROL; MASS-SPECTROMETRY; GENE-EXPRESSION; AERUGINOSA PAO1; REGULATORY RNA	Pseudomonas fluorescens CHA0, an antagonist of phytopathogenic fungi in the rhizosphere of crop plants, elaborates and excretes several secondary metabolites with antibiotic properties. Their synthesis depends on three small RNAs (RsmX, RsmY, and RsmZ), whose expression is positively controlled by the GacS-GacA two-component system at high cell population densities. To find regulatory links between primary and secondary metabolism in P. fluorescens and in the related species Pseudomonas aeruginosa, we searched for null mutations that affected central carbon metabolism as well as the expression of rsmY-gfp and rsmZ-gfp reporter constructs but without slowing down the growth rate in rich media. Mutation in the pycAB genes (for pyruvate carboxylase) led to down-regulation of rsmXYZ and secondary metabolism, whereas mutation in fumA (for a fumarase isoenzyme) resulted in up-regulation of the three small RNAs and secondary metabolism in the absence of detectable nutrient limitation. These effects required the GacS sensor kinase but not the accessory sensors RetS and LadS. An analysis of intracellular metabolites in P. fluorescens revealed a strong positive correlation between small RNA expression and the pools of 2-oxoglutarate, succinate, and fumarate. We conclude that Krebs cycle intermediates (already known to control GacA-dependent virulence factors in P. aeruginosa) exert a critical trigger function in secondary metabolism via the expression of GacA-dependent small RNAs.	[Takeuchi, Kasumi; Reimmann, Cornelia; Keel, Christoph; Dubuis, Christophe; Rolli, Joelle; Haas, Dieter] Univ Lausanne, Dept Microbiol Fondamentale, CH-1015 Lausanne, Switzerland; [Takeuchi, Kasumi] Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; [Kiefer, Patrick; Vorholt, Julia A.] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	University of Lausanne; National Institute of Agrobiological Sciences - Japan; Swiss Federal Institutes of Technology Domain; ETH Zurich	Haas, D (corresponding author), Univ Lausanne, Dept Microbiol Fondamentale, Batiment Biophore, CH-1015 Lausanne, Switzerland.	dieter.haas@unil.ch	Vorholt, Julia/K-3514-2016; Keel, Christoph/U-4071-2017; Kiefer, Patrick/G-5138-2010	Vorholt, Julia/0000-0002-6011-4910; Keel, Christoph/0000-0002-8968-735X; Takeuchi, Kasumi/0000-0002-6521-6748	Swiss National Foundation [3100A0-100180]; Japan Society for the Promotion of Science-Swiss National Foundation; Organisation for Economic Co-operation and Development	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Japan Society for the Promotion of Science-Swiss National Foundation(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Organisation for Economic Co-operation and Development	This work was supported by Swiss National Foundation for Scientific Research Project 3100A0-100180, the Japan Society for the Promotion of Science-Swiss National Foundation for Scientific Research Exchange Program, and an Organisation for Economic Co-operation and Development fellowship (to T. K.).	BAO Y, 1991, GENE, V109, P167, DOI 10.1016/0378-1119(91)90604-A; Bibb MJ, 2005, CURR OPIN MICROBIOL, V8, P208, DOI 10.1016/j.mib.2005.02.016; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; CARMI R, 1994, J NAT PROD, V57, P1200, DOI 10.1021/np50111a002; Dacheux D, 2002, INFECT IMMUN, V70, P3973, DOI 10.1128/IAI.70.7.3973-3977.2002; DEMAIN AL, 1986, PURE APPL CHEM, V58, P219, DOI 10.1351/pac198658020219; Dubuis C, 2006, APPL ENVIRON MICROB, V72, P2606, DOI 10.1128/AEM.72.4.2606-2613.2006; Dubuis C, 2007, EUR J PLANT PATHOL, V119, P311, DOI 10.1007/s10658-007-9157-1; Dubuis C, 2007, APPL ENVIRON MICROB, V73, P650, DOI 10.1128/AEM.01681-06; Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004; FELLAY R, 1987, GENE, V52, P147, DOI 10.1016/0378-1119(87)90041-2; Fox A, 2008, APPL ENVIRON MICROB, V74, P1902, DOI 10.1128/AEM.02539-07; GAMPER M, 1992, J MOL BIOL, V226, P943, DOI 10.1016/0022-2836(92)91044-P; Gonzalez N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-167; Haas D, 2005, NAT REV MICROBIOL, V3, P307, DOI 10.1038/nrmicro1129; Haas D, 2003, ANNU REV PHYTOPATHOL, V41, P117, DOI 10.1146/annurev.phyto.41.052002.095656; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; Heeb S, 2002, J BACTERIOL, V184, P1046, DOI 10.1128/jb.184.4.1046-1056.2002; Heeb S, 2001, MOL PLANT MICROBE IN, V14, P1351, DOI 10.1094/MPMI.2001.14.12.1351; Hill RL, 1969, METHOD ENZYMOL, V8, P91, DOI 10.1016/0076-6879(69)13021-9; Humair B, 2009, ISME J, V3, P955, DOI 10.1038/ismej.2009.42; IRETON K, 1995, P NATL ACAD SCI USA, V92, P2845, DOI 10.1073/pnas.92.7.2845; Kamilova F, 2006, MOL PLANT MICROBE IN, V19, P1121, DOI 10.1094/MPMI-19-1121; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; Kay E, 2006, J BACTERIOL, V188, P6026, DOI 10.1128/JB.00409-06; Kiefer P, 2008, ANAL BIOCHEM, V382, P94, DOI 10.1016/j.ab.2008.07.010; Lai HF, 2006, APPL ENVIRON MICROB, V72, P7785, DOI 10.1128/AEM.01564-06; Lambertsen L, 2004, ENVIRON MICROBIOL, V6, P726, DOI 10.1111/j.1462-2920.2004.00605.x; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; LAVILLE J, 1992, P NATL ACAD SCI USA, V89, P1562, DOI 10.1073/pnas.89.5.1562; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Leoni L, 1996, J BACTERIOL, V178, P2299, DOI 10.1128/jb.178.8.2299-2313.1996; Maurhofer M, 1998, PHYTOPATHOLOGY, V88, P678, DOI 10.1094/PHYTO.1998.88.7.678; Miller JH., 1972, EXPT MOL GENETICS; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Molofsky AB, 2004, MOL MICROBIOL, V53, P29, DOI 10.1111/j.1365-2958.2004.04129.x; Mulcahy H, 2006, INFECT IMMUN, V74, P3012, DOI 10.1128/IAI.74.5.3012-3015.2006; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; ORNSTON LN, 1966, J BIOL CHEM, V241, P3776; Paulsen IT, 2005, NAT BIOTECHNOL, V23, P873, DOI 10.1038/nbt1110; PHIBBS PV, 1974, J BACTERIOL, V118, P999, DOI 10.1128/JB.118.3.999-1009.1974; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Reimmann C, 2005, J BACTERIOL, V187, P276, DOI 10.1128/JB.187.1.276-285.2005; Rietsch A, 2006, MOL MICROBIOL, V59, P807, DOI 10.1111/j.1365-2958.2005.04990.x; Rietsch A, 2004, INFECT IMMUN, V72, P1383, DOI 10.1128/IAI.72.3.1383-1390.2004; Sambrook J, 2001, MOL CLONING LAB MANU; Schnider-Keel U, 2000, J BACTERIOL, V182, P1215, DOI 10.1128/JB.182.5.1215-1225.2000; Siddiqui IA, 2005, APPL ENVIRON MICROB, V71, P5646, DOI 10.1128/AEM.71.9.5646-5649.2005; Somerville GA, 2009, MICROBIOL MOL BIOL R, V73, P233, DOI 10.1128/MMBR.00005-09; Soscia C, 2007, J BACTERIOL, V189, P3124, DOI 10.1128/JB.01677-06; STUTZ EW, 1986, PHYTOPATHOLOGY, V76, P181, DOI 10.1094/Phyto-76-181; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Valverde C, 2003, MOL MICROBIOL, V50, P1361, DOI 10.1046/j.1365-2958.2003.03774.x; VINING LC, 1990, ANNU REV MICROBIOL, V44, P395, DOI 10.1146/annurev.mi.44.100190.002143; Viollier PH, 2001, J BACTERIOL, V183, P3184, DOI 10.1128/JB.183.10.3184-3192.2001; VOISARD C, 1994, MOLECULAR ECOLOGY OF RHIZOSPHERE MICROORGANISMS, P67, DOI 10.1002/9783527615810.ch6; VOISARD C, 1988, FEMS MICROBIOL LETT, V55, P9, DOI 10.1016/0378-1097(88)90143-7; VOISARD C, 1989, EMBO J, V8, P351, DOI 10.1002/j.1460-2075.1989.tb03384.x; Workentine ML, 2009, FEMS MICROBIOL LETT, V292, P50, DOI 10.1111/j.1574-6968.2008.01445.x; Wu L, 2005, ANAL BIOCHEM, V336, P164, DOI 10.1016/j.ab.2004.09.001; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214; Zuber S, 2003, MOL PLANT MICROBE IN, V16, P634, DOI 10.1094/MPMI.2003.16.7.634	63	56	62	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34976	34985		10.1074/jbc.M109.052571	http://dx.doi.org/10.1074/jbc.M109.052571			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840935	Green Published, hybrid			2022-12-25	WOS:000272439600053
J	Alonso, H; Blayney, MJ; Beck, JL; Whitney, SM				Alonso, Hernan; Blayney, Michelle J.; Beck, Jennifer L.; Whitney, Spencer M.			Substrate-induced Assembly of Methanococcoides burtonii D-Ribulose-1,5-bisphosphate Carboxylase/Oxygenase Dimers into Decamers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; RIBULOSEBISPHOSPHATE CARBOXYLASE; TOBACCO CHLOROPLASTS; LARGE SUBUNITS; RUBISCO; CHAPERONIN; CATALYSIS; PROTEINS; RIBULOSE-1,5-BISPHOSPHATE; PHOTOSYNTHESIS	Like many enzymes, the biogenesis of the multi-subunit CO2-fixing enzyme ribulose-1,5-bisphosphate (RuBP) carboxylase/oxygenase (Rubisco) in different organisms requires molecular chaperones. When expressed in Escherichia coli, the large (L) subunits of the Rubisco from the archaeabacterium Methanococcoides burtonii assemble into functional dimers (L-2). However, further assembly into pentamers of L-2 (L-10) occurs when expressed in tobacco chloroplasts or E. coli producing RuBP. In vitro analyses indicate that the sequential assembly of L-2 into L-10 (via detectable L-4 and L-6 intermediates) occurs without chaperone involvement and is stimulated by protein rearrangements associated with either the binding of substrate RuBP, the tight binding transition state analog carboxyarabinitol-1,5-bisphosphate, or inhibitory divalent metal ions within the active site. The catalytic properties of L-2 and L10 M. burtonii Rubisco (MbR) were indistinguishable. At 25 C they both shared a low specificity for CO2 over O-2 (1.1 mol.mol(-1)) and RuBP carboxylation rates that were distinctively enhanced at low pH (similar to 4 s(-1) at pH6, relative to 0.8 s(-1) at pH 8) with a temperature optimum of 55 degrees C. Like other archaeal Rubiscos, MbR also has a high O-2 affinity (K-m(O-2) = similar to 2.5 mu M). The catalytic and structural similarities of MbR to other archaeal Rubiscos contrast with its closer sequence homology to bacterial L-2 Rubisco, complicating its classification within the Rubisco superfamily.	[Alonso, Hernan; Whitney, Spencer M.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 2601, Australia; [Blayney, Michelle J.; Beck, Jennifer L.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia	Australian National University; University of Wollongong	Whitney, SM (corresponding author), Australian Natl Univ, Res Sch Biol, POB 475, Canberra, ACT 2601, Australia.	spencer.whitney@anu.edu.au	Beck, Jennifer L/B-6151-2016; Whitney, Spencer M/C-9266-2009	Beck, Jennifer L/0000-0001-6058-4886; Whitney, Spencer M/0000-0003-2954-2359	Australian Research Council Discovery [DP0450564]	Australian Research Council Discovery(Australian Research Council)	This work was supported by Australian Research Council Discovery Grant DP0450564 ( to S. M. W.).	Andersson I, 2008, PLANT PHYSIOL BIOCH, V46, P275, DOI 10.1016/j.plaphy.2008.01.001; ANDREWS TJ, 1988, J BIOL CHEM, V263, P12213; Baker RT, 2005, METHOD ENZYMOL, V398, P540, DOI 10.1016/S0076-6879(05)98044-0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Brutnell TP, 1999, PLANT CELL, V11, P849, DOI 10.1105/tpc.11.5.849; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Duff AP, 2000, J MOL BIOL, V298, P903, DOI 10.1006/jmbi.2000.3724; Emlyn-Jones D, 2006, PLANT CELL PHYSIOL, V47, P1630, DOI 10.1093/pcp/pcl028; Finn MW, 2004, J BACTERIOL, V186, P6360, DOI 10.1128/JB.186.19.6360-6366.2004; Finn MW, 2003, J BACTERIOL, V185, P3049, DOI 10.1128/JB.185.10.3049-3059.2003; FRANZMANN PD, 1992, SYST APPL MICROBIOL, V15, P573, DOI 10.1016/S0723-2020(11)80117-7; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Kane HJ, 1998, PLANT PHYSIOL, V117, P1059, DOI 10.1104/pp.117.3.1059; Kannappan B, 2008, J AM CHEM SOC, V130, P15063, DOI 10.1021/ja803464a; Karkehabadi S, 2003, J MOL BIOL, V334, P65, DOI 10.1016/j.jmb.2003.09.025; Kitano K, 2001, STRUCTURE, V9, P473, DOI 10.1016/S0969-2126(01)00608-6; Kreel NE, 2007, J BIOL CHEM, V282, P1341, DOI 10.1074/jbc.M609399200; Mueller-Cajar O, 2007, BIOCHEMISTRY-US, V46, P14067, DOI 10.1021/bi700820a; Mueller-Cajar O, 2007, BIOESSAYS, V29, P722, DOI 10.1002/bies.20616; Mueller-Cajar O, 2008, PHOTOSYNTH RES, V98, P667, DOI 10.1007/s11120-008-9324-z; Parry MAJ, 2007, J AGR SCI-CAMBRIDGE, V145, P31, DOI 10.1017/S0021859606006666; PAUL K, 1991, BIOCHEMISTRY-US, V30, P10019, DOI 10.1021/bi00105a029; PIERCE J, 1980, BIOCHEMISTRY-US, V19, P934, DOI 10.1021/bi00546a018; Raunser S, 2009, P NATL ACAD SCI USA, V106, P3160, DOI 10.1073/pnas.0810563106; ROBISON PD, 1979, BIOCHEMISTRY-US, V18, P4453, DOI 10.1021/bi00588a001; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; Saunders NFW, 2005, J PROTEOME RES, V4, P464, DOI 10.1021/pr049797+; Sharwood RE, 2008, PLANT PHYSIOL, V146, P83, DOI 10.1104/pp.107.109058; Tabita FR, 2008, PHILOS T R SOC B, V363, P2629, DOI 10.1098/rstb.2008.0023; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; VIITANEN PV, 1990, BIOCHEMISTRY-US, V29, P5665, DOI 10.1021/bi00476a003; Whitney SM, 2001, P NATL ACAD SCI USA, V98, P14738, DOI 10.1073/pnas.261417298; Whitney SM, 2001, PLANT J, V26, P535, DOI 10.1046/j.1365-313x.2001.01056.x; Whitney SM, 2008, J EXP BOT, V59, P1909, DOI 10.1093/jxb/erm311; Wostrikoff K, 2007, P NATL ACAD SCI USA, V104, P6466, DOI 10.1073/pnas.0610586104; Yoshida S, 2007, APPL ENVIRON MICROB, V73, P6254, DOI 10.1128/AEM.00044-07; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	39	37	38	1	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33876	33882		10.1074/jbc.M109.050989	http://dx.doi.org/10.1074/jbc.M109.050989			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19837658	Green Published, hybrid			2022-12-25	WOS:000272165200020
J	Nakajima, H; Amano, W; Kubo, T; Fukuhara, A; Ihara, H; Azuma, YT; Tajima, H; Inui, T; Sawa, A; Takeuchi, T				Nakajima, Hidemitsu; Amano, Wataru; Kubo, Takeya; Fukuhara, Ayano; Ihara, Hideshi; Azuma, Yasu-Taka; Tajima, Hisao; Inui, Takashi; Sawa, Akira; Takeuchi, Tadayoshi			Glyceraldehyde-3-phosphate Dehydrogenase Aggregate Formation Participates in Oxidative Stress-induced Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURODEGENERATIVE DISEASES; NEUROBLASTOMA-CELLS; NITRIC-OXIDE; GAPDH; PROTEIN; METHAMPHETAMINE; DOPAMINE; APOPTOSIS; NEUROTOXICITY; BINDING	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 2 is a classic glycolytic enzyme that also mediates cell death by its nuclear translocation under oxidative stress. Meanwhile, we previously presented that oxidative stress induced disulfide-bonded GAPDH aggregation in vitro. Here, we propose that GAPDH aggregate formation might participate in oxidative stress-induced cell death both in vitro and in vivo. We show that human GAPDH amyloid-like aggregate formation depends on the active site cysteine-152 (Cys-152) in vitro. In SH-SY5Y neuroblastoma, treatment with dopamine decreases the cell viability concentration-dependently (IC50 = 202 mu M). Low concentrations of dopamine (50-100 mu M) mainly cause nuclear translocation of GAPDH, whereas the levels of GAPDH aggregates correlate with high concentrations of dopamine (200-300 mu M)-induced cell death. Doxycycline-inducible overexpression of wild-typeGAPDHin SH-SY5Y, but not the Cys-152-substituted mutant (C152A-GAPDH), accelerates cell death accompanying both endogenous and exogenous GAPDH aggregate formation in response to high concentrations of dopamine. Deprenyl, a blocker of GAPDH nuclear translocation, fails to inhibit the aggregation both in vitro and in cells but reduced cell death in SH-SY5Y treated with only a low concentration of dopamine (100 mu M). These results suggest that GAPDH participates in oxidative stress-induced cell death via an alternative mechanism in which aggregation but not nuclear translocation of GAPDH plays a role. Moreover, we observe endogenous GAPDH aggregate formation in nigra-striatum dopaminergic neurons after methamphetamine treatment in mice. In transgenic mice overexpressing wildtype GAPDH, increased dopaminergic neuron loss and GAPDH aggregate formation are observed. These data suggest a critical role of GAPDH aggregates in oxidative stress-induced brain damage.	[Takeuchi, Tadayoshi] Osaka Prefecture Univ, Lab Vet Pharmacol, Osaka 5988531, Japan; [Fukuhara, Ayano; Inui, Takashi] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Grad Sch Sci, Lab Prot Sci, Osaka 5988531, Japan; [Ihara, Hideshi] Osaka Prefecture Univ, Dept Sci, Osaka 5988531, Japan; [Tajima, Hisao] Ono Pharmaceut Co Ltd, Dev Res Labs, Osaka 6188585, Japan; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA; [Sawa, Akira] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; Ono Pharmaceutical Co Ltd; Johns Hopkins University; Johns Hopkins University		hnakajima@vet.oskafu-u.ac.jp	Inui, Takashi/G-1069-2011; Tajima, Hisao/E-3241-2010; Azuma, Yasu-Taka/C-7561-2009	Azuma, Yasu-Taka/0000-0002-3515-171X; Nakajima, Hidemitsu/0000-0002-0441-1929	Japan Society for the Promotion of Science; Osaka Prefecture University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka Prefecture University	This work was supported in part by Grant-in-aid 19580346 for Scientific Research (to H.N.) from the Japan Society for the Promotion of Science and a special research grant (to H.N.) from Osaka Prefecture University.	Burke JR, 1996, NAT MED, V2, P347, DOI 10.1038/nm0396-347; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; GANTER C, 1990, BIOCHEMISTRY-US, V29, P9395, DOI 10.1021/bi00492a013; Hara MR, 2006, BBA-MOL BASIS DIS, V1762, P502, DOI 10.1016/j.bbadis.2006.01.012; Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Ishii T, 1999, BIOCHEM PHARMACOL, V58, P133, DOI 10.1016/S0006-2952(99)00060-X; Iwashita A, 2004, J PHARMACOL EXP THER, V310, P1114, DOI 10.1124/jpet.104.068932; Jiang HB, 2004, HUM MOL GENET, V13, P1745, DOI 10.1093/hmg/ddh180; Larsen KE, 2002, J NEUROSCI, V22, P8951; LaVoie MJ, 1999, J NEUROSCI, V19, P1484, DOI 10.1523/jneurosci.19-04-01484.1999; Lee MK, 2007, EXP MOL MED, V39, P376, DOI 10.1038/emm.2007.42; Lindersson E, 2004, J BIOL CHEM, V279, P12924, DOI 10.1074/jbc.M306390200; Lotharius J, 2000, J BIOL CHEM, V275, P38581, DOI 10.1074/jbc.M005385200; Mark KA, 2007, J NEUROSCI, V27, P6823, DOI 10.1523/JNEUROSCI.0013-07.2007; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Robinson CE, 1999, ANAL BIOCHEM, V266, P48, DOI 10.1006/abio.1998.2932; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; SCHULZE H, 1993, J NEUROCHEM, V60, P1915, DOI 10.1111/j.1471-4159.1993.tb13420.x; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Serpell LC, 2000, J MOL BIOL, V299, P225, DOI 10.1006/jmbi.2000.3650; Tsuchiya K, 2005, EUR J NEUROSCI, V21, P317, DOI 10.1111/j.1460-9568.2005.03870.x; Uhl GR, 2008, ARCH GEN PSYCHIAT, V65, P345, DOI 10.1001/archpsyc.65.3.345; Wang Q, 2005, FASEB J, V19, P869, DOI 10.1096/fj.04-3210fje; Yoshiike Y, 2003, J BIOL CHEM, V278, P23648, DOI 10.1074/jbc.M212785200	27	98	100	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					34331	34341		10.1074/jbc.M109.027698	http://dx.doi.org/10.1074/jbc.M109.027698			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19837666	hybrid, Green Published			2022-12-25	WOS:000272165200063
J	Chang, SH; Jobling, S; Brennan, K; Headon, DJ				Chang, Shie Hong; Jobling, Stephanie; Brennan, Keith; Headon, Denis J.			Enhanced Edar Signalling Has Pleiotropic Effects on Craniofacial and Cutaneous Glands	PLOS ONE			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; POSITIVE SELECTION; HAIR THICKNESS; POPULATION DIFFERENTIATION; RELATIVE-HUMIDITY; SUBMUCOSAL GLANDS; SEBACEOUS GLANDS; GENOMIC REGIONS; ECTODYSPLASIN-A; LIPID LAYER	The skin carries a number of appendages, including hair follicles and a range of glands, which develop under the influence of EDAR signalling. A gain of function allele of EDAR is found at high frequency in human populations of East Asia, with genetic evidence suggesting recent positive selection at this locus. The derived EDAR allele, estimated to have reached fixation more than 10,000 years ago, causes thickening of hair fibres, but the full spectrum of phenotypic changes induced by this allele is unknown. We have examined the changes in glandular structure caused by elevation of Edar signalling in a transgenic mouse model. We find that sebaceous and Meibomian glands are enlarged and that salivary and mammary glands are more elaborately branched with increased Edar activity, while the morphology of eccrine sweat and tracheal submucosal glands appears to be unaffected. Similar changes to gland sizes and structures may occur in human populations carrying the derived East Asian EDAR allele. As this allele attained high frequency in an environment that was notably cold and dry, increased glandular secretions could represent a trait that was positively selected to achieve increased lubrication and reduced evaporation from exposed facial structures and upper airways.			Chang, SH (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	keith.brennan@manchester.ac.uk; denis.headon@roslin.ed.ac.uk		Brennan, Keith/0000-0002-9384-125X	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ballard ST, 2004, J PHYSIOL-LONDON, V556, P1, DOI 10.1113/jphysiol.2003.052779; Binczek E, 2007, BIOL CHEM, V388, P405, DOI 10.1515/BC.2007.046; BLECHER SR, 1982, ANAT REC, V202, pA17; BLECHER SR, 1986, J INVEST DERMATOL, V87, P720, DOI 10.1111/1523-1747.ep12456718; Bron AJ, 2004, EXP EYE RES, V78, P347, DOI 10.1016/j.exer.2003.09.019; Bryk J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002209; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; CLARKE A, 1987, J MED GENET, V24, P659, DOI 10.1136/jmg.24.11.659; CLARKE A, 1987, ARCH DIS CHILD, V62, P989, DOI 10.1136/adc.62.10.989; Cohn BA, 1998, INT J DERMATOL, V37, P821, DOI 10.1046/j.1365-4362.1998.00575.x; Coon C., 1950, RACES STUDY PROBLEMS; Cui CY, 2003, HUM MOL GENET, V12, P2931, DOI 10.1093/hmg/ddg325; Daniel E, 2002, LARYNGOSCOPE, V112, P962, DOI 10.1097/00005537-200206000-00005; Fluhr JW, 2008, BRIT J DERMATOL, V159, P23, DOI 10.1111/j.1365-2133.2008.08643.x; Fluhr JW, 2003, J INVEST DERMATOL, V120, P728, DOI 10.1046/j.1523-1747.2003.12134.x; Fujimoto A, 2008, HUM GENET, V124, P179, DOI 10.1007/s00439-008-0537-1; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Fujimoto A, 2009, J HUM GENET, V54, P461, DOI 10.1038/jhg.2009.61; Haubrich Kathleen A, 2003, AACN Clin Issues, V14, P457, DOI 10.1097/00044067-200311000-00006; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Hofer T, 2009, ANN HUM GENET, V73, P95, DOI 10.1111/j.1469-1809.2008.00489.x; Jakobsson J, 2006, J CLIN ENDOCR METAB, V91, P687, DOI 10.1210/jc.2005-1643; Jaskoll T, 2003, ANAT REC PART A, V271A, P322, DOI 10.1002/ar.a.10045; Jiang DB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002167; Kaercher T, 2004, GRAEF ARCH CLIN EXP, V242, P495, DOI 10.1007/s00417-004-0868-0; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; Lamartine J, 2003, CLIN EXP DERMATOL, V28, P351, DOI 10.1046/j.1365-2230.2003.01319.x; Lee HJ, 2002, J AM ACAD DERMATOL, V46, P218, DOI 10.1067/mjd.2002.119558; Lexner MO, 2007, INT J PAEDIATR DENT, V17, P155, DOI 10.1111/j.1365-263X.2006.00812.x; Loussouarn G, 2005, INT J DERMATOL, V44, P6, DOI 10.1111/j.1365-4632.2005.02800.x; Majumder K, 1998, MAMM GENOME, V9, P863, DOI 10.1007/s003359900884; Maskarinec G, 2001, INT J EPIDEMIOL, V30, P959, DOI 10.1093/ije/30.5.959; McCulley JP, 2006, AM J OPHTHALMOL, V141, P758, DOI 10.1016/j.ajo.2005.10.057; McCulley JP, 2004, EXP EYE RES, V78, P361, DOI 10.1016/S0014-4835(03)00203-3; Mehta U, 2007, AM J RHINOL, V21, P55, DOI 10.2500/ajr.2007.21.2989; Melnik BC, 2009, J INVEST DERMATOL, V129, P1868, DOI 10.1038/jid.2009.8; Mese H, 2007, J ORAL REHABIL, V34, P711, DOI 10.1111/j.1365-2842.2007.01794.x; Miura K, 2007, HUM GENET, V121, P631, DOI 10.1007/s00439-007-0356-9; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Mou C, 2008, HUM MUTAT, V29, P1405, DOI 10.1002/humu.20795; MURRILL RUPERT IVAN, 1960, TRANS KANSAS ACAD SCI, V63, P194, DOI 10.2307/3626638; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Myles S, 2008, ANN HUM GENET, V72, P99, DOI 10.1111/j.1469-1809.2007.00390.x; Nagda NL, 2001, INDOOR AIR, V11, P200, DOI 10.1034/j.1600-0668.2001.011003200.x; NEWMAN MT, 1956, EVOLUTION, V10, P101, DOI 10.1111/j.1558-5646.1956.tb02835.x; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Pantalacci S, 2008, MOL BIOL EVOL, V25, P912, DOI 10.1093/molbev/msn038; Porter AMW, 2001, J ROY SOC MED, V94, P236, DOI 10.1177/014107680109400509; Rawlins EL, 2005, DEV DYNAM, V233, P1378, DOI 10.1002/dvdy.20461; Ray N, 2001, INTERNET ARCHAEOLOGY, V11; REED WB, 1970, ARCH DERMATOL, V102, P134, DOI 10.1001/archderm.102.2.134; ROLANDO M, 1983, EXP EYE RES, V36, P25, DOI 10.1016/0014-4835(83)90086-6; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sampath H, 2009, J BIOL CHEM, V284, P19961, DOI 10.1074/jbc.M109.014225; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; STEVENS A, 1996, HUMAN HISTOLOGY; Sunwoo Yujin, 2006, Journal of Physiological Anthropology and Applied Human Science, V25, P7, DOI 10.2114/jpa2.25.7; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; THODY AJ, 1989, PHYSIOL REV, V69, P383, DOI 10.1152/physrev.1989.69.2.383; Toyoda Y, 2009, FASEB J, V23, P2001, DOI 10.1096/fj.09-129098; Tsai RY, 2002, DERMATOL SURG, V28, P500, DOI 10.1046/j.1524-4725.2002.01194.x; Tucker AS, 2007, SEMIN CELL DEV BIOL, V18, P237, DOI 10.1016/j.semcdb.2007.01.006; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Xue YL, 2008, AM J HUM GENET, V83, P337, DOI 10.1016/j.ajhg.2008.08.004; Zhou WJ, 1999, PALAEOGEOGR PALAEOCL, V152, P163, DOI 10.1016/S0031-0182(99)00041-3; Zouboulis CC, 2007, HORM METAB RES, V39, P85, DOI 10.1055/s-2007-961807	67	46	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7591	10.1371/journal.pone.0007591	http://dx.doi.org/10.1371/journal.pone.0007591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855838	Green Submitted, Green Published, gold			2022-12-25	WOS:000271147200012
J	Djagaeva, I; Doronkin, S				Djagaeva, Inna; Doronkin, Sergey			Dual Regulation of Dendritic Morphogenesis in Drosophila by the COP9 Signalosome	PLOS ONE			English	Article							SMITH-MAGENIS-SYNDROME; CUBITUS INTERRUPTUS PROTEIN; LINKED MENTAL-RETARDATION; HEDGEHOG TARGET GENES; UBIQUITIN LIGASES; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; BETA-CATENIN; SCF; DEGRADATION	Altered dendritic arborization contributes to numerous physiological processes including synaptic plasticity, behavior, learning and memory, and is one of the most consistent neuropathologic conditions found in a number of mental retardation disorders, schizophrenia, and neurodegenerative disease. COP9 signalosome (CSN), an evolutionarily conserved regulator of the Cullin-based ubiquitin ligases that act in the proteasome pathway, has been found associated with diverse debilitating syndromes, suggesting that CSN may be involved in regulation of dendritic arborization. However, the mechanism of this control, if it exists, is unknown. To address whether the CSN pathway plays a role in dendrites, we used a simple and genetically tractable model, Drosophila larval peripheral nervous system. Our model study identified the COP9 signalosome as the key and multilayer regulator of dendritic arborization. CSN is responsible for shaping the entire dendritic tree through both stimulating and then repressing dendritic branching. We identified that CSN exerts its dualistic function via control of different Cullins. In particular, CSN stimulates dendritic branching through Cullin1, and inhibits it via control of Cullin3 function. We also identified that Cullin1 acts in neurons with the substrate-specific F-box protein Slimb to target the Cubitus interruptus protein for degradation.			Djagaeva, I (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA.	sdoronki@utmem.edu						Akiyama H, 2003, DEV BRAIN RES, V140, P45, DOI 10.1016/S0165-3806(02)00574-6; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; DJAGAEVA I, 2009, PLOS ONE IN PRESS; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; Doronkin S, 2002, DEVELOPMENT, V129, P5053; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Doronkin S, 2008, PROG NUCLEIC ACID RE, V82, P1, DOI 10.1016/S0079-6603(08)00001-9; Elsea SH, 1999, AM J MED GENET, V87, P342, DOI 10.1002/(SICI)1096-8628(19991203)87:4<342::AID-AJMG12>3.3.CO;2-1; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; FORBES AJ, 1993, DEVELOPMENT, P115; Fuchs SY, 1999, ONCOGENE, V18, P2039, DOI 10.1038/sj.onc.1202760; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Harari-Steinberg O, 2007, GENES CELLS, V12, P183, DOI 10.1111/j.1365-2443.2007.01049.x; Hepker J, 1997, DEVELOPMENT, V124, P549; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kalderon D, 2005, BIOCHEM SOC T, V33, P1509, DOI 10.1042/BST0331509; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Knowles A, 2009, J NEUROSCI, V29, P1152, DOI 10.1523/JNEUROSCI.0429-08.2009; Kuazi AD, 2003, J PATHOL, V199, P259, DOI 10.1002/path.1283; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mikus P, 2005, SEMIN CELL DEV BIOL, V16, P462, DOI 10.1016/j.semcdb.2005.03.002; Mori F, 2005, NEUROPATH APPL NEURO, V31, P53, DOI 10.1111/j.1365-2990.2004.00603.x; Oono K, 2004, NEUROCHEM INT, V45, P765, DOI 10.1016/j.neuint.2004.01.003; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Peyrl A, 2002, ELECTROPHORESIS, V23, P152, DOI 10.1002/1522-2683(200201)23:1<152::AID-ELPS152>3.0.CO;2-T; Potocki L, 1999, GENOMICS, V57, P180, DOI 10.1006/geno.1998.5748; Potocki L, 2000, J MED GENET, V37, P428, DOI 10.1136/jmg.37.6.428; Richardson KS, 2005, MOL CANCER RES, V3, P645, DOI 10.1158/1541-7786.MCR-05-0233; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Schwechheimer C, 2004, BBA-MOL CELL RES, V1695, P45, DOI 10.1016/j.bbamcr.2004.09.023; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; SHOLL DA, 1953, J ANAT, V87, P387; Smelkinson MG, 2006, CURR BIOL, V16, P110, DOI 10.1016/j.cub.2005.12.012; Spires TL, 2004, EUR J NEUROSCI, V19, P2799, DOI 10.1111/j.0953-816X.2004.03374.x; Suh GSB, 2002, NEURON, V33, P35, DOI 10.1016/S0896-6273(01)00576-1; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	59	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7577	10.1371/journal.pone.0007577	http://dx.doi.org/10.1371/journal.pone.0007577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855832	gold, Green Published, Green Submitted			2022-12-25	WOS:000271147200009
J	Hill, ER; Tian, JB; Tilley, MR; Zhu, MX; Gu, HH				Hill, Erik R.; Tian, Jinbin; Tilley, Michael R.; Zhu, Michael X.; Gu, Howard H.			Potencies of Cocaine Methiodide on Major Cocaine Targets in Mice	PLOS ONE			English	Article							INHIBITION; DOPAMINE; CHANNELS; SODIUM; NOREPINEPHRINE; TRANSPORTERS; SENSITIVITY; ADDICTION; ANALOG	Cocaine methiodide (CM), a charged cocaine analog, cannot pass the blood brain barrier. It has been assumed the effects of systemic CM represent cocaine actions in peripheral tissues. However, the IC50 values of CM have not been clearly determined for the major cocaine targets: dopamine, norepinephrine, and serotonin transporters, and sodium channels. Using cells transfected with individual transporters from mice and synaptosomes from mouse striatum tissues, we observed that the inhibition IC50 values for monoamine uptake by CM were 31-fold to 184-fold higher compared to cocaine at each of the transporters. In dorsal root ganglion neurons, cocaine inhibited sodium channels with an apparent IC50 of 75 mu M, while CM showed no observable effect at concentrations up to 3 mM. These results indicate that an equal dose of CM will not produce an equivalent peripheral effect of cocaine.			Hill, ER (corresponding author), Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA.	gu.37@osu.edu	Tian, JinBin/B-7001-2019; tian, jinbin/L-6006-2019	Tian, JinBin/0000-0002-5516-7778; 	NIDA NIH HHS [R01 DA014610, R01DA020124, R01DA014610, R01 DA020124] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014610, R01DA020124] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; BILLMAN GE, 1995, CRIT REV TOXICOL, V25, P113, DOI 10.3109/10408449509021610; Brown PL, 2006, EUR J NEUROSCI, V24, P1182, DOI 10.1111/j.1460-9568.2006.05001.x; Chen R, 2005, J NEUROCHEM, V94, P352, DOI 10.1111/j.1471-4159.2005.03199.x; Dickerson LW, 1999, J CARDIOVASC PHARM, V33, P36, DOI 10.1097/00005344-199901000-00006; Espana RA, 2008, NEUROSCIENCE, V155, P250, DOI 10.1016/j.neuroscience.2008.05.022; Francis MM, 2001, MOL PHARMACOL, V60, P71, DOI 10.1124/mol.60.1.71; Freeman KB, 2005, PHARMACOL BIOCHEM BE, V80, P281, DOI 10.1016/j.pbb.2004.11.009; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; Kalivas PW, 2007, AM J ADDICTION, V16, P71, DOI 10.1080/10550490601184142; Koob G, 2007, AM J PSYCHIAT, V164, P1149, DOI 10.1176/appi.ajp.2007.05030503; Ma YL, 2006, TOXICOLOGY, V220, P46, DOI 10.1016/j.tox.2005.11.025; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; RITZ MC, 1990, LIFE SCI, V46, P635, DOI 10.1016/0024-3205(90)90132-B; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; SCHINDLER CW, 1992, EUR J PHARMACOL, V213, P99, DOI 10.1016/0014-2999(92)90238-Y; Scholz A, 2002, BRIT J ANAESTH, V89, P52, DOI 10.1093/bja/aef163; SHRIVER DA, 1971, ARCH INT PHARMACOD T, V189, P198; STRYCKER SJ, 1968, J PHARM SCI, V57, P1822, DOI 10.1002/jps.2600571051; Tessel R E, 1978, J Pharmacol Exp Ther, V205, P568; TUFARIELLO JJ, 1979, J AM CHEM SOC, V101, P2435, DOI 10.1021/ja00503a033; Uhl GR, 1996, CURR BIOL, V6, P935, DOI 10.1016/S0960-9822(02)00630-9; Wei H, 2009, NEUROPHARMACOLOGY, V56, P399, DOI 10.1016/j.neuropharm.2008.09.008; Wise RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002846; WITKIN JM, 1991, J PHARMACOL EXP THER, V257, P706; WITKIN JM, 1993, J PHARMACOL EXP THER, V267, P266	26	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7578	10.1371/journal.pone.0007578	http://dx.doi.org/10.1371/journal.pone.0007578			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855831	Green Submitted, gold, Green Published			2022-12-25	WOS:000271147200010
J	Elefsinioti, A; Ackermann, M; Beyer, A				Elefsinioti, Antigoni; Ackermann, Marit; Beyer, Andreas			Accounting for Redundancy when Integrating Gene Interaction Databases	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; INTERACTION NETWORKS; YEAST; SCALE; RESOURCE; MAP; IDENTIFICATION; FRAMEWORK; BIOVERSE; GENOMES	During the last years gene interaction networks are increasingly being used for the assessment and interpretation of biological measurements. Knowledge of the interaction partners of an unknown protein allows scientists to understand the complex relationships between genetic products, helps to reveal unknown biological functions and pathways, and get a more detailed picture of an organism's complexity. Being able to measure all protein interactions under all relevant conditions is virtually impossible. Hence, computational methods integrating different datasets for predicting gene interactions are needed. However, when integrating different sources one has to account for the fact that some parts of the information may be redundant, which may lead to an overestimation of the true likelihood of an interaction. Our method integrates information derived from three different databases (Bioverse, HiMAP and STRING) for predicting human gene interactions. A Bayesian approach was implemented in order to integrate the different data sources on a common quantitative scale. An important assumption of the Bayesian integration is independence of the input data (features). Our study shows that the conditional dependency cannot be ignored when combining gene interaction databases that rely on partially overlapping input data. In addition, we show how the correlation structure between the databases can be detected and we propose a linear model to correct for this bias. Benchmarking the results against two independent reference data sets shows that the integrated model outperforms the individual datasets. Our method provides an intuitive strategy for weighting the different features while accounting for their conditional dependencies.			Elefsinioti, A (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany.	andreas.beyer@biotec.tu-dresden.de	Beyer, Andreas/A-3352-2009; Beyer, Andreas/AAQ-5519-2020	Beyer, Andreas/0000-0002-3891-2123; Beyer, Andreas/0000-0002-3891-2123				Albert J., 2007, BAYESIAN COMPUTATION; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Friedman J, 2000, ANN STAT, V28, P400; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guerquin Michal, 2009, V541, P511, DOI 10.1007/978-1-59745-243-4_22; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2004, CURR OPIN MICROBIOL, V7, P535, DOI 10.1016/j.mib.2004.08.012; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; McDermott J, 2005, NUCLEIC ACIDS RES, V33, pW324, DOI 10.1093/nar/gki401; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Ramirez F, 2007, PROTEOMICS, V7, P2541, DOI 10.1002/pmic.200600924; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1007/BF00116037; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904	38	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7492	10.1371/journal.pone.0007492	http://dx.doi.org/10.1371/journal.pone.0007492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847299	Green Published, gold, Green Submitted			2022-12-25	WOS:000271022000007
J	Shiao, YH; Lupascu, ST; Gu, YD; Kasprzak, W; Hwang, CJ; Fields, JR; Leighty, RM; Quinones, O; Shapiro, BA; Alvord, WG; Anderson, LM				Shiao, Yih-Horng; Lupascu, Sorin T.; Gu, Yuhan D.; Kasprzak, Wojciech; Hwang, Christopher J.; Fields, Janet R.; Leighty, Robert M.; Quinones, Octavio; Shapiro, Bruce A.; Alvord, W. Gregory; Anderson, Lucy M.			An Intergenic Non-Coding rRNA Correlated with Expression of the rRNA and Frequency of an rRNA Single Nucleotide Polymorphism in Lung Cancer Cells	PLOS ONE			English	Article							EXTERNAL TRANSCRIBED SPACER; PARALLEL GENETIC ALGORITHM; SECONDARY STRUCTURE; IN-VIVO; SEQUENCE; PROMOTER; DNA; INITIATION; PREDICTION; MECHANISM	Background: Ribosomal RNA (rRNA) is a central regulator of cell growth and may control cancer development. A cis noncoding rRNA (nc-rRNA) upstream from the 45S rRNA transcription start site has recently been implicated in control of rRNA transcription in mouse fibroblasts. We investigated whether a similar nc-rRNA might be expressed in human cancer epithelial cells, and related to any genomic characteristics. Methodology/Principal Findings: Using quantitative rRNA measurement, we demonstrated that a nc-rRNA is transcribed in human lung epithelial and lung cancer cells, starting from approximately -1000 nucleotides upstream of the rRNA transcription start site (+1) and extending at least to +203. This nc-rRNA was significantly more abundant in the majority of lung cancer cell lines, relative to a nontransformed lung epithelial cell line. Its abundance correlated negatively with total 45S rRNA in 12 of 13 cell lines (P = 0.014). During sequence analysis from -388 to +306, we observed diverse, frequent intercopy single nucleotide polymorphisms (SNPs) in rRNA, with a frequency greater than predicted by chance at 12 sites. A SNP at +139 (U/C) in the 59 leader sequence varied among the cell lines and correlated negatively with level of the nc-rRNA (P = 0.014). Modelling of the secondary structure of the rRNA 5'-leader sequence indicated a small increase in structural stability due to the +139 U/C SNP and a minor shift in local configuration occurrences. Conclusions/Significance: The results demonstrate occurrence of a sense nc-rRNA in human lung epithelial and cancer cells, and imply a role in regulation of the rRNA gene, which may be affected by a +139 SNP in the 5' leader sequence of the primary rRNA transcript.			Shiao, YH (corresponding author), Natl Canc Inst Frederick, Comparat Carcinogenesis Lab, Frederick, MD USA.	shiaoy@mail.nih.gov	Wang, Weili/D-1546-2011; Shiao, Yih-Horng/ABC-7262-2021	Shiao, Yih-Horng/0000-0001-9841-7784	CCR NIH HHS [HHSN261200800001C] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [HHSN261200800001E] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC008382, ZIABC005399] Funding Source: NIH RePORTER	CCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ayrault O, 2006, ONCOGENE, V25, P7577, DOI 10.1038/sj.onc.1209743; Ayrault O, 2006, EXP CELL RES, V312, P1185, DOI 10.1016/j.yexcr.2006.01.027; Barrandon C, 2008, BIOL CELL, V100, P83, DOI 10.1042/BC20070090; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; Brown SE, 2007, MOL CELL BIOL, V27, P4938, DOI 10.1128/MCB.01880-06; Cui CH, 2004, CANCER RES, V64, P5651, DOI 10.1158/0008-5472.CAN-04-0801; DECAPOA A, 1985, HUM GENET, V69, P212, DOI 10.1007/BF00293027; DECAPOA A, 1985, J CELL SCI, V74, P21; DEHNE N, 2002, HEARING RES, V16, P947; Demirtas H, 2009, MICRON, V40, P511, DOI 10.1016/j.micron.2009.02.014; Drygin Denis, 2008, Proceedings of the American Association for Cancer Research Annual Meeting, V49, P784; Gee AH, 2006, J BIOMOL STRUCT DYN, V23, P417, DOI 10.1080/07391102.2006.10531236; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; HUTCHIN T, 1994, ANTIMICROB AGENTS CH, V38, P2517, DOI 10.1128/AAC.38.11.2517; JONES MH, 1988, P NATL ACAD SCI USA, V85, P669, DOI 10.1073/pnas.85.3.669; Kasprzak W, 1999, BIOINFORMATICS, V15, P16, DOI 10.1093/bioinformatics/15.1.16; Kasprzak W, 2005, NUCLEIC ACIDS RES, V33, P7151, DOI 10.1093/nar/gki1015; KASS S, 1987, MOL CELL BIOL, V7, P2891, DOI 10.1128/MCB.7.8.2891; Kriegova E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-69; Kuo BA, 1996, NUCLEIC ACIDS RES, V24, P4817, DOI 10.1093/nar/24.23.4817; LEFFERS H, 1993, NUCLEIC ACIDS RES, V21, P1449, DOI 10.1093/nar/21.6.1449; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Linnstaedt SD, 2006, RNA, V12, P1521, DOI 10.1261/rna.89306; Linnstaedt SD, 2009, RNA, V15, P1177, DOI 10.1261/rna.1504009; MADEN BEH, 1987, BIOCHEM J, V246, P519, DOI 10.1042/bj2460519; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; MASER RL, 1989, P NATL ACAD SCI USA, V86, P6523, DOI 10.1073/pnas.86.17.6523; Masuda A, 1997, CANCER RES, V57, P4898; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mayer C, 2008, EMBO REP, V9, P774, DOI 10.1038/embor.2008.109; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; MCGOWAN PO, 2008, PLOS ONE, V3, DOI DOI 10.1371/JOURNAL/PONE.0002085; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; MICHOT B, 1991, EUR J BIOCHEM, V195, P601, DOI 10.1111/j.1432-1033.1991.tb15743.x; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; O'Brien Sean E., 2008, Proceedings of the American Association for Cancer Research Annual Meeting, V49, P556; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; QU LH, 1991, NUCLEIC ACIDS RES, V19, P1015, DOI 10.1093/nar/19.5.1015; RENALIER MH, 1989, FEBS LETT, V249, P279, DOI 10.1016/0014-5793(89)80641-6; RENALIER MH, 1989, FEBS LETT, V247, P298, DOI 10.1016/0014-5793(89)81356-0; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Serin G, 1996, BIOCHIMIE, V78, P530, DOI 10.1016/0300-9084(96)84759-6; Shapiro BA, 1996, J MOL GRAPH MODEL, V14, P194, DOI 10.1016/S0263-7855(96)00063-X; Shapiro BA, 1996, COMPUT APPL BIOSCI, V12, P171; SHAPIRO BA, 1994, J SUPERCOMPUT, V8, P195, DOI 10.1007/BF01204728; Shapiro BA, 2001, J MOL BIOL, V312, P27, DOI 10.1006/jmbi.2001.4931; Shapiro BA, 2001, BIOINFORMATICS, V17, P137, DOI 10.1093/bioinformatics/17.2.137; SHAPIRO BA, 1996, J MOL GRAPHICS, V14, P222; Shapiro BA, 2006, J MOL GRAPH MODEL, V25, P514, DOI 10.1016/j.jmgm.2006.04.004; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; TRUSS M, 1992, NUCLEIC ACIDS RES, V20, P1483, DOI 10.1093/nar/20.7.1483; Tseng H, 1998, Front Biosci, V3, pD985; TSENG H, 2008, PLOS ONE, V3, DOI DOI 10.1371/JOURNAL.PONE.00001834; Umlauf D, 2008, BIOL CHEM, V389, P323, DOI 10.1515/BC.2008.047; Van Camp G, 2000, CLIN GENET, V57, P409, DOI 10.1034/j.1399-0004.2000.570601.x; WORTON RG, 1988, SCIENCE, V239, P64, DOI 10.1126/science.3336775; Zhang SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000902; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	61	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7505	10.1371/journal.pone.0007505	http://dx.doi.org/10.1371/journal.pone.0007505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838300	gold, Green Published, Green Submitted			2022-12-25	WOS:000270880900009
J	Costa, A; Jan, E; Sarnow, P; Schneider, D				Costa, Alexandre; Jan, Eric; Sarnow, Peter; Schneider, David			The Imd Pathway Is Involved in Antiviral Immune Responses in Drosophila	PLOS ONE			English	Article							CRICKET PARALYSIS VIRUS; NF-KAPPA-B; HOST-DEFENSE; PGRP-LC; MELANOGASTER; ACTIVATION; INFECTION; PROTEIN; TOLL; BACTERIAL	Cricket Paralysis virus (CrPV) is a member of the Dicistroviridae family of RNA viruses, which infect a broad range of insect hosts, including the fruit fly Drosophila melanogaster. Drosophila has emerged as an effective system for studying innate immunity because of its powerful genetic techniques and the high degree of gene and pathway conservation. Intra-abdominal injection of CrPV into adult flies causes a lethal infection that provides a robust assay for the identification of mutants with altered sensitivity to viral infection. To gain insight into the interactions between viruses and the innate immune system, we injected wild type flies with CrPV and observed that antimicrobial peptides (AMPs) were not induced and hemocytes were depleted in the course of infection. To investigate the contribution of conserved immune signaling pathways to antiviral innate immune responses, CrPV was injected into isogenic mutants of the Immune Deficiency (Imd) pathway, which resembles the mammalian Tumor Necrosis Factor Receptor (TNFR) pathway. Loss-of-function mutations in several Imd pathway genes displayed increased sensitivity to CrPV infection and higher CrPV loads. Our data show that antiviral innate immune responses in flies infected with CrPV depend upon hemocytes and signaling through the Imd pathway.			Costa, A (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	dschneider@stanford.edu	Jan, Eric/O-1923-2019	Sarnow, Peter/0000-0002-2043-2770	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069164] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ayres JS, 2008, GENETICS, V178, P1807, DOI 10.1534/genetics.107.083782; Bangham J, 2008, GENETICS, V178, P2191, DOI 10.1534/genetics.107.085449; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Benedict CA, 2003, CURR OPIN IMMUNOL, V15, P59, DOI 10.1016/S0952-7915(02)00018-3; Braun A, 1997, GENETICS, V147, P623; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; Brennan CA, 2007, CURR BIOL, V17, P67, DOI 10.1016/j.cub.2006.11.026; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; Choe KM, 2005, P NATL ACAD SCI USA, V102, P1122, DOI 10.1073/pnas.0404952102; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Chotkowski HL, 2008, VIROLOGY, V377, P197, DOI 10.1016/j.virol.2008.04.021; Chung HK, 1996, VIROLOGY, V225, P359, DOI 10.1006/viro.1996.0610; Corby-Harris V, 2007, J EVOLUTION BIOL, V20, P526, DOI 10.1111/j.1420-9101.2006.01267.x; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Dionne MS, 2008, DIS MODEL MECH, V1, P43, DOI 10.1242/dmm.000307; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Fields B. N., 2007, FIELDS VIROLOGY; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Goto A, 2001, BIOCHEM J, V359, P99, DOI 10.1042/0264-6021:3590099; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hedengren-Olcott M, 2004, J BIOL CHEM, V279, P21121, DOI 10.1074/jbc.M313856200; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hedges LM, 2008, J GEN VIROL, V89, P1497, DOI 10.1099/vir.0.83684-0; Herbein G, 2000, P SOC EXP BIOL MED, V223, P241, DOI 10.1046/j.1525-1373.2000.22335.x; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MOORE N, 1991, VIRUSES INVERTEBRATE, P287; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Reed L.J., 1938, SIMPLE METHOD ESTIMA, V27, P493, DOI [10.1093/oxfordjournals.aje.a118408, DOI 10.1093/OXFORDJOURNALS.AJE.A118408]; REINGANUM C, 1975, INTERVIROLOGY, V5, P97, DOI 10.1159/000149886; REINGANUM C, 1970, J INVERTEBR PATHOL, V16, P214, DOI 10.1016/0022-2011(70)90062-5; ROSETTO M, 1995, BIOCHEM BIOPH RES CO, V209, P111, DOI 10.1006/bbrc.1995.1477; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Sabatier L, 2003, EUR J BIOCHEM, V270, P3398, DOI 10.1046/j.1432-1033.2003.03725.x; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Schmidt RL, 2008, FASEB J, V22, P918, DOI 10.1096/fj.06-7907com; Schneider D, 2000, SCIENCE, V288, P2376, DOI 10.1126/science.288.5475.2376; Schneider DS, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030041; SCHNEIDER I, 1964, J EXP ZOOL, V156, P91, DOI 10.1002/jez.1401560107; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SCOTTI PD, 1976, INTERVIROLOGY, V6, P333, DOI 10.1159/000149489; SCOTTI PD, 1977, J GEN VIROL, V35, P393, DOI 10.1099/0022-1317-35-2-393; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Sinenko SA, 2004, ONCOGENE, V23, P9120, DOI 10.1038/sj.onc.1208156; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tate J, 1999, NAT STRUCT BIOL, V6, P765, DOI 10.1038/11543; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Trudeau D, 2001, J VIROL, V75, P996, DOI 10.1128/JVI.75.2.996-1003.2001; Tsai CW, 2008, APPL ENVIRON MICROB, V74, P3251, DOI 10.1128/AEM.02248-07; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	72	171	181	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7436	10.1371/journal.pone.0007436	http://dx.doi.org/10.1371/journal.pone.0007436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829691	Green Submitted, Green Published, gold			2022-12-25	WOS:000270847800002
J	Saxena, S; Bottle, A; Gilbert, R; Sharland, M				Saxena, Sonia; Bottle, Alex; Gilbert, Ruth; Sharland, Mike			Increasing Short-Stay Unplanned Hospital Admissions among Children in England; Time Trends Analysis '97-'06	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; HEALTH-SERVICES; UNITED-STATES; ACUTELY ILL; CARE; CONTINUITY; PARENTS; CHILDHOOD; PROVIDER; QUALITY	Background: Timely care by general practitioners in the community keeps children out of hospital and provides better continuity of care. Yet in the UK, access to primary care has diminished since 2004 when changes in general practitioners' contracts enabled them to 'opt out' of providing out-of-hours care and since then unplanned pediatric hospital admission rates have escalated, particularly through emergency departments. We hypothesised that any increase in isolated short stay admissions for childhood illness might reflect failure to manage these cases in the community over a 10 year period spanning these changes. Methods and Findings: We conducted a population based time trends study of major causes of hospital admission in children <10 years using the Hospital Episode Statistics database, which records all admissions to all NHS hospitals in England using ICD10 codes. Outcomes measures were total and isolated short stay unplanned hospital admissions (lasting less than 2 days without readmission within 28 days) from 1997 to 2006. Over the period annual unplanned admission rates in children aged <10 years rose by 22% (from 73.6/1000 to 89.5/1000 child years) with larger increases of 41% in isolated short stay admissions (from 42.7/1000 to 60.2/1000 child years). There was a smaller fall of 12% in admissions with length of stay of >2 days. By 2006, 67.3% of all unplanned admissions were isolated short stays,2 days. The increases in admission rates were greater for common non-infectious than infectious causes of admissions. Conclusions: Short stay unplanned hospital admission rates in young children in England have increased substantially in recent years and are not accounted for by reductions in length of in-hospital stay. The majority are isolated short stay admissions for minor illness episodes that could be better managed by primary care in the community and may be evidence of a failure of primary care services.			Saxena, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London, England.	s.saxena@imperial.ac.uk	Saxena, Sonia K/G-4821-2013; Saxena, Sonia/ABD-7737-2021	Saxena, Sonia K/0000-0003-3787-2083; Saxena, Sonia/0000-0003-3787-2083; sharland, mike/0000-0001-8626-8291; Bottle, Alex/0000-0001-9978-2011; Gilbert, Ruth/0000-0001-9347-2709	Department of Health [PDA/02/06/076] Funding Source: Medline; Medical Research Council [G0400546B] Funding Source: researchfish; National Institute for Health Research [PDA/02/06/076] Funding Source: researchfish	Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Agency for Healthcare Research and Quality, 2008, CLIN CLASS SOFTW CCS; Chief Nursing Officer's Directorate Children Families and Maternity Analysis, 2008, TRENDS CHILDR YOUNG; Christakis DA, 2001, PEDIATRICS, V107, P524, DOI 10.1542/peds.107.3.524; *DEP HLTH, 2008, EV CHILD MATT; *DEP HLTH, 2009, HLTH LIV BRIGH FUT S; *DEP HLTH, 1998, HES BOOK; Dixon J, 1998, J PUBLIC HEALTH MED, V20, P63, DOI 10.1093/oxfordjournals.pubmed.a024721; Flores G, 2003, PEDIATRICS, V112, P1021, DOI 10.1542/peds.112.5.1021; Gadomski A, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e1; Gill JM, 1998, ARCH FAM MED, V7, P352, DOI 10.1001/archfami.7.4.352; Hargreaves S, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-153; *HEALTHC COMM, 2005, NHS PERF RAT 2004 20; Hippisley-Cox J, 2007, TRENDS CONSULTATION; Horton R, 2008, LANCET, V372, P3, DOI 10.1016/S0140-6736(08)60963-0; Inkelas M, 2004, PEDIATRICS, V113, P1917; Kai J, 1996, BRIT MED J, V313, P987; Kai J, 1996, BRIT MED J, V313, P983; Kmietowicz Z, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1207; Lachman P, 2004, BRIT MED J, V329, P693, DOI 10.1136/bmj.329.7468.693; Leibowitz R, 2003, FAM PRACT, V20, P311, DOI 10.1093/fampra/cmg313; MacFaul R, 2001, ARCH DIS CHILD, V85, P203, DOI 10.1136/adc.85.3.203; McDonald KM, 2008, PEDIATRICS, V122, pE416, DOI 10.1542/peds.2007-2477; National Collaborating Centre for Women's and Children's Health, 2007, FEV ILLN CHILDR ASS; *NHS CONF, 2003, INV GEN PRACT NEW GE; NHS Institute for Innovation and Improvement, 2008, FOC EM URG CAR PATHW; *OFF NAT STAT, 2009, MID 1997 POP EST ENG; Ogilvie D, 2005, ARCH DIS CHILD, V90, P138, DOI 10.1136/adc.2003.035543; *ORG EC COOP DEV, 2001, HLTH GLANC; Roland M, 2008, NEW ENGL J MED, V359, P2087, DOI 10.1056/NEJMp0805633; Royal College of Paediatrics and Child Health, 2008, MOD FUT; Salisbury C, 2000, BRIT MED J, V320, P618, DOI 10.1136/bmj.320.7235.618; Saxena S, 1999, BRIT MED J, V318, P642, DOI 10.1136/bmj.318.7184.642; Saxena S, 2002, BMJ-BRIT MED J, V325, P520, DOI 10.1136/bmj.325.7363.520; Starfield B., 1992, PRIMARY CARE CONCEPT; Stephenson T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1783; Stewart M, 1998, ARCH DIS CHILD, V79, P219, DOI 10.1136/adc.79.3.219; Wise PH, 2007, J PEDIATR-US, V151, pS6, DOI 10.1016/j.jpeds.2007.08.013; Wise PH, 2004, HEALTH AFFAIR, V23, P9, DOI 10.1377/hlthaff.23.5.9	38	68	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7484	10.1371/journal.pone.0007484	http://dx.doi.org/10.1371/journal.pone.0007484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829695	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000270847800017
J	Gilbert, MM; Robinson, BS; Moberg, KH				Gilbert, M. Melissa; Robinson, Brian S.; Moberg, Kenneth H.			Functional Interactions between the erupted/tsg101 Growth Suppressor Gene and the DaPKC and rbf1 Genes in Drosophila Imaginal Disc Tumors	PLOS ONE			English	Article							NEUROBLAST SELF-RENEWAL; CELL POLARITY; FOLLICLE CELLS; NOTCH PATHWAY; CYCLIN-E; PROTEIN; PROLIFERATION; APOPTOSIS; COMPLEX; EYE	Background: The Drosophila gene erupted (ept) encodes the fly homolog of human Tumor Susceptibility Gene-101 (TSG101), which functions as part of the conserved ESCRT-1 complex to facilitate the movement of cargoes through the endolysosomal pathway. Loss of ept or other genes that encode components of the endocytic machinery (e. g. synatxin7/avalanche, rab5, and vps25) produces disorganized overgrowth of imaginal disc tissue. Excess cell division is postulated to be a primary cause of these 'neoplastic' phenotypes, but the autonomous effect of these mutations on cell cycle control has not been examined. Principal Findings: Here we show that disc cells lacking ept function display an altered cell cycle profile indicative of deregulated progression through the G1-to-S phase transition and express reduced levels of the tumor suppressor ortholog and G1/S inhibitor Rbf1. Genetic reductions of the Drosophila aPKC kinase (DaPKC), which has been shown to promote tumor growth in other fly tumor models, prevent both the ept neoplastic phenotype and the reduction in Rbf1 levels that otherwise occurs in clones of ept mutant cells; this effect is coincident with changes in localization of Notch and Crumbs, two proteins whose sorting is altered in ept mutant cells. The effect on Rbf1 can also be blocked by removal of the gamma-secretase component presenilin, suggesting that cleavage of a gamma-secretase target influences Rbf1 levels in ept mutant cells. Expression of exogenous rbf1 completely ablates ept mutant eye tissues but only mildly affects the development of discs composed of cells with wild type ept. Conclusions: Together, these data show that loss of ept alters nuclear cell cycle control in developing imaginal discs and identify the DaPKC, presenilin, and rbf1 genes as modifiers of molecular and cellular phenotypes that result from loss of ept.			Gilbert, MM (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	kmoberg@cellbio.emory.edu	Moberg, Ken/J-4849-2017	Moberg, Ken/0000-0002-9820-5543; Gilbert-Ross, Melissa/0000-0002-1960-8302	NCI NIH HHS [R01 CA123368-01, R01 CA123368-03, R01 CA123368-04, R01 CA123368-05, R01 CA123368, R01 CA123368-02] Funding Source: Medline; NIGMS NIH HHS [F32 GM077898, T32 GM008169, F32-GM077898] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA123368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077898, T32GM008169] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Baonza A, 2005, DEV CELL, V8, P529, DOI 10.1016/j.devcel.2005.01.019; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Firth LC, 2005, DEV CELL, V8, P541, DOI 10.1016/j.devcel.2005.01.017; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Henrique D, 2003, CURR OPIN GENET DEV, V13, P341, DOI 10.1016/S0959-437X(03)00077-7; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; HOLLEY CL, 2002, NAT CELL BIOL, V14, P14; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lisi S, 2000, GENETICS, V154, P669; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Mahoney MB, 2006, GENETICS, V172, P2309, DOI 10.1534/genetics.104.035170; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Pellock BJ, 2007, DEV BIOL, V304, P102, DOI 10.1016/j.ydbio.2006.12.021; Pignoni F, 1997, DEVELOPMENT, V124, P271; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; RYOO HD, 2002, NAT CELL BIOL, V20, P20; Schaeffer V, 2004, CURR BIOL, V14, P630, DOI 10.1016/j.cub.2004.03.040; Shcherbata HR, 2004, DEVELOPMENT, V131, P3169, DOI 10.1242/dev.01172; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Spradling AC, 1999, GENETICS, V153, P135; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WOLFF T, 1991, DEVELOPMENT, V113, P841; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793	51	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7039	10.1371/journal.pone.0007039	http://dx.doi.org/10.1371/journal.pone.0007039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19855819	gold, Green Published			2022-12-25	WOS:000270290100001
J	Nakao, S; Maruyama, K; Zandi, S; Melhorn, MI; Taher, M; Noda, K; Nusayr, E; Doetschman, T; Hafezi-Moghadam, A				Nakao, Shintaro; Maruyama, Kazuichi; Zandi, Souska; Melhorn, Mark I.; Taher, Mahdi; Noda, Kousuke; Nusayr, Eyad; Doetschman, Tom; Hafezi-Moghadam, Ali			Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strains	FASEB JOURNAL			English	Article						cornea; conjunctiva; VEGF-A; FGF-2; VEGF-C; LYVE-1	FIBROBLAST-GROWTH-FACTOR; LYMPHATIC VESSELS; GENETIC-LOCI; FACTOR-C; NEOVASCULARIZATION; INFLAMMATION; HYPERPLASIA; MACROPHAGES; CORNEA; CELLS	Genetic background significantly affects angiogenesis in mice. However, lymphangiogenic response to growth factors (GFs) in different strains has not been studied. We report constitutive expression of corneal lymphatics that extends beyond the limits of normal limbal vessels. In untreated corneas, the total number (P = 0.006), the number above blood vessels (P = 10(-8)), and the area of preexisting lymphatics (P = 0.007) were significantly higher in C57BL/6 than in BALB/c mice. Normal corneas of three other strains, the nu/nu, 129E, and Black Swiss mice, showed in most parameters intermediate phenotypes. FGF-2(-/-) mice showed significantly less preexisting lymphatics than control (P = 0.009), which suggests a role for this GF in lymphatic development. VEGF-A-induced corneal lymphangiogenic response was significantly higher in BALB/c mice (P = 0.03), but it did not differ significantly in C57BL/6 mice, when compared to PBS-implanted control. FGFR-3 expression was higher in C57BL/6 than BALB/c mice, which suggests GF-receptor heterogeneity as a possible explanation for strain-dependent differences. The heterogeneity of preexisting lymphatic vessels in the limbal area significantly correlated with the extent of corneal lymphangiogenesis (VEGF-A: r = 0.7, P = 0.01; FGF-2: r = 0.96, P = 10(-5)) in BALB/c but not in C57BL/6 mice. Removal of conjunctival lymphatics did not affect GF-induced lymphangiogenesis. This work introduces physiological expression of lymphatics without blood vessels, which indicates that angiogenesis and lymphangiogenesis, even though intricately related, may occur independently. Furthermore, we show strain-dependence of normal and GF-induced lymphangiogenesis. These differences may affect disease development in various strains.-Nakao, S., Maruyama, K., Zandi, S., Melhorn, M. I., Taher, M., Noda, K., Nusayr, E., Doetschman, T., Hafezi-Moghadam, A. Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strains. FASEB J. 24, 504-513 (2010). www.fasebj.org	[Nakao, Shintaro; Zandi, Souska; Melhorn, Mark I.; Taher, Mahdi; Noda, Kousuke; Hafezi-Moghadam, Ali] Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA USA; [Nakao, Shintaro; Zandi, Souska; Melhorn, Mark I.; Taher, Mahdi; Noda, Kousuke; Hafezi-Moghadam, Ali] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; [Maruyama, Kazuichi] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Nusayr, Eyad; Doetschman, Tom] Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ USA; [Nusayr, Eyad; Doetschman, Tom] Univ Arizona, Inst BIO5, Tucson, AZ USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Eye & Ear Infirmary; Kyoto Prefectural University of Medicine; University of Arizona; University of Arizona	Hafezi-Moghadam, A (corresponding author), Angiogenesis Lab, 325 Cambridge St,3rd Floor, Boston, MA 02114 USA.	ali_hafezi-moghadam@meei.harvard.edu	Maruyama, Kazuichi/GRX-8129-2022	Maruyama, Kazuichi/0000-0001-6283-5466; Hafezi-Moghadam, Ali/0000-0002-5336-0697; Taher, Mahdi/0000-0001-8454-9751; Zandi, Souska/0000-0001-9351-4278	NIH [AI050775, HL086933, HL070174]; American Health Assistance Foundation; Japan Eye Bank Association and Tear Film and Ocular Surface Society; Young Investigator Fellowship; Massachusetts Lions Eye Research Fund; Research to Prevent Blindness; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070174, R01HL086933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI050775] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); Japan Eye Bank Association and Tear Film and Ocular Surface Society; Young Investigator Fellowship; Massachusetts Lions Eye Research Fund; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants AI050775 (A.H.-M.), HL086933 (Alan Cross, University of Maryland, principal investigator, and A. H.-M.), and HL070174 (T. D.), the American Health Assistance Foundation (A. H.-M.), an overseas research fellowship award from Bausch & Lomb, a fellowship award from the Japan Eye Bank Association and Tear Film and Ocular Surface Society, a Young Investigator Fellowship (to S.N. under the mentorship of A. H.-M.), the Massachusetts Lions Eye Research Fund, and Research to Prevent Blindness. The authors thank Alexander Schering and Eiichi Sekiyama for their help with the preparation of the manuscript and Dr. Patricia D'Amore for her critical view of the work and helpful suggestions.	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; AOKI K, 1951, KAIBO GOKU ZASSHI, V24, P142; Baluk P, 2005, J CLIN INVEST, V115, P247, DOI 10.1172/JCI200522037; Bjorndahl MA, 2005, CANCER RES, V65, P9261, DOI 10.1158/0008-5472.CAN-04-2345; Cao RH, 2004, CIRC RES, V94, P664, DOI 10.1161/01.RES.0000118600.91698.BB; Chang LK, 2004, P NATL ACAD SCI USA, V101, P11658, DOI 10.1073/pnas.0404272101; Chen L, 2005, INVEST OPHTH VIS SCI, V46, P4536, DOI 10.1167/iovs.05-0975; Collin H B, 1966, Invest Ophthalmol, V5, P337; Cursiefen C, 2006, CORNEA, V25, P443, DOI 10.1097/01.ico.0000183485.85636.ff; Cursiefen C, 2004, INVEST OPHTH VIS SCI, V45, P2666, DOI 10.1167/iovs.03-1380; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Cursiefen C, 2006, CORNEA, V25, P722, DOI 10.1097/01.ico.0000214230.21238.3d; FOLKMAN J, 1988, AM J PATHOL, V130, P393; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kubo H, 2002, P NATL ACAD SCI USA, V99, P8868, DOI 10.1073/pnas.062040199; Lohela M, 2008, AM J PATHOL, V173, P1891, DOI 10.2353/ajpath.2008.080378; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Nakao S, 2003, J IMMUNOL, V170, P5704, DOI 10.4049/jimmunol.170.11.5704; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Nakao S, 2007, AM J PATHOL, V171, P1058, DOI 10.2353/ajpath.2007.070172; Rogers MS, 2004, FASEB J, V18, P1050, DOI 10.1096/fj.03-1241com; Rogers MS, 2003, FASEB J, V17, P2112, DOI 10.1096/fj.03-0246fje; Rohan RM, 2000, FASEB J, V14, P871, DOI 10.1096/fasebj.14.7.871; Shin JW, 2006, MOL BIOL CELL, V17, P576, DOI 10.1091/mbc.E05-04-0368; Watari K, 2008, BIOCHEM BIOPH RES CO, V377, P826, DOI 10.1016/j.bbrc.2008.10.077; Yamada J, 1998, TRANSPL IMMUNOL, V6, P161, DOI 10.1016/S0966-3274(98)80041-5; Zhou M, 1998, NAT MED, V4, P201, DOI 10.1038/nm0298-201	29	39	41	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2010	24	2					504	513		10.1096/fj.09-134056	http://dx.doi.org/10.1096/fj.09-134056			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	549JS	19858096	Green Published			2022-12-25	WOS:000274045000018
J	Ha, SD; Ham, B; Mogridge, J; Saftig, P; Lin, SC; Kim, SO				Ha, Soon-Duck; Ham, Boram; Mogridge, Jeremy; Saftig, Paul; Lin, Shengcai; Kim, Sung Ouk			Cathepsin B-mediated Autophagy Flux Facilitates the Anthrax Toxin Receptor 2-mediated Delivery of Anthrax Lethal Factor into the Cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPILLARY MORPHOGENESIS PROTEIN-2; MACROPHAGE CELL-DEATH; PROTECTIVE ANTIGEN; BACILLUS-ANTHRACIS; LATE ENDOSOMES; NALP3 INFLAMMASOME; TUMOR ENDOTHELIUM; MEMBRANE; FUSION; LYSOSOMES	Anthrax lethal toxin (LeTx) is a virulence factor secreted by Bacillus anthracis and has direct cytotoxic effects on most cells once released into the cytoplasm. The cytoplasmic delivery of the proteolytically active component of LeTx, lethal factor (LF), is carried out by the transporter component, protective antigen, which interacts with either of two known surface receptors known as anthrax toxin receptor (ANTXR) 1 and 2. We found that the cytoplasmic delivery of LF by ANTXR2 was mediated by cathepsin B (CTSB) and required lysosomal fusion with LeTx-containing endosomes. Also, binding of protective antigen to ANXTR1 or 2 triggered autophagy, which facilitated the cytoplasmic delivery of ANTXR2-associated LF. We found that whereas cells treated with the membrane-permeable CTSB inhibitor CA074-Me- or CTSB-deficient cells had no defect in fusion of LC3-containing autophagic vacuoles with lysosomes, autophagic flux was significantly delayed. These results suggested that the ANTXR2-mediated cytoplasmic delivery of LF was enhanced by CTSB-dependent autophagic flux.	[Ha, Soon-Duck; Ham, Boram; Kim, Sung Ouk] Univ Western Ontario, Dept Microbiol & Immunol, Siebens Drake Res Inst, London, ON N6G 2V4, Canada; [Ha, Soon-Duck; Ham, Boram; Kim, Sung Ouk] Univ Western Ontario, Infect Dis Res Grp, Siebens Drake Res Inst, London, ON N6G 2V4, Canada; [Mogridge, Jeremy] Univ Toronto, Dept Lab Med & Pathol, Toronto, ON N5S 1A8, Canada; [Lin, Shengcai] Xiamen Univ, Sch Life Sci, Xiamen 361005, Peoples R China; [Saftig, Paul] Univ Kiel, Inst Biochem, D-24118 Kiel, Germany	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; Xiamen University; University of Kiel	Kim, SO (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, Siebens Drake Res Inst, London, ON N6G 2V4, Canada.	sung.kim@schulich.uwo.ca	KIM, Sung Ouk/A-1309-2008; Kim, Sung Ouk/AAO-1795-2020; Saftig, Paul/A-7966-2010; Lin, SC/G-4666-2010	Kim, Sung Ouk/0000-0002-0282-6661; 	Canadian Institute of Health Research Operating [MOP68841]; China-Canada Joint Health Research Initiative [CCI82416]	Canadian Institute of Health Research Operating(Canadian Institutes of Health Research (CIHR)); China-Canada Joint Health Research Initiative	This work was supported by Canadian Institute of Health Research Operating Grant MOP68841 and China-Canada Joint Health Research Initiative Grant CCI82416 (to S. O. K.).	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2004, J CELL BIOL, V166, P645, DOI 10.1083/jcb.200312072; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Abrami L, 2008, CELL MICROBIOL, V10, P2509, DOI 10.1111/j.1462-5822.2008.01226.x; ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Banks DJ, 2005, CELL MICROBIOL, V7, P1173, DOI 10.1111/j.1462-5822.2005.00545.x; Blom TS, 2003, HUM MOL GENET, V12, P257, DOI 10.1093/hmg/ddg025; Bonuccelli G, 2005, AM J PHYSIOL-CELL PH, V288, pC1402, DOI 10.1152/ajpcell.00582.2004; Bottger G, 1996, J BIOL CHEM, V271, P29191, DOI 10.1074/jbc.271.46.29191; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Bright NA, 1997, J CELL SCI, V110, P2027; Carson-Walter EB, 2001, CANCER RES, V61, P6649; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; FENGSRUD M, 1995, EXP CELL RES, V221, P504, DOI 10.1006/excr.1995.1402; Go MY, 2009, INFECT IMMUN, V77, P52, DOI 10.1128/IAI.01073-08; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Ha SD, 2008, J IMMUNOL, V181, P690, DOI 10.4049/jimmunol.181.1.690; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hentze H, 2003, CELL DEATH DIFFER, V10, P956, DOI 10.1038/sj.cdd.4401264; Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; HOYVIK H, 1991, J CELL BIOL, V113, P1305, DOI 10.1083/jcb.113.6.1305; Hui C, 2006, CELL SIGNAL, V18, P1844, DOI 10.1016/j.cellsig.2006.04.006; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim SO, 2003, J EXP MED, V197, P1441, DOI 10.1084/jem.20021842; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Liu SH, 2003, J BIOL CHEM, V278, P5227, DOI 10.1074/jbc.M210321200; Liu SL, 2009, P NATL ACAD SCI USA, V106, P12424, DOI 10.1073/pnas.0905409106; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; McGrath ME, 1999, ANNU REV BIOPH BIOM, V28, P181, DOI 10.1146/annurev.biophys.28.1.181; MIKESELL P, 1983, INFECT IMMUN, V39, P371, DOI 10.1128/IAI.39.1.371-376.1983; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Montaser M, 2002, BIOL CHEM, V383, P1305, DOI 10.1515/BC.2002.147; Mullock BM, 1998, J CELL BIOL, V140, P591, DOI 10.1083/jcb.140.3.591; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Newman ZL, 2009, INFECT IMMUN, V77, P4327, DOI 10.1128/IAI.00730-09; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rmali KA, 2004, INT J MOL MED, V14, P75; Scobie HM, 2006, PLOS PATHOG, V2, P949, DOI 10.1371/journal.ppat.0020111; Scobie HM, 2005, CURR OPIN MICROBIOL, V8, P106, DOI 10.1016/j.mib.2004.12.005; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; St Croix B, 2000, SCIENCE, V289, P1197; Tan YK, 2009, BIOCHEM BIOPH RES CO, V379, P293, DOI 10.1016/j.bbrc.2008.12.048; Tang GQ, 1999, INFECT IMMUN, V67, P3055, DOI 10.1128/IAI.67.6.3055-3060.1999; van der Goot FG, 2006, TRENDS CELL BIOL, V16, P514, DOI 10.1016/j.tcb.2006.08.003; Vitale G, 1998, BIOCHEM BIOPH RES CO, V248, P706, DOI 10.1006/bbrc.1998.9040; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Wolfe JT, 2005, J BIOL CHEM, V280, P39417, DOI 10.1074/jbc.M509049200; Yan SQ, 2003, BIOL CHEM, V384, P845, DOI 10.1515/BC.2003.095	68	57	58	3	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 15	2010	285	3					2120	2129		10.1074/jbc.M109.065813	http://dx.doi.org/10.1074/jbc.M109.065813			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	541PJ	19858192	Green Published, hybrid			2022-12-25	WOS:000273429100056
J	Puri, C; Chibalina, MV; Arden, SD; Kruppa, AJ; Kendrick-Jones, J; Buss, F				Puri, C.; Chibalina, M. V.; Arden, S. D.; Kruppa, A. J.; Kendrick-Jones, J.; Buss, F.			Overexpression of myosin VI in prostate cancer cells enhances PSA and VEGF secretion, but has no effect on endocytosis	ONCOGENE			English	Article						myosin VI; prostate cancer; PSA; VEGF	EPITHELIAL-MESENCHYMAL TRANSITION; UNCONVENTIONAL MYOSIN; MEDIATED ENDOCYTOSIS; SERINE PROTEASES; GOLGI-COMPLEX; MDCK CELLS; E-CADHERIN; PROTEIN; DISABLED-2; MEMBRANE	Tissue expression microarrays, employed to determine the players and mechanisms leading to prostate cancer development, have consistently shown that myosin VI, a unique actin-based motor, is upregulated in medium-grade human prostate cancers. Thus, to understand the role of myosin VI in prostate cancer development, we have characterized its intracellular localization and function in the prostate cancer cell line LNCaP. Using light and electron microscopy, we identified myosin VI on Rab5-positive early endosomes, as well as on recycling endosomes and the trans-Golgi network. Intracellular targeting seems to involve two myosin VI-interacting proteins, GIPC and LMTK2, both of which can be co-immunoprecipitated with myosin VI from LNCaP cells. The absence of Disabled-2 (Dab2), a tumour suppressor and myosin VI-binding partner, inhibits recruitment of myosin VI to endocytic structures at the plasma membrane in LNCaP cells, but interestingly has no effect on endocytosis. Small interfering RNA-mediated down-regulation of myosin VI expression results in a significant reduction in prostate-specific antigen (PSA) and vascular endothelial growth factor (VEGF) secretion in LNCaP cells. Our results suggest that in prostate cancer cells, myosin VI regulates protein secretion, but the overexpression of myosin VI has no major impact on clathrin-mediated endocytosis. Oncogene (2010) 29, 188-200; doi:10.1038/onc.2009.328; published online 26 October 2009	[Puri, C.; Chibalina, M. V.; Arden, S. D.; Kruppa, A. J.; Buss, F.] Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England; [Kendrick-Jones, J.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of Cambridge; MRC Laboratory Molecular Biology	Buss, F (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	fb1@mole.bio.cam.ac.uk		Buss, Folma/0000-0003-4457-3479	Cancer Research UK; Wellcome Trust; Medical Research Council; MRC [MC_U105184323] Funding Source: UKRI; Medical Research Council [MC_U105184323] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank A Peden for help with transferrin uptake assays and JP Luzio for helpful discussions. This work was funded by the Cancer Research UK project grant (CP), the Wellcome Trust Senior Fellowship (to FB), the Wellcome Trust PhD studentship (AJK) and was supported by the Medical Research Council. CIMR is in receipt of a strategic award from the Wellcome Trust.	Ameen N, 2007, TRAFFIC, V8, P998, DOI 10.1111/j.1600-0854.2007.00587.x; Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Buss F, 1998, J CELL BIOL, V143, P1535, DOI 10.1083/jcb.143.6.1535; Buss F, 2008, BIOCHEM BIOPH RES CO, V369, P165, DOI 10.1016/j.bbrc.2007.11.150; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Clements JA, 2004, CRIT REV CL LAB SCI, V41, P265, DOI 10.1080/10408360490471931; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; Dunn TA, 2006, AM J PATHOL, V169, P1843, DOI 10.2353/ajpath.2006.060316; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Fazili Z, 1999, ONCOGENE, V18, P3104, DOI 10.1038/sj.onc.1202649; Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; KELLERMAN KA, 1992, J CELL BIOL, V119, P823, DOI 10.1083/jcb.119.4.823; Lawrence MG, 2007, CELLS TISSUES ORGANS, V185, P111, DOI 10.1159/000101311; Maddugoda MP, 2007, J CELL BIOL, V178, P529, DOI 10.1083/jcb.200612042; Martin DB, 2004, CANCER RES, V64, P347, DOI 10.1158/0008-5472.CAN-03-2062; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Morris SM, 2001, TRAFFIC, V2, P111, DOI 10.1034/j.1600-0854.2001.020206.x; Morriswood B, 2007, J CELL SCI, V120, P2574, DOI 10.1242/jcs.007005; Peden AA, 2004, MOL BIOL CELL, V15, P3530, DOI 10.1091/mbc.E03-12-0918; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Schwahn DJ, 1998, ONCOGENE, V17, P1173, DOI 10.1038/sj.onc.1202038; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Su AI, 2001, CANCER RES, V61, P7388; Tseng CP, 1998, ENDOCRINOLOGY, V139, P3542, DOI 10.1210/en.139.8.3542; Veveris-Lowe TL, 2005, ENDOCR-RELAT CANCER, V12, P631, DOI 10.1677/erc.1.00958; Warner CL, 2003, EMBO J, V22, P569, DOI 10.1093/emboj/cdg055; Wei SZ, 2008, PROSTATE, V68, P1387, DOI 10.1002/pros.20806; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Whitbread AK, 2006, BIOL CHEM, V387, P707, DOI 10.1515/BC.2006.089; Yoshida H, 2004, P NATL ACAD SCI USA, V101, P8144, DOI 10.1073/pnas.0400400101	41	40	41	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN 14	2010	29	2					188	200		10.1038/onc.2009.328	http://dx.doi.org/10.1038/onc.2009.328			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	544IU	19855435	Green Accepted, Green Submitted			2022-12-25	WOS:000273650000003
J	Islam, MM; Nautiyal, M; Wynn, RM; Mobley, JA; Chuang, DT; Hutson, SM				Islam, Mohammad Mainul; Nautiyal, Manisha; Wynn, R. Max; Mobley, James A.; Chuang, David T.; Hutson, Susan M.			Branched-chain Amino Acid Metabolon INTERACTION OF GLUTAMATE DEHYDROGENASE WITH THE MITOCHONDRIAL BRANCHED-CHAIN AMINOTRANSFERASE (BCATm)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-KETOACID DEHYDROGENASE; PANCREATIC BETA-CELLS; INSULIN-SECRETION; ESCHERICHIA-COLI; REGULATORY MUTATIONS; SKELETAL-MUSCLE; CXXC MOTIF; AMINOTRANSFERASE; LEUCINE; COMPLEXES	The catabolic pathway for branched-chain amino acids includes deamination followed by oxidative decarboxylation of the deaminated product branched-chain alpha-keto acids, catalyzed by the mitochondrial branched-chain aminotransferase (BCATm) and branched-chain alpha-keto acid dehydrogenase enzyme complex (BCKDC). We found that BCA Tm binds to the E1 decarboxylase of BCKDC, forming a metabolon that allows channeling of branched-chain alpha-keto acids from BCATm to E1. The protein complex also contains glutamate dehydrogenase (GDH1), 4-nitrophenylphosphatase domain and non-neuronal SNAP25-like protein homolog 1, pyruvate carboxylase, and BCKDC kinase. GDH1 binds to the pyridoxamine 5'-phosphate (PMP) form of BCATm (PMP-BCATm) but not to the pyridoxal 5'-phosphate-BCATm and other metabolon proteins. Leucine activates GDH1, and oxidative deamination of glutamate is increased further by addition of PMP-BCATm. Isoleucine and valine are not allosteric activators of GDH1, but in the presence of 5'-phosphate-BCATm, they convert BCATm to PMP-BCATm, stimulating-GDH1 activity. Sensitivity to ADP activation of GDH1 was unaffected by PMP-BCATm; however, addition of a 3 or higher molar ratio of PMP-BCATm to GDH1 protected GDH1 from GTP inhibition by 50%. Kinetic results suggest that GDH1 facilitates regeneration of the form of BCATm that binds to E1 decarboxylase of the BCKDC, promotes metabolon formation, branched-chain amino acid oxidation, and cycling of nitrogen through glutamate.	[Islam, Mohammad Mainul; Hutson, Susan M.] Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA; [Nautiyal, Manisha] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Wynn, R. Max; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Wynn, R. Max; Chuang, David T.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Mobley, James A.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA	Virginia Polytechnic Institute & State University; Wake Forest University; Wake Forest Baptist Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alabama System; University of Alabama Birmingham	Hutson, SM (corresponding author), Virginia Polytech Inst & State Univ, Dept Human Nutr Foods & Exercise, Blacksburg, VA 24061 USA.	susanh5@vt.edu		Wynn, Richard/0000-0002-1879-2136	USPHS [DK34738, DK26758]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK026758, R01DK034738, R56DK034738] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK34738 (to S.M.H.) and DK26758 (to D.T.C.) from the USPHS.	Allen A, 2004, BIOCHEMISTRY-US, V43, P14431, DOI 10.1021/bi048817i; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; BAYLEY PM, 1980, EUR J BIOCHEM, V112, P521; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Choi MM, 2005, FEBS LETT, V579, P4125, DOI 10.1016/j.febslet.2005.06.041; Chuang JL, 2000, METHOD ENZYMOL, V324, P192; Conway ME, 2000, METHOD ENZYMOL, V324, P355; Conway ME, 2004, BIOCHEMISTRY-US, V43, P7356, DOI 10.1021/bi0498050; Conway ME, 2002, BIOCHEMISTRY-US, V41, P9070, DOI 10.1021/bi020200i; Davoodi J, 1998, J BIOL CHEM, V273, P4982, DOI 10.1074/jbc.273.9.4982; Fang J, 2002, BIOCHEM J, V363, P81, DOI 10.1042/0264-6021:3630081; FELIG P, 1973, P SOC EXP BIOL MED, V142, P230; Gao Z, 2003, ENDOCRINOLOGY, V144, P1949, DOI 10.1210/en.2002-0072; GYLFE E, 1976, ACTA DIABETOL LAT, V13, P20, DOI 10.1007/BF02591577; HARRIS RA, 1985, ARCH BIOCHEM BIOPHYS, V243, P542, DOI 10.1016/0003-9861(85)90531-4; HAYASHI H, 1993, BIOCHEMISTRY-US, V32, P12229, DOI 10.1021/bi00096a036; HUTSON SM, 1986, J BIOL CHEM, V261, P4420; HUTSON SM, 1978, J BIOL CHEM, V253, P8126; Hutson SM, 2005, J NUTR, V135, p1557S, DOI 10.1093/jn/135.6.1557S; HUTSON SM, 1989, ANN NY ACAD SCI, V573, P230, DOI 10.1111/j.1749-6632.1989.tb15000.x; Hutson SM, 2001, J NUTR, V131, p846S, DOI 10.1093/jn/131.3.846S; HUTTON JC, 1980, J BIOL CHEM, V255, P7340; Islam MM, 2007, J BIOL CHEM, V282, P11893, DOI 10.1074/jbc.M700198200; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Kagamiyama H, 2000, METHOD ENZYMOL, V324, P103; Kawajiri M, 2006, PEDIATR RES, V59, P359, DOI 10.1203/01.pdr.0000198775.22719.46; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Li J, 2004, J BIOL CHEM, V279, P32968, DOI 10.1074/jbc.M403611200; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; MacDonald MJ, 2008, BBA-GEN SUBJECTS, V1780, P966, DOI 10.1016/j.bbagen.2008.03.017; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; Machius M, 2006, STRUCTURE, V14, P287, DOI 10.1016/j.str.2005.10.009; MCCARTHY AD, 1985, BIOCHEM J, V230, P95, DOI 10.1042/bj2300095; Newsholme P, 2005, CLIN SCI, V108, P185, DOI 10.1042/CS20040290; PALMER TN, 1985, BIOSCIENCE REP, V5, P1015, DOI 10.1007/BF01119623; Pedersen P L, 1978, Methods Cell Biol, V20, P411, DOI 10.1016/S0091-679X(08)62030-0; REED LJ, 1990, J BIOL CHEM, V265, P8971; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; REED LJ, 1985, CURR TOP CELL REGUL, V27, P41; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; Smith TJ, 2002, J MOL BIOL, V318, P765, DOI 10.1016/S0022-2836(02)00161-4; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; Srere PA, 2000, TRENDS BIOCHEM SCI, V25, P150, DOI 10.1016/S0968-0004(00)01550-4; SRERE PA, 1985, TRENDS BIOCHEM SCI, V10, P109, DOI 10.1016/0968-0004(85)90266-X; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Sweatt AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE64, DOI 10.1152/ajpendo.00276.2003; Wallace JC, 1998, INT J BIOCHEM CELL B, V30, P1, DOI 10.1016/S1357-2725(97)00147-7; WALLIN R, 1990, J BIOL CHEM, V265, P6019; Wynn RM, 2000, METHOD ENZYMOL, V324, P179; Wynn RM, 2004, STRUCTURE, V12, P2185, DOI 10.1016/j.str.2004.09.013; Yennawar N, 2001, ACTA CRYSTALLOGR D, V57, P506, DOI 10.1107/S0907444901001925; Yennawar NH, 2006, J BIOL CHEM, V281, P39660, DOI 10.1074/jbc.M607552200; Yennawar NH, 2002, BIOCHEMISTRY-US, V41, P11592, DOI 10.1021/bi020221c; Yoon HY, 2004, BIOCHIMIE, V86, P261, DOI 10.1016/j.biochi.2004.04.005; ZEIRI L, 1979, BIOPOLYMERS, V18, P2289, DOI 10.1002/bip.1979.360180916; Zimmerman LJ, 2005, J PROTEOME RES, V4, P1672, DOI 10.1021/pr050138m	58	67	68	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					265	276		10.1074/jbc.M109.048777	http://dx.doi.org/10.1074/jbc.M109.048777			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19858196	Green Published, hybrid			2022-12-25	WOS:000273070100028
J	Lin, KBL; Tan, P; Freeman, SA; Lam, M; McNagny, KM; Gold, MR				Lin, K. B. L.; Tan, P.; Freeman, S. A.; Lam, M.; McNagny, K. M.; Gold, M. R.			The Rap GTPases regulate the migration, invasiveness and in vivo dissemination of B-cell lymphomas	ONCOGENE			English	Article						B cells; lymphoma; Rap GTPase; cell migrationl extravasation	PYK2 TYROSINE PHOSPHORYLATION; CHEMOKINE; ACTIVATION; ADHESION; LYMPHOCYTES; RECEPTOR; POLARIZATION; MOTILITY	B-cell lymphomas are common malignancies in which transformed B cells enter the circulation, extravasate into tissues and form tumors in multiple organs. Lymphoma cells are thought to exit the vasculature and enter tissues through the same chemokine- and adhesion molecule-dependent mechanisms as normal B cells. We have previously shown that activation of the Rap GTPases, proteins that control cytoskeletal organization and integrin activation, is critical for chemokine-induced migration and adhesion in B-lymphoma cell lines. Using the A20 murine B-lymphoma cell line as a model, we now show that Rap activation is important for circulating lymphoma cells to enter tissues and form tumors in vivo. In vitro assays showed that Rap activation is required for A20 cells to efficiently adhere to vascular endothelial cells and undergo transendothelial migration. These findings suggest that Rap or its effectors could be novel targets for treating B-cell lymphomas. Oncogene (2010) 29, 608-615; doi: 10.1038/onc.2009.345; published online 19 October 2009	[Gold, M. R.] Univ British Columbia, Dept Microbiol & Immunol, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada; [Lin, K. B. L.; Freeman, S. A.; Gold, M. R.] Univ British Columbia, I3 Res Grp, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Lin, K. B. L.; Freeman, S. A.; Gold, M. R.] Univ British Columbia, CELL Res Grp, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Tan, P.; Lam, M.; McNagny, K. M.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Gold, MR (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Life Sci Ctr, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mgold@interchange.ubc.ca	McNagny, Kelly/P-5239-2014; Gold, Michael/AAF-2081-2021	McNagny, Kelly/0000-0003-4737-3499; Gold, Michael/0000-0003-1222-3191	Canadian Institutes of Health Research [MOP-68865]; KMM [MOP-15477]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); KMM	We thank Andy Johnson of the UBC Flow Cytometry Facility and Goran Mansson of the LSI Imaging facility for technical assistance. This work was supported by grants from the Canadian Institutes of Health Research to MRG (GRANT MOP-68865) and KMM (GRANT MOP-15477). KMM is a Michael Smith Foundation for Health Research senior scholar.	Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Durand CA, 2006, EUR J IMMUNOL, V36, P2235, DOI 10.1002/eji.200535004; Gerard A, 2007, J CELL BIOL, V176, P863, DOI 10.1083/jcb.200608161; Goddard S, 2001, TRANSPLANTATION, V72, P1957, DOI 10.1097/00007890-200112270-00016; Ishida D, 2003, CANCER CELL, V4, P55, DOI 10.1016/S1535-6108(03)00163-6; Jeon TJ, 2007, J CELL BIOL, V179, P833, DOI 10.1083/jcb.200705068; KIM KJ, 1979, J IMMUNOL, V122, P549; Krebs Danielle L., 1999, Methods in Cell Science, V21, P57, DOI 10.1023/A:1009843325770; Lin KBL, 2008, IMMUNITY, V28, P75, DOI 10.1016/j.immuni.2007.11.019; McLeod SJ, 2004, J BIOL CHEM, V279, P12009, DOI 10.1074/jbc.M313098200; McLeod SJ, 1998, J BIOL CHEM, V273, P29218, DOI 10.1074/jbc.273.44.29218; McLeod SJ, 2002, J IMMUNOL, V169, P1365, DOI 10.4049/jimmunol.169.3.1365; Pals ST, 2007, BLOOD, V110, P3102, DOI 10.1182/blood-2007-05-075176; Shimonaka M, 2003, J CELL BIOL, V161, P417, DOI 10.1083/jcb.200301133; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; SIKORSKI EE, 1993, J IMMUNOL, V151, P5239; Staveley-O'Carroll K, 1998, P NATL ACAD SCI USA, V95, P1178, DOI 10.1073/pnas.95.3.1178; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Till KJ, 2008, CANCER RES, V68, P8429, DOI 10.1158/0008-5472.CAN-08-1758	20	22	22	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2010	29	4					608	615		10.1038/onc.2009.345	http://dx.doi.org/10.1038/onc.2009.345			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	549WH	19838206				2022-12-25	WOS:000274084600013
J	Puri, C				Puri, Claudia			Loss of Myosin VI No Insert Isoform (NoI) Induces a Defect in Clathrin-mediated Endocytosis and Leads to Caveolar Endocytosis of Transferrin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; SNELLS-WALTZER; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MEMBRANE DOMAINS; INNER-EAR; INTERNALIZATION; DEAFNESS; TRANSPORT; BINDING; MUTANT	Myosin VI is a motor protein that moves toward the minus end of actin filaments. It is involved in clathrin-mediated endocytosis and associates with clathrin-coated pits/vesicles at the plasma membrane. In this article the effect of the loss of myosin VI no insert isoform (NoI) on endocytosis in nonpolarized cells was examined. The absence of myosin VI in fibroblasts derived from the Snell's waltzer mouse (myosin VI knock-out) gives rise to defective clathrin-mediated endocytosis with shallow clathrin-coated pits and a strong reduction in the internalization of clathrin-coated vesicles. To compensate for this defect in clathrin-mediated endocytosis, plasma membrane receptors such as the transferrin receptor (TfR) are internalized by a caveola-dependent pathway. Moreover the clathrin adaptor protein, AP-2, necessary for TfR internalization, follows the receptor and relocalizes in caveolae in Snell's waltzer fibroblasts.	Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 2XY, England	University of Cambridge	Puri, C (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.	cp344@cam.ac.uk			Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK.	Abban CY, 2008, AM J THER, V15, P304, DOI 10.1097/MJT.0b013e3181754134; Ahmed ZM, 2003, AM J HUM GENET, V72, P1315, DOI 10.1086/375122; Ameen N, 2007, TRAFFIC, V8, P998, DOI 10.1111/j.1600-0854.2007.00587.x; Arden SD, 2007, MOL BIOL CELL, V18, P4750, DOI 10.1091/mbc.E07-02-0127; Aschenbrenner L, 2003, MOL BIOL CELL, V14, P2728, DOI 10.1091/mbc.E02-11-0767; Au JSY, 2007, J CELL BIOL, V177, P103, DOI 10.1083/jcb.200608126; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Biemesderfer D, 2002, AM J PHYSIOL-RENAL, V282, pF785, DOI 10.1152/ajprenal.00287.2001; Blot V, 2006, EMBO J, V25, P5648, DOI 10.1038/sj.emboj.7601462; Buss F, 2002, TRAFFIC, V3, P851, DOI 10.1034/j.1600-0854.2002.31201.x; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Conner SD, 2003, J CELL BIOL, V162, P773, DOI 10.1083/jcb.200304069; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; DAMKE H, 1995, METHOD ENZYMOL, V257, P209; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Dance AL, 2004, TRAFFIC, V5, P798, DOI 10.1111/j.1600-0854.2004.00224.x; Danielsen EM, 2006, MOL MEMBR BIOL, V23, P71, DOI 10.1080/09687860500445604; DEOL MS, 1966, GENET RES, V8, P339, DOI 10.1017/S0016672300010193; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Fujita A, 2009, P NATL ACAD SCI USA, V106, P9256, DOI 10.1073/pnas.0900216106; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Horonchik L, 2008, CHEM BIOL, V15, P647, DOI 10.1016/j.chembiol.2008.05.011; Imelli N, 2004, J VIROL, V78, P3089, DOI 10.1128/JVI.78.6.3089-3098.2004; Inoue A, 2002, BIOCHEM BIOPH RES CO, V292, P300, DOI 10.1006/bbrc.2002.6636; Inoue T, 2008, GENES CELLS, V13, P483, DOI 10.1111/j.1365-2443.2008.01184.x; Khan EM, 2006, J BIOL CHEM, V281, P14486, DOI 10.1074/jbc.M509332200; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kurzchalia TV, 1996, FEBS LETT, V389, P52, DOI 10.1016/0014-5793(96)00585-6; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Morris SM, 2002, TRAFFIC, V3, P331, DOI 10.1034/j.1600-0854.2002.30503.x; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Parton RG, 2003, NAT REV MOL CELL BIO, V4, P162, DOI 10.1038/nrm1017; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pike LJ, 1996, J BIOL CHEM, V271, P26453, DOI 10.1074/jbc.271.43.26453; Puri C, 2005, MOL BIOL CELL, V16, P2704, DOI 10.1091/mbc.e04-07-0596; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; SAKAI T, 1991, J BIOCHEM-TOKYO, V109, P528, DOI 10.1093/oxfordjournals.jbchem.a123415; Sato O, 2004, J BIOL CHEM, V279, P28844, DOI 10.1074/jbc.M314332200; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Shigematsu S, 2003, J BIOL CHEM, V278, P10683, DOI 10.1074/jbc.M208563200; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Singh RD, 2007, J CELL BIOL, V176, P895, DOI 10.1083/jcb.200609149; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Torgersen ML, 2001, J CELL SCI, V114, P3737; Tosoni D, 2005, CELL, V123, P875, DOI 10.1016/j.cell.2005.10.021; Vogel U, 1998, J CELL SCI, V111, P825; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Yun M, 2003, J BIOL CHEM, V278, P36572, DOI 10.1074/jbc.M304384200; Zhu JX, 2005, J BIOL CHEM, V280, P32468, DOI 10.1074/jbc.M503833200	60	26	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34998	35014		10.1074/jbc.M109.012328	http://dx.doi.org/10.1074/jbc.M109.012328			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19840950	Green Published, hybrid			2022-12-25	WOS:000272439600055
J	Lindsey-Boltz, LA; Sercin, O; Choi, JH; Sancar, A				Lindsey-Boltz, Laura A.; Sercin, Oezdemirhan; Choi, Jun-Hyuk; Sancar, Aziz			Reconstitution of Human Claspin-mediated Phosphorylation of Chk1 by the ATR (Ataxia Telangiectasia-mutated and Rad3-related) Checkpoint Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; REPEATED PHOSPHOPEPTIDE MOTIFS; RAD53 ACTIVATION; PROTEIN; BINDING; TOPBP1; DOMAIN; MEC1; COMPLEX; ADAPTER	ATR (ATM and Rad3-related) initiates a DNA damage signaling pathway in human cells upon DNA damage induced by UV and UV-mimetic agents and in response to inhibition of DNA replication. Genetic data with human cells and in vitro data with Xenopus egg extracts have led to the conclusion that the kinase activity of ATR toward the signal-transducing kinase Chk1 depends on the mediator protein Claspin. Here we have reconstituted a Claspin-mediated checkpoint system with purified human proteins. We find that the ATR-dependent phosphorylation of Chk1, but not p53, is strongly stimulated by Claspin. Similarly, DNA containing bulky base adducts stimulates ATR kinase activity, and Claspin acts synergistically with damaged DNA to increase phosphorylation of Chk1 by ATR. Mutations in putative phosphorylation sites in the Chk1-binding domain of Claspin abolish its ability to mediate ATR phosphorylation of Chk1. We also find that a fragment of Claspin containing the Chk1-binding domain together with a domain conserved in the yeast Mrc1 orthologs of Claspin is sufficient for its mediator activity. This in vitro system recapitulates essential components of the genetically defined ATR-signaling pathway.	[Lindsey-Boltz, Laura A.; Sercin, Oezdemirhan; Choi, Jun-Hyuk; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, CB 7260, Chapel Hill, NC 27599 USA.	Aziz_Sancar@med.unc.edu	Lindsey-Boltz, Laura/A-3121-2010	Lindsey-Boltz, Laura/0000-0001-6493-8194; Sercin, Ozdemirhan/0000-0002-4893-9135	National Institutes of Health [GM32833]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32833 ( to A. S.).	Bennett LN, 2008, BIOCHEM BIOPH RES CO, V369, P973, DOI 10.1016/j.bbrc.2008.02.154; Bennett LN, 2006, FEBS LETT, V580, P4176, DOI 10.1016/j.febslet.2006.06.071; Chen SH, 2009, J BIOL CHEM, V284, P18593, DOI 10.1074/jbc.M109.018242; Chini CCS, 2006, J BIOL CHEM, V281, P33276, DOI 10.1074/jbc.M604373200; Choi JH, 2007, P NATL ACAD SCI USA, V104, P13301, DOI 10.1073/pnas.0706013104; Choi JH, 2009, METHODS, V48, P3, DOI 10.1016/j.ymeth.2009.02.006; Choi JH, 2009, NUCLEIC ACIDS RES, V37, P1501, DOI 10.1093/nar/gkn1075; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Clarke CAL, 2005, BIOCHEM J, V388, P705, DOI 10.1042/BJ20041966; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Jeong SY, 2003, J BIOL CHEM, V278, P46782, DOI 10.1074/jbc.M304551200; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2003, NAT CELL BIOL, V5, P161, DOI 10.1038/ncb921; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Kumagai A, 2004, J BIOL CHEM, V279, P49599, DOI 10.1074/jbc.M408353200; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Liu QH, 2000, GENE DEV, V14, P1448; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Majka J, 2006, MOL CELL, V24, P891, DOI 10.1016/j.molcel.2006.11.027; Mordes DA, 2008, P NATL ACAD SCI USA, V105, P18730, DOI 10.1073/pnas.0806621105; Navadgi-Patil VM, 2008, J BIOL CHEM, V283, P35853, DOI 10.1074/jbc.M807435200; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sar F, 2004, J BIOL CHEM, V279, P39289, DOI 10.1074/jbc.M405793200; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Yan S, 2006, J CELL BIOL, V173, P181, DOI 10.1083/jcb.200601076; Yoo HY, 2006, GENE DEV, V20, P772, DOI 10.1101/gad.1398806; Yoshioka K, 2006, MOL CELL, V22, P501, DOI 10.1016/j.molcel.2006.04.023; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	31	39	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2009	284	48					33107	33114		10.1074/jbc.M109.064485	http://dx.doi.org/10.1074/jbc.M109.064485			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	522VS	19828454	hybrid, Green Published			2022-12-25	WOS:000272028500014
J	Meybohm, P; Gruenewald, M; Albrecht, M; Zacharowski, KD; Lucius, R; Zitta, K; Koch, A; Tran, N; Scholz, J; Bein, B				Meybohm, Patrick; Gruenewald, Matthias; Albrecht, Martin; Zacharowski, Kai D.; Lucius, Ralph; Zitta, Karina; Koch, Alexander; Tran, Nguyen; Scholz, Jens; Bein, Berthold			Hypothermia and Postconditioning after Cardiopulmonary Resuscitation Reduce Cardiac Dysfunction by Modulating Inflammation, Apoptosis and Remodeling	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; MYOCARDIAL ISCHEMIA-REPERFUSION; AMERICAN-HEART-ASSOCIATION; COMATOSE SURVIVORS; STROKE FOUNDATION; CRITICAL-CARE; ARREST; INFARCTION; MODEL; CARDIOLOGY	Background: Mild therapeutic hypothermia following cardiac arrest is neuroprotective, but its effect on myocardial dysfunction that is a critical issue following resuscitation is not clear. This study sought to examine whether hypothermia and the combination of hypothermia and pharmacological postconditioning are cardioprotective in a model of cardiopulmonary resuscitation following acute myocardial ischemia. Methodology/Principal Findings: Thirty pigs (28-34 kg) were subjected to cardiac arrest following left anterior descending coronary artery ischemia. After 7 minutes of ventricular fibrillation and 2 minutes of basic life support, advanced cardiac life support was started according to the current AHA guidelines. After successful return of spontaneous circulation (n = 21), coronary perfusion was reestablished after 60 minutes of occlusion, and animals were randomized to either normothermia at 38 degrees C, hypothermia at 33 degrees C or hypothermia at 33 degrees C combined with sevoflurane (each group n = 7) for 24 hours. The effects on cardiac damage especially on inflammation, apoptosis, and remodeling were studied using cellular and molecular approaches. Five animals were sham operated. Animals treated with hypothermia had lower troponin T levels (p<0.01), reduced infarct size (34 +/- 7 versus 57 +/- 12%; p<0.05) and improved left ventricular function compared to normothermia (p<0.05). Hypothermia was associated with a reduction in: (i) immune cell infiltration, (ii) apoptosis, (iii) IL-1 beta and IL-6 mRNA up-regulation, and (iv) IL-1 beta protein expression (p<0.05). Moreover, decreased matrix metalloproteinase-9 activity was detected in the ischemic myocardium after treatment with mild hypothermia. Sevoflurane conferred additional protective effects although statistic significance was not reached. Conclusions/Significance: Hypothermia reduced myocardial damage and dysfunction after cardiopulmonary resuscitation possible via a reduced rate of apoptosis and pro-inflammatory cytokine expression.			Meybohm, P (corresponding author), Univ Hosp Schleswig Holstein, Dept Anaesthesiol & Intens Care Med, Kiel, Germany.	meybohm@anaesthesie.uni-kiel.de	Albrecht, Martin/AAW-9303-2021; Lucius, Ralph/B-1614-2010; Meybohm, Patrick/K-4066-2017; Gruenewald, Matthias/F-9485-2012	Albrecht, Martin/0000-0003-2580-768X; Meybohm, Patrick/0000-0002-2666-8696; 				Abbate A, 2002, J CELL PHYSIOL, V193, P145, DOI 10.1002/jcp.10174; Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Bein B, 2005, ANESTH ANALG, V100, P610, DOI 10.1213/01.ANE.0000145012.27484.A7; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bolli R, 2004, CIRC RES, V95, P125, DOI 10.1161/01.RES.0000137171.97172.d7; Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; Dixon SR, 2002, J AM COLL CARDIOL, V40, P1928, DOI 10.1016/S0735-1097(02)02567-6; Hale SL, 1997, BASIC RES CARDIOL, V92, P351, DOI 10.1007/BF00788947; Holzer M, 2005, CRIT CARE MED, V33, P414, DOI 10.1097/01.CCM.0000153410.87750.53; Holzer M, 2008, BEST PRACT RES-CLIN, V22, P711, DOI 10.1016/j.bpa.2008.02.001; Idris AH, 1996, CIRCULATION, V94, P2324, DOI 10.1161/01.CIR.94.9.2324; KELLEY KW, 1973, J ANIM SCI, V36, P927; KERN KB, 1990, AM HEART J, V120, P324, DOI 10.1016/0002-8703(90)90076-A; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; Koreny M, 2009, RESUSCITATION, V80, P56, DOI 10.1016/j.resuscitation.2008.08.019; Lange M, 2009, ANESTHESIOLOGY, V110, P516, DOI 10.1097/ALN.0b013e318197ff62; Laurent I, 2002, J AM COLL CARDIOL, V40, P2110, DOI 10.1016/S0735-1097(02)02594-9; Ly HQ, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.200502.049; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Oddo M, 2008, CRIT CARE MED, V36, P2296, DOI 10.1097/CCM.0b013e3181802599; Pell JP, 2003, HEART, V89, P839, DOI 10.1136/heart.89.8.839; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Ren Guofeng, 2003, Current Drug Targets - Inflammation and Allergy, V2, P242, DOI 10.2174/1568010033484098; Riess ML, 2002, ANESTH ANALG, V95, P1540, DOI 10.1097/00000539-200212000-00013; Roesner JP, 2007, CRIT CARE MED, V35, P1730, DOI 10.1097/01.CCM.0000269035.30231.76; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Stangl V, 2002, CARDIOVASC RES, V53, P12, DOI 10.1016/S0008-6363(01)00420-5; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Tsai MS, 2008, J AM COLL CARDIOL, V51, P1988, DOI 10.1016/j.jacc.2007.12.057; von Bismarck P, 2007, CRIT CARE MED, V35, P2309, DOI 10.1097/01.CCM.0000281472.47067.45; Weber NC, 2005, BEST PRACT RES-CLIN, V19, P429, DOI 10.1016/j.bpa.2005.02.003; Wolfrum S, 2008, CRIT CARE MED, V36, P1780, DOI 10.1097/CCM.0b013e31817437ca; Xu TY, 2008, RESUSCITATION, V76, P103, DOI 10.1016/j.resuscitation.2007.06.004; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	36	59	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7588	10.1371/journal.pone.0007588	http://dx.doi.org/10.1371/journal.pone.0007588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855846	Green Published, gold, Green Submitted			2022-12-25	WOS:000271147200011
J	Gobeske, KT; Das, S; Bonaguidi, MA; Weiss, C; Radulovic, J; Disterhoft, JF; Kessler, JA				Gobeske, Kevin T.; Das, Sunit; Bonaguidi, Michael A.; Weiss, Craig; Radulovic, Jelena; Disterhoft, John F.; Kessler, John A.			BMP Signaling Mediates Effects of Exercise on Hippocampal Neurogenesis and Cognition in Mice	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; ENDOTHELIAL GROWTH-FACTOR; NEWLY GENERATED NEURONS; LONG-TERM POTENTIATION; NEURAL STEM-CELLS; RAT DENTATE GYRUS; ENHANCED SYNAPTIC PLASTICITY; SPATIAL WORKING-MEMORY; ANXIETY-LIKE BEHAVIOR; MORRIS WATER MAZE	Exposure to exercise or to environmental enrichment increases the generation of new neurons in the adult hippocampus and promotes certain kinds of learning and memory. While the precise role of neurogenesis in cognition has been debated intensely, comparatively few studies have addressed the mechanisms linking environmental exposures to cellular and behavioral outcomes. Here we show that bone morphogenetic protein (BMP) signaling mediates the effects of exercise on neurogenesis and cognition in the adult hippocampus. Elective exercise reduces levels of hippocampal BMP signaling before and during its promotion of neurogenesis and learning. Transgenic mice with decreased BMP signaling or wild type mice infused with a BMP inhibitor both exhibit remarkable gains in hippocampal cognitive performance and neurogenesis, mirroring the effects of exercise. Conversely, transgenic mice with increased BMP signaling have diminished hippocampal neurogenesis and impaired cognition. Exercise exposure does not rescue these deficits, suggesting that reduced BMP signaling is required for environmental effects on neurogenesis and learning. Together, these observations show that BMP signaling is a fundamental mechanism linking environmental exposure with changes in cognitive function and cellular properties in the hippocampus.			Gobeske, KT (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA.	kgobeske@md.northwestern.edu	Das, Sunit/J-3903-2015; Weiss, Craig/K-8910-2018	Das, Sunit/0000-0002-2146-4168; Disterhoft, John/0000-0002-8817-7913; Radulovic, Jelena/0000-0002-0268-2426	NIA NIH HHS [R37 AG008796, R01 AG017139] Funding Source: Medline; NIMH NIH HHS [R01 MH047340, R01 MH078064] Funding Source: Medline; NINDS NIH HHS [R01 NS020778, R01 NS020013-26, R01 NS020778-26, R01 NS020013] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078064, R01MH047340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020778, R01NS020013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017139, R37AG008796] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; Adlard PA, 2005, NEUROBIOL AGING, V26, P511, DOI 10.1016/j.neurobiolaging.2004.05.006; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Baines RA, 2004, J NEUROSCI, V24, P6904, DOI 10.1523/JNEUROSCI.1978-04.2004; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Baruch DE, 2004, BEHAV NEUROSCI, V118, P1123, DOI 10.1037/0735-7044.118.5.1123; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Branchi Igor, 2004, Ann Ist Super Sanita, V40, P231; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Burghardt PR, 2006, PHARMACOL BIOCHEM BE, V84, P306, DOI 10.1016/j.pbb.2006.05.015; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Carro E, 2000, J NEUROSCI, V20, P2926; Chambers RA, 2007, J COGNITIVE NEUROSCI, V19, P1, DOI 10.1162/jocn.2007.19.1.1; Chmielnicki E, 2004, J NEUROSCI, V24, P2133, DOI 10.1523/JNEUROSCI.1554-03.2004; Clark PJ, 2008, NEUROSCIENCE, V155, P1048, DOI 10.1016/j.neuroscience.2008.06.051; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Crandall J, 2004, P NATL ACAD SCI USA, V101, P5111, DOI 10.1073/pnas.0306336101; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Doetsch F, 1997, J NEUROSCI, V17, P5046; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Ehninger D, 2006, GENES BRAIN BEHAV, V5, P29, DOI 10.1111/j.1601-183X.2005.00129.x; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; FAN X, 2003, BRAIN RES BRAIN RES, V13, P99; Fan XT, 2004, BRAIN RES PROTOC, V13, P99, DOI 10.1016/j.brainresprot.2004.01.005; Fan Y, 2007, EUR J NEUROSCI, V25, P38, DOI 10.1111/j.1460-9568.2006.05269.x; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gerlai R, 2001, BEHAV BRAIN RES, V125, P269, DOI 10.1016/S0166-4328(01)00296-0; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; Goodrich-Hunsaker NJ, 2008, BEHAV NEUROSCI, V122, P16, DOI 10.1037/0735-7044.122.1.16; Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Guha U, 2004, AM J PATHOL, V165, P729, DOI 10.1016/S0002-9440(10)63336-6; Gutierrez R, 2003, J NEUROSCI, V23, P5594; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hernandez-Rabaza V, 2009, NEUROSCIENCE, V159, P59, DOI 10.1016/j.neuroscience.2008.11.054; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P1064, DOI 10.1002/hipo.20464; Ide Y, 2008, EUR J NEUROSCI, V28, P2381, DOI 10.1111/j.1460-9568.2008.06548.x; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; JACKSON WJ, 1969, J COMP PHYSIOL PSYCH, V68, P442, DOI 10.1037/h0027502; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jones SP, 2003, HIPPOCAMPUS, V13, P413, DOI 10.1002/hipo.10121; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Kim BW, 2008, CELL SIGNAL, V20, P714, DOI 10.1016/j.cellsig.2007.12.009; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Laplagne DA, 2007, EUR J NEUROSCI, V25, P2973, DOI 10.1111/j.1460-9568.2007.05549.x; Lee I, 2005, BEHAV NEUROSCI, V119, P145, DOI 10.1037/0735-7044.119.1.145; Lee I, 2004, HIPPOCAMPUS, V14, P66, DOI 10.1002/hipo.10167; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lichtenwalner RJ, 2001, NEUROSCIENCE, V107, P603, DOI 10.1016/S0306-4522(01)00378-5; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Massague J, 2000, GENE DEV, V14, P627; McCloskey DP, 2005, J NEUROSCI, V25, P8889, DOI 10.1523/JNEUROSCI.2577-05.2005; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Meltzer LA, 2005, TRENDS NEUROSCI, V28, P653, DOI 10.1016/j.tins.2005.09.007; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; NOHNO T, 1995, J BIOL CHEM, V270, P22522, DOI 10.1074/jbc.270.38.22522; O'Callaghan RM, 2007, BEHAV BRAIN RES, V176, P362, DOI 10.1016/j.bbr.2006.10.018; Peretto P, 2004, NEUROSCIENCE, V128, P685, DOI 10.1016/j.neuroscience.2004.06.053; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scharfman HE., 2007, DENTATE GYRUS COMPRE; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Shaw KN, 2003, EUR J NEUROSCI, V17, P2438, DOI 10.1046/j.1460-9568.2003.02643.x; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Singer BH, 2009, J COMP NEUROL, V514, P567, DOI 10.1002/cne.22052; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sun M, 2007, J NEUROSCI, V27, P7740, DOI 10.1523/JNEUROSCI.1604-07.2007; Suzuki S, 2007, J NEUROSCI, V27, P6417, DOI 10.1523/JNEUROSCI.0690-07.2007; THURET S, 2009, HIPPOCAMPUS DEPENDEN; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; Trouche S, 2009, P NATL ACAD SCI USA, V106, P5919, DOI 10.1073/pnas.0811054106; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Van Dam D, 2006, NEUROBIOL LEARN MEM, V85, P164, DOI 10.1016/j.nlm.2005.09.006; Van der Borght K, 2007, BEHAV NEUROSCI, V121, P324, DOI 10.1037/0735-7044.121.2.324; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Walker TL, 2008, J NEUROSCI, V28, P5240, DOI 10.1523/JNEUROSCI.0344-08.2008; Wang LP, 2005, MOL CELL NEUROSCI, V29, P181, DOI 10.1016/j.mcn.2005.02.002; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	134	79	80	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7506	10.1371/journal.pone.0007506	http://dx.doi.org/10.1371/journal.pone.0007506			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509JT	19841742	Green Submitted, Green Published, gold			2022-12-25	WOS:000271012900011
J	Webster, DR; Hekele, AG; Lauring, AS; Fischer, KF; Li, H; Andino, R; DeRisi, JL				Webster, Dale R.; Hekele, Armin G.; Lauring, Adam S.; Fischer, Kael F.; Li, Hao; Andino, Raul; DeRisi, Joseph L.			An Enhanced Single Base Extension Technique for the Analysis of Complex Viral Populations	PLOS ONE			English	Article							IN-VIVO; RNA; DNA; MUTATION; POLYMORPHISMS; PATHOGENESIS; MECHANISMS; DIVERSITY; RATES	Many techniques for the study of complex populations provide either specific information on a small number of variants or general information on the entire population. Here we describe a powerful new technique for elucidating mutation frequencies at each genomic position in a complex population. This single base extension (SBE) based microarray platform was designed and optimized using poliovirus as the target genotype, but can be easily adapted to assay populations derived from any organism. The sensitivity of the method was demonstrated by accurate and consistent readouts from a controlled population of mutant genotypes. We subsequently deployed the technique to investigate the effects of the nucleotide analog ribavirin on a typical poliovirus population through two rounds of passage. Our results show that this economical platform can be used to investigate dynamic changes occurring at frequencies below 1% within a complex nucleic acid population. Given that many key aspects of the study and treatment of disease are intimately linked to population-level genomic diversity, our SBE-based technique provides a scalable and cost-effective complement to both traditional and next generation sequencing methodologies.			Webster, DR (corresponding author), Pacific Biosci, Menlo Pk, CA USA.	raul.andino@ucsf.edu; joe@derisilab.ucsf.edu	Fischer, Kael/F-7756-2015	Fischer, Kael/0000-0002-7547-330X	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [K08 AI081754, N01AI40085, AI36178, R01 AI036178, R21 AI036178, R56 AI036178, K08 AI081754-03] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036178, K08AI081754, R21AI040085, R56AI036178, R21AI036178, R01AI040085] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agol VI, 2006, CURR TOP MICROBIOL, V299, P211; Amexis G, 2001, P NATL ACAD SCI USA, V98, P12097, DOI 10.1073/pnas.211423298; Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; BOYER JC, 1992, P NATL ACAD SCI USA, V89, P6919, DOI 10.1073/pnas.89.15.6919; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Brakmann S, 2001, CHEMBIOCHEM, V2, P212, DOI 10.1002/1439-7633(20010302)2:3<212::AID-CBIC212>3.3.CO;2-I; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2002, MICROBES INFECT, V4, P1301, DOI 10.1016/S1286-4579(02)00008-4; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DELWART EL, 1994, J VIROL, V68, P6672, DOI 10.1128/JVI.68.10.6672-6683.1994; Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Hacia JG, 1999, J MED GENET, V36, P730, DOI 10.1136/jmg.36.10.730; Holt RA, 2008, GENOME RES, V18, P839, DOI 10.1101/gr.073262.107; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jones E., 2001, SCIPY OPEN SOURCE SC; KIM S, 1981, CELL, V27, P573, DOI 10.1016/0092-8674(81)90399-8; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; Martin V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-117; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Villa-Angulo R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-19; Wang HY, 2005, GENOME RES, V15, P276, DOI 10.1101/gr.2885205	33	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7453	10.1371/journal.pone.0007453	http://dx.doi.org/10.1371/journal.pone.0007453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834618	gold, Green Submitted, Green Published			2022-12-25	WOS:000270880700005
J	Copeland, HE; Doherty, KE; Naugle, DE; Pocewicz, A; Kiesecker, JM				Copeland, Holly E.; Doherty, Kevin E.; Naugle, David E.; Pocewicz, Amy; Kiesecker, Joseph M.			Mapping Oil and Gas Development Potential in the US Intermountain West and Estimating Impacts to Species	PLOS ONE			English	Article							WINTER HABITAT SELECTION; MULE DEER; BIODIVERSITY; CLASSIFICATION; MODELS	Background: Many studies have quantified the indirect effect of hydrocarbon-based economies on climate change and biodiversity, concluding that a significant proportion of species will be threatened with extinction. However, few studies have measured the direct effect of new energy production infrastructure on species persistence. Methodology/Principal Findings: We propose a systematic way to forecast patterns of future energy development and calculate impacts to species using spatially-explicit predictive modeling techniques to estimate oil and gas potential and create development build-out scenarios by seeding the landscape with oil and gas wells based on underlying potential. We illustrate our approach for the greater sage-grouse (Centrocercus urophasianus) in the western US and translate the build-out scenarios into estimated impacts on sage-grouse. We project that future oil and gas development will cause a 7-19 percent decline from 2007 sage-grouse lek population counts and impact 3.7 million ha of sagebrush shrublands and 1.1 million ha of grasslands in the study area. Conclusions/Significance: Maps of where oil and gas development is anticipated in the US Intermountain West can be used by decision-makers intent on minimizing impacts to sage-grouse. This analysis also provides a general framework for using predictive models and build-out scenarios to anticipate impacts to species. These predictive models and build-out scenarios allow tradeoffs to be considered between species conservation and energy development prior to implementation.			Copeland, HE (corresponding author), Nature Conservancy, Lander, WY USA.	hcopeland@tnc.org						Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; [Anonymous], 1998, GEOGRAPHICAL ENV MOD; Aydemir A, 2008, J PETROL SCI ENG, V61, P33, DOI 10.1016/j.petrol.2007.10.004; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chen ZH, 2000, B CAN PETROL GEOL, V48, P150, DOI 10.2113/48.2.150; Chow J, 2003, SCIENCE, V302, P1528, DOI 10.1126/science.1091939; Clark WC, 2007, P NATL ACAD SCI USA, V104, P1737, DOI 10.1073/pnas.0611291104; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Connelly JW, 1997, WILDLIFE BIOL, V3, P229, DOI 10.2981/wlb.1997.028; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.1890/0012-9658(2000)081[3178:CARTAP]2.0.CO;2; DOHERTY K, 2009, STUD AVIAN IN PRESS; DOHERTY KE, 2008, THESIS MONTANA MISSO; Ehrlich PR, 2008, P NATL ACAD SCI USA, V105, P11579, DOI 10.1073/pnas.0801911105; Evans JS, 2009, LANDSCAPE ECOL, V24, P673, DOI 10.1007/s10980-009-9341-0; Fenneman N.M., 1946, PHYSIOGRAPHIC DIVISI; Groom MJ, 2008, CONSERV BIOL, V22, P602, DOI 10.1111/j.1523-1739.2007.00879.x; GUISAN A, 2000, ECOLOGICAL MODELLING, V186, P135; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Holloran M., 2005, THESIS U WYOMING LAR; HULSE D, 2009, LANDSCAPE E IN PRESS; Ingelfinger F, 2004, WEST N AM NATURALIST, V64, P385; International Energy Agency, 2007, WORLD EN OUTL 2007; IVANOV VL, 1985, POLAR GEOGRAPHY, V9, P116; Kiesecker JM, 2001, NATURE, V410, P681, DOI 10.1038/35070552; KIESECKER JM, 2009, FRONT ECOL ENV; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; KUCKS RP, 2000, WYOMING AEROMAGNETIC; McDaniel CN, 2002, BIOSCIENCE, V52, P929, DOI 10.1641/0006-3568(2002)052[0929:IHEUCB]2.0.CO;2; *MEDIAS FRANC POST, 2004, ESA ESA GLOBC PROJ; Nassauer JI, 2004, LANDSCAPE ECOL, V19, P343, DOI 10.1023/B:LAND.0000030666.55372.ae; *NAT ATL US, 2006, FED LANDS US; NAUGLE D, 2009, STUDIES AVI IN PRESS; NAUGLE DE, 2009, STUD AVIAN IN PRESS; NEWSON AC, 2001, LEADING EDGE, V20, P74, DOI DOI 10.1190/1.1438884; PHILLIPS JD, 1993, NATL GEOPHYS DATA GR; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pitman JC, 2005, J WILDLIFE MANAGE, V69, P1259, DOI 10.2193/0022-541X(2005)069[1259:LASOLP]2.0.CO;2; Pocewicz A, 2008, LANDSCAPE ECOL, V23, P195, DOI 10.1007/s10980-007-9159-6; Polasky S, 2008, P NATL ACAD SCI USA, V105, P6505, DOI 10.1073/pnas.0802815105; Pontius GR, 2005, INT J GEOGR INF SCI, V19, P243, DOI 10.1080/13658810410001713434; REED JC, 2007, GEOLOGIC MAP NATL AT; Rykiel EJ, 1996, ECOL MODEL, V90, P229, DOI 10.1016/0304-3800(95)00152-2; Sawyer H, 2005, WILDLIFE SOC B, V33, P1266, DOI 10.2193/0091-7648(2005)33[1266:MDAPMI]2.0.CO;2; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Sawyer H, 2009, J WILDLIFE MANAGE, V73, P1052, DOI 10.2193/2008-478; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sorensen T, 2008, J WILDLIFE MANAGE, V72, P900, DOI 10.2193/2007-079; Stiver S., 2006, GREATER SAGE GROUSE; *US BUR LAND MAN, 2008, NAT INT LANDS SYST N; *US BUR LAND MAN, 1997, WHIT RIV RES AR APPR; *US DOE, 2008, 20 EN 2030 INCR WIND; *US FISH WILDL SER, 2008, IN STAT REV GREAT SA; *US GOV ACC OFF, 2006, END SPEC REC; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529	56	110	111	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7400	10.1371/journal.pone.0007400	http://dx.doi.org/10.1371/journal.pone.0007400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826472	Green Published, gold, Green Submitted			2022-12-25	WOS:000270808700002
J	Doncaster, CP				Doncaster, C. Patrick			Ecological Equivalence: A Realistic Assumption for Niche Theory as a Testable Alternative to Neutral Theory	PLOS ONE			English	Article							COMMUNITY ECOLOGY; SPECIES ABUNDANCE; COEXISTENCE; COMPETITION; MODEL; HYPOTHESIS; BIODIVERSITY; POPULATION; DIVERSITY; DYNAMICS	Background: Hubbell's 2001 neutral theory unifies biodiversity and biogeography by modelling steady-state distributions of species richness and abundances across spatio-temporal scales. Accurate predictions have issued from its core premise that all species have identical vital rates. Yet no ecologist believes that species are identical in reality. Here I explain this paradox in terms of the ecological equivalence that species must achieve at their coexistence equilibrium, defined by zero net fitness for all regardless of intrinsic differences between them. I show that the distinction of realised from intrinsic vital rates is crucial to evaluating community resilience. Principal Findings: An analysis of competitive interactions reveals how zero-sum patterns of abundance emerge for species with contrasting life-history traits as for identical species. I develop a stochastic model to simulate community assembly from a random drift of invasions sustaining the dynamics of recruitment following deaths and extinctions. Species are allocated identical intrinsic vital rates for neutral dynamics, or random intrinsic vital rates and competitive abilities for niche dynamics either on a continuous scale or between dominant-fugitive extremes. Resulting communities have steady-state distributions of the same type for more or less extremely differentiated species as for identical species. All produce negatively skewed log-normal distributions of species abundance, zero-sum relationships of total abundance to area, and Arrhenius relationships of species to area. Intrinsically identical species nevertheless support fewer total individuals, because their densities impact as strongly on each other as on themselves. Truly neutral communities have measurably lower abundance/area and higher species/abundance ratios. Conclusions: Neutral scenarios can be parameterized as null hypotheses for testing competitive release, which is a sure signal of niche dynamics. Ignoring the true strength of interactions between and within species risks a substantial misrepresentation of community resilience to habitat loss.			Doncaster, CP (corresponding author), Univ Southampton, Sch Biol Sci, Southampton, Hants, England.	cpd@soton.ac.uk	Doncaster, C. Patrick/AAT-7621-2020	Doncaster, C. Patrick/0000-0001-9406-0693	NERC [NE/C003705/1] Funding Source: UKRI; Natural Environment Research Council [NE/C003705/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Allouche O, 2009, J THEOR BIOL, V258, P274, DOI 10.1016/j.jtbi.2008.12.024; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Calcagno V, 2006, ECOL LETT, V9, P897, DOI 10.1111/j.1461-0248.2006.00930.x; CASWELL H, 1976, ECOL MONOGR, V46, P327, DOI 10.2307/1942257; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; CHAVE J, 2006, SCIENCE, V441, pE1; Doncaster CP, 2003, J ANIM ECOL, V72, P116, DOI 10.1046/j.1365-2656.2003.00687.x; Doncaster CP, 2000, NATURE, V404, P281, DOI 10.1038/35005078; GILPIN ME, 1976, NATURE, V261, P40, DOI 10.1038/261040a0; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Hanski I, 1996, AM NAT, V147, P527, DOI 10.1086/285864; Holt RD, 2006, TRENDS ECOL EVOL, V21, P531, DOI 10.1016/j.tree.2006.08.003; Holyoak M, 2006, ECOLOGY, V87, P1368; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Maurer BA, 2004, BASIC APPL ECOL, V5, P413, DOI 10.1016/j.baae.2004.08.006; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; NEE S, 1992, J ANIM ECOL, V61, P37, DOI 10.2307/5506; NEE S, 1994, NATURE, V367, P123, DOI 10.1038/367123b0; Pound GE, 2004, J EVOLUTION BIOL, V17, P651, DOI 10.1111/j.1420-9101.2003.00690.x; Pound GE, 2002, J THEOR BIOL, V217, P535, DOI 10.1006/jtbi.2002.3040; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Purves Drew W., 2005, P107, DOI 10.1017/CBO9780511541971.006; Rosindell J, 2007, ECOL LETT, V10, P586, DOI 10.1111/j.1461-0248.2007.01050.x; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Sole RV, 2004, ECOL COMPLEX, V1, P65, DOI 10.1016/j.ecocom.2003.12.003; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; VOLKOV I, 2005, SCIENCE, V441, pE1; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Zhou SR, 2008, ECOLOGY, V89, P248, DOI 10.1890/06-1817.1	36	16	16	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7460	10.1371/journal.pone.0007460	http://dx.doi.org/10.1371/journal.pone.0007460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19829714	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000270808700019
J	Serasinghe, MN; Seneviratne, AMPB; Smrcka, AV; Yoon, Y				Serasinghe, Madhavika N.; Seneviratne, A. M. P. B.; Smrcka, Alan V.; Yoon, Yisang			Identification and Characterization of Unique Proline-rich Peptides Binding to the Mitochondrial Fission Protein hFis1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DYNAMIN-RELATED PROTEIN; DOMINANT OPTIC ATROPHY; CYTOCHROME-C RELEASE; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; FUSION; APOPTOSIS; OPA1; FIS1; MORPHOLOGY	Mammalian mitochondrial fission requires at least two proteins, hFis1 and the dynamin-like GTPase DLP1/Drp1. The mitochondrial protein hFis1 is anchored at the outer membrane by a C-terminal transmembrane domain. The cytosolic domain of hFis1 contains six alpha helices [alpha 1-alpha 6] out of which [alpha 2-alpha 5] form tetratricopeptide repeat (TPR)-like motifs. DLP1 and possibly other proteins are thought to interact with the hFis1 TPR region during the fission process. It has also been suggested that the alpha 1-helix regulates protein-protein interactions at the TPR. We performed random peptide phage display screening using the hFis1[alpha 2-alpha 6] as the target and identified ten different peptide sequences. Phage ELISA using mutant hFis1 indicates that the peptide binding requires the alpha 2 and alpha 3 helices and the intact TPR structure. Competition experiments and surface plasmon resonance analyses confirmed that a subset of free peptides enriched with proline residues directly bind to the target. Two of these peptides bind to the alpha 1-containing intact cytosolic domain of hFis1 with decreased affinity. Peptide microinjection into cells abolished the mitochondrial swelling induced by overexpression of alpha 1-deleted hFis1, and significantly decreased cytochrome c release from mitochondria upon apoptotic induction. Our data demonstrate that hFis1 can bind to multiple amino acid sequences selectively, and that the TPR constitutes the main binding region of hFis1, providing a first insight into the hFis1 TPR as a potential therapeutic target.	[Serasinghe, Madhavika N.; Yoon, Yisang] Univ Rochester, Sch Med & Dent, Dept Anesthesiol, Rochester, NY 14642 USA; [Serasinghe, Madhavika N.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Seneviratne, A. M. P. B.] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Smrcka, Alan V.; Yoon, Yisang] Univ Rochester, Sch Med & Dent, Dept Physiol & Pharmacol, Rochester, NY 14642 USA; [Serasinghe, Madhavika N.; Yoon, Yisang] Univ Rochester, Sch Med & Dent, Mitochondrial Res & Innovat Grp, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Yoon, Y (corresponding author), 601 Elmwood Ave,Box 604, Rochester, NY 14642 USA.	yisang_yoon@urmc.rochester.edu	Yoon, Yisang/AAJ-7910-2020	Yoon, Yisang/0000-0002-1618-5439	National Institutes of Health [DK 078618, GM 081772, GM 060286]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060286, R01GM081772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 078618 (to Y. Y.) and GM 081772 and GM 060286 (to A. V. S.).	Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Alirol E, 2006, MOL BIOL CELL, V17, P4593, DOI 10.1091/mbc.E06-05-0377; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Breckenridge DG, 2003, J CELL BIOL, V160, P1115, DOI 10.1083/jcb.200212059; Cassidy-Stone A, 2008, DEV CELL, V14, P193, DOI 10.1016/j.devcel.2007.11.019; Chang DTW, 2006, J NEUROSCI, V26, P7035, DOI 10.1523/JNEUROSCI.1012-06.2006; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chen HC, 2005, HUM MOL GENET, V14, pR283, DOI 10.1093/hmg/ddi270; Cho DH, 2009, SCIENCE, V324, P102, DOI 10.1126/science.1171091; Cipolat S, 2004, P NATL ACAD SCI USA, V101, P15927, DOI 10.1073/pnas.0407043101; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Dohm JA, 2004, PROTEINS, V54, P153, DOI 10.1002/prot.10524; Eura Y, 2003, J BIOCHEM, V134, P333, DOI 10.1093/jb/mvg150; Fehrenbacher KL, 2004, CURR BIOL, V14, P1996, DOI 10.1016/j.cub.2004.11.004; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Griparic L, 2004, J BIOL CHEM, V279, P18792, DOI 10.1074/jbc.M400920200; Hom JR, 2007, J CELL PHYSIOL, V212, P498, DOI 10.1002/jcp.21051; James DI, 2003, J BIOL CHEM, V278, P36373, DOI 10.1074/jbc.M303758200; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Martinou JC, 2006, CELL DEATH DIFFER, V13, P1291, DOI 10.1038/sj.cdd.4401985; Millward SW, 2007, ACS CHEM BIOL, V2, P625, DOI 10.1021/cb7001126; MORRIS RL, 1993, J CELL SCI, V104, P917; Nakada K, 2001, NAT MED, V7, P934, DOI 10.1038/90976; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Parone PA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003257; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Satoh M, 2003, BIOCHEM BIOPH RES CO, V300, P482, DOI 10.1016/S0006-291X(02)02874-7; Serasinghe MN, 2008, EXP CELL RES, V314, P3494, DOI 10.1016/j.yexcr.2008.09.009; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Stojanovski D, 2004, J CELL SCI, V117, P1201, DOI 10.1242/jcs.01058; Sugioka R, 2004, J BIOL CHEM, V279, P52726, DOI 10.1074/jbc.M408910200; Suzuki M, 2003, J MOL BIOL, V334, P445, DOI 10.1016/j.jmb.2003.09.064; Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002; Wells RC, 2007, J BIOL CHEM, V282, P33769, DOI 10.1074/jbc.M700807200; Westermann B, 2003, BBA-MOL CELL RES, V1641, P195, DOI 10.1016/S0167-4889(03)00091-0; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yoon Y, 2001, MOL BIOL CELL, V12, P2894, DOI 10.1091/mbc.12.9.2894; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Yu TZ, 2005, J CELL SCI, V118, P4141, DOI 10.1242/jcs.02537; Zhang Y, 2007, P NATL ACAD SCI USA, V104, P18526, DOI 10.1073/pnas.0706441104; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	55	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					620	630		10.1074/jbc.M109.027508	http://dx.doi.org/10.1074/jbc.M109.027508			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864424	Green Published, hybrid			2022-12-25	WOS:000273070100063
J	Fernandez-Murray, JP; Gaspard, GJ; Jesch, SA; McMaster, CR				Fernandez-Murray, J. Pedro; Gaspard, Gerard J.; Jesch, Stephen A.; McMaster, Christopher R.			NTE1-encoded Phosphatidylcholine Phospholipase B Regulates Transcription of Phospholipid Biosynthetic Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROPATHY TARGET ESTERASE; UNFOLDED PROTEIN RESPONSE; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; LIPIN HOMOLOG; FFAT MOTIF; YEAST; EXPRESSION; INOSITOL; CHOLINE	The Saccharomyces cerevisiae NTE1 gene encodes an evolutionarily conserved phospholipase B localized to the endoplasmic reticulum (ER) that degrades phosphatidylcholine (PC) generating glycerophosphocholine and free fatty acids. We show here that the activity of NTE1-encoded phospholipase B (Nte1p) prevents the attenuation of transcription of genes encoding enzymes involved in phospholipid synthesis in response to increased rates of PC synthesis by affecting the nuclear localization of the transcriptional repressor Opi1p. Nte1p activity becomes necessary for cells growing in inositol-free media under conditions of high rates of PC synthesis elicited by the presence of choline at 37 degrees C. The specific choline transporter encoded by the HNM1 gene is necessary for the burst of PC synthesis observed at 37 degrees C as follows: (i) Nte1p is dispensable in an hnm1 Delta strain under these conditions, and (ii) there is a 3-fold increase in the rate of choline transport via the Hnm1p choline transporter upon a shift to 37 degrees C. Overexpression of NTE1 alleviated the inositol auxotrophy of a plethora of mutants, including scs2 Delta, scs3 Delta, ire1 Delta, and hac1 Delta among others. Overexpression of NTE1 sustained phospholipid synthesis gene transcription under conditions that normally repress transcription. This effect was also observed in a strain defective in the activation of free fatty acids for phosphatidic acid synthesis. No changes in the levels of phosphatidic acid were detected under conditions of altered expression of NTE1. Consistent with a synthetic impairment between challenged ER function and inositol deprivation, increased expression of NTE1 improved the growth of cells exposed to tunicamycin in the absence of inositol. We describe a new role for Nte1p toward membrane homeostasis regulating phospholipid synthesis gene transcription. We propose that Nte1p activity, by controlling PC abundance at the ER, affects lateral membrane packing and that this parameter, in turn, impacts the repressing transcriptional activity of Opi1p, the main regulator of phospholipid synthesis gene transcription.	[Fernandez-Murray, J. Pedro; Gaspard, Gerard J.; McMaster, Christopher R.] Dalhousie Univ, Fac Med, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada; [Fernandez-Murray, J. Pedro; Gaspard, Gerard J.; McMaster, Christopher R.] Dalhousie Univ, Fac Med, Atlantic Res Ctr, Dept Biochem & Mol Biol, Halifax, NS B3H 4H7, Canada; [Jesch, Stephen A.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Dalhousie University; Dalhousie University; Cornell University	McMaster, CR (corresponding author), Dalhousie Univ, Fac Med, Atlantic Res Ctr, Dept Pediat, Halifax, NS B3H 4H7, Canada.	christopher.mcmaster@dal.ca		McMaster, Christopher/0000-0003-0822-5776	National Institutes of Health [GM019629]; McMaster; Henry laboratories; Canadian Institutes for Health Research [14124]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019629, R37GM019629, R01GM019629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McMaster; Henry laboratories; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM019629 (to S. Henry supporting the work of S. A. J. and collaborative studies between the McMaster and Henry laboratories). This work was also supported by Canadian Institutes for Health Research Grant 14124 (to C.R.M.).	Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P5075, DOI 10.1073/pnas.0401030101; BAILIS AM, 1992, NUCLEIC ACIDS RES, V20, P1411, DOI 10.1093/nar/20.6.1411; Black PN, 2007, BBA-MOL CELL BIOL L, V1771, P286, DOI 10.1016/j.bbalip.2006.05.003; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Dowd SR, 2001, J BIOL CHEM, V276, P3756, DOI 10.1074/jbc.M003694200; Ebbert R, 1999, MOL MICROBIOL, V32, P741, DOI 10.1046/j.1365-2958.1999.01390.x; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Fernandez JP, 2005, J BIOL CHEM, V280, P8544, DOI 10.1074/jbc.M413999200; Fernandez-Murray JP, 2005, J BIOL CHEM, V280, P38290, DOI 10.1074/jbc.M507700200; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Ford J, 2008, BIOCHEM BIOPH RES CO, V373, P602, DOI 10.1016/j.bbrc.2008.06.079; Ford J, 2007, BIOCHEM BIOPH RES CO, V361, P974, DOI 10.1016/j.bbrc.2007.07.109; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Glynn P, 2006, TOXICOL LETT, V162, P94, DOI 10.1016/j.toxlet.2005.10.012; Glynn P, 2005, BBA-MOL CELL BIOL L, V1736, P87, DOI 10.1016/j.bbalip.2005.08.002; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Greenberg ML, 1996, MICROBIOL REV, V60, P1; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; HOSAKA K, 1994, J BIOCHEM-TOKYO, V116, P1317, DOI 10.1093/oxfordjournals.jbchem.a124681; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Kadereit B, 2008, P NATL ACAD SCI USA, V105, P94, DOI 10.1073/pnas.0708579105; Kagiwada S, 2003, J BIOCHEM, V133, P515, DOI 10.1093/jb/mvg068; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; KODAKI T, 1995, J BIOCHEM-TOKYO, V117, P362, DOI 10.1093/jb/117.2.362; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MCMASTER CR, 1994, J BIOL CHEM, V269, P14776; McMaster CR, 2004, TOP CURR GENET, V6, P5; Moser M, 2004, MOL CELL BIOL, V24, P1667, DOI 10.1128/MCB.24.4.1667-1679.2004; Muhlig-Versen M, 2005, J NEUROSCI, V25, P2865, DOI 10.1523/JNEUROSCI.5097-04.2005; Newton AC, 2004, TRENDS PHARMACOL SCI, V25, P175, DOI 10.1016/j.tips.2004.02.010; NIKAWA J, 1990, J BIOL CHEM, V265, P15996; NIKAWA JI, 1992, MOL MICROBIOL, V6, P1441, DOI 10.1111/j.1365-2958.1992.tb00864.x; Nunez LR, 2008, J BIOL CHEM, V283, P34204, DOI 10.1074/jbc.M806391200; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; PattonVogt JL, 1997, J BIOL CHEM, V272, P20873, DOI 10.1074/jbc.272.33.20873; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Rainier S, 2008, AM J HUM GENET, V82, P780, DOI 10.1016/j.ajhg.2007.12.018; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Serhan CN, 2008, ANNU REV PATHOL-MECH, V3, P279, DOI 10.1146/annurev.pathmechdis.3.121806.151409; Shen XT, 2003, SCIENCE, V299, P112, DOI 10.1126/science.1078068; Shirra MK, 2001, MOL CELL BIOL, V21, P5710, DOI 10.1128/MCB.21.17.5710-5722.2001; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Winrow CJ, 2003, NAT GENET, V33, P477, DOI 10.1038/ng1131; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200	60	25	25	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36034	36046		10.1074/jbc.M109.063958	http://dx.doi.org/10.1074/jbc.M109.063958			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19841481	Green Published, hybrid			2022-12-25	WOS:000272970500005
J	Li, Y; Santoso, NG; Yu, SQ; Woodward, OM; Qian, F; Guggino, WB				Li, Yun; Santoso, Netty G.; Yu, Shengqiang; Woodward, Owen M.; Qian, Feng; Guggino, William B.			Polycystin-1 Interacts with Inositol 1,4,5-Trisphosphate Receptor to Modulate Intracellular Ca2+ Signaling with Implications for Polycystic Kidney Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; C-TERMINAL FRAGMENT; PKD1 GENE-PRODUCT; FUNCTIONAL POLYCYSTIN-1; EPITHELIAL-CELLS; CALCIUM-RELEASE; MOLECULAR-BASIS; CATION CHANNEL; CYST FORMATION; NUCLEAR-FACTOR	The PKD1 or PKD2 genes encode polycystins (PC) 1 and 2, which are associated with polycystic kidney disease. Previously we demonstrated that PC2 interacts with the inositol 1,4,5-trisphosphate receptor (IP3R) to modulate Ca2+ signaling. Here, we investigate whether PC1 also regulates IP3R. We generated a fragment encoding the last six transmembrane (TM) domains of PC1 and the C-terminal tail (QIF38), a section with the highest homology to PC2. Using a Xenopus oocyte Ca2+ imaging system, we observed that expression of QIF38 significantly reduced the initial amplitude of IP3-induced Ca2+ transients, whereas a mutation lacking the C-terminal tail did not. Thus, the C terminus is essential to QIF38 function. Co-immunoprecipitation assays demonstrated that through its C terminus, QIF38 associates with the IP3-binding domain of IP3R. A shorter PC1 fragment spanning only the last TM and the C-terminal tail also reduced IP3-induced Ca2+ release, whereas another C-terminal fragment lacking any TM domain did not. Thus, only endoplasmic reticulum-localized PC1 can modulate IP3R. Finally, we show that in the polarized Madin-Darby canine kidney cells, heterologous expression of full-length PC1 resulted in a smaller IP3-induced Ca2+ response. Overexpression of the IP3-binding domain of IP3R reversed the inhibitory effect of PC1, suggesting interaction of full-length PC1 (or its cleavage forms) with endogenous IP3R in Madin-Darby canine kidney cells. These results indicate that the behavior of full-length PC1 in mammalian cells is congruent with that of PC1 C-terminal fragments in the oocyte system. These data demonstrate that PC1 inhibits Ca2+ release, perhaps opposing the effect of PC2, which facilitates Ca2+ release through the IP3R.	[Li, Yun; Santoso, Netty G.; Woodward, Owen M.; Guggino, William B.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Yu, Shengqiang; Qian, Feng] Johns Hopkins Univ, Sch Med, Div Nephrol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Guggino, WB (corresponding author), Johns Hopkins Univ, Sch Med, Dept Physiol, 725 N Wolfe St, Baltimore, MD 21205 USA.	wguggino@jhmi.edu		Woodward, Owen M./0000-0001-9514-2180	National Institutes of Health [5 R01 DK 32753, DK 062199]; Polycystic Kidney Disease Foundation [125a2f]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062199, R01DK032753] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polycystic Kidney Disease Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants 5 R01 DK 32753 (to W. B. G.) and DK 062199 (to F. Q.). This work was also supported by Polycystic Kidney Disease Foundation Postdoctoral Fellowship Grant 125a2f (to Y. L.).	Aguiari G, 2008, CELL PROLIFERAT, V41, P554, DOI 10.1111/j.1365-2184.2008.00529.x; Aguiari G, 2003, BIOCHEM BIOPH RES CO, V301, P657, DOI 10.1016/S0006-291X(02)03011-5; Ahrabi AK, 2007, J AM SOC NEPHROL, V18, P1740, DOI 10.1681/ASN.2006010052; Anyatonwu GI, 2007, P NATL ACAD SCI USA, V104, P6454, DOI 10.1073/pnas.0610324104; Bezprozvanny I, 2005, CELL CALCIUM, V38, P261, DOI 10.1016/j.ceca.2005.06.030; Bhunia AK, 2002, CELL, V109, P157, DOI 10.1016/S0092-8674(02)00716-X; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Bukanov NO, 2002, HUM MOL GENET, V11, P923, DOI 10.1093/hmg/11.8.923; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Camandola S, 2005, J BIOL CHEM, V280, P22287, DOI 10.1074/jbc.M410923200; Chapman AB, 2007, J AM SOC NEPHROL, V18, P1399, DOI 10.1681/ASN.2007020155; Chernova MN, 2005, KIDNEY INT, V68, P632, DOI 10.1111/j.1523-1755.2005.00441.x; Stokely MY, 2006, J NEUROSCI RES, V84, P1727, DOI 10.1002/jnr.21076; Foggensteiner L, 2000, J AM SOC NEPHROL, V11, P814, DOI 10.1681/ASN.V115814; Gallagher AR, 2002, CELL MOL LIFE SCI, V59, P682, DOI 10.1007/s00018-002-8457-z; Gonzalez-Perrett S, 2001, P NATL ACAD SCI USA, V98, P1182, DOI 10.1073/pnas.021456598; Grantham JJ, 2003, KIDNEY INT, V64, P1157, DOI 10.1046/j.1523-1755.2003.00242.x; Grimm DH, 2003, J BIOL CHEM, V278, P36786, DOI 10.1074/jbc.M306536200; Hanaoka K, 1996, AM J PHYSIOL-CELL PH, V270, pC389, DOI 10.1152/ajpcell.1996.270.1.C389; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Hanaoka K, 2000, J AM SOC NEPHROL, V11, P1179, DOI 10.1681/ASN.V1171179; Hooper KM, 2005, AM J PHYSIOL-RENAL, V289, pF521, DOI 10.1152/ajprenal.00355.2004; Huan YH, 1999, J CLIN INVEST, V104, P1459, DOI 10.1172/JCI5111; Ikeda M, 2002, CURR OPIN NEPHROL HY, V11, P539, DOI 10.1097/00041552-200209000-00010; Jiang ST, 2006, AM J PATHOL, V168, P205, DOI 10.2353/ajpath.2006.050342; Kip SN, 2005, CIRC RES, V96, P873, DOI 10.1161/01.RES.0000163278.68142.8a; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Lantinga-van Leeuwen IS, 2004, HUM MOL GENET, V13, P3069, DOI 10.1093/hmg/ddh336; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; LIn XN, 2005, J BIOL CHEM, V280, P12820, DOI 10.1074/jbc.M411591200; Manzati E, 2005, EXP CELL RES, V304, P391, DOI 10.1016/j.yexcr.2004.10.023; NADASDY T, 1995, J AM SOC NEPHROL, V5, P1462; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Newby LJ, 2002, J BIOL CHEM, V277, P20763, DOI 10.1074/jbc.M107788200; Pritchard L, 2000, HUM MOL GENET, V9, P2617, DOI 10.1093/hmg/9.18.2617; Puri S, 2004, J BIOL CHEM, V279, P55455, DOI 10.1074/jbc.M402905200; Qian F, 2002, P NATL ACAD SCI USA, V99, P16981, DOI 10.1073/pnas.252484899; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Qian Q, 2003, HUM MOL GENET, V12, P1875, DOI 10.1093/hmg/ddg190; Sandford R, 1997, HUM MOL GENET, V6, P1483, DOI 10.1093/hmg/6.9.1483; Sandford R, 1999, CELL MOL LIFE SCI, V56, P567, DOI 10.1007/s000180050454; Sutters M, 2003, J LAB CLIN MED, V141, P91, DOI 10.1067/mlc.2003.13; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Vandorpe DH, 2001, J BIOL CHEM, V276, P4093, DOI 10.1074/jbc.M006252200; Watnick TJ, 1998, MOL CELL, V2, P247, DOI 10.1016/S1097-2765(00)80135-5; Weston BS, 2003, FEBS LETT, V538, P8, DOI 10.1016/S0014-5793(03)00130-3; Wildman SS, 2003, AM J PHYSIOL-RENAL, V285, pF1168, DOI 10.1152/ajprenal.00171.2003; Wilson PD, 1999, LAB INVEST, V79, P1311; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; WOO D, 1995, NEW ENGL J MED, V333, P18, DOI 10.1056/NEJM199507063330104; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Yamaguchi T, 2006, J AM SOC NEPHROL, V17, P178, DOI 10.1681/ASN.2005060645; YE M, 1993, NEW ENGL J MED, V329, P310, DOI 10.1056/NEJM199307293290503; Yu SQ, 2007, P NATL ACAD SCI USA, V104, P18688, DOI 10.1073/pnas.0708217104; Yuan JP, 2003, CELL, V114, P777, DOI 10.1016/S0092-8674(03)00716-5; Zatti A, 2005, MOL BIOL CELL, V16, P5087, DOI 10.1091/mbc.E05-03-0200	61	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36431	36441		10.1074/jbc.M109.068916	http://dx.doi.org/10.1074/jbc.M109.068916			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19854836	Green Published, hybrid			2022-12-25	WOS:000272970500045
J	Nagase, Y; Iwasawa, M; Akiyama, T; Kadono, Y; Nakamura, M; Oshima, Y; Yasui, T; Matsumoto, T; Hirose, J; Nakamura, H; Miyamoto, T; Bouillet, P; Nakamura, K; Tanaka, S				Nagase, Yuichi; Iwasawa, Mitsuyasu; Akiyama, Toru; Kadono, Yuho; Nakamura, Masaki; Oshima, Yasushi; Yasui, Tetsuro; Matsumoto, Takumi; Hirose, Jun; Nakamura, Hiroaki; Miyamoto, Takeshi; Bouillet, Philippe; Nakamura, Kozo; Tanaka, Sakae			Anti-apoptotic Molecule Bcl-2 Regulates the Differentiation, Activation, and Survival of Both Osteoblasts and Osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC KINASE-ACTIVITY; TARGETED DISRUPTION; SIGNALING PATHWAY; BONE-CELLS; C-SRC; EXPRESSION; FAMILY; DEATH; GENE; OSTEOPETROSIS	The anti-apoptotic molecule Bcl-2 inhibits apoptosis by preventing cytochrome c release from mitochondria. Although several studies have indicated the importance of Bcl-2 in maintaining skeletal integrity, the detailed cellular and molecular mechanisms remain elusive. Bcl-2(-/-) mice are growth-retarded and exhibit increased bone volume of the primary spongiosa, mainly due to the decreased number and dysfunction of osteoclasts. Osteoblast function is also impaired in Bcl-2(-/-) mice. Ex vivo studies on osteoblasts and osteoclasts showed that Bcl-2 promoted the differentiation, activation, and survival of both cell types. Because Bcl-2(-/-) mice die before 6 weeks of age due to renal failure and cannot be compared with adult wild type mice, we generated Bcl-2(-/-)Bim(+/-) mice, in which a single Bim allele was inactivated, and compared them with their Bcl-2(-/-)Bim(+/-) littermates. Loss of a single Bim allele restored normal osteoclast function in Bcl-2(-/-) mice but did not restore the impaired function of osteoblasts, and the mice exhibited osteopenia. These data demonstrate that Bcl-2 promotes the differentiation, activity, and survival of both osteoblasts and osteoclasts. The balance between Bcl-2 and Bim regulates osteoclast apoptosis and function, whereas other pro-apoptotic members are important for osteoblasts.	[Nagase, Yuichi; Iwasawa, Mitsuyasu; Akiyama, Toru; Kadono, Yuho; Nakamura, Masaki; Oshima, Yasushi; Yasui, Tetsuro; Matsumoto, Takumi; Hirose, Jun; Nakamura, Kozo; Tanaka, Sakae] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1130033, Japan; [Nakamura, Hiroaki] Matsumoto Dent Univ, Dept Histol & Cell Biol, Nagano 3990781, Japan; [Miyamoto, Takeshi] Keio Univ, Sch Med, Dept Orthopaed Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Bouillet, Philippe] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	University of Tokyo; Matsumoto Dental University; Keio University; Walter & Eliza Hall Institute	Tanaka, S (corresponding author), Univ Tokyo, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	TANAKAS-ORT@h.u-tokyo.ac.jp	Hirose, Jun/AAO-8474-2020; Tanaka, Sakae/Y-3061-2019; Bouillet, Philippe/E-1241-2013; Akiyama, Toru/AAA-5887-2020; Kadono, Yuho/AAO-2405-2020	Tanaka, Sakae/0000-0001-9210-9414; Bouillet, Philippe/0000-0002-9012-6058; Akiyama, Toru/0000-0001-9493-4768; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor, and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and health science research grants from the Ministry of Health, Labor, and Welfare of Japan (to S. T.).	Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Amling M, 1997, J CELL BIOL, V136, P205, DOI 10.1083/jcb.136.1.205; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Boot-Handford RP, 1998, INT J EXP PATHOL, V79, P329, DOI 10.1046/j.1365-2613.1998.790411.x; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Harada S, 2003, NATURE, V423, P349, DOI 10.1038/nature01660; Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793; Jilka RL, 2007, J BONE MINER RES, V22, P1492, DOI 10.1359/JBMR.070518; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kitamura T, 1998, INT J HEMATOL, V67, P351; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Lagasse E, 1997, CELL, V89, P1021, DOI 10.1016/S0092-8674(00)80290-1; Linette GP, 1996, P NATL ACAD SCI USA, V93, P9545, DOI 10.1073/pnas.93.18.9545; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Mocetti P, 2001, TISSUE CELL, V33, P1, DOI 10.1054/tice.2000.0144; NAKAYAMA K, 1993, SCIENCE, V261, P1584, DOI 10.1126/science.8372353; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Okahashi N, 1998, BONE, V23, P33, DOI 10.1016/S8756-3282(98)00069-6; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Ranger AM, 2001, NAT GENET, V28, P113, DOI 10.1038/88815; RATTS VS, 1995, ENDOCRINOLOGY, V136, P3665, DOI 10.1210/en.136.8.3665; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanaka S, 1996, NATURE, V383, P528, DOI 10.1038/383528a0; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Yamashita J, 2008, J BONE MINER RES, V23, P621, DOI 10.1359/JBMR.071211; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang W, 2007, CALCIFIED TISSUE INT, V80, P111, DOI 10.1007/s00223-006-0168-2	44	49	54	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36659	36669		10.1074/jbc.M109.016915	http://dx.doi.org/10.1074/jbc.M109.016915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19846553	hybrid, Green Published			2022-12-25	WOS:000272970500066
J	Ikeda, Y; Sato, K; Pimentel, DR; Sam, F; Shaw, RJ; Dyck, JRB; Walsh, K				Ikeda, Yasumasa; Sato, Kaori; Pimentel, David R.; Sam, Flora; Shaw, Reuben J.; Dyck, Jason R. B.; Walsh, Kenneth			Cardiac-specific Deletion of LKB1 Leads to Hypertrophy and Dysfunction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; PEUTZ-JEGHERS-SYNDROME; SKELETAL-MUSCLE; TRANSGENIC MICE; CONTRACTILE DYSFUNCTION; GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; ATRIAL-FIBRILLATION; PRESSURE-OVERLOAD; EXPRESSION	LKB1 encodes a serine/threonine kinase, which functions upstream of the AMP-activated protein kinase (AMPK) superfamily. To clarify the role of LKB1 in heart, we generated and characterized cardiac myocyte-specific LKB1 knock-out (KO) mice using alpha-myosin heavy chain-Cre deletor strain. LKB1-KO mice displayed biatrial enlargement with atrial fibrillation and cardiac dysfunction at 4 weeks of age. Left ventricular hypertrophy was observed in LKB1-KO mice at 12 weeks but not 4 weeks of age. Collagen I and III mRNA expression was elevated in atria at 4 weeks, and atrial fibrosis was seen at 12 weeks. LKB1-KO mice displayed cardiac dysfunction and atrial fibrillation and died within 6 months of age. Indicative of a prohypertrophic environment, the phosphorylation of AMPK and eEF2 was reduced, whereas mammalian target of rapamycin (mTOR) phosphorylation and p70S6 kinase phosphorylation were increased in both the atria and ventricles of LKB1-deficient mice. Consistent with vascular endothelial growth factor mRNA and protein levels being significantly reduced in LKB1-KO mice, these mice also exhibited a reduction in capillary density of both atria and ventricles. In cultured cardiac myocytes, LKB1 silencing induced hypertrophy, which was ameliorated by the expression of a constitutively active form AMPK or by treatment with the inhibitor of mTOR, rapamycin. These findings indicate that LKB1 signaling in cardiac myocytes is essential for normal development of the atria and ventricles. Cardiac hypertrophy and dysfunction in LKB1-deficient hearts are associated with alterations in AMPK and mTOR/p70S6 kinase/eEF2 signaling and with a reduction in vascular endothelial growth factor expression and vessel rarefaction.	[Walsh, Kenneth] Boston Univ, Mol Cardiol Whitaker Cardiovasc Inst, Sch Med, Boston, MA 02118 USA; [Pimentel, David R.] Boston Univ, Med Ctr, Dept Med, Cardiovasc Med Sect, Boston, MA 02118 USA; [Pimentel, David R.] Boston Univ, Myocardial Biol Unit, Sch Med, Boston, MA 02118 USA; [Sam, Flora] Boston Univ, Cardiac Remodeling Lab, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Shaw, Reuben J.] Salk Inst Biol Studies, Mol & Cell Biol Lab, San Diego, CA 92186 USA; [Dyck, Jason R. B.] Univ Alberta, Cardiovasc Res Ctr, Edmonton, AB T6G 2S2, Canada	Boston University; Boston University; Boston University; Boston University; Salk Institute; University of Alberta	Walsh, K (corresponding author), Boston Univ, Mol Cardiol Whitaker Cardiovasc Inst, Sch Med, Med Campus,715 Albany St,Rm W611, Boston, MA 02118 USA.	kxwalsh@bu.edu		Walsh, Kenneth/0000-0001-7580-2276; Sam, Flora/0000-0001-8442-9362; Ikeda, Yasumasa/0000-0003-4318-7349; Dyck, Jason/0000-0002-7045-2884; Pimentel, David/0000-0002-0537-7195	Japan Health Sciences Foundation; National Institutes of Health [HL079099, HL68758, HL77774, HL86785, AG15052]; Canadian Institutes of Health [MOP53088]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL095891, R01HL079099] Funding Source: NIH RePORTER	Japan Health Sciences Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by the Japan Health Sciences Foundation.; Supported by National Institutes of Health Grant HL079099.; Alberta Heritage Foundation for Medical Research Senior Scholar and a Canada Research Chair in Molecular Biology of Heart Disease and Metabolism and supported by Canadian Institutes of Health Research Grant MOP53088.; Supported by National Institutes of Health Grants HL68758, HL77774, HL86785, and AG15052.	Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Brundel BJJM, 2002, CARDIOVASC RES, V54, P315, DOI 10.1016/S0008-6363(02)00222-5; CARLBERG U, 1990, EUR J BIOCHEM, V191, P639, DOI 10.1111/j.1432-1033.1990.tb19169.x; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Chan AYM, 2005, CAN J PHYSIOL PHARM, V83, P24, DOI 10.1139/Y04-107; Dolinsky VW, 2006, AM J PHYSIOL-HEART C, V291, pH2557, DOI 10.1152/ajpheart.00329.2006; Dolinsky VW, 2009, CIRCULATION, V119, P1643, DOI 10.1161/CIRCULATIONAHA.108.787440; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; El-Armouche A, 2006, CIRCULATION, V114, P670, DOI 10.1161/CIRCULATIONAHA.106.636845; Fentzke RC, 1998, J CLIN INVEST, V101, P2415, DOI 10.1172/JCI2950; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Gulick James, 2009, Methods Mol Biol, V561, P91, DOI 10.1007/978-1-60327-019-9_6; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Ikeda Y, 2005, J BIOL CHEM, V280, P29661, DOI 10.1074/jbc.M411694200; Ikeda Y, 2008, FEBS LETT, V582, P1147, DOI 10.1016/j.febslet.2008.03.002; Izumiya Y, 2006, HYPERTENSION, V47, P887, DOI 10.1161/01.HYP.0000215207.54689.31; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; JOHNSON JE, 1989, MOL CELL BIOL, V9, P3393, DOI 10.1128/MCB.9.8.3393; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Karuman P, 2001, MOL CELL, V7, P1307, DOI 10.1016/S1097-2765(01)00258-1; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marignani PA, 2005, J CLIN PATHOL, V58, P15, DOI 10.1136/jcp.2003.015255; Marignani PA, 2001, J BIOL CHEM, V276, P32415, DOI 10.1074/jbc.C100207200; Mu J, 2001, MOL CELL, V7, P1085, DOI 10.1016/S1097-2765(01)00251-9; Muller FU, 2005, J BIOL CHEM, V280, P6906, DOI 10.1074/jbc.M407864200; Noga AA, 2007, AM J PHYSIOL-HEART C, V292, pH1460, DOI 10.1152/ajpheart.01133.2006; Ohashi K, 2006, HYPERTENSION, V47, P1108, DOI 10.1161/01.HYP.0000222368.43759.a1; Okamoto Y, 2001, AM J PATHOL, V159, P639, DOI 10.1016/S0002-9440(10)61735-X; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Pimentel DR, 2006, J MOL CELL CARDIOL, V41, P613, DOI 10.1016/j.yjmcc.2006.05.009; Saba S, 2005, AM J PHYSIOL-HEART C, V289, pH1456, DOI 10.1152/ajpheart.00733.2004; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sakamoto K, 2005, EMBO J, V24, P1810, DOI 10.1038/sj.emboj.7600667; Severs NJ, 2008, CARDIOVASC RES, V80, P9, DOI 10.1093/cvr/cvn133; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shield MA, 1996, MOL CELL BIOL, V16, P5058; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Shiojima I, 2002, J BIOL CHEM, V277, P37670, DOI 10.1074/jbc.M204572200; Smith DP, 2001, HUM MOL GENET, V10, P2869, DOI 10.1093/hmg/10.25.2869; Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Xiao HD, 2004, AM J PATHOL, V165, P1019, DOI 10.1016/S0002-9440(10)63363-9; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Xing YQ, 2003, J BIOL CHEM, V278, P28372, DOI 10.1074/jbc.M303521200; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074; Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702; Zhu Wei, 2003, J Cardiovasc Electrophysiol, V14, P982, DOI 10.1046/j.1540-8167.2003.02002.x	54	121	125	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35839	35849		10.1074/jbc.M109.057273	http://dx.doi.org/10.1074/jbc.M109.057273			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19828446	hybrid, Green Published			2022-12-25	WOS:000272645600060
J	Singh, V; Aballay, A				Singh, Varsha; Aballay, Alejandro			Regulation of DAF-16-mediated Innate Immunity in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATA TRANSCRIPTION FACTOR; SIGNALING PATHWAY; C. ELEGANS; LIFE-SPAN; FUNCTIONAL-ANALYSIS; KAPPA-B; DAF-16; STRESS; BACTERIAL; EXPRESSION	Activation of the innate immune system results in a rapid microbicidal response against microorganisms, which needs to be fine-tuned because uncontrolled immune responses can lead to infection and cancer, as well as conditions such as Crohn disease, atherosclerosis, and Alzheimer disease. Here we report that excessive activity of the conserved FOXO transcription factor DAF-16 enhances susceptibility to bacterial infections in Caenorhabditis elegans. We found that increased temperature activates not only DAF-16 nuclear import but also a control mechanism involved in DAF-16 nuclear export. The nuclear export of DAF-16 requires heat shock transcription factor HSF-1 and Hsp70/HSP-1. Furthermore, we show that increased expression of the water channel Aquoporin-1 is responsible for the deleterious consequences of excessive DAF-16-mediated immune response. These studies reveal a stress-inducible mechanism involved in the regulation of DAF-16 and indicate that uncontrolled DAF-16 activity and water homeostasis are a cause of the deleterious effects of excessive immune responses.	[Singh, Varsha; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Aballay, A (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, 268 Jones,Box 3054, Durham, NC 27710 USA.	a.aballay@duke.edu			National Institutes of Health [GM070977]; Whitehead Scholars Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehead Scholars Program	This work was supported, in whole or in part, by National Institutes of Health Grant GM070977 and The Whitehead Scholars Program ( to A. A.).	Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Bicego KC, 2002, J APPL PHYSIOL, V93, P512, DOI 10.1152/japplphysiol.00121.2002; BRENNER S, 1974, GENETICS, V77, P71; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chavez V, 2007, GENETICS, V176, P1567, DOI 10.1534/genetics.107.072587; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Huang CG, 2007, AM J PHYSIOL-CELL PH, V292, pC1867, DOI 10.1152/ajpcell.00514.2006; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Iser WB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001240; Ito H, 2006, J NEUROCHEM, V99, P107, DOI 10.1111/j.1471-4159.2006.04036.x; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kerry S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000077; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; King LS, 2004, NAT REV MOL CELL BIO, V5, P687, DOI 10.1038/nrm1469; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Li SZ, 2007, AM J PHYSIOL-CELL PH, V292, pC1606, DOI 10.1152/ajpcell.00588.2005; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Miyata S, 2008, GENETICS, V178, P903, DOI 10.1534/genetics.107.083923; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nikolaidis N, 2004, MOL BIOL EVOL, V21, P498, DOI 10.1093/molbev/msh041; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; Snoeks L, 2008, INFECT IMMUN, V76, P4677, DOI 10.1128/IAI.00227-08; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tops BBJ, 2005, NUCLEIC ACIDS RES, V33, P347, DOI 10.1093/nar/gki183; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; UNE T, 1984, INFECT IMMUN, V43, P895, DOI 10.1128/IAI.43.3.895-900.1984; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; WRAY C, 1978, RES VET SCI, V25, P139, DOI 10.1016/S0034-5288(18)32968-0; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	41	59	61	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35580	35587		10.1074/jbc.M109.060905	http://dx.doi.org/10.1074/jbc.M109.060905			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858203	hybrid, Green Published			2022-12-25	WOS:000272645600035
J	Bogan, KL; Evans, C; Belenky, P; Song, P; Burant, CF; Kennedy, R; Brenner, C				Bogan, Katrina L.; Evans, Charles; Belenky, Peter; Song, Peng; Burant, Charles F.; Kennedy, Robert; Brenner, Charles			Identification of Isn1 and Sdt1 as Glucose- and Vitamin-regulated Nicotinamide Mononucleotide and Nicotinic Acid Adenine Dinucleotide 5 '-Nucleotidases Responsible for Production of Nicotinamide Riboside and Nicotinic Acid Riboside	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIFE-SPAN EXTENSION; BIOCHEMICAL GENOMICS APPROACH; CALORIE RESTRICTION; NAD(+); METABOLISM; ACTIVATION; ENCODES; SALVAGE; GENE; BIOSYNTHESIS	Recently, we discovered that nicotinamide riboside and nicotinic acid riboside are biosynthetic precursors of NAD(+), which are utilized through two pathways consisting of distinct enzymes. In addition, we have shown that exogenously supplied nicotinamide riboside is imported into yeast cells by a dedicated transporter, and it extends replicative lifespan on high glucose medium. Here, we show that nicotinamide riboside and nicotinic acid riboside are authentic intracellular metabolites in yeast. Secreted nicotinamide riboside was detected with a biological assay, and intracellular levels of nicotinamide riboside, nicotinic acid riboside, and other NAD(+) metabolites were determined by a liquid chromatography-mass spectrometry method. A biochemical genomic screen indicated that three yeast enzymes possess nicotinamide mononucleotide 5'-nucleotidase activity in vitro. Metabolic profiling of knock-out mutants established that Isn1 and Sdt1 are responsible for production of nicotinamide riboside and nicotinic acid riboside in cells. Isn1, initially classified as an IMP-specific 5'-nucleotidase, and Sdt1, initially classified as a pyrimidine 5'-nucleotidase, area additionally responsible for dephosphorylation of pyridine mononucleotides. Sdt1 overexpression is growth-inhibitory to cells in a manner that depends on its active site and correlates with reduced cellular NAD(+). Expression of Isn1 protein is positively regulated by the availability of nicotinic acid and glucose. These results reveal unanticipated and highly regulated steps in NAD(+) metabolism.	[Bogan, Katrina L.; Brenner, Charles] Univ Iowa, Dept Biochem, Carver Coll Med, Iowa City, IA 52242 USA; [Bogan, Katrina L.; Belenky, Peter; Brenner, Charles] Dartmouth Med Sch, Biochem Grad Program, Lebanon, NH 03756 USA; [Evans, Charles; Song, Peng; Kennedy, Robert] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Evans, Charles; Burant, Charles F.] Univ Michigan, Michigan Metabol & Obes Ctr, Ann Arbor, MI 48109 USA	University of Iowa; Dartmouth College; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Brenner, C (corresponding author), Univ Iowa, Dept Biochem, Carver Coll Med, 51 Newton Rd,4-403 BSB, Iowa City, IA 52242 USA.	charles-brenner@uiowa.edu	Kennedy, Robert/G-9095-2016; Burant, Charles/GPC-5690-2022; Brenner, Charles/D-6339-2014	Kennedy, Robert/0000-0003-2447-7471; Burant, Charles/0000-0001-9189-5003; Evans, Charles/0000-0001-6698-5330; Brenner, Charles/0000-0002-4955-3226	National Institutes of Health [R37-DK046960, R01-DK079084, T32-DK07245]; National Science Foundation [MCB-0822581]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079084, T32DK007245, R37DK046960] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-DK046960, R01-DK079084, and T32-DK07245 and by National Science Foundation Grant MCB-0822581.	Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Belenky P, 2007, CELL, V129, P473, DOI 10.1016/j.cell.2007.03.024; Belenky P, 2009, J BIOL CHEM, V284, P158, DOI 10.1074/jbc.M807976200; Belenky PA, 2008, J BIOL CHEM, V283, P8075, DOI 10.1074/jbc.C800021200; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Bieganowski P, 2003, J BIOL CHEM, V278, P33056, DOI 10.1074/jbc.M302276200; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Brachmann CB, 1998, YEAST, V14, P115; CHENG WL, 1995, J BACTERIOL, V177, P6711, DOI 10.1128/jb.177.23.6711-6717.1995; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Gazzaniga F, 2009, MICROBIOL MOL BIOL R, V73, P529, DOI 10.1128/MMBR.00042-08; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghislain M, 2002, YEAST, V19, P215, DOI 10.1002/yea.810; Grose JH, 2005, J BACTERIOL, V187, P4521, DOI 10.1128/JB.187.13.4521-4530.2005; HAYAKAWA T, 1984, AGR BIOL CHEM TOKYO, V48, P445, DOI 10.1080/00021369.1984.10866148; HILLYARD D, 1981, J BIOL CHEM, V256, P8491; Hu G, 2007, ARCH BIOCHEM BIOPHYS, V461, P66, DOI 10.1016/j.abb.2007.01.037; Itoh Roichi, 2003, BMC Biochem, V4, P4, DOI 10.1186/1471-2091-4-4; Kurtz JE, 2002, CURR GENET, V41, P132, DOI 10.1007/s00294-002-0296-9; Lecoq K, 2001, J BACTERIOL, V183, P4910, DOI 10.1128/JB.183.16.4910-4913.2001; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Loret MO, 2007, YEAST, V24, P47, DOI 10.1002/yea.1435; Lu SP, 2009, J BIOL CHEM, V284, P17110, DOI 10.1074/jbc.M109.004010; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Nakanishi T, 2002, J BIOL CHEM, V277, P22103, DOI 10.1074/jbc.M200573200; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Phizicky EM, 2002, METHOD ENZYMOL, V350, P546; PREISS J, 1958, J BIOL CHEM, V233, P493; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sauve AA, 2005, MOL CELL, V17, P595, DOI 10.1016/j.molcel.2004.12.032; Suda Y, 2003, YEAST, V20, P995, DOI 10.1002/yea.1008; Tempel W, 2007, PLOS BIOL, V5, P2220, DOI 10.1371/journal.pbio.0050263; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	40	41	44	6	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34861	34869		10.1074/jbc.M109.056689	http://dx.doi.org/10.1074/jbc.M109.056689			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19846558	Green Published, hybrid			2022-12-25	WOS:000272439600041
J	Engel, J; Schmalhorst, PS; Dork-Bousset, T; Ferrieres, V; Routier, FH				Engel, Jakob; Schmalhorst, Philipp S.; Doerk-Bousset, Thilo; Ferrieres, Vincent; Routier, Francoise H.			A Single UDP-galactofuranose Transporter Is Required for Galactofuranosylation in Aspergillus fumigatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE SUGAR TRANSPORTERS; GDP-MANNOSE TRANSPORT; CELL-WALL; GALACTOPYRANOSE MUTASE; ENDOPLASMIC-RETICULUM; GALACTOSE TRANSPORTER; BETA-GALACTOFURANOSE; LEISHMANIA-MAJOR; GENE FAMILY; IDENTIFICATION	Galactofuranose (Galf) containing molecules have been described at the cell surface of several eukaryotes and shown to contribute to the virulence of the parasite Leishmania major and the fungus Aspergillus fumigatus. It is anticipated that a number of the surface glycoconjugates such as N-glycans or glycolipids are galactofuranosylated in the Golgi apparatus. This raises the question of how the substrate for galactofuranosylation reactions, UDP-Galf, which is synthesized in the cytosol, translocates into the organelles of the secretory pathway. Here we report the first identification of a Golgi-localized nucleotide sugar transporter, named GlfB, with specificity for a UDP-Galf. In vitro transport assays established binding of UDP-Galf to GlfB and excluded transport of several other nucleotide sugars. Furthermore, the implication of glfB in the galactofuranosylation of A. fumigatus glycoconjugates and galactomannan was demonstrated by a targeted gene deletion approach. Our data reveal a direct connection between galactomannan and the organelles of the secretory pathway that strongly suggests that the cell wall-bound polysaccharide originates from its glycosylphosphatidylinositol-anchored form.	[Routier, Francoise H.] Hannover Med Sch, Inst Cellular Chem, D-30625 Hannover, Germany; [Doerk-Bousset, Thilo] Hannover Med Sch, Ctr Biochem & Gynecol, Res Unit, Clin Obstet, D-30625 Hannover, Germany; [Doerk-Bousset, Thilo] Hannover Med Sch, Ctr Biochem & Gynecol, Res Unit, Clin Gynecol, D-30625 Hannover, Germany; [Ferrieres, Vincent] Ecole Natl Super Chim Rennes, CNRS, UMR 6226, CS 50837, F-35708 Rennes 7, France; [Ferrieres, Vincent] Univ Europeenne Bretagne, F-35000 Rennes, France	Hannover Medical School; Hannover Medical School; Hannover Medical School; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Superieure de Chimie de Rennes (ENSCR); Universite de Bretagne Occidentale	Routier, FH (corresponding author), Hannover Med Sch, Inst Cellular Chem, OE 4330,Carl Neuberg Str 1, D-30625 Hannover, Germany.	Routier.Francoise@mh-hannover.de	Routier, Francoise/O-1611-2019; Dörk, Thilo/J-8620-2012; FERRIERES, Vincent/B-4452-2009	Dörk, Thilo/0000-0002-9458-0282; FERRIERES, Vincent/0000-0002-2780-7774; Schmalhorst, Philipp/0000-0002-5795-0133; Routier, Francoise/0000-0002-7163-0590	German Research Foundation (Deutsche Forschungsgemeinschaft); French Research Agency [ANR JCJC06_140075]; Region Bretagne	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); French Research Agency(French National Research Agency (ANR)); Region Bretagne(Region Bretagne)	This work was supported by Graduate School 745 of the German Research Foundation (Deutsche Forschungsgemeinschaft), French Research Agency Grant ANR JCJC06_140075, and the Region Bretagne.	Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Bakker H, 2005, BIOL CHEM, V386, P657, DOI 10.1515/BC.2005.076; Bakker H, 2005, GLYCOBIOLOGY, V15, P193, DOI 10.1093/glycob/cwh159; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Beverley SM, 2005, EUKARYOT CELL, V4, P1147, DOI 10.1128/EC.4.6.1147-1154.2005; CAPASSO JM, 1984, BIOCHIM BIOPHYS ACTA, V777, P133, DOI 10.1016/0005-2736(84)90505-4; Capul AA, 2007, J BIOL CHEM, V282, P14006, DOI 10.1074/jbc.M610869200; Costachel C, 2005, J BIOL CHEM, V280, P39835, DOI 10.1074/jbc.M510163200; Damveld RA, 2008, GENETICS, V178, P873, DOI 10.1534/genetics.107.073148; Dean N, 1997, J BIOL CHEM, V272, P31908, DOI 10.1074/jbc.272.50.31908; DELEDERKREMER RM, 1995, GLYCOBIOLOGY, V5, P547, DOI 10.1093/glycob/5.6.547; Eckhardt M, 1999, J BIOL CHEM, V274, P8779, DOI 10.1074/jbc.274.13.8779; El-Ganiny AM, 2008, FUNGAL GENET BIOL, V45, P1533, DOI 10.1016/j.fgb.2008.09.008; Gao XD, 2001, J BIOL CHEM, V276, P4424, DOI 10.1074/jbc.M009114200; Gerardy-Schahn R, 2001, BIOCHIMIE, V83, P775, DOI 10.1016/S0300-9084(01)01322-0; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; GREEN JR, 1983, ISOLATION MEMBRANES, P135; Ha DS, 1996, MOL BIOCHEM PARASIT, V77, P57, DOI 10.1016/0166-6851(96)02580-7; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Jack DL, 2001, EUR J BIOCHEM, V268, P3620, DOI 10.1046/j.1432-1327.2001.02265.x; Kabuss R, 2005, GLYCOBIOLOGY, V15, P905, DOI 10.1093/glycob/cwi085; Kleczka B, 2007, J BIOL CHEM, V282, P10498, DOI 10.1074/jbc.M700023200; Klis F., 2007, BIOL FUNGAL CELL, P97; Knappe S, 2003, PLANT PHYSIOL, V131, P1178, DOI 10.1104/pp.016519; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Krappmann S, 2006, EUKARYOT CELL, V5, P212, DOI 10.1128/EC.5.1.212-215.2006; Krappmann S, 2005, EUKARYOT CELL, V4, P1298, DOI 10.1128/EC.4.7.1298-1307.2005; Lamarre C, 2009, CELL MICROBIOL, V11, P1612, DOI 10.1111/j.1462-5822.2009.01352.x; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; Latge JP, 2009, MED MYCOL, V47, pS104, DOI 10.1080/13693780802258832; LATGE JP, 1994, INFECT IMMUN, V62, P5424; Lee R, 1996, ANAL BIOCHEM, V242, P1, DOI 10.1006/abio.1996.0419; Leitao EA, 2003, GLYCOBIOLOGY, V13, P681, DOI 10.1093/glycob/cwg089; LORD JM, 1973, J CELL BIOL, V57, P659, DOI 10.1083/jcb.57.3.659; Marino K, 2005, EUR J ORG CHEM, V2005, P2958; Marlow AL, 2001, ORG LETT, V3, P2517, DOI 10.1021/ol016170d; Morelle W, 2005, EUKARYOT CELL, V4, P1308, DOI 10.1128/EC.4.7.1308-1316.2005; Muraoka M, 2007, J BIOL CHEM, V282, P24615, DOI 10.1074/jbc.M611358200; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nishikawa A, 2002, YEAST, V19, P691, DOI 10.1002/yea.854; Nishikawa A, 2002, J BACTERIOL, V184, P29, DOI 10.1128/JB.184.1.29-42.2002; Novelli JF, 2009, DEV BIOL, V335, P340, DOI 10.1016/j.ydbio.2009.09.010; Pan F, 2001, J BACTERIOL, V183, P3991, DOI 10.1128/JB.183.13.3991-3998.2001; Peltier P, 2008, CARBOHYD RES, V343, P1897, DOI 10.1016/j.carres.2008.02.010; Peltier P, 2007, ORG LETT, V9, P5227, DOI 10.1021/ol702392x; Peltier P, 2008, EUR J ORG CHEM, V2008, P5988, DOI 10.1002/ejoc.200800742; Puglielli L, 1999, J BIOL CHEM, V274, P35596, DOI 10.1074/jbc.274.50.35596; PUNT PJ, 1992, METHOD ENZYMOL, V216, P447; Record E, 1998, CAN J MICROBIOL, V44, P945, DOI 10.1139/cjm-44-10-945; Richards MR, 2009, CHEMBIOCHEM, V10, P1920, DOI 10.1002/cbic.200900208; Rollwitz I, 2006, FEBS LETT, V580, P4246, DOI 10.1016/j.febslet.2006.06.082; Roy SK, 2000, J BIOL CHEM, V275, P13580, DOI 10.1074/jbc.275.18.13580; Schmalhorst PS, 2008, EUKARYOT CELL, V7, P1268, DOI 10.1128/EC.00109-08; Schmidt M, 2004, MICROBIOL-SGM, V150, P3253, DOI 10.1099/mic.0.27197-0; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; Segawa H, 2005, J BIOL CHEM, V280, P2028, DOI 10.1074/jbc.M404915200; Simenel C, 2008, GLYCOBIOLOGY, V18, P84, DOI 10.1093/glycob/cwm122; Spath GF, 2000, P NATL ACAD SCI USA, V97, P9258, DOI 10.1073/pnas.160257897; Spath GF, 2003, SCIENCE, V301, P1241, DOI 10.1126/science.1087499; STYNEN D, 1992, INFECT IMMUN, V60, P2237, DOI 10.1128/IAI.60.6.2237-2245.1992; Suzuki E, 1997, GLYCOBIOLOGY, V7, P463, DOI 10.1093/glycob/7.4.463; Tiralongo J, 2006, GLYCOBIOLOGY, V16, P73, DOI 10.1093/glycob/cwj029; Toledo MS, 2007, J LIPID RES, V48, P1801, DOI 10.1194/jlr.M700149-JLR200; Wagener J, 2008, EUKARYOT CELL, V7, P1661, DOI 10.1128/EC.00221-08; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang K, 2004, MOL BIOCHEM PARASIT, V136, P11, DOI 10.1016/j.molbiopara.2004.02.012; Zhou H, 2007, EUKARYOT CELL, V6, P2260, DOI 10.1128/EC.00261-07	69	44	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33859	33868		10.1074/jbc.M109.070219	http://dx.doi.org/10.1074/jbc.M109.070219			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19840949	hybrid, Green Published			2022-12-25	WOS:000272165200018
J	Tao, Z; Zhang, YW; Agyiri, A; Rudnick, G				Tao, Zhen; Zhang, Yuan-Wei; Agyiri, Alice; Rudnick, Gary			Ligand Effects on Cross-linking Support a Conformational Mechanism for Serotonin Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT NEUROTRANSMITTER TRANSPORTERS; TRANSMEMBRANE DOMAIN-I; BACTERIAL HOMOLOG; ESCHERICHIA-COLI; PERMEATION PATHWAY; CRYSTAL-STRUCTURE; LACTOSE PERMEASE; RESIDUES; COCAINE; BINDING	Serotonin transporter (SERT) is responsible for the re-uptake of 5-hydroxytryptamine (5-HT) from the synaptic cleft after release from serotonergic neurons. We show here that cysteine residues at positions in transmembranes 1 and 3 of SERT, like the corresponding positions in the gamma-aminobutyric acid transporter, can be cross-linked using copper(II)(1,10-phenanthroline) 3. The presence of a cross-link was detected by a novel methionine mutagenesis strategy. A change in mobility for an N-terminal cyanogen bromide fragment accompanied disulfide cross-linking of the two cysteine residues. Cross-linking also inhibited transport, and this process was blocked by cocaine, which is expected to stabilize SERT in conformations where the two positions are separated, but cocaine did not decrease accessibility of either of the two cysteines to modification by 2-aminoethyl methanethiosulfonate. Cysteine was required at both positions on the same molecule for efficient cross-linking, indicating that the reaction was intramolecular.	[Tao, Zhen; Zhang, Yuan-Wei; Agyiri, Alice; Rudnick, Gary] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	Yale University	Rudnick, G (corresponding author), 333 Cedar St, New Haven, CT 06520 USA.	gary.rudnick@yale.edu		ZHANG, YUAN-WEI/0000-0002-4276-9251	National Institutes of Health through the National Institute on Drug Abuse [DA007259]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA007259, R01DA008213] Funding Source: NIH RePORTER	National Institutes of Health through the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA007259 through the National Institute on Drug Abuse.	Androutsellis-Theotokis A, 2003, J BIOL CHEM, V278, P12703, DOI 10.1074/jbc.M206563200; Barker EL, 1999, J NEUROSCI, V19, P4705; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; BLAKELY RD, 1991, ANAL BIOCHEM, V194, P302, DOI 10.1016/0003-2697(91)90233-J; Chen JG, 2000, P NATL ACAD SCI USA, V97, P1044, DOI 10.1073/pnas.97.3.1044; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FALKE JJ, 1987, SCIENCE, V237, P1596, DOI 10.1126/science.2820061; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; GALLAGHER S, 2003, CURRENT PROTOCOLS PR, P1; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Kaiser R, 1999, ANAL BIOCHEM, V266, P1, DOI 10.1006/abio.1998.2945; Kanner BI, 2008, CHEM REV, V108, P1654, DOI 10.1021/cr078246a; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MITCHELL P, 1990, RES MICROBIOL, V141, P286, DOI 10.1016/0923-2508(90)90002-8; PAKULA AA, 1992, P NATL ACAD SCI USA, V89, P4144, DOI 10.1073/pnas.89.9.4144; Quick M, 2006, J BIOL CHEM, V281, P26444, DOI 10.1074/jbc.M602438200; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sun JZ, 1997, BIOCHEMISTRY-US, V36, P11959, DOI 10.1021/bi971172k; URSITTI JA, 2001, CURRENT PROTOCOLS PR, P1; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Wu JH, 1996, P NATL ACAD SCI USA, V93, P14498, DOI 10.1073/pnas.93.25.14498; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhang YW, 2006, J BIOL CHEM, V281, P36213, DOI 10.1074/jbc.M605468200; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zomot E, 2005, J BIOL CHEM, V280, P25512, DOI 10.1074/jbc.M503864200	34	15	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 4	2009	284	49					33807	33814		10.1074/jbc.M109.071977	http://dx.doi.org/10.1074/jbc.M109.071977			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	524TE	19837674	hybrid, Green Published			2022-12-25	WOS:000272165200012
J	Yasrebi, H; Sperisen, P; Praz, V; Bucher, P				Yasrebi, Haleh; Sperisen, Peter; Praz, Viviane; Bucher, Philipp			Can Survival Prediction Be Improved By Merging Gene Expression Data Sets?	PLOS ONE			English	Article							BREAST-CANCER; MICROARRAY DATA; ESTROGEN-RECEPTOR; HISTOLOGIC GRADE; MARKER GENES; SIGNATURE; PLATFORM; CLASSIFICATION; CARCINOMAS; SUBTYPES	Background: High-throughput gene expression profiling technologies generating a wealth of data, are increasingly used for characterization of tumor biopsies for clinical trials. By applying machine learning algorithms to such clinically documented data sets, one hopes to improve tumor diagnosis, prognosis, as well as prediction of treatment response. However, the limited number of patients enrolled in a single trial study limits the power of machine learning approaches due to over-fitting. One could partially overcome this limitation by merging data from different studies. Nevertheless, such data sets differ from each other with regard to technical biases, patient selection criteria and follow-up treatment. It is therefore not clear at all whether the advantage of increased sample size outweighs the disadvantage of higher heterogeneity of merged data sets. Here, we present a systematic study to answer this question specifically for breast cancer data sets. We use survival prediction based on Cox regression as an assay to measure the added value of merged data sets. Results: Using time-dependent Receiver Operating Characteristic-Area Under the Curve (ROC-AUC) and hazard ratio as performance measures, we see in overall no significant improvement or deterioration of survival prediction with merged data sets as compared to individual data sets. This apparently was due to the fact that a few genes with strong prognostic power were not available on all microarray platforms and thus were not retained in the merged data sets. Surprisingly, we found that the overall best performance was achieved with a single-gene predictor consisting of CYB5D1. Conclusions: Merging did not deteriorate performance on average despite (a) The diversity of microarray platforms used. (b) The heterogeneity of patients cohorts. (c) The heterogeneity of breast cancer disease. (d) Substantial variation of time to death or relapse. (e) The reduced number of genes in the merged data sets. Predictors derived from the merged data sets were more robust, consistent and reproducible across microarray platforms. Moreover, merging data sets from different studies helps to better understand the biases of individual studies and can lead to the identification of strong survival factors like CYB5D1 expression.			Yasrebi, H (corresponding author), Swiss Fed Inst Technol EPFL, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, EPFL SV ISREC, Lausanne, Switzerland.	Haleh.Yasrebi@epfl.ch						Ach RA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-148; Acharya CR, 2008, JAMA-J AM MED ASSOC, V299, P1574, DOI 10.1001/jama.299.13.1574; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bloom G, 2004, AM J PATHOL, V164, P9, DOI 10.1016/S0002-9440(10)63090-8; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; BURKE HB, 1993, CANCER, V72, P3131, DOI 10.1002/1097-0142(19931115)72:10<3131::AID-CNCR2820721039>3.0.CO;2-J; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Calza S, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1517; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chen QR, 2008, GENOMICS, V92, P195, DOI 10.1016/j.ygeno.2008.05.014; Craven RJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2191; Dan L, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.7580; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grade M, 2006, CANCER RES, V66, P267, DOI 10.1158/0008-5472.CAN-05-2533; Grade M, 2007, CANCER RES, V67, P41, DOI 10.1158/0008-5472.CAN-06-1514; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jenssen TK, 2002, HUM GENET, V111, P411, DOI 10.1007/s00439-002-0804-5; Jiang HY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-81; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; LIN X, 2003, MAKING SENSE HUMAN L; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Lyman GH, 2006, CLIN BREAST CANCER, V7, P372, DOI 10.3816/CBC.2006.n.053; Mackay A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1732; Mullins M, 2007, CLIN CHEM, V53, P1273, DOI 10.1373/clinchem.2006.083725; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Perreard L, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1399; Praz V, 2004, NUCLEIC ACIDS RES, V32, pD542, DOI 10.1093/nar/gkh107; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; R Development Core Team, 2007, R LANG ENV STAT COMP; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; SCHULER GD, 1996, SCIENCE, V274; Shen RL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-94; Sohal D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002965; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stec J, 2005, J MOL DIAGN, V7, P357, DOI 10.1016/S1525-1578(10)60565-X; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Vachani A, 2007, CLIN CANCER RES, V13, P2905, DOI 10.1158/1078-0432.CCR-06-1670; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; Wain HM, 2002, GENOMICS, V79, P464, DOI 10.1006/geno.2002.6748; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Warnat P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-265; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Xu L, 2005, BIOINFORMATICS, V21, P3905, DOI 10.1093/bioinformatics/bti647; Xu L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-125	58	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7431	10.1371/journal.pone.0007431	http://dx.doi.org/10.1371/journal.pone.0007431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851466	Green Submitted, Green Published, gold			2022-12-25	WOS:000271022300002
J	Hall, JS; Ip, HS; Franson, JC; Meteyer, C; Nashold, S; TeSlaa, JL; French, J; Redig, P; Brand, C				Hall, Jeffrey S.; Ip, Hon S.; Franson, J. Christian; Meteyer, Carol; Nashold, Sean; TeSlaa, Joshua L.; French, John; Redig, Patrick; Brand, Christopher			Experimental Infection of a North American Raptor, American Kestrel (Falco sparverius), with Highly Pathogenic Avian Influenza Virus (H5N1)	PLOS ONE			English	Article							DUCKS; SUSCEPTIBILITY; GULLS	Several species of wild raptors have been found in Eurasia infected with highly pathogenic avian influenza virus (HPAIV) subtype H5N1. Should HPAIV (H5N1) reach North America in migratory birds, species of raptors are at risk not only from environmental exposure, but also from consuming infected birds and carcasses. In this study we used American kestrels as a representative species of a North American raptor to examine the effects of HPAIV (H5N1) infection in terms of dose response, viral shedding, pathology, and survival. Our data showed that kestrels are highly susceptible to HPAIV (H5N1). All birds typically died or were euthanized due to severe neurologic disease within 4-5 days of inoculation and shed significant amounts of virus both orally and cloacally, regardless of dose administered. The most consistent microscopic lesions were necrosis in the brain and pancreas. This is the first experimental study of HPAIV infection in a North American raptor and highlights the potential risks to birds of prey if HPAIV (H5N1) is introduced into North America.			Hall, JS (corresponding author), USGS Natl Wildlife Hlth Ctr, Madison, WI USA.	jshall@usgs.gov		Ip, Hon/0000-0003-4844-7533; TeSlaa, Joshua/0000-0001-7802-3454; Franson, J/0000-0002-0251-4238; Hall, Jeffrey/0000-0001-5599-2826; Meteyer, Carol/0000-0002-4007-3410; Nashold, Sean/0000-0002-8869-6633	PHS HHS [HHSN266200700007C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Beaty B.J., 1995, DIAGNOSTIC PROCEDURE, P189; Brown JD, 2008, AVIAN PATHOL, V37, P393, DOI 10.1080/03079450802216595; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2007, J WILDLIFE DIS, V43, P660, DOI 10.7589/0090-3558-43.4.660; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Clark L, 2006, ORNITHOL MONOGR, P3; COUACYHYMANN E, 2008, 1 SPECIFIC DETECTION, P1; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Lierz M, 2007, EMERG INFECT DIS, V13, P1667, DOI 10.3201/eid1311.070705; Medica DL, 2007, J WILDLIFE DIS, V43, P538, DOI 10.7589/0090-3558-43.3.538; REED L. J., 1938, AMER JOUR HYG, V27, P493; SAMOUR J, 2006, FALCO NEWSLETTER, V27, P21; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; SWAYNE D., 1998, LAB MANUAL ISOLATION, P150; Van Borm S, 2005, EMERG INFECT DIS, V11, P702, DOI 10.3201/eid1105.050211	16	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7555	10.1371/journal.pone.0007555	http://dx.doi.org/10.1371/journal.pone.0007555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847294	Green Published, Green Submitted, gold			2022-12-25	WOS:000271022000017
J	Louie, B; Higdon, R; Kolker, E				Louie, Brenton; Higdon, Roger; Kolker, Eugene			A Statistical Model of Protein Sequence Similarity and Function Similarity Reveals Overly-Specific Function Predictions	PLOS ONE			English	Article							GENE ONTOLOGY; SEMANTIC SIMILARITY; ANNOTATION TRANSFER; HYPOTHETICAL GENES; DATABASE; GENOMICS; ERRORS; BLAST; IDENTIFICATION; EXPRESSION	Background: Predicting protein function from primary sequence is an important open problem in modern biology. Not only are there many thousands of proteins of unknown function, current approaches for predicting function must be improved upon. One problem in particular is overly-specific function predictions which we address here with a new statistical model of the relationship between protein sequence similarity and protein function similarity. Methodology: Our statistical model is based on sets of proteins with experimentally validated functions and numeric measures of function specificity and function similarity derived from the Gene Ontology. The model predicts the similarity of function between two proteins given their amino acid sequence similarity measured by statistics from the BLAST sequence alignment algorithm. A novel aspect of our model is that it predicts the degree of function similarity shared between two proteins over a continuous range of sequence similarity, facilitating prediction of function with an appropriate level of specificity. Significance: Our model shows nearly exact function similarity for proteins with high sequence similarity (bit score > 244.7, e-value > 1e(-62), non-redundant NCBI protein database (NRDB)) and only small likelihood of specific function match for proteins with low sequence similarity (bit score < 54.6, e-value < 1e(-05), NRDB). For sequence similarity ranges in between our annotation model shows an increasing relationship between function similarity and sequence similarity, but with considerable variability. We applied the model to a large set of proteins of unknown function, and predicted functions for thousands of these proteins ranging from general to very specific. We also applied the model to a data set of proteins with previously assigned, specific functions that were electronically based. We show that, on average, these prior function predictions are more specific (quite possibly overly-specific) compared to predictions from our model that is based on proteins with experimentally determined function.			Louie, B (corresponding author), Seattle Childrens Res Inst, Bioinformat & High Throughput Anal Lab, Seattle, WA USA.	eugene.kolker@seattlechildrens.org	Kolker, Eugene/C-6711-2008		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076680] Funding Source: NIH RePORTER; NIDDK NIH HHS [UO1 DK072473, U01 DK072473] Funding Source: Medline; NIGMS NIH HHS [R01 GM076680, 5R01 GM076680-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Addou S, 2009, J MOL BIOL, V387, P416, DOI 10.1016/j.jmb.2008.12.045; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bork P, 2000, GENOME RES, V10, P398, DOI 10.1101/gr.10.4.398; Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Deonier R.C., 2005, COMPUTATIONAL GENOME; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; Frishman D, 2001, BIOINFORMATICS, V17, P44, DOI 10.1093/bioinformatics/17.1.44; FRISHMAN D, 2008, MODERN GENOME ANNOTA; Frishman D, 2007, CHEM REV, V107, P3448, DOI 10.1021/cr068303k; Galperin M Y, 1998, In Silico Biol, V1, P55; Galperin MY, 2006, CURR OPIN BIOTECH, V17, P440, DOI 10.1016/j.copbio.2006.08.007; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Gilks WR, 2002, BIOINFORMATICS, V18, P1641, DOI 10.1093/bioinformatics/18.12.1641; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Hastie T., 2007, ELEMENTS STAT LEARNI; Hegyi H, 2001, GENOME RES, V11, P1632, DOI 10.1101/gr. 183801; HENIKOFF S, 1994, GENOMICS, V19, P97, DOI 10.1006/geno.1994.1018; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Iliopoulos I, 2003, BIOINFORMATICS, V19, P717, DOI 10.1093/bioinformatics/btg077; Jones CE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-170; Joshi T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-222; Karp PD, 1998, BIOINFORMATICS, V14, P753, DOI 10.1093/bioinformatics/14.9.753; Karp PD, 2001, BIOINFORMATICS, V17, P526, DOI 10.1093/bioinformatics/17.6.526; Kolker E, 2005, P NATL ACAD SCI USA, V102, P2099, DOI 10.1073/pnas.0409111102; Kolker E, 2004, NUCLEIC ACIDS RES, V32, P2353, DOI 10.1093/nar/gkh555; Kolker E, 2003, J BACTERIOL, V185, P4593, DOI 10.1128/JB.185.15.4593-4602.2003; Koonin EV., 2003, SEQUENCE EVOLUTION F; Lee TJ, 2008, BIOINFORMATICS, V24, pI259, DOI 10.1093/bioinformatics/btn180; Lin D, 1998, P INT C MACH LEARN; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Louie B, 2008, OMICS, V12, P211, DOI 10.1089/omi.2008.0051; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Martin DMA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-178; McCullagh P, 1989, GEN LINEAR MODELS; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Ouzounis CA, 2002, GENOME BIOL, V3; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Raghunathan A, 2004, OMICS, V8, P25, DOI 10.1089/153623104773547471; Roberts RJ, 2004, PLOS BIOL, V2, P293, DOI 10.1371/journal.pbio.0020042; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Sangar V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-294; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Thomas GH, 1999, BIOINFORMATICS, V15, P860, DOI 10.1093/bioinformatics/15.10.860; Valencia A, 2005, CURR OPIN STRUC BIOL, V15, P267, DOI 10.1016/j.sbi.2005.05.010; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW6, DOI 10.1093/nar/gkl164	52	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7546	10.1371/journal.pone.0007546	http://dx.doi.org/10.1371/journal.pone.0007546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844580	gold, Green Published, Green Submitted			2022-12-25	WOS:000271013000019
J	Gershon, TR; Shirazi, A; Qin, LX; Gerald, WL; Kenney, AM; Cheung, NK				Gershon, Timothy R.; Shirazi, Arash; Qin, Li-Xuan; Gerald, William L.; Kenney, Anna M.; Cheung, Nai-Kong			Enteric Neural Crest Differentiation in Ganglioneuromas Implicates Hedgehog Signaling in Peripheral Neuroblastic Tumor Pathogenesis	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; B RECEPTOR GENE; SONIC HEDGEHOG; HIRSCHSPRUNGS-DISEASE; NEURONAL PRECURSORS; DESERT HEDGEHOG; MOUSE MODEL; CELLS; EXPRESSION; ZEBRAFISH	Peripheral neuroblastic tumors (PNTs) share a common origin in the sympathetic nervous system, but manifest variable differentiation and growth potential. Malignant neuroblastoma (NB) and benign ganglioneuroma (GN) stand at opposite ends of the clinical spectrum. We hypothesize that a common PNT progenitor is driven to variable differentiation by specific developmental signaling pathways. To elucidate developmental pathways that direct PNTs along the differentiation spectrum, we compared the expression of genes related to neural crest development in GN and NB. In GNs, we found relatively low expression of sympathetic markers including adrenergic biosynthesis enzymes, indicating divergence from sympathetic fate. In contrast, GNs expressed relatively high levels of enteric neuropeptides and key constituents of the Hedgehog (HH) signaling pathway, including Dhh, Gli1 and Gli3. Predicted HH targets were also differentially expressed in GN, consistent with transcriptional response to HH signaling. These findings indicate that HH signaling is specifically active in GN. Together with the known role of HH activity in enteric neural development, these findings further suggested a role for HH activity in directing PNTs away from the sympathetic lineage toward a benign GN phenotype resembling enteric ganglia. We tested the potential for HH signaling to advance differentiation in PNTs by transducing NB cell lines with Gli1 and determining phenotypic and transcriptional response. Gli1 inhibited proliferation of NB cells, and induced a pattern of gene expression that resembled the differential pattern of gene expression of GN, compared to NB (p<0.00001). Moreover, the transcriptional response of SY5Y cells to Gli1 transduction closely resembled the transcriptional response to the differentiation agent retinoic acid (p<0.00001). Notably, Gli1 did not induce N-MYC expression in neuroblastoma cells, but strongly induced RET, a known mediator of RA effect. The decrease in NB cell proliferation induced by Gli1, and the similarity in the patterns of gene expression induced by Gli1 and by RA, corroborated by closely matched gene sets in GN tumors, all support a model in which HH signaling suppresses PNT growth by promoting differentiation along alternative neural crest pathways.			Gershon, TR (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.	gershont@neurology.unc.edu	Gershon, Timothy/H-5398-2019	Gershon, Timothy/0000-0001-7034-6400	NATIONAL CANCER INSTITUTE [P01CA106450] Funding Source: NIH RePORTER; NCI NIH HHS [CA106450, P01 CA106450] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe M, 2007, INT J DEV BIOL, V51, P97, DOI 10.1387/ijdb.062237ma; Alaminos M, 2003, CANCER RES, V63, P4538; Barrallo-Gimeno A, 2004, DEVELOPMENT, V131, P1463, DOI 10.1242/dev.01033; Cariboni A, 2004, HUM MOL GENET, V13, P2781, DOI 10.1093/hmg/ddh309; Chamberlain CE, 2008, DEVELOPMENT, V135, P1097, DOI 10.1242/dev.013086; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Eggert A, 2008, PEDIATR CLIN N AM, V55, px; ELFVIN LG, 1987, CELL TISSUE RES, V250, P79, DOI 10.1007/BF00214657; Fu M, 2004, J CELL BIOL, V166, P673, DOI 10.1083/jcb.200401077; Galvin KE, 2008, STEM CELLS, V26, P1027, DOI 10.1634/stemcells.2007-0879; Gershon TR, 2005, NEOPLASIA, V7, P575, DOI 10.1593/neo.04637; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GRIFFIN ME, 1969, PEDIATRICS, V43, P377; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Han J, 2007, MECH DEVELOP, V124, P729, DOI 10.1016/j.mod.2007.06.006; Hong SJ, 2008, J BIOL CHEM, V283, P16860, DOI 10.1074/jbc.M709106200; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; JESSEN KR, 1984, J NEUROCYTOL, V13, P187, DOI 10.1007/BF01148114; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; KIRCHGESSNER AL, 1988, J COMP NEUROL, V276, P607, DOI 10.1002/cne.902760412; Kwiatkowski JL, 1998, CANCER RES, V58, P4602; Lee J, 1997, DEVELOPMENT, V124, P2537; LINDH B, 1989, CELL TISSUE RES, V256, P259; Lipinski RJ, 2005, DEV DYNAM, V233, P829, DOI 10.1002/dvdy.20414; Liu SQ, 2005, CANCER LETT, V228, P125, DOI 10.1016/j.canlet.2005.01.056; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Nair S, 2007, DEVELOPMENT, V134, P335, DOI 10.1242/dev.02704; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Oppenheimer O, 2007, MOL CANCER THER, V6, P1300, DOI 10.1158/1535-7163.MCT-06-0587; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Park JR, 2008, PEDIATR CLIN N AM, V55, P97, DOI 10.1016/j.pcl.2007.10.014; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; QUAK SH, 1988, AUST PAEDIATR J, V24, P55; Raffel C, 1997, CANCER RES, V57, P842; Rossi J, 2003, J CLIN INVEST, V112, P707, DOI 10.1172/JCI200317995; Sharghi-Namini S, 2006, J NEUROSCI, V26, P6364, DOI 10.1523/JNEUROSCI.0157-06.2006; Shkumatava A, 2005, EMBO REP, V6, P563, DOI 10.1038/sj.embor.7400416; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; Tischler AS, 2000, SEMIN DIAGN PATHOL, V17, P120; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Whitlock KE, 2003, DEV BIOL, V257, P140, DOI 10.1016/S0012-1606(03)00039-3; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Zigmond RE, 1997, ANN NY ACAD SCI, V814, P181, DOI 10.1111/j.1749-6632.1997.tb46157.x	49	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7491	10.1371/journal.pone.0007491	http://dx.doi.org/10.1371/journal.pone.0007491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834598	gold, Green Published, Green Submitted			2022-12-25	WOS:000270880700015
J	Salisbury, J; Hutchison, KW; Wigglesworth, K; Eppig, JJ; Graber, JH				Salisbury, Jesse; Hutchison, Keith W.; Wigglesworth, Karen; Eppig, John J.; Graber, Joel H.			Probe-Level Analysis of Expression Microarrays Characterizes Isoform-Specific Degradation during Mouse Oocyte Maturation	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; MESSENGER-RNAS; ALTERNATIVE POLYADENYLATION; DATABASE; TRANSCRIPTOME; SEQUENCES; CLEAVAGE; IMPROVES	Background: Gene expression microarrays have provided many insights into changes in gene expression patterns between different tissue types, developmental stages, and disease states. Analyses of these data focused primarily measuring the relative abundance of transcripts of a gene, while treating most or all transcript isoforms as equivalent. Differences in the selection between transcript isoforms can, however, represent critical changes to either the protein product or the posttranscriptional regulation of the transcript. Novel analyses on existing microarray data provide fresh insights and new interpretations into transcriptome-wide changes in expression. Methodology: A probe-level analysis of existing gene expression arrays revealed differences in mRNA processing, primarily affecting the 39-untranslated region. Working with the example of microarrays drawn from a transcriptionally silent period of mouse oocyte development, probe-level analysis (implemented here as rmodel) identified genes whose transcript isoforms have differing stabilities. Comparison of micorarrays measuring cDNA generated from oligo-dT and random primers revealed further differences in the polyadenylation status of some transcripts. Additional analysis provided evidence for sequence-targeted cleavage, including putative targeting sequences, as one mechanism of degradation for several hundred transcripts in the maturing oocyte. Conclusions: The capability of probe-level analysis to elicit novel findings from existing expression microarray data was demonstrated. The characterization of differences in stability between transcript isoforms in maturing mouse oocytes provided some mechanistic details of degradation. Similar analysis of existing archives of expression microarray data will likely provide similar discoveries.			Salisbury, J (corresponding author), Univ Maine, Funct Genom PhD Program, Orono, ME 04469 USA.	joel.graber@jax.org		Graber, Joel/0000-0001-5137-4553	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD021970] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016463] Funding Source: NIH RePORTER; NCRR NIH HHS [2 P20 RR16463-04, P20 RR016463] Funding Source: Medline; NICHD NIH HHS [1R01HD21970, U01 HD021970] Funding Source: Medline; NIGMS NIH HHS [1R01GM077206] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Affymetrix, 2005, GUID PROB LOG INT ER; Bemmo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-529; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; Brockman JM, 2005, BIOINFORMATICS, V21, P3691, DOI 10.1093/bioinformatics/bti589; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Comander J, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-17; Cui XQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004229; D'mello Veera, 2006, Appl Bioinformatics, V5, P249, DOI 10.2165/00822942-200605040-00007; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Evsikov AV, 2006, GENE DEV, V20, P2713, DOI 10.1101/gad.1471006; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kawaji H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r40; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Laajala E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r77; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Liu DL, 2007, NUCLEIC ACIDS RES, V35, P234, DOI 10.1093/nar/gkl919; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; Robinson MD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-156; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thompson W, 2003, NUCLEIC ACIDS RES, V31, P3580, DOI 10.1093/nar/gkg608; Wang ET, 2008, NATURE; Yu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-194; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	51	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7479	10.1371/journal.pone.0007479	http://dx.doi.org/10.1371/journal.pone.0007479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834616	Green Published, Green Submitted, gold			2022-12-25	WOS:000270880700007
J	Yasukochi, Y; Tanaka-Okuyama, M; Shibata, F; Yoshido, A; Marec, F; Wu, CC; Zhang, HB; Goldsmith, MR; Sahara, K				Yasukochi, Yuji; Tanaka-Okuyama, Makiko; Shibata, Fukashi; Yoshido, Atsuo; Marec, Frantisek; Wu, Chengcang; Zhang, Hongbin; Goldsmith, Marian R.; Sahara, Ken			Extensive Conserved Synteny of Genes between the Karyotypes of Manduca sexta and Bombyx mori Revealed by BAC-FISH Mapping	PLOS ONE			English	Article							GENOME SEQUENCE; LINKAGE MAP; CHROMOSOME EVOLUTION; LEPIDOPTERA; SILKWORM; REGIONS; ORDER; KINETOCHORE; EXPRESSION; LOCATION	Background: Genome sequencing projects have been completed for several species representing four highly diverged holometabolous insect orders, Diptera, Hymenoptera, Coleoptera, and Lepidoptera. The striking evolutionary diversity of insects argues a need for efficient methods to apply genome information from such models to genetically uncharacterized species. Constructing conserved synteny maps plays a crucial role in this task. Here, we demonstrate the use of fluorescence in situ hybridization with bacterial artificial chromosome probes as a powerful tool for physical mapping of genes and comparative genome analysis in Lepidoptera, which have numerous and morphologically uniform holokinetic chromosomes. Methodology/Principal Findings: We isolated 214 clones containing 159 orthologs of well conserved single-copy genes of a sequenced lepidopteran model, the silkworm, Bombyx mori, from a BAC library of a sphingid with an unexplored genome, the tobacco hornworm, Manduca sexta. We then constructed a BAC-FISH karyotype identifying all 28 chromosomes of M. sexta by mapping 124 loci using the corresponding BAC clones. BAC probes from three M. sexta chromosomes also generated clear signals on the corresponding chromosomes of the convolvulus hawk moth, Agrius convolvuli, which belongs to the same subfamily, Sphinginae, as M. sexta. Conclusions/Significance: Comparison of the M. sexta BAC physical map with the linkage map and genome sequence of B. mori pointed to extensive conserved synteny including conserved gene order in most chromosomes. Only a few rearrangements, including three inversions, three translocations, and two fission/fusion events were estimated to have occurred after the divergence of Bombycidae and Sphingidae. These results add to accumulating evidence for the stability of lepidopteran genomes. Generating signals on A. convolvuli chromosomes using heterologous M. sexta probes demonstrated that BAC-FISH with orthologous sequences can be used for karyotyping a wide range of related and genetically uncharacterized species, significantly extending the ability to develop synteny maps for comparative and functional genomics.			Yasukochi, Y (corresponding author), Natl Inst Agrobiol Sci, Insect Genome Res Unit, Tsukuba, Ibaraki, Japan.	yaskoch@affrc.go.jp	Marec, Frantisek/G-7943-2014; Yoshido, Atsuo/K-6437-2015; SHIBATA, Fukashi/B-2534-2011; Sahara, Ken/A-4266-2012	Marec, Frantisek/0000-0002-6745-5603; Yoshido, Atsuo/0000-0003-0343-2709; 				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Cabrero J, 2008, CHROMOSOME RES, V16, P595, DOI 10.1007/s10577-008-1214-x; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; CARPENTER JE, 2005, PRINCIPLES PRACTICE, P115; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Couble P, 2008, INSECT BIOCHEM MOLEC, V38, P1035, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Davis BW, 2009, GENOMICS, V93, P299, DOI 10.1016/j.ygeno.2008.09.010; Dernburg AF, 2001, J CELL BIOL, V153, pF33, DOI 10.1083/jcb.153.6.F33; Dopman EB, 2004, GENETICS, V167, P301, DOI 10.1534/genetics.167.1.301; DUBCOVSKY J, 1995, GENETICS, V140, P1367; Duch C, 2003, EUR J NEUROSCI, V17, P945, DOI 10.1046/j.1460-9568.2003.02523.x; Eleftherianos I, 2006, DEV COMP IMMUNOL, V30, P1099, DOI 10.1016/j.dci.2006.02.008; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Furusawa T, 2008, J PROTEOME RES, V7, P938, DOI 10.1021/pr070405j; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; HUGHESSCHRADER S, 1961, CHROMOSOMA, V12, P327, DOI 10.1007/BF00328928; Jiggins CD, 2005, GENETICS, V171, P557, DOI 10.1534/genetics.104.034686; Kawahara AY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005719; Keshan B, 2006, DEV BIOL, V295, P623, DOI 10.1016/j.ydbio.2006.03.049; Maddox PS, 2004, CHROMOSOME RES, V12, P641, DOI 10.1023/B:CHRO.0000036588.42225.2f; MALHEIROS NYDIA, 1947, AGRONOMIA LUSITANA, V9, P51; Marec F., 1995, Chromosome Research, V3, P117; MINET J, 1994, ENTOMOL SCAND, V25, P63, DOI 10.1163/187631294X00045; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Nagaki K, 2005, PLANT CELL, V17, P1886, DOI 10.1105/tpc.105.032961; Papa R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-345; Papanicolaou A, 2008, NUCLEIC ACIDS RES, V36, pD582, DOI 10.1093/nar/gkm853; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Pringle EG, 2007, GENETICS, V177, P417, DOI 10.1534/genetics.107.073122; Raudsepp T, 2001, CYTOGENET CELL GENET, V94, P180, DOI 10.1159/000048812; Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roberto R, 2007, GENOME RES, V17, P249, DOI 10.1101/gr.6052507; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Robinson R, 1971, LEPIDOPTERA GENETICS; Roy V, 2005, HEREDITY, V94, P388, DOI 10.1038/sj.hdy.6800612; Sahara K, 2003, CHROMOSOMA, V112, P48, DOI 10.1007/s00412-003-0245-5; Sahara K, 2007, GENOME, V50, P1061, DOI 10.1139/G07-082; SCHUBERT I, 1985, CHROMOSOMA, V92, P143, DOI 10.1007/BF00328466; Shibata F, 2009, ZOOL SCI, V26, P187, DOI 10.2108/zsj.26.187; Stanyon R, 2008, CHROMOSOME RES, V16, P17, DOI 10.1007/s10577-007-1209-z; Sundquist A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000484; Tobler A, 2005, HEREDITY, V94, P408, DOI 10.1038/sj.hdy.6800619; Traut W, 2007, SEX DEV, V1, P332, DOI 10.1159/000111765; Van't Hof AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003882; Wang BQ, 2004, GENETICS, V168, P215, DOI 10.1534/genetics.104.028118; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WHALLEY P, 1986, BIOL J LINN SOC, V28, P253, DOI 10.1111/j.1095-8312.1986.tb01756.x; Willis Judith H., 1995, P1; Wrensch Dana L., 1994, P282; Wu CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-283; Wyder S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r242; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yasukochi Y, 1998, GENETICS, V150, P1513; Yasukochi Y, 2006, GENETICS, V173, P1319, DOI 10.1534/genetics.106.055541; Yasukochi Yuji, 2002, Methods Mol Biol, V192, P401; Yoshido A, 2005, GENETICS, V170, P675, DOI 10.1534/genetics.104.040352; Young ND, 2009, CURR OPIN PLANT BIOL, V12, P193, DOI 10.1016/j.pbi.2008.11.005; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004; Zou Z, 2008, INSECT BIOCHEM MOLEC, V38, P677, DOI 10.1016/j.ibmb.2008.03.009	61	33	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7465	10.1371/journal.pone.0007465	http://dx.doi.org/10.1371/journal.pone.0007465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829706	gold, Green Published, Green Submitted			2022-12-25	WOS:000270847800007
J	Bourke, E; Brown, JAL; Takeda, S; Hochegger, H; Morrison, CG				Bourke, E.; Brown, J. A. L.; Takeda, S.; Hochegger, H.; Morrison, C. G.			DNA damage induces Chk1-dependent threonine-160 phosphorylation and activation of Cdk2	ONCOGENE			English	Article						centrosome; DNA damage response; Chk1; Cdk2; Cdk1	INDUCED CENTROSOME OVERDUPLICATION; CYCLIN-E OVEREXPRESSION; CELL-CYCLE; CHROMOSOME INSTABILITY; TUMOR-CELLS; AMPLIFICATION; PHASE; DUPLICATION; CHECKPOINT; CDC25A	Abnormal centrosome numbers arise in tumours and can cause multipolar mitoses and genome instability. Cdk2 controls normal centrosome duplication, but Chk1-dependent centrosome amplification also occurs after DNA damage. We investigated the involvement of cyclin-dependent kinases (Cdks) in DNA damage-induced centrosome amplification using cells lacking either Cdk2, or both Cdk1 and Cdk2 activity. Cdk2(-/-) DT40 cells showed robust centrosome amplification after ionizing radiation (IR), whereas Cdk1-deficient Cdk2(-/-) cells showed no centrosome amplification, demonstrating that Cdk1 can substitute for Cdk2 in this pathway. Surprisingly, we found that Cdk2 activity was upregulated by IR in wild-type but not in Chk1(-/-) DT40 cells. Cdk2 upregulation also occurred in HeLa cells after IR treatment. Chk1-dependent Cdk2 induction was not accompanied by increased levels of Cdk1, Cdk2, cyclin A or cyclin E, but activating T160 phosphorylation of Cdk2 increased after IR. Moreover, Cdk2 overexpression restored IR-induced centrosome amplification in Cdk1-deficient Cdk2(-/-) cells, but T160A mutation blocked this rescue. Our data suggest that Chk1 signalling causes centrosome amplification after IR by upregulating Cdk2 activity through activating phosphorylation. Oncogene (2010) 29, 616-624; doi: 10.1038/onc.2009.340; published online 19 October 2009	[Bourke, E.; Brown, J. A. L.; Morrison, C. G.] Natl Univ Ireland Galway, Ctr Chromosome Biol, Sch Nat Sci, Galway, Ireland; [Takeda, S.] Kyoto Univ, Sch Med, Dept Radiat Genet, Kyoto 606, Japan; [Hochegger, H.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England	Ollscoil na Gaillimhe-University of Galway; Kyoto University; University of Sussex	Morrison, CG (corresponding author), Natl Univ Ireland Galway, Ctr Chromosome Biol, Sch Nat Sci, Univ Rd, Galway, Ireland.	ciaran.morrison@nuigalway.ie	Morrison, Ciaran/B-6568-2008; Brown, James/H-3437-2019; Morrison, Ciaran/AAH-2034-2019	Morrison, Ciaran/0000-0003-2401-7029; Brown, James/0000-0002-3155-0334; Morrison, Ciaran/0000-0003-2401-7029; Hochegger, Helfrid/0000-0001-8366-6198; Takeda, Shunichi/0000-0002-7924-7991; Bourke, Emer/0000-0002-2218-3114	Science Foundation Ireland [08/IN.1/B1029]; Health Research Board [RP/2006/36]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board	This work was supported by Science Foundation Ireland Principal Investigator award 08/IN.1/B1029 and by Health Research Board project grant RP/2006/36. We thank Helen Dodson for helping us with the initial Cdk kinase assays and Corrado Santocanale for critical reading of the paper.	Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Balczon R, 2001, CHROMOSOMA, V110, P381, DOI 10.1007/s004120100157; Beamish H, 1996, J BIOL CHEM, V271, P20486, DOI 10.1074/jbc.271.34.20486; Berthet C, 2007, ONCOGENE, V26, P4469, DOI 10.1038/sj.onc.1210243; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Cannell EJ, 1998, FEBS LETT, V439, P297, DOI 10.1016/S0014-5793(98)01391-X; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; Dodson H, 2007, CELL CYCLE, V6, P364, DOI 10.4161/cc.6.3.3834; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Duensing A, 2006, ONCOGENE, V25, P2943, DOI 10.1038/sj.onc.1209310; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Hanashiro K, 2008, ONCOGENE, V27, P5288, DOI 10.1038/onc.2008.161; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Hinchcliffe EH, 1999, SCIENCE, V283, P851, DOI 10.1126/science.283.5403.851; Hochegger H, 2007, J CELL BIOL, V178, P257, DOI 10.1083/jcb.200702034; Kawamura K, 2004, CANCER RES, V64, P4800, DOI 10.1158/0008-5472.CAN-03-3908; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Lacey KR, 1999, P NATL ACAD SCI USA, V96, P2817, DOI 10.1073/pnas.96.6.2817; Mailand N, 2000, SCIENCE, V288, P1425, DOI 10.1126/science.288.5470.1425; Mailand N, 2002, EMBO J, V21, P5911, DOI 10.1093/emboj/cdf567; MATSUMOTO Y, 1999, P SPIE 3 DIM IM CAPT, V2, P2; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Muller-Tidow C, 2004, MOL CELL BIOL, V24, P8917, DOI 10.1128/MCB.24.20.8917-8928.2004; Mussman JG, 2000, ONCOGENE, V19, P1635, DOI 10.1038/sj.onc.1203460; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Prosser SL, 2009, MOL CELL BIOL, V29, P1760, DOI 10.1128/MCB.01124-08; Saladino C, 2009, ENVIRON MOL MUTAGEN, V50, P725, DOI 10.1002/em.20477; Sampath D, 2002, MOL PHARMACOL, V62, P680, DOI 10.1124/mol.62.3.680; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sato N, 2000, EXP CELL RES, V255, P321, DOI 10.1006/excr.1999.4797; Satyanarayana A, 2008, MOL BIOL CELL, V19, P65, DOI 10.1091/mbc.E07-06-0525; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Shreeram S, 2008, MOL CELL BIOL, V28, P7442, DOI 10.1128/MCB.00138-08; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Uto K, 2004, EMBO J, V23, P3386, DOI 10.1038/sj.emboj.7600328; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993; Yamazoe M, 2004, DNA REPAIR, V3, P1175, DOI 10.1016/j.dnarep.2004.03.039; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; Zhao H, 2002, P NATL ACAD SCI USA, V99, P14795, DOI 10.1073/pnas.182557299	47	35	37	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2010	29	4					616	624		10.1038/onc.2009.340	http://dx.doi.org/10.1038/onc.2009.340			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	549WH	19838212				2022-12-25	WOS:000274084600014
J	Cracan, V; Padovani, D; Banerjee, R				Cracan, Valentin; Padovani, Dominique; Banerjee, Ruma			IcmF Is a Fusion between the Radical B-12 Enzyme Isobutyryl-CoA Mutase and Its G-protein Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-CINNAMONENSIS; ESCHERICHIA-COLI; BUTYRIVIBRIO-FIBRISOLVENS; INSERTIONAL INACTIVATION; GEOBACILLUS-KAUSTOPHILUS; RECOMBINANT ENZYME; GENE FUSION; COENZYME; DEHYDROGENASE; CLONING	Coenzyme B-12 is used by two highly similar radical enzymes, which catalyze carbon skeleton rearrangements, methylmalonyl-CoA mutase and isobutyryl-CoA mutase (ICM). ICM catalyzes the reversible interconversion of isobutyryl-CoA and n-butyryl-CoA and exists as a heterotetramer. In this study, we have identified >70 bacterial proteins, which represent fusions between the subunits of ICM and a P-loop GTPase and are currently misannotated as methylmalonyl-CoA mutases. Wedesignate this fusion protein as IcmF (isobutyryl-CoA mutase fused). All IcmFs are composed of the following three domains: the N-terminal 5'-deoxyadenosylcobalamin binding region that is homologous to the small subunit of ICM (IcmB), a middle P-loop GTPase domain, and a C-terminal part that is homologous to the large subunit of ICM (IcmA). The P-loop GTPase domain has very high sequence similarity to the Methylobacterium extorquens MeaB, which is a chaperone for methylmalonyl-CoA mutase. We have demonstrated that IcmF is an active ICM by cloning, expressing, and purifying the IcmFs from Geobacillus kaustophilus, Nocardia farcinica, and Burkholderia xenovorans. This finding expands the known distribution of ICM activity well beyond the genus Streptomyces, where it is involved in polyketides biosynthesis, and suggests a role for this enzyme in novel bacterial pathways for amino acid degradation, myxalamid biosynthesis, and acetyl-CoA assimilation.	[Cracan, Valentin; Padovani, Dominique; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), 3220B MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Dominique, PADOVANI/EUS-9660-2022	PADOVANI, Dominique/0000-0003-1166-5801; Cracan, Valentin/0000-0002-3280-0593	National Institutes of Health [DK45776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK45776.	Akopiants K, 2006, J IND MICROBIOL BIOT, V33, P141, DOI 10.1007/s10295-005-0029-4; Alber BE, 2008, J BACTERIOL, V190, P1383, DOI 10.1128/JB.01593-07; Alm EJ, 2005, GENOME RES, V15, P1015, DOI 10.1101/gr.3844805; Asanuma N, 2005, CURR MICROBIOL, V51, P91, DOI 10.1007/s00284-005-4477-x; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; BANERJEE R, 1999, METHYLMALONYL COA MU, P707; BECKER DF, 1993, BIOCHEMISTRY-US, V32, P10736, DOI 10.1021/bi00091a026; Berg IA, 2007, SCIENCE, V318, P1782, DOI 10.1126/science.1149976; BIRCH A, 1993, J BACTERIOL, V175, P3511, DOI 10.1128/jb.175.11.3511-3519.1993; Bode HB, 2007, CHEMBIOCHEM, V8, P2139, DOI 10.1002/cbic.200700401; Dobson CM, 2002, P NATL ACAD SCI USA, V99, P15554, DOI 10.1073/pnas.242614799; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Gasper R, 2006, J BIOL CHEM, V281, P27492, DOI 10.1074/jbc.M600809200; GERTH K, 1983, J ANTIBIOT, V36, P1150, DOI 10.7164/antibiotics.36.1150; HOLLOWAY DE, 1994, J BIOL CHEM, V269, P20425; Hubbard PA, 2007, J BIOL CHEM, V282, P31308, DOI 10.1074/jbc.M704850200; Ishikawa J, 2004, P NATL ACAD SCI USA, V101, P14925, DOI 10.1073/pnas.0406410101; Jeon WB, 2001, J BIOL CHEM, V276, P38602, DOI 10.1074/jbc.M104945200; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; LEHMAN TC, 1990, ANAL BIOCHEM, V186, P280, DOI 10.1016/0003-2697(90)90080-S; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Mansoorabadi SO, 2005, BIOCHEMISTRY-US, V44, P3153, DOI 10.1021/bi0482102; MILLER TL, 1979, J BACTERIOL, V138, P99, DOI 10.1128/JB.138.1.99-104.1979; Montoro-Garcia S, 2009, J BACTERIOL, V191, P3076, DOI 10.1128/JB.01060-08; Muller RH, 2008, MICROBIOL-SGM, V154, P1414, DOI 10.1099/mic.0.2007/014159-0; Padovani D, 2006, BIOCHEMISTRY-US, V45, P9300, DOI 10.1021/bi0604532; Padovani D, 2006, J BIOL CHEM, V281, P17838, DOI 10.1074/jbc.M600047200; Pandit SB, 2003, PROTEINS, V52, P585, DOI 10.1002/prot.10420; Ratnatilleke A, 1999, J BIOL CHEM, V274, P31679, DOI 10.1074/jbc.274.44.31679; Rohwerder T, 2006, APPL ENVIRON MICROB, V72, P4128, DOI 10.1128/AEM.00080-06; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Takami H, 2004, NUCLEIC ACIDS RES, V32, P6292, DOI 10.1093/nar/gkh970; TAOKA S, 1994, J BIOL CHEM, V269, P31630; Vlasie MD, 2004, BIOCHEMISTRY-US, V43, P8410, DOI 10.1021/bi036299q; Vrijbloed JW, 1999, J BACTERIOL, V181, P5600, DOI 10.1128/JB.181.18.5600-5605.1999; Zambelli B, 2007, BIOCHEMISTRY-US, V46, P3171, DOI 10.1021/bi6024676; Zerbe-Burkhardt K, 1998, J BIOL CHEM, V273, P6508, DOI 10.1074/jbc.273.11.6508; ZERBEBURKHARDT K, 1998, CHEM BIOCH B12, P859	41	24	28	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					655	666		10.1074/jbc.M109.062182	http://dx.doi.org/10.1074/jbc.M109.062182			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19864421	Green Published, hybrid			2022-12-25	WOS:000273070100066
J	Martin, C; Gomez-Bilbao, G; Ostolaza, H				Martin, Cesar; Gomez-Bilbao, Geraxane; Ostolaza, Helena			Bordetella Adenylate Cyclase Toxin Promotes Calcium Entry into Both CD11b(+) and CD11b(-) Cells through cAMP-dependent L-type-like Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTINOBACILLUS-ACTINOMYCETEMCOMITANS LEUKOTOXIN; PASTEURELLA-HAEMOLYTICA LEUKOTOXIN; ESCHERICHIA-COLI; TARGET-CELLS; INTRACELLULAR CALCIUM; SIGNAL-TRANSDUCTION; LIPID MICRODOMAINS; EPITHELIAL-CELLS; ALPHA-HEMOLYSIN; PERTUSSIS	Adenylate cyclase toxin (ACT), a 200 kDa protein, is an essential virulence factor for Bordetella pertussis, the bacterium that causes whooping cough. ACT is a member of the pore-forming RTX(repeats-in-toxin) family of proteins that share a characteristic calcium-binding motif of Gly- and Asp-rich nonapeptide repeats and a marked cytolytic or cytotoxic activity. In addition, ACT exhibits a distinctive feature: it has an N-terminal calmodulin-dependent adenylate cyclase domain. Translocation of this domain into the host cytoplasm results in uncontrolled production of cAMP, and it has classically been assumed that this surge in cAMP is the basis for the toxin-mediated killing. Several members of the RTX family of toxins, including ACT, have been shown to induce intracellular calcium increases, through different mechanisms. We show here that ACT stimulates a raft-mediated calcium influx, through its cAMP production activity, that activates PKA, which in turn activates calcium channels with L-type properties. This process is shown to occur both in CD11b(+) and CD11b(-) cells, suggesting a common mechanism, independent of the toxin receptor. We also show that this ACT-induced calcium influx does not correlate with the toxin-induced cytotoxicity.	[Ostolaza, Helena] Univ Basque Country, Ctr Mixto, CSIC, Unidad Biofis,EHU, E-48080 Bilbao, Spain; Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country	Ostolaza, H (corresponding author), Univ Basque Country, Ctr Mixto, CSIC, Unidad Biofis,EHU, Aptdo 644, E-48080 Bilbao, Spain.	gbzoseth@lg.ehu.es	martin, cesar/L-1303-2014	martin, cesar/0000-0002-4087-8729; OSTOLAZA ECHABE, ELENA AMAYA/0000-0003-2933-9975	Spanish Ministerio de Ciencia y Tecnologia [BFU 2007-62062]; Basque Government; University of Basque Country [UE06/10]	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Government(Basque Government); University of Basque Country	This work was supported by grants from the Spanish Ministerio de Ciencia y Tecnologia (Project BFU 2007-62062), the Basque Government (ETORTEK Program), and the University of Basque Country (UPV/EHU, Project UE06/10).	Basler M, 2006, INFECT IMMUN, V74, P2207, DOI 10.1128/IAI.74.4.2207-2214.2006; Bassinet L, 2004, INFECT IMMUN, V72, P5530, DOI 10.1128/IAI.72.9.5530-5533.2004; Beaumont V, 2005, P NATL ACAD SCI USA, V102, P10700, DOI 10.1073/pnas.0501961102; BELLALOU J, 1990, INFECT IMMUN, V58, P3242, DOI 10.1128/IAI.58.10.3242-3247.1990; BENZ R, 1994, J BIOL CHEM, V269, P27231; Bergmeyer HU., 1974, METHODS ENZYMATIC AN, P574, DOI [10.1016/B978-0-12-091302-2.50010-4, DOI 10.1016/B978-0-12-091302-2.50010-4]; Berridge MJ, 2004, BBA-MOL CELL RES, V1742, P3, DOI 10.1016/j.bbamcr.2004.08.012; Chasserot-Golaz S, 2005, MOL BIOL CELL, V16, P1108, DOI 10.1091/mbc.E04-07-0627; Colucci A, 2009, ARCH BIOCHEM BIOPHYS, V481, P80, DOI 10.1016/j.abb.2008.10.002; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; Crossthwaite AJ, 2005, J BIOL CHEM, V280, P6380, DOI 10.1074/jbc.M411987200; Cudd L, 1999, FEMS MICROBIOL LETT, V172, P123, DOI 10.1111/j.1574-6968.1999.tb13459.x; Das R, 2009, CIRC RES, V105, P167, DOI 10.1161/CIRCRESAHA.109.200311; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; Fong KP, 2006, CELL MICROBIOL, V8, P1753, DOI 10.1111/j.1462-5822.2006.00746.x; Gao ZY, 2002, BIOCHEM J, V368, P397, DOI 10.1042/BJ20020999; GERBIG DG, 1989, VET MICROBIOL, V19, P325, DOI 10.1016/0378-1135(89)90098-9; Giorgi C, 2008, CURR MOL MED, V8, P119; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GOODWIN MS, 1990, INFECT IMMUN, V58, P3445, DOI 10.1128/IAI.58.10.3445-3447.1990; GORDON VM, 1989, J BIOL CHEM, V264, P14792; Grafton G, 2003, BIOCHEM PHARMACOL, V66, P2001, DOI 10.1016/j.bcp.2003.07.005; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HANSKI E, 1985, J BIOL CHEM, V260, P5526; Harder T, 1997, CURR OPIN CELL BIOL, V9, P534, DOI 10.1016/S0955-0674(97)80030-0; Hewlett EL, 2006, MOL MICROBIOL, V59, P447, DOI 10.1111/j.1365-2958.2005.04958.x; HEWLETT EL, 1991, J BIOL CHEM, V266, P17503; Hsuan SL, 1998, INFECT IMMUN, V66, P2836, DOI 10.1128/IAI.66.6.2836-2844.1998; Isshiki M, 2003, TRAFFIC, V4, P717, DOI 10.1034/j.1600-0854.2003.00130.x; IWAKI M, 1995, MOL MICROBIOL, V17, P1015, DOI 10.1111/j.1365-2958.1995.mmi_17061015.x; IWASWE M, 1992, J LEUKOCYTE BIOL, V52, P224, DOI 10.1002/jlb.52.2.224; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; KHELEF N, 1993, INFECT IMMUN, V61, P4064, DOI 10.1128/IAI.61.10.4064-4071.1993; Koschinski A, 2006, FASEB J, V20, P973, DOI 10.1096/fj.05-4561fje; LLINAS R, 1995, NEUROPHARMACOLOGY, V34, P1443, DOI 10.1016/0028-3908(95)00150-5; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; Okazaki R, 2009, INT HEART J, V50, P353, DOI 10.1536/ihj.50.353; ORTIZCARRANZA O, 1992, J LEUKOCYTE BIOL, V52, P558, DOI 10.1002/jlb.52.5.558; OTERO AS, 1995, J BIOL CHEM, V270, P9695, DOI 10.1074/jbc.270.17.9695; Paccani SR, 2008, INFECT IMMUN, V76, P2822, DOI 10.1128/IAI.00200-08; Petersen OH, 2008, ANNU REV PHYSIOL, V70, P273, DOI 10.1146/annurev.physiol.70.113006.100618; Philipova R, 2005, J BIOL CHEM, V280, P24957, DOI 10.1074/jbc.M414437200; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Rhodes CR, 2001, ARCH BIOCHEM BIOPHYS, V395, P169, DOI 10.1006/abbi.2001.2553; SHENKER BJ, 1994, J LEUKOCYTE BIOL, V55, P153, DOI 10.1002/jlb.55.2.153; Stokes L, 2004, J BIOL CHEM, V279, P19566, DOI 10.1074/jbc.M401481200; SZABO G, 1994, J BIOL CHEM, V269, P22496; Uhlen P, 2000, NATURE, V405, P694, DOI 10.1038/35015091; Valeva A, 2005, J BIOL CHEM, V280, P36657, DOI 10.1074/jbc.M507690200; van der Goot FG, 2004, J BIOL CHEM, V279, P47792, DOI 10.1074/jbc.M406824200; Weerth SH, 2007, CELL CALCIUM, V41, P155, DOI 10.1016/j.ceca.2006.06.006; Welch RA, 2001, CURR TOP MICROBIOL, V257, P85; YAO Y, 1995, J PHYSIOL-LONDON, V482, P533, DOI 10.1113/jphysiol.1995.sp020538	54	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 1	2010	285	1					357	364		10.1074/jbc.M109.003491	http://dx.doi.org/10.1074/jbc.M109.003491			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	536UT	19875442	Green Published, hybrid			2022-12-25	WOS:000273070100037
J	Bienert, R; Rombach-Riegraf, V; Diez, M; Graber, P				Bienert, Roland; Rombach-Riegraf, Verena; Diez, Manuel; Graeber, Peter			Subunit Movements in Single Membrane-bound H+-ATP Synthases from Chloroplasts during ATP Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; NUCLEOTIDE-BINDING-SITES; COUPLING FACTOR-I; GAMMA-SUBUNIT; COVALENT MODIFICATION; ESCHERICHIA-COLI; F-ATPASE; CONFORMATIONAL-CHANGES; MOLECULE FLUORESCENCE; CATALYTIC SITES	Subunit movements within the H+-ATP synthase from chloroplasts (CF0F1) are investigated during ATP synthesis. The gamma-subunit (gamma Cys-322) is covalently labeled with a fluorescence donor (ATTO532). A fluorescence acceptor (adenosine 5'-(beta,gamma-imino) triphosphate (AMPPNP)-ATTO665) is noncovalently bound to a noncatalytic site at one alpha-subunit. The labeled CF0F1 is integrated into liposomes, and a transmembrane pH difference is generated by an acid base transition. Single-pair fluorescence resonance energy transfer is measured in freely diffusing proteoliposomes with a confocal two-channel microscope. The fluorescence time traces reveal a repetitive three-step rotation of the gamma-subunit relative to the alpha-subunit during ATP synthesis. Some traces show splitting into sublevels with fluctuations between the sublevels. During catalysis the central stalk interacts, with equal probability, with each alpha beta-pair. Without catalysis the central stalk interacts with only one specific alpha beta-pair, and no stepping between FRET levels is observed. Two inactive states of the enzyme are identified: one in the presence of AMPPNP and one in the presence of ADP.	[Graeber, Peter] Univ Freiburg, Inst Phys Chem, Dept Phys Chem, D-79104 Freiburg, Germany	University of Freiburg	Graber, P (corresponding author), Univ Freiburg, Inst Phys Chem, Dept Phys Chem, Albertstr 23A, D-79104 Freiburg, Germany.	peter.graeber@physchem.uni-freiburg.de						ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Bald D, 2001, J BIOL CHEM, V276, P39505, DOI 10.1074/jbc.C100436200; Borsch M, 1998, FEBS LETT, V437, P251, DOI 10.1016/S0014-5793(98)01247-2; Borsch M, 2002, FEBS LETT, V527, P147, DOI 10.1016/S0014-5793(02)03198-8; Bottcher B, 2000, J MOL BIOL, V296, P449, DOI 10.1006/jmbi.1999.3435; BOTTCHER B, 2008, PHOTOSYNTHETIC PROTE, P201; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; BRUIST MF, 1981, BIOCHEMISTRY-US, V20, P6298, DOI 10.1021/bi00525a003; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; Fischer S, 2000, J BIOL CHEM, V275, P30157, DOI 10.1074/jbc.275.39.30157; Fischer S, 1999, FEBS LETT, V457, P327, DOI 10.1016/S0014-5793(99)01060-1; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRABER P, 1977, BIOCHIM BIOPHYS ACTA, V461, P426, DOI 10.1016/0005-2728(77)90231-6; Gumbiowski K, 2001, J BIOL CHEM, V276, P42287, DOI 10.1074/jbc.M106884200; Hisabori T, 1999, FEBS LETT, V463, P35, DOI 10.1016/S0014-5793(99)01602-6; JUNESCH U, 1987, BIOCHIM BIOPHYS ACTA, V893, P275, DOI 10.1016/0005-2728(87)90049-1; MAGDE D, 1979, J PHYS CHEM-US, V83, P696, DOI 10.1021/j100469a012; McCarty RE, 2000, ANNU REV PLANT PHYS, V51, P83, DOI 10.1146/annurev.arplant.51.1.83; Mellwig C, 2003, J BIOL CHEM, V278, P18544, DOI 10.1074/jbc.M212852200; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; NALIN CM, 1984, J BIOL CHEM, V259, P7275; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8; Possmayer FE, 2000, BBA-BIOENERGETICS, V1459, P202, DOI 10.1016/S0005-2728(00)00148-1; Possmayer FE, 2000, BBA-BIOENERGETICS, V1456, P77, DOI 10.1016/S0005-2728(99)00106-1; Possmayer FE, 2001, BBA-BIOMEMBRANES, V1510, P378, DOI 10.1016/S0005-2736(00)00371-0; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sabbert D, 1996, NATURE, V381, P623, DOI 10.1038/381623a0; Sambongi Y, 1999, SCIENCE, V286, P1722, DOI 10.1126/science.286.5445.1722; SHAPIRO AB, 1991, J BIOL CHEM, V266, P17276; SNYDER B, 1984, BIOCHEMISTRY-US, V23, P5787, DOI 10.1021/bi00319a018; Sokolov M, 1999, J BIOL CHEM, V274, P13824, DOI 10.1074/jbc.274.20.13824; Turina P, 2003, EMBO J, V22, P418, DOI 10.1093/emboj/cdg073; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Zimmermann B, 2005, EMBO J, V24, P2053, DOI 10.1038/sj.emboj.7600682; Zimmermann B, 2006, BBA-BIOENERGETICS, V1757, P311, DOI 10.1016/j.bbabio.2006.03.020	38	6	6	3	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 25	2009	284	52					36240	36247		10.1074/jbc.M109.060376	http://dx.doi.org/10.1074/jbc.M109.060376			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	535LT	19864418	Green Published, hybrid			2022-12-25	WOS:000272970500026
J	Borner, C; Smida, M; Hollt, V; Schraven, B; Kraus, J				Boerner, Christine; Smida, Michal; Hoellt, Volker; Schraven, Burkhart; Kraus, Juergen			Cannabinoid Receptor Type 1-and 2-mediated Increase in Cyclic AMP Inhibits T Cell Receptor-triggered Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MU-OPIOID RECEPTOR; PROTEIN-KINASE-A; TRANSMEMBRANE ADAPTER; IMMUNE FUNCTION; RAT-BRAIN; ENDOCANNABINOID SYSTEM; ENRICHED MICRODOMAINS; NEGATIVE REGULATION; MOUSE SPLENOCYTES; ADENYLYL-CYCLASE	The aim of this study was to characterize inhibitory mechanisms on T cell receptor signaling mediated by the cannabinoid receptors CB1 and CB2. Both receptors are coupled to G(i/o) proteins, which are associated with inhibition of cyclic AMP formation. In human primary and Jurkat T lymphocytes, activation of CB1 by R(+)-methanandamide, CB2 by JWH015, and both by Delta 9-tetrahydrocannabinol induced a short decrease in cyclic AMP lasting less than 1 h. However, this decrease was followed by a massive (up to 10-fold) and sustained (at least up to 48 h) increase in cyclic AMP. Mediated by the cyclic AMP-activated protein kinase A and C-terminal Src kinase, the cannabinoids induced a stable phosphorylation of the inhibitory Tyr-505 of the leukocyte-specific protein tyrosine kinase (Lck). By thus arresting Lck in its inhibited form, the cannabinoids prevented the dephosphorylation of Lck at Tyr-505 in response to T cell receptor activation, which is necessary for the subsequent initiation of T cell receptor signaling. In this way the cannabinoids inhibited the T cell receptor-triggered signaling, i.e. the activation of the zeta-chain-associated protein kinase of 70 kDa, the linker for activation of T cells, MAPK, the induction of interleukin-2, and T cell proliferation. All of the effects of the cannabinoids were blocked by the CB1 and CB2 antagonists AM281 and AM630. These findings help to better understand the immunosuppressive effects of cannabinoids and explain the beneficial effects of these drugs in the treatment of T cell-mediated autoimmune disorders like multiple sclerosis.	[Kraus, Juergen] Univ Magdeburg, Dept Pharmacol & Toxicol, D-39120 Magdeburg, Germany; [Smida, Michal; Schraven, Burkhart] Univ Magdeburg, Dept Mol & Clin Immunol, D-39120 Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University	Kraus, J (corresponding author), Univ Magdeburg, Dept Pharmacol & Toxicol, 44 Leipzigerstr, D-39120 Magdeburg, Germany.	juergen.kraus@med.ovgu.de	Smida, Michal/J-5046-2014	Smida, Michal/0000-0002-7335-3435	government of the state of Sachsen-Anhalt; University of Magdeburg, Faculty of Medicine (Initialprojekt); Deutsche Forschungsgemeinschaft [KR 1740/10-1]	government of the state of Sachsen-Anhalt; University of Magdeburg, Faculty of Medicine (Initialprojekt); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by research grants from the government of the state of Sachsen-Anhalt (to V. H. and B. S.), a grant from the University of Magdeburg, Faculty of Medicine (Initialprojekt) (to C. B.), and Deutsche Forschungsgemeinschaft Grant KR 1740/10-1 (to J. K.).	Ammer H, 1997, J PHARMACOL EXP THER, V280, P512; Ashton JC, 2006, NEUROSCI LETT, V396, P113, DOI 10.1016/j.neulet.2005.11.038; Bayewitch M, 1996, J BIOL CHEM, V271, P9902, DOI 10.1074/jbc.271.17.9902; Bayewitch ML, 1998, J BIOL CHEM, V273, P2273, DOI 10.1074/jbc.273.4.2273; Borner C, 2008, NEUROIMMUNOMODULAT, V14, P281, DOI 10.1159/000117809; Borner C, 2008, MOL PHARMACOL, V73, P1013, DOI 10.1124/mol.107.042945; Borner C, 2007, J LEUKOCYTE BIOL, V81, P336, DOI 10.1189/jlb.0306224; Borner C, 2007, J NEUROIMMUNOL, V188, P56, DOI 10.1016/j.jneuroim.2007.05.007; Borner C, 2006, MOL PHARMACOL, V69, P1486, DOI 10.1124/mol.105.018325; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brown AJ, 2007, BRIT J PHARMACOL, V152, P567, DOI 10.1038/sj.bjp.0707481; Buckley NE, 2008, BRIT J PHARMACOL, V153, P309, DOI 10.1038/sj.bjp.0707527; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Centonze D, 2008, CURR PHARM DESIGN, V14, P2370, DOI 10.2174/138161208785740018; Centonze D, 2007, BRAIN, V130, P2543, DOI 10.1093/brain/awm160; Curfs JHAJ, 1997, CLIN MICROBIOL REV, V10, P742, DOI 10.1128/CMR.10.4.742; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Daigle TL, 2008, NEUROPHARMACOLOGY, V54, P36, DOI 10.1016/j.neuropharm.2007.06.005; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Garzon J, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-11; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; Horejsi V, 2004, NAT REV IMMUNOL, V4, P603, DOI 10.1038/nri1414; HORTON JK, 1992, J IMMUNOL METHODS, V155, P31, DOI 10.1016/0022-1759(92)90268-X; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Ihenetu K, 2003, EUR J PHARMACOL, V464, P207, DOI 10.1016/S0014-2999(03)01379-7; Kaplan BLF, 2005, TOXICOL APPL PHARM, V205, P107, DOI 10.1016/j.taap.2004.09.013; Kaplan BLF, 2003, INT IMMUNOPHARMACOL, V3, P1503, DOI 10.1016/S1567-5769(03)00163-2; Kenakin T, 2001, FASEB J, V15, P598, DOI 10.1096/fj.00-0438rev; Klein TW, 1998, J NEUROIMMUNOL, V83, P102, DOI 10.1016/S0165-5728(97)00226-9; Klein TW, 2004, J NEUROIMMUNOL, V147, P91, DOI 10.1016/j.jneuroim.2003.10.019; KLEIN TW, 1995, P SOC EXP BIOL MED, V209, P205; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; LEE M, 1995, J PHARMACOL EXP THER, V275, P529; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; Mackie K, 2005, LIFE SCI, V77, P1667, DOI 10.1016/j.lfs.2005.05.011; Martini L, 2007, FASEB J, V21, P802, DOI 10.1096/fj.06-7132com; Massi P, 1998, J NEUROIMMUNOL, V92, P60, DOI 10.1016/S0165-5728(98)00177-5; Mustelin T, 2003, BIOCHEM J, V371, P15, DOI 10.1042/BJ20021637; OKADA M, 1991, J BIOL CHEM, V266, P24249; Ouyang YL, 1998, MOL PHARMACOL, V53, P676, DOI 10.1124/mol.53.4.676; Paquette JJ, 2007, BEHAV PHARMACOL, V18, P767, DOI 10.1097/FBP.0b013e3282f15890; Pertwee RG, 2005, LIFE SCI, V76, P1307, DOI 10.1016/j.lfs.2004.10.025; Porcella A, 1998, EUR J NEUROSCI, V10, P1743, DOI 10.1046/j.1460-9568.1998.00175.x; PRATHER PL, 2004, SCI STKE, pPE1; Rhee MH, 2000, MOL PHARMACOL, V57, P746, DOI 10.1124/mol.57.4.746; Rockwell CE, 2006, MOL PHARMACOL, V70, P101, DOI 10.1124/mol.105.019117; Ross RA, 1999, BRIT J PHARMACOL, V126, P665, DOI 10.1038/sj.bjp.0702351; Roth MD, 2002, CHEM PHYS LIPIDS, V121, P229, DOI 10.1016/S0009-3084(02)00159-7; Rubino T, 2000, NEUROPHARMACOLOGY, V39, P1331, DOI 10.1016/S0028-3908(99)00196-3; Smida M, 2007, BLOOD, V110, P596, DOI 10.1182/blood-2006-07-038752; Straiker A, 2005, J PHYSIOL-LONDON, V569, P501, DOI 10.1113/jphysiol.2005.091918; Torgersen KM, 2001, J BIOL CHEM, V276, P29313, DOI 10.1074/jbc.C100014200; Vang T, 2003, J BIOL CHEM, V278, P17597, DOI 10.1074/jbc.C300077200; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Yea SS, 2000, J PHARMACOL EXP THER, V292, P597; Yuan M, 2002, J NEUROIMMUNOL, V133, P124, DOI 10.1016/S0165-5728(02)00370-3	58	77	78	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 18	2009	284	51					35450	35460		10.1074/jbc.M109.006338	http://dx.doi.org/10.1074/jbc.M109.006338			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	531EI	19858202	Green Published, hybrid			2022-12-25	WOS:000272645600021
J	Becker, CE; Creagh, EM; O'Neill, LAJ				Becker, Christine E.; Creagh, Emma M.; O'Neill, Luke A. J.			Rab39a Binds Caspase-1 and Is Required for Caspase-1-dependent Interleukin-1 beta Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IL-1-BETA SECRETION; INFLAMMASOME; ACTIVATION; MACROPHAGES; IDENTIFICATION; RELEASE; GENE	Interleukin-1 beta (IL-1 beta) is an important pro-inflammatory cytokine that is secreted by unconventional means in a caspase-1-dependent manner. Using a one-step immunoprecipitation approach to isolate endogenous caspase-1 from the monocytic THP1 cell line, we identified previously undescribed binding partners using mass spectrometry. One of the proteins identified was Rab39a, a member of the Rab GTPase family, agroup of proteins that have important roles in protein trafficking and secretion. We confirmed by co-immunoprecipitation that Rab39a binds caspase-1. Knock down of Rab39a with small interfering RNA resulted in diminished levels of secreted IL-1 beta but had no effect on induction of pro-IL-1 beta mRNA by lipopolysaccharide. Rab39a contains a highly conserved caspase-1 cleavage site and was cleaved in the presence of recombinant caspase-1 or lipopolysaccharide. Finally, overexpression of Rab39a results in an increase in IL-1 beta secretion, and furthermore, overexpression of a Rab39a construct lacking the caspase-1 cleavage site leads to an additional increase in IL-1 beta secretion. Altogether, our findings show that Rab39a interacts with caspase-1 and suggest that Rab39a functions as a trafficking adaptor linking caspase-1 to IL-1 beta secretion.	[Becker, Christine E.; Creagh, Emma M.; O'Neill, Luke A. J.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie	Creagh, Emma/AAX-1064-2021	Creagh, Emma/0000-0001-7631-4370; O'Neill, Luke/0000-0002-4333-2748	Health Research Board Science Foundation Ireland; Wellcome Trust	Health Research Board Science Foundation Ireland(Science Foundation Ireland); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by grants from the Health Research Board Science Foundation Ireland and the Wellcome Trust.	Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Cheng H, 2002, CYTOGENET GENOME RES, V97, P72, DOI 10.1159/000064047; Creagh EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005055; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Eder C, 2009, IMMUNOBIOLOGY, V214, P543, DOI 10.1016/j.imbio.2008.11.007; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Stankovic T, 1997, GENOMICS, V40, P267, DOI 10.1006/geno.1996.4595; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Yao M, 2009, J IMMUNOL, V183, P1751, DOI 10.4049/jimmunol.0900249; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	21	42	45	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34531	34537		10.1074/jbc.M109.046102	http://dx.doi.org/10.1074/jbc.M109.046102			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19833722	hybrid, Green Published			2022-12-25	WOS:000272439600007
J	Kofuku, Y; Yoshiura, C; Ueda, T; Terasawa, H; Hirai, T; Tominaga, S; Hirose, M; Maeda, Y; Takahashi, H; Terashima, Y; Matsushima, K; Shimada, I				Kofuku, Yutaka; Yoshiura, Chie; Ueda, Takumi; Terasawa, Hiroaki; Hirai, Takahiro; Tominaga, Sae; Hirose, Masako; Maeda, Yoshitake; Takahashi, Hideo; Terashima, Yuya; Matsushima, Kouji; Shimada, Ichio			Structural Basis of the Interaction between Chemokine Stromal Cell-derived Factor-1/CXCL12 and Its G-protein-coupled Receptor CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-SATURATION EXPERIMENTS; MONOMER-DIMER EQUILIBRIUM; CRYSTAL-STRUCTURE; HIV-1 ENTRY; FACTOR-I; FUNCTIONAL-CHARACTERIZATION; LIGAND; CORECEPTOR; FACTOR-1-ALPHA; DIMERIZATION	The chemokine stromal cell-derived factor-1 (SDF-1/CXCL12) and its G-protein-coupled receptor (GPCR) CXCR4 play fundamental roles in many physiological processes, and CXCR4 is a drug target for various diseases such as cancer metastasis and human immunodeficiency virus, type 1, infection. However, almost no structural information about the SDF1-CXCR4 interaction is available, mainly because of the difficulties in expression, purification, and crystallization of CXCR4. In this study, an extensive investigation of the preparation of CXCR4 and optimization of the experimental conditions enables NMR analyses of the interaction between the full-length CXCR4 and SDF-1. We demonstrated that the binding of an extended surface on the SDF-1 beta-sheet, 50-s loop, and N-loop to the CXCR4 extracellular region and that of the SDF-1 N terminus to the CXCR4 transmembrane region, which is critical for G-protein signaling, take place independently by methyl-utilizing transferred cross-saturation experiments along with the usage of the CXCR4-selective antagonist AMD3100. Furthermore, based upon the data, we conclude that the highly dynamic SDF-1 N terminus in the 1st step bound state plays a crucial role in efficiently searching the deeply buried binding pocket in the CXCR4 transmembrane region by the "fly-casting" mechanism. This is the first structural analyses of the interaction between a full-length GPCR and its chemokine, and our methodology would be applicable to other GPCR-ligand systems, for which the structural studies are still challenging.	[Kofuku, Yutaka; Yoshiura, Chie; Ueda, Takumi; Terasawa, Hiroaki; Hirai, Takahiro; Tominaga, Sae; Shimada, Ichio] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; [Terashima, Yuya; Matsushima, Kouji] Univ Tokyo, Grad Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; [Hirose, Masako; Maeda, Yoshitake] Kyowa Hakko Kirin Co Ltd, Gunma 3701295, Japan; [Hirose, Masako; Takahashi, Hideo; Shimada, Ichio] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Terashima, Yuya] ECI Inc, Meguro Ku, Tokyo 1530042, Japan	University of Tokyo; University of Tokyo; Kyowa Kirin Ltd; National Institute of Advanced Industrial Science & Technology (AIST)	Shimada, I (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	shimada@iw-nmr.f.u-tokyo.ac.jp		Terashima, Yuya/0000-0003-3127-367X	Japan New Energy and Industrial Technology Development Organization	Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported by a grant from the Japan New Energy and Industrial Technology Development Organization.	Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Baryshnikova OK, 2006, PROTEIN SCI, V15, P2568, DOI 10.1110/ps.062255806; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bouvier M, 2007, NAT METHODS, V4, P3, DOI 10.1038/nmeth0107-3; Brelot A, 2000, J BIOL CHEM, V275, P23736, DOI 10.1074/jbc.M000776200; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; Dealwis C, 1998, P NATL ACAD SCI USA, V95, P6941, DOI 10.1073/pnas.95.12.6941; Doranz BJ, 1999, J VIROL, V73, P2752, DOI 10.1128/JVI.73.4.2752-2761.1999; Dukkipati A, 2006, PROTEIN EXPRES PURIF, V50, P203, DOI 10.1016/j.pep.2006.07.016; Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Goddard T. D., 2006, SPARKY 3; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Holmes WD, 2001, PROTEIN EXPRES PURIF, V21, P367, DOI 10.1006/prep.2001.1402; Inooka H, 2001, NAT STRUCT BIOL, V8, P161, DOI 10.1038/84159; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200; Johnson Z, 2005, CYTOKINE GROWTH F R, V16, P625, DOI 10.1016/j.cytogfr.2005.04.006; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Koenig BW, 2002, J MOL BIOL, V322, P441, DOI 10.1016/S0022-2836(02)00745-3; Kupce E, 1995, J MAGN RESON SER B, V109, P329, DOI 10.1006/jmrb.1995.9985; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murphy JW, 2007, J BIOL CHEM, V282, P10018, DOI 10.1074/jbc.M608796200; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nagasawa T, 1999, Adv Immunol, V71, P211; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nakanishi T, 2002, J MOL BIOL, V318, P245, DOI 10.1016/S0022-2836(02)00018-9; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Ohnishi Y, 2000, J INTERF CYTOK RES, V20, P691, DOI 10.1089/10799900050116390; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Princen K, 2005, CYTOKINE GROWTH F R, V16, P659, DOI 10.1016/j.cytogfr.2005.05.009; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Schlyer S, 2006, DRUG DISCOV TODAY, V11, P481, DOI 10.1016/j.drudis.2006.04.008; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; SENN H, 1989, FEBS LETT, V249, P113, DOI 10.1016/0014-5793(89)80027-4; Shimada I, 2005, METHOD ENZYMOL, V394, P483, DOI 10.1016/S0076-6879(05)94020-2; Shimada I, 2009, PROG NUCL MAG RES SP, V54, P123, DOI 10.1016/j.pnmrs.2008.07.001; Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Takahashi H, 2006, J BIOMOL NMR, V34, P167, DOI 10.1007/s10858-006-0008-8; Takahashi H, 2000, NAT STRUCT BIOL, V7, P220; TASHIRO K, 1993, SCIENCE, V261, P600, DOI 10.1126/science.8342023; Tugarinov V, 2004, J BIOMOL NMR, V28, P165, DOI 10.1023/B:JNMR.0000013824.93994.1f; Veldkamp CT, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160755; Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052; Veldkamp CT, 2009, PROTEIN SCI, V18, P1359, DOI 10.1002/pro.167; Veldkamp CT, 2005, PROTEIN SCI, V14, P1071, DOI 10.1110/ps.041219505; Wang JH, 2008, DRUG DISCOV TODAY, V13, P625, DOI 10.1016/j.drudis.2008.04.004; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Weis WI, 2008, CURR OPIN STRUC BIOL, V18, P734, DOI 10.1016/j.sbi.2008.09.010; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Zhou NM, 2001, J BIOL CHEM, V276, P42826, DOI 10.1074/jbc.M106582200; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	69	118	124	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					35240	35250		10.1074/jbc.M109.024851	http://dx.doi.org/10.1074/jbc.M109.024851			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19837984	Green Published, hybrid			2022-12-25	WOS:000272439600076
J	Silva, FD; Rezende, CA; Rossi, DCP; Esteves, E; Dyszy, FH; Schreier, S; Gueiros-Filho, F; Campos, CB; Pires, JR; Daffre, S				Silva, Fernanda D.; Rezende, Carlos A.; Rossi, Diego C. P.; Esteves, Eliane; Dyszy, Fabio H.; Schreier, Shirley; Gueiros-Filho, Frederico; Campos, Claudia B.; Pires, Jose R.; Daffre, Sirlei			Structure and Mode of Action of Microplusin, a Copper II-chelating Antimicrobial Peptide from the Cattle Tick Rhipicephalus (Boophilus) microplus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PASTEURELLA-HAEMOLYTICA; PSEUDOMONAS-AERUGINOSA; BINDING PROPERTIES; BACILLUS-SUBTILIS; HUMAN LACTOFERRIN; PROTEIN; HEPCIDIN; GOMESIN; MICROORGANISMS; IDENTIFICATION	Microplusin, a Rhipicephalus (Boophilus) microplus antimicrobial peptide (AMP) is the first fully characterized member of a new family of cysteine-rich AMPs with histidine-rich regions at the N and C termini. In the tick, microplusin belongs to the arsenal of innate defense molecules active against bacteria and fungi. Here we describe the NMR solution structure of microplusin and demonstrate that the protein binds copper II and iron II. Structured as a single alpha-helical globular domain, microplusin consists of five alpha-helices: alpha 1 (residues Gly-9 to Arg-21), alpha 2 (residues Glu-27 to Asn-40), alpha 3 (residues Arg-44 to Thr-54), alpha 4 (residues Leu-57 to Tyr-64), and alpha 5 (residues Asn-67 to Cys-80). The N and C termini are disordered. This structure is unlike any other AMP structures described to date. We also used NMR spectroscopy to map the copper binding region on microplusin. Finally, using the Gram-positive bacteria Micrococcus luteus as a model, we studied of mode of action of microplusin. Microplusin has a bacteriostatic effect and does not permeabilize the bacterial membrane. Because microplusin binds metals, we tested whether this was related to its antimicrobial activity. We found that the bacteriostatic effect of microplusin was fully reversed by supplementation of culture media with copper II but not iron II. We also demonstrated that microplusin affects M. luteus respiration, a copper-dependent process. Thus, we conclude that the antibacterial effect of microplusin is due to its ability to bind and sequester copper II.	[Silva, Fernanda D.; Rossi, Diego C. P.; Esteves, Eliane; Daffre, Sirlei] Univ Sao Paulo, Inst Ciencias Biomed, Dept Parasitol, BR-05508900 Sao Paulo, Brazil; [Rezende, Carlos A.; Pires, Jose R.] Univ Fed Rio de Janeiro, Ctr Ciencias Saude, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil; [Dyszy, Fabio H.; Schreier, Shirley; Gueiros-Filho, Frederico] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508000 Sao Paulo, Brazil; [Campos, Claudia B.] Univ Vale Paraiba, Inst Pesquisa & Desenvolvimento, BR-12244000 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade do Vale do Paraiba	Daffre, S (corresponding author), Ave Prof Lineu Prestes 1374, BR-05508900 Sao Paulo, Brazil.	sidaffre@icb.usp.br	Schreier, Shirley/F-7001-2014; Esteves, Eliane/H-9508-2013; Gueiros-Filho, Frederico J./D-2160-2013; Daffre, Sirlei/M-4233-2013; Silva, Fernanda D./F-2723-2012; Pires, Jose/C-2226-2013; Campos, Claudia B.L./I-4802-2018; Dyszy, Fábio/F-6782-2012; Esteves, Eliane/H-1037-2015; Rossi, Diego/J-1456-2018	Gueiros-Filho, Frederico J./0000-0001-5425-2439; Daffre, Sirlei/0000-0002-9966-0433; Silva, Fernanda D./0000-0002-3508-6241; Esteves, Eliane/0000-0002-4347-798X; Rossi, Diego/0000-0003-1385-1501; Pires, Jose Ricardo/0000-0001-6610-8530	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil, the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil.	Aguila A, 2001, FEMS IMMUNOL MED MIC, V31, P145, DOI 10.1111/j.1574-695X.2001.tb00511.x; Arnesano F, 2005, Q REV BIOPHYS, V38, P167, DOI 10.1017/S0033583506004161; ARNOLD RR, 1982, INFECT IMMUN, V35, P792, DOI 10.1128/IAI.35.3.792-799.1982; Azarkina N, 1999, J BIOL CHEM, V274, P32810, DOI 10.1074/jbc.274.46.32810; Benoff B, 2002, SCIENCE, V297, P1562, DOI 10.1126/science.1076376; Brewer D, 2000, RAPID COMMUN MASS SP, V14, P1736, DOI 10.1002/1097-0231(20001015)14:19<1736::AID-RCM86>3.0.CO;2-2; Brogden KA, 1996, P NATL ACAD SCI USA, V93, P412, DOI 10.1073/pnas.93.1.412; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Cavanagh J., 1996, PROTEIN NMR SPECTROS; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; Comolli JC, 2004, MOL MICROBIOL, V51, P1193, DOI 10.1046/j.1365-2958.2003.03904.x; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Das SK, 2006, NAT CLIN PRACT NEURO, V2, P482, DOI 10.1038/ncpneuro0291; DEGIER JWL, 1994, MOL MICROBIOL, V13, P183, DOI 10.1111/j.1365-2958.1994.tb00414.x; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Dur n RV, 2004, J BIOL CHEM, V279, P7229, DOI 10.1074/jbc.M311565200; Esteves E, 2009, DEV COMP IMMUNOL, V33, P913, DOI 10.1016/j.dci.2009.02.009; Esteves E, 2008, INSECT BIOCHEM MOLEC, V38, P568, DOI 10.1016/j.ibmb.2008.01.006; Falzacappa MVV, 2005, GENE, V364, P37, DOI 10.1016/j.gene.2005.07.020; Farnaud S, 2008, BIOCHEM J, V413, P553, DOI 10.1042/BJ20080406; Fazio MA, 2006, BIOPOLYMERS, V84, P205, DOI 10.1002/bip.20396; Fazio MA, 2007, BIOPOLYMERS, V88, P386, DOI 10.1002/bip.20660; Fogaca AC, 2006, PEPTIDES, V27, P667, DOI 10.1016/j.peptides.2005.07.013; Fogaca AC, 1999, J BIOL CHEM, V274, P25330, DOI 10.1074/jbc.274.36.25330; Fogaca AC, 2004, DEV COMP IMMUNOL, V28, P191, DOI 10.1016/j.dci.2003.08.001; Frangipani E, 2008, J BACTERIOL, V190, P6706, DOI 10.1128/JB.00450-08; Ganz T, 2006, CURR TOP MICROBIOL, V306, P183; Ganz T, 2005, COMB CHEM HIGH T SCR, V8, P209, DOI 10.2174/1386207053764594; Goumon Y, 1996, EUR J BIOCHEM, V235, P516, DOI 10.1111/j.1432-1033.1996.t01-1-00516.x; Grogan J, 2001, FEBS LETT, V491, P76, DOI 10.1016/S0014-5793(01)02157-3; Gusman H, 2001, BBA-PROTEIN STRUCT M, V1545, P86, DOI 10.1016/S0167-4838(00)00265-X; Harwood C., 1990, MOL BIOL METHODS BAC, P1; Heidari M, 2002, INT J ANTIMICROB AG, V20, P69, DOI 10.1016/S0924-8579(02)00048-1; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Horn D, 2008, IUBMB LIFE, V60, P421, DOI 10.1002/iub.50; Hsu CH, 2005, NUCLEIC ACIDS RES, V33, P4053, DOI 10.1093/nar/gki725; Kavanagh K, 2004, J PHARM PHARMACOL, V56, P285, DOI 10.1211/0022357022971; Kay LE, 1995, PROG BIOPHYS MOL BIO, V63, P277, DOI 10.1016/0079-6107(95)00007-0; Kragol G, 2001, BIOCHEMISTRY-US, V40, P3016, DOI 10.1021/bi002656a; Lai R, 2004, FASEB J, V18, P1447, DOI 10.1096/fj.03-1154fje; Lai R, 2002, BIOCHEM BIOPH RES CO, V295, P796, DOI 10.1016/S0006-291X(02)00762-3; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Lulloff SJ, 2004, J LAB CLIN MED, V144, P208, DOI 10.1016/j.lab.2004.07.007; Mans BJ, 2008, INSECT BIOCHEM MOLEC, V38, P42, DOI 10.1016/j.ibmb.2007.09.003; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Nilges M, 1998, PROG NUCL MAG RES SP, V32, P107, DOI 10.1016/S0079-6565(97)00025-3; Nishikawa M, 2004, ANTIMICROB AGENTS CH, V48, P229, DOI 10.1128/AAC.48.1.229-235.2004; Otvos L, 2005, J PEPT SCI, V11, P697, DOI 10.1002/psc.698; Park CB, 1998, BIOCHEM BIOPH RES CO, V244, P253, DOI 10.1006/bbrc.1998.8159; Rezende CA, 2009, BIOMOL NMR ASSIGN, V3, P187, DOI 10.1007/s12104-009-9171-7; RODRIGUES DG, 2005, THESIS U SAO PAULO; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Sforca ML, 2005, BIOCHEMISTRY-US, V44, P6440, DOI 10.1021/bi0475323; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Silva FR, 2008, THESIS U SAO PAULO; Silva PI, 2000, J BIOL CHEM, V275, P33464, DOI 10.1074/jbc.M001491200; Sohnle PG, 2001, J LAB CLIN MED, V137, P284, DOI 10.1067/mlc.2001.113577; Sonenshine DE., 1991, BIOL TICKS; Steffen H, 2006, ANTIMICROB AGENTS CH, V50, P2608, DOI 10.1128/AAC.00181-06; STERN AS, 1981, P NATL ACAD SCI-BIOL, V78, P1962, DOI 10.1073/pnas.78.3.1962; Stone Kathryn L., 1996, P415, DOI 10.1007/978-1-60327-259-9_71; Ulvatne H, 2004, FEMS MICROBIOL LETT, V237, P377, DOI 10.1016/j.femsle.2004.07.001; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543	69	64	65	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 11	2009	284	50					34735	34746		10.1074/jbc.M109.016410	http://dx.doi.org/10.1074/jbc.M109.016410			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	528JG	19828445	Green Published, hybrid			2022-12-25	WOS:000272439600029
J	Shahine, LK; Lamb, JD; Lathi, RB; Milki, AA; Langen, E; Westphal, LM				Shahine, Lora K.; Lamb, Julie D.; Lathi, Ruth B.; Milki, Amin A.; Langen, Elizabeth; Westphal, Lynn M.			Poor Prognosis with In Vitro Fertilization in Indian Women Compared to Caucasian Women Despite Similar Embryo Quality	PLOS ONE			English	Article							OVARY-SYNDROME PCOS; SOUTH ASIANS; ENDOMETRIOSIS; ORIGIN; IVF	Background: Disease prevalence and response to medical therapy may differ among patients of diverse ethnicities. Poor outcomes with in vitro fertilization (IVF) treatment have been previously shown in Indian women compared to Caucasian women, and some evidence suggests that poor embryo quality may be a cause for the discrepancy. In our center, only patients with the highest quality cleavage stage embryos are considered eligible for extending embryo culture to the blastocyst stage. We compared live birth rates (LBR) between Indian and Caucasian women after blastocyst transfer to investigate whether differences in IVF outcomes between these ethnicities would persist in patients who transferred similar quality embryos. Methodology/Principal Findings: In this retrospective cohort analysis, we compared IVF outcome between 145 Caucasians and 80 Indians who had a blastocyst transfer between January 1, 2005 and June 31, 2007 in our university center. Indians were younger than Caucasians by 2.7 years (34.03 vs. 36.71, P = 0.03), were more likely to have an agonist down regulation protocol (68% vs. 43%, P < 0.01), and were more likely to have polycystic ovarian syndrome (PCOS), although not significant, (24% vs. 14%, P = 0.06). Sixty eight percent of Indian patients had the highest quality embryos (4AB blastocyst or better) transferred compared to 71% of the Caucasians (P = 0.2). LBR was significantly lower in the Indians compared to the Caucasians (24% vs. 41%, P < 0.01) with an odds ratio of 0.63, (95% CI 0.46-0.86). Controlling for age, stimulation protocol and PCOS showed persistently lower LBR with an adjusted odds ratio of 0.56, (95% CI 0.40-0.79) in the multivariate analysis. Conclusions/Significance: Despite younger age and similar embryo quality, Indians had a significantly lower LBR than Caucasians. In this preliminary study, poor prognosis after IVF for Indian ethnicity persisted despite limiting analysis to patients with high quality embryos transferred. Further investigation into explanations for ethnic differences in reproduction is needed.			Shahine, LK (corresponding author), Stanford Univ, Dept Obstet & Gynecol, Div Reprod Med, Stanford, CA 94305 USA.	lora@shahine.com		Lathi, Ruth/0000-0003-2159-2714				Allahbadia Gautam N, 2008, Semin Reprod Med, V26, P22, DOI 10.1055/s-2007-992921; ARUMUGAM K, 1992, AUST NZ J OBSTET GYN, V32, P164, DOI 10.1111/j.1479-828X.1992.tb01932.x; Behr B, 2002, FERTIL STERIL, V77, P697, DOI 10.1016/S0015-0282(01)03267-8; Bhopal R, 2000, J PUBLIC HEALTH MED, V22, P375, DOI 10.1093/pubmed/22.3.375; Dam P, 2006, GYNECOL OBSTET INVES, V61, P223, DOI 10.1159/000091498; della Ragione T, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-2; Gardner D, 1999, REPROD CERTAINTY FER; Heijnen EMEW, 2006, HUM REPROD UPDATE, V12, P13, DOI 10.1093/humupd/dmi036; Jun SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002562; Kumar AV, 2004, FERTIL STERIL, V82, pS298, DOI 10.1016/j.fertnstert.2004.07.804; Lashen H, 1999, BRIT J OBSTET GYNAEC, V106, P407, DOI 10.1111/j.1471-0528.1999.tb08291.x; MAHMUD G, 1995, FERTIL STERIL, V64, P103, DOI 10.1016/S0015-0282(16)57663-8; Missmer SA, 2003, OBSTET GYN CLIN N AM, V30, P3; MIYAZAWA K, 1976, OBSTET GYNECOL, V48, P407; Palep-Singh A, 2007, EUR J OBSTET GYN R B, V134, P202, DOI 10.1016/j.ejogrb.2007.02.005; Rodin DA, 1998, CLIN ENDOCRINOL, V49, P91, DOI 10.1046/j.1365-2265.1998.00492.x; SANGIHAGHPEYKAR H, 1995, OBSTET GYNECOL, V85, P983, DOI 10.1016/0029-7844(95)00074-2; Sheth T, 1999, CAN MED ASSOC J, V161, P132; SUTHERLAND A, 1993, ARCH GYNECOL OBSTET, V234, P95; Veeck LL., 1999, ATLAS HUMAN GAMETES; Wijeyaratne CN, 2002, CLIN ENDOCRINOL, V57, P343, DOI 10.1046/j.1365-2265.2002.01603.x	21	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7599	10.1371/journal.pone.0007599	http://dx.doi.org/10.1371/journal.pone.0007599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855835	gold, Green Published, Green Submitted			2022-12-25	WOS:000271147200015
J	Bisson, IA; Safi, K; Holland, RA				Bisson, Isabelle-Anne; Safi, Kamran; Holland, Richard A.			Evidence for Repeated Independent Evolution of Migration in the Largest Family of Bats	PLOS ONE			English	Article							LONG-DISTANCE MIGRATION; AVIAN MIGRATION; CHIROPTERA; PATTERNS	Background: How migration evolved represents one of the most poignant questions in evolutionary biology. While studies on the evolution of migration in birds are well represented in the literature, migration in bats has received relatively little attention. Yet, more than 30 species of bats are known to migrate annually from breeding to non-breeding locations. Our study is the first to test hypotheses on the evolutionary history of migration in bats using a phylogenetic framework. Methods and Principal Findings: In addition to providing a review of bat migration in relation to existing hypotheses on the evolution of migration in birds, we use a previously published supertree to formulate and test hypotheses on the evolutionary history of migration in bats. Our results suggest that migration in bats has evolved independently in several lineages potentially as the need arises to track resources (food, roosting site) but not through a series of steps from short-to long-distance migrants, as has been suggested for birds. Moreover, our analyses do not indicate that migration is an ancestral state but has relatively recently evolved in bats. Our results also show that migration is significantly less likely to evolve in cave roosting bats than in tree roosting species. Conclusions and Significance: This is the first study to provide evidence that migration has evolved independently in bat lineages that are not closely related. If migration evolved as a need to track seasonal resources or seek adequate roosting sites, climate change may have a pivotal impact on bat migratory habits. Our study provides a strong framework for future research on the evolution of migration in chiropterans.			Bisson, IA (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	ibisson@princeton.edu	Safi, Kamran/B-2079-2008; Holland, Richard A/A-6107-2010	Safi, Kamran/0000-0002-8418-6759; Holland, Richard A/0000-0003-4495-8061				ADRIAENSEN F, 1990, J ANIM ECOL, V59, P1077, DOI 10.2307/5033; [Anonymous], 2020, ECONOMIST 0326; BERTHOLD P, 2001, BIRD MIGRATION GEN S, P253; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; COX GW, 1985, AM NAT, V126, P451, DOI 10.1086/284432; Cryan PM, 2004, J MAMMAL, V85, P995, DOI 10.1644/BRG-202; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; Desdevises Y, 2003, EVOLUTION, V57, P2647; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Diniz JAF, 2001, EVOLUTION, V55, P1104, DOI 10.1111/j.0014-3820.2001.tb00630.x; Fleming TH, 2003, BAT ECOLOGY, P156; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; GRZIMEK B, 1989, GRZIMEKS ENCY MAMMAL; HARMON L, 2008, GEIGER ANAL EVOLUTIO, P2; Helm B, 2006, PLOS BIOL, V4, P611, DOI 10.1371/journal.pbio.0040110; Hutterer R., 2005, BAT MIGRATIONS EUROP; Jones KE, 2005, EVOLUTION, V59, P2243, DOI 10.1111/j.0014-3820.2005.tb00932.x; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; Musser G G, 1993, MAMMAL SPECIES WORLD; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2006, ANAL PHYLOGENETICS E; Pierson E.D., 1986, THESIS U CALIF; Pulido F, 1996, P NATL ACAD SCI USA, V93, P14642, DOI 10.1073/pnas.93.25.14642; Pulido F, 2007, BIOSCIENCE, V57, P165, DOI 10.1641/B570211; R Core Team, 2022, R LANG ENV STAT COMP; Ransome R., 1990, NATURAL HIST HIBERNA; Rappole JH., 1995, ECOLOGY MIGRANT BIRD; ROER H, 1995, MYOTIS, V32, P251; Schwabl H., 1990, P144; Simmons NB, 1998, B AM MUS NAT HIST, P1; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001	35	36	37	7	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7504	10.1371/journal.pone.0007504	http://dx.doi.org/10.1371/journal.pone.0007504			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844569	Green Published, Green Submitted, gold			2022-12-25	WOS:000271013000004
J	Abrahao, JS; Guedes, MIM; Trindade, GS; Fonseca, FG; Campos, RK; Mota, BF; Lobato, ZIP; Silva-Fernandes, AT; Rodrigues, GOL; Lima, LS; Ferreira, PCP; Bonjardim, CA; Kroon, EG				Abrahao, Jonatas S.; Guedes, Maria Isabel M.; Trindade, Giliane S.; Fonseca, Flavio G.; Campos, Rafael K.; Mota, Bruno F.; Lobato, Zelia I. P.; Silva-Fernandes, Andre T.; Rodrigues, Gisele O. L.; Lima, Larissa S.; Ferreira, Paulo C. P.; Bonjardim, Claudio A.; Kroon, Erna G.			One More Piece in the VACV Ecological Puzzle: Could Peridomestic Rodents Be the Link between Wildlife and Bovine Vaccinia Outbreaks in Brazil?	PLOS ONE			English	Article							VIRUS-STRAINS; TRANSMISSION; INFECTION; SMALLPOX; HUMANS; POXVIRUS; CATTLE; MODEL; RATS; MICE	Background: Despite the fact that smallpox eradication was declared by the World Health Organization (WHO) in 1980, other poxviruses have emerged and re-emerged, with significant public health and economic impacts. Vaccinia virus (VACV), a poxvirus used during the WHO smallpox vaccination campaign, has been involved in zoonotic infections in Brazilian rural areas (Bovine Vaccinia outbreaks - BV), affecting dairy cattle and milkers. Little is known about VACV's natural hosts and its epidemiological and ecological characteristics. Although VACV was isolated and/or serologically detected in Brazilian wild animals, the link between wildlife and farms has not yet been elucidated. Methodology/Principal Findings: In this study, we describe for the first time, to our knowledge, the isolation of a VACV (Mariana virus - MARV) from a mouse during a BV outbreak. Genetic data, in association with biological assays, showed that this isolate was the same etiological agent causing exanthematic lesions observed in the cattle and human inhabitants of a particular BV-affected area. Phylogenetic analysis grouped MARV with other VACV isolated during BV outbreaks. Conclusion/Significance: These data provide new biological and epidemiological information on VACV and lead to an interesting question: could peridomestic rodents be the link between wildlife and BV outbreaks?			Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Belo Horizonte, MG, Brazil.	kroone@icb.ufmg.br	Abrahão, Jônatas/B-3895-2015; Bonjardim, Claudio A/J-2601-2014; Campos, Rafael Kroon/AAB-5135-2020; Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019	Abrahão, Jônatas/0000-0001-9420-1791; Campos, Rafael Kroon/0000-0002-4852-0449; Kroon, Erna Geessien/0000-0003-2721-3826; Lobato, Zelia/0000-0002-9399-3691; Mota, Bruno/0000-0003-0348-4875				Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012; da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223; Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603; DAMON I, 2007, FIELDS VIROLOGY, P2079; Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005; Fenner F., 1989, MONKEYPOX VIRUS ORTH, P227; Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365; GUEDES MIM, 2005, BRAZ SOC VIR C; Haenssle HA, 2006, J AM ACAD DERMATOL, V54, pS1, DOI 10.1016/j.jaad.2005.09.040; Heymann DL, 2006, CURR TOP MICROBIOL, V304, P1; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; Jezek Z, 1988, HUMAN MONKEYPOX; JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1; Kurth A, 2008, EMERG INFECT DIS, V14, P670, DOI 10.3201/eid1404.070817; Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773; Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9; Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001; LOPES ODS, 1965, AM J TROP MED HYG, V14, P156; MADUREIRA M, 2009, THESIS U FEDERAL MIN; MAIBORODA AD, 1982, ACTA VIROL, V26, P288; Ninove L, 2009, EMERG INFECT DIS, V15, P781, DOI 10.3201/eid1505.090235; OVERMAN JR, 1957, VIROLOGY, V3, P173, DOI 10.1016/0042-6822(57)90031-4; Parrino J, 2006, J ALLERGY CLIN IMMUN, V118, P1320, DOI 10.1016/j.jaci.2006.09.037; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880; ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995; Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007; SILVAFERNANDES AT, 2008, THESIS U FEDERAL NOR; SIMONETTI BR, 2007, VIRUS REV RES, V12, P1; Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259; Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043; Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0; Trindade GD, 2003, EMERG INFECT DIS, V9, P155; Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404; Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486	35	82	85	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7428	10.1371/journal.pone.0007428	http://dx.doi.org/10.1371/journal.pone.0007428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838293	Green Published, gold, Green Submitted			2022-12-25	WOS:000270880900002
J	Manthey, GM; Naik, N; Bailis, AM				Manthey, Glenn M.; Naik, Nilan; Bailis, Adam M.			Msh2 Blocks an Alternative Mechanism for Non-Homologous Tail Removal during Single-Strand Annealing in Saccharomyces cerevisiae	PLOS ONE			English	Article							MISMATCH REPAIR PROTEINS; INDUCED CHROMOSOMAL REARRANGEMENTS; BREAK-INDUCED RECOMBINATION; DIRECT-REPEAT RECOMBINATION; HOMOLOGOUS RECOMBINATION; MITOTIC RECOMBINATION; GENETIC-CONTROL; DNA-REPAIR; RECIPROCAL TRANSLOCATIONS; HETERODUPLEX REJECTION	Chromosomal translocations are frequently observed in cells exposed to agents that cause DNA double-strand breaks (DSBs), such as ionizing radiation and chemotherapeutic drugs, and are often associated with tumors in mammals. Recently, translocation formation in the budding yeast, Saccharomyces cerevisiae, has been found to occur at high frequencies following the creation of multiple DSBs adjacent to repetitive sequences on non-homologous chromosomes. The genetic control of translocation formation and the chromosome complements of the clones that contain translocations suggest that translocation formation occurs by single-strand annealing (SSA). Among the factors important for translocation formation by SSA is the central mismatch repair (MMR) and homologous recombination (HR) factor, Msh2. Here we describe the effects of several msh2 missense mutations on translocation formation that suggest that Msh2 has separable functions in stabilizing annealed single strands, and removing non-homologous sequences from their ends. Additionally, interactions between the msh2 alleles and a null allele of RAD1, which encodes a subunit of a nuclease critical for the removal of non-homologous tails suggest that Msh2 blocks an alternative mechanism for removing these sequences. These results suggest that Msh2 plays multiple roles in the formation of chromosomal translocations following acute levels of DNA damage.			Manthey, GM (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Biol, Duarte, CA 91010 USA.	abailis@coh.org		Bailis, Adam/0000-0001-5628-0468	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057484] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057484, GM057484] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Alani E, 1997, J MOL BIOL, V265, P289, DOI 10.1006/jmbi.1996.0743; Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; BARDWELL AJ, 1994, SCIENCE, V265, P2082, DOI 10.1126/science.8091230; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Evans E, 2000, MOL CELL, V5, P789, DOI 10.1016/S1097-2765(00)80319-6; Fasullo M, 2005, MUTAT RES-FUND MOL M, V578, P158, DOI 10.1016/j.mrfmmm.2005.05.003; Fasullo M, 1998, MOL CELL BIOL, V18, P1190, DOI 10.1128/MCB.18.3.1190; FASULLO M, 1994, MUTAT RES, V314, P121, DOI 10.1016/0921-8777(94)90076-0; FASULLO MT, 1988, MOL CELL BIOL, V8, P4370, DOI 10.1128/MCB.8.10.4370; FASULLO MT, 1987, P NATL ACAD SCI USA, V84, P6215, DOI 10.1073/pnas.84.17.6215; Featherstone C, 1999, MUTAT RES-DNA REPAIR, V434, P3, DOI 10.1016/S0921-8777(99)00006-3; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Flott S, 2005, BIOCHEM J, V391, P325, DOI 10.1042/BJ20050768; Flott S, 2007, MOL CELL BIOL, V27, P6433, DOI 10.1128/MCB.00135-07; Forrester HB, 2004, INT J RADIAT BIOL, V80, P757, DOI 10.1080/09553000400017952; Forrester HB, 1999, INT J RADIAT BIOL, V75, P543, DOI 10.1080/095530099140186; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; Goldfarb T, 2005, GENETICS, V169, P563, DOI 10.1534/genetics.104.035204; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; GROSOVSKY AJ, 1986, GENETICS, V113, P405; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Iadonato S P, 1996, Methods Mol Biol, V54, P75; Ivanov EL, 1996, GENETICS, V142, P693; KANO Y, 1984, CANCER RES, V44, P3706; Klymenko S V, 2005, Tsitol Genet, V39, P55; Knight W., 2006, CONFIDENCE INTERVALS; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Lambert V, 2001, INT J RADIAT BIOL, V77, P679, DOI 10.1080/09553000110042127; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Li FY, 2008, MOL CELL, V30, P325, DOI 10.1016/j.molcel.2008.02.028; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Liang F, 1996, P NATL ACAD SCI USA, V93, P8929, DOI 10.1073/pnas.93.17.8929; LIN FLM, 1990, MOL CELL BIOL, V10, P103, DOI 10.1128/MCB.10.1.103; LUKACSOVICH T, 1994, NUCLEIC ACIDS RES, V22, P5649, DOI 10.1093/nar/22.25.5649; Lyndaker AM, 2009, BIOESSAYS, V31, P315, DOI 10.1002/bies.200800195; Maines S, 1998, GENETICS, V150, P963; Maniatis T., 1989, MOL CLONING LAB MANU; Manthey GM, 2002, MOL CELL BIOL, V22, P5347, DOI 10.1128/MCB.22.15.5347-5356.2002; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Meyer DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003318; Moore JK, 1996, NATURE, V383, P644, DOI 10.1038/383644a0; Mullen JR, 2001, GENETICS, V157, P103; Muller I, 2005, INT J RADIAT ONCOL, V63, P1214, DOI 10.1016/j.ijrobp.2005.03.056; NEW L, 1993, MOL GEN GENET, V239, P97, DOI 10.1007/BF00281607; NICKOLOFF JA, 1986, P NATL ACAD SCI USA, V83, P7831, DOI 10.1073/pnas.83.20.7831; Nikiforov YE, 1999, ONCOGENE, V18, P6330, DOI 10.1038/sj.onc.1203019; OZENBERGER BA, 1991, MOL CELL BIOL, V11, P1222, DOI 10.1128/MCB.11.3.1222; Pannunzio NR, 2008, DNA REPAIR, V7, P788, DOI 10.1016/j.dnarep.2008.02.003; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paques F, 1997, MOL CELL BIOL, V17, P6765, DOI 10.1128/MCB.17.11.6765; PLESSIS A, 1992, GENETICS, V130, P451; REENAN RAG, 1992, GENETICS, V132, P963; RESNICK MA, 1976, MOL GEN GENET, V143, P119, DOI 10.1007/BF00266917; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; RONNE H, 1988, P NATL ACAD SCI USA, V85, P2696, DOI 10.1073/pnas.85.8.2696; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; RUDIN N, 1988, MOL CELL BIOL, V8, P3918, DOI 10.1128/MCB.8.9.3918; SAEKI T, 1980, MUTAT RES, V73, P251, DOI 10.1016/0027-5107(80)90192-X; Saparbaev M, 1996, GENETICS, V142, P727; SCHIESTL RH, 1990, MOL CELL BIOL, V10, P2485, DOI 10.1128/MCB.10.6.2485; SCHIESTL RH, 1988, MOL CELL BIOL, V8, P3619, DOI 10.1128/MCB.8.9.3619; Sherman F., 1986, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; Studamire B, 1999, MOL CELL BIOL, V19, P7558; Studamire B, 1998, MOL CELL BIOL, V18, P7590, DOI 10.1128/MCB.18.12.7590; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000; SUNG P, 1993, J BIOL CHEM, V268, P26391; Surtees JA, 2006, J MOL BIOL, V360, P523, DOI 10.1016/j.jmb.2006.05.032; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; THOMAS BJ, 1989, GENETICS, V123, P725; TOMKINSON AE, 1994, BIOCHEMISTRY-US, V33, P5305, DOI 10.1021/bi00183a038; TOMKINSON AE, 1993, NATURE, V362, P860, DOI 10.1038/362860a0; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028; WINEGAR RA, 1994, MUTAT RES, V307, P479, DOI 10.1016/0027-5107(94)90258-5; Yu X, 2004, GENETICS, V166, P741, DOI 10.1534/genetics.166.2.741	83	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7488	10.1371/journal.pone.0007488	http://dx.doi.org/10.1371/journal.pone.0007488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834615	Green Published, Green Submitted, gold			2022-12-25	WOS:000270880700012
J	Salimpoor, VN; Benovoy, M; Longo, G; Cooperstock, JR; Zatorre, RJ				Salimpoor, Valorie N.; Benovoy, Mitchel; Longo, Gregory; Cooperstock, Jeremy R.; Zatorre, Robert J.			The Rewarding Aspects of Music Listening Are Related to Degree of Emotional Arousal	PLOS ONE			English	Article							GALVANIC SKIN-RESPONSES; DOPAMINE RELEASE; COLLEGE-STUDENTS; CHILLS; BRAIN; CORRELATE; EXPOSURE; PLEASANT; STIMULI; BIOLOGY	Background: Listening to music is amongst the most rewarding experiences for humans. Music has no functional resemblance to other rewarding stimuli, and has no demonstrated biological value, yet individuals continue listening to music for pleasure. It has been suggested that the pleasurable aspects of music listening are related to a change in emotional arousal, although this link has not been directly investigated. In this study, using methods of high temporal sensitivity we investigated whether there is a systematic relationship between dynamic increases in pleasure states and physiological indicators of emotional arousal, including changes in heart rate, respiration, electrodermal activity, body temperature, and blood volume pulse. Methodology: Twenty-six participants listened to self-selected intensely pleasurable music and "neutral'' music that was individually selected for them based on low pleasure ratings they provided on other participants' music. The "chills'' phenomenon was used to index intensely pleasurable responses to music. During music listening, continuous real-time recordings of subjective pleasure states and simultaneous recordings of sympathetic nervous system activity, an objective measure of emotional arousal, were obtained. Principal Findings: Results revealed a strong positive correlation between ratings of pleasure and emotional arousal. Importantly, a dissociation was revealed as individuals who did not experience pleasure also showed no significant increases in emotional arousal. Conclusions/Significance: These results have broader implications by demonstrating that strongly felt emotions could be rewarding in themselves in the absence of a physically tangible reward or a specific functional goal.			Salimpoor, VN (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	valorie.salimpoor@mail.mcgill.ca	Cooperstock, Jeremy/AAU-1549-2020	Lauwereyns, Jan/0000-0003-0551-2550	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		BARTLETT DL, 1996, HDB MUSIC PSYCHOL, P343; Baumgartner T, 2006, INT J PSYCHOPHYSIOL, V60, P34, DOI 10.1016/j.ijpsycho.2005.04.007; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bradley MM., 2000, SER AFFECTIVE SCI, P242; Brown S, 2004, NEUROREPORT, V15, P2033, DOI 10.1097/00001756-200409150-00008; Camara E, 2009, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.019.2008; Carter FA, 1995, BEHAV CHANGE, V12, P159, DOI 10.1017/S0813483900006021; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio A. R., 1999, FEELING WHAT HAPPENS; Dube L, 2003, COGNITION EMOTION, V17, P263, DOI 10.1080/02699930302295; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; Etzel JA, 2006, INT J PSYCHOPHYSIOL, V61, P57, DOI 10.1016/j.ijpsycho.2005.10.025; Fitch WT, 2005, ANN NY ACAD SCI, V1060, P29, DOI 10.1196/annals.1360.004; Gabrielsson A., 2001, MUSIC EMOTION THEORY, P431; Gabrielsson A, 2001, MUSIC SCI, V5, P123, DOI 10.1177/10298649020050S105; GOLDSTEIN A, 1980, PHYSIOL PSYCHOL, V8, P126; Grewe O, 2005, ANN NY ACAD SCI, V1060, P446, DOI 10.1196/annals.1360.041; Grewe O, 2007, EMOTION, V7, P774, DOI 10.1037/1528-3542.7.4.774; Grewe O, 2009, ANN NY ACAD SCI, V1169, P351, DOI 10.1111/j.1749-6632.2009.04783.x; Guhn M, 2007, MUSIC PERCEPT, V24, P473, DOI 10.1525/MP.2007.24.5.473; Harrer G., 1977, MUSIC BRAIN STUDIES, P202; Huron D.B., 2006, SWEET ANTICIPATION M; Iwanaga M, 2005, BIOL PSYCHOL, V70, P61, DOI 10.1016/j.biopsycho.2004.11.015; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Johnsen EL, 2009, INT J PSYCHOPHYSIOL, V72, P24, DOI 10.1016/j.ijpsycho.2008.03.011; Juslin PN, 2001, MUSIC EMOTION THEORY; Khalfa S, 2005, NEUROREPORT, V16, P1981, DOI 10.1097/00001756-200512190-00002; Khalfa S, 2002, NEUROSCI LETT, V328, P145, DOI 10.1016/S0304-3940(02)00462-7; Khalfa S, 2008, INT J PSYCHOPHYSIOL, V68, P17, DOI 10.1016/j.ijpsycho.2007.12.001; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; LeDoux J. E., 1996, EMOTIONAL BRAIN; Leyton M, 2002, NEUROPSYCHOPHARMACOL, V27, P1027, DOI 10.1016/S0893-133X(02)00366-4; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Meyer L., 1956, EMOTION MEANING MUSI; Nater UM, 2006, INT J PSYCHOPHYSIOL, V62, P300, DOI 10.1016/j.ijpsycho.2006.05.011; North AC, 1997, SCAND J PSYCHOL, V38, P45, DOI 10.1111/1467-9450.00008; Nyklicek I, 1997, J PSYCHOPHYSIOL, V11, P304; Panksepp J, 2002, BEHAV PROCESS, V60, P133, DOI 10.1016/S0376-6357(02)00080-3; Panksepp J, 1995, MUSIC PERCEPT, V13, P171; PINKER S, 1997, HOW MIND WORKS; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; Rickard Nikki S, 2005, Behav Cogn Neurosci Rev, V4, P235, DOI 10.1177/1534582305285869; ROLLS ET, 1975, BRAIN REWARD; Roy M, 2009, INT J PSYCHOPHYSIOL, V71, P37, DOI 10.1016/j.ijpsycho.2008.07.010; Sammler D, 2007, PSYCHOPHYSIOLOGY, V44, P293, DOI 10.1111/j.1469-8986.2007.00497.x; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Schlaepfer TE, 1997, AM J PSYCHIAT, V154, P1209; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Sequeira H, 2009, INT J PSYCHOPHYSIOL, V71, P50, DOI 10.1016/j.ijpsycho.2008.07.009; Sloboda JA., 2001, MUSIC EMOTION THEORY; Sloboda JohnA., 1991, PSYCHOL MUSIC, V19, P110, DOI [10.1177/0305735691192002, DOI 10.1177/0305735691192002]; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Steinbeis N, 2006, J COGNITIVE NEUROSCI, V18, P1380, DOI 10.1162/jocn.2006.18.8.1380; THAUT MH, 1993, J MUSIC THER, V30, P210, DOI 10.1093/jmt/30.4.210; VANDERARK SD, 1992, PERCEPT MOTOR SKILL, V74, P1079, DOI 10.2466/PMS.74.4.1079-1090; VANDERARK SD, 1993, PERCEPT MOTOR SKILL, V77, P227, DOI 10.2466/pms.1993.77.1.227; Witvliet CVO, 2007, COGNITION EMOTION, V21, P3, DOI 10.1080/02699930601000672; ZIMNY GH, 1963, AM J PSYCHOL, V76, P311, DOI 10.2307/1419170	60	312	317	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7487	10.1371/journal.pone.0007487	http://dx.doi.org/10.1371/journal.pone.0007487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	507UN	19834599	Green Published, gold, Green Submitted			2022-12-25	WOS:000270880700011
J	Juncker, AS; Larsen, MV; Weinhold, N; Nielsen, M; Brunak, S; Lund, O				Juncker, Agnieszka S.; Larsen, Mette V.; Weinhold, Nils; Nielsen, Morten; Brunak, Soren; Lund, Ole			Systematic Characterisation of Cellular Localisation and Expression Profiles of Proteins Containing MHC Ligands	PLOS ONE			English	Article							PEPTIDE BINDING; GENE ONTOLOGY; RECOGNITION; PREDICTIONS; MOLECULES; MECHANISM; DENSITY; EPITOPE; DRIP	Background: Presentation of peptides on Major Histocompatibility Complex (MHC) molecules is the cornerstone in immune system activation and increased knowledge of the characteristics of MHC ligands and their source proteins is highly desirable. Methodology/Principal Finding: In the present large-scale study, we used a large data set of proteins containing experimentally identified MHC class I or II ligands and examined the proteins according to their expression profiles at the mRNA level and their Gene Ontology (GO) classification within the cellular component ontology. Proteins encoded by highly abundant mRNA were found to be much more likely to be the source of MHC ligands. Of the 2.5% most abundant mRNAs as much as 41% of the proteins encoded by these mRNAs contained MHC class I ligands. For proteins containing MHC class II ligands, the corresponding percentage was 11%. Furthermore, we found that most proteins containing MHC class I ligands were localised to the intracellular parts of the cell including the cytoplasm and nucleus. MHC class II ligand donors were, on the other hand, mostly membrane proteins. Conclusions/Significance: The results contribute to the ongoing debate concerning the nature of MHC ligand-containing proteins and can be used to extend the existing methods for MHC ligand predictions by including the source protein's localisation and expression profile. Improving the current methods is important in the growing quest for epitopes that can be used for vaccine or diagnostic purposes, especially when it comes to large DNA viruses and cancer.			Juncker, AS (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	metteb@cbs.dtu.dk	Lund, Ole/F-4437-2014; Nielsen, Morten/AAL-8700-2020; Nielsen, Morten/E-7754-2011; Brunak, Soren/O-6621-2016	Lund, Ole/0000-0003-1108-0491; Nielsen, Morten/0000-0001-7885-4311; Nielsen, Morten/0000-0001-7885-4311; Brunak, Soren/0000-0003-0316-5866	PHS HHS [HHSN266200400083C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Eklund AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r26; Engelhard VH, 2002, MOL IMMUNOL, V39, P127, DOI 10.1016/S0161-5890(02)00096-2; Ferris RL, 1996, J IMMUNOL, V156, P834; Fortier MH, 2008, J EXP MED, V205, P595, DOI 10.1084/jem.20071985; HAMMOND SA, 1995, J IMMUNOL, V154, P6140; Hickman HD, 2004, J IMMUNOL, V172, P2944, DOI 10.4049/jimmunol.172.5.2944; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jerzak G, 2005, J GEN VIROL, V86, P2175, DOI 10.1099/vir.0.81015-0; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Larsen Mette Voldby, 2006, Current Immunology Reviews, V2, P233; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; LODISH H, 1998, MOL CELL BIOL; Lundegaard C, 2007, BIOINFORMATICS, V23, P3265, DOI 10.1093/bioinformatics/btm471; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Milner E, 2006, MOL CELL PROTEOMICS, V5, P357, DOI 10.1074/mcp.M500241-MCP200; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; ROTZSCHKE O, 1994, CURR OPIN IMMUNOL, V6, P45, DOI 10.1016/0952-7915(94)90032-9; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SILICIANO RF, 1995, J IMMUNOL, V155, P2; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Weinzierl AO, 2007, MOL CELL PROTEOMICS, V6, P102, DOI 10.1074/mcp.M600310-MCP200; Yewdell J, 2002, MOL IMMUNOL, V39, P139, DOI 10.1016/S0161-5890(02)00097-4; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 1996, J IMMUNOL, V157, P1823	34	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7448	10.1371/journal.pone.0007448	http://dx.doi.org/10.1371/journal.pone.0007448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826487	Green Published, gold, Green Submitted			2022-12-25	WOS:000270808700010
J	Lycett, SJ				Lycett, Stephen J.			Understanding Ancient Hominin Dispersals Using Artefactual Data: A Phylogeographic Analysis of Acheulean Handaxes	PLOS ONE			English	Article							PHYLOGENETIC ANALYSES; LOS HUESOS; EVOLUTION; CHARACTERS; BEHAVIOR; CULTURE; AFRICA; DISTANCE; SUPPORT; MODEL	Background: Reconstructing the dispersal patterns of extinct hominins remains a challenging but essential goal. One means of supplementing fossil evidence is to utilize archaeological evidence in the form of stone tools. Based on broad dating patterns, it has long been thought that the appearance of Acheulean handaxe technologies outside of Africa was the result of hominin dispersals, yet independent tests of this hypothesis remain rare. Cultural transmission theory leads to a prediction of a strong African versus non-African phylogeographic pattern in handaxe datasets, if the African Acheulean hypothesis is to be supported. Methodology/Principal Findings: Here, this prediction is tested using an intercontinental dataset of Acheulean handaxes and a biological phylogenetic method ( maximum parsimony). The analyses produce a tree consistent with the phylogeographic prediction. Moreover, a bootstrap analysis provides evidence that this pattern is robust, and the maximum parsimony tree is also shown to be statistically different from a tree constrained by stone raw materials. Conclusions/Significance: These results demonstrate that nested analyses of behavioural data, utilizing methods drawn from biology, have the potential to shed light on ancient hominin dispersals. This is an encouraging prospect for human palaeobiology since sample sizes for lithic artefacts are many orders of magnitude higher than those of fossil data. These analyses also suggest that the sustained occurrence of Acheulean handaxe technologies in regions such as Europe and the Indian subcontinent resulted from dispersals by African hominin populations.			Lycett, SJ (corresponding author), Univ Kent, Dept Anthropol, Canterbury, Kent, England.	S.J.Lycett@kent.ac.uk						Anton SC, 2004, ANNU REV ANTHROPOL, V33, P271, DOI 10.1146/annurev.anthro.33.070203.144024; ASFAW B, 1992, NATURE, V360, P732, DOI 10.1038/360732a0; Bar-Yosef O, 2001, QUATERN INT, V75, P19, DOI 10.1016/S1040-6182(00)00074-4; BARYOSEF O, 1994, J WORLD PREHIST, V8, P211, DOI 10.1007/BF02221050; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Bischoff JL, 2007, J ARCHAEOL SCI, V34, P763, DOI 10.1016/j.jas.2006.08.003; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R., 2005, ORIGIN EVOLUTION CUL; Buchanan B, 2008, J ARCHAEOL SCI, V35, P1683, DOI 10.1016/j.jas.2007.11.009; Buchanan B, 2007, J ANTHROPOL ARCHAEOL, V26, P366, DOI 10.1016/j.jaa.2007.02.005; Cap H, 2008, CLADISTICS, V24, P917, DOI 10.1111/j.1096-0031.2008.00223.x; Carbonell E, 2006, CR PALEVOL, V5, P155, DOI 10.1016/j.crpv.2005.11.010; Carbonell E, 1999, J ANTHROPOL ARCHAEOL, V18, P119, DOI 10.1006/jaar.1998.0331; Cavalli-Sforza Luigi L., 1981, CULTURAL TRANSMISSIO; Chauhan PR, 2009, EVOL ANTHROPOL, V18, P62, DOI 10.1002/evan.20199; Christiansen P, 2008, CLADISTICS, V24, P977, DOI 10.1111/j.1096-0031.2008.00226.x; Clark J. D., 1994, INTEGRATIVE PATHS PA, P451; Collard M, 2006, EVOL HUM BEHAV, V27, P169, DOI 10.1016/j.evolhumbehav.2005.07.003; Dennell R, 2005, NATURE, V438, P1099, DOI 10.1038/nature04259; Dennell R, 2003, J HUM EVOL, V45, P421, DOI 10.1016/j.jhevol.2003.09.006; Dennell RW, 2009, PALAEOLITHIC SETTLEM; Dohrmann M, 2008, SYST BIOL, V57, P388, DOI 10.1080/10635150802161088; DURHAM WH, 1992, ANNU REV ANTHROPOL, V21, P331, DOI 10.1146/annurev.an.21.100192.001555; FALSETTI AB, 1993, INT J PRIMATOL, V14, P551, DOI 10.1007/BF02215447; Farris J.S., 1983, Advances in Cladistics, V2, P7; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finlayson C, 2005, TRENDS ECOL EVOL, V20, P457, DOI 10.1016/j.tree.2005.05.019; Gamble C., 1993, TIMEWALKERS PREHISTO; Gibbon RJ, 2009, J HUM EVOL, V56, P152, DOI 10.1016/j.jhevol.2008.09.006; Gibbs S, 2000, P NATL ACAD SCI USA, V97, P11130, DOI 10.1073/pnas.190252697; Goodman ME, 1944, AM ANTIQUITY, V9, P415, DOI 10.2307/275093; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Hamilton MJ, 2009, J ANTHROPOL ARCHAEOL, V28, P55, DOI 10.1016/j.jaa.2008.10.005; HAY RL, 1990, GEOLOGICAL SOC AM SP, V242, P23; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; Holmes KM, 2007, PALAEOGEOGR PALAEOCL, V248, P96, DOI 10.1016/j.palaeo.2006.11.012; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Humphries C.J., 1988, P371; Jordan P, 2003, J ANTHROPOL ARCHAEOL, V22, P42, DOI 10.1016/S0278-4165(03)00004-7; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kitching I. J., 1998, CLADISTICS THEORY PR; Klein R., 2005, HUMAN WORLD PREHISTO, P84; Klein R. G., 2009, HUMAN CAREER HUMAN B; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Leakey M.D., 1971, OLDUVAI GORGE EXCAVA, V3; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LIPO CP, 2006, CULTURAL PHYLOGENIES, P3; Lycett SJ, 2006, J ARCHAEOL SCI, V33, P847, DOI 10.1016/j.jas.2005.10.014; Lycett SJ, 2008, WORLD ARCHAEOL, V40, P295, DOI 10.1080/00438240802260970; Lycett SJ, 2007, J ANTHROPOL ARCHAEOL, V26, P541, DOI 10.1016/j.jaa.2007.07.003; Lycett SJ, 2008, J ARCHAEOL SCI, V35, P553, DOI 10.1016/j.jas.2007.05.003; Lycett SJ, 2007, P NATL ACAD SCI USA, V104, P17588, DOI 10.1073/pnas.0707930104; Lycett SJ, 2007, J ARCHAEOL SCI, V34, P1434, DOI 10.1016/j.jas.2006.11.001; Lycett SJ, 2009, J HUM EVOL, V56, P175, DOI 10.1016/j.jhevol.2008.10.001; MADDISON DR, 2001, MACCLADE 4 ANAL PHYL; Mallegni F, 2007, HUMAN EVOLUTION, V21, P261; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Mesoudi A, 2006, BEHAV BRAIN SCI, V29, P329, DOI 10.1017/S0140525X06009083; Mithen S, 2002, J HUM EVOL, V43, P433, DOI 10.1006/jhev.2002.0584; Mithen S, 1999, MAMMALIAN SOCIAL LEA, P389; Nadal-Roberts M, 2005, FOLIA PRIMATOL, V76, P207, DOI 10.1159/000086022; Nelson G., 1981, SYSTEMATICS BIOGEORA; O'Brien MJ, 2001, J ARCHAEOL SCI, V28, P1115, DOI 10.1006/jasc.2001.0681; O'Brien MJ., 2008, CULTURAL TRANSMISSIO, P39; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; O'Leary MA, 2008, CLADISTICS, V24, P397, DOI 10.1111/j.1096-0031.2007.00187.x; OBrien M.J., 2003, CLADISTICS ARCHAEOLO; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Rae Todd C., 1997, P59; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Roberts MB., 1999, BOXGROVE MIDDLE PLEI; Rogers DS, 2008, P NATL ACAD SCI USA, V105, P3416, DOI 10.1073/pnas.0711802105; Rogers DS, 2009, P ROY SOC B-BIOL SCI, V276, P3835, DOI 10.1098/rspb.2009.1088; Scott GR, 2009, NATURE, V461, P82, DOI 10.1038/nature08214; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; Shennan SJ., 1999, MAMMALIAN SOCIAL LEA, P367; Shennan Stephen, 2006, SOCIAL INFORM TRANSM, P173; SLOWINSKI JB, 1993, SYST BIOL, V42, P155, DOI 10.2307/2992538; SMITH AB, 1994, SYSTEMATICS FOSSIL R; Smith HF, 2008, J HUM EVOL, V54, P684, DOI 10.1016/j.jhevol.2007.10.012; Stout D, 2002, CURR ANTHROPOL, V43, P693, DOI 10.1086/342638; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tehrani J, 2002, J ANTHROPOL ARCHAEOL, V21, P443, DOI 10.1016/S0278-4165(02)00002-8; Tehrani JJ, 2009, EVOL HUM BEHAV, V30, P286, DOI 10.1016/j.evolhumbehav.2009.03.002; THORPE RS, 1984, EVOLUTION, V38, P244, DOI 10.1111/j.1558-5646.1984.tb00282.x; von Cramon-Taubadel N, 2008, AM J PHYS ANTHROPOL, V136, P108, DOI 10.1002/ajpa.20775; Wills MA, 2008, SYST BIOL, V57, P891, DOI 10.1080/10635150802570809; Wood B, 1997, NATURE, V385, P292, DOI 10.1038/385292a0	91	44	44	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7404	10.1371/journal.pone.0007404	http://dx.doi.org/10.1371/journal.pone.0007404			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506WT	19826473	Green Published, Green Submitted, gold			2022-12-25	WOS:000270808700004
